Citrus Sinensis ID: 003239

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------
Protein Sequence
MDEGSPSNGGQVFGASWRPKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQRWIIALVDLLCFILKNYVYG
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccEEEEccEEEccccccEEEEEEEcccccccccEEEEEcccccEEEEEEEEccHHHHHHHHHHHHHHHHHHHcccccccccEEEEcccEEEccEEEEEEccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEEEccccccEEEEcccccccEEEEEcccccccccEEEEEEEcccccccEEccccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccHHHHHHccccccccccccccccccccccccccccEEEEEHHHHHHHHHccccccccccccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHccccEEcccccccEEcccccccccccccccccccEEEEEEEEccEEEccccEEEEcEcccccEEEEEEEEccccccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccccccEEEEEEEEcccccEEEEEHHccccHHEHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccccEEccHHHcEEccEccccccccHHHccHHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHcccccccccccccccccccHHHHHHHHHHHcccHHHccccccccccccccccccHHHHHcccccccccHHHHHHcccccHHHHHHHHHHccccccccccHHHHHcccHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
mdegspsnggqvfgaswrpkgfsfgpylvqkdapslrvvvrkplVVRLTKDIVETYQIcnplfkyseelnpkryltspsvgvlndgydnvnSDLILAVNLVLVNAETQRRYIVKDLlghgtfgqVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLnkkydredkhHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLlkdagiihcdlkpenillctsvkpaeiKIIDfgsactedrtVYSYIQSryyrspevllgYQYTTAIDMWSFGCIVAELflglplfpgaseFDLLRRMIRILgaqppdyvlkeakntSKFFKCIGsvhniengevsiggrSAYQALTEIEYEARELkkpligkeyfhhkhleeivtnypyrknlsmediSKESQIRLALVDFLKGLvefdpakrwspfqasrhpfvtgepftcpyqpppetprvpvaqnfkvdhhpgaghwfaaglspnisgrskfsmhnsphfqvvpygygnsygsvgsygsyndgtglgssygsygdggntfayfspvgpsgmnlhaqsgvsvrgsspdARKMFIQYsqgnglgvspsagmfvplplgtspsqftppssygqvssgspghygptsparsschgsplgkmtAATHynrrknwgysgnpqsqespssqhwqgqfidgassgqaewnpqvlgsaslhlpsnpsatsskqqrggsgiaasysampnmpssltrgpaiaeaahdkpetslsvpdpgdwdpnysdeqllqedgsdessITTEFSKAmhlssadssvgvgrfnrtssassnipIQRWIIALVDLLCFILKNYVYG
Flexible Loop (DISEMBL)
mdegspsnggqVFGASWRPKGFSFGPYlvqkdapslrvvvrkplVVRLTKDIVETYQICNPlfkyseelnpkRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIdfgsactedRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVhniengevsigGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPsatsskqqrGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRtssassnipiqRWIIALVDLLCFILKNYVYG
Low Complexity Region (SEG)
MDEGSPSNGGQVFGASWRPKGFSFGPYLVQKDAPSlrvvvrkplvvrlTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIlavnlvlvnaETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPygygnsygsvgsygsyndgtglgssygsygdggNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQRWIIALVDLLCFILKNYVYG
Disordered region (IsUnstruct)
***********VFGASWRPKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY**********VAQNFKVDHHPGAGHWFAAGLSPNI*******MHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPV***************************************************************************************************************************************************************************************************************************************************************NIPIQRWIIALVDLLCFILKNYVY*
Disordered Region (DISOPRED)
************************************************TKDIVETYQICNPLFK**********************YDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQAL********************HHKHLE**********************IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP*******************************************************************************************************************************************************************************************************************************************************************************************************************NYSDEQL**********************************************RWIIALVDLLCFILKNYVYG
Disordered Region (DISEMBL)
**********QVFGASWRPKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQ*********PDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQF*******************************LGKMTAATHYNRRKNWGYS**************QGQFIDGASSGQAEWNPQVLGSASLHL*****************IAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLL**********TTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQRWIIALVDLLCFILKNYVYG
Disordered Region (DISPRO)
************************G*********SLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMF******NGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSP****************PLGKMT****YNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGI*A******************************SVPDPGDWDPNYSDEQLLQEDG*D**********************************NIPIQRWIIALVDLLCFILKNYVYG
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDEGSPSNGGQVFGASWRPKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQRWIIALVDLLCFILKNYVYG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	837	2.2.26 [Sep-21-2011]
Q54QV3	1458	Probable serine/threonine	yes	no	0.507	0.291	0.495	1e-121
Q9P6P3	534	Serine/threonine-protein	yes	no	0.471	0.739	0.512	1e-117
P14680	807	Dual specificity protein	yes	no	0.491	0.509	0.482	1e-114
Q8BI55	632	Dual specificity tyrosine	yes	no	0.379	0.503	0.410	3e-70
P49657	908	Serine/threonine-protein	no	no	0.450	0.415	0.367	7e-70
Q9Z188	629	Dual specificity tyrosine	no	no	0.476	0.634	0.359	3e-69
Q9Y463	629	Dual specificity tyrosine	yes	no	0.476	0.634	0.357	7e-69
Q8WQL7	882	Dual specificity tyrosine	yes	no	0.414	0.393	0.383	1e-68
Q9NR20	520	Dual specificity tyrosine	no	no	0.375	0.603	0.409	2e-68
Q9V3D5	722	Dual specificity tyrosine	no	no	0.389	0.451	0.376	1e-67

>sp|Q54QV3|YAKA_DICDI Probable serine/threonine-protein kinase yakA OS=Dictyostelium discoideum GN=yakA PE=1 SV=1

 Score =  436 bits (1122), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 212/428 (49%), Positives = 292/428 (68%), Gaps = 3/428 (0%)

Query: 45  VVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVN 104
           ++ LTK+++  Y+ CN  F Y   LNP+R LT PS  + NDGYDNVNSD I+ VN ++ N
Sbjct: 139 IIHLTKNLLHFYKKCNSNFNYISSLNPRRVLTHPSEPLSNDGYDNVNSDYIVYVNDIITN 198

Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
            E+ ++Y V D LG GTFGQV KC + + +  VA+KI+KN+ AY+QQ  +E+  L +LN 
Sbjct: 199 NESGQKYKVLDSLGQGTFGQVVKCKNCDTDELVAIKILKNKQAYFQQGRLEIQTLKSLND 258

Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
           ++D EDK+HI+R+ + F+ + HLCI FELL  NL+ELIK N+FRGLS +++++F  QIL 
Sbjct: 259 QHDPEDKNHILRLLDSFIHKMHLCIVFELLSVNLFELIKQNNFRGLSTNLIKVFLIQILD 318

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
            L +L +A IIHCDLKPENILL     PA IKIIDFGSAC E  T+Y+YIQSR+YRSPEV
Sbjct: 319 ALIVLANANIIHCDLKPENILLQNVNSPA-IKIIDFGSACYEKSTLYTYIQSRHYRSPEV 377

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
           L+G  Y  +IDMWS GCI AELFLGLPLFPG SE++ + R++ + G  P D + K   +T
Sbjct: 378 LVGTVYCASIDMWSLGCISAELFLGLPLFPGNSEYNQISRIVEMRGIFPSDLLDKGKSST 437

Query: 345 SKFFKCIG-SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLI-GKEYFHHKHLEEIV 402
             F + +G +  +  N   +  G+  Y  L   E   R+ K  L+  K+YF++K L EI+
Sbjct: 438 RYFHRHLGSNSDDNNNNNNNNNGKPYYYTLKSEEDYQRDSKTTLLPSKKYFNYKTLPEII 497

Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
            NY ++K++S +DI KE Q R+   DF+ GL++ DP +RWSP QA  HPF+TG+P+  P+
Sbjct: 498 QNYGFKKSMSPQDIEKEKQHRIVFTDFINGLLQLDPNERWSPMQAKEHPFITGQPYNGPF 557

Query: 463 QPPPETPR 470
            P P   R
Sbjct: 558 IPDPSKKR 565

General sensor of environmental conditions, such as heat stress, effecting changes through pkaC. Essential for survival to nitrosoative and oxidative stresses. Required for cell cycle control, not only at the onset but also during development (aggregation process and postaggregative development).
Dictyostelium discoideum (taxid: 44689)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1

>sp|Q9P6P3|PPK15_SCHPO Serine/threonine-protein kinase ppk15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk15 PE=1 SV=1

 Score =  422 bits (1084), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 212/414 (51%), Positives = 283/414 (68%), Gaps = 19/414 (4%)

Query: 48  LTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAET 107
           +T  + +TY ICNP F++S E NP+R LT PS GV N G+DNVN D +L VN  L+  + 
Sbjct: 68  MTVKLADTYSICNPKFQFSSEQNPRRPLTKPSEGVHNHGFDNVNHDYVLYVN-DLLGTDE 126

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
            R+Y++ D LGHGTFGQVA+C D +    VA+K+IKN+PA+Y Q ++EVSIL  LN KYD
Sbjct: 127 GRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILELLNNKYD 186

Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            EDK H++R+Y+ F+ + HLC+ FELL  NLYELIK N FRGL LS+V+ F+ Q+L   S
Sbjct: 187 PEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRGLHLSLVRSFATQLLSCTS 246

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
           LLK A IIHCDLKPENILL     P  +K+IDFGSAC E +TVY+YIQSR+YRSPEV+LG
Sbjct: 247 LLKQARIIHCDLKPENILLQDLSSPI-VKVIDFGSACHERQTVYTYIQSRFYRSPEVILG 305

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
             Y   IDMWS GCI+AELFLGLPLFPG SE++ L R++ +LG  PP ++L+  KN+ K+
Sbjct: 306 LHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLG-NPPTWMLEMGKNSKKY 364

Query: 348 FKCIGSVHNIENGEVSIGGRSAYQ--ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405
           +               + GR  Y+  ++ +   E  + ++P  GK+YF  K L+ IV NY
Sbjct: 365 Y-----------NSGFVNGRKTYELKSIEQFSIENNKTEQP--GKQYFGEKTLDAIVLNY 411

Query: 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459
           P RK  + +   +E + RL  +DF+K  +E +P KRW+P QA  HPF+TG  F+
Sbjct: 412 PRRKT-TPKLTPEEHEERLCFIDFIKQFLELNPLKRWTPDQAKNHPFITGASFS 464

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P14680|YAK1_YEAST Dual specificity protein kinase YAK1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YAK1 PE=1 SV=1

 Score =  413 bits (1061), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 204/423 (48%), Positives = 285/423 (67%), Gaps = 12/423 (2%)

Query: 45  VVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVN 104
           +V +TK ++ TY +C+P F Y    NPKR LT PS G  N+G+DN+NSD IL VN VL  
Sbjct: 304 LVSVTKSLITTYSLCSPEFTYQTSKNPKRVLTKPSEGKCNNGFDNINSDYILYVNDVL-G 362

Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
            E  R+Y+V D+LG GTFGQV KC +      +AVK++K++  Y  Q++ E  IL  LN+
Sbjct: 363 VEQNRKYLVLDILGQGTFGQVVKCQNLLTKEILAVKVVKSRTEYLTQSITEAKILELLNQ 422

Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
           K D  +KHH +R+Y+ FV + HLC+ FELL +NLYEL+K N F GLS+ +++ F+ QIL 
Sbjct: 423 KIDPTNKHHFLRMYDSFVHKNHLCLVFELLSNNLYELLKQNKFHGLSIQLIRTFTTQILD 482

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
            L +LK++ +IHCDLKPENILLC   KP E+KIIDFGS+C E RTVY+YIQSR+YR+PE+
Sbjct: 483 SLCVLKESKLIHCDLKPENILLCAPDKP-ELKIIDFGSSCEEARTVYTYIQSRFYRAPEI 541

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
           +LG  Y+T+IDMWS GCIVAELFLG+P+FPGASE++ L R+I  LG  PP +++   KN+
Sbjct: 542 ILGIPYSTSIDMWSLGCIVAELFLGIPIFPGASEYNQLTRIIDTLGY-PPSWMIDMGKNS 600

Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
            KF K +    +  + +     +   + + E   E   ++KP   K+YF  + L +I+ N
Sbjct: 601 GKFMKKLAPEESSSSTQ-----KHRMKTIEEFCREYNIVEKP--SKQYFKWRKLPDIIRN 653

Query: 405 YPYRKNL--SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
           Y Y K++  S E I +E Q R  L+ FL G++  +P +RW+P QA  HPF+T + FT  +
Sbjct: 654 YRYPKSIQNSQELIDQEMQNRECLIHFLGGVLNLNPLERWTPQQAMLHPFITKQEFTGEW 713

Query: 463 QPP 465
            PP
Sbjct: 714 FPP 716

Negative regulator of the cell cycle acting downstream of the cAMP-dependent protein kinase. Part of a glucose-sensing system involved in growth control in response to glucose availability. Phosphorylates POP2.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1

 Score =  267 bits (682), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 150/365 (41%), Positives = 214/365 (58%), Gaps = 47/365 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY V +++G G+FGQVAKC D + N  VA+KII+N+  ++ QALVE+ IL  L +K D++
Sbjct: 218 RYEVLEMIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHHQALVELKILEALRRK-DKD 276

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           + H++V + ++F  + HLCI FELL  NLYEL+K N F G +LSIV+ F+  IL+ L +L
Sbjct: 277 NNHNVVHMKDFFYFRNHLCITFELLGINLYELMKNNSFHGFNLSIVRRFTFSILKCLHML 336

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
               IIHCDLKPENI+L    +   +K+IDFGS+C E + VY+YIQSR+YRSPEV+LG+ 
Sbjct: 337 YVEKIIHCDLKPENIVLYQRGQ-VTVKVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHP 395

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
           Y  AIDMWS GCI+AEL+ G PLFPG +E + L  ++ +LG  PP +  + A     FF 
Sbjct: 396 YNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACIMEVLGL-PPAHFTQTASRRQVFFD 454

Query: 350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409
             G   NI N     GG+                                     YP  K
Sbjct: 455 SKGLPKNINNNR---GGK------------------------------------RYPDSK 475

Query: 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETP 469
           +L+M   + +S    + +DFL+  + ++P+ R +P QA +H ++  EP     +P P+  
Sbjct: 476 DLTMVVKTYDS----SFLDFLRRCLVWEPSLRMTPEQALKHAWI-HEPRKFKPRPKPQIL 530

Query: 470 RVPVA 474
           R P A
Sbjct: 531 RKPGA 535

Possible non-essential role in spermiogenesis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P49657|MNB_DROME Serine/threonine-protein kinase minibrain OS=Drosophila melanogaster GN=mnb PE=2 SV=2

 Score =  266 bits (679), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 152/414 (36%), Positives = 233/414 (56%), Gaps = 37/414 (8%)

Query: 47  RLTKDIVETYQICNPLFKYSEELNPKRYL------TSPSVGVLNDGYDNVNSDLILAVNL 100
           +L+ D+++TY+  N ++   ++   ++              + NDGYD+ N D I+    
Sbjct: 99  KLSVDLIKTYKHINEVYYAKKKRRAQQTQGDDDSSNKKERKLYNDGYDDDNHDYIIKNGE 158

Query: 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILT 160
             ++     RY +  L+G G+FGQV K +D E    VA+KIIKN+  +  QA +EV +L 
Sbjct: 159 KFLD-----RYEIDSLIGKGSFGQVVKAYDHEEQCHVAIKIIKNKKPFLNQAQIEVKLLE 213

Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
            +N+  D E+K++IV++  +F+ + HLC+ FELL  NLY+L++  +FRG+SL++ + F++
Sbjct: 214 MMNRA-DAENKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQ 272

Query: 221 QILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
           Q+   L  L   +  IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y YIQSR+
Sbjct: 273 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYHYIQSRF 331

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           YRSPEVLLG QY  AIDMWS GCI+ E+  G PLF G +E D + +++ +LG  PP Y+L
Sbjct: 332 YRSPEVLLGIQYDLAIDMWSLGCILVEMHTGEPLFSGCNEVDQMNKIVEVLG-MPPKYLL 390

Query: 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL 398
            +A  T KFF  I     + +G   +                R+ K P  G    H   +
Sbjct: 391 DQAHKTRKFFDKI-----VADGSYVLKKNQ----------NGRKYKPP--GSRKLH--DI 431

Query: 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
             + T  P  + L     S    ++    D +  +++FDP  R +P+ A +H F
Sbjct: 432 LGVETGGPGGRRLDEPGHSVSDYLKFK--DLILRMLDFDPKTRVTPYYALQHNF 483

Role in the specific control of proper proliferation of optic lobe neuronal progeny.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q9Z188|DYR1B_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Mus musculus GN=Dyrk1b PE=1 SV=3

 Score =  263 bits (673), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 160/445 (35%), Positives = 245/445 (55%), Gaps = 46/445 (10%)

Query: 25  GPYLVQKDAPSLRVVVRK-PLVVR---------LTKDIVETYQICNPLF-----KYSEEL 69
           GP    +  P +R++ R+ PL  R         L+ D+++TY+  N ++     + +++ 
Sbjct: 15  GPQEHTQVLPDVRLLPRRLPLAFRDAASAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQA 74

Query: 70  NPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCW 129
            P+   T     VLN GYD+ N D I     V        RY +  L+G G+FGQV K +
Sbjct: 75  PPQDSSTKKEKKVLNHGYDDDNHDYI-----VRSGERWLERYEIDSLIGKGSFGQVVKAY 129

Query: 130 DAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189
           D +    VA+KIIKN+ A+  QA +E+ +L  +N+ +D E K++IV +  +F+ + HLC+
Sbjct: 130 DHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ-HDTEMKYYIVHLKRHFMFRNHLCL 188

Query: 190 CFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLC 247
            FELL  NLY+L++  HFRG+SL++ +  ++Q+   L  L   +  IIHCDLKPENILLC
Sbjct: 189 VFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLC 248

Query: 248 TSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
              + A IKI+DFGS+C   + +Y YIQSR+YRSPEVLLG  Y  AIDMWS GCI+ E+ 
Sbjct: 249 NPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMH 307

Query: 308 LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGR 367
            G PLF G++E D + R++ +LG  PP  +L++A    K+F+            +  GG 
Sbjct: 308 TGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPKARKYFE-----------RLPGGGW 355

Query: 368 SAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALV 427
           +  +         +EL+K   G      + +  + T  P  +       S    +R    
Sbjct: 356 TLRR--------TKELRKDYQGPGTRRLQEVLGVQTGGPGGRRAGEPGHSPADYLRFQ-- 405

Query: 428 DFLKGLVEFDPAKRWSPFQASRHPF 452
           D +  ++E++PA R SP  A +H F
Sbjct: 406 DLVLRMLEYEPAARISPLGALQHGF 430

Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activity. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q9Y463|DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1

 Score =  262 bits (670), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 159/445 (35%), Positives = 243/445 (54%), Gaps = 46/445 (10%)

Query: 25  GPYLVQKDAPSLRVVVRK-PLVVR---------LTKDIVETYQICNPLF-----KYSEEL 69
           GP    +  P +R++ R+ PL  R         L+ D+++TY+  N ++     + +++ 
Sbjct: 15  GPQEHTQVLPDVRLLPRRLPLAFRDATSAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQA 74

Query: 70  NPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCW 129
            P+         VLN GYD+ N D I     V        RY +  L+G G+FGQV K +
Sbjct: 75  PPQDSSNKKEKKVLNHGYDDDNHDYI-----VRSGERWLERYEIDSLIGKGSFGQVVKAY 129

Query: 130 DAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189
           D +    VA+KIIKN+ A+  QA +E+ +L  +N+ +D E K++IV +  +F+ + HLC+
Sbjct: 130 DHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ-HDTEMKYYIVHLKRHFMFRNHLCL 188

Query: 190 CFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLC 247
            FELL  NLY+L++  HFRG+SL++ +  ++Q+   L  L   +  IIHCDLKPENILLC
Sbjct: 189 VFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLC 248

Query: 248 TSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
              + A IKI+DFGS+C   + +Y YIQSR+YRSPEVLLG  Y  AIDMWS GCI+ E+ 
Sbjct: 249 NPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMH 307

Query: 308 LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGR 367
            G PLF G++E D + R++ +LG  PP  +L +A    K+F+            +  GG 
Sbjct: 308 TGEPLFSGSNEVDQMNRIVEVLGI-PPAAMLDQAPKARKYFE-----------RLPGGGW 355

Query: 368 SAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALV 427
           +  +         +EL+K   G      + +  + T  P  +       S    +R    
Sbjct: 356 TLRR--------TKELRKDYQGPGTRRLQEVLGVQTGGPGGRRAGEPGHSPADYLRFQ-- 405

Query: 428 DFLKGLVEFDPAKRWSPFQASRHPF 452
           D +  ++E++PA R SP  A +H F
Sbjct: 406 DLVLRMLEYEPAARISPLGALQHGF 430

Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activities. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q8WQL7|MBK1_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis elegans GN=mbk-1 PE=1 SV=1

 Score =  262 bits (669), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 153/399 (38%), Positives = 228/399 (57%), Gaps = 52/399 (13%)

Query: 81  GVLNDGYDNVNSDLILAVNLVLVNAETQRRYIV--KDLLGHGTFGQVAKCWDAEMNSFVA 138
           G  N+GYD+ N D IL    +       +RY++     +G G+FGQV K +D      VA
Sbjct: 301 GPYNNGYDDQNYDYILKNGEIF-----DKRYVILSDTPVGKGSFGQVTKAYDTLNKEEVA 355

Query: 139 VKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNL 198
           +KIIKN+  ++ QA +E+ +L  L   +D+++K++IV +  +FV + HLC+ FELL  NL
Sbjct: 356 IKIIKNKKTFFDQAQIEIHLLE-LTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNL 414

Query: 199 YELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIK 256
           Y+L+K   FRG+SL++ + F++Q+ + L  L   +  IIHCDLKPEN+LL  + K ++I+
Sbjct: 415 YDLLKNTSFRGVSLNLARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNA-KRSQIR 473

Query: 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
           +IDFGS+C     +Y YIQSR+YRSPEVLLG  Y T IDMWS GCI+ E+  G PLF G+
Sbjct: 474 VIDFGSSCQTGHRIYQYIQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGS 533

Query: 317 SEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENG-----EVSIGGRSAYQ 371
           SE D + +++ +LG  PP  +L     T K+F         E+G     +   G R  Y+
Sbjct: 534 SEVDQMMKIVEVLGM-PPKEMLDIGPKTHKYFD------KTEDGIYYCKKTRDGYRHTYK 586

Query: 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL-----SMEDISKESQIRLAL 426
           A       AR+L + ++G           + +  P  + L     S+ED SK        
Sbjct: 587 APG-----ARKLHE-ILG-----------VTSGGPGGRRLGEPGHSVEDYSK-------F 622

Query: 427 VDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP 465
            D +K +++FDP +R SP+   RHPF+  +    P QPP
Sbjct: 623 KDLIKRMLQFDPKQRISPYYVVRHPFLKQKEERVPSQPP 661

Possible role in the function of olfactory neurons.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2

 Score =  261 bits (667), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 148/361 (40%), Positives = 213/361 (59%), Gaps = 47/361 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY V + +G G+FGQVAKC D + N  VA+KII+N+  ++QQAL+E+ IL  L KK D++
Sbjct: 103 RYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHQQALMELKILEALRKK-DKD 161

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           + +++V + ++F  + H CI FELL  NLYEL+K N+F+G SLSIV+ F+  +L+ L +L
Sbjct: 162 NTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQGFSLSIVRRFTLSVLKCLQML 221

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
               IIHCDLKPENI+L    + A +K+IDFGS+C E + VY+YIQSR+YRSPEV+LG+ 
Sbjct: 222 SVEKIIHCDLKPENIVLYQKGQ-ASVKVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHP 280

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
           Y  AIDMWS GCI AEL+ G PLFPG +E + L  ++ +LG  PP   ++ A     FF 
Sbjct: 281 YDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACIMEVLGL-PPAGFIQTASRRQTFFD 339

Query: 350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409
             G   NI N                             GK+             YP  K
Sbjct: 340 SKGFPKNITNNR---------------------------GKK------------RYPDSK 360

Query: 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETP 469
           +L+M   + ++    + +DFL+  + ++P+ R +P QA +H ++       P QP P+T 
Sbjct: 361 DLTMVLKTYDT----SFLDFLRRCLVWEPSLRMTPDQALKHAWIHQSRNLKP-QPRPQTL 415

Query: 470 R 470
           R
Sbjct: 416 R 416

Possible non-essential role in spermiogenesis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q9V3D5|DYRK2_DROME Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Drosophila melanogaster GN=smi35A PE=1 SV=1

 Score =  258 bits (660), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 142/377 (37%), Positives = 214/377 (56%), Gaps = 51/377 (13%)

Query: 77  SPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSF 136
           +P+    N GYD+ N +       ++ +     RY + +++G G+FGQV +  D + N+ 
Sbjct: 169 APTANTTNLGYDDDNGNY-----KIIEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTH 223

Query: 137 VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS 196
           VA+KII+N+  +  QA+VE++IL  L +K D +  H+++ + +Y   ++HLCI FEL+  
Sbjct: 224 VAIKIIRNKKRFLNQAVVELNILDELREK-DADGSHNVIHMLDYTYFRKHLCITFELMSL 282

Query: 197 NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256
           NLYELIK N++ G S+S+++ F   I++ L LL    IIHCDLKPENILL      + IK
Sbjct: 283 NLYELIKKNNYNGFSMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILL-KQRGSSSIK 341

Query: 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
           +IDFGS+C  DR +Y+YIQSR+YRSPEV+LG QY TAIDMWS GCI+AEL+ G PLFPG 
Sbjct: 342 VIDFGSSCYVDRKIYTYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTGFPLFPGE 401

Query: 317 SEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEI 376
           +E + L  ++ +LG  PP  ++  A+    FF                  R A + +T  
Sbjct: 402 NEVEQLACIMEVLGL-PPKVLISVARRRRLFF----------------DSRDAPRCIT-- 442

Query: 377 EYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEF 436
               +  K+    K   H  H ++                          +DFL+  +E+
Sbjct: 443 --NTKGRKRSPGSKSLAHILHCQD-----------------------RYFIDFLQRCLEW 477

Query: 437 DPAKRWSPFQASRHPFV 453
           DPA+R +P +A+ H F+
Sbjct: 478 DPAERMTPDEAAHHEFL 494

In vitro; can phosphorylate exogenous substrates on Ser and Thr residues. May have a physiological role in development being involved in cellular growth and differentiation.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	837
225454595	957	PREDICTED: uncharacterized protein LOC10	0.947	0.828	0.783	0.0
297737219	909	unnamed protein product [Vitis vinifera]	0.915	0.842	0.796	0.0
255566076	848	ATP binding protein, putative [Ricinus c	0.845	0.834	0.801	0.0
356559112	951	PREDICTED: uncharacterized protein LOC10	0.956	0.842	0.727	0.0
449451775	963	PREDICTED: uncharacterized protein LOC10	0.946	0.822	0.718	0.0
356523832	969	PREDICTED: uncharacterized protein LOC10	0.912	0.788	0.745	0.0
297801134	956	kinase family protein [Arabidopsis lyrat	0.936	0.820	0.684	0.0
42568145	956	YAK1-like protein 1 [Arabidopsis thalian	0.936	0.820	0.680	0.0
79329054	787	YAK1-like protein 1 [Arabidopsis thalian	0.891	0.947	0.689	0.0
224285202	1070	unknown [Picea sitchensis]	0.898	0.702	0.576	0.0

>gi|225454595|ref|XP_002267912.1| PREDICTED: uncharacterized protein LOC100240775 [Vitis vinifera]

 Score = 1288 bits (3333), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 639/816 (78%), Positives = 699/816 (85%), Gaps = 23/816 (2%)

Query: 17  WRPKGFSFGPYLVQKDAPS----LRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPK 72
           WRP    F PY    +A +    LRVVVR+PLV RLTKDIVETYQICNP FKYSEELNPK
Sbjct: 34  WRPSKLVFAPYSPSLEAATKSQALRVVVRRPLVARLTKDIVETYQICNPQFKYSEELNPK 93

Query: 73  RYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAE 132
           R+LTSPS+GVLNDG+DNVNSDLILAVN VLVN+ETQRRYI+KD+LGHGTFGQVAKCW  E
Sbjct: 94  RFLTSPSIGVLNDGHDNVNSDLILAVNSVLVNSETQRRYIIKDILGHGTFGQVAKCWVTE 153

Query: 133 MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192
            NSF AVKIIKNQPAYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YFV QRHLCI FE
Sbjct: 154 TNSFTAVKIIKNQPAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFVHQRHLCIAFE 213

Query: 193 LLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252
           LLD+NLYELIKINHFRGLSLSIVQLFSKQILRGL+L+KDAGIIHCDLKPENILLCT VKP
Sbjct: 214 LLDTNLYELIKINHFRGLSLSIVQLFSKQILRGLALMKDAGIIHCDLKPENILLCTRVKP 273

Query: 253 AEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL 312
           AEIKIIDFGSAC EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL
Sbjct: 274 AEIKIIDFGSACMEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL 333

Query: 313 FPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQA 372
           FPGASEFDLLRRMI+ILG QPPDYVLKEAKNTSKFFKCIGS H++ENG+VS+GGRSAY A
Sbjct: 334 FPGASEFDLLRRMIQILGGQPPDYVLKEAKNTSKFFKCIGSFHHVENGDVSMGGRSAYLA 393

Query: 373 LTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKG 432
           L+E +YEARELKKP IGKEYF HK+LE IVTNYPYRKNL+ EDI KES++RLAL+DFL+G
Sbjct: 394 LSEEDYEARELKKPSIGKEYFIHKNLEAIVTNYPYRKNLAEEDIVKESRVRLALIDFLRG 453

Query: 433 LVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAG 492
           LVEFDPAKRWSPFQAS+HPFVTGEPFTCPY+PP ETPRVPVAQN KVDHHPG GHWFAAG
Sbjct: 454 LVEFDPAKRWSPFQASKHPFVTGEPFTCPYRPPAETPRVPVAQNVKVDHHPGGGHWFAAG 513

Query: 493 LSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFA 552
           LSPNI GR++ ++HNSPHFQVVPY + +SYGS+GS+GSYNDGTGLGSSYGSYGD  N FA
Sbjct: 514 LSPNIPGRNRATLHNSPHFQVVPYAHASSYGSLGSHGSYNDGTGLGSSYGSYGDNSNMFA 573

Query: 553 YFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQ 612
           Y+SP GPS MN+HAQ GVS+ G+SPDAR+  I +  GNGLGVSPSAG F PLPLGTSPSQ
Sbjct: 574 YYSPAGPSAMNIHAQGGVSMLGTSPDARRRIIPFPHGNGLGVSPSAGNFAPLPLGTSPSQ 633

Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
           FTPP+SY QVS+GSPGHYGPTSPAR SCHGSPLGKM A + +NRRK+WGYSG+ QSQES 
Sbjct: 634 FTPPNSYSQVSTGSPGHYGPTSPARGSCHGSPLGKMAAVSQFNRRKSWGYSGSLQSQESS 693

Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNM 732
           SS HWQG F DG SS Q+E N Q  G + LHL SN +ATS KQQRGGSGI     A  N+
Sbjct: 694 SSAHWQGHFTDGTSSNQSEGNSQAFGGSPLHLQSNSNATSWKQQRGGSGI-----AFQNI 748

Query: 733 PSSLTRGPAI-----AEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFS 787
           PSS T G  +     A   H+KPE+SL +PDPGDWDPNYSDE LLQ+DGSD   + TEFS
Sbjct: 749 PSSFTLGSNVQFAQTAGVVHEKPESSLLLPDPGDWDPNYSDELLLQDDGSD---MATEFS 805

Query: 788 KAMHL----SSADSSVGVGRFNRTSSASSNI--PIQ 817
           K MHL     SA+  VGVGRF   SS SSN   PIQ
Sbjct: 806 KGMHLGQNFGSAEPLVGVGRFGHASSTSSNTSRPIQ 841

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297737219|emb|CBI26420.3| unnamed protein product [Vitis vinifera]

 Score = 1261 bits (3264), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 625/785 (79%), Positives = 682/785 (86%), Gaps = 19/785 (2%)

Query: 44  LVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLV 103
           LV RLTKDIVETYQICNP FKYSEELNPKR+LTSPS+GVLNDG+DNVNSDLILAVN VLV
Sbjct: 17  LVARLTKDIVETYQICNPQFKYSEELNPKRFLTSPSIGVLNDGHDNVNSDLILAVNSVLV 76

Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           N+ETQRRYI+KD+LGHGTFGQVAKCW  E NSF AVKIIKNQPAYYQQALVEVSILTTLN
Sbjct: 77  NSETQRRYIIKDILGHGTFGQVAKCWVTETNSFTAVKIIKNQPAYYQQALVEVSILTTLN 136

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
           KKYD EDK+HIVRIY+YFV QRHLCI FELLD+NLYELIKINHFRGLSLSIVQLFSKQIL
Sbjct: 137 KKYDPEDKNHIVRIYDYFVHQRHLCIAFELLDTNLYELIKINHFRGLSLSIVQLFSKQIL 196

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
           RGL+L+KDAGIIHCDLKPENILLCT VKPAEIKIIDFGSAC EDRTVYSYIQSRYYRSPE
Sbjct: 197 RGLALMKDAGIIHCDLKPENILLCTRVKPAEIKIIDFGSACMEDRTVYSYIQSRYYRSPE 256

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI+ILG QPPDYVLKEAKN
Sbjct: 257 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIQILGGQPPDYVLKEAKN 316

Query: 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVT 403
           TSKFFKCIGS H++ENG+VS+GGRSAY AL+E +YEARELKKP IGKEYF HK+LE IVT
Sbjct: 317 TSKFFKCIGSFHHVENGDVSMGGRSAYLALSEEDYEARELKKPSIGKEYFIHKNLEAIVT 376

Query: 404 NYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQ 463
           NYPYRKNL+ EDI KES++RLAL+DFL+GLVEFDPAKRWSPFQAS+HPFVTGEPFTCPY+
Sbjct: 377 NYPYRKNLAEEDIVKESRVRLALIDFLRGLVEFDPAKRWSPFQASKHPFVTGEPFTCPYR 436

Query: 464 PPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYG 523
           PP ETPRVPVAQN KVDHHPG GHWFAAGLSPNI GR++ ++HNSPHFQVVPY + +SYG
Sbjct: 437 PPAETPRVPVAQNVKVDHHPGGGHWFAAGLSPNIPGRNRATLHNSPHFQVVPYAHASSYG 496

Query: 524 SVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMF 583
           S+GS+GSYNDGTGLGSSYGSYGD  N FAY+SP GPS MN+HAQ GVS+ G+SPDAR+  
Sbjct: 497 SLGSHGSYNDGTGLGSSYGSYGDNSNMFAYYSPAGPSAMNIHAQGGVSMLGTSPDARRRI 556

Query: 584 IQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGS 643
           I +  GNGLGVSPSAG F PLPLGTSPSQFTPP+SY QVS+GSPGHYGPTSPAR SCHGS
Sbjct: 557 IPFPHGNGLGVSPSAGNFAPLPLGTSPSQFTPPNSYSQVSTGSPGHYGPTSPARGSCHGS 616

Query: 644 PLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLH 703
           PLGKM A + +NRRK+WGYSG+ QSQES SS HWQG F DG SS Q+E N Q  G + LH
Sbjct: 617 PLGKMAAVSQFNRRKSWGYSGSLQSQESSSSAHWQGHFTDGTSSNQSEGNSQAFGGSPLH 676

Query: 704 LPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAI-----AEAAHDKPETSLSVPD 758
           L SN +ATS KQQRGGSGI     A  N+PSS T G  +     A   H+KPE+SL +PD
Sbjct: 677 LQSNSNATSWKQQRGGSGI-----AFQNIPSSFTLGSNVQFAQTAGVVHEKPESSLLLPD 731

Query: 759 PGDWDPNYSDEQLLQEDGSDESSITTEFSKAMHL----SSADSSVGVGRFNRTSSASSNI 814
           PGDWDPNYSDE LLQ+DGSD   + TEFSK MHL     SA+  VGVGRF   SS SSN 
Sbjct: 732 PGDWDPNYSDELLLQDDGSD---MATEFSKGMHLGQNFGSAEPLVGVGRFGHASSTSSNT 788

Query: 815 --PIQ 817
             PIQ
Sbjct: 789 SRPIQ 793

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255566076|ref|XP_002524026.1| ATP binding protein, putative [Ricinus communis] gi|223536753|gb|EEF38394.1| ATP binding protein, putative [Ricinus communis]

 Score = 1185 bits (3066), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 571/712 (80%), Positives = 622/712 (87%), Gaps = 4/712 (0%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           YIVKD+LGHGTFGQVAKCW AE NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD ED
Sbjct: 14  YIVKDVLGHGTFGQVAKCWVAETNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDPED 73

Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           KHHIVRIY+YFV QRHLCICFELL +NLYELIK+N FRGLSLSIVQLFSKQIL GL+LLK
Sbjct: 74  KHHIVRIYDYFVFQRHLCICFELLYTNLYELIKLNQFRGLSLSIVQLFSKQILHGLALLK 133

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
           DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC EDRTVYSYIQSRYYRSPEVLLGYQY
Sbjct: 134 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACMEDRTVYSYIQSRYYRSPEVLLGYQY 193

Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKC 350
           TT+IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI ILG QPPDY+LKEAKNTSKFFKC
Sbjct: 194 TTSIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIEILGGQPPDYLLKEAKNTSKFFKC 253

Query: 351 IGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410
           IGSVHN+++G++S+G +SAYQALT  EYE RELKKP IGKEYFHHK+LE IVTNYPYRKN
Sbjct: 254 IGSVHNVDHGDMSLGSKSAYQALTVDEYEVRELKKPSIGKEYFHHKNLEAIVTNYPYRKN 313

Query: 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPR 470
           L  EDI KESQIRLAL+DFL+GLVEFDPAKRWSPFQASRHPFVTGEPFTCPY+PPPE+PR
Sbjct: 314 LPQEDIMKESQIRLALIDFLRGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYKPPPESPR 373

Query: 471 VPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGS 530
           +PVAQNFKVDHHPG GHWFAAGLSPNI GR++ S+HNSPHFQVVPY +GNSYGS+GS+GS
Sbjct: 374 MPVAQNFKVDHHPGGGHWFAAGLSPNIPGRTRASLHNSPHFQVVPYAHGNSYGSIGSHGS 433

Query: 531 YNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGN 590
           YNDG GLGSSYGSYGDG N FAY+SPVGPSGMN+H Q+G+S+ GSSPDAR+ FI YS  N
Sbjct: 434 YNDGIGLGSSYGSYGDGSNMFAYYSPVGPSGMNMHPQAGLSMLGSSPDARRRFIPYSHPN 493

Query: 591 GLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTA 650
           G+G+SPS G F PLPLGTSPSQFTPP+SY QVS+GSPGHYGPTSPARS+CHGSPLGKM A
Sbjct: 494 GIGMSPSTGNFAPLPLGTSPSQFTPPNSYSQVSAGSPGHYGPTSPARSNCHGSPLGKMAA 553

Query: 651 ATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSA 710
            T +NRRK+WGYSG+ Q+QESP S HWQGQF DG SS Q E NP +LGS+  H  SN S 
Sbjct: 554 VTQFNRRKSWGYSGSSQNQESPQSSHWQGQFADGTSSSQPEGNPPILGSSPSHRQSNSST 613

Query: 711 TSSKQQRGGSGIAASYSAMPNMPSSL----TRGPAIAEAAHDKPETSLSVPDPGDWDPNY 766
            S  QQ GG GI A +SA+ NMP S      + P  A  A DKPE SLS+PDPGDWDPNY
Sbjct: 614 ASWMQQHGGGGITAGHSAIQNMPGSFKPSSMQFPQNAGPAFDKPEASLSLPDPGDWDPNY 673

Query: 767 SDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQR 818
           SDE LLQEDGSD SSI TEF+K MHL S D SV  GR NR S+ SS+  +QR
Sbjct: 674 SDELLLQEDGSDVSSINTEFNKGMHLGSGDPSVTFGRSNRASNQSSSSLVQR 725

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356559112|ref|XP_003547845.1| PREDICTED: uncharacterized protein LOC100792777 [Glycine max]

 Score = 1177 bits (3046), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 595/818 (72%), Positives = 673/818 (82%), Gaps = 17/818 (2%)

Query: 13  FGASWRPKGFSFGP-----------YLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNP 61
             + WRP+G  F P              +K    L VVVRKPLV RLTK+IVETYQICNP
Sbjct: 17  LASGWRPRGSVFSPCKPKGEEEASAAAGKKPQQPLHVVVRKPLVARLTKEIVETYQICNP 76

Query: 62  LFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGT 121
            FKYSE+LNPKR+LTSPSVGVLNDGYDNVNSDLIL VN VL++ E  +RYIVKDLLGHGT
Sbjct: 77  QFKYSEDLNPKRFLTSPSVGVLNDGYDNVNSDLILTVNFVLIHLEKNKRYIVKDLLGHGT 136

Query: 122 FGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181
           FGQVAKCWD++ NSFVAVKIIKNQPAYYQQALVEV+ILTTLNKKYD EDKHHIVRIY+YF
Sbjct: 137 FGQVAKCWDSDTNSFVAVKIIKNQPAYYQQALVEVTILTTLNKKYDPEDKHHIVRIYDYF 196

Query: 182 VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKP 241
           V QRHLCICFELLD+NLYELIK+NHFRGLSL IVQLFSKQIL GL+LLK+AGIIHCDLKP
Sbjct: 197 VYQRHLCICFELLDTNLYELIKMNHFRGLSLGIVQLFSKQILYGLALLKEAGIIHCDLKP 256

Query: 242 ENILLCTS-VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG 300
           ENILLCTS VKPAEIKIIDFGSAC E+RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG
Sbjct: 257 ENILLCTSTVKPAEIKIIDFGSACMENRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG 316

Query: 301 CIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENG 360
           CIVAELFLGLPLFPGASEFDLL+RMI ILG QPPDYVL++AKNTSKFFKCIGS+ NIE+ 
Sbjct: 317 CIVAELFLGLPLFPGASEFDLLKRMIEILGGQPPDYVLRDAKNTSKFFKCIGSLQNIESS 376

Query: 361 EVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420
           E S  GRS YQ LT  EYEARELKKP IGKEYF+  +LE IVTNYPYRKNL  EDI KES
Sbjct: 377 ESSKNGRSVYQTLTVEEYEARELKKPSIGKEYFNQLNLEAIVTNYPYRKNLPKEDILKES 436

Query: 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVD 480
           QIRLAL+DFLKGLVEFDPAKRWSPFQAS+HPFVTGEPFT PY+PPPETP +PV QN KVD
Sbjct: 437 QIRLALIDFLKGLVEFDPAKRWSPFQASKHPFVTGEPFTHPYKPPPETPHMPVVQNIKVD 496

Query: 481 HHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSS 540
           +HPG GHWFAAGLSPN+SG+S+ S+++SPHFQ+V +   NSYGSVGS+GSYND  GLGSS
Sbjct: 497 NHPGGGHWFAAGLSPNVSGKSRASLYSSPHFQMVQHPPANSYGSVGSHGSYNDSVGLGSS 556

Query: 541 YGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGM 600
           YGSYG+  N FAY+SP+GPSGMN+H Q  +S+ G+SPDAR+  ++Y  GNGLG+SPSAG 
Sbjct: 557 YGSYGESSNMFAYYSPIGPSGMNMHNQGSMSMLGNSPDARRR-VKYQPGNGLGISPSAGN 615

Query: 601 FVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNW 660
           F PLPLG SPSQFTPPSSY QVS  SPGHYGPTSPAR + HGSPLGK  A + +NRRKNW
Sbjct: 616 FAPLPLGASPSQFTPPSSYSQVSVSSPGHYGPTSPARGTSHGSPLGKTAAVSQFNRRKNW 675

Query: 661 GYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGS 720
           G+SG+PQ+QE+ SS HW GQ+ D  S+   E   Q LGS+  +L SN S   + +QRG  
Sbjct: 676 GHSGSPQTQETFSS-HWPGQYPD--STSHTEGTSQALGSSPSYLQSN-SNPGNWKQRGSG 731

Query: 721 GIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDES 780
           G++A+ +    M  S +  P   E  HD  ET +S+PDPGDWDPNYSDE LLQEDGSDES
Sbjct: 732 GLSANQNISSLMKPSASMNPQSTEVVHDNAETGISLPDPGDWDPNYSDELLLQEDGSDES 791

Query: 781 SITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQR 818
           S+TTEF ++M+L S ++  G GRFN  SS S+ I +QR
Sbjct: 792 SLTTEFGRSMNLGSTETWAGFGRFNHVSSTSTPIIMQR 829

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449451775|ref|XP_004143636.1| PREDICTED: uncharacterized protein LOC101210441 [Cucumis sativus]

 Score = 1163 bits (3009), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 587/817 (71%), Positives = 660/817 (80%), Gaps = 25/817 (3%)

Query: 14  GASWRPKGFSFGPYLVQKDAPSLR-----VVVRKPLVVRLTKDIVETYQICNPLFKYSEE 68
           G+ W P+   F PYL +++A +          R PLV RLTKDIVETY+ CNP FKYSEE
Sbjct: 36  GSLWHPRQLGFSPYLQRENAAAKPPQDSCFAARIPLVARLTKDIVETYRKCNPEFKYSEE 95

Query: 69  LNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKC 128
           LN KR+LTSPS+GVLNDGYDNVNSDLILAVN VL+N E QRRY+VKDLLGHGTFGQVAKC
Sbjct: 96  LNLKRFLTSPSIGVLNDGYDNVNSDLILAVNSVLLNFEMQRRYVVKDLLGHGTFGQVAKC 155

Query: 129 WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188
           W AE NSFVAVKIIKNQPAYYQQALVEVSILT LN+KYD EDKHHIVRIY+YFV QRHLC
Sbjct: 156 WFAETNSFVAVKIIKNQPAYYQQALVEVSILTLLNQKYDPEDKHHIVRIYDYFVYQRHLC 215

Query: 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248
           ICFELLD+NLYELIKINHFRGLSLSIVQ+ SKQIL GL+LLKDAGIIHCDLKPENILLCT
Sbjct: 216 ICFELLDTNLYELIKINHFRGLSLSIVQMLSKQILCGLALLKDAGIIHCDLKPENILLCT 275

Query: 249 SVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308
           S KPAEIKIIDFGSAC EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL
Sbjct: 276 SAKPAEIKIIDFGSACLEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 335

Query: 309 GLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRS 368
           GLPLFPGASEFDLLRRMI ILGAQPPDYVLKEAK+TSKFFK IG  HN ENGE+   GRS
Sbjct: 336 GLPLFPGASEFDLLRRMIDILGAQPPDYVLKEAKHTSKFFKFIGGFHN-ENGEIYSSGRS 394

Query: 369 AYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVD 428
           ++QAL   EYEARE+KKP IGKEYF+   LE IVTNYPYRKNL+ EDI KESQ+RLAL+D
Sbjct: 395 SFQALKADEYEAREMKKPSIGKEYFNRMDLEAIVTNYPYRKNLAEEDIRKESQVRLALID 454

Query: 429 FLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKV-DHHPGAGH 487
           FLKGLVEFDPAKRWSPFQAS+HPFVTGEPFTCPY PPPET R+PV++N KV DHHPG GH
Sbjct: 455 FLKGLVEFDPAKRWSPFQASKHPFVTGEPFTCPYTPPPETRRLPVSKNIKVDDHHPGGGH 514

Query: 488 WFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDG 547
           WFAAGLSPN++GR++  + +SPHFQ+VPY + NSYGSVGS+GSYN+  G G+SYGSYGD 
Sbjct: 515 WFAAGLSPNLAGRNRV-LQSSPHFQMVPYPHANSYGSVGSHGSYNESIGFGNSYGSYGDN 573

Query: 548 GNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLG 607
           G   AY+SPVGPSGMN+H Q  +SV  SSPD R+   Q S  NG+GVSPS G F PLPLG
Sbjct: 574 G-MLAYYSPVGPSGMNMHPQGRISVLASSPDTRQRIFQLSHSNGIGVSPSTGNFAPLPLG 632

Query: 608 TSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQ 667
           TSPSQFTPPSSYGQVS GSPGHYGPTSPAR SC GSPLGKM     +NRRK W Y   P 
Sbjct: 633 TSPSQFTPPSSYGQVSMGSPGHYGPTSPARGSCQGSPLGKMATVGQFNRRKYWDY---PG 689

Query: 668 SQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYS 727
           + +  SS HWQGQ  +G S  QA+ N  + G +  HLP + +ATS KQQ+ GSG +A Y 
Sbjct: 690 THDGSSSSHWQGQSTEGTSYSQADGN-SLHGCSPSHLPPSSNATSWKQQQVGSGSSAGYP 748

Query: 728 AMPNMPSSLTRGPAI-----AEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDG-SDESS 781
            + +MP S   GP +      + A +K E    +PDPGDWDPNYSDE LLQ+DG S+ SS
Sbjct: 749 TIQSMPGSHLPGPNMQFSQSTDVARNKSE----LPDPGDWDPNYSDELLLQDDGDSNVSS 804

Query: 782 ITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQR 818
           ++T+FS  MH+ S++ S G+GRF+   S S N+  QR
Sbjct: 805 MSTDFSN-MHVGSSNPSTGIGRFS-VPSPSLNLSSQR 839

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523832|ref|XP_003530538.1| PREDICTED: uncharacterized protein LOC100786931 [Glycine max]

 Score = 1159 bits (2997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 574/770 (74%), Positives = 653/770 (84%), Gaps = 6/770 (0%)

Query: 44  LVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLV 103
           LV RLTK+IVETYQICNP FKYSE+LNPKR+LTSPSVGVLNDGYDNVNSDLIL VN VL+
Sbjct: 76  LVARLTKEIVETYQICNPQFKYSEDLNPKRFLTSPSVGVLNDGYDNVNSDLILTVNFVLI 135

Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           + E  +RYIVKDLLGHGTFGQVAKCWD++ NSFVAVKIIKNQPAYYQQALVEV+ILTTLN
Sbjct: 136 HLEKNKRYIVKDLLGHGTFGQVAKCWDSDTNSFVAVKIIKNQPAYYQQALVEVTILTTLN 195

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
           KKYD EDKHHIVRIY+YFV QRHLCICFELLD+NLYELIK+NHFRGLSL IVQLFSKQIL
Sbjct: 196 KKYDPEDKHHIVRIYDYFVYQRHLCICFELLDTNLYELIKMNHFRGLSLGIVQLFSKQIL 255

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSP 282
            GL+LLK+AGIIHCDLKPENILLCTS VKPAEIKIIDFGSAC E+RTVYSYIQSRYYRSP
Sbjct: 256 YGLALLKEAGIIHCDLKPENILLCTSTVKPAEIKIIDFGSACMENRTVYSYIQSRYYRSP 315

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
           EVLLG QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL+RMI ILG QPPDYVL++AK
Sbjct: 316 EVLLGCQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLKRMIEILGGQPPDYVLRDAK 375

Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
           NTSKFFKCIGS+ NI+N E S  GRS YQALT  EYEARELKKP IGKEYF+H +LE IV
Sbjct: 376 NTSKFFKCIGSLQNIDNSESSKNGRSVYQALTVEEYEARELKKPSIGKEYFNHMNLEAIV 435

Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
           TNYPYRKNL  EDI KESQIRLAL+DFLKGLVEFDPAKRWSPFQAS+HPFVTGEPFT PY
Sbjct: 436 TNYPYRKNLPKEDILKESQIRLALIDFLKGLVEFDPAKRWSPFQASKHPFVTGEPFTHPY 495

Query: 463 QPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSY 522
           +PPPETP +PV QN KVD+HPG GHWFAAGLSPN+ G+S+ S+++SPHFQ+V +   NSY
Sbjct: 496 KPPPETPHMPVVQNIKVDNHPGGGHWFAAGLSPNVPGKSRASLYSSPHFQMVQHPPANSY 555

Query: 523 GSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKM 582
           GSVGS+GSYND  GLGSSYGSYG+  N FAY+SP+GPS MN+H Q  +S+ G+SPDAR+ 
Sbjct: 556 GSVGSHGSYNDSVGLGSSYGSYGESSNMFAYYSPIGPSVMNMHNQGSMSMLGNSPDARRR 615

Query: 583 FIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHG 642
            ++Y  GNGLG+SP+AG F PLPLG SPSQFTPPSSY QVS GSPGHYGPTSPAR + HG
Sbjct: 616 -VKYQPGNGLGISPAAGNFAPLPLGASPSQFTPPSSYSQVSVGSPGHYGPTSPARGTSHG 674

Query: 643 SPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASL 702
           SPLGK  AA+ +NRRKNWG+SG+PQ+ E+ SS HWQGQ++D  S+   E   Q LGS+  
Sbjct: 675 SPLGKTAAASQFNRRKNWGHSGSPQTLEAFSS-HWQGQYLD--STSHTEGTSQALGSSPS 731

Query: 703 HLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDW 762
           +L SN S   + +QRG  G++A+ +    M  S +      E  +D  ET +S+PDPGDW
Sbjct: 732 YLQSN-SNPGNWKQRGSGGLSANQNISSLMKPSASMNSQSTELVYDNAETGISLPDPGDW 790

Query: 763 DPNYSDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASS 812
           DPNYSDE LLQEDGSDESS+TTEF ++M+L + ++  G GRFN  SS ++
Sbjct: 791 DPNYSDELLLQEDGSDESSLTTEFGRSMNLGATETWAGFGRFNHVSSTNT 840

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297801134|ref|XP_002868451.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297314287|gb|EFH44710.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score = 1081 bits (2796), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 544/795 (68%), Positives = 629/795 (79%), Gaps = 11/795 (1%)

Query: 17  WRPKGFSFGPYLVQKDAPS-LRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYL 75
           W+P    F  YL QK + S +RV V+KP+VVRLT+D+VETY+IC+P FKY  ELNPKRYL
Sbjct: 27  WKPIQLVFKRYLPQKGSDSKVRVAVKKPVVVRLTRDLVETYKICDPQFKYRGELNPKRYL 86

Query: 76  TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
           T+PSVGV NDG+DNVN DLILAVN    ++++++RYIVKDLLGHGTFGQVAKCW  E NS
Sbjct: 87  TTPSVGVHNDGFDNVNFDLILAVNDDFCSSDSRQRYIVKDLLGHGTFGQVAKCWVPETNS 146

Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD 195
           FVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YF+   HLCICFELLD
Sbjct: 147 FVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFLYHGHLCICFELLD 206

Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255
            NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIHCDLKPENILLC SVKP EI
Sbjct: 207 MNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIHCDLKPENILLCASVKPTEI 266

Query: 256 KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
           KIIDFGSACTED+TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG
Sbjct: 267 KIIDFGSACTEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 326

Query: 316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTE 375
            SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN+ NG  + G +SAY ALTE
Sbjct: 327 GSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHNLGNGGTNGGFKSAYMALTE 386

Query: 376 IEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVE 435
            E+EARE KKP IGKEYF+HK+LEEIV  YPY+ NL  +D+ KE+QIRLAL+DFL+GLVE
Sbjct: 387 EEFEAREKKKPEIGKEYFNHKNLEEIVKGYPYKINLPEDDVVKETQIRLALIDFLRGLVE 446

Query: 436 FDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSP 495
           FDPAKRWSPFQA++HPF+TGEPFTCPY P PETPRV V QN KVDHHPG GHWFAAGLSP
Sbjct: 447 FDPAKRWSPFQAAKHPFITGEPFTCPYNPAPETPRVHVTQNIKVDHHPGGGHWFAAGLSP 506

Query: 496 NISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFS 555
           N+SGR++  MHNSPHFQ++PY + NSYGS+GSYGSYNDG    SSYGSYG  GN FAY+S
Sbjct: 507 NVSGRTRIPMHNSPHFQMIPYSHANSYGSIGSYGSYNDGNIQESSYGSYGGTGNMFAYYS 566

Query: 556 PVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQG---NGLGVSPSAGMFVPLPLGTSPSQ 612
           PV   G+ +   SGVS+ G+SPDAR+  +QY  G   NGLG SPSAG F PLPLGTSPSQ
Sbjct: 567 PVNHPGLYMQNNSGVSMLGTSPDARRRVMQYPHGYGPNGLGTSPSAGNFAPLPLGTSPSQ 626

Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
           FT P++  Q  +GSPGH+GPTSP R+S HGSPLGKM A +  NRR + GYSG  QSQ+ P
Sbjct: 627 FT-PNTNNQFLAGSPGHHGPTSPVRNSSHGSPLGKMAAFSQINRRMSAGYSGGSQSQD-P 684

Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSA---M 729
           S    QG  +D     +  ++ Q  GS S     +    + KQ +GG+ ++  YS     
Sbjct: 685 SLSQAQGHGMDNFYQNEG-YSGQFSGSPSRRQ-LDSGGKNRKQTQGGTTLSTGYSTHNNS 742

Query: 730 PNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKA 789
            +   S    P+      + P+T+LSVPDPGDWDPNYSD+ LL+ED +DESS+   FS+ 
Sbjct: 743 NSSLRSNMSNPSSTAHHLENPDTALSVPDPGDWDPNYSDDLLLEEDSADESSLANAFSRG 802

Query: 790 MHLSSADSSVGVGRF 804
           M L S D+S    RF
Sbjct: 803 MQLGSTDASSYSRRF 817

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42568145|ref|NP_198447.2| YAK1-like protein 1 [Arabidopsis thaliana] gi|20260382|gb|AAM13089.1| unknown protein [Arabidopsis thaliana] gi|34365721|gb|AAQ65172.1| At5g35980 [Arabidopsis thaliana] gi|110741197|dbj|BAF02149.1| protein kinase like protein [Arabidopsis thaliana] gi|332006652|gb|AED94035.1| YAK1-like protein 1 [Arabidopsis thaliana]

 Score = 1080 bits (2794), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 541/795 (68%), Positives = 627/795 (78%), Gaps = 11/795 (1%)

Query: 17  WRPKGFSFGPYLVQKDAPS-LRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYL 75
           W+P    F  YL Q  + S + V V+KP+VVRLT+D+VETY+IC+P FKY  ELNPKRYL
Sbjct: 27  WKPIQLVFKRYLPQNGSASKVHVAVKKPVVVRLTRDLVETYKICDPQFKYRGELNPKRYL 86

Query: 76  TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
           T+PSVGV NDG+DNVN DLILAVN    ++++++RYIVKDLLGHGTFGQVAKCW  E NS
Sbjct: 87  TTPSVGVNNDGFDNVNYDLILAVNDDFCSSDSRQRYIVKDLLGHGTFGQVAKCWVPETNS 146

Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD 195
           FVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YF+ Q HLCICFELLD
Sbjct: 147 FVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFLHQSHLCICFELLD 206

Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255
            NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIHCDLKPENILLC SVKP EI
Sbjct: 207 MNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIHCDLKPENILLCASVKPTEI 266

Query: 256 KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
           KIIDFGSAC ED+TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG
Sbjct: 267 KIIDFGSACMEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 326

Query: 316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTE 375
            SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN+ NG    G +SAY ALT 
Sbjct: 327 GSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHNLGNGGTYGGLKSAYMALTG 386

Query: 376 IEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVE 435
            E+EARE KKP IGKEYF+HK+LEEIV +YPY+ NL  +D+ KE+QIRLAL+DFLKGL+E
Sbjct: 387 EEFEAREKKKPEIGKEYFNHKNLEEIVKSYPYKINLPEDDVVKETQIRLALIDFLKGLME 446

Query: 436 FDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSP 495
           FDPAKRWSPFQA++HPF+TGEPFTCPY PPPETPRV V QN KVDHHPG GHWFAAGLSP
Sbjct: 447 FDPAKRWSPFQAAKHPFITGEPFTCPYNPPPETPRVHVTQNIKVDHHPGEGHWFAAGLSP 506

Query: 496 NISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFS 555
           ++SGR++  MHNSPHFQ++PY + NSYGS+GSYGSYNDGT   +SYGSYG  GN FAY+S
Sbjct: 507 HVSGRTRIPMHNSPHFQMMPYSHANSYGSIGSYGSYNDGTIQDNSYGSYGGTGNMFAYYS 566

Query: 556 PVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQG---NGLGVSPSAGMFVPLPLGTSPSQ 612
           PV   G+ +  Q GVS+ G+SPDAR+  +QY  G   NGLG SPSAG F PLPLGTSPSQ
Sbjct: 567 PVNHPGLYMQNQGGVSMLGTSPDARRRVMQYPHGNGPNGLGTSPSAGNFAPLPLGTSPSQ 626

Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
           FT P++  Q  +GSPGH+GPTSP R+SCHGSPLGKM A +  NRR + GYSG     +  
Sbjct: 627 FT-PNTNNQFLAGSPGHHGPTSPVRNSCHGSPLGKMAAFSQINRRMSAGYSGG-SQSQDS 684

Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNM 732
           S    QG  +D     +  ++ Q  GS S     +    + KQ +GG+ ++  YS   N 
Sbjct: 685 SLSQAQGHGMDNFYQNEG-YSGQFSGSPSRRQ-LDSGVKNRKQTQGGTTLSTGYSTHNNA 742

Query: 733 PSSLTR---GPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKA 789
            SSL      P+      + P+T+LSVPDPGDWDPNYSD+ LL+ED +DESS+   FS+ 
Sbjct: 743 NSSLRSNMYNPSSTAHHLENPDTALSVPDPGDWDPNYSDDLLLEEDSADESSLANAFSRG 802

Query: 790 MHLSSADSSVGVGRF 804
           M L S D+S    RF
Sbjct: 803 MQLGSTDASSYSRRF 817

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|79329054|ref|NP_001031970.1| YAK1-like protein 1 [Arabidopsis thaliana] gi|9758801|dbj|BAB09254.1| protein kinase-like [Arabidopsis thaliana] gi|332006653|gb|AED94036.1| YAK1-like protein 1 [Arabidopsis thaliana]

 Score = 1044 bits (2699), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 522/757 (68%), Positives = 602/757 (79%), Gaps = 11/757 (1%)

Query: 17  WRPKGFSFGPYLVQKDAPS-LRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYL 75
           W+P    F  YL Q  + S + V V+KP+VVRLT+D+VETY+IC+P FKY  ELNPKRYL
Sbjct: 27  WKPIQLVFKRYLPQNGSASKVHVAVKKPVVVRLTRDLVETYKICDPQFKYRGELNPKRYL 86

Query: 76  TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
           T+PSVGV NDG+DNVN DLILAVN    ++++++RYIVKDLLGHGTFGQVAKCW  E NS
Sbjct: 87  TTPSVGVNNDGFDNVNYDLILAVNDDFCSSDSRQRYIVKDLLGHGTFGQVAKCWVPETNS 146

Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD 195
           FVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YF+ Q HLCICFELLD
Sbjct: 147 FVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFLHQSHLCICFELLD 206

Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255
            NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIHCDLKPENILLC SVKP EI
Sbjct: 207 MNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIHCDLKPENILLCASVKPTEI 266

Query: 256 KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
           KIIDFGSAC ED+TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG
Sbjct: 267 KIIDFGSACMEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 326

Query: 316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTE 375
            SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN+ NG    G +SAY ALT 
Sbjct: 327 GSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHNLGNGGTYGGLKSAYMALTG 386

Query: 376 IEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVE 435
            E+EARE KKP IGKEYF+HK+LEEIV +YPY+ NL  +D+ KE+QIRLAL+DFLKGL+E
Sbjct: 387 EEFEAREKKKPEIGKEYFNHKNLEEIVKSYPYKINLPEDDVVKETQIRLALIDFLKGLME 446

Query: 436 FDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSP 495
           FDPAKRWSPFQA++HPF+TGEPFTCPY PPPETPRV V QN KVDHHPG GHWFAAGLSP
Sbjct: 447 FDPAKRWSPFQAAKHPFITGEPFTCPYNPPPETPRVHVTQNIKVDHHPGEGHWFAAGLSP 506

Query: 496 NISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFS 555
           ++SGR++  MHNSPHFQ++PY + NSYGS+GSYGSYNDGT   +SYGSYG  GN FAY+S
Sbjct: 507 HVSGRTRIPMHNSPHFQMMPYSHANSYGSIGSYGSYNDGTIQDNSYGSYGGTGNMFAYYS 566

Query: 556 PVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQG---NGLGVSPSAGMFVPLPLGTSPSQ 612
           PV   G+ +  Q GVS+ G+SPDAR+  +QY  G   NGLG SPSAG F PLPLGTSPSQ
Sbjct: 567 PVNHPGLYMQNQGGVSMLGTSPDARRRVMQYPHGNGPNGLGTSPSAGNFAPLPLGTSPSQ 626

Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
           FT P++  Q  +GSPGH+GPTSP R+SCHGSPLGKM A +  NRR + GYSG     +  
Sbjct: 627 FT-PNTNNQFLAGSPGHHGPTSPVRNSCHGSPLGKMAAFSQINRRMSAGYSGG-SQSQDS 684

Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNM 732
           S    QG  +D     +  ++ Q  GS S     +    + KQ +GG+ ++  YS   N 
Sbjct: 685 SLSQAQGHGMDNFYQNEG-YSGQFSGSPS-RRQLDSGVKNRKQTQGGTTLSTGYSTHNNA 742

Query: 733 PSSLTR---GPAIAEAAHDKPETSLSVPDPGDWDPNY 766
            SSL      P+      + P+T+LSVPDPGDWDPNY
Sbjct: 743 NSSLRSNMYNPSSTAHHLENPDTALSVPDPGDWDPNY 779

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224285202|gb|ACN40327.1| unknown [Picea sitchensis]

 Score =  914 bits (2363), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 465/807 (57%), Positives = 569/807 (70%), Gaps = 55/807 (6%)

Query: 17  WRPKGFSFGPYLVQKDA-------------PSLRVVVRKPLVVRLTKDIVETYQICNPLF 63
           W+P    F  Y     A              +LRV+V KPLVVRLTK+I+ETYQICNP F
Sbjct: 30  WKPGALVFKAYASSTGAVNRSPNGGTMNRPGALRVIVAKPLVVRLTKEIIETYQICNPTF 89

Query: 64  KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFG 123
            YS+  NPKRYLT+PS GVLNDG DN NSDLILAVN VLVN+++ RRYIVKD+LG GTFG
Sbjct: 90  TYSDAFNPKRYLTNPSTGVLNDGTDNENSDLILAVNAVLVNSDSNRRYIVKDILGQGTFG 149

Query: 124 QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183
           QVAKCW  E N+ VA+K+IKNQPAYY QA+VE+SILT LN+ +D EDKHHIVRI ++FV 
Sbjct: 150 QVAKCWVPETNNHVAIKVIKNQPAYYHQAVVEISILTMLNQNFDPEDKHHIVRILDHFVF 209

Query: 184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN 243
           QRHLCI FE+L  NLYEL+K+N +RG+SL +++LF+KQIL  L +L+DA +IHCDLKPEN
Sbjct: 210 QRHLCISFEMLGVNLYELLKLNQYRGISLKLLRLFAKQILDALLVLRDARVIHCDLKPEN 269

Query: 244 ILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIV 303
           ILL T ++ AEIK+IDFGSAC E+RTVYSYIQSR+YRSPEVLLG+ YTTAIDMWSFGCIV
Sbjct: 270 ILLTTRLQSAEIKMIDFGSACMENRTVYSYIQSRFYRSPEVLLGHPYTTAIDMWSFGCIV 329

Query: 304 AELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVS 363
           AELFLGLPLFPGASE+DL++RMI IL  QPPD++L+ AKNTSK+FK +G    ++     
Sbjct: 330 AELFLGLPLFPGASEYDLIKRMIEILRDQPPDHILRSAKNTSKYFKHVGVSSRLDENRTG 389

Query: 364 IGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPY--RKNLSMEDISKESQ 421
            G +SAY+ LTE EYEARE+KKP  GK YF+   LE+IV NYP+  RK ++ E+I+KE+Q
Sbjct: 390 EGQQSAYRFLTESEYEAREMKKPESGKRYFNFDTLEDIVVNYPHLNRKKMTEEEIAKENQ 449

Query: 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDH 481
            RLA +DFL+GLVEFDP KRW+P QA+RHPFVT E FTCPY P PETPR PV+Q   VDH
Sbjct: 450 SRLAFIDFLRGLVEFDPEKRWTPGQAARHPFVTEEAFTCPYMPAPETPRKPVSQIVTVDH 509

Query: 482 HPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSY 541
           +PG+GHWF AGLSP +   +K    NSP +Q+ P+ Y +SYGS+GS+GSY DG GLGSS+
Sbjct: 510 NPGSGHWFGAGLSPQVVNMNKGIHFNSPQYQMAPFSYASSYGSLGSHGSYGDGVGLGSSF 569

Query: 542 GSYGDGGNTFAYFSPVGPSGMNL--HAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAG 599
           GSYGD  N +  + P+ PSG+N+  H   G +  G+SPD R    Q   G+ LG+SPS+G
Sbjct: 570 GSYGDTSNAYMGYCPITPSGLNIQNHGTPGGTSLGASPDTRWRLSQAPPGHALGISPSSG 629

Query: 600 MFVPLPLGTSPSQFTPPSSYGQVSS----GSPGHYGPTSPARSSCHGSPLGKMTAATHYN 655
           M  P+ LG SPSQFTPPSS  QVSS    GSPG YGPTSPARS  H + LGK  A   Y+
Sbjct: 630 MLRPMSLGASPSQFTPPSSQIQVSSGSPIGSPGRYGPTSPARSGIHVTGLGKAAAVGQYH 689

Query: 656 RRKNWGYSGNPQSQESPSS---QHWQGQ--------------FIDGASSGQAEWNPQVLG 698
           +R+ +  SG+  S  SP     QHWQG               F+DG + G    +P+   
Sbjct: 690 KRRGFSISGS--SHLSPQDNIPQHWQGHQNNLGVNMDVGAGSFVDGNTRGGYPGSPRNSQ 747

Query: 699 SASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRG-------PAIAEAAHDKPE 751
           + S   PS        +QRGG+GIA +     +  +S   G       P   E   +  E
Sbjct: 748 ATSHLQPS--------RQRGGNGIATASMVSNHQKNSSVYGSGLFGESPTAMETCSEGLE 799

Query: 752 TSLSVPDPGDWDPNYSDEQLLQEDGSD 778
           +S S PDPGDWDPNYSDE L QEDGSD
Sbjct: 800 SSSSPPDPGDWDPNYSDELLFQEDGSD 826

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	837
TAIR|locus:2162868	956	YAK1 "yeast YAK1-related gene	0.966	0.846	0.631	2.1e-274
ASPGD|ASPL0000065013	885	AN7104 [Emericella nidulans (t	0.482	0.456	0.501	1.1e-115
DICTYBASE|DDB_G0283605	1458	yakA "protein kinase, CMGC gro	0.501	0.288	0.494	9.3e-115
POMBASE|SPAC823.03	534	ppk15 "serine/threonine protei	0.470	0.737	0.510	1.2e-106
SGD|S000003677	807	YAK1 "Serine-threonine protein	0.486	0.504	0.472	4.2e-102
FB|FBgn0259168	908	mnb "minibrain" [Drosophila me	0.307	0.283	0.475	4.9e-73
RGD|1307223	629	Dyrk1b "dual-specificity tyros	0.347	0.462	0.424	2e-70
UNIPROTKB|D4A382	689	D4A382 "Uncharacterized protei	0.347	0.422	0.424	2e-70
MGI|MGI:1330302	629	Dyrk1b "dual-specificity tyros	0.347	0.462	0.424	2.5e-70
ZFIN|ZDB-GENE-091015-3	634	dyrk4 "dual-specificity tyrosi	0.297	0.392	0.496	9.8e-70

TAIR|locus:2162868 YAK1 "yeast YAK1-related gene 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2638 (933.7 bits), Expect = 2.1e-274, P = 2.1e-274
 Identities = 522/826 (63%), Positives = 607/826 (73%)

Query:     2 DEGSPSNGGQV--FGAS--WRPKGFSFGPYLVQKDAPSXXXXXXXX-XXXXXTKDIVETY 56
             D  + +  G++   G S  W+P    F  YL Q  + S              T+D+VETY
Sbjct:     8 DGAAAARAGEIGSIGVSTPWKPIQLVFKRYLPQNGSASKVHVAVKKPVVVRLTRDLVETY 67

Query:    57 QICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQRRYIVKDL 116
             +IC+P FKY  ELNPKRYLT+PSVGV NDG+DNVN DLI          ++++RYIVKDL
Sbjct:    68 KICDPQFKYRGELNPKRYLTTPSVGVNNDGFDNVNYDLILAVNDDFCSSDSRQRYIVKDL 127

Query:   117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
             LGHGTFGQVAKCW  E NSFVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVR
Sbjct:   128 LGHGTFGQVAKCWVPETNSFVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVR 187

Query:   177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIH 236
             IY+YF+ Q HLCICFELLD NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIH
Sbjct:   188 IYDYFLHQSHLCICFELLDMNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIH 247

Query:   237 CDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDM 296
             CDLKPENILLC SVKP EIKIIDFGSAC ED+TVYSYIQSRYYRSPEVLLGYQYTTAIDM
Sbjct:   248 CDLKPENILLCASVKPTEIKIIDFGSACMEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDM 307

Query:   297 WSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHN 356
             WSFGCIVAELFLGLPLFPG SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN
Sbjct:   308 WSFGCIVAELFLGLPLFPGGSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHN 367

Query:   357 IENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416
             + NG    G +SAY ALT  E+EARE KKP IGKEYF+HK+LEEIV +YPY+ NL  +D+
Sbjct:   368 LGNGGTYGGLKSAYMALTGEEFEAREKKKPEIGKEYFNHKNLEEIVKSYPYKINLPEDDV 427

Query:   417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQN 476
              KE+QIRLAL+DFLKGL+EFDPAKRWSPFQA++HPF+TGEPFTCPY PPPETPRV V QN
Sbjct:   428 VKETQIRLALIDFLKGLMEFDPAKRWSPFQAAKHPFITGEPFTCPYNPPPETPRVHVTQN 487

Query:   477 FKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPXXXXXXXXXXXXXXXXXXXXX 536
              KVDHHPG GHWFAAGLSP++SGR++  MHNSPHFQ++P                     
Sbjct:   488 IKVDHHPGEGHWFAAGLSPHVSGRTRIPMHNSPHFQMMPYSHANSYGSIGSYGSYNDGTI 547

Query:   537 XXXXXXXXXXXXNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNG---LG 593
                         N FAY+SPV   G+ +  Q GVS+ G+SPDAR+  +QY  GNG   LG
Sbjct:   548 QDNSYGSYGGTGNMFAYYSPVNHPGLYMQNQGGVSMLGTSPDARRRVMQYPHGNGPNGLG 607

Query:   594 VSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATH 653
              SPSAG F PLPLGTSPSQFTP ++  Q  +GSPGH+GPTSP R+SCHGSPLGKM A + 
Sbjct:   608 TSPSAGNFAPLPLGTSPSQFTPNTN-NQFLAGSPGHHGPTSPVRNSCHGSPLGKMAAFSQ 666

Query:   654 YNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSS 713
              NRR + GYSG  QSQ+S  SQ  QG  +D     +  ++ Q  GS S     +    + 
Sbjct:   667 INRRMSAGYSGGSQSQDSSLSQA-QGHGMDNFYQNEG-YSGQFSGSPSRR-QLDSGVKNR 723

Query:   714 KQQRGGSGIAASYSAMPNMPSSLTRG---PAIAEAAH-DKPETSLSVPDPGDWDPNYSDE 769
             KQ +GG+ ++  YS   N  SSL      P+ + A H + P+T+LSVPDPGDWDPNYSD+
Sbjct:   724 KQTQGGTTLSTGYSTHNNANSSLRSNMYNPS-STAHHLENPDTALSVPDPGDWDPNYSDD 782

Query:   770 QLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIP 815
              LL+ED +DESS+   FS+ M L S D+S    RFN  +S SS+ P
Sbjct:   783 LLLEEDSADESSLANAFSRGMQLGSTDASSYSRRFNSNASTSSSNP 828

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

ASPGD|ASPL0000065013 AN7104 [Emericella nidulans (taxid:162425)]

 Score = 1059 (377.8 bits), Expect = 1.1e-115, Sum P(4) = 1.1e-115
 Identities = 211/421 (50%), Positives = 285/421 (67%)

Query:    49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXET- 107
             T  +  TY+ICNP F Y    NP+R LT PS GV NDGYDN +SD I          E  
Sbjct:   277 TNHLPATYRICNPNFHYESSRNPRRVLTKPSKGVKNDGYDNEDSDYILYVNDILGSEEAG 336

Query:   108 -QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
              + RY++ D+LG GTFGQV KC + +    VAVK+IKN+ AY+ Q+++EVS+L  LN +Y
Sbjct:   337 HKNRYLILDVLGQGTFGQVVKCQNLKTQEVVAVKVIKNKTAYFNQSMMEVSVLDLLNSRY 396

Query:   167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
             D+ D HH++R+ + F+ ++HLC+ FELL  NLYELIK N FRGLS ++V++F++Q+L  L
Sbjct:   397 DKNDDHHLLRLKDTFIHRQHLCLVFELLSVNLYELIKQNQFRGLSTTLVRVFAQQLLNAL 456

Query:   227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
             SLL  A +IHCDLKPENILL     P  IK+IDFGSAC E +TVY+YIQSR+YRSPEVLL
Sbjct:   457 SLLNKAHLIHCDLKPENILLKNLESPI-IKVIDFGSACDERQTVYTYIQSRFYRSPEVLL 515

Query:   287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
             G  Y++AIDMWS GCIV ELFLGLPLFPG+SE++ + R++ +LG  PP ++L+  K + +
Sbjct:   516 GLPYSSAIDMWSLGCIVVELFLGLPLFPGSSEYNQVCRIVEMLGL-PPTWMLEMGKQSGE 574

Query:   347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELK-KPLIGKEYFHHKHLEEIVTNY 405
             FF         E  +   G R +Y+ L  +E  +RE   K    K+YF    LEEI+ +Y
Sbjct:   575 FF---------EKTQDEFG-RKSYR-LKSLEQYSREHNTKEQPSKKYFQASTLEEIIRSY 623

Query:   406 PY-RKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP 464
             P  RKN+   +I +E   R+A +DF++GL+  +P +RWSP QA  HPF+T + FT P+ P
Sbjct:   624 PMPRKNMKQAEIEREVNNRVAFIDFVRGLLSINPLERWSPQQAKLHPFITQQKFTGPFVP 683

Query:   465 P 465
             P
Sbjct:   684 P 684

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

DICTYBASE|DDB_G0283605 yakA "protein kinase, CMGC group" [Dictyostelium discoideum (taxid:44689)]

 Score = 1060 (378.2 bits), Expect = 9.3e-115, Sum P(3) = 9.3e-115
 Identities = 210/425 (49%), Positives = 287/425 (67%)

Query:    49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQ 108
             TK+++  Y+ CN  F Y   LNP+R LT PS  + NDGYDNVNSD I          E+ 
Sbjct:   143 TKNLLHFYKKCNSNFNYISSLNPRRVLTHPSEPLSNDGYDNVNSDYIVYVNDIITNNESG 202

Query:   109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
             ++Y V D LG GTFGQV KC + + +  VA+KI+KN+ AY+QQ  +E+  L +LN ++D 
Sbjct:   203 QKYKVLDSLGQGTFGQVVKCKNCDTDELVAIKILKNKQAYFQQGRLEIQTLKSLNDQHDP 262

Query:   169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
             EDK+HI+R+ + F+ + HLCI FELL  NL+ELIK N+FRGLS +++++F  QIL  L +
Sbjct:   263 EDKNHILRLLDSFIHKMHLCIVFELLSVNLFELIKQNNFRGLSTNLIKVFLIQILDALIV 322

Query:   229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
             L +A IIHCDLKPENILL     PA IKIIDFGSAC E  T+Y+YIQSR+YRSPEVL+G 
Sbjct:   323 LANANIIHCDLKPENILLQNVNSPA-IKIIDFGSACYEKSTLYTYIQSRHYRSPEVLVGT 381

Query:   289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
              Y  +IDMWS GCI AELFLGLPLFPG SE++ + R++ + G  P D + K   +T  F 
Sbjct:   382 VYCASIDMWSLGCISAELFLGLPLFPGNSEYNQISRIVEMRGIFPSDLLDKGKSSTRYFH 441

Query:   349 KCIGS-VHNIENGEVSIGGRSAYQAL-TEIEYEARELKKPLI-GKEYFHHKHLEEIVTNY 405
             + +GS   +  N   +  G+  Y  L +E +Y+ R+ K  L+  K+YF++K L EI+ NY
Sbjct:   442 RHLGSNSDDNNNNNNNNNGKPYYYTLKSEEDYQ-RDSKTTLLPSKKYFNYKTLPEIIQNY 500

Query:   406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP 465
              ++K++S +DI KE Q R+   DF+ GL++ DP +RWSP QA  HPF+TG+P+  P+ P 
Sbjct:   501 GFKKSMSPQDIEKEKQHRIVFTDFINGLLQLDPNERWSPMQAKEHPFITGQPYNGPFIPD 560

Query:   466 PETPR 470
             P   R
Sbjct:   561 PSKKR 565

GO:0030587 "sorocarp development" evidence=IMP

GO:0031152 "aggregation involved in sorocarp development" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0005829 "cytosol" evidence=TAS

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

POMBASE|SPAC823.03 ppk15 "serine/threonine protein kinase Ppk15 (predicted)" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
 Identities = 211/413 (51%), Positives = 280/413 (67%)

Query:    49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQ 108
             T  + +TY ICNP F++S E NP+R LT PS GV N G+DNVN D +          E  
Sbjct:    69 TVKLADTYSICNPKFQFSSEQNPRRPLTKPSEGVHNHGFDNVNHDYVLYVNDLLGTDEG- 127

Query:   109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
             R+Y++ D LGHGTFGQVA+C D +    VA+K+IKN+PA+Y Q ++EVSIL  LN KYD 
Sbjct:   128 RKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILELLNNKYDP 187

Query:   169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
             EDK H++R+Y+ F+ + HLC+ FELL  NLYELIK N FRGL LS+V+ F+ Q+L   SL
Sbjct:   188 EDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRGLHLSLVRSFATQLLSCTSL 247

Query:   229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
             LK A IIHCDLKPENILL     P  +K+IDFGSAC E +TVY+YIQSR+YRSPEV+LG 
Sbjct:   248 LKQARIIHCDLKPENILLQDLSSPI-VKVIDFGSACHERQTVYTYIQSRFYRSPEVILGL 306

Query:   289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
              Y   IDMWS GCI+AELFLGLPLFPG SE++ L R++ +LG  PP ++L+  KN+ K++
Sbjct:   307 HYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLG-NPPTWMLEMGKNSKKYY 365

Query:   349 KCIGSVHNIENGEVSIGGRSAYQ--ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP 406
                       +G V+  GR  Y+  ++ +   E  + ++P  GK+YF  K L+ IV NYP
Sbjct:   366 N---------SGFVN--GRKTYELKSIEQFSIENNKTEQP--GKQYFGEKTLDAIVLNYP 412

Query:   407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459
              RK  + +   +E + RL  +DF+K  +E +P KRW+P QA  HPF+TG  F+
Sbjct:   413 RRKT-TPKLTPEEHEERLCFIDFIKQFLELNPLKRWTPDQAKNHPFITGASFS 464

GO:0004674 "protein serine/threonine kinase activity" evidence=ISM

GO:0005524 "ATP binding" evidence=ISM

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISM

GO:0007165 "signal transduction" evidence=NAS

GO:0044732 "mitotic spindle pole body" evidence=IDA

GO:0051286 "cell tip" evidence=IDA

GO:0051519 "activation of bipolar cell growth" evidence=IMP

SGD|S000003677 YAK1 "Serine-threonine protein kinase" [Saccharomyces cerevisiae (taxid:4932)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 198/419 (47%), Positives = 277/419 (66%)

Query:    49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQ 108
             TK ++ TY +C+P F Y    NPKR LT PS G  N+G+DN+NSD I          E  
Sbjct:   308 TKSLITTYSLCSPEFTYQTSKNPKRVLTKPSEGKCNNGFDNINSDYILYVNDVLGV-EQN 366

Query:   109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
             R+Y+V D+LG GTFGQV KC +      +AVK++K++  Y  Q++ E  IL  LN+K D 
Sbjct:   367 RKYLVLDILGQGTFGQVVKCQNLLTKEILAVKVVKSRTEYLTQSITEAKILELLNQKIDP 426

Query:   169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
              +KHH +R+Y+ FV + HLC+ FELL +NLYEL+K N F GLS+ +++ F+ QIL  L +
Sbjct:   427 TNKHHFLRMYDSFVHKNHLCLVFELLSNNLYELLKQNKFHGLSIQLIRTFTTQILDSLCV 486

Query:   229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
             LK++ +IHCDLKPENILLC   KP E+KIIDFGS+C E RTVY+YIQSR+YR+PE++LG 
Sbjct:   487 LKESKLIHCDLKPENILLCAPDKP-ELKIIDFGSSCEEARTVYTYIQSRFYRAPEIILGI 545

Query:   289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
              Y+T+IDMWS GCIVAELFLG+P+FPGASE++ L R+I  LG  PP +++   KN+ KF 
Sbjct:   546 PYSTSIDMWSLGCIVAELFLGIPIFPGASEYNQLTRIIDTLG-YPPSWMIDMGKNSGKFM 604

Query:   349 KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408
             K +    +  + +     +   + + E   E   ++KP   K+YF  + L +I+ NY Y 
Sbjct:   605 KKLAPEESSSSTQ-----KHRMKTIEEFCREYNIVEKP--SKQYFKWRKLPDIIRNYRYP 657

Query:   409 KNL--SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP 465
             K++  S E I +E Q R  L+ FL G++  +P +RW+P QA  HPF+T + FT  + PP
Sbjct:   658 KSIQNSQELIDQEMQNRECLIHFLGGVLNLNPLERWTPQQAMLHPFITKQEFTGEWFPP 716

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0005634 "nucleus" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IMP;IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA;IMP;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IMP;IDA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

FB|FBgn0259168 mnb "minibrain" [Drosophila melanogaster (taxid:7227)]

 Score = 639 (230.0 bits), Expect = 4.9e-73, Sum P(4) = 4.9e-73
 Identities = 127/267 (47%), Positives = 176/267 (65%)

Query:    84 NDGYDNVNSDLIXXXXXXXXXXETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK 143
             NDGYD+ N D I              RY +  L+G G+FGQV K +D E    VA+KIIK
Sbjct:   142 NDGYDDDNHDYIIKNGEKFLD-----RYEIDSLIGKGSFGQVVKAYDHEEQCHVAIKIIK 196

Query:   144 NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIK 203
             N+  +  QA +EV +L  +N+  D E+K++IV++  +F+ + HLC+ FELL  NLY+L++
Sbjct:   197 NKKPFLNQAQIEVKLLEMMNRA-DAENKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLR 255

Query:   204 INHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
               +FRG+SL++ + F++Q+   L  L   +  IIHCDLKPENILLC   + A IKI+DFG
Sbjct:   256 NTNFRGVSLNLTRKFAQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-IKIVDFG 314

Query:   262 SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
             S+C   + +Y YIQSR+YRSPEVLLG QY  AIDMWS GCI+ E+  G PLF G +E D 
Sbjct:   315 SSCQLGQRIYHYIQSRFYRSPEVLLGIQYDLAIDMWSLGCILVEMHTGEPLFSGCNEVDQ 374

Query:   322 LRRMIRILGAQPPDYVLKEAKNTSKFF 348
             + +++ +LG  PP Y+L +A  T KFF
Sbjct:   375 MNKIVEVLG-MPPKYLLDQAHKTRKFF 400

GO:0007420 "brain development" evidence=NAS;IMP

GO:0008355 "olfactory learning" evidence=IMP

GO:0007623 "circadian rhythm" evidence=IGI

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;NAS

GO:0007632 "visual behavior" evidence=IMP

GO:0007399 "nervous system development" evidence=IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0007611 "learning or memory" evidence=NAS

GO:0005524 "ATP binding" evidence=IEA

RGD|1307223 Dyrk1b "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b" [Rattus norvegicus (taxid:10116)]

 Score = 635 (228.6 bits), Expect = 2.0e-70, Sum P(3) = 2.0e-70
 Identities = 130/306 (42%), Positives = 193/306 (63%)

Query:    51 DIVETYQICNPLF-----KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXX 105
             D+++TY+  N ++     + +++  P+   T     VLN GYD+ N D I          
Sbjct:    51 DLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKEKKVLNHGYDDDNHDYIVRSGERWL-- 108

Query:   106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
                 RY +  L+G G+FGQV K +D +    VA+KIIKN+ A+  QA +E+ +L  +N+ 
Sbjct:   109 ---ERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ- 164

Query:   166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
             +D E K++IV +  +F+ + HLC+ FELL  NLY+L++  HFRG+SL++ +  ++Q+   
Sbjct:   165 HDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTA 224

Query:   226 LSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
             L  L   +  IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y YIQSR+YRSPE
Sbjct:   225 LLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPE 283

Query:   284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
             VLLG  Y  AIDMWS GCI+ E+  G PLF G++E D + R++ +LG  PP  +L++A  
Sbjct:   284 VLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPK 342

Query:   344 TSKFFK 349
               K+F+
Sbjct:   343 ARKYFE 348

GO:0003713 "transcription coactivator activity" evidence=ISO

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007520 "myoblast fusion" evidence=ISO

GO:0043231 "intracellular membrane-bounded organelle" evidence=ISO

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=ISO

GO:0005730 "nucleolus" evidence=ISO

UNIPROTKB|D4A382 D4A382 "Uncharacterized protein" [Rattus norvegicus (taxid:10116)]

 Score = 635 (228.6 bits), Expect = 2.0e-70, Sum P(3) = 2.0e-70
 Identities = 130/306 (42%), Positives = 193/306 (63%)

Query:    51 DIVETYQICNPLF-----KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXX 105
             D+++TY+  N ++     + +++  P+   T     VLN GYD+ N D I          
Sbjct:   111 DLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKEKKVLNHGYDDDNHDYIVRSGERWL-- 168

Query:   106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
                 RY +  L+G G+FGQV K +D +    VA+KIIKN+ A+  QA +E+ +L  +N+ 
Sbjct:   169 ---ERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ- 224

Query:   166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
             +D E K++IV +  +F+ + HLC+ FELL  NLY+L++  HFRG+SL++ +  ++Q+   
Sbjct:   225 HDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTA 284

Query:   226 LSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
             L  L   +  IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y YIQSR+YRSPE
Sbjct:   285 LLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPE 343

Query:   284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
             VLLG  Y  AIDMWS GCI+ E+  G PLF G++E D + R++ +LG  PP  +L++A  
Sbjct:   344 VLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPK 402

Query:   344 TSKFFK 349
               K+F+
Sbjct:   403 ARKYFE 408

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1330302 Dyrk1b "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b" [Mus musculus (taxid:10090)]

 Score = 635 (228.6 bits), Expect = 2.5e-70, Sum P(3) = 2.5e-70
 Identities = 130/306 (42%), Positives = 193/306 (63%)

Query:    51 DIVETYQICNPLF-----KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXX 105
             D+++TY+  N ++     + +++  P+   T     VLN GYD+ N D I          
Sbjct:    51 DLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKEKKVLNHGYDDDNHDYIVRSGERWL-- 108

Query:   106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
                 RY +  L+G G+FGQV K +D +    VA+KIIKN+ A+  QA +E+ +L  +N+ 
Sbjct:   109 ---ERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ- 164

Query:   166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
             +D E K++IV +  +F+ + HLC+ FELL  NLY+L++  HFRG+SL++ +  ++Q+   
Sbjct:   165 HDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTA 224

Query:   226 LSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
             L  L   +  IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y YIQSR+YRSPE
Sbjct:   225 LLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPE 283

Query:   284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
             VLLG  Y  AIDMWS GCI+ E+  G PLF G++E D + R++ +LG  PP  +L++A  
Sbjct:   284 VLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPK 342

Query:   344 TSKFFK 349
               K+F+
Sbjct:   343 ARKYFE 348

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003713 "transcription coactivator activity" evidence=ISO

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0007520 "myoblast fusion" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=ISO

ZFIN|ZDB-GENE-091015-3 dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Danio rerio (taxid:7955)]

 Score = 650 (233.9 bits), Expect = 9.8e-70, Sum P(2) = 9.8e-70
 Identities = 125/252 (49%), Positives = 177/252 (70%)

Query:   110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
             RY V +++G G+FGQV KC D + N  VA+KII+N+  ++ QALVE+ IL  + ++ DR+
Sbjct:   211 RYEVLEVIGKGSFGQVLKCLDHKTNETVAIKIIRNKKRFHHQALVELKILDAVRRR-DRD 269

Query:   170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             + H+++ + EYF  + HLCI FELL +NLYELIK N+F+G SL +++ F+  +L+ L +L
Sbjct:   270 NCHNVIHMKEYFYFRNHLCISFELLGANLYELIKKNNFQGFSLGLIRRFAHSLLKCLQML 329

Query:   230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
                 IIHCDLKPENILL    +   IK++DFGS+C E + VY+YIQSR+YRSPEV+LG+ 
Sbjct:   330 HKEKIIHCDLKPENILLSQRGQ-GNIKVVDFGSSCYEQQRVYTYIQSRFYRSPEVILGHP 388

Query:   290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
             Y+ AIDMWS GCI+AEL+ G PLFPG SE + +  ++ I+G  P D+V + A     FF 
Sbjct:   389 YSMAIDMWSLGCILAELYTGYPLFPGESEVEQIACIMEIMGLPPNDFV-QTASRRRLFFD 447

Query:   350 CIGSVHNIENGE 361
               G+  NI N +
Sbjct:   448 SKGNPRNITNSK 459

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	837
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-66
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-56
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-54
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-53
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-53
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-48
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-45
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-44
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-42
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-40
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-39
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-39
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-38
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-37
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-36
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-36
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-36
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-36
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-35
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-35
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-35
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-34
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-33
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-33
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-33
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-33
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-33
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-33
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-33
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-32
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-32
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-32
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-32
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-31
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-31
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-31
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-30
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-30
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-29
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-29
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-29
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-29
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-29
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-27
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-27
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-27
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-27
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-27
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-27
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-27
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-27
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-25
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-25
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-24
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-24
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-11
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-07
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-05
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-05
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-04
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	0.001
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.001
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	0.002
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	0.003
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.003
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  220 bits (564), Expect = 3e-66
 Identities = 75/222 (33%), Positives = 114/222 (51%), Gaps = 17/222 (7%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDR 168
           Y + + LG G+FG+V    D +    VA+K+IK +      ++ L E+ IL  L      
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHP--- 57

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
               +IVR+Y+ F  +  L +  E  +  +L++L+K      LS    + + +QIL  L 
Sbjct: 58  ----NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALE 111

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVL 285
            L   GI+H DLKPENILL    +   +K+ DFG A        + +++ +  Y +PEVL
Sbjct: 112 YLHSKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           LG  Y  A+D+WS G I+ EL  G P FPG  +   L + I 
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  194 bits (496), Expect = 3e-56
 Identities = 85/232 (36%), Positives = 130/232 (56%), Gaps = 28/232 (12%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNK 164
           Y   + LG GT+G V K  D +    VA+K I+        P+    AL E+S+L     
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS---TALREISLL----- 52

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              +E KH +IV++ +    +R L + FE  D +L + +       LS ++++    Q+L
Sbjct: 53  ---KELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLD-KRPGPLSPNLIKSIMYQLL 108

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSY-IQSRYY 279
           RGL+      I+H DLKP+NIL+  +     +K+ DFG A       RT Y++ + + +Y
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILI--NRDG-VLKLADFGLARAFGIPLRT-YTHEVVTLWY 164

Query: 280 RSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           R+PE+LLG + Y+TA+D+WS GCI AE+  G PLFPG SE D L ++ +ILG
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  187 bits (476), Expect = 8e-54
 Identities = 82/233 (35%), Positives = 116/233 (49%), Gaps = 22/233 (9%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKYD 167
           Y +   LG G+FG V K         VAVKI+K +       Q A  E+ IL  L+    
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS---- 56

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
               H +IVR+ + F  + HL +  E  +  +L++ +       LS    +  + QILRG
Sbjct: 57  ----HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRG 110

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSP 282
           L  L   GIIH DLKPENILL    +   +KI DFG A        ++ +++ + +Y +P
Sbjct: 111 LEYLHSNGIIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167

Query: 283 EVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           EVLLG   Y   +D+WS G I+ EL  G P F G +  D L+ + RILG    
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE 220

Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  187 bits (476), Expect = 2e-53
 Identities = 90/244 (36%), Positives = 134/244 (54%), Gaps = 27/244 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  D      VA+K IK         + AL E+ +L  LN          
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN------- 59

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           I+++ + F  +  L + FE +D++LY+LIK    RGL  S+++ +  Q+L+GL+     G
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-------YIQSRYYRSPEVLL 286
           I+H DLKPEN+L+ T      +K+ DFG A    R+  S       Y+ +R+YR+PE+LL
Sbjct: 119 ILHRDLKPENLLINT---EGVLKLADFGLA----RSFGSPVRPYTHYVVTRWYRAPELLL 171

Query: 287 G-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345
           G   Y+T +D+WS GCI AEL    PLFPG SE D L ++ R LG  P   V  +  + +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT-PDPEVWPKFTSLA 230

Query: 346 KFFK 349
           + +K
Sbjct: 231 RNYK 234

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  186 bits (475), Expect = 9e-53
 Identities = 104/391 (26%), Positives = 155/391 (39%), Gaps = 92/391 (23%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKY 166
           RY +   +G G +G V    D      VA+K I N        ++ L E+ +L  L    
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL---- 56

Query: 167 DREDKH-HIVRIYEYFV-----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
               +H +I+ + +            + I  EL++++L+++IK      L+   +Q F  
Sbjct: 57  ----RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP--LTDDHIQYFLY 110

Query: 221 QILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG---SACTEDRTVY--- 271
           QILRGL  L  A +IH DLKP NIL+   C      ++KI DFG       ++       
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNC------DLKICDFGLARGVDPDEDEKGFLT 164

Query: 272 SYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            Y+ +R+YR+PE+LL    YT AID+WS GCI AEL    PLFPG    D L  ++ +LG
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224

Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
               +             K I S                         +AR   K L  K
Sbjct: 225 TPSEE-----------DLKFITSE------------------------KARNYLKSLPKK 249

Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
                K L ++                       A+ D L+ ++ FDP KR +  +A  H
Sbjct: 250 P---KKPLSKLFPGAS----------------PEAI-DLLEKMLVFDPKKRITADEALAH 289

Query: 451 PFVTGEPFTCPYQPPPETPRVPVAQNFKVDH 481
           P++       P   P   P          + 
Sbjct: 290 PYL--AQLHDPEDEPVAKPPFDFDFFDDDEL 318

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  176 bits (448), Expect = 1e-49
 Identities = 85/226 (37%), Positives = 126/226 (55%), Gaps = 16/226 (7%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ--ALVEVSILTTLNKKYDR 168
           Y V   LG GTFG V    + E    VA+K +K +   +++   L EV  L  LN+    
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE---- 56

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
              H +IV++ E F     L   FE ++ NLY+L+K    +  S S+++    QIL+GL+
Sbjct: 57  ---HPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVY-SYIQSRYYRSPEVL 285
            +   G  H DLKPEN+L+        +KI DFG A     R  Y  Y+ +R+YR+PE+L
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170

Query: 286 LGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           L    Y++ +D+W+ GCI+AEL+   PLFPG+SE D L ++  +LG
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG 216

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  169 bits (431), Expect = 3e-48
 Identities = 74/219 (33%), Positives = 110/219 (50%), Gaps = 28/219 (12%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG V    D +    VA+KIIK  +  +  ++ L E+ IL  LN         +I
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP-------NI 53

Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y  F  + HL +  E  +  +L +L+K  +   LS   +     QIL GL  L   G
Sbjct: 54  VKLYGVFEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSNG 112

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVLLGYQ- 289
           IIH DLKPENILL       ++K+ DFG +    ++   + + + +  Y +PEVLLG   
Sbjct: 113 IIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEF-DLLRRMIR 327
           Y+   D+WS G I+ EL           E  DL+R+M++
Sbjct: 171 YSEKSDIWSLGVILYEL----------PELKDLIRKMLQ 199

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  164 bits (418), Expect = 2e-45
 Identities = 79/249 (31%), Positives = 122/249 (48%), Gaps = 33/249 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ------ALVEVSILTTLN 163
           RY     LG GT+  V K  D E    VA+K IK       +      AL E+ +L    
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL---- 56

Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
               +E KH +I+ + + F  + ++ + FE ++++L ++IK      L+ + ++ +    
Sbjct: 57  ----QELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-LTPADIKSYMLMT 111

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSY-IQSRYY 279
           LRGL  L    I+H DLKP N+L+        +K+ DFG A +        ++ + +R+Y
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168

Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG-------- 330
           R+PE+L G   Y   +DMWS GCI AEL L +P  PG S+ D L ++   LG        
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228

Query: 331 --AQPPDYV 337
                PDYV
Sbjct: 229 GVTSLPDYV 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 2e-44
 Identities = 81/244 (33%), Positives = 126/244 (51%), Gaps = 23/244 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
           +Y V  ++G G +G V KC +      VA+K  K   +     + AL EV +L  L    
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL---- 57

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
               +H +IV + E F  +  L + FE ++  L EL++ +   GL    V+ +  Q+L+ 
Sbjct: 58  ----RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQA 112

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSA----CTEDRTVYSYIQSRYYR 280
           ++      IIH D+KPENIL    V  +  +K+ DFG A          +  Y+ +R+YR
Sbjct: 113 IAYCHSHNIIHRDIKPENIL----VSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168

Query: 281 SPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           +PE+L+G   Y   +D+W+ GCI+AEL  G PLFPG S+ D L  + + LG  PP +   
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228

Query: 340 EAKN 343
            + N
Sbjct: 229 FSSN 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  154 bits (392), Expect = 5e-42
 Identities = 101/356 (28%), Positives = 155/356 (43%), Gaps = 81/356 (22%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
           RY +   +G G  G V K  D E    VA+K +   + +     QAL E+  L      Y
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                  +V++ + F       +  E + S+L E+++ +  R L  + V+ + + +L+G+
Sbjct: 61  -------VVKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGV 112

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSY-IQSRYYRSP 282
           + +   GI+H DLKP N+L+        +KI DFG A     E+  +YS+ + +R+YR+P
Sbjct: 113 AYMHANGIMHRDLKPANLLISAD---GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169

Query: 283 EVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
           E+L G + Y   +D+W+ GCI AEL  G PLFPG ++ + L  + R LG           
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE------- 222

Query: 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK---HL 398
                                            E       L  P   K  F       L
Sbjct: 223 ---------------------------------ETWPGLTSL--PDYNKITFPESKPIPL 247

Query: 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454
           EEI    P        D S E+      +D LKGL+ +DP+KR S  +A RHP+ T
Sbjct: 248 EEIF---P--------DASPEA------LDLLKGLLVYDPSKRLSAAEALRHPYFT 286

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 5e-40
 Identities = 110/388 (28%), Positives = 163/388 (42%), Gaps = 97/388 (25%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V           VA+K I       + Q+ L E+ IL        
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF----- 60

Query: 168 REDKH-HIVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
              KH +I+ I +  +            I  EL++++LY+LIK  H   LS   +Q F  
Sbjct: 61  ---KHENIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQH---LSNDHIQYFLY 113

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED------RTVYSYI 274
           QILRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDHTGFLTEYV 170

Query: 275 QSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
            +R+YR+PE++L    YT AID+WS GCI+AE+    PLFPG    D L ++  ILG   
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK---DYLHQLNLILG--- 224

Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
              VL     + +   CI S+                         AR   K L      
Sbjct: 225 ---VLGTP--SQEDLNCIISL------------------------RARNYIKSL------ 249

Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF- 452
                       P++  +    +   +    AL D L  ++ F+P KR +  +A  HP+ 
Sbjct: 250 ------------PFKPKVPWNKLFPNAD-PKAL-DLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 453 ----------VTGEPFTCPYQPPPETPR 470
                     V  EPF   ++   + P+
Sbjct: 296 EQYHDPSDEPVAEEPFPFDFELFDDLPK 323

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  149 bits (378), Expect = 2e-39
 Identities = 108/381 (28%), Positives = 168/381 (44%), Gaps = 111/381 (29%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQP-AYYQQALVEVSILTTLN 163
           R+Y +   LG G +G V K  D      VA+K I    +N   A  Q+   E+  L  L 
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA--QRTFREIMFLQELG 64

Query: 164 KKYDREDKHHIVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK- 220
                 D  +IV++      +  + + + FE ++++L+ +I+ N        I++   K 
Sbjct: 65  ------DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN--------ILEDVHKR 110

Query: 221 ----QILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS- 272
               Q+L+ L  +    +IH DLKP NILL   C       +K+ DFG A    R++   
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR------VKLADFGLA----RSLSEL 160

Query: 273 -----------YIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320
                      Y+ +R+YR+PE+LLG  +YT  +DMWS GCI+ E+ LG PLFPG S  +
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220

Query: 321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEA 380
            L ++I ++G  PP                  S  +IE    SI   S + A T ++   
Sbjct: 221 QLEKIIEVIG--PP------------------SAEDIE----SIK--SPFAA-TMLDSLP 253

Query: 381 RELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAK 440
              +KP           L+E++           +D           +D LK L+ F+P K
Sbjct: 254 SRPRKP-----------LDELLPKAS-------DDA----------LDLLKKLLVFNPNK 285

Query: 441 RWSPFQASRHPFVTGEPFTCP 461
           R +  +A  HP+V    F  P
Sbjct: 286 RLTAEEALEHPYV--AQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  147 bits (373), Expect = 2e-39
 Identities = 83/251 (33%), Positives = 127/251 (50%), Gaps = 28/251 (11%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDR 168
           Y +   +G GTF +V K    +   + A+K +K      +Q   L E+  L  L+     
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----- 55

Query: 169 EDKHHIVRIYEYFVCQRH--LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
               +I+R+ E    ++   L + FEL+D NLYELIK    R L    V+ +  Q+L+ L
Sbjct: 56  -PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIK-GRKRPLPEKRVKSYMYQLLKSL 113

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS------YIQSRYYR 280
             +   GI H D+KPENIL+    K   +K+ DFGS     R +YS      YI +R+YR
Sbjct: 114 DHMHRNGIFHRDIKPENILI----KDDILKLADFGSC----RGIYSKPPYTEYISTRWYR 165

Query: 281 SPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           +PE LL  GY Y   +D+W+ GC+  E+    PLFPG +E D + ++  +LG    + + 
Sbjct: 166 APECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224

Query: 339 KEAKNTSKFFK 349
           K  K+    + 
Sbjct: 225 KFRKSRHMNYN 235

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 2e-38
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 27/235 (11%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYD 167
           Y     +G G +G V K  D     FVA+K ++   ++       L E+++L    K+ +
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALL----KQLE 56

Query: 168 REDKHHIVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
             +  +IVR+ +     R      L + FE +D +L   +      GL    ++   +Q+
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR----- 277
           LRG+  L    I+H DLKP+NIL+ +     ++KI DFG A      +YS+  +      
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLA-----RIYSFEMALTSVVV 168

Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
             +YR+PEVLL   Y T +DMWS GCI AELF   PLF G SE D L ++  ++G
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  140 bits (354), Expect = 6e-37
 Identities = 82/235 (34%), Positives = 125/235 (53%), Gaps = 32/235 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
           +Y    L+G G++G V KC   E    VA+K     ++     + A+ E+ +L  L    
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL---- 57

Query: 167 DREDKHH--IVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
                 H  +V + E F  ++ L + FE +D   L +L K  +  GL  S V+ +  QIL
Sbjct: 58  -----RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQIL 110

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-------YIQS 276
           RG+       IIH D+KPENIL+  S     +K+ DFG A    RT+ +       Y+ +
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFA----RTLAAPGEVYTDYVAT 163

Query: 277 RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           R+YR+PE+L+G  +Y  A+D+W+ GC+V E+  G PLFPG S+ D L  +I+ LG
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  141 bits (358), Expect = 7e-37
 Identities = 80/272 (29%), Positives = 119/272 (43%), Gaps = 67/272 (24%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           E   RY     +G G +GQV   +D +    VA+K                        K
Sbjct: 12  EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------------------------K 47

Query: 166 YDR--EDKHHIVRIYEYFVCQRHLC----ICF--------------------ELLDSNLY 199
             R  +   H  R Y      +H+     I                       L+ ++L 
Sbjct: 48  LSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLN 107

Query: 200 ELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIK 256
            ++K    + LS   +Q    QILRGL  +  AGIIH DLKP NI +   C      E+K
Sbjct: 108 NIVK---CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC------ELK 158

Query: 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPG 315
           I+DFG A   D  +  Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG
Sbjct: 159 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218

Query: 316 ASEFDLLRRMIRILGAQPPDYVLK----EAKN 343
           +   D L+R++ ++G    + + K     A+N
Sbjct: 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARN 250

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (349), Expect = 1e-36
 Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 20/241 (8%)

Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDREDK 171
           + + +G G FG+V K         VA+K+IK       ++ + E+ IL            
Sbjct: 4   ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPN----- 58

Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
             IV+ Y  ++ +  L I  E     +L +L+K +  + L+ S +    K++L+GL  L 
Sbjct: 59  --IVKYYGSYLKKDELWIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLH 115

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGY 288
             GIIH D+K  NILL +     E+K+IDFG +   ++ +   + + + Y+ +PEV+ G 
Sbjct: 116 SNGIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172

Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
            Y    D+WS G    EL  G P +   SE   ++ + +I  A      L+  +  S  F
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKI--ATNGPPGLRNPEKWSDEF 227

Query: 349 K 349
           K
Sbjct: 228 K 228

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  140 bits (355), Expect = 1e-36
 Identities = 104/392 (26%), Positives = 167/392 (42%), Gaps = 92/392 (23%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKY 166
           RY   + +G G +G V    D      VA+K I +    P   ++ L E+ IL       
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKIL------- 58

Query: 167 DREDKH-HIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
            R  KH +I+ I +         + + +  +L++S+L+ +I   H    L+   ++ F  
Sbjct: 59  -RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII---HSDQPLTEEHIRYFLY 114

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CT--EDRTVY--SY 273
           Q+LRGL  +  A +IH DLKP N+L+    +  E++I DFG A    +   +   +   Y
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 274 IQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
           + +R+YR+PE+LL   +YTTAIDMWS GCI AE+     LFPG +    L+ ++ +LG  
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG-S 230

Query: 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY 392
           P + VL            IGS                            +  +  I  + 
Sbjct: 231 PSEEVLNR----------IGS----------------------------DRVRKYI--QN 250

Query: 393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
              K        +P          S E+      +D L  +++FDP +R +  QA +HPF
Sbjct: 251 LPRKQPVPWSKIFP--------KASPEA------LDLLSQMLQFDPEERITVEQALQHPF 296

Query: 453 VTGEPFTCPYQPPPETPRVPVAQNFKVDHHPG 484
           +        Y  P + P  P   +F  +    
Sbjct: 297 LAQ------YHDPDDEPTCPPPFDFDFEAIEL 322

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 1e-36
 Identities = 77/247 (31%), Positives = 114/247 (46%), Gaps = 55/247 (22%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNK 164
           Y     +G GT+GQV K  + +    VA+K I+ +      P     A+ E+ +L  L  
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP---ITAIREIKLLQKLRH 57

Query: 165 KYDREDKHHIVRIYE----------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
                   +IVR+ E          Y V        FE +D +L  L+       +  + 
Sbjct: 58  P-------NIVRLKEIVTSKGKGSIYMV--------FEYMDHDLTGLL---DSPEVKFTE 99

Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
            Q+  + KQ+L GL  L   GI+H D+K  NIL+        +K+ DFG A    R    
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND---GVLKLADFGLA----RPYTK 152

Query: 273 YIQSRY--------YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
              + Y        YR PE+LLG  +Y   +DMWS GCI+AELFLG P+F G++E + L 
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212

Query: 324 RMIRILG 330
           ++  + G
Sbjct: 213 KIFELCG 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  140 bits (354), Expect = 2e-36
 Identities = 84/251 (33%), Positives = 129/251 (51%), Gaps = 21/251 (8%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
           E   RY+    +G G FG V    D      VA+K I      P   ++   E+ +L  L
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66

Query: 163 NKKYDREDKHHIVRIYEYFVCQRH-LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
             +       +I+ + + F+     +    ELL ++L+ L+     R L    +Q F  Q
Sbjct: 67  RHE-------NIISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQ 116

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
           ILRGL  +  AG++H DLKP NIL+  +    ++KI DFG A  +D  +  Y+ +RYYR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINEN---CDLKICDFGLARIQDPQMTGYVSTRYYRA 173

Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
           PE++L +Q Y   +D+WS GCI AE+  G PLFPG    +    +  +LG  PPD V+  
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG-TPPDDVINT 232

Query: 341 --AKNTSKFFK 349
             ++NT +F +
Sbjct: 233 ICSENTLRFVQ 243

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  138 bits (349), Expect = 3e-36
 Identities = 100/345 (28%), Positives = 155/345 (44%), Gaps = 77/345 (22%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKH- 172
           +G G++G V KC + E    VA+K     ++ P   + AL E+ +L  L        KH 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL--------KHP 60

Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           ++V + E F  +R L + FE  D + L EL K  + RG+   +++    Q L+ ++    
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLG- 287
              IH D+KPENIL+    K  +IK+ DFG A            Y+ +R+YR+PE+L+G 
Sbjct: 119 HNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
            QY   +D+W+ GC+ AEL  G PL+PG S+ D L  + + LG   P +  ++  +T++F
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH--QQIFSTNQF 233

Query: 348 FKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPY 407
           FK                       L+  E E RE               LE    N   
Sbjct: 234 FK----------------------GLSIPEPETREP--------------LESKFPNISS 257

Query: 408 RKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
                              + FLKG ++ DP +R S  +   HP+
Sbjct: 258 PA-----------------LSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  134 bits (341), Expect = 2e-35
 Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 31/244 (12%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVK---IIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           LLG G+FG V    D +    +AVK   +  +     +    E+ IL++L          
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHP------- 59

Query: 173 HIVRIY--EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           +IVR Y  E    +  L I  E +   +L  L+K   F  L   +++ +++QIL GL+ L
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTRQILEGLAYL 117

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRSPE 283
              GI+H D+K  NIL+ +      +K+ DFG A       T + T  S   + Y+ +PE
Sbjct: 118 HSNGIVHRDIKGANILVDSD---GVVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPE 173

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP----PDYVLK 339
           V+ G +Y  A D+WS GC V E+  G P  P +   + +  + +I  +      P+++ +
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKP--PWSELGNPMAALYKIGSSGEPPEIPEHLSE 231

Query: 340 EAKN 343
           EAK+
Sbjct: 232 EAKD 235

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  136 bits (343), Expect = 2e-35
 Identities = 74/222 (33%), Positives = 125/222 (56%), Gaps = 19/222 (8%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           LG GT+  V K  +      VA+K I    +      A+ E+S++        +E KH +
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLM--------KELKHEN 59

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKIN-HFRGLSLSIVQLFSKQILRGLSLLKDA 232
           IVR+++    +  L + FE +D +L + +  +     L  + V+ F+ Q+L+G++   + 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLGYQ 289
            ++H DLKP+N+L+    K  E+K+ DFG A        T  + + + +YR+P+VLLG +
Sbjct: 120 RVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 290 -YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            Y+T+ID+WS GCI+AE+  G PLFPG +  D L ++ RI+G
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  136 bits (344), Expect = 4e-35
 Identities = 87/269 (32%), Positives = 127/269 (47%), Gaps = 39/269 (14%)

Query: 105 AETQRRYIVKD-LLGHGTFGQVAKCWDAEMNSFVAVKIIKN-----QPAYYQQALVEVSI 158
                RYI K   LG GT+G+V K +D      VA+K +K           +Q +    I
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 159 -LTTLNK-KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
             TTL + K   E KH +I+ + + +V    + +  +++ S+L +++       L+ S V
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR--LTESQV 121

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--- 272
           +    QIL GL++L     +H DL P NI +         KI DFG A    R  Y    
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLA---RRYGYPPYS 175

Query: 273 -------YIQSR----------YYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFP 314
                   +Q R          +YR+PE+L+G + Y  A+DMWS GCI AEL  G PLFP
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235

Query: 315 GASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           G +E D L R+  +LG  P +    +AK 
Sbjct: 236 GENEIDQLGRIFELLGT-PNEDNWPQAKK 263

Length = 335

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 3e-34
 Identities = 77/225 (34%), Positives = 122/225 (54%), Gaps = 25/225 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDRED 170
           +G GT+G V K  D      VA+K I+ +      P+    A+ E+S+L        +E 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS---TAIREISLL--------KEL 55

Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
            H +IVR+ +    +  L + FE LD +L + +  +   GL   +++ +  Q+L+G++  
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLL 286
               ++H DLKP+N+L+        +K+ DFG A      V +Y   + + +YR+PE+LL
Sbjct: 116 HSHRVLHRDLKPQNLLIDRE---GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 172

Query: 287 G-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           G  QY+T +D+WS GCI AE+    PLFPG SE D L R+ R LG
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  135 bits (339), Expect = 3e-34
 Identities = 84/339 (24%), Positives = 138/339 (40%), Gaps = 42/339 (12%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
           Y +   LG G+FG+V    D      VA+K++     ++    ++ L E+ IL +LN   
Sbjct: 2   YRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLN--- 55

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG-LSLSIVQLFSKQILR 224
                 +IV++Y++F  +  L +  E +D  +L +L+K    +G LS S       QIL 
Sbjct: 56  ---HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---------TEDRTVYSYIQ 275
            L  L   GIIH D+KPENILL        +K+IDFG A          +      + + 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 276 SRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
           +  Y +PEVLLG      +++ D+WS G  + EL  GLP F G        + ++I+   
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230

Query: 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY 392
           P   +                +       +S       + L   + + R      +  + 
Sbjct: 231 PTPSLASP-------------LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Query: 393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLK 431
             H  L+E   +   + + S            AL+  L 
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLN 316

Length = 384

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  130 bits (329), Expect = 1e-33
 Identities = 82/231 (35%), Positives = 125/231 (54%), Gaps = 23/231 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
           +Y   + +G GT+G V K  + E +  VA+K ++   +       AL E+ +L       
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL------- 53

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILR 224
            +E KH +IVR+Y+     + L + FE  D +L +    +   G +   IV+ F  Q+L+
Sbjct: 54  -KELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYF--DSCNGDIDPEIVKSFMFQLLK 110

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRS 281
           GL+      ++H DLKP+N+L+    K  E+K+ DFG A      V  Y   + + +YR 
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 167

Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILG 330
           P+VL G + Y+T+IDMWS GCI AEL   G PLFPG    D L+R+ R+LG
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  131 bits (332), Expect = 1e-33
 Identities = 105/366 (28%), Positives = 162/366 (44%), Gaps = 93/366 (25%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN--SFVAVKIIKN---QPAYYQQALVEVSIL----- 159
           RY +   LG G +G V    +AE +    VA+K I N   +    ++AL E+ +L     
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 160 ----TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
               T L   YD +    IV    +      L +  EL++++L+++I+    + L+ +  
Sbjct: 61  HKNITCL---YDMD----IVFPGNF----NELYLYEELMEADLHQIIRSG--QPLTDAHF 107

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-------TEDR 268
           Q F  QIL GL  +  A ++H DLKP N LL  +    E+KI DFG A            
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGN-LLVNA--DCELKICDFGLARGFSENPGENAG 164

Query: 269 TVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
            +  Y+ +R+YR+PE++L +Q YT AID+WS GCI+AEL    P+F G    D L ++++
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224

Query: 328 ILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
           +LG  P +  L     + K    I S+ NI                          KKP 
Sbjct: 225 VLGT-PDEETLSRIG-SPKAQNYIRSLPNIP-------------------------KKP- 256

Query: 388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQA 447
                          + +P    L+              +D L+ L+ FDP KR S  +A
Sbjct: 257 -------------FESIFPNANPLA--------------LDLLEKLLAFDPTKRISVEEA 289

Query: 448 SRHPFV 453
             HP++
Sbjct: 290 LEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  131 bits (331), Expect = 2e-33
 Identities = 80/243 (32%), Positives = 126/243 (51%), Gaps = 26/243 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKY 166
           RY +++++G G++G V    D      VA+K I +   +   A   L E+ +L  L    
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 167 DREDKHHIV----RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
             E KH ++    R +      + + + FEL++S+L+++IK N    L+    Q F  Q+
Sbjct: 61  IVEIKHIMLPPSRREF------KDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQL 112

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR--TVY--SYIQS 276
           LR L  +  A + H DLKP+NIL     K   +KI DFG A     D    ++   Y+ +
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTAIFWTDYVAT 169

Query: 277 RYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           R+YR+PE+   +  +YT AID+WS GCI AE+  G PLFPG +    L  +  +LG   P
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229

Query: 335 DYV 337
           + +
Sbjct: 230 ETI 232

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  130 bits (330), Expect = 3e-33
 Identities = 81/241 (33%), Positives = 129/241 (53%), Gaps = 28/241 (11%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-----YQQALVEVSILT 160
           E   +Y+    +G G +G V    ++E N  VA+K I N  A+      ++ L E+ +L 
Sbjct: 2   EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN--AFDNRIDAKRTLREIKLLR 59

Query: 161 TLNKKYDREDKHHIVRIYEYF--VCQRH---LCICFELLDSNLYELIKINHFRGLSLSIV 215
            L       D  +++ I +      +     + I +EL+D++L+++I+ +  + LS    
Sbjct: 60  HL-------DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHC 110

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT---VYS 272
           Q F  Q+LRGL  +  A ++H DLKP N+LL  +    ++KI DFG A T       +  
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTE 167

Query: 273 YIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           Y+ +R+YR+PE+LL   +YTTAID+WS GCI AEL    PLFPG      L+ +  +LG+
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227

Query: 332 Q 332
            
Sbjct: 228 P 228

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score =  133 bits (336), Expect = 4e-33
 Identities = 104/372 (27%), Positives = 167/372 (44%), Gaps = 75/372 (20%)

Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           ++  TQR  I+  LLG GTFG+V + WD +   + AVKI++N P Y + A +E+  +  +
Sbjct: 124 IDVSTQRFKILS-LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV 182

Query: 163 NKKYDREDKHHIVRIYEYFVCQR-HLCICFELLDSNLYELI----KINHFRGLSLSIVQL 217
            ++ D  D+  +++I  YF  +  H+CI        L + I      +H R L+  I Q 
Sbjct: 183 -RQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH-RHLAQIIFQT 240

Query: 218 FSKQILRGLSL---LKDAGIIHCDLKPENILLCTS-------------VKPAEIKIIDFG 261
                  G++L     +  ++H DLKPENIL+ TS               P  ++I D G
Sbjct: 241 -------GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293

Query: 262 SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
             C E  +  + + +R+YRSPEV+LG  +  + DMWS GCI+ EL+ G  L+      + 
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353

Query: 322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEAR 381
           L  M + LG  P ++  +     +                     R  Y +  ++    R
Sbjct: 354 LHLMEKTLGRLPSEWAGRCGTEEA---------------------RLLYNSAGQL----R 388

Query: 382 ELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKR 441
               P         KHL  I    P R+ +  +D+         L D + GL+ +D  KR
Sbjct: 389 PCTDP---------KHLARIARARPVREVIR-DDL---------LCDLIYGLLHYDRQKR 429

Query: 442 WSPFQASRHPFV 453
            +  Q + HP+V
Sbjct: 430 LNARQMTTHPYV 441

Length = 467

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  128 bits (322), Expect = 8e-33
 Identities = 77/233 (33%), Positives = 123/233 (52%), Gaps = 18/233 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKY 166
           ++ V  ++G G +G V KC   E    VA+K  K+        +  L E+ +L TL ++ 
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE- 60

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 +IV + E F  +  L + FE ++ N+ EL++     G+    V+ +  Q+++ +
Sbjct: 61  ------NIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAI 113

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT----EDRTVYSYIQSRYYRSP 282
                  I+H D+KPEN+L+  +     +K+ DFG A       +     Y+ +R+YRSP
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHN---DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           E+LLG  Y  A+DMWS GCI+ EL  G PLFPG SE D L  + ++LG  P +
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 8e-33
 Identities = 78/233 (33%), Positives = 127/233 (54%), Gaps = 20/233 (8%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ--QALVEVSILTTLNKKYDR 168
           Y   D LG G++  V K         VA+K I+ +        A+ E S+L  L      
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL------ 60

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             KH +IV +++    ++ L + FE LD++L + +  +   GLS+  V+LF  Q+LRGL+
Sbjct: 61  --KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMD-DCGGGLSMHNVRLFLFQLLRGLA 117

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEV 284
                 ++H DLKP+N+L+       E+K+ DFG A  +    +T  + + + +YR P+V
Sbjct: 118 YCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174

Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE-FDLLRRMIRILGAQPPD 335
           LLG  +Y+T++DMW  GCI  E+  G PLFPG+++  D L ++ R+LG    +
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  127 bits (320), Expect = 2e-32
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 60

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQ- 289
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG + 
Sbjct: 121 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           Y+TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  126 bits (319), Expect = 2e-32
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 57/262 (21%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
           +    ++G G+F  V    + E N   A+KI+      +    +   +E  +LT LN   
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--- 59

Query: 167 DREDKHH--IVRIYE--------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
                 H  I+++Y         YFV +       ELL         I  +  L     +
Sbjct: 60  -----GHPGIIKLYYTFQDEENLYFVLE--YAPNGELLQ-------YIRKYGSLDEKCTR 105

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC------------ 264
            ++ +IL  L  L   GIIH DLKPENILL    K   IKI DFG+A             
Sbjct: 106 FYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 265 ---TEDRTVYSYIQSRY--------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
              T   +     + R+        Y SPE+L       + D+W+ GCI+ ++  G P F
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Query: 314 PGASEFDLLRRMIRILGAQPPD 335
            G++E+   ++++++  + PP+
Sbjct: 223 RGSNEYLTFQKILKLEYSFPPN 244

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  130 bits (327), Expect = 3e-32
 Identities = 86/252 (34%), Positives = 137/252 (54%), Gaps = 28/252 (11%)

Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +N    + Y + +++G+G+FG V +    + +  VA+K +   P Y  + L+ +  L  +
Sbjct: 60  INRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI 119

Query: 163 NKKYDREDKHHIVRIYEYFVCQRH------LCICFELLDSNLYELIKI----NHFRGLSL 212
           N  + ++        Y Y  C +       L +  E +   +++ +K     NH   L L
Sbjct: 120 NIIFLKD--------YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH--ALPL 169

Query: 213 SIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRT 269
            +V+L+S Q+ R L+ +    I H DLKP+N+L+        +K+ DFGSA       R+
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFGSAKNLLAGQRS 227

Query: 270 VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
           V SYI SR+YR+PE++LG   YTT ID+WS GCI+AE+ LG P+F G S  D L R+I++
Sbjct: 228 V-SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286

Query: 329 LGAQPPDYVLKE 340
           LG  P +  LKE
Sbjct: 287 LGT-PTEDQLKE 297

Length = 440

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  125 bits (316), Expect = 8e-32
 Identities = 76/221 (34%), Positives = 115/221 (52%), Gaps = 22/221 (9%)

Query: 120 GTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKYDREDKH-HIV 175
           GT+G V +  D +    VA+K +K +     +   +L E++IL  L         H +IV
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--------HPNIV 67

Query: 176 RIYEYFV--CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
            + E  V      + +  E ++ +L  L++    +    S V+    Q+L G++ L D  
Sbjct: 68  TVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW 126

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ-SRYYRSPEVLLGY-Q 289
           I+H DLK  N+LL        +KI DFG A         Y+ +  + +YR+PE+LLG  +
Sbjct: 127 ILHRDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           Y+TAIDMWS GCI AEL    PLFPG SE D L ++ ++LG
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 9e-32
 Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 27/235 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
            Y + DL+G G FG V K  + E   FVA+K I   K +    +  + E+ +L  L    
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
                 +IV+          L I  E  ++ +L ++IK   F     S+V ++  Q+L+G
Sbjct: 59  -----PNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQG 111

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSP 282
           L+ L + G+IH D+K  NIL     K   +K+ DFG A       +   S + + Y+ +P
Sbjct: 112 LAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQ-PP 334
           EV+     +TA D+WS GC V EL  G P +     +DL  +  + RI+    PP
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPY-----YDLNPMAALFRIVQDDHPP 218

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  124 bits (313), Expect = 3e-31
 Identities = 106/370 (28%), Positives = 154/370 (41%), Gaps = 89/370 (24%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDRED 170
           +G GT+G V +  D      VA+K ++        P     +L E+++L  L        
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPI---SSLREITLLLNL-------- 63

Query: 171 KHH--IVRIYEYFVCQR--HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
             H  IV + E  V +    + +  E  + +L  L+  N     S S V+    Q+LRGL
Sbjct: 64  -RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-NMPTPFSESQVKCLMLQLLRGL 121

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPE 283
             L +  IIH DLK  N+LL        +KI DFG A T           + + +YR+PE
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178

Query: 284 VLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
           +LLG   YTTAIDMW+ GCI+AEL    PL PG SE + L  +I++LG  P +       
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT-PNE------- 230

Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
                        +I  G         +  L            PL+GK     +      
Sbjct: 231 -------------SIWPG---------FSDL------------PLVGKFTLPKQ------ 250

Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
              PY  NL  +     S+  L L++F   L+ +DP KR +  +A    +   +P  C  
Sbjct: 251 ---PY-NNLKHK-FPWLSEAGLRLLNF---LLMYDPKKRATAEEALESSYFKEKPLPC-- 300

Query: 463 QPPPETPRVP 472
             P   P  P
Sbjct: 301 -EPEMMPTFP 309

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  123 bits (310), Expect = 5e-31
 Identities = 75/222 (33%), Positives = 120/222 (54%), Gaps = 18/222 (8%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKH- 172
           +G GT+G V K  D   N  +A+K I+           A+ E+S+L        +E +H 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLL--------KEMQHG 61

Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
           +IVR+ +    ++ L + FE LD +L + +  +     +  +++ +  QILRG++     
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLG-Y 288
            ++H DLKP+N+L+        +K+ DFG A       RT    + + +YR+PE+LLG  
Sbjct: 122 RVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            Y+T +D+WS GCI AE+    PLFPG SE D L ++ RILG
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG 221

Length = 294

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  124 bits (313), Expect = 7e-31
 Identities = 105/380 (27%), Positives = 167/380 (43%), Gaps = 87/380 (22%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +D      VA+K + ++P     + ++A  E+ ++  +N 
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNH 74

Query: 165 KYDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+       + +  EL+D+NL ++I+  ++H R +S  + Q
Sbjct: 75  K-------NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER-MSYLLYQ 126

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACT--EDRTVY 271
           +     L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T      + 
Sbjct: 127 M-----LCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 175

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
            Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG 
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235

Query: 332 QPPDYVLKEAKNTSKFFKCIG-SVHN-IENGEVSIGGRSAYQALTEIEYEARELKKPLIG 389
              +           F   +  +V N +EN       R  Y   +               
Sbjct: 236 PSDE-----------FMSRLQPTVRNYVEN-------RPKYAGYS--------------- 262

Query: 390 KEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASR 449
                    EE+  +  +  +    +  K SQ R    D L  ++  DP KR S   A +
Sbjct: 263 --------FEELFPDVLFPPDSESHNKLKASQAR----DLLSKMLVIDPEKRISVDDALQ 310

Query: 450 HPFVT--GEPFTCPYQPPPE 467
           HP++    +P      PPP 
Sbjct: 311 HPYINVWYDPSEV-EAPPPA 329

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  121 bits (306), Expect = 2e-30
 Identities = 78/233 (33%), Positives = 118/233 (50%), Gaps = 31/233 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G+V K  D      VA+K  +   ++      AL E+S+L  L++        +
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES------IY 62

Query: 174 IVRIYEYFVCQRH---------LCICFELLDSNLYELIKINH---FRGLSLSIVQLFSKQ 221
           IVR+    +   H         L + FE LDS+L + +  N     R L    ++ F  Q
Sbjct: 63  IVRL----LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRY 278
           +L+G++     G++H DLKP+N+L+        +KI D G        V SY   I + +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQK--GLLKIADLGLGRAFSIPVKSYTHEIVTLW 176

Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           YR+PEVLLG   Y+T +D+WS GCI AE+    PLFPG SE   L  + ++LG
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  122 bits (307), Expect = 3e-30
 Identities = 81/240 (33%), Positives = 119/240 (49%), Gaps = 39/240 (16%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G+ G V    D++ +  VAVK I+   P   + AL E+ I+  L       D  +IV
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-------DHDNIV 65

Query: 176 RIYEYFVCQRH--------------LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
           ++YE                     + I  E ++++L  +++      LS    +LF  Q
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFMYQ 122

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------I 274
           +LRGL  +  A ++H DLKP N+ + T  +   +KI DFG A   D   YS+       +
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVDPH-YSHKGYLSEGL 179

Query: 275 QSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
            +++YRSP +LL    YT AIDMW+ GCI AE+  G PLF GA E   L +M  IL + P
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE---LEQMQLILESVP 236

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  120 bits (303), Expect = 1e-29
 Identities = 79/257 (30%), Positives = 130/257 (50%), Gaps = 31/257 (12%)

Query: 106 ETQRRYIVKDLL--GHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILT 160
           E   RY  +DL   G G +G V    D    + VA+K +        + ++A  E+ +L 
Sbjct: 12  EVPDRY--RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL- 68

Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSI 214
               K+ + +  +++ + + F     L       +    + ++L +L+K      LS   
Sbjct: 69  ----KHMKHE--NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDR 119

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
           +Q    Q+L+GL  +  AGIIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+
Sbjct: 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQTDSEMTGYV 176

Query: 275 QSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
            +R+YR+PEV+L +  YT  +D+WS GCI+AE+  G PLF G    D L  ++++ G   
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236

Query: 334 PDYVLK----EAKNTSK 346
            ++V K    +AKN  K
Sbjct: 237 KEFVQKLQSEDAKNYVK 253

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  118 bits (299), Expect = 2e-29
 Identities = 74/251 (29%), Positives = 116/251 (46%), Gaps = 39/251 (15%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--IIKNQP-AYYQQALVEVSILTTLN 163
             R Y +   LG GTFG+V K    +    VA+K  ++ N+   +   AL E+ IL  L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 164 KK---------YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
                       +R DK    R   Y V           +D +L  L++    + L+ S 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMV--------TPYMDHDLSGLLENPSVK-LTESQ 116

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------- 263
           ++ +  Q+L G++ L +  I+H D+K  NIL+        +KI DFG A           
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGPPPNPK 173

Query: 264 --CTEDRTVY-SYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319
                    Y + + +R+YR PE+LLG  +YTTA+D+W  GC+ AE+F   P+  G S+ 
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233

Query: 320 DLLRRMIRILG 330
           D L  + ++ G
Sbjct: 234 DQLHLIFKLCG 244

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  119 bits (300), Expect = 3e-29
 Identities = 109/379 (28%), Positives = 172/379 (45%), Gaps = 86/379 (22%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +D  +   VAVK +    +NQ  + ++A  E+ +L  +N 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNH 79

Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELI--KINHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I  +++H R      + 
Sbjct: 80  K-------NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER------MS 126

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG---SACTEDRTV 270
               Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG   +ACT +  +
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTACT-NFMM 179

Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
             Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ EL  G  +F G    D   ++I  LG
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239

Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
               +++ +       +         +EN       R  Y  ++                
Sbjct: 240 TPSAEFMNRLQPTVRNY---------VEN-------RPQYPGIS---------------- 267

Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
                   EE+  ++ +    S  D  K SQ R    D L  ++  DP KR S  +A RH
Sbjct: 268 -------FEELFPDWIFPSE-SERDKLKTSQAR----DLLSKMLVIDPDKRISVDEALRH 315

Query: 451 PFVT--GEPFTCPYQPPPE 467
           P++T   +P      PPP+
Sbjct: 316 PYITVWYDPAEAE-APPPQ 333

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  117 bits (295), Expect = 3e-29
 Identities = 81/227 (35%), Positives = 127/227 (55%), Gaps = 19/227 (8%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
           Y+  D LG GT+  V K       + VA+K I+  ++      A+ EVS+L  L      
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL------ 60

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             KH +IV +++    +R L + FE LDS+L + +  N    +S+  V++F  Q+LRGLS
Sbjct: 61  --KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLD-NCGNLMSMHNVKIFMFQLLRGLS 117

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEV 284
                 I+H DLKP+N+L+    +  E+K+ DFG A  +     +Y   + + +YR P+V
Sbjct: 118 YCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174

Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           LLG  +Y+T IDMW  GCI+ E+  G P+FPG++  + L  + R+LG
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG 221

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (293), Expect = 5e-29
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           LG G+ G V K          A+K I       + +Q L E+  L        R  +  +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL--------RSCESPY 60

Query: 174 IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLL-KD 231
           +V+ Y  F  +  + I  E +D  +L +L+K      +   ++   ++QIL+GL  L   
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK 118

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTV--YSYIQSRYYRSPEVLLGY 288
             IIH D+KP N+L+ +     E+KI DFG S   E+      +++ +  Y SPE + G 
Sbjct: 119 RHIIHRDIKPSNLLINSK---GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 289 QYTTAIDMWSFGCIVAELFLG-LPLFP--GASEFDLLR 323
            Y+ A D+WS G  + E  LG  P  P    S F+L++
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  117 bits (294), Expect = 5e-29
 Identities = 80/236 (33%), Positives = 120/236 (50%), Gaps = 31/236 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G +G V K  D     FVA+K ++   N+       + EV++L    K+ +  D  +
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALL----KRLEAFDHPN 63

Query: 174 IVRIYEYFVC-------QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           IVR+ +  VC       +  + + FE +D +L   +      GL    ++   +Q LRGL
Sbjct: 64  IVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYY 279
             L    I+H DLKPENIL+ +     ++K+ DFG A      +YS        + + +Y
Sbjct: 122 DFLHANCIVHRDLKPENILVTSG---GQVKLADFGLA-----RIYSCQMALTPVVVTLWY 173

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+PEVLL   Y T +DMWS GCI AE+F   PLF G SE D L ++  ++G  P D
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  117 bits (294), Expect = 1e-28
 Identities = 77/263 (29%), Positives = 129/263 (49%), Gaps = 36/263 (13%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVE-- 155
           E   RY     +G G +G V   +D  +   VAVK        +I  +  Y +  L++  
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71

Query: 156 -----VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL 210
                + +L         E+ + +     Y V          L+ ++L  ++K    + L
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEV-----YLVTN--------LMGADLNNIVK---CQKL 115

Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           S   VQ    Q+LRGL  +  AGIIH DLKP N+ +    +  E++I+DFG A   D  +
Sbjct: 116 SDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEM 172

Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+R++ ++
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232

Query: 330 GAQPPDYVLK-EAKNTSKFFKCI 351
           G   P+ + K  +++  K+ + +
Sbjct: 233 GTPSPEVLKKISSEHARKYIQSL 255

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  115 bits (290), Expect = 1e-28
 Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 33/240 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTL 162
           +Y +   +G G+FG+V             +K I       K +    + AL EV IL  L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER----EDALNEVKILKKL 56

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS---IVQL 217
           N        H +I++ YE F  +  LCI  E  D  +L + IK     G       I+  
Sbjct: 57  N--------HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYI 274
           F  Q+   L  L    I+H D+KP+NI L ++     +K+ DFG +     TV    + +
Sbjct: 109 FV-QLCLALKYLHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSSTVDLAKTVV 164

Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            + YY SPE+     Y    D+WS GC++ EL      F G +  +L  ++++  G  PP
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPP 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 2e-28
 Identities = 65/237 (27%), Positives = 110/237 (46%), Gaps = 25/237 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH--I 174
           LG G+FG+V      +     A+K++K +     + +    +  TL ++      +H  I
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKK-----KIIKRKEVEHTLTERNILSRINHPFI 55

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V+++  F  +  L +  E       EL   ++     S    + ++ +I+  L  L   G
Sbjct: 56  VKLHYAFQTEEKLYLVLEYAPGG--ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG 113

Query: 234 IIHCDLKPENILLCTSVKPAE--IKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLGY 288
           II+ DLKPENILL      A+  IK+ DFG A    +E     ++  +  Y +PEVLLG 
Sbjct: 114 IIYRDLKPENILLD-----ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKEAKN 343
            Y  A+D WS G ++ E+  G P F      ++     +IL      P+++  EA++
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE---KILKDPLRFPEFLSPEARD 222

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  113 bits (284), Expect = 1e-27
 Identities = 81/247 (32%), Positives = 128/247 (51%), Gaps = 35/247 (14%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKH- 172
           +G GT+G V K  + +    VA+K I+    +      A+ E+S+L        +E +H 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLL--------KELQHP 59

Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYE-LIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           +IV + +  + +  L + FE L  +L + L  +   + +   +V+ +  QIL+G+     
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSY-IQSRYYRSPEV 284
             ++H DLKP+N+L+        IK+ DFG A    R       VY++ + + +YR+PEV
Sbjct: 120 RRVLHRDLKPQNLLIDNK---GVIKLADFGLA----RAFGIPVRVYTHEVVTLWYRAPEV 172

Query: 285 LLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV------ 337
           LLG   Y+T +D+WS G I AE+    PLF G SE D L R+ RILG  P + V      
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGVTS 231

Query: 338 LKEAKNT 344
           L + KNT
Sbjct: 232 LPDYKNT 238

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  115 bits (288), Expect = 1e-27
 Identities = 110/380 (28%), Positives = 174/380 (45%), Gaps = 84/380 (22%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82

Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I+  ++H R      + 
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MS 129

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VY 271
               Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  + 
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 183

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
            Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243

Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
             P++ +K+ + T + +        +EN       R  Y       Y   +L   ++   
Sbjct: 244 PCPEF-MKKLQPTVRTY--------VEN-------RPKYAG-----YSFEKLFPDVLFPA 282

Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
              H  L                   K SQ R    D L  ++  D +KR S  +A +HP
Sbjct: 283 DSEHNKL-------------------KASQAR----DLLSKMLVIDASKRISVDEALQHP 319

Query: 452 FVT--GEPFTCPYQPPPETP 469
           ++    +P      PPP+ P
Sbjct: 320 YINVWYDPSEAE-APPPKIP 338

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  113 bits (284), Expect = 1e-27
 Identities = 78/227 (34%), Positives = 126/227 (55%), Gaps = 19/227 (8%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
           YI  D LG GT+  V K      ++ VA+K I+  ++      A+ EVS+L  L      
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------ 61

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             KH +IV +++    ++ L + FE LD +L + +  +    +++  V+LF  Q+LRGL+
Sbjct: 62  --KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-DCGNSINMHNVKLFLFQLLRGLN 118

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEV 284
                 ++H DLKP+N+L+    +  E+K+ DFG A  +    +T  + + + +YR P++
Sbjct: 119 YCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175

Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           LLG   Y+T IDMW  GCI  E+  G PLFPG++  + L  + RILG
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  114 bits (286), Expect = 2e-27
 Identities = 77/259 (29%), Positives = 127/259 (49%), Gaps = 35/259 (13%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 70

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 71  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 117

Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 174

Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234

Query: 330 GAQPPDYVLKEAKNTSKFF 348
           G    + + K +  +++ +
Sbjct: 235 GTPGAELLKKISSESARNY 253

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  114 bits (285), Expect = 2e-27
 Identities = 109/378 (28%), Positives = 171/378 (45%), Gaps = 84/378 (22%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75

Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I+  ++H R      + 
Sbjct: 76  K-------NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER------MS 122

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VY 271
               Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  + 
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 176

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
            Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG 
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
             P+++ K       +         +EN       R  Y  LT      +     L   +
Sbjct: 237 PCPEFMKKLQPTVRNY---------VEN-------RPKYAGLT----FPKLFPDSLFPAD 276

Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
             H+K                     K SQ R    D L  ++  DPAKR S  +A +HP
Sbjct: 277 SEHNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDEALQHP 312

Query: 452 FVT--GEPFTCPYQPPPE 467
           ++    +P      PPP+
Sbjct: 313 YINVWYDPAEVE-APPPQ 329

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  112 bits (281), Expect = 4e-27
 Identities = 75/245 (30%), Positives = 118/245 (48%), Gaps = 33/245 (13%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYD 167
           + +   +G GT+GQV K  D +    VA+K ++    +  +   A+ E+ IL  LN +  
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR-- 66

Query: 168 REDKHHIVRIYEYFVCQ----------RHLCICFELLDSNLYELI--KINHFRGLSLSIV 215
                +IV + E    +              + FE +D +L  L+   + HF   S   +
Sbjct: 67  -----NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF---SEDHI 118

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYS 272
           + F KQ+L GL+       +H D+K  NILL       +IK+ DFG A    +E+   Y+
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK---GQIKLADFGLARLYNSEESRPYT 175

Query: 273 -YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
             + + +YR PE+LLG + Y  AID+WS GCI+ ELF   P+F    E   L  + R+ G
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235

Query: 331 AQPPD 335
           +  P 
Sbjct: 236 SPCPA 240

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  112 bits (280), Expect = 5e-27
 Identities = 79/232 (34%), Positives = 125/232 (53%), Gaps = 19/232 (8%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
           YI  + LG GT+  V K       + VA+K I+  ++      A+ EVS+L  L      
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL------ 61

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             KH +IV +++     + L + FE LD +L + +  +    +S+  V++F  QILRGL+
Sbjct: 62  --KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMD-DCGNIMSMHNVKIFLYQILRGLA 118

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEV 284
                 ++H DLKP+N+L+    +  E+K+ DFG A  +     +Y   + + +YR P+V
Sbjct: 119 YCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175

Query: 285 LLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           LLG  +Y+T IDMW  GCI  E+  G PLFPG++  D L  + R+LG    +
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  112 bits (281), Expect = 8e-27
 Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 20/248 (8%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V    D      VA+K +        + ++A  E+++L  +
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS--IVQLFSK 220
             +       +++ + + F          +      Y    +    G  LS   VQ    
Sbjct: 72  QHE-------NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVY 124

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           Q+L GL  +  AGIIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +R+YR
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLARHADAEMTGYVVTRWYR 181

Query: 281 SPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           +PEV+L +  Y   +D+WS GCI+AE+  G  LF G    D L +++++ G   P++V K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241

Query: 340 ----EAKN 343
                AK+
Sbjct: 242 LEDKAAKS 249

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 2e-26
 Identities = 97/372 (26%), Positives = 144/372 (38%), Gaps = 102/372 (27%)

Query: 118 GHGTFGQVAKCWDAEM--NSFVAVKIIKNQPAYY----QQALVEVSILTTLNKKYDREDK 171
           G GT+G+V K            A+K  K     Y    Q A  E+++L        RE K
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALL--------RELK 60

Query: 172 H-HIVRIYEYFVCQRHLCI--CFELLDSNLYELIKINHFRGLSLSIVQLFSK----QILR 224
           H ++V + E F+      +   F+  + +L+++IK  H +   +SI     K    QIL 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK-FHRQAKRVSIPPSMVKSLLWQILN 119

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQSRY---- 278
           G+  L    ++H DLKP NIL+     P    +KI D G A    R   + ++       
Sbjct: 120 GVHYLHSNWVLHRDLKPANILV-MGEGPERGVVKIGDLGLA----RLFNAPLKPLADLDP 174

Query: 279 ------YRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLL 322
                 YR+PE+LLG + YT AID+W+ GCI AEL    P+F G             D L
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234

Query: 323 RRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARE 382
            R+  +LG   P                                               E
Sbjct: 235 ERIFEVLG--TPT----------------------------------------------E 246

Query: 383 LKKPLIGKEYFHHKHLEEIVTNYPYRKNLS--MEDISKESQIRLALVDFLKGLVEFDPAK 440
              P I K   +   +++  T      +L+  ME   K       L   L+ L+E+DP K
Sbjct: 247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL---LRKLLEYDPTK 303

Query: 441 RWSPFQASRHPF 452
           R +  +A  HP+
Sbjct: 304 RITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (264), Expect = 4e-25
 Identities = 67/237 (28%), Positives = 107/237 (45%), Gaps = 30/237 (12%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDK 171
           + +G GTFG+V    + +    +AVK I+   N P   ++   E+ +L  L         
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHP------ 59

Query: 172 HHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            ++V+ Y   V +  + I  E      L EL++  H R L   ++++++ Q+L GL+ L 
Sbjct: 60  -NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRSPE 283
             GI+H D+KP NI L        IK+ DFG A        T    V S   +  Y +PE
Sbjct: 117 SHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 284 VLLGYQYT---TAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQPPDY 336
           V+ G +      A D+WS GC+V E+  G   +    +EF +   M  +     P  
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFHVGAGHKPPI 227

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  105 bits (263), Expect = 5e-25
 Identities = 71/232 (30%), Positives = 120/232 (51%), Gaps = 22/232 (9%)

Query: 117 LGHGTFGQVAKCWDAEMNS-FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +G G +G+V K  D +    FVA+K ++ Q       L  +  +  L +  +  +  ++V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL-RHLETFEHPNVV 67

Query: 176 RIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           R+++     R      L + FE +D +L   +      G+    ++    Q+LRGL  L 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRSPE 283
              ++H DLKP+NIL+ +S    +IK+ DFG A      +YS+       + + +YR+PE
Sbjct: 128 SHRVVHRDLKPQNILVTSS---GQIKLADFGLA-----RIYSFQMALTSVVVTLWYRAPE 179

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           VLL   Y T +D+WS GCI AE+F   PLF G+S+ D L +++ ++G    +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  104 bits (262), Expect = 8e-25
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)

Query: 120 GTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           G +G+V            A+K+I       KNQ     Q L E  IL+     Y      
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ---VDQVLTERDILSQAQSPY------ 54

Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
            +V++Y  F  +++L +  E L   +L  L++  +   L   + +++  +I+  L  L  
Sbjct: 55  -VVKLYYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHS 111

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR---------YYR 280
            GIIH DLKP+NIL+        +K+ DFG        R +      +          Y 
Sbjct: 112 NGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
           +PEV+LG  ++  +D WS GCI+ E  +G+P F G + 
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  105 bits (265), Expect = 2e-24
 Identities = 57/156 (36%), Positives = 89/156 (57%), Gaps = 10/156 (6%)

Query: 183 CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPE 242
               + +  EL+ S+L+++I     + LS   V++F  QILRGL  L  AGI+H D+KP 
Sbjct: 75  PFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPG 132

Query: 243 NILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMW 297
           N+L+ ++     +KI DFG A  E+    + +   + ++YYR+PE+L+G + YT+A+D+W
Sbjct: 133 NLLVNSNCV---LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIW 189

Query: 298 SFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           S GCI AEL     LF   S    L  +  +LG   
Sbjct: 190 SVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  103 bits (257), Expect = 5e-24
 Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 35/266 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ--QALVEVSILTTLNKKYDREDKH-H 173
           LG G++  V K         VA+K+I+ Q        A+ E S+L  L        KH +
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL--------KHAN 64

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV +++    +  L + FE + ++L + +   H  GL    V+LF  Q+LRGLS +    
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMD-KHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLG-YQ 289
           I+H DLKP+N+L+  +    E+K+ DFG A  +    ++Y   + + +YR P+VLLG  +
Sbjct: 124 ILHRDLKPQNLLISDT---GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEF-DLLRRMIRILGA---------------QP 333
           Y+T +DMW  GCI  E+  G+  FPG  +  D L R+  +LG                +P
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240

Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIEN 359
             + L   KN  + +  +  V++ E+
Sbjct: 241 ERFTLYSPKNLRQAWNKLSYVNHAED 266

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  101 bits (255), Expect = 5e-24
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 44/234 (18%)

Query: 114 KDLLGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
              LG G FG+V K    +         VAVK +K   +  Q    L E  I+  L    
Sbjct: 4   GKKLGEGAFGEVYKGT-LKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL---- 58

Query: 167 DREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
                H +IV++    VC  +  L I  E +   +L + ++ N  + LSLS +  F+ QI
Sbjct: 59  ----DHPNIVKLLG--VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-- 280
            RG+  L+    IH DL   N L+    +   +KI DFG +    R +Y      YY+  
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLS----RDLYDD---DYYKVK 162

Query: 281 ---------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
                    +PE L   ++T+  D+WSFG ++ E+F LG   +PG S  ++L  
Sbjct: 163 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY 216

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  101 bits (253), Expect = 7e-24
 Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 21/233 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
            + V   LG G++G V K      N F A+K +     +Q    + A+ E+ IL ++N  
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNH- 58

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG--LSLSIVQLFSKQI 222
                  +I+   E F+    LCI  E     +L + I     +   +    +     Q+
Sbjct: 59  ------PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRS 281
           LRGL  L +  I+H DLK  NILL        +KI D G S   +     + I + +Y +
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKKNMAKTQIGTPHYMA 169

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           PEV  G  Y+   D+WS GC++ E+    P F   S  DL  ++ R  G  PP
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--GKYPP 220

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  101 bits (253), Expect = 1e-23
 Identities = 78/233 (33%), Positives = 123/233 (52%), Gaps = 20/233 (8%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDR 168
           Y+  + LG G++  V K         VA+K+I  K +      A+ E S+L  L      
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL------ 60

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             KH +IV +++    +  L   FE + ++L + + I H  GL    V+LF  Q+LRGL+
Sbjct: 61  --KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYM-IQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEV 284
            +    I+H DLKP+N+L+       E+K+ DFG A  +    +T  S + + +YR P+V
Sbjct: 118 YIHGQHILHRDLKPQNLLISYL---GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE-FDLLRRMIRILGAQPPD 335
           LLG   Y++A+D+W  GCI  E+  G P FPG S+ F+ L ++  +LG    D
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 70/246 (28%), Positives = 118/246 (47%), Gaps = 37/246 (15%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALV----EVSILTTLNKKYDRE 169
           LLG G+FG V +  + +   F AVK +   +     Q+A+     E+++L+ L       
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL------- 59

Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQILR 224
            +H +IV+       + +L I  EL+     + L +      +      +++L+++QIL 
Sbjct: 60  -QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILL 113

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
           GL  L D   +H D+K  NIL+ T+     +K+ DFG A    E     S+  S Y+ +P
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTN---GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170

Query: 283 EVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI--LGAQP--PDYV 337
           EV+     Y  A D+WS GC V E+  G P +   S+ + +  + +I      P  PD++
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHL 227

Query: 338 LKEAKN 343
             EAK+
Sbjct: 228 SDEAKD 233

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 35/239 (14%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA------YYQQALVEVSILTTLNKKYDRE 169
           LLG G FG+V  C+D +    +AVK +   P              E+ +L  L       
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL------- 61

Query: 170 DKHHIVRIYEYFVCQR---HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
            +H   RI +Y+ C R    L I  E +   ++ + +K   +  L+ ++ + +++QIL G
Sbjct: 62  -QHE--RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEG 116

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYY 279
           +  L    I+H D+K  NIL  ++     +K+ DFG++      C+    + S   + Y+
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            SPEV+ G  Y    D+WS GC V E+    P  P A EF+ +  + +I   QP +  L
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKP--PWA-EFEAMAAIFKI-ATQPTNPQL 228

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 99.1 bits (248), Expect = 4e-23
 Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 45/234 (19%)

Query: 114 KDLLGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
              LG G FG+V K    +         VAVK +K   +  Q    L E  I+  L    
Sbjct: 4   GKKLGEGAFGEVYKGK-LKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL---- 58

Query: 167 DREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
                H ++V++    VC  +  L I  E ++  +L   ++ N    LSLS +  F+ QI
Sbjct: 59  ----DHPNVVKLLG--VCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQI 111

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-- 280
            RG+  L+    IH DL   N L+    +   +KI DFG +    R +Y      YYR  
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLS----RDLYDD---DYYRKR 161

Query: 281 ---------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
                    +PE L   ++T+  D+WSFG ++ E+F LG   +PG S  ++L  
Sbjct: 162 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY 215

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 98.8 bits (247), Expect = 6e-23
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 34/243 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G FG+V        N   A+K +K        Q  +      E  IL   N  +   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPF--- 54

Query: 170 DKHHIVRIYEYFVCQRHLCICFEL-LDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLS 227
               IV++Y  F  ++++ +  E  L   L+ ++     F        + +   ++    
Sbjct: 55  ----IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLF---DEYTARFYIACVVLAFE 107

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEV 284
            L + GII+ DLKPEN+LL ++     +K++DFG A    +  +T +++  +  Y +PE+
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKT-WTFCGTPEYVAPEI 163

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA----QPPDYVLKE 340
           +L   Y  ++D WS G ++ EL  G P F G  + D +     IL      + P+Y+ K 
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDILKGNGKLEFPNYIDKA 222

Query: 341 AKN 343
           AK+
Sbjct: 223 AKD 225

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 31/256 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            + + +++G GT+G+V K    +    VA+KI+       ++   E +IL    +KY   
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNIL----RKY--S 60

Query: 170 DKHHIVRIYEYFVCQRHLC------ICFELLDS-NLYELIKINHFRGLSLS--IVQLFSK 220
           +  +I   Y  F+ +          +  EL    ++ +L+K    +G  L    +    +
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSR 277
           + LRGL+ L +  +IH D+K +NILL  +   AE+K++DFG +   D T+    ++I + 
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKN---AEVKLVDFGVSAQLDSTLGRRNTFIGTP 177

Query: 278 YYRSPEVL-----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
           Y+ +PEV+         Y    D+WS G    EL  G P      +   +R + +I    
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIPRNP 234

Query: 333 PPDYVLKEAKNTSKFF 348
           PP   LK  +N SK F
Sbjct: 235 PP--TLKSPENWSKKF 248

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 30/238 (12%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GTFG+V K    +    VA+K +     +  +   AL E+ IL  L  +       +
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE-------N 72

Query: 174 IVRIYE--------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
           +V + E        Y   +    + FE  + +L  L+  N     +LS ++   K +L G
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS-NKNVKFTLSEIKKVMKMLLNG 131

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYS-YIQSRY 278
           L  +    I+H D+K  NIL+    K   +K+ DFG A             Y+  + + +
Sbjct: 132 LYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           YR PE+LLG   Y   IDMW  GCI+AE++   P+  G +E   L  + ++ G+  P+
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 32/243 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--IIKNQPAYYQQALV-EVSILTTLNKKYDREDKH- 172
           +G G  G+V K  D      VA+K   ++ Q    ++ ++ E+ I+        ++ KH 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQN---KELIINEILIM--------KDCKHP 75

Query: 173 HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           +IV  Y+ ++    L +  E +D   L ++I   +F  ++   +    +++L+GL  L  
Sbjct: 76  NIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-----SACTEDRTVYSYIQSRYYRSPEVLL 286
             +IH D+K +NILL    K   +K+ DFG     +     R   S + + Y+ +PEV+ 
Sbjct: 135 QNVIHRDIKSDNILLS---KDGSVKLADFGFAAQLTKEKSKRN--SVVGTPYWMAPEVIK 189

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
              Y   +D+WS G +  E+  G P  P       LR +  I     P   LK  +  S 
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEP--PYL-REPPLRALFLITTKGIPP--LKNPEKWSP 244

Query: 347 FFK 349
            FK
Sbjct: 245 EFK 247

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 21/242 (8%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           + + + LG G++G V K    E    VA+K++  +    Q+ + E+SIL   +  Y    
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPY---- 59

Query: 171 KHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
              IV+ Y  +     L I  E     ++ +++KI + + L+   +     Q L+GL  L
Sbjct: 60  ---IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYL 115

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVY--SYIQSRYYRSPEVLL 286
                IH D+K  NILL       + K+ DFG S    D      + I + ++ +PEV+ 
Sbjct: 116 HSNKKIHRDIKAGNILLNEE---GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
              Y    D+WS G    E+  G P +   S+   +R +  I    PP   L + +  S 
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMIPNKPPPT--LSDPEKWSP 227

Query: 347 FF 348
            F
Sbjct: 228 EF 229

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 93.3 bits (233), Expect = 5e-21
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 40/229 (17%)

Query: 117 LGHGTFGQVAKC-WDAEMNSF---VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRED 170
           LG G FG+V K     +       VAVK +K   +  ++   L E SI+  L+       
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS------- 59

Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            H +IVR+         L I  E +   +L + ++  H   L+L  +   + QI +G+  
Sbjct: 60  -HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEY 117

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-------- 280
           L+    +H DL   N L+    +   +KI DFG +    R +Y      YYR        
Sbjct: 118 LESKNFVHRDLAARNCLVT---ENLVVKISDFGLS----RDIYE---DDYYRKRGGGKLP 167

Query: 281 ----SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
               +PE L   ++T+  D+WSFG ++ E+F LG   +PG S  ++L  
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL 216

Length = 258

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 93.7 bits (233), Expect = 8e-21
 Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 27/235 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  +  PA   Q + E+ +L   N  Y       I
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY-------I 61

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + + +     +  +I+   S  +LRGL+ L++   
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  YT 
Sbjct: 121 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTV 177

Query: 293 AIDMWSFGCIVAELFLGL------------PLFPGASEFDLLRRMIRILGAQPPD 335
             D+WS G  + E+ +G              +F         +   R +   PPD
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.1 bits (223), Expect = 8e-20
 Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 22/227 (9%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V K  + E     A K+I  +     +  +VE+ IL +        D  +IV
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIV 65

Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           ++ + F  + +L I  E       + + +   R L+   +++  KQ L  L+ L +  II
Sbjct: 66  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125

Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLL-----G 287
           H DLK  NIL        +IK+ DFG +    RT+    S+I + Y+ +PEV++      
Sbjct: 126 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + E+     + P   E + +R +++I  ++PP
Sbjct: 183 RPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEPP 226

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 26/229 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V+K         +AVK I+     A  +Q L E+ IL   N  Y       I
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY-------I 61

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + I       +   I+   +  +L+GL+ L +   
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           IIH D+KP NIL+ +     +IK+ DFG S    +    +++ +  Y +PE + G  Y+ 
Sbjct: 122 IIHRDVKPSNILVNSR---GQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 293 AIDMWSFGCIVAELFLGLPLFPGASE-------FDLLRRMIRILGAQPP 334
             D+WS G  + EL  G   FP   E       F+LL+    I+   PP
Sbjct: 179 KSDIWSLGLSLIELATG--RFPYPPENDPPDGIFELLQ---YIVNEPPP 222

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 90.5 bits (224), Expect = 9e-20
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 24/228 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V K  + E  +  A K+I  K++    +  +VE+ IL T N         +I
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL-EDYMVEIEILATCNH-------PYI 71

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V++   F     L I  E       + I +   RGL+   +Q+  +Q+L  L  L    I
Sbjct: 72  VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLL----- 286
           IH DLK  N+LL       +IK+ DFG +    +T+    S+I + Y+ +PEV++     
Sbjct: 132 IHRDLKAGNVLLTLD---GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
              Y    D+WS G  + E+     + P   E + +R +++I  ++PP
Sbjct: 189 DTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEPP 233

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 89.1 bits (222), Expect = 1e-19
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 45/240 (18%)

Query: 115 DLLGHGTFGQVAKC-WDAEMNSF--VAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRE 169
             LG G FG+V K     +      VAVK +K        +  L E  ++  L       
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------ 54

Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKIN-----HFRGLSLSIVQL--FSK 220
             H ++VR+      +  L +  E ++  +L + ++ +          +LS+  L  F+ 
Sbjct: 55  --HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           QI +G+  L     +H DL   N L+    +   +KI DFG +    R VY      YYR
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLS----RDVYDD---DYYR 162

Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
                       +PE L    +T+  D+WSFG ++ E+F LG   +PG S  ++L  + +
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 22/227 (9%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V K    E   F A KII+       +  +VE+ IL+             IV
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN-------IV 65

Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +YE +  +  L I  E  D    + I +   RGL+   ++   +Q+L  L+ L    +I
Sbjct: 66  GLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125

Query: 236 HCDLKPENILLCTSVKPAEIKIIDFG-SA--CTEDRTVYSYIQSRYYRSPEVLL-----G 287
           H DLK  NILL       ++K+ DFG SA   +  +   ++I + Y+ +PEV+       
Sbjct: 126 HRDLKAGNILLTLD---GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + EL    P  P   E + +R +++IL ++PP
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEP--PH-HELNPMRVLLKILKSEPP 226

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 88.8 bits (220), Expect = 4e-19
 Identities = 79/288 (27%), Positives = 125/288 (43%), Gaps = 37/288 (12%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V          + AVK +K             +VE  +L          + 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL------AWEN 55

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             +  +Y  F  + HL    E L+    ++ +     F    L     ++ +I+ GL  L
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF---DLYRATFYAAEIVCGLQFL 112

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
              GII+ DLK +N++L    +   IKI DFG  C E    D    ++  +  Y +PE+L
Sbjct: 113 HSKGIIYRDLKLDNVML---DRDGHIKIADFG-MCKENVFGDNRASTFCGTPDYIAPEIL 168

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT- 344
            G +YT ++D WSFG ++ E+ +G   F G  E D L   IR+     P ++ KE+K+  
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVDTPHYPRWITKESKDIL 227

Query: 345 SKFF-----KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
            K F     + +G V NI        G   ++ +     E REL  P 
Sbjct: 228 EKLFERDPTRRLGVVGNIR-------GHPFFKTINWTALEKRELDPPF 268

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 68/245 (27%), Positives = 115/245 (46%), Gaps = 16/245 (6%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD-- 167
           ++I   L+G G+FG V    +A     +AVK ++           + S+L  L ++    
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           +E +H +IV+     +   HL I  E +       + +N++     ++V+ F +QIL+GL
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAAL-LNNYGAFEETLVRNFVRQILKGL 119

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--------SACTEDRTVYSYIQ-SR 277
           + L + GIIH D+K  NIL+        IKI DFG        S  T+       +Q S 
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           ++ +PEV+    YT   D+WS GC+V E+  G   FP  ++   + ++      + P  +
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI 236

Query: 338 LKEAK 342
             EA 
Sbjct: 237 SSEAI 241

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 88.1 bits (218), Expect = 8e-19
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 24/238 (10%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        N F A+K +K             +VE  +L+         + 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL------AWEH 55

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             +  +Y  F  + +L    E L+    ++ +   + F    L     ++ +I+ GL  L
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF---DLPRATFYAAEIICGLQFL 112

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
              GI++ DLK +NILL T      IKI DFG  C E    D    ++  +  Y +PE+L
Sbjct: 113 HSKGIVYRDLKLDNILLDTD---GHIKIADFG-MCKENMLGDAKTCTFCGTPDYIAPEIL 168

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           LG +Y T++D WSFG ++ E+ +G   F G  E +L +  IR+     P ++ +EAK+
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-IRMDNPCYPRWLTREAKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)

Query: 111 YIVKDLLGHGTFGQVAKCW---DAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
           + + + +G G+FG V K     D  + +   + + K      ++A+ E  +L  L+  Y 
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY- 60

Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 I+R YE F+ +  L I  E  ++ +L++L+K+   R L    V  F  QIL GL
Sbjct: 61  ------IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVY--SYIQSRYYRSPE 283
           + L    I+H D+K  N+ L        +KI D G A    D T +  + + + YY SPE
Sbjct: 115 AHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           +     Y    D+W+ G ++ E   G   F   ++  L+ ++IR  G  PP
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--GVFPP 220

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 70/236 (29%), Positives = 102/236 (43%), Gaps = 33/236 (13%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYD 167
           Y V + +G G+FG V K         +  K I          QQ + EV+IL        
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNIL-------- 53

Query: 168 REDKH-HIVRIYEYFV--CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
           RE KH +IVR Y+  +    + L I  E  +  +L +LI+    +     I + F  +IL
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ--KCKKERKYIEEEFIWRIL 111

Query: 224 RGLSL-------LKDAG--IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVY-- 271
             L L         D G  ++H DLKP NI L  +     +K+ DFG A      + +  
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN---NVKLGDFGLAKILGHDSSFAK 168

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           +Y+ + YY SPE L    Y    D+WS GC++ EL    P F   +    L   I+
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 31/249 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-----KNQPAYYQQALVEVSILTTLNK 164
            + + + +G G+FG+V K  D   N  VA+K+I     +++    QQ   E+  L+    
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFLSQCRS 58

Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
            Y       I + Y  F+    L I  E     +  +L+K        ++ +    +++L
Sbjct: 59  PY-------ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFI---LREVL 108

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYR 280
            GL  L + G IH D+K  NILL       ++K+ DFG +     T+    +++ + ++ 
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEE---GDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
           +PEV+    Y    D+WS G    EL  G P  P  S+   +R +  I    PP     E
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLIPKNNPP---SLE 219

Query: 341 AKNTSKFFK 349
               SK FK
Sbjct: 220 GNKFSKPFK 228

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 72/247 (29%), Positives = 112/247 (45%), Gaps = 31/247 (12%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
            +G GT GQV K    +    +AVK + +       +      IL  L+      D  +I
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK-----RILMDLDVVLKSHDCPYI 76

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDA- 232
           V+ Y YF+    + IC EL+ + L +L+K I     +   I+   +  I++ L  LK+  
Sbjct: 77  VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP--IPEDILGKMTVAIVKALHYLKEKH 134

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRSPEVL-- 285
           G+IH D+KP NILL  S     +K+ DFG +    R V S  ++R      Y +PE +  
Sbjct: 135 GVIHRDVKPSNILLDAS---GNVKLCDFGIS---GRLVDSKAKTRSAGCAAYMAPERIDP 188

Query: 286 --LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDYVLKEAK 342
                +Y    D+WS G  + EL  G   +    +EF++L    +IL  +PP   L   +
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL---TKILQEEPP--SLPPNE 243

Query: 343 NTSKFFK 349
             S  F 
Sbjct: 244 GFSPDFC 250

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 16/202 (7%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALVEVSILTTLNKKYDRE 169
            + DL G G  G V+K       + +A K+  I  + +  +Q L E+ I+      Y   
Sbjct: 9   TISDL-GAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY--- 64

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               IV  Y  F+ + ++C+C E +D    + I       + + I+   +  ++ GL+ L
Sbjct: 65  ----IVSFYGAFLNENNICMCMEFMDCGSLDRI-YKKGGPIPVEILGKIAVAVVEGLTYL 119

Query: 230 KDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLG 287
            +   I+H D+KP NIL+ +     +IK+ DFG S    +    +++ +  Y SPE + G
Sbjct: 120 YNVHRIMHRDIKPSNILVNSR---GQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG 176

Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
            +YT   D+WS G  + EL LG
Sbjct: 177 GKYTVKSDVWSLGISIIELALG 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V KC         A+K I     P   +Q L E+ I    NK        +I
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEI----NKSCKSP---YI 61

Query: 175 VRIYEYFV--CQRHLCICFEL-----LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           V+ Y  F+      + I  E      LDS +Y+ +K    R +   ++   ++ +L+GLS
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGR-IGEKVLGKIAESVLKGLS 119

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLL 286
            L    IIH D+KP NILL       ++K+ DFG S    +    ++  + +Y +PE + 
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFP 314
           G  Y+   D+WS G  + E+      FP
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 70/237 (29%), Positives = 115/237 (48%), Gaps = 29/237 (12%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSIL---TTLNKKYDREDKH 172
           LLG G FG+V  C+DA+    +AVK ++  P   + +  EV+ L     L K    E   
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHE--- 64

Query: 173 HIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
              RI +Y+ C     +R L I  E +     +  ++  +  L+ ++ + +++QIL G+S
Sbjct: 65  ---RIVQYYGCLRDPMERTLSIFMEHMPGGSIK-DQLKSYGALTENVTRKYTRQILEGVS 120

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRS 281
            L    I+H D+K  NIL  +      +K+ DFG++      C     + S   + Y+ S
Sbjct: 121 YLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           PEV+ G  Y    D+WS GC V E+    P +   +EF+ +  + +I   QP + VL
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKI-ATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 6e-17
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY----QQALVEVSILTTLNKK------Y 166
           +G G +GQV      +    VA+K +K    +     +  L E  ILTT   +      Y
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
             +D  ++    EY V        F  L +NL  ++  +H R         +  ++   +
Sbjct: 69  AFQDDEYLYLAMEY-VPGGD----FRTLLNNL-GVLSEDHAR--------FYMAEMFEAV 114

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
             L + G IH DLKPEN L+  S     IK+ DFG +        S + S  Y +PEVL 
Sbjct: 115 DALHELGYIHRDLKPENFLIDAS---GHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLR 171

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
           G  Y   +D WS GC++ E   G P F G++
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 67/255 (26%), Positives = 110/255 (43%), Gaps = 32/255 (12%)

Query: 111 YIVKDLLGHGTFGQV--AKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKY 166
           Y + +++G G    V  A C        VA+K I  +       +   EV  ++  N   
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEK--VAIKRIDLEKCQTSVDELRKEVQAMSQCN--- 57

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIK-INHFRGLSLSIVQLFSKQIL 223
                H ++V+ Y  FV    L +    L   +L +++K      GL  +I+    K++L
Sbjct: 58  -----HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED------RTVYSYIQS 276
           +GL  L   G IH D+K  NILL        +KI DFG SA   D      +   +++ +
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGED---GSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Query: 277 RYYRSPEVL-LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
             + +PEV+   + Y    D+WSFG    EL  G   +   S++  ++ ++  L   PP 
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTLQNDPPS 226

Query: 336 Y-VLKEAKNTSKFFK 349
                + K  SK F+
Sbjct: 227 LETGADYKKYSKSFR 241

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.9 bits (199), Expect = 8e-17
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 37/255 (14%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSIL---TTLNKKYDREDKH 172
           LLG G FG+V  C+D +    +A K ++  P   + +  EVS L     L K    E   
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS-KEVSALECEIQLLKNLQHE--- 64

Query: 173 HIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
              RI +Y+ C     ++ L I  E +     +  ++  +  L+ S+ + +++QIL G+S
Sbjct: 65  ---RIVQYYGCLRDRAEKTLTIFMEYMPGGSVK-DQLKAYGALTESVTRKYTRQILEGMS 120

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRS 281
            L    I+H D+K  NIL  ++     +K+ DFG++      C     + S   + Y+ S
Sbjct: 121 YLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP-----PDY 336
           PEV+ G  Y    D+WS GC V E+    P +   +E++ +  + +I   QP     P +
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKI-ATQPTNPQLPSH 233

Query: 337 VLKEAKNTSKFFKCI 351
           + + A++   F  CI
Sbjct: 234 ISEHARD---FLGCI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 21/202 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKI-----IKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           LG G FG+V  C         A K      +K +    Q AL E  IL  ++ ++     
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGE-QMALNEKKILEKVSSRF----- 54

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             IV +   F  +  LC+   L++     Y +  +    G   +    ++ QI+ GL  L
Sbjct: 55  --IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHL 111

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVLLG 287
               I++ DLKPEN+LL        ++I D G A      + +     +  Y +PEVL G
Sbjct: 112 HQRRIVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG 168

Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
             Y  ++D ++ GC + E+  G
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 27/238 (11%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK--KYDREDKHH 173
           LLG G FG+V  C+DA+    +AVK +   P   Q+   EV+ L    +  K  R D   
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS-QETSKEVNALECEIQLLKNLRHD--- 64

Query: 174 IVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
             RI +Y+ C     ++ L I  E +     +  ++  +  L+ ++ + +++QIL+G+S 
Sbjct: 65  --RIVQYYGCLRDPEEKKLSIFVEYMPGGSIK-DQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRSP 282
           L    I+H D+K  NIL  ++     +K+ DFG++      C     + S   + Y+ SP
Sbjct: 122 LHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
           EV+ G  Y    D+WS  C V E+    P +   +E++ +  + +I   QP   +L +
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKI-ATQPTKPMLPD 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
            LG G F    +  D +  + +AVK +         Q    +    E+ ++  LN     
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP--- 63

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
               HI+R+        H  +  E +       + ++ +     +++  +++Q+LRGLS 
Sbjct: 64  ----HIIRMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYGAFKEAVIINYTEQLLRGLSY 118

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRY-----YRS 281
           L +  IIH D+K  N+L+ ++ +   ++I DFG+A       T     Q +      + +
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           PEVL G QY  + D+WS GC++ E+    P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
            YI   +LG G FG+       E +S V  K +   +      + AL E+ IL+ L    
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL---- 56

Query: 167 DREDKHH--IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS--IVQLFSKQ 221
                 H  I+  Y +F+    L I  E  +   LY+  KI   +G      +V  +  Q
Sbjct: 57  -----QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYD--KIVRQKGQLFEEEMVLWYLFQ 109

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRY 278
           I+  +S +  AGI+H D+K  NI L    K   IK+ DFG +    +E     + + + Y
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
           Y SPE+  G +Y    D+W+ GC++ EL
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 22/237 (9%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        N F A+K +K          +  +VE  +L    +       
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEH------ 55

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             +  ++  F  + HL    E L+    ++ +     F     +  + ++ +I+ GL  L
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF---DEARARFYAAEIICGLQFL 112

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---DRTVYSYIQSRYYRSPEVLL 286
              GII+ DLK +N+LL    K   IKI DFG        +    ++  +  Y +PE+L 
Sbjct: 113 HKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           G +Y  ++D WSFG ++ E+ +G   F G  E D L   I       P ++ KEAK+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILNDRPHFPRWISKEAKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 37/293 (12%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   AVK++K     Q    +  + E  +L    K       
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------- 54

Query: 172 H-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           H  + +++  F  +  L    E ++  +L  +  I           + ++ +I+ GL  L
Sbjct: 55  HPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFL 112

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
            + GII+ DLK +N+LL +      IKI DFG  C E      T  ++  +  Y +PE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSE---GHIKIADFG-MCKEGILGGVTTSTFCGTPDYIAPEIL 168

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKEAKN 343
               Y  A+D W+ G ++ E+  G   F G  E +L +    IL  +   P ++ KEAK+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ---SILEDEVRYPRWLSKEAKS 225

Query: 344 TSKFF------KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
             K F      K +G +     GE  I G   ++ +   + E +E+K P   K
Sbjct: 226 ILKSFLTKNPEKRLGCL---PTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.1 bits (192), Expect = 9e-16
 Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 37/256 (14%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH- 173
           +++G+GT+GQV K    +     A+K++       ++  +E+++L    KKY     HH 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML----KKY----SHHR 73

Query: 174 -IVRIYEYFVCQR------HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
            I   Y  F+ +        L +  E   + ++ +L+K      L    +    ++ILRG
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSP 282
           L+ L    +IH D+K +N+LL  +   AE+K++DFG +   DRTV    ++I + Y+ +P
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190

Query: 283 EVLL-------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           EV+         Y Y +  D+WS G    E+  G P      +   +R +  I    PP 
Sbjct: 191 EVIACDENPDATYDYRS--DIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPPPK 245

Query: 336 YVLKEAKNTSKFFKCI 351
             LK  K + KF   I
Sbjct: 246 --LKSKKWSKKFIDFI 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)

Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +++LGHG  G V K +       +AVK+I         +Q + E+ IL   +  Y     
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY----- 60

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             I+  Y  F  +  + IC E +D        ++ +R +   ++   +  +++GL+ L  
Sbjct: 61  --IIGFYGAFFVENRISICTEFMDGG-----SLDVYRKIPEHVLGRIAVAVVKGLTYLWS 113

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
             I+H D+KP N+L+ T     ++K+ DFG S    +    +Y+ +  Y +PE + G QY
Sbjct: 114 LKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170

Query: 291 TTAIDMWSFGCIVAELFLGLPLFP 314
               D+WS G    EL LG   +P
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ----QALVEVSILTTLNKKY 166
           +     LG G+FG+V          + A+KI+              L E  IL ++   +
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILR 224
                  +V +Y  F    +L +  E +        L K   F      + + ++ Q++ 
Sbjct: 63  -------LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF---PEPVARFYAAQVVL 112

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRYYRSPE 283
            L  L    I++ DLKPEN+LL        IKI DFG A   + RT Y+   +  Y +PE
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPE 168

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           ++L   Y  A+D W+ G ++ E+  G P F
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 25/206 (12%)

Query: 115 DLLGHGTFGQVAKC-WDAEMNSF--VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
             LG G+FG V +  W         VAVK +K           L E +I+ +L       
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL------- 53

Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    L +  EL  L S L + ++ +      +S +  ++ QI  G+ 
Sbjct: 54  DHENLIRLYG-VVLTHPLMMVTELAPLGS-LLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRY----YRS 281
            L+    IH DL   NILL +  K   +KI DFG   A  ++   Y   +       + +
Sbjct: 112 YLESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D+W FG  + E+F
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMF 194

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 25/235 (10%)

Query: 110 RYIVKDLLGHGTFGQ---VAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
           +Y+    +G G+FG+   V    D +      + I K  P   +++  EV++L+ +    
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM---- 56

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFS--KQI 222
               KH +IV+  E F    +L I  +  +  +LY+  KIN  RG+     Q+     QI
Sbjct: 57  ----KHPNIVQYQESFEENGNLYIVMDYCEGGDLYK--KINAQRGVLFPEDQILDWFVQI 110

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYY 279
              L  + D  I+H D+K +NI L    K   IK+ DFG A   + TV    + I + YY
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            SPE+     Y    D+W+ GC++ E+      F   +  +L+ ++IR  G+ PP
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYPP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.6 bits (188), Expect = 5e-15
 Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 65

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + + +   + +   I+   S  +LRGL+ L++   
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQV-LKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 125 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 181

Query: 293 AIDMWSFGCIVAELFLG-LPLFP 314
             D+WS G  + EL +G  P+ P
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 75.9 bits (186), Expect = 5e-15
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 28/214 (13%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH- 173
           +L+G+GT+GQV K    +     A+K++       ++   E+++L    KKY     HH 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINML----KKY----SHHR 63

Query: 174 -IVRIYEYFVCQR------HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
            I   Y  F+ +        L +  E   + ++ +LIK      L    +    ++ILRG
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSP 282
           LS L    +IH D+K +N+LL  +   AE+K++DFG +   DRTV    ++I + Y+ +P
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 283 EVLLGYQ-----YTTAIDMWSFGCIVAELFLGLP 311
           EV+   +     Y    D+WS G    E+  G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 13/148 (8%)

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           +  ++ ++Y  F  + +L +  E L+  +   LIK     GL     + +  +++ G+  
Sbjct: 55  ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVED 112

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVL 285
           L   GIIH D+KPEN+L+  +     +K+ DFG +    R       ++ +  Y +PE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQT---GHLKLTDFGLS----RNGLENKKFVGTPDYLAPETI 165

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           LG       D WS GC++ E   G P F
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 46/247 (18%)

Query: 117 LGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           +G GT+G V  AK  D + +   A+K I+        A  E+++L        RE KH +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACREIALL--------RELKHPN 59

Query: 174 IVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQL-------FSKQILR 224
           ++ + + F+    R + + F+  + +L+ +IK +     +   VQL          QIL 
Sbjct: 60  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 225 GLSLLKDAGIIHCDLKPENIL-LCTSVKPAEIKIIDFGSA----------CTEDRTVYSY 273
           G+  L    ++H DLKP NIL +    +   +KI D G A             D  V ++
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 274 IQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLR 323
               +YR+PE+LLG + YT AID+W+ GCI AEL    P+F    E          D L 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235

Query: 324 RMIRILG 330
           R+  ++G
Sbjct: 236 RIFNVMG 242

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 38/248 (15%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKH-HI 174
           +G GT+G V K  D      VA+K+IK +P   ++    E+S+L        +E +H +I
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISML--------KECRHPNI 62

Query: 175 VRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           V  +  ++ +  L I  E        ++Y++ +      LS   +    ++ L+GL+ L 
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH 118

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVL-- 285
           + G IH D+K  NILL       ++K+ DFG +     T+    S+I + Y+ +PEV   
Sbjct: 119 ETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 286 -LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRR--MIRILGAQPPDYVLKE 340
                Y    D+W+ G    EL    P  P    FDL  +R   +I      PP   LK+
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQP--P---MFDLHPMRALFLISKSNFPPPK--LKD 228

Query: 341 AKNTSKFF 348
            +  S  F
Sbjct: 229 KEKWSPVF 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 35/215 (16%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN------QPAYYQQALVEVSILTTLN 163
           RYI++  LG G+FG V    D +  +   +K++K        P    QA  E  +L+ L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL- 59

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLSLS---IV 215
                 D   IV+ +  F+ +   CI  E      LD  L EL       G +LS   + 
Sbjct: 60  ------DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKH----TGKTLSENQVC 109

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVY 271
           + F  Q+L G+  +    I+H DLK +NI L  ++    +KI DFG +     + D    
Sbjct: 110 EWFI-QLLLGVHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLAT- 163

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
           ++  + YY SPE L    Y +  D+WS GCI+ E+
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 19/217 (8%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALV--EVSILTTLNKKYDREDK 171
            +G GTFG+V    D     + A+K+  I       Q+  V  E  +L  ++  +     
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF----- 62

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILRGLSLLK 230
             I+R++     QR L +  E +     EL       G  S S    ++ +I+  L  L 
Sbjct: 63  --IIRLFWTEHDQRFLYMLMEYVPGG--ELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYYRSPEVLLGYQ 289
              I++ DLKPENILL    K   IK+ DFG A    DRT ++   +  Y +PEV+    
Sbjct: 119 SKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRT-WTLCGTPEYLAPEVIQSKG 174

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
           +  A+D W+ G ++ E+ +G P F   + F +  +++
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 49/228 (21%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDR 168
           +++  +L+G GT+G+V    +      +AVK ++       +    +  ++  L  + + 
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 169 -EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSL------------SIV 215
            +D  H+  I +Y   +           +  Y  I + +  G S+             +V
Sbjct: 62  LKDLDHL-NIVQYLGFET----------TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILL-----CTSVKPAEIKIIDFG-SACTEDRT 269
           + F++Q+L GL+ L   GI+H DLK +N+L+     C        KI DFG S  ++D  
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC--------KISDFGISKKSDD-- 160

Query: 270 VYSYIQ------SRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLG 309
           +Y   Q      S ++ +PEV+  Y   Y+  +D+WS GC+V E+F G
Sbjct: 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 61/247 (24%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALV--EVSILTTL 162
            + V  ++G G FG+V    D +     A+K+++      +    Q A V  E  IL   
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN---QIAHVRAERDILADA 58

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS----NLYELIKINHFRGLSLSIVQLF 218
           +  +       IV++Y  F  + HL +  E +      NL  LI+ + F        + +
Sbjct: 59  DSPW-------IVKLYYSFQDEEHLYLVMEYMPGGDLMNL--LIRKDVFPE---ETARFY 106

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------------- 263
             +++  L  +   G IH D+KP+NIL+        IK+ DFG                 
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDAD---GHIKLADFGLCKKMNKAKDREYYLND 163

Query: 264 -----CTEDRTVYSYIQSRY------------YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
                  ++  V      +             Y +PEVL G  Y    D WS G I+ E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 307 FLGLPLF 313
             G P F
Sbjct: 224 LYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 46/247 (18%)

Query: 117 LGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           +G GT+G V  AK  D +     A+K I+        A  E+++L        RE KH +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-GISMSACREIALL--------RELKHPN 59

Query: 174 IVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRG-------LSLSIVQLFSKQILR 224
           ++ + + F+    R + + F+  + +L+ +IK +           L  S+V+    QIL 
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 225 GLSLLKDAGIIHCDLKPENIL-LCTSVKPAEIKIIDFGSA----------CTEDRTVYSY 273
           G+  L    ++H DLKP NIL +    +   +KI D G A             D  V ++
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 274 IQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLR 323
               +YR+PE+LLG + YT AID+W+ GCI AEL    P+F    E          D L 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235

Query: 324 RMIRILG 330
           R+  ++G
Sbjct: 236 RIFSVMG 242

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 23/215 (10%)

Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDR 168
           + + LG G+FG+V          + A+K +K +        Q    E SIL  L+  +  
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF-- 79

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG---LSLSIVQLFSKQILRG 225
                IV +   F  +  +    E +     EL    H R        + + +  +++  
Sbjct: 80  -----IVNMMCSFQDENRVYFLLEFVVGG--ELF--THLRKAGRFPNDVAKFYHAELVLA 130

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEV 284
              L    II+ DLKPEN+LL        +K+ DFG A    DRT ++   +  Y +PEV
Sbjct: 131 FEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT-FTLCGTPEYLAPEV 186

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319
           +    +  A+D W+ G ++ E   G P F   + F
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF 221

Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 25/217 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G FG+V      +     A+K +K          +  + E  I  T N     E   
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN----SERHP 62

Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
            +V ++  F  + H+C   E     +L   I  + F   S      ++  ++ GL  L +
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVFYAACVVLGLQYLHE 119

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE-----DRTVYSYIQSRYYRSPEVLL 286
             I++ DLK +N+LL T      +KI DFG  C E     DRT  ++  +  + +PEVL 
Sbjct: 120 NKIVYRDLKLDNLLLDTE---GFVKIADFG-LCKEGMGFGDRTS-TFCGTPEFLAPEVLT 174

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASE---FD 320
              YT A+D W  G ++ E+ +G   FPG  E   FD
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 30/232 (12%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDRE 169
           +L+G G +G V +         VA+KII      +  +  Q+   EV++L+ L +     
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS---- 59

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
              +I + Y  ++    L I  E  +  ++  L+K        +S++    +++L  L  
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI---IREVLVALKY 116

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   G+IH D+K  NIL+        +K+ DFG A      +  R+  +++ + Y+ +PE
Sbjct: 117 IHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRS--TFVGTPYWMAPE 171

Query: 284 VLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           V+  G  Y T  D+WS G  + E+  G P +   S+ D  R M+ I  ++PP
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPP 220

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 17/234 (7%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +    +    EV+   T ++      +H  +
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKD---EVAHTLTESRVLQNT-RHPFL 57

Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  S    + +  +I+  L  L    +
Sbjct: 58  TALKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
           ++ DLK EN++L    K   IKI DFG  C E      T+ ++  +  Y +PEVL    Y
Sbjct: 117 VYRDLKLENLML---DKDGHIKITDFG-LCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 291 TTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
             A+D W  G ++ E+  G LP +    + + L  +I +   + P  +  EAK+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFPRTLSPEAKS 224

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 28/233 (12%)

Query: 117 LGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRED 170
           LG G FG V K  W  E       VA+K+++ +  P   ++ L E  ++ ++       D
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-------D 67

Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
             H+VR+    +  +   I   +    L + ++ +     S  ++  +  QI +G+S L+
Sbjct: 68  HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN-WCVQIAKGMSYLE 126

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYRSPEVL 285
           +  ++H DL   N+L+ T   P  +KI DFG A   D     Y          + + E +
Sbjct: 127 EKRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 286 LGYQYTTAIDMWSFGCIVAEL--FLGLPL--FPGASEFDLLRRMIRILGAQPP 334
           L   YT   D+WS+G  V EL  F   P    P     DLL +  R+   QPP
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL--PQPP 234

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 41/236 (17%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII-KN---QPAYYQQALVEVSILTTLNKKYDREDK 171
           LLG G  G+V            A+K++ K    +    ++ L E  IL TL+  +     
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF----- 62

Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
             +  +Y  F  + +LC+  +      L+ L++    + LS  + + ++ ++L  L  L 
Sbjct: 63  --LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 231 DAGIIHCDLKPENILL----------------CTSVKPAEIKIIDFGS------------ 262
             GI++ DLKPENILL                     P   K +  GS            
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 263 -ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
            +        S++ +  Y +PEV+ G  + +A+D W+ G ++ E+  G   F G++
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 17/212 (8%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 65

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + + +     +   I+   S  +++GL+ L++   
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 125 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 181

Query: 293 AIDMWSFGCIVAELFLG-LPL-FPGASEFDLL 322
             D+WS G  + E+ +G  P+  P A E +L+
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 67/264 (25%), Positives = 111/264 (42%), Gaps = 30/264 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKH 172
           LG G FG+V            A K +  +     +  + AL+E  IL  +N  +      
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF------ 54

Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            IV +   F  + HLC+   L++     Y +  +   RGL +  V  +S QI  G+  L 
Sbjct: 55  -IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLH 112

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVLLGY 288
              I++ D+KPEN+LL         ++ D G A    + +T+     +  Y +PE+L   
Sbjct: 113 SMDIVYRDMKPENVLLDDQ---GNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169

Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEF----DLLRRMIRILGAQPPDYVLKEAKNT 344
            Y+  +D ++ GC + E+  G   F    E     +L RR +        D V  E +N 
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------DEVKFEHQNF 222

Query: 345 SKFFKCIGSVHNIENGEVSIGGRS 368
           ++  K I  +   +  E  +G R 
Sbjct: 223 TEESKDICRLFLAKKPEDRLGSRE 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 22/239 (9%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKH 172
           + +G G+FG+V K  D      VA+KII  + A    +    E+++L+  +  Y      
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY------ 63

Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
            + + Y  ++    L I  E L   +  +L++   F    ++ +    K+IL+GL  L  
Sbjct: 64  -VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHS 119

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGY 288
              IH D+K  N+LL    +  ++K+ DFG A     T     +++ + ++ +PEV+   
Sbjct: 120 EKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
            Y +  D+WS G    EL  G P  P  S+   +R +  I    PP    + +K   +F
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP--PN-SDMHPMRVLFLIPKNNPPTLTGEFSKPFKEF 232

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY +   +G G+FG++        +    +K I       ++       +  L K     
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM---- 56

Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFS--KQILRG 225
            KH +IV  +  F     L I  E  D    +L+K IN  RG+  S  Q+ S   QI  G
Sbjct: 57  -KHPNIVTFFASFQENGRLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQISLG 113

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSP 282
           L  + D  I+H D+K +NI L  +   A  K+ DFG A   + ++   Y+ + + YY SP
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSP 171

Query: 283 EVLLGYQYTTAIDMWSFGCIVAEL 306
           E+     Y    D+WS GC++ EL
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 29/219 (13%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLN 163
           Q  Y +   +G GT+G V K  +       AVKIIK +P    +  QQ +  V       
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV------- 60

Query: 164 KKYDREDKHH-IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQ 221
               +E KH  IV  +  ++ +  L IC E        L  I H  G LS   +    ++
Sbjct: 61  ----KECKHCNIVAYFGSYLSREKLWICMEYCGGG--SLQDIYHVTGPLSELQIAYVCRE 114

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRY 278
            L+GL+ L   G +H D+K  NILL  +    ++K+ DFG A     T+    S+I + Y
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDN---GDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 279 YRSPEVLLGYQ---YTTAIDMWSFGCIVAELF-LGLPLF 313
           + +PEV    +   Y    D+W+ G    EL  L  P+F
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 25/200 (12%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +GHG+FG V    D   N  VA+K +    K     +Q  + EV  L  L          
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP------- 75

Query: 173 HIVRIYEYFVC--QRHLC-ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           + +   EY  C  + H   +  E    +  +++++ H + L    +       L+GL+ L
Sbjct: 76  NTI---EYKGCYLREHTAWLVMEYCLGSASDILEV-HKKPLQEVEIAAICHGALQGLAYL 131

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY- 288
                IH D+K  NILL    +P  +K+ DFGSA        S++ + Y+ +PEV+L   
Sbjct: 132 HSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVS-PANSFVGTPYWMAPEVILAMD 187

Query: 289 --QYTTAIDMWSFGCIVAEL 306
             QY   +D+WS G    EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 68/243 (27%), Positives = 109/243 (44%), Gaps = 41/243 (16%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK---IIKNQPAYYQQALV--EVSILTTLNKKYDREDK 171
           +G G+ G V    D      VAVK   + K Q    ++ L+  EV I+          D 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ----RRELLFNEVVIM---------RDY 73

Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
            H  IV +Y  ++    L +  E L+      I + H R ++   +      +L+ LS L
Sbjct: 74  QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIATVCLAVLKALSFL 131

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTED---RTVYSYIQSRYYRSPEV 284
              G+IH D+K ++ILL +      +K+ DFG  +  +++   R   S + + Y+ +PEV
Sbjct: 132 HAQGVIHRDIKSDSILLTSD---GRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEV 186

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLKEAK 342
           +    Y T +D+WS G +V E+  G P +     F+   L+ M RI    PP   LK   
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPY-----FNEPPLQAMKRIRDNLPPK--LKNLH 239

Query: 343 NTS 345
             S
Sbjct: 240 KVS 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 47/240 (19%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVK-------IIKNQPAYYQQALVEVSILTTLNKKYDR 168
           L+ +G +G V      E     A+K       I++NQ    QQ  VE  ILT     +  
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ---IQQVFVERDILTFAENPF-- 62

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                +V ++  F  +RHLC+  E ++  +   L+K  +   L + + +++  + +  L 
Sbjct: 63  -----VVSMFCSFETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALE 115

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTE-------------- 266
            L + GI+H DLKP+N LL TS+    IK+ DFG       S  T               
Sbjct: 116 YLHNYGIVHRDLKPDN-LLITSM--GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
           D+ V    +   Y +PEV+L   Y   +D W+ G I+ E  +G   F G +  +L  ++I
Sbjct: 173 DKQVCGTPE---YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 19/197 (9%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +GHG+FG V    D   N  VA+K +    K     +Q  + EV  L  +      E K 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
             +R +  ++   + C+      S+L E+    H + L    +   +   L+GL+ L   
Sbjct: 93  CYLREHTAWLVMEY-CLGSA---SDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSH 144

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY---Q 289
            +IH D+K  NILL    +P ++K+ DFGSA        S++ + Y+ +PEV+L     Q
Sbjct: 145 NMIHRDIKAGNILL---TEPGQVKLADFGSASIAS-PANSFVGTPYWMAPEVILAMDEGQ 200

Query: 290 YTTAIDMWSFGCIVAEL 306
           Y   +D+WS G    EL
Sbjct: 201 YDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 38/212 (17%)

Query: 117 LGHGTFGQVAKC-WDAEMNS---FVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYD 167
           LG G FG+V  C +D   ++    VAVK +         + +++   E+ IL TL+ +  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHEN- 67

Query: 168 REDKHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                 IV+ Y+  VC+    R L +  E L S         H   ++L  + LFS QI 
Sbjct: 68  ------IVK-YKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS----- 276
           +G+  L     IH DL   NIL+        +KI DFG      ED+  Y Y++      
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYY-YVKEPGESP 175

Query: 277 -RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
             +Y +PE L   ++++A D+WSFG  + ELF
Sbjct: 176 IFWY-APECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 31/223 (13%)

Query: 111 YIVKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIK-NQPAYYQQA----------LVEVSI 158
           Y V + LG G FG V K        + +A+K I  + PA+ +            + EV+I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 159 LTTLNKKYDREDKHH--IVRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSL 212
           +        +E   H  IVR Y+ F+    L I  +L++       +  +K    R    
Sbjct: 62  I--------KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113

Query: 213 SIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY- 271
            I  +F + +L    L K+  I+H DL P NI+L    K   + I DFG A  +      
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKL 170

Query: 272 -SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
            S + +  Y  PE++    Y    D+W+FGCI+ ++    P F
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 21/198 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +GHG+FG V    ++  N  VAVK +    K     +Q  + EV  L  L        KH
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL--------KH 80

Query: 173 HIVRIYEYFVCQRHLC-ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
                Y+    + H   +  E    +  +L+++ H + L    +   +   L+GL+ L  
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY--- 288
             +IH D+K  NILL    +P ++K+ DFGSA ++     S++ + Y+ +PEV+L     
Sbjct: 140 HNMIHRDIKAGNILL---TEPGQVKLADFGSA-SKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 289 QYTTAIDMWSFGCIVAEL 306
           QY   +D+WS G    EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)

Query: 117 LGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHH 173
           LG G FG+V   W+   +    VA+KI+K+     QQ    EV  L  L  K       H
Sbjct: 14  LGSGYFGEV---WEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK-------H 63

Query: 174 IVRIYEYFVCQRH--LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           ++ ++   VC     + I  EL++  +L   ++    + L ++ +   + Q+  G++ L+
Sbjct: 64  LISLFA--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 231 DAGIIHCDLKPENIL-----LCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY---YRSP 282
           +   IH DL   NIL     +C        K+ DFG A      VY     +    + +P
Sbjct: 122 EQNSIHRDLAARNILVGEDLVC--------KVADFGLARLIKEDVYLSSDKKIPYKWTAP 173

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFL--GLPLFPGASEFDLLRRMIR 327
           E      ++T  D+WSFG ++ E+F    +P +PG +  ++  ++  
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP-YPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 22/235 (9%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169
            V D LG G +G V K         +A+K I+ +   + + Q ++E+ IL      Y   
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY--- 60

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELI--KINHFRGLSLSIVQLFSKQILRGLS 227
               IV  Y  F  +  + +C E +D+   + +        G+   +++  +  +++GL 
Sbjct: 61  ----IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 228 LLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVL 285
            LK+   IIH D+KP N+L+  +    ++K+ DFG S         + I  + Y +PE +
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGN---GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERI 173

Query: 286 LG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
                     YT   D+WS G  + E+ LG   +P  +  ++  ++  I+   PP
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.6 bits (167), Expect = 3e-12
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +    +  +      T    +  +  +H  +
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAH----TLTESRVLKNTRHPFL 57

Query: 176 RIYEY-FVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
              +Y F  +  LC   E ++    EL   ++  R  S    + +  +I+  L  L    
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
           I++ DLK EN++L    K   IKI DFG      T+  T+ ++  +  Y +PEVL    Y
Sbjct: 116 IVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 291 TTAIDMWSFGCIVAELFLG-LPLF 313
             A+D W  G ++ E+  G LP +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNK 164
             + ++  +G G F  V K         VA+K ++          Q  L E+ +L  L+ 
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD- 60

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGL-----SLSIVQL 217
                  H ++++    F+    L I  EL D+ +L  +IK  HF+         +I + 
Sbjct: 61  -------HPNVIKYLASFIENNELNIVLELADAGDLSRMIK--HFKKQKRLIPERTIWKY 111

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCT--SVKPAEIKIIDFGSACTEDRTVYSYIQ 275
           F  Q+   L  +    I+H D+KP N+ +     VK  ++ +  F S+ T     +S + 
Sbjct: 112 FV-QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVG 168

Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
           + YY SPE +    Y    D+WS GC++ E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 20/219 (9%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T R+Y V   LG G FG+V  C         A K ++ +    ++    AL E  IL  +
Sbjct: 1   TFRQYRV---LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV 57

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFR-GLSLSIVQLFSKQ 221
           N ++       +V +   +  +  LC+   +++    +    N    G        ++ +
Sbjct: 58  NSQF-------VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSYIQSRYY 279
           IL GL  L     ++ DLKPENILL        I+I D G A    E  ++   + +  Y
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEGESIRGRVGTVGY 167

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
            +PEVL   +YT + D W  GC++ E+  G   F G  E
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   A+KI+K     Q    +  +VE  +L    K       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP------ 60

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             + +++  F     L    E ++    +Y + ++  F+         ++ +I  GL  L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFFL 117

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
              GII+ DLK +N++L        IKI DFG  C E     +T  ++  +  Y +PE++
Sbjct: 118 HSKGIIYRDLKLDNVMLDAE---GHIKIADFG-MCKENIFGGKTTRTFCGTPDYIAPEII 173

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
               Y  ++D W+FG ++ E+  G P F G  E +L
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 25/239 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHH-- 173
           +G G+ G V    +      VAVK +  +    ++ L  EV I+          D HH  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIM---------RDYHHEN 80

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           +V +Y  ++    L +  E L+      I + H R ++   +      +LR LS L + G
Sbjct: 81  VVDMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIATVCLSVLRALSYLHNQG 138

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQY 290
           +IH D+K ++ILL +      IK+ DFG      + V    S + + Y+ +PEV+    Y
Sbjct: 139 VIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195

Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
            T +D+WS G +V E+  G P  P  +E   L+ M RI    PP   +K++   S   +
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEP--PYFNE-PPLQAMRRIRDNLPPR--VKDSHKVSSVLR 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T R+Y V   LG G FG+V  C         A K ++ +    ++    AL E  IL  +
Sbjct: 1   TFRQYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV 57

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF--RGLSLSIVQLFSK 220
           N ++       +V +   +  +  LC+   L++    +   I H    G        ++ 
Sbjct: 58  NSRF-------VVSLAYAYETKDALCLVLTLMNGGDLKF-HIYHMGEAGFEEGRAVFYAA 109

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRY 278
           +I  GL  L    I++ DLKPENILL        I+I D G A    E +T+   + +  
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVG 166

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           Y +PEV+   +YT + D W+ GC++ E+  G   F
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 53/224 (23%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVE-VSILTTLNKKYDREDKHHI 174
           +LG GT+G V    D      +A+K I  + + Y Q L E +++ + L  +       +I
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR-------NI 67

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS---------------IVQLFS 219
           V+         +L    E    N +  I +    G SLS                +  ++
Sbjct: 68  VQ---------YLGSDSE----NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------CTEDRTVY 271
           KQIL GL  L D  I+H D+K +N+L+ T      +KI DFG++        CTE     
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPCTE----- 167

Query: 272 SYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLF 313
           ++  +  Y +PEV+      Y    D+WS GC + E+  G P F
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 31/240 (12%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG+V +    +     A+K I+       +     L E ++L  +N  +      
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPF------ 54

Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            IV +   F     L +    ++     + L +   F    LS  + ++ ++L  L  L 
Sbjct: 55  -IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRF---DLSRARFYTAELLCALENLH 110

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFG----SACTEDRTVYSYIQSRYYRSPEVLL 286
              +I+ DLKPENILL        I + DFG    +   +D+T  ++  +  Y +PE+LL
Sbjct: 111 KFNVIYRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKT-NTFCGTPEYLAPELLL 166

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP---PDYVLKEAKN 343
           G+ YT A+D W+ G ++ E+  GLP F   +  ++ R++++    +P   PD   ++AK+
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----EPLRFPDGFDRDAKD 222

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 65.8 bits (161), Expect = 8e-12
 Identities = 41/121 (33%), Positives = 55/121 (45%), Gaps = 8/121 (6%)

Query: 199 YELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258
           Y L +   F   S   V+ +  +I+  L  L   GIIH D+KP+NILL    +   + I 
Sbjct: 89  YHLSQKVKF---SEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHIT 142

Query: 259 DFGSAC--TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
           DF  A   T D    S   +  Y +PEVL    Y+ A+D WS G    E   G   + G 
Sbjct: 143 DFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202

Query: 317 S 317
           S
Sbjct: 203 S 203

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 59/201 (29%), Positives = 86/201 (42%), Gaps = 23/201 (11%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYDREDKH 172
           ++G G FG V  C        V +K I  +         A  E  +L  L+         
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP------- 59

Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSL----SIVQLFSKQILRGLS 227
           +I+  YE F+  + L I  E      L E I+    R  SL    +I+  F  QIL  L 
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK---RCNSLLDEDTILHFFV-QILLALH 115

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVL 285
            +    I+H DLK +NILL        +KI DFG +   +     Y+ + +  Y SPE+ 
Sbjct: 116 HVHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 286 LGYQYTTAIDMWSFGCIVAEL 306
            G  Y    D+W+ GC++ EL
Sbjct: 174 EGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 35/230 (15%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII------KNQPAYYQQALVEVSILTTLNKKYDRE 169
            +G G FG V K       + +AVK I      K Q    ++ L+++ ++     +    
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ----KRLLMDLDVV----MR--SS 60

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGL 226
           D  +IV+ Y     +    IC EL+D +L +  K  +    S+    I+   +   ++ L
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 227 SLLK-DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS-----RYYR 280
           + LK +  IIH D+KP NILL  +     IK+ DFG +    + V S  ++     R Y 
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGIS---GQLVDSIAKTRDAGCRPYM 174

Query: 281 SPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMI 326
           +PE +       Y    D+WS G  + E+  G   +P   S FD L +++
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 19/197 (9%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +GHG+FG V    D   +  VA+K +    K     +Q  + EV  L  L      + + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
             +R +  ++   + C+      S+L E+    H + L    +   +   L+GL+ L   
Sbjct: 83  CYLREHTAWLVMEY-CLGSA---SDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY---Q 289
            +IH D+K  NILL    +P  +K+ DFGSA         ++ + Y+ +PEV+L     Q
Sbjct: 135 NMIHRDVKAGNILL---SEPGLVKLGDFGSASIMA-PANXFVGTPYWMAPEVILAMDEGQ 190

Query: 290 YTTAIDMWSFGCIVAEL 306
           Y   +D+WS G    EL
Sbjct: 191 YDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 57

Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 58  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+ ++  +  Y +PEVL    Y 
Sbjct: 117 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 22/235 (9%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLN 163
           + +  +   + +G G+FG+V K  D      VA+KII  + A    +    E+++L+  +
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
             Y       I R Y  ++    L I  E L   +  +L+K      L  + +    ++I
Sbjct: 61  SPY-------ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREI 110

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYY 279
           L+GL  L     IH D+K  N+LL    +  ++K+ DFG A     T     +++ + ++
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +PEV+    Y    D+WS G    EL  G P     S+   +R +  I    PP
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN---SDLHPMRVLFLIPKNSPP 219

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYD 167
           ++LG G +G V  C        +AVK ++   +        Y++   EV +L +L     
Sbjct: 6   EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL----- 59

Query: 168 REDKHHIVRIYEYF-VCQRH--LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
              KH  V I +Y   C     + I  E +       I +N F  L   +   ++KQIL 
Sbjct: 60  ---KH--VNIVQYLGTCLDDNTISIFMEFVPGGSISSI-LNRFGPLPEPVFCKYTKQILD 113

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVYSYIQ 275
           G++ L +  ++H D+K  N++L  +     IK+IDFG A          T    + S   
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           + Y+ +PEV+    Y    D+WS GC V E+  G P
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   A+KI+K     Q    +  +VE  +L    K       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP----- 61

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL----------FSKQ 221
                    F+ Q H   CF+ +D  LY +++  +   L   I Q+          ++ +
Sbjct: 62  ---------FLTQLH--SCFQTMD-RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAE 109

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR----TVYSYIQSR 277
           I  GL  L   GII+ DLK +N++L +      IKI DFG  C E+     T  ++  + 
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFG-MCKENMWDGVTTKTFCGTP 165

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            Y +PE++    Y  ++D W+FG ++ E+  G   F G  E +L + ++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 50/235 (21%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWDAEMN---SFVAVKIIKN--QPAYYQQALVEVS 157
             QR  IV K  LG G FG+V   +C+  E       VAVK +K        +    E  
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60

Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKIN--HFRGLS--- 211
           +LT            +IV+ Y          + FE ++  +L + ++ +      L    
Sbjct: 61  LLTNF-------QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113

Query: 212 -----LSIVQLF--SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
                L++ QL   + QI  G+  L     +H DL   N L+   +    +KI DFG + 
Sbjct: 114 SPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV---VKIGDFGMS- 169

Query: 265 TEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
              R VY+   + YYR             PE ++  ++TT  D+WSFG ++ E+F
Sbjct: 170 ---RDVYT---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 37/245 (15%)

Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKYDRE 169
           +LG G+FG+V    K    +     A+K++K          +  +E  IL  +N  +   
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF--- 59

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI------VQLFSKQIL 223
               IV+++  F  +  L +  + L          + F  LS  +      V+ +  ++ 
Sbjct: 60  ----IVKLHYAFQTEGKLYLILDFLRGG-------DLFTRLSKEVMFTEEDVKFYLAELA 108

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
             L  L   GII+ DLKPENILL        IK+ DFG    +   ++  YS+  +  Y 
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 165

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ--PPDYVL 338
           +PEV+    +T + D WSFG ++ E+  G   F G    D    M  IL A+   P ++ 
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKLGMPQFLS 222

Query: 339 KEAKN 343
            EA++
Sbjct: 223 PEAQS 227

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 43/293 (14%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   A+KI+K     Q    +  +VE  +L   +K       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----- 61

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL----------FSKQ 221
                    F+ Q H   CF+ +D  LY +++  +   L   I Q+          ++ +
Sbjct: 62  ---------FLTQLH--SCFQTVD-RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 109

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR----TVYSYIQSR 277
           I  GL  L   GII+ DLK +N++L +      IKI DFG  C E      T  ++  + 
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSE---GHIKIADFG-MCKEHMVDGVTTRTFCGTP 165

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
            Y +PE++    Y  ++D W++G ++ E+  G P F G  E +L + ++       P  +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVSYPKSL 224

Query: 338 LKEAKNTSKFFKCIGSVHNI---ENGEVSIGGRSAYQALTEIEYEARELKKPL 387
            KEA +  K          +     GE  I   + ++ +   + E RE++ P 
Sbjct: 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPF 277

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +    +    EV+   T N+   +  +H  +
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTLTENRVL-QNSRHPFL 57

Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
              +Y   Q H  +CF +  +N  EL   ++  R  S    + +  +I+  L  L  +  
Sbjct: 58  TALKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQ 289
           +++ DLK EN++L    K   IKI DFG  C E      T+ ++  +  Y +PEVL    
Sbjct: 117 VVYRDLKLENLML---DKDGHIKITDFG-LCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 290 YTTAIDMWSFGCIVAELFLG-LPLF 313
           Y  A+D W  G ++ E+  G LP +
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFY 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 34/239 (14%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKH-HI 174
           +G G+ G V    +      VAVK++  +    ++ L  EV I+        R+ +H ++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM--------RDYQHQNV 80

Query: 175 VRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           V +Y+ ++    L +  E L     +++    ++N  +      +    + +L+ L  L 
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQ------IATVCESVLQALCYLH 134

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLG 287
             G+IH D+K ++ILL        +K+ DFG      + V    S + + Y+ +PEV+  
Sbjct: 135 SQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 191

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
             Y T +D+WS G +V E+  G P +   S    ++R    L   PP     + KN  K
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPP----PKLKNAHK 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 21/219 (9%)

Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K      Q  L E +++ TL  ++D+     +
Sbjct: 14  LGAGQFGEV---WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL--QHDK-----L 63

Query: 175 VRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           VR+Y     +  + I  E +   +L + +K +    + L  +  FS QI  G++ ++   
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL+  N+L+  S+     KI DFG A   ED    +   +++   + +PE +    
Sbjct: 124 YIHRDLRAANVLVSESLM---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ E+   G   +PG S  D++  + R
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.5 bits (157), Expect = 6e-11
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 36/219 (16%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV----EVSILTTLNK-- 164
           + VK L+G G FG+V    +       A+K++K      Q+ +     E  IL+  N   
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 165 ----KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
               +Y  +DK ++  + EY                +L  L+   +       + Q +  
Sbjct: 63  IPQLQYAFQDKDNLYLVMEY------------QPGGDLLSLLN-RYEDQFDEDMAQFYLA 109

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSY--IQS 276
           +++  +  +   G +H D+KPEN+L+    +   IK+ DFGSA   T ++ V S   + +
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGT 166

Query: 277 RYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLG 309
             Y +PEVL          Y    D WS G I  E+  G
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G GT+G V K  +       A+K+IK +P     A+V+  I+   + K+      +IV 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHS-----NIVA 70

Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILRGLSLLKDAGII 235
            +  ++ +  L IC E        L  I H  G LS S +   S++ L+GL  L   G +
Sbjct: 71  YFGSYLRRDKLWICMEFCGGG--SLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128

Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGYQ--- 289
           H D+K  NILL  +     +K+ DFG +     T+    S+I + Y+ +PEV    +   
Sbjct: 129 HRDIKGANILLTDN---GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 290 YTTAIDMWSFGCIVAELF-LGLPLF 313
           Y    D+W+ G    EL  L  P+F
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.0 bits (161), Expect = 7e-11
 Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 12/115 (10%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-----------SACTEDRT 269
           Q+L  L+   + GI+H DLKP+NI++  +      K++DFG              T  RT
Sbjct: 87  QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146

Query: 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR 324
               + +  Y +PE L G   T   D++++G I  E   G  +  GAS  ++L +
Sbjct: 147 -TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 72/299 (24%), Positives = 123/299 (41%), Gaps = 55/299 (18%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   A+K++K     Q       + E  IL  L  K+     
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA-LAAKHP---- 56

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYEL---------IKINHFRGLSLSIVQLFSKQI 222
                    F+    L  CF+  D   + +          +I   R       + ++ ++
Sbjct: 57  ---------FLTA--LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEV 105

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRY 278
              L  L   G+I+ DLK +NILL         K+ DFG  C E      T  ++  +  
Sbjct: 106 TLALMFLHRHGVIYRDLKLDNILLDAE---GHCKLADFG-MCKEGILNGVTTTTFCGTPD 161

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDY 336
           Y +PE+L   +Y  ++D W+ G ++ E+  G P F   +E DL   ++   +L    P +
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL---YPVW 218

Query: 337 VLKEA---------KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKP 386
           + KEA         KN +K   C+ S    + GE +I     ++ +  +  E R++K P
Sbjct: 219 LSKEAVSILKAFMTKNPNKRLGCVAS----QGGEDAIKQHPFFKEIDWVLLEQRKIKPP 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 22/224 (9%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKHHI 174
           +G G+FG+V K  D      VA+KII  + A    +    E+++L+  +  Y       +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY-------V 64

Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
            + Y  ++    L I  E L   +  +L++        ++ +    ++IL+GL  L    
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---REILKGLDYLHSEK 121

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YIQSRYYRSPEVLLGYQY 290
            IH D+K  N+LL    +  E+K+ DFG A     T      ++ + ++ +PEV+    Y
Sbjct: 122 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  D+WS G    EL  G    P  SE   ++ +  I    PP
Sbjct: 179 DSKADIWSLGITAIELAKGE---PPHSELHPMKVLFLIPKNNPP 219

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 21/200 (10%)

Query: 113 VKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +G G FG V      +     VAVK +K+     Q  L E S++TTL         
Sbjct: 10  LGATIGKGEFGDV---MLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHP------ 60

Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            ++V++    +    L I  E +   +L + ++      ++L+    F+  +  G+  L+
Sbjct: 61  -NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 231 DAGIIHCDLKPENILLCTSVKPAE---IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
           +   +H DL   N+L+      +E    K+ DFG A    +   S      + +PE L  
Sbjct: 120 EKNFVHRDLAARNVLV------SEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALRE 173

Query: 288 YQYTTAIDMWSFGCIVAELF 307
            +++T  D+WSFG ++ E++
Sbjct: 174 KKFSTKSDVWSFGILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 28/223 (12%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T R Y V   LG G FG+V  C         A K ++ +    ++    AL E  IL  +
Sbjct: 1   TFRHYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 57

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-----NLYELIKINHFRGLSLSIVQL 217
           N ++       +V +   +  +  LC+   L++      ++Y +       G        
Sbjct: 58  NSRF-------VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN----PGFDEERAVF 106

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSYIQ 275
           ++ +I  GL  L    I++ DLKPENILL        I+I D G A    E  T+   + 
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDY---GHIRISDLGLAVEIPEGETIRGRVG 163

Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
           +  Y +PEV+   +YT + D W  GC++ E+  G   F    E
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 71/257 (27%), Positives = 111/257 (43%), Gaps = 60/257 (23%)

Query: 117 LGHGTFGQVAKCWDAEMN-----SFVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRE 169
           LG G FG+V K     +      + VAVK++K     +  +  L E ++L  +N      
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP---- 63

Query: 170 DKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKI------------------NH 206
              H++++Y        L +  E      L S L E  K+                    
Sbjct: 64  ---HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
            R L++  +  F+ QI RG+  L +  ++H DL   N+L+    K   +KI DFG +   
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLS--- 174

Query: 267 DRTVY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
            R VY   SY++    R      + E L  + YTT  D+WSFG ++ E+  LG   +PG 
Sbjct: 175 -RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233

Query: 317 SE---FDLLR---RMIR 327
           +    F+LL+   RM R
Sbjct: 234 APERLFNLLKTGYRMER 250

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 32/211 (15%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALVEVSILTTLNKKYD 167
           +Y V  ++G G+FG+         +   A+K I+   +    + +  E  +L  +     
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM----- 55

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
              KH +IV   E F    HL I  E  D  +L + IK+   +      +  +  Q+  G
Sbjct: 56  ---KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------CTEDRTVYSYIQ 275
           +  + +  ++H D+K +NI L  + K   +K+ DFGSA          CT       Y+ 
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGK---VKLGDFGSARLLTSPGAYACT-------YVG 162

Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
           + YY  PE+     Y    D+WS GCI+ EL
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)

Query: 117 LGHGTFGQVAK-CWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG+G FG+V    W+   N+ VAVK +K      +  L E  I+  L     R DK  +V
Sbjct: 14  LGNGQFGEVWMGTWNG--NTKVAVKTLKPGTMSPESFLEEAQIMKKL-----RHDK--LV 64

Query: 176 RIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y   V +  + I  E +   +L + +K    R L L  +   + Q+  G++ ++    
Sbjct: 65  QLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL+  NIL+   +     KI DFG A   ED    +   +++   + +PE  L  ++
Sbjct: 124 IHRDLRSANILVGDGLV---CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 291 TTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           T   D+WSFG ++ EL   G   +PG +  ++L ++ R
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 61/245 (24%), Positives = 102/245 (41%), Gaps = 30/245 (12%)

Query: 117 LGHGTFGQVAKC--WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           L  G+ G+V  C     E    V VK +       +    E+ IL T++ +        I
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHR-------AI 148

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           + +   +  +  +C+       +L+  +  +    L L       +++L  L+ L   GI
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGI 206

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQ 289
           IH D+K ENI L    +P    + DFG+AC  D        Y +  +    SPE+L    
Sbjct: 207 IHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263

Query: 290 YTTAIDMWSFGCIVAELFL-GLPLF----PGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
           Y    D+WS G ++ E+ +  + LF      +S    LR +IR +   P ++    + N 
Sbjct: 264 YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS--QLRSIIRCMQVHPLEFPQNGSTNL 321

Query: 345 SKFFK 349
            K FK
Sbjct: 322 CKHFK 326

Length = 392

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 20/210 (9%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKK 165
           +++Y   + +G G  G V    D      VA+K +  + QP   ++ L+   IL      
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVM---- 70

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
             RE+KH +IV   + ++    L +  E L      L  +     +    +    ++ L+
Sbjct: 71  --RENKHPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQ 126

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRS 281
            L  L    +IH D+K +NILL        +K+ DFG       E     + + + Y+ +
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           PEV+    Y   +D+WS G +  E+  G P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 39/231 (16%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFV----AVKIIKNQPAYYQQALVEVSILTTLN 163
           ++R   K+ LG G FG+V  C    M  F+    ++ +  NQP      LV V +L    
Sbjct: 4   RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPV-----LVAVKMLREDA 58

Query: 164 KKYDRED------------KHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRG- 209
            K  R D              +I+R+    +    LC+  E +++ +L + +  +  +  
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118

Query: 210 --------LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
                   +S S +   + QI  G+  L     +H DL   N   C   K   IKI DFG
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN---CLVGKNYTIKIADFG 175

Query: 262 SACTEDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            +       Y  IQ R      + S E +L  ++TTA D+W+FG  + E+ 
Sbjct: 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.5 bits (149), Expect = 6e-10
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 117 LGHGTFGQV--AKCWDAE-----MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG+V  A   + +     +  F   KIIK +         E  IL  +N  +   
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV--DHVFSERKILNYINHPF--- 92

Query: 170 DKHHIVRIYEYFVCQRHLCICFE-LLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
                V +Y  F  + +L +  E ++    +  ++ N  +     +   ++ QI+     
Sbjct: 93  ----CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEY 146

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
           L+   I++ DLKPEN+LL    K   IK+ DFG A   D   Y+   +  Y +PE+LL  
Sbjct: 147 LQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNV 203

Query: 289 QYTTAIDMWSFGCIVAELFLGLPLF 313
            +  A D W+ G  + E+ +G P F
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 57/191 (29%), Positives = 85/191 (44%), Gaps = 42/191 (21%)

Query: 159 LTTLNKKYDREDKHHIVRIY----EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
           L TL+  +  + K H++  Y    E F    HL               +  HF     S 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFT---HLY--------------QREHFT---ESE 106

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-----SACTEDRT 269
           V+++  +I+  L  L   GII+ D+K ENILL        + + DFG      A  E+R 
Sbjct: 107 VRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 270 VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFP--GA--SEFDLLR 323
            YS+  +  Y +PEV+ G    +  A+D WS G +  EL  G   F   G   S+ ++ R
Sbjct: 164 -YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222

Query: 324 RMIRILGAQPP 334
              RIL ++PP
Sbjct: 223 ---RILKSKPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 67/233 (28%), Positives = 98/233 (42%), Gaps = 50/233 (21%)

Query: 108 QRRYIV-KDLLGHGTFGQV--AKCWDAEMNS---FVAVKIIKNQPAYYQQALV-EVSILT 160
           +RR IV K  LG G FG+V  A+C +         VAVK +K      +Q    E  +LT
Sbjct: 3   KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 62

Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL--------------DSNLYELIKINH 206
            L  +       HIVR Y      R L + FE +              D+ +    +   
Sbjct: 63  VLQHQ-------HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
              L+L  +   + QI  G+  L     +H DL   N L+   +    +KI DFG +   
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV---VKIGDFGMS--- 169

Query: 267 DRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
            R +YS   + YYR             PE +L  ++TT  D+WSFG ++ E+F
Sbjct: 170 -RDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 67/266 (25%), Positives = 114/266 (42%), Gaps = 37/266 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V +         VAVK IK      Q  L E +++T L+ K       ++VR
Sbjct: 14  IGEGEFGAVLQ--GEYTGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHK-------NLVR 63

Query: 177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSL-SIVQL--FSKQILRGLSLLKDA 232
           +    +    L I  EL+   NL   ++    RG +L S++QL  FS  +  G+  L+  
Sbjct: 64  LLG-VILHNGLYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
            ++H DL   NIL+    +    K+ DFG A      V +      + +PE L   ++++
Sbjct: 120 KLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSS 176

Query: 293 AIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCI 351
             D+WS+G ++ E+F  G   +P  S  ++   + +    +PP+              C 
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE-------------GCP 223

Query: 352 GSVHNIENG--EVSIGGRSAYQALTE 375
             V+ +     E     R ++  L E
Sbjct: 224 ADVYVLMTSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T R Y V   LG G FG+V  C         A K ++ +    ++    AL E  IL  +
Sbjct: 1   TFRHYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV 57

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFR-GLSLSIVQLFSKQ 221
           N ++       +V +   +  +  LC+   +++    +    N    G        ++ +
Sbjct: 58  NSRF-------VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE 110

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSYIQSRYY 279
           +  GL  L+   I++ DLKPENILL        I+I D G A    E  TV   + +  Y
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDR---GHIRISDLGLAVQIPEGETVRGRVGTVGY 167

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLG 309
            +PEV+   +YT + D W  GC++ E+  G
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.7 bits (147), Expect = 8e-10
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+FG+V      E     AVK++K +    Q   VE    T   K+     ++H  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLK-KDVILQDDDVEC---TMTEKRILSLARNHP- 56

Query: 176 RIYEYFVCQRHLCICFELLDSNLYEL---------IKINHFRGLSLSIVQLFSKQILRGL 226
                F+ Q  L  CF+  D   + +           I   R    +  + ++ +I   L
Sbjct: 57  -----FLTQ--LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL 109

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSP 282
             L D GII+ DLK +N+LL         K+ DFG  C E     +T  ++  +  Y +P
Sbjct: 110 MFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFG-MCKEGIFNGKTTSTFCGTPDYIAP 165

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           E+L    Y  ++D W+ G ++ E+  G   F   +E DL 
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 20/238 (8%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
           ++G G FG+V  C  A+     A+K +  +    +Q    AL E  +L+ ++      D 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DC 56

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             IV +   F     L    +L++     Y L +   F   S + ++ ++ +I+ GL  +
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEAEMRFYAAEIILGLEHM 113

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYYRSPEVLL-G 287
            +  +++ DLKP NILL        ++I D G AC    +  ++ + +  Y +PEVL  G
Sbjct: 114 HNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD--LLRRMIRILGAQPPDYVLKEAKN 343
             Y ++ D +S GC++ +L  G   F      D   + RM   +  + PD    E ++
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 39/210 (18%)

Query: 117 LGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDK 171
           LG G FG V K       S   VAVKI+KN    PA   + L E +++  L+  Y     
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPY----- 57

Query: 172 HHIVRIYEYFVCQRHLCICFE---LLDSNLYELIKINHF----RGLSLSIVQLFSKQILR 224
             IVR+         + IC     +L   L EL  +N F    + ++   +     Q+  
Sbjct: 58  --IVRM---------IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM 106

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS-----R 277
           G+  L++   +H DL   N+LL T       KI DFG   A   D   Y          +
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADENYYKAKTHGKWPVK 163

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
           +Y +PE +  Y++++  D+WSFG ++ E F
Sbjct: 164 WY-APECMNYYKFSSKSDVWSFGVLMWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 20/238 (8%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
           ++G G FG+V  C  A+     A+K +  +    +Q    AL E  +L+ ++      D 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DC 56

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             IV +   F     LC   +L++     Y L +   F   S   ++ ++ +I+ GL  +
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF---SEKEMRFYATEIILGLEHM 113

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYYRSPEVLL-G 287
            +  +++ DLKP NILL    +   ++I D G AC    +  ++ + +  Y +PEVL  G
Sbjct: 114 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLKEAKN 343
             Y ++ D +S GC++ +L  G   F      D   + RM   +  + PD    E K+
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 22/219 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W A  N    VAVK +K      +  L E +++ TL  ++D+  K H 
Sbjct: 14  LGAGQFGEV---WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL--QHDKLVKLHA 68

Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V      V +  + I  E +   +L + +K +      L  +  FS QI  G++ ++   
Sbjct: 69  V------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL+  NIL+  S+     KI DFG A   ED    +   +++   + +PE +    
Sbjct: 123 YIHRDLRAANILVSASLV---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ E+   G   +PG S  +++R + R
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 25/214 (11%)

Query: 108 QRRYIVKDLLGHGTFGQVAKC-WDAEMNS---FVAVKIIKNQPAYYQQALV-EVSILTTL 162
           +R       LG G FG V  C +D   ++    VAVK +++  A + +    E+ IL +L
Sbjct: 3   ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL 62

Query: 163 NKKYDREDKHHIVRIYE---YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
                      IV+ Y+   Y   +R+L +  E L           H   L    + L++
Sbjct: 63  QHDN-------IVK-YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSR 277
            QI +G+  L     +H DL   NIL+ +      +KI DFG      +D+  Y   +  
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPG 171

Query: 278 ----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
               ++ +PE L   +++ A D+WSFG ++ ELF
Sbjct: 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 30/235 (12%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKN--QPAYYQQALVEVS 157
           E QR  I     +G G FG V +       + ++   VAVK  KN   P+  ++ L E  
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIA--VAVKTCKNCTSPSVREKFLQEAY 59

Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFELLD-SNLYELIKINHFRGLSLSIV 215
           I+          D  HIV++    V   + + I  EL     L   +++N +  L L+ +
Sbjct: 60  IMRQF-------DHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYS-LDLASL 109

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYI 274
            L+S Q+   L+ L+    +H D+   N+L+ +   P  +K+ DFG S   ED + Y   
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSS---PDCVKLGDFGLSRYLEDESYYKAS 166

Query: 275 QSRY---YRSPEVLLGYQYTTAIDMWSFG-CIVAELFLGLPLFPGASEFDLLRRM 325
           + +    + +PE +   ++T+A D+W FG C+   L LG+  F G    D++ R+
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 21/237 (8%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
           +G G+ G V           VAVK +  +    ++ L  EV I+    + Y  E+   +V
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 80

Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +Y  ++    L +  E L+      I + H R ++   +      +L+ LS+L   G+I
Sbjct: 81  EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLKALSVLHAQGVI 138

Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
           H D+K ++ILL        +K+ DFG      + V    S + + Y+ +PE++    Y  
Sbjct: 139 HRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 293 AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
            +D+WS G +V E+  G P  P  +E   L+ M  I    PP   LK     S   K
Sbjct: 196 EVDIWSLGIMVIEMVDGEP--PYFNE-PPLKAMKMIRDNLPPK--LKNLHKVSPSLK 247

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 26/203 (12%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G FG+V+ C         A K +  +       Y+ A+VE  IL  ++ ++      
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF------ 54

Query: 173 HIVRIYEYFVCQRHLCICFELLDS-----NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            IV +   F  +  LC+   +++      ++Y + + N   G        ++ QI+ GL 
Sbjct: 55  -IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN--PGFPEPRACFYTAQIISGLE 111

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT----EDRTVYSYIQSRYYRSPE 283
            L    II+ DLKPEN+LL        ++I D G A      + +T   Y  +  + +PE
Sbjct: 112 HLHQRRIIYRDLKPENVLLDND---GNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPE 167

Query: 284 VLLGYQYTTAIDMWSFGCIVAEL 306
           +L G +Y  ++D ++ G  + E+
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 37/126 (29%), Positives = 64/126 (50%), Gaps = 7/126 (5%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSR 277
           +I   L  L   GII+ DLKPENILL        +K+ DFG    +  E    +++  + 
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
            Y +PE+L+   +  A+D WS G ++ ++  G P F   +    + ++++     PP Y+
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP-YL 223

Query: 338 LKEAKN 343
             EA++
Sbjct: 224 TPEARD 229

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 28/208 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G V K       + +AVK I+      +Q      +L  L+      D  + V 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLDISMRSVDCPYTVT 64

Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSL--SIVQLFSKQILRGLSLLKDA-G 233
            Y     +  + IC E++D++L +  K  + +GL++   I+   +  I++ L  L     
Sbjct: 65  FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--------SACTEDRTVYSYIQSRYYRSPEVL 285
           +IH D+KP N+L+    +  ++K+ DFG         A T D         + Y +PE +
Sbjct: 125 VIHRDVKPSNVLIN---RNGQVKLCDFGISGYLVDSVAKTID------AGCKPYMAPERI 175

Query: 286 LG----YQYTTAIDMWSFGCIVAELFLG 309
                   Y    D+WS G  + EL  G
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)

Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL  +     +KI DFG A    R 
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLA----RD 228

Query: 270 VYS---YIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288

Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 289 EEFCRRLKEGTRMRAPDYTTPEMYQT 314

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 5e-09
 Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 8/103 (7%)

Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--- 264
           R L L+ V   ++Q+L  +  +   GIIH D+K EN+L+     P +I + DFG+AC   
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG---PEDICLGDFGAACFAR 311

Query: 265 -TEDRTVYSYIQSRY-YRSPEVLLGYQYTTAIDMWSFGCIVAE 305
            +     +  I       +PEVL G  YT ++D+WS G ++ E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 43/236 (18%)

Query: 116 LLGHGTFGQVAK------CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
            LG G FG+V +               VAVK ++      ++   L E  +++  N    
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHP-- 59

Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELI---KINHFRGLSLSIVQLFSK--Q 221
                +IV++    +      I  EL++  +L   +   ++  F    L++ +L      
Sbjct: 60  -----NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
           + +G   L+    IH DL   N L+          +KI DFG A    R +Y    S YY
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA----RDIYK---SDYY 167

Query: 280 R------------SPEVLLGYQYTTAIDMWSFGCIVAE-LFLGLPLFPGASEFDLL 322
           R            +PE LL  ++TT  D+WSFG ++ E L LG   +P  +  ++L
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)

Query: 108 QRRYIVK-DLLGHGTFGQVA-KCWDA---EMNSFVAVKIIK--NQPAYYQQALVEVSILT 160
            +RY+ K  +LG G FG+V+  C+D         VAVK +K             E++IL 
Sbjct: 2   HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK 61

Query: 161 TLNKKYDREDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
           TL          +IV+   Y  C      + L +  E +   L  L        L+L+ +
Sbjct: 62  TL-------YHENIVK---YKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQL 109

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSY 273
            LF++QI  G++ L     IH DL   N+LL        +KI DFG   A  E    Y  
Sbjct: 110 LLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRV 166

Query: 274 IQSR----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            +      ++ + E L   +++ A D+WSFG  + EL 
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 50/233 (21%)

Query: 108 QRRYIVKDLLGHGTFGQV--AKCWDAEMNS---FVAVKIIKNQPAYYQQALV-EVSILTT 161
           +R  ++K  LG G FG+V  A+C++         VAVK +K+     ++    E  +LT 
Sbjct: 4   RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63

Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELL---DSNLY-------ELIKIN----HF 207
           L  +       HIV+ Y        L + FE +   D N +        +I ++      
Sbjct: 64  LQHE-------HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 208 RG-LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
           +G L LS +   + QI  G+  L     +H DL   N L+  ++    +KI DFG +   
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFGMS--- 170

Query: 267 DRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
            R VYS   + YYR             PE ++  ++TT  D+WSFG I+ E+F
Sbjct: 171 -RDVYS---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 45/218 (20%)

Query: 117 LGHGTFGQV-----AKCWDAEMNSFVAVKIIKNQPAYYQ--QALVEVSILTTLNKKYDRE 169
           LG G+FG V           E  + VA+K +    +  +  + L E S++    K+++  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM----KEFN-- 67

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIK-----INHFRGLSLSIVQLF---SK 220
             HH+VR+       +   +  EL+   +L   ++       +  GL    +Q F   + 
Sbjct: 68  -CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++ YYR
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARN---CMVAEDLTVKIGDFGMT----RDIY---ETDYYR 176

Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
                       +PE L    +TT  D+WSFG ++ E+
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 35/208 (16%)

Query: 117 LGHGTFGQVAKCWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDK 171
           LGHG FG V K      +     VAVK +K +   A  ++ L E S++  L+        
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPC----- 57

Query: 172 HHIVRIYEYFVCQ-RHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGL 226
             IVR+    VC+   L +  EL       L  +  +    R + +S ++  + Q+  G+
Sbjct: 58  --IVRLIG--VCKGEPLMLVMELA-----PLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS-----RYY 279
           + L+    +H DL   N+LL   V   + KI DFG   A       Y    +     ++Y
Sbjct: 109 AYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            +PE +   ++++  D+WS+G  + E F
Sbjct: 166 -APECINYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 111 YIVKDLLGHGTFGQV--AKC-WDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           + ++  +G G F +V  A C  D +  +   V+I +   A  +Q  V E+ +L  LN   
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP- 62

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHF----RGLSLSIVQLFSKQ 221
                 ++++  + F+    L I  EL D+ +L ++IK  +F    R +    V  +  Q
Sbjct: 63  ------NVIKYLDSFIEDNELNIVLELADAGDLSQMIK--YFKKQKRLIPERTVWKYFVQ 114

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRY 278
           +   +  +    ++H D+KP N+ +  +     +K+ D G      ++    +S + + Y
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
           Y SPE +    Y    D+WS GC++ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 58/240 (24%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSF--------------VAVKIIKNQPAYYQQA- 152
           +++  +K+ LG G FG+V  C    +  F              VAVK+++       +  
Sbjct: 4   RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND 63

Query: 153 -LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL---DSNLY--------E 200
            L E+ I++ L          +I+R+    V    LC+  E +   D N +         
Sbjct: 64  FLKEIKIMSRLKNP-------NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 201 LIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260
               N+   +S++ +   + QI  G+  L     +H DL   N L+        IKI DF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT---IKIADF 173

Query: 261 GSACTEDRTVYSYIQSRYYRS-------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
           G +    R +YS     YYR                +LLG ++TTA D+W+FG  + E+F
Sbjct: 174 GMS----RNLYS---GDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 22/219 (10%)

Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  I+  L     R DK  +
Sbjct: 14  LGQGCFGEV---WMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDK--L 63

Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V +Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 64  VPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN 122

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            IH DL+  NIL+  ++     KI DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 123 YIHRDLRAANILVGDNLV---CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)

Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 14  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 63

Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 64  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 123 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 28/238 (11%)

Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           + + +G GT+G+V K  + +  S  AVKI+       ++   E +IL  L+      D  
Sbjct: 22  IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS------DHP 75

Query: 173 HIVRIYEYF-----VCQRHLCICFELLDS-NLYELIKINHFRGLSLS--IVQLFSKQILR 224
           ++V+ Y  +          L +  EL +  ++ +L+K    RG  +   I+     + L 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS 281
           GL  L     IH D+K  NILL T      +K++DFG +     T     + + + ++ +
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 282 PEVL-----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           PEV+     L   Y    D+WS G    EL  G P     ++   +R + +I    PP
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNPPP 247

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 8/102 (7%)

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVY 271
           + ++ +I   L  L    II+ DLKPENILL +      + + DFG  C E     +T  
Sbjct: 99  RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFG-LCKEGIEHSKTTS 154

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           ++  +  Y +PEVL    Y   +D W  G ++ E+  GLP F
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
           + ++  +G G F +V +         VA+K ++             + E+ +L  LN   
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP- 62

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHF----RGLSLSIVQLFSKQ 221
                 ++++ Y  F+    L I  EL D+ +L  +IK  HF    R +    V  +  Q
Sbjct: 63  ------NVIKYYASFIEDNELNIVLELADAGDLSRMIK--HFKKQKRLIPEKTVWKYFVQ 114

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
           +   L  +    ++H D+KP N+ +  +  VK  ++ +  F S+ T     +S + + YY
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYY 172

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAEL 306
            SPE +    Y    D+WS GC++ E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA----LVEVSILTTLNKKYDREDK 171
           ++G G+FG+V         SF AVK+++ +    ++     + E ++L        +  K
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-------KNLK 54

Query: 172 H-HIVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSLL 229
           H  +V ++  F     L    + ++    EL   +   R       + ++ ++   +  L
Sbjct: 55  HPFLVGLHYSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYL 112

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
               II+ DLKPENILL +      + + DFG  C E    + T  ++  +  Y +PEVL
Sbjct: 113 HSLNIIYRDLKPENILLDSQ---GHVVLTDFG-LCKEGVEPEETTSTFCGTPEYLAPEVL 168

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
               Y   +D W  G ++ E+  GLP F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 31/212 (14%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           ++G G+FG+V          F AVK+++ +           +IL    +K+   +++ ++
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKK-----------AILKKKEEKHIMSERNVLL 50

Query: 176 RIYEY-FVCQRHLCICFELLDSNLYELIKIN------HF---RGLSLSIVQLFSKQILRG 225
           +  ++ F+   H    F+  D   + L  IN      H    R       + ++ +I   
Sbjct: 51  KNVKHPFLVGLHFS--FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 108

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRS 281
           L  L    I++ DLKPENILL +      I + DFG  C E+     T  ++  +  Y +
Sbjct: 109 LGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFG-LCKENIEHNGTTSTFCGTPEYLA 164

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           PEVL    Y   +D W  G ++ E+  GLP F
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 39/108 (36%), Positives = 54/108 (50%), Gaps = 17/108 (15%)

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YI 274
           +S Q+ RG+  L     IH DL   NILL  +     +KI DFG A    R +Y    Y+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLA----RDIYKDPDYV 231

Query: 275 QSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
           +    R      +PE +    YTT  D+WSFG ++ E+F LG   +PG
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 31/238 (13%)

Query: 117 LGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N    VAVK +K      +  L E  I+  L     R DK  +
Sbjct: 14  LGAGQFGEV---WMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-----RHDK--L 63

Query: 175 VRIYEYFVCQRH--LCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           V++Y   VC     + I  E +   +L + +K    + L L  +   + QI  G++ L+ 
Sbjct: 64  VQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL   NIL+         KI DFG A   ED    +   +++   + +PE    
Sbjct: 122 RNYIHRDLAARNILV--GENLV-CKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY 178

Query: 288 YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR------RMIRILGAQPPDYVL 338
            ++T   D+WSFG ++ E+   G   +PG +  ++L       RM R        Y L
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 18/134 (13%)

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YI 274
           +S Q+ RG+  L     IH DL   NILL  +     +KI DFG A    R +Y    Y+
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLA----RDIYKDPDYV 230

Query: 275 QSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLLRRMI 326
           +    R      +PE +    YTT  D+WSFG ++ E+F LG   +PG   + +  RR+ 
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290

Query: 327 RILGAQPPDYVLKE 340
                + P+Y   E
Sbjct: 291 EGTRMRAPEYATPE 304

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           + +G GT+G+V K  + +  S  AVKI+       ++   E +IL +L       +  ++
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL------PNHPNV 81

Query: 175 VRIYEYFVCQRH-----LCICFELLDS-NLYELIKINHFRGLSL--SIVQLFSKQILRGL 226
           V+ Y  F          L +  EL +  ++ EL+K     G  L  +++       L GL
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPE 283
             L +  IIH D+K  NILL T      +K++DFG +     T     + + + ++ +PE
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 284 VL-----LGYQYTTAIDMWSFGCIVAELFLGLP 311
           V+       Y Y    D+WS G    EL  G P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 43/127 (33%), Positives = 59/127 (46%), Gaps = 29/127 (22%)

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F+ Q+ RG+  L     IH DL   N+L+    +   +KI DFG A    R ++      
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLA----RDIHH---ID 186

Query: 278 YYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG-ASE--FDL 321
           YYR            +PE L    YT   D+WSFG ++ E+F LG   +PG   E  F L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246

Query: 322 LR---RM 325
           L+   RM
Sbjct: 247 LKEGYRM 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 53/246 (21%)

Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G FG+V K       +    + VA+K +K   +P   Q+   E  +++ L       
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP---- 68

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKIN----------HFRGLSLSIVQL- 217
              +IV +      ++  C+ FE L   +L+E +  N              +  S+    
Sbjct: 69  ---NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 218 ---FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
               + QI  G+  L     +H DL   N L+   +    +KI DFG +    R +YS  
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL---TVKISDFGLS----RDIYS-- 176

Query: 275 QSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDL 321
            + YYR             PE +L  ++TT  D+WSFG ++ E+F  GL  + G S  ++
Sbjct: 177 -ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235

Query: 322 LRRMIR 327
           +  MIR
Sbjct: 236 I-EMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 24/165 (14%)

Query: 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247
           C+      S+LY  +     R L +    +  KQIL GL  L    IIH D+K ENI + 
Sbjct: 133 CMVLPHYSSDLYTYLT-KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI- 190

Query: 248 TSVKPAEIKIIDFGSA-----CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCI 302
             V   ++ I D G+A           +   +++    +PEVL   +Y +  D+WS G +
Sbjct: 191 NDVD--QVCIGDLGAAQFPVVAPAFLGLAGTVET---NAPEVLARDKYNSKADIWSAGIV 245

Query: 303 VAELFLGLP--LF---------PGASEFDLLRRMIRILGAQPPDY 336
           + E+ L  P  +F            S    L ++I  L   P ++
Sbjct: 246 LFEM-LAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289

Length = 357

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 26/200 (13%)

Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W+   N  + VAVK +K      +  L E  I+  L          H 
Sbjct: 14  LGAGQFGEV---WEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL---------RHP 61

Query: 175 VRIYEYFVCQRH--LCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             I  Y VC     + I  EL+   +L E ++    R L L  +   + Q+  G++ L+ 
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 232 AGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVY-SYIQSRY---YRSPEVLL 286
              IH DL   N+L    V    I K+ DFG A      +Y +   +++   + +PE  L
Sbjct: 122 QNYIHRDLAARNVL----VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177

Query: 287 GYQYTTAIDMWSFGCIVAEL 306
             +++   D+WSFG ++ E+
Sbjct: 178 YNRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.3 bits (135), Expect = 5e-08
 Identities = 71/248 (28%), Positives = 109/248 (43%), Gaps = 46/248 (18%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYD 167
           Y V   +G+G FG+V          F   K I     +     Q ++EV+++        
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM-------- 66

Query: 168 REDKH-HIVRIYEYFV--CQRHLCICFELLDS-----NLYELIKINHFRGLSLSIVQLFS 219
           RE KH +IVR  + F+    + L I  E  D+     N+ +  K+  F  +    +   +
Sbjct: 67  RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDIT 124

Query: 220 KQILRGLSL---LKDAG----IIHCDLKPENILLCTSVK-----PAEI---------KII 258
           +Q+L  L+    LKD      ++H DLKP+NI L T ++      A+          KI 
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 259 DFGSA--CTEDRTVYSYIQSRYYRSPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFP 314
           DFG +     +   +S + + YY SPE+LL     Y    DMW+ GCI+ EL  G   F 
Sbjct: 185 DFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244

Query: 315 GASEFDLL 322
            A+ F  L
Sbjct: 245 KANNFSQL 252

Length = 1021

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 16/130 (12%)

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTV 270
           VQ++S +I+  L  L   GII+ D+K ENILL ++     + + DFG +      E    
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFHEDEVERA 163

Query: 271 YSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFP----GASEFDLLRR 324
           YS+  +  Y +P+++ G    +  A+D WS G ++ EL  G   F       S+ ++ R 
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR- 222

Query: 325 MIRILGAQPP 334
             RIL ++PP
Sbjct: 223 --RILKSEPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 55.2 bits (133), Expect = 6e-08
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 33/233 (14%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           +G G  G V K          A+K+I   ++    +Q   E+ IL  +N         ++
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHP-------NV 134

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V+ ++ F     + +  E +D    E   I   + L+       ++QIL G++ L    I
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLL----- 286
           +H D+KP N LL  S K   +KI DFG +    +T+    S + +  Y SPE +      
Sbjct: 190 VHRDIKPSN-LLINSAK--NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246

Query: 287 ----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
               GY    A D+WS G  + E +LG   F    + D    M  I  +QPP+
Sbjct: 247 GAYDGY----AGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE 295

Length = 353

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 9/127 (7%)

Query: 195 DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254
           DS +  L+  +   GL+   +  F+ Q+ RG+  L     +H DL   N+LL        
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG---KI 275

Query: 255 IKIIDFGSA--CTEDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-L 308
           +KI DFG A     D    S   +     + +PE +    YTT  D+WS+G ++ E+F L
Sbjct: 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335

Query: 309 GLPLFPG 315
           G   +PG
Sbjct: 336 GGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.7 bits (131), Expect = 7e-08
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 16/213 (7%)

Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLN 163
            + +++Y   + +G G  G V    D      VA+K I  Q    ++ ++ E+ ++  L 
Sbjct: 15  GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                    +IV   + F+    L +  E L      L  +     +  + +    ++ L
Sbjct: 75  NP-------NIVNFLDSFLVGDELFVVMEYLAGG--SLTDVVTETCMDEAQIAAVCRECL 125

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
           + L  L    +IH D+K +N+LL        +K+ DFG       E     + + + Y+ 
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +PEV+    Y   +D+WS G +  E+  G P +
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 8e-08
 Identities = 35/144 (24%), Positives = 66/144 (45%), Gaps = 17/144 (11%)

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           I+++   F   +  C+      ++LY  +     R +++  +    + +LR +  L +  
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR 202

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY--------RSPEVL 285
           IIH D+K ENI +     P ++ + DFG+AC           ++YY         +PE+L
Sbjct: 203 IIHRDIKAENIFIN---HPGDVCLGDFGAACFP----VDINANKYYGWAGTIATNAPELL 255

Query: 286 LGYQYTTAIDMWSFGCIVAELFLG 309
               Y  A+D+WS G ++ E+   
Sbjct: 256 ARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 22/212 (10%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQ-QALVEVSILTTLNKKYDREDKH 172
           +LLG G FG+V K    +    VAVK  K   P   + + L E  IL    K+YD  +  
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARIL----KQYDHPN-- 53

Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLK 230
            IV++      ++ + I  EL+     + +     +   L   QL  F+     G++ L+
Sbjct: 54  -IVKLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE 110

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY----YRSPEVLL 286
               IH DL   N L+  +     +KI DFG +  ED  +YS    +     + +PE L 
Sbjct: 111 SKNCIHRDLAARNCLVGEN---NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167

Query: 287 GYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
             +Y++  D+WS+G ++ E F LG+  +PG +
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 20/215 (9%)

Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALVEVSILTTL 162
            + +++Y   + +G G  G V    D      VA+K   ++ QP   ++ L+   IL   
Sbjct: 15  GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVM- 70

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                RE+K+ +IV   + ++    L +  E L      L  +     +    +    ++
Sbjct: 71  -----RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRE 123

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRY 278
            L+ L  L    +IH D+K +NILL        +K+ DFG       E     + + + Y
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           + +PEV+    Y   +D+WS G +  E+  G P +
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 46/235 (19%)

Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +      +       VAVK +    +   ++  L+E  I++  N +    
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ---- 69

Query: 170 DKHHIVRIYEYFVCQRHL--CICFELLDS-NLYELIKINHFR-----GLSLSIVQLFSKQ 221
              +IVR+    V    L   I  EL+   +L   ++ N  R      L++  +   ++ 
Sbjct: 70  ---NIVRLIG--VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYR 280
           + +G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLL-TCKGPGRVAKIADFGMA----RDIY---RASYYR 176

Query: 281 S------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                        PE  L   +T+  D+WSFG ++ E+F LG   +PG +  +++
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 20/215 (9%)

Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALVEVSILTTL 162
            + +++Y   + +G G  G V    D      VA++   ++ QP   ++ L+   IL   
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVM- 71

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                RE+K+ +IV   + ++    L +  E L      L  +     +    +    ++
Sbjct: 72  -----RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRE 124

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYS-YIQSRY 278
            L+ L  L    +IH D+K +NILL        +K+ DFG  +  T +++  S  + + Y
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           + +PEV+    Y   +D+WS G +  E+  G P +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 19/212 (8%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
           ++G G++ +V      +     A+K++K +     +   ++  + T    +++   H  +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFL 58

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V ++  F  +  L    E ++     +  +   R L     + +S +I   L+ L + GI
Sbjct: 59  VGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
           I+ DLK +N+LL +      IK+ D+G  C E      T  ++  +  Y +PE+L G  Y
Sbjct: 118 IYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
             ++D W+ G ++ E      +  G S FD++
Sbjct: 174 GFSVDWWALGVLMFE------MMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 47/226 (20%)

Query: 112 IVKDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKK 165
           ++K  LG G FG+V  A+C++    +    VAVK +K+     ++    E  +LT L  +
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKI-----------NHFRGLSLS 213
                  HIV+ Y   V    L + FE +   +L + ++            N    L+ S
Sbjct: 68  -------HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY 273
            +   ++QI  G+  L     +H DL   N L+  ++    +KI DFG +    R VYS 
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL---VKIGDFGMS----RDVYS- 172

Query: 274 IQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
             + YYR             PE ++  ++TT  D+WS G ++ E+F
Sbjct: 173 --TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 32/215 (14%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
           Y V  ++G G FG+V            A+K++       ++  A++ +   E  I+   N
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 101

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
             +       +V+++  F   ++L +  E +     +L+ +     +     + ++ +++
Sbjct: 102 SPW-------VVQLFCAFQDDKYLYMVMEYMPGG--DLVNLMSNYDVPEKWAKFYTAEVV 152

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYY 279
             L  +   G+IH D+KP+N+LL    K   +K+ DFG+    D T      + + +  Y
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209

Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
            SPEVL      GY Y    D WS G  + E+ +G
Sbjct: 210 ISPEVLKSQGGDGY-YGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 59/242 (24%), Positives = 113/242 (46%), Gaps = 28/242 (11%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
            +K  LG G +G+V +    + +  VAVK +K      ++ L E +++        +E K
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM--------KEIK 60

Query: 172 H-HIVRIYEYFVCQRH--LCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H ++V++    VC R     I  E +   NL + ++  + + ++  ++   + QI   + 
Sbjct: 61  HPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPE 283
            L+    IH DL   N L+  +     +K+ DFG S      T  ++  +++   + +PE
Sbjct: 119 YLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175

Query: 284 VLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLR---RMIRILGAQPPDY 336
            L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL    RM R  G  P  Y
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY 235

Query: 337 VL 338
            L
Sbjct: 236 EL 237

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 67/236 (28%)

Query: 117 LGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE-- 169
           +G G FG+V +         E  + VAVK++K + +              +   + RE  
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------------ADMQADFQREAA 60

Query: 170 -----DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG-------------- 209
                D  +IV++       + +C+ FE +   +L E ++    R               
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 210 ------LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
                 LS +     +KQ+  G++ L +   +H DL   N   C   +   +KI DFG +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN---CLVGENMVVKIADFGLS 177

Query: 264 CTEDRTVYSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
               R +YS   + YY++            PE +   +YTT  D+W++G ++ E+F
Sbjct: 178 ----RNIYS---ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVY 271
           + ++ +I   L  L    I++ DLKPENILL +      + + DFG  C E      T  
Sbjct: 99  RFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---GHVVLTDFG-LCKEGIAQSDTTT 154

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           ++  +  Y +PEV+    Y   +D W  G ++ E+  GLP F
Sbjct: 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 31/217 (14%)

Query: 115 DLLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRED 170
           + +G G FG V   +   +     VAVK  ++   P   ++ L E  IL    K+YD  +
Sbjct: 1   EKIGKGNFGDV---YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL----KQYDHPN 53

Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLS--LSIVQL--FSKQILRGL 226
              IV++    V ++ + I  EL+         +   R     L++ +L   S     G+
Sbjct: 54  ---IVKLIGVCVQKQPIYIVMELVPGGSL----LTFLRKKKNRLTVKKLLQMSLDAAAGM 106

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYRS 281
             L+    IH DL   N   C   +   +KI DFG +  E+  +Y+           + +
Sbjct: 107 EYLESKNCIHRDLAARN---CLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
           PE L   +YT+  D+WS+G ++ E F LG   +PG S
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 39/221 (17%)

Query: 117 LGHGTFGQVAKCW-------DAEMNSFVAVKIIKNQP-AYYQQALV-EVSILTTLNKKYD 167
           LG G FG+V +         DA M   VAVK++K    +  ++AL+ E+ I++ L    +
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMK--VAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 168 RED-----KHH--IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
             +          I+ I EY       C   +LL+      ++      L+L  +  FS 
Sbjct: 101 IVNLLGACTIGGPILVITEY-------CCYGDLLN-----FLRRKRESFLTLEDLLSFSY 148

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ +G++ L     IH DL   N+LL        +KI DFG A     D        +R 
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHG---KIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
              + +PE +    YT   D+WS+G ++ E+F LG   +PG
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 60/289 (20%), Positives = 114/289 (39%), Gaps = 51/289 (17%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD---REDKH 172
           ++G G FG+V      +     A+KI++      +  ++E   +  +  + D     D  
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILVEADGA 61

Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V+++  F  +R+L +  E L     +  L+K +    LS    Q +  + +  +  + 
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH 118

Query: 231 DAGIIHCDLKPENILL-------------CTSVK---------------PAEIKIIDFGS 262
             G IH D+KP+N+LL             CT +K               P++    +  S
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 263 ACTED-------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
               +       +  YS + +  Y +PEV +   Y    D WS G I+ E+ +G P F  
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 316 ASEFDLLRRMI--RILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEV 362
            +  +  R+++  +     PP+  + E         C  S + I +  V
Sbjct: 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGV 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 7/97 (7%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSR 277
           +++  L  L    I++ DLKPENILL  +     I + DFG   +  T+++T  ++  + 
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDAT---GHIALCDFGLSKANLTDNKTTNTFCGTT 160

Query: 278 YYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLF 313
            Y +PEVLL  + YT  +D WS G +V E+  G   F
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 57/237 (24%), Positives = 86/237 (36%), Gaps = 59/237 (24%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVA--VKIIKNQPAYYQQALVEVSIL-----TTLNK 164
              + LG G FG+V  C   E +       K            LV V +L         +
Sbjct: 8   NFVEKLGEGQFGEVHLC---EADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64

Query: 165 KYDREDK-------HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF---------- 207
            + +E K        +I R+         LC+  E +     E   +N F          
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYM-----ENGDLNQFLQKHVAETSG 119

Query: 208 -----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262
                + LS S +   + QI  G+  L+    +H DL   N L+  +     IKI DFG 
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGM 176

Query: 263 ACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
                R +YS   S YYR            + E +L  ++TT  D+W+FG  + E+ 
Sbjct: 177 ----SRNLYS---SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 46/212 (21%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
           ++G G++ +V      + +   A+K++K +  +  +   ++  + T    +++   +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---DIDWVQTEKHVFEQASSNPFL 58

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V ++  F     L +  E ++     +  +   R L     + ++ +I   L+ L + GI
Sbjct: 59  VGLHSCFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
           I+ DLK +N+LL        IK+ D+G  C E      T  ++  +  Y +PE+L G +Y
Sbjct: 118 IYRDLKLDNVLLDAD---GHIKLTDYG-MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
             ++D W+ G ++ E      +  G S FD++
Sbjct: 174 GFSVDWWALGVLMFE------MMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 7e-07
 Identities = 36/121 (29%), Positives = 58/121 (47%), Gaps = 17/121 (14%)

Query: 195 DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254
           D +L++L+K      LS + V+   +Q++  L+ L    IIH D+K EN+ L    K   
Sbjct: 93  DGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV-LYDRAKD-R 148

Query: 255 IKIIDFG------SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308
           I + D+G      +    D T+       Y+ SPE + G+ Y  + D W+ G +  EL  
Sbjct: 149 IYLCDYGLCKIIGTPSCYDGTL------DYF-SPEKIKGHNYDVSFDWWAVGVLTYELLT 201

Query: 309 G 309
           G
Sbjct: 202 G 202

Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 43/128 (33%), Positives = 61/128 (47%), Gaps = 13/128 (10%)

Query: 209 GLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
            L+L    L  FS Q+ +G+S L     IH DL   NILL T  +    KI DFG A  +
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL-THGRIT--KICDFGLA-RD 263

Query: 267 DRTVYSYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
            R   +Y+     R      +PE +    YT   D+WS+G ++ E+F LG   +PG    
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323

Query: 320 DLLRRMIR 327
               +MI+
Sbjct: 324 SKFYKMIK 331

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 26/229 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N    VA+K +K      +  L E +++  L  ++ R     +
Sbjct: 14  LGAGQFGEV---WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL--QHPR-----L 63

Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ ++ 
Sbjct: 64  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER 120

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   +   Y+  +   +     +PE +  
Sbjct: 121 KNYIHRDLRAANILVSETL---CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177

Query: 288 YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 14/111 (12%)

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVY 271
           + +S +I   L+ L + GII+ DLK +N+LL        IK+ D+G  C E      T  
Sbjct: 99  RFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYG-MCKEGIRPGDTTS 154

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           ++  +  Y +PE+L G  Y  ++D W+ G ++ E      +  G S FD++
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE------MMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 33/204 (16%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V   +  E    VA+K I+      +  + E  ++  L+          +V+
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHP-------KLVQ 63

Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSL------- 228
           +Y     +  +C+ FE ++   L + ++    RG        FS++ L G+ L       
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYLRAQ--RGK-------FSQETLLGMCLDVCEGMA 114

Query: 229 -LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPE 283
            L+ + +IH DL   N L+  +     +K+ DFG +    D    S   +++   + SPE
Sbjct: 115 YLESSNVIHRDLAARNCLVGEN---QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171

Query: 284 VLLGYQYTTAIDMWSFGCIVAELF 307
           V    +Y++  D+WSFG ++ E+F
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 63/247 (25%), Positives = 106/247 (42%), Gaps = 52/247 (21%)

Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYYQQA---------------LVEVS 157
           +LG G +G+V    K    +     A+K+++ + A  Q+A               + +  
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQ-KAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 158 ILTTLNKKYDREDKHHIVRIY----EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS 213
            L TL+  +  E K H++  Y    E F              ++LY+    ++F   S  
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMF--------------THLYQR---DNF---SED 105

Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRT 269
            V+ +S +I+  L  L   GI++ D+K ENILL +      + + DFG +      E   
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLSEEKER 162

Query: 270 VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-R 327
            YS+  +  Y +PE++ G   +  A+D WS G ++ EL  G   F    E +    +  R
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222

Query: 328 ILGAQPP 334
           IL   PP
Sbjct: 223 ILKCDPP 229

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 21/198 (10%)

Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VA+K+IK       + + E  ++  L          H  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMKL---------SHEK 60

Query: 176 RIYEYFVC--QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
            +  Y VC  QR + I  E + +         H +    S +    K +  G++ L+   
Sbjct: 61  LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL   N   C       +K+ DFG S    D    S + S++   +  PEVLL  +
Sbjct: 121 FIHRDLAARN---CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 290 YTTAIDMWSFGCIVAELF 307
           +++  D+W+FG ++ E++
Sbjct: 178 FSSKSDVWAFGVLMWEVY 195

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 33/219 (15%)

Query: 108 QRRYI--VKDLLGHGTFGQVAKC-WDAEMNS---FVAVKIIKNQPAYYQQALV--EVSIL 159
           ++R++  ++DL G G FG+V  C +D E ++    VAVK +K +      A +  E+ IL
Sbjct: 2   EKRFLKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 60

Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQ----RHLCICFELLDS-NLYELIKINHFRGLSLSI 214
                   R   H  +  Y+  +C       + +  E L S +L E +  N  + ++L  
Sbjct: 61  --------RNLYHENIVKYKG-ICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQ 110

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYS 272
              ++ QI +G+  L     +H DL   N+L+ +     ++KI DFG   A   D+  Y+
Sbjct: 111 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETDKEYYT 167

Query: 273 YIQSR----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
                    ++ +PE L+  ++  A D+WSFG  + EL 
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 35/118 (29%), Positives = 54/118 (45%), Gaps = 11/118 (9%)

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N +L  S     +K+ DFG A    D+  YS    
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT---VKVADFGLARDIYDKEYYSVHNH 159

Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
              + P      E L   ++TT  D+WSFG ++ EL   G P +P    FD+   +++
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.4 bits (120), Expect = 3e-06
 Identities = 55/263 (20%), Positives = 97/263 (36%), Gaps = 61/263 (23%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G FG+V      +  +  A+K ++ +    +  +  V     +  + D E    +VR
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE---WVVR 65

Query: 177 IYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           +Y  F  + +L    + +     +  LI++  F      + + +  ++   +  +   G 
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE---DLARFYIAELTCAVESVHKMGF 122

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDF----GSACTEDRTVY------------------- 271
           IH D+KP+NIL+    +   IK+ DF    G   T D   Y                   
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179

Query: 272 ---------------------------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVA 304
                                      S + +  Y +PEVLL   YT   D WS G I+ 
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239

Query: 305 ELFLGLPLFPGASEFDLLRRMIR 327
           E+ +G P F   +  +   ++I 
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVIN 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.2 bits (120), Expect = 4e-06
 Identities = 28/75 (37%), Positives = 39/75 (52%), Gaps = 8/75 (10%)

Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY 273
           I+Q   +QIL  L  L   GI+H D+KP+NI+   S      KIID G+A  + R   +Y
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--SEGSGSFKIIDLGAA-ADLRVGINY 312

Query: 274 IQSRY-----YRSPE 283
           I   +     Y +PE
Sbjct: 313 IPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 27/207 (13%)

Query: 114 KDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA----LVEVSILTTLNKKY 166
           + ++G G FG+V +            VA+K +K  P Y ++     L E SI+   +   
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK--PGYTEKQRQDFLSEASIMGQFSH-- 65

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRG 225
                H+I+R+       +   I  E +++  L + ++ +     S  +V +  + I  G
Sbjct: 66  -----HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML-RGIAAG 119

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D   +H DL   NIL+ +++   E K+ DFG S   ED    +Y  S       +
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNL---ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAEL 306
            +PE +   ++T+A D+WSFG ++ E+
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEV 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 34/208 (16%)

Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           LLG G FG V K  W  E +S    VA+K I+++    +Q   E+   T         D 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEI---TDHMLAMGSLDH 68

Query: 172 HHIVRIYEYFVCQRHLCIC----FELLDSNLYELIKINHFR----GLSLSIVQLFSKQIL 223
            +IVR+         L IC     +L+         ++H R     L    +  +  QI 
Sbjct: 69  AYIVRL---------LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYIQSRY- 278
           +G+  L++  ++H +L   NILL +    + ++I DFG A      + +  YS  ++   
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
           + + E +L  +YT   D+WS+G  V E+
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 69/254 (27%)

Query: 117 LGHGTFGQVAKCW----DAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRED 170
           LG   FG++ K        +    VA+K +K  N P  + +   E S++  L        
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-------- 64

Query: 171 KHH--IVRIYEYFVCQRHLCICFELLDS-NLYELI---------------------KINH 206
            HH  IV +      ++ +C+ FE L+  +L+E +                      ++H
Sbjct: 65  -HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123

Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
              L ++I      QI  G+  L     +H DL   NIL+   +    +KI D G +   
Sbjct: 124 GDFLHIAI------QIAAGMEYLSSHFFVHKDLAARNILIGEQL---HVKISDLGLS--- 171

Query: 267 DRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLF 313
            R +YS   + YYR             PE ++  ++++  D+WSFG ++ E+F  GL  +
Sbjct: 172 -REIYS---ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Query: 314 PGASEFDLLRRMIR 327
            G S  +++  M+R
Sbjct: 228 YGFSNQEVI-EMVR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 48.6 bits (116), Expect = 6e-06
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 49/221 (22%)

Query: 116 LLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYDR 168
            LG G FG+V         +    + V VK ++       Q+    E+ +   L+ K   
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN-- 69

Query: 169 EDKHHIVRIYEYFVCQR---HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQIL- 223
                +VR+    +C+    H  +  E  D  +L + ++    +   L    L +KQ + 
Sbjct: 70  -----VVRLLG--LCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 224 ------RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
                  G+  L +A  +H DL   N L+ +     E+K+    S  +  + VY+   S 
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQR---EVKV----SLLSLSKDVYN---SE 171

Query: 278 YYR-----------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
           YY+           +PE +    ++T  D+WSFG ++ E+F
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 46/243 (18%)

Query: 116 LLGHGTFGQVAK-CW--DAE-MNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  D E +   VA+K+++    P   ++ L E  ++  +   Y   
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY--- 70

Query: 170 DKHHIVRIYEYFVCQRHLCICF--------ELLDSN-LYELIKINHFRGLSLSIVQLFSK 220
                       VC R L IC         +L+    L + ++ N  R  S  ++  +  
Sbjct: 71  ------------VC-RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCV 116

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           QI +G+S L++  ++H DL   N+L+ +   P  +KI DFG A     D T Y     + 
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKS---PNHVKITDFGLARLLDIDETEYHADGGKV 173

Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAEL--FLGLPL--FPGASEFDLLRRMIRILGA 331
              + + E +L  ++T   D+WS+G  V EL  F   P    P     DLL +  R+   
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL--P 231

Query: 332 QPP 334
           QPP
Sbjct: 232 QPP 234

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
           Y V  ++G G FG+V            A+K++       ++  A++ +   E  I+   N
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 101

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
             +       +V+++  F   R+L +  E +     +L+ +     +     + ++ +++
Sbjct: 102 SPW-------VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVV 152

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYY 279
             L  +   G IH D+KP+N+LL    K   +K+ DFG+    ++       + + +  Y
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209

Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
            SPEVL      GY Y    D WS G  + E+ +G
Sbjct: 210 ISPEVLKSQGGDGY-YGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 7e-06
 Identities = 53/245 (21%), Positives = 89/245 (36%), Gaps = 60/245 (24%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALV--EVSILTTLNKKYDREDK 171
           ++G G FG+V      +     A+K ++        Q A V  E  IL   +  +     
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW----- 62

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             +V++Y  F  + +L +  E L     +  L+K + F   +    + +  + +  +  +
Sbjct: 63  --VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF---TEEETRFYIAETILAIDSI 117

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---------------------------- 261
              G IH D+KP+N+LL        IK+ DFG                            
Sbjct: 118 HKLGYIHRDIKPDNLLLDAK---GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 262 SACTEDRT-------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308
            +                    YS + +  Y +PEV L   Y    D WS G I+ E+ +
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 309 GLPLF 313
           G P F
Sbjct: 235 GYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 24/137 (17%)

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           FS Q+ +G+  L     IH D+   N+LL T  + A  KI DFG A    R + +   S 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVA--KICDFGLA----RDIMN--DSN 267

Query: 278 Y-----------YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
           Y           + +PE +    YT   D+WS+G ++ E+F LG   +PG        +M
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327

Query: 326 IRILGAQ--PPDYVLKE 340
           ++  G Q   PD+   E
Sbjct: 328 VK-RGYQMSRPDFAPPE 343

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 11/106 (10%)

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYS- 272
           + ++ +++  L  +   G IH D+KP+N+LL  S     +K+ DFG+    D    V   
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMDANGMVRCD 201

Query: 273 -YIQSRYYRSPEVLLGY----QYTTAIDMWSFGCIVAELFLGLPLF 313
             + +  Y SPEVL        Y    D WS G  + E+ +G   F
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 52/246 (21%)

Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ +++  +   
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--- 70

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL------------ 217
                       VC R L IC   L S +  + ++  F G  L  V+             
Sbjct: 71  ------------VC-RLLGIC---LTSTVQLITQLMPF-GCLLDYVREHKDNIGSQYLLN 113

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           +  QI +G++ L++  ++H DL   N+L+ T   P  +KI DFG A     D   Y    
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG--ASEF-DLLRRMIRI 328
            +    + + E +L   YT   D+WS+G  V EL   G   + G  ASE   +L +  R+
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 230

Query: 329 LGAQPP 334
              QPP
Sbjct: 231 --PQPP 234

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 11/102 (10%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y Y ++   R
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDVNNIDY-YKKTTNGR 200

Query: 281 ------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
                 +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 45/198 (22%), Positives = 89/198 (44%), Gaps = 21/198 (10%)

Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  +++  VA+K+I+         + E  ++  L+         ++V
Sbjct: 12  LGSGQFGVVHLGKWRGKID--VAIKMIREGAMSEDDFIEEAKVMMKLSHP-------NLV 62

Query: 176 RIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y     QR + I  E + +  L   ++    +  +  ++ +    +   +  L+  G 
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-CSDVCEAMEYLESNGF 121

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
           IH DL   N   C   +   +K+ DFG A    +D+   S   +++   +  PEV    +
Sbjct: 122 IHRDLAARN---CLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSR 177

Query: 290 YTTAIDMWSFGCIVAELF 307
           +++  D+WSFG ++ E+F
Sbjct: 178 FSSKSDVWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 41/124 (33%), Positives = 56/124 (45%), Gaps = 26/124 (20%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           Q+ RG+  L+    IH DL   N+L+    +   +KI DFG A    R V+      YY+
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLA----RGVH---DIDYYK 191

Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LG---LPLFPGASEFDLLRR 324
                       +PE L    YT   D+WSFG ++ E+F LG    P  P    F LLR 
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251

Query: 325 MIRI 328
             R+
Sbjct: 252 GHRM 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 11/104 (10%)

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-- 275
           FS Q+  G+  L     +H DL   N+L+C       +KI DFG A    R   +YI   
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEG---KLVKICDFGLARDIMRDS-NYISKG 299

Query: 276 SRY----YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFP 314
           S +    + +PE +    YTT  D+WSFG ++ E+F LG   +P
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 37/120 (30%), Positives = 52/120 (43%), Gaps = 7/120 (5%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSR 277
           QI   L  L +  I+H DLK +N+ L    +   IK+ D G A     +     + I + 
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTP 166

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQPPDY 336
           YY SPE+     Y    D+W+ GC V E+      F       L+ R+I   L   P DY
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY 226

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 35/205 (17%)

Query: 117 LGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG V   K W A++   VA+K I       +  + E  ++  L+          +
Sbjct: 12  LGSGQFGVVHLGK-WRAQIK--VAIKAINEGAMSEEDFIEEAKVMMKLSHP-------KL 61

Query: 175 VRIYEYFVCQRHLCICFELLDSNL---YELIKINHF-RGLSLSIVQLFSKQILRGLSLLK 230
           V++Y     Q+ L I  E +++     Y   +     + + LS+ Q     +  G+  L+
Sbjct: 62  VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLE 117

Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY--SYIQSR------YYRSP 282
               IH DL   N L+ ++     +K+ DFG      R V    Y  S        +  P
Sbjct: 118 RNSFIHRDLAARNCLVSST---GVVKVSDFGMT----RYVLDDEYTSSSGAKFPVKWSPP 170

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELF 307
           EV    +Y++  D+WSFG ++ E+F
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 18/209 (8%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHI 174
           +G G FG+V        N+ VAVK  +    P    + L E  IL    K+Y   +   I
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARIL----KQYSHPN---I 55

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           VR+      ++ + I  EL+    +          L +  +    +    G+  L+    
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRSPEVLLGYQ 289
           IH DL   N   C   +   +KI DFG +  E+  VY+           + +PE L   +
Sbjct: 116 IHRDLAARN---CLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
           Y++  D+WSFG ++ E F LG   +   S
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLS 201

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.3 bits (112), Expect = 3e-05
 Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 8/117 (6%)

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY--- 271
           V L   QI+  L  +    ++H DLK  NI L  +     IK+ DFG +     +V    
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQYSDSVSLDV 227

Query: 272 --SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
             S+  + YY +PE+    +Y+   DMWS G I+ EL      F G S+ +++++++
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284

Length = 478

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.0 bits (111), Expect = 3e-05
 Identities = 27/80 (33%), Positives = 46/80 (57%), Gaps = 8/80 (10%)

Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CT--E 266
           +++++   +Q+L GL  L   GI+H D+KPEN+L+       ++KIIDFG+A   CT   
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGIN 364

Query: 267 DRTVYSYIQSRYYRSPEVLL 286
              +Y  +  RY    E+++
Sbjct: 365 FNPLYGMLDPRYSPPEELVM 384

Length = 507

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 62/290 (21%), Positives = 111/290 (38%), Gaps = 63/290 (21%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA----------LVEVSILTTLNKK 165
           ++G G FG+V      +     A+KI++      ++           LVE   L  +   
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
           Y  +DK ++  I E+      + +           L+K +    L+    Q +  + +  
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTL-----------LMKKD---TLTEEETQFYIAETVLA 113

Query: 226 LSLLKDAGIIHCDLKPENILL-------------CTSVK---------------PAEIKI 257
           +  +   G IH D+KP+N+LL             CT +K               P++   
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173

Query: 258 IDFGS---ACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310
            +  S   A T  R      +S + +  Y +PEV +   Y    D WS G I+ E+ +G 
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 311 PLFPGASEFDLLRRMI--RILGAQPPDYVLKE-AKNTSKFFKCIGSVHNI 357
           P F   +  +  ++++  +     PP+  + E AK+    F C    H I
Sbjct: 234 PPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWE-HRI 282

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 55/244 (22%)

Query: 108 QRRYIVKDLLGHGTFGQVAKC----------WDAEMNS------FVAVKIIKNQPAYYQQ 151
           +   + K+ LG G FG+V  C               N        VAVKI++  P   + 
Sbjct: 4   RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR--PDANKN 61

Query: 152 A----LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINH 206
           A    L EV IL+ L          +I+R+    V +  LC+  E +++ +L + +  +H
Sbjct: 62  ARNDFLKEVKILSRLKDP-------NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHH 114

Query: 207 F---------------RGLSLSIVQLFS--KQILRGLSLLKDAGIIHCDLKPENILLCTS 249
                              ++S   L     QI  G+  L     +H DL   N L+  +
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN 174

Query: 250 VKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVA 304
           +    IKI DFG +       Y  IQ R      + + E +L  ++TTA D+W+FG  + 
Sbjct: 175 L---TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231

Query: 305 ELFL 308
           E+ +
Sbjct: 232 EILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 42/131 (32%), Positives = 60/131 (45%), Gaps = 22/131 (16%)

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YI 274
           F   I  G+  L     IH DL   N +L  ++    + + DFG +    + +Y+   Y 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVADFGLS----KKIYNGDYYR 169

Query: 275 QSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGA--SE-FDLLRR 324
           Q R  + P      E L    YTT  D+WSFG  + E+   G   +PG   SE +D LR+
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229

Query: 325 MIRILGAQPPD 335
             R+   QPPD
Sbjct: 230 GNRL--KQPPD 238

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 8/109 (7%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-----SACTEDRTVYSYIQ 275
           Q+L  +  +    +IH D+K  NILLC++     +K+ DFG     +A   D    ++  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSN---GLVKLGDFGFSKMYAATVSDDVGRTFCG 207

Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR 324
           + YY +PE+     Y+   DM+S G ++ EL      F G +  +++ +
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256

Length = 496

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 40/127 (31%), Positives = 57/127 (44%), Gaps = 25/127 (19%)

Query: 212 LSIVQLFS--KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           LS   L S   Q+ RG+  L     IH DL   N+L+    +   +KI DFG A    R 
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLA----RD 189

Query: 270 VYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
           ++      YY+            +PE L    YT   D+WSFG ++ E+F LG   +PG 
Sbjct: 190 IH---HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 317 SEFDLLR 323
              +L +
Sbjct: 247 PVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 12/118 (10%)

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTV---YSYIQ 275
           KQ+L  +  + D  +IH D+K ENI L    K   I + DFG+A   E       Y ++ 
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK---IVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP----GASEFDLLRRMIRIL 329
           +    SPE+L G  Y    D+WS G I+ ++ L     P    G      L ++I  L
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDM-LSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.8 bits (106), Expect = 7e-05
 Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 3/98 (3%)

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
           V+ ++ +++  L  L   GI+  DL P NILL        I++  F      + +     
Sbjct: 87  VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDSCDGEA 143

Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL 312
               Y +PEV    + T A D WS G I+ EL  G  L
Sbjct: 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 23/108 (21%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A    R V++     YY+
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLA----RDVHNI---DYYK 191

Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
                       +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.6 bits (108), Expect = 8e-05
 Identities = 57/253 (22%), Positives = 96/253 (37%), Gaps = 73/253 (28%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK-------IIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           +G G FG+V      + N+  A+K       +++NQ A+ +    E  IL          
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILA-------EA 58

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D   +V++Y  F  + +L    + +     +  LI++  F      + + +  ++   + 
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE---DLARFYIAELTCAIE 115

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR------------------- 268
            +   G IH D+KP+NIL+    +   IK+ DFG  CT  R                   
Sbjct: 116 SVHKMGFIHRDIKPDNILI---DRDGHIKLTDFG-LCTGFRWTHDSKYYQKGDHHRQDSM 171

Query: 269 ----------------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG 300
                                         +S + +  Y +PEVLL   YT   D WS G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231

Query: 301 CIVAELFLGLPLF 313
            I+ E+ +G P F
Sbjct: 232 VILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 44.4 bits (106), Expect = 1e-04
 Identities = 15/60 (25%), Positives = 23/60 (38%), Gaps = 6/60 (10%)

Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
               L + +            DIS E        D ++ L+  DP KR +  +A +HPF 
Sbjct: 201 QLLELFKKIGKPKPPFPPPEWDISPE------AKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)

Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E  +    VA+KI+     P    + + E  I+ ++       
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM------- 66

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D  H+VR+    +      +   +    L + +   H   +   ++  +  QI +G+  L
Sbjct: 67  DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY---YRSPEV 284
           ++  ++H DL   N+L+ +   P  +KI DFG A     D   Y+    +    + + E 
Sbjct: 126 EERRLVHRDLAARNVLVKS---PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 285 LLGYQYTTAIDMWSFGCIVAEL--FLGLPL--FPGASEFDLLRRMIRILGAQPP 334
           +   ++T   D+WS+G  + EL  F G P    P     DLL +  R+   QPP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL--PQPP 234

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 35/208 (16%)

Query: 117 LGHGTFGQVAK-CWDAEMNSF-VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH 172
           LG G FG V K  +        VA+K++K  N+ +   + + E  I+  L+  Y      
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY------ 56

Query: 173 HIVRIYEYFVCQ-RHLCICFELLDSNLYELIKINHFRG-----LSLSIVQLFSKQILRGL 226
            IVR+    VC+   L +  E+          +N F       +++S V     Q+  G+
Sbjct: 57  -IVRMIG--VCEAEALMLVMEMASGG-----PLNKFLSGKKDEITVSNVVELMHQVSMGM 108

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS-----RYY 279
             L+    +H DL   N+LL   V     KI DFG   A   D + Y    +     ++Y
Sbjct: 109 KYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            +PE +   ++++  D+WS+G  + E F
Sbjct: 166 -APECINFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 56/268 (20%), Positives = 97/268 (36%), Gaps = 71/268 (26%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE-----D 170
           ++G G FG+V      +     A+K +     + +  L  V        K +R+     D
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHV--------KAERDVLAESD 59

Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
              +V +Y  F   ++L +  E L     +  LIK + F   S  + + +  + +  +  
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF---SEDVTRFYMAECVLAIEA 116

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG------------------------SAC 264
           +   G IH D+KP+NIL+    +   IK+ DFG                        +  
Sbjct: 117 VHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 265 TEDRTV--------------------------YSYIQSRYYRSPEVLLGYQYTTAIDMWS 298
               +V                          YS + +  Y +PE+ L   Y    D WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 299 FGCIVAELFLGLPLFPGASEFDLLRRMI 326
            G I+ E  +G P F   +  +  R++I
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKII 261

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 51/232 (21%)

Query: 105 AETQRRYIVKDLLGHGTFGQV--AKCWDAEMNSF--VAVKIIKNQPAYYQQA--LVEVSI 158
           A ++ R  + DLL  GTFG++      D +      V VK +K+  +  Q    L E  +
Sbjct: 2   AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61

Query: 159 LTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-----------SNLY------EL 201
           L  L+ +       +I+ I         L +C E  +            NL        L
Sbjct: 62  LYGLSHQ-------NILPI---------LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL 105

Query: 202 IKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
            + N+ + LS   +   + QI  G+S L   G+IH D+   N ++   ++   +KI D  
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ---VKITD-- 160

Query: 262 SACTED--RTVYSYIQSRYYR-----SPEVLLGYQYTTAIDMWSFGCIVAEL 306
           +A + D     Y  +     R     + E L+  +Y++A D+WSFG ++ EL
Sbjct: 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 57/260 (21%), Positives = 98/260 (37%), Gaps = 65/260 (25%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G FG+V      + ++  A+K ++ +    +  +  V     +  + D E    +V+
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE---WVVK 65

Query: 177 IYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           +Y  F  + +L    + +     +  LI++  F      + + +  ++   +  +   G 
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVF---PEVLARFYIAELTLAIESVHKMGF 122

Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACT----------------------------- 265
           IH D+KP+NIL+        IK+ DFG  CT                             
Sbjct: 123 IHRDIKPDNILIDLD---GHIKLTDFG-LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 266 --------------EDRT--------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIV 303
                         E R          +S + +  Y +PEVLL   YT   D WS G I+
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 304 AELFLGLPLF--PGASEFDL 321
            E+ +G P F  P  +E  L
Sbjct: 239 FEMLVGQPPFLAPTPTETQL 258

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 39/215 (18%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQ---ALV--EVSILTTLN 163
           ++G G FG+VA           A+KI+       + + A +++    LV  +   +TTL+
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
             Y  +D++++  + +Y+V    L +  +  D              L   + + +  +++
Sbjct: 68  --YAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-------------LPEDMARFYIAEMV 112

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQ--SRYY 279
             +  +     +H D+KP+N+LL  +     I++ DFGS     +D TV S +   +  Y
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169

Query: 280 RSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLG 309
            SPE+L   +     Y    D WS G  + E+  G
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 22/139 (15%)

Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L L  +  F   I  G+  L +   IH DL   N +L   +    + + DFG +    + 
Sbjct: 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVADFGLS----KK 162

Query: 270 VYS---YIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASE- 318
           +YS   Y Q R  + P      E L    YT+  D+W+FG  + E+   G   +PG    
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222

Query: 319 --FDLLRRMIRILGAQPPD 335
             +D LR   R+   QP D
Sbjct: 223 EIYDYLRHGNRL--KQPED 239

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 31/87 (35%), Positives = 43/87 (49%), Gaps = 14/87 (16%)

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQ--SRYYRSPEVLLG 287
           G +H D+KP+N+LL    K   I++ DFGS C     D TV S +   +  Y SPE+L  
Sbjct: 122 GYVHRDIKPDNVLL---DKNGHIRLADFGS-CLRLLADGTVQSNVAVGTPDYISPEILQA 177

Query: 288 YQ-----YTTAIDMWSFGCIVAELFLG 309
            +     Y    D WS G  + E+  G
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 41/216 (18%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLNKK--- 165
           ++G G FG+VA       +   A+KI+       + + A +++   E  +L   + +   
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDNQWIT 64

Query: 166 ---YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
              Y  +D++++  + +Y+V    L +  +  D              L   + + +  ++
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-------------LPEDMARFYLAEM 111

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ--SRY 278
           +  +  +     +H D+KP+NIL+  +     I++ DFGS     ED TV S +   +  
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168

Query: 279 YRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLG 309
           Y SPE+L   +     Y    D WS G  + E+  G
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 32/205 (15%)

Query: 117 LGHGTFGQVAK-CWDAEMNS----FVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           +G G FG+V +     ++       VA+K +K   +  Q+   L E SI+        + 
Sbjct: 12  IGGGEFGEVCRGRL--KLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM-------GQF 62

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFS--KQILRGL 226
           D  +I+R+       R + I  E +++ +L + ++ N  +    ++ QL    + I  G+
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGM 119

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED-RTVYSY----IQSRYYR 280
             L +   +H DL   NIL+ +++     K+ DFG S   ED    Y+     I  R+  
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRRLEDSEATYTTKGGKIPIRW-T 175

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAE 305
           +PE +   ++T+A D+WSFG ++ E
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 53/222 (23%)

Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 68

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SL  + 
Sbjct: 69  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 172

Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 24/120 (20%)

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           QI  G+  L    ++H DL   N+L+   +    +KI D G      R VY+   + YY+
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGLF----REVYA---ADYYK 181

Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
                       SPE ++  +++   D+WS+G ++ E+F  GL  + G S  D++  MIR
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI-EMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 42/220 (19%)

Query: 114 KDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDRE 169
           +D++G G FGQV  A+     +    A+K +K   +   ++    E+ +L  L       
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------ 65

Query: 170 DKHHIVRIYEYFVCQR----HLCICF----ELLD----SNLYEL---IKINHFRGLSLSI 214
             HH   I     C+     +L I +     LLD    S + E      I +    +LS 
Sbjct: 66  --HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
            QL  F+  + RG+  L     IH DL   NIL+  +      KI DFG +    R    
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLS----RGQEV 176

Query: 273 YIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAEL 306
           Y++    R P      E L    YTT  D+WS+G ++ E+
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 27/123 (21%), Positives = 44/123 (35%), Gaps = 18/123 (14%)

Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL---DSNLYELIKINHFRGLSLSI 214
           +L     +    D+   V I +     R      ++L   +S+ +  + +    G +L  
Sbjct: 25  VLKINPSREKGADREREVAILQLL--ARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE 82

Query: 215 VQLFSK--------QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACT 265
           V    K        ++L  L  L    + H DL P NIL    V   +I  IID+  A  
Sbjct: 83  VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL----VDDGKILGIIDWEYAGY 138

Query: 266 EDR 268
              
Sbjct: 139 GPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 13/104 (12%)

Query: 212 LSIVQLFS--KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDR 268
            +++QL    + I  G+  L D G +H DL   NIL+ +++     K+ DFG S   ED 
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDD 159

Query: 269 TVYSY------IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
              +Y      I  R+  +PE +   ++T+A D+WS+G ++ E+
Sbjct: 160 PEAAYTTRGGKIPIRW-TAPEAIAYRKFTSASDVWSYGIVMWEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 54/259 (20%)

Query: 115 DLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDR 168
           D++G G FGQV K         M++  A+K +K   +   ++    E+ +L  L      
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDA--AIKRMKEYASKDDHRDFAGELEVLCKLG----- 53

Query: 169 EDKHHIVRIYEYFVCQR--HLCICFELLD-SNLYELIKIN------------HFRGLSLS 213
              HH   I     C+   +L +  E     NL + ++ +            +    +LS
Sbjct: 54  ---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110

Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
             QL  F+  + RG+  L     IH DL   NIL+  +      KI DFG +  ++    
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQE---- 163

Query: 272 SYIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
            Y++    R P      E L    YTT  D+WS+G ++ E+  LG   + G +  +L  +
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223

Query: 325 MIRILGAQPPDYVLKEAKN 343
           +       P  Y L++  N
Sbjct: 224 L-------PQGYRLEKPLN 235

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 64/260 (24%), Positives = 111/260 (42%), Gaps = 54/260 (20%)

Query: 114 KDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYD 167
           +D++G G FGQV +        +MN+  A+K++K   +   ++    E+ +L  L     
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNA--AIKMLKEFASENDHRDFAGELEVLCKLG---- 60

Query: 168 REDKHHIVRIYEYFVCQR--HLCICFELLD-SNLYELIKIN------------HFRGLSL 212
               HH   I     C+   +L I  E     NL + ++ +            H    +L
Sbjct: 61  ----HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +  QL  F+  +  G+  L +   IH DL   N+L+  ++     KI DFG +  E+   
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS---KIADFGLSRGEE--- 170

Query: 271 YSYIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
             Y++    R P      E L    YTT  D+WSFG ++ E+  LG   + G +  +L  
Sbjct: 171 -VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229

Query: 324 RMIRILGAQPPDYVLKEAKN 343
           ++       P  Y +++ +N
Sbjct: 230 KL-------PQGYRMEKPRN 242

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 17/136 (12%)

Query: 206 HFRGLSLSIVQL-FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
               ++   V    + ++  GL  L  A  IH DL   N  L        +KI D+G A 
Sbjct: 92  MVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD---LSVKIGDYGLAL 148

Query: 265 TEDRTVYSYIQSRY-----YRSPEV-------LLGYQYTTAIDMWSFGCIVAELF-LGLP 311
            +    Y   +  +     + +PE+       LL    T   ++WS G  + ELF     
Sbjct: 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208

Query: 312 LFPGASEFDLLRRMIR 327
            +P  S+  +L++++R
Sbjct: 209 PYPDLSDEQVLKQVVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +++++G G FG+V +       +   FVA+K +K+     Q+   L E SI+        
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF----- 62

Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFS--KQILR 224
             D  +I+ +       R + I  E +++  L   ++ N  +    +++QL    + I  
Sbjct: 63  --DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIAA 117

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSR----- 277
           G+  L +   +H DL   NIL+ +++     K+ DFG +    +D +  +Y  S      
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174

Query: 278 -YYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
             + +PE +   ++T+A D+WS+G ++ E+
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 40/204 (19%), Positives = 84/204 (41%), Gaps = 21/204 (10%)

Query: 113 VKDLLGHGTFGQVAKCW---DAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           ++ +LG G FG++ +      ++    VA+  ++   +  Q+   L E   L        
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF----- 63

Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             D  +IVR+         + I  E + +   +     H   L    +      +  G+ 
Sbjct: 64  --DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQSR---YYRSP 282
            L + G +H  L    +L+ + +     KI  F     ED+   +Y+ +  +    + +P
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV---CKISGFRRL-QEDKSEAIYTTMSGKSPVLWAAP 177

Query: 283 EVLLGYQYTTAIDMWSFGCIVAEL 306
           E +  + +++A D+WSFG ++ E+
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 21/196 (10%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V    D   N  VAVK IKN  A  Q  L E S++T L          ++V+
Sbjct: 14  IGKGEFGDVM-LGDYRGNK-VAVKCIKND-ATAQAFLAEASVMTQLRHS-------NLVQ 63

Query: 177 IYEYFVCQR-HLCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGLSLLKDA 232
           +    V ++  L I  E +      L+     RG S+     +  FS  +   +  L+  
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 233 GIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
             +H DL   N+L    V    + K+ DFG       T  +      + +PE L   +++
Sbjct: 122 NFVHRDLAARNVL----VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFS 177

Query: 292 TAIDMWSFGCIVAELF 307
           T  D+WSFG ++ E++
Sbjct: 178 TKSDVWSFGILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 46/209 (22%), Positives = 74/209 (35%), Gaps = 34/209 (16%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQP-AYYQQALVEVSILTTLNKKYDREDKHH 173
                   +AK      N+ VAVK I   +      +    E+     L          +
Sbjct: 10  FEDLMIVHLAKHKPT--NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP-------N 60

Query: 174 IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKD 231
           I+     F+    L +   L+   +  +L+K  HF  GL    +    K +L  L  +  
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLK-THFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT------EDRTVYSYIQSR----YYRS 281
            G IH  +K  +ILL    K   + +     + +        R V+ + +S      + S
Sbjct: 120 KGFIHRSVKASHILLSGDGK---VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 282 PEVLLGYQ----YTTAIDMWSFGCIVAEL 306
           PEVL   Q    Y    D++S G    EL
Sbjct: 177 PEVL--QQNLQGYNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 40.7 bits (96), Expect = 0.002
 Identities = 19/58 (32%), Positives = 27/58 (46%), Gaps = 7/58 (12%)

Query: 395 HKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
            K L +I TN P      + +  K S       DFLK  ++ +P KR +  Q  +HPF
Sbjct: 203 MKALFKIATNGPPG----LRNPEKWSDE---FKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 39.9 bits (94), Expect = 0.003
 Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 5/70 (7%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLS---MEDISKESQIRLALVDFLKGLVEFDPAKRWS 443
           L GK  F  +++ +       R+ L      D  K S       D +K  +  DP+KR +
Sbjct: 193 LTGKPPFSGENILDQ--LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPT 250

Query: 444 PFQASRHPFV 453
             +  +HP+ 
Sbjct: 251 AEEILQHPWF 260

Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 63/251 (25%), Positives = 103/251 (41%), Gaps = 48/251 (19%)

Query: 116 LLGHGTFGQVAKCW-DAEMNSF--VAVKIIK---NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V +    +E  SF  VAVK++K      +  ++ L E + +    K++D  
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACM----KEFDHP 61

Query: 170 DKHHIVRIYEYFVCQRHLCICFELL------DSNLYEL---IKINHFRGLSLSIVQLFSK 220
           +   ++ +      +  L I   +L      D + + L   I    F  L L  +  F  
Sbjct: 62  NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRFMI 120

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
            I  G+  L     IH DL   N +L  ++    + + DFG +    + +YS     YYR
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVADFGLS----KKIYS---GDYYR 170

Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMI- 326
                       + E L    YTT  D+W+FG  + E+   G   + G    ++   +I 
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230

Query: 327 --RILGAQPPD 335
             R+   QPPD
Sbjct: 231 GNRL--KQPPD 239

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 49/220 (22%)

Query: 117 LGHGTFGQV----AK-CWDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKYDR 168
           LG G+FG V    A+     E  + VAVK + N+ A  ++    L E S++         
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASVMKGFTC---- 68

Query: 169 EDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYEL---IKINHFRGLSL--SIVQLF 218
              HH+VR+       +   +  EL     L S L  L    + N  R       ++Q+ 
Sbjct: 69  ---HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM- 124

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
           + +I  G++ L     +H DL   N   C       +KI DFG      R +Y   ++ Y
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARN---CMVAHDFTVKIGDFGMT----RDIY---ETDY 174

Query: 279 YR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
           YR            +PE L    +TT+ DMWSFG ++ E+
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	837
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
PRK10345	210	hypothetical protein; Provisional	99.76
PRK12274	218	serine/threonine protein kinase; Provisional	99.75
smart00090	237	RIO RIO-like kinase.	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
PRK14879	211	serine/threonine protein kinase; Provisional	99.64
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.57
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.5
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.28
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.24
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.23
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
KOG1243	690	consensus Protein kinase [General function predict	99.05
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.94
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.76
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.69
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.59
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.47
PRK09902	216	hypothetical protein; Provisional	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.29
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.17
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.16
PF01636	239	APH: Phosphotransferase enzyme family This family	98.1
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.99
COG4248	637	Uncharacterized protein with protein kinase and he	97.94
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.93
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.9
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.85
PLN02876	822	acyl-CoA dehydrogenase	97.67
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.63
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.49
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.44
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.41
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.32
KOG2270	520	consensus Serine/threonine protein kinase involved	97.18
PRK05231	319	homoserine kinase; Provisional	97.09
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.05
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.02
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.95
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.82
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.7
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.63
PLN02236	344	choline kinase	96.6
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.51
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.36
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.2
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.64
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.55
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.51
PRK12396	409	5-methylribose kinase; Reviewed	95.43
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.4
PRK11768	325	serine/threonine protein kinase; Provisional	95.4
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.34
PRK10593	297	hypothetical protein; Provisional	95.28
PTZ00384	383	choline kinase; Provisional	94.82
PLN02756	418	S-methyl-5-thioribose kinase	94.76
COG2334	331	Putative homoserine kinase type II (protein kinase	94.21
PRK06148	1013	hypothetical protein; Provisional	94.04
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	93.73
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.67
PTZ00296	442	choline kinase; Provisional	93.15
KOG1236	565	consensus Predicted unusual protein kinase [Genera	90.74
KOG2269	531	consensus Serine/threonine protein kinase [Signal	90.14
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	89.53

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-62  Score=556.23  Aligned_cols=396  Identities=46%  Similarity=0.759  Sum_probs=331.8

Q ss_pred             cchhhHHhhhhHHHHhhhcCCCcccccccCCCccccCCCccccCCCccCCCCcceEEeeeeeeccccCCceEEEEEeccC
Q 003239           41 RKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHG  120 (837)
Q Consensus        41 ~~~~~~~Lt~~i~~~y~~~~p~~~~~~~~~~~r~lt~p~~~~~~~g~d~~~~~~~~~l~~~l~~~~~~~~Y~i~~~LG~G  120 (837)
                      +...+..++....++|.+|+..+.+....++++..+.+.......++++.++++++..++.+.     .+|+|++.||+|
T Consensus       123 ~~~~~~~~~~s~~e~~ei~~~~~~~~~~~~~~~~~t~~~~~~~~~~~~~~~~dY~~v~~d~i~-----~rY~V~e~LGkG  197 (586)
T KOG0667|consen  123 QASPLYKHSLSLIETYEIINYPEVYFVGLNAKKVLTFPSEGINTKNFDDEDGDYQLVVNDHIA-----YRYEVLEVLGKG  197 (586)
T ss_pred             hhhhhhccccchhhhhhccChHHhhhhccccccccCCCcccccCCCCCCCCCceeEEecceeE-----EEEEEEEEeccc
Confidence            344566677778999999999999999999999999999998888899999999999999998     599999999999


Q ss_pred             CceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccchhHHH
Q 003239          121 TFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYE  200 (837)
Q Consensus       121 ~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d  200 (837)
                      +||+|.+|.+..|++.||||++++......+...|+.||..|++ .+..+..|||+++|+|...+|+|||+|+++.+|++
T Consensus       198 tFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~-~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYe  276 (586)
T KOG0667|consen  198 SFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNK-HDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYE  276 (586)
T ss_pred             ccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhc-cCCCCCeeEEEeeeccccccceeeeehhhhhhHHH
Confidence            99999999999999999999999999999999999999999985 56667789999999999999999999999999999


Q ss_pred             HHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeeccCcccc
Q 003239          201 LIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR  280 (837)
Q Consensus       201 ~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~  280 (837)
                      +++.+++.+|+...++.|+.||+.||.+||+.+|||+|||||||||... ....|||+|||+|+...+...+++++++|+
T Consensus       277 llK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~q~vytYiQSRfYR  355 (586)
T KOG0667|consen  277 LLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFESQRVYTYIQSRFYR  355 (586)
T ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccCCcceeeeeccccc
Confidence            9999999999999999999999999999999999999999999999754 456999999999999999999999999999


Q ss_pred             CchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCC
Q 003239          281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENG  360 (837)
Q Consensus       281 APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~  360 (837)
                      |||+|++.+|+.++||||||||++||++|.++|+|.++.+++..|++++| .||.+|++.+++..+||++......... 
T Consensus       356 APEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG-~Pp~~mL~~~~~~~kff~~~~~~~~~~~-  433 (586)
T KOG0667|consen  356 APEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG-LPPPKMLDTAKKAHKFFTSLKGFPRLCV-  433 (586)
T ss_pred             cchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC-CCCHHHHHhccccceehhccCCceeeee-
Confidence            99999999999999999999999999999999999999999999999999 9999999999999999998321111000 


Q ss_pred             ccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCC
Q 003239          361 EVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAK  440 (837)
Q Consensus       361 ~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~k  440 (837)
                                      +.+.....+....+.++....++..   .|  ......+..........|+|||++||++||.+
T Consensus       434 ----------------~~~~~~~~k~~~~~~~~~~~~~~~~---~P--~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  434 ----------------ETSAPRGTKSPEVRKYYRKARLERR---GP--PGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             ----------------eecccccccchhhhhhhhhhccccc---CC--CCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                            0000000011111111111111111   11  01111111122245678999999999999999


Q ss_pred             CCCHHHHHcCccCCCCCCCCCCCCCC
Q 003239          441 RWSPFQASRHPFVTGEPFTCPYQPPP  466 (837)
Q Consensus       441 RpTa~EaL~HPff~~~~~~~~~~~~~  466 (837)
                      |+|+.|||+||||++..+.+....+.
T Consensus       493 R~tp~qal~Hpfl~~~~~~~~~~~~~  518 (586)
T KOG0667|consen  493 RITPAQALNHPFLTGTSLERRNQSPL  518 (586)
T ss_pred             cCCHHHHhcCcccccccccccCCCCc
Confidence            99999999999999877765544443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-52  Score=454.53  Aligned_cols=285  Identities=36%  Similarity=0.550  Sum_probs=240.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHH--HHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ--ALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~--~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|+++++||.|+||.||+|+.+++++.||||.+++.-...++  -++|++.|++|+      .|||||+|.+++.+.+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln------~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN------PHPNIIKLKEVIRDND   82 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC------CCCcchhhHHHhhccC
Confidence            37999999999999999999999999999999999976444444  467999999994      4999999999999988


Q ss_pred             -eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 -HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 -~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                       ++++|||||+.+|+++++.+ .+.|++..++.|++||++||+|+|++|+.||||||||||+.   ....|||+|||+|+
T Consensus        83 ~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   83 RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAR  158 (538)
T ss_pred             ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEeccccccc
Confidence             99999999999999999988 57899999999999999999999999999999999999995   47789999999998


Q ss_pred             ccCC--cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....  ..+.++-|+||+|||+++.. -|+.++||||+|||++|+.+-+++|+|.++.|++.+|.+++| .|.+..+.++
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG-tP~~~~~~eg  237 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG-TPDKDSWPEG  237 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC-CCccccchhH
Confidence            7653  34678999999999999765 799999999999999999999999999999999999999999 5654443332


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .+.                            ....          .+...++....+..++.+                 
T Consensus       238 ~~L----------------------------a~~m----------nf~~P~~~~~~l~~L~p~-----------------  262 (538)
T KOG0661|consen  238 YNL----------------------------ASAM----------NFRFPQVKPSPLKDLLPN-----------------  262 (538)
T ss_pred             HHH----------------------------HHHh----------ccCCCcCCCCChHHhCcc-----------------
Confidence            111                            0000          011122334455555443                 


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ++.++.+||.+||.+||.+||||+|+|+||||+...-
T Consensus       263 ~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  263 ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            5588999999999999999999999999999997553

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4e-52  Score=433.81  Aligned_cols=281  Identities=32%  Similarity=0.592  Sum_probs=237.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+.+.++|+|+||+||+|+++.||+.||||++...   +...+-+++||++|++|       .|+|+|.++++|..+.
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-------kH~NLVnLiEVFrrkr   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-------KHENLVNLIEVFRRKR   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-------ccchHHHHHHHHHhcc
Confidence            5789999999999999999999999999999999753   34556789999999999       5789999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++||||||+.++++.+.... .+++.+.++.+++|++.|+.|||+++|||||||||||||+   ..+.+||||||+|+.
T Consensus        75 klhLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~  150 (396)
T KOG0593|consen   75 KLHLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFART  150 (396)
T ss_pred             eeEEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHh
Confidence            999999999999888887765 5799999999999999999999999999999999999997   789999999999986


Q ss_pred             cC---CcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 ED---RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~---~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ..   +..+.++.|+||+|||++.+ .+|+..+||||+||++.||++|.+.|++.++.+++..|...+|..+|..+.--.
T Consensus       151 L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  151 LSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             hcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            54   34456789999999999998 589999999999999999999999999999999999999999988877643211


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                        ...||.-+. ++.                                      ...++.+-..||              .
T Consensus       231 --~N~~F~Gv~-lP~--------------------------------------~~~~epLe~k~p--------------~  255 (396)
T KOG0593|consen  231 --SNPFFHGVR-LPE--------------------------------------PEHPEPLERKYP--------------K  255 (396)
T ss_pred             --cCCceeeee-cCC--------------------------------------CCCccchhhhcc--------------c
Confidence              112222111 000                                      001111222222              3


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ++..++||+++||+.||.+|++.+|+|.||||.+
T Consensus       256 ~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  256 ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             chHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            5568899999999999999999999999999954

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3e-51  Score=421.56  Aligned_cols=287  Identities=33%  Similarity=0.559  Sum_probs=240.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .+|..+++||+|.||.||+|++.++|+.||||+|+..+   .....+++||+.|+++       .|+||+.++|+|...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-------~h~nIi~LiD~F~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-------KHPNIIELIDVFPHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-------cCcchhhhhhhccCCC
Confidence            58999999999999999999999999999999998542   3356788999999999       6889999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+.||+||++.+|..+++... ..++..+++.++.++++||+|||++.|+||||||.|+|++   .++.+||+|||+|+.
T Consensus        75 ~l~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   75 NLSLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARF  150 (318)
T ss_pred             ceEEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhc
Confidence            999999999999999988765 5699999999999999999999999999999999999996   789999999999986


Q ss_pred             cCCcc---eeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDRTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~~~---~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .....   ...+-|++|+|||++.+. .|+..+||||+|||+.||+.|.|.|+|.++.+++..|.+.+| .|.+..|++.
T Consensus       151 f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG-TP~~~~WP~~  229 (318)
T KOG0659|consen  151 FGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG-TPTPDQWPEM  229 (318)
T ss_pred             cCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC-CCCcccCccc
Confidence            54332   333789999999999987 799999999999999999999999999999999999999999 6655555544


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....|.+-.                                        .++...+..++                 ..
T Consensus       230 ~~lpdY~~~~----------------------------------------~~P~~~~~~lf-----------------~a  252 (318)
T KOG0659|consen  230 TSLPDYVKIQ----------------------------------------QFPKPPLNNLF-----------------PA  252 (318)
T ss_pred             cccccHHHHh----------------------------------------cCCCCcccccc-----------------cc
Confidence            3332221110                                        11111121111                 12


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP  464 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~  464 (837)
                      .+.+++|||.+||.+||.+|+||.|+|+|+||+..|.+++...
T Consensus       253 as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~  295 (318)
T KOG0659|consen  253 ASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSK  295 (318)
T ss_pred             ccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhh
Confidence            4567799999999999999999999999999999776655433

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.3e-50  Score=421.55  Aligned_cols=302  Identities=29%  Similarity=0.479  Sum_probs=248.9

Q ss_pred             cccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       105 ~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ....+.|+.+.+|++|+||.||+|+++.|++.||+|.++.+   ....-..++||.+|.++       +|||||.+.++.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-------~H~NIV~vkEVV  144 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-------RHPNIVEVKEVV  144 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-------CCCCeeeeEEEE
Confidence            34458899999999999999999999999999999999854   23445678999999998       689999999988


Q ss_pred             eec--ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          182 VCQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       182 ~~~--~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      .-.  +.+|||||||+.+|..++..-. ++|...+++.++.|+++||+|||.+.|+|||||++|+|++   ..+.+||+|
T Consensus       145 vG~~~d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaD  220 (419)
T KOG0663|consen  145 VGSNMDKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIAD  220 (419)
T ss_pred             eccccceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecc
Confidence            754  5799999999999999887654 6799999999999999999999999999999999999996   789999999


Q ss_pred             cccccccCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       260 FGlA~~~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      ||+|+.....   .+..+-|.+|+|||++++. .|++++|+||+|||+.||+++++.|+|.++.+++.+|++.+| .|.+
T Consensus       221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG-tPte  299 (419)
T KOG0663|consen  221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG-TPSE  299 (419)
T ss_pred             cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC-CCcc
Confidence            9999987765   5566889999999999987 799999999999999999999999999999999999999999 7777


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      .+|+......          .          ..                     ...|.......+-+.|+..       
T Consensus       300 ~iwpg~~~lp----------~----------~k---------------------~~~f~~~pyn~lr~kF~~~-------  331 (419)
T KOG0663|consen  300 AIWPGYSELP----------A----------VK---------------------KMTFSEHPYNNLRKKFGAL-------  331 (419)
T ss_pred             ccCCCccccc----------h----------hh---------------------ccccCCCCchhhhhhcccc-------
Confidence            6665322110          0          00                     0001111111222222211       


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCCCCCCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRV  471 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~~~~p~~  471 (837)
                           ..++...|||.++|.+||++|+||+|+|+|.||.+.|.+++....|..|..
T Consensus       332 -----~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k  382 (419)
T KOG0663|consen  332 -----SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAK  382 (419)
T ss_pred             -----ccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccc
Confidence                 145778999999999999999999999999999999988776666655543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-50  Score=441.50  Aligned_cols=292  Identities=30%  Similarity=0.553  Sum_probs=242.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .+.|+.+++||+|+||.||+|++..+|+.||+|+++.+   +.......+||.||++|       +||||++|.+...+.
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-------~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-------DHPNIIKLEEIVTSK  188 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-------CCCcccceeeEEEec
Confidence            47899999999999999999999999999999999853   45667788999999999       789999999999887


Q ss_pred             --ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          185 --RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       185 --~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                        ..+|||||||+.+|..++.... -.|++.+|+.+++||+.||+|||++||+|||||..||||+   ..+.+||+|||+
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid---n~G~LKiaDFGL  264 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID---NNGVLKIADFGL  264 (560)
T ss_pred             CCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc---CCCCEEeccccc
Confidence              6899999999999998887653 3599999999999999999999999999999999999995   789999999999


Q ss_pred             ccccC----CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          263 ACTED----RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       263 A~~~~----~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |+...    ...+..+-|+||+|||++++. .|+.++|+||+||||.||++|++.|++.++.+++..|.+++| .|.+..
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG-SP~e~~  343 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG-SPTEDY  343 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC-CCChhc
Confidence            98432    234556789999999999997 799999999999999999999999999999999999999999 555443


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      |+. .+.. ++..                   |+              |.  .. + ...+.+....             
T Consensus       344 W~~-~kLP-~~~~-------------------~k--------------p~--~~-y-~r~l~E~~~~-------------  371 (560)
T KOG0600|consen  344 WPV-SKLP-HATI-------------------FK--------------PQ--QP-Y-KRRLRETFKD-------------  371 (560)
T ss_pred             ccc-ccCC-cccc-------------------cC--------------CC--Cc-c-cchHHHHhcc-------------
Confidence            331 1110 0000                   00              00  00 0 1223333333             


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPE  467 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~~~  467 (837)
                          ++..+++||..||.+||.+|.||.++|+|+||+..++.|...-.|.
T Consensus       372 ----~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~  417 (560)
T KOG0600|consen  372 ----FPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPK  417 (560)
T ss_pred             ----CCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCC
Confidence                4478899999999999999999999999999999888876555444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-50  Score=436.01  Aligned_cols=261  Identities=30%  Similarity=0.509  Sum_probs=219.6

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      ..+.|.+.+.||+|+||.|-+|..+.|++.||||++++..        .......+|++||++|       +|||||+++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-------~HP~IV~~~  242 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-------SHPNIVRIK  242 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-------CCCCEEEEe
Confidence            4578999999999999999999999999999999998532        1233457899999999       789999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      ++|...+..||||||++ |+|.+.+-.+.  .+.+...+.+++||+.||.|||++||+||||||+|||+..+.++..+||
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence            99999999999999998 68999887654  5889999999999999999999999999999999999987778899999


Q ss_pred             Eeccccccc--CCcceeeccCccccCchhhcCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Q 003239          258 IDFGSACTE--DRTVYSYIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFD-LLRRMIRILGA  331 (837)
Q Consensus       258 ~DFGlA~~~--~~~~~~~~GT~~Y~APEvl~~~~---yt~ksDIWSLG~ILyELltG~~PF~g~s~~e-~l~~I~~~lG~  331 (837)
                      +|||+|+..  ...+.+.|||+.|.|||++....   +..++||||||||||-+++|.+||.+..... +.++|.+  | 
T Consensus       321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~--G-  397 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK--G-  397 (475)
T ss_pred             cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc--C-
Confidence            999999876  44567889999999999998764   3348999999999999999999997654322 3333322  1 


Q ss_pred             CCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       332 ~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                                                           .|.                     |.                 
T Consensus       398 -------------------------------------~y~---------------------f~-----------------  402 (475)
T KOG0615|consen  398 -------------------------------------RYA---------------------FG-----------------  402 (475)
T ss_pred             -------------------------------------ccc---------------------cc-----------------
Confidence                                                 000                     00                 


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                          -..+..++++++|||.+||+.||++|+|++|||+||||+..+.
T Consensus       403 ----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  403 ----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             ----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence                0133456789999999999999999999999999999997663

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-49  Score=423.95  Aligned_cols=280  Identities=33%  Similarity=0.605  Sum_probs=238.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe---CChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik---~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ..+|..++.||+|+||.|+.+.++.+++.||||++.   ......++..+|+++|+.+       .|+||+.+++++...
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-------~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-------RHENIIGLLDIFRPP   93 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-------cCCCcceEEeecccc
Confidence            367888899999999999999999999999999997   3456788899999999999       588999999999872


Q ss_pred             -----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       185 -----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                           +.+|+|+|+|+.+|..+++...  .+++..++.+++||+.||+|+|+.+|+||||||.|+|++   .+..+||||
T Consensus        94 ~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~D  168 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICD  168 (359)
T ss_pred             cccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEecc
Confidence                 4799999999999999998764  499999999999999999999999999999999999996   678899999


Q ss_pred             cccccccC-----CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          260 FGSACTED-----RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       260 FGlA~~~~-----~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      ||+|+..+     ...+.++.|++|+|||++... .|+.++||||+|||+.||++|++.|+|.+..+++..|++.+| .|
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG-tP  247 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG-TP  247 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC-CC
Confidence            99998773     445778999999999998764 899999999999999999999999999999999999999999 56


Q ss_pred             chHHHHhhh--cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          334 PDYVLKEAK--NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       334 p~~~l~~~k--~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                      +++.+....  +.+.|.....                                       ..+..++..++++       
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp---------------------------------------~~p~~~f~~~fp~-------  281 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLP---------------------------------------QIPKQPFSSIFPN-------  281 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCC---------------------------------------CCCCCCHHHHcCC-------
Confidence            666555432  2222222211                                       1112233444332       


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                                .++.++|||++||++||.+|+|++|||+||||..-
T Consensus       282 ----------a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  282 ----------ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             ----------CCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                      45889999999999999999999999999999873

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-49  Score=442.41  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=227.7

Q ss_pred             eeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCc
Q 003239           98 VNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHH  173 (837)
Q Consensus        98 l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~Hpn  173 (837)
                      +++.+.+... .+|+..+.||+|+|++||++++..+|+.||+|++.+    .....++..+||+|.+.|       .|||
T Consensus         8 ip~~i~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-------~Hpn   79 (592)
T KOG0575|consen    8 IPEVIEDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-------KHPN   79 (592)
T ss_pred             CCCeeecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-------CCCc
Confidence            3445555555 899999999999999999999999999999999986    456678899999999999       6899


Q ss_pred             eeEEeEEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          174 IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       174 IVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                      ||+++++|++.+++|||.|+|. ++|.++++.  .+.++|.+++.+++||+.||.|||+++|||||||..||||+   ++
T Consensus        80 IV~f~~~FEDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~~  154 (592)
T KOG0575|consen   80 IVQFYHFFEDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---EN  154 (592)
T ss_pred             EEeeeeEeecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---Cc
Confidence            9999999999999999999998 678777773  35799999999999999999999999999999999999995   77


Q ss_pred             CeEEEEecccccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          253 AEIKIIDFGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      .+|||+|||+|+...   +...+.|||+.|.|||++....++..+||||+|||||.||+|+|||...+-.+.+.+|...-
T Consensus       155 ~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~  234 (592)
T KOG0575|consen  155 MNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE  234 (592)
T ss_pred             CcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC
Confidence            899999999998654   66788999999999999999999999999999999999999999998877777666654311


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                                                                                                 |.++ 
T Consensus       235 ---------------------------------------------------------------------------Y~~P-  238 (592)
T KOG0575|consen  235 ---------------------------------------------------------------------------YSMP-  238 (592)
T ss_pred             ---------------------------------------------------------------------------cccc-
Confidence                                                                                       0011 


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                                ..++.++.|||.+||+.||.+|||+++||.|+||+..
T Consensus       239 ----------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  239 ----------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ----------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence                      1245778999999999999999999999999999653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-49  Score=423.28  Aligned_cols=324  Identities=36%  Similarity=0.667  Sum_probs=271.9

Q ss_pred             cCCCCcceEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccC
Q 003239           88 DNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD  167 (837)
Q Consensus        88 d~~~~~~~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~  167 (837)
                      |+..++++...++.+.     .+|+|++++|+|+||.|.+|.+.+++..||||+++.-..+.+..+.|+++|+++++. +
T Consensus        73 dD~dGH~v~~~gD~l~-----~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~-D  146 (415)
T KOG0671|consen   73 DDKDGHYVYQVGDILT-----NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINES-D  146 (415)
T ss_pred             CCCCceEEEEeccccc-----cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhc-C
Confidence            6788889999999886     899999999999999999999999999999999999888889999999999999753 2


Q ss_pred             CCCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeee
Q 003239          168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC  247 (837)
Q Consensus       168 ~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~  247 (837)
                      ..+..-+|++.++|...++.|||+|.++-+++++++.+...+++...++.+.+||+++++|||+.+++|.||||||||+.
T Consensus       147 P~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfv  226 (415)
T KOG0671|consen  147 PNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFV  226 (415)
T ss_pred             CCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEe
Confidence            33344589999999999999999999999999999999989999999999999999999999999999999999999995


Q ss_pred             cc-----------------CCCCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCC
Q 003239          248 TS-----------------VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL  310 (837)
Q Consensus       248 ~~-----------------~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~  310 (837)
                      .+                 .+...|||+|||.|+...+.....+.|+.|+|||++++..++..+||||+||||+||++|.
T Consensus       227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence            32                 1245689999999999888888899999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCc
Q 003239          311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK  390 (837)
Q Consensus       311 ~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~  390 (837)
                      .+|+..++.+.+..|.+++| ++|..|+...+ ..+||...    .+++++....+...|.+.           .     
T Consensus       307 ~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~-~~Kyf~~~----rldw~e~~~~~~~k~v~~-----------~-----  364 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILG-PIPSRMIKKTR-KEKYFRRG----RLDWPEVSSKGKSKYVFE-----------P-----  364 (415)
T ss_pred             eecccCCcHHHHHHHHHhhC-CCcHHHhhhhh-hHhhhhcc----cccCccccccccchhhhc-----------C-----
Confidence            99999999999999999999 77888877654 45666654    233333333332211111           0     


Q ss_pred             ccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       391 ~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                          .++|..++..              .+....+|+|||++||.+||.+|+|+.|||.||||+...
T Consensus       365 ----ckpl~~~~~~--------------~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  365 ----CKPLKKYMLQ--------------DDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             ----CccHHHHhcc--------------CcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence                1223332211              122345799999999999999999999999999999743

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=409.49  Aligned_cols=273  Identities=26%  Similarity=0.461  Sum_probs=233.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+|+.++.+.+++.+|+|++++..    ...+....|..||..+       .||.||+++-.|++
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-------~hPFiv~l~ysFQt   96 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-------KHPFIVKLIYSFQT   96 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-------CCCcEeeeEEeccc
Confidence            489999999999999999999999999999999998643    3466788899999997       78999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+++|||+||+.| .|.-.|.+.  +.++|..++.++.+|+.||.|||++||||||||||||||+   ..++|+|+|||+
T Consensus        97 ~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL  171 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGL  171 (357)
T ss_pred             CCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEecccc
Confidence            9999999999985 888777654  4699999999999999999999999999999999999995   889999999999


Q ss_pred             ccc---cCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~---~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++.   .+....+.|||+.|||||++.+..|+.++|.|||||++|||++|.+||.+.+.....++|.+.-...+|     
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-----  246 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-----  246 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-----
Confidence            974   334556789999999999999999999999999999999999999999998887777776552110000     


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                                      
T Consensus       247 --------------------------------------------------------------------------------  246 (357)
T KOG0598|consen  247 --------------------------------------------------------------------------------  246 (357)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCC----CHHHHHcCccCCCCCCCCCCCCCCCCCCCCccccc
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRW----SPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNF  477 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRp----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~~~~~~  477 (837)
                      ..++.+++|||+++|..||++|+    .++++-+||||.+..|.........+|..|...+.
T Consensus       247 ~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~  308 (357)
T KOG0598|consen  247 GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGL  308 (357)
T ss_pred             ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCc
Confidence            01346789999999999999996    78999999999999886655555555555554443

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-47  Score=410.21  Aligned_cols=301  Identities=34%  Similarity=0.564  Sum_probs=241.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---  185 (837)
                      -.|+-.+++|.|+||.||+|+..++++.||||.+-.+..   ..-+|+++|+.+       +|||||+++-+|....   
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l-------~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKL-------DHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhc-------CCcCeeeEEEEEEecCCCc
Confidence            578889999999999999999999999999999976543   233699999977       7999999999887542   


Q ss_pred             --eEEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          186 --HLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       186 --~l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                        ++.+||||++.+|.++++..  ....++.-.++.++.||++||.|||+.||+||||||.|||++  .+.+.+||||||
T Consensus        94 ~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFG  171 (364)
T KOG0658|consen   94 EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFG  171 (364)
T ss_pred             hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCC
Confidence              56899999999999999853  235689999999999999999999999999999999999997  678999999999


Q ss_pred             ccccc--CCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          262 SACTE--DRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       262 lA~~~--~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      .|+..  ++....++.|++|+|||++.+. .|+.++||||.|||+.||+.|++.|+|++..+++..|++++| .|.++-+
T Consensus       172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG-~Pt~e~I  250 (364)
T KOG0658|consen  172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG-TPTREDI  250 (364)
T ss_pred             cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC-CCCHHHH
Confidence            99754  4556788999999999999987 799999999999999999999999999999999999999999 6666544


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                      ...+-...                                   ....|.+.     ...+.+++                
T Consensus       251 ~~mn~~y~-----------------------------------~~~~p~ik-----~~~~~~~~----------------  274 (364)
T KOG0658|consen  251 KSMNPNYT-----------------------------------EFKFPQIK-----AHPWHKVF----------------  274 (364)
T ss_pred             hhcCcccc-----------------------------------cccCcccc-----cccceeec----------------
Confidence            43221100                                   00001000     01111110                


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCCCCCCCCCCCcccccccc
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVD  480 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~~~~p~~~~~~~~~~~  480 (837)
                      ....++++.||+.++|+++|.+|.||.|+|+||||++.+..  ....+.....|...+++..
T Consensus       275 ~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~--~~~l~~g~~lp~lf~f~~~  334 (364)
T KOG0658|consen  275 FKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP--NTKLPNGRPLPPLFNFKRA  334 (364)
T ss_pred             ccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc--CccCcCCCcCCCccCchHH
Confidence            11245788999999999999999999999999999986643  3444444456666666554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=411.76  Aligned_cols=253  Identities=30%  Similarity=0.493  Sum_probs=217.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe--CChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik--~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-  185 (837)
                      .+.+.++.||+|..|+||+|+++.|++.+|+|++.  .++...+++.+|++|++..       .||+||++|+.|..+. 
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-------~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-------QSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-------CCCCeeeEeEEEEeCCc
Confidence            57788899999999999999999999999999995  4567788999999999998       6899999999999999 


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .++|+||||+ |+|.++++..  ++++|..+.+|+++|++||.|||+ ++||||||||+|||++   ..++|||||||.+
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN---skGeVKicDFGVS  226 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN---SKGEVKICDFGVS  226 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec---cCCCEEecccccc
Confidence            5999999998 5777777654  569999999999999999999995 9999999999999996   7899999999999


Q ss_pred             cccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCCchHH
Q 003239          264 CTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-----SEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       264 ~~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~-----s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ..... ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||...     ...+++..|+.   .+||.  
T Consensus       227 ~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~--  301 (364)
T KOG0581|consen  227 GILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPR--  301 (364)
T ss_pred             HHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCC--
Confidence            76544 447889999999999999999999999999999999999999999764     23333333322   11110  


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                         .|           
T Consensus       302 -------------------------------------------------------------------lP-----------  303 (364)
T KOG0581|consen  302 -------------------------------------------------------------------LP-----------  303 (364)
T ss_pred             -------------------------------------------------------------------CC-----------
Confidence                                                                               00           


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                       +..++++|++||..||++||.+|+|++|+|+|||+++..
T Consensus       304 -~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  304 -EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             -cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence             013678999999999999999999999999999999754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-47  Score=418.69  Aligned_cols=260  Identities=29%  Similarity=0.462  Sum_probs=228.4

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ...+|.+.+.||+|+|++|++|+++.+++.||||++.+.    +...+.+.+|-.+|.+|.      +||.|++|+-.|+
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~------~hPgivkLy~TFQ  144 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS------GHPGIVKLYFTFQ  144 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh------CCCCeEEEEEEee
Confidence            347899999999999999999999999999999999753    233455778999999996      6999999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ++..+|+|+||+. |+|+++|++.  +.|++..++.++.||+.||+|||++||||||||||||||+   +++++||+|||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd---~dmhikITDFG  219 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD---KDGHIKITDFG  219 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc---CCCcEEEeecc
Confidence            9999999999997 7999999876  5799999999999999999999999999999999999995   88999999999


Q ss_pred             cccccCC----------------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          262 SACTEDR----------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       262 lA~~~~~----------------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      .|.....                ....++||..|.+||++.....++.+|||+||||||+|+.|.+||.+.++.-.+++|
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            9953221                114579999999999999999999999999999999999999999999999999998


Q ss_pred             HHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcC
Q 003239          326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY  405 (837)
Q Consensus       326 ~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~  405 (837)
                      +++--..                                                                         
T Consensus       300 ~~l~y~f-------------------------------------------------------------------------  306 (604)
T KOG0592|consen  300 QALDYEF-------------------------------------------------------------------------  306 (604)
T ss_pred             HHhcccC-------------------------------------------------------------------------
Confidence            8743211                                                                         


Q ss_pred             CCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCC
Q 003239          406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQ  463 (837)
Q Consensus       406 p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~  463 (837)
                        +.           ..++.+.|||+++|+.||.+|+|++||.+||||.+..|...+.
T Consensus       307 --p~-----------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~  351 (604)
T KOG0592|consen  307 --PE-----------GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQ  351 (604)
T ss_pred             --CC-----------CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhh
Confidence              11           1336789999999999999999999999999999998865443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.7e-46  Score=415.27  Aligned_cols=325  Identities=25%  Similarity=0.417  Sum_probs=248.5

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..++|++++.||+|+||.||+|+.+.||+.+|+|++++..    ...+.++.|-.||...       +.+.||+||-.|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-------ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-------DSPWVVKLYYSFQ  211 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-------CCCcEEEEEEEec
Confidence            4589999999999999999999999999999999999753    3345566777777775       6789999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +.+++||||||++ |++..+|...  ..|++..++.++.+++.||+-||+.|+|||||||+|+||+   ..|+|||+|||
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD---~~GHiKLSDFG  286 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID---AKGHIKLSDFG  286 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---CCCCEeecccc
Confidence            9999999999998 5888887765  4699999999999999999999999999999999999995   88999999999


Q ss_pred             cccccC-------------------------Cc-------------------------ceeeccCccccCchhhcCCCCC
Q 003239          262 SACTED-------------------------RT-------------------------VYSYIQSRYYRSPEVLLGYQYT  291 (837)
Q Consensus       262 lA~~~~-------------------------~~-------------------------~~~~~GT~~Y~APEvl~~~~yt  291 (837)
                      ++....                         ..                         ....+|||.|+|||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            982100                         00                         1235899999999999999999


Q ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchh
Q 003239          292 TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQ  371 (837)
Q Consensus       292 ~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~  371 (837)
                      ..+|+|||||||||||.|.+||.+.+..+...+|+....             +.                          
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-------------~l--------------------------  407 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-------------TL--------------------------  407 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-------------hc--------------------------
Confidence            999999999999999999999999999998888876211             00                          


Q ss_pred             hhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCC---HHHHH
Q 003239          372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQAS  448 (837)
Q Consensus       372 ~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT---a~EaL  448 (837)
                                                      .+|           .+...+++++|||.+||+ ||++|+-   ++||.
T Consensus       408 --------------------------------~fP-----------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  408 --------------------------------KFP-----------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             --------------------------------cCC-----------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence                                            001           011244789999999999 9999995   89999


Q ss_pred             cCccCCCCCCCCCCCCCCCCCCCCccccccccCCCC-----CCCCccCCCCCCccCCccccc----CCCCCCccCCCCCC
Q 003239          449 RHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPG-----AGHWFAAGLSPNISGRSKFSM----HNSPHFQVVPYGYG  519 (837)
Q Consensus       449 ~HPff~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-----~~~~~~~~l~~~~s~r~~~~~----~n~~~~~~~~~~yg  519 (837)
                      +||||++..|...+..++  |.+|...+........     ...+.-+..  ...++....+    -+.....++.|.|.
T Consensus       444 ~HPfF~~v~W~~l~~~~a--pfvP~v~~~~DT~yFddF~e~~~~~~~~~~--~~~~~k~~~~~~~~~~~~~~~FvgfTyk  519 (550)
T KOG0605|consen  444 KHPFFKGVDWDHLREMPA--PFVPQVNSELDTQYFDDFPEEDSMTPTADK--SGPSRKMLSMVDTNNSSKDINFVGFTYK  519 (550)
T ss_pred             cCCccccCCcchhhcCCC--CCCCCCCCcccccccccCcccccCcccccc--cccchhhhhcccccCCcccccccceeee
Confidence            999999999977665542  3333333332221111     000000000  0001111111    23677889999999


Q ss_pred             CccccccCCcc
Q 003239          520 NSYGSVGSYGS  530 (837)
Q Consensus       520 ~s~~~~~~~~~  530 (837)
                      |.-+.-+....
T Consensus       520 ~~~~~~~~~~~  530 (550)
T KOG0605|consen  520 NFDGLNKANSL  530 (550)
T ss_pred             ccccccccccc
Confidence            99887665543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-46  Score=401.41  Aligned_cols=282  Identities=36%  Similarity=0.622  Sum_probs=233.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---hHHHHHHHHHHHHHhhcccCCCCCCc-eeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKYDREDKHH-IVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~---~~~~~~~Ei~iL~~L~~~~~~~~Hpn-IVkl~d~f~~~  184 (837)
                      ..|+.+++||+|+||+||+|+++.+|+.||+|+++.+..   .....++|+.+|+.|+       |+| ||++++++...
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-------~~~~iv~L~dv~~~~   83 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-------HANHIVRLHDVIHTS   83 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-------CCcceEEEEeeeeec
Confidence            567778899999999999999999999999999985433   5567899999999995       556 99999999988


Q ss_pred             c------eEEEEEeccchhHHHHHHhhcc--CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEE
Q 003239          185 R------HLCICFELLDSNLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       185 ~------~l~LVmEy~~gsL~d~l~~~~~--~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                      +      .+++||||++.+|..++.....  .+++...++.+++||+.||+|||+++|+||||||.||||+   +.+.+|
T Consensus        84 ~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lK  160 (323)
T KOG0594|consen   84 NNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLK  160 (323)
T ss_pred             ccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEe
Confidence            7      8999999999999999987654  4688899999999999999999999999999999999996   689999


Q ss_pred             EEecccccccC---CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          257 IIDFGSACTED---RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       257 L~DFGlA~~~~---~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      |+|||+|+...   ......+.|.+|+|||++.+. .|+...||||+|||++||+++++.|++.++.+++.+|.+++| .
T Consensus       161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG-t  239 (323)
T KOG0594|consen  161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG-T  239 (323)
T ss_pred             eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC-C
Confidence            99999997543   334556889999999999998 799999999999999999999999999999999999999999 6


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCccccc---ccchHHHHhcCCCCC
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFH---HKHLEEIVTNYPYRK  409 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~---~~~L~~il~~~p~~~  409 (837)
                      |.+..|+.......|                       ..                  .++.   .+.+..++   |   
T Consensus       240 P~e~~Wp~v~~~~~~-----------------------k~------------------~f~~~~~~~~l~~~~---~---  272 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDY-----------------------KA------------------PFPKWPGPKDLSSIL---P---  272 (323)
T ss_pred             CCccCCCCccccccc-----------------------cc------------------cCcCCCCccchHHhc---c---
Confidence            665544432211110                       00                  0111   11122221   1   


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                                 .......||+.+||++||++|+||+.+|.||||...+..
T Consensus       273 -----------~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  273 -----------KLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             -----------ccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence                       123578999999999999999999999999999987643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-45  Score=398.55  Aligned_cols=318  Identities=34%  Similarity=0.606  Sum_probs=269.7

Q ss_pred             CcceEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhccc-CCCC
Q 003239           92 SDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY-DRED  170 (837)
Q Consensus        92 ~~~~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~-~~~~  170 (837)
                      ++..+.+++++.+    .||.++++||.|-|++||+|+|..+.+.||+|+.|....+.+..+.||++|++++..= ...+
T Consensus        65 GYHpV~IGD~F~~----gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~  140 (590)
T KOG1290|consen   65 GYHPVRIGDVFNG----GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPG  140 (590)
T ss_pred             CCceeeccccccC----ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            3556778887753    8999999999999999999999999999999999998889999999999999997541 1344


Q ss_pred             CCceeEEeEEEeec----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCee
Q 003239          171 KHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENIL  245 (837)
Q Consensus       171 HpnIVkl~d~f~~~----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNIL  245 (837)
                      ..+||+|+|.|...    .|+|+|+|+++.+|+.+|+....++++...++.|++|||.||.|||+ +||||.||||+|||
T Consensus       141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL  220 (590)
T KOG1290|consen  141 KKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL  220 (590)
T ss_pred             CceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence            56899999999975    48999999999999999999999999999999999999999999995 69999999999999


Q ss_pred             eecc----------------------------------------------------------------------------
Q 003239          246 LCTS----------------------------------------------------------------------------  249 (837)
Q Consensus       246 l~~~----------------------------------------------------------------------------  249 (837)
                      +..+                                                                            
T Consensus       221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~  300 (590)
T KOG1290|consen  221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ  300 (590)
T ss_pred             eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence            8310                                                                            


Q ss_pred             -------------------------------------C------------------------------------------
Q 003239          250 -------------------------------------V------------------------------------------  250 (837)
Q Consensus       250 -------------------------------------~------------------------------------------  250 (837)
                                                           .                                          
T Consensus       301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v  380 (590)
T KOG1290|consen  301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV  380 (590)
T ss_pred             cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence                                                 0                                          


Q ss_pred             --------CCCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC------C
Q 003239          251 --------KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG------A  316 (837)
Q Consensus       251 --------~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g------~  316 (837)
                              .+-+|||+|||.||.....++..++|+.|+||||+.+..|++.+||||++|++|||+||..+|.-      .
T Consensus       381 ~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~  460 (590)
T KOG1290|consen  381 NPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS  460 (590)
T ss_pred             CCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence                    00147999999999999989999999999999999999999999999999999999999999953      3


Q ss_pred             CHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCccccccc
Q 003239          317 SEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK  396 (837)
Q Consensus       317 s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~  396 (837)
                      .+++.+..|++++| ..|..+...++..+.||++.+.+.++..       ...|                          
T Consensus       461 rDEDHiA~i~ELLG-~iPr~ia~~Gk~SRdFFnr~G~LrhI~~-------LK~W--------------------------  506 (590)
T KOG1290|consen  461 RDEDHIALIMELLG-KIPRKIALGGKYSRDFFNRRGELRHIRR-------LKPW--------------------------  506 (590)
T ss_pred             ccHHHHHHHHHHHh-hccHHHHhcCcchHhhhccccceecccc-------cCCC--------------------------
Confidence            47889999999999 7777888889999999999998777543       1111                          


Q ss_pred             chHHHH-hcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          397 HLEEIV-TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       397 ~L~~il-~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      .|.+++ .+|-+.           .+...++.|||.-||+++|+||+||.++|+|||+...+.
T Consensus       507 pL~~VL~eKY~~s-----------~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  507 PLYEVLIEKYEWS-----------EEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             cHHHHHHHHhCCC-----------HHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence            122222 222211           124578999999999999999999999999999997654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.5e-46  Score=412.60  Aligned_cols=341  Identities=33%  Similarity=0.553  Sum_probs=284.1

Q ss_pred             cccCCCccCCCCcceEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHH
Q 003239           81 GVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILT  160 (837)
Q Consensus        81 ~~~~~g~d~~~~~~~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~  160 (837)
                      ..+.+.||+..++|.+.++++|.     .+|.|....|+|-|++|.+|.+...+..||||||.+++...+.-+.|++||+
T Consensus       409 ~~L~DNWdDaEGYYrv~igE~LD-----~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLk  483 (752)
T KOG0670|consen  409 PGLQDNWDDAEGYYRVRIGELLD-----SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILK  483 (752)
T ss_pred             CccccCcccccceEEEehhhhhc-----ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHH
Confidence            44678899999999999999997     8999999999999999999999999999999999999998999999999999


Q ss_pred             HhhcccCCCCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       161 ~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      +|+.. +.++..|+++|+..|...+|+|||||.+.-+|.+++++.. .-+|....++.++.||+.||..|-.+||+|+||
T Consensus       484 KL~~A-D~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDI  562 (752)
T KOG0670|consen  484 KLNDA-DPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADI  562 (752)
T ss_pred             Hhhcc-CchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence            99764 6667789999999999999999999999999999998754 335889999999999999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccC-CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTED-RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~-~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      ||+||||+  .....+||||||.|.... ...+.+.-+++|+|||++++.+|+...|+||+||+||||.||+.+|+|.++
T Consensus       563 KPDNiLVN--E~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  563 KPDNILVN--ESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             CccceEec--cCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            99999997  567889999999997665 446677889999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccch
Q 003239          319 FDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL  398 (837)
Q Consensus       319 ~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L  398 (837)
                      .+++..++++-| ..|..|+..+.....-|+...++-.++.+.++........          ...+        +.+.|
T Consensus       641 N~MLrl~me~KG-k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm----------~~vk--------Ptkdl  701 (752)
T KOG0670|consen  641 NQMLRLFMELKG-KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVM----------VNVK--------PTKDL  701 (752)
T ss_pred             HHHHHHHHHhcC-CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEe----------cccC--------cchhH
Confidence            999999999999 7788888888777777776655544443333222110000          0000        11233


Q ss_pred             HHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       399 ~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ...+...+   .++.    .+...-..|.|||.+||..||++|+|+.|||+||||++
T Consensus       702 ~s~l~~~q---~~~d----eq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  702 GSELIAVQ---RLPD----EQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHHhccC---CCCc----hhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            33333321   1111    22345678999999999999999999999999999986

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-44  Score=415.77  Aligned_cols=304  Identities=31%  Similarity=0.574  Sum_probs=234.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-ce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-RH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-~~  186 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++...........|+++++.+++. ...+|.+|++++++|..+ .+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA-DPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhc-CcccCcceeeeEEEEEcCCce
Confidence            4789999999999999999999999999999999986555556677899999988653 334567899999998865 58


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccC-------------CC
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSV-------------KP  252 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~-------------~~  252 (837)
                      +|||||+++++|.+++...  ..+++..++.|+.||+.||+|||+ .|||||||||+|||++.+.             +.
T Consensus       207 ~~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        207 MCIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            9999999999999888754  369999999999999999999997 5999999999999996432             12


Q ss_pred             CeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          253 AEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      ..+||+|||.++.........+||+.|+|||++.+..|+.++||||||||+|||++|++||.+.+..+.+..+.+.+|..
T Consensus       285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence            36999999998766555567789999999999999999999999999999999999999999999999999999999944


Q ss_pred             CchHHHHhh--hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCC
Q 003239          333 PPDYVLKEA--KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN  410 (837)
Q Consensus       333 Pp~~~l~~~--k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~  410 (837)
                       |..+....  .....+++....+.                              +     .+..+.+..+....+.   
T Consensus       365 -p~~~~~~~~~~~~~~~~~~~~~~~------------------------------~-----~~~~~~~~~~~~~~~~---  405 (467)
T PTZ00284        365 -PSEWAGRCGTEEARLLYNSAGQLR------------------------------P-----CTDPKHLARIARARPV---  405 (467)
T ss_pred             -CHHHHhhccchhHHHHhhhccccc------------------------------c-----cCCHHHHHhhhcccch---
Confidence             44443321  11112222211000                              0     0001111111111000   


Q ss_pred             CchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCC
Q 003239          411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTC  460 (837)
Q Consensus       411 l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~  460 (837)
                             .+....+.++|||.+||++||++|+|++|||+||||.+....|
T Consensus       406 -------~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  448 (467)
T PTZ00284        406 -------REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC  448 (467)
T ss_pred             -------hhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence                   0011246789999999999999999999999999999855433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=396.89  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=222.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ..+|.+.+.||.|+|++||+|+++.++..||||.+.+.   ....+....|+.||+.+       .|+|||+++++++..
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-------~H~nIV~l~d~~~~~   81 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-------KHPNIVRLLDCIEDD   81 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-------CCcceeeEEEEEecC
Confidence            37899999999999999999999999999999999754   45567788999999999       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC---CeEEEEec
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP---AEIKIIDF  260 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~---~~IKL~DF  260 (837)
                      +.+|||||||+ |+|.++++...  .++|..++.++.||+.||++||+++||||||||+||||+.....   ..+||+||
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            99999999998 69999998764  69999999999999999999999999999999999999865333   68999999


Q ss_pred             ccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          261 GSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       261 GlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      |+|+.....  ..+.||++.|||||++..++|+.|+|+||+|+|+|+|++|++||...+..+++..+.+.-..       
T Consensus       160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~-------  232 (429)
T KOG0595|consen  160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI-------  232 (429)
T ss_pred             chhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-------
Confidence            999876543  45789999999999999999999999999999999999999999998888877644331110       


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                     ++.             .
T Consensus       233 ---------------------------------------------------------------~~~-------------~  236 (429)
T KOG0595|consen  233 ---------------------------------------------------------------VPV-------------L  236 (429)
T ss_pred             ---------------------------------------------------------------cCc-------------h
Confidence                                                                           000             0


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +...+..+.+|+..+|..||.+|.+..+-+.|+++...+
T Consensus       237 ~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  237 PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            011234456999999999999999999999999999876

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=381.75  Aligned_cols=266  Identities=25%  Similarity=0.451  Sum_probs=233.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||.|+||+|.+++.+.++..+|+|++++..    ...+...+|..+|+.+       .||.++++++.|.+.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-------~~PFlv~l~~t~~d~  116 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-------SHPFLVKLYGTFKDN  116 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-------cCceeEEEEEeeccC
Confidence            78999999999999999999999999999999998653    3445677899999998       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+||||++ |.|..++++.  +++++..++.++.||+.||+|||+++|++|||||||||++   .+|.|||+|||+|
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD---~~G~iKitDFGFA  191 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD---QNGHIKITDFGFA  191 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec---cCCcEEEEeccce
Confidence            99999999998 5888888775  4699999999999999999999999999999999999995   8899999999999


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      +.......+.|||+.|+|||++...+|..++|.|||||++|||+.|.+||...+.....++|++.--.            
T Consensus       192 K~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~------------  259 (355)
T KOG0616|consen  192 KRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK------------  259 (355)
T ss_pred             EEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc------------
Confidence            99988899999999999999999999999999999999999999999999999888888777662110            


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                   +|             ...+
T Consensus       260 -------------------------------------------------------------fP-------------~~fs  265 (355)
T KOG0616|consen  260 -------------------------------------------------------------FP-------------SYFS  265 (355)
T ss_pred             -------------------------------------------------------------CC-------------cccC
Confidence                                                                         01             1245


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCCCCCCCCCCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCPYQPPPETPRVP  472 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~  472 (837)
                      .+++|||+++|+.|-.+|.     -.++|.+||||++..|.......-++|..|
T Consensus       266 ~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p  319 (355)
T KOG0616|consen  266 SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP  319 (355)
T ss_pred             HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence            7789999999999999994     567999999999988765544444444444

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.5e-44  Score=384.72  Aligned_cols=278  Identities=32%  Similarity=0.540  Sum_probs=222.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.++||.|+||+||+|++..+++.||+|+++..  ......+.+|+.+++.+       .|+||+++++++..++.
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~   77 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-------KHANIVTLHDIIHTERC   77 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-------CCCCEeeEEEEEcCCCe
Confidence            6899999999999999999999999999999999743  22344677899999998       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~  153 (288)
T cd07871          78 LTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAK  153 (288)
T ss_pred             EEEEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeec
Confidence            99999999999988886543 3589999999999999999999999999999999999995   6688999999998654


Q ss_pred             CC---cceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          267 DR---TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       267 ~~---~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..   ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .|+...+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG-TPTEETWPGIT  232 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChHHhhccc
Confidence            32   2234567899999999876 4689999999999999999999999999999999999999888 44444433221


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                      ....+....-                                 +.     +....+..                 .....
T Consensus       233 ~~~~~~~~~~---------------------------------~~-----~~~~~~~~-----------------~~~~~  257 (288)
T cd07871         233 SNEEFRSYLF---------------------------------PQ-----YRAQPLIN-----------------HAPRL  257 (288)
T ss_pred             cchhhhcccc---------------------------------Cc-----cCCCchHH-----------------hCCCC
Confidence            1111110000                                 00     00000000                 11124


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      +.+++|||++||++||.+|+|++|||+||||
T Consensus       258 ~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         258 DTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            5678999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.7e-44  Score=380.45  Aligned_cols=279  Identities=31%  Similarity=0.538  Sum_probs=221.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-  183 (837)
                      ++|++++.||+|+||+||+|++.. +++.||||+++..   ........+|+.+++.+...    .||||+++++++.. 
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~hpniv~~~~~~~~~   76 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----EHPNVVRLFDVCTVS   76 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhccc----CCCCcceEEEEEecc
Confidence            479999999999999999998854 4788999998743   22334567788888887543    79999999999863 


Q ss_pred             ----cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          184 ----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       184 ----~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                          ...+++||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~D  153 (290)
T cd07862          77 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD  153 (290)
T ss_pred             cCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEcc
Confidence                3569999999999999998776556699999999999999999999999999999999999995   668899999


Q ss_pred             cccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||++.....  ......+++.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+.+..+.+.+..+
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999965432  233457899999999999889999999999999999999999999999999999999988874443332


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      ..........+.                                          ......++++..              
T Consensus       234 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~--------------  257 (290)
T cd07862         234 PRDVALPRQAFH------------------------------------------SKSAQPIEKFVT--------------  257 (290)
T ss_pred             hhhhcccchhcc------------------------------------------CCCCCCHHHHcc--------------
Confidence            221100000000                                          000111222221              


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                         ..++.+.+||.+||++||++|||+.|+|+||||
T Consensus       258 ---~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         258 ---DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ---CCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence               244678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-44  Score=398.90  Aligned_cols=252  Identities=28%  Similarity=0.439  Sum_probs=217.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----h--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----P--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|++.+.||+|+||+|++|++..+++.||||++.+.    .  ...+.+.+|+.+++.++      .||||+++++++
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~------~HpnI~~l~ev~   89 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR------SHPNIIRLLEVF   89 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc------cCCCEeEEEEEE
Confidence            37999999999999999999999999999999988753    1  23456668999999994      389999999999


Q ss_pred             eecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC-CeEEEEe
Q 003239          182 VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIID  259 (837)
Q Consensus       182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~-~~IKL~D  259 (837)
                      ....++++|||||.| +|++.+..  .+++.|.+++.+++||+.|++|||++||+||||||||||++   .+ +.+||+|
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~D  164 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSD  164 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEec
Confidence            999999999999984 99999988  35799999999999999999999999999999999999996   44 8999999


Q ss_pred             ccccccc---CCcceeeccCccccCchhhcCCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          260 FGSACTE---DRTVYSYIQSRYYRSPEVLLGYQ-YT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       260 FGlA~~~---~~~~~~~~GT~~Y~APEvl~~~~-yt-~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      ||++...   .....+.|||+.|+|||++.+.. |+ .++||||+|||||.|++|+.||...+...+..+|.+..-    
T Consensus       165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~----  240 (370)
T KOG0583|consen  165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF----  240 (370)
T ss_pred             cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc----
Confidence            9999865   45667889999999999999987 87 799999999999999999999988666555555332100    


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                                                  .                                         +|  .     
T Consensus       241 ----------------------------~-----------------------------------------~p--~-----  244 (370)
T KOG0583|consen  241 ----------------------------K-----------------------------------------IP--S-----  244 (370)
T ss_pred             ----------------------------c-----------------------------------------CC--C-----
Confidence                                        0                                         00  0     


Q ss_pred             hhhhhHHh-HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          415 DISKESQI-RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       415 ~l~~~~~~-s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                            .. +.++.+||++||+.||.+|+|+.|+++||||+..
T Consensus       245 ------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  245 ------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             ------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence                  12 5778999999999999999999999999999984

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-44  Score=405.96  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=222.5

Q ss_pred             ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       106 ~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      +..+-|++.+.||.|+.|.|-+|++..||+.+|||++.+.    ......+.+||-||+.+       .||||+++|+++
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-------~HpnVl~LydVw   81 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-------EHPNVLRLYDVW   81 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-------cCCCeeeeeeee
Confidence            3447899999999999999999999999999999999754    23455678999999999       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      +.+.++|+|.||+. |.|++++..+  +++++.++.++++||+.|+.|||..+||||||||+|+||+   ..+.|||+||
T Consensus        82 e~~~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADF  156 (786)
T KOG0588|consen   82 ENKQHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADF  156 (786)
T ss_pred             ccCceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeecc
Confidence            99999999999997 6899988765  4799999999999999999999999999999999999995   5566999999


Q ss_pred             ccccc--cCCcceeeccCccccCchhhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          261 GSACT--EDRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       261 GlA~~--~~~~~~~~~GT~~Y~APEvl~~~~yt-~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |+|..  .+....+.||++.|.|||++.+.+|+ .++||||+|||||.||+|+.||.+++...++.++.+..-       
T Consensus       157 GMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-------  229 (786)
T KOG0588|consen  157 GMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-------  229 (786)
T ss_pred             ceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-------
Confidence            99964  34556788999999999999999997 699999999999999999999998877777666544111       


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                               .+                                           +         
T Consensus       230 -------------------------~M-------------------------------------------P---------  232 (786)
T KOG0588|consen  230 -------------------------EM-------------------------------------------P---------  232 (786)
T ss_pred             -------------------------cC-------------------------------------------C---------
Confidence                                     00                                           0         


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                        ..++.++.|||++||+.||++|+|.+||++|||+.+..-
T Consensus       233 --s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  233 --SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             --CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence              124578899999999999999999999999999998554

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-43  Score=382.66  Aligned_cols=285  Identities=30%  Similarity=0.499  Sum_probs=220.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++...  .....+.+|+.+++.+       .|+||+++++++....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-------KHANIVLLHDIIHTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-------CCCCcCeEEEEEecCC
Confidence            478999999999999999999999999999999997532  2234567899999988       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..|+||||+.++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||++..
T Consensus        77 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~  152 (303)
T cd07869          77 TLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARA  152 (303)
T ss_pred             eEEEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCccee
Confidence            999999999999998887543 4689999999999999999999999999999999999995   678899999999864


Q ss_pred             cCC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCchHHHHh
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS-EFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s-~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ...   .....++++.|+|||++.+. .++.++|||||||++|||++|..||.+.. ..+.+..+...++ .|....+..
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  231 (303)
T cd07869         153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG-TPNEDTWPG  231 (303)
T ss_pred             ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhC-CCChhhccc
Confidence            332   22345778999999998764 68899999999999999999999998754 4556667776666 333222211


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      ......+ .         .        ..+                    ..+....+.+....               .
T Consensus       232 ~~~~~~~-~---------~--------~~~--------------------~~~~~~~~~~~~~~---------------~  258 (303)
T cd07869         232 VHSLPHF-K---------P--------ERF--------------------TLYSPKNLRQAWNK---------------L  258 (303)
T ss_pred             hhhcccc-c---------c--------ccc--------------------cccCCccHHHHhhc---------------c
Confidence            1100000 0         0        000                    00011111111111               0


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..+..+.|||++||++||++|+|++|||+||||++.+
T Consensus       259 ~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             CCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            1346788999999999999999999999999999854

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-43  Score=376.00  Aligned_cols=280  Identities=33%  Similarity=0.588  Sum_probs=222.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..   ....+.+.+|+.+++.+       .|+||+++++++..++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-------KQENIVELKEAFRRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-------CCccccchhhhEecCC
Confidence            4799999999999999999999999999999999753   23345677899999988       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+|+||||+.+++.+.+.... ..+++..++.++.||+.||.|||+.+|+||||||+||+++   .++.+||+|||++..
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~  149 (287)
T cd07848          74 KLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARN  149 (287)
T ss_pred             EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCccc
Confidence            999999999987777665432 4699999999999999999999999999999999999995   667899999999975


Q ss_pred             cCC----cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDR----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~----~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...    ......+++.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+.+..+..|++.+....
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            432    2234578999999999999899999999999999999999999999998888888888888855544332111


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .+ ..+ ...                                ..+..    .....+.                ......
T Consensus       230 ~~-~~~-~~~--------------------------------~~~~~----~~~~~~~----------------~~~~~~  255 (287)
T cd07848         230 SN-PRF-HGL--------------------------------RFPAV----NHPQSLE----------------RRYLGI  255 (287)
T ss_pred             cc-chh-ccc--------------------------------ccCcc----cCcccHH----------------Hhhhcc
Confidence            00 000 000                                00000    0000000                001122


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .+.++.|||++||++||++|+|++|+|+||||
T Consensus       256 ~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         256 LSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            56789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=406.58  Aligned_cols=268  Identities=25%  Similarity=0.437  Sum_probs=229.8

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..++|+++++||+|.||+|+++..+.+++.+|||++|++    +...+..+.|..|+...+      .||.++.++.+|+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~------~HPFL~~L~~~fQ  439 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN------RHPFLVNLFSCFQ  439 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc------cCCeEeecccccc
Confidence            457999999999999999999999999999999999975    456788889999998885      6999999999999


Q ss_pred             ecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          183 CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       183 ~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .++++|+||||+.|+.  ++.....+.+++..++.++.+|+.||+|||++|||+||||.+||||+   ..|++||+|||+
T Consensus       440 T~~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD---~eGh~kiADFGl  514 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD---TEGHVKIADFGL  514 (694)
T ss_pred             cCCeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc---ccCcEEeccccc
Confidence            9999999999998754  33333345699999999999999999999999999999999999995   889999999999


Q ss_pred             ccc---cCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~---~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++.   .+....+.|||+.|+|||++.+..|+.++|.|+|||+||||+.|..||++++++++...|+..--         
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~---------  585 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV---------  585 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            975   34567789999999999999999999999999999999999999999999999998887754100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .||             
T Consensus       586 ----------------------------------------------------------------~yP-------------  588 (694)
T KOG0694|consen  586 ----------------------------------------------------------------RYP-------------  588 (694)
T ss_pred             ----------------------------------------------------------------CCC-------------
Confidence                                                                            011             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCCCCCCCCCCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFTCPYQPPPETPRV  471 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~~~~~~~~~~p~~  471 (837)
                      ..++.+++++|++||..||++|+-     +++|.+||||+...|..-....-.+|..
T Consensus       589 ~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~  645 (694)
T KOG0694|consen  589 RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFV  645 (694)
T ss_pred             CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCC
Confidence            124577899999999999999995     5899999999998875444433333333

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-42  Score=371.20  Aligned_cols=278  Identities=33%  Similarity=0.551  Sum_probs=219.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      +|++++.||+|+||+||+|+++.+++.||||+++..   ........+|+.+++.+.+.    +|+||+++++++...  
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~ni~~~~~~~~~~~~   76 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF----DHPNIVRLMDVCATSRT   76 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhc----CCCCeeeeeeeeccccC
Confidence            589999999999999999999999999999999743   22234566788888888543    799999999998753  


Q ss_pred             ---ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 ---RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ---~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                         ..+++|||++.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        77 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~dfg  153 (288)
T cd07863          77 DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADFG  153 (288)
T ss_pred             CCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccC
Confidence               468999999999999888766555699999999999999999999999999999999999995   66889999999


Q ss_pred             cccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          262 SACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       262 lA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++......  .....++..|+|||++.+..++.++|||||||++|+|++|++||.+....+.+.++....+......+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            99754322  2345678999999999988999999999999999999999999999888888888888777332222111


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                      ........                      +              .+      .....+.++.                 
T Consensus       234 ~~~~~~~~----------------------~--------------~~------~~~~~~~~~~-----------------  254 (288)
T cd07863         234 DVTLPRGA----------------------F--------------SP------RGPRPVQSVV-----------------  254 (288)
T ss_pred             cccccccc----------------------c--------------CC------CCCCchHHhC-----------------
Confidence            00000000                      0              00      0000111111                 


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ...+..+.|||.+||++||++|||++|+|+||||
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         255 PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1244678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=401.66  Aligned_cols=265  Identities=23%  Similarity=0.423  Sum_probs=224.8

Q ss_pred             eEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCc
Q 003239           95 ILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHH  173 (837)
Q Consensus        95 ~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~Hpn  173 (837)
                      ...+..+....+...+|...++||+|+.|.||.|+...+++.||||.+.... ...+-+++|+.+|+.+       .|+|
T Consensus       259 ~~~l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-------~H~N  331 (550)
T KOG0578|consen  259 LAKLKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-------HHPN  331 (550)
T ss_pred             HHHhheeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-------cchH
Confidence            3334444555666789999999999999999999999999999999997543 3456688999999998       6889


Q ss_pred             eeEEeEEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          174 IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       174 IVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                      ||.+++.|...+.+|+|||||+ |+|.|++....   ++|.+|..|++++|+||+|||.+||+|||||.+|||++   .+
T Consensus       332 iVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~  405 (550)
T KOG0578|consen  332 IVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MD  405 (550)
T ss_pred             HHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cC
Confidence            9999999999999999999998 58888887665   99999999999999999999999999999999999996   67


Q ss_pred             CeEEEEecccccccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          253 AEIKIIDFGSACTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      +.+||+|||++.+...   ...+.+||++|||||++....|++|+||||||++++||+-|++||-.++....+..|.. .
T Consensus       406 g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-n  484 (550)
T KOG0578|consen  406 GSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-N  484 (550)
T ss_pred             CcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-c
Confidence            8899999999976543   34577999999999999999999999999999999999999999987666555544432 1


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      | .|.                                                                           
T Consensus       485 g-~P~---------------------------------------------------------------------------  488 (550)
T KOG0578|consen  485 G-TPK---------------------------------------------------------------------------  488 (550)
T ss_pred             C-CCC---------------------------------------------------------------------------
Confidence            1 000                                                                           


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                            +.....++.+|+|||.+||+.|+++|+||.|+|+||||+.
T Consensus       489 ------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  489 ------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                  0111236789999999999999999999999999999954

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=371.07  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=222.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +.|++.+.||+|.|+.|+++.+..+|+.+|+|++..   .....+++.+|+.|-+.|       .|||||+|.+.+....
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-------qHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-------QHPNIVRLHDSIQEES   83 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-------CCCcEeehhhhhcccc
Confidence            789999999999999999999999999999999863   234678889999999999       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..|||||+|.| +|..-|-.+.  -++|..+-.+++||+++|.|||.++|||||+||+|+|+...+...-+||+|||+|.
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999986 6655444432  38899999999999999999999999999999999999877777889999999998


Q ss_pred             ccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      .....  ....+||+.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+...+.++|++.--..++.       
T Consensus       162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~-------  234 (355)
T KOG0033|consen  162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP-------  234 (355)
T ss_pred             EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc-------
Confidence            76532  345689999999999999999999999999999999999999999998888888887632211110       


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                                 +++.+
T Consensus       235 ---------------------------------------------------------------------------~w~~i  239 (355)
T KOG0033|consen  235 ---------------------------------------------------------------------------EWDTV  239 (355)
T ss_pred             ---------------------------------------------------------------------------ccCcC
Confidence                                                                                       11235


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +++++|||++||..||.+|+|+.|+|+|||+.+..
T Consensus       240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             CHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            67899999999999999999999999999999743

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.5e-44  Score=397.22  Aligned_cols=251  Identities=31%  Similarity=0.501  Sum_probs=220.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|.+.+.||+|+||.||+++.+.+.+.||||.+.+.   +...+...+|++|++.|       .|||||.++++|+...
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-------kHpniv~m~esfEt~~   74 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-------KHPNIVEMLESFETSA   74 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-------CCcchhhHHHhhcccc
Confidence            5788999999999999999999999999999999753   45567789999999999       5899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ++|+|.|||.|+|..++....  .++|+.++.|+.|++.||.|||+++|+|||+||.|||+.   +.+.+||||||+|+.
T Consensus        75 ~~~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   75 HLWVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARA  149 (808)
T ss_pred             eEEEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhh
Confidence            999999999999999988764  699999999999999999999999999999999999995   889999999999986


Q ss_pred             cCCcc---eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~~---~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      .....   ....||+.|||||++.+.+|+..+|+||||||+|||++|+|||...+..++++.|..    .|+.+      
T Consensus       150 m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----d~v~~------  219 (808)
T KOG0597|consen  150 MSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----DPVKP------  219 (808)
T ss_pred             cccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc----CCCCC------
Confidence            65432   345799999999999999999999999999999999999999977666555555443    11100      


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                                  ...+
T Consensus       220 ----------------------------------------------------------------------------p~~~  223 (808)
T KOG0597|consen  220 ----------------------------------------------------------------------------PSTA  223 (808)
T ss_pred             ----------------------------------------------------------------------------cccc
Confidence                                                                                        0125


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +..++.||+.+|..||.+|+|=.++|.|||+++.-
T Consensus       224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             cHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence            67899999999999999999999999999999743

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-42  Score=378.59  Aligned_cols=280  Identities=31%  Similarity=0.546  Sum_probs=220.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      +|++.++||+|+||.||+|++..+++.||||+++..   ......+.+|+.+++.+       .|+||+++++++...  
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~   73 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-------RHPDIVEIKHIMLPPSR   73 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-------CCCCEeeecceEeccCC
Confidence            699999999999999999999999999999998742   23345678899999998       689999999988654  


Q ss_pred             ---ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 ---RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ---~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                         ..+|+|||||+++|.+++...  ..+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||
T Consensus        74 ~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg  148 (338)
T cd07859          74 REFKDIYVVFELMESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFG  148 (338)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCc
Confidence               358999999999999888754  3599999999999999999999999999999999999995   67889999999


Q ss_pred             cccccCCc------ceeeccCccccCchhhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          262 SACTEDRT------VYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       262 lA~~~~~~------~~~~~GT~~Y~APEvl~~--~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      ++......      ....++|+.|+|||++.+  ..++.++|||||||++|||++|++||.+.+....+..+...+| .|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~-~~  227 (338)
T cd07859         149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG-TP  227 (338)
T ss_pred             cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC-CC
Confidence            98643211      123578999999999876  5789999999999999999999999999988888888888888 44


Q ss_pred             chHHHHhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          334 PDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       334 p~~~l~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                      +..........  ..++....                              ...         ...+.+.+         
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~------------------------------~~~---------~~~~~~~~---------  259 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMR------------------------------KKQ---------PVPFSQKF---------  259 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhc------------------------------ccC---------CCchHHhc---------
Confidence            44333322110  00000000                              000         00000000         


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                              ...++.+.+||.+||+.||++|||++|+|+||||++...
T Consensus       260 --------~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         260 --------PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             --------CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                    123467899999999999999999999999999987543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=379.02  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=214.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||+|++..+++.||||+++...    ...+.+.+|+.+++.+       .||||+++++++.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~   73 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-------SHPFIIRLFWTEHDQ   73 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-------CCCcHhhhHhhhccC
Confidence            47899999999999999999999999999999997532    2345677899999988       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+||||+. ++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~  148 (291)
T cd05612          74 RFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFA  148 (291)
T ss_pred             CeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcc
Confidence            99999999997 5888888654  3689999999999999999999999999999999999995   6788999999999


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ..........+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....-             
T Consensus       149 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------  215 (291)
T cd05612         149 KKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-------------  215 (291)
T ss_pred             hhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------------
Confidence            8766555567899999999999998999999999999999999999999988776555544432000             


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                  .+|             ...+
T Consensus       216 ------------------------------------------------------------~~~-------------~~~~  222 (291)
T cd05612         216 ------------------------------------------------------------EFP-------------RHLD  222 (291)
T ss_pred             ------------------------------------------------------------CCC-------------ccCC
Confidence                                                                        000             0123


Q ss_pred             HHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF  458 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~  458 (837)
                      ..+.+||++||+.||.+|++     ++|+++||||+...+
T Consensus       223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            56889999999999999995     999999999997665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-42  Score=382.91  Aligned_cols=289  Identities=30%  Similarity=0.543  Sum_probs=224.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||++++..+++.||||+++..   ......+.+|+.+++.+       .|+||+++++++...
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~   92 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-------NHKNIISLLNVFTPQ   92 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-------CCCCEeeeeeeeccC
Confidence            37999999999999999999999999999999999743   34456677899999888       689999999998755


Q ss_pred             c------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 R------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ~------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      +      .+|+||||++++|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+
T Consensus        93 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~  165 (359)
T cd07876          93 KSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKIL  165 (359)
T ss_pred             CCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEe
Confidence            3      5799999999988877642    488999999999999999999999999999999999995   67899999


Q ss_pred             ecccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          259 DFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       259 DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      |||++.....  ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++ .|+..
T Consensus       166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~  244 (359)
T cd07876         166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG-TPSAE  244 (359)
T ss_pred             cCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCcHH
Confidence            9999965432  22345789999999999999999999999999999999999999999998888888988888 44444


Q ss_pred             HHHhhh-cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          337 VLKEAK-NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       337 ~l~~~k-~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      ++.... ....+.....                                       .+....+.++...+....     .
T Consensus       245 ~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~~-----~  280 (359)
T cd07876         245 FMNRLQPTVRNYVENRP---------------------------------------QYPGISFEELFPDWIFPS-----E  280 (359)
T ss_pred             HHHHHHHHHHHHHhhCC---------------------------------------CCCCcchhhhcccccccc-----c
Confidence            333221 1111111110                                       000111112211111100     0


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      .......++.+.+||.+||++||++|||++|+|+||||+.
T Consensus       281 ~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         281 SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             cccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            0011124567899999999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.5e-42  Score=395.29  Aligned_cols=282  Identities=33%  Similarity=0.594  Sum_probs=220.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---  184 (837)
                      .++|++.++||+|+||+||+|++..+++.||||++.....   ...+|+.+|+.+       .|+||++++++|...   
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-------~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNL-------NHINIIFLKDYYYTECFK  134 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhc-------CCCCCcceeeeEeecccc
Confidence            4789999999999999999999999999999999875432   234699999998       689999999987542   


Q ss_pred             -----ceEEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          185 -----RHLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       185 -----~~l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                           ..+++||||+.++|.+++...  ....+++..++.++.||+.||+|||+++||||||||+|||++  .....+||
T Consensus       135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL  212 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKL  212 (440)
T ss_pred             cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceee
Confidence                 257899999999888877642  235699999999999999999999999999999999999995  23457999


Q ss_pred             EecccccccC--CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          258 IDFGSACTED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       258 ~DFGlA~~~~--~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      +|||+|+...  ......++|+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+.++++.+| .|+
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~p~  291 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG-TPT  291 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCC
Confidence            9999997543  233456789999999998765 699999999999999999999999999999999999999998 444


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                      ...+.....   .+....                                .+     ......+...   +|        
T Consensus       292 ~~~~~~~~~---~~~~~~--------------------------------~~-----~~~~~~l~~~---~p--------  320 (440)
T PTZ00036        292 EDQLKEMNP---NYADIK--------------------------------FP-----DVKPKDLKKV---FP--------  320 (440)
T ss_pred             HHHHHHhch---hhhccc--------------------------------CC-----ccCchhHHHH---hc--------
Confidence            333221100   000000                                00     0000111111   11        


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                           ...++++++||.+||++||.+|+|+.|+|+||||.+...
T Consensus       321 -----~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        321 -----KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             -----cCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                 113467899999999999999999999999999987543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-42  Score=381.70  Aligned_cols=254  Identities=24%  Similarity=0.423  Sum_probs=216.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||++++..    ...+.+.+|+.+++.+       .|+||+++++++..
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~   89 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-------SHPFIVNMMCSFQD   89 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-------CCCCCCcEEEEEEc
Confidence            378999999999999999999999999999999998532    2345678899999988       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++.+|+||||+. ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~  164 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGF  164 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccC
Confidence            999999999997 5888888754  3689999999999999999999999999999999999995   678899999999


Q ss_pred             ccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       263 A~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      +..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.+..-            
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------  232 (329)
T PTZ00263        165 AKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL------------  232 (329)
T ss_pred             ceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc------------
Confidence            98776666667899999999999999999999999999999999999999987766554443322000            


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                   .+|             ...
T Consensus       233 -------------------------------------------------------------~~p-------------~~~  238 (329)
T PTZ00263        233 -------------------------------------------------------------KFP-------------NWF  238 (329)
T ss_pred             -------------------------------------------------------------CCC-------------CCC
Confidence                                                                         000             002


Q ss_pred             HHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT  459 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~  459 (837)
                      +..+.+||++||+.||++|++     ++++|+||||++..+.
T Consensus       239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            356789999999999999997     7999999999986543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-42  Score=389.02  Aligned_cols=282  Identities=20%  Similarity=0.364  Sum_probs=218.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..+|+++++||+|+||.||+|++..+++.||||+...     ..+.+|+++|++|       .||||++++++|......
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAI-------NHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhC-------CCCCCCCEeEEEEECCee
Confidence            4689999999999999999999999999999997653     3467899999998       689999999999999999


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      |+|||++.++|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++   ..+.+||+|||+++...
T Consensus       159 ~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        159 CLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCcccccc
Confidence            999999999998888654  3689999999999999999999999999999999999995   66889999999996432


Q ss_pred             ----CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhCCCCchH
Q 003239          268 ----RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-------SEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       268 ----~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~-------s~~e~l~~I~~~lG~~Pp~~  336 (837)
                          ......+||+.|+|||++.+..++.++|||||||++|||++|..||...       .....+..+++.+|..|.++
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence                2223457999999999999989999999999999999999998776432       24566777888777443322


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      ...........+...                           .......+      .....+.                 
T Consensus       314 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~------~~~~~~~-----------------  343 (391)
T PHA03212        314 PIDAQANLDEIYIGL---------------------------AKKSSRKP------GSRPLWT-----------------  343 (391)
T ss_pred             CcchhHHHHHHHHHH---------------------------HhccCCCC------CCCCCHH-----------------
Confidence            111111100000000                           00000000      0000000                 


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                       .....+.++.+||.+||++||++||||+|+|+||||++.+
T Consensus       344 -~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        344 -NLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             -HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence             1112456789999999999999999999999999998754

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.5e-42  Score=381.16  Aligned_cols=290  Identities=30%  Similarity=0.534  Sum_probs=224.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..   ......+.+|+.+++.+       .|+||+++++++...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~ii~~~~~~~~~   95 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-------CCCCccccceeeccc
Confidence            37999999999999999999999999999999999753   33456677899999888       689999999988654


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            ..+|+||||+.++|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEE
Confidence                  35799999999998887753    388999999999999999999999999999999999995   67889999


Q ss_pred             ecccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          259 DFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       259 DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      |||++......  .....+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.++++.
T Consensus       169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             eCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99999765432  2345789999999999999999999999999999999999999999999999999999888554443


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      +.........+.....                                  .     +....++++.......     .+.
T Consensus       249 ~~~~~~~~~~~~~~~~----------------------------------~-----~~~~~~~~~~~~~~~~-----~~~  284 (364)
T cd07875         249 MKKLQPTVRTYVENRP----------------------------------K-----YAGYSFEKLFPDVLFP-----ADS  284 (364)
T ss_pred             HHhhhHHHHHHHhhCC----------------------------------C-----cCCCChHhhCcccccc-----ccc
Confidence            2221111111111110                                  0     0000111111110000     000


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ......+..++|||.+||++||.+|||++|+|+||||..
T Consensus       285 ~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         285 EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             cccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            111123467899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-42  Score=379.91  Aligned_cols=247  Identities=25%  Similarity=0.425  Sum_probs=205.4

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      +.||+|+||+||+|++..+++.||||++++.    ......+.+|+.+++.+       .|+||+++++++...+.+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~i~~~~~~~~~~~~~~lv   73 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-------RHPFLTALKYSFQTHDRLCFV   73 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-------CCCCCCCEEEEEEcCCEEEEE
Confidence            3699999999999999999999999999853    23345667889999888       689999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+.+...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||++...   
T Consensus        74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          74 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccC
Confidence            99998 5787777654  4689999999999999999999999999999999999995   6788999999998643   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.....                
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~----------------  212 (323)
T cd05571         149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------  212 (323)
T ss_pred             CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            2233456799999999999999999999999999999999999999987665444333221000                


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...++++
T Consensus       213 ---------------------------------------------------------~~p-------------~~~~~~~  222 (323)
T cd05571         213 ---------------------------------------------------------RFP-------------RTLSPEA  222 (323)
T ss_pred             ---------------------------------------------------------CCC-------------CCCCHHH
Confidence                                                                     000             0134678


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                      .+||++||+.||++|+     +++|+|+||||.+..+.
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999999999     89999999999986553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=375.35  Aligned_cols=265  Identities=24%  Similarity=0.376  Sum_probs=219.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .+.|++.+.||.|..++||+|++..+++.||||++..+  ....+.+.+|++.|..+       +||||++++..|..+.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-------~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-------DHPNIVTYHCSFVVDS   97 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-------CCCCcceEEEEEEecc
Confidence            48999999999999999999999999999999999854  34467888999999998       7999999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||.||. |+++++++..-..+++|..|..|++++++||.|||.+|.||||||+.||||+   .+|.|||+|||.+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~---~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID---SDGTVKLADFGVSA  174 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc---CCCcEEEcCceeee
Confidence            9999999998 7999999988878899999999999999999999999999999999999995   88999999999873


Q ss_pred             ccC---Cc----ceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          265 TED---RT----VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       265 ~~~---~~----~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      ...   ..    ....+||++|||||++...  .|+.|+||||||++..||.+|..||.......++..  .+-+ .||.
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn-~pp~  251 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQN-DPPT  251 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcC-CCCC
Confidence            221   11    1456899999999997654  799999999999999999999999976544333322  1112 2221


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      -.                                                                         ....+
T Consensus       252 ~~-------------------------------------------------------------------------t~~~~  258 (516)
T KOG0582|consen  252 LL-------------------------------------------------------------------------TSGLD  258 (516)
T ss_pred             cc-------------------------------------------------------------------------cccCC
Confidence            10                                                                         00011


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      .......+..|+++|..||+.||++||||.++|+|+||+....
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            1122345568999999999999999999999999999998654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.8e-43  Score=369.62  Aligned_cols=294  Identities=30%  Similarity=0.527  Sum_probs=236.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg----~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ..|++++.||+|+||.||+|..+.++    +.+|||.++.+   ......+.+|+.++++|       .|+||+.|..+|
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-------~h~nvi~Lv~Vf   96 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-------KHPNVISLVKVF   96 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-------cCCcchhHHHHH
Confidence            67999999999999999999665553    37899999854   23456788999999999       688999999999


Q ss_pred             ee-cceEEEEEeccchhHHHHHHhhc---cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc-CCCCeEE
Q 003239          182 VC-QRHLCICFELLDSNLYELIKINH---FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIK  256 (837)
Q Consensus       182 ~~-~~~l~LVmEy~~gsL~d~l~~~~---~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~IK  256 (837)
                      .. +..+++++||.+.+|+.+|+..+   .+.++...++.|+.||+.|+.|||++=|+||||||.||||..+ .+.+.||
T Consensus        97 l~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen   97 LSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             hccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence            88 78999999999999999997653   3459999999999999999999999999999999999999643 3459999


Q ss_pred             EEecccccccCCcc------eeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC---------HHH
Q 003239          257 IIDFGSACTEDRTV------YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS---------EFD  320 (837)
Q Consensus       257 L~DFGlA~~~~~~~------~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s---------~~e  320 (837)
                      |+|||+++......      ...+-|.+|+|||++++. .|+.++|||++|||+.||++-++.|.+..         ..+
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999998655433      345779999999999987 79999999999999999999999998753         467


Q ss_pred             HHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHH
Q 003239          321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEE  400 (837)
Q Consensus       321 ~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~  400 (837)
                      ++.+|++++| .|.+..|+..++...+-..+..                                  +...++....|..
T Consensus       257 Ql~rIf~vLG-~Pt~~~Wp~lkk~Pe~q~~ls~----------------------------------f~~~~~~n~sL~~  301 (438)
T KOG0666|consen  257 QLDRIFEVLG-TPTDKDWPDLKKMPEYQTLLSD----------------------------------FRRHYYDNVSLHK  301 (438)
T ss_pred             HHHHHHHHcC-CCccccchhhhhCcchHHHHHH----------------------------------hHHhhcCcchHHH
Confidence            8999999999 8877777766665444222110                                  0011233333433


Q ss_pred             HHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          401 IVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       401 il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      .....-              .-++...|||.+||.+||.+|+||+|||+|+||++.+.
T Consensus       302 ~~~~~k--------------~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l  345 (438)
T KOG0666|consen  302 YYHKHK--------------VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL  345 (438)
T ss_pred             HHHHhc--------------CCCchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence            332211              12345889999999999999999999999999999765

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.8e-42  Score=369.87  Aligned_cols=282  Identities=31%  Similarity=0.525  Sum_probs=223.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.++||+|+||.||+|++..+++.||||+++...  .....+.+|+++++.+       .|+||+++++++..++.
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~   78 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-------KHANIVTLHDIVHTDKS   78 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-------CCCCcceEEEEEeeCCe
Confidence            68999999999999999999999999999999997432  2234567899999988       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .|+||||+.++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++   ..+.+||+|||++...
T Consensus        79 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAK  154 (309)
T ss_pred             EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceec
Confidence            99999999999988876543 4589999999999999999999999999999999999995   6688999999998653


Q ss_pred             CC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          267 DR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       267 ~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..   ......++..|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .|+...+....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (309)
T cd07872         155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-TPTEETWPGIS  233 (309)
T ss_pred             CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHHhhhc
Confidence            32   22334678999999998764 689999999999999999999999999999999999999888 44443333221


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                      ....+.+ ..                                .+.     +....+   ..              .....
T Consensus       234 ~~~~~~~-~~--------------------------------~~~-----~~~~~~---~~--------------~~~~~  258 (309)
T cd07872         234 SNDEFKN-YN--------------------------------FPK-----YKPQPL---IN--------------HAPRL  258 (309)
T ss_pred             chhhhhh-hh--------------------------------cCc-----cCCCch---hh--------------hccCC
Confidence            1111000 00                                000     000000   00              01124


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++++.|||.+||++||++|+|++|+|+||||+...
T Consensus       259 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         259 DTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             CHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            56789999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.3e-42  Score=382.64  Aligned_cols=283  Identities=30%  Similarity=0.464  Sum_probs=223.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-  185 (837)
                      +|++.++||+|+||+||++++..+++.||||++...   ....+.+.+|+.+|+.+       .|+||+++++++...+ 
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~   73 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-------KHDNVLSALDILQPPHI   73 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-------CCCCcCCHhheecCCCc
Confidence            477899999999999999999999999999998743   23456788899999988       6899999999998876 


Q ss_pred             ----eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          186 ----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       186 ----~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                          .+|+||||+.++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        74 ~~~~~~~lv~e~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg  148 (372)
T cd07853          74 DPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFG  148 (372)
T ss_pred             cccceEEEEeeccccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEecccc
Confidence                89999999999988887654  3699999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCC----cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          262 SACTEDR----TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       262 lA~~~~~----~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ++.....    ......+++.|+|||++.+. .++.++||||||||+|||++|++||.+.+..+++..+.+.+|..+.+.
T Consensus       149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             ceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9975432    12334678999999999875 589999999999999999999999999999999999999999544433


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      +.........++....                               ..+         ..+..+..             
T Consensus       229 ~~~~~~~~~~~~~~~~-------------------------------~~~---------~~~~~~~~-------------  255 (372)
T cd07853         229 MRSACEGARAHILRGP-------------------------------HKP---------PSLPVLYT-------------  255 (372)
T ss_pred             HHHhhHHHHHHHHhCC-------------------------------CCC---------CchHHhcc-------------
Confidence            3222111111110000                               000         00000000             


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                       .....++++.+||.+||++||++|||++|+|+||||++.++
T Consensus       256 -~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  296 (372)
T cd07853         256 -LSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL  296 (372)
T ss_pred             -cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence             01123577899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-43  Score=341.63  Aligned_cols=279  Identities=33%  Similarity=0.563  Sum_probs=233.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .+|...++||+|+||+||++++.++++.||+|.++.+   +......++|+.+|++|+       |.|||+++++...++
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-------hknivrl~dvlhsdk   74 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-------HKNIVRLHDVLHSDK   74 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-------hcceeehhhhhccCc
Confidence            3567788999999999999999999999999999854   344567899999999994       679999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+.+|+|||+.+|..++...+ +.++.+.++.++.|+++||.|+|++++.||||||.|+||+   .++.+||+|||+++.
T Consensus        75 kltlvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglara  150 (292)
T KOG0662|consen   75 KLTLVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARA  150 (292)
T ss_pred             eeEEeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhh
Confidence            999999999999999988765 5699999999999999999999999999999999999996   789999999999987


Q ss_pred             cCCcce---eeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          266 EDRTVY---SYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       266 ~~~~~~---~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ..-...   ..+-|.+|++|.++.+. -|++.+|+||.|||+.|+.. |++.|++.+..+++.+|.+.+| .|.+..|+.
T Consensus       151 fgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg-~p~ed~wps  229 (292)
T KOG0662|consen  151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEDQWPS  229 (292)
T ss_pred             cCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC-CCccccCCc
Confidence            665543   33679999999999987 58999999999999999996 9999999999999999999999 565544433


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      ......|                       ..                ...|-....+.+++++                
T Consensus       230 ~t~lpdy-----------------------k~----------------yp~ypattswsqivp~----------------  254 (292)
T KOG0662|consen  230 MTKLPDY-----------------------KP----------------YPIYPATTSWSQIVPK----------------  254 (292)
T ss_pred             cccCCCC-----------------------cc----------------cCCccccchHHHHhhh----------------
Confidence            2221111                       10                0011122345555544                


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                       ....-+|||+++|..+|.+|++|+++|+||||.+
T Consensus       255 -lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  255 -LNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             -hcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence             2345689999999999999999999999999986

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=376.68  Aligned_cols=261  Identities=24%  Similarity=0.371  Sum_probs=213.4

Q ss_pred             eeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------------hhHHHHHHHHHHHHHhhc
Q 003239          100 LVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------------AYYQQALVEVSILTTLNK  164 (837)
Q Consensus       100 ~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------------~~~~~~~~Ei~iL~~L~~  164 (837)
                      +........+.|++++.||+|.||.|-+|++..+++.||||++.+.+               ...++..+||.||++|  
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl--  165 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL--  165 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc--
Confidence            33344455689999999999999999999999999999999996421               1235788999999999  


Q ss_pred             ccCCCCCCceeEEeEEEeec--ceEEEEEeccchhHHHHHHhhccCC-CCHHHHHHHHHhHHHHHhhhhcCCeeeccCCC
Q 003239          165 KYDREDKHHIVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKP  241 (837)
Q Consensus       165 ~~~~~~HpnIVkl~d~f~~~--~~l~LVmEy~~gsL~d~l~~~~~~~-L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKP  241 (837)
                           +|+|||+|+++..+.  +.+|||+|||...-..  .....+. +++.+++++++.++.||+|||.+|||||||||
T Consensus       166 -----~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~--w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKP  238 (576)
T KOG0585|consen  166 -----HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVK--WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKP  238 (576)
T ss_pred             -----CCcCeeEEEEeecCcccCceEEEEEeccCCccc--cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence                 689999999998875  6899999999843221  1222234 89999999999999999999999999999999


Q ss_pred             CCeeeeccCCCCeEEEEecccccccC--------CcceeeccCccccCchhhcCC---C-CCccchHHHHHHHHHHHHhC
Q 003239          242 ENILLCTSVKPAEIKIIDFGSACTED--------RTVYSYIQSRYYRSPEVLLGY---Q-YTTAIDMWSFGCIVAELFLG  309 (837)
Q Consensus       242 eNILl~~~~~~~~IKL~DFGlA~~~~--------~~~~~~~GT~~Y~APEvl~~~---~-yt~ksDIWSLG~ILyELltG  309 (837)
                      +|+||+   .++++||+|||.+....        ......+||+.|+|||.+.+.   . .+.+.||||+||+||+|+.|
T Consensus       239 sNLLl~---~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG  315 (576)
T KOG0585|consen  239 SNLLLS---SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG  315 (576)
T ss_pred             hheEEc---CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence            999996   67999999999986431        223346899999999999873   2 34799999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCC
Q 003239          310 LPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIG  389 (837)
Q Consensus       310 ~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~  389 (837)
                      +.||-+....++..+|+..--                                                           
T Consensus       316 ~~PF~~~~~~~l~~KIvn~pL-----------------------------------------------------------  336 (576)
T KOG0585|consen  316 QLPFFDDFELELFDKIVNDPL-----------------------------------------------------------  336 (576)
T ss_pred             cCCcccchHHHHHHHHhcCcc-----------------------------------------------------------
Confidence            999999888888777765110                                                           


Q ss_pred             cccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          390 KEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       390 ~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                                    .+|.           ..++.+.+.|||++||++||++|+|..++..|||.+..
T Consensus       337 --------------~fP~-----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  337 --------------EFPE-----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             --------------cCCC-----------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                          0110           01245778999999999999999999999999999875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.2e-42  Score=369.83  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=209.7

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .|++.++||+|+||+||+|.+..+++.||||++....    .....+.+|+.+++.+       .|++|+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~iv~~~~~~~~~~   73 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-------NSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-------CCCcEEEEEEEEccCC
Confidence            3788999999999999999999999999999987532    2233567899999988       6789999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+. ++|.+.+.......+++..++.++.||+.||+|||+++|+||||||+|||++   +++.+||+|||++.
T Consensus        74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~  150 (285)
T cd05631          74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAV  150 (285)
T ss_pred             eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcE
Confidence            9999999998 5777776654444699999999999999999999999999999999999995   66789999999997


Q ss_pred             ccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....  ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+...+. ..         
T Consensus       151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~---------  220 (285)
T cd05631         151 QIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-ED---------  220 (285)
T ss_pred             EcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-cc---------
Confidence            5432  23345789999999999999999999999999999999999999977654322222221110 00         


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                 .                ..+             ....
T Consensus       221 -------------------------------------------~----------------~~~-------------~~~~  228 (285)
T cd05631         221 -------------------------------------------Q----------------EEY-------------SEKF  228 (285)
T ss_pred             -------------------------------------------c----------------ccC-------------CccC
Confidence                                                       0                000             0113


Q ss_pred             HHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT  459 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~  459 (837)
                      +..+.+||++||..||++|+|     ++|+++||||.+..+.
T Consensus       229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence            467899999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=384.07  Aligned_cols=259  Identities=31%  Similarity=0.483  Sum_probs=224.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ...|++.+.||.|.||+||+|+.+.+|+.+|+|++++...    ..+.+.+|++||++|.      .|||||.++++|++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~------~hpniv~l~~~~e~  107 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS------GHPNIVQLKDAFED  107 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc------CCCCEEEEEEEEEc
Confidence            4789999999999999999999999999999999986432    4468899999999994      39999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC-CCeEEEEecc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKIIDFG  261 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~IKL~DFG  261 (837)
                      ...++||||+|. |.|++.+...   .++|..+..+++||+.+++|||+.|||||||||+|||+..... ...+|++|||
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999998 6899988776   2999999999999999999999999999999999999986543 4589999999


Q ss_pred             cccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          262 SACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       262 lA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++.....  .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+.......|.+.--         
T Consensus       185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---------  255 (382)
T KOG0032|consen  185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---------  255 (382)
T ss_pred             CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---------
Confidence            9976654  56778999999999999999999999999999999999999999999987777665543100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                     .+...+                          .
T Consensus       256 -----------------------------------------------~f~~~~--------------------------w  262 (382)
T KOG0032|consen  256 -----------------------------------------------DFTSEP--------------------------W  262 (382)
T ss_pred             -----------------------------------------------CCCCCC--------------------------c
Confidence                                                           000111                          1


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..++..+.|||++||..||.+|+||.++|+|||+++..
T Consensus       263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            22467899999999999999999999999999999854

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-42  Score=374.38  Aligned_cols=257  Identities=28%  Similarity=0.486  Sum_probs=222.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||.|.-|+||+|+...++..+|+|++.+..    ....++..|-+||+.+       +||.++.||..|+.+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-------DHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-------DHPFLPTLYASFETD  149 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-------CCCccchhhheeecc
Confidence            78999999999999999999999999999999998643    3445677789999998       899999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..|+|||||. |+|..+++++..+.+++..++.++.+|+.||+|||-.|||+||||||||||.   ++|+|.|+||.++
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS  226 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLS  226 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeecccc
Confidence            99999999998 5898888888888899999999999999999999999999999999999995   8899999999987


Q ss_pred             ccc-----------------------------------C-C-----------------------cceeeccCccccCchh
Q 003239          264 CTE-----------------------------------D-R-----------------------TVYSYIQSRYYRSPEV  284 (837)
Q Consensus       264 ~~~-----------------------------------~-~-----------------------~~~~~~GT~~Y~APEv  284 (837)
                      ...                                   . .                       .....+||-.|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            210                                   0 0                       0113478888999999


Q ss_pred             hcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCcccc
Q 003239          285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSI  364 (837)
Q Consensus       285 l~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i  364 (837)
                      +.+...+.++|.|+|||++|||+.|..||.|.+..+.+..|+.    .++.                             
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----~~l~-----------------------------  353 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----QPLK-----------------------------  353 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----CCCc-----------------------------
Confidence            9999999999999999999999999999999998888777654    1110                             


Q ss_pred             CCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCC-
Q 003239          365 GGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS-  443 (837)
Q Consensus       365 ~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT-  443 (837)
                                                              +|           .....+..++|||+++|++||++|+. 
T Consensus       354 ----------------------------------------Fp-----------~~~~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  354 ----------------------------------------FP-----------EEPEVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             ----------------------------------------CC-----------CCCcchhHHHHHHHHHhccChhhhhcc
Confidence                                                    11           01124577899999999999999998 


Q ss_pred             ---HHHHHcCccCCCCCCC
Q 003239          444 ---PFQASRHPFVTGEPFT  459 (837)
Q Consensus       444 ---a~EaL~HPff~~~~~~  459 (837)
                         |.||.+||||++..|.
T Consensus       383 ~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  383 KRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             ccchHHhhcCccccCCChh
Confidence               9999999999999885

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.4e-42  Score=378.14  Aligned_cols=291  Identities=29%  Similarity=0.515  Sum_probs=224.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||+++..   ......+.+|+.+++.+       .|+||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~   88 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIISLLNVFTPQ   88 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-------CCCchhceeeeeecc
Confidence            37999999999999999999999999999999999753   33456677899999888       689999999998754


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            ...|+||||++++|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+
T Consensus        89 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~  161 (355)
T cd07874          89 KSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKIL  161 (355)
T ss_pred             ccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEe
Confidence                  35799999999988877653    388999999999999999999999999999999999995   67889999


Q ss_pred             ecccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          259 DFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       259 DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      |||+++.....  .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+++.++...++.
T Consensus       162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             eCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99999765433  2345789999999999999999999999999999999999999999998888888888888555544


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      +.........+........                                  .     ..+.........     ..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~----------------------------------~-----~~~~~~~~~~~~-----~~~~  277 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYA----------------------------------G-----LTFPKLFPDSLF-----PADS  277 (355)
T ss_pred             HHhhcHHHHHHHhcCCccc----------------------------------c-----ccchhhcccccc-----cccc
Confidence            3322111122211111000                                  0     000000000000     0000


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ......+..+.+||.+||+.||++|||++|+|+||||...
T Consensus       278 ~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         278 EHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             ccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            1111235678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-42  Score=377.19  Aligned_cols=279  Identities=30%  Similarity=0.595  Sum_probs=222.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++++.||+|+||+||+|.+..+++.||||+++...   ...+.+.+|+.+|+.+       .|+||++++++|...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   86 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-------KHENVIGLLDVFTPA   86 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-------CCCchhhhhhhhccc
Confidence            378999999999999999999999999999999997532   2345577899999988       689999999988643


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            ...|+|||+++++|.++++.   ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~  160 (343)
T cd07878          87 TSIENFNEVYLVTNLMGADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRIL  160 (343)
T ss_pred             ccccccCcEEEEeecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEc
Confidence                  45799999998898877754   3599999999999999999999999999999999999995   67889999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||++..........++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+..+..++ ..
T Consensus       161 Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  239 (343)
T cd07878         161 DFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP-EV  239 (343)
T ss_pred             CCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH-HH
Confidence            99999877666666789999999999987 47899999999999999999999999999888888888888874433 32


Q ss_pred             HHhhhc--chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          338 LKEAKN--TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       338 l~~~k~--~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      ......  ...+....                                       ..+....+..++.            
T Consensus       240 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~------------  268 (343)
T cd07878         240 LKKISSEHARKYIQSL---------------------------------------PHMPQQDLKKIFR------------  268 (343)
T ss_pred             HHhcchhhHHHHhhcc---------------------------------------ccccchhHHHhcc------------
Confidence            221100  00000000                                       0000111111111            


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                           ..++.++|||.+||++||++|||+.|+|+||||.+.
T Consensus       269 -----~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         269 -----GANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             -----CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                 134568999999999999999999999999999874

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-43  Score=367.40  Aligned_cols=209  Identities=29%  Similarity=0.430  Sum_probs=184.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE-EEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE-YFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d-~f~~~  184 (837)
                      ..|+|+++||.|+||+||++++..+++.||.|.++-   +....+....|+.+|++|       .|||||++++ .|..+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-------~HpNIVqYy~~~f~~~   91 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-------NHPNIVQYYAHSFIED   91 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-------CCchHHHHHHHhhhcc
Confidence            679999999999999999999999999999999983   445667888999999999       6899999998 55555


Q ss_pred             ce-EEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhc--CC--eeeccCCCCCeeeeccCCCCeEE
Q 003239          185 RH-LCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKD--AG--IIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       185 ~~-l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs--~g--IVHrDLKPeNILl~~~~~~~~IK  256 (837)
                      +. ++||||+|+ |+|..+++..+  .+.++|..+++++.|++.||..||.  ..  |+||||||.||+|+   .++.+|
T Consensus        92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvvK  168 (375)
T KOG0591|consen   92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVVK  168 (375)
T ss_pred             chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCcee
Confidence            55 999999998 79998887543  4569999999999999999999998  45  99999999999996   789999


Q ss_pred             EEecccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 003239          257 IIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       257 L~DFGlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~  327 (837)
                      |+|||+++.....   ..+++||++||+||++.+.+|+.|+|||||||++|||+.-++||.+.+-.++.++|.+
T Consensus       169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q  242 (375)
T KOG0591|consen  169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ  242 (375)
T ss_pred             eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence            9999999876544   3467999999999999999999999999999999999999999999976666666554

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-41  Score=376.09  Aligned_cols=206  Identities=23%  Similarity=0.456  Sum_probs=178.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||+|+||+||+|++..+++.||||++++..    .....+.+|+.++.++       +|+||+++++.+.+.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-------~~~~iv~~~~~~~~~   73 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-------DSLWVVKMFYSFQDK   73 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-------CCCCcceEEEEEecC
Confidence            47899999999999999999999999999999998532    2334567788888887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ..+|||||||. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla  148 (363)
T cd05628          74 LNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLC  148 (363)
T ss_pred             CeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCc
Confidence            99999999997 5888888654  4699999999999999999999999999999999999995   6788999999998


Q ss_pred             cccCCc--------------------------------------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHH
Q 003239          264 CTEDRT--------------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAE  305 (837)
Q Consensus       264 ~~~~~~--------------------------------------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyE  305 (837)
                      ......                                      ....+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e  228 (363)
T cd05628         149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence            643210                                      123579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHH
Q 003239          306 LFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       306 LltG~~PF~g~s~~e~l~~I~  326 (837)
                      |++|++||.+.+..+...++.
T Consensus       229 ll~G~~Pf~~~~~~~~~~~i~  249 (363)
T cd05628         229 MLIGYPPFCSETPQETYKKVM  249 (363)
T ss_pred             HHhCCCCCCCCCHHHHHHHHH
Confidence            999999998877666655544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.1e-42  Score=378.46  Aligned_cols=253  Identities=24%  Similarity=0.406  Sum_probs=213.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCC-eEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg-~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|++.+.||+|+||.||+|++..++ ..||||++.+.    ....+.+.+|+.+++.+       .||||+++++++..
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-------NHPFCVNLYGSFKD  102 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-------CCCCCcceEEEEEe
Confidence            78999999999999999999876554 78999999743    23345677899999988       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|+||||+. ++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~  177 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGF  177 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCC
Confidence            999999999997 5888888754  3699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       263 A~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      +..........+||+.|+|||++.+..++.++||||||||+|||++|.+||.+.+.......+.+...            
T Consensus       178 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~------------  245 (340)
T PTZ00426        178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII------------  245 (340)
T ss_pred             CeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC------------
Confidence            98766656677899999999999998999999999999999999999999987766554444322100            


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                   .+|             ...
T Consensus       246 -------------------------------------------------------------~~p-------------~~~  251 (340)
T PTZ00426        246 -------------------------------------------------------------YFP-------------KFL  251 (340)
T ss_pred             -------------------------------------------------------------CCC-------------CCC
Confidence                                                                         000             012


Q ss_pred             HHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                      ++.+.+||++||+.||++|+     |++|+++||||.+..+.
T Consensus       252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            35678999999999999996     89999999999986653

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2e-41  Score=368.05  Aligned_cols=284  Identities=27%  Similarity=0.476  Sum_probs=209.0

Q ss_pred             EEEeccCCceeEEEeecc--CCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--cceEEE
Q 003239          114 KDLLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCI  189 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~~~l~L  189 (837)
                      .++||+|+||+||+|+++  .+++.||+|+++.... .....+|+.+|+++       .|+||++++++|..  ...+|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLREL-------KHPNVISLQKVFLSHADRKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhc-------CCCCCcceeeeEecCCCcEEEE
Confidence            357999999999999865  4678999999975432 34567899999998       68999999999865  457899


Q ss_pred             EEeccchhHHHHHHhhc-------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc-CCCCeEEEEecc
Q 003239          190 CFELLDSNLYELIKINH-------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFG  261 (837)
Q Consensus       190 VmEy~~gsL~d~l~~~~-------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~IKL~DFG  261 (837)
                      ||||+.++|.+++....       ...+++..++.++.||+.||+|||++|||||||||+|||+... +..+.+||+|||
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          78 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            99999999988876432       1248999999999999999999999999999999999999532 356789999999


Q ss_pred             cccccCCc------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q 003239          262 SACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLRRM  325 (837)
Q Consensus       262 lA~~~~~~------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~---------~e~l~~I  325 (837)
                      ++......      ....++|+.|+|||++.+. .++.++|||||||++|||++|++||.+...         .+++..+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            99754322      2345789999999999875 689999999999999999999999975432         4567778


Q ss_pred             HHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcC
Q 003239          326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY  405 (837)
Q Consensus       326 ~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~  405 (837)
                      ...+| .|....++.............                        .+.          ...+....+...+...
T Consensus       238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~------------------------~~~----------~~~~~~~~~~~~~~~~  282 (317)
T cd07868         238 FNVMG-FPADKDWEDIKKMPEHSTLMK------------------------DFR----------RNTYTNCSLIKYMEKH  282 (317)
T ss_pred             HHhcC-CCChHHhHHHhhccchhhhhh------------------------hhh----------ccccCcccccchHHhc
Confidence            88887 444444333221111000000                        000          0000000000000000


Q ss_pred             CCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       406 p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                                   ....+..++|||++||++||++|+|++|||+||||
T Consensus       283 -------------~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         283 -------------KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             -------------CCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         00123568999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-41  Score=374.00  Aligned_cols=247  Identities=27%  Similarity=0.453  Sum_probs=204.1

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||+||++++..+++.||||++++.    ......+.+|+.+++.+       .|+||+++++++...+.+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~~~~lv   73 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-------RHPFLTSLKYSFQTKDRLCFV   73 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCcceEEEEEcCCEEEEE
Confidence            3699999999999999999999999999853    23345677888888887       689999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC--
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--  267 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~--  267 (837)
                      |||+. ++|.+.+...  +.+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++....  
T Consensus        74 ~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~  148 (328)
T cd05593          74 MEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITD  148 (328)
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCc
Confidence            99997 4777766543  3699999999999999999999999999999999999995   67889999999986432  


Q ss_pred             -CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       268 -~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..  + .+             
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~-~~-------------  212 (328)
T cd05593         149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--E-DI-------------  212 (328)
T ss_pred             ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--C-Cc-------------
Confidence             223345789999999999998999999999999999999999999987665443332211  0 00             


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...+.++
T Consensus       213 ---------------------------------------------------------~~p-------------~~~~~~~  222 (328)
T cd05593         213 ---------------------------------------------------------KFP-------------RTLSADA  222 (328)
T ss_pred             ---------------------------------------------------------cCC-------------CCCCHHH
Confidence                                                                     000             0134678


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                      .+||++||+.||++|+     |++|+|+||||++..+.
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            8999999999999997     89999999999986553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.4e-41  Score=370.19  Aligned_cols=252  Identities=23%  Similarity=0.435  Sum_probs=208.7

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      |+++++||+|+||.||+|++..+++.||||++++..    ...+.+.+|+.++..++..    .|+||+++++++...+.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l----~hp~i~~~~~~~~~~~~   76 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE----RHPFLVNLFACFQTEDH   76 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc----CCCChhceeeEEEcCCE
Confidence            788999999999999999999999999999998532    2345667787777666433    79999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|+||||+.+ +|...+..   ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        77 ~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~  150 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKE  150 (324)
T ss_pred             EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCcc
Confidence            9999999985 67666543   3599999999999999999999999999999999999995   678999999999864


Q ss_pred             c---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 E---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      .   .......+|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.....            
T Consensus       151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------  218 (324)
T cd05589         151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------  218 (324)
T ss_pred             CCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            2   2223456789999999999999999999999999999999999999988776655444332100            


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                   .+|             ..+
T Consensus       219 -------------------------------------------------------------~~p-------------~~~  224 (324)
T cd05589         219 -------------------------------------------------------------RYP-------------RFL  224 (324)
T ss_pred             -------------------------------------------------------------CCC-------------CCC
Confidence                                                                         000             013


Q ss_pred             HHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      +..+.+||++||+.||.+||     +++++++||||++..+
T Consensus       225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence            46688999999999999999     7999999999998654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=377.35  Aligned_cols=206  Identities=24%  Similarity=0.459  Sum_probs=176.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|++..+++.||||++.+..    ...+.+.+|+++++.+       +|+||++++++|...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~iv~~~~~~~~~   73 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-------DSPWVVSLYYSFQDA   73 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-------CCCCcceEEEEEEcC
Confidence            47999999999999999999999999999999997532    2345667789888887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++||||||+. ++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla  148 (377)
T cd05629          74 QYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS  148 (377)
T ss_pred             CeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeecccc
Confidence            99999999997 6888887654  4689999999999999999999999999999999999995   6788999999998


Q ss_pred             cccCCc--------------------------------------------------ceeeccCccccCchhhcCCCCCcc
Q 003239          264 CTEDRT--------------------------------------------------VYSYIQSRYYRSPEVLLGYQYTTA  293 (837)
Q Consensus       264 ~~~~~~--------------------------------------------------~~~~~GT~~Y~APEvl~~~~yt~k  293 (837)
                      +.....                                                  ....+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  228 (377)
T cd05629         149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE  228 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence            521100                                                  012468999999999999999999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          294 IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       294 sDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      +||||||||+|||++|.+||.+.+..+.+..+.
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  261 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKII  261 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999999999998877655554443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-42  Score=358.15  Aligned_cols=254  Identities=29%  Similarity=0.475  Sum_probs=216.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      .+|.-.+.||.|..++|-+|.++.+++.+|+|++...         ....+....|+.||+++.      +||+|+++.|
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~------GHP~II~l~D   90 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM------GHPYIIDLQD   90 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc------CCCcEEEeee
Confidence            5778889999999999999999999999999999631         223455678999999995      8999999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      +|+.+..+++|+|+|. |.|.|++...-  .++|...++|++||++|++|||.++||||||||+|||++   ++-+|||+
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld---dn~~i~is  165 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD---DNMNIKIS  165 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec---cccceEEe
Confidence            9999999999999998 89999998764  599999999999999999999999999999999999995   77889999


Q ss_pred             eccccccc--CCcceeeccCccccCchhhcCC------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003239          259 DFGSACTE--DRTVYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG  330 (837)
Q Consensus       259 DFGlA~~~--~~~~~~~~GT~~Y~APEvl~~~------~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG  330 (837)
                      |||+|+..  ++.....|||+.|+|||.+...      .|+..+|+|++|||||.|+.|.+||......-++..|++  |
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--G  243 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--G  243 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--c
Confidence            99999865  4566788999999999999632      588999999999999999999999977655555554443  1


Q ss_pred             CCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCC
Q 003239          331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN  410 (837)
Q Consensus       331 ~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~  410 (837)
                                                            .|++.                     ..              
T Consensus       244 --------------------------------------kyqF~---------------------sp--------------  250 (411)
T KOG0599|consen  244 --------------------------------------KYQFR---------------------SP--------------  250 (411)
T ss_pred             --------------------------------------ccccC---------------------Cc--------------
Confidence                                                  11111                     11              


Q ss_pred             CchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       411 l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                             ++.+++...+|||.+||+.||.+|+|++|+|+||||.+
T Consensus       251 -------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  251 -------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             -------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence                   22345677899999999999999999999999999954

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=369.65  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=216.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||.||+|++..+++.||||++++..    .....+.+|+.+++.+       .|+||+++++++...
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~iv~~~~~~~~~   73 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-------KSEWLVKLLYAFQDD   73 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-------CCCCCccEEEEEEcC
Confidence            47999999999999999999999999999999998532    2345677889988888       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..||||||+. ++|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++   ..+.+||+|||++
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a  148 (333)
T cd05600          74 EYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLS  148 (333)
T ss_pred             CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCC
Confidence            99999999997 5888888654  3589999999999999999999999999999999999995   6788999999999


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..... .           
T Consensus       149 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~-----------  216 (333)
T cd05600         149 KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-T-----------  216 (333)
T ss_pred             cccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-c-----------
Confidence            8766555667899999999999999999999999999999999999999988776665554432110 0           


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                             ..                                .+.     +..                      ....++
T Consensus       217 -------~~--------------------------------~~~-----~~~----------------------~~~~~s  230 (333)
T cd05600         217 -------LQ--------------------------------RPV-----YDD----------------------PRFNLS  230 (333)
T ss_pred             -------cc--------------------------------CCC-----CCc----------------------cccccC
Confidence                   00                                000     000                      001245


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      +++.+||.+||..+|.+|+|++|+++||||++..+
T Consensus       231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            77899999999999999999999999999998654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=373.17  Aligned_cols=255  Identities=24%  Similarity=0.449  Sum_probs=210.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++..    ......+.+|+.+|+.+       +|+||++++++|...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~h~~iv~~~~~~~~~   73 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-------DNPWVVKLYYSFQDE   73 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCcceEEEEEcC
Confidence            4799999999999999999999999999999999853    23345567899999988       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. ++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~  148 (364)
T cd05599          74 NYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLC  148 (364)
T ss_pred             CeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccc
Confidence            99999999997 5888887654  3599999999999999999999999999999999999995   6789999999998


Q ss_pred             cccCCc-----------------------------------------ceeeccCccccCchhhcCCCCCccchHHHHHHH
Q 003239          264 CTEDRT-----------------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCI  302 (837)
Q Consensus       264 ~~~~~~-----------------------------------------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~I  302 (837)
                      ......                                         ....+||+.|+|||++.+..++.++|||||||+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  228 (364)
T cd05599         149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI  228 (364)
T ss_pred             eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence            532110                                         112468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHh
Q 003239          303 VAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARE  382 (837)
Q Consensus       303 LyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~  382 (837)
                      +|||++|.+||...+..+....+..... .                                                  
T Consensus       229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~-~--------------------------------------------------  257 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQETYRKIINWKE-T--------------------------------------------------  257 (364)
T ss_pred             HHHhhcCCCCCCCCCHHHHHHHHHcCCC-c--------------------------------------------------
Confidence            9999999999988776555444332100 0                                                  


Q ss_pred             hcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCC---HHHHHcCccCCCCCC
Q 003239          383 LKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQASRHPFVTGEPF  458 (837)
Q Consensus       383 ~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT---a~EaL~HPff~~~~~  458 (837)
                                +          .+|           .....++++.+||++||. ||.+|++   ++|+|+||||++..+
T Consensus       258 ----------~----------~~~-----------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         258 ----------L----------QFP-----------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             ----------c----------CCC-----------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence                      0          000           000134678999999997 9999998   999999999998665

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-41  Score=369.32  Aligned_cols=246  Identities=24%  Similarity=0.410  Sum_probs=203.8

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      +.||+|+||.||++++..+++.||+|+++..    ......+.+|+.+++.+       .||||++++++|...+.+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~i~~~~~~~~~~~~~~lv   73 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-------RHPFLTALKYAFQTHDRLCFV   73 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-------CCCCCcceeeEEecCCEEEEE
Confidence            3699999999999999999999999999853    23344567788888888       689999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC--
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--  267 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~--  267 (837)
                      |||+. ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++....  
T Consensus        74 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          74 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCC
Confidence            99998 5777766544  3689999999999999999999999999999999999995   67889999999986432  


Q ss_pred             -CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       268 -~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.....                
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~----------------  212 (323)
T cd05595         149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------  212 (323)
T ss_pred             CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence             222345789999999999999999999999999999999999999987665544433321000                


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ..+++.+
T Consensus       213 ---------------------------------------------------------~~p-------------~~~~~~~  222 (323)
T cd05595         213 ---------------------------------------------------------RFP-------------RTLSPEA  222 (323)
T ss_pred             ---------------------------------------------------------CCC-------------CCCCHHH
Confidence                                                                     000             0134678


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      .+||++||+.||++|+     ++.++|+||||.+..+
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            8999999999999998     9999999999998664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.7e-41  Score=366.20  Aligned_cols=252  Identities=25%  Similarity=0.427  Sum_probs=209.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +|++++.||+|+||.||+|++..+++.||||++++.    ....+.+..|+.++..+.      .|++|+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG------KPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC------CCCceeeeEEEEEcCC
Confidence            488999999999999999999999999999999853    233456777888888774      3567999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+. ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~  149 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcce
Confidence            9999999997 5888777654  3589999999999999999999999999999999999995   66889999999986


Q ss_pred             cc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ..   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.+...           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----------  218 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----------  218 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            42   2233456799999999999999999999999999999999999999988776655544432100           


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                    .+|             ..
T Consensus       219 --------------------------------------------------------------~~~-------------~~  223 (324)
T cd05587         219 --------------------------------------------------------------SYP-------------KS  223 (324)
T ss_pred             --------------------------------------------------------------CCC-------------CC
Confidence                                                                          000             01


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCH-----HHHHcCccCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPF  458 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa-----~EaL~HPff~~~~~  458 (837)
                      .+..+.+||++||..||.+|+++     +++++||||....+
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            34678899999999999999986     89999999998654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.4e-41  Score=375.26  Aligned_cols=204  Identities=25%  Similarity=0.447  Sum_probs=175.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +|+++++||+|+||+||+|++..+++.||||++.+..    ...+.+.+|+.+++++       .|+||++++++|...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-------~h~~iv~~~~~~~~~~   74 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-------DNEWVVRLYYSFQDKD   74 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-------CCCcCCeEEEEEEeCC
Confidence            6899999999999999999999999999999997532    3345677899999888       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|||||||. |+|.+++...  +.+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~  149 (382)
T cd05625          75 NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCT  149 (382)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCc
Confidence            9999999997 5888887654  3589999999999999999999999999999999999995   67899999999974


Q ss_pred             ccCC--------------------------------------------------cceeeccCccccCchhhcCCCCCccc
Q 003239          265 TEDR--------------------------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAI  294 (837)
Q Consensus       265 ~~~~--------------------------------------------------~~~~~~GT~~Y~APEvl~~~~yt~ks  294 (837)
                      ....                                                  .....+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (382)
T cd05625         150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  229 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence            2110                                                  01124689999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          295 DMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       295 DIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ||||||||+|||++|++||.+.+..+....+
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i  260 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKV  260 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999887665544433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=372.49  Aligned_cols=256  Identities=29%  Similarity=0.458  Sum_probs=206.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--  185 (837)
                      .+|...+.||+|+||.||++.+.++++..|||.+.... ...+...+|+.+|.+|       .|||||++++......  
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-------~~p~IV~~~G~~~~~~~~   89 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-------NHPNIVQYYGSSSSREND   89 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-------CCCCEEeeCCccccccCe
Confidence            56888999999999999999999999999999998542 2256688999999999       5899999999755544  


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC-CCeEEEEecccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKIIDFGSA  263 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~IKL~DFGlA  263 (837)
                      .++|+|||+. |+|.++++.... .|+|..++.+++||++||+|||++|||||||||+|||++   . ++.+||+|||++
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLA  165 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCccc
Confidence            6999999998 699999988764 799999999999999999999999999999999999996   4 689999999999


Q ss_pred             cccC------CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          264 CTED------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       264 ~~~~------~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ....      .......||+.|||||++... ....++|||||||++.||+||++||...  .+....+.....      
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~------  237 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGR------  237 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhc------
Confidence            7554      223457899999999999963 3345999999999999999999999653  111111111110      


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                            .                                       .                 ..+.+|          
T Consensus       238 ------~---------------------------------------~-----------------~~P~ip----------  245 (313)
T KOG0198|consen  238 ------E---------------------------------------D-----------------SLPEIP----------  245 (313)
T ss_pred             ------c---------------------------------------C-----------------CCCCCC----------
Confidence                  0                                       0                 000011          


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                         ..+++++.|||.+||..||++||||+++|+|||.++...
T Consensus       246 ---~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  246 ---DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ---cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence               124578899999999999999999999999999988543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=372.21  Aligned_cols=256  Identities=25%  Similarity=0.465  Sum_probs=213.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||+|++..+++.||||+++...    .....+..|+.++..+       .|+||+++++++.++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~   73 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-------DSPWIVKLYYSFQDE   73 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-------CCCCccchhhheecC
Confidence            47999999999999999999999999999999998532    3345677888888888       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++|+||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~  148 (350)
T cd05573          74 EHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLC  148 (350)
T ss_pred             CeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCC
Confidence            99999999997 5888888765  4699999999999999999999999999999999999995   6788999999998


Q ss_pred             cccCCc--------------------------------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCC
Q 003239          264 CTEDRT--------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       264 ~~~~~~--------------------------------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      ......                                .....||+.|+|||++.+..++.++||||||||+|||++|+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence            654322                                234578999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcc
Q 003239          312 LFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE  391 (837)
Q Consensus       312 PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~  391 (837)
                      ||...+..+...++.....                   ..                                        
T Consensus       229 Pf~~~~~~~~~~~i~~~~~-------------------~~----------------------------------------  249 (350)
T cd05573         229 PFYSDTLQETYNKIINWKE-------------------SL----------------------------------------  249 (350)
T ss_pred             CCCCCCHHHHHHHHhccCC-------------------cc----------------------------------------
Confidence            9988775554444432110                   00                                        


Q ss_pred             cccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCC-HHHHHcCccCCCCCCC
Q 003239          392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS-PFQASRHPFVTGEPFT  459 (837)
Q Consensus       392 ~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT-a~EaL~HPff~~~~~~  459 (837)
                                  .+|.           ...+++.+.+||.+||. ||.+|++ ++|+|+||||++..+.
T Consensus       250 ------------~~p~-----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         250 ------------RFPP-----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             ------------cCCC-----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence                        0000           00134678999999998 9999999 9999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.9e-41  Score=374.47  Aligned_cols=204  Identities=24%  Similarity=0.434  Sum_probs=175.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .|++++.||+|+||+||+|++..+++.||||++++..    .....+.+|+.+++.+       .|+||+++++++.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-------~h~~iv~l~~~~~~~~   74 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-------DNEWVVKLYYSFQDKD   74 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-------CCCCeeeeEEEEecCC
Confidence            5899999999999999999999999999999997532    3345677899999888       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ++|||||||. ++|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++   ..+.+||+|||++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~  149 (381)
T cd05626          75 NLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCT  149 (381)
T ss_pred             EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCc
Confidence            9999999997 5888887654  3589999999999999999999999999999999999995   67899999999874


Q ss_pred             ccCC--------------------------------------------------cceeeccCccccCchhhcCCCCCccc
Q 003239          265 TEDR--------------------------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAI  294 (837)
Q Consensus       265 ~~~~--------------------------------------------------~~~~~~GT~~Y~APEvl~~~~yt~ks  294 (837)
                      ....                                                  .....+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (381)
T cd05626         150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC  229 (381)
T ss_pred             ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence            2110                                                  01234789999999999998999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          295 DMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       295 DIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ||||||||+|||++|.+||...+..+....+
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  260 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKV  260 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHH
Confidence            9999999999999999999877655544433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-41  Score=366.14  Aligned_cols=244  Identities=27%  Similarity=0.505  Sum_probs=203.2

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||+|+||+||+|++..+++.||||++++.    ......+.+|+.+|+.+       +|+||+++++++...+.+|+|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~~lv~e   73 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-------NCPFIVPLKFSFQSPEKLYLVLA   73 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCcEeceeeEEecCCeEEEEEc
Confidence            79999999999999999999999999753    23445677899999888       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC---C
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---R  268 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~---~  268 (837)
                      |+. ++|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||++....   .
T Consensus        74 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~  148 (312)
T cd05585          74 FINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDD  148 (312)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCC
Confidence            997 5888887654  3599999999999999999999999999999999999995   67889999999986432   2


Q ss_pred             cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhh
Q 003239          269 TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF  348 (837)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f  348 (837)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+...    +.              
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~----~~--------------  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE----PL--------------  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----CC--------------
Confidence            233457899999999999999999999999999999999999999876655443332210    00              


Q ss_pred             hhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHH
Q 003239          349 KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVD  428 (837)
Q Consensus       349 ~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~D  428 (837)
                                                                             .+|             ...++.+.+
T Consensus       211 -------------------------------------------------------~~~-------------~~~~~~~~~  222 (312)
T cd05585         211 -------------------------------------------------------RFP-------------DGFDRDAKD  222 (312)
T ss_pred             -------------------------------------------------------CCC-------------CcCCHHHHH
Confidence                                                                   000             013467899


Q ss_pred             HHHHhcccCcCCCC---CHHHHHcCccCCCCCC
Q 003239          429 FLKGLVEFDPAKRW---SPFQASRHPFVTGEPF  458 (837)
Q Consensus       429 LL~kmL~~DP~kRp---Ta~EaL~HPff~~~~~  458 (837)
                      ||.+||..||++|+   ++.|+|+||||++..+
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence            99999999999997   5899999999998654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.5e-41  Score=369.23  Aligned_cols=257  Identities=22%  Similarity=0.386  Sum_probs=210.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||+|++..+++.||||+++....    ..+.+.+|+.+++.+       .|+||+++++++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-------~~~~i~~~~~~~~~~   73 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-------NSPWIPQLQYAFQDK   73 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCcceeeEEecC
Confidence            469999999999999999999999999999999985422    345567788888776       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++   ..+.+||+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a  149 (330)
T cd05601          74 DNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSA  149 (330)
T ss_pred             CeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCC
Confidence            99999999997 58888887653 4699999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCCc----ceeeccCccccCchhhc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          264 CTEDRT----VYSYIQSRYYRSPEVLL------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       264 ~~~~~~----~~~~~GT~~Y~APEvl~------~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      ......    .....+|+.|+|||++.      ...++.++||||||||+|||++|..||...+....+..+.....   
T Consensus       150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---  226 (330)
T cd05601         150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR---  226 (330)
T ss_pred             eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC---
Confidence            754322    12346899999999997      45688999999999999999999999987766555444332100   


Q ss_pred             chHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       334 p~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                                       .                                                   ..+|       
T Consensus       227 -----------------~---------------------------------------------------~~~~-------  231 (330)
T cd05601         227 -----------------F---------------------------------------------------LKFP-------  231 (330)
T ss_pred             -----------------c---------------------------------------------------cCCC-------
Confidence                             0                                                   0000       


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                          .....+..+.+||++||. ||++|+|++++++||||+...+.
T Consensus       232 ----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         232 ----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             ----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                001134678999999998 99999999999999999986553

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-40  Score=358.98  Aligned_cols=282  Identities=32%  Similarity=0.537  Sum_probs=221.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|+++++||+|+||.||+|++..+++.||+|.++..  ......+.+|+.+++.+       .|+||+++++++...+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~nI~~~~~~~~~~~   77 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-------KHANIVTLHDIIHTEK   77 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-------CCCCcceEEEEEecCC
Confidence            37899999999999999999999999999999999743  22334567899999998       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..|+||||+.++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+|||++   .++.+||+|||++..
T Consensus        78 ~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~  153 (301)
T cd07873          78 SLTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARA  153 (301)
T ss_pred             eEEEEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhc
Confidence            999999999999988876543 4589999999999999999999999999999999999995   667899999999865


Q ss_pred             cCC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...   ......++..|+|||++.+. .++.++|||||||++|||++|++||...+..+.+..+.+.++ .+....+...
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (301)
T cd07873         154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-TPTEETWPGI  232 (301)
T ss_pred             cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCChhhchhh
Confidence            332   22234568899999998764 588899999999999999999999999988888888888877 3333322211


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+ ....                                .+.     +....+..                 ....
T Consensus       233 ~~~~~~-~~~~--------------------------------~~~-----~~~~~~~~-----------------~~~~  257 (301)
T cd07873         233 LSNEEF-KSYN--------------------------------YPK-----YRADCLHN-----------------HAPR  257 (301)
T ss_pred             hccccc-cccc--------------------------------cCc-----cccccHHh-----------------hcCC
Confidence            000000 0000                                000     00000000                 1112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .++.+.|||.+||++||.+|||++|+|+||||+..
T Consensus       258 ~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         258 LDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            45678999999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-41  Score=369.78  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      +.||+|+||+||+|++..+++.||+|++++..    .......+|+++++.+       .|+||+++++++...+.+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-------~hp~i~~~~~~~~~~~~~~lv   73 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-------RHPFLTALKYSFQTHDRLCFV   73 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCCceEEEEEcCCEEEEE
Confidence            36999999999999999999999999998532    2344566788888777       689999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccccccc--
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~--  266 (837)
                      |||+. ++|.+.+...  +.+++..++.++.||+.||+|||+ +||+||||||+|||++   .++.+||+|||++...  
T Consensus        74 ~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          74 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCC
Confidence            99998 4777766543  369999999999999999999997 7999999999999995   6788999999998642  


Q ss_pred             -CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcch
Q 003239          267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS  345 (837)
Q Consensus       267 -~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~  345 (837)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....-               
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~---------------  213 (325)
T cd05594         149 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------------  213 (325)
T ss_pred             CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence             2223345799999999999999999999999999999999999999987665444333211000               


Q ss_pred             hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHH
Q 003239          346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA  425 (837)
Q Consensus       346 ~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~  425 (837)
                                                                                .+|             ...+++
T Consensus       214 ----------------------------------------------------------~~p-------------~~~~~~  222 (325)
T cd05594         214 ----------------------------------------------------------RFP-------------RTLSPE  222 (325)
T ss_pred             ----------------------------------------------------------CCC-------------CCCCHH
Confidence                                                                      000             013467


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          426 LVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       426 l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                      +.+||++||+.||++|+     +++++|+||||++..+.
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            88999999999999997     99999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.3e-41  Score=374.25  Aligned_cols=204  Identities=24%  Similarity=0.430  Sum_probs=175.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .+|+++++||+|+||+||+|++..+++.||||++.+..    .....+.+|+++|+.+       .|+||+++++.|..+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~h~~iv~~~~~~~~~   73 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-------DNEWVVKLYYSFQDK   73 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-------CCCCcceEEEEEEcC
Confidence            36999999999999999999999999999999997532    2345677899999988       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+|
T Consensus        74 ~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a  148 (376)
T cd05598          74 DNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLC  148 (376)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCC
Confidence            99999999997 5888888664  3589999999999999999999999999999999999995   6788999999997


Q ss_pred             cccCC----------------------------------------------cceeeccCccccCchhhcCCCCCccchHH
Q 003239          264 CTEDR----------------------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMW  297 (837)
Q Consensus       264 ~~~~~----------------------------------------------~~~~~~GT~~Y~APEvl~~~~yt~ksDIW  297 (837)
                      .....                                              .....+||+.|+|||++.+..++.++|||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  228 (376)
T cd05598         149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  228 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence            42100                                              01134789999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003239          298 SFGCIVAELFLGLPLFPGASEFDLLRR  324 (837)
Q Consensus       298 SLG~ILyELltG~~PF~g~s~~e~l~~  324 (837)
                      |||||+|||++|+.||.+.+..+....
T Consensus       229 SlGvilyell~G~~Pf~~~~~~~~~~~  255 (376)
T cd05598         229 SVGVILYEMLVGQPPFLADTPAETQLK  255 (376)
T ss_pred             eccceeeehhhCCCCCCCCCHHHHHHH
Confidence            999999999999999988776554443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-41  Score=368.27  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=205.2

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||+||+|+++.+++.||||++++.    ....+.+..|+.++..+.      .|+||+++++++...+.+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR------NHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc------CCCchhceeeEEEcCCEEEEE
Confidence            3699999999999999999999999999853    233455667888877663      589999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+.+...  ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          75 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             EcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcC
Confidence            99998 5888777654  3699999999999999999999999999999999999995   6788999999998643   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------------  213 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------  213 (320)
T ss_pred             CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence            2223445789999999999998999999999999999999999999988776655544432000                


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...+.++
T Consensus       214 ---------------------------------------------------------~~~-------------~~~~~~~  223 (320)
T cd05590         214 ---------------------------------------------------------VYP-------------TWLSQDA  223 (320)
T ss_pred             ---------------------------------------------------------CCC-------------CCCCHHH
Confidence                                                                     000             0134678


Q ss_pred             HHHHHHhcccCcCCCCCH------HHHHcCccCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRWSP------FQASRHPFVTGEPF  458 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRpTa------~EaL~HPff~~~~~  458 (837)
                      .+||++||+.||++|+++      +++++||||+...+
T Consensus       224 ~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         224 VDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             HHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999999999999998      99999999998655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.4e-41  Score=365.05  Aligned_cols=247  Identities=24%  Similarity=0.403  Sum_probs=205.3

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||+||+|++..+++.||||++++.    ....+.+..|++++..+.      .|+||++++++|...+.+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~------~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------KHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc------CCCCccceeeEEEcCCeEEEE
Confidence            3699999999999999999999999999853    233445667888877653      689999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+.+...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          75 MEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccC
Confidence            99998 5787777654  3689999999999999999999999999999999999995   6789999999998643   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+....-                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~----------------  213 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV----------------  213 (321)
T ss_pred             CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            2223345789999999999998999999999999999999999999988877666554432000                


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...+.++
T Consensus       214 ---------------------------------------------------------~~p-------------~~~~~~~  223 (321)
T cd05591         214 ---------------------------------------------------------LYP-------------VWLSKEA  223 (321)
T ss_pred             ---------------------------------------------------------CCC-------------CCCCHHH
Confidence                                                                     000             0123568


Q ss_pred             HHHHHHhcccCcCCCC-------CHHHHHcCccCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRW-------SPFQASRHPFVTGEPF  458 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRp-------Ta~EaL~HPff~~~~~  458 (837)
                      .+||++||+.||++|+       +++++++||||....+
T Consensus       224 ~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            8999999999999999       9999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.5e-40  Score=351.28  Aligned_cols=277  Identities=31%  Similarity=0.512  Sum_probs=217.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++++.||+|+||.||+|++..+++.||||+++..   ....+.+.+|+.+++.+       .|+||+++++++..++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   73 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-------QHPNIVCLQDVLMQESR   73 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-------CCCCEeeeEEEEeeCCe
Confidence            588999999999999999999999999999998743   22345677899999998       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhcc-CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDSNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~-~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|+||||+.++|.+++..... ..+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|||++..
T Consensus        74 ~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~  150 (285)
T cd07861          74 LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARA  150 (285)
T ss_pred             EEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceee
Confidence            999999999988888765432 4689999999999999999999999999999999999995   678899999999864


Q ss_pred             cCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   .....++..|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+.+.++ .+.+..+...
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  229 (285)
T cd07861         151 FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG-TPTEDVWPGV  229 (285)
T ss_pred             cCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhcc
Confidence            4322   1223568889999998765 578999999999999999999999999888888887777776 3333322211


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+....                                  +.     +....+...                 ...
T Consensus       230 ~~~~~~~~~~----------------------------------~~-----~~~~~~~~~-----------------~~~  253 (285)
T cd07861         230 TSLPDYKNTF----------------------------------PK-----WKKGSLRSA-----------------VKN  253 (285)
T ss_pred             hhhHHHHhhc----------------------------------cc-----cCcchhHHh-----------------cCC
Confidence            1111100000                                  00     000000010                 112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .++++.+||++||+.||++|||++|+|+||||
T Consensus       254 ~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         254 LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            45788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-40  Score=371.67  Aligned_cols=256  Identities=22%  Similarity=0.379  Sum_probs=210.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||+|++..+++.||||++++..    .....+.+|+.+++.+       +|+||+++++++...
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-------~h~~iv~~~~~~~~~  115 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-------NSEWIVQLHYAFQDD  115 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-------CCCCcceEEEEEecC
Confidence            78999999999999999999999999999999997532    2334466788888887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+||||+. ++|.+++...   .+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~  189 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTC  189 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccce
Confidence            99999999997 5888877643   489999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCCc----ceeeccCccccCchhhcCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          264 CTEDRT----VYSYIQSRYYRSPEVLLGY----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       264 ~~~~~~----~~~~~GT~~Y~APEvl~~~----~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      ......    ....+||+.|+|||++.+.    .++.++|||||||++|||++|++||.+.+....+..+.....   . 
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~-  265 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---S-  265 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---c-
Confidence            754322    2345789999999999754    478999999999999999999999988776555444432100   0 


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                                                                             .            .+|         
T Consensus       266 -------------------------------------------------------~------------~~~---------  269 (370)
T cd05596         266 -------------------------------------------------------L------------TFP---------  269 (370)
T ss_pred             -------------------------------------------------------C------------CCC---------
Confidence                                                                   0            000         


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCC--CCCHHHHHcCccCCCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAK--RWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~k--RpTa~EaL~HPff~~~~~~  459 (837)
                        .....+.++.+||++||+.+|++  |+|++|+|+||||++..+.
T Consensus       270 --~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         270 --DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             --CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence              00113577899999999999998  9999999999999986653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=369.74  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=226.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ..-|.+.+.||+|-|.+|-+|++..||+.||||+|.+.   ......+..|+..|+.+       .|||||+||++...+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-------QHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-------QHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-------cCcCeeeeeehhccc
Confidence            36788999999999999999999999999999999864   34456788999999999       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ..+|||+|+-+ |+|+|+|.+.. .++.|+.++++++||+.||.|||+..+|||||||+||++-  .+-+.|||+|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccc
Confidence            99999999987 59999998876 5799999999999999999999999999999999999886  56789999999998


Q ss_pred             c--ccCCcceeeccCccccCchhhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 C--TEDRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~--~~~~~~~~~~GT~~Y~APEvl~~~~yt-~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      .  ..++...+.||+..|-|||++++..|+ +++||||||||||-|++|++||...++.+.+..|+.+.-..        
T Consensus       167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv--------  238 (864)
T KOG4717|consen  167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV--------  238 (864)
T ss_pred             ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC--------
Confidence            5  346677889999999999999999998 68999999999999999999999999999888876632200        


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                                                    ..
T Consensus       239 ------------------------------------------------------------------------------Ps  240 (864)
T KOG4717|consen  239 ------------------------------------------------------------------------------PS  240 (864)
T ss_pred             ------------------------------------------------------------------------------ch
Confidence                                                                                          12


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..+.+++|||..||+.||++|.|.+||..|+|++...
T Consensus       241 hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  241 HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            3567899999999999999999999999999999754

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=365.62  Aligned_cols=196  Identities=23%  Similarity=0.410  Sum_probs=167.8

Q ss_pred             ceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      +|+++++||+|+||+||+|++.   .+++.||+|++++.     ....+.+..|+.+++.++      +|+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR------QSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc------CCCCcccEEEEE
Confidence            4889999999999999998763   57899999999753     223455678899998885      489999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      ..++.+++||||+. ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Df  149 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDF  149 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeC
Confidence            99999999999998 5888887654  3599999999999999999999999999999999999995   6678999999


Q ss_pred             ccccccC----CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          261 GSACTED----RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       261 GlA~~~~----~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      |+++...    ......+||+.|+|||++.+. .++.++||||||||+|||++|..||...
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            9986432    122345789999999999875 4889999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-40  Score=370.49  Aligned_cols=205  Identities=24%  Similarity=0.416  Sum_probs=176.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||.||++++..+++.||+|++++.    ....+.+.+|+.+++.+       .||||+++++++..+
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-------~hp~iv~~~~~~~~~  115 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-------NSPWVVQLFCAFQDD  115 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence            7899999999999999999999999999999999752    22334566788888887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+|||||. ++|.+++...   .+++..++.++.||+.||+|||+++|+||||||+|||++   ..+.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a  189 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTC  189 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccc
Confidence            99999999997 5888888653   489999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCCc----ceeeccCccccCchhhcCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          264 CTEDRT----VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       264 ~~~~~~----~~~~~GT~~Y~APEvl~~~~----yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      ......    ....+||+.|+|||++.+..    ++.++|||||||++|||++|++||.+.+....+.++.
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~  260 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            754322    23457999999999997643    7889999999999999999999998877655554443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-40  Score=364.42  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=209.4

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +|++++.||+|+||+||+|++..+++.||||++++..    ...+....|..++..+.      .|++|+++++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG------KPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc------CCCeEeeEEEEEecCC
Confidence            4889999999999999999999999999999998542    22344566777776653      5789999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+||||||+. ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~  149 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCce
Confidence            9999999997 5888777654  3589999999999999999999999999999999999995   67889999999986


Q ss_pred             ccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.+...           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----------  218 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----------  218 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            432   223356789999999999999999999999999999999999999988776665555433100           


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                    .+|             ..
T Consensus       219 --------------------------------------------------------------~~p-------------~~  223 (323)
T cd05616         219 --------------------------------------------------------------AYP-------------KS  223 (323)
T ss_pred             --------------------------------------------------------------CCC-------------Cc
Confidence                                                                          000             01


Q ss_pred             hHHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT  459 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~  459 (837)
                      .+.++.+||.+||+.||.+|++     .+++++||||+...+.
T Consensus       224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            3467889999999999999998     4899999999986653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-40  Score=356.91  Aligned_cols=289  Identities=31%  Similarity=0.487  Sum_probs=225.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.++||+|+||.||+|++..+++.||+|+++...   .......+|+.+++++       .|+||+++++++...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~   78 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-------RHPNIVELKEVVVGK   78 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-------CCCCCcceEEEEecC
Confidence            478999999999999999999999999999999997432   2233456799999998       688999999999765


Q ss_pred             --ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          185 --RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       185 --~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                        +.+++||||+.++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||+++   ..+.+||+|||+
T Consensus        79 ~~~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~  154 (309)
T cd07845          79 HLDSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGL  154 (309)
T ss_pred             CCCeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccce
Confidence              5689999999998888887643 4699999999999999999999999999999999999995   678899999999


Q ss_pred             ccccCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          263 ACTEDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       263 A~~~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +......   .....++..|+|||++.+. .++.++|||||||++|||++|.+||...+..+.+..+...++ .++..++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~  233 (309)
T cd07845         155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLG-TPNESIW  233 (309)
T ss_pred             eeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCChhhc
Confidence            9754322   2223457789999998764 688999999999999999999999999999999999998888 4433333


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                      ...+.....                    ..+.+                ....+  ..+...                 
T Consensus       234 ~~~~~~~~~--------------------~~~~~----------------~~~~~--~~~~~~-----------------  258 (309)
T cd07845         234 PGFSDLPLV--------------------GKFTL----------------PKQPY--NNLKHK-----------------  258 (309)
T ss_pred             hhhhccccc--------------------ccccc----------------cCCCC--CchHHh-----------------
Confidence            221110000                    00000                00000  000000                 


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQ  463 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~  463 (837)
                      ....++.+.|||.+||++||++|||++|+|+||||++.+..+...
T Consensus       259 ~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~  303 (309)
T cd07845         259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPE  303 (309)
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCC
Confidence            011356789999999999999999999999999999988776543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-40  Score=374.57  Aligned_cols=282  Identities=24%  Similarity=0.413  Sum_probs=215.4

Q ss_pred             CceEEEEEeccCCceeEEEeecc--CCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .+|++++.||+|+||.||+|...  .+++.||||++....    ...+|+++|+.+       .|+||++++++|.....
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l-------~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTI-------SHRAIINLIHAYRWKST  160 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhc-------CCCCccceeeeEeeCCE
Confidence            68999999999999999999643  456889999987542    345799999998       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .|+|||++.++|.+++...  ..+++.+++.++.||+.||.|||++|||||||||+|||++   ..+.+||+|||+++..
T Consensus       161 ~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        161 VCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCcccccc
Confidence            9999999999999888433  4699999999999999999999999999999999999995   6788999999999654


Q ss_pred             CCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCchHHH
Q 003239          267 DRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS---EFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       267 ~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s---~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ....+..+++.++..+.+...
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            322     224578999999999999999999999999999999999999997653   355666777766633322111


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                      .......+.+...                           ..  ...+    . +   .+.+++.               
T Consensus       316 ~~~~~~~~~~~~~---------------------------~~--~~~~----~-~---~~~~~~~---------------  343 (392)
T PHA03207        316 NGSTNLCKHFKQY---------------------------AI--VLRP----P-Y---TIPPVIR---------------  343 (392)
T ss_pred             ccchhHHHHHHhh---------------------------cc--cccC----C-c---cccchhh---------------
Confidence            0000000000000                           00  0000    0 0   0011110               


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ....+.++.+||++||++||++|||+.|+|+||||++.+.
T Consensus       344 ~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        344 KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            1123467889999999999999999999999999998664

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6e-40  Score=355.62  Aligned_cols=283  Identities=28%  Similarity=0.470  Sum_probs=206.4

Q ss_pred             EEeccCCceeEEEeecc--CCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--cceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~~~l~LV  190 (837)
                      .+||+|+||+||+|++.  .+++.||+|.++.... ...+.+|+++|+++       .|+||+++++++..  +..+|+|
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLREL-------KHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhC-------CCCCeeeEEEEEeccCCCeEEEE
Confidence            57999999999999854  3668899999975432 34567899999998       68999999999864  4678999


Q ss_pred             EeccchhHHHHHHhhc-------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc-CCCCeEEEEeccc
Q 003239          191 FELLDSNLYELIKINH-------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGS  262 (837)
Q Consensus       191 mEy~~gsL~d~l~~~~-------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~IKL~DFGl  262 (837)
                      |||+.++|.+++....       ...+++..++.++.||+.||.|||+++|+||||||+|||+..+ ...+.+||+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            9999999988876431       1248899999999999999999999999999999999999532 3567899999999


Q ss_pred             ccccCCc------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHH
Q 003239          263 ACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLRRMI  326 (837)
Q Consensus       263 A~~~~~~------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~---------~e~l~~I~  326 (837)
                      ++.....      .....+|..|+|||++.+. .++.++|||||||++|||++|++||....+         .+.+.++.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            9754322      2234678999999999874 589999999999999999999999975432         34566677


Q ss_pred             HHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCC
Q 003239          327 RILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP  406 (837)
Q Consensus       327 ~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p  406 (837)
                      ..++ .+....++..+....+.......                                  ....+....+...+... 
T Consensus       239 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~-  282 (317)
T cd07867         239 SVMG-FPADKDWEDIRKMPEYPTLQKDF----------------------------------RRTTYANSSLIKYMEKH-  282 (317)
T ss_pred             HhcC-CCChhhhhhhhhcccchhhhhhh----------------------------------cccccCCchhhhhhhcc-
Confidence            7777 33333333222221111100000                                  00000000111111100 


Q ss_pred             CCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       407 ~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                                  ....+..+++||.+||+.||++|||++|+|+||||
T Consensus       283 ------------~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         283 ------------KVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ------------cCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                        01134568999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.1e-40  Score=360.79  Aligned_cols=247  Identities=29%  Similarity=0.491  Sum_probs=201.1

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||+||+|++..+++.||||+++...    ...+....|..++..+.      .|+||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW------EHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc------CCCCccceeeEEEcCCEEEEE
Confidence            36999999999999999999999999998532    23344556666665442      699999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC--
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--  267 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~--  267 (837)
                      |||+. ++|.+.+...  ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++....  
T Consensus        75 ~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          75 MEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCC
Confidence            99997 5787777654  3699999999999999999999999999999999999995   67889999999986432  


Q ss_pred             -CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       268 -~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------  213 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP----------------  213 (316)
T ss_pred             CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence             223445789999999999998999999999999999999999999988776555443321000                


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...+.++
T Consensus       214 ---------------------------------------------------------~~~-------------~~~~~~~  223 (316)
T cd05592         214 ---------------------------------------------------------HFP-------------RWISKEA  223 (316)
T ss_pred             ---------------------------------------------------------CCC-------------CCCCHHH
Confidence                                                                     000             0123567


Q ss_pred             HHHHHHhcccCcCCCCCH-HHHHcCccCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRWSP-FQASRHPFVTGEPF  458 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRpTa-~EaL~HPff~~~~~  458 (837)
                      .+||++||+.||++|+++ +++++||||....+
T Consensus       224 ~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         224 KDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             HHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence            899999999999999986 58889999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-40  Score=354.30  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=210.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .|++.++||+|+||+||++.+..+++.||||++....    .....+.+|+.+++.+       +|+||+++++++..++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~   73 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-------NSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-------CCCCEeeeeeeecCCC
Confidence            4889999999999999999999999999999997532    2234467799999988       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+. ++|.+.+.......+++..++.++.||+.||.|||+.+|+||||||+||+++   +.+.++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~  150 (285)
T cd05605          74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAV  150 (285)
T ss_pred             eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCce
Confidence            9999999997 5787777654445699999999999999999999999999999999999995   66889999999987


Q ss_pred             ccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....  .....+++..|+|||++.+..++.++|||||||++|||++|..||.+.........+...+...+         
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         151 EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------  221 (285)
T ss_pred             ecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence            5432  22345789999999999988999999999999999999999999987654433333222111000         


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                  ..+             ....
T Consensus       222 ------------------------------------------------------------~~~-------------~~~~  228 (285)
T cd05605         222 ------------------------------------------------------------EEY-------------SEKF  228 (285)
T ss_pred             ------------------------------------------------------------ccc-------------Cccc
Confidence                                                                        000             0113


Q ss_pred             HHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                      ++.+.+||.+||..||++|+     +++++++||||....+.
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         229 SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence            46788999999999999999     99999999999986654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-41  Score=346.34  Aligned_cols=254  Identities=25%  Similarity=0.431  Sum_probs=223.9

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..++|++.+.||+|-||.||+|+.++++-.||+|++.+..    ...+++.+|++|-..|       .||||+++|++|.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-------~hpnilrlY~~fh   92 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-------RHPNILRLYGYFH   92 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-------CCccHHhhhhhee
Confidence            3478999999999999999999999999999999997643    2345677788887777       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ++..+||++||.. |.++..+.....+.+++.....+++|++.||.|||.++||||||||+|+|++   ..+.+||+|||
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfG  169 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFG  169 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCC
Confidence            9999999999997 7999999877778899999999999999999999999999999999999995   77899999999


Q ss_pred             ccccc-CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          262 SACTE-DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       262 lA~~~-~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      .+... .....+.|||..|.+||...+..++.++|+|++|++.||++.|.+||...+..+..++|.++--.         
T Consensus       170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~---------  240 (281)
T KOG0580|consen  170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK---------  240 (281)
T ss_pred             ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc---------
Confidence            98655 55567889999999999999999999999999999999999999999988887777777653210         


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                                      +|             .
T Consensus       241 ----------------------------------------------------------------~p-------------~  243 (281)
T KOG0580|consen  241 ----------------------------------------------------------------FP-------------S  243 (281)
T ss_pred             ----------------------------------------------------------------CC-------------c
Confidence                                                                            00             1


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .++..+.|||.+||..+|.+|++..|+++|||+...
T Consensus       244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  244 TISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            245678999999999999999999999999999753

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.9e-40  Score=361.01  Aligned_cols=247  Identities=30%  Similarity=0.496  Sum_probs=202.0

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||.||+|+++.+++.||||++++..    ...+....|..++..+.      +|+||+++++++..++++|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW------ENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc------CCCCccCeeEEEEeCCEEEEE
Confidence            46999999999999999999999999998542    23345566777766542      689999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             ECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccC
Confidence            99998 5787777654  3589999999999999999999999999999999999995   6678999999998642   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~---~-------------  213 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT---P-------------  213 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---C-------------
Confidence            223345678999999999999999999999999999999999999998776654443332100   0             


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...+.++
T Consensus       214 ---------------------------------------------------------~~~-------------~~~~~~~  223 (316)
T cd05620         214 ---------------------------------------------------------HYP-------------RWITKES  223 (316)
T ss_pred             ---------------------------------------------------------CCC-------------CCCCHHH
Confidence                                                                     000             0123568


Q ss_pred             HHHHHHhcccCcCCCCCH-HHHHcCccCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRWSP-FQASRHPFVTGEPF  458 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRpTa-~EaL~HPff~~~~~  458 (837)
                      .+||++||+.||++|+|+ +++++||||+...+
T Consensus       224 ~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         224 KDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             HHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence            899999999999999998 58889999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1e-40  Score=370.67  Aligned_cols=205  Identities=25%  Similarity=0.480  Sum_probs=176.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||+|+||+||+|++..+++.||||+++..    ......+..|+.++..+       .|++|+++++.+...
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~iv~~~~~~~~~   73 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-------DGAWVVKMFYSFQDK   73 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence            3689999999999999999999999999999999743    22345667788888887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++|||||||. ++|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~  148 (360)
T cd05627          74 RNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLC  148 (360)
T ss_pred             CEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCC
Confidence            99999999997 5888887654  3599999999999999999999999999999999999995   6789999999998


Q ss_pred             cccCCc--------------------------------------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHH
Q 003239          264 CTEDRT--------------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAE  305 (837)
Q Consensus       264 ~~~~~~--------------------------------------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyE  305 (837)
                      ......                                      ....+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye  228 (360)
T cd05627         149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence            532110                                      123478999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHH
Q 003239          306 LFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       306 LltG~~PF~g~s~~e~l~~I  325 (837)
                      |++|++||.+.+..+....+
T Consensus       229 l~tG~~Pf~~~~~~~~~~~i  248 (360)
T cd05627         229 MLIGYPPFCSETPQETYRKV  248 (360)
T ss_pred             cccCCCCCCCCCHHHHHHHH
Confidence            99999999887765554444

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-39  Score=358.12  Aligned_cols=200  Identities=31%  Similarity=0.485  Sum_probs=176.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++++.||+|+||.||++++..++..||+|+++..  ....+.+.+|+++|+++       .|+||+++++++..++.
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-------CCCCCCeEEEEEEECCE
Confidence            7899999999999999999999999999999999853  34456788999999998       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +++||||+.+ +|.+++...  ..+++..+..++.||+.||.|||++ +|+||||||+|||++   .++.+||+|||++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~  152 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSG  152 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCcccc
Confidence            9999999984 888887654  3589999999999999999999986 699999999999995   66889999999986


Q ss_pred             ccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          265 TEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       265 ~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      .... ......++..|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus       153 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~  209 (331)
T cd06649         153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE  209 (331)
T ss_pred             cccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5432 2334578999999999999899999999999999999999999998766544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-39  Score=341.29  Aligned_cols=252  Identities=33%  Similarity=0.501  Sum_probs=209.0

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHH---HHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ---QALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~---~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      |+++++||+|+||+||++++..+++.||+|++........   ...+|+.+++.+       .|+||+++++++......
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~   73 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-------RHPNIVQILDVFQDDNYL   73 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-------TBTTBCHEEEEEEESSEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-------cccccccccccccccccc
Confidence            8899999999999999999999999999999997653333   234599999999       588999999999999999


Q ss_pred             EEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc-
Q 003239          188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-  265 (837)
Q Consensus       188 ~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~-  265 (837)
                      ++|||++.+ +|.+++...  ..+++..++.++.||++||++||+++|+|+||||+||+++   .++.++|+|||.+.. 
T Consensus        74 ~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   74 YIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             EEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEES
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccc
Confidence            999999997 899888833  4689999999999999999999999999999999999995   778999999999964 


Q ss_pred             --cCCcceeeccCccccCchhhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 --EDRTVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 --~~~~~~~~~GT~~Y~APEvl~-~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                        .........++..|+|||++. +..++.++|||||||++|+|++|..||......+....+.+......+.       
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------  221 (260)
T PF00069_consen  149 SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS-------  221 (260)
T ss_dssp             TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH-------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc-------
Confidence              234445567899999999998 7789999999999999999999999998775445444444332200000       


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                              ........
T Consensus       222 ------------------------------------------------------------------------~~~~~~~~  229 (260)
T PF00069_consen  222 ------------------------------------------------------------------------SSQQSREK  229 (260)
T ss_dssp             ------------------------------------------------------------------------HTTSHTTS
T ss_pred             ------------------------------------------------------------------------cccccchh
Confidence                                                                                    00000012


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ...+.+||++||..||++|||+.|+++||||
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            3678999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.7e-40  Score=349.88  Aligned_cols=276  Identities=32%  Similarity=0.549  Sum_probs=215.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...   .....+.+|+++++.+       .|+||+++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~i~~~~~~~~~~~~   73 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-------KHKNIVRLYDVLHSDKK   73 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-------CCCCeeeHHHHhccCCc
Confidence            5899999999999999999999999999999997432   2234567899999998       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      +++|+||++++|.+.+.... ..+++..++.++.||++||.|||+++|+||||||+||+++   .++.+||+|||++...
T Consensus        74 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~  149 (284)
T cd07839          74 LTLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAF  149 (284)
T ss_pred             eEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhcc
Confidence            99999999999988876543 4599999999999999999999999999999999999995   6688999999998754


Q ss_pred             CCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPL-FPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~P-F~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...   .....++..|+|||++.+. .++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++ .++...+...
T Consensus       150 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  228 (284)
T cd07839         150 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEESWPGV  228 (284)
T ss_pred             CCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC-CCChHHhHHh
Confidence            322   2234668899999998775 478999999999999999998766 667777778888888777 3333322211


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+ ...                                  +    .+.....+.+..                 ..
T Consensus       229 ~~~~~~-~~~----------------------------------~----~~~~~~~~~~~~-----------------~~  252 (284)
T cd07839         229 SKLPDY-KPY----------------------------------P----MYPATTSLVNVV-----------------PK  252 (284)
T ss_pred             hhcccc-ccc----------------------------------C----CCCCcchhhhhc-----------------cc
Confidence            110000 000                                  0    000000011111                 12


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .++++.|||.+||..||.+|||++|+|+||||
T Consensus       253 ~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         253 LNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            45788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.1e-40  Score=359.09  Aligned_cols=247  Identities=25%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||+||+|++..+++.||||++++.    ........+|+.+++.+.      .|+||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~------~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------KHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc------CCCCccceeeEEEcCCEEEEE
Confidence            3699999999999999999999999999853    233455677888887763      589999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+.+...  ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          75 MEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcC
Confidence            99997 5777776554  3699999999999999999999999999999999999995   6788999999998642   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                      .......+++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....                
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----------------  213 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----------------  213 (318)
T ss_pred             CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            2223345789999999999999999999999999999999999999987765544433321000                


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...+..+
T Consensus       214 ---------------------------------------------------------~~~-------------~~~~~~~  223 (318)
T cd05570         214 ---------------------------------------------------------RYP-------------RWLSKEA  223 (318)
T ss_pred             ---------------------------------------------------------CCC-------------CcCCHHH
Confidence                                                                     000             0134678


Q ss_pred             HHHHHHhcccCcCCCCCH-----HHHHcCccCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPF  458 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRpTa-----~EaL~HPff~~~~~  458 (837)
                      .+||++||+.||++|||+     .++++||||+...+
T Consensus       224 ~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         224 KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999999999     99999999988654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=358.17  Aligned_cols=206  Identities=23%  Similarity=0.365  Sum_probs=174.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||+|+||+||++++..+++.||||++++.    ....+.+.+|+.+++.+       +|+||++++++|..+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~   73 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-------DRRWITNLHYAFQDE   73 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-------CCCCCCceEEEEecC
Confidence            4799999999999999999999999999999999752    22344567788888776       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~  149 (331)
T cd05597          74 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSC  149 (331)
T ss_pred             CeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCce
Confidence            99999999996 58888886532 4699999999999999999999999999999999999995   6788999999998


Q ss_pred             cccCCc----ceeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          264 CTEDRT----VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       264 ~~~~~~----~~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ......    ....+||+.|+|||++..     ..++.++|||||||++|||++|+.||.+.+..+....+
T Consensus       150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i  220 (331)
T cd05597         150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (331)
T ss_pred             eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            654321    123468999999999973     35788999999999999999999999877655544443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-39  Score=356.44  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=208.2

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +|++.+.||+|+||+||+|+++.+++.||||++++..    ...+....|+.++..+.      +|++|+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD------KPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc------CCCchhheeeEEecCC
Confidence            4788999999999999999999999999999998532    23345667888877763      4678999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+. ++|.+.+...  ..+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~  149 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEecccccc
Confidence            9999999997 5888777654  3599999999999999999999999999999999999995   67889999999986


Q ss_pred             ccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+....+..+.+...           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----------  218 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----------  218 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            432   122345689999999999998999999999999999999999999988776555554433100           


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                    .+|             ..
T Consensus       219 --------------------------------------------------------------~~p-------------~~  223 (323)
T cd05615         219 --------------------------------------------------------------SYP-------------KS  223 (323)
T ss_pred             --------------------------------------------------------------CCC-------------cc
Confidence                                                                          000             01


Q ss_pred             hHHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF  458 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~  458 (837)
                      .+..+.+||.+||+.||.+|++     .+++++||||....+
T Consensus       224 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         224 LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            2356789999999999999997     589999999998664

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.5e-40  Score=358.73  Aligned_cols=246  Identities=23%  Similarity=0.440  Sum_probs=199.2

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHH-HHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSI-LTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~i-L~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      ++||+|+||+||+|++..+++.||||++.+..    .....+..|..+ ++.+       .|+||+++++++...+..|+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-------~hp~iv~~~~~~~~~~~~~l   73 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-------KHPFLVGLHYSFQTADKLYF   73 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-------CCCCCCCeeEEEEeCCEEEE
Confidence            36999999999999999999999999997532    122334444443 3444       78999999999999999999


Q ss_pred             EEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc--
Q 003239          190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--  266 (837)
Q Consensus       190 VmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~--  266 (837)
                      ||||+. ++|.+.+...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...  
T Consensus        74 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          74 VLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             EEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCccccc
Confidence            999998 4787777654  3689999999999999999999999999999999999995   6789999999998642  


Q ss_pred             -CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcch
Q 003239          267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS  345 (837)
Q Consensus       267 -~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~  345 (837)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+....-               
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------------  213 (323)
T cd05575         149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL---------------  213 (323)
T ss_pred             CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence             2223345789999999999999999999999999999999999999987766554444322000               


Q ss_pred             hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHH
Q 003239          346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA  425 (837)
Q Consensus       346 ~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~  425 (837)
                                                                                  ..           ....+..
T Consensus       214 ------------------------------------------------------------~~-----------~~~~~~~  222 (323)
T cd05575         214 ------------------------------------------------------------RL-----------KPNISVS  222 (323)
T ss_pred             ------------------------------------------------------------CC-----------CCCCCHH
Confidence                                                                        00           0012467


Q ss_pred             HHHHHHHhcccCcCCCCCH----HHHHcCccCCCCCC
Q 003239          426 LVDFLKGLVEFDPAKRWSP----FQASRHPFVTGEPF  458 (837)
Q Consensus       426 l~DLL~kmL~~DP~kRpTa----~EaL~HPff~~~~~  458 (837)
                      +.+||++||+.||++|+++    +|+++||||....+
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            8899999999999999998    69999999988654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-40  Score=365.04  Aligned_cols=191  Identities=26%  Similarity=0.395  Sum_probs=167.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      .+|++++.||+|+||+||+|++..+++.||+|+.....     ...|+.+++.+       .|+||+++++++......|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----TLIEAMLLQNV-------NHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----cHHHHHHHHhC-------CCCCCcChhheEEeCCeeE
Confidence            57999999999999999999999999999999865432     34688899888       6899999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC-
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED-  267 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~-  267 (837)
                      +|||++.++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+|||++   ..+.+||+|||++.... 
T Consensus       134 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        134 MVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EEEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEecCcccccccc
Confidence            999999999998887643 5699999999999999999999999999999999999995   67789999999996432 


Q ss_pred             -CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CCCCCC
Q 003239          268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPG  315 (837)
Q Consensus       268 -~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~PF~g  315 (837)
                       .......||..|+|||++.+..++.++|||||||++|||+++ .++|..
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence             223345789999999999999999999999999999999985 555543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.7e-40  Score=358.90  Aligned_cols=247  Identities=29%  Similarity=0.501  Sum_probs=202.7

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      +.||+|+||+||+|++..+++.||||+++...    ........|..++..+.      .||||+++++++...+.++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc------CCCcCcceEEEEEeCCEEEEE
Confidence            36999999999999999999999999998542    23345566777776542      699999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+++...  ..+++.+++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          75 MEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCC
Confidence            99997 5888887654  3589999999999999999999999999999999999995   6678999999998642   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                      .......+||..|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+... .  +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~--~-------------  213 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-N--P-------------  213 (316)
T ss_pred             CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C--C-------------
Confidence            22334567899999999999989999999999999999999999999877655544333210 0  0             


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                                               .+|             ...+..+
T Consensus       214 ---------------------------------------------------------~~~-------------~~~~~~~  223 (316)
T cd05619         214 ---------------------------------------------------------CYP-------------RWLTREA  223 (316)
T ss_pred             ---------------------------------------------------------CCC-------------ccCCHHH
Confidence                                                                     000             0123567


Q ss_pred             HHHHHHhcccCcCCCCCHH-HHHcCccCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRWSPF-QASRHPFVTGEPF  458 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRpTa~-EaL~HPff~~~~~  458 (837)
                      .+||.+||+.||++|+++. ++++||||++..+
T Consensus       224 ~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         224 KDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             HHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence            8999999999999999996 9999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-39  Score=358.52  Aligned_cols=190  Identities=24%  Similarity=0.415  Sum_probs=165.8

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||.||+|++..+++.||||++++.    ......+..|+.+++.+.      +||||++++++|...+.+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~------~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS------NHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc------CCCCCCceEEEEEcCCEEEEE
Confidence            3689999999999999999999999999853    233455677888888774      589999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      ||||. ++|.+.+...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          75 IEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccC
Confidence            99997 5787776544  4699999999999999999999999999999999999995   6788999999998642   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            2333456899999999999999999999999999999999999999953

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.8e-39  Score=357.94  Aligned_cols=290  Identities=30%  Similarity=0.540  Sum_probs=223.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||++++.   ......+.+|+.+++.+       .|+||++++++|...
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   87 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-------NHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-------CCCCCcceeeeeccC
Confidence            37899999999999999999999999999999998742   33445677899999988       689999999998754


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            ...|+||||+.++|.+.+...    +++..++.++.||+.||+|||++||+||||||+||+++   .++.+||+
T Consensus        88 ~~~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~  160 (353)
T cd07850          88 KSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKIL  160 (353)
T ss_pred             CCccccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEc
Confidence                  357999999999988877542    89999999999999999999999999999999999995   66789999


Q ss_pred             ecccccccCCcc--eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          259 DFGSACTEDRTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       259 DFGlA~~~~~~~--~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      |||++.......  ....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+.+.++ .|+..
T Consensus       161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~  239 (353)
T cd07850         161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG-TPSDE  239 (353)
T ss_pred             cCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC-CCCHH
Confidence            999997654332  234678899999999999999999999999999999999999999998889999999888 44444


Q ss_pred             HHHhhhcc-hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          337 VLKEAKNT-SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       337 ~l~~~k~~-~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      +....... ..+.....                                       .+....+.+++....+....    
T Consensus       240 ~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~~~~----  276 (353)
T cd07850         240 FMSRLQPTVRNYVENRP---------------------------------------KYAGYSFEELFPDVLFPPDS----  276 (353)
T ss_pred             HHHHhhhhhhHHhhcCC---------------------------------------CCCCcchhhhCcccccCccc----
Confidence            43332211 11111000                                       00001111111110000000    


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      .......+..+.+||.+||++||++|||++|+|+||||+.
T Consensus       277 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         277 ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             ccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence            0001224567899999999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6e-40  Score=359.29  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=202.3

Q ss_pred             EEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          115 DLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++||+|+||.||+|++.   .+++.||||++++..     .....+.+|+.+|+.+       .||||++++++|..++.
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~iv~~~~~~~~~~~   74 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-------KHPFIVDLIYAFQTGGK   74 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-------CCCchhceeeEEecCCe
Confidence            67999999999999763   578899999998532     2334567899999988       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|+||||+. ++|.+.+...  +.+.+..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~  149 (323)
T cd05584          75 LYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKE  149 (323)
T ss_pred             EEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCee
Confidence            999999998 4888877654  3588999999999999999999999999999999999995   678999999999864


Q ss_pred             cC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 ED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..   ......+|++.|+|||++.+..++.++|||||||++|||++|+.||...+....+..+.....            
T Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~------------  217 (323)
T cd05584         150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL------------  217 (323)
T ss_pred             cccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            22   222345789999999999998999999999999999999999999987765544443322000            


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                   .+|             ...
T Consensus       218 -------------------------------------------------------------~~~-------------~~~  223 (323)
T cd05584         218 -------------------------------------------------------------NLP-------------PYL  223 (323)
T ss_pred             -------------------------------------------------------------CCC-------------CCC
Confidence                                                                         000             013


Q ss_pred             HHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      ++.+.+||++||+.||++|+     +++++++||||+...+
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            46788999999999999999     8999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.5e-40  Score=350.14  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=200.3

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||+|+||+||++++..+++.||||++....    ...+.+..|+.+++.+       +|+||+++++++..+...|+|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~i~~~~~~~~~~~~~~lv~e   73 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSRFIVSLAYAFQTKTDLCLVMT   73 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-------CCCcEeeeeEEEcCCCeEEEEEe
Confidence            799999999999999999999999997532    2234567799999988       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc
Q 003239          193 LLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT  269 (837)
Q Consensus       193 y~~-gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~  269 (837)
                      |+. ++|.+.+...  ....+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+|||++......
T Consensus        74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCC
Confidence            997 5776666432  234589999999999999999999999999999999999995   5788999999998654322


Q ss_pred             ---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          270 ---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       270 ---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                         .....+++.|+|||++.+..++.++|||||||++|||++|+.||...........+....-..              
T Consensus       151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------  216 (280)
T cd05608         151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--------------  216 (280)
T ss_pred             CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--------------
Confidence               234578999999999999999999999999999999999999997654322111111100000              


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                                                             +                             .......++.+
T Consensus       217 ---------------------------------------~-----------------------------~~~~~~~~~~~  228 (280)
T cd05608         217 ---------------------------------------S-----------------------------VTYPDKFSPAS  228 (280)
T ss_pred             ---------------------------------------C-----------------------------CCCcccCCHHH
Confidence                                                   0                             00001244678


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          427 VDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                      .+||.+||+.||++|+     |++|+|+||||++..+.
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         229 KSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence            9999999999999999     89999999999986554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.4e-39  Score=345.13  Aligned_cols=277  Identities=31%  Similarity=0.575  Sum_probs=219.7

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .|++++.||.|+||.||+|++..+++.||||+++.+.   .....+.+|+++++++       +|+||+++++++...+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~   73 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-------NHPNIVKLLDVIHTENK   73 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-------CCCCCcchhhhcccCCc
Confidence            4889999999999999999999999999999987432   2335678899999998       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .++||||+.++|.+++.......+++..++.++.||+.||+|||+.+|+|+||||+||+++   .++.+||+|||++...
T Consensus        74 ~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~  150 (284)
T cd07860          74 LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF  150 (284)
T ss_pred             EEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhc
Confidence            9999999998888888766556799999999999999999999999999999999999995   6678999999998654


Q ss_pred             CCc---ceeeccCccccCchhhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~-yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ...   .....++..|+|||++.+.. ++.++|||||||++|||++|+.||...++.+.+.++.+..+ .++..++....
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  229 (284)
T cd07860         151 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVWPGVT  229 (284)
T ss_pred             ccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhhhh
Confidence            322   22335678899999987654 68899999999999999999999999988888888888877 44443332211


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                      ....+-...                                  +     .+....+..+..                 ..
T Consensus       230 ~~~~~~~~~----------------------------------~-----~~~~~~~~~~~~-----------------~~  253 (284)
T cd07860         230 SLPDYKPSF----------------------------------P-----KWARQDFSKVVP-----------------PL  253 (284)
T ss_pred             HHHHHHhhc----------------------------------c-----cccccCHHHHcc-----------------cC
Confidence            110000000                                  0     000111111111                 13


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ++.+.+||.+||+.||++|||++|+|+||||
T Consensus       254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             CHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            4678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4e-39  Score=342.84  Aligned_cols=275  Identities=33%  Similarity=0.578  Sum_probs=220.6

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||+|+||.||+|.+..+++.||||++...   ....+.+.+|+.+++.+       .|+||+++++++.....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~   73 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-------QHPYVVKLLDVFPHGSG   73 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-------CCCCCcceeeEEecCCe
Confidence            589999999999999999999999999999999753   23456788899999988       58999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .++||||++++|.+++.... ..+++.+++.++.||+.||+|||+.+|+|+||||+||+++   ..+.++|+|||++...
T Consensus        74 ~~~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~  149 (286)
T cd07832          74 FVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLF  149 (286)
T ss_pred             eEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccc
Confidence            99999999779998887654 5699999999999999999999999999999999999996   5788999999998754


Q ss_pred             CCc----ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          267 DRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       267 ~~~----~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...    .....++..|+|||++.+. .++.++|||||||++|||++|.++|.+.++.+.+..+.+.++ .+....+...
T Consensus       150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  228 (286)
T cd07832         150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG-TPNEETWPGL  228 (286)
T ss_pred             cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcC-CCChHHHhhc
Confidence            332    2345688899999998765 568999999999999999999999999888888888888877 3333322221


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCccccc---ccchHHHHhcCCCCCCCchhhhhh
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFH---HKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~---~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                      .....+ .                                        ...|.   ...+.++.                
T Consensus       229 ~~~~~~-~----------------------------------------~~~~~~~~~~~~~~~~----------------  251 (286)
T cd07832         229 TSLPDY-N----------------------------------------KITFPESKPIPLEEIF----------------  251 (286)
T ss_pred             cCcchh-h----------------------------------------cccCCCCCcchHHHhC----------------
Confidence            111000 0                                        00000   00111111                


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT  454 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~  454 (837)
                       ...+..+.+||++||..||++|||++++|+||||.
T Consensus       252 -~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         252 -PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             -CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             12347889999999999999999999999999995

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3e-39  Score=347.14  Aligned_cols=281  Identities=31%  Similarity=0.551  Sum_probs=220.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh------hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      +|++.+.||+|+||.||+|.+..+++.||||+++....      ....+..|+++++.+       .|+||+++++++..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~   73 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-------KHPNIIGLLDVFGH   73 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-------CCCCChhhhheeec
Confidence            58899999999999999999999999999999985422      234566788888888       58999999999999


Q ss_pred             cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       184 ~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .+.+++||||+.++|.+++.... ..+++..++.++.||++||.|||++||+|+||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~  149 (298)
T cd07841          74 KSNINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLA  149 (298)
T ss_pred             CCEEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceee
Confidence            99999999999889988887543 3699999999999999999999999999999999999996   6788999999999


Q ss_pred             cccCCc---ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          264 CTEDRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       264 ~~~~~~---~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ......   .....++..|+|||.+.+ ..++.++|||||||++|||++|.++|.+.+..+.+.++.+.++ .+....+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  228 (298)
T cd07841         150 RSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG-TPTEENWP  228 (298)
T ss_pred             eeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcC-CCchhhhh
Confidence            754332   223356788999999865 4678999999999999999999999998888888888877766 33333222


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                      .......+...                                        .......+..+.                 
T Consensus       229 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~-----------------  251 (298)
T cd07841         229 GVTSLPDYVEF----------------------------------------KPFPPTPLKQIF-----------------  251 (298)
T ss_pred             hcccccccccc----------------------------------------cccCCcchhhhc-----------------
Confidence            11111000000                                        000001111111                 


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                      ...+..+++||.+||.+||++|||++|+|+||||++.+..
T Consensus       252 ~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         252 PAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence            1235778999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-41  Score=358.61  Aligned_cols=249  Identities=27%  Similarity=0.445  Sum_probs=219.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      +.+|++.+.||+|+||+|-+|.....|+.||||.|+++    +.+.-.+.+||+||..|       +||||+.+|++|+.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-------NHPhII~IyEVFEN  124 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-------NHPHIIQIYEVFEN  124 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-------CCCceeehhhhhcC
Confidence            47999999999999999999999999999999999864    44556788999999999       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.++|||||.. |.|+|++....  .|+|.+++.|++||..|+.|||++++||||||.+|||++   .++.+||+|||+
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD---~N~NiKIADFGL  199 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD---QNNNIKIADFGL  199 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec---CCCCeeeeccch
Confidence            999999999997 79999998764  699999999999999999999999999999999999995   889999999999


Q ss_pred             cccc--CCcceeeccCccccCchhhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTE--DRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~--~~~~~~~~GT~~Y~APEvl~~~~yt-~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +...  .....++||++-|.+||++.+.+|. +.+|.|||||+||.|+.|..||.+.+...++.+|.+..-         
T Consensus       200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY---------  270 (668)
T KOG0611|consen  200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY---------  270 (668)
T ss_pred             hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---------
Confidence            9543  3445688999999999999999986 789999999999999999999999988777776654111         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                           +..                        
T Consensus       271 -----------------------------------------------------rEP------------------------  273 (668)
T KOG0611|consen  271 -----------------------------------------------------REP------------------------  273 (668)
T ss_pred             -----------------------------------------------------cCC------------------------
Confidence                                                                 000                        


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                       ..+..+.-||+.||..||++|.|++++..|-|+.=
T Consensus       274 -~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  274 -ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             -CCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence             01235678999999999999999999999999874

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.3e-39  Score=345.03  Aligned_cols=280  Identities=32%  Similarity=0.533  Sum_probs=217.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...   .....+.+|+.+++.+.      +|+||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS------ESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc------CCCCccceeeeEeecC
Confidence            46999999999999999999999999999999987432   23356778999999984      4799999999998776


Q ss_pred             e-----EEEEEeccchhHHHHHHhhc---cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          186 H-----LCICFELLDSNLYELIKINH---FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       186 ~-----l~LVmEy~~gsL~d~l~~~~---~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      .     .|+||||+.++|.+++....   ...+++..++.++.||+.||.|||+++|+||||||+||+++  ...+.+||
T Consensus        75 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl  152 (295)
T cd07837          75 KNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKI  152 (295)
T ss_pred             CCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEE
Confidence            5     89999999999988876543   23589999999999999999999999999999999999996  23688999


Q ss_pred             EecccccccCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          258 IDFGSACTEDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       258 ~DFGlA~~~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      +|||++......   .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.++.+.+..+.+.++ .|
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~  231 (295)
T cd07837         153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TP  231 (295)
T ss_pred             eecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CC
Confidence            999998643222   1223567889999998764 678999999999999999999999999888888888877766 34


Q ss_pred             chHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       334 p~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                      +...+........+...                                        ..+....+...            
T Consensus       232 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~------------  259 (295)
T cd07837         232 TEQVWPGVSKLRDWHEF----------------------------------------PQWKPQDLSRA------------  259 (295)
T ss_pred             ChhhCcchhhccchhhc----------------------------------------CcccchhHHHh------------
Confidence            33322211110000000                                        00000001111            


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCC
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT  454 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~  454 (837)
                           ....+..+.+||.+||.+||.+|||++|+|+||||+
T Consensus       260 -----~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         260 -----VPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                 112457789999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-39  Score=361.83  Aligned_cols=253  Identities=26%  Similarity=0.368  Sum_probs=200.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..+|+++++||+|+||+||+|++..+++.||||++...  ....+.+.+|+++++.+       .|+||+++++++...+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-------NHPNVVKCHDMFDHNG  145 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-------CCCCcceeeeEeccCC
Confidence            36788999999999999999999999999999999753  33456788999999988       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+++||||+.+ +|.+.      ..+.+..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||++.
T Consensus       146 ~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~  216 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSR  216 (353)
T ss_pred             eEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccce
Confidence            99999999985 54321      2367888999999999999999999999999999999995   66889999999997


Q ss_pred             ccCCc---ceeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          265 TEDRT---VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       265 ~~~~~---~~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      .....   .....||..|+|||++..     ...+.++|||||||++|||++|+.||......+....+.......    
T Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  292 (353)
T PLN00034        217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----  292 (353)
T ss_pred             ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence            54322   234578999999999853     234568999999999999999999996432221111111100000    


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                      .+                              
T Consensus       293 ------------------------------------------------~~------------------------------  294 (353)
T PLN00034        293 ------------------------------------------------PP------------------------------  294 (353)
T ss_pred             ------------------------------------------------CC------------------------------
Confidence                                                            00                              


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ......+.++.+||.+||..||++|||++|+|+||||.+...
T Consensus       295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            000113467899999999999999999999999999998643

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-39  Score=363.99  Aligned_cols=205  Identities=23%  Similarity=0.418  Sum_probs=175.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||+|++..+++.||+|++++..    ...+.+.+|+.+++.+       .||||+++++++...
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-------~hp~iv~~~~~~~~~  115 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-------NSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEcC
Confidence            79999999999999999999999999999999997422    2334566788888877       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+|||||. ++|.+++...   .+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a  189 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTC  189 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCce
Confidence            99999999997 5888887653   489999999999999999999999999999999999995   6788999999999


Q ss_pred             cccCCc----ceeeccCccccCchhhcCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          264 CTEDRT----VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       264 ~~~~~~----~~~~~GT~~Y~APEvl~~~~----yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      ......    ....+||+.|+|||++.+..    ++.++|||||||++|||++|.+||.+.+.......+.
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  260 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            754322    23457999999999997643    7899999999999999999999998877655554443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5e-39  Score=353.34  Aligned_cols=206  Identities=22%  Similarity=0.349  Sum_probs=173.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+++++.+++.||+|++.+..    .....+..|+.++..+       .|++|+++++++...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~   73 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-------DNQWITTLHYAFQDE   73 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-------CCCCEeeEEEEEecC
Confidence            47999999999999999999999999999999997422    2233456677777766       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+||||||+. |+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a  149 (332)
T cd05623          74 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSC  149 (332)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchh
Confidence            99999999997 68988887643 4589999999999999999999999999999999999995   6788999999998


Q ss_pred             cccCCc----ceeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          264 CTEDRT----VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       264 ~~~~~~----~~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ......    ....+||+.|+|||++..     ..++.++|||||||++|||++|+.||...+..+.+..+
T Consensus       150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i  220 (332)
T cd05623         150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (332)
T ss_pred             eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            643221    123578999999999863     46889999999999999999999999887665555444

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-39  Score=343.01  Aligned_cols=280  Identities=30%  Similarity=0.524  Sum_probs=214.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.||+|+||.||+|+++.+++.||||.++...  .....+.+|+++++.+       .|+||+++++++..++.
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~   77 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-------KHANIVTLHDIIHTKKT   77 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-------CCcceeeEEEEEecCCe
Confidence            78999999999999999999999999999999987432  2224566899999998       58899999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .|+||||+.++|.+++.... ..+++..++.++.||++||.|||+++|+||||||+||+++   .++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~  153 (291)
T cd07844          78 LTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECcccccccc
Confidence            99999999999988876543 3689999999999999999999999999999999999995   6678999999998654


Q ss_pred             CCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCchHHHHhh
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS-EFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s-~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...   .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.... ..+.+..+.+.++. +....+...
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  232 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT-PTEETWPGV  232 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC-CChhhhhhh
Confidence            321   1223467889999998764 68899999999999999999999997765 56667777777773 333322221


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+.....                                      ..+....+...+...               .
T Consensus       233 ~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~---------------~  259 (291)
T cd07844         233 SSNPEFKPYSF--------------------------------------PFYPPRPLINHAPRL---------------D  259 (291)
T ss_pred             hhccccccccc--------------------------------------cccCChhHHHhCcCC---------------C
Confidence            11110000000                                      000001111110000               0


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ....+.+||.+||..||++|||+.|+|+||||
T Consensus       260 ~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         260 RIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            12577899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=369.79  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=212.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ..|+.+++||+|+||.||+|.+..+++.||||++..+  ....+.+..|+.+|.++       .++||.++|+.|..+..
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-------~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-------DSPNITEYYGSYLKGTK   85 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-------CcchHHhhhhheeeccc
Confidence            6788889999999999999999999999999999854  34567788899999999       56899999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ++|+||||. |.+.++++...  .+.|..+..++++++.||.|||.++.+|||||+.|||+.   ..+.+||+|||.+.+
T Consensus        86 LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeee
Confidence            999999998 58888887654  358999999999999999999999999999999999996   559999999999965


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   ..+++||++|||||++.+..|+.|+||||||++++||++|.+|+....+...+..|                 
T Consensus       161 l~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-----------------  223 (467)
T KOG0201|consen  161 LTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-----------------  223 (467)
T ss_pred             eechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-----------------
Confidence            5432   36789999999999999889999999999999999999999999765431111110                 


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                 .++.|..         .+..+
T Consensus       224 -----------------------------------------------------------pk~~PP~---------L~~~~  235 (467)
T KOG0201|consen  224 -----------------------------------------------------------PKSAPPR---------LDGDF  235 (467)
T ss_pred             -----------------------------------------------------------cCCCCCc---------ccccc
Confidence                                                                       0001100         11146


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ++.|++||..||+.||+.||||.++|+|+|++.
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            688999999999999999999999999999997

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=352.14  Aligned_cols=319  Identities=25%  Similarity=0.386  Sum_probs=250.1

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +.++|..+++||+|.||+|.+|+.+.+++.+|||+++++    .......+.|-++|+..       .||.+..|.-.|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-------~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-------RHPFLTSLKYSFQ  238 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-------cCcHHHHhhhhhc
Confidence            457899999999999999999999999999999999875    23344456677788777       6889999999999


Q ss_pred             ecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      .++.+|+||||..| .|.-.+...  +.++|...+.+-.+|+.||.|||+++||.||||.+|+|++   ++++|||+|||
T Consensus       239 t~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD---kDGHIKitDFG  313 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD---KDGHIKITDFG  313 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---cCCceEeeecc
Confidence            99999999999985 666555443  4699999999999999999999999999999999999994   88999999999


Q ss_pred             cccc---cCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          262 SACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       262 lA~~---~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +++.   ......+.|||+.|+|||++....|+.++|.|-+||+||||++|+.||...+...+.+.|+-           
T Consensus       314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-----------  382 (516)
T KOG0690|consen  314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-----------  382 (516)
T ss_pred             cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------
Confidence            9964   35667789999999999999999999999999999999999999999988776655554432           


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                                 +++..
T Consensus       383 ---------------------------------------------------------------------------ed~kF  387 (516)
T KOG0690|consen  383 ---------------------------------------------------------------------------EDLKF  387 (516)
T ss_pred             ---------------------------------------------------------------------------hhccC
Confidence                                                                                       11111


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCCCCCCCCCCCCCCCccccccccCCCCCCCCc---c
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWF---A  490 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~  490 (837)
                      ...++++++.||..+|..||++|+     .|.|+.+|+||....|...+...-++|..|...+.+...--.  .-+   .
T Consensus       388 Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD--~EFT~q~  465 (516)
T KOG0690|consen  388 PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFD--EEFTSQP  465 (516)
T ss_pred             CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhh--hhhhcce
Confidence            123567889999999999999998     589999999999998877666655666655543332211110  001   0


Q ss_pred             CCCCCCccCCcccccCCCCCCccCCCCCCCccccc
Q 003239          491 AGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSV  525 (837)
Q Consensus       491 ~~l~~~~s~r~~~~~~n~~~~~~~~~~yg~s~~~~  525 (837)
                      -.+.|.--............+.+++|.|-.+-||.
T Consensus       466 v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~~~s~  500 (516)
T KOG0690|consen  466 VTLTPPDRYGSTVDEDEERRPHFPQFSYSASMGSI  500 (516)
T ss_pred             eEecCCCCCCcccchhhhhccCCcceeeecchhhh
Confidence            11222222223344566667788899998888875

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.2e-39  Score=346.91  Aligned_cols=197  Identities=27%  Similarity=0.427  Sum_probs=171.2

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .|++.+.||+|+||+||++.+..+++.||||.+....    .....+..|+.+++.+       .|++|+++++.+...+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~i~~~~~~~~~~~   73 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-------NSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-------CCCCeeeeeEEEecCC
Confidence            4788899999999999999999999999999987532    2234567799999888       6789999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+. ++|.+++.......+++..+..++.||+.||.|||+++|+||||||+||+++   ..+.++|+|||++.
T Consensus        74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~  150 (285)
T cd05630          74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAV  150 (285)
T ss_pred             EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeecccee
Confidence            9999999997 5788877655445699999999999999999999999999999999999995   66789999999986


Q ss_pred             ccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ....  ......++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         151 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             ecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            5432  223357899999999999989999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-38  Score=342.58  Aligned_cols=283  Identities=30%  Similarity=0.520  Sum_probs=222.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.+.||+|.+|+||++++..+++.||||+++...   ...+.+.+|+++++.+       .|+||+++++++....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-------QHGNIVRLQDVVHSEK   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-------cCCCEeeEEEEEecCC
Confidence            57999999999999999999999999999999986432   2345677899999998       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..|+||||++++|.+.+.......+++..++.++.||+.||+|||+++|+|+||||+||+++  .....+||+|||++..
T Consensus        75 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         75 RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARA  152 (294)
T ss_pred             eEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccc
Confidence            99999999999988888765544578899999999999999999999999999999999996  2456799999999965


Q ss_pred             cCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   .....++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+.++.+.++ .|.+.++...
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  231 (294)
T PLN00009        153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG-TPNEETWPGV  231 (294)
T ss_pred             cCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhcccc
Confidence            4322   2234568899999998764 678999999999999999999999998888888888887777 4444433321


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+....                                  +     -+....+...                 ...
T Consensus       232 ~~~~~~~~~~----------------------------------~-----~~~~~~~~~~-----------------~~~  255 (294)
T PLN00009        232 TSLPDYKSAF----------------------------------P-----KWPPKDLATV-----------------VPT  255 (294)
T ss_pred             ccchhhhhhc----------------------------------c-----cCCCCCHHHh-----------------CcC
Confidence            1111110000                                  0     0000011111                 112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .++.+.+||.+||+.||++||+++++|+||||.+.+
T Consensus       256 ~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             CChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            456789999999999999999999999999998754

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-39  Score=353.88  Aligned_cols=246  Identities=24%  Similarity=0.445  Sum_probs=196.9

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHH-HHHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVS-ILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~-iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      ++||+|+||+||+|++..+++.||||++.+..    .....+..|.. +++.+       .|+||+++++++...+..|+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-------~h~~iv~~~~~~~~~~~~~l   73 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-------KHPFLVGLHYSFQTAEKLYF   73 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-------CCCCccceeeEEEcCCEEEE
Confidence            36999999999999999999999999997532    12233444443 34444       68999999999999999999


Q ss_pred             EEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc--
Q 003239          190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--  266 (837)
Q Consensus       190 VmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~--  266 (837)
                      ||||+.+ +|.+.+...  ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++...  
T Consensus        74 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          74 VLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCC
Confidence            9999985 777666543  4689999999999999999999999999999999999995   6789999999998642  


Q ss_pred             -CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcch
Q 003239          267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS  345 (837)
Q Consensus       267 -~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~  345 (837)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+....+...    +.           
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~-----------  213 (321)
T cd05603         149 PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----PL-----------  213 (321)
T ss_pred             CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC----CC-----------
Confidence             22233457899999999999989999999999999999999999999877654443332210    00           


Q ss_pred             hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHH
Q 003239          346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA  425 (837)
Q Consensus       346 ~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~  425 (837)
                                                                                .+|             ...+..
T Consensus       214 ----------------------------------------------------------~~~-------------~~~~~~  222 (321)
T cd05603         214 ----------------------------------------------------------QLP-------------GGKTVA  222 (321)
T ss_pred             ----------------------------------------------------------CCC-------------CCCCHH
Confidence                                                                      000             012356


Q ss_pred             HHHHHHHhcccCcCCCCCH----HHHHcCccCCCCCC
Q 003239          426 LVDFLKGLVEFDPAKRWSP----FQASRHPFVTGEPF  458 (837)
Q Consensus       426 l~DLL~kmL~~DP~kRpTa----~EaL~HPff~~~~~  458 (837)
                      +.+||.+||+.||.+|+++    .|+++|+||....+
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            8899999999999999976    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-38  Score=341.40  Aligned_cols=280  Identities=29%  Similarity=0.472  Sum_probs=214.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...  .....+.+|+.+++.+       .|+||+++++++...+.
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-------KHANIVLLHDIIHTKET   77 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-------CCCCEeEEEEEEecCCe
Confidence            78999999999999999999999999999999997542  2234567899999988       68899999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .|+||||+.++|.+.+.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++   .++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEecccccccc
Confidence            99999999988888776543 4588899999999999999999999999999999999995   6678999999998643


Q ss_pred             CC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCchHHHHhh
Q 003239          267 DR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS-EFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       267 ~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s-~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ..   ......++..|+|||++.+. .++.++|||||||++|+|++|..||...+ ..+.+.++...++ .|...+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG-VPTEDTWPGV  232 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcC-CCChhhhhhh
Confidence            22   22334568899999998764 58889999999999999999999997654 4456666667677 4443333322


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+......                                     . .....+..+....               .
T Consensus       233 ~~~~~~~~~~~~-------------------------------------~-~~~~~~~~~~~~~---------------~  259 (291)
T cd07870         233 SKLPNYKPEWFL-------------------------------------P-CKPQQLRVVWKRL---------------S  259 (291)
T ss_pred             hhcccccchhcc-------------------------------------c-cCCcchhhhcccc---------------C
Confidence            221111110000                                     0 0000011111000               1


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .+..+.+||.+||+.||++|||++|+|.||||
T Consensus       260 ~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         260 RPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             CChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            24678899999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=347.13  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=217.2

Q ss_pred             CceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---
Q 003239          109 RRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---  184 (837)
Q Consensus       109 ~~Y~i~-~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---  184 (837)
                      ++|.|. ++||-|-.|.|..|.++.|++.+|+|++...    .++.+|+++.-...      .|+|||.++|+|+..   
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s------~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS------GHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc------CCCceEEeehhhhhhccC
Confidence            677776 5799999999999999999999999999743    45677887765553      799999999998753   


Q ss_pred             -ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          185 -RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       185 -~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                       +++.||||.|+ |.|+..+..+..+.++|.++..|++||..|+.|||+.+|.||||||||+|++....+..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence             68899999998 5899999888777899999999999999999999999999999999999999888889999999999


Q ss_pred             ccccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          263 ACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       263 A~~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      |+...  ....+.|-|++|.|||++-..+|+..+|+||+|||+|-|++|.+||....-..            .+.-|..+
T Consensus       211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------------ispgMk~r  278 (400)
T KOG0604|consen  211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------------ISPGMKRR  278 (400)
T ss_pred             ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc------------CChhHHhH
Confidence            98665  45667789999999999999999999999999999999999999997653211            11111111


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      .+                        ...|.                     |+.                     +++.
T Consensus       279 I~------------------------~gqy~---------------------FP~---------------------pEWs  292 (400)
T KOG0604|consen  279 IR------------------------TGQYE---------------------FPE---------------------PEWS  292 (400)
T ss_pred             hh------------------------ccCcc---------------------CCC---------------------hhHh
Confidence            00                        00111                     111                     1345


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ..+++++|||++||..||.+|+|++|+++|||+.+...
T Consensus       293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  293 CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            57889999999999999999999999999999998653

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.8e-39  Score=356.96  Aligned_cols=189  Identities=23%  Similarity=0.422  Sum_probs=164.1

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      +.||+|+||+||+|++..+++.||+|++++.    ....+.+.+|+.++.++.      .|+||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~------~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS------NHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC------CCCcCCceeeEEEeCCEEEEE
Confidence            3699999999999999999999999999853    233455677888877663      689999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+.+...  +.+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCC
Confidence            99998 5777666543  4699999999999999999999999999999999999995   6788999999998642   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      .......+||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            222345678999999999999999999999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.5e-40  Score=356.77  Aligned_cols=246  Identities=26%  Similarity=0.431  Sum_probs=203.2

Q ss_pred             EEeccCCceeEEEeec---cCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          115 DLLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~---~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      +.||+|+||.||++++   ..+++.||||++++..   ........|+++|+++       .|+||+++++++...+.+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~~   74 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-------NHPFIVKLHYAFQTEGKLY   74 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-------CCCCcccEEEEEEcCCEEE
Confidence            5799999999999876   4578999999998532   2334566788898888       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+.+...  ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++....
T Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          75 LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESI  149 (318)
T ss_pred             EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccC
Confidence            9999997 6888887654  3589999999999999999999999999999999999995   66789999999986543


Q ss_pred             C---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          268 R---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       268 ~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      .   .....+|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+.+...              
T Consensus       150 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--------------  215 (318)
T cd05582         150 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--------------  215 (318)
T ss_pred             CCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            2   23345789999999999998999999999999999999999999987766555444322100              


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                                 .+|             ...++
T Consensus       216 -----------------------------------------------------------~~p-------------~~~~~  223 (318)
T cd05582         216 -----------------------------------------------------------GMP-------------QFLSP  223 (318)
T ss_pred             -----------------------------------------------------------CCC-------------CCCCH
Confidence                                                                       000             01346


Q ss_pred             HHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF  458 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~  458 (837)
                      .+.+||++||+.||++|+|     ++++++||||....+
T Consensus       224 ~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             HHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence            6889999999999999999     788999999998654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.5e-39  Score=351.05  Aligned_cols=190  Identities=23%  Similarity=0.409  Sum_probs=165.9

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      ++||+|+||+||+|++..+++.||||++++..    ...+.+.+|+.++.++.      .|+||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~------~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS------SNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc------CCCCEeeEEEEEEeCCEEEEE
Confidence            36999999999999999999999999998642    33455778888888774      589999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---  266 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---  266 (837)
                      |||+. ++|.+.+...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...   
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCC
Confidence            99997 5787776544  3699999999999999999999999999999999999995   6788999999998642   


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            2333456799999999999999999999999999999999999999954

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-39  Score=345.27  Aligned_cols=288  Identities=29%  Similarity=0.514  Sum_probs=214.8

Q ss_pred             ceEEEEEeccCCceeEEEeeccC--CCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAE--MNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~--tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      +|++.++||+|+||.||+|++..  +++.||||+++..    ....+...+|+.+++.+       .|+||+++++++..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   73 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-------KHENVVSLVEVFLE   73 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-------CCCCccceEEEEeC
Confidence            58899999999999999999988  8999999999863    23345677899999988       68999999999998


Q ss_pred             c--ceEEEEEeccchhHHHHHHhhcc---CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec-cCCCCeEEE
Q 003239          184 Q--RHLCICFELLDSNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT-SVKPAEIKI  257 (837)
Q Consensus       184 ~--~~l~LVmEy~~gsL~d~l~~~~~---~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~-~~~~~~IKL  257 (837)
                      .  ..+|+||||++++|.+++.....   ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++..+.+||
T Consensus        74 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          74 HADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             CCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence            8  88999999999888887764332   25899999999999999999999999999999999999963 122789999


Q ss_pred             EecccccccCCc------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCH---------HHH
Q 003239          258 IDFGSACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDL  321 (837)
Q Consensus       258 ~DFGlA~~~~~~------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~---------~e~  321 (837)
                      +|||++......      ....+++..|+|||++.+. .++.++|||||||++|+|++|++||.+...         .+.
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            999998754322      1234678889999998764 688999999999999999999999976543         235


Q ss_pred             HHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHH
Q 003239          322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEI  401 (837)
Q Consensus       322 l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~i  401 (837)
                      +..+++.++ .+....+........+.....                             .     ....-+....+...
T Consensus       234 ~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~-----------------------------~-----~~~~~~~~~~~~~~  278 (316)
T cd07842         234 LERIFEVLG-TPTEKDWPDIKKMPEYDTLMK-----------------------------D-----FKTKTYPSNSLAKW  278 (316)
T ss_pred             HHHHHHHhC-CCchhHHHHHhhcccchhhhh-----------------------------h-----ccCCCCCCccHHHH
Confidence            566666666 333322222111111100000                             0     00000000111111


Q ss_pred             HhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          402 VTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       402 l~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..              .....+..+.+||.+||..||++|||++|+++||||
T Consensus       279 ~~--------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         279 ME--------------KHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HH--------------hccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            10              001345789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-38  Score=336.40  Aligned_cols=279  Identities=33%  Similarity=0.568  Sum_probs=214.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.++||+|+||.||+|++..+++.||+|++....   ...+.+.+|+++++.+       .|+||+++++++....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-------KHPNLVNLIEVFRRKR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-------CCCCEeeeeeEEeeCC
Confidence            47999999999999999999999999999999987432   2335577899999988       6889999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..++||||+++++++.+.... ..+++..++.++.||+.+|+|||+.+|+|+||||+||+++   .++.+||+|||++..
T Consensus        74 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~  149 (286)
T cd07847          74 KLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARI  149 (286)
T ss_pred             EEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECcccccee
Confidence            999999999976665554332 3599999999999999999999999999999999999995   667899999999975


Q ss_pred             cCCcc---eeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDRTV---YSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~~~---~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .....   ....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++...+... . .
T Consensus       150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~-~  227 (286)
T cd07847         150 LTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ-Q-I  227 (286)
T ss_pred             cCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh-h-h
Confidence            43322   23467889999999876 46889999999999999999999999988887877777776663222110 0 0


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+++...                                .+..    .....++..+                 ..
T Consensus       228 ~~~~~~~~~~~--------------------------------~~~~----~~~~~~~~~~-----------------~~  254 (286)
T cd07847         228 FSTNQFFKGLS--------------------------------IPEP----ETREPLESKF-----------------PN  254 (286)
T ss_pred             ccccccccccc--------------------------------CCCc----ccccCHHHHh-----------------cc
Confidence            00000000000                                0000    0000011111                 12


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .+..+.+||.+||+.||++|||+.|+|.||||
T Consensus       255 ~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         255 ISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            45788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-39  Score=354.27  Aligned_cols=246  Identities=22%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHH-HHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSI-LTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~i-L~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      +.||+|+||+||+|++..+++.||||++++..    .....+..|..+ ++.+       .|+||+++++++...+.+|+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-------~hp~iv~~~~~~~~~~~~~l   73 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-------KHPFLVGLHYSFQTTEKLYF   73 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-------CCCCCccEEEEEecCCEEEE
Confidence            36999999999999999999999999997532    223344455443 3334       78999999999999999999


Q ss_pred             EEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc--
Q 003239          190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--  266 (837)
Q Consensus       190 VmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~--  266 (837)
                      ||||+.+ +|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...  
T Consensus        74 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          74 VLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCC
Confidence            9999984 777766543  4699999999999999999999999999999999999995   6788999999998642  


Q ss_pred             -CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcch
Q 003239          267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS  345 (837)
Q Consensus       267 -~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~  345 (837)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+....+....-               
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---------------  213 (325)
T cd05604         149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---------------  213 (325)
T ss_pred             CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------------
Confidence             2223456789999999999999999999999999999999999999987765554443322000               


Q ss_pred             hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHH
Q 003239          346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA  425 (837)
Q Consensus       346 ~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~  425 (837)
                                                                                  ...           ...+..
T Consensus       214 ------------------------------------------------------------~~~-----------~~~~~~  222 (325)
T cd05604         214 ------------------------------------------------------------VLR-----------PGASLT  222 (325)
T ss_pred             ------------------------------------------------------------cCC-----------CCCCHH
Confidence                                                                        000           012356


Q ss_pred             HHHHHHHhcccCcCCCCCH----HHHHcCccCCCCCC
Q 003239          426 LVDFLKGLVEFDPAKRWSP----FQASRHPFVTGEPF  458 (837)
Q Consensus       426 l~DLL~kmL~~DP~kRpTa----~EaL~HPff~~~~~  458 (837)
                      +.+||++||+.||++|+++    +++++||||....+
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            7899999999999999987    59999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-38  Score=337.42  Aligned_cols=275  Identities=34%  Similarity=0.587  Sum_probs=215.2

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--ce
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--RH  186 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--~~  186 (837)
                      |+++++||+|+||.||++++..+++.||||+++..  ........+|+.+++++.      +|+||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS------PHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC------CCCCccceEEEEecCCCCc
Confidence            67899999999999999999999999999998753  222234456888887773      589999999999988  89


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      +++||||+.++|.+.+.... ..+++..++.++.||+.||+|||+++|+||||||+||+++   . +.+||+|||++...
T Consensus        75 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEeccccccc
Confidence            99999999999998887643 4689999999999999999999999999999999999996   4 89999999999754


Q ss_pred             CCc--ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          267 DRT--VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       267 ~~~--~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...  .....++..|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..+.+.++ .++..+......
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  228 (282)
T cd07831         150 YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG-TPDAEVLKKFRK  228 (282)
T ss_pred             ccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcC-CCCHHHHHhhcc
Confidence            322  233467889999998754 4578899999999999999999999999998888888888888 444433221100


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                      ...                     ..+.+             +.     .....+..+.                 ...+
T Consensus       229 ~~~---------------------~~~~~-------------~~-----~~~~~~~~~~-----------------~~~~  252 (282)
T cd07831         229 SRH---------------------MNYNF-------------PS-----KKGTGLRKLL-----------------PNAS  252 (282)
T ss_pred             ccc---------------------ccccC-------------cc-----cccccHHHHc-----------------cccc
Confidence            000                     00000             00     0000111111                 1245


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+.+||.+||.+||++|||++|+|+||||
T Consensus       253 ~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         253 AEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            789999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=357.24  Aligned_cols=248  Identities=25%  Similarity=0.413  Sum_probs=198.1

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||+|+||+||+|++..+++.||||++.+..    ........|..++..+..    .+||||+++++++...+.+|+|||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~----~~~p~i~~~~~~~~~~~~~~lv~e   76 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL----DESPFIVGLKFSFQTDSDLYLVTD   76 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhcc----CCCCcCcceEEEEecCCeEEEEEc
Confidence            799999999999999999999999997532    122334456666655421    269999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC---C
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---R  268 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~---~  268 (837)
                      |+. ++|.+.+...  ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++....   .
T Consensus        77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCC
Confidence            997 5888777653  4699999999999999999999999999999999999995   66889999999986432   2


Q ss_pred             cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhh
Q 003239          269 TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF  347 (837)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~  347 (837)
                      .....+||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....                 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  214 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-----------------  214 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            23356799999999999765 589999999999999999999999987765544333221000                 


Q ss_pred             hhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHH
Q 003239          348 FKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALV  427 (837)
Q Consensus       348 f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~  427 (837)
                                                                  .            +|            ....++.+.
T Consensus       215 --------------------------------------------~------------~~------------~~~~~~~~~  226 (330)
T cd05586         215 --------------------------------------------R------------FP------------KNVLSDEGR  226 (330)
T ss_pred             --------------------------------------------C------------CC------------CccCCHHHH
Confidence                                                        0            00            001346678


Q ss_pred             HHHHHhcccCcCCCC----CHHHHHcCccCCCCCC
Q 003239          428 DFLKGLVEFDPAKRW----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       428 DLL~kmL~~DP~kRp----Ta~EaL~HPff~~~~~  458 (837)
                      +||++||+.||++|+    +++|+++||||....+
T Consensus       227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             HHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            999999999999998    7999999999987543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.3e-38  Score=337.06  Aligned_cols=277  Identities=30%  Similarity=0.549  Sum_probs=218.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      +|++.++||.|++|.||+|++..+++.||||+++...  .....+.+|+.+++.+       .|+||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-------KHENIVRLHDVIHTENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-------cCCCEeeeeeeEeeCCcE
Confidence            5899999999999999999999999999999997542  2345677899999998       589999999999999999


Q ss_pred             EEEEeccchhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLDSNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      +|||||+.++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+||+++   +++.+||+|||++...
T Consensus        74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~  150 (284)
T cd07836          74 MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF  150 (284)
T ss_pred             EEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhh
Confidence            9999999999988876543 24589999999999999999999999999999999999995   6688999999998644


Q ss_pred             CCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ...   .....++..|++||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++.+... .|....++...
T Consensus       151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  229 (284)
T cd07836         151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTESTWPGIS  229 (284)
T ss_pred             cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChhhHHHHh
Confidence            322   2234568889999998764 578999999999999999999999999888888888887766 44333333222


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                      ....+.....                                       ......+..+.                 ...
T Consensus       230 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~-----------------~~~  253 (284)
T cd07836         230 QLPEYKPTFP---------------------------------------RYPPQDLQQLF-----------------PHA  253 (284)
T ss_pred             cCchhccccc---------------------------------------CCChHHHHHHh-----------------hhc
Confidence            1111000000                                       00000011111                 123


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      +..+.+||.+||+.||.+|||++|+|+||||
T Consensus       254 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         254 DPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            5778999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-39  Score=368.92  Aligned_cols=190  Identities=26%  Similarity=0.421  Sum_probs=167.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....     ....+|+++|++|       .|+|||++++++...+..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L-------~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRL-------SHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHC-------CCCCCCcEEEEEEECCEE
Confidence            3579999999999999999999999999999997542     3456899999998       689999999999999999


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      |||||++.++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+   ..+.+||+|||+++...
T Consensus       236 ~lv~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        236 CLVLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceecc
Confidence            9999999999998886543 4699999999999999999999999999999999999995   66789999999997543


Q ss_pred             Cc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          268 RT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       268 ~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      ..     ....+||+.|+|||++.+..++.++||||||||||||++|..++
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            21     12346899999999999999999999999999999999986544

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-38  Score=350.28  Aligned_cols=206  Identities=22%  Similarity=0.345  Sum_probs=174.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||++++..+++.||||++++..    .....+.+|+.++..+       .|++|+++++++...
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~l~~~~~~~   73 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-------DCQWITTLHYAFQDE   73 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence            47999999999999999999999999999999997532    2234456677777766       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..||||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a  149 (331)
T cd05624          74 NYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSC  149 (331)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccce
Confidence            99999999997 58888887643 4689999999999999999999999999999999999995   6778999999998


Q ss_pred             cccCCcc----eeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          264 CTEDRTV----YSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       264 ~~~~~~~----~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      .......    ...+|++.|+|||++.+     ..++.++|||||||++|||++|+.||...+..+.+..+
T Consensus       150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i  220 (331)
T cd05624         150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (331)
T ss_pred             eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH
Confidence            6543221    23478999999999976     46889999999999999999999999877665544443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-38  Score=350.97  Aligned_cols=199  Identities=30%  Similarity=0.469  Sum_probs=175.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.++||+|+||.||++.+..+++.||+|+++..  ......+.+|+++++.+       +|+||++++++|..+++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~   77 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-------CCCcccceeEEEEECCE
Confidence            7899999999999999999999999999999998753  33456788999999998       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +|+||||+. ++|.+++...  +.+++..++.++.||+.||.|||+. +|+||||||+|||++   .++.+||+|||++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~  152 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG  152 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcch
Confidence            999999997 5888888654  3589999999999999999999975 799999999999995   56789999999986


Q ss_pred             ccCCc-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q 003239          265 TEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF  319 (837)
Q Consensus       265 ~~~~~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~  319 (837)
                      ..... .....++..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~  208 (333)
T cd06650         153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK  208 (333)
T ss_pred             hhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            54322 23457899999999999889999999999999999999999999776543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=371.69  Aligned_cols=258  Identities=28%  Similarity=0.461  Sum_probs=221.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC-ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~-~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .+.|+|+..||.|+||.||+|.++.++-..|-|+|.. .....+.++.||+||..+       +||+||+|++.|..++.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-------dHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-------DHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-------CChHHHHHHHHHhccCc
Confidence            3678899999999999999999999999999999974 456678899999999998       79999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++|+.|||+|+-.|.+...-.+.|++.+|+.+++|+|.||.|||+++|||||||..|||++   -+|.|+|+|||.+...
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKN  180 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccc
Confidence            9999999998766666555557899999999999999999999999999999999999997   6789999999998543


Q ss_pred             C---CcceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          267 D---RTVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       267 ~---~~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      .   .....++||++|||||++.     ..+|++++||||||++|.||..+.||-..-+...++-+|.+   ..||.   
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPT---  254 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPT---  254 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCc---
Confidence            3   3346789999999999985     45899999999999999999999999877766655554433   12221   


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                                   +..
T Consensus       255 -----------------------------------------------------------------------------Llq  257 (1187)
T KOG0579|consen  255 -----------------------------------------------------------------------------LLQ  257 (1187)
T ss_pred             -----------------------------------------------------------------------------ccC
Confidence                                                                                         112


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ...++..|.|||++||..||..||++.|+|+||||+..+-
T Consensus       258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            2346788999999999999999999999999999997664

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-38  Score=341.30  Aligned_cols=191  Identities=28%  Similarity=0.427  Sum_probs=164.7

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||+|+||+||+++++.+++.||+|++....    ........|+++++++       +|+||+++++++..+.++|+|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~i~~~~~~~~~~~~~~lv~e   73 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-------NSPFIVNLAYAFESKTHLCLVMS   73 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-------CCCcEEEEEEEEecCCeEEEEEe
Confidence            799999999999999999999999997432    1233456689999888       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc--
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--  269 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~--  269 (837)
                      |+. ++|.+.+.......+++..+..++.||+.||+|||++||+||||||+||+++   .++.+||+|||++......  
T Consensus        74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCce
Confidence            997 5787777655545689999999999999999999999999999999999995   6778999999998654332  


Q ss_pred             ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence            233468899999999998899999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=348.01  Aligned_cols=280  Identities=32%  Similarity=0.573  Sum_probs=218.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC--ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-  184 (837)
                      .++|++.++||+|+||.||+|++..+++.||||+++.  .......+.+|+.+++.+       .|+||+++++++... 
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~   76 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-------KHENIIGILDIIRPPS   76 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-------CCCCcCchhheeeccc
Confidence            3789999999999999999999999999999999974  233456677899999998       588999999987654 


Q ss_pred             ----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 ----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                          ...|+||||+.++|.+.+...   .+++..++.++.||+.||+|||+++|+||||||+|||++   ..+.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~df  150 (336)
T cd07849          77 FESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDF  150 (336)
T ss_pred             ccccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcc
Confidence                358999999999888877543   599999999999999999999999999999999999995   6788999999


Q ss_pred             ccccccCCc------ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          261 GSACTEDRT------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       261 GlA~~~~~~------~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      |++......      ....+++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++..+
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~  230 (336)
T cd07849         151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS  230 (336)
T ss_pred             cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            998643221      123467899999998765 4689999999999999999999999999888888888888888444


Q ss_pred             chHHHHhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          334 PDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       334 p~~~l~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                      ++.+ ......  ..++...                                  +.     -....+....         
T Consensus       231 ~~~~-~~~~~~~~~~~~~~~----------------------------------~~-----~~~~~~~~~~---------  261 (336)
T cd07849         231 QEDL-NCIISLRARNYIKSL----------------------------------PF-----KPKVPWNKLF---------  261 (336)
T ss_pred             HHHH-HHhhchhhhhHHhhc----------------------------------Cc-----CCcccHHHHh---------
Confidence            3332 211100  0000000                                  00     0000011111         


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                              ...++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       262 --------~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         262 --------PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             --------cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                    12356789999999999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.6e-39  Score=353.13  Aligned_cols=246  Identities=23%  Similarity=0.417  Sum_probs=198.6

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHH-HHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSI-LTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~~~~~~~Ei~i-L~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      +.||+|+||+||+|++..+++.||+|++.+...    ....+..|..+ ++.+       .|+||+++++++...+.+|+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-------~h~~Iv~~~~~~~~~~~~~l   73 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-------KHPFLVGLHFSFQTADKLYF   73 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-------CCCCCCceeEEEEcCCeEEE
Confidence            369999999999999999999999999985321    12233334333 3334       78999999999999999999


Q ss_pred             EEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc--
Q 003239          190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--  266 (837)
Q Consensus       190 VmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~--  266 (837)
                      ||||+.+ +|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...  
T Consensus        74 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          74 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCccccc
Confidence            9999985 787777653  3588999999999999999999999999999999999995   6788999999998643  


Q ss_pred             -CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcch
Q 003239          267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS  345 (837)
Q Consensus       267 -~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~  345 (837)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.....               
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------------  213 (325)
T cd05602         149 HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------------  213 (325)
T ss_pred             CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc---------------
Confidence             2223456799999999999999999999999999999999999999988776555444332000               


Q ss_pred             hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHH
Q 003239          346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA  425 (837)
Q Consensus       346 ~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~  425 (837)
                                                                                  .           .....+..
T Consensus       214 ------------------------------------------------------------~-----------~~~~~~~~  222 (325)
T cd05602         214 ------------------------------------------------------------Q-----------LKPNITNS  222 (325)
T ss_pred             ------------------------------------------------------------C-----------CCCCCCHH
Confidence                                                                        0           00013467


Q ss_pred             HHHHHHHhcccCcCCCCCHH----HHHcCccCCCCCC
Q 003239          426 LVDFLKGLVEFDPAKRWSPF----QASRHPFVTGEPF  458 (837)
Q Consensus       426 l~DLL~kmL~~DP~kRpTa~----EaL~HPff~~~~~  458 (837)
                      +.+||++||+.||.+|+++.    ++++|+||....+
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            89999999999999999876    8999999987554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-38  Score=340.65  Aligned_cols=258  Identities=26%  Similarity=0.388  Sum_probs=210.2

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .|++.+.||+|+||+||++.+..+++.||+|++....    .....+.+|+++|+.+       .|+||+++++.+..++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~i~~~~~~~~~~~   73 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-------NSQFVVNLAYAYETKD   73 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-------CCcCceeEEEEEecCC
Confidence            3788899999999999999999999999999997542    2234567899999988       5789999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..|+||||+.+ +|.+.+.......+++..+..++.||+.||.|||+++|+||||||+||+++   ..+.+||+|||++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~  150 (285)
T cd05632          74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAV  150 (285)
T ss_pred             EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcce
Confidence            99999999984 777777654444699999999999999999999999999999999999995   56789999999986


Q ss_pred             ccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....  ......++..|+|||++.+..++.++|||||||++|+|++|..||...........+.+.......        
T Consensus       151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--------  222 (285)
T cd05632         151 KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--------  222 (285)
T ss_pred             ecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--------
Confidence            5432  223457899999999999889999999999999999999999999876554443333221110000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                   .+             ....
T Consensus       223 -------------------------------------------------------------~~-------------~~~~  228 (285)
T cd05632         223 -------------------------------------------------------------VY-------------SAKF  228 (285)
T ss_pred             -------------------------------------------------------------cc-------------CccC
Confidence                                                                         00             0013


Q ss_pred             HHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT  459 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~  459 (837)
                      +..+.+||.+||+.||++|+|     +.++++|+||+..+++
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence            456789999999999999999     8999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=348.09  Aligned_cols=282  Identities=32%  Similarity=0.546  Sum_probs=219.6

Q ss_pred             CCceEE-EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhH---------------HHHHHHHHHHHHhhcccCCCCC
Q 003239          108 QRRYIV-KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---------------QQALVEVSILTTLNKKYDREDK  171 (837)
Q Consensus       108 ~~~Y~i-~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~---------------~~~~~Ei~iL~~L~~~~~~~~H  171 (837)
                      .++|.+ .+.||.|+||+||+|++..+++.||||+++......               ..+.+|+++++.+       .|
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h   79 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-------KH   79 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-------CC
Confidence            367765 477999999999999999999999999997532211               2467899999988       68


Q ss_pred             CceeEEeEEEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       172 pnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      +||+++++++...+..|+||||+.++|.+++...  ..+++..+..++.||+.||+|||++||+|+||||+||+++   .
T Consensus        80 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~  154 (335)
T PTZ00024         80 ENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---S  154 (335)
T ss_pred             cceeeeeEEEecCCcEEEEEeccccCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---C
Confidence            9999999999999999999999999999888654  3589999999999999999999999999999999999995   6


Q ss_pred             CCeEEEEecccccccC-----------------CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 003239          252 PAEIKIIDFGSACTED-----------------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~-----------------~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      .+.+||+|||++....                 .......++..|+|||++.+. .++.++|||||||++|||++|.+||
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            6789999999986433                 111223457889999999765 4789999999999999999999999


Q ss_pred             CCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccc
Q 003239          314 PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF  393 (837)
Q Consensus       314 ~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f  393 (837)
                      .+.+..+.+..+.+.++ .|+...+........+..                    +                    ...
T Consensus       235 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~--------------------~--------------------~~~  273 (335)
T PTZ00024        235 PGENEIDQLGRIFELLG-TPNEDNWPQAKKLPLYTE--------------------F--------------------TPR  273 (335)
T ss_pred             CCCCHHHHHHHHHHHhC-CCchhhCcchhhcccccc--------------------c--------------------CcC
Confidence            99999888888888887 333322221111000000                    0                    000


Q ss_pred             cccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       394 ~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                      ....+..+.                 ...+..+.+||.+||+.||++|||++|+|.||||+..+..
T Consensus       274 ~~~~~~~~~-----------------~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        274 KPKDLKTIF-----------------PNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             CcccHHHhC-----------------cCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            001111111                 1134678999999999999999999999999999987654

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-38  Score=340.24  Aligned_cols=252  Identities=25%  Similarity=0.481  Sum_probs=212.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||++.+..+++.||||+++...    ...+.+.+|+++++.+       +|+||+++++++...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   73 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-------RHPFLVNLYGSFQDD   73 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCccceeeEEEcC
Confidence            47999999999999999999999999999999997532    3345677899999988       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+|||++   .++.+||+|||++
T Consensus        74 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~  148 (290)
T cd05580          74 SNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFA  148 (290)
T ss_pred             CeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCc
Confidence            99999999995 7898888765  4699999999999999999999999999999999999995   6688999999999


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...........+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+..+.+..  + .+          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~-~~----------  215 (290)
T cd05580         149 KRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--G-KV----------  215 (290)
T ss_pred             cccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C-Cc----------
Confidence            7765555566789999999999888899999999999999999999999977664433333221  0 00          


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                  .+|             ...+
T Consensus       216 ------------------------------------------------------------~~~-------------~~~~  222 (290)
T cd05580         216 ------------------------------------------------------------RFP-------------SFFS  222 (290)
T ss_pred             ------------------------------------------------------------cCC-------------ccCC
Confidence                                                                        000             0123


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      ..+.+||++||..||.+|+     +++|+++||||....+
T Consensus       223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence            6788999999999999999     9999999999988664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.8e-38  Score=340.18  Aligned_cols=280  Identities=29%  Similarity=0.476  Sum_probs=213.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.++||+|+||.||+|++..+++.||||++....   .......+|+++++++       .|+||+++++++....
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~   84 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTKA   84 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-------CCCCccceEEEEeccc
Confidence            78999999999999999999999999999999986432   2234556799999988       6899999999987654


Q ss_pred             --------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          186 --------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       186 --------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                              ..++||||+.++|.+.+.... ..+++.+++.++.||+.||+|||+++|+|+||||+||+++   ..+.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEE
Confidence                    459999999998888876543 3589999999999999999999999999999999999995   6788999


Q ss_pred             EecccccccCCc-------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          258 IDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       258 ~DFGlA~~~~~~-------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      +|||++......       .....++..|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+..+.+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999998643221       1234567889999998765 47899999999999999999999999988888888888877


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      +..+++ +.+..... ..++...                                .+.   ...  ..+...+       
T Consensus       241 ~~~~~~-~~~~~~~~-~~~~~~~--------------------------------~~~---~~~--~~~~~~l-------  274 (310)
T cd07865         241 GSITPE-VWPGVDKL-ELFKKME--------------------------------LPQ---GQK--RKVKERL-------  274 (310)
T ss_pred             CCCChh-hcccccch-hhhhhcc--------------------------------CCC---ccc--hhhHHhc-------
Confidence            744433 22211100 0000000                                000   000  0000000       


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                              .....+..+.|||.+||..||++|||++|+|+||||
T Consensus       275 --------~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         275 --------KPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             --------ccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                    000123567899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.7e-38  Score=339.32  Aligned_cols=280  Identities=33%  Similarity=0.532  Sum_probs=220.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-  184 (837)
                      ++|++.+.||.|+||.||+|.+..+++.||||.++...   .....+.+|+.+++++       .|+||+++++++... 
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~~~~~   77 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-------QHPNIVTVKEVVVGSN   77 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-------CCCCEEEEEEEEEecC
Confidence            67999999999999999999999999999999997432   2234567899999988       589999999999887 


Q ss_pred             -ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 -RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 -~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                       +..||||||+.++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+|||++   ..+.+||+|||++
T Consensus        78 ~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~  153 (293)
T cd07843          78 LDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLA  153 (293)
T ss_pred             CCcEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCce
Confidence             8999999999999988877643 3689999999999999999999999999999999999995   6688999999998


Q ss_pred             cccCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          264 CTEDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       264 ~~~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ......   .....++..|+|||++.+. .++.++|||||||++|+|++|.+||......+.+.++...++ .|....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~  232 (293)
T cd07843         154 REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG-TPTEKIWP  232 (293)
T ss_pred             eeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCchHHHH
Confidence            754332   2334578889999998765 468999999999999999999999999988888888888888 44444333


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                      ..........                                         ..+.......+...++.            
T Consensus       233 ~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~------------  259 (293)
T cd07843         233 GFSELPGAKK-----------------------------------------KTFTKYPYNQLRKKFPA------------  259 (293)
T ss_pred             Hhhccchhcc-----------------------------------------cccccccchhhhccccc------------
Confidence            2211100000                                         00000000111111110            


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+++.+.+||++||+.||++|||++|+|+||||
T Consensus       260 ~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         260 LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            0035678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=351.55  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=217.8

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ..+-|.++++||+|+||.||+|.++++|+.||||.+..+ .+.++++.|+.||+++       ..++||++|+.|.....
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC-------~S~yVVKYYGSYFK~sD  102 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQC-------KSKYVVKYYGSYFKHSD  102 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHc-------CCchhhhhhhhhccCCc
Confidence            336688899999999999999999999999999999865 3478899999999999       45799999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|||||||+ |+..|+++.++ +.|+|.++..+++..++||+|||...-||||||..|||++   .++..||+|||.|.+
T Consensus       103 LWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN---T~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN---TDGIAKLADFGVAGQ  178 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---ccchhhhhhccccch
Confidence            999999998 78888887765 6899999999999999999999999999999999999996   678999999999977


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..+.   ..+.+||+.|||||++..-.|+.++||||||++..||..|++||..-.....   |.-+-..+||        
T Consensus       179 LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPP--------  247 (502)
T KOG0574|consen  179 LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPP--------  247 (502)
T ss_pred             hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCC--------
Confidence            6554   3567999999999999999999999999999999999999999965432111   1000000000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                              .+.+...+
T Consensus       248 ------------------------------------------------------------------------TF~KPE~W  255 (502)
T KOG0574|consen  248 ------------------------------------------------------------------------TFKKPEEW  255 (502)
T ss_pred             ------------------------------------------------------------------------CCCChHhh
Confidence                                                                                    11122347


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +.+|-|||++||...|++|-||.++++|||+++.+
T Consensus       256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            88999999999999999999999999999999865

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=342.61  Aligned_cols=259  Identities=25%  Similarity=0.468  Sum_probs=213.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||+||+|.+..+++.||||.+....    ...+.+..|+++++.+       .|+||+++++.+...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~   73 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-------DHPFLPTLYASFQTE   73 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-------CCCCchhheeeeecC
Confidence            47999999999999999999999999999999998543    2445677899999888       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..|+||||+. ++|.+++.......+++..++.++.||+.||+|||+.||+|+||||+||+++   .++.++|+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~  150 (316)
T cd05574          74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLS  150 (316)
T ss_pred             CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchh
Confidence            99999999997 4888888765556799999999999999999999999999999999999996   5678999999998


Q ss_pred             cccCCc--------------------------------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCC
Q 003239          264 CTEDRT--------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       264 ~~~~~~--------------------------------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      ......                                ....+|+..|+|||++.+..++.++|||||||++|+|++|..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence            533211                                112367888999999998889999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcc
Q 003239          312 LFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE  391 (837)
Q Consensus       312 PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~  391 (837)
                      ||.+.+....+..+.....                                                             
T Consensus       231 pf~~~~~~~~~~~~~~~~~-------------------------------------------------------------  249 (316)
T cd05574         231 PFKGSNRDETFSNILKKEV-------------------------------------------------------------  249 (316)
T ss_pred             CCCCCchHHHHHHHhcCCc-------------------------------------------------------------
Confidence            9987765544433321000                                                             


Q ss_pred             cccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCC----HHHHHcCccCCCCCCCCC
Q 003239          392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS----PFQASRHPFVTGEPFTCP  461 (837)
Q Consensus       392 ~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT----a~EaL~HPff~~~~~~~~  461 (837)
                                  .++           .....++.+.+||++||+.||++|||    ++|+|+||||++.++...
T Consensus       250 ------------~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~  300 (316)
T cd05574         250 ------------TFP-----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI  300 (316)
T ss_pred             ------------cCC-----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence                        000           00013467899999999999999999    999999999999776433

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=336.06  Aligned_cols=276  Identities=32%  Similarity=0.575  Sum_probs=217.8

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      |++.++||.|++|.||+|.+..+++.||||++....   .....+.+|+++++.+       .|+||+++++++...+..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-------~~~~iv~~~~~~~~~~~~   73 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-------NHPNIVRLLDVVHSENKL   73 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-------CCCCccCHhheeccCCeE
Confidence            678899999999999999999999999999997542   2335677899999988       589999999999999999


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      |+||||++++|.+++.......+++..++.++.||++||+|||+++++|+||+|+||+++   .++.++|+|||++....
T Consensus        74 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~  150 (283)
T cd07835          74 YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFG  150 (283)
T ss_pred             EEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccC
Confidence            999999998998888765444689999999999999999999999999999999999996   57889999999986543


Q ss_pred             Ccc---eeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          268 RTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       268 ~~~---~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...   ....++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+.+..+ .|....+.....
T Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  229 (283)
T cd07835         151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG-TPDEDVWPGVTS  229 (283)
T ss_pred             CCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChHHhhhhhh
Confidence            221   223567889999988765 578999999999999999999999999888888888887776 444443322111


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                      ...+.....                                       .+....+...                 ....+
T Consensus       230 ~~~~~~~~~---------------------------------------~~~~~~~~~~-----------------~~~~~  253 (283)
T cd07835         230 LPDYKPTFP---------------------------------------KWARQDLSKV-----------------VPNLD  253 (283)
T ss_pred             chhhhhhcc---------------------------------------cccccchhhh-----------------cCCCC
Confidence            111100000                                       0000001111                 11244


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+.+||.+||+.||++|||++|+|+||||
T Consensus       254 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         254 EDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-39  Score=359.22  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=223.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +.|.++++||+|+||.+++++++...+.|++|.|...   ....+.+..|+.+++++       .|||||.+++.|..++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-------~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-------LHPNIVEYKDSFEEDG   76 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-------cCCCeeeeccchhcCC
Confidence            6899999999999999999999999999999999743   33445788999999998       6899999999999998


Q ss_pred             e-EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          186 H-LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       186 ~-l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      . +||||+||+ |++.+.++..+..-++|+.+..++.||+.||.|||++.|+|||||+.|||++   ++..|||.|||+|
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGla  153 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLA  153 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhh
Confidence            8 999999998 5888898888767799999999999999999999999999999999999997   6778899999999


Q ss_pred             cccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      +.....   ..+++||+.|+.||++.+.+|+.|+|||||||++|||++-+++|.+.+-..++.+|.+....+.       
T Consensus       154 K~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl-------  226 (426)
T KOG0589|consen  154 KILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL-------  226 (426)
T ss_pred             hhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence            876543   4678999999999999999999999999999999999999999999988888888776442000       


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                                                    ..
T Consensus       227 ------------------------------------------------------------------------------p~  228 (426)
T KOG0589|consen  227 ------------------------------------------------------------------------------PS  228 (426)
T ss_pred             ------------------------------------------------------------------------------Cc
Confidence                                                                                          01


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      .++.++..||+.||..+|+.||+|.++|.+|.+..
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            24578899999999999999999999999988874

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-38  Score=364.36  Aligned_cols=252  Identities=24%  Similarity=0.320  Sum_probs=209.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC-CeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t-g~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+... ......+.+|+.+|+.+       +|||||+++++|...+.
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-------~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-------DHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCEeEEEEEEEECCE
Confidence            5699999999999999999988877 788999987644 33345667799999888       78999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          187 LCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +||||||+. ++|.+.+...  ....+++..+..++.||+.||.|||+++||||||||+|||++   ..+.+||+|||++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla  216 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCc
Confidence            999999997 5888877543  234589999999999999999999999999999999999995   6788999999999


Q ss_pred             cccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          264 CTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       264 ~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +.....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.....  +     
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~--~-----  289 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY--D-----  289 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--C-----
Confidence            754332     2345789999999999999999999999999999999999999987766555444332000  0     


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                     +                  +|            
T Consensus       290 -----------------------------------------------~------------------~~------------  292 (478)
T PTZ00267        290 -----------------------------------------------P------------------FP------------  292 (478)
T ss_pred             -----------------------------------------------C------------------CC------------
Confidence                                                           0                  00            


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                       ..++..+.+||.+||..||++|||++|+|+|+|++.
T Consensus       293 -~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        293 -CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             -ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence             013467899999999999999999999999999975

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-38  Score=370.24  Aligned_cols=286  Identities=22%  Similarity=0.265  Sum_probs=204.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC-CeEEE------------------EEEEeCChhhHHHHHHHHHHHHHhhcccCC
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM-NSFVA------------------VKIIKNQPAYYQQALVEVSILTTLNKKYDR  168 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t-g~~VA------------------IKiik~~~~~~~~~~~Ei~iL~~L~~~~~~  168 (837)
                      .++|+++++||+|+||+||+|..+.. ++.++                  .|.++........+.+|+.+|+.+      
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l------  220 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL------  220 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC------
Confidence            37899999999999999999865432 12222                  222222333455678899999998      


Q ss_pred             CCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhhcc---CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCee
Q 003239          169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL  245 (837)
Q Consensus       169 ~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~---~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL  245 (837)
                       .|+|||++++++...+..|+|||++.++|.+++.....   .......++.|+.||+.||+|||++|||||||||+|||
T Consensus       221 -~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL  299 (501)
T PHA03210        221 -NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF  299 (501)
T ss_pred             -CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence             68999999999999999999999999988887754321   22446778899999999999999999999999999999


Q ss_pred             eeccCCCCeEEEEecccccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCC-CCC--CCH
Q 003239          246 LCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL-FPG--ASE  318 (837)
Q Consensus       246 l~~~~~~~~IKL~DFGlA~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~P-F~g--~s~  318 (837)
                      ++   .++.+||+|||++......    ....+||..|+|||++.+..++.++||||||||+|||++|..+ |..  ...
T Consensus       300 l~---~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        300 LN---CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             EC---CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            95   6788999999999754322    2245789999999999999999999999999999999998754 432  234


Q ss_pred             HHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccch
Q 003239          319 FDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL  398 (837)
Q Consensus       319 ~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L  398 (837)
                      ...+.+++..++ .+.+.+.....+...++...                         .+          .   .....+
T Consensus       377 ~~~~~~~~~~~~-~~~~~~p~~~~~~~~~i~~~-------------------------~~----------~---~~~~~~  417 (501)
T PHA03210        377 GKQLLKIIDSLS-VCDEEFPDPPCKLFDYIDSA-------------------------EI----------D---HAGHSV  417 (501)
T ss_pred             HHHHHHHHHhcc-cChhhcCCcHHHHHHHhhhh-------------------------hc----------c---cCccch
Confidence            455555555444 22211111000000000000                         00          0   000111


Q ss_pred             HHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       399 ~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..++..               ...+..+.+||.+||.+||++|||+.|+|+||||....
T Consensus       418 ~~~~~~---------------~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        418 PPLIRN---------------LGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             hhHHHh---------------cCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            122211               12346789999999999999999999999999998754

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=331.72  Aligned_cols=277  Identities=32%  Similarity=0.542  Sum_probs=216.6

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce-
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH-  186 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~-  186 (837)
                      |++.+.||+|+||.||++++..+++.||||+++..   ......+.+|+.+++++...    .|+||+++++++...+. 
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~~i~~~~~~~~~~~~~   76 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESF----EHPNIVRLLDVCHGPRTD   76 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhcc----CCCCcceEEEEEeeccCC
Confidence            67899999999999999999888999999999743   22234566788888888543    69999999999998876 


Q ss_pred             ----EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          187 ----LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       187 ----l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                          +++|||++.++|.+++.......+++..++.++.||+.||.|||+.+|+|+||||+||+++   .++.+||+|||+
T Consensus        77 ~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~  153 (287)
T cd07838          77 RELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGL  153 (287)
T ss_pred             CCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCc
Confidence                9999999999898888765444699999999999999999999999999999999999996   568899999999


Q ss_pred             ccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          263 ACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       263 A~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      +......  .....++..|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+......+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            8654322  22345788899999999989999999999999999999999999999888888888776552111110000


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      .....                                        .....  .....+..+                 ..
T Consensus       234 ~~~~~----------------------------------------~~~~~--~~~~~~~~~-----------------~~  254 (287)
T cd07838         234 VSLPR----------------------------------------SSFPS--YTPRSFKSF-----------------VP  254 (287)
T ss_pred             cccch----------------------------------------hhccc--ccccchhhh-----------------hh
Confidence            00000                                        00000  000000111                 11


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..++.+.+||.+||..||++|||++|+|+||||
T Consensus       255 ~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         255 EICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.2e-38  Score=338.04  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=206.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .+.|+++++||.|+||.||++++..+++.||+|++... ....+.+.+|+.+++.+       .|+||+++++++..++.
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   83 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-------NHPYIVKLLGAFYWDGK   83 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCcEeeeEEEEEeCCe
Confidence            37899999999999999999999999999999999754 34466778899999888       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|+||||+.+ +|..++.... ..+++..++.++.||+.+|.|||+++|+||||||+||+++   .++.+||+|||++..
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~  159 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAK  159 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCcccee
Confidence            9999999986 5555554433 4689999999999999999999999999999999999995   567899999999864


Q ss_pred             cCC---cceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ...   ......++..|+|||++.     ...++.++|||||||++|||++|.+||...+....+.++...   .++.  
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~--  234 (292)
T cd06644         160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPT--  234 (292)
T ss_pred             ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCcc--
Confidence            322   123456788999999985     335788999999999999999999999765543332222110   0000  


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                                    ..
T Consensus       235 ------------------------------------------------------------------------------~~  236 (292)
T cd06644         235 ------------------------------------------------------------------------------LS  236 (292)
T ss_pred             ------------------------------------------------------------------------------CC
Confidence                                                                                          00


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ....++.++.+||++||..||++|||++|+|+||||.....
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            00113456889999999999999999999999999987554

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.3e-38  Score=334.94  Aligned_cols=201  Identities=28%  Similarity=0.487  Sum_probs=172.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---  184 (837)
                      .+.|++.+.||+|+||.||+|++..+++.||||++.........+..|+.+++.+.      .|+||++++++|...   
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS------HHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc------CCCCeeeEeeEEeecCCC
Confidence            47899999999999999999999999999999999876555567888999998874      589999999998763   


Q ss_pred             ---ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 ---RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 ---~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                         ..+|+||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+|+||||+||+++   +++.+||+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~Df  155 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDF  155 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEccC
Confidence               46899999998 5888888765445689999999999999999999999999999999999996   6678999999


Q ss_pred             ccccccCC---cceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          261 GSACTEDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       261 GlA~~~~~---~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      |++.....   ......++..|+|||++.     +..++.++|||||||++|||++|..||....
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~  220 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            99875432   223457889999999986     3368889999999999999999999996543

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-38  Score=334.50  Aligned_cols=279  Identities=33%  Similarity=0.595  Sum_probs=219.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++..   ....+.+.+|+++++.+       .|+||+++++++...+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-------RHENIVNLKEAFRRKG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-------CCCCeeehhheEEECC
Confidence            4799999999999999999999999999999998743   23346788899999998       5889999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..++||||+++++.+.+.... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++   +++.+||+|||++..
T Consensus        74 ~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~  149 (288)
T cd07833          74 RLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARA  149 (288)
T ss_pred             EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccc
Confidence            999999999987766655443 4589999999999999999999999999999999999995   678899999999875


Q ss_pred             cCCc----ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          266 EDRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       266 ~~~~----~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ....    .....++..|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+...++..++......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            4432    2345678899999999888 8899999999999999999999999988888888888887774444322111


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCccccccc-chHHHHhcCCCCCCCchhhhhhh
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK-HLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~-~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                      . ... .+....                                        +... ....+...+             .
T Consensus       230 ~-~~~-~~~~~~----------------------------------------~~~~~~~~~~~~~~-------------~  254 (288)
T cd07833         230 S-SNP-RFAGVA----------------------------------------FPEPSQPESLERRY-------------P  254 (288)
T ss_pred             c-cCc-cccccc----------------------------------------cCCCCCcHHHHHhc-------------C
Confidence            0 000 000000                                        0000 000000000             1


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ...+.++.+||++||..||++|||++++++||||
T Consensus       255 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         255 GKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            1235789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-38  Score=345.75  Aligned_cols=279  Identities=28%  Similarity=0.566  Sum_probs=219.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|.+.+.||+|+||.||+|++..+++.||||++++.   ......+.+|+.+++.+       .|+||+++++++....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~~~~~~~   87 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-------QHENVIGLLDVFTSAV   87 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-------CCCCccchhheecccc
Confidence            7899999999999999999999999999999998753   22345677899999988       6899999999987653


Q ss_pred             ------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          186 ------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       186 ------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                            .+|+||||+..+|...+.    ..+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~d  160 (342)
T cd07879          88 SGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILD  160 (342)
T ss_pred             cCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEee
Confidence                  569999999877665542    3589999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          260 FGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       260 FGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ||++...........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+....+.+.+ .+.
T Consensus       161 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  239 (342)
T cd07879         161 FGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP-EFV  239 (342)
T ss_pred             CCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH-HHH
Confidence            9999766555555677889999999876 46899999999999999999999999998888888888888773333 333


Q ss_pred             Hhhhcch--hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          339 KEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       339 ~~~k~~~--~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      +......  .+...                                  .+     .+....+....              
T Consensus       240 ~~~~~~~~~~~~~~----------------------------------~~-----~~~~~~~~~~~--------------  266 (342)
T cd07879         240 QKLEDKAAKSYIKS----------------------------------LP-----KYPRKDFSTLF--------------  266 (342)
T ss_pred             HHhcccchHHHHhh----------------------------------cC-----CcccchHHHHh--------------
Confidence            2211100  00000                                  00     00011111111              


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                         ...+..+++||++||+.||++|||++|+|+||||.+.+.
T Consensus       267 ---~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         267 ---PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             ---cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence               123467899999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.8e-38  Score=346.15  Aligned_cols=198  Identities=18%  Similarity=0.260  Sum_probs=166.5

Q ss_pred             EEEEeccC--CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          113 VKDLLGHG--TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       113 i~~~LG~G--~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ++++||+|  +|++||+++++.+++.||||+++..   ....+.+.+|+++++.+       +||||++++++|..++..
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~hpniv~~~~~~~~~~~~   74 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-------NHPNIVPYRATFIADNEL   74 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEEECCEE
Confidence            56789999  7899999999999999999999753   23345667799999888       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |+||||+. ++|.+++.......+++..++.++.||+.||+|||+++||||||||+|||++   .++.++|+||+.+...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~  151 (327)
T cd08227          75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSM  151 (327)
T ss_pred             EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcc
Confidence            99999998 5888888765545699999999999999999999999999999999999996   5678999999865322


Q ss_pred             CC----------cceeeccCccccCchhhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          267 DR----------TVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       267 ~~----------~~~~~~GT~~Y~APEvl~~--~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      ..          ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  217 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ  217 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence            11          1112345677999999976  368999999999999999999999997765444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=352.35  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=203.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe---CChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik---~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..|+++++||.|+.+.||++.... ...||+|.+.   .+.....-+.+|+..|.+|+      +|.+||+|+|+-..++
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk------g~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLK------GHDKIIQLYDYEVTDG  433 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc------CCceEEEEeeeeccCc
Confidence            789999999999999999997654 4456666655   34566778999999999996      6789999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+|+|||+-+.+|..+|++.. ..++.-.++.+.+|||.|+.++|.+||||.||||.|+|+    -.|.+||+|||+|..
T Consensus       434 ~lYmvmE~Gd~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  434 YLYMVMECGDIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANA  508 (677)
T ss_pred             eEEEEeecccccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcc
Confidence            999999999999999988764 334545899999999999999999999999999999999    478999999999975


Q ss_pred             cCCcc-----eeeccCccccCchhhcCC-----------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          266 EDRTV-----YSYIQSRYYRSPEVLLGY-----------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       266 ~~~~~-----~~~~GT~~Y~APEvl~~~-----------~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      .....     ...+||+.||+||.+...           +.+.++||||||||||+|+.|++||..-  ...+.++..+.
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI~  586 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAIT  586 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhhc
Confidence            54332     345899999999999643           2567899999999999999999999432  22333333322


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      .  |..+                                                      .-|+.         .|   
T Consensus       587 ~--P~~~------------------------------------------------------Iefp~---------~~---  598 (677)
T KOG0596|consen  587 D--PNHE------------------------------------------------------IEFPD---------IP---  598 (677)
T ss_pred             C--CCcc------------------------------------------------------ccccC---------CC---
Confidence            1  0000                                                      00000         00   


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                                  -..+++|+++.||..||++|||+.|+|+|||++..+.
T Consensus       599 ------------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i  635 (677)
T KOG0596|consen  599 ------------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI  635 (677)
T ss_pred             ------------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence                        0123899999999999999999999999999997554

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=331.03  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=206.2

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-  185 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-  185 (837)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.+++.+.      .|+||+++++++.... 
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS------NHPNIATFYGAFIKKNP   77 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc------CCCChheEEEEEEecCC
Confidence            348999999999999999999999989999999999876666677889999999884      5899999999997654 


Q ss_pred             -----eEEEEEeccch-hHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          186 -----HLCICFELLDS-NLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       186 -----~l~LVmEy~~g-sL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                           .+|+||||+.+ +|.+++....  ...+++..++.++.||+.||.|||+++|+|+||+|+||+++   .++.+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l  154 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKL  154 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEE
Confidence                 58999999985 7888776533  35699999999999999999999999999999999999996   5688999


Q ss_pred             EecccccccCCc---ceeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          258 IDFGSACTEDRT---VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       258 ~DFGlA~~~~~~---~~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      +|||++......   .....++..|+|||++..     ..++.++|||||||++|+|++|.+||........+.++.+. 
T Consensus       155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  233 (275)
T cd06608         155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-  233 (275)
T ss_pred             CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-
Confidence            999998654322   234567889999999854     24778999999999999999999999755433332222110 


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                        .++                                                                           
T Consensus       234 --~~~---------------------------------------------------------------------------  236 (275)
T cd06608         234 --PPP---------------------------------------------------------------------------  236 (275)
T ss_pred             --CCC---------------------------------------------------------------------------
Confidence              000                                                                           


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                           .+.....++..+.+||++||..||++|||++|+++|||+
T Consensus       237 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 -----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                 000011244678999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-38  Score=347.45  Aligned_cols=281  Identities=31%  Similarity=0.610  Sum_probs=224.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||++...   ....+.+.+|+.+++.+       .|+||+++++++...
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   86 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-------DHENVIGLLDVFTPA   86 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-------cCCCHHHHHHHhhcc
Confidence            47899999999999999999999999999999998742   23445677899999888       689999999988766


Q ss_pred             ce------EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 RH------LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ~~------l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      +.      .|+|+||++++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+||+++   .++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~  160 (343)
T cd07851          87 SSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKIL  160 (343)
T ss_pred             ccccccccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEc
Confidence            54      999999999999888875   3599999999999999999999999999999999999996   56889999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||++...........++..|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+.+.++ .+++.+
T Consensus       161 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~  239 (343)
T cd07851         161 DFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG-TPDEEL  239 (343)
T ss_pred             cccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCHHH
Confidence            999998766555566788999999998764 688999999999999999999999999888888888888887 444444


Q ss_pred             HHhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          338 LKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       338 l~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      +......  ..+.....                                       ......+.++.             
T Consensus       240 ~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~-------------  267 (343)
T cd07851         240 LQKISSESARNYIQSLP---------------------------------------QMPKKDFKEVF-------------  267 (343)
T ss_pred             HhhccchhHHHHHHhcc---------------------------------------ccCCCCHHHHh-------------
Confidence            3321110  00000000                                       00000111111             


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                          ...++.+.|||++||..||++|||+.|||+||||.+...
T Consensus       268 ----~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         268 ----SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             ----ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence                113578999999999999999999999999999997543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-37  Score=343.56  Aligned_cols=280  Identities=29%  Similarity=0.555  Sum_probs=221.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||++.+..+++.||||+++...   ...+.+.+|+.+++.+       .|+||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-------~h~~iv~~~~~~~~~   88 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-------KHENVIGLLDVFTPA   88 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-------CCCcccceeeeeeec
Confidence            378999999999999999999999999999999997532   2345677899999988       689999999988643


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            ...|+|+++++++|.+++...   .+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+
T Consensus        89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~  162 (345)
T cd07877          89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKIL  162 (345)
T ss_pred             ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEe
Confidence                  357999999988888777543   489999999999999999999999999999999999995   66789999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||++...........++..|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+.+..+ .++..+
T Consensus       163 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~  241 (345)
T cd07877         163 DFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-TPGAEL  241 (345)
T ss_pred             cccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHH
Confidence            99999876655556678999999999876 4788999999999999999999999998888888888888877 444443


Q ss_pred             HHhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          338 LKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       338 l~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      .......  +.++....                                  ....     ..+.+..             
T Consensus       242 ~~~~~~~~~~~~~~~~~----------------------------------~~~~-----~~~~~~~-------------  269 (345)
T cd07877         242 LKKISSESARNYIQSLT----------------------------------QMPK-----MNFANVF-------------  269 (345)
T ss_pred             HhhcccHhHHHHHHHhc----------------------------------ccCC-----cchhhhc-------------
Confidence            3321100  00000000                                  0000     0000000             


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                          ...++.+++||.+||+.||.+|+|+.++|+||||++..
T Consensus       270 ----~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         270 ----IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             ----CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence                01346789999999999999999999999999999743

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.2e-38  Score=344.60  Aligned_cols=282  Identities=33%  Similarity=0.575  Sum_probs=221.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||+||++++..+++.||||.++..   ......+.+|+.+++.+       .|+||+++++++...
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~ni~~~~~~~~~~   76 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-------DHENVIAIKDIMPPP   76 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-------CCCCccchHHheecc
Confidence            37899999999999999999999999999999998742   23345667899999988       689999999988754


Q ss_pred             -----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       185 -----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                           ..+|+||||+.++|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+||+++   .++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~D  151 (337)
T cd07858          77 HREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICD  151 (337)
T ss_pred             cccccCcEEEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECc
Confidence                 358999999999998888654  4699999999999999999999999999999999999995   567899999


Q ss_pred             cccccccCCc---ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          260 FGSACTEDRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       260 FGlA~~~~~~---~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      ||++......   .....++..|+|||++.. ..++.++|||||||++|+|++|++||.+.+....+..+.+.++..+++
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         152 FGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE  231 (337)
T ss_pred             CccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            9999754332   234567889999999875 468899999999999999999999999988888888888888844433


Q ss_pred             HHHHhhh--cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          336 YVLKEAK--NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       336 ~~l~~~k--~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                      .+ ....  ...++.                                                      ...+.......
T Consensus       232 ~~-~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~  256 (337)
T cd07858         232 DL-GFIRNEKARRYI------------------------------------------------------RSLPYTPRQSF  256 (337)
T ss_pred             Hh-hhcCchhhhHHH------------------------------------------------------HhcCcccccCH
Confidence            22 1100  000000                                                      00000000000


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      .  .....+++.+.+||++||+.||++|||++|+|+||||.....
T Consensus       257 ~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         257 A--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             H--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            0  011125678899999999999999999999999999987543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-37  Score=325.35  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-c
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-R  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-~  185 (837)
                      .|++++.||+|++|.||++++..+++.||+|++...   ....+.+.+|+++++++       .|+||+++++.+... .
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-------KHPNIVAYRESWEGEDG   73 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-------CCCCeeeeeeeecCCCC
Confidence            489999999999999999999999999999999753   23445677888888888       688999999988754 4


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+. ++|.+.+.......+++.+++.++.||+.||++||++||+|+||||+||+++   ..+.++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~  150 (257)
T cd08223          74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIAR  150 (257)
T ss_pred             EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceE
Confidence            6899999997 5888888765555699999999999999999999999999999999999995   67889999999986


Q ss_pred             ccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   ......++..|+|||++.+..++.++|||||||++++|++|+.||...+.......+....-  +        
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~--------  220 (257)
T cd08223         151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--P--------  220 (257)
T ss_pred             EecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--C--------
Confidence            4422   22334678899999999998999999999999999999999999977654443332221000  0        


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                    ..             ...
T Consensus       221 --------------------------------------------------------------~~-------------~~~  225 (257)
T cd08223         221 --------------------------------------------------------------PM-------------PKD  225 (257)
T ss_pred             --------------------------------------------------------------CC-------------ccc
Confidence                                                                          00             001


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .++++.+||.+||..||++|||+.++|+||||
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            34678899999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-37  Score=325.80  Aligned_cols=249  Identities=28%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||+|+||.||+|.+..+++.|++|.+...   ....+.+.+|+++++.+       .|+||+++++++...+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   73 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-------DSSYIIRYYESFLDKGK   73 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-------CCCCeehheeeeccCCE
Confidence            488999999999999999999999999999998743   34566788899999888       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+. ++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+||+++   .++.+||+|||++..
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~  150 (256)
T cd08529          74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKL  150 (256)
T ss_pred             EEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEccccccee
Confidence            999999997 5898888776556799999999999999999999999999999999999996   568899999999865


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.+...  +         
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~---------  219 (256)
T cd08529         151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF--P---------  219 (256)
T ss_pred             ccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C---------
Confidence            4332   2234678899999999998999999999999999999999999987765444333322000  0         


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                   ..+             ...
T Consensus       220 -------------------------------------------------------------~~~-------------~~~  225 (256)
T cd08529         220 -------------------------------------------------------------PVS-------------QMY  225 (256)
T ss_pred             -------------------------------------------------------------CCc-------------ccc
Confidence                                                                         000             013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      +..+.++|++||+.||++||++.|+++|||+
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            4678999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=351.58  Aligned_cols=205  Identities=31%  Similarity=0.427  Sum_probs=175.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeE-EEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSF-VAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~-VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ....+.+.||.|+||+||++...  |+. ||||++....   ...+.+.+|+.+|.+|       .|||||++++++...
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-------~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-------RHPNIVQFYGACTSP  111 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEcCC
Confidence            44556677999999999999654  455 9999998532   2256899999999998       689999999999998


Q ss_pred             c-eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC-eeeccCCCCCeeeeccCCCC-eEEEEec
Q 003239          185 R-HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG-IIHCDLKPENILLCTSVKPA-EIKIIDF  260 (837)
Q Consensus       185 ~-~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g-IVHrDLKPeNILl~~~~~~~-~IKL~DF  260 (837)
                      . .++|||||+. |+|.+++.......++...+..++.||++||.|||+++ ||||||||+|||++   ... ++||+||
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DF  188 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADF  188 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCC
Confidence            7 7999999998 68888887754567999999999999999999999999 99999999999996   554 9999999


Q ss_pred             ccccccC---CcceeeccCccccCchhhc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          261 GSACTED---RTVYSYIQSRYYRSPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       261 GlA~~~~---~~~~~~~GT~~Y~APEvl~--~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      |+++...   .......||..|||||++.  ...|+.|+||||||++||||+||+.||.+.........+
T Consensus       189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v  258 (362)
T KOG0192|consen  189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV  258 (362)
T ss_pred             ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9997655   3344468999999999999  559999999999999999999999999988774444433

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.4e-38  Score=364.67  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++..   ......+.+|+.++..+       .|+||+++++.+...
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-------~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-------DFFSIVKCHEDFAKK  103 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-------CCCcEEEeecceecc
Confidence            37999999999999999999999999999999999753   33445677788888776       688999999887654


Q ss_pred             c--------eEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC
Q 003239          185 R--------HLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       185 ~--------~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      +        .+++||||+. |+|.+++....  ...+++..++.++.||+.||.|||+++||||||||+|||++   .++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCC
Confidence            2        4789999998 68988886532  34689999999999999999999999999999999999996   678


Q ss_pred             eEEEEecccccccCC-----cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003239          254 EIKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI  328 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~-----~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~  328 (837)
                      .+||+|||+++....     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~  260 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG  260 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            899999999864322     223457899999999999999999999999999999999999999877655544433220


Q ss_pred             hCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCC
Q 003239          329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR  408 (837)
Q Consensus       329 lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~  408 (837)
                      .-  .                                                    +                  .|  
T Consensus       261 ~~--~----------------------------------------------------~------------------~~--  266 (496)
T PTZ00283        261 RY--D----------------------------------------------------P------------------LP--  266 (496)
T ss_pred             CC--C----------------------------------------------------C------------------CC--
Confidence            00  0                                                    0                  00  


Q ss_pred             CCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       409 ~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                                 ...++++.+||.+||..||.+|||+.++|+|||++.
T Consensus       267 -----------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        267 -----------PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             -----------CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence                       013467899999999999999999999999999875

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-38  Score=342.71  Aligned_cols=280  Identities=34%  Similarity=0.560  Sum_probs=224.0

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-  185 (837)
                      +|++.+.||.|+||.||+|++..+++.||||++...   ....+.+.+|+.+++.+       .|+||+++++++...+ 
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-------RHENIIGLLDILRPPSP   73 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-------CCcchhhhhhhhcccCc
Confidence            689999999999999999999999999999998753   33456788899999998       5899999999998875 


Q ss_pred             ----eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          186 ----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       186 ----~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                          .+|+||||+.++|.+++....  .+++..++.++.||+.||+|||++||+|+||||+|||++   .++.++|+|||
T Consensus        74 ~~~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg  148 (330)
T cd07834          74 EDFNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFG  148 (330)
T ss_pred             ccccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccC
Confidence                899999999998888886543  699999999999999999999999999999999999996   56899999999


Q ss_pred             cccccCCc------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          262 SACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       262 lA~~~~~~------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      ++......      .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...++..++
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  228 (330)
T cd07834         149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE  228 (330)
T ss_pred             ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence            99754332      2345678899999999888 8999999999999999999999999999999999999988884443


Q ss_pred             hHHHHhhh--cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          335 DYVLKEAK--NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       335 ~~~l~~~k--~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                      +. +....  ....+....                                 ..      .....+..+.          
T Consensus       229 ~~-~~~~~~~~~~~~~~~~---------------------------------~~------~~~~~~~~~~----------  258 (330)
T cd07834         229 ED-LKFITSEKARNYLKSL---------------------------------PK------KPKKPLSKLF----------  258 (330)
T ss_pred             hH-hhhccccchhhHHhhc---------------------------------cc------CCcchhHHhc----------
Confidence            32 22100  000000000                                 00      0001111111          


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                             ...+..+.+||.+||++||++|||++++|+||||++...
T Consensus       259 -------~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         259 -------PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             -------ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                   114578999999999999999999999999999997553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.7e-38  Score=345.38  Aligned_cols=281  Identities=31%  Similarity=0.547  Sum_probs=222.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--  183 (837)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ...+.+.+|+.+|+.+       .|+||++++++|..  
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~   77 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-------KHDNIIAIRDILRPPG   77 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-------CCCCccCHHHhccccC
Confidence            78999999999999999999999999999999997532   3345677899999988       58999999998864  


Q ss_pred             --cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 --QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 --~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                        ...+++||||+.++|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+||+++   .++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehhhhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEecccc
Confidence              3578999999999988887654  3599999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCCc-------ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          262 SACTEDRT-------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       262 lA~~~~~~-------~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      ++......       .....++..|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+...+| .|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g-~~  231 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG-SP  231 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC-CC
Confidence            98643221       123477889999999876 4689999999999999999999999999988888888888888 45


Q ss_pred             chHHHHhhhc--chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          334 PDYVLKEAKN--TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       334 p~~~l~~~k~--~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                      +..++.....  ...+++...                                       ......+.++.         
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~---------  263 (334)
T cd07855         232 SEEVLNRIGSDRVRKYIQNLP---------------------------------------RKQPVPWSKIF---------  263 (334)
T ss_pred             hhHhhhhhchhhHHHHHhhcc---------------------------------------cCCCCCHHHHc---------
Confidence            4444332110  000000000                                       00000111111         


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                              ...++.+.+||++||+.||++|||++++|+||||.+.+.
T Consensus       264 --------~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         264 --------PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             --------ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                    123578999999999999999999999999999997553

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-38  Score=328.42  Aligned_cols=198  Identities=28%  Similarity=0.490  Sum_probs=170.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +.|++.++||+|++|.||+|.+..+++.||||++....      ...+.+.+|+++++++       .|+||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~   74 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-------QHERIVQYYGCLR   74 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-------CCCCeeeeEEEEc
Confidence            46899999999999999999999999999999987432      1234677888888888       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      .++.+++||||+. ++|.+.+...  ..+++..++.++.||+.||.|||+.+|+|+||||+||+++   .++.++|+|||
T Consensus        75 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg  149 (263)
T cd06625          75 DDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFG  149 (263)
T ss_pred             cCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecc
Confidence            9999999999997 4788877654  3589999999999999999999999999999999999995   66789999999


Q ss_pred             cccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          262 SACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       262 lA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      ++.......      ....++..|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  212 (263)
T cd06625         150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA  212 (263)
T ss_pred             cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence            986432211      234577889999999998999999999999999999999999976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.4e-38  Score=334.16  Aligned_cols=201  Identities=26%  Similarity=0.489  Sum_probs=172.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee----
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC----  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~----  183 (837)
                      .+.|++.+.||.|+||+||+|++..+++.||+|++.........+..|+.+++++.      +|+||+++++++..    
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS------HHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc------CCCcEEEEeeehhccccc
Confidence            37899999999999999999999999999999999876655667788999888884      58999999999863    


Q ss_pred             --cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          184 --QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       184 --~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                        ...+|+||||+.+ +|.+++.......+++..++.++.||+.||.|||+.+|+|+||||+||+++   ..+.++|+||
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~df  165 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDF  165 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeC
Confidence              4678999999984 888888765555689999999999999999999999999999999999996   5678999999


Q ss_pred             ccccccCC---cceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          261 GSACTEDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       261 GlA~~~~~---~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      |++.....   ......++..|+|||++.     ...++.++|||||||++|||++|..||....
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            99865432   223456889999999986     3468889999999999999999999996544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-37  Score=342.08  Aligned_cols=282  Identities=28%  Similarity=0.561  Sum_probs=220.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++++.||+|+||.||++.+..+++.||||+++..   ....+.+.+|+.+|+.+       .|+||+++++++...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   86 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-------KHENVIGLLDVFTPD   86 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-------CCCCccceeeeecCC
Confidence            47899999999999999999999999999999998642   23345677899999998       689999999999865


Q ss_pred             c------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 R------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ~------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      .      .+|+||||++++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+||+++   ..+.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~  160 (343)
T cd07880          87 LSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKIL  160 (343)
T ss_pred             ccccccceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEe
Confidence            4      4699999998888877764   3599999999999999999999999999999999999996   56789999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+....+ .++..+
T Consensus       161 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~  239 (343)
T cd07880         161 DFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG-TPSKEF  239 (343)
T ss_pred             ecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHH
Confidence            99999876655555677899999999876 3688999999999999999999999998888777777777665 333333


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      ........                             ...+....   +     .+....+..+.               
T Consensus       240 ~~~~~~~~-----------------------------~~~~~~~~---~-----~~~~~~~~~~~---------------  267 (343)
T cd07880         240 VQKLQSED-----------------------------AKNYVKKL---P-----RFRKKDFRSLL---------------  267 (343)
T ss_pred             HHhhcchh-----------------------------HHHHHHhc---c-----ccCcchHHHhc---------------
Confidence            32211000                             00000000   0     00000111111               


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...+..+.+||.+||+.||++|||+.++|+||||+...
T Consensus       268 --~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         268 --PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             --cCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence              12456789999999999999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-40  Score=338.60  Aligned_cols=289  Identities=27%  Similarity=0.463  Sum_probs=228.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-  184 (837)
                      ..|+-+.+||+|.||.||+|+.+.+++.||+|++--   ...+....++|+++|+.|       .|+|++.++++|... 
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-------kHenv~nliEic~tk~   89 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTKA   89 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-------cchhHHHHHHHHhhcc
Confidence            678888899999999999999999999999998643   345567789999999999       477888888877643 


Q ss_pred             -------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          185 -------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       185 -------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                             ..+|+||.+|+.+|..++.... .+++..+|++++.+++.||.|+|+..|+|||+|++|+||+   .++.+||
T Consensus        90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilkl  165 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKL  165 (376)
T ss_pred             CCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEe
Confidence                   3599999999999998886553 4699999999999999999999999999999999999995   7799999


Q ss_pred             EecccccccCC-------cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          258 IDFGSACTEDR-------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       258 ~DFGlA~~~~~-------~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      +|||+++....       .....+-|.+|++||.+++. .|+++.|||..|||+.||+++.+.|.+.++..++..|...+
T Consensus       166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc  245 (376)
T KOG0669|consen  166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC  245 (376)
T ss_pred             eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence            99999964321       12334669999999999987 79999999999999999999999999999999999999999


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      | ....++|+...+...| ..+.                               ..| .++..|  ..++..++.|    
T Consensus       246 G-s~tkevWP~~d~lpL~-~sie-------------------------------~eP-l~~~~~--rkv~n~~kp~----  285 (376)
T KOG0669|consen  246 G-SITKEVWPNVDNLPLY-QSIE-------------------------------LEP-LPKGQK--RKVKNRLKPY----  285 (376)
T ss_pred             c-cCCcccCCCcccchHH-Hhcc-------------------------------CCC-CCcchh--hhhhhhcccc----
Confidence            9 4444444433322111 1110                               011 111111  1122222211    


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                                 --++++.|||.+||.+||.+|+++.|+|+|.||..++.+
T Consensus       286 -----------~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  286 -----------VKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             -----------cCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                       123678999999999999999999999999999987753

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-37  Score=342.14  Aligned_cols=280  Identities=30%  Similarity=0.516  Sum_probs=211.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      ..+|++.+.||.|+||.||+|++..+++.||+|++.... ...+.+.+|+++++.+       .|+||+++++++...  
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-------~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-------DHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-------CCCcchhhHhhhccccc
Confidence            479999999999999999999999999999999987543 3446678899999988       689999999876654  


Q ss_pred             ------------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          185 ------------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       185 ------------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                                  ...|+||||+.++|.+++...   .+++..++.++.||++||.|||+.||+||||||+||+++  ..+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~  151 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TED  151 (342)
T ss_pred             ccccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCC
Confidence                        368999999999888877543   489999999999999999999999999999999999996  345


Q ss_pred             CeEEEEecccccccCCc------ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          253 AEIKIIDFGSACTEDRT------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~~------~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ..+||+|||.+......      .....++..|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            67999999998654321      122356888999998765 46889999999999999999999999988877776666


Q ss_pred             HHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcC
Q 003239          326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY  405 (837)
Q Consensus       326 ~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~  405 (837)
                      ........++....       +.....                        ......   .     ......+.+++.  
T Consensus       232 ~~~~~~~~~~~~~~-------~~~~~~------------------------~~~~~~---~-----~~~~~~~~~~~~--  270 (342)
T cd07854         232 LESVPVVREEDRNE-------LLNVIP------------------------SFVRND---G-----GEPRRPLRDLLP--  270 (342)
T ss_pred             HHhcCCCChHHhhh-------hhhhhh------------------------hhhhhc---c-----cccCCCHHHHcc--
Confidence            65443111111100       000000                        000000   0     000011111111  


Q ss_pred             CCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       406 p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                                     ..+.++++||++||+.||++|||++|+|+||||+.
T Consensus       271 ---------------~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         271 ---------------GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             ---------------CCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                           24467899999999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.8e-38  Score=338.94  Aligned_cols=257  Identities=21%  Similarity=0.396  Sum_probs=209.0

Q ss_pred             cccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       105 ~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .....+|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.+++.+       .|+||+++++.|..
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-------~h~~v~~~~~~~~~   88 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDSYLV   88 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-------CCCCEeeEEEEEEe
Confidence            344589999999999999999999999999999999997542 3346678899999887       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ..+.|+||||+. ++|.+++...   .+++.++..++.||+.||+|||+.||+||||||+|||++   .++.+||+|||+
T Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~  162 (296)
T cd06654          89 GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGF  162 (296)
T ss_pred             CCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECcccc
Confidence            999999999997 5788877543   489999999999999999999999999999999999995   567899999999


Q ss_pred             ccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........+..+.. .+ .++     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~~-----  235 (296)
T cd06654         163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NG-TPE-----  235 (296)
T ss_pred             chhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CC-CCC-----
Confidence            8653322   2234678899999999988899999999999999999999999976654332221110 00 000     


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                                  +...
T Consensus       236 ----------------------------------------------------------------------------~~~~  239 (296)
T cd06654         236 ----------------------------------------------------------------------------LQNP  239 (296)
T ss_pred             ----------------------------------------------------------------------------CCCc
Confidence                                                                                        0000


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ...+..+.+||.+||..||++|||++|+|+||||....
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            11346688999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.6e-38  Score=333.59  Aligned_cols=254  Identities=29%  Similarity=0.467  Sum_probs=206.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      +.|++.+.||+|+||.||++++..++..+|+|.+... ....+.+.+|+++++.+       +|+||+++++++...+..
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~ii~~~~~~~~~~~~   77 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIVKLLDAFYYENNL   77 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-------CCCCeeeEEEEEeeCCEE
Confidence            4578899999999999999999999999999999754 34556788899999988       689999999999999999


Q ss_pred             EEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+.+ +|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++...
T Consensus        78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~  153 (282)
T cd06643          78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEccccccccc
Confidence            999999985 565555432 34699999999999999999999999999999999999995   6678999999998644


Q ss_pred             CCc---ceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          267 DRT---VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ...   .....++..|+|||++.     +..++.++|||||||++|||++|.+||...+..+....+.....   +.   
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~---  227 (282)
T cd06643         154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---PT---  227 (282)
T ss_pred             cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC---CC---
Confidence            322   23346788999999984     34678899999999999999999999987665544433322100   00   


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                                   +..
T Consensus       228 -----------------------------------------------------------------------------~~~  230 (282)
T cd06643         228 -----------------------------------------------------------------------------LAQ  230 (282)
T ss_pred             -----------------------------------------------------------------------------CCC
Confidence                                                                                         000


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ...++..+.+||.+||..||.+|||++++|+||||+..
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            01134678999999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=334.85  Aligned_cols=255  Identities=29%  Similarity=0.499  Sum_probs=207.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++++.||.|+||+||++.+..+++.||+|+++.. ....+.+.+|+++++.+       .|+||+++++.+..+..
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   76 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-------KHPNIVGLYEAYFYENK   76 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-------CCCceeEEEEEEecCCe
Confidence            37899999999999999999999889999999999754 34456788899999988       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++   .++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~  152 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAK  152 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchh
Confidence            9999999985 7777766543 4699999999999999999999999999999999999995   678899999998864


Q ss_pred             cCC---cceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ...   ......++..|+|||++.     ...++.++|||||||++|+|++|++||...+....+..+..  + .++.  
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~-~~~~--  227 (280)
T cd06611         153 NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--S-EPPT--  227 (280)
T ss_pred             hcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--C-CCCC--
Confidence            322   223456889999999985     34578899999999999999999999977654433322211  0 0000  


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                                    +.
T Consensus       228 ------------------------------------------------------------------------------~~  229 (280)
T cd06611         228 ------------------------------------------------------------------------------LD  229 (280)
T ss_pred             ------------------------------------------------------------------------------cC
Confidence                                                                                          00


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ....++..+.+||.+||+.||.+|||++++|+||||++.
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            001134678899999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=346.57  Aligned_cols=322  Identities=23%  Similarity=0.368  Sum_probs=253.3

Q ss_pred             CccccchhccchhhHHhhhhHHHHhhhcCCCccccc------ccCCCccc---cCCCccccCC--CccCCCCcceEEeee
Q 003239           32 DAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSE------ELNPKRYL---TSPSVGVLND--GYDNVNSDLILAVNL  100 (837)
Q Consensus        32 ~~~~L~~~~~~~~~~~Lt~~i~~~y~~~~p~~~~~~------~~~~~r~l---t~p~~~~~~~--g~d~~~~~~~~~l~~  100 (837)
                      +.+||+......|.+.|+++.-++|++-.+.-....      ..+..+.-   +.|.......  ...+..      ..+
T Consensus       271 gisEl~K~p~~GWyKlLsqeEGEyyNvp~~~~~~e~~~~lr~k~~~~~~~~~~s~p~~~~~~~~~~~~~~~------~~d  344 (683)
T KOG0696|consen  271 GISELQKAPVDGWYKLLSQEEGEYYNVPVPDEDSEDNEELRQKFERARIGPGSSKPEKKTMPTDSKFHNSS------KRD  344 (683)
T ss_pred             cHHHHhhcchhhHHHHhhhhcCceeccCCCCchhhHHHHHHHHHhhcccCCCcCCCCCCCCCCcccCCCCC------ccc
Confidence            679999999999999999999999987665433211      11111111   1122211111  111111      011


Q ss_pred             eeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeE
Q 003239          101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVR  176 (837)
Q Consensus       101 ~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk  176 (837)
                      .+    ...+|.++.+||+|+||+|.++..+.+.+.+|||+++++    ..+.+-.+.|.++|....+      -|.+++
T Consensus       345 ~i----~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~k------ppFL~q  414 (683)
T KOG0696|consen  345 RI----KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK------PPFLVQ  414 (683)
T ss_pred             ce----eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCC------CchHHH
Confidence            11    126899999999999999999999999999999999975    3445566678777766543      478999


Q ss_pred             EeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeE
Q 003239          177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       177 l~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                      ++.+|+.-+.+|+||||+.| +|.-.+++  .+.+.|..+..++.+|+.||-|||++|||.||||.+|||++   ..++|
T Consensus       415 lHScFQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd---~eGHi  489 (683)
T KOG0696|consen  415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHI  489 (683)
T ss_pred             HHHHhhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec---cCCce
Confidence            99999999999999999985 66555544  35699999999999999999999999999999999999995   88999


Q ss_pred             EEEecccccc---cCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          256 KIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       256 KL~DFGlA~~---~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      ||+|||+++.   ......+.|||+.|+|||++.-++|+..+|.||+||+||||+.|++||.++++.++.+.|.+..-  
T Consensus       490 Ki~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--  567 (683)
T KOG0696|consen  490 KIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--  567 (683)
T ss_pred             EeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--
Confidence            9999999964   34556788999999999999999999999999999999999999999999999999888876221  


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                                                                                             .||      
T Consensus       568 -----------------------------------------------------------------------syP------  570 (683)
T KOG0696|consen  568 -----------------------------------------------------------------------SYP------  570 (683)
T ss_pred             -----------------------------------------------------------------------cCc------
Confidence                                                                                   011      


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCH-----HHHHcCccCCCCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPFTC  460 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa-----~EaL~HPff~~~~~~~  460 (837)
                             ..++.++.++++.+|...|.+|+.+     .++-+||||+...|..
T Consensus       571 -------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  571 -------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             -------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence                   1245778999999999999999965     6899999999877643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.7e-38  Score=343.58  Aligned_cols=201  Identities=28%  Similarity=0.443  Sum_probs=167.0

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||.||+|.+     ..+++.||||+++..  ....+.+.+|+.+|+.+.      .|+||++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~niv~~~~~   79 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG------NHLNVVNLLGA   79 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc------cCcceeeEEeE
Confidence            47899999999999999999974     344678999999753  234467888999999984      58999999998


Q ss_pred             Eeec-ceEEEEEeccc-hhHHHHHHhhc----------------------------------------------------
Q 003239          181 FVCQ-RHLCICFELLD-SNLYELIKINH----------------------------------------------------  206 (837)
Q Consensus       181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~----------------------------------------------------  206 (837)
                      +... ..+++||||+. |+|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8765 46899999998 68888886532                                                    


Q ss_pred             --------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcc-----eee
Q 003239          207 --------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSY  273 (837)
Q Consensus       207 --------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~  273 (837)
                              ...+++..+..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||+++......     ...
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~  236 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSA  236 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcchhcccCC
Confidence                    12478889999999999999999999999999999999995   56789999999997542211     122


Q ss_pred             ccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       274 ~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      .++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            44678999999999999999999999999999997 999997754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-37  Score=326.17  Aligned_cols=198  Identities=28%  Similarity=0.466  Sum_probs=174.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.++||+|+||.||+++...+++.||+|.++.... .+.+.+|+++++.+       .|+||+++++++.....+|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-------DSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-------CCCcEeeeeeeeecCCcEE
Confidence            689999999999999999999998899999999986544 67888999999998       6899999999999999999


Q ss_pred             EEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +|+||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++   .++.+||+|||++....
T Consensus        75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcc
Confidence            99999985 7888776533 4689999999999999999999999999999999999996   56789999999987544


Q ss_pred             Cc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          268 RT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       268 ~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      ..   .....++..|+|||++.+..++.++||||||||+|+|++|+.||.....
T Consensus       151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~  204 (256)
T cd06612         151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP  204 (256)
T ss_pred             cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence            32   2234578899999999988999999999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=329.50  Aligned_cols=276  Identities=36%  Similarity=0.639  Sum_probs=218.9

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      |++.+.||.|++|.||+|++..+++.+|+|+++...   .....+.+|+++++.+       .|+||+++++++...+..
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~   73 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-------NHPNIIKLLDVFRHKGDL   73 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-------cCCCcchHHHhhccCCCE
Confidence            567899999999999999999999999999987542   2356778899999988       589999999999999999


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ++||||+.++|.+.+.... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++   .++.+||+|||.+....
T Consensus        74 ~~v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~  149 (283)
T cd05118          74 YLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFG  149 (283)
T ss_pred             EEEEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecC
Confidence            9999999999988887654 4699999999999999999999999999999999999995   56889999999986544


Q ss_pred             Ccc---eeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          268 RTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       268 ~~~---~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...   ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+.+..+.+.++...+ ..+.....
T Consensus       150 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  228 (283)
T cd05118         150 SPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP-EVWPKFTS  228 (283)
T ss_pred             CCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCch-Hhcccchh
Confidence            322   234578889999999877 7899999999999999999999999999988888888887773322 22221111


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                      ...+..                                                     ..++.......+  ......+
T Consensus       229 ~~~~~~-----------------------------------------------------~~~~~~~~~~~~--~~~~~~~  253 (283)
T cd05118         229 LARNYK-----------------------------------------------------FSFPKKAGMPLP--KLFPNAS  253 (283)
T ss_pred             hhhhhh-----------------------------------------------------hhhccccccCHH--HhhhhhC
Confidence            000000                                                     000000000000  0112356


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+++||.+||..||.+||+++|+|+||||
T Consensus       254 ~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         254 PQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            789999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.1e-37  Score=333.50  Aligned_cols=279  Identities=30%  Similarity=0.494  Sum_probs=214.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.++||+|+||.||+|++..+++.||||++....   .......+|+++++.+       +|+||+++++++...
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   79 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-------KHPNVVPLIDMAVER   79 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-------CCCCccchhhheecc
Confidence            479999999999999999999999999999999986432   2234567899999988       689999999987654


Q ss_pred             --------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEE
Q 003239          185 --------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       185 --------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                              ..+++||||+.++|.+.+.... ..+++..++.++.||++||+|||++||+|+||||+||+++   +++.+|
T Consensus        80 ~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~  155 (311)
T cd07866          80 PDKSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILK  155 (311)
T ss_pred             cccccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEE
Confidence                    3579999999988887776543 4699999999999999999999999999999999999995   678899


Q ss_pred             EEecccccccCCc--------------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 003239          257 IIDFGSACTEDRT--------------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL  321 (837)
Q Consensus       257 L~DFGlA~~~~~~--------------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~  321 (837)
                      |+|||++......              .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~  235 (311)
T cd07866         156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ  235 (311)
T ss_pred             ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999998643221              1223567889999998764 588999999999999999999999999998888


Q ss_pred             HHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHH
Q 003239          322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEI  401 (837)
Q Consensus       322 l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~i  401 (837)
                      ...+....+..++. .+.............            .                         .... ...+.+.
T Consensus       236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------------~-------------------------~~~~-~~~~~~~  276 (311)
T cd07866         236 LHLIFKLCGTPTEE-TWPGWRSLPGCEGVH------------S-------------------------FTNY-PRTLEER  276 (311)
T ss_pred             HHHHHHHhCCCChh-hchhhhhcccccccc------------c-------------------------CCCC-CccHHHH
Confidence            88888887733332 222111110000000            0                         0000 0001111


Q ss_pred             HhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          402 VTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       402 l~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .                 ....+.+.+||.+||..||++|||+.|+|.||||
T Consensus       277 ~-----------------~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         277 F-----------------GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             c-----------------ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            0                 1133678999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=353.58  Aligned_cols=252  Identities=28%  Similarity=0.403  Sum_probs=218.0

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      +.||+|.||+||-++++++|+.||||+|.+.   .....+..+|+.||+++       .||.||.+--.|+..+.+++||
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-------~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-------HHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-------CCCCeeEEEEeecCCceEEEEe
Confidence            6899999999999999999999999999753   23346788999999999       7899999999999999999999


Q ss_pred             eccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcc-
Q 003239          192 ELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-  270 (837)
Q Consensus       192 Ey~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~-  270 (837)
                      |-+.|+.++.|.....++|++...+.++.||+.||.|||-++|||+||||||||+...+.-.++||||||+|+...+.. 
T Consensus       643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            9999999999999888999999999999999999999999999999999999999877777899999999999877653 


Q ss_pred             -eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhh
Q 003239          271 -YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK  349 (837)
Q Consensus       271 -~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~  349 (837)
                       ...+||+.|+|||+++.+.|...-|+||+|||+|--+.|..||..+.+  +-.+|....-.                  
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFM------------------  782 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFM------------------  782 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccc------------------
Confidence             467999999999999999999999999999999999999999965432  22222111000                  


Q ss_pred             hcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHH
Q 003239          350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDF  429 (837)
Q Consensus       350 ~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DL  429 (837)
                                                                 |+..                     .+.++++.++||
T Consensus       783 -------------------------------------------yPp~---------------------PW~eis~~Aidl  798 (888)
T KOG4236|consen  783 -------------------------------------------YPPN---------------------PWSEISPEAIDL  798 (888)
T ss_pred             -------------------------------------------cCCC---------------------chhhcCHHHHHH
Confidence                                                       1111                     123356789999


Q ss_pred             HHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          430 LKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       430 L~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      |..+|+..=++|.|.++.|.|||+++..
T Consensus       799 In~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  799 INNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999999999855

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-37  Score=322.34  Aligned_cols=202  Identities=28%  Similarity=0.448  Sum_probs=175.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++... ....+.+.+|+++++.+       +|+||+++++++...+.
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~~   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-------RHPNIVAYFGSYLRRDK   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-------CCCChhceEEEEEeCCE
Confidence            37899999999999999999999999999999999854 23456788899999988       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++   +++.+||+|||++..
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~  150 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQ  150 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchh
Confidence            9999999985 7777766542 4699999999999999999999999999999999999996   677899999999865


Q ss_pred             cCCc---ceeeccCccccCchhhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~---~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      ....   .....++..|+|||++.+.   .++.++|||||||++|+|++|.+||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~  211 (262)
T cd06613         151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR  211 (262)
T ss_pred             hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            4332   2345678899999999877   88999999999999999999999997765443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=327.55  Aligned_cols=277  Identities=32%  Similarity=0.580  Sum_probs=216.9

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--c
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--R  185 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--~  185 (837)
                      |++.++||.|+||.||+|++..+++.||+|+++..   ......+.+|+++++.+       .|+||+++++++...  +
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~   73 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-------RHPNIVRLKEIVTSKGKG   73 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-------cCCCeeeheeeEecCCCC
Confidence            67899999999999999999999999999999864   33445678899999998       589999999999988  8


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..++||||+.++|.+++.... ..+++..++.++.||+.||+|||+.+++|+||||+||+++   +++.+||+|||++..
T Consensus        74 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~  149 (287)
T cd07840          74 SIYMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARP  149 (287)
T ss_pred             cEEEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceee
Confidence            999999999999888886553 4699999999999999999999999999999999999995   678999999999975


Q ss_pred             cCCc----ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          266 EDRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       266 ~~~~----~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ....    .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+.+..+.+..+...+.. +..
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  228 (287)
T cd07840         150 YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN-WPG  228 (287)
T ss_pred             ccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh-ccc
Confidence            5433    2234567889999988754 688999999999999999999999999888888888888776333222 111


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      .... .++....                                 +.   ..+ ...+.+.+..                
T Consensus       229 ~~~~-~~~~~~~---------------------------------~~---~~~-~~~~~~~~~~----------------  254 (287)
T cd07840         229 VSKL-PWFENLK---------------------------------PK---KPY-KRRLREFFKH----------------  254 (287)
T ss_pred             cccc-hhhhhcc---------------------------------cc---ccc-hhHHHHHhcc----------------
Confidence            1000 0000000                                 00   000 0011111111                


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+..+.+||++||..||.+|||++++|+||||
T Consensus       255 ~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         255 LIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            125789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-37  Score=328.45  Aligned_cols=256  Identities=23%  Similarity=0.355  Sum_probs=201.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++++.||+|+||.||++++..+++.||||+++...  ....++..|+.++.+.      .+|+||+++++++..++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~------~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS------VDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH------cCCCCeeeeeEEEecCCc
Confidence            46899999999999999999999999999999998542  2334555566654333      278999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          187 LCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .|+||||++++|.+++...  ....+++..++.++.||+.||+|||++ +|+||||||+||+++   .++.+||+|||++
T Consensus        75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~---~~~~~kl~dfg~~  151 (283)
T cd06617          75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGIS  151 (283)
T ss_pred             EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecccc
Confidence            9999999999888887653  224589999999999999999999997 999999999999995   6788999999998


Q ss_pred             cccCCcc--eeeccCccccCchhhcC----CCCCccchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCchH
Q 003239          264 CTEDRTV--YSYIQSRYYRSPEVLLG----YQYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       264 ~~~~~~~--~~~~GT~~Y~APEvl~~----~~yt~ksDIWSLG~ILyELltG~~PF~g~-s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      .......  ....++..|+|||++.+    ..++.++|||||||++|+|++|+.||... ...+.+..+..  + .+   
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~-~~---  225 (283)
T cd06617         152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--E-PS---  225 (283)
T ss_pred             cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--c-CC---
Confidence            7543221  22467888999999865    45788999999999999999999999532 11121111111  0 00   


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                       +                 .+|          
T Consensus       226 -------------------------------------------------~-----------------~~~----------  229 (283)
T cd06617         226 -------------------------------------------------P-----------------QLP----------  229 (283)
T ss_pred             -------------------------------------------------C-----------------CCC----------
Confidence                                                             0                 000          


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...++.++.+||.+||..||++|||++|+++||||....
T Consensus       230 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         230 --AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             --ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence              001346789999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=328.41  Aligned_cols=275  Identities=35%  Similarity=0.584  Sum_probs=220.8

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      |++.++||+|.||.||+|++..+++.||+|+++..   ....+.+..|+.+++.+       .|+||+++++++...+..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~~   73 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-------KHPNIVKLLDVIHTERKL   73 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-------CCCCHHHHHhhhhcCCce
Confidence            67788999999999999999999999999999864   33456677899999988       589999999999999999


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ++|||++.++|.+++.... ..+++..++.++.||+.||+|||+++|+||||+|+||+++   +++.+||+|||.+....
T Consensus        74 ~~v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          74 YLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFG  149 (282)
T ss_pred             EEEecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccC
Confidence            9999999999999988753 3599999999999999999999999999999999999995   57889999999987543


Q ss_pred             Ccc---eeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          268 RTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       268 ~~~---~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...   .....+..|+|||.+.+. .++.++|||||||++|||++|.+||...+..+.+.++.+.++ .+.+..+.....
T Consensus       150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  228 (282)
T cd07829         150 IPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG-TPTEESWPGVTK  228 (282)
T ss_pred             CCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhC-CCcHHHHHhhcc
Confidence            322   233557789999999877 889999999999999999999999999998888889988888 444444333222


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                      .. +++..-                                      ..+....+.+.++                 ..+
T Consensus       229 ~~-~~~~~~--------------------------------------~~~~~~~~~~~~~-----------------~~~  252 (282)
T cd07829         229 LP-DYKPTF--------------------------------------PKFPPKDLEKVLP-----------------RLD  252 (282)
T ss_pred             cc-cccccc--------------------------------------cccCccchHHhcc-----------------ccc
Confidence            11 000000                                      0000011111111                 124


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+.+||++||..||++|||++|++.||||
T Consensus       253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.1e-38  Score=338.42  Aligned_cols=260  Identities=22%  Similarity=0.396  Sum_probs=209.2

Q ss_pred             eeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          102 LVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       102 l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      +.......+|++++.||+|+||.||++++..+++.||||.+.... ...+.+.+|+.+++.+       +|+||++++++
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~   84 (297)
T cd06656          12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDS   84 (297)
T ss_pred             cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-------CCCCEeeEEEE
Confidence            333444589999999999999999999999999999999997532 3345677899988887       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      |...+..|+||||+. ++|.+++...   .+++..+..++.|++.||.|||+.+|+||||||+|||++   .++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~D  158 (297)
T cd06656          85 YLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTD  158 (297)
T ss_pred             EecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECc
Confidence            999999999999997 5787777543   489999999999999999999999999999999999995   678899999


Q ss_pred             cccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       260 FGlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ||++......   .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+....+..+.. .+ .+   
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~-~~---  233 (297)
T cd06656         159 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG-TP---  233 (297)
T ss_pred             CccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC-CC---
Confidence            9998654322   2234678899999999998899999999999999999999999966543221111000 00 00   


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                        .                            .
T Consensus       234 --------------------------------------------------~----------------------------~  235 (297)
T cd06656         234 --------------------------------------------------E----------------------------L  235 (297)
T ss_pred             --------------------------------------------------C----------------------------C
Confidence                                                              0                            0


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ......+..+.+||.+||..||++|||++++|+||||...+
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            00011346688999999999999999999999999999755

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4e-37  Score=321.73  Aligned_cols=250  Identities=27%  Similarity=0.372  Sum_probs=207.4

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||+|+||.||+|.+..+++.||||++...   ....+.+.+|+++|+.+       .|+||+++++.+...+.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~   73 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-------SHPNIIEYYENFLEDKA   73 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-------CCCchhheeeeEecCCE
Confidence            589999999999999999999999999999998753   23456778899999988       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++||||+. ++|.+++.......+++..++.++.|++.+|+|||+++|+|+||||+||+++  .....+||+|||.+..
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~  151 (256)
T cd08220          74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKI  151 (256)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCcee
Confidence            999999997 4898888776555689999999999999999999999999999999999996  3456789999999975


Q ss_pred             cCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          266 EDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       266 ~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ....  .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         152 LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             cCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            5432  2335678899999999988899999999999999999999999977654443332221000             


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                .                   +           .....+
T Consensus       219 ------------------------------------------~-------------------~-----------~~~~~~  226 (256)
T cd08220         219 ------------------------------------------A-------------------P-----------ISDRYS  226 (256)
T ss_pred             ------------------------------------------C-------------------C-----------CCCCcC
Confidence                                                      0                   0           000134


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+.+||.+||..||++|||+.|+|+||||
T Consensus       227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         227 PDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            678899999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-37  Score=331.06  Aligned_cols=192  Identities=28%  Similarity=0.495  Sum_probs=167.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+++++||+|+||.||+|++..+++.||||++..+  ......+.+|+++++++       +|+||+++++.+...+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-------DSPYIIGFYGAFFVENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEEECCE
Confidence            3688899999999999999999999999999999754  33445688899999888       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .++||||+.+..++..     ..+++..+..++.||+.||.|||+.+|+|+||||+|||++   .++.+||+|||++...
T Consensus        74 ~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~  145 (279)
T cd06619          74 ISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQL  145 (279)
T ss_pred             EEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceec
Confidence            9999999986544332     2478999999999999999999999999999999999995   6788999999999754


Q ss_pred             CC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          267 DR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       267 ~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      .. .....+++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       146 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         146 VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             ccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            33 23345789999999999998999999999999999999999999954

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.3e-37  Score=329.76  Aligned_cols=279  Identities=32%  Similarity=0.568  Sum_probs=212.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.++||+|+||.||+|.+..+++.||||++....   ...+.+.+|+++++.+       .|+||+++++++..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-------RHENLVNLIEVFRRKK   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-------CCcchhhHHHhcccCC
Confidence            47999999999999999999999899999999986432   2345677899999888       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..|+||||+.+.+++.+.... ..+++..++.++.||+.||+|||+.+|+|+||+|+||+++   +++.+||+|||++..
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~  149 (286)
T cd07846          74 RLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFART  149 (286)
T ss_pred             eEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeee
Confidence            999999999975554443332 3589999999999999999999999999999999999995   678899999999865


Q ss_pred             cCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   .....++..|+|||++.+. .++.++|||||||++|||++|.+||...+..+.+..+....+...+... .  
T Consensus       150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--  226 (286)
T cd07846         150 LAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ-E--  226 (286)
T ss_pred             ccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH-H--
Confidence            3222   2234678899999998764 5788999999999999999999999988887877777776662221110 0  


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                           .+......                          .....+...    ....+..                 ....
T Consensus       227 -----~~~~~~~~--------------------------~~~~~~~~~----~~~~~~~-----------------~~~~  254 (286)
T cd07846         227 -----IFQKNPLF--------------------------AGMRLPEVK----EIEPLEK-----------------RFPK  254 (286)
T ss_pred             -----HhccchHh--------------------------hcccccccc----CcchHHH-----------------hCCC
Confidence                 00000000                          000000000    0000000                 1112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ++..+.+||.+||..||++|||++++|+||||
T Consensus       255 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         255 LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            45789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.1e-37  Score=329.08  Aligned_cols=204  Identities=27%  Similarity=0.413  Sum_probs=171.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---  184 (837)
                      .++|++.+.||+|+||.||++.+..+++.||+|++.........+.+|+.+++.+.      .|+||+++++++...   
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~------~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP------NHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc------CCCCeEEEEEEEEecccc
Confidence            37899999999999999999999999999999999865545566778999988874      589999999998754   


Q ss_pred             --ceEEEEEeccc-hhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          185 --RHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       185 --~~l~LVmEy~~-gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                        +..++||||+. ++|.+++...  ....+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEee
Confidence              36899999997 4888877542  234689999999999999999999999999999999999995   567899999


Q ss_pred             cccccccCCc---ceeeccCccccCchhhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       260 FGlA~~~~~~---~~~~~GT~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      ||++......   .....++..|+|||++...     .++.++|||||||++|||++|++||.......
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence            9998654321   2234678899999998643     36889999999999999999999997655433

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.6e-37  Score=333.75  Aligned_cols=198  Identities=31%  Similarity=0.491  Sum_probs=173.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.++||+|+||.||++++..+++.||+|+++..  .....++.+|+++++++       .|+||++++++|..++.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-------NSPYIVGFYGAFYSDGE   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEeeCCE
Confidence            3689999999999999999999999999999998754  33456688899999998       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +|+||||+. ++|.+++...  +.+++..++.++.||++||.|||+ .+|+|+||||+|||++   .++.+||+|||++.
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~  148 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG  148 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCcc
Confidence            999999998 5888887654  468999999999999999999997 6999999999999996   56789999999986


Q ss_pred             ccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          265 TEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       265 ~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      .... .....+++..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus       149 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~  203 (308)
T cd06615         149 QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA  203 (308)
T ss_pred             cccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence            5432 22345788999999999888899999999999999999999999976653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=352.96  Aligned_cols=209  Identities=29%  Similarity=0.384  Sum_probs=185.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      +.+++++.||+|-||.||++.... ...||+|.++......+.+.+|+++|++|       .|+|||++++++..++.+|
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-------~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKL-------RHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhC-------cccCeEEEEEEEecCCceE
Confidence            456677899999999999997653 34699999998777778899999999999       6889999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||||||. |+|+++++......+...+...++.||++|++||+++++|||||...||||+   ++..+||+|||+|+...
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccC
Confidence            9999997 8999999986667799999999999999999999999999999999999995   77899999999999655


Q ss_pred             Ccceee-cc---CccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 003239          268 RTVYSY-IQ---SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRI  328 (837)
Q Consensus       268 ~~~~~~-~G---T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~~  328 (837)
                      +..... .+   ...|.|||.+....++.|+|||||||+||||+| |+.||++.+..++++.+.+.
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G  420 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG  420 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence            443322 22   456999999999999999999999999999998 99999999999998887663

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=332.00  Aligned_cols=271  Identities=28%  Similarity=0.419  Sum_probs=213.1

Q ss_pred             ceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          110 RYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       110 ~Y~i~-~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      -|++. +.||+|+|+.|--|+...++..||||+|.+.+. ...++.+|++++.+..      +|+||++|+++|+++..+
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq------gh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ------GHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc------CCccHHHHHHHhcccceE
Confidence            45544 579999999999999999999999999987654 3567889999998885      799999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||-|. |.|+..|.++.  .++|.++.+++++|+.||.|||.+||.||||||+|||....+.-.-||||||.++...
T Consensus       152 YLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             EEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            99999997 58888877664  5999999999999999999999999999999999999976556667899999987421


Q ss_pred             C----------CcceeeccCccccCchhhc---C--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003239          267 D----------RTVYSYIQSRYYRSPEVLL---G--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA  331 (837)
Q Consensus       267 ~----------~~~~~~~GT~~Y~APEvl~---~--~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~  331 (837)
                      .          ....+.+|+..|||||+..   +  ..|+.++|.||||||||-|+.|.+||.+....+        +| 
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--------CG-  300 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--------CG-  300 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--------CC-
Confidence            1          1234568899999999974   2  268999999999999999999999998754221        11 


Q ss_pred             CCchHHHHhhhcch----hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCC
Q 003239          332 QPPDYVLKEAKNTS----KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPY  407 (837)
Q Consensus       332 ~Pp~~~l~~~k~~~----~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~  407 (837)
                            |.++...+    +.|..+.                                   .++--|+++           
T Consensus       301 ------WdrGe~Cr~CQ~~LFesIQ-----------------------------------EGkYeFPdk-----------  328 (463)
T KOG0607|consen  301 ------WDRGEVCRVCQNKLFESIQ-----------------------------------EGKYEFPDK-----------  328 (463)
T ss_pred             ------ccCCCccHHHHHHHHHHHh-----------------------------------ccCCcCChh-----------
Confidence                  01100000    1111111                                   011112222           


Q ss_pred             CCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          408 RKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       408 ~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                                .+..++.++.|||..+|..|+.+|.+|.++|+|||+......
T Consensus       329 ----------dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  329 ----------DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ----------hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence                      334577899999999999999999999999999999986543

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.7e-37  Score=321.47  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.++||+|+||.||++++..+++.||||++...   ....+.+.+|+.+++.+       .|+||+++++++...++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-------KHPNIVQYQESFEENGN   73 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-------CCCCeeeeEeeecCCCe
Confidence            589999999999999999999999999999998742   33455788899999988       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++||||+. ++|.+.+.......+++..+..++.||+.||.|||+++++|+||+|+|||++   .++.++|+|||++..
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~  150 (256)
T cd08218          74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARV  150 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceee
Confidence            999999997 5888888765444689999999999999999999999999999999999995   567899999999865


Q ss_pred             cCCcc---eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~~---~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      .....   ....++..|+|||++.+..++.++|||||||++++|++|..||...+..+....+..  +..++        
T Consensus       151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~--------  220 (256)
T cd08218         151 LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYPP--------  220 (256)
T ss_pred             cCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCCC--------
Confidence            43321   234578889999999988999999999999999999999999976655544433321  10000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                    .             ....
T Consensus       221 --------------------------------------------------------------~-------------~~~~  225 (256)
T cd08218         221 --------------------------------------------------------------V-------------SSHY  225 (256)
T ss_pred             --------------------------------------------------------------C-------------cccC
Confidence                                                                          0             0013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      +..+.+||.+||+.||++||++.|+|+||||
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            4678999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=328.58  Aligned_cols=278  Identities=35%  Similarity=0.590  Sum_probs=216.4

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      |++.+.||+|+||+||+|++..+++.||||++.....  ......+|+..++++.      +|+||+++++++..++..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN------EHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc------CCCCchhHHHHhhcCCcEE
Confidence            6788999999999999999998999999999875422  2233456777777773      3899999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      +||||+.++|.+.+.......+++..++.++.||+.+|.|||+++|+|+||||+||+++   ..+.++|+|||.+.....
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccC
Confidence            99999998999988776545689999999999999999999999999999999999995   678999999999975543


Q ss_pred             c--ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcch
Q 003239          269 T--VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS  345 (837)
Q Consensus       269 ~--~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~  345 (837)
                      .  .....++..|+|||++.. ..++.++|||||||+++||++|++||...+..+.+.++...++.+. ...+.......
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  230 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPT-KQDWPEGYKLA  230 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCC-hhhhhhHhhhh
Confidence            2  234567889999998864 4688999999999999999999999999998889999888888333 32222111100


Q ss_pred             hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHH
Q 003239          346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA  425 (837)
Q Consensus       346 ~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~  425 (837)
                      ..+.                    +.+                  .......+...+                 ...+..
T Consensus       231 ~~~~--------------------~~~------------------~~~~~~~~~~~~-----------------~~~~~~  255 (283)
T cd07830         231 SKLG--------------------FRF------------------PQFAPTSLHQLI-----------------PNASPE  255 (283)
T ss_pred             cccc--------------------ccc------------------cccccccHHHHc-----------------ccCCHH
Confidence            0000                    000                  000000011110                 012467


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          426 LVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       426 l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      +.+||++||..||++|||++|++.||||
T Consensus       256 ~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         256 AIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            8999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.8e-37  Score=329.44  Aligned_cols=202  Identities=26%  Similarity=0.409  Sum_probs=169.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe-----
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-----  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-----  182 (837)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++........+.+|+.+++.+.      +|+||+++++++.     
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS------DHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh------cCCCeeeeeeeeeecccC
Confidence            47999999999999999999999999999999998765444566778999998884      5899999999884     


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQRHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..+..++||||++ ++|.+++...  ....+++..++.++.||+.||.|||+++|+||||||+||+++   ..+.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEcc
Confidence            3457999999997 5787776532  224589999999999999999999999999999999999996   567799999


Q ss_pred             cccccccCC---cceeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          260 FGSACTEDR---TVYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       260 FGlA~~~~~---~~~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      ||++.....   ......++..|+|||++..     ..++.++|||||||++|||++|+.||.....
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            999865432   2233468899999999853     3578999999999999999999999976543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.7e-37  Score=335.48  Aligned_cols=280  Identities=34%  Similarity=0.616  Sum_probs=222.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-  183 (837)
                      .++|++++.||.|+||.||+|++..+++.||||++.+.   ....+.+..|+++++.+       .||||++++++|.. 
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~   81 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-------RHENIISLSDIFISP   81 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-------CCCCeeeEeeeEecC
Confidence            47899999999999999999999999999999988642   23346677899999998       68999999999876 


Q ss_pred             cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       184 ~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ....|+||||++++|.+++...   .+++..++.++.||++||+|||+++|+||||||+|||++   ..+.+||+|||.+
T Consensus        82 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~  155 (328)
T cd07856          82 LEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLA  155 (328)
T ss_pred             CCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCccccc
Confidence            4678999999998888777643   488999999999999999999999999999999999995   6788999999999


Q ss_pred             cccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ...........++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.+.++ .+++.+.....
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (328)
T cd07856         156 RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG-TPPDDVINTIC  234 (328)
T ss_pred             cccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHHHhcc
Confidence            766555555677889999999876 5789999999999999999999999999888888888888888 45544433211


Q ss_pred             c--chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          343 N--TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       343 ~--~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      .  ..+++....                               .     ..   .....+.+                 .
T Consensus       235 ~~~~~~~~~~~~-------------------------------~-----~~---~~~~~~~~-----------------~  258 (328)
T cd07856         235 SENTLRFVQSLP-------------------------------K-----RE---PVPFSEKF-----------------K  258 (328)
T ss_pred             chhhHHHHhhcc-------------------------------c-----cC---CCcHHHHc-----------------C
Confidence            0  000000000                               0     00   00001111                 1


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..++.+.+||++||+.||++|||++++|.||||....
T Consensus       259 ~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence            2357889999999999999999999999999997643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.9e-37  Score=335.84  Aligned_cols=279  Identities=33%  Similarity=0.567  Sum_probs=217.8

Q ss_pred             ceEEEEEeccCCceeEEEeeccCC--CeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEM--NSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~t--g~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      +|++.+.||+|+||.||++++..+  ++.||||+++..   ....+.+.+|+.+++++.      +|+||+++++.+...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~~~~~   74 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR------GHKNITCLYDMDIVF   74 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc------CCCChheeeeeeeec
Confidence            588999999999999999999888  899999998742   233456788999998884      589999999875432


Q ss_pred             ----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 ----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                          ..++++||+++++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   ..+.+||+||
T Consensus        75 ~~~~~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Df  149 (332)
T cd07857          75 PGNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDF  149 (332)
T ss_pred             cccCCcEEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcC
Confidence                468999999999998888654  4699999999999999999999999999999999999995   6678999999


Q ss_pred             ccccccCCc-------ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          261 GSACTEDRT-------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       261 GlA~~~~~~-------~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      |++......       .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+++.+| .
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~  228 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-T  228 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-C
Confidence            998643321       223468899999998876 4789999999999999999999999999999999999999999 4


Q ss_pred             CchHHHHhhhcchh--hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCC
Q 003239          333 PPDYVLKEAKNTSK--FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN  410 (837)
Q Consensus       333 Pp~~~l~~~k~~~~--~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~  410 (837)
                      |+...+........  +.....                               .        .....+..+.        
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~-------------------------------~--------~~~~~~~~~~--------  261 (332)
T cd07857         229 PDEETLSRIGSPKAQNYIRSLP-------------------------------N--------IPKKPFESIF--------  261 (332)
T ss_pred             CCHHHHHhhhhhhHHHHHHhcc-------------------------------c--------cCCcchHhhC--------
Confidence            44443332111000  000000                               0        0000011110        


Q ss_pred             CchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       411 l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                               ...+..+.+||.+||+.||++|||++|+|+||||++-
T Consensus       262 ---------~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         262 ---------PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             ---------CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                     1134678999999999999999999999999999753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.6e-37  Score=322.80  Aligned_cols=201  Identities=26%  Similarity=0.421  Sum_probs=173.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++...  ....+.+.+|+++++.+       .|+||+++++.+...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-------NHPNVVKYYTSFVVGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-------CCCCEEEEEEEEeeCCE
Confidence            4799999999999999999998889999999999743  23456788899998888       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhcc-CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~-~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++|||++. ++|.+++..... ..+++..++.++.||+.||+|||+.||+|+||||+||+++   +++.+||+|||++.
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~  150 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSA  150 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHH
Confidence            999999997 588888876432 4689999999999999999999999999999999999996   56789999999985


Q ss_pred             ccCCc-------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q 003239          265 TEDRT-------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEF  319 (837)
Q Consensus       265 ~~~~~-------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~  319 (837)
                      .....       .....++..|+|||++... .++.++|||||||++|+|++|+.||...+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~  213 (267)
T cd06610         151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM  213 (267)
T ss_pred             HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence            43321       1234678899999999877 7899999999999999999999999765543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.3e-37  Score=329.90  Aligned_cols=279  Identities=30%  Similarity=0.509  Sum_probs=215.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||+||+|.++.+++.||||+++..   ......+.+|+++++.+       .|+||+++++++...
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-------~h~~i~~~~~~~~~~   78 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-------NHRNIVNLKEIVTDK   78 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-------CCCCeeeeeheecCc
Confidence            37899999999999999999999999999999999743   22334567899999988       689999999998775


Q ss_pred             c----------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCe
Q 003239          185 R----------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       185 ~----------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                      .          .+|+||||+++++.+.+... ...+++..++.++.||+.||+|||+.+|+|+||||+||+++   +.+.
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~  154 (302)
T cd07864          79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQ  154 (302)
T ss_pred             chhhhccccCCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCc
Confidence            5          89999999999888877654 34689999999999999999999999999999999999995   6788


Q ss_pred             EEEEecccccccCCcc----eeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          255 IKIIDFGSACTEDRTV----YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       255 IKL~DFGlA~~~~~~~----~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      +||+|||.+.......    ....++..|+|||++.+. .++.++|||||||++|||++|++||...+..+.+..+.+..
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~  234 (302)
T cd07864         155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC  234 (302)
T ss_pred             EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999986543221    223457789999998754 57899999999999999999999999888888888888877


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      +..++..+ ........+....                                     .+.... ..+...        
T Consensus       235 ~~~~~~~~-~~~~~~~~~~~~~-------------------------------------~~~~~~-~~~~~~--------  267 (302)
T cd07864         235 GSPCPAVW-PDVIKLPYFNTMK-------------------------------------PKKQYR-RRLREE--------  267 (302)
T ss_pred             CCCChhhc-ccccccccccccc-------------------------------------cccccc-cchhhh--------
Confidence            74443321 1111000000000                                     000000 000000        


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                               ....+..+.+||.+||..||.+|||++++|+||||
T Consensus       268 ---------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         268 ---------FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ---------cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                     01134678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.3e-37  Score=320.23  Aligned_cols=249  Identities=28%  Similarity=0.455  Sum_probs=209.1

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++++.||.|+||.||.+++..+++.|++|.+...   ......+.+|+++++++       +|+||+++++++...+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~~   73 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-------QHPNIIAYYNHFMDDNT   73 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-------CCCCeeEEEeEEecCCe
Confidence            589999999999999999999999999999998743   34456788899999998       68899999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +++||||+. ++|.+++.......+++..++.++.|++.+|.|||+.+|+|+||||+||+++   ..+.+||+|||++..
T Consensus        74 ~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~  150 (256)
T cd08221          74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKI  150 (256)
T ss_pred             EEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEE
Confidence            999999997 5899888765445689999999999999999999999999999999999996   567899999999865


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   .....++..|+|||++.+..++.++|||||||++|||++|..||...+..+....+..  + .++        
T Consensus       151 ~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~-~~~--------  219 (256)
T cd08221         151 LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--G-NYT--------  219 (256)
T ss_pred             cccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--C-CCC--------
Confidence            4332   2345688999999999988899999999999999999999999977665554443322  1 000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                 +                               .....
T Consensus       220 -------------------------------------------~-------------------------------~~~~~  225 (256)
T cd08221         220 -------------------------------------------P-------------------------------VVSVY  225 (256)
T ss_pred             -------------------------------------------C-------------------------------Ccccc
Confidence                                                       0                               00013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      +..+.+||.+||..||++|||++|+|+|||+
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            4668899999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-37  Score=328.86  Aligned_cols=198  Identities=27%  Similarity=0.464  Sum_probs=170.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++.++||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.+       .|+||+++++++...+.
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-------~h~~ii~~~~~~~~~~~   80 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-------KHSNIVAYFGSYLRRDK   80 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-------CCCCeeeEEEEEEeCCE
Confidence            368999999999999999999999999999999998543 3345677899988888       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +++||||++ ++|.+++...  +.+++.+++.++.||+.||.|||++||+|+||||+||+++   ..+.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~  155 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQ  155 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeE
Confidence            999999998 5888877654  3699999999999999999999999999999999999995   667899999999864


Q ss_pred             cCCc---ceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ....   .....++..|+|||++.   ...++.++|||||||++|+|++|..||....
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~  213 (267)
T cd06645         156 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH  213 (267)
T ss_pred             ccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence            4322   23447889999999985   4468899999999999999999999986543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=345.08  Aligned_cols=277  Identities=25%  Similarity=0.353  Sum_probs=226.9

Q ss_pred             ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       106 ~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .+.+.|+.-++||+|+||.|+-|+.+.||+.+|+|.+.+..    ......++|..||.+++       .+.||.+--.|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-------s~FiVslaYAf  254 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-------SPFIVSLAYAF  254 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-------cCcEEEEeeee
Confidence            44578999999999999999999999999999999986532    33456788999999994       46899999999


Q ss_pred             eecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      +..+.+|+||..|+| +|.-.|.+.....+++..++.++.+|+.||++||+.+||.|||||+|||++   +.++|+|+|+
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD---d~GhvRISDL  331 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD---DHGHVRISDL  331 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec---cCCCeEeecc
Confidence            999999999999985 665445444445799999999999999999999999999999999999995   8899999999


Q ss_pred             ccccccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          261 GSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       261 GlA~~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      |+|+...  +.....+||..|||||++.+..|+...|.|+|||+||||+.|+.||....+....+++-+..-        
T Consensus       332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--------  403 (591)
T KOG0986|consen  332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--------  403 (591)
T ss_pred             ceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--------
Confidence            9998654  445566999999999999999999999999999999999999999965543332222221110        


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                   .                             +.+..
T Consensus       404 ---------------------------------------------~-----------------------------~~~ey  409 (591)
T KOG0986|consen  404 ---------------------------------------------E-----------------------------DPEEY  409 (591)
T ss_pred             ---------------------------------------------c-----------------------------chhhc
Confidence                                                         0                             11112


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCCCCCCCCCCCCCCCcc
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCPYQPPPETPRVPVA  474 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~~~  474 (837)
                      ....++++++|++.+|..||++|+     .++++.+||||+...|...+.-+-++|.+|..
T Consensus       410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp  470 (591)
T KOG0986|consen  410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP  470 (591)
T ss_pred             ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence            234678999999999999999998     56799999999999987776666666666543

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.8e-37  Score=324.82  Aligned_cols=197  Identities=31%  Similarity=0.515  Sum_probs=169.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++....          ...+.+.+|+.+++++       .|+||+++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~   73 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-------QHENIVQYLG   73 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-------CCCCeeeEEE
Confidence            4778899999999999999999899999999986431          1234577889999988       6899999999


Q ss_pred             EEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          180 YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      ++...+..++||||+.+ +|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~  148 (267)
T cd06628          74 SSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKIS  148 (267)
T ss_pred             EEEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEec
Confidence            99999999999999975 788887654  4589999999999999999999999999999999999995   67889999


Q ss_pred             ecccccccCCc---------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          259 DFGSACTEDRT---------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       259 DFGlA~~~~~~---------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      |||.+......         .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  217 (267)
T cd06628         149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ  217 (267)
T ss_pred             ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence            99998654311         1123578889999999988899999999999999999999999976544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.9e-37  Score=336.79  Aligned_cols=282  Identities=32%  Similarity=0.591  Sum_probs=219.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++++.      +|+||++++++|...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~------~h~ni~~~~~~~~~~   79 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG------DHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc------CCCCccceeeeeccC
Confidence            47899999999999999999999999999999988542   233456678999999883      478999999998754


Q ss_pred             --ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          185 --RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       185 --~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                        ...|+||||+.++|.+++...   .+++..++.++.||+.||+|||++||+||||||+||+++   .++.+||+|||+
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~  153 (337)
T cd07852          80 NDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGL  153 (337)
T ss_pred             CCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccc
Confidence              368999999999998887654   588999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCC--------cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          263 ACTEDR--------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       263 A~~~~~--------~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      +.....        ....+.++..|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+.++....+ .+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~-~~  232 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG-PP  232 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CC
Confidence            864321        22345688899999988654 678999999999999999999999999988888888888877 33


Q ss_pred             chHHHHhhhc-ch-hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          334 PDYVLKEAKN-TS-KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       334 p~~~l~~~k~-~~-~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                      +...+..... .. .+++...                                       ......+..+.         
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~---------  264 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLP---------------------------------------SRPRKPLDELL---------  264 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcc---------------------------------------cccccchhhhc---------
Confidence            3322221110 00 0000000                                       00000011111         


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                              ...+.++.+||.+||+.||++|||+.++|+||||++...
T Consensus       265 --------~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         265 --------PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             --------cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                    114578999999999999999999999999999988543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=331.34  Aligned_cols=287  Identities=32%  Similarity=0.584  Sum_probs=232.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .||.-++.++.|.- .|..|.|.-.++.||+|++...   ....+++.+|+.++..+       .|+||++++.+|.-..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-------~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-------NHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-------cccceeeeeeccCccc
Confidence            78999999999998 8888989999999999998642   34457788999999999       6789999999998653


Q ss_pred             ------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          186 ------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       186 ------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                            ..|+|||+|..+|.+++..    .++-+.++.|+.|++.|++|||+.||+||||||+||++.   .++.+||.|
T Consensus        89 ~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~d  161 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILD  161 (369)
T ss_pred             cHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeecc
Confidence                  6899999999999998873    378889999999999999999999999999999999995   778999999


Q ss_pred             cccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||+|+..+..  ...++.|+.|+|||++.+..|...+||||+|||+.||++|+..|+|.+..++..++.+.+|.+-+..+
T Consensus       162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            9999876543  56789999999999999999999999999999999999999999999999999999999994444444


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      .+.....+.|+..                +..|+..                       .+.++++..-+.     ...+
T Consensus       242 ~qL~~~~r~yv~~----------------~~~y~~~-----------------------~f~~~fpD~~f~-----~~~e  277 (369)
T KOG0665|consen  242 KQLQPTVRNYVEN----------------RPQYQAI-----------------------SFSELFPDSLFP-----VVLE  277 (369)
T ss_pred             HHhhHHHHHHhhc----------------ChHhhcc-----------------------chhhhCCccccc-----cccc
Confidence            4433333333331                1122221                       122222221111     1111


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT  454 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~  454 (837)
                      .+......+.||+.+||..||++|+++++||+||||+
T Consensus       278 ~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  278 GSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             CCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            2223456789999999999999999999999999998

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=327.49  Aligned_cols=252  Identities=25%  Similarity=0.438  Sum_probs=208.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.||.|+||.||++++..+++.||+|++....  .....+.+|+++++.+       .|+||+++++++.....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-------RSPYITKYYGSFLKGSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-------CCCCeeeeeEEEEECCe
Confidence            47889999999999999999999999999999997542  3445677899999988       58999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|+|+||+. ++|.+++...   .+++..++.++.||+.||.|||+++|+|+||+|+||+++   +++.++|+|||++..
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~  147 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQ  147 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccccccee
Confidence            999999997 4888887654   589999999999999999999999999999999999995   678899999999976


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   .....++..|+|||++.+..++.++|||||||++|+|++|.+||...+.......+....   +         
T Consensus       148 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~---------  215 (274)
T cd06609         148 LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---P---------  215 (274)
T ss_pred             ecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC---C---------
Confidence            5432   234567888999999998889999999999999999999999997654333222211100   0         


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                 +..                 +            +..+
T Consensus       216 -------------------------------------------~~~-----------------~------------~~~~  223 (274)
T cd06609         216 -------------------------------------------PSL-----------------E------------GNKF  223 (274)
T ss_pred             -------------------------------------------CCC-----------------c------------cccc
Confidence                                                       000                 0            0003


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +..+.+||.+||..||++|||++++++||||++..
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            45688999999999999999999999999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-37  Score=330.41  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=206.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++++.||+|+||.||++++..+++.||+|.++..  ......+.+|+++++++       .|+||+++++.+...+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-------VSPYIVDFYGAFFIEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-------CCCcHHhhhhheecCCe
Confidence            3688999999999999999999999999999998753  34456788899999988       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          187 LCICFELLDS-NLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++||||+.+ +|..++.... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++   .++.+||+|||++
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~  150 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVS  150 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCc
Confidence            9999999985 7777665531 2358999999999999999999996 6999999999999996   5788999999998


Q ss_pred             cccCC-cceeeccCccccCchhhcCC------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          264 CTEDR-TVYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       264 ~~~~~-~~~~~~GT~~Y~APEvl~~~------~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ..... ......++..|+|||++.+.      .++.++|||||||++|+|++|..||...........+.......++  
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  228 (286)
T cd06622         151 GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP--  228 (286)
T ss_pred             ccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC--
Confidence            65432 23344678889999998654      3588999999999999999999999765433332222221110000  


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                                         ..           
T Consensus       229 -------------------------------------------------------------------~~-----------  230 (286)
T cd06622         229 -------------------------------------------------------------------TL-----------  230 (286)
T ss_pred             -------------------------------------------------------------------CC-----------
Confidence                                                                               00           


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...++.++.+||.+||+.||++|||++++++||||....
T Consensus       231 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         231 --PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             --CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence              001346788999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.1e-37  Score=331.27  Aligned_cols=254  Identities=24%  Similarity=0.421  Sum_probs=208.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ..+|++.+.||.|+||.||++.+..+++.||||.+... ....+.+.+|+.+++.+       .|+||+++++++...+.
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~   90 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-------KNPNIVNFLDSFLVGDE   90 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-------CCCceeeeeeeEecCce
Confidence            36899999999999999999999999999999998753 23356678899999888       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|+||||+.+ +|.+++...   .+++.++..++.||+.||+|||++||+|+||||+||+++   .++.+||+|||++..
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~  164 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQ  164 (296)
T ss_pred             EEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchh
Confidence            9999999985 777766543   489999999999999999999999999999999999995   578899999999865


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+..+.+..+... + .++        
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~-~~~--------  234 (296)
T cd06655         165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G-TPE--------  234 (296)
T ss_pred             cccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-Ccc--------
Confidence            4322   22346788999999999888999999999999999999999999877654433322110 0 000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                               +......
T Consensus       235 -------------------------------------------------------------------------~~~~~~~  241 (296)
T cd06655         235 -------------------------------------------------------------------------LQNPEKL  241 (296)
T ss_pred             -------------------------------------------------------------------------cCCcccC
Confidence                                                                                     0000113


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++.+.+||++||..||++|||+.++++||||+...
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            46788999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.8e-37  Score=326.20  Aligned_cols=197  Identities=28%  Similarity=0.467  Sum_probs=169.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++++       .|+||+++++++..++.
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-------~h~~ii~~~~~~~~~~~   80 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-------KHCNIVAYFGSYLSREK   80 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-------CCCCeeeeeEEEEeCCE
Confidence            478999999999999999999999999999999997532 3345677899999888       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+||+++   .++.+||+|||++..
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~  155 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAK  155 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCcccee
Confidence            999999998 5788877643  3689999999999999999999999999999999999995   667899999999875


Q ss_pred             cCCc---ceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ....   .....++..|+|||.+.   ...++.++|||||||++|||++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            4322   23456788999999985   335788999999999999999999998544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.9e-37  Score=323.74  Aligned_cols=197  Identities=25%  Similarity=0.456  Sum_probs=169.2

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +|+..+.||+|+||.||++.+..+++.||+|+++...       ...+.+.+|+++++.+       .|+||+++++++.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~   73 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-------NHPHIIRMLGATC   73 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-------CCCceehhhceec
Confidence            4778899999999999999999999999999997432       2356788899999998       6889999999999


Q ss_pred             ecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+..++||||+.+ +|.+++...  +.+++..++.++.||+.||.|||++||+|+||||+||+++  .....+||+|||
T Consensus        74 ~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg  149 (268)
T cd06630          74 EDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFG  149 (268)
T ss_pred             cCCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEcccc
Confidence            99999999999985 788877654  3689999999999999999999999999999999999995  233469999999


Q ss_pred             cccccCCc-------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       262 lA~~~~~~-------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .+......       .....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            98654322       123467889999999988899999999999999999999999996543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.6e-37  Score=372.10  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=206.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-  184 (837)
                      ++|+++++||+|+||+||+|++..+++.||+|+++..   ......+..|+.+|+.|       .|+|||+++++|... 
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-------~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-------KHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-------CCCCcCeEEEEEEecC
Confidence            7899999999999999999999999999999999743   34456788899999999       689999999998654 


Q ss_pred             -ceEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcC-------CeeeccCCCCCeeeecc----
Q 003239          185 -RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDA-------GIIHCDLKPENILLCTS----  249 (837)
Q Consensus       185 -~~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~-------gIVHrDLKPeNILl~~~----  249 (837)
                       ..+|||||||. ++|.++|....  ...+++..++.|+.||+.||.|||+.       +||||||||+||||+..    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence             57999999998 58988886532  24699999999999999999999984       49999999999999632    


Q ss_pred             ----------CCCCeEEEEecccccccCCc--ceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          250 ----------VKPAEIKIIDFGSACTEDRT--VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       250 ----------~~~~~IKL~DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                                +....+||+|||++......  ....++|+.|+|||++.+.  .++.++||||||||||||++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      12345899999999754322  2345789999999999653  588999999999999999999999976


Q ss_pred             CCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccc
Q 003239          316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHH  395 (837)
Q Consensus       316 ~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~  395 (837)
                      ......+...+..   .|.                                                             
T Consensus       246 ~~~~~qli~~lk~---~p~-------------------------------------------------------------  261 (1021)
T PTZ00266        246 ANNFSQLISELKR---GPD-------------------------------------------------------------  261 (1021)
T ss_pred             CCcHHHHHHHHhc---CCC-------------------------------------------------------------
Confidence            5543322221110   000                                                             


Q ss_pred             cchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          396 KHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       396 ~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                               .|.            ...+.++.+||..||.+||.+|||+.|+|.||||+...
T Consensus       262 ---------lpi------------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        262 ---------LPI------------KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             ---------CCc------------CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence                     000            01236788999999999999999999999999998643

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-39  Score=355.28  Aligned_cols=258  Identities=24%  Similarity=0.387  Sum_probs=220.9

Q ss_pred             ccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe----CChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       104 ~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik----~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      +.+....|.-++.||.|+||.||-|++..+.+.||||++.    ......+.++.|+..|++|       .|||+|.+.+
T Consensus        21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-------~HPntieYkg   93 (948)
T KOG0577|consen   21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-------RHPNTIEYKG   93 (948)
T ss_pred             cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-------cCCCcccccc
Confidence            3444467777889999999999999999999999999986    2345678899999999999       6899999999


Q ss_pred             EEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          180 YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ||..+...|||||||-|+-.|++.-.. +++.+.+|..|+.+.+.||+|||+.+.||||||..|||++   +.+.|||+|
T Consensus        94 CyLre~TaWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaD  169 (948)
T KOG0577|consen   94 CYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLAD  169 (948)
T ss_pred             eeeccchHHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeecc
Confidence            999999999999999987777766554 6799999999999999999999999999999999999996   889999999


Q ss_pred             cccccccCCcceeeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          260 FGSACTEDRTVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       260 FGlA~~~~~~~~~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ||.|.... ....++||++|||||||+.   +.|+-++||||||+++.||...+||+-..+....+..|.+.-   +|  
T Consensus       170 FGSAsi~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe---sP--  243 (948)
T KOG0577|consen  170 FGSASIMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SP--  243 (948)
T ss_pred             ccchhhcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC---CC--
Confidence            99996543 3467899999999999974   479999999999999999999999987777666666654410   00  


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                        .                             
T Consensus       244 --------------------------------------------------t-----------------------------  244 (948)
T KOG0577|consen  244 --------------------------------------------------T-----------------------------  244 (948)
T ss_pred             --------------------------------------------------C-----------------------------
Confidence                                                              0                             


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .....+++.|+.||..||+.=|.+|||.+++|.|+|+...+
T Consensus       245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            01224778999999999999999999999999999998755

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.4e-37  Score=322.65  Aligned_cols=196  Identities=26%  Similarity=0.454  Sum_probs=167.4

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +|++.+.||+|+||+||+|.+ .+++.+|||+++...       .....+.+|+++++.+       .|+||+++++++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~   72 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-------KHVNIVQYLGTCL   72 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-------CCCCEeeEeeEee
Confidence            478899999999999999976 478899999987431       2234577899998888       6889999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+..++||||+. ++|.+++...  ..+++..++.++.||+.||+|||+.+|+|+||||+||+++   ..+.+||+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg  147 (265)
T cd06631          73 DDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFG  147 (265)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccch
Confidence            9999999999997 4888887654  3589999999999999999999999999999999999995   67889999999


Q ss_pred             cccccC---------CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          262 SACTED---------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       262 lA~~~~---------~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      ++....         .......++..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  213 (265)
T cd06631         148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR  213 (265)
T ss_pred             hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh
Confidence            986431         112234678899999999988999999999999999999999999976543

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-36  Score=329.57  Aligned_cols=255  Identities=26%  Similarity=0.455  Sum_probs=207.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||+|+||.||++.+..+++.||||.++...    ...+.+.+|+++++.+       .|+||+++++.+..+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~   73 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-------ENPFVVSMFCSFETK   73 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-------CCCCeeeeEEEEecC
Confidence            36899999999999999999999999999999997542    2344667888888877       689999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++|+||||+.+ +|.+++...  +.+++..++.++.|++.||.|||+++|+||||||+||+++   ..+.+||+|||++
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~  148 (305)
T cd05609          74 RHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLS  148 (305)
T ss_pred             CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCc
Confidence            999999999985 788887654  3589999999999999999999999999999999999995   6788999999987


Q ss_pred             cccCCc------------------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          264 CTEDRT------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       264 ~~~~~~------------------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ......                  .....++..|+|||.+.+..++.++|||||||++|||++|..||.+....+.+..+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~  228 (305)
T cd05609         149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  228 (305)
T ss_pred             cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            531100                  01235677899999999889999999999999999999999999876655444433


Q ss_pred             HHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcC
Q 003239          326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY  405 (837)
Q Consensus       326 ~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~  405 (837)
                      ..... .                                                                        +
T Consensus       229 ~~~~~-~------------------------------------------------------------------------~  235 (305)
T cd05609         229 ISDDI-E------------------------------------------------------------------------W  235 (305)
T ss_pred             Hhccc-C------------------------------------------------------------------------C
Confidence            22100 0                                                                        0


Q ss_pred             CCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCC---HHHHHcCccCCCCCC
Q 003239          406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQASRHPFVTGEPF  458 (837)
Q Consensus       406 p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT---a~EaL~HPff~~~~~  458 (837)
                      |.          .....+..+.+||++||..||++|||   +.|+|+||||...++
T Consensus       236 ~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         236 PE----------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             CC----------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            00          00013467899999999999999998   899999999988665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.8e-37  Score=327.86  Aligned_cols=192  Identities=27%  Similarity=0.452  Sum_probs=159.4

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      +||+|+||.||++.+..+++.||||++.+..    .......+|..+++.+..    ..|+||+.+++++...+..++||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~lv~   76 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----GDCPFIVCMTYAFHTPDKLCFIL   76 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh----CCCCcEeEEEEEEecCCeEEEEE
Confidence            4899999999999999999999999997532    112234455555555533    27899999999999999999999


Q ss_pred             eccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC-c
Q 003239          192 ELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-T  269 (837)
Q Consensus       192 Ey~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~-~  269 (837)
                      ||+. ++|.+++...  +.+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++..... .
T Consensus        77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceeccccC
Confidence            9998 5777777644  3599999999999999999999999999999999999995   667899999999865432 2


Q ss_pred             ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          270 VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      .....++..|+|||++.. ..++.++|||||||++|+|++|..||...
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            233478999999999874 56899999999999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-37  Score=333.00  Aligned_cols=254  Identities=24%  Similarity=0.426  Sum_probs=206.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .+.|.....||+|+||.||++.+..+++.||||++.... ...+.+.+|+.+++.+       .|+||+++++.+...+.
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~ii~~~~~~~~~~~   93 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-------HHENVVDMYNSYLVGDE   93 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-------CCCcHHHHHHheecCCe
Confidence            356666788999999999999999999999999987533 3455678899988888       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+.+ +|.+++..   ..+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+|||++..
T Consensus        94 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~  167 (292)
T cd06658          94 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQ  167 (292)
T ss_pred             EEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhh
Confidence            9999999985 66666643   3489999999999999999999999999999999999995   567899999999864


Q ss_pred             cCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ...   ......++..|+|||++.+..++.++|||||||++|||++|..||...+..+.+..+...+.   +.       
T Consensus       168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~-------  237 (292)
T cd06658         168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP---PR-------  237 (292)
T ss_pred             cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---Cc-------
Confidence            322   22345788999999999888999999999999999999999999987655443333222110   00       


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                               +......
T Consensus       238 -------------------------------------------------------------------------~~~~~~~  244 (292)
T cd06658         238 -------------------------------------------------------------------------VKDSHKV  244 (292)
T ss_pred             -------------------------------------------------------------------------ccccccc
Confidence                                                                                     0000013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +..+.+||.+||..||++|||++|+|+||||...+
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence            45688999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=372.56  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=216.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|.|+++||+|+||.|.+++.+.+++.||+|++++    .......|..|-.||..-       +.+=|+.++-.|++
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-------ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-------NSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-------CcHHHHHHHHHhcC
Confidence            3789999999999999999999999999999999986    234455677777787665       34569999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++++|+||||+. |+|..++....  .+++..++.++..|+.||.-||+.|+|||||||+||||+   ..|+|||+|||.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld---~~GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD---KSGHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec---ccCcEeeccchh
Confidence            999999999997 68998887764  799999999999999999999999999999999999995   889999999999


Q ss_pred             ccccCCc----ceeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          263 ACTEDRT----VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       263 A~~~~~~----~~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      +...+..    ....+|||.|.+||++..     ..|+..+|.|||||++|||+.|..||..++-.+.+.+|+..-.   
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~---  298 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE---  298 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh---
Confidence            9765432    234689999999999963     4689999999999999999999999988877777776655210   


Q ss_pred             chHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       334 p~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                                      ++                                                    .||       
T Consensus       299 ----------------~l----------------------------------------------------~FP-------  303 (1317)
T KOG0612|consen  299 ----------------SL----------------------------------------------------SFP-------  303 (1317)
T ss_pred             ----------------hc----------------------------------------------------CCC-------
Confidence                            00                                                    011       


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCCCCC---HHHHHcCccCCCCCCC
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQASRHPFVTGEPFT  459 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT---a~EaL~HPff~~~~~~  459 (837)
                          .+..+++++.|||+++|. +|+.|+.   ++++..||||.+.+|.
T Consensus       304 ----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  304 ----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             ----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence                112367889999999886 8999999   9999999999999884

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.8e-38  Score=317.01  Aligned_cols=288  Identities=22%  Similarity=0.441  Sum_probs=220.8

Q ss_pred             ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-
Q 003239          106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-  184 (837)
Q Consensus       106 ~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-  184 (837)
                      ..+++|++++++|+|.|+.||.+.+..+++.++||+++.  ...+.+.+|+.||+.|.      +|+||++++++..+. 
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~------gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLR------GGPNIIKLLDIVKDPE  106 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhcc------CCCCeeehhhhhcCcc
Confidence            355899999999999999999999999999999999984  34578899999999996      799999999999876 


Q ss_pred             -ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 -RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 -~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                       ....|||||++..-...+-    ..++..+++.++.||+.||.|||+.||+|||+||.|++|+  .+...++|+|+|+|
T Consensus       107 SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLA  180 (338)
T ss_pred             ccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchH
Confidence             4678999999864333222    2478889999999999999999999999999999999997  46678999999999


Q ss_pred             cccC--CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          264 CTED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       264 ~~~~--~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG-~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ....  ..-...+.++.|.-||++... .|+..-|+|||||++..|+.. .+.|.|.++.+++-+|.+++|   .+++..
T Consensus       181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG---t~el~~  257 (338)
T KOG0668|consen  181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG---TDELYA  257 (338)
T ss_pred             hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC---hHHHHH
Confidence            6543  333445778999999999875 689999999999999999986 556689999999999999999   222222


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                      ..       .+-.                   +.-..+++...        ..+..+.+...+..         +   ..
T Consensus       258 Yl-------~KY~-------------------i~Ldp~~~~i~--------~~~~rk~w~~Fi~~---------~---n~  291 (338)
T KOG0668|consen  258 YL-------NKYQ-------------------IDLDPQFEDIL--------GRHSRKPWSRFINS---------E---NQ  291 (338)
T ss_pred             HH-------HHHc-------------------cCCChhHhhHh--------hccccccHHHhCCc---------c---cc
Confidence            21       1110                   00000011000        00111222222211         0   01


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      --.+++++|||.++|.+|-.+|+||+||+.||||...
T Consensus       292 hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  292 HLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             ccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            1145889999999999999999999999999999753

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.4e-37  Score=325.11  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=202.0

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||+|+||+||+|.+..+++.||||++....    .....+.+|+++|+.+       .|+||+++++++...+..|+|||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~lv~e   73 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-------SSRFIVSLAYAFETKDDLCLVMT   73 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-------CCCCEeeeeeEEecCCeEEEEEe
Confidence            689999999999999999999999997432    2234556799999888       58999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC--c
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--T  269 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~--~  269 (837)
                      |+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++   .++.+||+|||.+.....  .
T Consensus        74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~  150 (277)
T cd05577          74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKK  150 (277)
T ss_pred             cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCc
Confidence            998 5888888765545699999999999999999999999999999999999995   667899999999865432  2


Q ss_pred             ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhh
Q 003239          270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK  349 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~  349 (837)
                      .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.+..-                   
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  211 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-------------------  211 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-------------------
Confidence            2334677889999999888899999999999999999999999966543111111111000                   


Q ss_pred             hcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHH
Q 003239          350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDF  429 (837)
Q Consensus       350 ~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DL  429 (837)
                        .                                .                    +         .......++.+.+|
T Consensus       212 --~--------------------------------~--------------------~---------~~~~~~~~~~~~~l  228 (277)
T cd05577         212 --E--------------------------------M--------------------A---------VEYPDKFSPEAKDL  228 (277)
T ss_pred             --c--------------------------------c--------------------c---------ccCCccCCHHHHHH
Confidence              0                                0                    0         00001134678999


Q ss_pred             HHHhcccCcCCCC-----CHHHHHcCccCCCCCCCCC
Q 003239          430 LKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCP  461 (837)
Q Consensus       430 L~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~  461 (837)
                      |++||+.||++||     ++.++++||||+...+...
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         229 CEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             HHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence            9999999999999     9999999999998776433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-36  Score=320.26  Aligned_cols=203  Identities=21%  Similarity=0.362  Sum_probs=177.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      .+|.+.++||+|+||.||+|.+..+++.||+|+++.+......+.+|+++++.+       .|+||+++++++..++.++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-------CCCChhheEEEEcCCCCcE
Confidence            579999999999999999999999999999999987766667888999999998       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+||+++   +++.+||+|||++....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~  155 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccc
Confidence            9999997 6898888765555689999999999999999999999999999999999995   67889999999987544


Q ss_pred             Cccee----eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          268 RTVYS----YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       268 ~~~~~----~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      .....    ...+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~  214 (263)
T cd05052         156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV  214 (263)
T ss_pred             cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            32211    123557999999998899999999999999999998 9999987665444

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.1e-36  Score=315.26  Aligned_cols=201  Identities=30%  Similarity=0.455  Sum_probs=171.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--c
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--Q  184 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~  184 (837)
                      +|++++.||.|+||.||++.+..+++.||+|+++..   ....+.+..|+++++.+       .|+||+++++++..  .
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-------KHPNIVRYYDRIIDRSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-------CCCccceeeeeeecCCC
Confidence            588999999999999999999999999999999743   34456677899999988       68899999998764  3


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhh-----cCCeeeccCCCCCeeeeccCCCCeEE
Q 003239          185 RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLK-----DAGIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLH-----s~gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                      ...++||||+. ++|.+++....  ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++   ..+.+|
T Consensus        74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~k  150 (265)
T cd08217          74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVK  150 (265)
T ss_pred             CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEE
Confidence            56899999997 58888876532  346899999999999999999999     89999999999999996   568999


Q ss_pred             EEecccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          257 IIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       257 L~DFGlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      |+|||++......   .....++..|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus       151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  217 (265)
T cd08217         151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ  217 (265)
T ss_pred             EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH
Confidence            9999998755432   234568899999999998889999999999999999999999998766433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.9e-37  Score=323.17  Aligned_cols=197  Identities=29%  Similarity=0.470  Sum_probs=172.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.||.|+||.||++.+..+++.||+|++...  ....+.+.+|+++++.+       .|+||+++++.+...+.
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-------NSPYIVGFYGAFYNNGD   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-------CCCchhhhheeeecCCE
Confidence            3678889999999999999999999999999998764  34456678899999888       58999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+ .+++|+||||+||+++   ..+.+||+|||.+.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~  149 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSG  149 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccch
Confidence            999999999 68888887653 569999999999999999999999 9999999999999996   57889999999986


Q ss_pred             ccCCc-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          265 TEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       265 ~~~~~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         150 QLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             hhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            44221 12267788999999999989999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-36  Score=316.95  Aligned_cols=202  Identities=27%  Similarity=0.434  Sum_probs=175.8

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      +|++.++||+|+||.||++++..+++.||+|.++..  ....+.+.+|+.+++.+       .|+||+++++.+..++.+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-------KHPNIVAFKESFEADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-------CCCCcceEEEEEEECCEE
Confidence            588999999999999999999999999999998643  34456778899998888       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |+||||+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++   +++.++|+|||.+...
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~  150 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLL  150 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceee
Confidence            99999997 5888888765555689999999999999999999999999999999999995   6788999999998654


Q ss_pred             CCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL  321 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~  321 (837)
                      ...   .....++..|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~  208 (255)
T cd08219         151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL  208 (255)
T ss_pred             cccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence            322   2245688899999999988999999999999999999999999977654443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-36  Score=327.36  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=208.5

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..++|++.+.||+|+||+||++++..+++.||||++...    ....+.+.+|+++++.+       .|+||+++++++.
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-------~h~niv~~~~~~~   85 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-------RHPNTIEYKGCYL   85 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEE
Confidence            347899999999999999999999999999999998642    23345678899999988       6899999999999


Q ss_pred             ecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          183 CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       183 ~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ..+..|+||||+.+++.+++.... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++   +++.+||+|||+
T Consensus        86 ~~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~  161 (307)
T cd06607          86 REHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGS  161 (307)
T ss_pred             eCCeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCc
Confidence            999999999999999888876543 4699999999999999999999999999999999999995   668899999999


Q ss_pred             ccccCCcceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~~~~~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +...... ....++..|+|||++.   ...++.++|||||||++|||++|.+||...+....+..+..  . .++     
T Consensus       162 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~-~~~-----  232 (307)
T cd06607         162 ASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--N-DSP-----  232 (307)
T ss_pred             ceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--C-CCC-----
Confidence            8654322 3456788999999985   34688999999999999999999999976654433222111  0 000     


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                     .                       .      ..
T Consensus       233 -----------------------------------------------~-----------------------~------~~  236 (307)
T cd06607         233 -----------------------------------------------T-----------------------L------SS  236 (307)
T ss_pred             -----------------------------------------------C-----------------------C------Cc
Confidence                                                           0                       0      00


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..++..+.+||.+||..||++|||+.+++.||||....
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            01346789999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-36  Score=326.48  Aligned_cols=207  Identities=26%  Similarity=0.403  Sum_probs=170.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC----------------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCC
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE----------------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE  169 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~----------------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~  169 (837)
                      .++|++.++||+|+||.||+|.+..                ++..||||+++..  ......+.+|+++|.++       
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------   76 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-------   76 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-------
Confidence            4789999999999999999997532                3457999999853  33455788999999988       


Q ss_pred             CCCceeEEeEEEeecceEEEEEeccc-hhHHHHHHhhcc-----------------CCCCHHHHHHHHHhHHHHHhhhhc
Q 003239          170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF-----------------RGLSLSIVQLFSKQILRGLSLLKD  231 (837)
Q Consensus       170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----------------~~L~e~~i~~I~~QIl~aL~yLHs  231 (837)
                      .|+||+++++++...+..|+||||+. ++|.+++.....                 ..+++..+..++.||+.||.|||+
T Consensus        77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            68999999999999999999999997 588888765321                 236778899999999999999999


Q ss_pred             CCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHH
Q 003239          232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL  306 (837)
Q Consensus       232 ~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyEL  306 (837)
                      +||+||||||+|||++   .++.+||+|||++.......     ....++..|+|||++....++.++|||||||++|||
T Consensus       157 ~~ivH~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el  233 (304)
T cd05096         157 LNFVHRDLATRNCLVG---ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI  233 (304)
T ss_pred             CCccccCcchhheEEc---CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence            9999999999999996   66889999999997543221     122346789999999988999999999999999999


Q ss_pred             Hh--CCCCCCCCCHHHHHHH
Q 003239          307 FL--GLPLFPGASEFDLLRR  324 (837)
Q Consensus       307 lt--G~~PF~g~s~~e~l~~  324 (837)
                      ++  +..||...+..+.+..
T Consensus       234 ~~~~~~~p~~~~~~~~~~~~  253 (304)
T cd05096         234 LMLCKEQPYGELTDEQVIEN  253 (304)
T ss_pred             HHccCCCCCCcCCHHHHHHH
Confidence            86  5678877665554443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=358.09  Aligned_cols=199  Identities=25%  Similarity=0.343  Sum_probs=172.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe-CChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE-Eeec--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY-FVCQ--  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik-~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~-f~~~--  184 (837)
                      .+++|.+.|.+|+|+.||+|++...+..||+|++- .++...+.+.+||++|++|.      +|+|||.++|. ....  
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~------gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS------GHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc------CCCceeeEeccccccccC
Confidence            68899999999999999999999988899999875 46677788999999999996      79999999993 2221  


Q ss_pred             ----ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEE
Q 003239          185 ----RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       185 ----~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                          -++.|.||||. |.|.|++..+...+|+|.+|.+|+.|+++|+++||...  |||||||-|||||.   .++.+||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KL  187 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKL  187 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEe
Confidence                36889999999 69999999776667999999999999999999999987  99999999999996   7789999


Q ss_pred             EecccccccCCcc------------eeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          258 IDFGSACTEDRTV------------YSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       258 ~DFGlA~~~~~~~------------~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ||||.|+..-...            .....|+.|||||+|.   +.+.+.|+|||+|||+||.|+....||...
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            9999996432222            1224589999999984   668999999999999999999999999654

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.6e-36  Score=310.19  Aligned_cols=200  Identities=31%  Similarity=0.526  Sum_probs=176.0

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      +|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+++++.+       .|++|+++++++......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-------KHPNIVKYYGSYLKKDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-------CCCCEeEEEEEEecCCeEE
Confidence            47889999999999999999998999999999986543 567788899999988       5889999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +|+||++ ++|.+++.... ..+++..+..++.||+.+|.+||+++++|+||+|+||+++   .++.++|+|||.+....
T Consensus        74 l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             EEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccc
Confidence            9999998 58888876653 4699999999999999999999999999999999999996   57889999999987654


Q ss_pred             Ccc--eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          268 RTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       268 ~~~--~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      ...  ....++..|+|||.+.+..++.++|||||||++|+|++|..||...+..+
T Consensus       150 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  204 (253)
T cd05122         150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK  204 (253)
T ss_pred             ccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence            432  45678889999999998889999999999999999999999997664433

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9e-37  Score=320.75  Aligned_cols=197  Identities=27%  Similarity=0.432  Sum_probs=173.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +|++.+.||.|+||.||+|++..+++.||+|++.+..    ...+.+.+|+++++++       +||||+++++++....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~   73 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-------NHPFLVNLWYSFQDEE   73 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-------CCCChHHHHHhhcCCC
Confidence            4899999999999999999999999999999997532    3456788899999988       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..++||||+.+ +|.+.+...  ..+++..+..++.||++||.|||+++|+|+||||+||+++   +++.++|+|||.+.
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~  148 (258)
T cd05578          74 NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIAT  148 (258)
T ss_pred             eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeeccccc
Confidence            99999999974 888887665  4699999999999999999999999999999999999995   67889999999987


Q ss_pred             ccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          265 TEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       265 ~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      .....  .....++..|+|||++....++.++|||||||++|+|++|..||...+.
T Consensus       149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         149 KVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             ccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            54332  2345678889999999988899999999999999999999999976653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1e-36  Score=325.85  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=202.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+..+.||+|+||.||++++..+++.||||++...  ......+.+|+.++.++.      .|+||+++++++..++.
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~iv~~~~~~~~~~~   77 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS------DCPYIVKFYGALFREGD   77 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc------CCCCEeeeeeEEecCCc
Confidence            4667788999999999999999999999999998753  234456778988888873      48999999999999999


Q ss_pred             EEEEEeccchhHHHHHH---hhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          187 LCICFELLDSNLYELIK---INHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~---~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .++||||+..++.++..   ......+++..+..++.|++.||+|||+ .+|+||||||+||+++   ..+.+||+|||+
T Consensus        78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~  154 (288)
T cd06616          78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGI  154 (288)
T ss_pred             EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecch
Confidence            99999999876554432   2233569999999999999999999997 5999999999999995   567899999999


Q ss_pred             ccccCCc--ceeeccCccccCchhhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          263 ACTEDRT--VYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       263 A~~~~~~--~~~~~GT~~Y~APEvl~~~---~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      +......  .....++..|+|||++.+.   .++.++|||||||++|+|++|++||....  .....+.+.....++.  
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~--  230 (288)
T cd06616         155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI--  230 (288)
T ss_pred             hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc--
Confidence            8643322  2334678899999999876   68999999999999999999999996543  1222222211100000  


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                        .                 +.      .   
T Consensus       231 --------------------------------------------------~-----------------~~------~---  234 (288)
T cd06616         231 --------------------------------------------------L-----------------SN------S---  234 (288)
T ss_pred             --------------------------------------------------C-----------------CC------c---
Confidence                                                              0                 00      0   


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ....++.++.+||++||..||++|||++|+++||||+...
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            0011446789999999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.4e-36  Score=321.64  Aligned_cols=193  Identities=24%  Similarity=0.380  Sum_probs=161.9

Q ss_pred             CceEEEEEe--ccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLL--GHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~L--G~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.+  |+|+||.||+++++.+++.+|+|+++......    .|+.+...+.      +|+||++++++|...+.
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~------~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMK------DNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhh------cCCCEEEEEEEEecCCe
Confidence            456666665  99999999999999999999999997542211    1333333222      58999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC-eEEEEeccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~-~IKL~DFGlA~  264 (837)
                      .|+||||+. ++|.+++....  .+++.+++.++.||++||.|||+.+|+||||||+||+++   ..+ .++|+|||++.
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~  158 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCK  158 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccce
Confidence            999999997 69999887653  699999999999999999999999999999999999996   344 89999999987


Q ss_pred             ccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          265 TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ..... ....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       159 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        159 IIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             ecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            55433 23467889999999999899999999999999999999999997543

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-36  Score=316.17  Aligned_cols=202  Identities=27%  Similarity=0.401  Sum_probs=173.0

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||+|+||.||++.++.++..||+|.+...   ....+.+.+|+++++.+       .|+||+++++.+.....
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-------~h~~i~~~~~~~~~~~~   73 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-------KHPNIVTFFASFQENGR   73 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-------CCCChhhhhheeccCCe
Confidence            588999999999999999999999999999999753   23345677899999988       58899999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++|+||+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++  .+...+||+|||.+..
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~  151 (257)
T cd08225          74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQ  151 (257)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchh
Confidence            999999997 5888888765544589999999999999999999999999999999999996  2334679999999865


Q ss_pred             cCCcc---eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       266 ~~~~~---~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      .....   ....++..|+|||++.+..++.++|||||||++|||++|..||...+..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  209 (257)
T cd08225         152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ  209 (257)
T ss_pred             ccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            43322   23467888999999988889999999999999999999999997655433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.8e-36  Score=320.97  Aligned_cols=198  Identities=27%  Similarity=0.448  Sum_probs=169.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++....  .....+.+|+++++.+       .|+||++++++|...  
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-------KSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-------CCCCeeeeeeEEEccCC
Confidence            46899999999999999999999999999999998542  3456788899999888       689999999998754  


Q ss_pred             ceEEEEEeccc-hhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 RHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +.+|+||||++ ++|.+++...  ....+++..+..++.||+.||.|||+.+++|+||+|+||+++   ..+.++|+|||
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg  150 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFG  150 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeecc
Confidence            47899999997 5787776532  234589999999999999999999999999999999999996   56789999999


Q ss_pred             cccccCCc-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          262 SACTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       262 lA~~~~~~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            98644322 22346788899999999889999999999999999999999999755

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.4e-36  Score=322.04  Aligned_cols=252  Identities=24%  Similarity=0.426  Sum_probs=207.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ..|+++++||.|+||.||+|.+..+++.||||+++..  ....+.+.+|+.+++.+       .|+||+++++++.....
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   76 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYVTKYYGSYLKGTK   76 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEECCE
Confidence            5688899999999999999999999999999999854  34456778899998888       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+.+ +|.+++..   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++   ..+.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~  150 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEccccccee
Confidence            9999999974 88887764   3589999999999999999999999999999999999995   667899999999864


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   .....++..|+|||++.+..++.++|||||||++|||++|.+||...........+..  + .+         
T Consensus       151 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~-~~---------  218 (277)
T cd06640         151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--N-NP---------  218 (277)
T ss_pred             ccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--C-CC---------
Confidence            4321   2234678889999999988999999999999999999999999976544322211100  0 00         


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                 +          .                    .....
T Consensus       219 -------------------------------------------~----------~--------------------~~~~~  225 (277)
T cd06640         219 -------------------------------------------P----------T--------------------LTGEF  225 (277)
T ss_pred             -------------------------------------------C----------C--------------------Cchhh
Confidence                                                       0          0                    00113


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      +..+.+||.+||..||++|||++++|+|+||.....
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            467889999999999999999999999999988665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-36  Score=320.08  Aligned_cols=206  Identities=19%  Similarity=0.304  Sum_probs=171.2

Q ss_pred             CceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|++.++||+|+||.||+|+..   ..+..||+|+++...  .....+.+|+.+++++       .|+||+++++++..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~   77 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-------DHSNIVRLEGVITR   77 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-------CCCCcCeEEEEEec
Confidence            68999999999999999999754   456789999998642  3345678899988887       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~  153 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRR  153 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCcc
Confidence            9999999999985 6777776542 4689999999999999999999999999999999999995   677899999998


Q ss_pred             ccccCCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          263 ACTEDRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       263 A~~~~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      +.......    ....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~  221 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV  221 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            75432211    11234567999999999999999999999999999775 99999877665544443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.9e-36  Score=316.17  Aligned_cols=197  Identities=29%  Similarity=0.490  Sum_probs=168.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .+|++.++||+|+||.||++++..+++.||||++...      ....+.+.+|+.+++.+       .|+||+++++++.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~   74 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-------LHERIVQYYGCLR   74 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-------CCCCeeeEEeEec
Confidence            5799999999999999999999999999999998632      12345677899999988       6899999999987


Q ss_pred             ec--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      +.  ..+++||||+. ++|.+++...  ..+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|
T Consensus        75 ~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~D  149 (265)
T cd06652          75 DPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGD  149 (265)
T ss_pred             cCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECc
Confidence            64  56889999997 5888887654  3589999999999999999999999999999999999995   678899999


Q ss_pred             cccccccCC------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          260 FGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       260 FGlA~~~~~------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ||++.....      ......++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  213 (265)
T cd06652         150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE  213 (265)
T ss_pred             CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence            999864321      1233467889999999998889999999999999999999999996543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-36  Score=318.02  Aligned_cols=197  Identities=28%  Similarity=0.527  Sum_probs=167.6

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      +|.+.+.||.|+||.||+|.+..+++.||||.++...           ...+.+.+|+.+++.+       +|+||++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~   74 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-------DHLNIVQYL   74 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-------CCCCcceEE
Confidence            5889999999999999999999999999999986321           1123566788888888       689999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      +++...+..++||||+. ++|.+++...  ..+++..++.++.||+.||.|||+++++|+||||+||+++   .++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l  149 (272)
T cd06629          75 GFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKI  149 (272)
T ss_pred             EEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEE
Confidence            99999999999999997 5888887665  4689999999999999999999999999999999999995   6789999


Q ss_pred             EecccccccCCc-----ceeeccCccccCchhhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          258 IDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       258 ~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~--yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      +|||++......     .....++..|+|||++....  ++.++|||||||++|+|++|..||.....
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  217 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA  217 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence            999998654321     22345788899999998754  88999999999999999999999965443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.9e-36  Score=317.38  Aligned_cols=197  Identities=28%  Similarity=0.491  Sum_probs=167.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..|++.+.||+|+||.||++.+..+++.||+|+++..      ....+.+.+|+.+++.+       .|+||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~   74 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-------QHERIVQYYGCLR   74 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-------CCCCeeeEEEEEE
Confidence            4688999999999999999999999999999998642      12345677899999998       6899999999987


Q ss_pred             ec--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..  ..+++||||+. ++|.+.+....  .+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|
T Consensus        75 ~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~d  149 (266)
T cd06651          75 DRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGD  149 (266)
T ss_pred             cCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEcc
Confidence            63  67899999997 57888876543  589999999999999999999999999999999999995   567899999


Q ss_pred             cccccccCC------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          260 FGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       260 FGlA~~~~~------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ||++.....      ......++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~  213 (266)
T cd06651         150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE  213 (266)
T ss_pred             CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence            999864322      1123457888999999998899999999999999999999999996543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-36  Score=316.86  Aligned_cols=189  Identities=26%  Similarity=0.454  Sum_probs=166.2

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||.|+||.||+|++..+++.||||++.+..    ...+.+.+|+.+++.+       .|+||+++++.+.....+|+|||
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~lv~e   73 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-------NHPFIVKLYRTFKDKKYIYMLME   73 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-------CCCCEeeeeeeEEcCCccEEEEe
Confidence            689999999999999999999999997532    3446678899998888       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc--
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--  269 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~--  269 (837)
                      |+. ++|.+++...  ..+++..++.++.||+.||+|||+++++|+||||+||+++   .++.+||+|||++......  
T Consensus        74 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~  148 (262)
T cd05572          74 YCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQK  148 (262)
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccc
Confidence            997 5888888664  3589999999999999999999999999999999999995   5688999999999765432  


Q ss_pred             ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            234567889999999988889999999999999999999999997665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-36  Score=322.22  Aligned_cols=192  Identities=26%  Similarity=0.430  Sum_probs=159.6

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      .||+|+||.||+|++..+++.||||++.+..    ........|..+++.++.    ..|++|+++++++...+.+|+||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~~v~   76 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----GDCPFIVCMSYAFHTPDKLSFIL   76 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh----CCCCcEeeeeeeeecCCEEEEEE
Confidence            4899999999999999999999999987532    112234455555555543    27899999999999999999999


Q ss_pred             eccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC-c
Q 003239          192 ELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-T  269 (837)
Q Consensus       192 Ey~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~-~  269 (837)
                      ||+.+ +|.+++...  ..+++..++.++.|++.||.|||+.+|+||||||+||+++   .++.+||+|||++..... .
T Consensus        77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCccC
Confidence            99974 777766543  4699999999999999999999999999999999999995   667899999999864432 2


Q ss_pred             ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          270 VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ....+++..|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            2345789999999999754 6899999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=316.17  Aligned_cols=250  Identities=24%  Similarity=0.438  Sum_probs=196.1

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCChhh----HHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~----~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      +.||+|+||.||+|.+..+++.||||++++....    ......|..++...      ..|+||+++++++...+.+|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~------~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ------GESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhc------CCCCCeeeeeeeEEcCCeEEEE
Confidence            5699999999999999999999999999754321    12233343333222      2789999999999999999999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT  269 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~  269 (837)
                      |||+. ++|.+++...  ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++   .++.+||+|||++..... 
T Consensus        76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceeccc-
Confidence            99997 5888877654  3589999999999999999999999999999999999995   567899999999865433 


Q ss_pred             ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhh
Q 003239          270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK  349 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~  349 (837)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|.+||...+..+....+.....                   
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  210 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI-------------------  210 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-------------------
Confidence            2334678899999999988899999999999999999999999987665444333221000                   


Q ss_pred             hcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHH
Q 003239          350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDF  429 (837)
Q Consensus       350 ~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DL  429 (837)
                                                                .+...                     ....++..+.+|
T Consensus       211 ------------------------------------------~~~~~---------------------~~~~~~~~~~~~  227 (260)
T cd05611         211 ------------------------------------------NWPEE---------------------VKEFCSPEAVDL  227 (260)
T ss_pred             ------------------------------------------CCCCc---------------------ccccCCHHHHHH
Confidence                                                      00000                     000134678999


Q ss_pred             HHHhcccCcCCCCCH---HHHHcCccCCCCCC
Q 003239          430 LKGLVEFDPAKRWSP---FQASRHPFVTGEPF  458 (837)
Q Consensus       430 L~kmL~~DP~kRpTa---~EaL~HPff~~~~~  458 (837)
                      |.+||..||++|||+   +|+|.||||+...+
T Consensus       228 i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         228 INRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            999999999999954   79999999987543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.2e-36  Score=319.41  Aligned_cols=208  Identities=25%  Similarity=0.410  Sum_probs=173.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.++..  ......+.+|+.+++.+       +|+||++++++
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~   77 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-------NHQNIVRLIGV   77 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEE
Confidence            3789999999999999999999877     7789999998743  23345678899999888       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhcc-----CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                      +...+..++||||+. ++|.+++.....     ..+++..+..++.||+.||+|||+++++||||||+|||++.+.....
T Consensus        78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence            999999999999996 589888876532     24899999999999999999999999999999999999975444567


Q ss_pred             EEEEecccccccCCcce-----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          255 IKIIDFGSACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       255 IKL~DFGlA~~~~~~~~-----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      +||+|||+++.......     ....+..|+|||++.+..++.++|||||||++|||++ |..||...+..+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~  231 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM  231 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999975532211     1223467999999998899999999999999999997 99999877655443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.1e-36  Score=322.48  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=206.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..|...++||+|++|.||++.+..+++.||||+++... ...+.+.+|+.+++.+       .|+||+++++++...+..
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-------~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-------CCCChheEEEEEEcCCeE
Confidence            45666789999999999999998899999999987433 3345678899998888       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |+|+||+. ++|.+++..   ..+++..++.++.||+.||+|||+++|+||||||+||+++   .++.++|+|||.+...
T Consensus        92 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~  165 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhh
Confidence            99999997 588887765   3589999999999999999999999999999999999995   6789999999987643


Q ss_pred             CCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...   .....++..|+|||++.+..++.++|||||||++|+|++|..||...+....+..+...   .++.        
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~--------  234 (285)
T cd06648         166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPK--------  234 (285)
T ss_pred             ccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCC--------
Confidence            221   22346888999999999889999999999999999999999999766554443332210   0000        


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                  .                            ......+
T Consensus       235 --------------------------------------------~----------------------------~~~~~~~  242 (285)
T cd06648         235 --------------------------------------------L----------------------------KNLHKVS  242 (285)
T ss_pred             --------------------------------------------C----------------------------cccccCC
Confidence                                                        0                            0000134


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..+.+||.+||..||++|||++++|+||||++.+
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            6789999999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.7e-36  Score=327.96  Aligned_cols=253  Identities=25%  Similarity=0.440  Sum_probs=204.8

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      -|.....||+|+||.||++.+..+++.||||++... ....+.+.+|+.+++.+       +|+||+++++++...+..|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~hp~i~~~~~~~~~~~~~~   94 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-------QHQNVVEMYKSYLVGEELW   94 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-------CCCchhhhhhheeeCCeEE
Confidence            444556799999999999999999999999998743 23345677898888888       6899999999999999999


Q ss_pred             EEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+.+ +|.+++..   ..+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|||++....
T Consensus        95 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~  168 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             EEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhcc
Confidence            99999985 67666543   3489999999999999999999999999999999999995   67889999999986433


Q ss_pred             Cc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          268 RT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       268 ~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      ..   .....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+..    .++..        
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~--------  236 (297)
T cd06659         169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----SPPPK--------  236 (297)
T ss_pred             cccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----cCCCC--------
Confidence            22   2345788999999999988999999999999999999999999977665444332211    00000        


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                      +                       ......+.
T Consensus       237 ------------------------------------------------~-----------------------~~~~~~~~  245 (297)
T cd06659         237 ------------------------------------------------L-----------------------KNAHKISP  245 (297)
T ss_pred             ------------------------------------------------c-----------------------cccCCCCH
Confidence                                                            0                       00001335


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      .+.+||.+||+.||++|||++|+++||||.+...
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            6889999999999999999999999999998665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.5e-36  Score=315.34  Aligned_cols=206  Identities=27%  Similarity=0.406  Sum_probs=176.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|+++++||+|+||.||+|.+. +++.||+|.++......+.+.+|+.+++.+       .|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-------QHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-------CCCCeeeEEEEEcCCCCc
Confidence            378999999999999999999864 556799999886655567888999999998       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.......+++..++.++.||+.||+|||+++++||||||+||+++   ..+.+||+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~  153 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVI  153 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceec
Confidence            99999997 6999988776556689999999999999999999999999999999999995   6788999999999755


Q ss_pred             CCcce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          267 DRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       267 ~~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      .....    ...++..|+|||++....++.++|||||||++|+|++ |..||......+....
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~  216 (261)
T cd05072         154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA  216 (261)
T ss_pred             CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence            43221    2234567999999988889999999999999999998 9999987665554433

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-37  Score=342.79  Aligned_cols=249  Identities=28%  Similarity=0.466  Sum_probs=204.5

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEeC-ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEecc
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN-QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL  194 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik~-~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~  194 (837)
                      +||+|+||+||-|+|..+...+|||.|.. +....+-...||.+.++|+       |.|||++++.+..++++-|.||-+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-------HkNIVrYLGs~senGf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-------HKNIVRYLGSVSENGFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh-------hHhHHHHhhccCCCCeEEEEeecC
Confidence            69999999999999999999999999974 4455667788999999995       569999999999999999999999


Q ss_pred             ch-hHHHHHHhhccCCC--CHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc---CC
Q 003239          195 DS-NLYELIKINHFRGL--SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---DR  268 (837)
Q Consensus       195 ~g-sL~d~l~~~~~~~L--~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~---~~  268 (837)
                      +| +|.++++. ..+++  .|..+-.+.+||++||.|||++.|||||||-+||||+  .-.+.+||.|||.++..   +.
T Consensus       655 PGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP  731 (1226)
T KOG4279|consen  655 PGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP  731 (1226)
T ss_pred             CCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc
Confidence            85 67766654 45677  8999999999999999999999999999999999997  46789999999998653   34


Q ss_pred             cceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchh
Q 003239          269 TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK  346 (837)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~  346 (837)
                      ...++.||..|||||++..+  .|+.++|||||||++.||.||+|||.......  ..|.+ .|                
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFk-VG----------------  792 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFK-VG----------------  792 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhh-hc----------------
Confidence            45677899999999999876  69999999999999999999999995432111  01111 01                


Q ss_pred             hhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHH
Q 003239          347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL  426 (837)
Q Consensus       347 ~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l  426 (837)
                      +|+.                                  .|                 .+|             ..++.++
T Consensus       793 myKv----------------------------------HP-----------------~iP-------------eelsaea  808 (1226)
T KOG4279|consen  793 MYKV----------------------------------HP-----------------PIP-------------EELSAEA  808 (1226)
T ss_pred             ceec----------------------------------CC-----------------CCc-------------HHHHHHH
Confidence            0000                                  00                 011             1356789


Q ss_pred             HHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          427 VDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       427 ~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +.||.+|+.+||.+||+|.++|+.||++..+
T Consensus       809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             HHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence            9999999999999999999999999998763

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.1e-36  Score=310.32  Aligned_cols=249  Identities=29%  Similarity=0.443  Sum_probs=207.4

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||.|+||.||++.+..+++.||+|++....   ...+.+.+|+++++.+       .|+|++++++.+...+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~~~~~~~~~~~~~~   73 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-------NHPNIIKYYESFEEKGK   73 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-------CCCChhheEEEEecCCE
Confidence            5889999999999999999999999999999998542   4556788899999988       58999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          187 LCICFELLDS-NLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .++|||++++ +|.+.+....  ...+++..+..++.||+.||.|||++|++|+||+|+||+++   ..+.++|+|||++
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~  150 (258)
T cd08215          74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccce
Confidence            9999999985 8888887653  35699999999999999999999999999999999999996   5688999999998


Q ss_pred             cccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ......   .....++..|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.+...          
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  220 (258)
T cd08215         151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----------  220 (258)
T ss_pred             eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----------
Confidence            654332   2334678899999999988999999999999999999999999976654433332211000          


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                   +                 ..|             .
T Consensus       221 ---------------------------------------------~-----------------~~~-------------~  225 (258)
T cd08215         221 ---------------------------------------------P-----------------PIP-------------S  225 (258)
T ss_pred             ---------------------------------------------C-----------------CCC-------------C
Confidence                                                         0                 000             0


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      ..+..+.++|++||..||++|||++|+|+||||
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            134678999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.1e-36  Score=313.31  Aligned_cols=196  Identities=31%  Similarity=0.487  Sum_probs=170.1

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      +|++.+.||+|+||+||+|.+..+++.||||++....      ...+.+.+|+.+++.+       .|+||+++++++..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~   73 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-------QHPNIVQYLGTERE   73 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-------CCCCchheeeeEec
Confidence            5778899999999999999999899999999987432      3456788899999888       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ...+++||||+.+ +|.+++...  ..+++..++.++.||+.||+|||+.+|+|+||||+||+++   .++.+||+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~  148 (258)
T cd06632          74 EDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGM  148 (258)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCcc
Confidence            9999999999974 888887654  3589999999999999999999999999999999999995   678899999999


Q ss_pred             ccccCCc--ceeeccCccccCchhhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          263 ACTEDRT--VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       263 A~~~~~~--~~~~~GT~~Y~APEvl~~~~-yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      +......  .....++..|+|||.+.... ++.++|+|||||++|+|++|..||....
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         149 AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             ceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence            8654322  23456788999999998776 8999999999999999999999996654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.3e-36  Score=326.04  Aligned_cols=256  Identities=22%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       106 ~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ...++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.+++.+       .|+||+++++++...
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~hp~i~~~~~~~~~~   88 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-------KHPNIVNYLDSYLVG   88 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-------CCCCeeehhheeeeC
Confidence            3448999999999999999999999889999999998743 33346678899888887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..|+|+||+. ++|.+++...   .+++..+..++.||+.||.|||++|++|+||||+||+++   ..+.+||+|||++
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~  162 (293)
T cd06647          89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFC  162 (293)
T ss_pred             CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcce
Confidence            99999999997 5888877653   488999999999999999999999999999999999995   5678999999987


Q ss_pred             cccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ......   .....+++.|+|||.+....++.++|||||||++|+|++|+.||...+..+.+..+..  +..        
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~~--------  232 (293)
T cd06647         163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGT--------  232 (293)
T ss_pred             ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CCC--------
Confidence            543221   2234678889999999888899999999999999999999999976544322111100  000        


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                   +     .+            +           ...
T Consensus       233 ---------------------------------------------~-----~~------------~-----------~~~  239 (293)
T cd06647         233 ---------------------------------------------P-----EL------------Q-----------NPE  239 (293)
T ss_pred             ---------------------------------------------C-----CC------------C-----------Ccc
Confidence                                                         0     00            0           001


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..+..+.+||++||..||++|||+.|++.|+||+...
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            1345688999999999999999999999999999755

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.4e-36  Score=320.64  Aligned_cols=205  Identities=28%  Similarity=0.393  Sum_probs=172.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCC-----eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMN-----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg-----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .+|++.+.||+|+||.||+|.+...+     +.||+|+++..  ......+.+|+.+++.+       .|+||+++++++
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~i~~~~~~~   77 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-------QHPNIVCLLGVC   77 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-------CCcccceEEEEE
Confidence            68999999999999999999866554     78999999743  33455678899999888       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhcc--------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeee
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL  246 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl  246 (837)
                      ...+..|+||||+. ++|.+++.....              ..+++..++.++.||+.||.|||+++|+|+||||+||++
T Consensus        78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~  157 (283)
T cd05048          78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV  157 (283)
T ss_pred             cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence            99999999999997 689888875421              458899999999999999999999999999999999999


Q ss_pred             eccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          247 CTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       247 ~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      +   +++.+||+|||++......     .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       158 ~---~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05048         158 G---EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE  234 (283)
T ss_pred             c---CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            6   5678999999998653221     123355788999999998899999999999999999998 999998776655


Q ss_pred             HHH
Q 003239          321 LLR  323 (837)
Q Consensus       321 ~l~  323 (837)
                      ...
T Consensus       235 ~~~  237 (283)
T cd05048         235 VIE  237 (283)
T ss_pred             HHH
Confidence            443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.7e-36  Score=314.16  Aligned_cols=205  Identities=23%  Similarity=0.370  Sum_probs=173.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.+.||+|+||.||++... .+..+|+|.++........+.+|+++|+.+       .|+||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-------SHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-------CCCCceeEEEEEccCCCEE
Confidence            67999999999999999999765 456799999886655567788899999998       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+|||.+....
T Consensus        76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVL  151 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccC
Confidence            9999997 68888876543 3589999999999999999999999999999999999995   66789999999987543


Q ss_pred             Ccce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          268 RTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       268 ~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ....    ...++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i  214 (256)
T cd05114         152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI  214 (256)
T ss_pred             CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            2211    1234567999999998899999999999999999999 89999877665554444

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.3e-36  Score=313.65  Aligned_cols=195  Identities=31%  Similarity=0.498  Sum_probs=170.4

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~---~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||+|+||.||++.+..+++.||+|+++....   ..+.+.+|+.+++.+       .|+||+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~   73 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-------KHPNLVKYYGVEVHREK   73 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-------CCCChhheeeeEecCCE
Confidence            68999999999999999999998999999999986533   567788999999998       67899999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +++|+||+. ++|.+++...  ..+++..++.++.||+.||.|||+.+|+|+||||+||+++   ..+.+||+|||++..
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~  148 (264)
T cd06626          74 VYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVK  148 (264)
T ss_pred             EEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccc
Confidence            999999998 5788877654  3488999999999999999999999999999999999996   578899999999865


Q ss_pred             cCCcc-------eeeccCccccCchhhcCCC---CCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          266 EDRTV-------YSYIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       266 ~~~~~-------~~~~GT~~Y~APEvl~~~~---yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      .....       ....++..|+|||++.+..   ++.++|||||||++|+|++|..||...
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            43221       1245678899999998766   889999999999999999999999654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-36  Score=330.31  Aligned_cols=200  Identities=20%  Similarity=0.256  Sum_probs=163.6

Q ss_pred             EEeccC--CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHG--TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G--~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      ..||.|  +|++||++++..+++.||||+++..   ....+.+.+|+.+++.+       +|+||++++++|...+..|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-------~h~niv~~~~~~~~~~~~~~   76 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-------RHPNIMTSWTVFTTGSWLWV   76 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCcceEeeeEecCCceEE
Confidence            456666  9999999999999999999998743   23346677888888777       68999999999999999999


Q ss_pred             EEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       190 VmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      ||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++   ..+.+|++||+.+.....
T Consensus        77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhc
Confidence            999998 5888888765545699999999999999999999999999999999999996   567899999986532111


Q ss_pred             ---c-------ceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003239          269 ---T-------VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR  324 (837)
Q Consensus       269 ---~-------~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~  324 (837)
                         .       .....++..|+|||++.+.  .++.++|||||||++|||++|.+||........+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  221 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ  221 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence               0       0111235669999999764  578999999999999999999999987765544433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-36  Score=313.19  Aligned_cols=196  Identities=30%  Similarity=0.469  Sum_probs=173.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      +|++.+.||+|++|.||+|++..+++.||||++....  ...+.+.+|+.++..+       .|+||+++++++...+..
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-------ESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEccCCeE
Confidence            6889999999999999999999999999999998653  3467788899999988       588999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ++||||+. ++|.+++...  ..+++..++.++.||++||+|||+ .+++|+||+|+||+++   .++.++|+|||.+..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~  149 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKV  149 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCcccee
Confidence            99999998 6888888764  469999999999999999999999 9999999999999995   678899999999875


Q ss_pred             cCCcc---eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       266 ~~~~~---~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .....   ....++..|+|||.+....++.++|||||||++|+|++|..||....
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         150 LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             cccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            43322   23467889999999998899999999999999999999999996653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.7e-36  Score=318.17  Aligned_cols=202  Identities=32%  Similarity=0.527  Sum_probs=173.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+.    ....+.+.+|+++++.+.      .|+||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN------GHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc------cCCCchhHHHHhcCC
Confidence            4799999999999999999999999999999999752    233456778888888883      389999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..++|||++. ++|.+++....  .+++..++.++.||+.||.|||+++++|+||||+||+++   .++.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~  149 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTA  149 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccc
Confidence            99999999995 78988887653  699999999999999999999999999999999999995   6788999999998


Q ss_pred             cccCCcc-----------------------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          264 CTEDRTV-----------------------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       264 ~~~~~~~-----------------------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      .......                       ....++..|+|||++....++.++|||||||++++|++|..||...+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            6433221                       22356788999999988889999999999999999999999998766433


Q ss_pred             H
Q 003239          321 L  321 (837)
Q Consensus       321 ~  321 (837)
                      .
T Consensus       230 ~  230 (280)
T cd05581         230 T  230 (280)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.9e-36  Score=336.82  Aligned_cols=201  Identities=25%  Similarity=0.367  Sum_probs=167.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||.||+|++..     +.+.||||+++..  ....+.+.+|+.+++.+.      .|+||++++++
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~------~h~nIv~~~~~  110 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG------QHKNIVNLLGA  110 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc------cCCceeeEeeE
Confidence            3689999999999999999998543     3457999999753  334556788999999883      58999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc-----------------------------------------------------
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH-----------------------------------------------------  206 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~-----------------------------------------------------  206 (837)
                      +...+..|+|||||. |+|.+++....                                                     
T Consensus       111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            999999999999997 68888875431                                                     


Q ss_pred             ---------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcce
Q 003239          207 ---------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY  271 (837)
Q Consensus       207 ---------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~  271 (837)
                                     ...+++..++.++.||+.||.|||++||+||||||+|||++   +...+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcc
Confidence                           12478889999999999999999999999999999999996   567899999999975432211


Q ss_pred             -----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          272 -----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       272 -----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                           ...++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence                 1223567999999998899999999999999999997 999997653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-36  Score=319.62  Aligned_cols=197  Identities=28%  Similarity=0.460  Sum_probs=171.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+++++||+|+||+||++++..+++.||+|++...  ....+.+.+|+++++.+       +|+||+++++++...+.
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~   77 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-------RSPYIVSFYGAFLNENN   77 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-------CCCCcceEeeeEecCCE
Confidence            6899999999999999999999999999999998753  34456788999999988       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +++||||+.+ +|.+++...  +.+++..++.++.||+.+|.|||+ .+|+||||||+||+++   .++.++|+|||++.
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~  152 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSG  152 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCccc
Confidence            9999999985 777766553  468999999999999999999996 6999999999999995   66889999999986


Q ss_pred             ccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          265 TEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       265 ~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .... ......++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         153 ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             chhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            4322 2234578999999999988899999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-35  Score=313.85  Aligned_cols=192  Identities=28%  Similarity=0.449  Sum_probs=163.1

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ...||+|+||.||++++..+++.||+|.+... ....+.+.+|+.+++.+       .|+||+++++++...+..++|||
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-------KHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-------CCCCeeeeeeeeccCCEEEEEEe
Confidence            45799999999999999999999999998754 33456788899999988       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCC--CHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC-
Q 003239          193 LLD-SNLYELIKINHFRGL--SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-  268 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L--~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~-  268 (837)
                      |+. ++|.+++.... ..+  ++..+..++.||+.||+|||+++|+||||||+||+++  ...+.+||+|||++..... 
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          86 QVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccC
Confidence            997 58888876542 235  8889999999999999999999999999999999996  2356899999999864322 


Q ss_pred             --cceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          269 --TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       269 --~~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                        ......++..|+|||++.+.  .++.++|||||||++|+|++|..||..
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence              12234578899999998765  378999999999999999999999954

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-36  Score=318.62  Aligned_cols=198  Identities=25%  Similarity=0.473  Sum_probs=170.4

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .|++.+.||+|+||.||+|.+..+++.||||+++..  ......+.+|+.+++.+.+.    .|+||+++++++......
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~----~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQS----QPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccC----CCCCeeeEeeeeeeCCEE
Confidence            478889999999999999999999999999998753  34456778899999999643    689999999999999999


Q ss_pred             EEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |+||||+.+ +|.+++...   .+++..++.++.||+.||.|||+.||+|+||+|+||+++   ..+.++|+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~  151 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeec
Confidence            999999975 787777543   589999999999999999999999999999999999996   5788999999998654


Q ss_pred             CCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ...   .....++..|+|||.+.+. .++.++|||||||++|+|++|..||....
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            322   2334688899999998754 57899999999999999999999997653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-35  Score=318.08  Aligned_cols=205  Identities=24%  Similarity=0.333  Sum_probs=167.8

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||.||+|..+     ..+..||+|+++...  .....+.+|+.+++.+       +|+||++++++
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~   77 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-------TCHHVVRLLGV   77 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEE
Confidence            379999999999999999998654     235689999987543  2334567788888888       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc--------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH--------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~--------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      +...+..|+||||+. ++|.+++....        ...++...++.++.||+.||.|||+++|+||||||+|||++   .
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~  154 (288)
T cd05061          78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---H  154 (288)
T ss_pred             EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---C
Confidence            999999999999997 68998886532        12356778899999999999999999999999999999996   5


Q ss_pred             CCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          252 PAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      ++.+||+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~  231 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL  231 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            7889999999986433211     12234667999999998899999999999999999998 78999776655443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7e-36  Score=319.48  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=212.0

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ..+.|++.+.||+|+||.||++.+..+++.||+|+++......+.+.+|+++++.+       .|+||+++++++...+.
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-------KHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-------CCCCeeEEEEEEEECCE
Confidence            44779999999999999999999998899999999986654566788899999888       68899999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+|+||+. ++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++   .++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~~  165 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAAQ  165 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhhh
Confidence            999999998 68998887653 3699999999999999999999999999999999999995   667899999998864


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   .....++..|+|||++.+..++.++||||||||+|+|++|..||...+.......+... + .++        
T Consensus       166 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~-~~~--------  235 (286)
T cd06614         166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-G-IPP--------  235 (286)
T ss_pred             hccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-CCC--------
Confidence            3322   12335678899999999889999999999999999999999999766554333222110 0 000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                               ......+
T Consensus       236 -------------------------------------------------------------------------~~~~~~~  242 (286)
T cd06614         236 -------------------------------------------------------------------------LKNPEKW  242 (286)
T ss_pred             -------------------------------------------------------------------------CcchhhC
Confidence                                                                                     0000113


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +..+.+||++||..||.+|||+.|+|+|+||++.-
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            46788999999999999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.6e-36  Score=318.76  Aligned_cols=206  Identities=26%  Similarity=0.367  Sum_probs=173.2

Q ss_pred             CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|.+.+.||+|+||.||+|.+.     .+++.||||+++...  ...+.+.+|+++|+.+       .|+||+++++++
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~   77 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-------QHENIVKFYGVC   77 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-------CCCCchheeeEE
Confidence            67999999999999999999764     346789999998543  2356788999999998       688999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT  248 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~  248 (837)
                      ......++||||+. ++|.+++....            ...+++..+..++.||+.||.|||+++|+||||||+||+++ 
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~-  156 (280)
T cd05049          78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG-  156 (280)
T ss_pred             ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc-
Confidence            99999999999997 58888886542            23478999999999999999999999999999999999996 


Q ss_pred             cCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          249 SVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       249 ~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                        .++.+||+|||++......     .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+
T Consensus       157 --~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~  234 (280)
T cd05049         157 --YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI  234 (280)
T ss_pred             --CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence              6689999999998643221     112244678999999999999999999999999999998 99999776655544


Q ss_pred             HH
Q 003239          323 RR  324 (837)
Q Consensus       323 ~~  324 (837)
                      ..
T Consensus       235 ~~  236 (280)
T cd05049         235 EC  236 (280)
T ss_pred             HH
Confidence            33

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=312.36  Aligned_cols=206  Identities=25%  Similarity=0.403  Sum_probs=175.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||.||+|.+. +++.||||.++......+.+.+|+.+++++       .|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-------RHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-------CCCCccceeEEEecCCCe
Confidence            368999999999999999999865 456799999987655567788999999998       588999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |+||||+. ++|.+++.......+++..+..++.||+.||.|||+++|+||||||+||+++   .++.+||+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~  153 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVI  153 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEc
Confidence            99999995 7999988765445689999999999999999999999999999999999996   6678999999998754


Q ss_pred             CCcce-eecc---CccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          267 DRTVY-SYIQ---SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       267 ~~~~~-~~~G---T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ..... ...+   +..|+|||++.+..++.++|||||||++|||++ |+.||.+......+..
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~  216 (261)
T cd05068         154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ  216 (261)
T ss_pred             cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            42211 1122   346999999998899999999999999999999 9999987665544443

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.9e-36  Score=321.49  Aligned_cols=197  Identities=19%  Similarity=0.239  Sum_probs=167.7

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee----cce
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC----QRH  186 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~----~~~  186 (837)
                      ..|++|+++.||+|+.  +++.||||+++...    ...+.+.+|+.+|+++       .||||+++++++.+    ...
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~nIv~~~g~~~~~~~~~~~   96 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-------DSNNILKIYGFIIDIVDDLPR   96 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-------CCCCEEEEeeeEEecccCCCc
Confidence            4689999999999976  68999999997542    2246677999999999       68899999999877    357


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +++||||+. |+|.+++...  +.+++.....++.|++.||.|||+ .+++||||||+|||++   +++.+||+|||++.
T Consensus        97 ~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~  171 (283)
T PHA02988         97 LSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEK  171 (283)
T ss_pred             eEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHh
Confidence            899999998 5788888764  368999999999999999999998 4999999999999995   67889999999997


Q ss_pred             ccCCcceeeccCccccCchhhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          265 TEDRTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~--~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ..........++..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..+....+
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i  234 (283)
T PHA02988        172 ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI  234 (283)
T ss_pred             hhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            65555555678999999999976  68999999999999999999999999877665544433

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-35  Score=314.97  Aligned_cols=202  Identities=25%  Similarity=0.369  Sum_probs=170.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.++||+|+||+||+|++..+. .||||+++......+.+.+|+++++.+       .|+||+++++++. ....+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l-------~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhC-------CCCCcceEEEEEC-CCCcE
Confidence            68999999999999999999876654 599999986555556788899999998       6899999999875 45689


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+|||.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeecc
Confidence            9999998 5899888765445689999999999999999999999999999999999996   57789999999996543


Q ss_pred             Ccce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          268 RTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       268 ~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      ....    ...++..|+|||++.+..++.++|||||||++|+|++ |.+||......+.+
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~  213 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  213 (262)
T ss_pred             ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence            3221    2234667999999988899999999999999999999 89999776554443

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=343.67  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=209.1

Q ss_pred             ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       106 ~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ...+.|++...||.|+|+.|-.|.+..+++..++|++.+..   .+..+|+.++....      .|+||+++++++.+..
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~------~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR------DHPNIVKSHDVYEDGK  389 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc------CCCcceeecceecCCc
Confidence            34578999999999999999999999999999999998762   23445777776664      7999999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +.|+|||++.| .+++-+....   ....++..|++||+.|+.|||++|||||||||+|||+.  ...++|+|+|||.++
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence            99999999986 4555554433   33377888999999999999999999999999999995  467899999999999


Q ss_pred             ccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          265 TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      .......+.+-|..|.|||++....|+.++||||||++||+|++|+.||......   ..|...++ .++.         
T Consensus       465 ~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~-~~~~---------  531 (612)
T KOG0603|consen  465 ELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ-MPKF---------  531 (612)
T ss_pred             hCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc-CCcc---------
Confidence            8877766778899999999999999999999999999999999999999776544   12222222 1100         


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                                                ...+++
T Consensus       532 --------------------------------------------------------------------------s~~vS~  537 (612)
T KOG0603|consen  532 --------------------------------------------------------------------------SECVSD  537 (612)
T ss_pred             --------------------------------------------------------------------------ccccCH
Confidence                                                                                      012567


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      .++|||++||++||.+|+|+.|++.||||.+.+.
T Consensus       538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t  571 (612)
T KOG0603|consen  538 EAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT  571 (612)
T ss_pred             HHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence            8999999999999999999999999999955554

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=310.44  Aligned_cols=200  Identities=25%  Similarity=0.369  Sum_probs=175.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.+.||.|+||.||+|...  ++.||||+++......+++.+|+.+++.+       .|+||+++++++......+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTL-------RHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhc-------CCcceeeeEEEEcCCCCeE
Confidence            68999999999999999999754  78899999987655567888999999998       6789999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.......+++..++.++.|++.||.|||+++|+|+||||+||+++   .++.+||+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEcccccccccc
Confidence            9999998 5999988776545699999999999999999999999999999999999995   67889999999997664


Q ss_pred             CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          268 RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      ........+..|+|||.+....++.++|||||||++|||++ |..||......+
T Consensus       154 ~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  207 (256)
T cd05039         154 QGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD  207 (256)
T ss_pred             cccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            44333445667999999988889999999999999999997 999997665444

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-35  Score=306.44  Aligned_cols=196  Identities=32%  Similarity=0.509  Sum_probs=173.8

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      +|++.+.||+|++|.||+|.+..+++.|++|+++...   ...+.+.+|+.+++++       .|+||+++++++...  
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-------QHPNIVRYYGSERDEEK   73 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-------CCCCEeeEEEEEecCCC
Confidence            4788999999999999999999999999999998654   4567788899999998       589999999999998  


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ...++|||++. ++|.+++....  .+++..++.++.|++.+|+|||+.+++|+||+|+||+++   ..+.+||+|||.+
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~  148 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCA  148 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccE
Confidence            89999999995 68888887653  699999999999999999999999999999999999996   5788999999998


Q ss_pred             cccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          264 CTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       264 ~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ......     .....++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            755433     234567889999999998889999999999999999999999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8e-36  Score=334.28  Aligned_cols=201  Identities=26%  Similarity=0.382  Sum_probs=168.1

Q ss_pred             CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.++||+|+||+||+|++     ..++..||||+++..  ....+.+.+|+.+|+.+.      .||||+++++++
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~------~HpnIv~l~~~~  108 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG------NHINIVNLLGAC  108 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc------CCcceeeeeeee
Confidence            6899999999999999999963     456778999999743  234456788999999984      589999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc------------------------------------------------------
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH------------------------------------------------------  206 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~------------------------------------------------------  206 (837)
                      ...+..++|||||. |+|.+++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999998 68888886432                                                      


Q ss_pred             -------------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          207 -------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       207 -------------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                                         ...+++..++.++.||+.||+|||+++|+||||||+|||++   ....+||+|||++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceecc
Confidence                               12478889999999999999999999999999999999996   56789999999997543


Q ss_pred             Ccce-----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          268 RTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       268 ~~~~-----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      ....     ...++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence            2211     1233567999999999999999999999999999998 8999976543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=306.18  Aligned_cols=197  Identities=32%  Similarity=0.527  Sum_probs=173.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.+.||+|++|.||++++..+++.||||.+....   ...+.+.+|+++++++       .|+||+++++++...+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-------KHPNIVKYIGSIETSDS   73 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-------CCCCccEEEEEEEeCCE
Confidence            5889999999999999999999999999999998654   4566788899999988       57899999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++|||++.+ +|.+++...  ..+++..++.++.|++.+|.|||++||+|+||||+||+++   .++.+||+|||.+..
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~  148 (254)
T cd06627          74 LYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATK  148 (254)
T ss_pred             EEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEecccccee
Confidence            9999999985 888887654  4699999999999999999999999999999999999996   568899999999975


Q ss_pred             cCCcc---eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       266 ~~~~~---~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      .....   ....++..|+|||.+.+..++.++|||+||+++|+|++|..||...+.
T Consensus       149 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~  204 (254)
T cd06627         149 LNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP  204 (254)
T ss_pred             cCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence            54332   235678889999999888889999999999999999999999976543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-35  Score=312.24  Aligned_cols=204  Identities=23%  Similarity=0.335  Sum_probs=171.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.+.||+|+||+||++.... +..||||.++......+.+.+|+.+++.+       +|+||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-------SHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-------CCCCeeeEEEEEccCCCcE
Confidence            689999999999999999997654 44699999986555556788899999888       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|||.+....
T Consensus        76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecC
Confidence            9999997 57888876543 3689999999999999999999999999999999999995   56789999999986443


Q ss_pred             Ccc-ee---eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          268 RTV-YS---YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       268 ~~~-~~---~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ... ..   ..++..|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK  213 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            221 11   234567999999998889999999999999999998 9999977665544443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.8e-36  Score=322.55  Aligned_cols=196  Identities=28%  Similarity=0.464  Sum_probs=169.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +.|++.+.||+|+||.||+|.+..+++.||||+++..  ....+.+.+|+.+++.+       +|+||+++++++..+..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   76 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYITRYYGSYLKGTK   76 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-------CCCccHhhhcccccCCc
Confidence            4677788899999999999999999999999998743  23445678899998887       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+.+ +|.+++..   ..+++..++.++.||+.||.|||+++|+|+||+|+||+++   .++.+||+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~  150 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQ  150 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEcccccccc
Confidence            9999999984 77777654   3589999999999999999999999999999999999996   567899999999865


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ....   .....++..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06642         151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH  205 (277)
T ss_pred             ccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence            4322   123457888999999998899999999999999999999999986543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-35  Score=314.84  Aligned_cols=251  Identities=25%  Similarity=0.435  Sum_probs=203.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +-|++.++||.|+||.||++.+..+++.||||++...  ......+.+|+.+++.+       .|+||+++++++..+..
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~   76 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYVTKYYGSYLKDTK   76 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-------CCCCEeEEEEEEEeCCe
Confidence            4578889999999999999999999999999998743  23445677888988888       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+.+ +|.+++..   ..+++..+..++.||+.+|.+||+++|+|+||||+||+++   .++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~  150 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeeccccee
Confidence            9999999985 77777654   3589999999999999999999999999999999999995   567899999999865


Q ss_pred             cCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....   .....++..|+|||.+.+..++.++|||||||++|+|++|..||...........+..  + .+         
T Consensus       151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-~~---------  218 (277)
T cd06641         151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--N-NP---------  218 (277)
T ss_pred             cccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--C-CC---------
Confidence            4322   2234678889999999888899999999999999999999999966543332222110  0 00         


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                 +.                 .             ....
T Consensus       219 -------------------------------------------~~-----------------~-------------~~~~  225 (277)
T cd06641         219 -------------------------------------------PT-----------------L-------------EGNY  225 (277)
T ss_pred             -------------------------------------------CC-----------------C-------------Cccc
Confidence                                                       00                 0             0013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +..+.+||.+||..||.+||++.++|+||||.+..
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         226 SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            36688999999999999999999999999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-35  Score=319.16  Aligned_cols=206  Identities=24%  Similarity=0.344  Sum_probs=171.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe--EEEEEEEeC--ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS--FVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~--~VAIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||+|++..++.  .+++|.++.  .....+.+.+|++++.++.      .|+||+++++++...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~~~~~   75 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG------HHPNIINLLGACENR   75 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc------CCCchhheEEEEccC
Confidence            579999999999999999998877664  478888874  2344567888999998884      489999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          185 RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      +.+|+||||+. ++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++  
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~--  153 (297)
T cd05089          76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG--  153 (297)
T ss_pred             CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC--
Confidence            99999999997 68988886532              12488999999999999999999999999999999999995  


Q ss_pred             CCCCeEEEEecccccccCCcceee--ccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          250 VKPAEIKIIDFGSACTEDRTVYSY--IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~~~~~~~~--~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                       .++.+||+|||++..........  ..+..|+|||++....++.++|||||||++|||++ |..||......+...
T Consensus       154 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~  229 (297)
T cd05089         154 -ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE  229 (297)
T ss_pred             -CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence             56789999999986433222222  22456999999998899999999999999999997 999998776555443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.8e-35  Score=319.71  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      +.|...++||+|+||+||+|++..+++.||||++...    ....+.+.+|+++++.+       .|+||+++++++...
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   93 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-------KHPNTIEYKGCYLKE   93 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-------CCCCCccEEEEEEeC
Confidence            4577788999999999999999999999999998742    23345677899999888       689999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ...|+||||+.+++.+++.... ..+++.+++.++.||+.+|.|||++||+|+||||+||+++   .++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~  169 (313)
T cd06633          94 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSAS  169 (313)
T ss_pred             CEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCc
Confidence            9999999999999888876543 4689999999999999999999999999999999999995   56789999999986


Q ss_pred             ccCCcceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .... .....++..|+|||++.   ...++.++|||||||++|+|++|.+||...+....+..+...   .++..     
T Consensus       170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~-----  240 (313)
T cd06633         170 KSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSPTL-----  240 (313)
T ss_pred             ccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCC-----
Confidence            4332 23457888999999985   346889999999999999999999999776554444332210   00000     


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                  ....
T Consensus       241 ----------------------------------------------------------------------------~~~~  244 (313)
T cd06633         241 ----------------------------------------------------------------------------QSNE  244 (313)
T ss_pred             ----------------------------------------------------------------------------Cccc
Confidence                                                                                        0001


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++..+.+||.+||+.||.+|||+.++|+||||...+
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            235688999999999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=313.57  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=211.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++.+++..||.|+.|+|++++.+.++...|||.+.+.  ....++++..+.++..-+      ++|.||+.+++|..+..
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~------dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH------DCPYIVQCFGYFITNTD  165 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc------CCCeeeeeeeEEeeCch
Confidence            5667788999999999999999999999999999864  344556667777765542      68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ++|.||.|...+..+++.- .++++|..+-++...+++||.||.+ ++|||||+||+|||++   +.+.|||||||++-.
T Consensus       166 V~IcMelMs~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---e~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  166 VFICMELMSTCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---cCCCEEeecccccce
Confidence            9999999987776666654 3679999999999999999999985 6899999999999995   889999999999965


Q ss_pred             cC--CcceeeccCccccCchhhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCchHHHH
Q 003239          266 ED--RTVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       266 ~~--~~~~~~~GT~~Y~APEvl~~~---~yt~ksDIWSLG~ILyELltG~~PF~g~-s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      .-  .......|.+.|||||.+.-.   .|+.++||||||++++||.||+.||.+. .+++++.+|...   .||.    
T Consensus       242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~---ePP~----  314 (391)
T KOG0983|consen  242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE---EPPL----  314 (391)
T ss_pred             eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc---CCCC----
Confidence            43  333456889999999999643   7999999999999999999999999885 567777766551   2210    


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                                  +...
T Consensus       315 ----------------------------------------------------------------------------L~~~  318 (391)
T KOG0983|consen  315 ----------------------------------------------------------------------------LPGH  318 (391)
T ss_pred             ----------------------------------------------------------------------------CCcc
Confidence                                                                                        0011


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ..+++.|++|+..||..|+.+||.-.++|+|||+...
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            1256889999999999999999999999999999863

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.9e-35  Score=320.29  Aligned_cols=190  Identities=22%  Similarity=0.268  Sum_probs=158.4

Q ss_pred             CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccc-h
Q 003239          121 TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-S  196 (837)
Q Consensus       121 ~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~-g  196 (837)
                      +++.||++++..+++.||||+++..   ....+.+.+|+++++.+       .|+||++++++|...+..+++|||+. +
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-------~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-------QHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-------CCcchhhhhheeecCCeEEEEEeccCCC
Confidence            4455666666779999999999754   34556788999999998       68999999999999999999999998 5


Q ss_pred             hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC--------
Q 003239          197 NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--------  268 (837)
Q Consensus       197 sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~--------  268 (837)
                      +|.+++.......+++..++.+++||+.||+|||+++|+||||||+||+++   .++.+||+||+.+.....        
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccccccccc
Confidence            788888765545699999999999999999999999999999999999996   568899999998853321        


Q ss_pred             --cceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          269 --TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       269 --~~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                        ......++..|+|||++...  .++.++|||||||++|||++|..||.......
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~  217 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ  217 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence              11233567789999999763  58899999999999999999999998765433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.6e-35  Score=310.46  Aligned_cols=204  Identities=25%  Similarity=0.389  Sum_probs=173.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|+++++||+|+||.||+|... +++.||+|++.........+.+|+.+++.+       .|+||+++++++. .+..+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-------QHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-------CCcCeeeEEEEEc-cCCcE
Confidence            78999999999999999999754 567899999987665567888999999998       6889999999874 56789


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.......+++.++..++.||+.||+|||+.+|+||||||+||+++   .++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceeecC
Confidence            9999997 6899888765555789999999999999999999999999999999999995   67789999999986544


Q ss_pred             Ccc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ...    ....++..|+|||++....++.++|||||||++|||++ |++||.+.+..+....
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  215 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN  215 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence            211    12234567999999998899999999999999999999 9999987765554443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-35  Score=311.21  Aligned_cols=245  Identities=28%  Similarity=0.524  Sum_probs=200.9

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||.|+||.||++++..+++.||+|+++...    ...+.+.+|+++++.+       .|+||+++++.+...+..|+|||
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~~~~lv~e   73 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-------QSPYVVKLYYSFQGKKNLYLVME   73 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-------CCcchhHHHHheecCcEEEEEEe
Confidence            689999999999999999999999997543    3455677888888888       58999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc--
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--  269 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~--  269 (837)
                      |+. ++|.+++....  .+++..+..++.||+.||+|||+++|+|+||+|+||+++   .++.+||+|||++......  
T Consensus        74 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~  148 (265)
T cd05579          74 YLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQ  148 (265)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCcc
Confidence            997 58888887643  689999999999999999999999999999999999996   6778999999998643221  


Q ss_pred             ---------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          270 ---------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       270 ---------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                               .....++..|+|||.+....++.++|||||||++|+|++|..||......+....+..  +..+       
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-------  219 (265)
T cd05579         149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE-------  219 (265)
T ss_pred             cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC-------
Confidence                     2234678889999999988899999999999999999999999977665444333221  0000       


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                          +            |           ...
T Consensus       220 ----------------------------------------------------~------------~-----------~~~  224 (265)
T cd05579         220 ----------------------------------------------------W------------P-----------EDV  224 (265)
T ss_pred             ----------------------------------------------------C------------C-----------ccc
Confidence                                                                0            0           000


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCH---HHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSP---FQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa---~EaL~HPff~~~~  457 (837)
                      ..+..+.+||++||+.||++|||+   .|+|+||||++..
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            024678999999999999999999   9999999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.9e-36  Score=313.33  Aligned_cols=207  Identities=25%  Similarity=0.411  Sum_probs=177.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ..+|++.++||.|+||.||+|.+.. ++.||+|+++.... ....+..|+.+++.+       .|+||+++++++...+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-------RHKHLISLFAVCSVGEP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-------CCcchhheeeeEecCCC
Confidence            3679999999999999999999877 88999999986543 456788899999888       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++   .++.+||+|||.+..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~  153 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARL  153 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhh
Confidence            999999997 5999998876556689999999999999999999999999999999999996   677899999999965


Q ss_pred             cCCcce---eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          266 EDRTVY---SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       266 ~~~~~~---~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ......   ...++..|+|||++....++.++|||||||++|+|++ |+.||...+..+.+..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~  217 (261)
T cd05148         154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI  217 (261)
T ss_pred             cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            433221   2234567999999998899999999999999999998 89999877655544443

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-35  Score=313.28  Aligned_cols=206  Identities=25%  Similarity=0.360  Sum_probs=169.4

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||+||++.+.     .+++.||||+++...  .....+.+|+.+++.+       .|+||++++++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~iv~~~~~   77 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-------NCHHVVRLLGV   77 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEE
Confidence            478999999999999999998754     345789999986432  3345677899998887       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhcc--------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHF--------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      +......++||||+. ++|.+++.....        ..+++..+..++.||+.||+|||+.+++|+||||+||+++   .
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~  154 (277)
T cd05062          78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---E  154 (277)
T ss_pred             EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---C
Confidence            999999999999998 588888765321        2357788999999999999999999999999999999996   6


Q ss_pred             CCeEEEEecccccccCCcce-----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          252 PAEIKIIDFGSACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~~~~-----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ++.+||+|||++........     ...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~  232 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR  232 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            78899999999864432211     1234677999999998899999999999999999999 789997766544433

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.6e-35  Score=308.97  Aligned_cols=198  Identities=23%  Similarity=0.389  Sum_probs=170.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||+|++..+++.||||+++.    +......+.+|+.+++.+       .|+||+++++++...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   74 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-------NHPNVIKYLDSFIED   74 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-------CCcceeeeeeeEEEC
Confidence            579999999999999999999999999999998863    233345678899999988       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +..++||||+. ++|.+++....  ...+++..+..++.||+.||.|||+++|+|+||||+||+++   .++.++|+|||
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g  151 (267)
T cd08228          75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLG  151 (267)
T ss_pred             CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccc
Confidence            99999999998 48887775432  23489999999999999999999999999999999999995   56789999999


Q ss_pred             cccccCCcc---eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          262 SACTEDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       262 lA~~~~~~~---~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++.......   ....++..|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            986543322   2346788999999999888999999999999999999999998544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-35  Score=319.15  Aligned_cols=198  Identities=27%  Similarity=0.417  Sum_probs=166.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  .....+..|+.++..+.      +|+||+++++++.....
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~------~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH------DCPYIVKCYGYFITDSD   88 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc------CCCchHhhheeeecCCe
Confidence            78999999999999999999999899999999998542  23445566776665552      58999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+.+.+.+++.... ..+++..+..++.||+.||+|||+ .+|+||||+|+||+++   +++.+||+|||++..
T Consensus        89 ~~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~  164 (296)
T cd06618          89 VFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGR  164 (296)
T ss_pred             EEEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchh
Confidence            99999999988777766543 468999999999999999999997 6999999999999995   678899999999865


Q ss_pred             cCCc--ceeeccCccccCchhhcCCC----CCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          266 EDRT--VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       266 ~~~~--~~~~~GT~~Y~APEvl~~~~----yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ....  .....++..|+|||.+.+..    ++.++|||||||++|+|++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence            4322  22235678899999997553    889999999999999999999999653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.6e-35  Score=313.57  Aligned_cols=205  Identities=24%  Similarity=0.392  Sum_probs=170.3

Q ss_pred             CceEEEEEeccCCceeEEEeec----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .+|++.++||+|+||+||+|..    ..+++.||+|.++..  ......+.+|+.+++.+       .|+||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~   77 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-------HHPNIVCLLGVVT   77 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-------CCCCeeeEEEEEe
Confidence            5789999999999999999974    345688999999743  23345678899999988       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhc---------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeee
Q 003239          183 CQRHLCICFELLD-SNLYELIKINH---------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL  246 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~---------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl  246 (837)
                      ..+..|+||||+. ++|.+++....               ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili  157 (283)
T cd05090          78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI  157 (283)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence            9999999999997 58888875321               1247889999999999999999999999999999999999


Q ss_pred             eccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          247 CTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       247 ~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      +   .+..+||+|||++......     .....++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus       158 ~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         158 G---EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             c---CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            6   5678999999999654221     122344667999999998889999999999999999998 999997766544


Q ss_pred             HHH
Q 003239          321 LLR  323 (837)
Q Consensus       321 ~l~  323 (837)
                      ...
T Consensus       235 ~~~  237 (283)
T cd05090         235 VIE  237 (283)
T ss_pred             HHH
Confidence            433

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.5e-35  Score=310.53  Aligned_cols=204  Identities=27%  Similarity=0.381  Sum_probs=171.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.++||+|+||.||+|.+. .+..||+|+++......+.+.+|+.+++++       .|+||+++++++. ....+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-------~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-------RHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-------CCCceEEEEeEEC-CCCcE
Confidence            68999999999999999999765 556699999986555556788999999998       6889999999875 45689


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+||+++   +++.+||+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeecc
Confidence            9999997 5898888765545689999999999999999999999999999999999996   56789999999996543


Q ss_pred             Ccc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ...    ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~  215 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ  215 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            221    11234567999999988899999999999999999999 8999987665554443

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-35  Score=315.01  Aligned_cols=207  Identities=27%  Similarity=0.392  Sum_probs=173.4

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ..+|.+.+.||+|+||+||++.+     ..++..||+|.++.. ....+.+.+|+++++++       .|+||+++++++
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~   76 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-------QHEHIVKFYGVC   76 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEE
Confidence            36899999999999999999974     345677999999754 34456788999999998       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc-----------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH-----------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~-----------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      ...+.+++||||+. ++|.+++....           ...+++..++.++.||+.||+|||++||+||||||+|||++  
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~--  154 (288)
T cd05093          77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG--  154 (288)
T ss_pred             ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc--
Confidence            99999999999997 68888886432           12489999999999999999999999999999999999995  


Q ss_pred             CCCCeEEEEecccccccCCcce-----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          250 VKPAEIKIIDFGSACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~~~~~~-----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                       +++.+||+|||++........     ...++..|+|||++.+..++.++|||||||++|+|++ |.+||......+.+.
T Consensus       155 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~  233 (288)
T cd05093         155 -ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  233 (288)
T ss_pred             -cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             678899999999975432211     2234667999999998899999999999999999998 999997776555444


Q ss_pred             H
Q 003239          324 R  324 (837)
Q Consensus       324 ~  324 (837)
                      .
T Consensus       234 ~  234 (288)
T cd05093         234 C  234 (288)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=306.80  Aligned_cols=196  Identities=24%  Similarity=0.366  Sum_probs=169.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-  185 (837)
                      .+||+|.++||+|+|+-||+++...+++.||+|++.-.. ...+..++|++..+++       +||||++++++...+. 
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-------~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-------NSPNVLRLVDHQLREEK   92 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-------CCcchHHHHHHHHHhhc
Confidence            389999999999999999999999999999999998543 6678899999999999       6789999998766543 


Q ss_pred             ----eEEEEEeccc-hhHHHHHHhhccC--CCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEE
Q 003239          186 ----HLCICFELLD-SNLYELIKINHFR--GLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       186 ----~l~LVmEy~~-gsL~d~l~~~~~~--~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IK  256 (837)
                          ..||+++|.. |+|.+.+.....+  .++|.++..|+.+|++||++||+..  +.||||||.|||++   +.+.++
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~v  169 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPV  169 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceE
Confidence                4999999987 7899988765433  4999999999999999999999998  99999999999996   578999


Q ss_pred             EEecccccccCCcce------------eeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          257 IIDFGSACTEDRTVY------------SYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       257 L~DFGlA~~~~~~~~------------~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      |+|||.++...-...            ....|..|+|||++.-   ...+.++|||||||+||+|+.|..||
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf  241 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF  241 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence            999999975433221            1244888999999964   36789999999999999999999999

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.6e-35  Score=305.75  Aligned_cols=201  Identities=30%  Similarity=0.431  Sum_probs=172.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +|++.++||+|+||.||++++..+++.+|||+++..   ......+.+|+++++.+       .|+||+++++++.....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~   73 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-------NHPNIISYKEAFLDGNK   73 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-------CCCCchhhhhhhccCCE
Confidence            588999999999999999999999999999999753   23345667888888888       58899999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          187 LCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .++||||+. ++|.+++....  ...+++..+..++.||+.||+|||+.|++|+||+|+||+++   ..+.+||+|||++
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~  150 (256)
T cd08530          74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGIS  150 (256)
T ss_pred             EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccch
Confidence            999999997 47888776532  24589999999999999999999999999999999999996   4678999999998


Q ss_pred             cccCCc-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          264 CTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       264 ~~~~~~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      ...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  208 (256)
T cd08530         151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD  208 (256)
T ss_pred             hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            654332 223467889999999999899999999999999999999999997766543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-35  Score=320.52  Aligned_cols=253  Identities=24%  Similarity=0.419  Sum_probs=203.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..|+...+||+|+||.||++.+..+++.||||++... ......+.+|+.+++.+       .|+||+++++.+...+..
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~   92 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHENVVEMYNSYLVGDEL   92 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-------CCcchhheeeEEEeCCEE
Confidence            3444456899999999999999999999999998643 23445678899999888       688999999999999999


Q ss_pred             EEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+.+ +|.+++..   ..+++..++.++.||+.+|+|||+.||+|+||||+||+++   .++.++|+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~  166 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceec
Confidence            999999985 67666543   2489999999999999999999999999999999999995   5678999999988644


Q ss_pred             CCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...   .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+....+.+..+...+.   +.        
T Consensus       167 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~--------  235 (292)
T cd06657         167 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PK--------  235 (292)
T ss_pred             ccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---cc--------
Confidence            322   2235678899999999888899999999999999999999999987665444333222100   00        


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                            +.                  .....+
T Consensus       236 ------------------------------------------------------~~------------------~~~~~~  243 (292)
T cd06657         236 ------------------------------------------------------LK------------------NLHKVS  243 (292)
T ss_pred             ------------------------------------------------------cC------------------CcccCC
Confidence                                                                  00                  000123


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..+.+||.+||..||.+|||+.|+|+||||....
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            5678999999999999999999999999999855

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.4e-35  Score=308.84  Aligned_cols=200  Identities=26%  Similarity=0.362  Sum_probs=170.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe-ecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-~~~~l  187 (837)
                      ++|++.+.||+|+||.||++..  .++.||+|.++.+. ..+.+.+|+.+++.+       .|+||+++++++. .....
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-hHHHHHHHHHHHHhC-------CCCCeeeEEEEEEcCCCce
Confidence            6899999999999999999965  47789999997654 346688899999988       6889999999765 45679


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++   +++.+||+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~  152 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA  152 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCccceec
Confidence            99999997 5899988776545589999999999999999999999999999999999995   6788999999998765


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      .........+..|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~  208 (256)
T cd05082         153 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  208 (256)
T ss_pred             cccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            444344455678999999998899999999999999999997 9999976554433

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=310.80  Aligned_cols=202  Identities=23%  Similarity=0.327  Sum_probs=170.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      .+|++.+.||+|+||.||++++. ++..+|||++++.......+.+|+++++.+       .|+||+++++++...+..|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-------SHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-------CCCCEEEEEEEEcCCCceE
Confidence            57889999999999999999875 466799999986554456778899999988       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++   .++.+||+|||++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVL  151 (256)
T ss_pred             EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceecc
Confidence            9999997 58888887543 3689999999999999999999999999999999999995   67889999999986543


Q ss_pred             Ccce-ee---ccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          268 RTVY-SY---IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       268 ~~~~-~~---~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      .... ..   ..+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+..
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~  211 (256)
T cd05059         152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV  211 (256)
T ss_pred             cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence            2211 11   22346999999998899999999999999999999 89999776554443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.6e-35  Score=318.67  Aligned_cols=253  Identities=24%  Similarity=0.406  Sum_probs=206.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ..|++.+.||+|+||.||++++..+++.||||++...    ......+.+|+++++.+       .|+||+++++++..+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~   97 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-------KHPNSIEYKGCYLRE   97 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEeeC
Confidence            5688899999999999999999999999999998743    23345677899999888       689999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ...++||||+.++|.+.+.... ..+++..+..++.||+.||.|||+++|+||||+|+||+++   .++.+||+|||++.
T Consensus        98 ~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~~  173 (317)
T cd06635          98 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSAS  173 (317)
T ss_pred             CeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCcc
Confidence            9999999999998888776543 4689999999999999999999999999999999999995   56889999999986


Q ss_pred             ccCCcceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .... .....++..|+|||++.   ...++.++|||||||++|||++|.+||........+..+.....  ++       
T Consensus       174 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~-------  243 (317)
T cd06635         174 IASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PT-------  243 (317)
T ss_pred             ccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC--CC-------
Confidence            4432 23456888999999984   34688999999999999999999999976554443333322100  00       


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                         +                        ....
T Consensus       244 ---------------------------------------------------~------------------------~~~~  248 (317)
T cd06635         244 ---------------------------------------------------L------------------------QSNE  248 (317)
T ss_pred             ---------------------------------------------------C------------------------CCcc
Confidence                                                               0                        0001


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+..+.+||.+||+.||.+|||+.++++|+|+....
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            345689999999999999999999999999997644

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.6e-35  Score=308.60  Aligned_cols=194  Identities=26%  Similarity=0.403  Sum_probs=163.7

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      +.||+|+||.||+|++..+++.||+|++...  ......+.+|+++++.+       +|+||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-------SHPNIVRLIGVCTQKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEcCCCCeEEEEe
Confidence            3699999999999999999999999998743  34456788899999988       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcce
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY  271 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~  271 (837)
                      |+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||++........
T Consensus        74 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          74 LVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             eccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccc
Confidence            997 58888876532 4589999999999999999999999999999999999995   567899999999865432211


Q ss_pred             ee-----ccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 003239          272 SY-----IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEF  319 (837)
Q Consensus       272 ~~-----~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~  319 (837)
                      ..     ..+..|+|||.+.+..++.++|||||||++|||++ |.+||......
T Consensus       150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~  203 (252)
T cd05084         150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ  203 (252)
T ss_pred             cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence            11     12356999999998899999999999999999997 89998655443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-35  Score=307.86  Aligned_cols=207  Identities=26%  Similarity=0.358  Sum_probs=176.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.++||+|+||.||+|.+. .++.||||+++......+.+.+|+.+++++       .|+||+++++++......
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-------RHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-------CCCCEeeeeeeeecCCce
Confidence            378999999999999999999865 457799999987666667888999999998       689999999999998999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++   .++.+||+|||++...
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~  153 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLI  153 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceec
Confidence            99999997 5898888775545699999999999999999999999999999999999996   6689999999998654


Q ss_pred             CCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ....    .....+..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+....+..+
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  217 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV  217 (261)
T ss_pred             cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            3221    11223567999999998899999999999999999998 99999877665554443

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-35  Score=306.55  Aligned_cols=200  Identities=27%  Similarity=0.403  Sum_probs=171.1

Q ss_pred             EEeccCCceeEEEeeccCC---CeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      +.||+|+||.||+|.+...   +..||||+++....  ..+.+.+|+++++.+       .|+||+++++++.....+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-------GHPNVVRLLGVCTEEEPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-------CCCChheeeeeecCCCceEE
Confidence            4699999999999998866   88999999986533  257788899999988       58999999999999999999


Q ss_pred             EEeccc-hhHHHHHHhhc-------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          190 CFELLD-SNLYELIKINH-------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       190 VmEy~~-gsL~d~l~~~~-------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ||||+. ++|.+++....       ...+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|||
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg  150 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFG  150 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccc
Confidence            999995 78998887652       25699999999999999999999999999999999999995   66899999999


Q ss_pred             cccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          262 SACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       262 lA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      .+......     .....++..|+|||.+....++.++|||||||++|+|++ |..||......+....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  219 (262)
T cd00192         151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY  219 (262)
T ss_pred             cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99755432     233456788999999998899999999999999999999 6999987755544433

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.9e-35  Score=308.08  Aligned_cols=203  Identities=26%  Similarity=0.367  Sum_probs=171.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.++||+|+||.||+|.+..+. .||+|++.......+.+.+|+++++.+       .|+||+++++++. .+..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKL-------RHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhC-------CCCCeeeEEEEEc-CCCcE
Confidence            68999999999999999999876554 599999886555556788899999998       6899999999875 45689


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.......+++..+..++.||+.||.|||+.+|+|+||||+||+++   +++.+||+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEcc
Confidence            9999998 5899988765545589999999999999999999999999999999999995   67889999999996543


Q ss_pred             Ccc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ...    ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~  214 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE  214 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            221    12234667999999998899999999999999999999 999998766554443

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-35  Score=310.63  Aligned_cols=206  Identities=23%  Similarity=0.356  Sum_probs=171.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t-----g~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||.||++.+...     ++.||+|++....  .....+.+|+.+++.+       .|+||++++++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~   77 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-------NCHHVVRLLGV   77 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-------CCCceeEEEEE
Confidence            37899999999999999999987643     4889999987542  3345677899988888       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc--------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH--------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~--------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      +......++||||+. ++|.+++....        ...+++..+..++.||+.||.|||+++|+||||||+|||++   .
T Consensus        78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~  154 (277)
T cd05032          78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---E  154 (277)
T ss_pred             EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---C
Confidence            999999999999997 68888886532        12368889999999999999999999999999999999996   6


Q ss_pred             CCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          252 PAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ++.+||+|||+++.....     .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+...
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  232 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK  232 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence            788999999998643322     122345778999999988889999999999999999998 999998766554433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-36  Score=338.82  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=209.6

Q ss_pred             Cce-EEEEEeccCCceeEEEeeccCCCeEEEEEEEe-----CChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRY-IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y-~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik-----~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .+| +...+||+|+|-+||+|.|..+|..||--.++     +.+...+++..|+.+|+.|       .|+|||++|+.+.
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-------~H~NIirfy~SW~  111 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-------KHPNIIRFYDSWV  111 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-------CCCceeeeeehee
Confidence            444 45578999999999999999999888865554     3455668899999999999       6899999999999


Q ss_pred             ecc--eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEE
Q 003239          183 CQR--HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       183 ~~~--~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      +..  .+.+|+|++. |+|..++++.+  .++...++.|++|||+||.|||++.  |||||||.+||+|+  ...|.|||
T Consensus       112 d~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKI  187 (632)
T KOG0584|consen  112 DTDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKI  187 (632)
T ss_pred             cCCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceee
Confidence            865  4889999997 89999988764  6899999999999999999999884  99999999999997  56799999


Q ss_pred             EecccccccCCcc-eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCch
Q 003239          258 IDFGSACTEDRTV-YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD-LLRRMIRILGAQPPD  335 (837)
Q Consensus       258 ~DFGlA~~~~~~~-~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e-~l~~I~~~lG~~Pp~  335 (837)
                      +|+|+|....... ...+|||.|||||+.. ..|+..+||||||++|+||+|+..||....... +++++..  | ..|.
T Consensus       188 GDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--G-iKP~  263 (632)
T KOG0584|consen  188 GDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--G-IKPA  263 (632)
T ss_pred             cchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--C-CCHH
Confidence            9999998765544 3469999999999998 699999999999999999999999997654444 3444333  2 2221


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      .+.                                                             +               
T Consensus       264 sl~-------------------------------------------------------------k---------------  267 (632)
T KOG0584|consen  264 ALS-------------------------------------------------------------K---------------  267 (632)
T ss_pred             Hhh-------------------------------------------------------------c---------------
Confidence            110                                                             0               


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                           -..+++++||.+||.. .++|+||.|+|+||||.....
T Consensus       268 -----V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  268 -----VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             -----cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence                 0237889999999999 999999999999999998754

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-35  Score=309.04  Aligned_cols=201  Identities=21%  Similarity=0.314  Sum_probs=165.2

Q ss_pred             eEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~---tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      |++.+.||+|+||.||+|....   +++.||||+++.+   ......+.+|+.+++.+       +|+||+++++++...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~   73 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-------DHPNVMKLIGVCFEA   73 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEeeeccC
Confidence            5678999999999999998654   3478999999854   23456788899999888       689999999988765


Q ss_pred             ce------EEEEEeccc-hhHHHHHHhhc----cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC
Q 003239          185 RH------LCICFELLD-SNLYELIKINH----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       185 ~~------l~LVmEy~~-gsL~d~l~~~~----~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      ..      .++||||+. ++|.+++....    ...+++..++.++.||+.||+|||+++|+||||||+||+++   +++
T Consensus        74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~  150 (273)
T cd05035          74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDM  150 (273)
T ss_pred             CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCC
Confidence            54      799999998 57877775432    23589999999999999999999999999999999999995   678


Q ss_pred             eEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          254 EIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      .+||+|||+++......     .....+..|+|||++.+..++.++|||||||++|||++ |.+||.+....+.
T Consensus       151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~  224 (273)
T cd05035         151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI  224 (273)
T ss_pred             eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            89999999987543221     11234567999999988899999999999999999999 8999977665443

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.6e-35  Score=313.91  Aligned_cols=205  Identities=27%  Similarity=0.427  Sum_probs=170.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t-----g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.+.||+|+||.||++.....     .+.||+|+++..  ......+.+|+++++.+.      .|+||+++++++
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~i~~~~~~~   85 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLLGVC   85 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc------CCCCeeeEEEEE
Confidence            7899999999999999999987543     378999999753  233456788999998883      489999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhh--------------ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeee
Q 003239          182 VCQRHLCICFELLD-SNLYELIKIN--------------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL  246 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~--------------~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl  246 (837)
                      ..++.+++||||+. ++|.+++...              ....+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            99999999999997 6888888642              23458999999999999999999999999999999999999


Q ss_pred             eccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          247 CTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       247 ~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      +   .++.+||+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus       166 ~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         166 T---EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             c---CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            5   67899999999997543221     11223567999999998899999999999999999997 999997765544


Q ss_pred             HH
Q 003239          321 LL  322 (837)
Q Consensus       321 ~l  322 (837)
                      ..
T Consensus       243 ~~  244 (293)
T cd05053         243 LF  244 (293)
T ss_pred             HH
Confidence            43

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-35  Score=319.75  Aligned_cols=200  Identities=24%  Similarity=0.381  Sum_probs=167.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .+|++.+.||+|+||+||+|++..+++    .||||+++..  ....+.+.+|+.+++.+       .|+||+++++++.
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~g~~~   79 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGICL   79 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEc
Confidence            689999999999999999998766555    4899998743  34456788899999988       6899999999987


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      .. ..++|+||+. |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||
T Consensus        80 ~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG  154 (316)
T cd05108          80 TS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFG  154 (316)
T ss_pred             CC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEcccc
Confidence            65 5779999987 68988887653 4588999999999999999999999999999999999995   66789999999


Q ss_pred             cccccCCcce-----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          262 SACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       262 lA~~~~~~~~-----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      +++.......     ....+..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~  219 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE  219 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9975432211     1223567999999999999999999999999999997 999997765433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.4e-35  Score=313.98  Aligned_cols=196  Identities=24%  Similarity=0.421  Sum_probs=166.8

Q ss_pred             ceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .|++.+.||+|+||.||+|++.   .+++.||+|+++...     ...+.+.+|+++++.+.      +|+||++++++|
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR------QSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc------cCCChhceeeEe
Confidence            4889999999999999999864   478999999997532     23456778999999884      489999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      ..+..+|+||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.+|+||||||+|||++   .++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~df  149 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDF  149 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeC
Confidence            99999999999998 5888888654  3589999999999999999999999999999999999995   5688999999


Q ss_pred             ccccccCCc----ceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          261 GSACTEDRT----VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       261 GlA~~~~~~----~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      |++......    .....++..|+|||.+...  .++.++|||||||++|+|++|..||...
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  211 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD  211 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence            998654321    2235688899999998753  4788999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-35  Score=325.94  Aligned_cols=201  Identities=28%  Similarity=0.428  Sum_probs=166.2

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||.||+|++.     .+++.||+|+++..  ....+.+..|+.+++++.      .|+||++++++
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~------~h~niv~~~~~   79 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG------HHLNVVNLLGA   79 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc------cCcchhheeee
Confidence            368999999999999999999743     34578999999753  233456778999998884      58999999998


Q ss_pred             Eeec-ceEEEEEeccc-hhHHHHHHhhc----------------------------------------------------
Q 003239          181 FVCQ-RHLCICFELLD-SNLYELIKINH----------------------------------------------------  206 (837)
Q Consensus       181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~----------------------------------------------------  206 (837)
                      +... ..+++||||+. ++|.+++....                                                    
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            8754 57899999998 58888775432                                                    


Q ss_pred             -------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcc-----eeec
Q 003239          207 -------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYI  274 (837)
Q Consensus       207 -------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~  274 (837)
                             ...+++..+..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++.......     ....
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~  236 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDAR  236 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCC
Confidence                   12588999999999999999999999999999999999996   56789999999997543211     1234


Q ss_pred             cCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       275 GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            4677999999999999999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.7e-35  Score=318.06  Aligned_cols=203  Identities=25%  Similarity=0.320  Sum_probs=168.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe--EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~--~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||+||+|.+..++.  .+|+|.++..  ......+.+|++++.++.      +|+||+++++++..+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~------~h~~iv~~~~~~~~~   80 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHR   80 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc------CCCCcceEEEEECCC
Confidence            689999999999999999999877765  4577777642  334456788999998884      589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          185 RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      +.+++||||+. ++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++  
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~--  158 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--  158 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec--
Confidence            99999999997 68988886542              12478999999999999999999999999999999999995  


Q ss_pred             CCCCeEEEEecccccccCCccee--eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          250 VKPAEIKIIDFGSACTEDRTVYS--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~~~~~~~--~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                       .++.+||+|||++.........  ...+..|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus       159 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  231 (303)
T cd05088         159 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  231 (303)
T ss_pred             -CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence             6678999999998643222112  123567999999988889999999999999999998 999997665443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.4e-35  Score=318.24  Aligned_cols=253  Identities=24%  Similarity=0.379  Sum_probs=206.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      +.|++.+.||+|+||.||++++..+++.||||.+...    ....+.+.+|+++++.+       .|+||+++++++...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   87 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-------RHPNTIQYRGCYLRE   87 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-------CCCCcccEEEEEEcC
Confidence            6788889999999999999999999999999998632    23445677899999988       689999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ...++||||+.+++.+.+.... ..+++..++.++.||+.||.|||+++++||||||+||+++   .++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~  163 (308)
T cd06634          88 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSAS  163 (308)
T ss_pred             CeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCcccce
Confidence            9999999999998888776543 4589999999999999999999999999999999999995   56889999999986


Q ss_pred             ccCCcceeeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDRTVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .... .....++..|+|||++.+   ..++.++|||||||++|+|++|..||...+..+.+..+.+...  +        
T Consensus       164 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~--------  232 (308)
T cd06634         164 IMAP-ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--P--------  232 (308)
T ss_pred             eecC-cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--C--------
Confidence            5433 234567889999999853   4688899999999999999999999866544333322211000  0        


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                   .                 .            ....
T Consensus       233 ---------------------------------------------~-----------------~------------~~~~  238 (308)
T cd06634         233 ---------------------------------------------A-----------------L------------QSGH  238 (308)
T ss_pred             ---------------------------------------------C-----------------c------------Cccc
Confidence                                                         0                 0            0001


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+..+.+||++||..+|++|||++++++|||+....
T Consensus       239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            346688999999999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.7e-35  Score=309.92  Aligned_cols=248  Identities=29%  Similarity=0.437  Sum_probs=197.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      +|.+.+.||+|+||.||++++..++..+++|+++..      ......+..|+.+++.+       .|+||+++++++..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   73 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-------DHPAIVKFHASFLE   73 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-------CCCcHHHHHHHHhc
Confidence            689999999999999999999888777777777631      22334566788888887       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          184 QRHLCICFELLDS-NLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      ....++||||+.+ +|.+++...  ....+++..++.++.||+.||.|||++||+|+||||+||+++    .+.+||+||
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~  149 (260)
T cd08222          74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDF  149 (260)
T ss_pred             CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeeccc
Confidence            9999999999984 777776542  234699999999999999999999999999999999999995    356999999


Q ss_pred             ccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          261 GSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       261 GlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |.+......   .....++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..  + .++.  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~-~~~~--  224 (260)
T cd08222         150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--G-PTPS--  224 (260)
T ss_pred             CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--C-CCCC--
Confidence            998644221   2234578889999999888899999999999999999999999976544333222211  0 0000  


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                                      
T Consensus       225 --------------------------------------------------------------------------------  224 (260)
T cd08222         225 --------------------------------------------------------------------------------  224 (260)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .....+.++.+||.+||..||++||+++|+|+||||
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            001134678899999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=317.43  Aligned_cols=315  Identities=30%  Similarity=0.467  Sum_probs=236.1

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-----
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-----  184 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-----  184 (837)
                      -.+.||.|+||+||.+.|..+++.||+|++.+-   -...+.+.+|+++|..+       .|.|++..+|+.+-.     
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-------kHdNVLSaLDILQPph~dfF  129 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-------RHDNVLSLLDILQPANPSFF  129 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-------ccccHHHHHHhcCCCCchHH
Confidence            346799999999999999999999999998753   34567788999999998       467999999887654     


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++|+|.|+|..+|..+|-..  +.++.+.++-+++||++||+|||+.+|.||||||.|+|++   .+..+||||||+|+
T Consensus       130 qEiYV~TELmQSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLAR  204 (449)
T KOG0664|consen  130 QELYVLTELMQSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHHHHHhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEeccccccc
Confidence            368999999999998877654  4699999999999999999999999999999999999995   78899999999998


Q ss_pred             ccCCc----ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          265 TEDRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       265 ~~~~~----~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ..+..    +...+-|.+|+|||++++. .|+.++||||+|||+.||+..+.+|...+..++++.|.+.+| .|..+.++
T Consensus       205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG-TPs~EaMr  283 (449)
T KOG0664|consen  205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG-TPSQEAMK  283 (449)
T ss_pred             ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC-CCcHHHHH
Confidence            65432    3445678999999999987 799999999999999999999999999999999999999999 55554443


Q ss_pred             hh-hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          340 EA-KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       340 ~~-k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                      .. ...+.-.-                              .+..+.|.....|                      .+..
T Consensus       284 ~ACEGAk~H~L------------------------------R~~~k~Ps~~vLY----------------------tlsS  311 (449)
T KOG0664|consen  284 YACEGAKNHVL------------------------------RAGLRAPDTQRLY----------------------KIAS  311 (449)
T ss_pred             HHhhhhHHHhh------------------------------ccCCCCCCcccee----------------------eecC
Confidence            22 11100000                              0000011111100                      0011


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCCC---CCCCCCCCccccccccCCCCCCCCccCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP---PPETPRVPVAQNFKVDHHPGAGHWFAAGL  493 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~l  493 (837)
                      ......+..+++.+||.+||++|++.+++|.|+|+.+.++......   ...++. -..+.+..+..|..+..|..-.
T Consensus       312 ~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~sCmC~~~~tt~~-~~~r~f~~~~~P~~~~pFd~~~  388 (449)
T KOG0664|consen  312 PDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHSCMCSCCYTKPN-MPSRLFAQDLDPRHESPFDPKW  388 (449)
T ss_pred             CcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeeeeeEeeeccCCC-cchhhhccccCcccCCCcChhH
Confidence            1123356789999999999999999999999999998876322111   111111 2235566666666555554333

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.7e-35  Score=314.82  Aligned_cols=203  Identities=26%  Similarity=0.391  Sum_probs=168.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ++|.+.+.||+|+||.||++++..       +...||+|+++..  ......+.+|+.+++.+.      .|+||+++++
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~   91 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG------KHKNIINLLG   91 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc------CCCCEeeEEE
Confidence            789999999999999999997543       3357999999854  334556788999998884      4899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhcc--------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      ++...+..|+||||+. ++|.+++.....              ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            9999999999999997 589999876421              2488899999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++   .++.+||+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus       172 ll~---~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         172 LVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             EEc---CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            995   56789999999986543211     11223467999999998899999999999999999998 8999976554


Q ss_pred             HH
Q 003239          319 FD  320 (837)
Q Consensus       319 ~e  320 (837)
                      .+
T Consensus       249 ~~  250 (307)
T cd05098         249 EE  250 (307)
T ss_pred             HH
Confidence            33

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=335.00  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=213.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ...|.+.++||+|.|++|.++++..++..||||+|.+.   ....+...+|+++|+.|       .|||||+++.+...+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-------~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-------NHPNIVKLFSVIETE  127 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-------CCcceeeeeeeeeec
Confidence            47899999999999999999999999999999999864   34445688999999999       789999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ..+|+||||+. |.+++++.+..  .+.+..++.++.|++.|++|||+++|||||||.+||||+   .+..+||+|||++
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~---~~mnikIaDfgfS  202 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD---ENMNIKIADFGFS  202 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc---cccceeeeccccc
Confidence            99999999997 68999988764  577899999999999999999999999999999999995   6667999999999


Q ss_pred             cccC--CcceeeccCccccCchhhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTED--RTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~--~~~~~~~GT~~Y~APEvl~~~~yt-~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ....  ....+.||++.|.|||++.+..|+ +.+|+||+|+++|.|+.|..||.+.+-.++-.+.+..            
T Consensus       203 ~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g------------  270 (596)
T KOG0586|consen  203 TFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG------------  270 (596)
T ss_pred             eeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee------------
Confidence            7544  445678999999999999999876 7999999999999999999999887543332221110            


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                  .|+                                 +|             .
T Consensus       271 ----------------------------k~r---------------------------------Ip-------------~  276 (596)
T KOG0586|consen  271 ----------------------------KYR---------------------------------IP-------------F  276 (596)
T ss_pred             ----------------------------eec---------------------------------cc-------------c
Confidence                                        000                                 00             0


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      -++.++.+||++||..+|.+|.+++|+..|.|+....
T Consensus       277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             eeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence            1345678999999999999999999999999998644

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-34  Score=311.03  Aligned_cols=204  Identities=28%  Similarity=0.389  Sum_probs=171.7

Q ss_pred             CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|.+.+.||+|+||.||+|++.     .++..|++|.++... ...+.+.+|+++++.+       .|+||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~   77 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-------QHEHIVKFYGVCG   77 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-------CCCCcceEEEEEc
Confidence            67999999999999999999743     356679999987543 3345678899999888       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeee
Q 003239          183 CQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC  247 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~  247 (837)
                      ..+..++||||+. ++|.+++....              ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~  157 (291)
T cd05094          78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG  157 (291)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence            9999999999997 68988886542              13488999999999999999999999999999999999995


Q ss_pred             ccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          248 TSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       248 ~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                         .++.+||+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.
T Consensus       158 ---~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  234 (291)
T cd05094         158 ---ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV  234 (291)
T ss_pred             ---cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence               66899999999996543221     22345778999999999899999999999999999998 9999977665544


Q ss_pred             H
Q 003239          322 L  322 (837)
Q Consensus       322 l  322 (837)
                      +
T Consensus       235 ~  235 (291)
T cd05094         235 I  235 (291)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=304.80  Aligned_cols=192  Identities=30%  Similarity=0.514  Sum_probs=167.5

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ||.|+||.||++.+..+++.||+|++++..    .....+..|+++++.+       .|+||+++++.+..++..|+|||
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~~v~e   73 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-------NHPFIVKLHYAFQTEEKLYLVLE   73 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-------CCCcHHHHHHHeecCCeeEEEEe
Confidence            689999999999998889999999997542    2455778899999888       58999999999999999999999


Q ss_pred             cc-chhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc--
Q 003239          193 LL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--  269 (837)
Q Consensus       193 y~-~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~--  269 (837)
                      ++ .++|.+++....  .+++..+..++.||+.||.|||+.+++|+||||+||+++   ..+.++|+|||++......  
T Consensus        74 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~  148 (250)
T cd05123          74 YAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGS  148 (250)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCC
Confidence            99 578988887653  589999999999999999999999999999999999996   5678999999998754332  


Q ss_pred             -ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          270 -VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       270 -~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                       .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+...
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  200 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE  200 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence             344567889999999998889999999999999999999999997765533

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-34  Score=302.25  Aligned_cols=204  Identities=30%  Similarity=0.447  Sum_probs=172.2

Q ss_pred             eEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg----~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      +++.+.||.|+||.||++++..++    +.||+|+++....  ..+.+..|+.+++.+       +|+||+++++++...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~   73 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-------DHPNIVKLLGVCTEE   73 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-------CCCchheEEEEEcCC
Confidence            356789999999999999988766    8999999986543  467788899999988       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..++|||++. ++|.+++.......+++..++.++.||+.||+|||+.+++|+||||+||+++   ..+.++|+|||++
T Consensus        74 ~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~  150 (258)
T smart00219       74 EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLS  150 (258)
T ss_pred             CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCc
Confidence            99999999997 5888888765433389999999999999999999999999999999999995   6678999999999


Q ss_pred             cccCCcce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          264 CTEDRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       264 ~~~~~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ........    ...++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~  216 (258)
T smart00219      151 RDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY  216 (258)
T ss_pred             eecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            65443211    1225678999999988889999999999999999998 8999977655444433

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=306.04  Aligned_cols=203  Identities=23%  Similarity=0.343  Sum_probs=170.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|++.+.||+|+||+||+|++..+   ...||||+++..  ......+.+|+.+++.+       .|+||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   76 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-------DHPNIIRLEGVVTK   76 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-------CCCCcceEeEEEec
Confidence            6799999999999999999987644   568999998753  33445678899999888       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+++|+|+||||+|||++   .++.+||+|||+
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~  152 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGL  152 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccch
Confidence            999999999997 58888876643 4689999999999999999999999999999999999995   678899999999


Q ss_pred             ccccCCc---cee--eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          263 ACTEDRT---VYS--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       263 A~~~~~~---~~~--~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      +......   ...  ..++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~  218 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI  218 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence            9765311   111  223567999999998899999999999999999998 99999766554443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-34  Score=303.69  Aligned_cols=203  Identities=22%  Similarity=0.388  Sum_probs=171.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      .+|++.+.||+|+||.||++.+. .++.+|+|+++........+.+|+++++.+       .|+||+++++++......|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-------SHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-------CCCCeeeEEEEEccCCceE
Confidence            58999999999999999999775 467899999986655556788899999998       6889999999999999999


Q ss_pred             EEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+.+ +|.+++.... ..++++.++.++.|++.+|+|||+++|+|+||||+||+++   .++.+||+|||.+....
T Consensus        76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecc
Confidence            99999984 7777776443 4589999999999999999999999999999999999995   66789999999986543


Q ss_pred             Ccce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          268 RTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       268 ~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ....    ...++..|+|||++.+..++.++|||||||++|||++ |..||......+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  212 (256)
T cd05112         152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE  212 (256)
T ss_pred             cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            2211    1234567999999998899999999999999999998 999997665544433

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.2e-34  Score=301.72  Aligned_cols=198  Identities=25%  Similarity=0.390  Sum_probs=171.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..    ....+.+.+|+++++++       .|+||+++++++...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-------~~~~i~~~~~~~~~~   74 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-------DHPNVIKYLASFIEN   74 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-------CCCCeeeeeeeeecC
Confidence            5899999999999999999999999999999998632    23356788899999988       688999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +..++||||+. ++|.+++....  ...+++..++.++.||+.||.|||+.||+|+||||+||+++   .++.++|+|||
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~  151 (267)
T cd08224          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLG  151 (267)
T ss_pred             CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccc
Confidence            99999999998 58888876432  24589999999999999999999999999999999999995   66789999999


Q ss_pred             cccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          262 SACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       262 lA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++......   .....++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            98654322   23356788899999999889999999999999999999999999544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=304.18  Aligned_cols=198  Identities=28%  Similarity=0.483  Sum_probs=169.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .+|++.+.||+|+||.||++++..+++.||+|++...      ......+.+|+++++.+       .|+||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~i~~~~~~~~   74 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-------RHDRIVQYYGCLR   74 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-------CCCCcceEEEEEE
Confidence            5799999999999999999999999999999998532      23345678899999998       5889999999987


Q ss_pred             ec--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..  ..+++||||+. ++|.+.+...  ..+++..++.++.||+.||.|||+++|+|+||||+||+++   .++.++|+|
T Consensus        75 ~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~d  149 (264)
T cd06653          75 DPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGD  149 (264)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECc
Confidence            64  46899999997 4788877654  3589999999999999999999999999999999999995   567899999


Q ss_pred             cccccccCC------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          260 FGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       260 FGlA~~~~~------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      ||++.....      ......++..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  214 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA  214 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence            999965322      12234678899999999988899999999999999999999999976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.2e-35  Score=308.86  Aligned_cols=204  Identities=29%  Similarity=0.407  Sum_probs=170.0

Q ss_pred             EEEEEeccCCceeEEEeecc----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          112 IVKDLLGHGTFGQVAKCWDA----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       112 ~i~~~LG~G~fG~Vyka~~~----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++.+.||.|.||.||+|...    ..+..|+||+++..  ....+.+.+|+++++++       .|+||+++++++...+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~g~~~~~~   74 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-------RHPNIVKLYGFCIENE   74 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-------SBTTBE-EEEEEESSS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-------cccccccccccccccc
Confidence            56789999999999999876    45678999999753  34468889999999998       5899999999999888


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..++||||+. ++|.+++.......+++..+..|+.||+.||.|||+++|+|+||+++|||++   .++.+||+|||++.
T Consensus        75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~  151 (259)
T PF07714_consen   75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSR  151 (259)
T ss_dssp             SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc
Confidence            8999999998 6899999887455799999999999999999999999999999999999996   67899999999997


Q ss_pred             ccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          265 TEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       265 ~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ......     ........|+|||++....++.++||||||+++|||++ |+.||...+..+....+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~  218 (259)
T PF07714_consen  152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL  218 (259)
T ss_dssp             ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            652211     12345677999999999899999999999999999999 78999877666655544

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-34  Score=306.85  Aligned_cols=200  Identities=23%  Similarity=0.321  Sum_probs=163.7

Q ss_pred             EEEEEeccCCceeEEEeeccCCCe--EEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          112 IVKDLLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       112 ~i~~~LG~G~fG~Vyka~~~~tg~--~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      .+.++||+|+||.||+|++..+++  .||||.++..   ....+.+.+|+.+++.+       +|+||+++++++...  
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~   74 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-------DHPNVMRLIGVCLQTVE   74 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEccCCc
Confidence            467899999999999998877765  6999998753   34456778899999888       689999999977532  


Q ss_pred             ----ceEEEEEeccc-hhHHHHHHhhc----cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeE
Q 003239          185 ----RHLCICFELLD-SNLYELIKINH----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       185 ----~~l~LVmEy~~-gsL~d~l~~~~----~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                          ...++||||+. ++|.+++....    ...+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+
T Consensus        75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~  151 (272)
T cd05075          75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNV  151 (272)
T ss_pred             ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCE
Confidence                25789999997 68877764322    23489999999999999999999999999999999999995   67889


Q ss_pred             EEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          256 KIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       256 KL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      ||+|||++.......     .....+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  223 (272)
T cd05075         152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI  223 (272)
T ss_pred             EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999997543221     12235667999999999899999999999999999999 8999987655443

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.1e-34  Score=313.52  Aligned_cols=206  Identities=26%  Similarity=0.416  Sum_probs=170.3

Q ss_pred             CceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ++|.+.++||+|+||.||+|++.       .....||+|+++..  ......+..|+++++.+.      .|+||+++++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~   85 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG------KHKNIINLLG   85 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc------CCCCeeeEEE
Confidence            78999999999999999999753       23567999998853  234556788999988873      4899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      ++...+.+|+||||+. ++|.+++....              ...+++.++..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            9999999999999997 58988886532              13488999999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++   .++.+||+|||+++......     ....++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus       166 ll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         166 LVT---EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EEc---CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            995   56789999999997543211     11223457999999998899999999999999999999 8999977655


Q ss_pred             HHHHH
Q 003239          319 FDLLR  323 (837)
Q Consensus       319 ~e~l~  323 (837)
                      .+...
T Consensus       243 ~~~~~  247 (314)
T cd05099         243 EELFK  247 (314)
T ss_pred             HHHHH
Confidence            44443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-34  Score=304.22  Aligned_cols=199  Identities=27%  Similarity=0.418  Sum_probs=169.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.+.||+|+||.||++.  .+++.||+|+++... ..+.+.+|+.+++.+       .|+||+++++++..+ ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKL-------HHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhC-------CCCCcCeEEEEEcCC-CcE
Confidence            689999999999999999985  467889999997643 345678899999888       689999999998764 579


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++   .++.+||+|||++....
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS  151 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceecc
Confidence            9999997 5999988776555689999999999999999999999999999999999995   56789999999987544


Q ss_pred             CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          268 RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       268 ~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      ........+..|+|||.+.+..++.++|||||||++|||++ |++||...+..+.
T Consensus       152 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  206 (254)
T cd05083         152 MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV  206 (254)
T ss_pred             ccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence            33333344667999999988899999999999999999997 9999977655443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.7e-34  Score=346.52  Aligned_cols=144  Identities=24%  Similarity=0.409  Sum_probs=128.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++..    ......+..|+.+++.+       .|+||+++++++...
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~Iv~~~~~~~~~   76 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-------KSPFIVHLYYSLQSA   76 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-------CCCCcCeEEEEEEEC
Confidence            7899999999999999999999999999999999753    23346677888888887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++||||||+. ++|.+++...  +.+++..++.|+.||+.||+|||.++||||||||+||||+   .++.+||+|||++
T Consensus        77 ~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls  151 (669)
T cd05610          77 NNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS  151 (669)
T ss_pred             CEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCC
Confidence            99999999996 5888888654  3589999999999999999999999999999999999995   5678999999987


Q ss_pred             c
Q 003239          264 C  264 (837)
Q Consensus       264 ~  264 (837)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-34  Score=307.54  Aligned_cols=199  Identities=24%  Similarity=0.361  Sum_probs=165.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|+++++||+|+||+||+|++..+++    .||||+++..  ....+.+.+|+.+++.+       .|+||+++++++.
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~   79 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-------GSPYVCRLLGICL   79 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-------CCCCCceEEEEEc
Confidence            789999999999999999998776665    4899998743  33456677888888877       6899999999987


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      . ...+++||++. |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++   +.+.+||+|||
T Consensus        80 ~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG  154 (279)
T cd05109          80 T-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFG  154 (279)
T ss_pred             C-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCC
Confidence            5 45789999997 68888887543 4589999999999999999999999999999999999995   56789999999


Q ss_pred             cccccCCcce-----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 003239          262 SACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEF  319 (837)
Q Consensus       262 lA~~~~~~~~-----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~  319 (837)
                      ++........     ...++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  218 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR  218 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9875432211     1223567999999998899999999999999999998 89999765443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5e-35  Score=312.07  Aligned_cols=207  Identities=23%  Similarity=0.328  Sum_probs=169.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-----tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .+|++.++||+|+||.||+|.+..     .++.||||+++...  ...+.+.+|+.++..+       .|+||+++++++
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-------~h~~iv~~~~~~   77 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-------QHPNIVCLLGVV   77 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-------CCCCcCeEEEEE
Confidence            568889999999999999997653     35789999998543  2345677888888887       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeee
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL  246 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl  246 (837)
                      ......++++||+. ++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~  157 (283)
T cd05091          78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV  157 (283)
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence            99999999999997 57887775321              1348889999999999999999999999999999999999


Q ss_pred             eccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          247 CTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       247 ~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      +   ++..+||+|||+++......     ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus       158 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  234 (283)
T cd05091         158 F---DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  234 (283)
T ss_pred             c---CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            5   56789999999986543221     12344678999999988899999999999999999998 889998766655


Q ss_pred             HHHHH
Q 003239          321 LLRRM  325 (837)
Q Consensus       321 ~l~~I  325 (837)
                      .+..+
T Consensus       235 ~~~~i  239 (283)
T cd05091         235 VIEMI  239 (283)
T ss_pred             HHHHH
Confidence            44443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.9e-35  Score=306.76  Aligned_cols=198  Identities=24%  Similarity=0.387  Sum_probs=171.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||++++..+++.||||.+...    ......+.+|+.+++.+       .|+||+++++++...
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~   74 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-------NHPNVIKYYASFIED   74 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-------cCCchhhhhheeEeC
Confidence            5788999999999999999999999999999988642    23445678899999988       689999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 RHLCICFELLDS-NLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +..++||||+.+ +|.+++....  ...+++..++.++.||+.||.|||++||+|+||||+||+++   .++.++|+|||
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg  151 (267)
T cd08229          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLG  151 (267)
T ss_pred             CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcch
Confidence            999999999984 8888776422  24589999999999999999999999999999999999995   56789999999


Q ss_pred             cccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          262 SACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       262 lA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++......   .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98654322   22346888999999999889999999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-34  Score=310.13  Aligned_cols=208  Identities=25%  Similarity=0.387  Sum_probs=172.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCC----------------eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCC
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMN----------------SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE  169 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg----------------~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~  169 (837)
                      .++|++++.||+|+||.||+|.+..++                ..||+|++...  ....+.+.+|+++++++       
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-------   76 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-------   76 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-------
Confidence            378999999999999999998766543                56899999854  34456788899999998       


Q ss_pred             CCCceeEEeEEEeecceEEEEEeccc-hhHHHHHHhhc---------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINH---------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~---------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      .|+||+++++++..++..++|||++. ++|.+++....         ...+++..++.++.||+.||+|||+++|+||||
T Consensus        77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl  156 (296)
T cd05051          77 SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL  156 (296)
T ss_pred             CCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence            58999999999999999999999997 58888876543         125899999999999999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh--CCCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPL  312 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt--G~~P  312 (837)
                      ||+||+++   ..+.++|+|||++......     .....++..|+|||++.+..++.++|||||||++|||++  +..|
T Consensus       157 kp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  233 (296)
T cd05051         157 ATRNCLVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP  233 (296)
T ss_pred             chhceeec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence            99999996   5689999999998653222     122345678999999998889999999999999999998  7788


Q ss_pred             CCCCCHHHHHHHH
Q 003239          313 FPGASEFDLLRRM  325 (837)
Q Consensus       313 F~g~s~~e~l~~I  325 (837)
                      |...+..+.+..+
T Consensus       234 ~~~~~~~~~~~~~  246 (296)
T cd05051         234 YEHLTDQQVIENA  246 (296)
T ss_pred             CCCcChHHHHHHH
Confidence            8766555544433

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.5e-34  Score=303.24  Aligned_cols=204  Identities=26%  Similarity=0.386  Sum_probs=172.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.++||+|+||.||++.+. .+..||+|+++......+.+.+|+++++.+       .|+||+++++++.. ...
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-------QHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-------CCCCcceEEEEEcC-CCe
Confidence            379999999999999999999754 456699999987665567788999999988       68899999999887 788


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.......+++..++.++.||+.||.|||+.+++|+||||+||+++   ..+.+||+|||.+...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~  152 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVI  152 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeec
Confidence            99999997 5899998775545688999999999999999999999999999999999995   6789999999998654


Q ss_pred             CCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ....    ....++..|+|||++....++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~  214 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR  214 (260)
T ss_pred             cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            3221    11234567999999998889999999999999999998 999998766554443

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-34  Score=312.51  Aligned_cols=203  Identities=25%  Similarity=0.378  Sum_probs=171.1

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|.+.+.||+|+||.||++.+     ..++..||||+++..  ....+.+.+|+.+++++.      +|+||++++++
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~  107 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG------NHENIVNLLGA  107 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc------CCCCcceEEEE
Confidence            36899999999999999999964     345668999998753  334456788999999883      48999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      +...+..++||||+. ++|.+++.......+++.++..++.||+.||+|||+++|+|+||||+|||++   ....+||+|
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~d  184 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICD  184 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECC
Confidence            999999999999997 6898888765434489999999999999999999999999999999999995   667899999


Q ss_pred             cccccccCCcce-----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 003239          260 FGSACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEF  319 (837)
Q Consensus       260 FGlA~~~~~~~~-----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~  319 (837)
                      ||++........     ...++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~  250 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD  250 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence            999865432211     1234677999999999899999999999999999998 99999765443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-34  Score=327.48  Aligned_cols=201  Identities=28%  Similarity=0.393  Sum_probs=167.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||.||+|.+..     ++..||||+++..  ....+.+.+|+++|+.+.      .||||++++++
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~------~HpnIv~l~~~  109 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG------PHLNIVNLLGA  109 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC------CCCCeeeEEEE
Confidence            4789999999999999999997643     3457999999753  334467889999999983      48999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc-----------------------------------------------------
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH-----------------------------------------------------  206 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~-----------------------------------------------------  206 (837)
                      +...+.+|||||||. |+|.+++....                                                     
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            999999999999997 68888775431                                                     


Q ss_pred             -----------------------------------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCee
Q 003239          207 -----------------------------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL  245 (837)
Q Consensus       207 -----------------------------------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL  245 (837)
                                                               ...+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil  269 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence                                                     124788889999999999999999999999999999999


Q ss_pred             eeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          246 LCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       246 l~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ++   .++.+||+|||++......     .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       270 l~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         270 LA---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             Ee---CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            96   5678999999998654221     112345678999999999899999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-34  Score=308.07  Aligned_cols=205  Identities=29%  Similarity=0.391  Sum_probs=170.9

Q ss_pred             CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|.+.++||+|+||.||+++.     ..++..||+|.++.. ....+.+.+|+++++.+       .|+||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~   77 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-------QHQHIVRFYGVCT   77 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-------CCCCCceEEEEEe
Confidence            6789999999999999999963     345678999998753 34456788899999988       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhcc-------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHF-------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT  248 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~-------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~  248 (837)
                      ..+..++||||+. ++|.+++.....             ..+++..++.++.||+.||+|||+++|+||||||+|||++ 
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~-  156 (280)
T cd05092          78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG-  156 (280)
T ss_pred             cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc-
Confidence            9999999999997 588888865421             2488999999999999999999999999999999999996 


Q ss_pred             cCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          249 SVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       249 ~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                        +++.+||+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |.+||......+.+
T Consensus       157 --~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  234 (280)
T cd05092         157 --QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI  234 (280)
T ss_pred             --CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence              57889999999986443211     12234677999999999899999999999999999998 99999766555443


Q ss_pred             H
Q 003239          323 R  323 (837)
Q Consensus       323 ~  323 (837)
                      .
T Consensus       235 ~  235 (280)
T cd05092         235 E  235 (280)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-34  Score=303.47  Aligned_cols=206  Identities=23%  Similarity=0.329  Sum_probs=170.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~---~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|+..+.||+|+||.||+|++..+++   .||||+++..  ....+.+..|+++++.+       .|+||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   77 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-------SHHNIIRLEGVVTK   77 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-------CCCCeeEEEEEEcc
Confidence            678999999999999999998876554   7999998754  33456678899888888       68899999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+..++||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.+|+|+||||+||+++   .+..+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~  153 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGL  153 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCcc
Confidence            9999999999984 7777776543 4689999999999999999999999999999999999995   567899999999


Q ss_pred             ccccCCccee------eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          263 ACTEDRTVYS------YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       263 A~~~~~~~~~------~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      +.........      ...+..|+|||++....++.++|||||||++|||++ |..||...+..+....+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i  223 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI  223 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence            8644322111      112346999999998889999999999999999997 99999776655544443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-34  Score=309.17  Aligned_cols=201  Identities=26%  Similarity=0.408  Sum_probs=167.3

Q ss_pred             ceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~-----tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +|++.+.||+|+||.||+|++..     ..+.||+|+++...  ...+.+.+|+.+++.+       .|+||+++++.+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~   73 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-------NHPHVIKLYGACS   73 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-------CCCCEeeEEEEEe
Confidence            47889999999999999997643     33679999987543  3456788899999988       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhc----------------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          183 CQRHLCICFELLD-SNLYELIKINH----------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~----------------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      .++..++||||+. ++|.+++....                      ...+++..+..++.||+.||+|||+++|+||||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di  153 (290)
T cd05045          74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL  153 (290)
T ss_pred             cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence            9999999999998 68888876421                      134789999999999999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLF  313 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF  313 (837)
                      ||+|||++   +++.+||+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       154 kp~nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         154 AARNVLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             hhheEEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            99999995   56789999999986532211     12234678999999988899999999999999999998 99999


Q ss_pred             CCCCHHH
Q 003239          314 PGASEFD  320 (837)
Q Consensus       314 ~g~s~~e  320 (837)
                      .+....+
T Consensus       231 ~~~~~~~  237 (290)
T cd05045         231 PGIAPER  237 (290)
T ss_pred             CCCCHHH
Confidence            7765443

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-34  Score=348.66  Aligned_cols=199  Identities=25%  Similarity=0.359  Sum_probs=170.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||.||+|++..+++.||||+++.+    ....+++.+|+++++.+       .||||+++++++...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-------~HPNIVkl~~v~~d~   74 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-------IHPGIVPVYSICSDG   74 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-------CCcCcCeEEEEEeeC
Confidence            6899999999999999999999999999999999743    23456788899999998       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc---------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCe
Q 003239          185 RHLCICFELLD-SNLYELIKINH---------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~---------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                      +..|+||||+. ++|.+++....         ...++...+..++.||+.||+|||++||+||||||+|||++   ..+.
T Consensus        75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~  151 (932)
T PRK13184         75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGE  151 (932)
T ss_pred             CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCC
Confidence            99999999998 58888776421         12356677889999999999999999999999999999995   6688


Q ss_pred             EEEEecccccccCC---------------------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          255 IKIIDFGSACTEDR---------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       255 IKL~DFGlA~~~~~---------------------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      +||+|||++.....                     .....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF  231 (932)
T PRK13184        152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY  231 (932)
T ss_pred             EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence            99999999964410                     011246899999999999999999999999999999999999999


Q ss_pred             CCCC
Q 003239          314 PGAS  317 (837)
Q Consensus       314 ~g~s  317 (837)
                      ....
T Consensus       232 ~~~~  235 (932)
T PRK13184        232 RRKK  235 (932)
T ss_pred             CCcc
Confidence            7643

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-34  Score=310.43  Aligned_cols=207  Identities=25%  Similarity=0.393  Sum_probs=171.0

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      .++|++.+.||+|+||.||+|+..       .++..||||+++..  ....+.+.+|+.+++.+.      .|+||++++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~i~~~~   87 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLL   87 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc------cCCCchhee
Confidence            378999999999999999999642       23457999998753  344567888999998884      589999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                      +++......++||||+. ++|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999997 58888887642              1347888999999999999999999999999999999


Q ss_pred             eeeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          244 ILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       244 ILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ||++   .++.+||+|||++.......     ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus       168 ili~---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         168 VLVT---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             EEEc---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9995   66889999999997543211     12234567999999998899999999999999999998 888997765


Q ss_pred             HHHHHH
Q 003239          318 EFDLLR  323 (837)
Q Consensus       318 ~~e~l~  323 (837)
                      ..+...
T Consensus       245 ~~~~~~  250 (304)
T cd05101         245 VEELFK  250 (304)
T ss_pred             HHHHHH
Confidence            544433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-34  Score=310.66  Aligned_cols=208  Identities=25%  Similarity=0.401  Sum_probs=169.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCC--------------eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCC
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMN--------------SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDK  171 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg--------------~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~H  171 (837)
                      .++|++.+.||+|+||.||+|++..++              ..||||+++..  ......+.+|+++++++       .|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-------~h   76 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-------KN   76 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-------CC
Confidence            378999999999999999999875432              35999999753  33345688899999998       68


Q ss_pred             CceeEEeEEEeecceEEEEEeccc-hhHHHHHHhhcc----------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCC
Q 003239          172 HHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF----------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLK  240 (837)
Q Consensus       172 pnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~----------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLK  240 (837)
                      +||+++++++...+..++||||+. ++|.+++.....          ..+++..+..++.||+.||+|||+++|+|||||
T Consensus        77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  156 (295)
T cd05097          77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA  156 (295)
T ss_pred             CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence            999999999999999999999998 588887754321          236888999999999999999999999999999


Q ss_pred             CCCeeeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh--CCCCC
Q 003239          241 PENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPLF  313 (837)
Q Consensus       241 PeNILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt--G~~PF  313 (837)
                      |+||+++   .++.+||+|||++.......     ....++..|+|||++.+..++.++|||||||++|+|++  +..||
T Consensus       157 p~Nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~  233 (295)
T cd05097         157 TRNCLVG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY  233 (295)
T ss_pred             hhhEEEc---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence            9999996   56789999999986432211     11234668999999998899999999999999999998  67888


Q ss_pred             CCCCHHHHHHHH
Q 003239          314 PGASEFDLLRRM  325 (837)
Q Consensus       314 ~g~s~~e~l~~I  325 (837)
                      ...+..+.+..+
T Consensus       234 ~~~~~~~~~~~~  245 (295)
T cd05097         234 SLLSDEQVIENT  245 (295)
T ss_pred             cccChHHHHHHH
Confidence            776655544443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-34  Score=307.92  Aligned_cols=205  Identities=23%  Similarity=0.410  Sum_probs=170.5

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||+++..  ......+.+|+.+++.+       +|+||++++++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~iv~~~~~   76 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-------DHPNIVKLLGV   76 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-------CCCchheEEEE
Confidence            378999999999999999999864     36789999998754  23346688899999988       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc--------------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH--------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      +...+..|+||||+. ++|.+++....                    ...+++..++.++.||+.||+|||+++++||||
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl  156 (288)
T cd05050          77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL  156 (288)
T ss_pred             EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            999999999999998 58888886432                    124788899999999999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLF  313 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF  313 (837)
                      ||+||+++   .++.+||+|||++......     ......+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       157 ~p~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         157 ATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             cHhheEec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999995   6788999999998643221     112234567999999998899999999999999999997 88888


Q ss_pred             CCCCHHHHH
Q 003239          314 PGASEFDLL  322 (837)
Q Consensus       314 ~g~s~~e~l  322 (837)
                      .+.+..+.+
T Consensus       234 ~~~~~~~~~  242 (288)
T cd05050         234 YGMAHEEVI  242 (288)
T ss_pred             CCCCHHHHH
Confidence            766554433

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-34  Score=301.98  Aligned_cols=194  Identities=26%  Similarity=0.373  Sum_probs=161.9

Q ss_pred             EEeccCCceeEEEeeccCCC---eEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg---~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      ++||+|+||.||+|+...++   ..||+|+++....  ..+.+.+|+++++.+       .|+||+++++++. .+..++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~-~~~~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-------DHPCIVRLIGVCK-GEPLML   72 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEc-CCceEE
Confidence            46999999999999765554   7899999986543  456788899999988       6899999999876 456899


Q ss_pred             EEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       190 VmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      ||||+. ++|.+++....  .+++..+..++.||+.||+|||.++|+|+||||+|||++   .++.+||+|||+++....
T Consensus        73 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          73 VMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGA  147 (257)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeec
Confidence            999997 58998887653  689999999999999999999999999999999999995   678899999999875432


Q ss_pred             cceee------ccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          269 TVYSY------IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       269 ~~~~~------~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      .....      .++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+.
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~  207 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV  207 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            22111      12357999999998899999999999999999998 9999976655443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2e-34  Score=308.52  Aligned_cols=196  Identities=24%  Similarity=0.400  Sum_probs=165.1

Q ss_pred             ceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      +|++.+.||+|+||.||++++.   .+++.||||++++..     ...+.+.+|+++++.+.      +|+||+++++.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~------~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR------RCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc------CCcchhhhheee
Confidence            4889999999999999998753   467889999997532     23355678999999884      589999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      ...+..|+||||+. ++|.+.+...  ..+++..++.++.|++++|.|||+.+++||||||+||+++   .++.++|+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df  149 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDF  149 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEEC
Confidence            99999999999997 5888777653  3589999999999999999999999999999999999995   5678999999


Q ss_pred             ccccccCCc----ceeeccCccccCchhhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          261 GSACTEDRT----VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       261 GlA~~~~~~----~~~~~GT~~Y~APEvl~~~~--yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      |++......    .....++..|+|||.+.+..  .+.++|||||||++|||++|..||...
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  211 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD  211 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence            998653322    12346788999999987764  788999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.1e-34  Score=303.73  Aligned_cols=205  Identities=23%  Similarity=0.363  Sum_probs=170.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~---~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ..|++.+.||+|+||.||+|.+..+++   .||||+++..  ....+.+..|+.+++.+       .|+||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~~~   76 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-------DHPNIIHLEGVVTK   76 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCcCcceEEEEECC
Confidence            578999999999999999998876654   6999999753  44456788899999988       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      +...++||||+.+ +|.+++.... ..+++.+++.++.|++.||.|||++|++|+||||+||+++   .+..+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~  152 (269)
T cd05065          77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGL  152 (269)
T ss_pred             CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCcc
Confidence            9999999999985 7777776543 4689999999999999999999999999999999999995   667899999999


Q ss_pred             ccccCCcce-----eec---cCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          263 ACTEDRTVY-----SYI---QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       263 A~~~~~~~~-----~~~---GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      +........     ...   .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~  223 (269)
T cd05065         153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA  223 (269)
T ss_pred             ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            864332111     111   1346999999998899999999999999999886 9999977665544433

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=336.85  Aligned_cols=259  Identities=25%  Similarity=0.454  Sum_probs=219.7

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      ..+.|+|.+.||.|.+|.||+++.+.+++.+|+||..-+....+++..|.+||+.+.      +|||++.++++|...  
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~------~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS------HHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc------CCCCcceEEEEEEEecC
Confidence            448899999999999999999999999999999999877777778888999998885      799999999999864  


Q ss_pred             ---ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 ---RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 ---~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                         +.+|||||||+ |+.-|+++......+.|+.+..|++.++.||.+||.+.++|||||-.|||++   .++.|||+||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeee
Confidence               58999999998 6888888887777899999999999999999999999999999999999997   7799999999


Q ss_pred             ccccccCCc---ceeeccCccccCchhhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          261 GSACTEDRT---VYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       261 GlA~~~~~~---~~~~~GT~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      |.+.+.+..   ..+.+||++|||||++...     .|+..+|+||||++..||.-|.+|+-.......+-.|-+   -+
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NP  244 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP  244 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CC
Confidence            999776543   4567999999999999643     477899999999999999999999966543322221111   01


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                      ||                                                                              
T Consensus       245 PP------------------------------------------------------------------------------  246 (953)
T KOG0587|consen  245 PP------------------------------------------------------------------------------  246 (953)
T ss_pred             Cc------------------------------------------------------------------------------
Confidence            11                                                                              


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        .+.....++.+|.|||..||..|-++||+..++|+|||+++.+
T Consensus       247 --kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  247 --KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             --cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence              1112345778999999999999999999999999999999655

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.6e-34  Score=301.56  Aligned_cols=196  Identities=27%  Similarity=0.420  Sum_probs=161.8

Q ss_pred             EeccCCceeEEEeec--cCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          116 LLGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~--~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      .||+|+||.||+|..  ..+++.||||+++..   ....+.+.+|+.+++.+       .|+||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-------DNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEc-CCCcEEE
Confidence            589999999999953  567889999998753   23456788899999888       6899999999875 4577999


Q ss_pred             Eeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc
Q 003239          191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT  269 (837)
Q Consensus       191 mEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~  269 (837)
                      |||+. ++|.+++...  ..+++..+..++.||+.||+|||++||+||||||.|||++   .++.+||+|||++......
T Consensus        74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          74 MELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCC
Confidence            99998 5788887654  3589999999999999999999999999999999999996   5678999999998654332


Q ss_pred             ce------eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          270 VY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       270 ~~------~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ..      ...++..|+|||.+....++.++|||||||++|||++ |.+||...+..+....
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~  210 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM  210 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            11      1123568999999988889999999999999999998 9999987665544333

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=360.05  Aligned_cols=255  Identities=30%  Similarity=0.483  Sum_probs=208.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      -++.-...||.|.||.||.|.+..+|+..|+|-++-..   .....+.+|..+|..+       .|||+|+++++=.+.+
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-------nHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-------NHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-------cCccccccCceeecHH
Confidence            46777789999999999999999999999999998433   3345677899999999       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..+|.||||. |+|.+++...+  -.+|...+.+..|++.||+|||+.|||||||||+||+++   ..+.||++|||.|.
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeeccccee
Confidence            9999999998 57888776543  478888999999999999999999999999999999995   67899999999997


Q ss_pred             ccCCc-------ceeeccCccccCchhhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Q 003239          265 TEDRT-------VYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE-FDLLRRMIRILGAQP  333 (837)
Q Consensus       265 ~~~~~-------~~~~~GT~~Y~APEvl~~~---~yt~ksDIWSLG~ILyELltG~~PF~g~s~-~e~l~~I~~~lG~~P  333 (837)
                      .....       ...+.||+.|||||++.+.   ....++||||||||+.||+||+.||...+. ..++.++-.  |   
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--g--- 1457 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--G--- 1457 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--c---
Confidence            65433       3456899999999999875   356799999999999999999999965432 222222111  1   


Q ss_pred             chHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       334 p~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                                                                        .+|                 .+|       
T Consensus      1458 --------------------------------------------------h~P-----------------q~P------- 1463 (1509)
T KOG4645|consen 1458 --------------------------------------------------HKP-----------------QIP------- 1463 (1509)
T ss_pred             --------------------------------------------------CCC-----------------CCc-------
Confidence                                                              011                 111       


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCC
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTC  460 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~  460 (837)
                            ..++.+..|||.+||+.||++|+|+.|+|+|-|-+...-.+
T Consensus      1464 ------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1464 ------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             ------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence                  01567789999999999999999999999999998766543

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.7e-34  Score=314.52  Aligned_cols=206  Identities=26%  Similarity=0.393  Sum_probs=169.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      .+|++.+.||+|+||.||+|++..       ....||+|+++..  ....+.+.+|+++++++.      .|+||+++++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~   85 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG------KHKNIINLLG   85 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc------CCCCeeeeeE
Confidence            589999999999999999997543       2347999998753  334567889999999884      4899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      ++...+.+++||||+. ++|.+++....              ...++...+..++.||+.||+|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            9999999999999997 58988887532              12478888999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++   .++.+||+|||+++......     ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus       166 ll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         166 LVT---EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEc---CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            995   56789999999987543221     11233467999999999999999999999999999998 8999987665


Q ss_pred             HHHHH
Q 003239          319 FDLLR  323 (837)
Q Consensus       319 ~e~l~  323 (837)
                      .+...
T Consensus       243 ~~~~~  247 (334)
T cd05100         243 EELFK  247 (334)
T ss_pred             HHHHH
Confidence            54433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.6e-34  Score=302.42  Aligned_cols=204  Identities=22%  Similarity=0.331  Sum_probs=170.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .+|++.+.||+|+||.||+|++..++   ..||+|.++..  ....+.+.+|+.+++.+       .||||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   76 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-------DHPNIIHLEGVVTK   76 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEec
Confidence            68999999999999999999876444   47999998753  33456788899999888       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++..|+||||+. ++|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~  152 (267)
T cd05066          77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGL  152 (267)
T ss_pred             CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCc
Confidence            999999999997 57888876543 4589999999999999999999999999999999999995   567899999999


Q ss_pred             ccccCCcce---e---eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          263 ACTEDRTVY---S---YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       263 A~~~~~~~~---~---~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      +........   .   ...+..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~  220 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK  220 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH
Confidence            875432211   1   122457999999998899999999999999999886 999997765544433

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-34  Score=300.18  Aligned_cols=200  Identities=27%  Similarity=0.412  Sum_probs=167.7

Q ss_pred             EEeccCCceeEEEeeccC-CC--eEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAE-MN--SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~-tg--~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      ++||+|++|.||+|.+.. .+  ..||||+++...  ...+.+.+|+.+++++       .|+||+++++++.. ...++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~-~~~~~   72 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-------DHENLIRLYGVVLT-HPLMM   72 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-------CCCCccceeEEEcC-CeEEE
Confidence            368999999999998755 33  369999998653  3456788899999988       68999999999988 89999


Q ss_pred             EEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       190 VmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      ||||+. ++|.+.+.......+++..++.++.||+.||+|||+++|+|+||||+||+++   .++.+||+|||++.....
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccc
Confidence            999997 6899888765434689999999999999999999999999999999999996   568999999999865433


Q ss_pred             cc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          269 TV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       269 ~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ..      ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  213 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI  213 (257)
T ss_pred             cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            11      12345678999999998899999999999999999998 99999776665544443

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-34  Score=303.69  Aligned_cols=197  Identities=25%  Similarity=0.331  Sum_probs=163.8

Q ss_pred             EeccCCceeEEEeeccCCCe--EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          116 LLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~--~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      .||+|+||.||+|++..++.  .+|+|.++..  ....+.+.+|+++++++.      .|+||+++++++...+..++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~~~~~~~~~lv~   75 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHRGYLYLAI   75 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc------cCCCeeeEEEEEecCCCceEEE
Confidence            58999999999999887765  4688888742  344567888999999884      5899999999999999999999


Q ss_pred             eccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEE
Q 003239          192 ELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       192 Ey~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                      ||+. ++|.+++....              ...+++..++.++.||+.||+|||+++|+||||||+|||++   +++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEE
Confidence            9997 68999887542              12478999999999999999999999999999999999995   678899


Q ss_pred             EEecccccccCCccee--eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          257 IIDFGSACTEDRTVYS--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       257 L~DFGlA~~~~~~~~~--~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      |+|||++.........  ...+..|+|||++....++.++|||||||++|||++ |..||.+.+..+.
T Consensus       153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~  220 (270)
T cd05047         153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  220 (270)
T ss_pred             ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH
Confidence            9999998543322111  223567999999988899999999999999999997 9999976654443

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.9e-34  Score=306.81  Aligned_cols=204  Identities=26%  Similarity=0.406  Sum_probs=168.2

Q ss_pred             CCceEEEEEeccCCceeEEEeecc----------------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCC
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA----------------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE  169 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~----------------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~  169 (837)
                      .++|++.++||+|+||.||++.+.                .+...||+|+++..  ......+.+|+++++.+       
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-------   76 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-------   76 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-------
Confidence            368999999999999999998543                23457999999853  33456788999999998       


Q ss_pred             CCCceeEEeEEEeecceEEEEEeccc-hhHHHHHHhhcc---------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF---------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~---------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      .|+||+++++++...+..++||||+. ++|.+++.....         ..+++..+..++.||+.||+|||+++|+||||
T Consensus        77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl  156 (296)
T cd05095          77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL  156 (296)
T ss_pred             CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence            58899999999999999999999997 588888865321         23778899999999999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh--CCCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPL  312 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt--G~~P  312 (837)
                      ||+|||++   .++.+||+|||++.......     .....+..|+|||++.+..++.++|||||||++|||++  |..|
T Consensus       157 kp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         157 ATRNCLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             ChheEEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            99999996   56789999999986542221     11233567999999988899999999999999999998  7788


Q ss_pred             CCCCCHHHH
Q 003239          313 FPGASEFDL  321 (837)
Q Consensus       313 F~g~s~~e~  321 (837)
                      |...+..+.
T Consensus       234 ~~~~~~~~~  242 (296)
T cd05095         234 YSQLSDEQV  242 (296)
T ss_pred             ccccChHHH
Confidence            876655443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=331.26  Aligned_cols=194  Identities=24%  Similarity=0.362  Sum_probs=168.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +...+...||+|.||+||+|++..+   ||||+++.   .....+.|++|+.+|++-       .|.||+-+.+++....
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-------RH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKT-------RHENILLFMGACMNPP  461 (678)
T ss_pred             HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhc-------chhhheeeehhhcCCc
Confidence            5678889999999999999987654   99999985   356778899999999998       4679999999999887


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      . .||.-+|+| +|+.++...+ ..|....++.|++||++|+.|||.++|||||||..||++.   ++++|||+|||++.
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~---~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH---EDLKVKIGDFGLAT  536 (678)
T ss_pred             e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc---cCCcEEEeccccee
Confidence            7 999999997 7888887655 4599999999999999999999999999999999999995   56999999999995


Q ss_pred             cc-----CCcceeeccCccccCchhhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          265 TE-----DRTVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       265 ~~-----~~~~~~~~GT~~Y~APEvl~~~---~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ..     ........|...|||||+++.+   +|++.+||||||||+|||++|..||....
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~  597 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN  597 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC
Confidence            32     2233445678889999999744   79999999999999999999999998443

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-34  Score=317.33  Aligned_cols=201  Identities=27%  Similarity=0.411  Sum_probs=165.4

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||+||+|++     ..+++.||||+++..  ......+.+|+.+|.++.      +|+||++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~niv~~~~~   79 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA   79 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc------CCccHhhhcce
Confidence            37899999999999999999974     356789999999753  334556888999999984      47999999998


Q ss_pred             Eeec-ceEEEEEeccc-hhHHHHHHhhc----------------------------------------------------
Q 003239          181 FVCQ-RHLCICFELLD-SNLYELIKINH----------------------------------------------------  206 (837)
Q Consensus       181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~----------------------------------------------------  206 (837)
                      +... ..+++|||||. ++|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            7654 46899999998 58888876431                                                    


Q ss_pred             -------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcc---
Q 003239          207 -------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---  270 (837)
Q Consensus       207 -------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~---  270 (837)
                                   ...+++..+..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++.......   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~  236 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYV  236 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchh
Confidence                         12367888899999999999999999999999999999995   66789999999986532211   


Q ss_pred             --eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          271 --YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       271 --~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                        ....++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence              11234567999999998899999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.6e-35  Score=303.62  Aligned_cols=179  Identities=22%  Similarity=0.298  Sum_probs=152.8

Q ss_pred             CCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccc-hhH
Q 003239          120 GTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNL  198 (837)
Q Consensus       120 G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL  198 (837)
                      |.|+.||+|++..+++.||+|+++....    ..+|...+...       .|+||+++++++...+..|+||||+. ++|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~-------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPH-------CVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhc-------CCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            8999999999999999999999986532    22333333222       58999999999999999999999998 588


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeeccCcc
Q 003239          199 YELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY  278 (837)
Q Consensus       199 ~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~  278 (837)
                      .+.+....  .+++..+..++.||+.||+|||+++|+||||||+||+++   .++.++|+|||.+...........++..
T Consensus        73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~  147 (237)
T cd05576          73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDSCDGEAVENM  147 (237)
T ss_pred             HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhccccccccCCcCcc
Confidence            88886543  599999999999999999999999999999999999995   6678999999988665554445566778


Q ss_pred             ccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 003239          279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       279 Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      |+|||.+....++.++||||+||++|||++|..||.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            999999988889999999999999999999998773

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.5e-34  Score=301.80  Aligned_cols=194  Identities=22%  Similarity=0.224  Sum_probs=153.7

Q ss_pred             EEeccCCceeEEEeeccC------------CCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          115 DLLGHGTFGQVAKCWDAE------------MNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~------------tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      +.||+|+||+||+++...            ....||+|++.... .....+..|+.+++.+       .||||+++++++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-------~hp~iv~~~~~~   73 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-------SHKHIVLLYGVC   73 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-------CCCCEeeEEEEE
Confidence            368999999999997432            23468999887543 3334566778888887       689999999999


Q ss_pred             eecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC----CCCeEE
Q 003239          182 VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV----KPAEIK  256 (837)
Q Consensus       182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~----~~~~IK  256 (837)
                      ..+...++||||+++ .|..++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.+.    ....+|
T Consensus        74 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          74 VRDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             ecCCCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence            999999999999985 55544443 334689999999999999999999999999999999999996321    112489


Q ss_pred             EEecccccccCCcceeeccCccccCchhhc-CCCCCccchHHHHHHHHHHHH-hCCCCCCCCC
Q 003239          257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS  317 (837)
Q Consensus       257 L~DFGlA~~~~~~~~~~~GT~~Y~APEvl~-~~~yt~ksDIWSLG~ILyELl-tG~~PF~g~s  317 (837)
                      |+|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||....
T Consensus       153 l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         153 LSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             eCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            9999998654322 3346788899999987 457899999999999999998 5888886543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=327.34  Aligned_cols=184  Identities=28%  Similarity=0.412  Sum_probs=162.6

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      -++-||.|+-|.||+++.  .++.||||+++..      ...+|+-|++|       .|+||+.+.++|...-.+|||||
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~el------kETdIKHLRkL-------kH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVREL------KETDIKHLRKL-------KHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhhh------hhhhHHHHHhc-------cCcceeeEeeeecCCceeEEeee
Confidence            356699999999999954  4788999998632      23467778888       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc--
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--  269 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~--  269 (837)
                      ||. |-|+++++..+  .+....+..|.++|+.|+.|||.+.|||||||.-||||+   .+..|||+|||.++...+.  
T Consensus       193 fCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST  267 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST  267 (904)
T ss_pred             ccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh
Confidence            998 89999998765  689999999999999999999999999999999999997   5567999999999765543  


Q ss_pred             ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ...++||..|||||+|.+.+++.|+|||||||||||||||..||..-
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV  314 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV  314 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence            45679999999999999999999999999999999999999999654

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.5e-34  Score=302.54  Aligned_cols=203  Identities=24%  Similarity=0.332  Sum_probs=170.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|++.+.||+|+||.||+|.+..    +++.||+|+++..  ....+.+.+|+.+++.+       .|+||+++++++
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~   77 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-------SHQNILPILHVC   77 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEE
Confidence            3789999999999999999998776    3688999998753  34456678899999888       689999999987


Q ss_pred             ee-cceEEEEEeccc-hhHHHHHHhhcc------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC
Q 003239          182 VC-QRHLCICFELLD-SNLYELIKINHF------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       182 ~~-~~~l~LVmEy~~-gsL~d~l~~~~~------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      .. ....++++||+. ++|.+++.....      ..+++..++.++.||+.||+|||+++|+|+||||+||+++   +++
T Consensus        78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~  154 (280)
T cd05043          78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EEL  154 (280)
T ss_pred             ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCC
Confidence            66 467899999997 688888865432      3589999999999999999999999999999999999996   568


Q ss_pred             eEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          254 EIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      .+||+|||+++......     ....++..|+|||++.+..++.++|||||||++|||++ |++||...+..+
T Consensus       155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  227 (280)
T cd05043         155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE  227 (280)
T ss_pred             cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence            89999999997542221     12234667999999998899999999999999999998 999997765544

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.8e-34  Score=304.25  Aligned_cols=195  Identities=28%  Similarity=0.374  Sum_probs=163.0

Q ss_pred             Cce-EEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRY-IVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y-~i~~~LG~G~fG~Vyka~----~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++| ++++.||+|+||+||++.    ...+++.||+|+++...  .....+.+|+++|+.+       .|+||+++++++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~   75 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-------YHENIVKYKGCC   75 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEE
Confidence            455 999999999999998764    44578899999998542  3456778899999998       689999999988


Q ss_pred             eec--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          182 VCQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       182 ~~~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      ...  ..+++||||+. ++|.+++...   .+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~  149 (283)
T cd05080          76 SEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIG  149 (283)
T ss_pred             ecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEe
Confidence            764  46899999998 5788877653   499999999999999999999999999999999999995   56789999


Q ss_pred             ecccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          259 DFGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       259 DFGlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      |||++.......      ....++..|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            999987543321      1123456799999999889999999999999999999999998543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.2e-34  Score=300.27  Aligned_cols=204  Identities=26%  Similarity=0.421  Sum_probs=168.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|.+.++||+|+||.||+|.+...   ...||||.+...  ....+.+.+|+.+++.+       .|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~   77 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-------DHPHIVKLIGVIT   77 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-------CCCchhceeEEEc
Confidence            36799999999999999999986544   456999998754  34456788899999988       6899999999887


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      . ...++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++++|+||||+|||++   ..+.+||+|||
T Consensus        78 ~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g  152 (270)
T cd05056          78 E-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFG  152 (270)
T ss_pred             C-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCc
Confidence            5 56789999997 68988887643 3589999999999999999999999999999999999996   56789999999


Q ss_pred             cccccCCcce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          262 SACTEDRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       262 lA~~~~~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ++........    ...++..|+|||.+....++.++|||||||++|||++ |..||...+..+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~  219 (270)
T cd05056         153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG  219 (270)
T ss_pred             eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9865433211    1223457999999988889999999999999999996 999998776554443

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.4e-34  Score=303.36  Aligned_cols=199  Identities=25%  Similarity=0.327  Sum_probs=163.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~----~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|++.+.||+|+||+||+|++..+++    .|++|++....  ....++..|+.++..+       .|+||+++++++.
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-------~h~~iv~~~~~~~   79 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-------DHAYIVRLLGICP   79 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-------CCCCcceEEEEEC
Confidence            689999999999999999999877766    47777775432  2334566666676666       7899999999875


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       ....++|+||+. ++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++   .++.+||+|||
T Consensus        80 -~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg  154 (279)
T cd05111          80 -GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFG  154 (279)
T ss_pred             -CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCc
Confidence             456788999987 79998887543 4689999999999999999999999999999999999995   67889999999


Q ss_pred             cccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 003239          262 SACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEF  319 (837)
Q Consensus       262 lA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~  319 (837)
                      +++.....     .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  218 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH  218 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99643221     122345678999999998899999999999999999998 99999776543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.6e-34  Score=336.09  Aligned_cols=274  Identities=21%  Similarity=0.255  Sum_probs=181.0

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCC----CeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE--
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEM----NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY--  180 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~t----g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~--  180 (837)
                      ..++|++.++||+|+||.||+|++..+    ++.||||+++....      .|+.+...+.+.    .+.+++.++..  
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~----~~~~~~~~~~~~~  199 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRA----CPNSCADFVYGFL  199 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhh----chhhHHHHHHhhh
Confidence            457999999999999999999999888    89999999874322      122222222211    11122211111  


Q ss_pred             ----EeecceEEEEEeccc-hhHHHHHHhhccC------------------CCCHHHHHHHHHhHHHHHhhhhcCCeeec
Q 003239          181 ----FVCQRHLCICFELLD-SNLYELIKINHFR------------------GLSLSIVQLFSKQILRGLSLLKDAGIIHC  237 (837)
Q Consensus       181 ----f~~~~~l~LVmEy~~-gsL~d~l~~~~~~------------------~L~e~~i~~I~~QIl~aL~yLHs~gIVHr  237 (837)
                          ......++|||||+. ++|.+++......                  ...+..++.++.||+.||+|||+++||||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                234568999999998 5788877643210                  12244577899999999999999999999


Q ss_pred             cCCCCCeeeeccCCCCeEEEEecccccccCC----cceeeccCccccCchhhcCC----------------------CCC
Q 003239          238 DLKPENILLCTSVKPAEIKIIDFGSACTEDR----TVYSYIQSRYYRSPEVLLGY----------------------QYT  291 (837)
Q Consensus       238 DLKPeNILl~~~~~~~~IKL~DFGlA~~~~~----~~~~~~GT~~Y~APEvl~~~----------------------~yt  291 (837)
                      ||||+|||++  .+.+.+||+|||+|+....    .....++++.|+|||.+...                      .++
T Consensus       280 DLKP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        280 DVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             cCCHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            9999999996  3457899999999975322    23456789999999976432                      244


Q ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchh
Q 003239          292 TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQ  371 (837)
Q Consensus       292 ~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~  371 (837)
                      .++||||||||||||+++..++  .+....+.+++...+.....+ ...          ..                   
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~-~~~----------~~-------------------  405 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAW-RKL----------VE-------------------  405 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHH-HHh----------hc-------------------
Confidence            5679999999999999866543  333444444444333111000 000          00                   


Q ss_pred             hhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCc
Q 003239          372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP  451 (837)
Q Consensus       372 ~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HP  451 (837)
                                    +.     + ...+.+.              +.........+.|||++||++||++|||++|||+||
T Consensus       406 --------------~~-----~-~~~~~~~--------------~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp  451 (566)
T PLN03225        406 --------------PR-----A-SPDLRRG--------------FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP  451 (566)
T ss_pred             --------------cc-----c-chhhhhh--------------hhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence                          00     0 0000000              000011234678999999999999999999999999


Q ss_pred             cCCCCCC
Q 003239          452 FVTGEPF  458 (837)
Q Consensus       452 ff~~~~~  458 (837)
                      ||++...
T Consensus       452 ff~~~~~  458 (566)
T PLN03225        452 YFDREGL  458 (566)
T ss_pred             CcCCCCc
Confidence            9998654

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-33  Score=301.54  Aligned_cols=195  Identities=27%  Similarity=0.405  Sum_probs=163.6

Q ss_pred             CceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~----~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .+|++++.||+|+||.||++.    +..+++.||||+++.. ....+.+.+|+++++.+       .|+||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~   76 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-------QHDNIVKYKGVCYS   76 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCCeeEEEEEEcc
Confidence            689999999999999999986    4567889999999754 34456788899999988       68999999998754


Q ss_pred             c--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          184 Q--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       184 ~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      .  ..+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++   .++.+||+||
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~df  152 (284)
T cd05081          77 AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDF  152 (284)
T ss_pred             CCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCC
Confidence            3  46899999997 68988886543 3589999999999999999999999999999999999995   6678999999


Q ss_pred             ccccccCCcce------eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 003239          261 GSACTEDRTVY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       261 GlA~~~~~~~~------~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      |++........      ....+..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            99975432211      1123446999999998899999999999999999999877664

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8e-34  Score=301.15  Aligned_cols=202  Identities=22%  Similarity=0.315  Sum_probs=169.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-----tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++++.||+|+||.||+|+.+.     +.+.||+|.+.....  ..+.+.+|+++++++       .|+||+++++++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~   77 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-------SHKNVVRLLGLC   77 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-------CCcceeeeEEEE
Confidence            689999999999999999998653     356799999875432  456788999999998       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhcc-------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHF-------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~-------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      ...+..|+||||+. ++|.+++.....       ..+++..++.++.||+.||+|||+++|+||||||+||+++   ..+
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~  154 (275)
T cd05046          78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQR  154 (275)
T ss_pred             CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCC
Confidence            99999999999998 689888875541       1589999999999999999999999999999999999996   567


Q ss_pred             eEEEEecccccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          254 EIKIIDFGSACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      .++|+|||++......    .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~  226 (275)
T cd05046         155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE  226 (275)
T ss_pred             cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence            8999999998643211    122345677999999988889999999999999999998 888997654433

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6e-34  Score=300.74  Aligned_cols=200  Identities=25%  Similarity=0.374  Sum_probs=164.1

Q ss_pred             EeccCCceeEEEeeccCCC------eEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          116 LLGHGTFGQVAKCWDAEMN------SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg------~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .||+|+||.||++++....      +.||||.+....  .....+.+|+++++.+       .|+||+++++++...+..
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~   74 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-------NHPNIVKLLGVCLLNEPQ   74 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-------CCCCeeeEeeeecCCCCe
Confidence            6899999999999876543      789999987543  4456788899999988       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhc-----cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC--CCCeEEEEe
Q 003239          188 CICFELLD-SNLYELIKINH-----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIID  259 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~-----~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~IKL~D  259 (837)
                      ++||||+. ++|.+++....     ...+++..+..++.||+.||+|||+++++|+||||+||+++.+.  ....+||+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999997 58888886532     12378899999999999999999999999999999999997332  223799999


Q ss_pred             cccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          260 FGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       260 FGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      ||++.......     .....+..|+|||++.+..++.++|||||||++|||++ |..||...+..+..
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~  223 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL  223 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence            99986432211     12244678999999999899999999999999999998 99999776654433

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-33  Score=295.00  Aligned_cols=194  Identities=28%  Similarity=0.433  Sum_probs=163.9

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ++||+|+||.||++.+.. ++.||+|+++...  .....+.+|+++++++       .|+||+++++++......++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-------DHPNIVKLIGVCVQKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCeEEEEEEEecCCCeEEEEE
Confidence            369999999999999877 9999999988543  2456788899999988       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcce
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY  271 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~  271 (837)
                      |+. ++|.+++.... ..+++..+..++.|++.+|+|||+++|+||||||+|||++   .++.+||+|||++........
T Consensus        73 ~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          73 LVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCcc
Confidence            997 57888876543 3589999999999999999999999999999999999995   677899999999875442211


Q ss_pred             e-----eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          272 S-----YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       272 ~-----~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      .     ...+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~  203 (251)
T cd05041         149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ  203 (251)
T ss_pred             eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence            1     122456999999988899999999999999999999 899997665433

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-33  Score=302.28  Aligned_cols=194  Identities=20%  Similarity=0.226  Sum_probs=154.1

Q ss_pred             EeccCCceeEEEeeccC------------------------CCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCC
Q 003239          116 LLGHGTFGQVAKCWDAE------------------------MNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDRED  170 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~------------------------tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~  170 (837)
                      .||+|+||.||++....                        ....||+|++.... .....+.+|+.+++.+       .
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-------~   74 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-------S   74 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-------C
Confidence            59999999999986422                        12458999987543 2334566777777777       6


Q ss_pred             CCceeEEeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          171 KHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       171 HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      |+||+++++++......++||||+++ +|..++... ...+++..+..++.||+.||+|||+++|+||||||+|||++..
T Consensus        75 h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             CCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence            89999999999999999999999985 565565443 3568999999999999999999999999999999999999632


Q ss_pred             ----CCCCeEEEEecccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCH
Q 003239          250 ----VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELF-LGLPLFPGASE  318 (837)
Q Consensus       250 ----~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELl-tG~~PF~g~s~  318 (837)
                          .....+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence                12345899999998543222 23457788999999876 46899999999999999995 68999976543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-33  Score=294.25  Aligned_cols=195  Identities=28%  Similarity=0.430  Sum_probs=163.2

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ++||+|+||.||++.. .+++.||+|+++..  ......+.+|+++++.+       .|+||+++++++...+..++|||
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-------DHPNIVKLIGVCTQRQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-------CCCCcCeEEEEEecCCccEEEEE
Confidence            3689999999999975 46788999998754  23345678899999888       68999999999999999999999


Q ss_pred             ccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcce
Q 003239          193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY  271 (837)
Q Consensus       193 y~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~  271 (837)
                      |+. ++|.+++.... ..+++..+..++.||+.+|.|||++|++||||||+||+++   .++.+||+|||++........
T Consensus        73 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          73 LVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceecccccc
Confidence            997 58888776543 4589999999999999999999999999999999999995   677899999999865433221


Q ss_pred             ----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          272 ----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       272 ----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                          ....+..|+|||++....++.++|||||||++|+|++ |..||........
T Consensus       149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~  203 (250)
T cd05085         149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA  203 (250)
T ss_pred             ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence                1233567999999988889999999999999999998 9999977655443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-33  Score=297.57  Aligned_cols=195  Identities=24%  Similarity=0.342  Sum_probs=159.8

Q ss_pred             EeccCCceeEEEeecc--CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          116 LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      .||+|+||.||+|.+.  .++..||||+++...  ...+.+.+|+.+++++       .|+||+++++++. ....++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~ii~~~~~~~-~~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-------DNPYIVRMIGVCE-AEALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-------CCCCeEEEEEEEc-CCCeEEEE
Confidence            3899999999998654  456679999997542  3345688999999998       6899999999876 45789999


Q ss_pred             eccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcc
Q 003239          192 ELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV  270 (837)
Q Consensus       192 Ey~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~  270 (837)
                      ||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.......
T Consensus        74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCc
Confidence            9997 57887776432 4689999999999999999999999999999999999995   66789999999986432221


Q ss_pred             e------eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          271 Y------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       271 ~------~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      .      ...++..|+|||++....++.++|||||||++|||++ |..||......+..
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  208 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM  208 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence            1      1122467999999988889999999999999999996 99999776654443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-33  Score=299.40  Aligned_cols=202  Identities=24%  Similarity=0.387  Sum_probs=169.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~----~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .+|++.+.||+|+||+||+|.++.+++    .||+|+++...  .....+.+|+.+++.+       .|+||+++++++.
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~   79 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-------DHPHVVRLLGICL   79 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEe
Confidence            689999999999999999998776654    68999987543  3456778899999988       6899999999988


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      . ...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||
T Consensus        80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg  154 (279)
T cd05057          80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFG  154 (279)
T ss_pred             c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCc
Confidence            7 78999999997 68888887643 3589999999999999999999999999999999999995   66789999999


Q ss_pred             cccccCCcce--e---eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          262 SACTEDRTVY--S---YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       262 lA~~~~~~~~--~---~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      .+........  .   ...+..|+|||.+....++.++|||||||++|||++ |..||.+....+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  221 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP  221 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            9975432211  1   122467999999988899999999999999999998 99999876654443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=325.85  Aligned_cols=257  Identities=24%  Similarity=0.422  Sum_probs=220.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .+++++..||-|+||.|-+++.......+|+|++++.    ....+.+..|-+||...+       .+.||++|..|.++
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-------s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-------SDFIVRLYRTFRDS  492 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-------chHHHHHHHHhccc
Confidence            5677888999999999999977666667999999863    344566778999998884       57999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++|+.||-|- |.|...++.+  +.|++..++.++..+++|++|||++|||.|||||+|+|++   .++-+||.|||+|
T Consensus       493 kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd---~~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD---NRGYLKLVDFGFA  567 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec---cCCceEEeehhhH
Confidence            99999999996 6898888765  4699999999999999999999999999999999999995   7899999999999


Q ss_pred             ccc--CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          264 CTE--DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       264 ~~~--~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      +..  +....++|||+.|.|||++++...+.++|.||||+++|||++|.+||.+.++......|++.+..          
T Consensus       568 Kki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------  637 (732)
T KOG0614|consen  568 KKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------  637 (732)
T ss_pred             HHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence            875  45678899999999999999999999999999999999999999999999988887777763320          


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                               +                                                    .+|             ..
T Consensus       638 ---------i----------------------------------------------------~~P-------------r~  643 (732)
T KOG0614|consen  638 ---------I----------------------------------------------------EFP-------------RR  643 (732)
T ss_pred             ---------h----------------------------------------------------hcc-------------cc
Confidence                     0                                                    001             12


Q ss_pred             hHHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFTCP  461 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~~~  461 (837)
                      +...+.+||+++...+|.+|+.     +.+|-+|.||.+-.|...
T Consensus       644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence            3456789999999999999996     899999999999777543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-33  Score=298.63  Aligned_cols=200  Identities=22%  Similarity=0.277  Sum_probs=159.9

Q ss_pred             EeccCCceeEEEeecc--CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          116 LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      .||+|+||+||+|...  .....+|+|.+...  ......+.+|+.+++.+       .|+||+++++.+......|+||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-------~h~nii~~~~~~~~~~~~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-------NHPNVLQCLGQCIESIPYLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-------CCCCcceEEEEECCCCceEEEE
Confidence            5899999999999543  34567889987643  23345677899888887       6899999999999999999999


Q ss_pred             eccc-hhHHHHHHhhcc---CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          192 ELLD-SNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       192 Ey~~-gsL~d~l~~~~~---~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||+. ++|.+++.....   ...++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++....
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccc
Confidence            9998 589888876432   2356788899999999999999999999999999999995   67889999999986432


Q ss_pred             Cc-----ceeeccCccccCchhhcC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          268 RT-----VYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       268 ~~-----~~~~~GT~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ..     .....++..|+|||++..       ..++.++|||||||++|||++ |..||....+.+.+..+
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~  222 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV  222 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence            21     122244667999999753       357889999999999999999 78899877665554443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.4e-34  Score=303.48  Aligned_cols=194  Identities=26%  Similarity=0.353  Sum_probs=163.8

Q ss_pred             CceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~----~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +-|++++.||+|+||.||+|+    ...+++.||+|.++..  ......+.+|+++++.+       .|+||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~   76 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-------YHENIVKYKGICT   76 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-------CCCCeeeeeeEEe
Confidence            567999999999999999997    3567889999999743  33456788899999998       6899999999988


Q ss_pred             ec--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..  ...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++   .++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~d  152 (284)
T cd05079          77 EDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGD  152 (284)
T ss_pred             cCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECC
Confidence            75  57899999997 58888876543 3589999999999999999999999999999999999996   567899999


Q ss_pred             cccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       260 FGlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      ||++.......      ....++..|+|||++.+..++.++|||||||++|||++++.|+
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            99986543221      1234566799999999889999999999999999999987765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-33  Score=319.60  Aligned_cols=203  Identities=28%  Similarity=0.411  Sum_probs=168.4

Q ss_pred             CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|.+.++||+|+||.||+|++     ..+++.||||+++..  ....+.+.+|+++|..+.      .|+||+++++++
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~------~H~niv~~~~~~  110 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG------PHLNIVNLLGAC  110 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC------CCCCeEEEEEEE
Confidence            6788999999999999999984     345678999999854  233456788999999883      389999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhcc-----------------------------------------------------
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHF-----------------------------------------------------  207 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~-----------------------------------------------------  207 (837)
                      ...+..+||||||. |+|.+++.....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            99999999999998 689988865321                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          208 -------------------------------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       208 -------------------------------------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                                                                 ..+++..++.++.||+.||+|||+.+|+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                       2367778899999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++   +...+||+|||++......     .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       271 Ll~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         271 LIC---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEe---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            996   5678999999998643211     122356778999999998889999999999999999998 8999976543


Q ss_pred             HH
Q 003239          319 FD  320 (837)
Q Consensus       319 ~e  320 (837)
                      .+
T Consensus       348 ~~  349 (401)
T cd05107         348 NE  349 (401)
T ss_pred             hH
Confidence            33

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.2e-34  Score=300.86  Aligned_cols=193  Identities=25%  Similarity=0.371  Sum_probs=157.1

Q ss_pred             EEeccCCceeEEEeeccCCCe-------EEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          115 DLLGHGTFGQVAKCWDAEMNS-------FVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~-------~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +.||+|+||.||+|.+..++.       .||+|++.... ...+.+..|+.+++.+       .|+||+++++++...+.
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-------~h~~iv~~~~~~~~~~~   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-------SHKHLVLNYGVCVCGDE   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-------CCCChhheeeEEEeCCC
Confidence            369999999999998765543       48889886543 3345677788888887       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC-----CCeEEEEec
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-----PAEIKIIDF  260 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-----~~~IKL~DF  260 (837)
                      .++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+..     ...++|+||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999998 47877776543 35899999999999999999999999999999999999974321     234899999


Q ss_pred             ccccccCCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhC-CCCCCCC
Q 003239          261 GSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLG-LPLFPGA  316 (837)
Q Consensus       261 GlA~~~~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG-~~PF~g~  316 (837)
                      |.+..... .....++..|+|||++.+. .++.++|||||||++|||++| .+||...
T Consensus       153 g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~  209 (258)
T cd05078         153 GISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL  209 (258)
T ss_pred             ccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence            99865432 2335678899999999874 589999999999999999998 4666443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.9e-34  Score=335.95  Aligned_cols=210  Identities=28%  Similarity=0.418  Sum_probs=183.2

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      ..+.++.+.||+|+||+||+|+..     .....||||.+|...  ...++|.+|+++|..|       +|+|||+|+++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-------~H~nIVrLlGV  557 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-------QHPNIVRLLGV  557 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-------cCCCeEEEEEE
Confidence            356778899999999999999743     345689999999643  3577899999999999       78999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhcc------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeee
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHF------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC  247 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~  247 (837)
                      |..++.+|+|||||. |+|.++|+....            .+|+..+...|+.||+.|++||-++.+|||||..+|+||.
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence            999999999999998 899999986531            2288899999999999999999999999999999999995


Q ss_pred             ccCCCCeEEEEecccccccCCcceeecc-----CccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          248 TSVKPAEIKIIDFGSACTEDRTVYSYIQ-----SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       248 ~~~~~~~IKL~DFGlA~~~~~~~~~~~G-----T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                         +.-.|||+|||+++..-...+...+     ..+||+||.|+..+|++++||||+||+|||+++ |+.|+.+.+++++
T Consensus       638 ---e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  638 ---ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             ---cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence               7789999999999866544333332     577999999999999999999999999999998 9999999999998


Q ss_pred             HHHHHH
Q 003239          322 LRRMIR  327 (837)
Q Consensus       322 l~~I~~  327 (837)
                      ++.|.+
T Consensus       715 Ie~i~~  720 (774)
T KOG1026|consen  715 IECIRA  720 (774)
T ss_pred             HHHHHc
Confidence            887754

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-33  Score=295.81  Aligned_cols=192  Identities=22%  Similarity=0.265  Sum_probs=159.2

Q ss_pred             EEeccCCceeEEEeeccCCC----------eEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          115 DLLGHGTFGQVAKCWDAEMN----------SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg----------~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      +.||+|+||.||++.+..++          ..|++|+++........+.+|+.+++.+       .|+||+++++++.. 
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~-   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-------SHKHLVKLYGVCVR-   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-------CCcchhheeeEEec-
Confidence            36899999999999988776          4588898876544467788899998888       68999999999988 


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC----CCCeEEEEe
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV----KPAEIKIID  259 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~----~~~~IKL~D  259 (837)
                      ...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+.    ....+||+|
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence            78899999998 57777776543 3689999999999999999999999999999999999997322    112799999


Q ss_pred             cccccccCCcceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 003239          260 FGSACTEDRTVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFL-GLPLFPGA  316 (837)
Q Consensus       260 FGlA~~~~~~~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELlt-G~~PF~g~  316 (837)
                      ||++..... .....++..|+|||++.+.  .++.++|||||||++|||++ |..||...
T Consensus       152 fg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         152 PGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             CCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            999976543 2234567789999999876  78999999999999999999 57777554

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.8e-33  Score=301.33  Aligned_cols=201  Identities=22%  Similarity=0.226  Sum_probs=157.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCChhhH--HH-------HHHHHHHHHHhhcccCCCCCCcee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQPAYY--QQ-------ALVEVSILTTLNKKYDREDKHHIV  175 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~~~~~--~~-------~~~Ei~iL~~L~~~~~~~~HpnIV  175 (837)
                      .++|++.++||+|+||+||+|++..+   ++.+|+|+........  +.       ...++..+..+    ....|++|+
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~----~~~~h~~i~   86 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI----HNIDHLGIP   86 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh----ccCCCCCCC
Confidence            37999999999999999999998777   6778888754322110  10       01122222333    234799999


Q ss_pred             EEeEEEeecc----eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          176 RIYEYFVCQR----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       176 kl~d~f~~~~----~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      ++++++....    ..++++|++..++.+.+...  ...++..++.++.||+.||+|||+++|+||||||+|||++   .
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~  161 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---G  161 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence            9998766543    45788998887777766543  2467889999999999999999999999999999999995   5


Q ss_pred             CCeEEEEecccccccCC----------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          252 PAEIKIIDFGSACTEDR----------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~----------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .+.+||+|||+|+....          ......||+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            67899999999864321          1123468999999999999999999999999999999999999998763

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.8e-33  Score=295.01  Aligned_cols=203  Identities=27%  Similarity=0.432  Sum_probs=167.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC-----------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ-----------PAYYQQALVEVSILTTLNKKYDREDKHHIVRI  177 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~-tg~~VAIKiik~~-----------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl  177 (837)
                      .|++.+.||+|+||.||++++.. +++.+|+|.+...           .....++..|+.++.+.      ..|+||+++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~------~~h~~i~~~   74 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ------LRHPNIVRY   74 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc------CCCCCeeeE
Confidence            37889999999999999999887 6889999998632           22334456677766553      268999999


Q ss_pred             eEEEeecceEEEEEeccch-hHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCC
Q 003239          178 YEYFVCQRHLCICFELLDS-NLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       178 ~d~f~~~~~l~LVmEy~~g-sL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      ++++..++..++||||+.+ +|.+++...  ....+++..++.++.|++.+|.|||+ .+|+|+||||+||+++   ..+
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~  151 (269)
T cd08528          75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDD  151 (269)
T ss_pred             EeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCC
Confidence            9999999999999999974 787776442  23458999999999999999999996 7899999999999995   678


Q ss_pred             eEEEEecccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 003239          254 EIKIIDFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL  321 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~  321 (837)
                      .+||+|||.+......  .....++..|+|||.+.+..++.++|||||||++|+|++|++||........
T Consensus       152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~  221 (269)
T cd08528         152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL  221 (269)
T ss_pred             cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence            8999999999654332  2345678899999999988899999999999999999999999976554433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-34  Score=320.04  Aligned_cols=257  Identities=23%  Similarity=0.414  Sum_probs=205.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh----HHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~----~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      +.-|..++.||-|+||+|.+++...|...||+|.+++....    ...+..|-.||.+.       +.+=||+||-.|++
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-------Dn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-------DNEWVVRLYYSFQD  700 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-------CCcceEEEEEEecc
Confidence            45788999999999999999999999999999999865432    23455677777776       56679999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++.+|+||||+. |++..+|.+.  +-|+|..++.++.++..|+++.|+.|+|||||||+||||+   .+++|||+|||+
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID---rdGHIKLTDFGL  775 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGL  775 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc---cCCceeeeeccc
Confidence            999999999998 5777776554  4599999999999999999999999999999999999995   889999999999


Q ss_pred             cccc-----------CC----------------------------------cceeeccCccccCchhhcCCCCCccchHH
Q 003239          263 ACTE-----------DR----------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMW  297 (837)
Q Consensus       263 A~~~-----------~~----------------------------------~~~~~~GT~~Y~APEvl~~~~yt~ksDIW  297 (837)
                      +.-.           +.                                  .....+||+.|+|||++....|+..+|.|
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww  855 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW  855 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence            8310           00                                  01135789999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHH
Q 003239          298 SFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIE  377 (837)
Q Consensus       298 SLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~  377 (837)
                      |.|||||||+.|++||......+...+|                                               ++|..
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv-----------------------------------------------~nw~~  888 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKV-----------------------------------------------INWRN  888 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeee-----------------------------------------------eehhh
Confidence            9999999999999999776543322222                                               11111


Q ss_pred             HHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCC---CHHHHHcCccCC
Q 003239          378 YEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRW---SPFQASRHPFVT  454 (837)
Q Consensus       378 ~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRp---Ta~EaL~HPff~  454 (837)
                                             .+ .+|           ....++.++.|||.++ +.++++|+   -++|+..||||+
T Consensus       889 -----------------------~l-~~~-----------~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFk  932 (1034)
T KOG0608|consen  889 -----------------------FL-HIP-----------YQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFK  932 (1034)
T ss_pred             -----------------------cc-ccc-----------cccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCcccc
Confidence                                   00 111           1223567889999985 56999998   478899999999


Q ss_pred             CCCCC
Q 003239          455 GEPFT  459 (837)
Q Consensus       455 ~~~~~  459 (837)
                      +..|.
T Consensus       933 gIDfs  937 (1034)
T KOG0608|consen  933 GIDFS  937 (1034)
T ss_pred             ccchH
Confidence            98874

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.6e-33  Score=295.92  Aligned_cols=196  Identities=20%  Similarity=0.241  Sum_probs=159.5

Q ss_pred             EeccCCceeEEEeecc--CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          116 LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      .||+|+||.||+|...  .++..+|+|.++...  .....+.+|+.+++.+       .|+||+++++++......++||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~~lv~   74 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-------QHSNLLQCLGQCTEVTPYLLVM   74 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEcCCCCcEEEE
Confidence            5899999999999743  456789999987543  2334677899999888       6899999999999999999999


Q ss_pred             eccc-hhHHHHHHhhc---cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          192 ELLD-SNLYELIKINH---FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       192 Ey~~-gsL~d~l~~~~---~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||+. ++|.+++....   ...+++..++.++.||+.||+|||+++|+|+||||+||+++   ..+.+||+|||++....
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCcccccccc
Confidence            9998 68888886532   12467778889999999999999999999999999999996   56889999999986433


Q ss_pred             Ccc-----eeeccCccccCchhhcCC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          268 RTV-----YSYIQSRYYRSPEVLLGY-------QYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       268 ~~~-----~~~~GT~~Y~APEvl~~~-------~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      ...     ....++..|+|||++.+.       .++.++|||||||++|||++ |..||......+.
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  218 (269)
T cd05087         152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV  218 (269)
T ss_pred             CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence            221     123467789999998643       35789999999999999996 9999977655443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.8e-33  Score=294.49  Aligned_cols=195  Identities=23%  Similarity=0.349  Sum_probs=157.4

Q ss_pred             EEeccCCceeEEEeeccC---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe-ecceEE
Q 003239          115 DLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHLC  188 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-~~~~l~  188 (837)
                      +.||+|+||+||+|++..   ....||||.+...  ....+.+.+|+.+++.+       .|+||+++++++. .++..+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~~~   73 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-------SHPNVLSLLGICLPSEGSPL   73 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-------CCCCcceEEEEeecCCCCcE
Confidence            368999999999998643   3467999998642  33456777888888877       6899999999765 455789


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+|+||||||+|||++   ..+.+||+|||+++...
T Consensus        74 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          74 VVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIY  149 (262)
T ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCcccccccc
Confidence            9999997 68888876543 3467888899999999999999999999999999999995   56789999999986443


Q ss_pred             Cc-------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          268 RT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       268 ~~-------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      ..       .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~  210 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD  210 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            21       112244668999999988899999999999999999999 577786655443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=315.00  Aligned_cols=197  Identities=26%  Similarity=0.361  Sum_probs=171.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh-HHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-e
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-H  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~-~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-~  186 (837)
                      +.|.-..+||+|+||.||+|.... ++.||||.+...... ..++.+|+.+|.++       .|+|+|+|+++|.+.+ +
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-------~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRL-------RHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcC-------CCcCcccEEEEEecCCce
Confidence            678888899999999999997654 488999988865443 56699999999999       6899999999999998 5


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC---eeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG---IIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g---IVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+||+||+. |+|.+.+.......++|....+|+.++++||+|||...   |||||||++||||+   ++...||+|||+
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD---~~~~aKlsDFGL  223 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD---EDFNAKLSDFGL  223 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC---CCCCEEccCccC
Confidence            999999998 79998887654227899999999999999999999854   99999999999995   788999999999


Q ss_pred             ccccCC-cce--ee-ccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          263 ACTEDR-TVY--SY-IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       263 A~~~~~-~~~--~~-~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      |+.... ...  .. .||..|+|||.+.....+.|+|||||||+|.||++|+.+....
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            976543 222  22 7999999999999999999999999999999999999877543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-33  Score=297.53  Aligned_cols=197  Identities=29%  Similarity=0.389  Sum_probs=167.3

Q ss_pred             CceEEEEEeccCCceeEEEeecc----CCCeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA----EMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~----~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|++.+.||+|+||.||+++..    .+++.||||+++....  ..+.+.+|+++++.+       .|+||+++++++.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-------~~~~i~~~~~~~~   76 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-------DHENIVKYKGVCE   76 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-------CCCChheEEeeee
Confidence            67889999999999999999854    4588999999986544  467788999999988       6889999999988


Q ss_pred             e--cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 C--QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~--~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      .  ....++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++   .++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~d  152 (284)
T cd05038          77 KPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISD  152 (284)
T ss_pred             cCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcc
Confidence            7  568999999997 58888886543 3589999999999999999999999999999999999996   568899999


Q ss_pred             cccccccCCcce------eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          260 FGSACTEDRTVY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       260 FGlA~~~~~~~~------~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ||.+........      ....+..|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            999976542211      123355699999998889999999999999999999999988543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.6e-33  Score=293.45  Aligned_cols=200  Identities=22%  Similarity=0.337  Sum_probs=162.6

Q ss_pred             eEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          111 YIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      |++.+.||+|+||.||+|.+.   .+++.||||+++.+   ....+++.+|+++++.+       .|+||+++++++...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~   73 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-------DHPNVIKLIGVSLRS   73 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-------CCCCcceEEEEEccC
Confidence            567889999999999999754   35789999999753   34456778899999888       689999999988754


Q ss_pred             c------eEEEEEeccc-hhHHHHHHhhc----cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC
Q 003239          185 R------HLCICFELLD-SNLYELIKINH----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       185 ~------~l~LVmEy~~-gsL~d~l~~~~----~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      +      ..++++||+. ++|.+++....    ...+++..++.++.||+.||+|||+++|+||||||+||+++   .+.
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~  150 (273)
T cd05074          74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENM  150 (273)
T ss_pred             CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCC
Confidence            2      3478899987 67777664332    12478999999999999999999999999999999999995   567


Q ss_pred             eEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          254 EIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      .+||+|||+++......     ....++..|++||.+....++.++|||||||++|||++ |++||.+.+..+
T Consensus       151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~  223 (273)
T cd05074         151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE  223 (273)
T ss_pred             CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence            89999999987543221     12234567999999998899999999999999999999 899997765544

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.2e-33  Score=299.96  Aligned_cols=199  Identities=23%  Similarity=0.361  Sum_probs=164.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~----~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ..+|++.+.||+|+||.||++++..+++    .||+|++....  .....+.+|+.+++.+       .|+||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-------~h~niv~~~~~~   78 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-------DHPHLVRLLGVC   78 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCcccEEEEE
Confidence            3688999999999999999999877775    57889887542  3334677888888888       689999999988


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      ... ..++|+||+. |+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||+++   .++.+||+||
T Consensus        79 ~~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Df  153 (303)
T cd05110          79 LSP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDF  153 (303)
T ss_pred             cCC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEccc
Confidence            754 5779999997 68888876543 3589999999999999999999999999999999999995   5678999999


Q ss_pred             ccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          261 GSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       261 GlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++.......     ....++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~  217 (303)
T cd05110         154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT  217 (303)
T ss_pred             cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9997543221     12234678999999998899999999999999999997 8999976543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=318.11  Aligned_cols=207  Identities=27%  Similarity=0.418  Sum_probs=176.8

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCe---E-EEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNS---F-VAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~---~-VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      +-.+.++||+|+||.||+|..+..+.   . ||||..+.    ......++++|.++|+++       +|+|||++|++.
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-------~H~NVVr~yGVa  230 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-------NHPNVVRFYGVA  230 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEE
Confidence            44556899999999999998665422   3 89999984    245677899999999999       789999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      ..+..++||||+|. |+|.++++... ..++..+...++.+.+.||+|||++++|||||-.+|+|++   .+..+||+||
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDF  306 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDF  306 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCcc
Confidence            99999999999998 59999998875 3699999999999999999999999999999999999996   5567899999


Q ss_pred             ccccccCCcce---eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003239          261 GSACTEDRTVY---SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       261 GlA~~~~~~~~---~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~  327 (837)
                      |+++.......   ...-...|+|||.+....|+.++|||||||++||+++ |..||++....+...+|..
T Consensus       307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~  377 (474)
T KOG0194|consen  307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK  377 (474)
T ss_pred             ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence            99976542111   1123577999999999999999999999999999998 8889999988877777643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=9.3e-34  Score=308.29  Aligned_cols=302  Identities=26%  Similarity=0.406  Sum_probs=216.9

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~---tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ..+.|.++++||+|+|++||++.+..   ..+.||+|.+.... ....+.+|+++|..+.      ++.||+++.+++..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~g------G~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLG------GSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhc------cchhhhcchhhhcc
Confidence            34789999999999999999999887   78999999997543 2466889999999996      67899999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++..++||||++. ...+++.     .++..+++.+++.++.||.++|.+|||||||||.|+|.+  ...+.-.|+|||+
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGL  179 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechh
Confidence            9999999999986 4555543     377899999999999999999999999999999999997  5677889999999


Q ss_pred             ccc-----------c------CC------------------------------cceeeccCccccCchhhcCC-CCCccc
Q 003239          263 ACT-----------E------DR------------------------------TVYSYIQSRYYRSPEVLLGY-QYTTAI  294 (837)
Q Consensus       263 A~~-----------~------~~------------------------------~~~~~~GT~~Y~APEvl~~~-~yt~ks  294 (837)
                      |..           .      ..                              ......||++|+|||++... ..++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            830           0      00                              00124689999999999876 578999


Q ss_pred             hHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhh
Q 003239          295 DMWSFGCIVAELFLGLPLF-PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQAL  373 (837)
Q Consensus       295 DIWSLG~ILyELltG~~PF-~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~  373 (837)
                      ||||.|+|+..+++++.|| ...++.+.+.+|..++|   +..|.+.    .....+.. +..    .      ..+-..
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG---~~~mrk~----A~l~g~~~-l~~----k------sn~~~~  321 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFG---SAEMRKC----AALPGRIL-LWQ----K------SNIPTI  321 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhC---hHHHHHH----hhcCCcee-eec----c------cccccc
Confidence            9999999999999998776 55677888999999888   2223222    11111100 000    0      000000


Q ss_pred             hHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          374 TEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       374 s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                      .+.....+..             ..+.+ ...... +...+  ......+..+.|||.+||+.||.+|+||+++|+||||
T Consensus       322 ~e~~~~f~s~-------------~~~~~-~~~~q~-n~~~~--~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF  384 (418)
T KOG1167|consen  322 PELRVNFETL-------------HIESI-YKSRQP-NTERE--IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF  384 (418)
T ss_pred             HHHHhchhcc-------------Chhhc-cccccc-ceeec--cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence            0000000000             00000 000000 00000  0111234588999999999999999999999999999


Q ss_pred             CCCC
Q 003239          454 TGEP  457 (837)
Q Consensus       454 ~~~~  457 (837)
                      +...
T Consensus       385 ~~~~  388 (418)
T KOG1167|consen  385 DEAD  388 (418)
T ss_pred             cchh
Confidence            9643

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.2e-32  Score=290.37  Aligned_cols=200  Identities=20%  Similarity=0.263  Sum_probs=159.4

Q ss_pred             EeccCCceeEEEeeccCC--CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          116 LLGHGTFGQVAKCWDAEM--NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~t--g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      +||+|+||+||+++....  ...+++|.++..  ....+.+.+|+.+++.+       +||||+++++.+......|+||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-------~h~~iv~~~~~~~~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-------QHPNILQCLGQCVEAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-------CCcchhheEEEecCCCccEEEE
Confidence            599999999999964433  345677776643  23456788888888877       6899999999999999999999


Q ss_pred             eccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          192 ELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       192 Ey~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      ||+. ++|.+++....  ...+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++.....
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCc
Confidence            9998 58988887542  23467788899999999999999999999999999999995   678899999999853211


Q ss_pred             -----cceeeccCccccCchhhcC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          269 -----TVYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       269 -----~~~~~~GT~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                           .....+++..|+|||++..       ..++.++|||||||++|||++ +..||...++.+.+..+
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~  221 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV  221 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence                 1223467888999999853       246789999999999999997 57888776665554443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-33  Score=333.34  Aligned_cols=210  Identities=25%  Similarity=0.405  Sum_probs=180.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t-----g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      ....++.+.||+|.||.||.|....-     ...||||.+++.  .....++++|..+|.++       +|||||+++++
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-------~HpNiv~liGv  763 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-------DHPNIVSLIGV  763 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-------CCcceeeEEEe
Confidence            46788899999999999999975433     235999999864  56778899999999999       78999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc-----cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH-----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~-----~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                      +.+....+|++|||. |+|+.+|++.+     ...++..++..|+.||++|+.||+++++|||||..+|+||+   ....
T Consensus       764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~  840 (1025)
T KOG1095|consen  764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRV  840 (1025)
T ss_pred             ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCc
Confidence            999999999999998 69999998873     23589999999999999999999999999999999999996   6689


Q ss_pred             EEEEecccccccCCcceee-----ccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003239          255 IKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       255 IKL~DFGlA~~~~~~~~~~-----~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~  327 (837)
                      +||+|||+|+.........     .-...|||||.+....++.|+|||||||+|||+++ |..||+..++.+++..+.+
T Consensus       841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~  919 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE  919 (1025)
T ss_pred             EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence            9999999998543332222     22467999999999999999999999999999998 9999999988887765544

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=306.29  Aligned_cols=261  Identities=27%  Similarity=0.443  Sum_probs=207.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      .++|-++.+||+|+|+.||+|.+...+++||||+-...        ..+.+.+.+|..|.+.|       +||.||++||
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-------DHpRIVKlYD  534 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-------DHPRIVKLYD  534 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-------Ccceeeeeee
Confidence            47999999999999999999999999999999997532        34456678899998888       8999999999


Q ss_pred             EEeec-ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC--CeeeccCCCCCeeeeccCCCCeEE
Q 003239          180 YFVCQ-RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--GIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       180 ~f~~~-~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~--gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                      +|..+ +.+|-|+|||+|+-+|+..+.. +-++|.+++.|+.||+.||.||.+.  -|||-||||.|||+......+.||
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            99865 6799999999997667665544 4699999999999999999999976  599999999999998767788999


Q ss_pred             EEecccccccCCcc----------eeeccCccccCchhhcCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 003239          257 IIDFGSACTEDRTV----------YSYIQSRYYRSPEVLLGY----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL  322 (837)
Q Consensus       257 L~DFGlA~~~~~~~----------~~~~GT~~Y~APEvl~~~----~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l  322 (837)
                      |+|||+++..+...          ....||.||++||.+.-.    ..+.|+||||+|||+|..+.|+.||...-.   .
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---Q  690 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---Q  690 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---H
Confidence            99999997654322          235789999999998643    578899999999999999999999965422   1


Q ss_pred             HHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHH
Q 003239          323 RRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV  402 (837)
Q Consensus       323 ~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il  402 (837)
                      +.|++.-.      +++                   +                             .+.           
T Consensus       691 QdILqeNT------Ilk-------------------A-----------------------------tEV-----------  705 (775)
T KOG1151|consen  691 QDILQENT------ILK-------------------A-----------------------------TEV-----------  705 (775)
T ss_pred             HHHHhhhc------hhc-------------------c-----------------------------eec-----------
Confidence            12222100      000                   0                             001           


Q ss_pred             hcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       403 ~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                       .||..           +..+.++.+||++||.+.-++|+...|+..||||.-.
T Consensus       706 -qFP~K-----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  706 -QFPPK-----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             -cCCCC-----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence             12211           1245788999999999999999999999999999763

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=293.45  Aligned_cols=196  Identities=22%  Similarity=0.415  Sum_probs=174.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|.++++||+|+|++|.+++.++|.+.+|+|++|+    +....+....|..+..+..      +||.+|-++.+|+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as------n~pflvglhscfqt  322 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS------NNPFLVGLHSCFQT  322 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc------CCCeEEehhhhhcc
Confidence            3789999999999999999999999999999999985    3445566667777777664      78999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      +..+++|.||++| +|.-.+++.  +.++|+.++.+..+|+.||.|||++|||.||||.+|||++   ..++|||+|+|+
T Consensus       323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld---aeghikltdygm  397 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGM  397 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc---cCCceeecccch
Confidence            9999999999985 554333333  4699999999999999999999999999999999999995   889999999999


Q ss_pred             ccc---cCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 003239          263 ACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       263 A~~---~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      ++.   ......++|||+.|.|||++++..|...+|.|+|||+|+||+.|+.||.
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence            964   3556678899999999999999999999999999999999999999994

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=295.40  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=206.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +..+-+..||.|+||+|++..++.+|+..|||.|+..  ....++++.|.+...+-      .++||||++|+....++.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks------~~cp~IVkfyGa~F~EGd  137 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS------SNCPNIVKFYGALFSEGD  137 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh------cCCcHHHHHhhhhhcCCc
Confidence            3444566899999999999999999999999999854  34556677777765554      378999999999999999


Q ss_pred             EEEEEeccchhHHHHHH---hhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          187 LCICFELLDSNLYELIK---INHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~---~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .||.||+|+-+|..+.+   .-....++|..+-.|....+.||.||.+ ..||||||||+|||++   ..+.|||||||.
T Consensus       138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld---r~G~vKLCDFGI  214 (361)
T KOG1006|consen  138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD---RHGDVKLCDFGI  214 (361)
T ss_pred             eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe---cCCCEeeecccc
Confidence            99999999976554443   2334569999999999999999999985 5899999999999995   789999999999


Q ss_pred             ccccCCcc--eeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          263 ACTEDRTV--YSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       263 A~~~~~~~--~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +-+.....  ....|.+.|||||.+...  .|+.++||||||++|||+.||..|+.+-+.  ++.++..+.-..||.-..
T Consensus       215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC
Confidence            97654432  345788999999999754  599999999999999999999999976533  444444433323332100


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                      .                                                                             .+
T Consensus       293 ~-----------------------------------------------------------------------------~~  295 (361)
T KOG1006|consen  293 D-----------------------------------------------------------------------------KE  295 (361)
T ss_pred             c-----------------------------------------------------------------------------cc
Confidence            0                                                                             00


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ....+..+++||.-||..|-.+||.-.+++++||++.-.
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            112457789999999999999999999999999998643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.6e-33  Score=331.02  Aligned_cols=189  Identities=33%  Similarity=0.517  Sum_probs=156.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      .+|+.++.||+|+||.||+|+++-+|+.||||+|...  .....++.+|+.+|.+|       +|||||+++..+.+   
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-------nHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-------NHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-------CCcceeeeehhhhccCC
Confidence            5788889999999999999999999999999999865  45567788999999999       68899998852211   


Q ss_pred             --------------------------------------------------------------------------------
Q 003239          184 --------------------------------------------------------------------------------  183 (837)
Q Consensus       184 --------------------------------------------------------------------------------  183 (837)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------c--------ceEEEEEeccchhHH-HHHHhhccCCCCHHHHHHHHHhHHHHH
Q 003239          184 ----------------------------Q--------RHLCICFELLDSNLY-ELIKINHFRGLSLSIVQLFSKQILRGL  226 (837)
Q Consensus       184 ----------------------------~--------~~l~LVmEy~~gsL~-d~l~~~~~~~L~e~~i~~I~~QIl~aL  226 (837)
                                                  +        -.+||-||||+.+++ +++..+... -....++++++||++||
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGL  710 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHH
Confidence                                        0        137899999997555 455544321 14778999999999999


Q ss_pred             hhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC---------------------CcceeeccCccccCchhh
Q 003239          227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---------------------RTVYSYIQSRYYRSPEVL  285 (837)
Q Consensus       227 ~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~---------------------~~~~~~~GT~~Y~APEvl  285 (837)
                      .|+|+.|||||||||.||+++   ..+.|||+|||+|+...                     ...+..+||..|+|||++
T Consensus       711 aYIH~~giIHRDLKP~NIFLd---~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHDQGIIHRDLKPRNIFLD---SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHhCceeeccCCcceeEEc---CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            999999999999999999996   77899999999996410                     023456899999999999


Q ss_pred             cCC---CCCccchHHHHHHHHHHHHh
Q 003239          286 LGY---QYTTAIDMWSFGCIVAELFL  308 (837)
Q Consensus       286 ~~~---~yt~ksDIWSLG~ILyELlt  308 (837)
                      .+.   .|+.|+||||||+||+||+.
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc
Confidence            765   49999999999999999984

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=7.6e-33  Score=316.10  Aligned_cols=200  Identities=28%  Similarity=0.411  Sum_probs=172.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      .-|...+.||+|+||.||+++++++|+.||||.+++.  ....+...+|+++|++|       .|+|||+++++-+..  
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-------nh~NIVk~f~iee~~~~   85 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-------NHPNIVKLFDIEETKFL   85 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-------CchhhhhhcccCCcccc
Confidence            4566778999999999999999999999999999863  34467788999999999       578999999976654  


Q ss_pred             ----ceEEEEEeccc-hhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC-CCCeEEE
Q 003239          185 ----RHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKI  257 (837)
Q Consensus       185 ----~~l~LVmEy~~-gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~IKL  257 (837)
                          +...+|||||. |+|+..+.... ..+|++.+++.++..+..||.|||++|||||||||+||++-... ..-..||
T Consensus        86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence                36789999998 68888887543 45799999999999999999999999999999999999996443 3334599


Q ss_pred             EecccccccC--CcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          258 IDFGSACTED--RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       258 ~DFGlA~~~~--~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      +|||.|+..+  ......+||..|.+||++.. ..|+..+|.|||||++|+.+||..||.-
T Consensus       166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999998764  44667899999999999995 7899999999999999999999999954

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=1.5e-31  Score=274.04  Aligned_cols=184  Identities=40%  Similarity=0.672  Sum_probs=161.8

Q ss_pred             CceeEEEeeccCCCeEEEEEEEeCChhh--HHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccch-h
Q 003239          121 TFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-N  197 (837)
Q Consensus       121 ~fG~Vyka~~~~tg~~VAIKiik~~~~~--~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-s  197 (837)
                      +||.||+|++..+++.||+|++......  .+.+.+|+++++++       .|+||+++++++......++|||++.+ +
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-------KHPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-------CCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            5899999999988999999999854322  57788899999888       688999999999999999999999986 8


Q ss_pred             HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC--cceeecc
Q 003239          198 LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQ  275 (837)
Q Consensus       198 L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~--~~~~~~G  275 (837)
                      |.+++....  .+++..+..++.+++.+|.+||+.+|+|+||+|.||+++   ..+.++|+|||.+.....  ......+
T Consensus        74 L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~  148 (244)
T smart00220       74 LFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVG  148 (244)
T ss_pred             HHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccC
Confidence            988887643  389999999999999999999999999999999999996   558999999999976544  3345577


Q ss_pred             CccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       276 T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      +..|++||.+.+..++.++|||+||+++++|++|..||...
T Consensus       149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~  189 (244)
T smart00220      149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD  189 (244)
T ss_pred             CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            88999999999888999999999999999999999999763

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=302.63  Aligned_cols=204  Identities=21%  Similarity=0.355  Sum_probs=183.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      .+.++..+||-|.||.||.+.+++-...||||.++.+....++|+.|..+|+.+       .|||+|+|+++|..+-.+|
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-------kHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-------cCccHHHHhhhhccCCCeE
Confidence            355677899999999999999999999999999999999999999999999999       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||.|||. |+|+++++..+...++.-.+..++.||..|++||..+++|||||...|+|+.   ++..||++|||+++...
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhc
Confidence            9999997 8999999998877888889999999999999999999999999999999995   77889999999998765


Q ss_pred             Cccee-ecc---CccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          268 RTVYS-YIQ---SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       268 ~~~~~-~~G---T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      ...++ ..|   ...|.|||-+.-+.++.|+|||+|||+|||+.| |..||++-+-..++
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY  476 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  476 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH
Confidence            44333 334   456999999999999999999999999999998 99999987654443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-32  Score=305.08  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=208.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC-C--eEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM-N--SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t-g--~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++.++.++||+|.||.|+++.+... |  ..||||+++.+.  .....|++|+.+|.+|       .|+|+++||++..+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-------~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-------QHPHLIRLYGVVLD  182 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-------cCcceeEEeeeecc
Confidence            5667788999999999999976543 3  369999998653  3578899999999999       68999999999987


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                       ..+.+|||++. |+|++.+.+.....|....+..++.||+.||.||..+++|||||...||||.   ....|||+|||+
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGL  258 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGL  258 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccc
Confidence             67889999998 7999999885556789999999999999999999999999999999999996   577899999999


Q ss_pred             ccccCCcceeec------cCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          263 ACTEDRTVYSYI------QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       263 A~~~~~~~~~~~------GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      .+........|+      -...|+|||.+....++.++|||++||+||||++ |+-||.+....+++++|-+  |     
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--~-----  331 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--G-----  331 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--c-----
Confidence            987654433332      2455999999999999999999999999999998 8999999988777766532  1     


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                                                                                                    |.
T Consensus       332 ------------------------------------------------------------------------------er  333 (1039)
T KOG0199|consen  332 ------------------------------------------------------------------------------ER  333 (1039)
T ss_pred             ------------------------------------------------------------------------------cc
Confidence                                                                                          00


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      +.....+++++.++++.|+..+|++|||...|.+.-++.+
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            0011125678899999999999999999998876656554

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=305.44  Aligned_cols=199  Identities=30%  Similarity=0.472  Sum_probs=169.5

Q ss_pred             EEEEEeccCCceeEEEeeccC--CC--eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          112 IVKDLLGHGTFGQVAKCWDAE--MN--SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       112 ~i~~~LG~G~fG~Vyka~~~~--tg--~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++.++||.|.||.||++....  .|  -.||||..|.+  ....+.++.|..+|+++       +|||||++++++.+ .
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-------dHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-------DHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-------CCcchhheeeeeec-c
Confidence            344589999999999997432  23  35999999963  56688999999999999       89999999999875 5


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..|||||++. |.|..+++.+. ..++...+..++.||+.||+|||+.++|||||...|||+.   ....|||+|||+++
T Consensus       464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSR  539 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhh
Confidence            7899999998 89999998765 5699999999999999999999999999999999999996   67889999999998


Q ss_pred             ccCCcceee----ccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          265 TEDRTVYSY----IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       265 ~~~~~~~~~----~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      .........    .-...|||||.+.-..++.++|||.|||+|||++. |..||.+-.+.+++
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI  602 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI  602 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence            766543221    22556999999999999999999999999999996 99999886655543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=5.1e-31  Score=304.82  Aligned_cols=205  Identities=21%  Similarity=0.335  Sum_probs=148.7

Q ss_pred             ccCCceEEEEEeccCCceeEEEeecc----------------CCCeEEEEEEEeCChh-hHH--------------HHHH
Q 003239          106 ETQRRYIVKDLLGHGTFGQVAKCWDA----------------EMNSFVAVKIIKNQPA-YYQ--------------QALV  154 (837)
Q Consensus       106 ~~~~~Y~i~~~LG~G~fG~Vyka~~~----------------~tg~~VAIKiik~~~~-~~~--------------~~~~  154 (837)
                      ...++|++.++||+|+||+||++...                ..++.||||.++.... ..+              ....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34579999999999999999998642                3456799999875321 112              2334


Q ss_pred             HHHHHHHhhcccCCCCCCceeEEeEEEee--------cceEEEEEeccc-hhHHHHHHhhc-------------------
Q 003239          155 EVSILTTLNKKYDREDKHHIVRIYEYFVC--------QRHLCICFELLD-SNLYELIKINH-------------------  206 (837)
Q Consensus       155 Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--------~~~l~LVmEy~~-gsL~d~l~~~~-------------------  206 (837)
                      |+.++.++++.  ...+.++++++++|..        ++..+|||||+. ++|.+++....                   
T Consensus       222 E~~~l~~l~~~--~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        222 EAYMCAKIKRN--PIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHhhcc--cchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            66666666431  1123456777777653        356899999998 57877775321                   


Q ss_pred             ---cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcc--e--eeccCccc
Q 003239          207 ---FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV--Y--SYIQSRYY  279 (837)
Q Consensus       207 ---~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~--~--~~~GT~~Y  279 (837)
                         ...+++..++.++.||+.+|.|||+.+|+||||||+|||++   .++.+||+|||++.......  .  ....++.|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y  376 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY  376 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence               11246778999999999999999999999999999999996   56789999999996533211  1  12347899


Q ss_pred             cCchhhcCCC--------------------CC--ccchHHHHHHHHHHHHhCCC-CCCC
Q 003239          280 RSPEVLLGYQ--------------------YT--TAIDMWSFGCIVAELFLGLP-LFPG  315 (837)
Q Consensus       280 ~APEvl~~~~--------------------yt--~ksDIWSLG~ILyELltG~~-PF~g  315 (837)
                      +|||++....                    |.  .+.||||+|||+|+|+++.. ||..
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            9999986432                    12  24799999999999999875 6643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=298.23  Aligned_cols=210  Identities=25%  Similarity=0.364  Sum_probs=177.2

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ...+..++++||+|.||.|.+|+- ..+.+||||+++.+.  .....+.+|+++|.+|       .|||||+|+++|..+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-------khPNIveLvGVC~~D  607 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-------KHPNIVELLGVCVQD  607 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-------CCCCeeEEEeeeecC
Confidence            346889999999999999999964 336899999998643  3357899999999999       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+|+||++ |+|.+++..+....+.-.....|+.||+.||+||.+.++|||||.+.|+|++   .+.++||+|||++
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgms  684 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMS  684 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCcccc
Confidence            99999999998 8999999988543345556677999999999999999999999999999995   8899999999999


Q ss_pred             cccCCccee-----eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHH
Q 003239          264 CTEDRTVYS-----YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       264 ~~~~~~~~~-----~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt--G~~PF~g~s~~e~l~~I~~  327 (837)
                      +..-.....     .+-...|||+|.+...+++.++|+|+||+++||+++  ...||....+++.++..-+
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~  755 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE  755 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh
Confidence            854433222     234678999999999999999999999999999875  6889977776665554443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=8e-32  Score=311.28  Aligned_cols=192  Identities=27%  Similarity=0.351  Sum_probs=158.0

Q ss_pred             EEeccCCcee-EEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEec
Q 003239          115 DLLGHGTFGQ-VAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL  193 (837)
Q Consensus       115 ~~LG~G~fG~-Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy  193 (837)
                      +.+|.|+-|+ ||++.  -.++.||||.+-.  ....-+.+|+..|+.-.      .|+|||++++.=.+...+||+.|+
T Consensus       515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~--e~~~~A~rEi~lL~eSD------~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGV--YEGREVAVKRLLE--EFFDFAQREIQLLQESD------EHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             HHcccCCCCcEEEEEe--eCCceehHHHHhh--HhHHHHHHHHHHHHhcc------CCCceEEEEeeccCCceEEEEehH
Confidence            5689999876 68884  4578999998864  33456788999998874      799999999999999999999999


Q ss_pred             cchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC--CCCeEEEEecccccccCCc
Q 003239          194 LDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTEDRT  269 (837)
Q Consensus       194 ~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~IKL~DFGlA~~~~~~  269 (837)
                      |..+|.+++...  ..........+.++.|+++||++||+.+||||||||.||||...+  ....++|+|||+++.....
T Consensus       585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            999999999874  111112245688999999999999999999999999999998532  3467899999999765432


Q ss_pred             ------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CCCCCCC
Q 003239          270 ------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGA  316 (837)
Q Consensus       270 ------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~PF~g~  316 (837)
                            .....||-+|+|||++....-+.++||+|||||+|..++| ..||...
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence                  3345789999999999998888899999999999999985 9999543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=303.82  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=216.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ....+|.++||.|.||.|++++.+..+   ..||||.+|..  +....+|+.|..||-++       +||||++|-++..
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-------dHPNIIrLEGVVT  700 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-------DHPNIIRLEGVVT  700 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-------CCCcEEEEEEEEe
Confidence            356788999999999999999887665   46999999963  45567899999999999       8999999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+.+.||.|||+ |.|..+|+.+. +.|+..++.-+++.|+.|++||-+.++|||||...||||+   .+-.+|++|||
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN---snLvCKVsDFG  776 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN---SNLVCKVSDFG  776 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---cceEEEecccc
Confidence            9999999999998 78888888876 5599999999999999999999999999999999999995   77889999999


Q ss_pred             cccccCCcceee---cc---CccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          262 SACTEDRTVYSY---IQ---SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       262 lA~~~~~~~~~~---~G---T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      +++...+.....   .|   ...|.|||.|...+++.++||||+|++|||.+. |..||...++.+++..|.+....+||
T Consensus       777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP  856 (996)
T KOG0196|consen  777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP  856 (996)
T ss_pred             ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence            998764443222   11   467999999999999999999999999999886 99999999999999999886663332


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                                                                                                      
T Consensus       857 --------------------------------------------------------------------------------  856 (996)
T KOG0196|consen  857 --------------------------------------------------------------------------------  856 (996)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcC--ccCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH--PFVTG  455 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~H--Pff~~  455 (837)
                           .+++..+..|+..|+++|-.+||+..||+.+  ..+++
T Consensus       857 -----mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  857 -----MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             -----CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                 1245678999999999999999999999863  45544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=1.7e-29  Score=315.18  Aligned_cols=186  Identities=19%  Similarity=0.243  Sum_probs=154.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ..|+..+.||+|+||.||+|++..+++.||||+++....   ....|+++++++       +|||||++++++...+..|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l-------~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL-------QHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC-------CCCCcceEEEEEEcCCCCE
Confidence            456677899999999999999989999999999975432   123467777777       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh---cCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK---DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH---s~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +||||+. ++|.++++     .+++..+..++.||++||+|||   +.+|+||||||+||+++   .....++. |+.+.
T Consensus       760 lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~  830 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPG  830 (968)
T ss_pred             EEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccc
Confidence            9999997 68888874     3889999999999999999999   67999999999999996   33444543 55443


Q ss_pred             ccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 003239          265 TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      .... .....++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       831 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        831 LLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             cccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            2211 123367899999999999999999999999999999999999984

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-30  Score=286.33  Aligned_cols=197  Identities=27%  Similarity=0.473  Sum_probs=176.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHH---------HHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ---------ALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~---------~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ..|..++.+|+|+||.|++|.++++...|+||.|.+++...+.         +-.||+||..|++.    .|+||+++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~----sH~NIlKlLd  636 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH----SHENILKLLD  636 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc----Cccchhhhhh
Confidence            4699999999999999999999999999999999876543333         33599999999765    7999999999


Q ss_pred             EEeecceEEEEEeccc-h-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          180 YFVCQRHLCICFELLD-S-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      +|++++++||+||--+ | +|.++|..+.  .++|.+++.|++||+.|+++||+.||||||||-+||.++   .++.+||
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd---~~g~~kl  711 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD---SNGFVKL  711 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEe---cCCeEEE
Confidence            9999999999999987 4 8999988764  699999999999999999999999999999999999995   8899999


Q ss_pred             Eeccccccc-CCcceeeccCccccCchhhcCCCCC-ccchHHHHHHHHHHHHhCCCCCC
Q 003239          258 IDFGSACTE-DRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       258 ~DFGlA~~~-~~~~~~~~GT~~Y~APEvl~~~~yt-~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      +|||.|... ......++||..|.|||++.+.+|- ..-|||+||++||.++....||.
T Consensus       712 idfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999998654 5566788999999999999999875 57999999999999999998885

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-31  Score=298.16  Aligned_cols=258  Identities=28%  Similarity=0.454  Sum_probs=211.5

Q ss_pred             ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       106 ~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      +.+++|+++..+|.|+||.||+++++.+++..|+|+++... ....-...|+-+++..       .|+|||.+++.+...
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-------~h~nivay~gsylr~   84 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-------RHPNIVAYFGSYLRR   84 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-------CCcChHHHHhhhhhh
Confidence            56689999999999999999999999999999999999764 3455566788888777       689999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.++|+||||++ +|.+...-  ...++|.++..++++.+++|+|||+.|-+|||||-.|||++   +.+.+||+|||.+
T Consensus        85 dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvs  159 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVS  159 (829)
T ss_pred             cCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCch
Confidence            999999999985 66655433  35799999999999999999999999999999999999996   7789999999998


Q ss_pred             cccCCc---ceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          264 CTEDRT---VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       264 ~~~~~~---~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      .+....   ...++||++|||||+..   ...|...+|||++|++..|+-.-++|.........+..+.+. +..||.  
T Consensus       160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-~~qpp~--  236 (829)
T KOG0576|consen  160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-GFQPPT--  236 (829)
T ss_pred             hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-CCCCCc--
Confidence            765543   34679999999999874   447999999999999999999888776544443333332221 111110  


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                                    +.
T Consensus       237 ------------------------------------------------------------------------------lk  238 (829)
T KOG0576|consen  237 ------------------------------------------------------------------------------LK  238 (829)
T ss_pred             ------------------------------------------------------------------------------cc
Confidence                                                                                          01


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ....+++.|.+|++.+|..+|++|||++.+|+|||+.+.
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            112366889999999999999999999999999999874

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-29  Score=272.63  Aligned_cols=191  Identities=26%  Similarity=0.316  Sum_probs=159.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---  185 (837)
                      ...++.++||+|.||.||+|+.  +++.||||++...  ..+.+..|-+|......     .|+||++++..-....   
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m-----~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPGM-----KHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHH--HHHHHHhHHHHHhccCc-----cchhHHHhhchhccCCccc
Confidence            4556788999999999999954  4699999999743  45678889888887754     6999999998765544   


Q ss_pred             -eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC---------CeeeccCCCCCeeeeccCCCCe
Q 003239          186 -HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA---------GIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       186 -~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~---------gIVHrDLKPeNILl~~~~~~~~  254 (837)
                       .++||+||.. |+|.++++.+.   +++....+|+..|++||+|||+.         .|+|||||..||||.   .+.+
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---~DlT  354 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---NDLT  354 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc---cCCc
Confidence             8999999997 89999999875   99999999999999999999953         599999999999996   7789


Q ss_pred             EEEEecccccccC-----CcceeeccCccccCchhhcCC-CCC-----ccchHHHHHHHHHHHHhCCCCCC
Q 003239          255 IKIIDFGSACTED-----RTVYSYIQSRYYRSPEVLLGY-QYT-----TAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       255 IKL~DFGlA~~~~-----~~~~~~~GT~~Y~APEvl~~~-~yt-----~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      ..|+|||+|....     ......+||.+|||||++.+. .+.     .++||||+|.|||||++....+.
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~  425 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD  425 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            9999999996433     122336899999999999875 233     47999999999999999876553

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=251.90  Aligned_cols=210  Identities=22%  Similarity=0.389  Sum_probs=176.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      +....+..||+|+||.|-+.++..+|...|+|.++..  ....++.++|+.+....      ..+|.+|++|+.+..+..
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~------~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT------VDCPFTVHFYGALFREGD  119 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC------CCCCeEEEeehhhhcccc
Confidence            5666678899999999999999999999999999843  34455566677665443      479999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          187 LCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ++|.||.|..+|..+.++-  ..+.++|..+-+|+..++.||.|||++ .|||||+||.|||++   ..+++|+||||.+
T Consensus       120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn---~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN---YDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc---cCCcEEEcccccc
Confidence            9999999998877665542  235699999999999999999999965 899999999999995   7899999999999


Q ss_pred             cccCCccee--eccCccccCchhhcCC----CCCccchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q 003239          264 CTEDRTVYS--YIQSRYYRSPEVLLGY----QYTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIR  327 (837)
Q Consensus       264 ~~~~~~~~~--~~GT~~Y~APEvl~~~----~yt~ksDIWSLG~ILyELltG~~PF~g-~s~~e~l~~I~~  327 (837)
                      -...+....  ..|...|||||.+...    .|+.++||||||+++.||.+++.||.. .++++++.++++
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            765544322  4677889999998643    799999999999999999999999964 578888888877

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4e-28  Score=288.33  Aligned_cols=200  Identities=28%  Similarity=0.436  Sum_probs=168.4

Q ss_pred             CceEEEEEeccCCceeEEEeecc----C---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA----E---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~----~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ++.++.+.||+|.||+|+++...    .   ....||||.++..  ....+.+..|+++|+.+.      .|+||+.+++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g------~H~niv~llG  369 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG------KHPNIVNLLG  369 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc------CCcchhhhee
Confidence            34467779999999999998632    1   2567999999853  345678899999999996      5999999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhc------c--------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINH------F--------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~------~--------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      ++...+.+++|+||+. |+|+++++..+      .        ..++..++..++.||+.|++||+++.+|||||..+||
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence            9999999999999998 89999998765      0        1288999999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCcc-eeec-----cCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRTV-YSYI-----QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~~-~~~~-----GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      |++   ++..+||+|||+|+...... ....     -...|||||.+....|+.++||||+|++||||++ |..||++-.
T Consensus       450 Li~---~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  450 LIT---KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             Eec---CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            996   66889999999998543322 2211     1344999999999999999999999999999998 899998743

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.7e-28  Score=262.90  Aligned_cols=191  Identities=25%  Similarity=0.349  Sum_probs=159.2

Q ss_pred             eccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       103 ~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ...+..++.++++.||+|.||.||++..  .|+.||||++...+  .....+|.+|.+.+.-     .|+||+.++..-.
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd--E~SWfrEtEIYqTvmL-----RHENILgFIaaD~  275 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD--ERSWFRETEIYQTVML-----RHENILGFIAADN  275 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc--hhhhhhHHHHHHHHHh-----ccchhhhhhhccc
Confidence            3445568899999999999999999955  48899999998543  3567789999988743     6999999998655


Q ss_pred             ec----ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC--------CeeeccCCCCCeeeecc
Q 003239          183 CQ----RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--------GIIHCDLKPENILLCTS  249 (837)
Q Consensus       183 ~~----~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~--------gIVHrDLKPeNILl~~~  249 (837)
                      .+    ..++||.+|.+ |+|+|++....   ++.+...+++..++.||++||..        .|.|||||..||||.  
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK--  350 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK--  350 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc--
Confidence            44    36999999998 89999998854   99999999999999999999942        499999999999996  


Q ss_pred             CCCCeEEEEeccccccc-------CCcceeeccCccccCchhhcCC----CCC--ccchHHHHHHHHHHHHh
Q 003239          250 VKPAEIKIIDFGSACTE-------DRTVYSYIQSRYYRSPEVLLGY----QYT--TAIDMWSFGCIVAELFL  308 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~-------~~~~~~~~GT~~Y~APEvl~~~----~yt--~ksDIWSLG~ILyELlt  308 (837)
                       +++.+.|+|+|+|...       +......+||..|||||++...    .+.  ..+||||||.|+||++.
T Consensus       351 -kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  351 -KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             -cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence             7899999999999543       2334567999999999999654    122  46999999999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1e-26  Score=231.28  Aligned_cols=179  Identities=39%  Similarity=0.598  Sum_probs=157.2

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEecc
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL  194 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~  194 (837)
                      ||+|.+|.||++.+..+++.+++|++.....  ..+.+.+|+++++.+       .|++|+++++++......++|||++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-------NHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-------CCCCeeeEeeeeecCCeEEEEEecC
Confidence            6899999999999988899999999986543  356788999999998       4689999999999999999999999


Q ss_pred             c-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC-CCeEEEEecccccccCCc---
Q 003239          195 D-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKIIDFGSACTEDRT---  269 (837)
Q Consensus       195 ~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~IKL~DFGlA~~~~~~---  269 (837)
                      . ++|.+++.... ..+++..++.++.+++.+|++||+.+++|+||+|.||+++   . ...++|+|||.+......   
T Consensus        74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~  149 (215)
T cd00180          74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSL  149 (215)
T ss_pred             CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcch
Confidence            9 68888877652 3589999999999999999999999999999999999996   4 678999999999765543   


Q ss_pred             ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHH
Q 003239          270 VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAEL  306 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyEL  306 (837)
                      .....+...|++||.+... .++.+.|+|+||+++++|
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            3445678889999999887 888999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.9e-28  Score=277.31  Aligned_cols=199  Identities=24%  Similarity=0.347  Sum_probs=168.6

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~----~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ..+..++||+|+||+||++.....++    .||||++....  ...+++++|+-+|..|       +|+|+++|++++..
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-------dHpnl~RLLgvc~~  769 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-------DHPNLLRLLGVCML  769 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-------CCchHHHHhhhccc
Confidence            34557899999999999997655444    68999987543  3467889999999988       79999999999998


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .. +-||++|++ |.|+|+++.++ ..+-......|..||++||.|||++++|||||-.+||||.   ....+||.|||+
T Consensus       770 s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgl  844 (1177)
T KOG1025|consen  770 ST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGL  844 (1177)
T ss_pred             ch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecch
Confidence            76 889999998 79999999865 5688999999999999999999999999999999999996   778999999999


Q ss_pred             ccccCCcceee---c--cCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          263 ACTEDRTVYSY---I--QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       263 A~~~~~~~~~~---~--GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      ++........+   .  -.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+
T Consensus       845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e  908 (1177)
T KOG1025|consen  845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE  908 (1177)
T ss_pred             hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence            97554332222   2  2456999999999999999999999999999998 999997765544

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=253.95  Aligned_cols=198  Identities=21%  Similarity=0.330  Sum_probs=170.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE-Eeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY-FVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~-f~~~~~  186 (837)
                      .+.|.|.+.||+|.||.+-+|+++.+++.+++|.+.+......++.+|...--.|      ..|.||+.-|++ |+..+.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~L------s~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFL------SPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceee------ccchhhhHHHHHHhhcCce
Confidence            4789999999999999999999999999999999998777777888877654444      368899988875 677789


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +++++||++ |+|..-+..   .++-|...++++.|++.||.|||++++||||||.+||||-+. +..+|||||||..+.
T Consensus        97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRK  172 (378)
T ss_pred             EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccc
Confidence            999999998 788776654   358999999999999999999999999999999999999754 445999999999988


Q ss_pred             cCCcceeeccCccccCchhhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          266 EDRTVYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      .+......--+..|.+||+....     ...+..|||.||+|+|.++||++||..
T Consensus       173 ~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  173 VGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             cCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            87776666667789999988643     467889999999999999999999964

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.4e-26  Score=234.17  Aligned_cols=205  Identities=34%  Similarity=0.520  Sum_probs=174.3

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      |.+.+.||.|+++.||++.+..+++.+|||.+.....  ..+.+.+|++.++.+       .|+||+++++++......+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-------~~~~i~~~~~~~~~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-------KHPNIVKLYGVFEDPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-------CCCChhhheeeeecCCceE
Confidence            5678999999999999999998899999999986532  467788899999888       5789999999999999999


Q ss_pred             EEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +|+|++.+ +|.+++..... .+++..+..++.|++.+|.+||+++++|+||+|.||+++   ....++|+|||.+....
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIH  149 (225)
T ss_pred             EEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEec
Confidence            99999986 88888876531 289999999999999999999999999999999999996   45899999999987654


Q ss_pred             Ccc----eeeccCccccCchhh-cCCCCCccchHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHH
Q 003239          268 RTV----YSYIQSRYYRSPEVL-LGYQYTTAIDMWSFGCIVAELFLGLPLFPG-ASEF-DLLRRMI  326 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl-~~~~yt~ksDIWSLG~ILyELltG~~PF~g-~s~~-e~l~~I~  326 (837)
                      ...    ....++..|++||.+ ....++.++|||+|||++++|++|+.||.. .+.. .+.+.|.
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            432    455778889999999 566788899999999999999999999977 4443 4444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=8.6e-28  Score=294.18  Aligned_cols=142  Identities=18%  Similarity=0.235  Sum_probs=115.0

Q ss_pred             CceeEEeEEE-------eecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          172 HHIVRIYEYF-------VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       172 pnIVkl~d~f-------~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      +||++++++|       ...+.++++||+++++|.+++.... ..+++.+++.+++||++||+|||++|||||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4777777777       2335688999999999999987542 4699999999999999999999999999999999999


Q ss_pred             eeec----------------cCCCCeEEEEecccccccCCc-------------------ceeeccCccccCchhhcCCC
Q 003239          245 LLCT----------------SVKPAEIKIIDFGSACTEDRT-------------------VYSYIQSRYYRSPEVLLGYQ  289 (837)
Q Consensus       245 Ll~~----------------~~~~~~IKL~DFGlA~~~~~~-------------------~~~~~GT~~Y~APEvl~~~~  289 (837)
                      ||+.                .+....+||+|||+++.....                   ....++|++|||||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9952                123456788888887532110                   01235788999999999999


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCC
Q 003239          290 YTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       290 yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      |+.++||||||||||||++|.+|+.
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchh
Confidence            9999999999999999999888764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=9e-25  Score=217.32  Aligned_cols=107  Identities=25%  Similarity=0.318  Sum_probs=93.0

Q ss_pred             hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeecc
Q 003239          196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ  275 (837)
Q Consensus       196 gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~G  275 (837)
                      |+|.+++.... ..+++.+++.|+.||+.||+|||+++      ||+|||++   .++.+|+  ||++......  ...+
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~--~~~g   66 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPE--QSRV   66 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeeccc--cCCC
Confidence            57888887543 46999999999999999999999998      99999995   6678888  9998765432  2368


Q ss_pred             CccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       276 T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99999999999999999999999999999999999999654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-24  Score=230.86  Aligned_cols=209  Identities=21%  Similarity=0.292  Sum_probs=164.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t-----g~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      +.|+++..++-+|.||.||.+...+.     .+.|-+|.++....  ....++.|--.|..+       .|||++.+.++
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-------sH~nll~V~~V  355 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-------SHPNLLSVLGV  355 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-------cCCCccceeEE
Confidence            36788889999999999999965433     34466777765432  233444455444444       69999999998


Q ss_pred             Eeec-ceEEEEEeccc-hhHHHHHHhhc------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          181 FVCQ-RHLCICFELLD-SNLYELIKINH------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                      ..++ ...++++.+++ |+|..++...+      .+.++..++..++.|++.|++|||+++|||.||..+|.+|+   +.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId---d~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID---DQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh---hh
Confidence            8765 46778888888 89999998543      23477788889999999999999999999999999999995   67


Q ss_pred             CeEEEEecccccccCCcceeecc-----CccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          253 AEIKIIDFGSACTEDRTVYSYIQ-----SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~~~~~~~G-----T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      -++||+|=.+++..-.......|     ...||+||.+.+..|+.++|+||||++||||+| |+.|+..-+++++...+.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            89999999998765444333333     456999999999999999999999999999998 999998887777655443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=3.4e-22  Score=208.54  Aligned_cols=195  Identities=36%  Similarity=0.564  Sum_probs=163.5

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHhhcccCCCCCC-ceeEEeEEEeecc
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQR  185 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~Hp-nIVkl~d~f~~~~  185 (837)
                      |++.+.||.|+|+.||++.+.   +.+++|.+.....    ....+.+|+.++..+.       |+ +|+++++++....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-------~~~~i~~~~~~~~~~~   71 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-------HPPNIVKLYDFFQDEG   71 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-------CCcceeeEEEEEecCC
Confidence            788999999999999999887   7899999985422    4667888999888884       44 7999999998888


Q ss_pred             eEEEEEeccch-hHHHHHHhhcc-CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC-eEEEEeccc
Q 003239          186 HLCICFELLDS-NLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGS  262 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~-~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~-~IKL~DFGl  262 (837)
                      ..+++++++.+ .+.+++..... ..+.+..+..++.|++.+|.|+|+.+++||||||+||+++   ... .++++|||.
T Consensus        72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~  148 (384)
T COG0515          72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGL  148 (384)
T ss_pred             EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCc
Confidence            88999999985 66655544321 2589999999999999999999999999999999999996   444 799999999


Q ss_pred             ccccCC---------cceeeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          263 ACTEDR---------TVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       263 A~~~~~---------~~~~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      +.....         .....+++..|+|||++.+   ..+....|+|++|++++++++|..||.....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            864332         2356689999999999988   5788999999999999999999999876653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=4.7e-23  Score=226.91  Aligned_cols=209  Identities=26%  Similarity=0.284  Sum_probs=173.6

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCC-eEEEEEEEeCChh-hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE-eecce
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF-VCQRH  186 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg-~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f-~~~~~  186 (837)
                      +|++.++||+|+||.||+|.+..++ +.+|+|+...... ....+..|+.++..+..   .....++.++++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~---~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK---KNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh---hcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999987774 6899999875422 12267789999999964   11235899999999 57789


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC--CCCeEEEEeccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~IKL~DFGlA~  264 (837)
                      .+|||+.++.+|.++.+....+.++..++..|+.|++.+|++||+.|+|||||||+|+++....  ....+.|.|||+++
T Consensus        96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            9999999999999988766667799999999999999999999999999999999999997442  12579999999997


Q ss_pred             --cc----CC------c-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 003239          265 --TE----DR------T-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL  321 (837)
Q Consensus       265 --~~----~~------~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~  321 (837)
                        ..    ..      . .....||..|+++++..+...+.+.|+||++.++.||+.|..||.+......
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence              31    10      1 1234599999999999999999999999999999999999999977654333

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4.2e-23  Score=210.99  Aligned_cols=207  Identities=22%  Similarity=0.295  Sum_probs=178.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      .+|+++++||.|+||.+|++.....|+.||||+-++... ..+...|..+.+.|+.      ...|..+..++.+..+-.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~------g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQG------GVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhcc------CCCCchhhhhccccccce
Confidence            799999999999999999999999999999999876543 3456679999999964      467888888889999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC-
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED-  267 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~-  267 (837)
                      +|||+++.+|.+++.... +.++..++..++-||+.-|+|+|.+++|||||||+|+|+.-+....++.|+|||+|+... 
T Consensus        88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999999999999888765 569999999999999999999999999999999999999877777889999999996432 


Q ss_pred             ---------CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 003239          268 ---------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR  323 (837)
Q Consensus       268 ---------~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~  323 (837)
                               .......||..|.+-....+...+...|+-|+|.+|..+.-|..||.+-......+
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence                     12234578999999888888888999999999999999999999998865444333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.6e-24  Score=252.76  Aligned_cols=261  Identities=25%  Similarity=0.319  Sum_probs=190.2

Q ss_pred             Cce-EEEEEeccCCceeEEEeeccCCCeEEEEEEEe----CChh---hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          109 RRY-IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPA---YYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       109 ~~Y-~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik----~~~~---~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      +.| .....+|.|++|.|+.+......+.++.|..+    ....   ....+..|+.+-..|       .|+||+..++.
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-------~h~~~~e~l~~  389 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-------SHPNIIETLDI  389 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-------cCCchhhhHHH
Confidence            334 45678999999988888777776666666544    2111   111133344443344       78999888887


Q ss_pred             EeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          181 FVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       181 f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      +.+.....-+||||.++|+.++...  ..+...++..+++||+.||+|||+.||.|||||++|++++   ..+.+||+||
T Consensus       390 ~~~~~~~~~~mE~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Df  464 (601)
T KOG0590|consen  390 VQEIDGILQSMEYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDF  464 (601)
T ss_pred             HhhcccchhhhhcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeec
Confidence            7777666666999999998888765  2488899999999999999999999999999999999996   6779999999


Q ss_pred             ccccccC-------CcceeeccCccccCchhhcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          261 GSACTED-------RTVYSYIQSRYYRSPEVLLGYQYTT-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       261 GlA~~~~-------~~~~~~~GT~~Y~APEvl~~~~yt~-ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      |.+....       ......+|+..|+|||++.+..|++ ..||||.|+|+..|++|+.||......+...         
T Consensus       465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------  535 (601)
T KOG0590|consen  465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------  535 (601)
T ss_pred             CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------
Confidence            9984321       1234568899999999999999986 7999999999999999999996554322211         


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                                     +.....      +...+                              ......++          
T Consensus       536 ---------------~~~~~~------~~~~~------------------------------~~~~~~~~----------  554 (601)
T KOG0590|consen  536 ---------------KTNNYS------DQRNI------------------------------FEGPNRLL----------  554 (601)
T ss_pred             ---------------hhhccc------ccccc------------------------------ccChHHHH----------
Confidence                           000000      00000                              00001111          


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                             ..++...+.+|.+||++||.+|+|+++||+.+||+....
T Consensus       555 -------~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  555 -------SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             -------HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                   123456789999999999999999999999999998664

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.6e-21  Score=206.99  Aligned_cols=212  Identities=22%  Similarity=0.281  Sum_probs=180.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      -.|+|.++||+|+||+++.+++.-+++.||||.-.... ..-+...|....+.|.      ..+.|..+|-+-.+..+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~------g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLG------GTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHc------CCCCCCceeeeccccchhh
Confidence            57999999999999999999999999999999876432 2456778999999986      4689999999888889999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc--CCCCeEEEEeccccccc
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTE  266 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~--~~~~~IKL~DFGlA~~~  266 (837)
                      ||||+++.+|.|++.-.. +.|+..++..++.||+.-++|+|++.+|.|||||+|+||...  .+...|.|+|||+|+..
T Consensus       101 LVidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999999999888765 579999999999999999999999999999999999999642  34467899999999643


Q ss_pred             CCc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHH
Q 003239          267 DRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA---SEFDLLRRMIRI  328 (837)
Q Consensus       267 ~~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~---s~~e~l~~I~~~  328 (837)
                      .+.          .....||..||+=...++.+.+...|+-|||-++...|-|..||.+-   +..+..++|-+.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~  254 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET  254 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence            222          23457899999999999999999999999999999999999999875   344455555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.6e-21  Score=217.54  Aligned_cols=167  Identities=22%  Similarity=0.275  Sum_probs=126.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC------hhhHHHHHHHHHHHHHhhcccCCCCCCcee-EEeEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIV-RIYEY  180 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIV-kl~d~  180 (837)
                      .+|++.++||+|+||+||+|++.. +++.||||++...      ....+.+.+|+++|++|       .|+||+ +++++
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-------~h~~iv~~l~~~   90 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-------RGIGVVPQLLAT   90 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-------cCCCCCcEEEEc
Confidence            789999999999999999998876 6788899987532      22355688999999999       567877 45542


Q ss_pred             EeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC-CCCCeeeeccCCCCeEEEEe
Q 003239          181 FVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL-KPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       181 f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL-KPeNILl~~~~~~~~IKL~D  259 (837)
                          +..|||||||.|..+..+.  .   ..   ...++.|++++|.|||++||+|||| ||+|||++   .++.+||+|
T Consensus        91 ----~~~~LVmE~~~G~~L~~~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiD  155 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLAR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVID  155 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHhC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEE
Confidence                4689999999864333221  1   11   2467899999999999999999999 99999995   557899999


Q ss_pred             cccccccCCc-----------ceeeccCccccCchhhcCC------CCCccchHH
Q 003239          260 FGSACTEDRT-----------VYSYIQSRYYRSPEVLLGY------QYTTAIDMW  297 (837)
Q Consensus       260 FGlA~~~~~~-----------~~~~~GT~~Y~APEvl~~~------~yt~ksDIW  297 (837)
                      ||+|+.....           .....+++.|+|||.+...      ..+...|-|
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9999743322           1344677889999998643      233446766

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-21  Score=231.67  Aligned_cols=193  Identities=27%  Similarity=0.386  Sum_probs=147.6

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .|...+.||.+.|=+|.+|++.+ |. |+||++-+..  ...+.+.++++-++...     ..+||++.+.-+...++..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l-----~~~pn~lPfqk~~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFAL-----MKAPNCLPFQKVLVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHh-----hcCCcccchHHHHHhhHHH
Confidence            56778899999999999997765 33 8999986532  22333333333333111     1689999998888888889


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc-
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE-  266 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~-  266 (837)
                      |||-+|+..+|+|.+..+.+  +.+.+.+.|+.||+.||.-+|+.||+|||||.|||||+   .-+-+.|+||..-+.. 
T Consensus        97 ylvRqyvkhnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtY  171 (1431)
T KOG1240|consen   97 YLVRQYVKHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTY  171 (1431)
T ss_pred             HHHHHHHhhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCcc
Confidence            99999999999998876653  77888999999999999999999999999999999997   5667899999875421 


Q ss_pred             ---CCc--ceee----ccCccccCchhhcCC----------C-CCccchHHHHHHHHHHHHh-CCCCCC
Q 003239          267 ---DRT--VYSY----IQSRYYRSPEVLLGY----------Q-YTTAIDMWSFGCIVAELFL-GLPLFP  314 (837)
Q Consensus       267 ---~~~--~~~~----~GT~~Y~APEvl~~~----------~-yt~ksDIWSLG~ILyELlt-G~~PF~  314 (837)
                         ++.  ...+    ..-..|.|||.+...          . .+++.||||+||+++||++ |++||.
T Consensus       172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence               111  1111    223459999998531          2 6789999999999999998 799993

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=2.9e-20  Score=220.51  Aligned_cols=222  Identities=24%  Similarity=0.385  Sum_probs=168.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..+|..+++|..|+||.||.++++.+.+.+|+|+-+++ ...+.      ||..       .+.|.+|            
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-lilRn------ilt~-------a~npfvv------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-LILRN------ILTF-------AGNPFVV------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-hhhhc------cccc-------cCCccee------------
Confidence            37899999999999999999999999999999654432 11110      1111       1233333            


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                              |+-..+++..  +.++..        ++.+++|||+.||||||+||+|.+|+   .-+++|++|||+.+...
T Consensus       136 --------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 --------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             --------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhh
Confidence                    4444444432  234432        37899999999999999999999997   77999999999984211


Q ss_pred             C------------------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          268 R------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       268 ~------------------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      .                  .....|||+.|+|||++..+.|...+|+|++|+|+||.+.|+.||.++..++++..++...
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            0                  1234689999999999999999999999999999999999999999999999888776643


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      . ..|+                                                                          
T Consensus       275 i-~wpE--------------------------------------------------------------------------  279 (1205)
T KOG0606|consen  275 I-EWPE--------------------------------------------------------------------------  279 (1205)
T ss_pred             c-cccc--------------------------------------------------------------------------
Confidence            3 0000                                                                          


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCC---CHHHHHcCccCCCCCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRW---SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRp---Ta~EaL~HPff~~~~~~  459 (837)
                              .+....+++.|+|.++|+.+|..|.   .+-++.+|+||+...|.
T Consensus       280 --------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  280 --------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             --------cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence                    0011346789999999999999997   56788899999998886

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=6.6e-22  Score=225.34  Aligned_cols=240  Identities=23%  Similarity=0.378  Sum_probs=190.8

Q ss_pred             EeccCCceeEEEeec---cCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEE
Q 003239          116 LLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI  189 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~---~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L  189 (837)
                      .+|+|+||.|++++.   ...+..+|+|+.++..   ........|-.++..++      .|+.+|++.-.|+.+..+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~------~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH------NTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc------CCCceeeeeeeeccccchhH
Confidence            379999999998743   4557789999987532   11114445667777764      48999999999999999999


Q ss_pred             EEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       190 VmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      ++++..| .|..-+...  ..+.+...+.+...++.+++++|+.+|+|||+|++||+++   ..|++|+.|||+++..-.
T Consensus        75 ~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld---~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL---LEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec---ccCccccCCchhhhHhHh
Confidence            9999985 665554433  3588899999999999999999999999999999999994   889999999999975433


Q ss_pred             cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhh
Q 003239          269 TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF  348 (837)
Q Consensus       269 ~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f  348 (837)
                      .... |||..|||||++.  ....++|.||||++++||++|..||..    +....|.+..-                  
T Consensus       150 ~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~------------------  204 (612)
T KOG0603|consen  150 EKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL------------------  204 (612)
T ss_pred             hhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc------------------
Confidence            3222 9999999999998  678899999999999999999999976    44444433110                  


Q ss_pred             hhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHH
Q 003239          349 KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVD  428 (837)
Q Consensus       349 ~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~D  428 (837)
                                                                                          ......+..+.+
T Consensus       205 --------------------------------------------------------------------~~p~~l~~~a~~  216 (612)
T KOG0603|consen  205 --------------------------------------------------------------------EMPRELSAEARS  216 (612)
T ss_pred             --------------------------------------------------------------------CCchhhhHHHHH
Confidence                                                                                001124567889


Q ss_pred             HHHHhcccCcCCCCCH-----HHHHcCccCCCCCCC
Q 003239          429 FLKGLVEFDPAKRWSP-----FQASRHPFVTGEPFT  459 (837)
Q Consensus       429 LL~kmL~~DP~kRpTa-----~EaL~HPff~~~~~~  459 (837)
                      ++..|+..+|..|.-+     .|+++|+||....+.
T Consensus       217 ~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  217 LFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            9999999999999855     799999999998765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=1.8e-20  Score=201.85  Aligned_cols=205  Identities=21%  Similarity=0.262  Sum_probs=133.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCC---CCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDR---EDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~---~~HpnIVkl~d~f  181 (837)
                      ..+...+.||.|+++.||.+.+.+|++.+|+|+....    ....+++.+|.-....+......   ..|-.++..++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            4567788999999999999999999999999998632    22344555554333222110000   0111333344433


Q ss_pred             eec------------c-----eEEEEEeccchhHHHHHHh---hccC--CCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          182 VCQ------------R-----HLCICFELLDSNLYELIKI---NHFR--GLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       182 ~~~------------~-----~l~LVmEy~~gsL~d~l~~---~~~~--~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      ...            .     ..+++|+-+.++|.+++..   ....  .+.......+..|+++.+++||..||||+||
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            321            1     3478899988888777553   2211  1223333456699999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCCcceeeccCccccCchhhcC--------CCCCccchHHHHHHHHHHHHhCCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG--------YQYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~--------~~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      ||+|++++   .++.++|+||+.....+........+..|.+||+...        ..++.+.|.|+||+++|.|+++..
T Consensus       172 ~~~nfll~---~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLD---QDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEc---CCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999995   7899999999988776665544445677999998743        258899999999999999999999


Q ss_pred             CCCCC
Q 003239          312 LFPGA  316 (837)
Q Consensus       312 PF~g~  316 (837)
                      ||...
T Consensus       249 Pf~~~  253 (288)
T PF14531_consen  249 PFGLS  253 (288)
T ss_dssp             STCCC
T ss_pred             CCCCC
Confidence            99644

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.9e-20  Score=202.47  Aligned_cols=145  Identities=23%  Similarity=0.345  Sum_probs=118.1

Q ss_pred             CCCCceeEEeEEEeec---------------------------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHh
Q 003239          169 EDKHHIVRIYEYFVCQ---------------------------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ  221 (837)
Q Consensus       169 ~~HpnIVkl~d~f~~~---------------------------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~Q  221 (837)
                      ..|||||++...|.+.                           ..+|+||.....+|.+++..+.   .+....+.++.|
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHH
Confidence            4799999999988753                           3589999999999999998765   778888999999


Q ss_pred             HHHHHhhhhcCCeeeccCCCCCeeeecc-CCCCeEEEEecccccccCC---------cceeeccCccccCchhhcCCC--
Q 003239          222 ILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTEDR---------TVYSYIQSRYYRSPEVLLGYQ--  289 (837)
Q Consensus       222 Il~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~IKL~DFGlA~~~~~---------~~~~~~GT~~Y~APEvl~~~~--  289 (837)
                      +++|+.|||++||.|||||.+|||+..+ |.-..++|+|||++--.+.         .....-|.-.-||||+....+  
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            9999999999999999999999999654 3345789999998732221         112234577789999997542  


Q ss_pred             ---CC-ccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          290 ---YT-TAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       290 ---yt-~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                         .+ .|+|.|+.|.+.||++....||.+.
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~r  460 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKR  460 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence               22 4899999999999999999999763

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=5.8e-20  Score=192.46  Aligned_cols=168  Identities=10%  Similarity=0.135  Sum_probs=126.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHH------HHHHHHHHHHhhcccCCCCCCceeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQ------ALVEVSILTTLNKKYDREDKHHIVRI  177 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~------~~~Ei~iL~~L~~~~~~~~HpnIVkl  177 (837)
                      .++|+++++||.|+||.||++.+  ++..+|||+++...    .....      +.+|+..+.+|       .|++|..+
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-------~~~GI~~~  100 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-------RSEGLASL  100 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-------HHCCCCcc
Confidence            48999999999999999999755  46679999997432    22222      56888889998       46788888


Q ss_pred             eEEEeec--------ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec
Q 003239          178 YEYFVCQ--------RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT  248 (837)
Q Consensus       178 ~d~f~~~--------~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~  248 (837)
                      .+++...        ...+|||||++| +|.++.      .+++    ..+.+|+.+|..||+.||+||||||.||+++ 
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~-  169 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS-  169 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe-
Confidence            8886644        358999999997 666552      1333    2456999999999999999999999999996 


Q ss_pred             cCCCCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHH
Q 003239          249 SVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF  307 (837)
Q Consensus       249 ~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELl  307 (837)
                        ..+ ++|+|||...........         ..+++...|+.++|||+||+++.-+.
T Consensus       170 --~~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 --KNG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             --CCC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence              345 999999988544221111         11445556788999999999876553

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=1.3e-19  Score=185.29  Aligned_cols=138  Identities=20%  Similarity=0.152  Sum_probs=103.2

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---h------------------------HHHHHHHHHHHHHhhccc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---Y------------------------YQQALVEVSILTTLNKKY  166 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~---~------------------------~~~~~~Ei~iL~~L~~~~  166 (837)
                      .++||+|+||+||+|.+. +|+.||||+++....   .                        ......|+++|..+.+..
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 899999999975321   0                        112345999999996431


Q ss_pred             CCCCCCceeEEeEEEeecceEEEEEeccchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhh-hcCCeeeccCCCCCe
Q 003239          167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLL-KDAGIIHCDLKPENI  244 (837)
Q Consensus       167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yL-Hs~gIVHrDLKPeNI  244 (837)
                        ..+|+++.      .. ..+|||||++|+ +...+..  ...+++..+..++.||+.+|.+| |+.||+||||||+||
T Consensus        81 --v~~p~~~~------~~-~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NI  149 (190)
T cd05147          81 --IPCPEPIL------LK-SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNL  149 (190)
T ss_pred             --CCCCcEEE------ec-CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence              12233321      12 238999999974 3333222  24689999999999999999999 799999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccC
Q 003239          245 LLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      |++    ++.++|+|||+|....
T Consensus       150 li~----~~~v~LiDFG~a~~~~  168 (190)
T cd05147         150 LYH----DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EEE----CCcEEEEEccccccCC
Confidence            995    3679999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=1.8e-18  Score=176.32  Aligned_cols=138  Identities=21%  Similarity=0.194  Sum_probs=104.5

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh---------------------------HHHHHHHHHHHHHhhccc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---------------------------YQQALVEVSILTTLNKKY  166 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~---------------------------~~~~~~Ei~iL~~L~~~~  166 (837)
                      .+.||+|+||+||+|++. +|+.||||+++.....                           ......|.+.+.++.+  
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--   78 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE--   78 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh--
Confidence            468999999999999887 8999999999854110                           1223568888888853  


Q ss_pred             CCCCCCceeEEeEEEeecceEEEEEeccchh-HHHH-HHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCC
Q 003239          167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYEL-IKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPEN  243 (837)
Q Consensus       167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~d~-l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeN  243 (837)
                           ++|.....+...  ..||||||++|. +... +..   ..+++..+..++.|++.+|.+||. +||+||||||+|
T Consensus        79 -----~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          79 -----AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             -----CCCCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence                 444322222222  248999999874 3322 322   358889999999999999999999 999999999999


Q ss_pred             eeeeccCCCCeEEEEecccccccCC
Q 003239          244 ILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       244 ILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      ||++    ++.++|+|||++.....
T Consensus       149 Ill~----~~~~~liDFG~a~~~~~  169 (190)
T cd05145         149 ILYH----DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEEE----CCCEEEEEcccceecCC
Confidence            9995    47899999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=8.1e-19  Score=212.09  Aligned_cols=195  Identities=23%  Similarity=0.370  Sum_probs=159.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..+|.|.+.||+|+||+||+|.... ++.||||+-+....+  ++..-.+++.+|+    ..--+.|..+...+...+.-
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk----~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLK----PQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhc----hhhhcchHHHHHHHccCCcc
Confidence            4789999999999999999998877 999999998754332  1111223333432    11235677777777778889


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec----cCCCCeEEEEeccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT----SVKPAEIKIIDFGS  262 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~----~~~~~~IKL~DFGl  262 (837)
                      +||+||.+ |+|++++.  ..+.+++..+..|+.|||..++.||..+|||+||||+|+||..    +....-|+|+|||.
T Consensus       770 ~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            99999998 89999998  3457999999999999999999999999999999999999953    23456799999999


Q ss_pred             cccc-----CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCC
Q 003239          263 ACTE-----DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       263 A~~~-----~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      +...     ...+...++|-.+-.+|+..+.+++..+|.|.|+.+++.||.|+.
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9532     235566788999999999999999999999999999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=7.9e-18  Score=174.85  Aligned_cols=140  Identities=19%  Similarity=0.158  Sum_probs=109.7

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---e-EE
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---H-LC  188 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---~-l~  188 (837)
                      .+.||+|+|+.||.  +..+... +||++... ....+.+.+|+.+++.|.+  ....|+||++++++++++.   . +.
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~--~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSR--RLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhc--cCCCCcccceeeEEEEeCCCCeEEEE
Confidence            46899999999995  6667665 69988753 2345678999999999965  2346899999999999873   4 44


Q ss_pred             EEEeccc---hhHHHHHHhhccCCCCHHHHHHHHHhHHHHH-hhhhcCCeeeccCCCCCeeeeccC-CCCeEEEEecccc
Q 003239          189 ICFELLD---SNLYELIKINHFRGLSLSIVQLFSKQILRGL-SLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSA  263 (837)
Q Consensus       189 LVmEy~~---gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL-~yLHs~gIVHrDLKPeNILl~~~~-~~~~IKL~DFGlA  263 (837)
                      +||||++   ++|.++++..   .+++.  ..++.|++.++ +|||+++||||||||+|||++... ....++|+||+-+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            8999955   6999999653   36666  35688888888 999999999999999999997432 3458999995443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1e-17  Score=172.75  Aligned_cols=182  Identities=17%  Similarity=0.130  Sum_probs=135.8

Q ss_pred             EEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHH-----HHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ-----QALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       112 ~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~-----~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .+...|+.|+||+|+.+..  .+..++.+.+........     .+.+|+++|++|.      ++++|++++++    +.
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~------~~~~vP~ll~~----~~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLD------GLPRTPRLLHW----DG   72 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcC------CCCCCCEEEEE----cC
Confidence            3567899999999998744  677888888876554333     5788999999995      35788888886    45


Q ss_pred             EEEEEeccchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC-CCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL-KPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL-KPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++||||+.|. |.+.+.        .. ...++.|++.+|.+||++||||||| ||+|||++   .++.++|+|||+|.
T Consensus        73 ~~lvmeyI~G~~L~~~~~--------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~  140 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPP--------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAV  140 (218)
T ss_pred             EEEEEeeecCccHHhhhh--------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCce
Confidence            79999999874 432211        11 2357889999999999999999999 79999995   56789999999997


Q ss_pred             ccCCcce----------------eeccCccccCchhhcCC-CCC-ccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          265 TEDRTVY----------------SYIQSRYYRSPEVLLGY-QYT-TAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       265 ~~~~~~~----------------~~~GT~~Y~APEvl~~~-~yt-~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .......                ....++.|++|+...-. ..+ ...+.++.|+-+|.++|+..++.++.
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            4433221                01236667777765433 334 56778899999999999998886554

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=7.1e-17  Score=170.78  Aligned_cols=145  Identities=19%  Similarity=0.145  Sum_probs=110.4

Q ss_pred             CceEEEEEeccCCceeEEEee-ccCCCeEEEEEEEeCChh-------------------------hHHHHHHHHHHHHHh
Q 003239          109 RRYIVKDLLGHGTFGQVAKCW-DAEMNSFVAVKIIKNQPA-------------------------YYQQALVEVSILTTL  162 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~-~~~tg~~VAIKiik~~~~-------------------------~~~~~~~Ei~iL~~L  162 (837)
                      .-|.+.+.||+|+||.||+|. +..+++.||||+++....                         ....+.+|+.+++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999998 677899999999974321                         012356799999999


Q ss_pred             hcccCCCCCCceeEEeEEEeecceEEEEEeccchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC-eeeccCC
Q 003239          163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG-IIHCDLK  240 (837)
Q Consensus       163 ~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g-IVHrDLK  240 (837)
                      .+.     ...+.++++.    ...+|||||++|. |.......  ..+.+..+..++.||+.+|.+||+.| |+|||||
T Consensus       108 ~~~-----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik  176 (237)
T smart00090      108 YEA-----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS  176 (237)
T ss_pred             Hhc-----CCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence            531     2334444443    2358999999984 43332221  24667778899999999999999999 9999999


Q ss_pred             CCCeeeeccCCCCeEEEEecccccccCC
Q 003239          241 PENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       241 PeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      |+||+++    .+.++|+|||.+.....
T Consensus       177 p~NIli~----~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      177 EYNILVH----DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhhEEEE----CCCEEEEEChhhhccCC
Confidence            9999995    56799999999865443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=4.5e-17  Score=183.12  Aligned_cols=118  Identities=32%  Similarity=0.514  Sum_probs=101.5

Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          185 RHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .++||.|++|. .+|.+++.... ....+...++.++.|+..+++|   ++.+|+|+||.||++.   .+.++||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence            36899999998 68888887433 3457788899999999999999   9999999999999996   556899999999


Q ss_pred             ccccCC---------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh
Q 003239          263 ACTEDR---------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL  308 (837)
Q Consensus       263 A~~~~~---------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt  308 (837)
                      ......         .....+||..||+||.|.+..|+.++||||||+||+||+.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            864432         2345689999999999999999999999999999999986

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=1.5e-15  Score=156.06  Aligned_cols=132  Identities=26%  Similarity=0.292  Sum_probs=105.2

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +.||+|++|.||+|..  .+..|+||+.....         .......+|+.++..+.       |++|.....++...+
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~~~i~~p~~~~~~~~   72 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-------KAGVNVPAVYFVDPE   72 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-------HCCCCCCeEEEEeCC
Confidence            5799999999999976  67789999865321         11235678999999884       456665555666677


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..++||||++| +|.+++....     . ....++.+|+.+|.+||+.+++|+|++|.|||++    .+.++|+|||.+.
T Consensus        73 ~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~  142 (211)
T PRK14879         73 NFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAE  142 (211)
T ss_pred             CCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCccc
Confidence            88999999986 7777765432     2 7889999999999999999999999999999995    5679999999986


Q ss_pred             c
Q 003239          265 T  265 (837)
Q Consensus       265 ~  265 (837)
                      .
T Consensus       143 ~  143 (211)
T PRK14879        143 F  143 (211)
T ss_pred             C
Confidence            5

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.61  E-value=2.9e-16  Score=163.16  Aligned_cols=199  Identities=19%  Similarity=0.202  Sum_probs=150.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ....++.+|.+...|..|+++..  |..++.|+++..   ....+.+..|.-.|+.+       .||||+.+++.|...-
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-------shpnilpvlgacnspp  260 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-------SHPNILPVLGACNSPP  260 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-------cCCchhhhhhhccCCC
Confidence            34556678899999999999765  445677887643   22334566676666666       7899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++.++..||+ |+|+.++.....--++..++.+++.+|++|++|||+..  |----|....|+++.+ -..++-.+|--+
T Consensus       261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kf  339 (448)
T KOG0195|consen  261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKF  339 (448)
T ss_pred             CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheeccccee
Confidence            9999999998 89999998765555788899999999999999999864  3344678888999632 233444555444


Q ss_pred             ccccCCcceeeccCccccCchhhcCCCCC---ccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 003239          263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYT---TAIDMWSFGCIVAELFLGLPLFPGASEFDL  321 (837)
Q Consensus       263 A~~~~~~~~~~~GT~~Y~APEvl~~~~yt---~ksDIWSLG~ILyELltG~~PF~g~s~~e~  321 (837)
                      +.+...    ..-.+.||+||.+...+-+   .++|+|||.+++|||.|...||..-++.+.
T Consensus       340 sfqe~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec  397 (448)
T KOG0195|consen  340 SFQEVG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC  397 (448)
T ss_pred             eeeccc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence            433221    2346889999999887544   589999999999999999999977665443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=3.6e-15  Score=152.65  Aligned_cols=138  Identities=23%  Similarity=0.268  Sum_probs=103.4

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-----------------------hHHHHHHHHHHHHHhhccc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-----------------------YYQQALVEVSILTTLNKKY  166 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-----------------------~~~~~~~Ei~iL~~L~~~~  166 (837)
                      .|.+.+.||+|+||.||++... +++.||||+++....                       .......|+.++..+.+. 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE-   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc-
Confidence            4788899999999999999774 799999999764320                       011356788888888432 


Q ss_pred             CCCCCCceeEEeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCee
Q 003239          167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL  245 (837)
Q Consensus       167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL  245 (837)
                          ...++.+++.    ...++||||+.| +|.++..        ......++.+|+.+|.++|+.||+||||||+||+
T Consensus        94 ----~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil  157 (198)
T cd05144          94 ----GFPVPKPIDW----NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL  157 (198)
T ss_pred             ----CCCCCceeec----CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence                1134444442    456899999987 4443221        1346678999999999999999999999999999


Q ss_pred             eeccCCCCeEEEEecccccccCC
Q 003239          246 LCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       246 l~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      ++   +++.++|+|||.+.....
T Consensus       158 l~---~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VD---DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             Ec---CCCcEEEEECCccccCCC
Confidence            95   578999999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.60  E-value=6.2e-15  Score=150.20  Aligned_cols=128  Identities=21%  Similarity=0.247  Sum_probs=97.4

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .||+|+||.||++.  .++..|++|+.....         ....++.+|+++++.+.+.     +-+++.++  +.....
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-----~i~~p~~~--~~~~~~   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA-----GVNTPVVY--DVDPDN   71 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHC-----CCCCCEEE--EEECCC
Confidence            38999999999997  456789999865321         1124567899999998542     12333443  345566


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++||||++| +|.+++....         ..++.||+.+|.+||+.|++|+|+||+||+++    .+.++|+|||++..
T Consensus        72 ~~lv~e~~~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~  138 (199)
T TIGR03724        72 KTIVMEYIEGKPLKDVIEEGN---------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY  138 (199)
T ss_pred             CEEEEEEECCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence            7999999985 7776654321         17899999999999999999999999999995    57899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=9.7e-15  Score=147.14  Aligned_cols=136  Identities=25%  Similarity=0.273  Sum_probs=96.9

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhH---HH----------------------HHHHHHHHHHhhcccCC
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQ----------------------ALVEVSILTTLNKKYDR  168 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~---~~----------------------~~~Ei~iL~~L~~~~~~  168 (837)
                      .+.||+|+||+||+|.+. +++.||||+++......   ..                      ...|...+..+...   
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---   77 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA---   77 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc---
Confidence            467999999999999876 78999999987532111   11                      13456666666431   


Q ss_pred             CCCCceeEEeEEEeecceEEEEEeccch-hHH-HHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCee
Q 003239          169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLY-ELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENIL  245 (837)
Q Consensus       169 ~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~-d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNIL  245 (837)
                        +..+.+++.+    ...++||||+.+ .+. ..+....   . ...++.++.+++.+|.+||. .+|+|+||||+||+
T Consensus        78 --~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nil  147 (187)
T cd05119          78 --GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNIL  147 (187)
T ss_pred             --CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEE
Confidence              2234555543    246999999987 211 1111111   1 16688999999999999999 99999999999999


Q ss_pred             eeccCCCCeEEEEecccccccC
Q 003239          246 LCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       246 l~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ++    ++.++|+|||.+....
T Consensus       148 i~----~~~~~liDfg~a~~~~  165 (187)
T cd05119         148 VD----DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EE----CCcEEEEECccccccc
Confidence            95    6789999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.57  E-value=1.1e-14  Score=171.31  Aligned_cols=135  Identities=21%  Similarity=0.273  Sum_probs=104.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEE--eC--C-----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KN--Q-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKii--k~--~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ..|...++||+|+||+||++......  +++|+.  +.  .     ....+.+.+|+++++.+       .|++|+..+.
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~~~~i~~p~~  403 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-------RRAGVPTPVI  403 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-------cccCCCeeEE
Confidence            45567899999999999998764433  333432  21  1     11235677899999999       4568887777


Q ss_pred             EEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          180 YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      ++......++||||++| +|.+++.          ....++.||+.+|.+||+.+|+||||||+|||++    ++.++|+
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~li  469 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLI  469 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEE
Confidence            77777788999999985 7777664          2467899999999999999999999999999993    4679999


Q ss_pred             eccccccc
Q 003239          259 DFGSACTE  266 (837)
Q Consensus       259 DFGlA~~~  266 (837)
                      |||+++..
T Consensus       470 DFGla~~~  477 (535)
T PRK09605        470 DFGLGKYS  477 (535)
T ss_pred             eCcccccC
Confidence            99998653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.54  E-value=1.9e-14  Score=164.40  Aligned_cols=143  Identities=23%  Similarity=0.338  Sum_probs=120.7

Q ss_pred             CCCceeEEeEEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCe-eeccCCCCCeeee
Q 003239          170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI-IHCDLKPENILLC  247 (837)
Q Consensus       170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gI-VHrDLKPeNILl~  247 (837)
                      .|.|+.++++.+.+....++|.+||. |+|.|.+.... ..++......++++|+.||+|||...| .|+.|+..|.+++
T Consensus         5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd   83 (484)
T KOG1023|consen    5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD   83 (484)
T ss_pred             chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee
Confidence            78999999999999999999999998 89999988744 458888899999999999999998766 9999999999995


Q ss_pred             ccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCC---C----CCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          248 TSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGY---Q----YTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       248 ~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~---~----yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                         ..+.+||+|||+.......     ........-|.|||++...   .    .+.+.||||+|++++|+++...||..
T Consensus        84 ---~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   84 ---SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             ---eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence               8899999999998654321     1112234559999999864   1    46789999999999999999999965


Q ss_pred             C
Q 003239          316 A  316 (837)
Q Consensus       316 ~  316 (837)
                      .
T Consensus       161 ~  161 (484)
T KOG1023|consen  161 R  161 (484)
T ss_pred             c
Confidence            3

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=5.4e-16  Score=183.66  Aligned_cols=199  Identities=26%  Similarity=0.356  Sum_probs=158.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ..|.+.+.||+|+|+.|-.+.... ....+|+|.+...   ....+....|..+-+.+.      .|.|++++++.....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s------~h~n~~~~~~~~~~~   93 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS------KHSNTVHMIEPSSSP   93 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc------ccccccccCCccCCC
Confidence            578888899999999999887643 4556777777643   233344445666655553      389999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh-cCCeeeccCCCCCeeeeccCCCC-eEEEEecc
Q 003239          185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLCTSVKPA-EIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~~~~~~~-~IKL~DFG  261 (837)
                      +..++++|+..| ++.+.+........+...+..++.|+..+|.|+| ..++.|+||||+|.+++   ..+ .+++.|||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~  170 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFG  170 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCch
Confidence            999999999874 6766663333335788889999999999999999 99999999999999996   445 89999999


Q ss_pred             cccccCC------cceeecc-CccccCchhhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          262 SACTEDR------TVYSYIQ-SRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       262 lA~~~~~------~~~~~~G-T~~Y~APEvl~~~~-yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      +|.....      .....+| ++.|+|||...+.. .....|+||+|+++..+++|..|+...
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~  233 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP  233 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence            9964433      2334578 99999999999864 457899999999999999999998544

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.50  E-value=1.4e-13  Score=130.83  Aligned_cols=134  Identities=21%  Similarity=0.172  Sum_probs=108.5

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      +++.|+.|.++.||++....  +.++||+.+.... ...+..|+.+++.+.+.     ..++++++.++...+..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~-----~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK-----GLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc-----CCCCCeEEEEcCCCCccEEEEE
Confidence            45789999999999997644  6799999876543 46788899999999642     3578888888888889999999


Q ss_pred             ccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC---CeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          193 LLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA---GIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       193 y~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~---gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      |+.+.....+        +......++.+++++|++||..   +++|+||+|+||+++   ..+.++|+||+.+..
T Consensus        74 ~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            9986432211        4456677899999999999985   799999999999996   467899999999853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.48  E-value=3.4e-13  Score=142.96  Aligned_cols=134  Identities=21%  Similarity=0.212  Sum_probs=98.1

Q ss_pred             EEec-cCCceeEEEeeccCCCeEEEEEEEeCCh--------------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          115 DLLG-HGTFGQVAKCWDAEMNSFVAVKIIKNQP--------------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       115 ~~LG-~G~fG~Vyka~~~~tg~~VAIKiik~~~--------------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ..|| .|+.|+||.+...  +..++||.+....              .....+.+|++++..|.+.     +..+++.++
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~-----gi~vP~pl~  109 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEA-----GLPVPRPIA  109 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhC-----CCCCceeEe
Confidence            3566 7788888887543  6779999885311              2234677899999999652     233567777


Q ss_pred             EEeecc----eEEEEEeccch--hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC
Q 003239          180 YFVCQR----HLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       180 ~f~~~~----~l~LVmEy~~g--sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      +...+.    ..+||||+++|  +|.+++...   .+++..    +.||+.+|.+||++||+||||||+|||++   .++
T Consensus       110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~  179 (239)
T PRK01723        110 ARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDG  179 (239)
T ss_pred             eeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCC
Confidence            644432    23699999985  677776542   355543    57899999999999999999999999996   456


Q ss_pred             eEEEEecccccc
Q 003239          254 EIKIIDFGSACT  265 (837)
Q Consensus       254 ~IKL~DFGlA~~  265 (837)
                      .++|+|||.+..
T Consensus       180 ~v~LIDfg~~~~  191 (239)
T PRK01723        180 KFWLIDFDRGEL  191 (239)
T ss_pred             CEEEEECCCccc
Confidence            899999999854

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3e-13  Score=154.91  Aligned_cols=194  Identities=26%  Similarity=0.251  Sum_probs=156.8

Q ss_pred             CceEEEEEecc--CCceeEEEeec--cCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGH--GTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~--G~fG~Vyka~~--~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ..+.+.+.+|.  |.+|.||.+..  ..+...+|+|.-+..   ......-.+|+...+.+.      .|+|.++.+..+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~------~~~~~v~~~~~~  187 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID------SHENPVRDSPAW  187 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC------ccccccccCccc
Confidence            57788899999  99999999988  889999999985421   222233445655555553      688999999999


Q ss_pred             eecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHH----HHhhhhcCCeeeccCCCCCeeeeccCCC-CeEE
Q 003239          182 VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR----GLSLLKDAGIIHCDLKPENILLCTSVKP-AEIK  256 (837)
Q Consensus       182 ~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~----aL~yLHs~gIVHrDLKPeNILl~~~~~~-~~IK  256 (837)
                      +..+.+++-+|+|+..|.++..... .-+++..++.++.+...    ||..+|..+|+|-|+||+||++.   .+ ..++
T Consensus       188 e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCK  263 (524)
T ss_pred             ccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceee
Confidence            9999999999999988887765443 34889999999999999    99999999999999999999996   44 7889


Q ss_pred             EEecccccccCCcc--------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          257 IIDFGSACTEDRTV--------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       257 L~DFGlA~~~~~~~--------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      ++|||+........        ....+...|++||++.+ -++.+.||++||.++.+..++..++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence            99999986554322        11245677999999866 7889999999999999999886655

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.28  E-value=1.4e-12  Score=155.99  Aligned_cols=258  Identities=19%  Similarity=0.286  Sum_probs=190.4

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHH----HHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ----QALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~----~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..+.+.+.+-+-+|.++.++.+.-..++...++|+.+.......    ....+-.++-       ...+|-+++..-.|.
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-------~p~~P~v~~~~~s~~  874 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-------TPRSPAVVRSFPSFP  874 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc-------cCCCCceecccCCCC
Confidence            44678888899999999999998888888888888765432111    1111111111       123456666555566


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      .....+|||+|++ ++|...+....  ..+++-.+..+..+..++++||...++|+|++|.|+|+.   ..+..++.||+
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~  949 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFG  949 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccc
Confidence            7788999999997 47776665543  577888899999999999999999999999999999995   77889999998


Q ss_pred             cccccC----------------------------------CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHH
Q 003239          262 SACTED----------------------------------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF  307 (837)
Q Consensus       262 lA~~~~----------------------------------~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELl  307 (837)
                      ......                                  .......+|+.|.+||.+.+......+|+|++|++++|.+
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence            431000                                  0012346789999999999999999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCc
Q 003239          308 LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL  387 (837)
Q Consensus       308 tG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~  387 (837)
                      +|.+||.........+.|...--                                                         
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~~--------------------------------------------------------- 1052 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDI--------------------------------------------------------- 1052 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCCC---------------------------------------------------------
Confidence            99999988776555443322100                                                         


Q ss_pred             CCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHH---HHHcCccCCCCCCC
Q 003239          388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPF---QASRHPFVTGEPFT  459 (837)
Q Consensus       388 ~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~---EaL~HPff~~~~~~  459 (837)
                                        |+...        ....+..+.+++.++|..+|.+|..+.   ++-.|+||+...+.
T Consensus      1053 ------------------~~p~g--------~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1053 ------------------PWPEG--------PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             ------------------CCCCC--------ccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence                              00000        011346788999999999999999998   89999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.24  E-value=3.4e-11  Score=138.50  Aligned_cols=144  Identities=20%  Similarity=0.291  Sum_probs=93.8

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCChhh-H----------------------------------------HHHH
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-Y----------------------------------------QQAL  153 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~-~----------------------------------------~~~~  153 (837)
                      +.||.|++|+||+|+. .+|+.||||+.+..-.. .                                        -.+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999975 47899999998642100 0                                        0123


Q ss_pred             HHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHH-HHhhhhc
Q 003239          154 VEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR-GLSLLKD  231 (837)
Q Consensus       154 ~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~-aL~yLHs  231 (837)
                      +|...+.+++..+.....-.|.+++..  .....+|||||++| +|.++..... ..+.   ...++.+++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~--~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWD--RTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehh--hcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHh
Confidence            344445555433221112223333322  23457999999986 6666554322 1222   3445566655 4788899


Q ss_pred             CCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       232 ~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      .|++|+|+||.||++.   .++.++|+|||++...+.
T Consensus       276 ~g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVL---KDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEEC---CCCcEEEEeCCCeeECCH
Confidence            9999999999999995   568899999999866543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.23  E-value=7.8e-12  Score=146.10  Aligned_cols=149  Identities=15%  Similarity=0.273  Sum_probs=95.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------------------------------hhHHHH-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------------------------------AYYQQA-  152 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-----------------------------------~~~~~~-  152 (837)
                      ..|+. +.||.|++|+||+|+.+.+|+.||||+++..-                                   ...+.. 
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 78999999999999988889999999997431                                   011122 


Q ss_pred             -----HHHHHHHHHhhcccCCCCCCceeEEeEEEee-cceEEEEEeccch-hHHHHHHhhcc----CCCCHHHHHHHHHh
Q 003239          153 -----LVEVSILTTLNKKYDREDKHHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHF----RGLSLSIVQLFSKQ  221 (837)
Q Consensus       153 -----~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-~~~l~LVmEy~~g-sL~d~l~~~~~----~~L~e~~i~~I~~Q  221 (837)
                           .+|+..+.+++..+.   +...+.+-.++.+ ....+|||||+.| .+.++......    +.+.+..+..++.|
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~---~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFE---DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHcc---CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence                 233334444433221   2222333333322 3567899999986 56553221111    12555556666677


Q ss_pred             HHHHHhhhhcCCeeeccCCCCCeeeecc-CCCCeEEEEecccccccCC
Q 003239          222 ILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       222 Il~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~IKL~DFGlA~~~~~  268 (837)
                      |+       ..|++|+|+||.||+++.+ ...++++++|||++...+.
T Consensus       276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            65       4899999999999999632 1234899999999966544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.23  E-value=6.1e-11  Score=122.02  Aligned_cols=137  Identities=16%  Similarity=0.181  Sum_probs=101.3

Q ss_pred             EEeccCCceeEEEeeccC------CCeEEEEEEEeC--------------Ch---------hhHHH----HHHHHHHHHH
Q 003239          115 DLLGHGTFGQVAKCWDAE------MNSFVAVKIIKN--------------QP---------AYYQQ----ALVEVSILTT  161 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~------tg~~VAIKiik~--------------~~---------~~~~~----~~~Ei~iL~~  161 (837)
                      .+||.|--+.||.|....      .+..+|||+.+.              +.         ...+.    ..+|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999997653      357899999851              10         01112    3479999999


Q ss_pred             hhcccCCCCCCceeEEeEEEeecceEEEEEeccchh-HH-HHHHhhccCCCCHHHHHHHHHhHHHHHhhh-hcCCeeecc
Q 003239          162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN-LY-ELIKINHFRGLSLSIVQLFSKQILRGLSLL-KDAGIIHCD  238 (837)
Q Consensus       162 L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~-d~l~~~~~~~L~e~~i~~I~~QIl~aL~yL-Hs~gIVHrD  238 (837)
                      +...     .-++.+++++    ..-+|||||++++ +. ..++.   ..+++.++..++.|++.+|..| |+.||||+|
T Consensus        83 l~~~-----Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD  150 (197)
T cd05146          83 MQKA-----GIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHAD  150 (197)
T ss_pred             HHHc-----CCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9763     3456677764    4578999999863 21 12222   1356667788899999999999 899999999


Q ss_pred             CCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          239 LKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       239 LKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      |++.|||+.    ++.++|+|||.+...+
T Consensus       151 Ls~~NIL~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE----CCcEEEEECCCceeCC
Confidence            999999995    4679999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.21  E-value=4.9e-11  Score=117.88  Aligned_cols=127  Identities=19%  Similarity=0.097  Sum_probs=93.9

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEec
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL  193 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy  193 (837)
                      ++.|+.|.++.||+++..  ++.|++|+............+|+.+++.+...      ..+.+++.+..  ...++|||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~------~~~P~~~~~~~--~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEA------GIGPKLYYFDP--ETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHh------CCCCceEEEeC--CCCeEEEEe
Confidence            467899999999999754  77899999875542234567899999998642      12455655543  345799999


Q ss_pred             cchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCe-----eeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          194 LDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI-----IHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       194 ~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gI-----VHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ++|. +.+.          ......++.+++++|+.||..++     +|+|++|.||+++    .+.++|+||+.+.
T Consensus        73 i~G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence            9973 3221          01123467899999999999885     9999999999995    4579999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=2.3e-11  Score=139.68  Aligned_cols=196  Identities=22%  Similarity=0.193  Sum_probs=147.6

Q ss_pred             CceEEEEEeccCCceeEEEeecc-CCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA-EMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~-~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .+|..+..||.|.|+.|+.+... .++..|++|.+.+..   ......+.|+.+...+.      .|.++++.+..+...
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~------~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILG------SHLPSVGKNSSWSQL  338 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhh------cccccCCCCCCcccc
Confidence            67899999999999999998644 778899999887542   22233456777766664      578999998888888


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +..||--|||.+...++.. .....+.+...+++..|++.++.++|+..++|+|+||+||++..+.  +..++.||+++.
T Consensus       339 r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t  415 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWT  415 (524)
T ss_pred             ccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccc
Confidence            8888999999753222222 1123488889999999999999999999999999999999996322  778999999986


Q ss_pred             ccCCcceeeccCcccc--CchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          265 TEDRTVYSYIQSRYYR--SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       265 ~~~~~~~~~~GT~~Y~--APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      ...-........-++.  ++++.....+..++|++|||..+.|.+++.+.-
T Consensus       416 ~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  416 RLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccceecccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            5332222233333344  555555568889999999999999999987543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=1.2e-10  Score=124.91  Aligned_cols=138  Identities=21%  Similarity=0.268  Sum_probs=105.1

Q ss_pred             CCCceeEEeEEEeecc-----eEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcC--CeeeccC
Q 003239          170 DKHHIVRIYEYFVCQR-----HLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDA--GIIHCDL  239 (837)
Q Consensus       170 ~HpnIVkl~d~f~~~~-----~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~--gIVHrDL  239 (837)
                      .|.|||+++.++.+.+     ...++.||+. |.+..+|++..  .+.+.+...++|+-||+.||.|||+.  -|+|+++
T Consensus       125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl  204 (458)
T KOG1266|consen  125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL  204 (458)
T ss_pred             HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence            4779999999988764     4788999998 78888887653  24588899999999999999999987  4999999


Q ss_pred             CCCCeeeeccCCCCeEEEEeccccccc-------CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTE-------DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL  310 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~-------~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~  310 (837)
                      ..+-|++.   .++.||+.--......       ........+-++|.|||.=.....+.++|||++|+...||..+.
T Consensus       205 Tc~tifiq---~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  205 TCDTIFIQ---HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             chhheeec---CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999996   5666666432211100       00111224567799999876667788999999999999998765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=2e-09  Score=108.09  Aligned_cols=144  Identities=20%  Similarity=0.164  Sum_probs=109.6

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeC---------ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---------QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---------~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .+..|-+|+-+.|+++.  ..|+.++||.-..         .....++..+|+++|.++...       .|.-..-+|.+
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-------GI~~P~l~~~D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-------GIPAPRLIFID   81 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-------CCCCceEEEEe
Confidence            56788899999999984  4577777776321         123345677899999998653       23333334556


Q ss_pred             cceEEEEEeccch--hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 QRHLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 ~~~l~LVmEy~~g--sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ...-+|+|||++|  ++.+++...............++++|-+.|.-||..+|||+||..+||++..+.....+.|+|||
T Consensus        82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeec
Confidence            6677899999998  88888887654444445557899999999999999999999999999999866666667999999


Q ss_pred             cccc
Q 003239          262 SACT  265 (837)
Q Consensus       262 lA~~  265 (837)
                      ++..
T Consensus       162 ls~~  165 (229)
T KOG3087|consen  162 LSSV  165 (229)
T ss_pred             chhc
Confidence            9843

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.05  E-value=9.3e-10  Score=127.77  Aligned_cols=165  Identities=23%  Similarity=0.266  Sum_probs=125.4

Q ss_pred             EeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhh
Q 003239          127 KCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKIN  205 (837)
Q Consensus       127 ka~~~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~  205 (837)
                      .+..+.++..|.|++++.... ..+...+-++-|+.|       .||||+++++.++.++.+|||+|.+.. |..+++. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-------RHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~-  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-------RHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE-  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-------cCchhhhhhhhhcccCceEEEeecccc-HHHHHHH-
Confidence            456677888999999986543 344566667777777       689999999999999999999999863 2223332 


Q ss_pred             ccCCCCHHHHHHHHHhHHHHHhhhh-cCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcce---eeccCccccC
Q 003239          206 HFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS  281 (837)
Q Consensus       206 ~~~~L~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~---~~~GT~~Y~A  281 (837)
                          +....+...+.||+.||.||| +++++|++|.-..|+|+   ..+..||++|..++.......   ...---.|..
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~  173 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDD  173 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccCCcccccchhhhcccC
Confidence                336778889999999999997 77899999999999996   789999999999865443321   1111223566


Q ss_pred             chhhcCCCCCccchHHHHHHHHHHHHhC
Q 003239          282 PEVLLGYQYTTAIDMWSFGCIVAELFLG  309 (837)
Q Consensus       282 PEvl~~~~yt~ksDIWSLG~ILyELltG  309 (837)
                      |+.+....  ...|.|-|||+++|++.|
T Consensus       174 P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  174 PEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            76653322  457999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.94  E-value=3.5e-09  Score=108.73  Aligned_cols=141  Identities=14%  Similarity=0.158  Sum_probs=98.5

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---ceEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---RHLCI  189 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~~l~L  189 (837)
                      +.|+.|..+.||++.... ++.+++|+......  .......|+++++.++..     +..+.+++.+....   +..++
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~-----~~~vp~~~~~~~~~~~~~~~~~   77 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGT-----GVPVPKVLALCEDPSVLGTPFY   77 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCC-----CCCCCCEEEECCCCCccCCceE
Confidence            578999999999997643 57899999875432  355778899999999652     33466667666554   36789


Q ss_pred             EEeccchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-------------------------------------
Q 003239          190 CFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-------------------------------------  231 (837)
Q Consensus       190 VmEy~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-------------------------------------  231 (837)
                      |||+++|. +.+.+..   ..+++.....++.++++.|..||+                                     
T Consensus        78 v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          78 VMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             EEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            99999863 3332211   135555555666666666666652                                     


Q ss_pred             -------------------CCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          232 -------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       232 -------------------~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                                         ..+||+|+++.||+++.+ ..+.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                               347999999999999632 145689999998853

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=2e-08  Score=101.38  Aligned_cols=129  Identities=22%  Similarity=0.237  Sum_probs=92.3

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEe-C--------ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK-N--------QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik-~--------~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..|.+|+-+.|+.+..  -+..+++|.=. +        .....++..+|..+|.++...     --++..++++  +.+
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~-----GV~~P~v~dv--D~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA-----GVPVPIVYDV--DPD   72 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc-----CCCCCeEEEE--cCC
Confidence            3578899999999844  23346666532 1        123345677899999998653     2345555554  456


Q ss_pred             eEEEEEeccchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ...|+|||++|. |.+.+...         ...+++.+=.-+.-||..||||+||.++||++.    ...+.++|||++.
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~  139 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGE  139 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccc
Confidence            678999999985 55566544         145677777788889999999999999999995    3459999999985


Q ss_pred             c
Q 003239          265 T  265 (837)
Q Consensus       265 ~  265 (837)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            3

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.82  E-value=6.4e-08  Score=104.53  Aligned_cols=127  Identities=16%  Similarity=0.054  Sum_probs=91.4

Q ss_pred             CCeEEEEEEEeCChh--hH----------HHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-----cceEEEEEeccc
Q 003239          133 MNSFVAVKIIKNQPA--YY----------QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-----QRHLCICFELLD  195 (837)
Q Consensus       133 tg~~VAIKiik~~~~--~~----------~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-----~~~l~LVmEy~~  195 (837)
                      .|+.|.||.......  ..          ..+.+|...+..|...     .-.+++++.+.+.     ...-+||||+++
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~-----GIptP~pVa~~e~~~~~~~~~s~LVte~l~  118 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEV-----GVDTMTGVAFGERGSNPATRTSFIITEDLA  118 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHc-----CCCCCCeeEEEEecCCCccceeEEEEeeCC
Confidence            456788886643220  01          1477899999888653     1223444444433     235789999999


Q ss_pred             h--hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc----CCCCeEEEEeccccc
Q 003239          196 S--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----VKPAEIKIIDFGSAC  264 (837)
Q Consensus       196 g--sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~----~~~~~IKL~DFGlA~  264 (837)
                      +  +|.+++........++.....++.+|+..+.-||..||+|+||++.|||++.+    .+...+.|+||+.+.
T Consensus       119 ~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        119 PTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            7  68888764323446777888999999999999999999999999999999731    245789999999884

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=2.9e-08  Score=101.73  Aligned_cols=127  Identities=28%  Similarity=0.296  Sum_probs=81.3

Q ss_pred             eEEEeeccCCCeEEEEEEEeCC---------------------------hhhHHHHHHHHHHHHHhhcccCCCCCCceeE
Q 003239          124 QVAKCWDAEMNSFVAVKIIKNQ---------------------------PAYYQQALVEVSILTTLNKKYDREDKHHIVR  176 (837)
Q Consensus       124 ~Vyka~~~~tg~~VAIKiik~~---------------------------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk  176 (837)
                      .||.|.. ..++.+|||+.+..                           ........+|.+.|.++...     .-++.+
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~-----Gv~vP~   74 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEA-----GVPVPK   74 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCT-----T-SS--
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHC-----CccCCc
Confidence            4788865 45778999998521                           01124567799999998653     235667


Q ss_pred             EeEEEeecceEEEEEeccc--hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhh-hhcCCeeeccCCCCCeeeeccCCCC
Q 003239          177 IYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSL-LKDAGIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       177 l~d~f~~~~~l~LVmEy~~--gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~y-LHs~gIVHrDLKPeNILl~~~~~~~  253 (837)
                      ++++-    .-+|||||++  |.....+....   ++......++.+++..+.. +|+.||||+||.+.|||++    .+
T Consensus        75 p~~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~  143 (188)
T PF01163_consen   75 PYDYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DG  143 (188)
T ss_dssp             EEEEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TT
T ss_pred             EEEEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cc
Confidence            76552    4579999999  64333333322   2244567788888885555 5799999999999999995    23


Q ss_pred             eEEEEecccccccC
Q 003239          254 EIKIIDFGSACTED  267 (837)
Q Consensus       254 ~IKL~DFGlA~~~~  267 (837)
                      .+.|+|||.+....
T Consensus       144 ~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CEEE--GTTEEETT
T ss_pred             eEEEEecCcceecC
Confidence            89999999986544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.69  E-value=2.9e-07  Score=104.56  Aligned_cols=166  Identities=16%  Similarity=0.154  Sum_probs=123.4

Q ss_pred             ceeEEEeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec----ceEEEEEeccc-
Q 003239          122 FGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ----RHLCICFELLD-  195 (837)
Q Consensus       122 fG~Vyka~~~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~----~~l~LVmEy~~-  195 (837)
                      -.+.|+|....+|..|++|.+..++. .......-+++++++       .|.|||++.++|...    ..+++|++|.+ 
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-------~h~NvV~frevf~t~tF~D~SlvlvYDYyP~  361 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-------CHTNVVPFREVFLTYTFGDLSLVLVYDYYPS  361 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-------ccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence            35789999999999999999943221 122233456677777       688999999999843    47999999997 


Q ss_pred             -hhHHHHHHhhc-------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          196 -SNLYELIKINH-------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       196 -gsL~d~l~~~~-------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       ++|+++.-...             ....+|+.+|.++.||..||.++|+.|+.-+-|.+.+||++   .+.+|+|.-.|
T Consensus       362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~  438 (655)
T KOG3741|consen  362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCG  438 (655)
T ss_pred             CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEeccc
Confidence             48888764321             23478999999999999999999999999999999999996   44478887777


Q ss_pred             cccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCC
Q 003239          262 SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       262 lA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      ..........           |.+..   -.+-|.=.||.+++.|.||..
T Consensus       439 i~Dvl~~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  439 IMDVLQEDPT-----------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             ceeeecCCCC-----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            6543322210           11211   235688899999999999953

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=1.4e-08  Score=118.68  Aligned_cols=152  Identities=22%  Similarity=0.314  Sum_probs=109.2

Q ss_pred             hHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcce------------eeccCccccCchhhcC
Q 003239          221 QILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY------------SYIQSRYYRSPEVLLG  287 (837)
Q Consensus       221 QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~------------~~~GT~~Y~APEvl~~  287 (837)
                      +++.||.|+|. .++||++|.|++|.++   ..+..||+.|+++........            .......|.|||++..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            44499999995 5999999999999995   778899999998854332110            1123566999999999


Q ss_pred             CCCCccchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCC
Q 003239          288 YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGG  366 (837)
Q Consensus       288 ~~yt~ksDIWSLG~ILyELl-tG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~  366 (837)
                      ...+.++|++||||++|.+. .|+..+......... .+.....                         +          
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~-------------------------~----------  227 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLL-------------------------N----------  227 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhccc-------------------------c----------
Confidence            88999999999999999999 567666443221111 1100000                         0          


Q ss_pred             ccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHH
Q 003239          367 RSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ  446 (837)
Q Consensus       367 ~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~E  446 (837)
                                             ...|                       .....++.++++=|.++|..|+..||++.+
T Consensus       228 -----------------------~~~~-----------------------~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  228 -----------------------AGAF-----------------------GYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             -----------------------cccc-----------------------cccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence                                   0000                       001234578899999999999999999999


Q ss_pred             HHcCccCCCCC
Q 003239          447 ASRHPFVTGEP  457 (837)
Q Consensus       447 aL~HPff~~~~  457 (837)
                      ++..|||.+..
T Consensus       262 l~~~~ff~D~~  272 (700)
T KOG2137|consen  262 LLSIPFFSDPG  272 (700)
T ss_pred             hhcccccCCch
Confidence            99999999855

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=5.2e-07  Score=93.59  Aligned_cols=110  Identities=24%  Similarity=0.199  Sum_probs=85.4

Q ss_pred             HHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec----ceEEEEEeccch--hHHHHHHhhccCCCCHHHHHHHHHhH
Q 003239          149 YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ----RHLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQI  222 (837)
Q Consensus       149 ~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~----~~l~LVmEy~~g--sL~d~l~~~~~~~L~e~~i~~I~~QI  222 (837)
                      .....+|...+..|...     .-.+.+.+.+.+..    ...+||+|++++  +|.+++.....  ++......++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~-----Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l  127 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREA-----GIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRAL  127 (206)
T ss_pred             chHHHHHHHHHHHHHHc-----CCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHH
Confidence            34677898888888653     22355666655543    246899999986  68888776432  6677788999999


Q ss_pred             HHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       223 l~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +..+.-||.+||+|+|+++.|||+..+.....+.|+||+.+..
T Consensus       128 ~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  128 ARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999999999998555456899999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.47  E-value=6.6e-07  Score=95.34  Aligned_cols=148  Identities=20%  Similarity=0.212  Sum_probs=105.6

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----------Ch-------------hhHHHHHHHHHHHHHhhcccC
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----------QP-------------AYYQQALVEVSILTTLNKKYD  167 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----------~~-------------~~~~~~~~Ei~iL~~L~~~~~  167 (837)
                      +.+..+||.|--+.||.|.+. .+..+|||.-+.          ..             .....+.+|.++|++|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~--  169 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE--  169 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc--
Confidence            456789999999999999876 578899998541          11             1234567899999999531  


Q ss_pred             CCCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeee
Q 003239          168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC  247 (837)
Q Consensus       168 ~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~  247 (837)
                         --.|.+.+++    +..++|||+++|..+.-+      +++.+....++..|++-+.-+-..||||+|+.+-||+++
T Consensus       170 ---G~~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~  236 (304)
T COG0478         170 ---GVKVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT  236 (304)
T ss_pred             ---CCCCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence               1246666654    567899999998422111      123455666677777777777789999999999999996


Q ss_pred             ccCCCCeEEEEecccccccCCcceeeccCccccCchhhcC
Q 003239          248 TSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG  287 (837)
Q Consensus       248 ~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~  287 (837)
                         +++.+.++||-.+......          -|+|++..
T Consensus       237 ---~dg~~~vIDwPQ~v~~~hp----------~a~e~l~R  263 (304)
T COG0478         237 ---EDGDIVVIDWPQAVPISHP----------DAEELLER  263 (304)
T ss_pred             ---cCCCEEEEeCcccccCCCC----------CHHHHHHh
Confidence               6788999999887554433          35666654

>PRK09902 hypothetical protein; Provisional

Probab=98.42  E-value=2.7e-06  Score=88.44  Aligned_cols=139  Identities=13%  Similarity=0.091  Sum_probs=102.1

Q ss_pred             ccCCceeEEEeeccCCCeEEEEEEEeCC-------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-----c
Q 003239          118 GHGTFGQVAKCWDAEMNSFVAVKIIKNQ-------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-----R  185 (837)
Q Consensus       118 G~G~fG~Vyka~~~~tg~~VAIKiik~~-------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-----~  185 (837)
                      |.|+-+-|++....  |+.+-+|.-.+.       +.....+.+|+..|+.|...    +-| +.++. ++...     -
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~----GvP-VP~pv-f~~~~k~~~~~   98 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERA----GVI-VPKIV-FGEAVKIEGEW   98 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHc----CCC-CCccc-eeeeeccCCce
Confidence            55888888887432  335777765421       22356788999999999764    333 55555 33221     2


Q ss_pred             eEEEEEeccch--hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          186 HLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       186 ~l~LVmEy~~g--sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .-+||+|-+++  +|.+++......+.++.....++.+|+..|.-||+.|+.|+|+.+.||+++.. ....++++||.-+
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~  177 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKS  177 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhcc
Confidence            47899999984  88888766554557888889999999999999999999999999999999632 2346999999877


Q ss_pred             cc
Q 003239          264 CT  265 (837)
Q Consensus       264 ~~  265 (837)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            53

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.29  E-value=7.2e-08  Score=111.53  Aligned_cols=184  Identities=17%  Similarity=0.157  Sum_probs=142.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCc-eeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH-IVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~Hpn-IVkl~d~f~~~~~l  187 (837)
                      +.|...+-++++++++++|.+...+...+ .|.+...    ....-++++|.++       +||| .+..++-++.+.+.
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~-------n~P~~~v~~~~d~~~E~~~  309 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKV-------NNPNPVVRYLEDYDGEDYL  309 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHc-------cCCCCcccccccCCccccc
Confidence            45666677899999999999887776666 7777654    3344578888888       5778 77778888888899


Q ss_pred             EEEEeccchh--HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          188 CICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       188 ~LVmEy~~gs--L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +++|+++.+.  ......... -.+.+-+...+++.-+++|++||+.-=+|+|    ||+.+    ....|+.||+.+..
T Consensus       310 ~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQ  380 (829)
T ss_pred             chhhhhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcc
Confidence            9999999853  222111111 1245556677888889999999998889998    88884    46789999999877


Q ss_pred             cCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          266 EDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       266 ~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      ....  .....+++.++|||++....+..+.|.|++++-..+|.-|.+|-
T Consensus       381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            6665  56678999999999999999999999999998777777777665

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.17  E-value=1.2e-05  Score=85.13  Aligned_cols=138  Identities=22%  Similarity=0.215  Sum_probs=96.2

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh-------------------------HHHHHHHHHHHHHhhcccCC
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-------------------------YQQALVEVSILTTLNKKYDR  168 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~-------------------------~~~~~~Ei~iL~~L~~~~~~  168 (837)
                      ...|..|--+.||+|.. .++..||+|+++.....                         ......|..-|+++...   
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA---  128 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA---  128 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc---
Confidence            34788899999999954 56889999999632111                         11234577777777543   


Q ss_pred             CCCCceeEEeEEEeecceEEEEEeccchhH--HHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCee
Q 003239          169 EDKHHIVRIYEYFVCQRHLCICFELLDSNL--YELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENIL  245 (837)
Q Consensus       169 ~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL--~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNIL  245 (837)
                        +-.+.+.+.+.    .-.|||||++...  .-.|+.-   ++...++..+..++++.+.-|-. .++||+||..-|||
T Consensus       129 --GVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         129 --GVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             --CCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence              33455555543    3579999997431  1111111   23344688888999999998887 89999999999999


Q ss_pred             eeccCCCCeEEEEecccccccCC
Q 003239          246 LCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       246 l~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      +.    ++.+.|+||+.|.....
T Consensus       200 ~~----~~~p~iID~~QaV~~~h  218 (268)
T COG1718         200 VH----DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             EE----CCeEEEEECccccccCC
Confidence            94    67899999999976553

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.16  E-value=2.1e-05  Score=82.38  Aligned_cols=137  Identities=15%  Similarity=0.179  Sum_probs=89.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHH----------HHHHHHHHHHhhcccCCCCCCceeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----------ALVEVSILTTLNKKYDREDKHHIVRI  177 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~----------~~~Ei~iL~~L~~~~~~~~HpnIVkl  177 (837)
                      ..+|++++++-......|.+.  ..+++.+++|.-+......++          ..+++..+..+...    +...+..+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~----g~~~~~~~  103 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNE----GFTEPADP  103 (229)
T ss_pred             hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHc----Cccccccc
Confidence            478999999998888888776  445688999998754222222          22334444444322    22233333


Q ss_pred             eEE-----EeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          178 YEY-----FVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       178 ~d~-----f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      +-+     +......+|||||++| .|.++..      +++    .+...|.++|.-||+.|++|+|++|.|++++    
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----  169 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----  169 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----
Confidence            222     2223456799999998 4544321      232    2445677889999999999999999999995    


Q ss_pred             CCeEEEEeccccc
Q 003239          252 PAEIKIIDFGSAC  264 (837)
Q Consensus       252 ~~~IKL~DFGlA~  264 (837)
                      ++.++++||+..+
T Consensus       170 ~~~i~iID~~~k~  182 (229)
T PF06176_consen  170 NNGIRIIDTQGKR  182 (229)
T ss_pred             CCcEEEEECcccc
Confidence            4559999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.10  E-value=6.1e-05  Score=77.42  Aligned_cols=75  Identities=12%  Similarity=0.137  Sum_probs=54.0

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---cceEEEE
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---QRHLCIC  190 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---~~~l~LV  190 (837)
                      ++.|+.|..+.||++....  ..+++|+.... .....+..|..+++.|...    . ..+.+++.....   ....+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~----~-~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEH----G-IPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHT----T-SBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhc----C-CCCceEEeecccccccccceEE
Confidence            5679999999999997654  47899998755 4566788899999999753    1 135566654433   3457999


Q ss_pred             Eeccch
Q 003239          191 FELLDS  196 (837)
Q Consensus       191 mEy~~g  196 (837)
                      |+++.|
T Consensus        74 ~~~i~g   79 (239)
T PF01636_consen   74 MEYIPG   79 (239)
T ss_dssp             EEEESS
T ss_pred             EEEecc
Confidence            999886

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.05  E-value=1.6e-05  Score=93.06  Aligned_cols=146  Identities=18%  Similarity=0.282  Sum_probs=88.4

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------------------------------hhHH------HHH
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------------------------------AYYQ------QAL  153 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-----------------------------------~~~~------~~~  153 (837)
                      +.|+.++-|+||+|+.+. |+.||||+.+..-                                   ...+      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            579999999999997654 9999999984210                                   0011      123


Q ss_pred             HHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC
Q 003239          154 VEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA  232 (837)
Q Consensus       154 ~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~  232 (837)
                      +|..-+.++++.+.  +.++|.--.=+++....-+|+|||++| .+.+...... .+++...+.....++.  +..+-..
T Consensus       210 ~EA~n~~~~~~nf~--~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFK--DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcC--CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence            35555555554432  233322222222334667999999998 4555432222 3355333322222211  1222237


Q ss_pred             CeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc
Q 003239          233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT  269 (837)
Q Consensus       233 gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~  269 (837)
                      |++|+|.+|.||++.   .++++.+.|||+....+..
T Consensus       285 gffHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVR---SDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEe---cCCcEEEEcCcceecCCHH
Confidence            999999999999996   6689999999998655443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=8.2e-05  Score=77.08  Aligned_cols=134  Identities=22%  Similarity=0.312  Sum_probs=99.4

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------------hhHHHHHHHHHHHHHhhcccCCCCCCceeEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------------AYYQQALVEVSILTTLNKKYDREDKHHIVRI  177 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-----------------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl  177 (837)
                      ..||+|+.-.||.-  .. ....+||+++...                 ....+..+|+.....+.. .....+.+|.++
T Consensus         7 ~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~-~~~~~~~~i~r~   82 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSL-RRGVDWSHIPRF   82 (199)
T ss_pred             cccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhh-ccCCcccccccE
Confidence            46999999999975  32 3346789987544                 335677888888888863 234467799999


Q ss_pred             eEEEeecceEEEEEeccc---h----hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC
Q 003239          178 YEYFVCQRHLCICFELLD---S----NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV  250 (837)
Q Consensus       178 ~d~f~~~~~l~LVmEy~~---g----sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~  250 (837)
                      +++.+.+..+-+|+|.+.   |    +|.++++..   .+++ .++..+.   +-.+||-+.+|+.+||+|.||++....
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecC
Confidence            999999999999999863   3    677777544   3655 4444444   445677888999999999999998665


Q ss_pred             CCC-eEEEEe
Q 003239          251 KPA-EIKIID  259 (837)
Q Consensus       251 ~~~-~IKL~D  259 (837)
                      +.. .+.|+|
T Consensus       156 ~~~~~lvlID  165 (199)
T PF10707_consen  156 SGEFRLVLID  165 (199)
T ss_pred             CCceEEEEEe
Confidence            555 788888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.99  E-value=8.4e-05  Score=78.45  Aligned_cols=73  Identities=11%  Similarity=0.018  Sum_probs=53.9

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEecc
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL  194 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~  194 (837)
                      ..|++|..+.||+..    +..+++|+..... ......+|.++++.+...     .-.+.+++++....+...+|||++
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~-----glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-DKETIKREFDASRKVFSL-----GIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHc-----CCCCCceEEEEecCCeeeeeeeec
Confidence            578999999999842    3457788887533 335568899999998642     123567777777777888999999


Q ss_pred             chh
Q 003239          195 DSN  197 (837)
Q Consensus       195 ~gs  197 (837)
                      +|.
T Consensus        77 ~G~   79 (226)
T TIGR02172        77 VGK   79 (226)
T ss_pred             CCc
Confidence            873

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.94  E-value=3e-05  Score=86.59  Aligned_cols=189  Identities=13%  Similarity=0.215  Sum_probs=125.3

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe------ec-ce
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV------CQ-RH  186 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~------~~-~~  186 (837)
                      .+.||+|+-+.+|-.-..  +. .+-|++..-..-.+.-  .+..|..      ..+||-+-.-+.+-.      .. ..
T Consensus        16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aq--k~a~la~------~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQ--KVAELAA------TPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CccccCCccceeeecchh--hc-hhheeecCCCchHHHH--HHHHhcc------CCCCcchhhhhcccHHHhhCCCccce
Confidence            467999999999976322  22 3447776543222211  1111211      224443332111111      11 23


Q ss_pred             EEEEEeccch--hHHHHHHh----hccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          187 LCICFELLDS--NLYELIKI----NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       187 l~LVmEy~~g--sL~d~l~~----~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      +-+.|+.+.|  ...+++.-    ..+....+..+.++.+.|+.+.+.||..|.+-+|++++|||+.   ++..+.|+|=
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcc
Confidence            6778888875  44444432    2233477889999999999999999999999999999999996   6788899885


Q ss_pred             cccc--ccCCcceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhC-CCCCCCC
Q 003239          261 GSAC--TEDRTVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG-LPLFPGA  316 (837)
Q Consensus       261 GlA~--~~~~~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG-~~PF~g~  316 (837)
                      ..-.  ..+......+|...|.+||.-.     +..-+...|.|-||+++++|+.| +.||.+-
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            5432  1223334567899999999875     33556789999999999999986 9999764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.93  E-value=9e-05  Score=76.71  Aligned_cols=127  Identities=24%  Similarity=0.346  Sum_probs=93.1

Q ss_pred             CceEEEEEeccCCc-eeEEEeeccCCCeEEEEEEEeC---------------Ch-------hhHHHHHHHHHHHHHhhcc
Q 003239          109 RRYIVKDLLGHGTF-GQVAKCWDAEMNSFVAVKIIKN---------------QP-------AYYQQALVEVSILTTLNKK  165 (837)
Q Consensus       109 ~~Y~i~~~LG~G~f-G~Vyka~~~~tg~~VAIKiik~---------------~~-------~~~~~~~~Ei~iL~~L~~~  165 (837)
                      .+++.++.||.|.- |.||+++  -.|+.+|||+.+.               ..       ....-+..|.+..-+|+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68899999999999 9999994  4577999999431               00       2233467788888888654


Q ss_pred             cCCCCCCce--eEEeEEEeecc------------------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHH
Q 003239          166 YDREDKHHI--VRIYEYFVCQR------------------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG  225 (837)
Q Consensus       166 ~~~~~HpnI--Vkl~d~f~~~~------------------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~a  225 (837)
                          ++.++  |++++++.-..                  ...||.||+...-          .+..    .-+.+|++-
T Consensus       115 ----~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~d  176 (207)
T PF13095_consen  115 ----GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRD  176 (207)
T ss_pred             ----cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHH
Confidence                55566  99999885431                  2467888776432          1222    234577788


Q ss_pred             HhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       226 L~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      |..+|+.||+-+|+|+.|..=.        ||+|||.+
T Consensus       177 l~~~~k~gI~~~Dv~~~ny~~G--------~lvDfs~~  206 (207)
T PF13095_consen  177 LKILHKLGIVPRDVKPRNYRGG--------KLVDFSSS  206 (207)
T ss_pred             HHHHHHCCeeeccCccccccCC--------EEEecccC
Confidence            8899999999999999998643        99999975

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.90  E-value=0.00011  Score=77.68  Aligned_cols=71  Identities=15%  Similarity=0.066  Sum_probs=51.1

Q ss_pred             EeccCCc-eeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEecc
Q 003239          116 LLGHGTF-GQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL  194 (837)
Q Consensus       116 ~LG~G~f-G~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~  194 (837)
                      .|-.|.. ..||++...  +..+.||+.....  .....+|+++++.+..      +--+.+++++....+..++|||++
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~------~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAG------KLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHh------cCCCCeEEEEEecCCccEEEEEee
Confidence            3445555 789998543  3678888886543  3456789999999864      234677788777767789999999


Q ss_pred             ch
Q 003239          195 DS  196 (837)
Q Consensus       195 ~g  196 (837)
                      +|
T Consensus        75 ~G   76 (244)
T cd05150          75 PG   76 (244)
T ss_pred             CC
Confidence            87

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.85  E-value=6.6e-05  Score=87.92  Aligned_cols=147  Identities=17%  Similarity=0.186  Sum_probs=88.3

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCCh--------------------------------hhHHH------HHHHH
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--------------------------------AYYQQ------ALVEV  156 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--------------------------------~~~~~------~~~Ei  156 (837)
                      +.|+.-+.++|++|+.+. |+.||||+-+..-                                ...+.      +.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999997665 9999999975210                                00111      22233


Q ss_pred             HHHHHhhcccCCCC---CCceeEEeEEEeecceEEEEEeccch---hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh
Q 003239          157 SILTTLNKKYDRED---KHHIVRIYEYFVCQRHLCICFELLDS---NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK  230 (837)
Q Consensus       157 ~iL~~L~~~~~~~~---HpnIVkl~d~f~~~~~l~LVmEy~~g---sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH  230 (837)
                      +-..++++.+....   --.|.++|-.+  ....+|+||||+|   +-.+.++..   +++...+..-+.++..-+  |=
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~q--If  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQ--IF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHH--HH
Confidence            33333322221111   11144443322  2467999999997   333455544   366554444333332222  22


Q ss_pred             cCCeeeccCCCCCeeeecc-CCCCeEEEEecccccccCCc
Q 003239          231 DAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTEDRT  269 (837)
Q Consensus       231 s~gIVHrDLKPeNILl~~~-~~~~~IKL~DFGlA~~~~~~  269 (837)
                      ..|++|+|-+|.||++..+ ..+..+.|-|||+.......
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            4689999999999999743 24678999999998765544

>PLN02876 acyl-CoA dehydrogenase

Probab=97.67  E-value=0.00036  Score=86.99  Aligned_cols=80  Identities=11%  Similarity=0.065  Sum_probs=54.6

Q ss_pred             EEEeccCCceeEEEeeccCCC--eEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---ce
Q 003239          114 KDLLGHGTFGQVAKCWDAEMN--SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---RH  186 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg--~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~~  186 (837)
                      ++.|+.|.+..+|+......+  ..+++|+.....  .....+.+|.++|+.|...    ....+.+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~----~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEH----TDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhc----CCCCCCcEEEEecCCCcCCC
Confidence            577899999999998654332  457777764321  2234677999999999521    122357777777654   46


Q ss_pred             EEEEEeccchh
Q 003239          187 LCICFELLDSN  197 (837)
Q Consensus       187 l~LVmEy~~gs  197 (837)
                      .|+|||+++|.
T Consensus       119 ~flVME~v~G~  129 (822)
T PLN02876        119 AFYIMEYLEGR  129 (822)
T ss_pred             ceEEEEecCCc
Confidence            78999999874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.63  E-value=0.0007  Score=83.96  Aligned_cols=150  Identities=17%  Similarity=0.236  Sum_probs=97.0

Q ss_pred             HHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE----EEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHh
Q 003239          153 LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC----ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS  227 (837)
Q Consensus       153 ~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~----LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~  227 (837)
                      ..|+..+.++       .|+|++.++.+-......-    +..|+|.. ++...+..-  ..++.+.++.+..++++||.
T Consensus       230 E~e~~~l~k~-------~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~  300 (1351)
T KOG1035|consen  230 EIELESLSKI-------AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLA  300 (1351)
T ss_pred             HHHHHHHHhh-------ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHH
Confidence            3345555555       5889999988876654332    33445553 455554433  45889999999999999999


Q ss_pred             hhhcCCeeeccCCCCCeeeeccCCCCeEEEE--ecccccccCCcce--eeccCccccCchhhcCCCCCc--cchHHHHHH
Q 003239          228 LLKDAGIIHCDLKPENILLCTSVKPAEIKII--DFGSACTEDRTVY--SYIQSRYYRSPEVLLGYQYTT--AIDMWSFGC  301 (837)
Q Consensus       228 yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~--DFGlA~~~~~~~~--~~~GT~~Y~APEvl~~~~yt~--ksDIWSLG~  301 (837)
                      |+|+....|.-|...-..-...+..+.+.+.  ||+..........  ....+..+.++|......++.  ..|+|.+|.
T Consensus       301 ~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  301 YLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            9999855444433332211112344555555  8888765543322  234456678888887776655  479999999


Q ss_pred             HHHHHHhCCC
Q 003239          302 IVAELFLGLP  311 (837)
Q Consensus       302 ILyELltG~~  311 (837)
                      .+..+..|..
T Consensus       381 l~~~~~~~~~  390 (1351)
T KOG1035|consen  381 LLLQLSQGED  390 (1351)
T ss_pred             HHhhhhhcCc
Confidence            9988887654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.49  E-value=0.0013  Score=68.83  Aligned_cols=73  Identities=18%  Similarity=0.220  Sum_probs=47.9

Q ss_pred             EEEeccCCceeEEEeeccC-CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEe
Q 003239          114 KDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE  192 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~-tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE  192 (837)
                      ++.|..|-...||++.... .++.|++|+............+|+.+++.+...      .-.++++..+.    -.+|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~------gl~P~v~~~~~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKH------GLAPKLYATFQ----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhC------CCCCeEEEEeC----CcEEEE
Confidence            4667888889999986543 356788998765432223345799999998642      12455555433    147999


Q ss_pred             ccch
Q 003239          193 LLDS  196 (837)
Q Consensus       193 y~~g  196 (837)
                      |++|
T Consensus        73 ~i~G   76 (235)
T cd05157          73 FIPG   76 (235)
T ss_pred             eeCC
Confidence            9875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.44  E-value=0.00046  Score=69.88  Aligned_cols=131  Identities=26%  Similarity=0.230  Sum_probs=89.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ...++.+.|++|.++.||++..  .+..+|+|+-+.+. ....+..|.++|+.++..      ---.++|.+    +...
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~------~~~p~vy~y----g~~~   88 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-PRRNLEKEAKILEILAGE------GVTPEVYFY----GEDF   88 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCc-chhhHHHHHHHHHHhhhc------CCCceEEEe----chhh
Confidence            3445678899999999999954  46689999887553 356788899999998643      123344444    3345


Q ss_pred             EEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCC-CC-CeeeeccCCCCeEEEEecccccc
Q 003239          189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLK-PE-NILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       189 LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLK-Pe-NILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +.|||+.| .|.+.....     +    ++-+..+++.---|-..||-|+.|. |. ||++    .+..+.|+||..|+.
T Consensus        89 i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~  155 (201)
T COG2112          89 IRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence            66999998 665543321     1    2334456666556777899999886 44 5555    345899999999963

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.41  E-value=0.00086  Score=70.71  Aligned_cols=72  Identities=11%  Similarity=0.011  Sum_probs=43.7

Q ss_pred             EEeccCCce-eEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---ceEEEE
Q 003239          115 DLLGHGTFG-QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---RHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG-~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~~l~LV  190 (837)
                      +.|+.|+.. .||++.     ..+++|+.+.. .......+|.++|+.|.... ..   -+.++++.....   ...++|
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~-~v---~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHL-PL---PVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc-chHHHHHHHHHHHHHHhccC-CC---CCCceeecCCCccCCCcceEE
Confidence            457766666 599862     24677876543 23457888999999986420 11   233444433322   245889


Q ss_pred             Eeccch
Q 003239          191 FELLDS  196 (837)
Q Consensus       191 mEy~~g  196 (837)
                      ||+++|
T Consensus        73 ~~~i~G   78 (235)
T cd05155          73 YRWLEG   78 (235)
T ss_pred             EEeecC
Confidence            999876

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.32  E-value=0.0036  Score=71.59  Aligned_cols=77  Identities=22%  Similarity=0.255  Sum_probs=55.3

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeC------C--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN------Q--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~------~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .+.||.|.+..||++.+...++.|+||.-..      +  ....++...|.+.|+.+...    .-.++.+++.+  +.+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~----~p~~VPkV~~~--D~~  104 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKY----VPDLVPKVYHY--DEE  104 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhh----CCCCCCeEEEE--CCC
Confidence            4679999999999998765446899998431      1  22456778899999988642    22357777776  345


Q ss_pred             eEEEEEeccch
Q 003239          186 HLCICFELLDS  196 (837)
Q Consensus       186 ~l~LVmEy~~g  196 (837)
                      ..++|||++++
T Consensus       105 ~~~lVME~L~~  115 (401)
T PRK09550        105 LAVTVMEDLSD  115 (401)
T ss_pred             CCEEEEecCCC
Confidence            67899999874

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.18  E-value=0.0026  Score=70.87  Aligned_cols=140  Identities=23%  Similarity=0.233  Sum_probs=96.6

Q ss_pred             EEEEEeccCCceeEEEeeccCCCeEEEEEEEeC------C-------------------h--hhHHHHHHHHHHHHHhhc
Q 003239          112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN------Q-------------------P--AYYQQALVEVSILTTLNK  164 (837)
Q Consensus       112 ~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~------~-------------------~--~~~~~~~~Ei~iL~~L~~  164 (837)
                      .|..+|..|--+.||.|. ..+|..+|||+++.      +                   +  .....+..|+.-|++|+.
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            355688899999999995 45677799999862      0                   1  111234567778888865


Q ss_pred             ccCCCCCCceeEEeEEEeecceEEEEEeccchhH--HHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh-cCCeeeccCCC
Q 003239          165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNL--YELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKP  241 (837)
Q Consensus       165 ~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL--~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKP  241 (837)
                      .-....-|.++         ...+|||++++.+-  .-.|+..   .++...++.+-.|++.-+.-|- .+++||.||.-
T Consensus       226 aGIP~PePIlL---------k~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE  293 (520)
T KOG2270|consen  226 AGIPCPEPILL---------KNHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE  293 (520)
T ss_pred             cCCCCCCceee---------ecceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence            42222222222         23579999998432  2222222   3777788888888888888775 67899999999


Q ss_pred             CCeeeeccCCCCeEEEEecccccccCC
Q 003239          242 ENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       242 eNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      -|+|+    ..+.+.|+|.+.+...+.
T Consensus       294 fN~Ly----hdG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  294 FNLLY----HDGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             hhheE----ECCEEEEEEccccccCCC
Confidence            99999    578999999998865443

>PRK05231 homoserine kinase; Provisional

Probab=97.09  E-value=0.0061  Score=67.12  Aligned_cols=77  Identities=5%  Similarity=-0.091  Sum_probs=46.2

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe---EEEeecceEEEE
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY---EYFVCQRHLCIC  190 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~---d~f~~~~~l~LV  190 (837)
                      ++.|..|....+|++... ++ .+++|++..  ...+....|+.+++.|...  ....|.+++-.   .+....+..+++
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~--glpvP~~i~~~~G~~~~~~~g~~~~l  100 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAAR--GVPVPAPVARRDGAALGELAGKPAAI  100 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHC--CCCCCcceeCCCCCEeeeeCCEEEEE
Confidence            345777888899998543 33 588898762  2234555677888888643  11223333211   122335678999


Q ss_pred             Eeccch
Q 003239          191 FELLDS  196 (837)
Q Consensus       191 mEy~~g  196 (837)
                      ||+++|
T Consensus       101 ~~~l~G  106 (319)
T PRK05231        101 VTFLEG  106 (319)
T ss_pred             EEecCC
Confidence            999876

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.05  E-value=0.0029  Score=68.69  Aligned_cols=140  Identities=16%  Similarity=0.150  Sum_probs=80.7

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE------EEeecceE
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE------YFVCQRHL  187 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d------~f~~~~~l  187 (837)
                      ++.|..|....+|++..  .+..+++|+...  ........|+++++.|...    +. .+.+++.      +....+..
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~----g~-~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAER----GL-PVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHC----CC-CCCccccCCCCcEeeeeCCce
Confidence            55677888889999853  334688898875  2345677799999998653    21 2444433      22334567


Q ss_pred             EEEEeccchhHH------------HHHHhhc--cCCCC--------HHHHH------------HHHHhHHHHHhhhhc--
Q 003239          188 CICFELLDSNLY------------ELIKINH--FRGLS--------LSIVQ------------LFSKQILRGLSLLKD--  231 (837)
Q Consensus       188 ~LVmEy~~gsL~------------d~l~~~~--~~~L~--------e~~i~------------~I~~QIl~aL~yLHs--  231 (837)
                      ++||++++|...            ..+..-.  ...+.        .....            .....+..++.++.+  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            899999875211            1110000  00000        00000            011112233444442  


Q ss_pred             -----CCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          232 -----AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       232 -----~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                           .++||+|+.|.|||++   ++..+.|+||+.+..
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~  205 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT  205 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence                 4799999999999996   445568999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.02  E-value=0.0029  Score=69.03  Aligned_cols=73  Identities=14%  Similarity=0.110  Sum_probs=47.6

Q ss_pred             EEEeccCCceeEEEeeccC------CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          114 KDLLGHGTFGQVAKCWDAE------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ++.|..|-...||++....      .++.|++|+............+|.++++.+...      --..+++.++..    
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~------g~~P~~~~~~~~----   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSER------NLGPKLYGIFPN----   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhC------CCCCceEEEeCC----
Confidence            3456667777888886433      257899999876544445667899999999653      123455555432    


Q ss_pred             EEEEeccch
Q 003239          188 CICFELLDS  196 (837)
Q Consensus       188 ~LVmEy~~g  196 (837)
                      .+|+||++|
T Consensus        73 ~~v~e~i~G   81 (302)
T cd05156          73 GRIEEFIPS   81 (302)
T ss_pred             CchhheeCC
Confidence            357888765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.95  E-value=0.0022  Score=68.48  Aligned_cols=132  Identities=16%  Similarity=0.112  Sum_probs=72.5

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCChhhH-HHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccc
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY-QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD  195 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~-~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~  195 (837)
                      +..|-...+|++.  .+++.+++|+........ -...+|..+++.+...    +  -..+++....    -++||||++
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~----g--~~P~~i~~~~----~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSAL----G--LAPKPILVNE----HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhc----C--CCCceEEEeC----CEEEEEecc
Confidence            4567778899885  456678888865432221 2356799999999642    1  1233333322    368999988


Q ss_pred             hhHH---------------HHHHhhcc-----CCCCH-HHHHHHHHh------------HHHHHhhhh-----cCCeeec
Q 003239          196 SNLY---------------ELIKINHF-----RGLSL-SIVQLFSKQ------------ILRGLSLLK-----DAGIIHC  237 (837)
Q Consensus       196 gsL~---------------d~l~~~~~-----~~L~e-~~i~~I~~Q------------Il~aL~yLH-----s~gIVHr  237 (837)
                      |...               +.+.+-..     ..++. ..+..+..+            ++..+....     ...++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            6221               11111110     11111 112222111            111111111     1258999


Q ss_pred             cCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          238 DLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       238 DLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      |+.|.||+++   +++ ++|+||..|.
T Consensus       152 Dl~~~Nil~~---~~~-~~lIDwE~a~  174 (256)
T TIGR02721       152 DVHAYNLVVT---PQG-LKLIDWEYAS  174 (256)
T ss_pred             CCCcCcEEEe---CCC-CEEEeccccC
Confidence            9999999996   223 7899999874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.82  E-value=0.0051  Score=71.04  Aligned_cols=173  Identities=21%  Similarity=0.331  Sum_probs=107.5

Q ss_pred             HHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhh
Q 003239          150 QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL  228 (837)
Q Consensus       150 ~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~y  228 (837)
                      .+++-..++++.+       .|+|....+++-... ....+|||+++.+|.+.++.....   ..       +++     
T Consensus        27 ~~ilgr~~~lktl-------~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~---~~-------s~~-----   84 (725)
T KOG1093|consen   27 IQILGRFQYLKSL-------QHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLK---DE-------SLL-----   84 (725)
T ss_pred             HHHhhhhHHHHhh-------cCccceeeEeeecCccceEEEEehhhccchHHHHHhcccc---hh-------hhc-----
Confidence            4455566777777       678999998877654 458899999999999988765411   11       111     


Q ss_pred             hhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh
Q 003239          229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL  308 (837)
Q Consensus       229 LHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt  308 (837)
                        .+++.|     -||+          +++| -++...               |-     +..+|+|||++|.|+.|+..
T Consensus        85 --~~~~~~-----~~~~----------~~td-~~~t~~---------------~~-----~~~pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   85 --AHGVLH-----LNII----------YITD-HFLTKY---------------PS-----PIGPKSDVWSLGFIILELYL  126 (725)
T ss_pred             --ccccce-----ehhh----------hccc-cccccC---------------CC-----CCCcchhhhhHHHHHHHHHH
Confidence              122221     1222          3333 111000               10     11149999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcC
Q 003239          309 GLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLI  388 (837)
Q Consensus       309 G~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~  388 (837)
                      |...+......+.+..+.+..- .+.+...-                                                 
T Consensus       127 ~~~l~~~~~~s~~l~~i~k~~~-~d~~~~~~-------------------------------------------------  156 (725)
T KOG1093|consen  127 GISLEAELTESEYLEILLKYYT-DDQELLST-------------------------------------------------  156 (725)
T ss_pred             hhHHHHHHHHHHHHHHHHHhcc-CchhHHHH-------------------------------------------------
Confidence            9888876666666655544322 11000000                                                 


Q ss_pred             CcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          389 GKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       389 ~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                                             .++. .-.-.++..+++++++|+-..|..|+...++++|+-|.+.
T Consensus       157 -----------------------a~e~-~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  157 -----------------------AMEH-LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             -----------------------HHHH-HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence                                   0000 0111245678999999999999999999999999999875

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.70  E-value=0.0011  Score=72.69  Aligned_cols=135  Identities=18%  Similarity=0.262  Sum_probs=94.2

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----------Chh-------------hHHHHHHHHHHHHHhhccc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----------QPA-------------YYQQALVEVSILTTLNKKY  166 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----------~~~-------------~~~~~~~Ei~iL~~L~~~~  166 (837)
                      -+.+.++||-|.-+.||.+-+. .|+..++|+-+.          ...             ..-.+.+|...|+.|... 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~-  170 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER-  170 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc-
Confidence            4678889999999999999664 467788887431          110             112356788888888542 


Q ss_pred             CCCCCCceeEEeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCee
Q 003239          167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL  245 (837)
Q Consensus       167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL  245 (837)
                          .--|.+.+++    +..|+|||++.| .|..+...        ..+..+...+..-+.-|-.+|+||+|..-=||+
T Consensus       171 ----gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim  234 (465)
T KOG2268|consen  171 ----GFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIM  234 (465)
T ss_pred             ----CCCCCCcccc----cceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence                1235555554    457899999986 44433221        224455566666777888999999999999999


Q ss_pred             eeccCCCCeEEEEecccccc
Q 003239          246 LCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       246 l~~~~~~~~IKL~DFGlA~~  265 (837)
                      +.   ++..++++||-....
T Consensus       235 v~---dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  235 VK---DDDKIVVIDFPQMVS  251 (465)
T ss_pred             Ee---cCCCEEEeechHhhc
Confidence            96   578899999976643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.63  E-value=0.014  Score=64.03  Aligned_cols=141  Identities=16%  Similarity=0.159  Sum_probs=78.9

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE------Eeecce
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY------FVCQRH  186 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~------f~~~~~  186 (837)
                      .++.|+.|....||++.. .++ .+++|+..... .......|+++++.|...    +- .+.+++..      ....+.
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~----g~-pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAAR----GL-PVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHC----CC-CCCccccCCCCCeehhcCCe
Confidence            356677887889999853 334 57789876432 134556788888888543    11 23333331      122456


Q ss_pred             EEEEEeccchhH-----HH-------HHHhhc--cCCC--------CHHH-----HH----------HHHHhHHHHHhhh
Q 003239          187 LCICFELLDSNL-----YE-------LIKINH--FRGL--------SLSI-----VQ----------LFSKQILRGLSLL  229 (837)
Q Consensus       187 l~LVmEy~~gsL-----~d-------~l~~~~--~~~L--------~e~~-----i~----------~I~~QIl~aL~yL  229 (837)
                      .++|||+++|.-     .+       .+..-.  ...+        ....     ..          .....+...+++|
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            789999987511     11       111000  0001        0000     00          0011123344444


Q ss_pred             h-------cCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          230 K-------DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       230 H-------s~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .       ..++||+|+++.||+++   .++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence            3       36899999999999996   34456899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.60  E-value=0.012  Score=66.20  Aligned_cols=138  Identities=18%  Similarity=0.161  Sum_probs=76.5

Q ss_pred             EEeccCCceeEEEeeccC----CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAE----MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC  190 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~----tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV  190 (837)
                      +.|-.|-...+|++....    .++.|++|+........-...+|..+++.+...      .--.++++.+...    .|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~------gl~P~~~~~~~~g----~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRH------GQGPRLLGRFPNG----RV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHc------CCCCceEEEECCc----eE
Confidence            345557778888875322    346789998875433333346799999998653      1233455555332    46


Q ss_pred             Eeccch-hHH--------------HHHHhhccC-------CCCHHHHHHHHHhHH-----------------HHHhh---
Q 003239          191 FELLDS-NLY--------------ELIKINHFR-------GLSLSIVQLFSKQIL-----------------RGLSL---  228 (837)
Q Consensus       191 mEy~~g-sL~--------------d~l~~~~~~-------~L~e~~i~~I~~QIl-----------------~aL~y---  228 (837)
                      .||+++ .+.              ..+.+-...       ......+..++.++.                 ..+..   
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            777764 211              111110000       011223333332211                 11111   


Q ss_pred             -----hhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          229 -----LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       229 -----LHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                           .+...++|+|+++.|||++  .++..++|+||..+.
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~  230 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS  230 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence                 2234689999999999996  234679999998874

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.51  E-value=0.014  Score=65.05  Aligned_cols=72  Identities=13%  Similarity=0.148  Sum_probs=42.6

Q ss_pred             EEeccCCceeEEEeeccCC---CeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      +.|..|-...+|++.....   ...|++|+........-...+|..+++.+...      .--.+++.++. .+   +|.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~------gl~P~~l~~~~-~G---~i~   89 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAA------GFGAKLLGVFG-NG---MIQ   89 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhc------CCCCceeEEeC-Cc---Eee
Confidence            3444477778888854322   33788998865433333445799999998643      11235555553 22   467


Q ss_pred             eccch
Q 003239          192 ELLDS  196 (837)
Q Consensus       192 Ey~~g  196 (837)
                      +|+.+
T Consensus        90 ~fi~g   94 (330)
T PLN02421         90 SFINA   94 (330)
T ss_pred             hhhcC
Confidence            77654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.36  E-value=0.0085  Score=61.59  Aligned_cols=100  Identities=19%  Similarity=0.275  Sum_probs=75.1

Q ss_pred             HHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccch-hHHHHHH-hhccCCCCHHHHHHHHHhHHHHHhhhhc
Q 003239          154 VEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKD  231 (837)
Q Consensus       154 ~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~-~~~~~~L~e~~i~~I~~QIl~aL~yLHs  231 (837)
                      .|.-+|+.+..      .+++++++++|-    ..+|.||... .+..... .......++..+.+|+.++++.+.+|+.
T Consensus         8 ~E~lll~~l~~------~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    8 NEPLLLQLLQG------SEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             cHHHHHHHcCC------CCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            47888888854      248999999883    3568899883 4432100 0011236889999999999999999997


Q ss_pred             ---CCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          232 ---AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       232 ---~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                         ..+.-+|++++|+.++   +++++|++|...+...
T Consensus        78 ~~~~~~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCCcEEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence               3578899999999996   6678999999987543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.20  E-value=0.039  Score=62.28  Aligned_cols=73  Identities=22%  Similarity=0.261  Sum_probs=50.3

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEe----C---C-hhhHHHHHHHHHHHHHhhcccCCCCCC-ceeEEeEEEeecce
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----N---Q-PAYYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQRH  186 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik----~---~-~~~~~~~~~Ei~iL~~L~~~~~~~~Hp-nIVkl~d~f~~~~~  186 (837)
                      .||.|....||++.+...++.|+||.-.    .   . +...++...|..+|+.+...     .| .+.++|.+  +.+.
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~-----~P~~vP~vy~~--D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH-----VPHLVPRIFHF--DTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc-----CccccCeEEEE--cccc
Confidence            4789999999999875444679999753    1   1 33456677899999887542     23 45555543  4456


Q ss_pred             EEEEEeccc
Q 003239          187 LCICFELLD  195 (837)
Q Consensus       187 l~LVmEy~~  195 (837)
                      ..+|||+++
T Consensus        75 ~~~vMEdL~   83 (370)
T TIGR01767        75 AVTVMEDLS   83 (370)
T ss_pred             ceehHhhCc
Confidence            679999985

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.64  E-value=0.18  Score=55.03  Aligned_cols=29  Identities=38%  Similarity=0.528  Sum_probs=24.7

Q ss_pred             CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       232 ~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++||+|+++.||+++   . +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            5799999999999996   2 568999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.55  E-value=0.029  Score=58.07  Aligned_cols=31  Identities=45%  Similarity=0.598  Sum_probs=20.5

Q ss_pred             CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       232 ~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .-++|.||.+.|||+.  ..++.++|+||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILIN--NKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence            3589999999999993  367889999999874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.51  E-value=0.0056  Score=77.83  Aligned_cols=141  Identities=13%  Similarity=-0.037  Sum_probs=105.1

Q ss_pred             CCCceeEEeEEEee--cceEEEEEeccc-hhHHHHHHhhcc--CCCCHHHHHHHHHhHHHHHhhhhcC-----CeeeccC
Q 003239          170 DKHHIVRIYEYFVC--QRHLCICFELLD-SNLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDA-----GIIHCDL  239 (837)
Q Consensus       170 ~HpnIVkl~d~f~~--~~~l~LVmEy~~-gsL~d~l~~~~~--~~L~e~~i~~I~~QIl~aL~yLHs~-----gIVHrDL  239 (837)
                      .|+++.....-...  ....+++++++. |.+.+.+.+.-.  ..+.+.-+.....+.+.+..-+|+.     -.+|++|
T Consensus      1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~L 1366 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSL 1366 (2724)
T ss_pred             hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhh
Confidence            56777765554443  246789999997 688888765432  2344555555555557777777754     2789999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      |+-|.+|.   .+..+|+.++|+.+....   ......+++.|+++++.....++.++|||..+|-+|++..|..+|
T Consensus      1367 kf~lpmIV---tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1367 KFTLPMIV---TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhcccee---cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            99999995   677899999999983222   123446788899999998889999999999999999999888777

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.43  E-value=0.1  Score=59.68  Aligned_cols=75  Identities=20%  Similarity=0.279  Sum_probs=53.2

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEe----C--C-hhhHHHHHHHHHHHHHhhcccCCCCCC-ceeEEeEEEeecc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----N--Q-PAYYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQR  185 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik----~--~-~~~~~~~~~Ei~iL~~L~~~~~~~~Hp-nIVkl~d~f~~~~  185 (837)
                      .+.||.|.-.-||++.+...++.|+||.-.    .  + +...++...|.++|+.+...     .| ++.++|.+  +..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~-----~P~~VP~vy~~--D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEEL-----APGLVPKVYLF--DSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhh-----CCCcCCeEEEE--CcH
Confidence            567899999999999874445678998743    1  1 34467778899999988653     23 46666553  455


Q ss_pred             eEEEEEeccc
Q 003239          186 HLCICFELLD  195 (837)
Q Consensus       186 ~l~LVmEy~~  195 (837)
                      ...+|||++.
T Consensus       107 ~~~~vMEdL~  116 (409)
T PRK12396        107 MNCCVMEDLS  116 (409)
T ss_pred             HhhHHHHhCc
Confidence            6778999985

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.40  E-value=0.13  Score=56.12  Aligned_cols=46  Identities=17%  Similarity=0.035  Sum_probs=30.7

Q ss_pred             eccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhc
Q 003239          117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK  164 (837)
Q Consensus       117 LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~  164 (837)
                      .++|-...|+.+. ..+|+.+++|.-+.. .......+|.++|+.|..
T Consensus        19 ~~~g~~~~v~~i~-~~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~~   64 (276)
T cd05152          19 NESGLDFQVVFAK-DTDGVPWVLRIPRRP-DVSERAAAEKRVLALVRK   64 (276)
T ss_pred             cCCcceeEEEEEE-cCCCCeEEEEecCCH-HHHHHHHHHHHHHHHHHh
Confidence            4555556677662 234667888887643 334567899999999965

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.40  E-value=0.21  Score=55.71  Aligned_cols=71  Identities=17%  Similarity=0.026  Sum_probs=43.6

Q ss_pred             CCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe---E--EEeecceEEEEEecc
Q 003239          120 GTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY---E--YFVCQRHLCICFELL  194 (837)
Q Consensus       120 G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~---d--~f~~~~~l~LVmEy~  194 (837)
                      +.-..||++.. .+++.+++|+.+........+..|++.+..|...    +-| ++...   +  +...++..+.|++++
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~----gip-v~~p~~~~G~~~~~~~g~~~~l~~~~  109 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA----EIP-VVAPLAFNGQTLHEHQGFRFALFPRR  109 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC----CCC-CCCCccCCCCEEEEECCEEEEEEeee
Confidence            34457888753 4456799999864443456677899999888653    122 22111   1  223346678899987


Q ss_pred             ch
Q 003239          195 DS  196 (837)
Q Consensus       195 ~g  196 (837)
                      +|
T Consensus       110 ~G  111 (325)
T PRK11768        110 GG  111 (325)
T ss_pred             CC
Confidence            65

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.34  E-value=0.16  Score=55.82  Aligned_cols=76  Identities=11%  Similarity=0.061  Sum_probs=51.5

Q ss_pred             EEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEE
Q 003239          112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF  191 (837)
Q Consensus       112 ~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm  191 (837)
                      +-.+.|+.|....+|+..  .+++.+.||+-..  .....+..|.+-|+.|...    .--.+.+++.+...++..+|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~----~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEA----NPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHT----TTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhc----CCCCCCeEEEEEeecCCceEEE
Confidence            345678889999999985  6677899999873  3345677899999999543    3346888999888888889999


Q ss_pred             eccc
Q 003239          192 ELLD  195 (837)
Q Consensus       192 Ey~~  195 (837)
                      ||++
T Consensus        92 e~l~   95 (288)
T PF03881_consen   92 EFLE   95 (288)
T ss_dssp             E---
T ss_pred             Eeec
Confidence            9976

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK10593 hypothetical protein; Provisional

Probab=95.28  E-value=0.096  Score=57.64  Aligned_cols=106  Identities=11%  Similarity=0.089  Sum_probs=73.6

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---cceEEE
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---QRHLCI  189 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---~~~l~L  189 (837)
                      -.+.||.|..+.||+..... + .+.+|..+. ......+..|...|+.|...    .--.+.++++++..   .+..+|
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~----~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARS----GTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccC----CCCCcCcEEEEeccCCcCCCeEE
Confidence            45789999999999985432 3 467787553 11235788899999999642    12357778877654   367899


Q ss_pred             EEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC
Q 003239          190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA  232 (837)
Q Consensus       190 VmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~  232 (837)
                      |||+++| .+.+.       .........+..+++++|+-||+.
T Consensus        91 VmE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         91 LLERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            9999987 34331       123445667778889999999975

>PTZ00384 choline kinase; Provisional

Probab=94.82  E-value=0.23  Score=56.76  Aligned_cols=73  Identities=14%  Similarity=0.056  Sum_probs=42.5

Q ss_pred             EEEeccCCceeEEEeeccCC-C-----eEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          114 KDLLGHGTFGQVAKCWDAEM-N-----SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~t-g-----~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ++.|..|-...+|++..... +     +.|.+++........-...+|+++++.|..      +..-.++++.|..    
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~------~glgP~l~~~f~~----  124 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGD------NNFGPKIIGRFGD----  124 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHh------CCCCCeEEEecCC----
Confidence            34555588888998854322 1     225555433222222234568999999864      2344566666642    


Q ss_pred             EEEEeccch
Q 003239          188 CICFELLDS  196 (837)
Q Consensus       188 ~LVmEy~~g  196 (837)
                      ++|.||++|
T Consensus       125 g~l~efIeG  133 (383)
T PTZ00384        125 FTIQEWVEG  133 (383)
T ss_pred             EEEEEEecc
Confidence            588888875

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.76  E-value=0.27  Score=56.58  Aligned_cols=75  Identities=15%  Similarity=0.156  Sum_probs=52.0

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEe-----CCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik-----~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .+.||.|.-..||++.+.  +..|+||.-.     ...   ....+...|...|+.+...    ...++.+++.++.  +
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~----~p~~VPkVy~~de--d  108 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRL----CPDHVPEVYHFDR--T  108 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhc----CCCCCCeEEEECC--C
Confidence            577899999999999763  4458888854     111   1345566678888777532    1236778887776  4


Q ss_pred             eEEEEEeccch
Q 003239          186 HLCICFELLDS  196 (837)
Q Consensus       186 ~l~LVmEy~~g  196 (837)
                      ..++|||++++
T Consensus       109 ~~vlvME~L~~  119 (418)
T PLN02756        109 MALIGMRYLEP  119 (418)
T ss_pred             CCEEEEeecCC
Confidence            56888999865

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.21  E-value=0.2  Score=56.11  Aligned_cols=142  Identities=20%  Similarity=0.201  Sum_probs=78.4

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE--Eeecc--eEEEEE
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY--FVCQR--HLCICF  191 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~--f~~~~--~l~LVm  191 (837)
                      .|.+ .-..||++.... ++ +++|+.... ....+...|+..|+.|...-....-| |..+-+-  .....  +..-|+
T Consensus        33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhhccCCceeEEEE
Confidence            3444 556788885433 33 389999876 55677778999999997652111112 2222111  11223  677888


Q ss_pred             eccchhHHH------HHH----------h--hccC--------CCCHH----HH---------HHHHHhHHHHHhhhhc-
Q 003239          192 ELLDSNLYE------LIK----------I--NHFR--------GLSLS----IV---------QLFSKQILRGLSLLKD-  231 (837)
Q Consensus       192 Ey~~gsL~d------~l~----------~--~~~~--------~L~e~----~i---------~~I~~QIl~aL~yLHs-  231 (837)
                      +|++|....      .+.          .  ....        ...+.    ..         .....++...+..+.+ 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            988763332      110          0  0000        01111    00         1123344444444442 


Q ss_pred             -------CC--eeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          232 -------AG--IIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       232 -------~g--IVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                             .+  |||+|+.|.||+++.+  +..+.++||+-++
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~--~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDD--TDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCC--CCeeeEEEccccc
Confidence                   23  9999999999999622  2258899999885

>PRK06148 hypothetical protein; Provisional

Probab=94.04  E-value=0.55  Score=60.26  Aligned_cols=147  Identities=20%  Similarity=0.177  Sum_probs=77.3

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE-----EEee-cc--e
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE-----YFVC-QR--H  186 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d-----~f~~-~~--~  186 (837)
                      +.|+ |..-.+|++.. .+++.+++|+.+... .......|.++|..|...-.....|.+++-.+     .... ++  +
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3453 34567777743 456679999998542 23344557778877764311123344444321     1111 22  5


Q ss_pred             EEEEEeccchh-HHH-------HHH-------h-----hcc------CCCCH-----------------HHHHHHHHhHH
Q 003239          187 LCICFELLDSN-LYE-------LIK-------I-----NHF------RGLSL-----------------SIVQLFSKQIL  223 (837)
Q Consensus       187 l~LVmEy~~gs-L~d-------~l~-------~-----~~~------~~L~e-----------------~~i~~I~~QIl  223 (837)
                      .+.+|+|++|. +.+       .+.       +     ..+      ..+.+                 ...+.++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            67889998873 222       000       0     000      00111                 11223333333


Q ss_pred             HHHhh-----hh--cCCeeeccCCCCCeeeeccCCCCeEE-EEecccccc
Q 003239          224 RGLSL-----LK--DAGIIHCDLKPENILLCTSVKPAEIK-IIDFGSACT  265 (837)
Q Consensus       224 ~aL~y-----LH--s~gIVHrDLKPeNILl~~~~~~~~IK-L~DFGlA~~  265 (837)
                      +.+.-     |.  ..++||+|+++.|||++.+.. .++. |+|||.++.
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~-~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDG-ERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCC-cceEEEEECccccc
Confidence            33321     21  357999999999999973321 2454 999999854

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=93.73  E-value=0.56  Score=52.26  Aligned_cols=143  Identities=11%  Similarity=0.119  Sum_probs=76.7

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc--eE
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--HL  187 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--~l  187 (837)
                      +++.+..|.-..+|.....  ++.++++ ...   .........+|..+|+.+...     ---+.+.+.++..+.  ..
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~-----~vP~p~~~~~~~~~~~g~p  100 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDV-----DVPVPRAFGLCGEGYLGTP  100 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCC-----CCCCcccccccccCCCCCc
Confidence            3344444444444554333  6667777 321   123345666788888888542     122445566666554  67


Q ss_pred             EEEEeccch-------------------hHHHHHHhhcc------------CCCCHHHHHHHHHhH--------------
Q 003239          188 CICFELLDS-------------------NLYELIKINHF------------RGLSLSIVQLFSKQI--------------  222 (837)
Q Consensus       188 ~LVmEy~~g-------------------sL~d~l~~~~~------------~~L~e~~i~~I~~QI--------------  222 (837)
                      +.||+++.|                   .|-+++..-..            ......++..+..+.              
T Consensus       101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            999999876                   11222211100            001111222222222              


Q ss_pred             HHHHhhhhc--------CCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          223 LRGLSLLKD--------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       223 l~aL~yLHs--------~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ..-..+|+.        ..+||+|+++.||+++   ....+-|+||+++..-
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lG  229 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEEEeccccccC
Confidence            122333432        2599999999999997   3344899999998543

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.67  E-value=0.69  Score=50.91  Aligned_cols=30  Identities=20%  Similarity=0.215  Sum_probs=26.0

Q ss_pred             CeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       233 gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ++||+|+.+.|||++   .++.+.|+||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYD---ETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEc---CCCCEEEEEhhhccc
Confidence            799999999999995   556789999998854

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00296 choline kinase; Provisional

Probab=93.15  E-value=0.54  Score=54.81  Aligned_cols=74  Identities=15%  Similarity=0.056  Sum_probs=45.7

Q ss_pred             EEEEeccCCceeEEEeeccC--------CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          113 VKDLLGHGTFGQVAKCWDAE--------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~--------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      -++.|..|-...+|++....        .++.|.+|+.-......-....|..+++.+...   .-.|   ++++.+.  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~---gi~P---~l~~~f~--  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKY---RIAP---QLLNTFS--  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHC---CCCC---ceEEEeC--
Confidence            45667778888899886432        256799999865443333556788888888653   1122   4455543  


Q ss_pred             ceEEEEEeccch
Q 003239          185 RHLCICFELLDS  196 (837)
Q Consensus       185 ~~l~LVmEy~~g  196 (837)
                        -..|.||++|
T Consensus       181 --gg~I~efi~g  190 (442)
T PTZ00296        181 --GGRIEEWLYG  190 (442)
T ss_pred             --CCEEEEeeCC
Confidence              2345677654

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=90.74  E-value=0.58  Score=53.46  Aligned_cols=58  Identities=19%  Similarity=0.291  Sum_probs=40.6

Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh-cCCeeeccCCCCCeeee
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLC  247 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~  247 (837)
                      ..||=+|..| .+..+++..   ..+|+..++++.-...||.-+- -.+++|.|++|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            4555566665 666666544   3667677777776666655443 46899999999999995

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=90.14  E-value=0.51  Score=52.39  Aligned_cols=137  Identities=16%  Similarity=0.237  Sum_probs=88.6

Q ss_pred             EEEEeccCCceeEEEeec--c----C----CCeEEEEEEEeCC-------------------------hhhHHHHHH--H
Q 003239          113 VKDLLGHGTFGQVAKCWD--A----E----MNSFVAVKIIKNQ-------------------------PAYYQQALV--E  155 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~--~----~----tg~~VAIKiik~~-------------------------~~~~~~~~~--E  155 (837)
                      |..+|..|.-+.|+.|.-  .    .    .-+.+|||+++..                         .........  |
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            446788888899988732  0    1    1345899987521                         111112222  3


Q ss_pred             HHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEeccchh-H-HHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh-cC
Q 003239          156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN-L-YELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DA  232 (837)
Q Consensus       156 i~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L-~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH-s~  232 (837)
                      ..-|.++.  .....+|.+|.+..       .+|||-|++.. + .--++.-   .|+..+.+..-.|++.++..|- ++
T Consensus       336 mhNL~RMq--~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~v---~l~d~E~~~aY~q~~~~M~~lY~Ec  403 (531)
T KOG2269|consen  336 MHNLSRMQ--KHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKNV---ELTDDERRNAYDQVQSIMCRLYKEC  403 (531)
T ss_pred             HHHHHHHH--hcCCCCCceeeeec-------ceEEEEeecCCCCCCcccccc---ccChHHHHHHHHHHHHHHHHHHHhh
Confidence            33333332  22346777887644       46899998732 1 1122222   3888888888899999888875 67


Q ss_pred             CeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       233 gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      -+||.||.--|||..    .+.+-++|...+..
T Consensus       404 ~LVHADlSEyN~Lw~----~gKvw~IDVsQsve  432 (531)
T KOG2269|consen  404 LLVHADLSEYNLLWT----PGKVWVIDVSQSVE  432 (531)
T ss_pred             heeecchhhhhheec----CCceEEEechhccC
Confidence            899999999999994    56899999877643

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=89.53  E-value=0.9  Score=51.34  Aligned_cols=71  Identities=21%  Similarity=0.244  Sum_probs=55.9

Q ss_pred             cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ..+.|++|++-++.+. .++     ....+++..|+.+.+..|.-+..+ ..-|||+.-.||||    +.|.|.|+||-+
T Consensus       298 ~~y~yl~~kdhgt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDHGTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecCCceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEeee
Confidence            4578899998877654 222     234677888888888877777754 68999999999999    378999999999


Q ss_pred             cc
Q 003239          263 AC  264 (837)
Q Consensus       263 A~  264 (837)
                      ++
T Consensus       368 sR  369 (488)
T COG5072         368 SR  369 (488)
T ss_pred             ee
Confidence            97

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	837
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-63
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-62
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-62
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-62
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-62
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-62
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-39
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-39
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		7e-39
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-39
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-38
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-38
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-35
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-35
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-31
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-28
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-28
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-28
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-28
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		3e-28
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-27
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-27
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-27
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-27
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-27
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-27
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-27
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-27
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-27
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-27
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-27
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-27
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-27
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-27
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-27
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-27
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-27
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-27
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-27
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-27
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-27
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-27
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-27
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-27
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-27
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-27
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-27
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-27
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-27
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-27
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-27
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-26
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-26
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-26
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-26
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-26
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-26
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-26
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-26
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-26
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-26
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-26
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-26
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-26
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-26
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-26
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-26
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-26
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-26
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-26
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-26
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-26
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-26
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-26
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-26
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-26
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-26
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-26
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-26
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-26
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-26
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-26
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-26
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-26
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-26
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-26
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-26
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-26
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-25
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-25
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-25
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-25
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-25
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-25
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-25
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-25
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-25
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-25
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-25
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-25
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-25
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-25
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-25
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-25
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-25
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-25
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-25
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-25
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-25
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-25
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-25
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-25
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-25
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-25
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-25
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-25
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-25
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-25
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-24
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-24
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-24
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-24
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-24
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-24
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-24
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-24
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-24
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-24
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-24
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-24
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-24
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-24
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-24
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-24
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-24
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-24
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-24
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-24
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-24
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-24
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-24
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-24
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-24
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-24
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-24
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-24
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-24
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-24
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-24
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-24
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-24
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-24
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-24
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-24
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-24
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-24
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-24
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-24
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-24
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-24
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-24
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-24
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-24
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-24
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-24
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-24
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-24
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-24
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-24
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-24
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-24
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-24
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-24
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-24
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-24
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-24
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-24
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-24
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-24
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-24
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-24
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-24
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-24
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-24
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-24
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-24
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-23
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-23
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-23
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-23
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-23
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-23
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-23
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-23
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-23
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-23
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-23
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-23
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-23
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-23
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-23
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-22
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-22
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-22
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-22
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-22
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-22
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-22
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-22
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-21
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-21
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-21
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-19
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-19
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-19
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-19
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-18
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-17
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-15
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-12
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-12
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-12
3soa_A	444	Full-Length Human Camkii Length = 444		5e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-11
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-11
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		7e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-06
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-06
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-05
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-04
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-04
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-04
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  239 bits (609), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 138/349 (39%), Positives = 197/349 (56%), Gaps = 39/349 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY V  ++G G+FGQV K +D +++  VA+K+++N+  +++QA  E+ IL  L K+ D++
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ-DKD 156
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           +  +++ + E F  + H+C+ FELL  NLYELIK N F+G SL +V+ F+  IL+ L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
               IIHCDLKPENILL    +   IK+IDFGS+C E + VY+ IQSR+YR+PEV+LG +
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGAR 275
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
           Y   IDMWS GCI+AEL  G PL PG  E D L  MI +LG  P   +L  +K    F  
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM-PSQKLLDASKRAKNFVS 334
Query: 350 CIG-----SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
             G     +V  + +G V + G  + +       E+RE    L G              +
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG-------------CD 381
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
            P                    +DFLK  +E+DPA R +P QA RHP++
Sbjct: 382 DPL------------------FLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  238 bits (607), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 138/349 (39%), Positives = 197/349 (56%), Gaps = 39/349 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY V  ++G G+FGQV K +D +++  VA+K+++N+  +++QA  E+ IL  L K+ D++
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ-DKD 156
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           +  +++ + E F  + H+C+ FELL  NLYELIK N F+G SL +V+ F+  IL+ L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
               IIHCDLKPENILL    +   IK+IDFGS+C E + VY+ IQSR+YR+PEV+LG +
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGAR 275
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
           Y   IDMWS GCI+AEL  G PL PG  E D L  MI +LG  P   +L  +K    F  
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM-PSQKLLDASKRAKNFVS 334
Query: 350 CIG-----SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
             G     +V  + +G V + G  + +       E+RE    L G              +
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG-------------CD 381
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
            P                    +DFLK  +E+DPA R +P QA RHP++
Sbjct: 382 DP------------------LFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  237 bits (605), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 138/349 (39%), Positives = 195/349 (55%), Gaps = 39/349 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY V  ++G G FGQV K +D +++  VA+K+++N+  +++QA  E+ IL  L K+ D++
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ-DKD 156
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           +  +++ + E F  + H+C+ FELL  NLYELIK N F+G SL +V+ F+  IL+ L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
               IIHCDLKPENILL    +   IK+IDFGS+C E + VY  IQSR+YR+PEV+LG +
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGAR 275
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
           Y   IDMWS GCI+AEL  G PL PG  E D L  MI +LG  P   +L  +K    F  
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM-PXQKLLDASKRAKNFVS 334
Query: 350 CIG-----SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
             G     +V  + +G V + G  + +       E+RE    L G              +
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG-------------CD 381
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
            P                    +DFLK  +E+DPA R +P QA RHP++
Sbjct: 382 DPL------------------FLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  237 bits (604), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 116/242 (47%), Positives = 166/242 (68%), Gaps = 5/242 (2%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY +  L+G G+FGQV K +D     +VA+KIIKN+ A+  QA +EV +L  +NK +D E
Sbjct: 36  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK-HDTE 94
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
            K++IV +  +F+ + HLC+ FE+L  NLY+L++  +FRG+SL++ + F++Q+   L  L
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 230 K--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
              +  IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y  IQSR+YRSPEVLLG
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLG 213
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
             Y  AIDMWS GCI+ E+  G PLF GA+E D + +++ +LG  PP ++L +A    KF
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI-PPAHILDQAPKARKF 272
Query: 348 FK 349
           F+
Sbjct: 273 FE 274

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  236 bits (602), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 116/242 (47%), Positives = 166/242 (68%), Gaps = 5/242 (2%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY +  L+G G+FGQV K +D     +VA+KIIKN+ A+  QA +EV +L  +NK +D E
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK-HDTE 113
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
            K++IV +  +F+ + HLC+ FE+L  NLY+L++  +FRG+SL++ + F++Q+   L  L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 230 K--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
              +  IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y  IQSR+YRSPEVLLG
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLG 232
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
             Y  AIDMWS GCI+ E+  G PLF GA+E D + +++ +LG  PP ++L +A    KF
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI-PPAHILDQAPKARKF 291
Query: 348 FK 349
           F+
Sbjct: 292 FE 293

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  236 bits (601), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 116/242 (47%), Positives = 166/242 (68%), Gaps = 5/242 (2%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY +  L+G G+FGQV K +D     +VA+KIIKN+ A+  QA +EV +L  +NK +D E
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK-HDTE 113
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
            K++IV +  +F+ + HLC+ FE+L  NLY+L++  +FRG+SL++ + F++Q+   L  L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 230 K--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
              +  IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y  IQSR+YRSPEVLLG
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRXA-IKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLG 232
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
             Y  AIDMWS GCI+ E+  G PLF GA+E D + +++ +LG  PP ++L +A    KF
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI-PPAHILDQAPKARKF 291
Query: 348 FK 349
           F+
Sbjct: 292 FE 293

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  160 bits (406), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 116/361 (32%), Positives = 173/361 (47%), Gaps = 62/361 (17%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           RY + D LG G FG+V +C D +     VAVKI+KN   Y + A  E+ +L  LN   D 
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT-DP 73
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
                 V++ E+F    H+CI FELL  + Y+ IK N F    L  ++  + QI + ++ 
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 229 LKDAGIIHCDLKPENILLCTS---------VKPAE-------IKIIDFGSACTEDRTVYS 272
           L    + H DLKPENIL   S         +K  E       IK++DFGSA  +D    +
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
            + +R+YR+PEV+L   ++   D+WS GCI+ E +LG  +FP     + L  M RILG  
Sbjct: 194 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 333 PPDYVLKEAKNTSKFFKCIGSVHN-IENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
           P   + K  K   K+F      H+ ++  E S  GR          Y +R  K       
Sbjct: 254 PKHMIQKTRKR--KYFH-----HDRLDWDEHSSAGR----------YVSRACK------- 289
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
                         P ++ +  +D+  E      L D ++ ++E+DPAKR +  +A +HP
Sbjct: 290 --------------PLKEFMLSQDVEHER-----LFDLIQKMLEYDPAKRITLREALKHP 330
Query: 452 F 452
           F
Sbjct: 331 F 331

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  159 bits (402), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 116/361 (32%), Positives = 172/361 (47%), Gaps = 62/361 (17%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           RY + D LG G FG+V +C D +     VAVKI+KN   Y + A  E+ +L  LN   D 
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT-DP 73
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
                 V++ E+F    H+CI FELL  + Y+ IK N F    L  ++  + QI + ++ 
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 229 LKDAGIIHCDLKPENILLCTS---------VKPAE-------IKIIDFGSACTEDRTVYS 272
           L    + H DLKPENIL   S         +K  E       IK++DFGSA  +D    +
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
            +  R+YR+PEV+L   ++   D+WS GCI+ E +LG  +FP     + L  M RILG  
Sbjct: 194 LVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 333 PPDYVLKEAKNTSKFFKCIGSVHN-IENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
           P   + K  K   K+F      H+ ++  E S  GR          Y +R  K       
Sbjct: 254 PKHMIQKTRKR--KYFH-----HDRLDWDEHSSAGR----------YVSRACK------- 289
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
                         P ++ +  +D+  E      L D ++ ++E+DPAKR +  +A +HP
Sbjct: 290 --------------PLKEFMLSQDVEHER-----LFDLIQKMLEYDPAKRITLREALKHP 330
Query: 452 F 452
           F
Sbjct: 331 F 331

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score =  159 bits (402), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 118/365 (32%), Positives = 172/365 (47%), Gaps = 60/365 (16%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
           Q RY +   LG GTFG+V +C D A   S VA+KII+N   Y + A +E+++L  + +K 
Sbjct: 50  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK- 108
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           D+E+K   V + ++F    H+CI FELL  N +E +K N+F+   L  V+  + Q+   L
Sbjct: 109 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 168
Query: 227 SLLKDAGIIHCDLKPENILLCT----------------SVKPAEIKIIDFGSACTEDRTV 270
             L +  + H DLKPENIL                   SVK   I++ DFGSA  +    
Sbjct: 169 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 228
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            + + +R+YR PEV+L   +    D+WS GCI+ E + G  LF      + L  M +ILG
Sbjct: 229 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 288
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
             P   + +  K   K+F   G V +    E S  GR             +E  KPL  K
Sbjct: 289 PIPSHMIHRTRK--QKYFYKGGLVWD----ENSSDGRY-----------VKENCKPL--K 329
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
            Y     LE +                        L D ++ ++EFDPA+R +  +A  H
Sbjct: 330 SYMLQDSLEHV-----------------------QLFDLMRRMLEFDPAQRITLAEALLH 366
Query: 451 PFVTG 455
           PF  G
Sbjct: 367 PFFAG 371

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score =  159 bits (401), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 108/362 (29%), Positives = 177/362 (48%), Gaps = 60/362 (16%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
           Q RY +   LG GTFG+V +C D     + VA+KIIKN   Y + A +E+++L  +N+K 
Sbjct: 32  QERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEK- 90
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           D ++K+  V+++++F    H+CI FELL  + ++ +K N++    +  V+  + Q+ + +
Sbjct: 91  DPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAV 150
Query: 227 SLLKDAGIIHCDLKPENILLCTS----------------VKPAEIKIIDFGSACTEDRTV 270
             L D  + H DLKPENIL   S                VK   ++++DFGSA  +    
Sbjct: 151 KFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHH 210
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            + + +R+YR+PEV+L   ++   D+WS GCI+ E ++G  LF      + L  M RILG
Sbjct: 211 STIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILG 270
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
             P   + K  K   K+F                 GR  +   T      RE  KPL  +
Sbjct: 271 PIPSRMIRKTRK--QKYF---------------YRGRLDWDENTSAGRYVRENCKPL--R 311
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
            Y                       ++ E++    L D ++ ++E++PAKR +  +A +H
Sbjct: 312 RY-----------------------LTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQH 348
Query: 451 PF 452
           PF
Sbjct: 349 PF 350

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 118/365 (32%), Positives = 172/365 (47%), Gaps = 60/365 (16%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
           Q RY +   LG GTFG+V +C D A   S VA+KII+N   Y + A +E+++L  + +K 
Sbjct: 27  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK- 85
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           D+E+K   V + ++F    H+CI FELL  N +E +K N+F+   L  V+  + Q+   L
Sbjct: 86  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 145
Query: 227 SLLKDAGIIHCDLKPENILLCT----------------SVKPAEIKIIDFGSACTEDRTV 270
             L +  + H DLKPENIL                   SVK   I++ DFGSA  +    
Sbjct: 146 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 205
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            + + +R+YR PEV+L   +    D+WS GCI+ E + G  LF      + L  M +ILG
Sbjct: 206 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 265
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
             P   + +  K   K+F   G V +    E S  GR             +E  KPL  K
Sbjct: 266 PIPSHMIHRTRK--QKYFYKGGLVWD----ENSSDGRY-----------VKENCKPL--K 306
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
            Y     LE +                        L D ++ ++EFDPA+R +  +A  H
Sbjct: 307 SYMLQDSLEHV-----------------------QLFDLMRRMLEFDPAQRITLAEALLH 343
Query: 451 PFVTG 455
           PF  G
Sbjct: 344 PFFAG 348

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 118/365 (32%), Positives = 172/365 (47%), Gaps = 60/365 (16%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
           Q RY +   LG GTFG+V +C D A   S VA+KII+N   Y + A +E+++L  + +K 
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK- 76
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           D+E+K   V + ++F    H+CI FELL  N +E +K N+F+   L  V+  + Q+   L
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 227 SLLKDAGIIHCDLKPENILLCT----------------SVKPAEIKIIDFGSACTEDRTV 270
             L +  + H DLKPENIL                   SVK   I++ DFGSA  +    
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            + + +R+YR PEV+L   +    D+WS GCI+ E + G  LF      + L  M +ILG
Sbjct: 197 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
             P   + +  K   K+F   G V +    E S  GR             +E  KPL  K
Sbjct: 257 PIPSHMIHRTRK--QKYFYKGGLVWD----ENSSDGRY-----------VKENCKPL--K 297
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
            Y     LE +                        L D ++ ++EFDPA+R +  +A  H
Sbjct: 298 SYMLQDSLEHV-----------------------QLFDLMRRMLEFDPAQRITLAEALLH 334
Query: 451 PFVTG 455
           PF  G
Sbjct: 335 PFFAG 339

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 143/266 (53%), Gaps = 19/266 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK----K 165
           RYI+   LG G F  V    D   N+ VA+KI++    Y + A  E+ +L  +N     K
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 166 YDREDKHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
            D    +HI+++ ++F  +     H+ + FE+L  NL  LIK    RG+ L  V+  SKQ
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 222 ILRGLSLL-KDAGIIHCDLKPENILLCTSVKPA---EIKIIDFGSACTEDRTVYSYIQSR 277
           +L GL  + +  GIIH D+KPEN+L+     P    +IKI D G+AC  D    + IQ+R
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF---PGAS---EFDLLRRMIRILGA 331
            YRSPEVLLG  +    D+WS  C++ EL  G  LF    G S   + D + ++I +LG 
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG- 258
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNI 357
           + P Y+L+  K T  FF   G + NI
Sbjct: 259 ELPSYLLRNGKYTRTFFNSRGLLRNI 284

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 141/266 (53%), Gaps = 19/266 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK----K 165
           RYI+   LG G F  V    D   N+ VA+KI++    Y + A  E+ +L  +N     K
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 166 YDREDKHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
            D    +HI+++ ++F  +     H+ + FE+L  NL  LIK    RG+ L  V+  SKQ
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 222 ILRGLSLL-KDAGIIHCDLKPENILLCTSVKPA---EIKIIDFGSACTEDRTVYSYIQSR 277
           +L GL  + +  GIIH D+KPEN+L+     P    +IKI D G+AC  D    + IQ+R
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP------GASEFDLLRRMIRILGA 331
            YRSPEVLLG  +    D+WS  C++ EL  G  LF          + D + ++I +LG 
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG- 258
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNI 357
           + P Y+L+  K T  FF   G + NI
Sbjct: 259 ELPSYLLRNGKYTRTFFNSRGLLRNI 284

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score =  132 bits (332), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 107/366 (29%), Positives = 170/366 (46%), Gaps = 66/366 (18%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           ++V   +G GTFG+V  C   +   + AVK+++N   Y + A +E  IL  +  + D  +
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI--QNDDIN 94
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            ++IV+ +  F+   H+C+ FE L  +LYE+I  N++ G  +  ++L+  +IL+ L+ L+
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 231 DAGIIHCDLKPENILL----------------------CTSVKPAEIKIIDFGSACTEDR 268
              + H DLKPENILL                          K   IK+IDFG A  +  
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 269 TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              S I +R YR+PEV+L   +  + DMWSFGC++AEL+ G  LF      + L  M  I
Sbjct: 215 YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274
Query: 329 LGAQP-PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
           +  QP P  +L EA  T+      GS + +   E+ +       ++  I           
Sbjct: 275 I--QPIPKNMLYEATKTN------GSKY-VNKDELKLAWPENASSINSI----------- 314
Query: 388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQA 447
                   KH+         +K L +  I K         DFL  +++ DP  R SP + 
Sbjct: 315 --------KHV---------KKCLPLYKIIKHE----LFCDFLYSILQIDPTLRPSPAEL 353
Query: 448 SRHPFV 453
            +H F+
Sbjct: 354 LKHKFL 359

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  125 bits (314), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/226 (34%), Positives = 133/226 (58%), Gaps = 22/226 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           LG+GT+  V K  +     +VA+K +K  ++      A+ E+S++        +E KH +
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLM--------KELKHEN 64
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKI----NHFRGLSLSIVQLFSKQILRGLSLL 229
           IVR+Y+    +  L + FE +D++L + +      N  RGL L++V+ F  Q+L+GL+  
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEVLL 286
            +  I+H DLKP+N+L+    K  ++K+ DFG A        T  S + + +YR+P+VL+
Sbjct: 125 HENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 287 GYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           G + Y+T+ID+WS GCI+AE+  G PLFPG ++ + L+ +  I+G 
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  124 bits (312), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/222 (36%), Positives = 123/222 (55%), Gaps = 19/222 (8%)
Query: 117 LGHGTFGQVAKCWD--AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           +G GT+G V K  +   E  +   +++ K         + E+SIL        +E KH +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISIL--------KELKHSN 61
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++Y+    ++ L + FE LD +L +L+ +    GL     + F  Q+L G++   D  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLG-YQ 289
           ++H DLKP+N+L+    +  E+KI DFG A      V  Y   I + +YR+P+VL+G  +
Sbjct: 121 VLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           Y+T ID+WS GCI AE+  G PLFPG SE D L R+ RILG 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 123/222 (55%), Gaps = 19/222 (8%)
Query: 117 LGHGTFGQVAKCWD--AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           +G GT+G V K  +   E  +   +++ K         + E+SIL        +E KH +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISIL--------KELKHSN 61
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++Y+    ++ L + FE LD +L +L+ +    GL     + F  Q+L G++   D  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLG-YQ 289
           ++H DLKP+N+L+    +  E+KI DFG A      V  Y   + + +YR+P+VL+G  +
Sbjct: 121 VLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           Y+T ID+WS GCI AE+  G PLFPG SE D L R+ RILG 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 123/222 (55%), Gaps = 19/222 (8%)
Query: 117 LGHGTFGQVAKCWD--AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           +G GT+G V K  +   E  +   +++ K         + E+SIL        +E KH +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISIL--------KELKHSN 61
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++Y+    ++ L + FE LD +L +L+ +    GL     + F  Q+L G++   D  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLG-YQ 289
           ++H DLKP+N+L+    +  E+KI DFG A      V  Y   + + +YR+P+VL+G  +
Sbjct: 121 VLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           Y+T ID+WS GCI AE+  G PLFPG SE D L R+ RILG 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGT 219

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 143/305 (46%), Gaps = 59/305 (19%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY V   LG G F  V  CWD +   FVA+K++K+   Y + AL E+ +L  + ++ D  
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCV-RESDPS 90
Query: 170 D--KHHIVRIYEYFVCQR----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
           D  K  +V++ + F        H+C+ FE+L  +L + I  ++++GL +  V+   +Q+L
Sbjct: 91  DPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVL 150
Query: 224 RGLSLL-KDAGIIHCDLKPENILLC----------------------------TSVKPA- 253
           +GL  L     IIH D+KPENIL+C                             S  PA 
Sbjct: 151 QGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAA 210
Query: 254 ---------------EIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWS 298
                           +KI D G+AC   +     IQ+R YRS EVL+G  Y+T  D+WS
Sbjct: 211 DLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRSIEVLIGAGYSTPADIWS 270
Query: 299 FGCIVAELFLGLPLFPGAS------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIG 352
             C+  EL  G  LF   S      + D +  +I +LG+ P  + L   K + +FF   G
Sbjct: 271 TACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFAL-SGKYSREFFNRRG 329
Query: 353 SVHNI 357
            + +I
Sbjct: 330 ELRHI 334

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 65
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKPEN+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 126 VLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 229

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 64
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKPEN+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 125 VLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 228

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 66
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKPEN+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 127 VLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 230

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 70
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 131 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 187
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 234

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKPEN+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 64
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKPEN+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 125 VLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 228

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 124/229 (54%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 66
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE +D +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 67  IVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 127 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 230

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  120 bits (302), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 65
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 126 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 229

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 70
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 131 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 234

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GLS      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 67
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 128 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 184
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 231

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 66
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 127 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 230

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 67
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 128 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 184
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 66
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 127 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 230

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  120 bits (301), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 66
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 127 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 230

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  120 bits (301), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 65
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 126 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 65
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 126 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 229

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 64
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 125 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 181
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 228

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 64
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 125 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 228

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 64
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 125 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 228

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 62
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 123 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 226

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  119 bits (299), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 62
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 123 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 226

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  119 bits (299), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 122/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 66
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L   +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 127 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 230

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 62
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 123 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 226

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  119 bits (299), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 62
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 123 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 123/236 (52%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL     +  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHE-- 83
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
                +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 84  -----NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 135
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+   +++KI DFG A   D        +  Y+ +
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTT---SDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 248

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 121/239 (50%), Gaps = 35/239 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVE-------VSILTT 161
           +G G +G V   +DA +   VAVK        +I  +  Y +  L++       + +L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                  ED   +     Y V          L+ ++L  ++K    + LS   VQ    Q
Sbjct: 96  FTPATSIEDFSEV-----YLVTT--------LMGADLNNIVKC---QALSDEHVQFLVYQ 139
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
           +LRGL  +  AGIIH DLKP N+ +    + +E++I+DFG A   D  +  Y+ +R+YR+
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVN---EDSELRILDFGLARQADEEMTGYVATRWYRA 196
Query: 282 PEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           PE++L +  Y   +D+WS GCI+AEL  G  LFPG+   D L+R++ ++G   P+ + K
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAK 255

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 121/239 (50%), Gaps = 35/239 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVE-------VSILTT 161
           +G G +G V   +DA +   VAVK        +I  +  Y +  L++       + +L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                  ED   +     Y V          L+ ++L  ++K    + LS   VQ    Q
Sbjct: 96  FTPATSIEDFSEV-----YLVTT--------LMGADLNNIVK---SQALSDEHVQFLVYQ 139
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
           +LRGL  +  AGIIH DLKP N+ +    + +E++I+DFG A   D  +  Y+ +R+YR+
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVN---EDSELRILDFGLARQADEEMTGYVATRWYRA 196
Query: 282 PEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           PE++L +  Y   +D+WS GCI+AEL  G  LFPG+   D L+R++ ++G   P+ + K
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAK 255

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  119 bits (297), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILL------- 80
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  119 bits (297), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 76
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 246

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL     +  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHE-- 83
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
                +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 84  -----NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 135
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 248

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 96
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 153
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 266

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 78
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 135
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 248

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 120/239 (50%), Gaps = 35/239 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVE-------VSILTT 161
           +G G +G V   +DA +   VAVK        +I  +  Y +  L++       + +L  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                  ED   +     Y V          L+ ++L  ++K    + LS   VQ    Q
Sbjct: 88  FTPATSIEDFSEV-----YLVTT--------LMGADLNNIVKC---QALSDEHVQFLVYQ 131
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
           +LRGL  +  AGIIH DLKP N+ +    +  E++I+DFG A   D  +  Y+ +R+YR+
Sbjct: 132 LLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADEEMTGYVATRWYRA 188
Query: 282 PEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           PE++L +  Y   +D+WS GCI+AEL  G  LFPG+   D L+R++ ++G   P+ + K
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAK 247

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 76
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 246

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 84
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 141
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 142 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 254

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 76
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 246

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 76
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 246

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 76
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 246

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 81
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 138
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 251

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 82
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 139
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 140 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 252

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 73
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 130
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 131 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 243

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 80
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 74
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 131
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 244

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 80
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 74
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 131
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 244

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/245 (33%), Positives = 130/245 (53%), Gaps = 31/245 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I+  ++H R      + 
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYI 274
               Q+L G+  L  AGIIH DLKP NI++ +    A +KI+DFG A T   +  +  Y+
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYV 186
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 335 DYVLK 339
           +++ K
Sbjct: 247 EFMKK 251

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 122/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+  I+           A+ E+S+L  LN         +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP-------N 63
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 124 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 227

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 122/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+  I+           A+ E+S+L  LN         +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP-------N 62
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 123 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 80
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH---LSNDHICYFLYQI 137
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 141/306 (46%), Gaps = 59/306 (19%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL-NKKYDR 168
           RY V   LG G F  V   WD +   FVA+K++K+   Y + AL E+ +L ++ N   + 
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 169 EDKHHIVRIYEYF----VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
            ++  +V++ + F    V   H+C+ FE+L  +L + I  ++++GL L  V+   +Q+L+
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 225 GLSLL-KDAGIIHCDLKPENILLCTS---------------------------------- 249
           GL  L     IIH D+KPENILL  +                                  
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 250 ----VKPAE--------IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMW 297
               V P E        +KI D G+AC   +     IQ+R YRS EVL+G  Y T  D+W
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 298 SFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCI 351
           S  C+  EL  G  LF   S      + D +  +I +LG  P   ++   K + +FF   
Sbjct: 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA-GKYSKEFFTKK 336
Query: 352 GSVHNI 357
           G + +I
Sbjct: 337 GDLKHI 342

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  117 bits (293), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 150
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 151 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 208
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 209 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 266
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 326
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 327 REMNPNYTEF 336

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 82/245 (33%), Positives = 130/245 (53%), Gaps = 31/245 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I+  ++H R      + 
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYI 274
               Q+L G+  L  AGIIH DLKP NI++ +    A +KI+DFG A T   +  +  Y+
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYV 186
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 335 DYVLK 339
           +++ K
Sbjct: 247 EFMKK 251

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 109
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 110 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 167
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 168 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRY 225
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 285
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 286 REMNPNYTEF 295

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 122/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA++ I       Y Q+ L E+ IL        
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILL------- 80
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  117 bits (292), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 107
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 108 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 165
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 166 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRY 223
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 283
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 284 REMNPNYTEF 293

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 105
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 163
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 282 REMNPNYTEF 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 122/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  +      VA+K I+           A+ E+S+L  LN         +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 62
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV++ +    +  L + FE +  +L   +  +   G+ L +++ +  Q+L+GL+      
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQY 290
           ++H DLKP+N+L+ T      IK+ DFG A      V +Y   + + +YR+PE+LLG +Y
Sbjct: 123 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 291 -TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +TA+D+WS GCI AE+     LFPG SE D L R+ R LG   PD V+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 226

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  116 bits (291), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 99
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 100 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 157
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 158 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 215
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 275
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 276 REMNPNYTEF 285

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 141/306 (46%), Gaps = 59/306 (19%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL-NKKYDR 168
           RY V   LG G F  V   WD +   FVA+K++K+   Y + AL E+ +L ++ N   + 
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 169 EDKHHIVRIYEYF----VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
            ++  +V++ + F    V   H+C+ FE+L  +L + I  ++++GL L  V+   +Q+L+
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 141
Query: 225 GLSLL-KDAGIIHCDLKPENILLCTS---------------------------------- 249
           GL  L     IIH D+KPENILL  +                                  
Sbjct: 142 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 201
Query: 250 ----VKPAE--------IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMW 297
               V P E        +KI D G+AC   +     IQ+R YRS EVL+G  Y T  D+W
Sbjct: 202 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 261
Query: 298 SFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCI 351
           S  C+  EL  G  LF   S      + D +  +I +LG  P   ++   K + +FF   
Sbjct: 262 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA-GKYSKEFFTKK 320
Query: 352 GSVHNI 357
           G + +I
Sbjct: 321 GDLKHI 326

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  116 bits (290), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 78/233 (33%), Positives = 122/233 (52%), Gaps = 21/233 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V+  +D    + VA+K I       Y Q+ L E+ IL     ++ 
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILL----RFR 99
Query: 168 REDKHHIVRIYE--YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            E+   I  I         R + I  +L++++LY+L+K      LS   +  F  QILRG
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ---LSNDHICYFLYQILRG 156
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQSRYY 279
           L  +  A ++H DLKP N+L+ T+    ++KI DFG A   D        +   + +R+Y
Sbjct: 157 LKYIHSANVLHRDLKPSNLLINTT---CDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 280 RSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 266

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  116 bits (290), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 82/245 (33%), Positives = 130/245 (53%), Gaps = 31/245 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I+  ++H R      + 
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYI 274
               Q+L G+  L  AGIIH DLKP NI++ +    A +KI+DFG A T   +  +  Y+
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYV 186
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 335 DYVLK 339
           +++ K
Sbjct: 247 EFMKK 251

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  115 bits (289), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 120/236 (50%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 96
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + +   L+ ++LY+L+K  H   LS   +  F  QI
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQI 153
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +  Y+ +
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNTT---XDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 266

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  115 bits (289), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 76
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 77  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 134
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 135 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 192
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 252
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 253 REMNPNYTEF 262

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  115 bits (288), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 21/233 (9%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK------NQPAYYQQALVEVSILTTL 162
           +RY   D LG G F  V K  D   N  VA+K IK       +    + AL E+ +L  L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           +         +I+ + + F  + ++ + F+ ++++L  +IK N    L+ S ++ +    
Sbjct: 70  SHP-------NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-LTPSHIKAYMLMT 121
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
           L+GL  L    I+H DLKP N+LL  +     +K+ DFG A    + +R     + +R+Y
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNRAYXHQVVTRWY 178
Query: 280 RSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+PE+L G + Y   +DMW+ GCI+AEL L +P  PG S+ D L R+   LG 
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 129/245 (52%), Gaps = 31/245 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I+  ++H R      + 
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYI 274
               Q+L G+  L  AGIIH DLKP NI++ +    A +KI+DFG A T   +  +  Y+
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYV 186
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +RYYR+PEV+LG  Y   +D+WS G I+ E+  G  LFPG    D   ++I  LG   P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 335 DYVLK 339
           +++ K
Sbjct: 247 EFMKK 251

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 132/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +    A+  +   E+ I+  L       D
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKL-------D 71
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 248 REMNPNYTEF 257

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 132/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +    A+  +   E+ I+  L       D
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKL-------D 71
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 248 REMNPNYTEF 257

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 121/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 80
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +   + +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 121/236 (51%), Gaps = 27/236 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL        
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL------- 81
Query: 168 REDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           R    +I+ I +          + + I  +L++++LY+L+K  H   LS   +  F  QI
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 138
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSYIQS 276
           LRGL  +  A ++H DLKP N+LL T+    ++KI DFG A   D        +   + +
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ ILG+
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 251

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 84
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 85  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 142
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 143 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRY 200
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 260
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 261 REMNPNYTEF 270

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 129/245 (52%), Gaps = 31/245 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I+  ++H R      + 
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYI 274
               Q+L G+  L  AGIIH DLKP NI++ +    A +KI+DFG A T   +  +  Y+
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYV 186
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +RYYR+PEV+LG  Y   +D+WS G I+ E+  G  LFPG    D   ++I  LG   P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 335 DYVLK 339
           +++ K
Sbjct: 247 EFMKK 251

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 115/233 (49%), Gaps = 22/233 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSIL--TTLNKKYDREDKHHI 174
           +G G +G V K  D     FVA+K ++          + +S +    L ++ +  +  ++
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 175 VRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           VR+ +     R      + + FE +D +L   +      GL    ++   +Q LRGL  L
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRSP 282
               I+H DLKPENIL+ +      +K+ DFG A      +YSY       + + +YR+P
Sbjct: 137 HANCIVHRDLKPENILVTSG---GTVKLADFGLA-----RIYSYQMALTPVVVTLWYRAP 188
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           EVLL   Y T +DMWS GCI AE+F   PLF G SE D L ++  ++G  P D
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 55/268 (20%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
           + ++Y +   LG G+FG V + +D E     A+K +   P Y  + L  + +L  +N   
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN--- 61
Query: 167 DREDKHHIVRIYEYFVC--------------------------------------QRHLC 188
                  I+++ +YF                                         ++L 
Sbjct: 62  -------IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 189 ICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246
           +  E +   L++++K  I   R + ++++ ++  Q+ R +  +   GI H D+KP+N+L+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 247 CTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIV 303
            +  K   +K+ DFGSA          + I SR+YR+PE++LG  +YT +ID+WS GC+ 
Sbjct: 175 NS--KDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 304 AELFLGLPLFPGASEFDLLRRMIRILGA 331
            EL LG PLF G +  D L R+I+I+G 
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGT 260

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/248 (33%), Positives = 130/248 (52%), Gaps = 37/248 (14%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I+  ++H R      + 
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VY 271
               Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  + 
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 183
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
            Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 332 QPPDYVLK 339
             P+++ K
Sbjct: 244 PSPEFMKK 251

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 128/246 (52%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 185
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 246 PEFMKK 251

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 71
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRY
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 248 REMNPNYTEF 257

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 105
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 163
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRY 221
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 282 REMNPNYTEF 291

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 106/400 (26%), Positives = 182/400 (45%), Gaps = 81/400 (20%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKK 165
           R+Y +   LG G +G V K  D      VAVK I +        Q+   E+ ILT L+  
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            +  +  +++R        R + + F+ ++++L+ +I+ N    +     Q    Q+++ 
Sbjct: 69  ENIVNLLNVLRADN----DRDVYLVFDYMETDLHAVIRANILEPVH---KQYVVYQLIKV 121
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-------------------- 265
           +  L   G++H D+KP NILL        +K+ DFG + +                    
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAE---CHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 266 ---EDRTVYS-YIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320
              +D+ + + Y+ +R+YR+PE+LLG  +YT  IDMWS GCI+ E+  G P+FPG+S  +
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEA 380
            L R+I ++                  F     V +I+    S   ++  ++L E + E 
Sbjct: 239 QLERIIGVID-----------------FPSNEDVESIQ----SPFAKTMIESLKE-KVEI 276
Query: 381 RELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAK 440
           R+  K              +I T +   KNL ++ I+ ++      +D L  L++F+P K
Sbjct: 277 RQSNK-------------RDIFTKW---KNLLLK-INPKADCNEEALDLLDKLLQFNPNK 319
Query: 441 RWSPFQASRHPFVTGEPFTCPYQPP--PETPRVPVAQNFK 478
           R S   A +HPFV+   F  P + P       +P+  N K
Sbjct: 320 RISANDALKHPFVS--IFHNPNEEPNCDHIITIPINDNVK 357

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 117/234 (50%), Gaps = 27/234 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G +G V K  D     FVA+K ++    +       + EV++L    ++ +  +  +
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALL----RRLEAFEHPN 67
Query: 174 IVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           +VR+ +     R      + + FE +D +L   +      GL    ++   +Q LRGL  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRS 281
           L    I+H DLKPENIL+ +      +K+ DFG A      +YSY       + + +YR+
Sbjct: 128 LHANCIVHRDLKPENILVTSG---GTVKLADFGLA-----RIYSYQMALAPVVVTLWYRA 179
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           PEVLL   Y T +DMWS GCI AE+F   PLF G SE D L ++  ++G  P D
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 233

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 126/227 (55%), Gaps = 23/227 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  D++    VA+K I+           A+ E+S+L  L         HH
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKEL---------HH 78
Query: 174 --IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             IV + +    +R L + FE ++ +L +++  N   GL  S ++++  Q+LRG++    
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLG- 287
             I+H DLKP+N+L+ +      +K+ DFG A      V SY   + + +YR+P+VL+G 
Sbjct: 138 HRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +Y+T++D+WS GCI AE+  G PLFPG ++ D L ++  ILG   P
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 128/246 (52%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 83
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 84  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 132
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 186
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 247 PEFMKK 252

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 128/246 (52%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 84
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 85  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 133
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  +
Sbjct: 134 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMVPF 187
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   
Sbjct: 188 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 247
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 248 PEFMKK 253

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 132/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +    A+  +   E+ I+  L       D
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKL-------D 71
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + + + +Y + +  H+    + L +  V+L+  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 248 REMNPNYTEF 257

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 117/234 (50%), Gaps = 27/234 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G +G V K  D     FVA+K ++    +       + EV++L    ++ +  +  +
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALL----RRLEAFEHPN 67
Query: 174 IVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           +VR+ +     R      + + FE +D +L   +      GL    ++   +Q LRGL  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRS 281
           L    I+H DLKPENIL+ +      +K+ DFG A      +YSY       + + +YR+
Sbjct: 128 LHANCIVHRDLKPENILVTSG---GTVKLADFGLA-----RIYSYQMALDPVVVTLWYRA 179
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           PEVLL   Y T +DMWS GCI AE+F   PLF G SE D L ++  ++G  P D
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 233

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 128/246 (52%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 185
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 246 PEFMKK 251

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 117/234 (50%), Gaps = 27/234 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G +G V K  D     FVA+K ++    +       + EV++L    ++ +  +  +
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALL----RRLEAFEHPN 67
Query: 174 IVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           +VR+ +     R      + + FE +D +L   +      GL    ++   +Q LRGL  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRS 281
           L    I+H DLKPENIL+ +      +K+ DFG A      +YSY       + + +YR+
Sbjct: 128 LHANCIVHRDLKPENILVTSG---GTVKLADFGLA-----RIYSYQMALFPVVVTLWYRA 179
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           PEVLL   Y T +DMWS GCI AE+F   PLF G SE D L ++  ++G  P D
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 233

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 126/227 (55%), Gaps = 23/227 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GT+G V K  D++    VA+K I+           A+ E+S+L  L         HH
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKEL---------HH 78
Query: 174 --IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             IV + +    +R L + FE ++ +L +++  N   GL  S ++++  Q+LRG++    
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLG- 287
             I+H DLKP+N+L+ +      +K+ DFG A      V SY   + + +YR+P+VL+G 
Sbjct: 138 HRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +Y+T++D+WS GCI AE+  G PLFPG ++ D L ++  ILG   P
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 99  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 148
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 149 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 205
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 265
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 266 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 325
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 326 AYFAQYH 332

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 98  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 147
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 148 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 204
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 264
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 265 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 324
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 325 AYFAQYH 331

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  112 bits (281), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 85  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 134
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 135 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 191
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G  P  
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGA 250
Query: 336 YVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
            +LK+  + S   + + +  +  +    V IG 
Sbjct: 251 ELLKKISSESARNYIQSLAQMPKMNFANVFIGA 283

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  112 bits (281), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 121/226 (53%), Gaps = 18/226 (7%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           L+G G++G V KC + +    VA+K      +     + A+ E+ +L  L  +       
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE------- 84
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
           ++V + E    ++   + FE +D  + + +++    GL   +VQ +  QI+ G+      
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYS-YIQSRYYRSPEVLLG-Y 288
            IIH D+KPENIL+  S     +K+ DFG A T      VY   + +R+YR+PE+L+G  
Sbjct: 144 NIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           +Y  A+D+W+ GC+V E+F+G PLFPG S+ D L  ++  LG   P
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  112 bits (281), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 106/362 (29%), Positives = 168/362 (46%), Gaps = 81/362 (22%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 120
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I+  ++H R      + 
Sbjct: 121 K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MS 167
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VY 271
               Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  + 
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 221
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
            Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG 
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
             P++ +K+ + T + +        +EN       R  Y  LT      +     L   +
Sbjct: 282 PCPEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPAD 321
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
             H+K                     K SQ R    D L  ++  DPAKR S   A +HP
Sbjct: 322 SEHNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHP 357
Query: 452 FV 453
           ++
Sbjct: 358 YI 359

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 103/357 (28%), Positives = 165/357 (46%), Gaps = 71/357 (19%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKXVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYIQS 276
             Q+L G+  L  AGIIH DLKP NI++ +      +KI+DFG A T   +  +  Y+ +
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   P++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 248
Query: 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK 396
            +K+ + T + +        +EN       R  Y  LT      +     L   +  H+K
Sbjct: 249 -MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSEHNK 288
Query: 397 HLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
                                K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 289 --------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  112 bits (280), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 83
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 141
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 259
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 260 REMNPNYTEF 269

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 103/357 (28%), Positives = 165/357 (46%), Gaps = 71/357 (19%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYIQS 276
             Q+L G+  L  AGIIH DLKP NI++ +      +KI+DFG A T   +  +  Y+ +
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   P++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 248
Query: 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK 396
            +K+ + T + +        +EN       R  Y  LT      +     L   +  H+K
Sbjct: 249 -MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSEHNK 288
Query: 397 HLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
                                K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 289 --------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 83
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 141
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 259
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 260 REMNPNYTEF 269

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 135/278 (48%), Gaps = 36/278 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 81
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 82  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 128
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    + +E+KI+DFG A   D  +
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLARHTDDEM 185
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGG 366
           G    + + K +  +++ + + +  +  +    V IG 
Sbjct: 246 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 283

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 145/314 (46%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 77
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 78  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 124
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    + +E+KI+DFG A   D  +
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLARHTDDEM 181
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 242 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 301 AAQALAHAYFAQYH 314

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 103/357 (28%), Positives = 165/357 (46%), Gaps = 71/357 (19%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 76  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYL 124
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYIQS 276
             Q+L G+  L  AGIIH DLKP NI++ +      +KI+DFG A T   +  +  Y+ +
Sbjct: 125 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   P++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK 396
            +K+ + T + +        +EN       R  Y  LT      +     L   +  H+K
Sbjct: 242 -MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSEHNK 281
Query: 397 HLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
                                K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 282 --------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 75  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 124
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 181
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 242 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 302 AYFAQYH 308

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 90
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 91  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 148
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 149 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRY 206
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 266
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 267 REMNPNYTEF 276

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 79
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 80  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 137
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 138 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRY 195
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 255
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 256 REMNPNYTEF 265

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 134/272 (49%), Gaps = 24/272 (8%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 79  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 128
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 185
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGG 366
            + K +  +++ + + +  +  +    V IG 
Sbjct: 246 LLKKISSESARNYIQSLAQMPKMNFANVFIGA 277

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 98  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 147
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 148 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 204
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 264
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 265 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 324
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 325 AYFAQYH 331

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 131/261 (50%), Gaps = 24/261 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G +G V   +D +    VAVK +        + ++   E+ +L  +  +       +
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE-------N 92
Query: 174 IVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           ++ + + F   R L       +   L+ ++L  ++K    + L+   VQ    QILRGL 
Sbjct: 93  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLK 149
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
            +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +R+YR+PE++L 
Sbjct: 150 YIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN 206
Query: 288 Y-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
           +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    + + K +  +++
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 266
Query: 347 -FFKCIGSVHNIENGEVSIGG 366
            + + +  +  +    V IG 
Sbjct: 267 NYIQSLAQMPKMNFANVFIGA 287

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 120
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 121 K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 169
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 223
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 284 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 323
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 324 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  111 bits (278), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 99  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 148
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 149 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 205
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 265
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 266 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 325
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 326 AYFAQYH 332

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  111 bits (278), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 102 KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 151
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 152 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 208
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 268
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 269 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 328
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 329 AYFAQYH 335

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 144/314 (45%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 98
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 99  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 145
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 202
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 203 XGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 263 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 321
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 322 AAQALAHAYFAQYH 335

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 91  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 140
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 141 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 197
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 257
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 258 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 317
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 318 AYFAQYH 324

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 38/279 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
           G  P   +LK+  + S   + + +  +  +    V IG 
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 85  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 134
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 135 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 191
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G  P  
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGA 250
Query: 336 YVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
            +LK+  + S   + + +  +  +    V IG 
Sbjct: 251 ELLKKISSESARNYIQSLTQMPKMNFANVFIGA 283

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 105/363 (28%), Positives = 163/363 (44%), Gaps = 81/363 (22%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +D  +   VAVK +    +NQ  + ++A  E+ +L  +N 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNH 80
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELI--KINHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I  +++H R      + 
Sbjct: 81  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHER------MS 127
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACT--EDRTVY 271
               Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  + 
Sbjct: 128 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTASTNFMMT 181
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
            Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ EL  G  +F G    D   ++I  LG 
Sbjct: 182 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 241
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
              +++         +         +EN       R AY  +                  
Sbjct: 242 PSAEFMAALQPTVRNY---------VEN-------RPAYPGIA----------------- 268
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
                  EE+  ++ +    S  D  K SQ R    D L  ++  DP KR S  +A RHP
Sbjct: 269 ------FEELFPDWIFPSE-SERDKIKTSQAR----DLLSKMLVIDPDKRISVDEALRHP 317
Query: 452 FVT 454
           ++T
Sbjct: 318 YIT 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 91  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 140
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 141 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 197
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 257
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 258 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 317
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 318 AYFAQYH 324

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 91  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 140
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 141 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 197
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 257
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 258 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 317
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 318 AYFAQYH 324

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 75
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 76  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 133
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 134 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRY 191
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 251
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 252 REMNPNYTEF 261

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 105/364 (28%), Positives = 164/364 (45%), Gaps = 83/364 (22%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +D  +   VAVK +    +NQ  + ++A  E+ +L  +N 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELI--KINHFRGLSLSIVQ 216
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I  +++H R      + 
Sbjct: 83  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG---SACTEDRTV 270
               Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG   +ACT +  +
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTACT-NFMM 182
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
             Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ EL  G  +F G    D   ++I  LG
Sbjct: 183 TPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLG 242
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
               +++         +         +EN       R  Y  +                 
Sbjct: 243 TPSAEFMAALQPTVRNY---------VEN-------RPKYPGIK---------------- 270
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
                   EE+  ++ +    S  D  K SQ R    D L  ++  DP KR S  +A RH
Sbjct: 271 -------FEELFPDWIFPSE-SERDKIKTSQAR----DLLSKMLVIDPDKRISVDEALRH 318
Query: 451 PFVT 454
           P++T
Sbjct: 319 PYIT 322

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 38/279 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 86
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 87  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 133
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEM 190
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 191 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
           G  P   +LK+  + S   + + +  +  +    V IG 
Sbjct: 251 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 288

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 84  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 133
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 134 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMTGYVAT 190
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G  P  
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGA 249
Query: 336 YVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
            +LK+  + S   + + +  +  +    V IG 
Sbjct: 250 ELLKKISSESARNYIQSLTQMPKMNFANVFIGA 282

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 81  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 130
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 131 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 187
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 247
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 248 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 307
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 308 AYFAQYH 314

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 81  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 130
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 131 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 187
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 247
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 248 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 307
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 308 AYFAQYH 314

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 143/313 (45%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL--- 71
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K      L
Sbjct: 72  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCA---KL 118
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 175
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 236 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 296 AQALAHAYFAQYH 308

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 144/308 (46%), Gaps = 30/308 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 90  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 139
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 140 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 196
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G  P  
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGA 255
Query: 336 YVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIG 389
            +LK+  + S   + + +  +  +    V IG       L E    ++ + R      + 
Sbjct: 256 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 315
Query: 390 KEYFHHKH 397
             YF   H
Sbjct: 316 HAYFAQYH 323

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 38/279 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
           G  P   +LK+  + S   + + +  +  +    V IG 
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 71
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 248 REMNPNYTEF 257

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 73
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 74  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 120
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 121 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 177
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 237
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 238 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 297
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 298 AQALAHAYFAQYH 310

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 77
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 78  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 124
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 181
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 242 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 301
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 302 AQALAHAYFAQYH 314

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 38/279 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 80
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 81  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 127
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEM 184
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
           G  P   +LK+  + S   + + +  +  +    V IG 
Sbjct: 245 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 282

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 300 AQALAHAYFAQYH 312

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 144/308 (46%), Gaps = 30/308 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 85  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 134
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 135 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 191
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G  P  
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGA 250
Query: 336 YVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIG 389
            +LK+  + S   + + +  +  +    V IG       L E    ++ + R      + 
Sbjct: 251 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 310
Query: 390 KEYFHHKH 397
             YF   H
Sbjct: 311 HAYFAQYH 318

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 71
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 248 REMNPNYTEF 257

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 144/314 (45%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 82
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 83  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 129
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 186
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 247 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 306 AAQALAHAYFAQYH 319

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 144/314 (45%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 299 AAQALAHAYFAQYH 312

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 300 AQALAHAYFAQYH 312

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 129/253 (50%), Gaps = 29/253 (11%)
Query: 110 RYIVKDL--LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNK 164
           R + +DL  +G G +G V    D    + VA+K +        + ++A  E+ +L  +  
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           +       +++ + + F     L       +    + ++L +L+K      L    +Q  
Sbjct: 84  E-------NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQFL 133
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
             Q+L+GL  +  AGIIH DLKP N+ +    +  E+KI+DFG A   D  +   + +R+
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMXGXVVTRW 190
Query: 279 YRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PEV+L + +YT  +D+WS GCI+AE+  G  LF G+   D L+ ++++ G  P ++V
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 338 LK----EAKNTSK 346
            +    EAKN  K
Sbjct: 251 QRLQSDEAKNYMK 263

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/231 (33%), Positives = 122/231 (52%), Gaps = 19/231 (8%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKK 165
           ++Y   + +G GT+G V K  + E +  VA+K ++   +       AL E+ +L  L  K
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
                  +IVR+++     + L + FE  D +L +     +   L   IV+ F  Q+L+G
Sbjct: 62  -------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKG 113
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSP 282
           L       ++H DLKP+N+L+    +  E+K+ +FG A      V  Y   + + +YR P
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 283 EVLLGYQ-YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGA 331
           +VL G + Y+T+IDMWS GCI AEL   G PLFPG    D L+R+ R+LG 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 80
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 81  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 127
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 184
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 245 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 304
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 305 AQALAHAYFAQYH 317

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 94/335 (28%), Positives = 156/335 (46%), Gaps = 45/335 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---SQKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    + +E+KI+DFG     D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLCRHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298
Query: 384 KKPLIGKEYF--HHKHLEEIVTNYPYRKNLSMEDI 416
               +   YF  +H   +E V + PY ++L   D+
Sbjct: 299 AAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDL 332

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 144/314 (45%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 299 AAQALAHAYFAQYH 312

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 144/314 (45%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 299 AAQALAHAYFAQYH 312

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 72
Query: 171 KHHIVRIYEYFVC------QRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F        + +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 73  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 130
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 131 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 188
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 248
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 249 REMNPNYTEF 258

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 300 AQALAHAYFAQYH 312

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/231 (33%), Positives = 121/231 (52%), Gaps = 19/231 (8%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKK 165
           ++Y   + +G GT+G V K  + E +  VA+K ++   +       AL E+ +L  L  K
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
                  +IVR+++     + L + FE  D +L +     +   L   IV+ F  Q+L+G
Sbjct: 62  -------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKG 113
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSP 282
           L       ++H DLKP+N+L+    +  E+K+ DFG A      V  Y   + + +YR P
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 283 EVLLGYQ-YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGA 331
           +VL G + Y+T+IDMWS GCI AEL     PLFPG    D L+R+ R+LG 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGT 221

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 71
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 72  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 118
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 175
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 296 AQALAHAYFAQYH 308

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 185
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 246 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 285
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 286 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 300 AQALAHAYFAQYH 312

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 83
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 84  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 132
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 186
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 247 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 286
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 287 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 80
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 81  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 127
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 184
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 245 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 304
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 305 AQALAHAYFAQYH 317

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 74
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 75  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 121
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 122 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 178
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 179 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 238
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 239 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 298
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 299 AQALAHAYFAQYH 311

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 83
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 84  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 132
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 186
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 247 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 286
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 287 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 81
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 82  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 130
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 131 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 184
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 185 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 244
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 245 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 284
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 285 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 101/349 (28%), Positives = 161/349 (46%), Gaps = 71/349 (20%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N K       
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKXVNHK------- 83
Query: 173 HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +     Q+L G+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYLLYQMLCGI 139
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--YIQSRYYRSPEV 284
             L  AGIIH DLKP NI++ +      +KI+DFG A T   +     Y+ +RYYR+PEV
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
           +LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   P++ +K+ + T
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF-MKKLQPT 255
Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
            + +        +EN       R  Y  LT      +     L   +  H+K        
Sbjct: 256 VRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSEHNK-------- 288
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
                        K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 289 ------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 72
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 73  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 119
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 176
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 237 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 296
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 297 AQALAHAYFAQYH 309

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 144/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 75  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 124
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  ++ +
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMAGFVAT 181
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 242 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 302 AYFAQYH 308

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 72
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 73  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 119
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 176
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 237 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 296
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 297 AQALAHAYFAQYH 309

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 185
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 246 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 285
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 286 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 104/360 (28%), Positives = 162/360 (45%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 76
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 77  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 125
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 179
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P+++ K       +         +EN       R  Y  LT      +     L   +  
Sbjct: 240 PEFMKKLQPTVRNY---------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 279
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 280 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 134/272 (49%), Gaps = 24/272 (8%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 79  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 128
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  ++ +
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMAGFVAT 185
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGG 366
            + K +  +++ + + +  +  +    V IG 
Sbjct: 246 LLKKISSESARNYIQSLAQMPKMNFANVFIGA 277

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 76
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 77  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 125
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 179
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 240 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 279
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 280 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 39/258 (15%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVE-- 155
           E   RY     +G G +G V   +D +    +AVK        II  +  Y +  L++  
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 156 -----VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL 210
                + +L         E+ + +     Y V          L+ ++L  ++K    + L
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDV-----YLVTH--------LMGADLNNIVKC---QKL 151
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 152 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 208
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    + L++++R+ 
Sbjct: 209 TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLT 268
Query: 330 GAQPPDYVLK----EAKN 343
           G  P   + +    EA+N
Sbjct: 269 GTPPASVISRMPSHEARN 286

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 126/246 (51%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYSY-- 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +      
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPE 185
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  LG   
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 246 PEFMKK 251

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 105/360 (29%), Positives = 166/360 (46%), Gaps = 77/360 (21%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +   
Sbjct: 76  K-------NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 124
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 178
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P++ +K+ + T + +        +EN       R  Y  LT      +     L   +  
Sbjct: 239 PEF-MKKLQPTVRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSE 278
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
           H+K                     K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 279 HNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L       D
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------D 71
Query: 171 KHHIVRIYEYFVCQ------RHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSK 220
             +IVR+  +F          +L +  + +   +Y + +  H+    + L +  V+L+  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMY 129
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          S I SRY
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           YR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 338 LKEAKNTSKF 347
            +   N ++F
Sbjct: 248 REMNPNYTEF 257

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 143/307 (46%), Gaps = 28/307 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 99  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 148
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +   + +
Sbjct: 149 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMXGXVAT 205
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 265
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIGK 390
            + K +  +++ + + +  +  +    V IG       L E    ++ + R      +  
Sbjct: 266 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 325
Query: 391 EYFHHKH 397
            YF   H
Sbjct: 326 AYFAQYH 332

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 127/246 (51%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 87
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 88  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 136
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 137 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 190
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 191 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 250
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 251 PEFMKK 256

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 133/279 (47%), Gaps = 38/279 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L    Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
           G  P   +LK+  + S   + + +  +  +    V IG 
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/228 (34%), Positives = 125/228 (54%), Gaps = 19/228 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
           YI  D LG GT+  V K      ++ VA+K I+  ++      A+ EVS+L  L      
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------ 57
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             KH +IV +++    ++ L + FE LD +L + +  +    +++  V+LF  Q+LRGL+
Sbjct: 58  --KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-DCGNIINMHNVKLFLFQLLRGLA 114
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEV 284
                 ++H DLKP+N+L+    +  E+K+ DFG A  +     +Y   + + +YR P++
Sbjct: 115 YCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           LLG   Y+T IDMW  GCI  E+  G PLFPG++  + L  + RILG 
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 134/272 (49%), Gaps = 24/272 (8%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 79  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 128
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  ++ +
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMAGFVAT 185
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 336 YVLKEAKNTSK-FFKCIGSVHNIENGEVSIGG 366
            + K +  +++ + + +  +  +    V IG 
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGA 277

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 81/241 (33%), Positives = 131/241 (54%), Gaps = 24/241 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKH- 172
           +G G++G V KC + +    VA+K     ++ P   + AL E+ +L  L        KH 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL--------KHP 62
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           ++V + E F  +R L + FE  D   L+EL +    RG+   +V+  + Q L+ ++    
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK 120
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS-YIQSRYYRSPEVLLG- 287
              IH D+KPENIL+    K + IK+ DFG A   T     Y   + +R+YRSPE+L+G 
Sbjct: 121 HNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
            QY   +D+W+ GC+ AEL  G+PL+PG S+ D L  + + LG   P +  ++  +T+++
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH--QQVFSTNQY 235
Query: 348 F 348
           F
Sbjct: 236 F 236

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 101/349 (28%), Positives = 161/349 (46%), Gaps = 71/349 (20%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G  G V   +DA ++  VA+K +    +NQ  + ++A  E+ ++  +N K       
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKXVNHK------- 83
Query: 173 HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           +I+ +   F  Q+ L       +  EL+D+NL ++I++     L    +     Q+L G+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGI 139
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--YIQSRYYRSPEV 284
             L  AGIIH DLKP NI++ +      +KI+DFG A T   +     Y+ +RYYR+PEV
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
           +LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   P++ +K+ + T
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF-MKKLQPT 255
Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
            + +        +EN       R  Y  LT      +     L   +  H+K        
Sbjct: 256 VRNY--------VEN-------RPKYAGLT----FPKLFPDSLFPADSEHNK-------- 288
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
                        K SQ R    D L  ++  DPAKR S   A +HP++
Sbjct: 289 ------------LKASQAR----DLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 134/279 (48%), Gaps = 38/279 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+D+G A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDYGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
           G  P   +LK+  + S   + + +  +  +    V IG 
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 127/246 (51%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 76
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 77  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 125
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VYSY 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +  +  Y
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMTPY 179
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 240 PEFMKK 245

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 94/335 (28%), Positives = 155/335 (46%), Gaps = 45/335 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 82
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 83  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 129
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A      +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEM 186
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 247 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305
Query: 384 KKPLIGKEYF--HHKHLEEIVTNYPYRKNLSMEDI 416
               +   YF  +H   +E V + PY ++L   D+
Sbjct: 306 AAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDL 339

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 120/230 (52%), Gaps = 18/230 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
           RY     LG GT+G+V K  D   N  VA+K I+    +      A+ EVS+L  L  + 
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR- 93
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 +I+ +         L + FE  +++L + +  N    +S+ +++ F  Q++ G+
Sbjct: 94  ------NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGV 145
Query: 227 SLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRS 281
           +       +H DLKP+N+LL  S   +   +KI DFG A      +  +   I + +YR 
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           PE+LLG + Y+T++D+WS  CI AE+ +  PLFPG SE D L ++  +LG
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +G G +G+V K  D +    FVA+K ++ Q       L  +  +  L +  +  +  ++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL-RHLETFEHPNVV 77
Query: 176 RIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           R+++     R      L + FE +D +L   +      G+    ++    Q+LRGL  L 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRSPE 283
              ++H DLKP+NIL+ +S    +IK+ DFG A      +YS+       + + +YR+PE
Sbjct: 138 SHRVVHRDLKPQNILVTSS---GQIKLADFGLA-----RIYSFQMALTSVVVTLWYRAPE 189
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           VLL   Y T +D+WS GCI AE+F   PLF G+S+ D L +++ ++G
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 143/313 (45%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
              + +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 300 AQALAHAYFAQYH 312

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 143/314 (45%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 82
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 83  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 129
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A      +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEM 186
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 247 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 306 AAQALAHAYFAQYH 319

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 143/313 (45%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 82
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 83  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 129
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A      +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEM 186
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 307 AQALAHAYFAQYH 319

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 143/314 (45%), Gaps = 42/314 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+ FG A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILGFGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEAREL 383
           G  P   +LK+  + S   + + +  +  +    V IG       L E    ++ + R  
Sbjct: 240 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298
Query: 384 KKPLIGKEYFHHKH 397
               +   YF   H
Sbjct: 299 AAQALAHAYFAQYH 312

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 133/273 (48%), Gaps = 26/273 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 79  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 128
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DF  A   D  +  Y+ +
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFYLARHTDDEMTGYVAT 185
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G  P  
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGA 244
Query: 336 YVLKEAKNTS--KFFKCIGSVHNIENGEVSIGG 366
            +LK+  + S   + + +  +  +    V IG 
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 118/222 (53%), Gaps = 12/222 (5%)
Query: 117 LGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +G G +G+V K  D +    FVA+K ++ Q       L  +  +  L +  +  +  ++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL-RHLETFEHPNVV 77
Query: 176 RIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           R+++     R      L + FE +D +L   +      G+    ++    Q+LRGL  L 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGY 288
              ++H DLKP+NIL+ +S    +IK+ DFG A   +    + S + + +YR+PEVLL  
Sbjct: 138 SHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            Y T +D+WS GCI AE+F   PLF G+S+ D L +++ ++G
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 143/308 (46%), Gaps = 30/308 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F   R L       +   L+ ++L  ++K    + L+   VQ
Sbjct: 79  KHE-------NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 128
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+D G A   D  +  Y+ +
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDAGLARHTDDEMTGYVAT 185
Query: 277 RYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G  P  
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGA 244
Query: 336 YVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELKKPLIG 389
            +LK+  + S   + + +  +  +    V IG       L E    ++ + R      + 
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 304
Query: 390 KEYFHHKH 397
             YF   H
Sbjct: 305 HAYFAQYH 312

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 143/313 (45%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+D G A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDRGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 300 AQALAHAYFAQYH 312

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 143/313 (45%), Gaps = 40/313 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
           E   RY     +G G +G V   +D +    VAVK        II  +  Y +  L+   
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
                     +  KH +++ + + F   R L       +   L+ ++L  ++K    + L
Sbjct: 76  ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 122
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +   VQ    QILRGL  +  A IIH DLKP N+ +    +  E+KI+D G A   D  +
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDGGLARHTDDEM 179
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
             Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 330 GAQPPDYVLKEAKNTSK-FFKCIGSVHNIENGEVSIGGRSAYQALTE----IEYEARELK 384
           G    + + K +  +++ + + +  +  +    V IG       L E    ++ + R   
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 385 KPLIGKEYFHHKH 397
              +   YF   H
Sbjct: 300 AQALAHAYFAQYH 312

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +G G +G+V K  D +    FVA+K ++ Q       L  +  +  L +  +  +  ++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL-RHLETFEHPNVV 77
Query: 176 RIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           R+++     R      L + FE +D +L   +      G+    ++    Q+LRGL  L 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRSPE 283
              ++H DLKP+NIL+ +S    +IK+ DFG A      +YS+       + + +YR+PE
Sbjct: 138 SHRVVHRDLKPQNILVTSS---GQIKLADFGLA-----RIYSFQMALTSVVVTLWYRAPE 189
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           VLL   Y T +D+WS GCI AE+F   PLF G+S+ D L +++ ++G
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/246 (32%), Positives = 125/246 (50%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYSY-- 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +      
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMEPE 185
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 334 PDYVLK 339
           P+++ K
Sbjct: 246 PEFMKK 251

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 125/245 (51%), Gaps = 28/245 (11%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRED 170
           +K LLG G +G V           VA+K I+  ++P +  + L E+ IL    K +  E+
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL----KHFKHEN 70
Query: 171 KHHIVRIY--EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
              I  I   + F     + I  EL+ ++L+ +I     + LS   +Q F  Q LR + +
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKV 127
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-------------VYSYIQ 275
           L  + +IH DLKP N+L+ ++    ++K+ DFG A   D +             +  Y+ 
Sbjct: 128 LHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 276 SRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           +R+YR+PEV+L   +Y+ A+D+WS GCI+AELFL  P+FPG      L  +  I+G    
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 335 DYVLK 339
           D  L+
Sbjct: 245 DNDLR 249

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/223 (35%), Positives = 114/223 (51%), Gaps = 18/223 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKY 166
           RY +  +LG G+FG+V KC D       AVK+I    A  +     L EV +L  L    
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL---- 78
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLY-ELIKINHFRGLSLSIVQLFSKQILR 224
              D  +I++++E         I  EL     L+ E+IK   F     + +    KQ+  
Sbjct: 79  ---DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI---IKQVFS 132
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRT-VYSYIQSRYYRSP 282
           G++ +    I+H DLKPENILL +  K  +IKIIDFG S C +  T +   I + YY +P
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           EVL G  Y    D+WS G I+  L  G P F G +E+D+L+R+
Sbjct: 193 EVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 125/245 (51%), Gaps = 28/245 (11%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRED 170
           +K LLG G +G V           VA+K I+  ++P +  + L E+ IL    K +  E+
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL----KHFKHEN 70
Query: 171 KHHIVRIY--EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
              I  I   + F     + I  EL+ ++L+ +I     + LS   +Q F  Q LR + +
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKV 127
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-------------VYSYIQ 275
           L  + +IH DLKP N+L+ ++    ++K+ DFG A   D +             +  ++ 
Sbjct: 128 LHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 276 SRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           +R+YR+PEV+L   +Y+ A+D+WS GCI+AELFL  P+FPG      L  +  I+G    
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 335 DYVLK 339
           D  L+
Sbjct: 245 DNDLR 249

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 115/224 (51%), Gaps = 19/224 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKK 165
           RY  + +LG G+FG+V  C D       AVK+I      Q    +  L EV +L  L   
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL--- 107
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQIL 223
               D  +I+++YE+F  + +  +  E+        E+I    F  +  + +    +Q+L
Sbjct: 108 ----DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI---IRQVL 160
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRS 281
            G++ +    I+H DLKPEN+LL +  K A I+IIDFG +      + +   I + YY +
Sbjct: 161 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           PEVL G  Y    D+WS G I+  L  G P F GA+E+D+L+++
Sbjct: 221 PEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 263

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 118/223 (52%), Gaps = 17/223 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKK 165
           RY  + +LG G+FG+V  C D       AVK+I      Q    +  L EV +L  L   
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL--- 106
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
               D  +I+++YE+F  + +  +  E+     L++ I I+  R   +   ++  +Q+L 
Sbjct: 107 ----DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII-RQVLS 160
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSP 282
           G++ +    I+H DLKPEN+LL +  K A I+IIDFG +      + +   I + YY +P
Sbjct: 161 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 220
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           EVL G  Y    D+WS G I+  L  G P F GA+E+D+L+++
Sbjct: 221 EVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 262

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/246 (32%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           +RY     +G G  G V   +DA +   VA+K +    +NQ  + ++A  E+ ++  +N 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSIVQLF 218
           K       +I+ +   F  Q+ L       I  EL+D+NL ++I++     L    +   
Sbjct: 83  K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYSY-- 273
             Q+L G+  L  AGIIH DLKP NI++   CT      +KI+DFG A T   +      
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMEPE 185
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
           + +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 334 PDYVLK 339
           P ++ K
Sbjct: 246 PAFMKK 251

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/324 (28%), Positives = 152/324 (46%), Gaps = 35/324 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           R+ V+ + G GTFG V    +      VA+K +   P +  + L  +  L  L       
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL------- 76
Query: 170 DKHH--IVRIYEYF--VCQR-----HLCICFELLDSNLYELIKINHFRGLSLS---IVQL 217
             HH  IV++  YF  + +R     +L +  E +   L+   + N++R        ++++
Sbjct: 77  --HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR-NYYRRQVAPPPILIKV 133
Query: 218 FSKQILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSY 273
           F  Q++R +  L      + H D+KP N+L+  +     +K+ DFGSA   +      +Y
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 274 IQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
           I SRYYR+PE++ G Q YTTA+D+WS GCI AE+ LG P+F G +    L  ++R+LG  
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC- 250
Query: 333 PPDYVLKEAKNTSKFFKCIGSV----HNIENGEVSIGGRSAYQALTE-IEYEARELKKPL 387
           P   VL++   +        S      N+ +       + AY  L+  ++Y   E  KP 
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 388 IGKEYFHHKHLEEIVTNYPYRKNL 411
               + +   L +  T  P  K+L
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDL 334

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/223 (35%), Positives = 114/223 (51%), Gaps = 18/223 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKY 166
           RY +  +LG G+FG+V KC D       AVK+I    A  +     L EV +L  L    
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL---- 78
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLY-ELIKINHFRGLSLSIVQLFSKQILR 224
              D  +I++++E         I  EL     L+ E+IK   F     + +    KQ+  
Sbjct: 79  ---DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI---IKQVFS 132
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRT-VYSYIQSRYYRSP 282
           G++ +    I+H DLKPENILL +  K  +IKIIDFG S C +  T +   I + YY +P
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           EVL G  Y    D+WS G I+  L  G P F G +E+D+L+R+
Sbjct: 193 EVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/223 (35%), Positives = 114/223 (51%), Gaps = 18/223 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKY 166
           RY +  +LG G+FG+V KC D       AVK+I    A  +     L EV +L  L    
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL---- 78
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLY-ELIKINHFRGLSLSIVQLFSKQILR 224
              D  +I++++E         I  EL     L+ E+IK   F     + +    KQ+  
Sbjct: 79  ---DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI---IKQVFS 132
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRT-VYSYIQSRYYRSP 282
           G++ +    I+H DLKPENILL +  K  +IKIIDFG S C +  T +   I + YY +P
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           EVL G  Y    D+WS G I+  L  G P F G +E+D+L+R+
Sbjct: 193 EVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 119/230 (51%), Gaps = 30/230 (13%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
           ++G+G+FG V +    E +  VA+K +     +  + L  + I+           KH ++
Sbjct: 47  VIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIV-----------KHPNV 94
Query: 175 VRIYEYFVC------QRHLCICFELLDSNLYELIKINHFRGLS----LSIVQLFSKQILR 224
           V +  +F        +  L +  E +   +Y   +  H+  L     + +++L+  Q+LR
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASR--HYAKLKQTMPMLLIKLYMYQLLR 152
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
            L+ +   GI H D+KP+N+LL        +K+IDFGSA          S I SRYYR+P
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAP 210
Query: 283 EVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           E++ G   YTT ID+WS GC++AEL  G PLFPG S  D L  +I++LG 
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 127/242 (52%), Gaps = 25/242 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYD 167
           Y + + +G+G +G V+          VA+K I N        ++ L E+ IL     K+ 
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKIL-----KHF 111
Query: 168 REDK----HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
           + D       I+R    +   + + +  +L++S+L+++I  +  + L+L  V+ F  Q+L
Sbjct: 112 KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLL 169
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRT----VYSYIQS 276
           RGL  +  A +IH DLKP N+L+  +    E+KI DFG A   CT        +  Y+ +
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNEN---CELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 277 RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L  ++YT AID+WS GCI  E+     LFPG +    L+ ++ +LG   P 
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 286
Query: 336 YV 337
            +
Sbjct: 287 VI 288

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRED 170
           +K LLG G +G V           VA+K I+  ++P +  + L E+ IL    K +  E+
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL----KHFKHEN 70
Query: 171 KHHIVRIY--EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
              I  I   + F     + I  EL+ ++L+ +I     + LS   +Q F  Q LR + +
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKV 127
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-------------VYSYIQ 275
           L  + +IH DLKP N+L+ ++    ++K+ DFG A   D +             +   + 
Sbjct: 128 LHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 276 SRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           +R+YR+PEV+L   +Y+ A+D+WS GCI+AELFL  P+FPG      L  +  I+G    
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 335 DYVLK 339
           D  L+
Sbjct: 245 DNDLR 249

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 118/223 (52%), Gaps = 17/223 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKK 165
           RY  + +LG G+FG+V  C D       AVK+I      Q    +  L EV +L  L   
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL--- 83
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
               D  +I+++YE+F  + +  +  E+     L++ I I+  R   +   ++  +Q+L 
Sbjct: 84  ----DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII-RQVLS 137
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSP 282
           G++ +    I+H DLKPEN+LL +  K A I+IIDFG +      + +   I + YY +P
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           EVL G  Y    D+WS G I+  L  G P F GA+E+D+L+++
Sbjct: 198 EVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 106/388 (27%), Positives = 172/388 (44%), Gaps = 95/388 (24%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKYD 167
           YI+K L+G G++G V   +D      VA+K +          ++ L E++IL  L   Y 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY- 86
Query: 168 REDKHHIVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
                 I+R+Y+  +         L I  E+ DS+L +L K   F  L+   ++     +
Sbjct: 87  ------IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF--LTEEHIKTILYNL 138
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--------------- 267
           L G + + ++GIIH DLKP N LL    +   +K+ DFG A T +               
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 268 ----------RTVYSYIQSRYYRSPE-VLLGYQYTTAIDMWSFGCIVAELFLGL------ 310
                     + + S++ +R+YR+PE +LL   YT +ID+WS GCI AEL   L      
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 311 -----PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIG 365
                PLFPG+S F L            PD   K+    S   + +  + NI      IG
Sbjct: 256 PTNRFPLFPGSSCFPL-----------SPDRNSKKVHEKSNRDQ-LNIIFNI------IG 297
Query: 366 GRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA 425
                   T  E + + + KP + K           +  +P+RK ++++   K   I   
Sbjct: 298 --------TPTEDDLKNINKPEVIK----------YIKLFPHRKPINLK--QKYPSISDD 337
Query: 426 LVDFLKGLVEFDPAKRWSPFQASRHPFV 453
            ++ L+ +++F+P KR +  QA  HP++
Sbjct: 338 GINLLESMLKFNPNKRITIDQALDHPYL 365

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 127/242 (52%), Gaps = 25/242 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYD 167
           Y + + +G+G +G V+          VA+K I N        ++ L E+ IL     K+ 
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKIL-----KHF 110
Query: 168 REDK----HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
           + D       I+R    +   + + +  +L++S+L+++I  +  + L+L  V+ F  Q+L
Sbjct: 111 KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLL 168
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CT----EDRTVYSYIQS 276
           RGL  +  A +IH DLKP N+L+  +    E+KI DFG A   CT        +  Y+ +
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNEN---CELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 277 RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L  ++YT AID+WS GCI  E+     LFPG +    L+ ++ +LG   P 
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285
Query: 336 YV 337
            +
Sbjct: 286 VI 287

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 115/224 (51%), Gaps = 19/224 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKK 165
           RY  + +LG G+FG+V  C D       AVK+I      Q    +  L EV +L  L   
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL--- 89
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQIL 223
               D  +I+++YE+F  + +  +  E+        E+I    F  +  + +    +Q+L
Sbjct: 90  ----DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI---IRQVL 142
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRS 281
            G++ +    I+H DLKPEN+LL +  K A I+IIDFG +      + +   I + YY +
Sbjct: 143 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           PEVL G  Y    D+WS G I+  L  G P F GA+E+D+L+++
Sbjct: 203 PEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 245

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 115/223 (51%), Gaps = 17/223 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKK 165
           RY  + +LG G+FG+V  C D       AVK+I      Q    +  L EV +L  L   
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL--- 83
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
               D  +I ++YE+F  + +  +  E+     L++ I I+  R   +   ++  +Q+L 
Sbjct: 84  ----DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII-RQVLS 137
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSP 282
           G++      I+H DLKPEN+LL +  K A I+IIDFG +      +     I + YY +P
Sbjct: 138 GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAP 197
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           EVL G  Y    D+WS G I+  L  G P F GA+E+D+L+++
Sbjct: 198 EVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 118/247 (47%), Gaps = 16/247 (6%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E  + Y+    +G G +G V    D      VA+K +        + ++A  E+ +L  +
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 98
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS--IVQLFSK 220
             +       +++ + + F     L   ++      +    +    G+  S   +Q    
Sbjct: 99  QHE-------NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVY 151
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           Q+L+GL  +  AG++H DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +R+YR
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLARHADAEMTGYVVTRWYR 208
Query: 281 SPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           +PEV+L +  Y   +D+WS GCI+AE+  G  LF G    D L +++++ G    ++V K
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268
Query: 340 EAKNTSK 346
                +K
Sbjct: 269 LNDKAAK 275

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 118/247 (47%), Gaps = 16/247 (6%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E  + Y+    +G G +G V    D      VA+K +        + ++A  E+ +L  +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS--IVQLFSK 220
             +       +++ + + F     L   ++      +    +    GL  S   +Q    
Sbjct: 81  QHE-------NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY 133
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           Q+L+GL  +  AG++H DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +R+YR
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLARHADAEMTGYVVTRWYR 190
Query: 281 SPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           +PEV+L +  Y   +D+WS GCI+AE+  G  LF G    D L +++++ G    ++V K
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250
Query: 340 EAKNTSK 346
                +K
Sbjct: 251 LNDKAAK 257

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 119/220 (54%), Gaps = 26/220 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHH 173
           LG G +G+V  C D   +   A+KII+      +   + L EV++L  L       D  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-------DHPN 97
Query: 174 IVRIYEYFVCQRHLCI---CF---ELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           I+++Y++F  +R+  +   C+   EL D    E+I    F  +  +++    KQ+L G++
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFD----EIIHRMKFNEVDAAVI---IKQVLSGVT 150
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED-RTVYSYIQSRYYRSPEVL 285
            L    I+H DLKPEN+LL +  K A IKI+DFG SA  E+ + +   + + YY +PEVL
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
              +Y    D+WS G I+  L  G P F G ++ ++LR++
Sbjct: 211 RK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKK 165
           RY     LG G +G+V  C D    +  A+KIIK             L EV++L  L   
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL--- 78
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQIL 223
               D  +I+++YE+F  +R+  +  E+        E+I    F  +  +++    KQ+L
Sbjct: 79  ----DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM---KQVL 131
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQSRYYRS 281
            G + L    I+H DLKPEN+LL +  + A IKI+DFG +   +    +   + + YY +
Sbjct: 132 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 191
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQPPDY--VL 338
           PEVL   +Y    D+WS G I+  L  G P F G ++ ++L+R+ +      PPD+  V 
Sbjct: 192 PEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVS 250
Query: 339 KEAKNTSKFF 348
            EAK   K  
Sbjct: 251 DEAKQLVKLM 260

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 125/250 (50%), Gaps = 22/250 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKK 165
           RY     LG G +G+V  C D    +  A+KIIK             L EV++L  L   
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL--- 61
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLY-ELIKINHFRGLSLSIVQLFSKQIL 223
               D  +I+++YE+F  +R+  +  E+     L+ E+I    F  +  +++    KQ+L
Sbjct: 62  ----DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM---KQVL 114
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTE-DRTVYSYIQSRYYRS 281
            G + L    I+H DLKPEN+LL +  + A IKI+DFG SA  E    +   + + YY +
Sbjct: 115 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 174
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQPPDY--VL 338
           PEVL   +Y    D+WS G I+  L  G P F G ++ ++L+R+ +      PPD+  V 
Sbjct: 175 PEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVS 233
Query: 339 KEAKNTSKFF 348
            EAK   K  
Sbjct: 234 DEAKQLVKLM 243

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 62/262 (23%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKY 166
           RY ++ L+G G++G V + +D      VA+K I          ++ L E++IL  LN   
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD- 112
Query: 167 DREDKHHIVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                 H+V++ +  + +       L +  E+ DS+  +L +   +  L+   ++     
Sbjct: 113 ------HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY--LTELHIKTLLYN 164
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED-------------- 267
           +L G+  +  AGI+H DLKP N   C   +   +K+ DFG A T D              
Sbjct: 165 LLVGVKYVHSAGILHRDLKPAN---CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 268 ----------------RTVYSYIQSRYYRSPE-VLLGYQYTTAIDMWSFGCIVAELFLGL 310
                           R +  ++ +R+YR+PE +LL   YT AID+WS GCI AEL   +
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 311 -----------PLFPGASEFDL 321
                      PLFPG+S F L
Sbjct: 282 KENVAYHADRGPLFPGSSCFPL 303

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 121/259 (46%), Gaps = 60/259 (23%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKYD 167
           Y +K L+G G++G V   +D   N  VA+K +          ++ L E++IL  L   Y 
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY- 88
Query: 168 REDKHHIVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
                 I+R+++  + +       L I  E+ DS+L +L K   F  L+   V+     +
Sbjct: 89  ------IIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIF--LTEQHVKTILYNL 140
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVY--------- 271
           L G   + ++GIIH DLKP N LL    +   +KI DFG A T   D+ ++         
Sbjct: 141 LLGEKFIHESGIIHRDLKPANCLLN---QDCSVKICDFGLARTINSDKDIHIVNDLEEKE 197
Query: 272 -----------------SYIQSRYYRSPE-VLLGYQYTTAIDMWSFGCIVAELFLGL--- 310
                            S++ +R+YR+PE +LL   YT +ID+WS GCI AEL   +   
Sbjct: 198 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSH 257
Query: 311 --------PLFPGASEFDL 321
                   PLFPG+S F L
Sbjct: 258 INNPTNRFPLFPGSSCFPL 276

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 129/239 (53%), Gaps = 30/239 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT--LNKKYDR 168
           Y V+  +  G++G V    D+E    VA+K + N  +  +     V+IL+   L K+  R
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRT----VNILSDSFLCKRVLR 78
Query: 169 EDK-----HH--IVRIYEYFV-----CQRHLCICFELLDSNLYELIKINHFRGLSLS--I 214
           E +     HH  I+ + + FV         L +  EL+ ++L ++I   H + + +S   
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVISPQH 135
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYS 272
           +Q F   IL GL +L +AG++H DL P NILL  +    +I I DF  A   T D     
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN---NDITICDFNLAREDTADANKTH 192
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           Y+  R+YR+PE+++ ++ +T  +DMWS GC++AE+F    LF G++ ++ L +++ ++G
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 129/239 (53%), Gaps = 30/239 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT--LNKKYDR 168
           Y V+  +  G++G V    D+E    VA+K + N  +  +     V+IL+   L K+  R
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRT----VNILSDSFLCKRVLR 78
Query: 169 EDK-----HH--IVRIYEYFV-----CQRHLCICFELLDSNLYELIKINHFRGLSLS--I 214
           E +     HH  I+ + + FV         L +  EL+ ++L ++I   H + + +S   
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVISPQH 135
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYS 272
           +Q F   IL GL +L +AG++H DL P NILL  +    +I I DF  A   T D     
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN---NDITICDFNLAREDTADANKTH 192
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           Y+  R+YR+PE+++ ++ +T  +DMWS GC++AE+F    LF G++ ++ L +++ ++G
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V K  + E +   A K+I  +     +  +VE+ IL +        D  +IV
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIV 97
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           ++ + F  + +L I  E       + + +   R L+ S +Q+  KQ L  L+ L D  II
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGYQ--- 289
           H DLK  NIL        +IK+ DFG +    RT+    S+I + Y+ +PEV++      
Sbjct: 158 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 290 --YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + E+     + P   E + +R +++I  ++PP
Sbjct: 215 RPYDYKADVWSLGITLIEM---AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 27/226 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--------------NQPAYYQQALVEVSILTTL 162
           LG G +G+V  C +   +S  A+K+IK              N   ++++   E+S+L +L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
                  D  +I+++++ F  +++  +  E  +   L+E I IN  +        +  KQ
Sbjct: 104 -------DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIM-KQ 154
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYY 279
           IL G+  L    I+H D+KPENILL        IKI+DFG  S  ++D  +   + + YY
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
            +PEV L  +Y    D+WS G I+  L  G P F G ++ D+++++
Sbjct: 215 IAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 118/241 (48%), Gaps = 38/241 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNKKYDR 168
           RY+    LG G  G V    D + +  VA+K I+   P   + AL E+ I+        R
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIR-------R 64
Query: 169 EDKHHIVRIYEYF--------------VCQRHLCICFELLDSNLYELIKINHFRG-LSLS 213
            D  +IV+++E                     + I  E ++++L  +++    +G L   
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE----QGPLLEE 120
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY 273
             +LF  Q+LRGL  +  A ++H DLKP N+ + T  +   +KI DFG A   D   YS+
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPH-YSH 177
Query: 274 -------IQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
                  + +++YRSP +LL    YT AIDMW+ GCI AE+  G  LF GA E + ++ +
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 326 I 326
           +
Sbjct: 238 L 238

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V K  + E +   A K+I  +     +  +VE+ IL +        D  +IV
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIV 97
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           ++ + F  + +L I  E       + + +   R L+ S +Q+  KQ L  L+ L D  II
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGYQ--- 289
           H DLK  NIL        +IK+ DFG +    R +    S+I + Y+ +PEV++      
Sbjct: 158 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 290 --YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + E+     + P   E + +R +++I  ++PP
Sbjct: 215 RPYDYKADVWSLGITLIEM---AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 15/217 (6%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHH 173
           ++LG G FGQV KC +      +A KIIK +    ++ +  E+S++  L       D  +
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-------DHAN 147
Query: 174 IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
           ++++Y+ F  +  + +  E +D   L++ I    +    L  + LF KQI  G+  +   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQM 206
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVLLGYQY 290
            I+H DLKPENI LC +    +IKIIDFG A        +     +  + +PEV + Y +
Sbjct: 207 YILHLDLKPENI-LCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 291 TTA-IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            +   DMWS G I   L  GL  F G ++ + L  ++
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V K  + E +   A K+I  +     +  +VE+ IL +        D  +IV
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIV 97
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           ++ + F  + +L I  E       + + +   R L+ S +Q+  KQ L  L+ L D  II
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGYQ--- 289
           H DLK  NIL        +IK+ DFG +    R +     +I + Y+ +PEV++      
Sbjct: 158 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 290 --YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + E+     + P   E + +R +++I  ++PP
Sbjct: 215 RPYDYKADVWSLGITLIEM---AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 115/243 (47%), Gaps = 24/243 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKY 166
           +I+  +LG G+FG+V      + N F A+K +K             +VE  +L+      
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL----- 73
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILR 224
              +   +  ++  F  + +L    E L+    +Y +   + F    LS    ++ +I+ 
Sbjct: 74  -AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF---DLSRATFYAAEIIL 129
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYR 280
           GL  L   GI++ DLK +NILL    K   IKI DFG  C E    D     +  +  Y 
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFG-MCKENMLGDAKTNXFCGTPDYI 185
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
           +PE+LLG +Y  ++D WSFG ++ E+ +G   F G  E +L    IR+     P ++ KE
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-IRMDNPFYPRWLEKE 244
Query: 341 AKN 343
           AK+
Sbjct: 245 AKD 247

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G+F    KC   + N   AVKII K   A  Q+ +  + +          E   +IV
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLC---------EGHPNIV 69
Query: 176 RIYEYFVCQRHLCICFELLDS-NLYELIKIN-HFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           +++E F  Q H  +  ELL+   L+E IK   HF     S +    ++++  +S + D G
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM---RKLVSAVSHMHDVG 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLGYQY 290
           ++H DLKPEN+L        EIKIIDFG A     +++ + +   + +Y +PE+L    Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 291 TTAIDMWSFGCIVAELFLG 309
             + D+WS G I+  +  G
Sbjct: 187 DESCDLWSLGVILYTMLSG 205

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 96
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 97  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++     S++ +  Y SPE+L    
Sbjct: 155 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 211
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 250

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 24/238 (10%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V      + N F A+K +K             +VE  +L+         + 
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL------AWEH 78
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             +  ++  F  + +L    E L+    +Y +   + F    LS    ++ +I+ GL  L
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF---DLSRATFYAAEIILGLQFL 135
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
              GI++ DLK +NILL    K   IKI DFG  C E    D     +  +  Y +PE+L
Sbjct: 136 HSKGIVYRDLKLDNILL---DKDGHIKIADFG-MCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           LG +Y  ++D WSFG ++ E+ +G   F G  E +L    IR+     P ++ KEAK+
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-IRMDNPFYPRWLEKEAKD 248

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V K  + E  +  A K+I+ +     +  +VE+ IL T +  Y       IV
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY-------IV 79
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           ++   +     L I  E       + I +   RGL+   +Q+  +Q+L  L+ L    II
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGYQ--- 289
           H DLK  N+L+       +I++ DFG +    +T+    S+I + Y+ +PEV++      
Sbjct: 140 HRDLKAGNVLMTLE---GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 290 --YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + E+     + P   E + +R +++I  + PP
Sbjct: 197 TPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSDPP 240

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V K  + E  +  A K+I+ +     +  +VE+ IL T +  Y       IV
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY-------IV 71
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           ++   +     L I  E       + I +   RGL+   +Q+  +Q+L  L+ L    II
Sbjct: 72  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGYQ--- 289
           H DLK  N+L+       +I++ DFG +    +T+    S+I + Y+ +PEV++      
Sbjct: 132 HRDLKAGNVLMTLE---GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 290 --YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + E+     + P   E + +R +++I  + PP
Sbjct: 189 TPYDYKADIWSLGITLIEMA---QIEPPHHELNPMRVLLKIAKSDPP 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 93
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 94  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++     +++ +  Y SPE+L    
Sbjct: 152 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKS 208
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 118/268 (44%), Gaps = 45/268 (16%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G FGQV K  +A  + + A+K I++        L EV +L +LN +Y       +V
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQY-------VV 65
Query: 176 RIYEYFVCQRH-------------LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
           R Y  ++ +R+             L I  E  ++  LY+LI   +         +LF +Q
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQ 124
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------------ 269
           IL  LS +   GIIH DLKP NI +  S     +KI DFG A    R+            
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES---RNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 270 -----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
                + S I +  Y + EVL G   Y   IDM+S G I  E+    P   G    ++L+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 324 RMIRILGAQPPDYVLKEAKNTSKFFKCI 351
           ++  +    PPD+   + K   K  + +
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLL 267

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 118/268 (44%), Gaps = 45/268 (16%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G FGQV K  +A  + + A+K I++        L EV +L +LN +Y       +V
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQY-------VV 65
Query: 176 RIYEYFVCQRH-------------LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
           R Y  ++ +R+             L I  E  ++  LY+LI   +         +LF +Q
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-RQ 124
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------------ 269
           IL  LS +   GIIH DLKP NI +  S     +KI DFG A    R+            
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES---RNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 270 -----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
                + S I +  Y + EVL G   Y   IDM+S G I  E+    P   G    ++L+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 324 RMIRILGAQPPDYVLKEAKNTSKFFKCI 351
           ++  +    PPD+   + K   K  + +
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLL 267

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 42  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 98
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 99  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 157 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 213
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 252

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 96
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 97  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 155 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 211
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 250

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 95
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 96  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 154 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 95
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 96  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 154 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 93
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 94  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 152 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 93
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 94  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 152 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 95
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 96  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 154 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 100
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 101 KLY--FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 159 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 215
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 254

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 92
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 93  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++     S++ +  Y SPE+L    
Sbjct: 151 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 207
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 246

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 73
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 74  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 132 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 188
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 227

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 95
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +    L+K I        +  + ++ +I+  L  L   GI
Sbjct: 96  KLY--FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++     S++ +  Y SPE+L    
Sbjct: 154 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 210
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
            + + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 72
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 73  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 131 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 187
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 226

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 76
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + + +   + +   I+   S  +LRGL+ L++   
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQV-LKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y +PE L G  Y+ 
Sbjct: 136 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSV 192
Query: 293 AIDMWSFGCIVAELFLG 309
             D+WS G  + EL +G
Sbjct: 193 QSDIWSMGLSLVELAVG 209

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 12/221 (5%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           ++ +I  ++LG G F +V            A+K IK  PA+   +L  E+++L    KK 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL----KKI 63
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-SLSIVQLFSKQILRG 225
             E+   IV + + +    H  +  +L+     EL      RG+ +     L  +Q+L  
Sbjct: 64  KHEN---IVTLEDIYESTTHYYLVMQLVSGG--ELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-IQSRYYRSPEV 284
           +  L + GI+H DLKPEN+L  T  + ++I I DFG +  E   + S    +  Y +PEV
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV 178
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           L    Y+ A+D WS G I   L  G P F   +E  L  ++
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 70
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 71  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 129 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 185
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 224

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G + +V +  +   N  V VKI+K  P    +   E+ IL  L    +      IV+
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILK--PVKKNKIKREIKILENLRGGPNIITLADIVK 102
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIH 236
                   R   + FE +++  ++ +    ++ L+   ++ +  +IL+ L      GI+H
Sbjct: 103 D----PVSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMH 154
Query: 237 CDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGYQ-YTTA 293
            D+KP N+++    +  ++++ID+G A      +     + SRY++ PE+L+ YQ Y  +
Sbjct: 155 RDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 212
Query: 294 IDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMIRILGAQPP-DYVLK 339
           +DMWS GC++A + F   P F G   +D L R+ ++LG +   DY+ K
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 71
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 72  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 130 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 186
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH- 173
           +L+G+GT+GQV K    +     A+K++       ++   E+++L    KKY     HH 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINML----KKY----SHHR 81
Query: 174 -IVRIYEYFVCQR------HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
            I   Y  F+ +        L +  E   + ++ +LIK      L    +    ++ILRG
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSP 282
           LS L    +IH D+K +N+LL  +   AE+K++DFG +   DRTV    ++I + Y+ +P
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 283 EVLLGYQ-----YTTAIDMWSFGCIVAELFLGLP 311
           EV+   +     Y    D+WS G    E+  G P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F       +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 37  ILGEGSFSTTVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 93
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 94  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 152 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 77
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 78  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 136 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 192
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 95
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 96  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 154 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E  +  ++I++
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL 249

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 92
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 93  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 151 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 207
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E+ + +++I++
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 246

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 12/221 (5%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y  +D+LG G F +V    D      VA+K I  +    ++  +E  I   L+K      
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEI-AVLHKI----- 73
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           KH +IV + + +    HL +  +L+    L++ I    F     +   +F  Q+L  +  
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF--QVLDAVKY 131
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVLL 286
           L D GI+H DLKPEN+L  +  + ++I I DFG +  ED    + +   +  Y +PEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Y+ A+D WS G I   L  G P F   ++  L  ++++
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 14/219 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G+F  V    +   +   A+KI++ +    +    +V  +T       R D    V
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFV 95
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y  F  Q    + F L  +   EL+K I        +  + ++ +I+  L  L   GI
Sbjct: 96  KLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQ 289
           IH DLKPENILL   +    I+I DFG+A      ++      ++ +  Y SPE+L    
Sbjct: 154 IHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
              + D+W+ GCI+ +L  GLP F   +E  +  ++I++
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL 249

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 128
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 187
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 188 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 244
Query: 293 AIDMWSFGCIVAELFLG---LPLFPGASEFDLL 322
             D+WS G  + E+ +G   +P  P A E +L+
Sbjct: 245 QSDIWSMGLSLVEMAVGRYPIPP-PDAKELELM 276

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYDR 168
           Y + + LG G FG V +C +         K I N P    +  V  E+SI+  L      
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQL------ 105
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
              HH  ++ +++ F  +  + +  E L    L++ I    ++     ++  + +Q   G
Sbjct: 106 ---HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN-YMRQACEG 161
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPE 283
           L  + +  I+H D+KPENI +C + K + +KIIDFG A     D  V     +  + +PE
Sbjct: 162 LKHMHEHSIVHLDIKPENI-MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           ++         DMW+ G +   L  GL  F G  + + L+ + R
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 12/221 (5%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y  +D+LG G F +V    D      VA+K I  +    ++  +E  I   L+K      
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI-AVLHKI----- 73
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           KH +IV + + +    HL +  +L+    L++ I    F     +   +F  Q+L  +  
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF--QVLDAVKY 131
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVLL 286
           L D GI+H DLKPEN+L  +  + ++I I DFG +  ED    + +   +  Y +PEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Y+ A+D WS G I   L  G P F   ++  L  ++++
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+L+    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 12/221 (5%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y  +D+LG G F +V    D      VA+K I  +    ++  +E  I   L+K      
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI-AVLHKI----- 73
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           KH +IV + + +    HL +  +L+    L++ I    F     +   +F  Q+L  +  
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF--QVLDAVKY 131
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVLL 286
           L D GI+H DLKPEN+L  +  + ++I I DFG +  ED    + +   +  Y +PEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Y+ A+D WS G I   L  G P F   ++  L  ++++
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 12/221 (5%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y  +D+LG G F +V    D      VA+K I  +    ++  +E  I   L+K      
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI-AVLHKI----- 73
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           KH +IV + + +    HL +  +L+    L++ I    F     +   +F  Q+L  +  
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF--QVLDAVKY 131
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVLL 286
           L D GI+H DLKPEN+L  +  + ++I I DFG +  ED    + +   +  Y +PEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Y+ A+D WS G I   L  G P F   ++  L  ++++
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 181
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 242 VRIAKVLGTEDLYDYIDK 259

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 181
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 242 VRIAKVLGTEDLYDYIDK 259

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 116/268 (43%), Gaps = 45/268 (16%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           +LG G FGQV K  +A  + + A+K I++        L EV +L +LN +Y       +V
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQY-------VV 65
Query: 176 RIYEYFVCQRH-------------LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
           R Y  ++ +R+             L I  E  ++  LY+LI   +         +LF +Q
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-RQ 124
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------------ 269
           IL  LS +   GIIH +LKP NI +  S     +KI DFG A    R+            
Sbjct: 125 ILEALSYIHSQGIIHRNLKPXNIFIDES---RNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 270 -----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
                + S I +  Y + EVL G   Y   ID +S G I  E     P   G    ++L+
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXERVNILK 239
Query: 324 RMIRILGAQPPDYVLKEAKNTSKFFKCI 351
           ++  +    PPD+   + K   K  + +
Sbjct: 240 KLRSVSIEFPPDFDDNKXKVEKKIIRLL 267

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 130 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 187
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 188 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 247
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 248 VRIAKVLGTEDLYDYIDK 265

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 123 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 180
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 241 VRIAKVLGTEDLYDYIDK 258

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 79/138 (57%), Gaps = 7/138 (5%)
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
           ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A   
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLL 322
              +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 323 RRMIRILGAQPP-DYVLK 339
            R+ ++LG +   DY+ K
Sbjct: 243 VRIAKVLGTEDLYDYIDK 260

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 73/124 (58%), Gaps = 10/124 (8%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTV 270
           ++ +  ++L+ L      GI+H D+KP N+++    K  ++++ID+G A      ++  V
Sbjct: 134 IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNV 191
Query: 271 YSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMIRI 328
              + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L R+ ++
Sbjct: 192 --RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKV 249
Query: 329 LGAQ 332
           LG +
Sbjct: 250 LGTE 253

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 84/151 (55%), Gaps = 11/151 (7%)
Query: 198 LYELIKINHFRGLSLSI----VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253
           ++E +    F+ L  ++    ++ +  +IL+ L      GI+H D+KP N+++    +  
Sbjct: 112 VFEHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-- 169
Query: 254 EIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLG 309
           ++++ID+G A      +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F  
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
Query: 310 LPLFPGASEFDLLRRMIRILGAQPP-DYVLK 339
            P F G   +D L R+ ++LG +   DY+ K
Sbjct: 230 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 111 YIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           Y + + LG G FG V +  + A  N+F A  ++    +  +    E+  ++ L       
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL------- 105
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H  +V +++ F     + + +E +    L+E +   H +      V+ + +Q+ +GL 
Sbjct: 106 -RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE-YMRQVCKGLC 163
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVL 285
            + +   +H DLKPENI+  T  +  E+K+IDFG     D  ++V     +  + +PEV 
Sbjct: 164 HMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 222
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
            G       DMWS G +   L  GL  F G ++ + LR +
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 262

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 73/124 (58%), Gaps = 10/124 (8%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTV 270
           ++ +  ++L+ L      GI+H D+KP N+++    K  ++++ID+G A      ++  V
Sbjct: 139 IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNV 196
Query: 271 YSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMIRI 328
              + SRY++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L R+ ++
Sbjct: 197 --RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKV 254
Query: 329 LGAQ 332
           LG +
Sbjct: 255 LGTE 258

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 111 YIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           Y + + LG G FG V +  + A  N+F A  ++    +  +    E+  ++ L       
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL------- 211
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H  +V +++ F     + + +E +    L+E +   H +      V+ + +Q+ +GL 
Sbjct: 212 -RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE-YMRQVCKGLC 269
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVL 285
            + +   +H DLKPENI+  T  +  E+K+IDFG     D  ++V     +  + +PEV 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
            G       DMWS G +   L  GL  F G ++ + LR +
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYD 167
           Y VK+ LG G F  V +C         A KII  +      +Q+   E  I   L     
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP-- 88
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                +IVR+++    +    + F+L+    L+E I    F   S +      +QIL  +
Sbjct: 89  -----NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 141
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
           +     GI+H +LKPEN+LL +  K A +K+ DFG A    +    + +  +  Y SPEV
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L    Y+  +D+W+ G I+  L +G P F
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 66
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 126 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 293 AIDMWSFGCIVAELFLG---LPLFPGASEFDLL 322
             D+WS G  + E+ +G   +P  P A E +L+
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPP-PDAKELELM 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----------PAYYQQALVEVSIL 159
           YI+   LG G  G+V   ++ +    VA+KII  +           PA   +   E+ IL
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET--EIEIL 75
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
             LN          I++I  +F  + +  I  EL++   L++  K+   + L  +  +L+
Sbjct: 76  KKLNHPC-------IIKIKNFFDAEDYY-IVLELMEGGELFD--KVVGNKRLKEATCKLY 125
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
             Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +   +
Sbjct: 126 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 185
Query: 277 RYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
             Y +PEVL+      Y  A+D WS G I   LF+ L  +P  SE
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSE 227

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 69
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 128
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D     ++ +R Y SPE L G  Y+ 
Sbjct: 129 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSV 185
Query: 293 AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
             D+WS G  + E+ +G    P  + F+LL  ++     +PP
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVN----EPP 223

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 93
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 152
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 153 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 209
Query: 293 AIDMWSFGCIVAELFLG---LPLFPGASEFDLL 322
             D+WS G  + E+ +G   +P  P A E +L+
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPP-PDAKELELM 241

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 66
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 126 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 293 AIDMWSFGCIVAELFLG---LPLFPGASEFDLL 322
             D+WS G  + E+ +G   +P  P A E +L+
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPP-PDAKELELM 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----------PAYYQQALVEVSIL 159
           YI+   LG G  G+V   ++ +    VA+KII  +           PA   +   E+ IL
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET--EIEIL 69
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
             LN          I++I  +F  + +  I  EL++   L++  K+   + L  +  +L+
Sbjct: 70  KKLNHPC-------IIKIKNFFDAEDYY-IVLELMEGGELFD--KVVGNKRLKEATCKLY 119
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
             Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +   +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 277 RYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
             Y +PEVL+      Y  A+D WS G I   LF+ L  +P  SE
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSE 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 16/223 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 85
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 144
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 145 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 201
Query: 293 AIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPP 334
             D+WS G  + E+ +G  P+  G+    +   +  I+   PP
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPP 244

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 66
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 126 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 293 AIDMWSFGCIVAELFLG 309
             D+WS G  + E+ +G
Sbjct: 183 QSDIWSMGLSLVEMAVG 199

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 116/235 (49%), Gaps = 24/235 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--IIKNQP-AYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GTFG+V K    +    VA+K  +++N+   +   AL E+ IL  L      E+  +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK----HENVVN 81
Query: 174 IVRIYE-----YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           ++ I       Y  C+  + + F+  + +L  L+  N     +LS ++   + +L GL  
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRS 281
           +    I+H D+K  N+L+    +   +K+ DFG A        ++     + + + +YR 
Sbjct: 141 IHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           PE+LLG + Y   ID+W  GCI+AE++   P+  G +E   L  + ++ G+  P+
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----------PAYYQQALVEVSIL 159
           YI+   LG G  G+V   ++ +    VA+KII  +           PA   +   E+ IL
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET--EIEIL 69
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
             LN          I++I  +F  + +  I  EL++   L++  K+   + L  +  +L+
Sbjct: 70  KKLNHPC-------IIKIKNFFDAEDYY-IVLELMEGGELFD--KVVGNKRLKEATCKLY 119
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
             Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +   +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 277 RYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
             Y +PEVL+      Y  A+D WS G I   LF+ L  +P  SE
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSE 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----------PAYYQQALVEVSIL 159
           YI+   LG G  G+V   ++ +    VA+KII  +           PA   +   E+ IL
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET--EIEIL 68
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
             LN          I++I  +F  + +  I  EL++   L++  K+   + L  +  +L+
Sbjct: 69  KKLNHPC-------IIKIKNFFDAEDYY-IVLELMEGGELFD--KVVGNKRLKEATCKLY 118
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
             Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +   +
Sbjct: 119 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 178
Query: 277 RYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
             Y +PEVL+      Y  A+D WS G I   LF+ L  +P  SE
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSE 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----------PAYYQQALVEVSIL 159
           YI+   LG G  G+V   ++ +    VA+KII  +           PA   +   E+ IL
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET--EIEIL 69
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
             LN          I++I  +F  + +  I  EL++   L++  K+   + L  +  +L+
Sbjct: 70  KKLNHPC-------IIKIKNFFDAEDYY-IVLELMEGGELFD--KVVGNKRLKEATCKLY 119
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
             Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +   +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 277 RYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
             Y +PEVL+      Y  A+D WS G I   LF+ L  +P  SE
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSE 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 66
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 126 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 293 AIDMWSFGCIVAELFLG---LPLFPGASEFDLL 322
             D+WS G  + E+ +G   +P  P A E +L+
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPP-PDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G  G V K         +A K+I  + +PA   Q + E+ +L   N  Y       I
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 66
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
           V  Y  F     + IC E +D    + +     R +   I+   S  +++GL+ L++   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
           I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L G  Y+ 
Sbjct: 126 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 293 AIDMWSFGCIVAELFLG---LPLFPGASEFDLL 322
             D+WS G  + E+ +G   +P  P A E +L+
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPP-PDAKELELM 214

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 56
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 113
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG +C   +  RT  S  
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSCHAPSSRRTTLSGT 170
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
               Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 171 LD--YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 227
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 228 DFVTEGARD 236

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 116/235 (49%), Gaps = 24/235 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--IIKNQPAYY-QQALVEVSILTTLNKKYDREDKHH 173
           +G GTFG+V K    +    VA+K  +++N+   +   AL E+ IL  L      E+  +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK----HENVVN 81
Query: 174 IVRIYE-----YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           ++ I       Y  C+  + + F+  + +L  L+  N     +LS ++   + +L GL  
Sbjct: 82  LIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRS 281
           +    I+H D+K  N+L+    +   +K+ DFG A        ++     + + + +YR 
Sbjct: 141 IHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           PE+LLG + Y   ID+W  GCI+AE++   P+  G +E   L  + ++ G+  P+
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 28/223 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL---------VEVSILTT 161
           YI+   LG G  G+V   ++ +    VA++II  +      A           E+ IL  
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
           LN          I++I  +F  + +  I  EL++   L++ +  N  + L  +  +L+  
Sbjct: 197 LNHPC-------IIKIKNFFDAEDYY-IVLELMEGGELFDKVVGN--KRLKEATCKLYFY 246
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +   +  
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306
Query: 279 YRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
           Y +PEVL+      Y  A+D WS G I   LF+ L  +P  SE
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSE 346

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 116/235 (49%), Gaps = 24/235 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--IIKNQPAYY-QQALVEVSILTTLNKKYDREDKHH 173
           +G GTFG+V K    +    VA+K  +++N+   +   AL E+ IL  L      E+  +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK----HENVVN 81
Query: 174 IVRIYE-----YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           ++ I       Y  C+  + + F+  + +L  L+  N     +LS ++   + +L GL  
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRS 281
           +    I+H D+K  N+L+    +   +K+ DFG A        ++     + + + +YR 
Sbjct: 141 IHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           PE+LLG + Y   ID+W  GCI+AE++   P+  G +E   L  + ++ G+  P+
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYD 167
           Y VK+ LG G F  V +C         A KII  +      +Q+   E  I   L     
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP-- 65
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                +IVR+++    +    + F+L+    L+E I    F   S +      +QIL  +
Sbjct: 66  -----NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 118
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
           +     GI+H +LKPEN+LL +  K A +K+ DFG A    +    + +  +  Y SPEV
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L    Y+  +D+W+ G I+  L +G P F
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 116/235 (49%), Gaps = 24/235 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--IIKNQP-AYYQQALVEVSILTTLNKKYDREDKHH 173
           +G GTFG+V K    +    VA+K  +++N+   +   AL E+ IL  L      E+  +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK----HENVVN 80
Query: 174 IVRIYE-----YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           ++ I       Y  C+  + + F+  + +L  L+  N     +LS ++   + +L GL  
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRS 281
           +    I+H D+K  N+L+    +   +K+ DFG A        ++     + + + +YR 
Sbjct: 140 IHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           PE+LLG + Y   ID+W  GCI+AE++   P+  G +E   L  + ++ G+  P+
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 28/223 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL---------VEVSILTT 161
           YI+   LG G  G+V   ++ +    VA++II  +      A           E+ IL  
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 210
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
           LN          I++I  +F  + +  I  EL++   L++ +  N  + L  +  +L+  
Sbjct: 211 LNHPC-------IIKIKNFFDAEDYY-IVLELMEGGELFDKVVGN--KRLKEATCKLYFY 260
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
           Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +   +  
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 320
Query: 279 YRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
           Y +PEVL+      Y  A+D WS G I   LF+ L  +P  SE
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSE 360

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKK 165
           Q  Y + + LG G F  V +C         A KII  K   A   Q L   + +  L K 
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 80
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
            +      IVR+++    + H  + F+L+    L+E I    +   S +      +QIL 
Sbjct: 81  PN------IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILE 132
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRS 281
            +      G++H DLKPEN+LL + +K A +K+ DFG A     E +  + +  +  Y S
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 192
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           PEVL    Y   +D+W+ G I+  L +G P F
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYD 167
           Y VK+ LG G F  V +C         A KII  +      +Q+   E  I   L     
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP-- 65
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                +IVR+++    +    + F+L+    L+E I    F   S +      +QIL  +
Sbjct: 66  -----NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 118
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
           +     GI+H +LKPEN+LL +  K A +K+ DFG A    +    + +  +  Y SPEV
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L    Y+  +D+W+ G I+  L +G P F
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYD 167
           Y VK+ LG G F  V +C         A KII  +      +Q+   E  I   L     
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP-- 64
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                +IVR+++    +    + F+L+    L+E I    F   S +      +QIL  +
Sbjct: 65  -----NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 117
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
           +     GI+H +LKPEN+LL +  K A +K+ DFG A    +    + +  +  Y SPEV
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 177
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L    Y+  +D+W+ G I+  L +G P F
Sbjct: 178 LKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 35/194 (18%)
Query: 168 REDKH-HIVRIYEYFV--CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL------- 217
           RE KH +++ + + F+    R + + F+  + +L+ +IK +     +   VQL       
Sbjct: 73  RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLC-TSVKPAEIKIIDFGSA----------CTE 266
              QIL G+  L    ++H DLKP NIL+     +   +KI D G A             
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 267 DRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASE------- 318
           D  V ++    +YR+PE+LLG + YT AID+W+ GCI AEL    P+F    E       
Sbjct: 193 DPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 319 --FDLLRRMIRILG 330
              D L R+  ++G
Sbjct: 249 YHHDQLDRIFNVMG 262

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALV-EVSILTTLNK 164
           Y + +++G G F  V +C + E     AVKI+      + P    + L  E SI   L  
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-- 83
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN--LYELIK-INHFRGLSLSIVQLFSK 220
                 KH HIV + E +     L + FE +D     +E++K  +     S ++   + +
Sbjct: 84  ------KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT---VYSYIQSR 277
           QIL  L    D  IIH D+KPEN+LL +    A +K+ DFG A     +       + + 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
           ++ +PEV+    Y   +D+W  G I+  L  G   F G  E
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 131/293 (44%), Gaps = 77/293 (26%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ-----PAYYQQALVEVSIL 159
           E Q++Y +K  +G G++G V    + +  +  A+KI+ KN+     P   ++   EV ++
Sbjct: 23  ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 160 TTLNKKYDREDKHH--IVRIYEYFVCQRHLCICFEL------LDS-NLY----------E 200
             L         HH  I R+YE +  ++++C+  EL      LD  N++          +
Sbjct: 83  KKL---------HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 201 LIK-----------------INHFRGLSLSIVQ---LFS---KQILRGLSLLKDAGIIHC 237
           ++K                 I+ FR  SL  VQ   L S   +QI   L  L + GI H 
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRE-SLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 238 DLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY-----------RSPEVL- 285
           D+KPEN L  T+ K  EIK++DFG +    +  Y      YY            +PEVL 
Sbjct: 193 DIKPENFLFSTN-KSFEIKLVDFGLS----KEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247
Query: 286 -LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQPPDY 336
                Y    D WS G ++  L +G   FPG ++ D + +++ + L  + P+Y
Sbjct: 248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           + ++ +  K+ LG G F +V    +       AVK I  +    +++ +E  I       
Sbjct: 19  DIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL---- 74
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
             R+ KH +IV + + +    HL +  +L+    L++ I    F   +        +Q+L
Sbjct: 75  --RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF--YTEKDASTLIRQVL 130
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQSRYYRS 281
             +  L   GI+H DLKPEN+L  +  + ++I I DFG +  E +   + +   +  Y +
Sbjct: 131 DAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVA 190
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           PEVL    Y+ A+D WS G I   L  G P F   ++  L  ++++
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK 236

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 126/257 (49%), Gaps = 29/257 (11%)
Query: 107 TQRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT 161
           ++R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVL------FKTQLEKAGVEHQ 58
Query: 162 LNKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           L ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +   
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT-- 116
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSY 273
            +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  + 
Sbjct: 117 -YITELANALSYCHSKRVIHRDIKPENLLLGSN---GELKIADFGWSVHAPSSRRT--TL 170
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
             +  Y  PE++ G  +   +D+WS G +  E  +G+P F   +  +  RR+ R+     
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-EFTF 229
Query: 334 PDYVLKEAKN-TSKFFK 349
           PD+V + A++  S+  K
Sbjct: 230 PDFVTEGARDLISRLLK 246

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 107/239 (44%), Gaps = 18/239 (7%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           ++ R  +VKD+ G G FG      D + N  VAVK I+      +    E+     +N +
Sbjct: 17  DSDRYELVKDI-GAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREI-----INHR 70
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
             R    +IVR  E  +   HL I  E      L+E  +I +    S    + F +Q++ 
Sbjct: 71  SLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLIS 126
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSP 282
           G+S      + H DLK EN LL  S  P  +KI DFG   A        S + +  Y +P
Sbjct: 127 GVSYAHAMQVAHRDLKLENTLLDGSPAP-RLKIADFGYSKASVLHSQPKSAVGTPAYIAP 185
Query: 283 EVLLGYQYTTAI-DMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ--PPDYV 337
           EVLL  +Y   + D+WS G  +  + +G   F    E    R+ I RIL  Q   PDYV
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 244

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 81
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 82  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 138
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 139 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 193
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 252
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 253 DFVTEGARD 261

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 33/295 (11%)
Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR---- 168
           +LG G +G   QV K   A      A+K++K       +A++  +   T + K +R    
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILE 76
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS-KQILRGL 226
           E KH  IV +   F     L +  E L     EL       G+ +     F   +I   L
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGG--ELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---DRTV-YSYIQSRYYRSP 282
             L   GII+ DLKPENI+L        +K+ DFG  C E   D TV +++  +  Y +P
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQ---GHVKLTDFG-LCKESIHDGTVTHTFCGTIEYMAP 190
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
           E+L+   +  A+D WS G ++ ++  G P F G +    + ++++     PP Y+ +EA+
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP-YLTQEAR 249
Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYE---ARELK---KPLIGKE 391
           +  K      +   +  G    G   A+     I +E   AR+++   KPL+  E
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 304

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 20/222 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL----VEVSILTTLNKKY 166
           Y +++ +G G++G+V            A K I   P Y+ + +     E+ I+ +L    
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI---PKYFVEDVDRFKQEIEIMKSL---- 80
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
              D  +I+R+YE F     + +  EL     L+E  ++ H R    S      K +L  
Sbjct: 81  ---DHPNIIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMKDVLSA 135
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPE 283
           ++      + H DLKPEN L  T    + +K+IDFG A      + + + + + YY SP+
Sbjct: 136 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 195
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           VL G  Y    D WS G ++  L  G P F   ++ +++ ++
Sbjct: 196 VLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI 236

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLN 163
           E   +Y++ + LG G FG V +C +         K +K +     Q LV  E+SIL    
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIAR 59
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
            +       +I+ ++E F     L + FE +   +++E I  + F      IV  +  Q+
Sbjct: 60  HR-------NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVS-YVHQV 111
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---DRTVYSYIQSRYY 279
              L  L    I H D++PENI+  T  + + IKII+FG A      D     +    YY
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
            +PEV      +TA DMWS G +V  L  G+  F   +
Sbjct: 171 -APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 20/222 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL----VEVSILTTLNKKY 166
           Y +++ +G G++G+V            A K I   P Y+ + +     E+ I+ +L    
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI---PKYFVEDVDRFKQEIEIMKSL---- 63
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
              D  +I+R+YE F     + +  EL     L+E  ++ H R    S      K +L  
Sbjct: 64  ---DHPNIIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMKDVLSA 118
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPE 283
           ++      + H DLKPEN L  T    + +K+IDFG A      + + + + + YY SP+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           VL G  Y    D WS G ++  L  G P F   ++ +++ ++
Sbjct: 179 VLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI 219

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ---------QALVEV 156
           E  ++Y     LG G FG V    D E N  V VK IK +              +  +E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 157 SILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           +IL+       R +  +I+++ + F  Q    +  E   S L     I+    L   +  
Sbjct: 81  AILS-------RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYI 274
              +Q++  +  L+   IIH D+K ENI++        IK+IDFGSA   +R    Y++ 
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFC 190
Query: 275 QSRYYRSPEVLLGYQYTT-AIDMWSFGCIVAEL 306
            +  Y +PEVL+G  Y    ++MWS G  +  L
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 33/295 (11%)
Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR---- 168
           +LG G +G   QV K   A      A+K++K       +A++  +   T + K +R    
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILE 76
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS-KQILRGL 226
           E KH  IV +   F     L +  E L     EL       G+ +     F   +I   L
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGG--ELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---DRTV-YSYIQSRYYRSP 282
             L   GII+ DLKPENI+L        +K+ DFG  C E   D TV + +  +  Y +P
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQ---GHVKLTDFG-LCKESIHDGTVTHXFCGTIEYMAP 190
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
           E+L+   +  A+D WS G ++ ++  G P F G +    + ++++     PP Y+ +EA+
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP-YLTQEAR 249
Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYE---ARELK---KPLIGKE 391
           +  K      +   +  G    G   A+     I +E   AR+++   KPL+  E
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 304

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           K +LG G  G+V +C+        A+K++ + P   Q+          ++  +      H
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----------VDHHWQASGGPH 83
Query: 174 IVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           IV I + +    H    L I  E ++   L+  I+    +  +        + I   +  
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEVLLG 287
           L    I H D+KPEN+L  +  K A +K+ DFG A  T    + +   + YY +PEVL  
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGP 203
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRMIRI 328
            +Y  + DMWS G I+  L  G P F    G +    ++R IR+
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN-KKYDRE 169
           Y + + LG G F  V +C          VK++  Q   Y   ++    L+  + +K +RE
Sbjct: 13  YQLFEELGKGAFSVVRRC----------VKVLAGQE--YAAMIINTKKLSARDHQKLERE 60
Query: 170 D------KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
                  KH +IVR+++    + H  + F+L+    L+E I    +   S +      +Q
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQ 118
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRY 278
           IL  +      G++H +LKPEN+LL + +K A +K+ DFG A     E +  + +  +  
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           Y SPEVL    Y   +D+W+ G I+  L +G P F
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 37/245 (15%)
Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYYQQAL---VEVSILTTLNKKYDRE 169
           +LG G+FG+V    K   ++     A+K++K      +  +   +E  IL  +N  +   
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF--- 87
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI------VQLFSKQIL 223
               IV+++  F  +  L +  + L          + F  LS  +      V+ +  ++ 
Sbjct: 88  ----IVKLHYAFQTEGKLYLILDFLRGG-------DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
             L  L   GII+ DLKPENILL    +   IK+ DFG    +   ++  YS+  +  Y 
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ--PPDYVL 338
           +PEV+    +T + D WSFG ++ E+  G   F G    D    M  IL A+   P ++ 
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLGMPQFLS 250
Query: 339 KEAKN 343
            EA++
Sbjct: 251 PEAQS 255

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 123/255 (48%), Gaps = 25/255 (9%)
Query: 107 TQRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT 161
           ++R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVL------FKTQLEKAGVEHQ 58
Query: 162 LNKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           L ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +   
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT-- 116
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ 275
            +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S         +   
Sbjct: 117 -YITELANALSYCHSKRVIHRDIKPENLLLGSN---GELKIADFGWSVHAPSSRRDTLCG 172
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           +  Y  PE++ G  +   +D+WS G +  E  +G+P F   +  +  RR+ R+     PD
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-EFTFPD 231
Query: 336 YVLKEAKN-TSKFFK 349
           +V + A++  S+  K
Sbjct: 232 FVTEGARDLISRLLK 246

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           K +LG G  G+V +C+        A+K++ + P   Q+          ++  +      H
Sbjct: 15  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----------VDHHWQASGGPH 64
Query: 174 IVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           IV I + +    H    L I  E ++   L+  I+    +  +        + I   +  
Sbjct: 65  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 124
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEVLLG 287
           L    I H D+KPEN+L  +  K A +K+ DFG A  T    + +   + YY +PEVL  
Sbjct: 125 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGP 184
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRMIRI 328
            +Y  + DMWS G I+  L  G P F    G +    ++R IR+
Sbjct: 185 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 228

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 19  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 72
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 73  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 129
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 130 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 184
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 243
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 244 DFVTEGARD 252

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 107/239 (44%), Gaps = 18/239 (7%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           ++ R  +VKD+ G G FG      D + N  VAVK I+      +    E+     +N +
Sbjct: 16  DSDRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-----INHR 69
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
             R    +IVR  E  +   HL I  E      L+E  +I +    S    + F +Q++ 
Sbjct: 70  SLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLIS 125
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSP 282
           G+S      + H DLK EN LL  S  P  +KI DFG   +        S + +  Y +P
Sbjct: 126 GVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 184
Query: 283 EVLLGYQYTTAI-DMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ--PPDYV 337
           EVLL  +Y   + D+WS G  +  + +G   F    E    R+ I RIL  Q   PDYV
Sbjct: 185 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 243

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           ++ R  +VKD+ G G FG      D + N  VAVK I+           E+     +N +
Sbjct: 17  DSDRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREI-----INHR 70
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
             R    +IVR  E  +   HL I  E      L+E  +I +    S    + F +Q++ 
Sbjct: 71  SLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLIS 126
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSP 282
           G+S      + H DLK EN LL  S  P  +KI DFG   +        S + +  Y +P
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 185
Query: 283 EVLLGYQYTTAI-DMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ--PPDYV 337
           EVLL  +Y   + D+WS G  +  + +G   F    E    R+ I RIL  Q   PDYV
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 244

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 22/247 (8%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-----EVSILT 160
           E    + V +LLG G+F  V +         VA+K+I ++ A Y+  +V     EV I  
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-DKKAMYKAGMVQRVQNEVKIHC 66
Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
            L        KH  I+ +Y YF    ++ +  E+  +        N  +  S +  + F 
Sbjct: 67  QL--------KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQS 276
            QI+ G+  L   GI+H DL   N+LL    +   IKI DFG A          Y+   +
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGT 175
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             Y SPE+     +    D+WS GC+   L +G P F   +  + L +++ +   + P +
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-LADYEMPSF 234
Query: 337 VLKEAKN 343
           +  EAK+
Sbjct: 235 LSIEAKD 241

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDR 168
           +I K  LG G FG V    +        +K I    +    +Q   E+ +L +L      
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL------ 77
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS--IVQLFSKQILRG 225
            D  +I++I+E F    ++ I  E  +   L E I     RG +LS   V    KQ++  
Sbjct: 78  -DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPE 283
           L+      ++H DLKPENIL   +   + IKIIDFG A     D    +   +  Y +PE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
           V      T   D+WS G ++  L  G   F G S
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 117/247 (47%), Gaps = 24/247 (9%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 81
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 82  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 138
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQS 276
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S             +
Sbjct: 139 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRDDLCGT 195
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF 254
Query: 337 VLKEAKN 343
           V + A++
Sbjct: 255 VTEGARD 261

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYD 167
           Y + + LG G F  V +C         A KII  +      +Q+   E  I   L     
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL----- 60
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
              KH +IVR+++    +    + F+L+    L+E I    +   S +      +QIL  
Sbjct: 61  ---KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILES 115
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSP 282
           ++     GI+H DLKPEN+LL +  K A +K+ DFG A     + +  + +  +  Y SP
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           EVL    Y   +DMW+ G I+  L +G P F
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 37/245 (15%)
Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYYQQAL---VEVSILTTLNKKYDRE 169
           +LG G+FG+V    K   ++     A+K++K      +  +   +E  IL  +N  +   
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF--- 88
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI------VQLFSKQIL 223
               IV+++  F  +  L +  + L          + F  LS  +      V+ +  ++ 
Sbjct: 89  ----IVKLHYAFQTEGKLYLILDFLRGG-------DLFTRLSKEVMFTEEDVKFYLAELA 137
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
             L  L   GII+ DLKPENILL    +   IK+ DFG    +   ++  YS+  +  Y 
Sbjct: 138 LALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 194
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ--PPDYVL 338
           +PEV+    +T + D WSFG ++ E+  G   F G    D    M  IL A+   P ++ 
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLGMPQFLS 251
Query: 339 KEAKN 343
            EA++
Sbjct: 252 PEAQS 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 122/250 (48%), Gaps = 28/250 (11%)
Query: 107 TQRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT 161
           ++R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQ 58
Query: 162 LNKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           L ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +   
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-- 116
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSY 273
            +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  + 
Sbjct: 117 -YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TL 170
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
             +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTF 229
Query: 334 PDYVLKEAKN 343
           PD+V + A++
Sbjct: 230 PDFVTEGARD 239

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 37/245 (15%)
Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYYQQAL---VEVSILTTLNKKYDRE 169
           +LG G+FG+V    K   ++     A+K++K      +  +   +E  IL  +N  +   
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF--- 87
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI------VQLFSKQIL 223
               IV+++  F  +  L +  + L          + F  LS  +      V+ +  ++ 
Sbjct: 88  ----IVKLHYAFQTEGKLYLILDFLRGG-------DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
             L  L   GII+ DLKPENILL    +   IK+ DFG    +   ++  YS+  +  Y 
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ--PPDYVL 338
           +PEV+    +T + D WSFG ++ E+  G   F G    D    M  IL A+   P ++ 
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLGMPQFLS 250
Query: 339 KEAKN 343
            EA++
Sbjct: 251 PEAQS 255

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 60
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 117
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 172
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 231
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 232 DFVTEGARD 240

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 114/235 (48%), Gaps = 23/235 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED--KH-H 173
           LG G FG V    + +    +A+K++      ++  L +  +   L ++ + +   +H +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 174 IVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           I+R+Y YF    + +L + +  L +   EL K++ F     +    +  ++   LS    
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---YITELANALSYCHS 126
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGY 288
             +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +   +  Y  PE++ G 
Sbjct: 127 KRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGR 181
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
            +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+V + A++
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARD 235

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 58
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 115
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 170
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 229
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 230 DFVTEGARD 238

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 60
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 117
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 172
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE + G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 231
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 232 DFVTEGARD 240

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 102/242 (42%), Gaps = 55/242 (22%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 148 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 205
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 206 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 265
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
                                              G +AY     IE + +         
Sbjct: 266 TD---------------------------------GLNAYLNKYRIELDPQ--------- 283
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
                  LE +V  +  +  L   +   +  +    +DFL  L+ +D  +R +  +A  H
Sbjct: 284 -------LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 336
Query: 451 PF 452
           P+
Sbjct: 337 PY 338

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED--KH-H 173
           LG G FG V    + +    +A+K++      ++  L +  +   L ++ + +   +H +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 174 IVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           I+R+Y YF    + +L + +  L +   EL K++ F     +    +  ++   LS    
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---YITELANALSYCHS 126
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGY 288
             +IH D+KPEN+LL ++    E+KI DFG    A +  RT      +  Y  PE++ G 
Sbjct: 127 KRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--ELCGTLDYLPPEMIEGR 181
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
            +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+V + A++
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARD 235

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           V+  LG G    V +C         A+K++K          V+  I+ T      R    
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--------VDKKIVRTEIGVLLRLSHP 108
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHF---RGLSLSIVQLFSKQILRGLSL 228
           +I+++ E F     + +  EL+    L++ I    +   R  + ++     KQIL  ++ 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV-----KQILEAVAY 163
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYI-QSRYYRSPEVLL 286
           L + GI+H DLKPEN+L  T    A +KI DFG S   E + +   +  +  Y +PE+L 
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR 223
Query: 287 GYQYTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMI 326
           G  Y   +DMWS G I   L  G  P +    +  + RR++
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 60
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 117
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT     
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--DLC 172
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 231
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 232 DFVTEGARD 240

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHH-- 173
           +G G+ G V    +      VAVK +  +    ++ L  EV I+          D HH  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIM---------RDYHHDN 103
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           +V +Y  ++    L +  E L+      I + H R ++   +      +LR LS L + G
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIATVCLSVLRALSYLHNQG 161
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQY 290
           +IH D+K ++ILL +      IK+ DFG      + V      + + Y+ +PEV+    Y
Sbjct: 162 VIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY 218
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
            T +D+WS G +V E+  G P +        +RR+
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 54
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 55  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 111
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 112 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 166
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 225
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 226 DFVTEGARD 234

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 84
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 144
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 204
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 205 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 56
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 113
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT     
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--DLC 168
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 227
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 228 DFVTEGARD 236

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 28/241 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +G G+FG+V K  D      VA+KII      ++    QQ   E+++L+  +  Y     
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSSY----- 82
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
             + + Y  ++    L I  E L   +  +L++   F    ++ +    K+IL+GL  L 
Sbjct: 83  --VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLH 137
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLG 287
               IH D+K  N+LL    +  ++K+ DFG A     T     +++ + ++ +PEV+  
Sbjct: 138 SEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 194
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
             Y +  D+WS G    EL  G P  P  S+   +R +  I    PP  V    K+  +F
Sbjct: 195 SAYDSKADIWSLGITAIELAKGEP--PN-SDMHPMRVLFLIPKNNPPTLVGDFTKSFKEF 251
Query: 348 F 348
Sbjct: 252 I 252

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYDREDKH- 172
           LG G F  V +C         A KII  +      +Q+   E  I   L        KH 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL--------KHP 63
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           +IVR+++    +    + F+L+    L+E I    +   S +      +QIL  ++    
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILESVNHCHL 121
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLGY 288
            GI+H DLKPEN+LL +  K A +K+ DFG A     + +  + +  +  Y SPEVL   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLF 313
            Y   +DMW+ G I+  L +G P F
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +       + +  +  TL +    ++  H  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVI-----VAKDEVAHTLTENRVLQNSRHPF 209
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
                +  Q H  +CF +  +N  EL   ++  R  S    + +  +I+  L  L  +  
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
           +++ DLK EN++L    K   IKI DFG       +  T+ ++  +  Y +PEVL    Y
Sbjct: 270 VVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 326
Query: 291 TTAIDMWSFGCIVAELFLG-LPLFPGASE--FDLL 322
             A+D W  G ++ E+  G LP +    E  F+L+
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTT 161
            T +RY+    LG G F +  +  D +     A K++      +P   ++   E++I  +
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
           L       D  H+V  + +F     + +  E+    +L EL K    + ++    + F +
Sbjct: 99  L-------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMR 149
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSR 277
           Q ++G+  L +  +IH DLK  N+ L   +   ++KI DFG A     +     +   + 
Sbjct: 150 QTIQGVQYLHNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
            Y +PEVL    ++  +D+WS GCI+  L +G P F
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 37/245 (15%)
Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYYQQAL---VEVSILTTLNKKYDRE 169
           +LG G+FG+V    K    +     A+K++K      +  +   +E  IL  +N  +   
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPF--- 91
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI------VQLFSKQIL 223
               +V+++  F  +  L +  + L          + F  LS  +      V+ +  ++ 
Sbjct: 92  ----VVKLHYAFQTEGKLYLILDFLRGG-------DLFTRLSKEVMFTEEDVKFYLAELA 140
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
            GL  L   GII+ DLKPENILL    +   IK+ DFG    A   ++  YS+  +  Y 
Sbjct: 141 LGLDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYM 197
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ--PPDYVL 338
           +PEV+    ++ + D WS+G ++ E+  G   F G    D    M  IL A+   P ++ 
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGK---DRKETMTLILKAKLGMPQFLS 254
Query: 339 KEAKN 343
            EA++
Sbjct: 255 TEAQS 259

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +      A  EV+   T N+   +  +H  +
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENRVL-QNSRHPFL 213
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
              +Y   Q H  +CF +  +N  EL   ++  R  S    + +  +I+  L  L  +  
Sbjct: 214 TALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 272
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
           +++ DLK EN++L    K   IKI DFG       +  T+ ++  +  Y +PEVL    Y
Sbjct: 273 VVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 329
Query: 291 TTAIDMWSFGCIVAELFLG-LPLFPGASE--FDLL 322
             A+D W  G ++ E+  G LP +    E  F+L+
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 58
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 115
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 170
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 229
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 230 DFVTEGARD 238

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W A  N  + VAVK +K      +  L E +++ TL  ++D+  K H 
Sbjct: 196 LGAGQFGEV---WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL--QHDKLVKLHA 250
Query: 175 VRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V      V +  + I  E +   +L + +K +      L  +  FS QI  G++ ++   
Sbjct: 251 V------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL+  NIL+  S+     KI DFG A   ED    +   +++   + +PE +    
Sbjct: 305 YIHRDLRAANILVSASLV---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ E+   G   +PG S  +++R + R
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILT-------TLNKKY 166
           LG G F  V +C         A K +K +        + L E+++L         +N   
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
             E+   I+ I EY        +C       L E++  N        +++L  KQIL G+
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCL----PELAEMVSEN-------DVIRLI-KQILEGV 144
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF------GSACTEDRTVYSYIQSRYYR 280
             L    I+H DLKP+NILL +     +IKI+DF      G AC E R +   + +  Y 
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-ELREI---MGTPEYL 200
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
           +PE+L     TTA DMW+ G I   L      F G
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 114/240 (47%), Gaps = 20/240 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED--KH-H 173
           LG G FG V    + +    +A+K++      ++  L +  +   L ++ + +   +H +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 174 IVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           I+R+Y YF    + +L + +  L +   EL K++ F     +    +  ++   LS    
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---YITELANALSYCHS 129
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
             +IH D+KPEN+LL ++    E+KI DFG S         +   +  Y  PE++ G  +
Sbjct: 130 KRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMH 186
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN-TSKFFK 349
              +D+WS G +  E  +G P F   +  +  +R+ R+     PD+V + A++  S+  K
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARDLISRLLK 245

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 55
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 112
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT     
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--DLC 167
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 226
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 227 DFVTEGARD 235

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 55
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 112
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT     
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRTXLCGT 169
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
               Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 170 LD--YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 226
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 227 DFVTEGARD 235

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 117/248 (47%), Gaps = 24/248 (9%)
Query: 107 TQRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT 161
            +R++ ++D      LG G FG V    +      +A+K++      ++  L +  +   
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVL------FKAQLEKAGVEHQ 54
Query: 162 LNKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           L ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +   
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-- 112
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ 275
            +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S         +   
Sbjct: 113 -YITELANALSYCHSKKVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRAALCG 168
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  D  +R+ R+     PD
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-EFTFPD 227
Query: 336 YVLKEAKN 343
           +V + A++
Sbjct: 228 FVTEGARD 235

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 123/256 (48%), Gaps = 29/256 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 55
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 112
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT     
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--DLC 167
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 226
Query: 335 DYVLKEAKN-TSKFFK 349
           D+V + A++  S+  K
Sbjct: 227 DFVTEGARDLISRLLK 242

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 76
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 136
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 137 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 196
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 197 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 57
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 58  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 114
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI +FG    A +  RT  +  
Sbjct: 115 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIANFGWSVHAPSSRRT--TLC 169
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 228
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 229 DFVTEGARD 237

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 114/235 (48%), Gaps = 23/235 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED--KH-H 173
           LG G FG V    + +    +A+K++      ++  L +  +   L ++ + +   +H +
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 174 IVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           I+R+Y YF    + +L + +  L +   EL K++ F     +    +  ++   LS    
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---YITELANALSYCHS 123
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGY 288
             +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +   +  Y  PE++ G 
Sbjct: 124 KRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGR 178
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
            +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+V + A++
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARD 232

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTT 161
            T +RY+    LG G F +  +  D +     A K++      +P   ++   E++I  +
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
           L       D  H+V  + +F     + +  E+    +L EL K    + ++    + F +
Sbjct: 99  L-------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMR 149
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSR 277
           Q ++G+  L +  +IH DLK  N+ L   +   ++KI DFG A     +         + 
Sbjct: 150 QTIQGVQYLHNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
            Y +PEVL    ++  +D+WS GCI+  L +G P F
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 117/247 (47%), Gaps = 24/247 (9%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 57
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 58  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 114
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQS 276
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S             +
Sbjct: 115 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRXXLCGT 171
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF 230
Query: 337 VLKEAKN 343
           V + A++
Sbjct: 231 VTEGARD 237

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 118/247 (47%), Gaps = 24/247 (9%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 56
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 113
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQS 276
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S         +   +
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRDTLCGT 170
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF 229
Query: 337 VLKEAKN 343
           V + A++
Sbjct: 230 VTEGARD 236

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W A  N  + VAVK +K      +  L E +++ TL  ++D+  K H 
Sbjct: 23  LGAGQFGEV---WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL--QHDKLVKLHA 77
Query: 175 VRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V      V +  + I  E +   +L + +K +      L  +  FS QI  G++ ++   
Sbjct: 78  V------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL+  NIL+  S+     KI DFG A   ED    +   +++   + +PE +    
Sbjct: 132 YIHRDLRAANILVSASLV---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ E+   G   +PG S  +++R + R
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTT 161
            T +RY+    LG G F +  +  D +     A K++      +P   ++   E++I  +
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
           L       D  H+V  + +F     + +  E+    +L EL K    + ++    + F +
Sbjct: 99  L-------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMR 149
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSR 277
           Q ++G+  L +  +IH DLK  N+ L   +   ++KI DFG A     +         + 
Sbjct: 150 QTIQGVQYLHNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
            Y +PEVL    ++  +D+WS GCI+  L +G P F
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 15  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 70
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 71  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 129
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+ ++  +  Y +PEVL    Y 
Sbjct: 130 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFY 209

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           ++ R  +VKD+ G G FG      D + N  VAVK I+      +    E+     +N +
Sbjct: 17  DSDRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-----INHR 70
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
             R    +IVR  E  +   HL I  E      L+E  +I +    S    + F +Q++ 
Sbjct: 71  SLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLIS 126
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSP 282
           G+S      + H DLK EN LL  S  P  +KI  FG   +        S + +  Y +P
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICAFGYSKSSVLHSQPKSTVGTPAYIAP 185
Query: 283 EVLLGYQYTTAI-DMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ--PPDYV 337
           EVLL  +Y   + D+WS G  +  + +G   F    E    R+ I RIL  Q   PDYV
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 244

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 118/248 (47%), Gaps = 24/248 (9%)
Query: 107 TQRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT 161
            +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQ 54
Query: 162 LNKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           L ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +   
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-- 112
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ 275
            +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S         +   
Sbjct: 113 -YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRAALCG 168
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPD 227
Query: 336 YVLKEAKN 343
           +V + A++
Sbjct: 228 FVTEGARD 235

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 67
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 68  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+ ++  +  Y +PEVL    Y 
Sbjct: 127 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 74
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 134
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 135 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 194
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 195 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 75
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 135
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 136 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 195
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 196 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   AVKI+K     Q    +  +VE  +L    K       
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP------ 401
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             + +++  F     L    E ++    +Y + ++  F+         ++ +I  GL  L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH---AVFYAAEIAIGLFFL 458
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVL 285
           +  GII+ DLK +N++L +      IKI DFG  C E+     T   +  +  Y +PE++
Sbjct: 459 QSKGIIYRDLKLDNVMLDSE---GHIKIADFG-MCKENIWDGVTTKXFCGTPDYIAPEII 514
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
               Y  ++D W+FG ++ E+  G   F G  E +L + ++
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 117/247 (47%), Gaps = 24/247 (9%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 55
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 112
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQS 276
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S             +
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRXXLCGT 169
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF 228
Query: 337 VLKEAKN 343
           V + A++
Sbjct: 229 VTEGARD 235

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 67
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 68  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+ ++  +  Y +PEVL    Y 
Sbjct: 127 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 68
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 120
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 180
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 181 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 240
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 241 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 69
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 129
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 130 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 189
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 190 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 184
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244
Query: 331 A 331
Sbjct: 245 T 245

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 184
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244
Query: 331 A 331
Sbjct: 245 T 245

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 129 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 186
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 187 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 246
Query: 331 A 331
Sbjct: 247 T 247

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 184
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244
Query: 331 A 331
Sbjct: 245 T 245

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 128 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 185
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 245
Query: 331 A 331
Sbjct: 246 T 246

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 114
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 58
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 115
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI +FG    A +  RT  +  
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIANFGWSVHAPSSRRT--TLC 170
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 229
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 230 DFVTEGARD 238

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 184
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244
Query: 331 A 331
Sbjct: 245 T 245

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 55/242 (22%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 184
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
                                              G + Y     IE + +         
Sbjct: 245 TD---------------------------------GLNVYLNKYRIELDPQ--------- 262
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
                  LE +V  +  +  L   +   +  +    +DFL  L+ +D  +R +  +A  H
Sbjct: 263 -------LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 451 PF 452
           P+
Sbjct: 316 PY 317

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 70
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 20/229 (8%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +    +    EV+   T N+   +  +H  +
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTLTENRVL-QNSRHPFL 72
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
              +Y   Q H  +CF +  +N  EL   ++  R  S    + +  +I+  L  L  +  
Sbjct: 73  TALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 131
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
           +++ DLK EN++L    K   IKI DFG       +  T+  +  +  Y +PEVL    Y
Sbjct: 132 VVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY 188
Query: 291 TTAIDMWSFGCIVAELFLG-LPLFPGASE--FDLLR----RMIRILGAQ 332
             A+D W  G ++ E+  G LP +    E  F+L+     R  R LG +
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 237

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V            A+KI+K     Q    +  +VE  +L  L+K       
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP----- 80
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL----------FSKQ 221
                    F+ Q H   CF+ +D  LY +++  +   L   I Q+          ++ +
Sbjct: 81  ---------FLTQLH--SCFQTVD-RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR----TVYSYIQSR 277
           I  GL  L   GII+ DLK +N++L +      IKI DFG  C E      T   +  + 
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSE---GHIKIADFG-MCKEHMMDGVTTREFCGTP 184
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            Y +PE++    Y  ++D W++G ++ E+  G P F G  E +L + ++
Sbjct: 185 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 233

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 128 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 185
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 245
Query: 331 A 331
Sbjct: 246 T 246

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 70
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 113/240 (47%), Gaps = 20/240 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED--KH-H 173
           LG G FG V    + +    +A+K++      ++  L +  +   L ++ + +   +H +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 174 IVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           I+R+Y YF    + +L + +  L +   EL K++ F     +    +  ++   LS    
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---YITELANALSYCHS 129
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
             +IH D+KPEN+LL ++    E+KI DFG S             +  Y  PE++ G  +
Sbjct: 130 KRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN-TSKFFK 349
              +D+WS G +  E  +G P F   +  +  +R+ R+     PD+V + A++  S+  K
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARDLISRLLK 245

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTT 161
            T +RY+    LG G F +  +  D +     A K++      +P   ++   E++I  +
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
           L       D  H+V  + +F     + +  E+    +L EL K    + ++    + F +
Sbjct: 83  L-------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMR 133
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSR 277
           Q ++G+  L +  +IH DLK  N+ L   +   ++KI DFG A     +         + 
Sbjct: 134 QTIQGVQYLHNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
            Y +PEVL    ++  +D+WS GCI+  L +G P F
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 68/121 (56%), Gaps = 6/121 (4%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
           ++ +  ++L+ L      GI+H D+KP N+++   ++  ++++ID+G A      +    
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNV 184
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILG 330
            + SRY++ PE+L+  Q Y  ++DMWS GC+ A  +F   P F G    D L ++ ++LG
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244
Query: 331 A 331
Sbjct: 245 T 245

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 119/249 (47%), Gaps = 28/249 (11%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 60
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +        EL K++ F     +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT--- 117
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYI 274
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG    A +  RT  +  
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT--TLC 172
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +  Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP 231
Query: 335 DYVLKEAKN 343
           D+V + A++
Sbjct: 232 DFVTEGARD 240

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 20/229 (8%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +    +    EV+   T N+   +  +H  +
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTLTENRVL-QNSRHPFL 70
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
              +Y   Q H  +CF +  +N  EL   ++  R  S    + +  +I+  L  L  +  
Sbjct: 71  TALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 129
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
           +++ DLK EN++L    K   IKI DFG       +  T+  +  +  Y +PEVL    Y
Sbjct: 130 VVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY 186
Query: 291 TTAIDMWSFGCIVAELFLG-LPLFPGASE--FDLLR----RMIRILGAQ 332
             A+D W  G ++ E+  G LP +    E  F+L+     R  R LG +
Sbjct: 187 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 235

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 67
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 68  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+  +  +  Y +PEVL    Y 
Sbjct: 127 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYDREDKH- 172
           LG G F  V +C         A KII  +      +Q+   E  I   L        KH 
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL--------KHP 90
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           +IVR+++    +    + F+L+    L+E I    +   S +       QIL  ++ +  
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY--YSEADASHCIHQILESVNHIHQ 148
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLGY 288
             I+H DLKPEN+LL +  K A +K+ DFG A     E +  + +  +  Y SPEVL   
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
            Y   +D+W+ G I+  L +G P F    +  L +++
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 245

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ-QALVEVSILTTLNKKYDREDKH 172
           +D+LG G   +V  C +   +   AVKII+ QP + + +   EV +L      Y  +   
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML------YQCQGHR 71
Query: 173 HIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           +++ + E+F  +    + FE +   S L  + K  HF  L  S+V    + +   L  L 
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLH 128
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFG--------SACTEDRT--VYSYIQSRYYR 280
           + GI H DLKPENIL     + + +KI DFG          C+   T  + +   S  Y 
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 281 SPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGLPLFPG 315
           +PEV+  +      Y    D+WS G I+  L  G P F G
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI+K +    +    EV+   T N+   +  +H  +
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTLTENRVL-QNSRHPFL 71
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
              +Y   Q H  +CF +  +N  EL   ++  R  S    + +  +I+  L  L  +  
Sbjct: 72  TALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 130
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
           +++ DLK EN++L    K   IKI DFG       +  T+  +  +  Y +PEVL    Y
Sbjct: 131 VVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 291 TTAIDMWSFGCIVAELFLG-LPLF 313
             A+D W  G ++ E+  G LP +
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 68
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++     + YY +PEV
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEV 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + DMWS G I+  L  G P F
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 72
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 73  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 131
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+  +  +  Y +PEVL    Y 
Sbjct: 132 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 67
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 68  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+  +  +  Y +PEVL    Y 
Sbjct: 127 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 109/241 (45%), Gaps = 22/241 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           ++ R  +VKD+ G G FG      D + N  VAVK I+      +    E+     +N +
Sbjct: 17  DSDRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-----INHR 70
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
             R    +IVR  E  +   HL I  E      L+E  +I +    S    + F +Q++ 
Sbjct: 71  SLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLIS 126
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY----IQSRYYR 280
           G+S      + H DLK EN LL  S  P  +KI  FG   ++   ++S     + +  Y 
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICAFGY--SKSSVLHSQPKDTVGTPAYI 183
Query: 281 SPEVLLGYQYTTAI-DMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ--PPDY 336
           +PEVLL  +Y   + D+WS G  +  + +G   F    E    R+ I RIL  Q   PDY
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY 243
Query: 337 V 337
           V
Sbjct: 244 V 244

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 117/247 (47%), Gaps = 24/247 (9%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 58
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +  L +   EL K++ F     +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--- 115
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQS 276
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG S             +
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRXXLCGT 172
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF 231
Query: 337 VLKEAKN 343
           V + A++
Sbjct: 232 VTEGARD 238

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 14/221 (6%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDR 168
           Y + + +G G F  V +C         A KII  K   A   Q L   + +  L K  + 
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSN- 64
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                IVR+++    +    + F+L+    L+E I    +   S +      +QIL  + 
Sbjct: 65  -----IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVL 117
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEV 284
                G++H DLKPEN+LL +  K A +K+ DFG A     + +  + +  +  Y SPEV
Sbjct: 118 HCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
           L    Y   +D+W+ G I+  L +G P F    +  L +++
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 218

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 31/242 (12%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEVSI 158
           +R++ + D      LG G FG V    + +    +A+K++ K+Q        Q   E+ I
Sbjct: 9   KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 68
Query: 159 LTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL-DSNLY-ELIKINHFRGLSLSIVQ 216
            + L          +I+R+Y YF  ++ + +  E      LY EL K   F     +   
Sbjct: 69  QSHLRHP-------NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT-- 119
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG----SACTEDRTVYS 272
            F +++   L    +  +IH D+KPEN+L+       E+KI DFG    +     R +  
Sbjct: 120 -FMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPSLRRRXMCG 175
Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
            +    Y  PE++ G  +   +D+W  G +  E  +G+P F   S  +  RR++ +    
Sbjct: 176 TLD---YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF 232
Query: 333 PP 334
           PP
Sbjct: 233 PP 234

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 116/247 (46%), Gaps = 24/247 (9%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           +R++ ++D      LG G FG V    + +    +A+K++      ++  L +  +   L
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 60
Query: 163 NKKYDRED--KH-HIVRIYEYF--VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
            ++ + +   +H +I+R+Y YF    + +L + +        EL K++ F     +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT--- 117
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           +  ++   LS      +IH D+KPEN+LL ++    E+KI DFG +     +    +   
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRXXLXGT 174
Query: 278 Y-YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             Y  PE++ G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF 233
Query: 337 VLKEAKN 343
           V + A++
Sbjct: 234 VTEGARD 240

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LLG GTFG+V    +     + A+KI++ +    +  +      T    +  +  +H  +
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 67
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
              +Y   Q H  +CF +  +N  EL   ++  R  +    + +  +I+  L  L    +
Sbjct: 68  TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           ++ D+K EN++L    K   IKI DFG      ++  T+  +  +  Y +PEVL    Y 
Sbjct: 127 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
            A+D W  G ++ E+  G LP +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ-QALVEVSILTTLNKKYDRED 170
           +  +LLG G + +V      +     AVKII+ Q  + + +   EV  L      Y  + 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETL------YQCQG 69
Query: 171 KHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
             +I+ + E+F       + FE L   S L  + K  HF     S V    + +   L  
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRV---VRDVAAALDF 126
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDF--------GSACTEDRT--VYSYIQSRY 278
           L   GI H DLKPENIL  +  K + +KI DF         ++CT   T  + +   S  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 279 YRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGLPLFPG 315
           Y +PEV+  +      Y    D+WS G ++  +  G P F G
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG 228

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH-- 173
           +LG G+FG+V      E     AVK++K +    Q   VE    T   K+     ++H  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQDDDVEC---TMTEKRILSLARNHPF 85
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           + +++  F     L    E ++     +  I   R    +  + ++ +I+  L  L D G
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQ 289
           II+ DLK +N+LL         K+ DFG  C E      T  ++  +  Y +PE+L    
Sbjct: 145 IIYRDLKLDNVLL---DHEGHCKLADFG-MCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
           Y  A+D W+ G ++ E+  G   F   +E DL   ++
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 31/242 (12%)
Query: 108 QRRYIVKDL-----LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEVSI 158
           +R++ + D      LG G FG V    + +    +A+K++ K+Q        Q   E+ I
Sbjct: 8   KRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 159 LTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL-DSNLY-ELIKINHFRGLSLSIVQ 216
            + L          +I+R+Y YF  ++ + +  E      LY EL K   F     +   
Sbjct: 68  QSHLRHP-------NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT-- 118
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG----SACTEDRTVYS 272
            F +++   L    +  +IH D+KPEN+L+       E+KI DFG    +     R +  
Sbjct: 119 -FMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPSLRRRXMCG 174
Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
            +    Y  PE++ G  +   +D+W  G +  E  +G+P F   S  +  RR++ +    
Sbjct: 175 TLD---YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF 231
Query: 333 PP 334
           PP
Sbjct: 232 PP 233

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ-QALVEVSILTTLNKKYDREDKH 172
           +D+LG G   +V  C +   +   AVKII+ QP + + +   EV +L      Y  +   
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML------YQCQGHR 71
Query: 173 HIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           +++ + E+F  +    + FE +   S L  + K  HF  L  S+V    + +   L  L 
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLH 128
Query: 231 DAGIIHCDLKPENILLC---TSVKPAEIKIIDFGSA------CTEDRT--VYSYIQSRYY 279
           + GI H DLKPENI LC     V P +I   D GS       C+   T  + +   S  Y
Sbjct: 129 NKGIAHRDLKPENI-LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 280 RSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGLPLFPG 315
            +PEV+  +      Y    D+WS G I+  L  G P F G
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   AVKI+K     Q    +  +VE  +L    K       
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----- 81
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL----------FSKQ 221
                    F+ Q H   CF+ +D  LY +++  +   L   I Q+          ++ +
Sbjct: 82  ---------FLTQLH--SCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSR 277
           I  GL  L+  GII+ DLK +N++L +      IKI DFG  C E+     T   +  + 
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFG-MCKENIWDGVTTKXFCGTP 185
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            Y +PE++    Y  ++D W+FG ++ E+  G   F G  E +L + ++
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALV-EVSILTTLNK 164
           Y + +++G G F  V +C + E     AVKI+      + P    + L  E SI   L  
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-- 85
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN--LYELIK-INHFRGLSLSIVQLFSK 220
                 KH HIV + E +     L + FE +D     +E++K  +     S ++   + +
Sbjct: 86  ------KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 139
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT---VYSYIQSR 277
           QIL  L    D  IIH D+KP  +LL +    A +K+  FG A     +       + + 
Sbjct: 140 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 199
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
           ++ +PEV+    Y   +D+W  G I+  L  G   F G  E
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 240

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLN 163
           Y + + LG G F  V KC +       A K IK + +   +  V       EVSIL    
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL---- 69
Query: 164 KKYDREDKHH-IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               R+  HH ++ +++ +  +  + +  EL+    L++ +       LS      F KQ
Sbjct: 70  ----RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC-TEDRTVYSYI-QSRY 278
           IL G++ L    I H DLKPENI+L     P   IK+IDFG A   ED   +  I  +  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W A  N  + VAVK +K      +  L E +++ TL  ++D+  K H 
Sbjct: 190 LGAGQFGEV---WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL--QHDKLVKLHA 244
Query: 175 VRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V      V +  + I  E +   +L + +K +      L  +  FS QI  G++ ++   
Sbjct: 245 V------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTA 293
            IH DL+  NIL+  S+     KI DFG A    +    +       +PE +    +T  
Sbjct: 299 YIHRDLRAANILVSASLV---CKIADFGLARVGAKFPIKWT------APEAINFGSFTIK 349
Query: 294 IDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
            D+WSFG ++ E+   G   +PG S  +++R + R
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 384

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 23/201 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKN-------QPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG+V          + A+K++K        Q  +     + +SI+T         
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--------- 64
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
               I+R++  F   + + +  + ++   L+ L++ +  +     + + ++ ++   L  
Sbjct: 65  -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEY 121
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
           L    II+ DLKPENILL    K   IKI DFG A       Y    +  Y +PEV+   
Sbjct: 122 LHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTK 178
Query: 289 QYTTAIDMWSFGCIVAELFLG 309
            Y  +ID WSFG ++ E+  G
Sbjct: 179 PYNKSIDWWSFGILIYEMLAG 199

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 117 LGHGTFGQV-AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG+G FG+V    W+   N+ VA+K +K      +  L E  I+  L  K+D+     +V
Sbjct: 17  LGNGQFGEVWMGTWNG--NTKVAIKTLKPGTMSPESFLEEAQIMKKL--KHDK-----LV 67
Query: 176 RIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y   V +  + I  E ++  +L + +K    R L L  +   + Q+  G++ ++    
Sbjct: 68  QLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 126
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL+  NIL+   +     KI DFG A   ED    +   +++   + +PE  L  ++
Sbjct: 127 IHRDLRSANILVGNGLI---CKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 183
Query: 291 TTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           T   D+WSFG ++ EL   G   +PG +  ++L ++ R
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 101/232 (43%), Gaps = 16/232 (6%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           ++ R   VKD+ G G FG      D      VAVK I+   A  +    E+     +N +
Sbjct: 18  DSDRYDFVKDI-GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREI-----INHR 71
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
             R    +IVR  E  +   HL I  E      LYE  +I +    S    + F +Q+L 
Sbjct: 72  SLRHP--NIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQQLLS 127
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSP 282
           G+S      I H DLK EN LL  S  P  +KI DFG   +        S + +  Y +P
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186
Query: 283 EVLLGYQYTTAI-DMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ 332
           EVLL  +Y   I D+WS G  +  + +G   F    E    R+ I RIL  +
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKY 166
           YI+++ LG G+FG+V      +    VA+K I  Q       + +   E+S L  L    
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL---- 66
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
               +H HI+++Y+       + +  E     L++ I     + ++    + F +QI+  
Sbjct: 67  ----RHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQIICA 120
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPE 283
           +       I+H DLKPEN+LL  ++    +KI DFG  +  T+   + +   S  Y +PE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 284 VLLGYQYTT-AIDMWSFGCIVAELFLGLPLFPGASEF 319
           V+ G  Y    +D+WS G ++  + +G    P   EF
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVG--RLPFDDEF 212

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLN 163
           Y + + LG G F  V KC +       A K IK + +   +  V       EVSIL    
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL---- 69
Query: 164 KKYDREDKHH-IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               R+  HH ++ +++ +  +  + +  EL+    L++ +       LS      F KQ
Sbjct: 70  ----RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC-TEDRTVYSYI-QSRY 278
           IL G++ L    I H DLKPENI+L     P   IK+IDFG A   ED   +  I  +  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLN 163
           Y + + LG G F  V KC +       A K IK + +   +  V       EVSIL    
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL---- 69
Query: 164 KKYDREDKHH-IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               R+  HH ++ +++ +  +  + +  EL+    L++ +       LS      F KQ
Sbjct: 70  ----RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC-TEDRTVYSYI-QSRY 278
           IL G++ L    I H DLKPENI+L     P   IK+IDFG A   ED   +  I  +  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALV-EVSILTTLNK 164
           Y + +++G G F  V +C + E     AVKI+      + P    + L  E SI   L  
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-- 83
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN--LYELIK-INHFRGLSLSIVQLFSK 220
                 KH HIV + E +     L + FE +D     +E++K  +     S ++   + +
Sbjct: 84  ------KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT---VYSYIQSR 277
           QIL  L    D  IIH D+KP  +LL +    A +K+  FG A     +       + + 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
           ++ +PEV+    Y   +D+W  G I+  L  G   F G  E
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +G G+FG+V K  D      VA+KII      ++    QQ   E+++L+  +  Y     
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPY----- 81
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + + Y  ++    L I  E L       + +     L  + +    ++IL+GL  L  
Sbjct: 82  --VTKYYGSYLKDTKLWIIMEYLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHS 137
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YIQSRYYRSPEVLLGY 288
              IH D+K  N+LL       E+K+ DFG A     T      ++ + ++ +PEV+   
Sbjct: 138 EKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 289 QYTTAIDMWSFGCIVAELFLGLP 311
            Y +  D+WS G    EL  G P
Sbjct: 195 AYDSKADIWSLGITAIELARGEP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLN 163
           Y + + LG G F  V KC +       A K IK + +   +  V       EVSIL    
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL---- 69
Query: 164 KKYDREDKHH-IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               R+  HH ++ +++ +  +  + +  EL+    L++ +       LS      F KQ
Sbjct: 70  ----RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC-TEDRTVYSYI-QSRY 278
           IL G++ L    I H DLKPENI+L     P   IK+IDFG A   ED   +  I  +  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLN 163
           Y + + LG G F  V KC +       A K IK + +   +  V       EVSIL    
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL---- 69
Query: 164 KKYDREDKHH-IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               R+  HH ++ +++ +  +  + +  EL+    L++ +       LS      F KQ
Sbjct: 70  ----RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC-TEDRTVYSYI-QSRY 278
           IL G++ L    I H DLKPENI+L     P   IK+IDFG A   ED   +  I  +  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDKHHI 174
           +LG GT+G V    D      +A+K I  + + Y Q L  E+++   L  K       +I
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK-------NI 81
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL--SLSIVQLFSKQILRGLSLLKDA 232
           V+    F     + I  E +       +  + +  L  +   +  ++KQIL GL  L D 
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------CTEDRTVYSYIQSRYYRSPEV 284
            I+H D+K +N+L+ T      +KI DFG++        CTE     ++  +  Y +PE+
Sbjct: 142 QIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTE-----TFTGTLQYMAPEI 194
Query: 285 LLG--YQYTTAIDMWSFGCIVAELFLGLPLF 313
           +      Y  A D+WS GC + E+  G P F
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 123
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 124 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 179
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       ++   +  Y +PE++L   Y
Sbjct: 180 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGY 236
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYDREDKH 172
           D +G G+FG+V K  D      VA+KII  + A  +   +  E+++L+  +  Y      
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY------ 78
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
            I R +  ++    L I  E L   +  +L+K      L  + +    ++IL+GL  L  
Sbjct: 79  -ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHS 134
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YIQSRYYRSPEVLLGY 288
              IH D+K  N+LL    +  ++K+ DFG A     T      ++ + ++ +PEV+   
Sbjct: 135 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 289 QYTTAIDMWSFGCIVAELFLGLP 311
            Y    D+WS G    EL  G P
Sbjct: 192 AYDFKADIWSLGITAIELAKGEP 214

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
           +G G+ G V           VAVK +  +    ++ L  EV I+    + Y  E+   +V
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 211
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +Y  ++    L +  E L+      I + H R ++   +      +L+ LS+L   G+I
Sbjct: 212 EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLQALSVLHAQGVI 269
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
           H D+K ++ILL        +K+ DFG      + V      + + Y+ +PE++    Y  
Sbjct: 270 HRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 293 AIDMWSFGCIVAELFLGLP 311
            +D+WS G +V E+  G P
Sbjct: 327 EVDIWSLGIMVIEMVDGEP 345

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 17/223 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYD 167
           Y ++  +G G F +V           VAVKII K Q  P   Q+   EV I+  LN    
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP-- 74
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                +IV+++E    ++ L +  E           + H R         F +QI+  + 
Sbjct: 75  -----NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQ 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVL 285
                 I+H DLK EN+LL   +    IKI DFG  +  T    + ++  S  Y +PE+ 
Sbjct: 129 YCHQKYIVHRDLKAENLLLDGDMN---IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELF 185
Query: 286 LGYQYTT-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
            G +Y    +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 94
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +   S    + ++ QI+  
Sbjct: 95  IQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   IK+ DFG A       +    +  Y +PE++
Sbjct: 155 FEYLHSLDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEII 211
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   IK+ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 69
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 127
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 69
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 127
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +G G+FG+V K  D      VA+KII      ++    QQ   E+++L+  +  Y     
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPY----- 66
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + + Y  ++    L I  E L       + +     L  + +    ++IL+GL  L  
Sbjct: 67  --VTKYYGSYLKDTKLWIIMEYLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGY 288
              IH D+K  N+LL       E+K+ DFG A     T     +++ + ++ +PEV+   
Sbjct: 123 EKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 289 QYTTAIDMWSFGCIVAELFLGLP 311
            Y +  D+WS G    EL  G P
Sbjct: 180 AYDSKADIWSLGITAIELARGEP 202

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 123
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 124 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 179
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 180 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDKHHI 174
           +LG GT+G V    D      +A+K I  + + Y Q L  E+++   L  K       +I
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK-------NI 67
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL--SLSIVQLFSKQILRGLSLLKDA 232
           V+    F     + I  E +       +  + +  L  +   +  ++KQIL GL  L D 
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------CTEDRTVYSYIQSRYYRSPEV 284
            I+H D+K +N+L+ T      +KI DFG++        CTE     ++  +  Y +PE+
Sbjct: 128 QIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTE-----TFTGTLQYMAPEI 180
Query: 285 LLG--YQYTTAIDMWSFGCIVAELFLGLPLF 313
           +      Y  A D+WS GC + E+  G P F
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 22/238 (9%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ----QALVEVSILTTL 162
           T R+Y V   LG G FG+V  C         A K ++ +    +     AL E  IL  +
Sbjct: 185 TFRQYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF--RGLSLSIVQLFSK 220
           N ++       +V +   +  +  LC+   L++    +   I H    G   +    ++ 
Sbjct: 242 NSRF-------VVSLAYAYETKDALCLVLTLMNGGDLKF-HIYHMGQAGFPEARAVFYAA 293
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRY 278
           +I  GL  L    I++ DLKPENILL        I+I D G A    E +T+   + +  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           Y +PEV+   +YT + D W+ GC++ E+  G   F    +      + R++   P +Y
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K +++ P    +A  EV +       +     
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCP----KARREVEL------HWRASQC 114
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEV 284
             L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   + YY +PEV
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   +Y  + D WS G I   L  G P F
Sbjct: 235 LGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 104 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 159
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       ++   +  Y +PE++L   Y
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   IK+ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q       L E+    TLN+K          R
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVV---KLKEIE--HTLNEK----------R 93
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +   S    + ++ QI+  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+++    +   IK+ DFG A       +    +  Y +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLMID---QQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLN 163
           Y + + LG G F  V KC         A K IK +     +  V       EV+IL    
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL---- 83
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               RE +H +I+ +++ F  +  + +  EL+    L++ +       L+      F KQ
Sbjct: 84  ----REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQ 137
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFG-----SACTEDRTVYSYIQ 275
           IL G+  L    I H DLKPENI+L     P   IK+IDFG      A  E + ++   +
Sbjct: 138 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 197
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
              + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 198 ---FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 241

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 94
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +   S    + ++ QI+  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+++    +   IK+ DFG A       +    +  Y +PE++
Sbjct: 155 FEYLHSLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEII 211
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVS-ILTTLNKKYDREDKHHIV 175
           LG G+FG+V      E  +  A+KI+       +Q +V++  I  TLN+K          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILD------KQKVVKLKQIEHTLNEK---------- 92
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILR 224
           RI +       + + F   D SNLY +++        +H R +   S    + ++ QI+ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
               L    +I+ DLKPEN+++    +   IK+ DFG A       +    +  Y +PE+
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEI 209
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +L   Y  A+D W+ G ++ E+  G P F
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +G G+FG+V K  D      VA+KII      ++    QQ   E+++L+  +  Y     
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPY----- 86
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + + Y  ++    L I  E L       + +     L  + +    ++IL+GL  L  
Sbjct: 87  --VTKYYGSYLKDTKLWIIMEYLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGY 288
              IH D+K  N+LL    +  E+K+ DFG A     T     +++ + ++ +PEV+   
Sbjct: 143 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 199
Query: 289 QYTTAIDMWSFGCIVAELFLGLP 311
            Y +  D+WS G    EL  G P
Sbjct: 200 AYDSKADIWSLGITAIELARGEP 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLN 163
           Y + + LG G F  V KC         A K IK +           ++   EV+IL    
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL---- 62
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               RE +H +I+ +++ F  +  + +  EL+    L++ +       L+      F KQ
Sbjct: 63  ----REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQ 116
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFG-----SACTEDRTVYSYIQ 275
           IL G+  L    I H DLKPENI+L     P   IK+IDFG      A  E + ++   +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 176
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
              + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 177 ---FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 28/232 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSI 158
           + +  Y + + LG G F  V KC         A K IK +           ++   EV+I
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 159 LTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQ 216
           L        RE +H +I+ +++ F  +  + +  EL+    L++ +       L+     
Sbjct: 69  L--------REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEAT 118
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFG-----SACTEDRTV 270
            F KQIL G+  L    I H DLKPENI+L     P   IK+IDFG      A  E + +
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 178
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +   +   + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 179 FGTPE---FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 227

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +G G+FG+V K  D      VA+KII      ++    QQ   E+++L+  +  Y     
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPY----- 66
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + + Y  ++    L I  E L       + +     L  + +    ++IL+GL  L  
Sbjct: 67  --VTKYYGSYLKDTKLWIIMEYLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YIQSRYYRSPEVLLGY 288
              IH D+K  N+LL       E+K+ DFG A     T      ++ + ++ +PEV+   
Sbjct: 123 EKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 289 QYTTAIDMWSFGCIVAELFLGLP 311
            Y +  D+WS G    EL  G P
Sbjct: 180 AYDSKADIWSLGITAIELARGEP 202

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   IK+ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 104 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 159
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 104 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 159
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVS-ILTTLNKKYDREDKHHIV 175
           LG G+FG+V      E  +  A+KI+       +Q +V++  I  TLN+K          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILD------KQKVVKLKQIEHTLNEK---------- 92
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILR 224
           RI +       + + F   D SNLY +++        +H R +        + ++ QI+ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
               L    +I+ DLKPEN+++    +   IK+ DFG A       +    +  Y +PE+
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEI 209
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +L   Y  A+D W+ G ++ E+  G P F
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           ++G G+FG+V          F AVK+++ +           +IL    +K+   +++ ++
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKK-----------AILKKKEEKHIMSERNVLL 93
Query: 176 RIYEY-FVCQRHLCICFELLDSNLYELIKIN------HF---RGLSLSIVQLFSKQILRG 225
           +  ++ F+   H    F+  D   + L  IN      H    R       + ++ +I   
Sbjct: 94  KNVKHPFLVGLHFS--FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRS 281
           L  L    I++ DLKPENILL +      I + DFG  C E+     T  ++  +  Y +
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFG-LCKENIEHNSTTSTFCGTPEYLA 207
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           PEVL    Y   +D W  G ++ E+  GLP F
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 22/238 (9%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ----QALVEVSILTTL 162
           T R+Y V   LG G FG+V  C         A K ++ +    +     AL E  IL  +
Sbjct: 185 TFRQYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF--RGLSLSIVQLFSK 220
           N ++       +V +   +  +  LC+   L++    +   I H    G   +    ++ 
Sbjct: 242 NSRF-------VVSLAYAYETKDALCLVLTLMNGGDLKF-HIYHMGQAGFPEARAVFYAA 293
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRY 278
           +I  GL  L    I++ DLKPENILL        I+I D G A    E +T+   + +  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           Y +PEV+   +YT + D W+ GC++ E+  G   F    +      + R++   P +Y
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 104 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 159
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 104 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 159
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDK 171
           +LG G FG+V  C         A K +  +       YQ A+VE  IL  ++ ++     
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF----- 246
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFR-GLSLSIVQLFSKQILRGLSL 228
             IV +   F  +  LC+   +++     Y +  ++    G        ++ QI+ GL  
Sbjct: 247 --IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVL 285
           L    II+ DLKPEN+LL        ++I D G A            Y  +  + +PE+L
Sbjct: 305 LHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 286 LGYQYTTAIDMWSFGCIVAEL 306
           LG +Y  ++D ++ G  + E+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEM 382

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 88
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 89  -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 144
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       ++   +  Y +PE++L   Y
Sbjct: 145 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 202 NKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
           +G G+ G V           VAVK +  +    ++ L  EV I+    + Y  E+   +V
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 134
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +Y  ++    L +  E L+      I + H R ++   +      +L+ LS+L   G+I
Sbjct: 135 EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLQALSVLHAQGVI 192
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
           H D+K ++ILL        +K+ DFG      + V      + + Y+ +PE++    Y  
Sbjct: 193 HRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 293 AIDMWSFGCIVAELFLGLP 311
            +D+WS G +V E+  G P
Sbjct: 250 EVDIWSLGIMVIEMVDGEP 268

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
            LG G F +  +  DA+     A KI+      +P   ++  +E+SI  +L  +      
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ------ 101
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            H+V  + +F     + +  EL    +L EL K    + L+    + + +QI+ G   L 
Sbjct: 102 -HVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPEVL 285
              +IH DLK  N+ L   +   E+KI DFG A       E + V     +  Y +PEVL
Sbjct: 159 RNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKVLCGTPN--YIAPEVL 213
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
               ++  +D+WS GCI+  L +G P F
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
            LG G F +  +  DA+     A KI+      +P   ++  +E+SI  +L  +      
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ------ 81
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            H+V  + +F     + +  EL    +L EL K    + L+    + + +QI+ G   L 
Sbjct: 82  -HVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLH 138
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLG 287
              +IH DLK  N+ L   +   E+KI DFG A     +     +   +  Y +PEVL  
Sbjct: 139 RNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 195
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLF 313
             ++  +D+WS GCI+  L +G P F
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDK 171
           +LG G FG+V  C         A K +  +       YQ A+VE  IL  ++ ++     
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF----- 246
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFR-GLSLSIVQLFSKQILRGLSL 228
             IV +   F  +  LC+   +++     Y +  ++    G        ++ QI+ GL  
Sbjct: 247 --IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVL 285
           L    II+ DLKPEN+LL        ++I D G A            Y  +  + +PE+L
Sbjct: 305 LHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 286 LGYQYTTAIDMWSFGCIVAEL 306
           LG +Y  ++D ++ G  + E+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEM 382

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVS-ILTTLNKKYDREDKHHIV 175
           LG G+FG+V      E  +  A+KI+       +Q +V++  I  TLN+K          
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILD------KQKVVKLKQIEHTLNEK---------- 93
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILR 224
           RI +         + F   D SNLY +++        +H R +   S    + ++ QI+ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
               L    +I+ DLKPEN+++    +   IK+ DFG A       +    +  Y +PE+
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEI 210
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVS-ILTTLNKKYDREDKHHIV 175
           LG G+FG+V      E  +  A+KI+       +Q +V++  I  TLN+K          
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILD------KQKVVKLKQIEHTLNEK---------- 93
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILR 224
           RI +         + F   D SNLY +++        +H R +   S    + ++ QI+ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
               L    +I+ DLKPEN+++    +   IK+ DFG A       +    +  Y +PE+
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEI 210
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 25/239 (10%)
Query: 106 ETQRRYIVKDLLGHGTFGQ---VAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           ++  +Y+    +G G+FG+   V    D        + I +      +++  EV++L  +
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFS- 219
                   KH +IV+  E F     L I  +  +  +L++  +IN  +G+     Q+   
Sbjct: 81  --------KHPNIVQYRESFEENGSLYIVMDYCEGGDLFK--RINAQKGVLFQEDQILDW 130
Query: 220 -KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQ 275
             QI   L  + D  I+H D+K +NI L    K   +++ DFG A   + TV    + I 
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIG 187
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           + YY SPE+     Y    D+W+ GC++ EL      F   S  +L+ ++I   G+ PP
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFPP 244

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDK 171
           +LG G FG+V  C         A K +  +       YQ A+VE  IL  ++ ++     
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF----- 246
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFR-GLSLSIVQLFSKQILRGLSL 228
             IV +   F  +  LC+   +++     Y +  ++    G        ++ QI+ GL  
Sbjct: 247 --IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVL 285
           L    II+ DLKPEN+LL        ++I D G A            Y  +  + +PE+L
Sbjct: 305 LHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 286 LGYQYTTAIDMWSFGCIVAEL 306
           LG +Y  ++D ++ G  + E+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEM 382

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAV-----KIIKNQPAYYQQALVEVSILTTLNK 164
           +Y++ DLLG G++G+V +  D+E     AV     K ++  P        E+ +L  L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 165 K--------YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           K           E+K  +  + EY VC        E+LDS   +   +    G       
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQ-----EMLDSVPEKRFPVCQAHG------- 113
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCT--SVKPAEIKIIDFGSACTEDRTVYSYI 274
            +  Q++ GL  L   GI+H D+KP N+LL T  ++K + + + +       D T  +  
Sbjct: 114 -YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 275 QSRYYRSPEVLLGYQYTTA--IDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
            S  ++ PE+  G    +   +D+WS G  +  +  GL  F G + + L   +
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 95
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 96  -LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 151
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 152 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLNKKYDRE 169
           LG G F  V KC +       A K IK +     +  V       EVSIL        +E
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL--------KE 70
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
            +H +++ ++E +  +  + +  EL+    L++ +       L+      F KQIL G+ 
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVY 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTED--RTVYSYIQSRYYRSPEV 284
            L    I H DLKPENI+L     P   IKIIDFG A   D      +   +  + +PE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +         DMWS G I   L  G   F G ++ + L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-------EVSILTTLN 163
           Y + + LG G F  V KC +       A K IK + +   +  V       EVSIL    
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL---- 69
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQ 221
               R+  H +I+ +++ +  +  + +  EL+    L++ +       LS      F KQ
Sbjct: 70  ----RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC-TEDRTVYSYI-QSRY 278
           IL G++ L    I H DLKPENI+L     P   IK+IDFG A   ED   +  I  +  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           + +PE++         DMWS G I   L  G   F G ++ + L
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 21/282 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV--LKEAKNTSKFF 348
             A+D W+ G ++ E+  G P F       +  +++      P  +   LK+        
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 349 KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
               +  N++NG   I     +     I    R+++ P I K
Sbjct: 276 DLTKAFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q       L E+    TLN+K          R
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVV---KLKEIE--HTLNEK----------R 93
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +   S    + ++ QI+  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+++    +   I++ DFG A       +    +  Y +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLMID---QQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVS-ILTTLNKKYDREDKHHIV 175
           LG G+FG+V      E  +  A+KI+       +Q +V++  I  TLN+K          
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILD------KQKVVKLKQIEHTLNEK---------- 93
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILR 224
           RI +         + F   D SNLY +++        +H R +        + ++ QI+ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
               L    +I+ DLKPEN+++    +   IK+ DFG A       +    +  Y +PE+
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEI 210
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVS-ILTTLNKKYDREDKHHIV 175
           LG G+FG+V      E  +  A+KI+       +Q +V++  I  TLN+K          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILD------KQKVVKLKQIEHTLNEK---------- 92
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILR 224
           RI +       + + F   D SNLY +++        +H R +        + ++ QI+ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
               L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE+
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEI 209
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +L   Y  A+D W+ G ++ E+  G P F
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
            LG G F +  +  DA+     A KI+      +P   ++  +E+SI  +L  +      
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ------ 77
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            H+V  + +F     + +  EL    +L EL K    + L+    + + +QI+ G   L 
Sbjct: 78  -HVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLH 134
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLG 287
              +IH DLK  N+ L   +   E+KI DFG A     +     +   +  Y +PEVL  
Sbjct: 135 RNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 191
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLF 313
             ++  +D+WS GCI+  L +G P F
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVS-ILTTLNKKYDREDKHHIV 175
           LG G+FG+V      E  +  A+KI+       +Q +V++  I  TLN+K          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILD------KQKVVKLKQIEHTLNEK---------- 92
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGL---SLSIVQLFSKQILR 224
           RI +       + + F   D SNLY +++        +H R +   S    + ++ QI+ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
               L    +I+ DLKPEN+++    +   I++ DFG A       +    +  Y +PE+
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEI 209
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +L   Y  A+D W+ G ++ E+  G P F
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
            LG G F +  +  DA+     A KI+      +P   ++  +E+SI  +L  +      
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ------ 99
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            H+V  + +F     + +  EL    +L EL K    + L+    + + +QI+ G   L 
Sbjct: 100 -HVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLH 156
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPEVL 285
              +IH DLK  N+ L   +   E+KI DFG A       E + V     +  Y +PEVL
Sbjct: 157 RNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKVLCGTPN--YIAPEVL 211
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
               ++  +D+WS GCI+  L +G P F
Sbjct: 212 SKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 104 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 159
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 94
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT 154
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 155 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 211
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
            LG G F +  +  DA+     A KI+      +P   ++  +E+SI  +L  +      
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ------ 77
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            H+V  + +F     + +  EL    +L EL K    + L+    + + +QI+ G   L 
Sbjct: 78  -HVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLH 134
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLG 287
              +IH DLK  N+ L   +   E+KI DFG A     +     +   +  Y +PEVL  
Sbjct: 135 RNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 191
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLF 313
             ++  +D+WS GCI+  L +G P F
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 93
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 114
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 174
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 175 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 231
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 34/222 (15%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRED 170
           +K+ LG G FG V +    +    VA+K  + +  P   ++  +E+ I+  LN       
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN------- 71
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIK------------INHFR---GLSLSIV 215
                  +   V  R +    + L  N   L+             +N F    GL    +
Sbjct: 72  -------HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 124
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSY 273
           +     I   L  L +  IIH DLKPENI+L    +    KIID G A   D+      +
Sbjct: 125 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 184
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL-PLFP 314
           + +  Y +PE+L   +YT  +D WSFG +  E   G  P  P
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 34/222 (15%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRED 170
           +K+ LG G FG V +    +    VA+K  + +  P   ++  +E+ I+  LN       
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN------- 70
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIK------------INHFR---GLSLSIV 215
                  +   V  R +    + L  N   L+             +N F    GL    +
Sbjct: 71  -------HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSY 273
           +     I   L  L +  IIH DLKPENI+L    +    KIID G A   D+      +
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL-PLFP 314
           + +  Y +PE+L   +YT  +D WSFG +  E   G  P  P
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKH-HI 174
           +G G+ G V    +      VAVK++  +    ++ L  EV I+        R+ +H ++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM--------RDYQHFNV 104
Query: 175 VRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
           V +Y+ ++    L +  E L     +++   +++N  +      +    + +L+ L+ L 
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ------IATVCEAVLQALAYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLG 287
             G+IH D+K ++ILL        +K+ DFG      + V      + + Y+ +PEV+  
Sbjct: 159 AQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISR 215
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
             Y T +D+WS G +V E+  G P +   S    ++R+
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 86
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT 146
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 147 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 203
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALVEVSILTTLNKKYDR 168
           Y +   LG G+FG+V   +       VA+KII  +       Q  +E  I       Y R
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI------SYLR 68
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             +H HI+++Y+    +  + +  E   + L++ I       +S    + F +QI+  + 
Sbjct: 69  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIISAVE 126
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVL 285
                 I+H DLKPEN+LL   +    +KI DFG  +  T+   + +   S  Y +PEV+
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 183
Query: 286 LGYQYTT-AIDMWSFGCIV 303
            G  Y    +D+WS G I+
Sbjct: 184 SGKLYAGPEVDVWSCGVIL 202

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +GHG+FG V    D   +  VA+K +    K     +Q  + EV  L  L        +H
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL--------RH 113
Query: 173 HIVRIYEYFVCQRHLC-ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
                Y     + H   +  E    +  +L+++ H + L    +   +   L+GL+ L  
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY--- 288
             +IH D+K  NILL    +P  +K+ DFGSA         ++ + Y+ +PEV+L     
Sbjct: 173 HNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM-APANXFVGTPYWMAPEVILAMDEG 228
Query: 289 QYTTAIDMWSFGCIVAEL 306
           QY   +D+WS G    EL
Sbjct: 229 QYDGKVDVWSLGITCIEL 246

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDK 171
           +LG G FG+V  C         A K +  +       YQ A+VE  IL  ++ ++     
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF----- 246
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFR-GLSLSIVQLFSKQILRGLSL 228
             IV +   F  +  LC+   +++     Y +  ++    G        ++ QI+ GL  
Sbjct: 247 --IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVL 285
           L    II+ DLKPEN+LL        ++I D G A            Y  +  + +PE+L
Sbjct: 305 LHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 286 LGYQYTTAIDMWSFGCIVAEL 306
           LG +Y  ++D ++ G  + E+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEM 382

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALVEVSILTTLNKKYDR 168
           Y +   LG G+FG+V   +       VA+KII  +       Q  +E  I       Y R
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI------SYLR 69
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             +H HI+++Y+    +  + +  E   + L++ I       +S    + F +QI+  + 
Sbjct: 70  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIISAVE 127
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVL 285
                 I+H DLKPEN+LL   +    +KI DFG  +  T+   + +   S  Y +PEV+
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 184
Query: 286 LGYQYTT-AIDMWSFGCIV 303
            G  Y    +D+WS G I+
Sbjct: 185 SGKLYAGPEVDVWSCGVIL 203

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 29  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 78
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 79  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 135
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 136 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY 192
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 241

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSI---LTTLNK 164
           Y+VK+ +G G++ +  +C     N   AVK+I   K  P+   + L+       + TL  
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
            YD  D  H+  + E       L    ELLD    ++++   F     S V      I +
Sbjct: 89  VYD--DGKHVYLVTE-------LMRGGELLD----KILRQKFFSEREASFVL---HTIGK 132
Query: 225 GLSLLKDAGIIHCDLKPENILLC-TSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYR 280
            +  L   G++H DLKP NIL    S  P  ++I DFG A     E+  + +   +  + 
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRM 325
           +PEVL    Y    D+WS G ++  +  G   F   P  +  ++L R+
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI 240

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALVEVSILTTLNKKYDR 168
           Y +   LG G+FG+V   +       VA+KII  +       Q  +E  I       Y R
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI------SYLR 63
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             +H HI+++Y+    +  + +  E   + L++ I       +S    + F +QI+  + 
Sbjct: 64  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIISAVE 121
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVL 285
                 I+H DLKPEN+LL   +    +KI DFG  +  T+   + +   S  Y +PEV+
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 178
Query: 286 LGYQYTT-AIDMWSFGCIV 303
            G  Y    +D+WS G I+
Sbjct: 179 SGKLYAGPEVDVWSCGVIL 197

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 27  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 76
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 77  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 133
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 134 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY 190
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 239

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 31  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 80
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 81  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 137
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 138 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 194
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 243

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALVEVSILTTLNKKYDR 168
           Y +   LG G+FG+V   +       VA+KII  +       Q  +E  I       Y R
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI------SYLR 59
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             +H HI+++Y+    +  + +  E   + L++ I       +S    + F +QI+  + 
Sbjct: 60  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIISAVE 117
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVL 285
                 I+H DLKPEN+LL   +    +KI DFG  +  T+   + +   S  Y +PEV+
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 174
Query: 286 LGYQYTT-AIDMWSFGCIV 303
            G  Y    +D+WS G I+
Sbjct: 175 SGKLYAGPEVDVWSCGVIL 193

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 33/236 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY + ++LG G   +V    D  ++  VAVK+++      P++Y +   E      LN  
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 166 YDREDKHHIVRIYEYFVCQRHLC----ICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
                   IV +Y+    +        I  E +D     L  I H  G ++         
Sbjct: 73  A-------IVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPKRAIEVIA 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVY 271
              + L+     GIIH D+KP NI++  +     +K++DFG A          T+   V 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Q   Y SPE   G       D++S GC++ E+  G P F G S   +  + +R
Sbjct: 181 GTAQ---YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 93
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 93
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 93
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K      Q  L E +++ TL     + DK  +
Sbjct: 21  LGAGQFGEV---WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-----QHDK--L 70
Query: 175 VRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           VR+Y     +  + I  E +   +L + +K +    + L  +  FS QI  G++ ++   
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL+  N+L+  S+     KI DFG A   ED    +   +++   + +PE +    
Sbjct: 131 YIHRDLRAANVLVSESLM---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
           +T   D+WSFG ++ E+   G   +PG +  D++
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVM 221

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 37/236 (15%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
            RY + D LG G    V    D  +N  VA+K I   P   ++ L          K+++R
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL----------KRFER 60
Query: 169 E-------DKHHIVRIYEYFVCQRHLC--ICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
           E          +IV + +  V +   C  +  E ++   L E I+      LS+     F
Sbjct: 61  EVHNSSQLSHQNIVSMID--VDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINF 116
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTEDRTVY 271
           + QIL G+    D  I+H D+KP+NIL+ ++     +KI DFG       ++ T+   V 
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
             +Q   Y SPE   G       D++S G ++ E+ +G P F G +   +  + I+
Sbjct: 174 GTVQ---YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ 226

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSI---LTTLNK 164
           Y+VK+ +G G++ +  +C     N   AVK+I   K  P+   + L+       + TL  
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
            YD  D  H+  + E       L    ELLD    ++++   F     S V      I +
Sbjct: 89  VYD--DGKHVYLVTE-------LMRGGELLD----KILRQKFFSEREASFVL---HTIGK 132
Query: 225 GLSLLKDAGIIHCDLKPENILLC-TSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYR 280
            +  L   G++H DLKP NIL    S  P  ++I DFG A     E+  + +   +  + 
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRM 325
           +PEVL    Y    D+WS G ++  +  G   F   P  +  ++L R+
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI 240

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           V + LG G++G V K    E    VA+K +  + +  Q+ + E+SI+          D  
Sbjct: 33  VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQC-------DSP 84
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
           H+V+ Y  +     L I  E   + ++ ++I++ + + L+   +    +  L+GL  L  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF 143
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YIQSRYYRSPEVLLGY 288
              IH D+K  NILL T       K+ DFG A      +      I + ++ +PEV+   
Sbjct: 144 MRKIHRDIKAGNILLNTE---GHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 289 QYTTAIDMWSFGCIVAELFLGLP 311
            Y    D+WS G    E+  G P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKP 223

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 89
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 90  -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 145
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 146 SLDLIYRDLKPENLLID---EQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 30  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 79
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 80  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 136
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 137 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY 193
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 242

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 93
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ ++  G P F
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPF 238

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 21  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 70
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 71  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 128 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V      E  +  A+KI+  Q     +      I  TLN+K          R
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-----QIEHTLNEK----------R 88
Query: 177 IYEYFVCQRHLCICFELLD-SNLYELIK-------INHFRGLSLSI---VQLFSKQILRG 225
           I +       + + F   D SNLY +++        +H R +        + ++ QI+  
Sbjct: 89  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT 148
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +PE++
Sbjct: 149 FEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEII 205
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           L   Y  A+D W+ G ++ E+  G P F
Sbjct: 206 LSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
           +G G+ G V           VAVK +  +    ++ L  EV I+    + Y  E+   +V
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 91
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +Y  ++    L +  E L+      I + H R ++   +      +L+ LS+L   G+I
Sbjct: 92  EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLQALSVLHAQGVI 149
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
           H D+K ++ILL        +K+ DFG      + V      + + Y+ +PE++    Y  
Sbjct: 150 HRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 293 AIDMWSFGCIVAELFLGLP 311
            +D+WS G +V E+  G P
Sbjct: 207 EVDIWSLGIMVIEMVDGEP 225

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 113 VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           V++++G G FG V K  W A+    VA+K I+++ +  +  +VE+  L+ +N        
Sbjct: 13  VEEVVGRGAFGVVCKAKWRAK---DVAIKQIESE-SERKAFIVELRQLSRVNHP------ 62
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIK----INHFRGLSLSIVQLFSKQILRGL 226
            +IV++Y    C   +C+  E  +  +LY ++     + ++         L   Q +  L
Sbjct: 63  -NIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
             ++   +IH DLKP N+LL        +KI DFG+AC     + +   S  + +PEV  
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 177
Query: 287 GYQYTTAIDMWSFGCIVAELF 307
           G  Y+   D++S+G I+ E+ 
Sbjct: 178 GSNYSEKCDVFSWGIILWEVI 198

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 107/245 (43%), Gaps = 20/245 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VA+KII K Q  P   Q+   EV I+  LN         +
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP-------N 72
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-RQIVSAVQYCHQKR 131
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL   +    IKI DFG  +  T    + ++  S  Y +PE+  G +Y 
Sbjct: 132 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA-QPPDYVLKEAKNTSKFFK 349
              +D+WS G I+  L  G   F G +  +L  R++R  G  + P Y+  + +N  K F 
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCENLLKRFL 246
Query: 350 CIGSV 354
            +  +
Sbjct: 247 VLNPI 251

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 27/233 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY + ++LG G   +V    D   +  VAVK+++      P++Y +   E      LN  
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 166 YDREDKHHIVRIYEYFVCQRHLC----ICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
                   IV +Y+    +        I  E +D     L  I H  G ++         
Sbjct: 73  A-------IVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPKRAIEVIA 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTED-----RTVYSYI 274
              + L+     GIIH D+KP NIL+  +     +K++DFG A    D         + I
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILISAT---NAVKVVDFGIARAIADSGNSVXQTAAVI 180
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
            +  Y SPE   G       D++S GC++ E+  G P F G S   +  + +R
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
            LG G F +  +  DA+     A KI+      +P   ++  +E+SI  +L  +      
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ------ 75
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            H+V  + +F     + +  EL    +L EL K    + L+    + + +QI+ G   L 
Sbjct: 76  -HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH 132
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPEVL 285
              +IH DLK  N+ L   +   E+KI DFG A       E + V     +  Y +PEVL
Sbjct: 133 RNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKVLCGTPN--YIAPEVL 187
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
               ++  +D+WS GCI+  L +G P F
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 109/261 (41%), Gaps = 49/261 (18%)
Query: 117 LGHGTFGQVAKCWDA------EMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDR 168
           LG G FGQV +  DA           VAVK++K    +  ++  + E+ IL  +      
Sbjct: 35  LGRGAFGQVIEA-DAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG----- 88
Query: 169 EDKHHIVRIYEYFVCQRH---LCICFELLD-SNL--YELIKINHF--------RGLSLSI 214
              HH+  +     C +    L +  E     NL  Y   K N F          L+L  
Sbjct: 89  ---HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY--- 271
           +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R +Y   
Sbjct: 146 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLA----RDIYKDP 198
Query: 272 SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLLR 323
            Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   + +  R
Sbjct: 199 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXR 258
Query: 324 RMIRILGAQPPDYVLKEAKNT 344
           R+      + PDY   E   T
Sbjct: 259 RLKEGTRMRAPDYTTPEMYQT 279

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+++    +   I++ DFG A       +    +  Y +PE+++   Y
Sbjct: 159 SLDLIYRDLKPENLIID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K      Q  L E +++ TL     + DK  +
Sbjct: 20  LGAGQFGEV---WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-----QHDK--L 69
Query: 175 VRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           VR+Y     +  + I  E +   +L + +K +    + L  +  FS QI  G++ ++   
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL+  N+L+  S+     KI DFG A   ED    +   +++   + +PE +    
Sbjct: 130 YIHRDLRAANVLVSESLM---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
           +T   ++WSFG ++ E+   G   +PG +  D++
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVM 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSI---LTTLNK 164
           Y VK+ +G G++    +C     N   AVKII   K  P    + L+       + TL  
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
            YD          Y Y V +  L    ELLD    ++++   F     S V LF+  I +
Sbjct: 84  VYDDGK-------YVYVVTE--LMKGGELLD----KILRQKFFSEREASAV-LFT--ITK 127
Query: 225 GLSLLKDAGIIHCDLKPENILLCT-SVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYR 280
            +  L   G++H DLKP NIL    S  P  I+I DFG A     E+  + +   +  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRM 325
           +PEVL    Y  A D+WS G ++  +  G   F   P  +  ++L R+
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
           +G G+ G V           VAVK +  +    ++ L  EV I+    + Y  E+   +V
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 89
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +Y  ++    L +  E L+      I + H R ++   +      +L+ LS+L   G+I
Sbjct: 90  EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLQALSVLHAQGVI 147
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
           H D+K ++ILL        +K+ DFG      + V      + + Y+ +PE++    Y  
Sbjct: 148 HRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 293 AIDMWSFGCIVAELFLGLP 311
            +D+WS G +V E+  G P
Sbjct: 205 EVDIWSLGIMVIEMVDGEP 223

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 27  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 76
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 77  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 133
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 134 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 190
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 239

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 26  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 75
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 76  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 132
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 133 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 189
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 33/236 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY + ++LG G   +V    D  ++  VAVK+++      P++Y +   E      LN  
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 166 YDREDKHHIVRIYEYFVCQRHLC----ICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
                   IV +Y     +        I  E +D     L  I H  G ++         
Sbjct: 73  A-------IVAVYATGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPKRAIEVIA 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVY 271
              + L+     GIIH D+KP NI++  +     +K++DFG A          T+   V 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Q   Y SPE   G       D++S GC++ E+  G P F G S   +  + +R
Sbjct: 181 GTAQ---YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +GHG+FG V    D   +  VA+K +    K     +Q  + EV  L  L        +H
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL--------RH 74
Query: 173 HIVRIYEYFVCQRHLC-ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
                Y     + H   +  E    +  +L+++ H + L    +   +   L+GL+ L  
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY--- 288
             +IH D+K  NILL    +P  +K+ DFGSA         ++ + Y+ +PEV+L     
Sbjct: 134 HNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM-APANXFVGTPYWMAPEVILAMDEG 189
Query: 289 QYTTAIDMWSFGCIVAEL 306
           QY   +D+WS G    EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 22/228 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G GT GQV K    +    +AVK ++      +       IL  L+      D  +IV+
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK----RILMDLDVVLKSHDCPYIVQ 88
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILRGLSLLKDA-GI 234
            +  F+    + I  EL+ +   +L K    +G +   I+   +  I++ L  LK+  G+
Sbjct: 89  CFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVL-----LG 287
           IH D+KP NILL    +  +IK+ DFG +    +D+          Y +PE +       
Sbjct: 147 IHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 288 YQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPP 334
             Y    D+WS G  + EL  G  P     ++F++L    ++L  +PP
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL---TKVLQEEPP 248

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 17/233 (7%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ-QALVEVSILTTLNK 164
           E  ++Y  KD++G G    V +C         AVKI++        + L EV   T    
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 165 KYDRE--DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQ 221
              R+     HI+ + + +     + + F+L+     EL   +     LS    +   + 
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG--ELFDYLTEKVALSEKETRSIMRS 208
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYY 279
           +L  +S L    I+H DLKPENILL  ++   +I++ DFG +C  +    +     +  Y
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNM---QIRLSDFGFSCHLEPGEKLRELCGTPGY 265
Query: 280 RSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            +PE+L          Y   +D+W+ G I+  L  G P F    +  +LR ++
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 23  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 72
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 73  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 129
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 130 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY 186
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 235

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
           +G G+ G V           VAVK +  +    ++ L  EV I+    + Y  E+   +V
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 84
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +Y  ++    L +  E L+      I + H R ++   +      +L+ LS+L   G+I
Sbjct: 85  EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLQALSVLHAQGVI 142
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
           H D+K ++ILL        +K+ DFG      + V      + + Y+ +PE++    Y  
Sbjct: 143 HRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 293 AIDMWSFGCIVAELFLGLP 311
            +D+WS G +V E+  G P
Sbjct: 200 EVDIWSLGIMVIEMVDGEP 218

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y++ D LG GTFG+V           VAVKI+  Q       + ++      N K  R  
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHP 71
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             HI+++Y+         +  E +    L++ I   H R   +   +LF +QIL  +   
Sbjct: 72  --HIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLF-QQILSAVDYC 127
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLG 287
               ++H DLKPEN+LL   +     KI DFG  +  ++   + +   S  Y +PEV+ G
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 288 YQYTT-AIDMWSFGCIVAELFLG 309
             Y    +D+WS G I+  L  G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 113 VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           V++++G G FG V K  W A+    VA+K I+++ +  +  +VE+  L+ +N        
Sbjct: 12  VEEVVGRGAFGVVCKAKWRAKD---VAIKQIESE-SERKAFIVELRQLSRVNHP------ 61
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIK----INHFRGLSLSIVQLFSKQILRGL 226
            +IV++Y    C   +C+  E  +  +LY ++     + ++         L   Q +  L
Sbjct: 62  -NIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
             ++   +IH DLKP N+LL        +KI DFG+AC     + +   S  + +PEV  
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 176
Query: 287 GYQYTTAIDMWSFGCIVAELF 307
           G  Y+   D++S+G I+ E+ 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVI 197

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E ++   +L++ I       L   + + F
Sbjct: 67  KVSSGFS-----GVIRLLDWFERPDSFVLILERMEPVQDLFDFI--TERGALQEELARSF 119
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 177
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 21  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 70
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 71  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 128 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
           +G G+ G V           VAVK +  +    ++ L  EV I+    + Y  E+   +V
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 80
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
            +Y  ++    L +  E L+      I + H R ++   +      +L+ LS+L   G+I
Sbjct: 81  EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLQALSVLHAQGVI 138
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
           H D+K ++ILL        +K+ DFG      + V      + + Y+ +PE++    Y  
Sbjct: 139 HRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 293 AIDMWSFGCIVAELFLGLP 311
            +D+WS G +V E+  G P
Sbjct: 196 EVDIWSLGIMVIEMVDGEP 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 22  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 71
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 72  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 128
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 129 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINY 185
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 234

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 33/236 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY + ++LG G   +V    D  ++  VAVK+++      P++Y +   E      LN  
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 89
Query: 166 YDREDKHHIVRIYEYFVCQRHLC----ICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
                   IV +Y+    +        I  E +D     L  I H  G ++         
Sbjct: 90  A-------IVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPKRAIEVIA 140
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVY 271
              + L+     GIIH D+KP NI++  +     +K++DFG A          T+   V 
Sbjct: 141 DACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVI 197
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Q   Y SPE   G       D++S GC++ E+  G P F G S   +  + +R
Sbjct: 198 GTAQ---YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 250

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +  Y +P ++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKC-WDA---EMNSFVAVKIIKNQ-PAYYQQALVEVSILT 160
           E   +YI +  LG G FG V  C +D       + VAVK +++  P   +    E+ IL 
Sbjct: 10  ERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 161 TLNKKYDREDKHHIV--RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLF 218
            L+  +       IV  R   Y   ++ L +  E L S         H   L  S + L+
Sbjct: 68  ALHSDF-------IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 120
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
           S QI +G+  L     +H DL   NIL+ +    A +KI DFG A     D+  Y   + 
Sbjct: 121 SSQICKGMEYLGSRRCVHRDLAARNILVESE---AHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 277 R----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
                ++ +PE L    ++   D+WSFG ++ ELF
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 110/265 (41%), Gaps = 57/265 (21%)
Query: 117 LGHGTFGQVAKCWDAEMNSF----------VAVKIIKNQPAY--YQQALVEVSILTTLNK 164
           LG G FGQV      E ++F          VAVK++K    +  ++  + E+ IL  +  
Sbjct: 35  LGRGAFGQVI-----EADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG- 88
Query: 165 KYDREDKHHIVRIYEYFVCQRH---LCICFELLD-SNL--YELIKINHF--------RGL 210
                  HH+  +     C +    L +  E     NL  Y   K N F          L
Sbjct: 89  -------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R +
Sbjct: 142 TLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLA----RDI 194
Query: 271 Y---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EF 319
           Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   + 
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 254
Query: 320 DLLRRMIRILGAQPPDYVLKEAKNT 344
           +  RR+      + PDY   E   T
Sbjct: 255 EFCRRLKEGTRMRAPDYTTPEMYQT 279

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKC-WDA---EMNSFVAVKIIKNQ-PAYYQQALVEVSILT 160
           E   +YI +  LG G FG V  C +D       + VAVK +++  P   +    E+ IL 
Sbjct: 9   ERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 161 TLNKKYDREDKHHIV--RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLF 218
            L+  +       IV  R   Y   ++ L +  E L S         H   L  S + L+
Sbjct: 67  ALHSDF-------IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 119
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
           S QI +G+  L     +H DL   NIL+ +    A +KI DFG A     D+  Y   + 
Sbjct: 120 SSQICKGMEYLGSRRCVHRDLAARNILVESE---AHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 277 R----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
                ++ +PE L    ++   D+WSFG ++ ELF
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 55/112 (49%), Gaps = 11/112 (9%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ RG+  L +   +H DL   N +L  S     +K+ DFG A    DR  YS  Q 
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT---VKVADFGLARDILDREYYSVQQH 185
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321
           R+ R P      E L  Y++TT  D+WSFG ++ EL   G P +     FDL
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 21  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 70
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 71  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 128 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VAVKII K Q   +  Q+   EV I+  LN         +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP-------N 74
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKF 133
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL   +    IKI DFG  +  T    + ++  S  Y +PE+  G +Y 
Sbjct: 134 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VAVKII K Q   +  Q+   EV I+  LN         +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP-------N 74
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKF 133
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL   +    IKI DFG  +  T    + ++  S  Y +PE+  G +Y 
Sbjct: 134 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 33/236 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY + ++LG G   +V    D   +  VAVK+++      P++Y +   E      LN  
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 166 YDREDKHHIVRIYEYFVCQRHLC----ICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
                   IV +Y+    +        I  E +D     L  I H  G ++         
Sbjct: 73  A-------IVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPKRAIEVIA 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVY 271
              + L+     GIIH D+KP NI++  +     +K++DFG A          T+   V 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              Q   Y SPE   G       D++S GC++ E+  G P F G S   +  + +R
Sbjct: 181 GTAQ---YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y++ D LG GTFG+V           VAVKI+  Q       + ++      N K  R  
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHP 71
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             HI+++Y+         +  E +    L++ I   H R   +   +LF +QIL  +   
Sbjct: 72  --HIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLF-QQILSAVDYC 127
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLG 287
               ++H DLKPEN+LL   +     KI DFG  +  ++   +     S  Y +PEV+ G
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 288 YQYTT-AIDMWSFGCIVAELFLG 309
             Y    +D+WS G I+  L  G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSI---LTTLNK 164
           Y VK+ +G G++    +C     N   AVKII   K  P    + L+       + TL  
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
            YD          Y Y V +  L    ELLD    ++++   F     S V LF+  I +
Sbjct: 84  VYDDGK-------YVYVVTE--LXKGGELLD----KILRQKFFSEREASAV-LFT--ITK 127
Query: 225 GLSLLKDAGIIHCDLKPENILLC-TSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYR 280
            +  L   G++H DLKP NIL    S  P  I+I DFG A     E+  + +   +  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRM 325
           +PEVL    Y  A D+WS G ++     G   F   P  +  ++L R+
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARI 235

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 42  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 102 KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 154
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 212
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 249
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 250 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 309
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQT 335

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKC-WDA---EMNSFVAVKIIKNQ-PAYYQQALVEVSILT 160
           E   +YI +  LG G FG V  C +D       + VAVK +++  P   +    E+ IL 
Sbjct: 22  ERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 161 TLNKKYDREDKHHIV--RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLF 218
            L+  +       IV  R   Y   ++ L +  E L S         H   L  S + L+
Sbjct: 80  ALHSDF-------IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
           S QI +G+  L     +H DL   NIL+ +    A +KI DFG A     D+  Y   + 
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESE---AHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 277 R----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
                ++ +PE L    ++   D+WSFG ++ ELF
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 188
Query: 270 VYS---YIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQT 274

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 247
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 248 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 307
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQT 333

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 275 LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 324
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 325 VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 384 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G+FG++    + + N  VA+K+ +N    + Q L E  I   L      +    I  
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRIL------QGGTGIPN 67
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIH 236
           +  + V   +  +  +LL  +L +L      R LSL  V + + Q++  +  +     +H
Sbjct: 68  VRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 237 CDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSR---------YYRSPEVLL 286
            D+KP+N L+    +  ++ IIDFG A    D + + +I  R          Y S    L
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186
Query: 287 GYQYTTAIDMWSFGCIVAELFLG 309
           G + +   D+ S G ++     G
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRG 209

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 83  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 135
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 193
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 16  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 65
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 66  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 122
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 123 RNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 179
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 228

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 83  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 135
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 193
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 68  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 120
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 188
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQT 274

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 240
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 241 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 300
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 301 EEFCRRLKEGTRMRAPDYTTPEMYQT 326

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 242
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQT 328

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  +      
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V++   F    +L +  E +        L +I  F   S    + ++ QI+     L 
Sbjct: 103 -LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
              +I+ DLKPEN+L+    +   I++ DFG A       +    +    +PE++L   Y
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSKGY 215
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
             A+D W+ G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 33/226 (14%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY + ++LG G   +V    D   +  VAVK+++      P++Y +   E      LN  
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 166 YDREDKHHIVRIYEYFVCQRHLC----ICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
                   IV +Y+    +        I  E +D     L  I H  G ++         
Sbjct: 73  A-------IVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPKRAIEVIA 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVY 271
              + L+     GIIH D+KP NI++  +     +K++DFG A          T+   V 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
              Q   Y SPE   G       D++S GC++ E+  G P F G S
Sbjct: 181 GTAQ---YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 82  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 134
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 192
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 199
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 200 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 259
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 260 EEFCRRLKEGTRMRAPDYTTPEMYQT 285

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 107/245 (43%), Gaps = 20/245 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VA+KII K Q  P   Q+   EV I+  LN         +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP-------N 75
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-RQIVSAVQYCHQKR 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL   +    IKI DFG  +  T    + ++  +  Y +PE+  G +Y 
Sbjct: 135 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA-QPPDYVLKEAKNTSKFFK 349
              +D+WS G I+  L  G   F G +  +L  R++R  G  + P Y+  + +N  K F 
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCENLLKRFL 249
Query: 350 CIGSV 354
            +  +
Sbjct: 250 VLNPI 254

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 55  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 114
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 115 KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 167
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 225
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 226 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           LG G FG V    + + +  VA+K++ K+Q        Q   E+ I   L         H
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL---------H 81
Query: 173 H--IVRIYEYFVCQRHLCICFELL-DSNLY-ELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           H  I+R+Y YF  +R + +  E      LY EL K   F     + +    +++   L  
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM---EELADALMY 138
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG----SACTEDRTVYSYIQSRYYRSPEV 284
                +IH D+KPEN+         E+KI DFG    +     +T+   +    Y  PE+
Sbjct: 139 CHGKKVIHRDIKPENL---LLGLKGELKIADFGWSVHAPSLRRKTMCGTLD---YLPPEM 192
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
           + G  +   +D+W  G +  EL +G P F  AS  +  RR++++
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 197
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQT 283

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 83  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 135
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 193
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VAV+II K Q   +  Q+   EV I+  LN         +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP-------N 74
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKF 133
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL   +    IKI DFG  +  T    + ++  S  Y +PE+  G +Y 
Sbjct: 134 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
           ++G G++ +V      + +   A++++K +     +   ++  + T    +++   H  +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFL 115
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V ++  F  +  L    E ++     +  +   R L     + +S +I   L+ L + GI
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
           I+ DLK +N+LL +      IK+ D+G  C E      T  ++  +  Y +PE+L G  Y
Sbjct: 175 IYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 291 TTAIDMWSFGCIVAELFLG 309
             ++D W+ G ++ E+  G
Sbjct: 231 GFSVDWWALGVLMFEMMAG 249

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 82  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 134
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 192
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    R 
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----RD 234
Query: 270 VY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
           +Y    Y++    R      +PE +    YT   D+WSFG ++ E+F LG   +PG   +
Sbjct: 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
            +  RR+      + PDY   E   T
Sbjct: 295 EEFCRRLKEGTRMRAPDYTTPEMYQT 320

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 110 KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 162
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 220
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 96  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 148
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 108/263 (41%), Gaps = 51/263 (19%)
Query: 117 LGHGTFGQVAKCWDAEMNSF----------VAVKIIKNQPAY--YQQALVEVSILTTLNK 164
           LG G FGQV      E ++F          VAVK++K    +  ++  + E+ IL  +  
Sbjct: 37  LGRGAFGQVI-----EADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG- 90
Query: 165 KYDREDKHHIVRIYEYFVCQRH---LCICFELLD-SNL--YELIKINHF----------R 208
                  HH+  +     C +    L +  E     NL  Y   K N F           
Sbjct: 91  -------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 209 GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTE 266
            L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    +
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXK 200
Query: 267 DRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDL 321
           D        +R    + +PE +    YT   D+WSFG ++ E+F LG   +PG   + + 
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 322 LRRMIRILGAQPPDYVLKEAKNT 344
            RR+      + PDY   E   T
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQT 283

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 96  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 148
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 110/259 (42%), Gaps = 57/259 (22%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN-----SFVAVKIIKNQ--PAYYQQALVEVSILT 160
           ++  ++   LG G FG+V K     +      + VAVK++K    P+  +  L E ++L 
Sbjct: 22  RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKIN---------- 205
            +N         H++++Y        L +  E      L   L E  K+           
Sbjct: 82  QVNHP-------HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 206 --------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257
                     R L++  +  F+ QI +G+  L +  ++H DL   NIL+    K   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKI 191
Query: 258 IDFGSACTEDRTVY---SYIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELF- 307
            DFG +    R VY   SY++    R P      E L  + YTT  D+WSFG ++ E+  
Sbjct: 192 SDFGLS----RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 308 LG---LPLFPGASEFDLLR 323
           LG    P  P    F+LL+
Sbjct: 248 LGGNPYPGIPPERLFNLLK 266

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 96  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 148
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 95  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 147
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 95  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 147
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 95  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 147
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 96  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 148
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T   + V  ++G G FG+V  C  A+     A+K +  +    +Q    AL E  +L+ +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSK 220
           +      D   IV +   F     L    +L++     Y L +   F   S + ++ ++ 
Sbjct: 247 STG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAA 299
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYY 279
           +I+ GL  + +  +++ DLKP NILL    +   ++I D G AC    +  ++ + +  Y
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGTHGY 356
Query: 280 RSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPD 335
            +PEVL  G  Y ++ D +S GC++ +L  G   F      D   + RM   +  + PD
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T   + V  ++G G FG+V  C  A+     A+K +  +    +Q    AL E  +L+ +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSK 220
           +      D   IV +   F     L    +L++     Y L +   F   S + ++ ++ 
Sbjct: 246 STG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAA 298
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYY 279
           +I+ GL  + +  +++ DLKP NILL    +   ++I D G AC    +  ++ + +  Y
Sbjct: 299 EIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGTHGY 355
Query: 280 RSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPD 335
            +PEVL  G  Y ++ D +S GC++ +L  G   F      D   + RM   +  + PD
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 414

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VAVKII K Q   +  Q+   EV I+  LN         +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP-------N 74
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKF 133
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL   +    IKI DFG  +  T    + ++  +  Y +PE+  G +Y 
Sbjct: 134 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 30  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 89
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 90  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 142
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 143 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 200
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 36/235 (15%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKII----------KNQPAYYQQALVEVSILTTLN 163
           K++LG G    V +C         AVKII          +      +  L EV IL  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                    +I+++ + +       + F+L+        ++  +    +++ +  +++I+
Sbjct: 82  ------GHPNIIQLKDTYETNTFFFLVFDLMKKG-----ELFDYLTEKVTLSEKETRKIM 130
Query: 224 RGL----SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSR 277
           R L      L    I+H DLKPENILL   +    IK+ DFG +C  D    + S   + 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLRSVCGTP 187
Query: 278 YYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            Y +PE++          Y   +DMWS G I+  L  G P F    +  +LR ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
           ++G G++ +V      + +   A+K++K +     +   ++  + T    +++   H  +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFL 72
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V ++  F  +  L    E ++     +  +   R L     + +S +I   L+ L + GI
Sbjct: 73  VGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
           I+ DLK +N+LL +      IK+ D+G  C E      T   +  +  Y +PE+L G  Y
Sbjct: 132 IYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 291 TTAIDMWSFGCIVAELFLG 309
             ++D W+ G ++ E+  G
Sbjct: 188 GFSVDWWALGVLMFEMMAG 206

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VAV+II K Q   +  Q+   EV I+  LN         +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP-------N 74
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKF 133
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL   +    IKI DFG  +  T    +  +  S  Y +PE+  G +Y 
Sbjct: 134 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 95  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 147
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 278 YYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 68  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 120
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 113 VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +++++G G FG+V +  W   +   VAVK  ++ P       +E   +    K +     
Sbjct: 11  LEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIEN--VRQEAKLFAMLKH 65
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
            +I+ +    + + +LC+  E        L ++   + +   I+  ++ QI RG++ L D
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGG--PLNRVLSGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 232 AGI---IHCDLKPENILLCTSVKPAEI-----KIIDFGSACTEDRTVYSYIQSRY-YRSP 282
             I   IH DLK  NIL+   V+  ++     KI DFG A    RT        Y + +P
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAP 183
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
           EV+    ++   D+WS+G ++ EL  G   F G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 110 KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 162
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 220
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 123 GQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180
           GQ  + W    N  + VAVK +K         L E +++  L  +        +VR+Y  
Sbjct: 24  GQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RLVRLYA- 75
Query: 181 FVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKDAGIIHC 237
            V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++   IH 
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 238 DLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQYTTA 293
           DL+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +    +T  
Sbjct: 134 DLRAANILVSDTLS---CKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 294 IDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
            D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           YI+ D LG GTFG+V           VAVKI+  Q       + ++      N K  R  
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHP 76
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
             HI+++Y+       + +  E +    L++ I  N  R       +LF +QIL G+   
Sbjct: 77  --HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLF-QQILSGVDYC 132
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLG 287
               ++H DLKPEN+LL   +     KI DFG  +  ++   +     S  Y +PEV+ G
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 288 YQYT-TAIDMWSFGCIVAELFLG 309
             Y    +D+WS G I+  L  G
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCG 212

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 68  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 120
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 67  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 119
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 177
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VAVK +K         L E +++  L  +        +
Sbjct: 17  LGAGQFGEV---WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-------RL 66
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF--SKQILRGLSLLKD 231
           VR+Y   V Q  + I  E +++ +L + +K     G+ L+I +L   + QI  G++ +++
Sbjct: 67  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 123
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
              IH +L+  NIL+  ++     KI DFG A   ED    +   +++   + +PE +  
Sbjct: 124 RNYIHRNLRAANILVSDTLS---CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 180
Query: 288 YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335
             +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 229

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
           ++G G++ +V      + +   A+K++K +     +   ++  + T    +++   H  +
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFL 68
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V ++  F  +  L    E ++     +  +   R L     + +S +I   L+ L + GI
Sbjct: 69  VGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 127
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
           I+ DLK +N+LL +      IK+ D+G  C E      T   +  +  Y +PE+L G  Y
Sbjct: 128 IYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 291 TTAIDMWSFGCIVAELFLG 309
             ++D W+ G ++ E+  G
Sbjct: 184 GFSVDWWALGVLMFEMMAG 202

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
           ++G G++ +V      + +   A+K++K +     +   ++  + T    +++   H  +
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFL 83
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V ++  F  +  L    E ++     +  +   R L     + +S +I   L+ L + GI
Sbjct: 84  VGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 142
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
           I+ DLK +N+LL +      IK+ D+G  C E      T   +  +  Y +PE+L G  Y
Sbjct: 143 IYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 291 TTAIDMWSFGCIVAELFLG 309
             ++D W+ G ++ E+  G
Sbjct: 199 GFSVDWWALGVLMFEMMAG 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG+V      +     A+K +  Q        +    E+ I+  L   +      
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF------ 76
Query: 173 HIVRIYEYFVCQRHLCICFELL--DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
            +V ++  F  +  + +  +LL      Y L +  HF+      V+LF  +++  L  L+
Sbjct: 77  -LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE---ETVKLFICELVMALDYLQ 132
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVL--- 285
           +  IIH D+KP+NILL    +   + I DF  A    R   + +   ++ Y +PE+    
Sbjct: 133 NQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189
Query: 286 LGYQYTTAIDMWSFGCIVAELFLG 309
            G  Y+ A+D WS G    EL  G
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T   + V  ++G G FG+V  C  A+     A+K +  +    +Q    AL E  +L+ +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSK 220
           +      D   IV +   F     L    +L++     Y L +   F   S + ++ ++ 
Sbjct: 247 STG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAA 299
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYY 279
           +I+ GL  + +  +++ DLKP NILL    +   ++I D G AC    +  ++ + +  Y
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGTHGY 356
Query: 280 RSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPD 335
            +PEVL  G  Y ++ D +S GC++ +L  G   F      D   + RM   +  + PD
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
           T   + V  ++G G FG+V  C  A+     A+K +  +    +Q    AL E  +L+ +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSK 220
           +      D   IV +   F     L    +L++     Y L +   F   S + ++ ++ 
Sbjct: 247 STG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAA 299
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYY 279
           +I+ GL  + +  +++ DLKP NILL    +   ++I D G AC    +  ++ + +  Y
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGTHGY 356
Query: 280 RSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPD 335
            +PEVL  G  Y ++ D +S GC++ +L  G   F      D   + RM   +  + PD
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 108/264 (40%), Gaps = 52/264 (19%)
Query: 117 LGHGTFGQVAKCWDAEMNSF----------VAVKIIKNQPAY--YQQALVEVSILTTLNK 164
           LG G FGQV      E ++F          VAVK++K    +  ++  + E+ IL  +  
Sbjct: 36  LGRGAFGQVI-----EADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG- 89
Query: 165 KYDREDKHHIVRIYEYFVCQRH---LCICFELLD-SNL--YELIKINHF----------- 207
                  HH+  +     C +    L +  E     NL  Y   K N F           
Sbjct: 90  -------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYK 142
Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CT 265
             L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIX 199
Query: 266 EDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFD 320
           +D        +R    + +PE +    YT   D+WSFG ++ E+F LG   +PG   + +
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 321 LLRRMIRILGAQPPDYVLKEAKNT 344
             RR+      + PDY   E   T
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQT 283

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTED 267
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    +D
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKD 192
Query: 268 RTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLL 322
                   +R    + +PE +    YT   D+WSFG ++ E+F LG   +PG   + +  
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
Query: 323 RRMIRILGAQPPDYVLKEAKNT 344
           RR+      + PDY   E   T
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQT 274

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTED 267
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    +D
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKD 192
Query: 268 RTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLL 322
                   +R    + +PE +    YT   D+WSFG ++ E+F LG   +PG   + +  
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
Query: 323 RRMIRILGAQPPDYVLKEAKNT 344
           RR+      + PDY   E   T
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQT 274

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 17/217 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VAVKII       +  Q+   EV I   LN         +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP-------N 74
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           IV+++E    ++ L +  E           + H R         F +QI+  +       
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF-RQIVSAVQYCHQKF 133
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
           I+H DLK EN+LL        IKI DFG  +  T    + ++  +  Y +PE+  G +Y 
Sbjct: 134 IVHRDLKAENLLLDAD---XNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 292 T-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
           + + +LG+G+ G V         SF    VAVK  +    +   AL+E+ +LT      +
Sbjct: 36  VSEKILGYGSSGTVV-----FQGSFQGRPVAVK--RMLIDFCDIALMEIKLLT------E 82
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS-----KQI 222
            +D  +++R Y      R L I  EL + NL +L++  +    +L + + ++     +QI
Sbjct: 83  SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTS----------VKPAEIKIIDFGSACTEDRTVYS 272
             G++ L    IIH DLKP+NIL+ TS           +   I I DFG     D     
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 273 YIQSRY-------YRSPEVL---LGYQYTTAIDMWSFGCI 302
           +  +         +R+PE+L      + T +ID++S GC+
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
           + + +LG+G+ G V         SF    VAVK  +    +   AL+E+ +LT      +
Sbjct: 36  VSEKILGYGSSGTVV-----FQGSFQGRPVAVK--RMLIDFCDIALMEIKLLT------E 82
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS-----KQI 222
            +D  +++R Y      R L I  EL + NL +L++  +    +L + + ++     +QI
Sbjct: 83  SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTS----------VKPAEIKIIDFGSACTEDRTVYS 272
             G++ L    IIH DLKP+NIL+ TS           +   I I DFG     D     
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 273 YIQSRY-------YRSPEVL---LGYQYTTAIDMWSFGCI 302
           +  +         +R+PE+L      + T +ID++S GC+
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 63  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 115
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 173
Query: 278 YYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTED 267
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    +D
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKD 201
Query: 268 RTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLL 322
                   +R    + +PE +    YT   D+WSFG ++ E+F LG   +PG   + +  
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 323 RRMIRILGAQPPDYVLKEAKNT 344
           RR+      + PDY   E   T
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQT 283

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRG-LSLSIVQL 217
            ++  +       ++R+ ++F       +  E  +   +L++ I     RG L   + + 
Sbjct: 63  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARS 114
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQS 276
           F  Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGT 172
Query: 277 RYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLG 309
           R Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 6   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 65
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLF 218
            ++  +       ++R+ ++F       +  E  +   +L++ I       L   + + F
Sbjct: 66  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSF 118
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQSR 277
             Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +R
Sbjct: 119 FWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTR 176
Query: 278 YYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLG 309
            Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKC-WDA---EMNSFVAVKIIKNQ-PAYYQQALVEVSILT 160
           E   +YI +  LG G FG V  C +D       + VAVK +++  P   +    E+ IL 
Sbjct: 6   ERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 161 TLNKKYDREDKHHIV--RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLF 218
            L+  +       IV  R   Y   +  L +  E L S         H   L  S + L+
Sbjct: 64  ALHSDF-------IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 116
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYI 274
           S QI +G+  L     +H DL   NIL+ +    A +KI DFG A      +D  V    
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESE---AHVKIADFGLAKLLPLDKDXXVVREP 173
Query: 275 QSR--YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
                ++ +PE L    ++   D+WSFG ++ ELF
Sbjct: 174 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKII----------KNQPAYYQQALVEVSILTTLN 163
           K++LG G    V +C         AVKII          +      +  L EV IL  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                    +I+++ + +       + F+L+        ++  +    +++ +  +++I+
Sbjct: 82  ------GHPNIIQLKDTYETNTFFFLVFDLMKKG-----ELFDYLTEKVTLSEKETRKIM 130
Query: 224 RGL----SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSR 277
           R L      L    I+H DLKPENILL   +    IK+ DFG +C  D    +     + 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 278 YYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            Y +PE++          Y   +DMWS G I+  L  G P F    +  +LR ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           V++Y     +    +C  +   +L + +K    + L L  +   + QI  G++ ++    
Sbjct: 76  VQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  ++
Sbjct: 136 VHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 291 TTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL-------VEVSILT 160
           + +Y V  LLG G FG V        N  VA+K ++         L       +EV +L 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--SNLYELIKINHFRG-LSLSIVQL 217
            ++  +       ++R+ ++F       +  E  +   +L++ I     RG L   + + 
Sbjct: 63  KVSSGFS-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARS 114
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-YIQS 276
           F  Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+ +  +
Sbjct: 115 FFWQVLEAVRHCHNXGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGT 172
Query: 277 RYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLG 309
           R Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y +++++G G    V   + A     VA+K I  +         + S+   L +      
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-------QTSMDELLKEIQAMSQ 64
Query: 171 KHH--IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRG------LSLSIVQLFSKQ 221
            HH  IV  Y  FV +  L +  +LL   ++ ++IK    +G      L  S +    ++
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--------TEDRTVYSY 273
           +L GL  L   G IH D+K  NILL    +   ++I DFG +         T ++   ++
Sbjct: 125 VLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 274 IQSRYYRSPEVL---LGYQYTTAIDMWSFGCIVAELFLG 309
           + +  + +PEV+    GY +    D+WSFG    EL  G
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKA--DIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           Y +++++G G    V   + A     VA+K I  +         + S+   L +      
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-------QTSMDELLKEIQAMSQ 69
Query: 171 KHH--IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRG------LSLSIVQLFSKQ 221
            HH  IV  Y  FV +  L +  +LL   ++ ++IK    +G      L  S +    ++
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--------TEDRTVYSY 273
           +L GL  L   G IH D+K  NILL    +   ++I DFG +         T ++   ++
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 274 IQSRYYRSPEVL---LGYQYTTAIDMWSFGCIVAELFLG 309
           + +  + +PEV+    GY +    D+WSFG    EL  G
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKA--DIWSFGITAIELATG 223

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 49/232 (21%)
Query: 108 QRRYIVKDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQAL-VEVSILTT 161
           +R  ++K  LG G FG+V  A+C +    +    VAVK +K      +Q    E  +LT 
Sbjct: 40  RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 99
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINH------FRG------ 209
           L  +       HIVR +      R L + FE +          +H        G      
Sbjct: 100 LQHQ-------HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 210 --LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267
             L L  +   + Q+  G+  L     +H DL   N L+   +    +KI DFG +    
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV---VKIGDFGMS---- 205
Query: 268 RTVYSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
           R +YS   + YYR             PE +L  ++TT  D+WSFG ++ E+F
Sbjct: 206 RDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTED 267
           L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A    +D
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKD 201
Query: 268 RTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLL 322
                   +R    + +PE +    YT   D+WSFG ++ E+F LG   +PG   + +  
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 323 RRMIRILGAQPPDYVLKEAKNT 344
           RR+      + PDY   E   T
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQT 283

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 108 QRRYI--VKDLLGHGTFGQVA-KCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSIL 159
            +RY+  ++DL G G FG+V+  C+D   +     VAVK +K    P +      E+ IL
Sbjct: 29  HKRYLKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFR------GLSLS 213
            TL  +       HI++      C+       +L+     E + +   R       + L+
Sbjct: 88  RTLYHE-------HIIKYKG--CCEDAGAASLQLV----MEYVPLGSLRDYLPRHSIGLA 134
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY 271
            + LF++QI  G++ L     IH DL   N+LL        +KI DFG   A  E    Y
Sbjct: 135 QLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEXY 191
Query: 272 SYIQS----RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
              +      ++ +PE L  Y++  A D+WSFG  + EL 
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 49/255 (19%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN-----SFVAVKIIKNQ--PAYYQQALVEVSILT 160
           ++  ++   LG G FG+V K     +      + VAVK++K    P+  +  L E ++L 
Sbjct: 22  RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKIN---------- 205
            +N         H++++Y        L +  E      L   L E  K+           
Sbjct: 82  QVNHP-------HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 206 --------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257
                     R L++  +  F+ QI +G+  L +  ++H DL   NIL+    K   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRK---MKI 191
Query: 258 IDFGSA--CTEDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LG-- 309
            DFG +    E+ +     Q R    + + E L  + YTT  D+WSFG ++ E+  LG  
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 310 -LPLFPGASEFDLLR 323
             P  P    F+LL+
Sbjct: 252 PYPGIPPERLFNLLK 266

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 48/225 (21%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
           + + +LG+G+ G V         SF    VAVK  +    +   AL+E+ +LT      +
Sbjct: 18  VSEKILGYGSSGTVVF-----QGSFQGRPVAVK--RMLIDFCDIALMEIKLLT------E 64
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS-----KQI 222
            +D  +++R Y      R L I  EL + NL +L++  +    +L + + ++     +QI
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTS----------VKPAEIKIIDFGSACTEDRTVYS 272
             G++ L    IIH DLKP+NIL+ TS           +   I I DFG  C +  +  S
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG-LCKKLDSGQS 183
Query: 273 YIQSRY--------YRSPEVL-------LGYQYTTAIDMWSFGCI 302
             ++          +R+PE+L          + T +ID++S GC+
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 69
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 70  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 121 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKII----------KNQPAYYQQALVEVSILTTLN 163
           K++LG G    V +C         AVKII          +      +  L EV IL  ++
Sbjct: 9   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 68
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                    +I+++ + +       + F+L+        ++  +    +++ +  +++I+
Sbjct: 69  ------GHPNIIQLKDTYETNTFFFLVFDLMKKG-----ELFDYLTEKVTLSEKETRKIM 117
Query: 224 RGL----SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSR 277
           R L      L    I+H DLKPENILL   +    IK+ DFG +C  D    +     + 
Sbjct: 118 RALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTP 174
Query: 278 YYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            Y +PE++          Y   +DMWS G I+  L  G P F    +  +LR ++
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVKI+K     P  +Q    EV++L        R+ +H
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKILKVVDPTPEQFQAFRNEVAVL--------RKTRH 91
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  ++ + +L I  +  + S+LY+ + +   +     ++ + ++Q  +G+  L  
Sbjct: 92  VNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDI-ARQTAQGMDYLHA 150
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLL 286
             IIH D+K  NI L   +    +KI DFG A  + R      V     S  + +PEV+ 
Sbjct: 151 KNIIHRDMKSNNIFLHEGLT---VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 ++   D++S+G ++ EL  G
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 49/255 (19%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN-----SFVAVKIIKNQ--PAYYQQALVEVSILT 160
           ++  ++   LG G FG+V K     +      + VAVK++K    P+  +  L E ++L 
Sbjct: 22  RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKIN---------- 205
            +N         H++++Y        L +  E      L   L E  K+           
Sbjct: 82  QVNHP-------HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 206 --------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257
                     R L++  +  F+ QI +G+  L +  ++H DL   NIL+    K   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKI 191
Query: 258 IDFGSA--CTEDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LG-- 309
            DFG +    E+ +     Q R    + + E L  + YTT  D+WSFG ++ E+  LG  
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 310 -LPLFPGASEFDLLR 323
             P  P    F+LL+
Sbjct: 252 PYPGIPPERLFNLLK 266

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 50/233 (21%)
Query: 108 QRRYIVKDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKN-QPAYYQQALVEVSILTT 161
           +R  ++K  LG G FG+V  A+C++    +    VAVK +K+   A  +    E  +LT 
Sbjct: 14  RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 73
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELL---DSNLY-------ELIKIN----HF 207
           L  +       HIV+ Y        L + FE +   D N +        +I ++      
Sbjct: 74  LQHE-------HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 208 RG-LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
           +G L LS +   + QI  G+  L     +H DL   N L+  ++    +KI DFG +   
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFGMS--- 180
Query: 267 DRTVYSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
            R VYS   + YYR             PE ++  ++TT  D+WSFG I+ E+F
Sbjct: 181 -RDVYS---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 23  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 72
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E ++  +L + +K    + L L  +   S QI  G++ ++   
Sbjct: 73  VQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 132 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 188
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 189 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 23  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 72
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E ++  +L + +K    + L L  +   S QI  G++ ++   
Sbjct: 73  VQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 132 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGR 188
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 189 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           +++Y   + +G G  G V    D      VA++ +  Q    ++ ++ E+ ++       
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM------- 71
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            RE+K+ +IV   + ++    L +  E L      L  +     +    +    ++ L+ 
Sbjct: 72  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSP 282
           L  L    +IH D+K +NILL        +K+ DFG       E     + + + Y+ +P
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           EV+    Y   +D+WS G +  E+  G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
           Y V  ++G G FG+V            A+K++       ++  A++ +   E  I+   N
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 133
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
             +       +V+++  F   ++L +  E +     +L+ +     +     + ++ +++
Sbjct: 134 SPW-------VVQLFCAFQDDKYLYMVMEYMPGG--DLVNLMSNYDVPEKWAKFYTAEVV 184
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY----Y 279
             L  +   G+IH D+KP+N+LL    K   +K+ DFG+    D T   +  +      Y
Sbjct: 185 LALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY 241
Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
            SPEVL      GY Y    D WS G  + E+ +G
Sbjct: 242 ISPEVLKSQGGDGY-YGRECDWWSVGVFLFEMLVG 275

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 76  VQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 135 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR 191
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII-KNQ--PAYYQQALVEVSILTTLNKKYDREDKHH 173
           +G G F +V           VAVKII K Q   +  Q+   EV I+  LN         +
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP-------N 67
Query: 174 IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
           IV+++E    ++ L +  E      +++ +  + +     +  +   +QI+  +      
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF--RQIVSAVQYCHQK 125
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
            I+H DLK EN+LL   +    IKI DFG  +  T    + ++  S  Y +PE+  G +Y
Sbjct: 126 FIVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 291 TT-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
               +D+WS G I+  L  G   F G +  +L  R++R
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 220

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 107 TQRRYIVKDLLGHGTFGQV--AKCW-DAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTL 162
           T   + ++  +G G F +V  A C  D    +   V+I     A  +   + E+ +L  L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSI----VQL 217
           N         ++++ Y  F+    L I  EL D+ +L  +IK  HF+     I    V  
Sbjct: 90  NHP-------NVIKYYASFIEDNELNIVLELADAGDLSRMIK--HFKKQKRLIPERTVWK 140
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVYSYIQ 275
           +  Q+   L  +    ++H D+KP N+ +  +  VK  ++ +  F S+ T     +S + 
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVG 198
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
           + YY SPE +    Y    D+WS GC++ E+
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 49/232 (21%)
Query: 108 QRRYIVKDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQAL-VEVSILTT 161
           +R  ++K  LG G FG+V  A+C +    +    VAVK +K      +Q    E  +LT 
Sbjct: 11  RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 70
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINH------FRG------ 209
           L  +       HIVR +      R L + FE +          +H        G      
Sbjct: 71  LQHQ-------HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 123
Query: 210 --LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267
             L L  +   + Q+  G+  L     +H DL   N   C   +   +KI DFG +    
Sbjct: 124 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN---CLVGQGLVVKIGDFGMS---- 176
Query: 268 RTVYSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
           R +YS   + YYR             PE +L  ++TT  D+WSFG ++ E+F
Sbjct: 177 RDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 69
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 70  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 121 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 69
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 70  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 121 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 69
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 70  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 121 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 76  VQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 135 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           +++Y   + +G G  G V    D      VA++ +  Q    ++ ++ E+ ++       
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM------- 71
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            RE+K+ +IV   + ++    L +  E L      L  +     +    +    ++ L+ 
Sbjct: 72  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYS-YIQSRYYRSP 282
           L  L    +IH D+K +NILL        +K+ DFG  +  T +++  S  + + Y+ +P
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAP 185
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           EV+    Y   +D+WS G +  E+  G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 192 LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 241
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 242 VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 301 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 49/232 (21%)
Query: 108 QRRYIVKDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQAL-VEVSILTT 161
           +R  ++K  LG G FG+V  A+C +    +    VAVK +K      +Q    E  +LT 
Sbjct: 17  RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 76
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINH------FRG------ 209
           L  +       HIVR +      R L + FE +          +H        G      
Sbjct: 77  LQHQ-------HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 129
Query: 210 --LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267
             L L  +   + Q+  G+  L     +H DL   N   C   +   +KI DFG +    
Sbjct: 130 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN---CLVGQGLVVKIGDFGMS---- 182
Query: 268 RTVYSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
           R +YS   + YYR             PE +L  ++TT  D+WSFG ++ E+F
Sbjct: 183 RDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 192 LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 241
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 242 VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 301 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           +++Y   + +G G  G V    D      VA++ +  Q    ++ ++ E+ ++       
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM------- 71
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            RE+K+ +IV   + ++    L +  E L      L  +     +    +    ++ L+ 
Sbjct: 72  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYS-YIQSRYYRSP 282
           L  L    +IH D+K +NILL        +K+ DFG  +  T +++  S  + + Y+ +P
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 185
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           EV+    Y   +D+WS G +  E+  G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
           + + +LG+G+ G V         SF    VAVK  +    +   AL+E+ +LT      +
Sbjct: 18  VSEKILGYGSSGTVVF-----QGSFQGRPVAVK--RMLIDFCDIALMEIKLLT------E 64
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS-----KQI 222
            +D  +++R Y      R L I  EL + NL +L++  +    +L + + ++     +QI
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTS----------VKPAEIKIIDFGSACTEDRTVYS 272
             G++ L    IIH DLKP+NIL+ TS           +   I I DFG     D     
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 273 YIQSRY-------YRSPEVL-------LGYQYTTAIDMWSFGCI 302
           +  +         +R+PE+L          + T +ID++S GC+
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 12/210 (5%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQAL---VEVSILTTLNK 164
           +  Y +  LLG G FG V           VA+K+I          L   V   +   L  
Sbjct: 30  EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFE--LLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
           K      H  ++R+ ++F  Q    +  E  L   +L++ I      G   S  + F  Q
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS--RCFFGQ 147
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS-ACTEDRTVYSYIQSRYYR 280
           ++  +      G++H D+K ENIL+   ++    K+IDFGS A   D     +  +R Y 
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205
Query: 281 SPEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
            PE +  +QY      +WS G ++ ++  G
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 117 LGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY----- 166
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 167 ---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              + E    ++ + E     ++L     + D N+ EL+                  Q+ 
Sbjct: 438 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH-----------------QVS 480
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY-- 278
            G+  L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++  
Sbjct: 481 MGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            + +PE +  Y++++  D+WSFG ++ E F
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAF 567

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V +  D +     AVK ++ +  +  + L+  + LT+            IV 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLE-VFRAEELMACAGLTSPR----------IVP 130
Query: 177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           +Y        + I  ELL+  +L +L+K      L       +  Q L GL  L    I+
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEGLEYLHSRRIL 188
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACT-------EDRTVYSYI-QSRYYRSPEVLLG 287
           H D+K +N+LL  S   +   + DFG A         +D     YI  +  + +PEV+LG
Sbjct: 189 HGDVKADNVLL--SSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
                 +D+WS  C++  +  G
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 117 LGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY----- 166
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 167 ---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              + E    ++ + E     ++L     + D N+ EL+                  Q+ 
Sbjct: 437 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH-----------------QVS 479
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY-- 278
            G+  L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++  
Sbjct: 480 MGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            + +PE +  Y++++  D+WSFG ++ E F
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAF 566

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--XINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 192 LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 241
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 242 VQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 301 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 108/239 (45%), Gaps = 35/239 (14%)
Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +LG G +G+V    K    +     A+K++K       +A +     TT + + +R+   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLE 113
Query: 173 HI------VRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRG 225
           HI      V ++  F  +  L +  + ++    EL   ++     +   VQ++  +I+  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGG--ELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYIQSRYYRS 281
           L  L   GII+ D+K ENILL ++     + + DFG +      E    Y +  +  Y +
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 282 PEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLF----PGASEFDLLRRMIRILGAQPP 334
           P+++ G    +  A+D WS G ++ EL  G   F       S+ ++ R   RIL ++PP
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RILKSEPP 284

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           +++Y   + +G G  G V    D      VA++ +  Q    ++ ++ E+ ++       
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM------- 72
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            RE+K+ +IV   + ++    L +  E L      L  +     +    +    ++ L+ 
Sbjct: 73  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQA 129
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYS-YIQSRYYRSP 282
           L  L    +IH D+K +NILL        +K+ DFG  +  T +++  S  + + Y+ +P
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 186
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           EV+    Y   +D+WS G +  E+  G P
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 63/130 (48%), Gaps = 18/130 (13%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYI 274
           +S Q+ RG+  L     IH DL   NILL  +     +KI DFG A    R +Y    Y+
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSEN---NVVKICDFGLA----RDIYKNPDYV 256
Query: 275 QSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLLRRMI 326
           +    R      +PE +    Y+T  D+WS+G ++ E+F LG   +PG   + D   R+ 
Sbjct: 257 RKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLR 316
Query: 327 RILGAQPPDY 336
             +  + P+Y
Sbjct: 317 EGMRMRAPEY 326

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +    L + +K    + L L  +   + QI  G++ ++   
Sbjct: 76  VQLYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 135 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 135 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 72
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L E ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQ-YTSQICKGME 131
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 132 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 34/207 (16%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           +   +LG G  G+V + ++       A+K++++ P    +A  EV +       +     
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVEL------HWRASQC 70
Query: 172 HHIVRI---YE-YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            HIVRI   YE  +  ++ L I  E LD   L+  I+    +  +        K I   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
             L    I H D+KPEN+L  +    A +K+ DFG A                   +   
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------KETT 171
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLF 313
           G +Y  + DMWS G I+  L  G P F
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--XINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G V K         +AVK I+      +Q      +L  L+      D    V 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK----RLLMDLDISMRTVDCPFTVT 114
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
            Y     +  + IC EL+D++L +  K  I+  + +   I+   +  I++ L  L     
Sbjct: 115 FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 174
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS--RYYRSPEVL---LGY 288
           +IH D+KP N+L+       ++K+ DFG +     +V   I +  + Y +PE +   L  
Sbjct: 175 VIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 289 Q-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMI 326
           + Y+   D+WS G  + EL  L  P     + F  L++++
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 69
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+  +   +      ++ +
Sbjct: 129 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/235 (21%), Positives = 101/235 (42%), Gaps = 47/235 (20%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ------------------- 150
           +Y +KD +G G++G V   ++   N++ A+K++  +    Q                   
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 151 --------QALVEVSILTTLNKKYDREDKHHIVRIYEYFV--CQRHLCICFELLDSNLYE 200
                   Q   E++IL  L       D  ++V++ E      + HL + FEL++     
Sbjct: 74  IQPRGPIEQVYQEIAILKKL-------DHPNVVKLVEVLDDPNEDHLYMVFELVNQG--P 124
Query: 201 LIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260
           ++++   + LS    + + + +++G+  L    IIH D+KP N+L+        IKI DF
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED---GHIKIADF 181
Query: 261 GSACT---EDRTVYSYIQSRYYRSPEVLLGYQYT---TAIDMWSFGCIVAELFLG 309
           G +      D  + + + +  + +PE L   +      A+D+W+ G  +     G
Sbjct: 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V +  D +     AVK ++ +  +  + L+  + LT+            IV 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLE-VFRAEELMACAGLTSPR----------IVP 149
Query: 177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           +Y        + I  ELL+  +L +L+K      L       +  Q L GL  L    I+
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEGLEYLHSRRIL 207
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSA-CTE-DRTVYSYIQSRY------YRSPEVLLG 287
           H D+K +N+LL  S   +   + DFG A C + D    S +   Y      + +PEV+LG
Sbjct: 208 HGDVKADNVLL--SSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
                 +D+WS  C++  +  G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 193 LGQGCFGEV---WMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKL-----RHEK--L 242
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 243 VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 301
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG     ED    +   +++   + +PE  L  +
Sbjct: 302 YVHRDLRAANILVGENLV---CKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGR 358
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 359 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 397

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 67
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 68  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 119 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 209 GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268
            L   + + F  Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      
Sbjct: 153 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKD 210
Query: 269 TVYS-YIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLG 309
           TVY+ +  +R Y  PE +  ++Y   +  +WS G ++ ++  G
Sbjct: 211 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 19  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 68
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 69  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 127
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 128 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 184
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 185 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 223

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +    L + +K    + L L  +   + QI  G++ ++   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 135 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFV--AVKIIK----NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG V +  WDA     V  AVK +K    +QP      + EV+ + +L       
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 78
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    + +  EL  L S L  L K  H     L  +  ++ Q+  G+ 
Sbjct: 79  DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 135
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR------S 281
            L+    IH DL   N+LL T      +KI DFG      +    Y+   + +      +
Sbjct: 136 YLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D W FG  + E+F
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  +     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKI-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 135 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 270
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 271 ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH +L   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 26  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 75
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL   NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 135 YVHRDLAAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 70
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 71  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 129
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH +L   NIL+    +   +KI DFG      +D+  Y   +      ++ +
Sbjct: 130 YLGTKRYIHRNLATRNILVENENR---VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELF 212

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 108 QRRYI--VKDLLGHGTFGQVA-KCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSIL 159
            +RY+  ++DL G G FG+V+  C+D   +     VAVK +K    P +      E+ IL
Sbjct: 12  HKRYLKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDIL 70
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNL---YELIKINHFR------GL 210
            TL  +       HI++   Y  C      C +  + +L    E + +   R       +
Sbjct: 71  RTLYHE-------HIIK---YKGC------CEDQGEKSLQLVMEYVPLGSLRDYLPRHSI 114
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDR 268
            L+ + LF++QI  G++ L     IH +L   N+LL        +KI DFG   A  E  
Sbjct: 115 GLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDND---RLVKIGDFGLAKAVPEGH 171
Query: 269 TVYSYIQS----RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
             Y   +      ++ +PE L  Y++  A D+WSFG  + EL 
Sbjct: 172 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFV--AVKIIK----NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG V +  WDA     V  AVK +K    +QP      + EV+ + +L       
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 72
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    + +  EL  L S L  L K  H     L  +  ++ Q+  G+ 
Sbjct: 73  DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 129
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR------S 281
            L+    IH DL   N+LL T      +KI DFG      +    Y+   + +      +
Sbjct: 130 YLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D W FG  + E+F
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMF 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
           Y V  ++G G FG+V            A+K++       ++  A++ +   E  I+   N
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 132
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
             +       +V+++  F   R+L +  E +     +L+ +     +     + ++ +++
Sbjct: 133 SPW-------VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVV 183
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYY 279
             L  +   G IH D+KP+N+LL    K   +K+ DFG+    ++       + + +  Y
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
            SPEVL      GY Y    D WS G  + E+ +G
Sbjct: 241 ISPEVLKSQGGDGY-YGRECDWWSVGVFLYEMLVG 274

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 69
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 70  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 121 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           +++Y   + +G G  G V    D      VA++ +  Q    ++ ++ E+ ++       
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM------- 72
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            RE+K+ +IV   + ++    L +  E L      L  +     +    +    ++ L+ 
Sbjct: 73  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQA 129
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSP 282
           L  L    +IH ++K +NILL        +K+ DFG       E     + + + Y+ +P
Sbjct: 130 LEFLHSNQVIHRNIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           EV+    Y   +D+WS G +  E+  G P
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V   +    +  VA+K I+      +  + E  ++  L+          +V+
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHP-------KLVQ 66
Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQL-FSKQILRGLSLLKDAGI 234
           +Y   + Q  +C+ FE ++   L + ++    RGL  +   L     +  G++ L++A +
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEASV 124
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL   N   C   +   IK+ DFG +    D    S   +++   + SPEV    +Y
Sbjct: 125 IHRDLAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+WSFG ++ E+F
Sbjct: 182 SSKSDVWSFGVLMWEVF 198

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 76
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 77  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 135
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 136 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYELF 218

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
           Y V  ++G G FG+V            A+K++       ++  A++ +   E  I+   N
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 127
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
             +       +V+++  F   R+L +  E +     +L+ +     +     + ++ +++
Sbjct: 128 SPW-------VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVV 178
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYY 279
             L  +   G IH D+KP+N+LL    K   +K+ DFG+    ++       + + +  Y
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
            SPEVL      GY Y    D WS G  + E+ +G
Sbjct: 236 ISPEVLKSQGGDGY-YGRECDWWSVGVFLYEMLVG 269

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 108 QRRYI--VKDLLGHGTFGQVA-KCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSIL 159
            +RY+  ++DL G G FG+V+  C+D   +     VAVK +K    P +      E+ IL
Sbjct: 12  HKRYLKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDIL 70
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNL---YELIKINHFR------GL 210
            TL  +       HI++   Y  C      C +  + +L    E + +   R       +
Sbjct: 71  RTLYHE-------HIIK---YKGC------CEDQGEKSLQLVMEYVPLGSLRDYLPRHSI 114
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDR 268
            L+ + LF++QI  G++ L     IH +L   N+LL        +KI DFG   A  E  
Sbjct: 115 GLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDND---RLVKIGDFGLAKAVPEGH 171
Query: 269 TVYSYIQS----RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
             Y   +      ++ +PE L  Y++  A D+WSFG  + EL 
Sbjct: 172 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 51/228 (22%)
Query: 112 IVKDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKK 165
           ++K  LG G FG+V  A+C++    +    VAVK +K+     ++    E  +LT L  +
Sbjct: 16  VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 75
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG--------------LS 211
                  HIV+ Y   V    L + FE +     +L K     G              L+
Sbjct: 76  -------HIVKFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNPPTELT 126
Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
            S +   ++QI  G+  L     +H DL   N L+  ++    +KI DFG +    R VY
Sbjct: 127 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL---VKIGDFGMS----RDVY 179
Query: 272 SYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
           S   + YYR             PE ++  ++TT  D+WS G ++ E+F
Sbjct: 180 S---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 74
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 75  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 133
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 134 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYELF 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 35/209 (16%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALVEVSILTTLNKKYDREDKHHI 174
           LG G +G+V    +      VAVKI+  + A    +    E+ I   LN +       ++
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE-------NV 67
Query: 175 VRIY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
           V+ Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+
Sbjct: 68  VKFYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRS 281
             L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +
Sbjct: 119 VYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 282 PEVLLGYQY-TTAIDMWSFGCIVAELFLG 309
           PE+L   ++    +D+WS G ++  +  G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 72
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 131
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 132 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 100
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 159
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 160 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELF 242

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 75
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 76  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 134
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 135 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYELF 217

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFV--AVKIIK----NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG V +  WDA     V  AVK +K    +QP      + EV+ + +L       
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 72
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    + +  EL  L S L  L K  H     L  +  ++ Q+  G+ 
Sbjct: 73  DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 129
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR------S 281
            L+    IH DL   N+LL T      +KI DFG      +    Y+   + +      +
Sbjct: 130 YLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D W FG  + E+F
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMF 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 309
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 310 ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH +L   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 365 QISSAMEYLEKKNFIHRNLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 421
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 477

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
           Y V  ++G G FG+V            A+K++       ++  A++ +   E  I+   N
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 132
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
             +       +V+++  F   R+L +  E +     +L+ +     +     + ++ +++
Sbjct: 133 SPW-------VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVV 183
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYY 279
             L  +   G IH D+KP+N+LL    K   +K+ DFG+    ++       + + +  Y
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
            SPEVL      GY Y    D WS G  + E+ +G
Sbjct: 241 ISPEVLKSQGGDGY-YGRECDWWSVGVFLYEMLVG 274

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 87
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 88  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 146
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 147 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELF 229

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 69
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 129 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G FG+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 61
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 62  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 173
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRM 229

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V   +    +  VA+K IK         + E  ++  L+          +V+
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-VAIKTIKEGSMSEDDFIEEAEVMMKLSHP-------KLVQ 86
Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQL-FSKQILRGLSLLKDAGI 234
           +Y   + Q  +C+ FE ++   L + ++    RGL  +   L     +  G++ L++A +
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV 144
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL   N   C   +   IK+ DFG +    D    S   +++   + SPEV    +Y
Sbjct: 145 IHRDLAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 201
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+WSFG ++ E+F
Sbjct: 202 SSKSDVWSFGVLMWEVF 218

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V   +    +  VA+K I+      +  + E  ++  L+          +V+
Sbjct: 18  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHP-------KLVQ 69
Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQL-FSKQILRGLSLLKDAGI 234
           +Y   + Q  +C+ FE ++   L + ++    RGL  +   L     +  G++ L++A +
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV 127
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL   N   C   +   IK+ DFG +    D    S   +++   + SPEV    +Y
Sbjct: 128 IHRDLAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 184
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+WSFG ++ E+F
Sbjct: 185 SSKSDVWSFGVLMWEVF 201

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 72
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQ-YTSQICKGME 131
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 132 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFV--AVKIIK----NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG V +  WDA     V  AVK +K    +QP      + EV+ + +L       
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 68
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    + +  EL  L S L  L K  H     L  +  ++ Q+  G+ 
Sbjct: 69  DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 125
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR------S 281
            L+    IH DL   N+LL T      +KI DFG      +    Y+   + +      +
Sbjct: 126 YLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D W FG  + E+F
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKY 166
           +++ D+LG G    V +    +     A+K+  N    +P   Q  + E  +L  LN K 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHK- 67
Query: 167 DREDKHHIVRIY--EYFVCQRHLCICFELLD-SNLYELIKI-NHFRGLSLSIVQLFSKQI 222
                 +IV+++  E     RH  +  E     +LY +++  ++  GL  S   +  + +
Sbjct: 68  ------NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSA--CTEDRTVYSYIQSRYY 279
           + G++ L++ GI+H ++KP NI+         + K+ DFG+A    +D    S   +  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 280 RSPEVLL--------GYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRR----MI 326
             P++            +Y   +D+WS G        G LP  P    F+  RR    M 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP----FEGPRRNKEVMY 237
Query: 327 RILGAQP 333
           +I+  +P
Sbjct: 238 KIITGKP 244

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 73
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 74  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 132
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS----RYYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 133 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYELF 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 16  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 65
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 66  VQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   ED    +   +++   + +PE  L  +
Sbjct: 125 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR 181
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 182 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 220

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 67
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 68  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 126
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 127 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELF 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 87
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 88  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 146
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 147 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELF 229

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 31/207 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G  G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG 309
           +L   ++    +D+WS G ++  +  G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 117 LGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY----- 166
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 167 ---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              + E    ++ + E     ++L     + D N+ EL+                  Q+ 
Sbjct: 73  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH-----------------QVS 115
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY-- 278
            G+  L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++  
Sbjct: 116 MGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPV 172
Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            + +PE +  Y++++  D+WSFG ++ E F
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAF 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 9/109 (8%)
Query: 204 INHFRGLSLSIV---QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260
           I   RG  L  V   +LF +QI +G+  +    +IH DLKP NI L   V   ++KI DF
Sbjct: 125 IEKRRGEKLDKVLALELF-EQITKGVDYIHSKKLIHRDLKPSNIFL---VDTKQVKIGDF 180
Query: 261 G--SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
           G  ++   D        +  Y SPE +    Y   +D+++ G I+AEL 
Sbjct: 181 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 117 LGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY----- 166
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 167 ---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              + E    ++ + E     ++L     + D N+ EL+                  Q+ 
Sbjct: 75  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH-----------------QVS 117
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY-- 278
            G+  L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++  
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            + +PE +  Y++++  D+WSFG ++ E F
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAF 204

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 69
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 128
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR----YYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 129 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 68
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 69  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL    +   +KI DFG A        +R +     +  Y +PE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG-LP 311
           +L   ++    +D+WS G ++  +  G LP
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 17  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 66
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 67  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 125
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 126 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 182
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 183 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 221

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFV--AVKIIK----NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG V +  WDA     V  AVK +K    +QP      + EV+ + +L       
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 68
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    + +  EL  L S L  L K  H     L  +  ++ Q+  G+ 
Sbjct: 69  DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 125
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR------S 281
            L+    IH DL   N+LL T      +KI DFG      +    Y+   + +      +
Sbjct: 126 YLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D W FG  + E+F
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 117 LGHGTFGQVAKC----WDAEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKKYDREDK 171
           LG G FG V  C            VAVK +++    + +    E+ IL +L        +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------Q 68
Query: 172 HHIVRIYE---YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           H  +  Y+   Y   +R+L +  E L   +L + ++ +  R   + ++Q ++ QI +G+ 
Sbjct: 69  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGME 127
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS----RYYRS 281
            L     IH DL   NIL+    +   +KI DFG      +D+      +      ++ +
Sbjct: 128 YLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L   +++ A D+WSFG ++ ELF
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYELF 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 61
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 62  ---KEIKHPNLVQLLG--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 173
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRM 229

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V   +    +  VA+K I+      +  + E  ++  L+          +V+
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHP-------KLVQ 66
Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQL-FSKQILRGLSLLKDAGI 234
           +Y   + Q  +C+ FE ++   L + ++    RGL  +   L     +  G++ L++A +
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV 124
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL   N   C   +   IK+ DFG +    D    S   +++   + SPEV    +Y
Sbjct: 125 IHRDLAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+WSFG ++ E+F
Sbjct: 182 SSKSDVWSFGVLMWEVF 198

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 117 LGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY----- 166
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 167 ---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              + E    ++ + E     ++L     + D N+ EL+                  Q+ 
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH-----------------QVS 121
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY-- 278
            G+  L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++  
Sbjct: 122 MGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENXYKAQTHGKWPV 178
Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            + +PE +  Y++++  D+WSFG ++ E F
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAF 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--CINKMLNHEN---VVK 69
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 70  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL    +   +KI DFG A        +R +     +  Y +PE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG-LP 311
           +L   ++    +D+WS G ++  +  G LP
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           LG G FG+V   W    N  + VA+K +K      +  L E  ++  L     R +K  +
Sbjct: 15  LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 64
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           V++Y   V +  + I  E +   +L + +K    + L L  +   + QI  G++ ++   
Sbjct: 65  VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
            +H DL+  NIL+  ++     K+ DFG A   +   Y+  Q   +     +PE  L  +
Sbjct: 124 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 180
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
           +T   D+WSFG ++ EL   G   +PG    ++L ++ R
Sbjct: 181 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 219

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G+V    +      VAVKI+  + A      ++  I   +NK  + E+   +V+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI--XINKMLNHEN---VVK 69
Query: 177 IY--------EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            Y        +Y   +   C   EL D       +I    G+     Q F  Q++ G+  
Sbjct: 70  FYGHRREGNIQYLFLE--YCSGGELFD-------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           L   GI H D+KPEN+LL    +   +KI DFG A        +R +     +  Y +PE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLG-LP 311
           +L   ++    +D+WS G ++  +  G LP
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 117 LGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY----- 166
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 167 ---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              + E    ++ + E     ++L     + D N+ EL+                  Q+ 
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH-----------------QVS 121
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY-- 278
            G+  L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++  
Sbjct: 122 MGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPV 178
Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            + +PE +  Y++++  D+WSFG ++ E F
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAF 208

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKY 166
           +++ D+LG G    V +    +     A+K+  N    +P   Q  + E  +L  LN K 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHK- 67
Query: 167 DREDKHHIVRIY--EYFVCQRHLCICFELLD-SNLYELIKI-NHFRGLSLSIVQLFSKQI 222
                 +IV+++  E     RH  +  E     +LY +++  ++  GL  S   +  + +
Sbjct: 68  ------NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSAC-TEDRTVY-------SY 273
           + G++ L++ GI+H ++KP NI+         + K+ DFG+A   ED   +        Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEY 181
Query: 274 IQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRR----MI 326
           +    Y    +   +Q  Y   +D+WS G        G LP  P    F+  RR    M 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP----FEGPRRNKEVMY 237
Query: 327 RILGAQP 333
           +I+  +P
Sbjct: 238 KIITGKP 244

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMN--SFVAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  F  L L+ 
Sbjct: 446 RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKF-SLDLAS 492
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 549
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V   +    +  VA+K I+      +  + E  ++  L+          +V+
Sbjct: 13  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHP-------KLVQ 64
Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQL-FSKQILRGLSLLKDAGI 234
           +Y   + Q  +C+ FE ++   L + ++    RGL  +   L     +  G++ L++A +
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL   N   C   +   IK+ DFG +    D    S   +++   + SPEV    +Y
Sbjct: 123 IHRDLAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+WSFG ++ E+F
Sbjct: 180 SSKSDVWSFGVLMWEVF 196

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 63
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 64  ---KEIKHPNLVQLLG--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 68
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 69  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 79
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  +  +  +     ++ + ++Q  RG+  L  
Sbjct: 80  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDI-ARQTARGMDYLHA 138
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L    +   +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
                 Y+   D+++FG ++ EL  G   +   +  D +  M+   G+  PD     +  
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-RGSLSPDLSKVRSNC 254
Query: 344 TSKFFKCIGSVHNIENGEVSIGGRSAY-QALTEIEYEAREL 383
             +  + +      +  E     R ++ + L EIE  AREL
Sbjct: 255 PKRMKRLMAECLKKKRDE-----RPSFPRILAEIEELAREL 290

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMN--SFVAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  F  L L+ 
Sbjct: 446 RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKF-SLDLAS 492
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+  +     +K+ DFG S   ED T Y  
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKA 549
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 63
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 64  ---KEIKHPNLVQLLG--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 20  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 67
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  +  +  +     ++ + ++Q  RG+  L  
Sbjct: 68  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDI-ARQTARGMDYLHA 126
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L    +   +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 127 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
                 Y+   D+++FG ++ EL  G   +   +  D +  M+   G+  PD     +  
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-RGSLSPDLSKVRSNC 242
Query: 344 TSKFFKCIGSVHNIENGEVSIGGRSAY-QALTEIEYEAREL 383
             +  + +      +  E     R ++ + L EIE  AREL
Sbjct: 243 PKRMKRLMAECLKKKRDE-----RPSFPRILAEIEELAREL 278

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAK-CW--DAEMNSF-VAVKIIKNQ--PAYYQQALVEVSIL 159
           ET+ R +   +LG G FG V K  W  D E     VA+K+++    P   ++ L E  ++
Sbjct: 16  ETELRKV--KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 73
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIK----INHFRG----LS 211
             +   Y                  R L IC       + +L+     ++H R     L 
Sbjct: 74  AGVGSPY----------------VSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLG 117
Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRT 269
              +  +  QI +G+S L+D  ++H DL   N+L+ +   P  +KI DFG A     D T
Sbjct: 118 SQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKS---PNHVKITDFGLARLLDIDET 174
Query: 270 VYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            Y     +    + + E +L  ++T   D+WS+G  V EL 
Sbjct: 175 EYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELM 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 31/206 (15%)
Query: 117 LGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDK 171
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY----- 87
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGLS 227
             IVR+    +C+        +L   + EL  +N +    R +    +     Q+  G+ 
Sbjct: 88  --IVRMIG--ICEAESW----MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 139
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY---YRS 281
            L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++   + +
Sbjct: 140 YLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 196
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE +  Y++++  D+WSFG ++ E F
Sbjct: 197 PECINYYKFSSKSDVWSFGVLMWEAF 222

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQPAYYQQALVEVSILTT 161
           ET+ R +   +LG G FG V K  W  E  S    V +K+I+++        V   +L  
Sbjct: 30  ETELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 87
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCIC----FELLDSNLYELIKINHFR----GLSLS 213
                   D  HIVR+         L +C     +L+   L     ++H R     L   
Sbjct: 88  -----GSLDHAHIVRL---------LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ 133
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT----EDRT 269
           ++  +  QI +G+  L++ G++H +L   N+LL +   P+++++ DFG A      + + 
Sbjct: 134 LLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS---PSQVQVADFGVADLLPPDDKQL 190
Query: 270 VYSYIQS--RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
           +YS  ++  ++     +  G +YT   D+WS+G  V EL 
Sbjct: 191 LYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELM 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 42/217 (19%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           +L+G G FGQV K   A+        +IK      ++A  EV  L  L+           
Sbjct: 17  ELIGSGGFGQVFK---AKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDH---------- 63
Query: 175 VRIYEYFVC-------------------QRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
           V I  Y  C                    + L I  E  D    E   I   RG  L  V
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW-IEKRRGEKLDKV 122
Query: 216 ---QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTV 270
              +LF +QI +G+  +    +I+ DLKP NI L   V   ++KI DFG  ++   D   
Sbjct: 123 LALELF-EQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKR 178
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
                +  Y SPE +    Y   +D+++ G I+AEL 
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 115 SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 170
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   GI+H DLKP N L+   +    +K+IDFG A      T      S + +  Y  PE
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 284 VLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
            +     +              D+WS GCI+  +  G
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 115 SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 170
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   GI+H DLKP N L+   +    +K+IDFG A      T      S + +  Y  PE
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 284 VLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
            +     +              D+WS GCI+  +  G
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 33/254 (12%)
Query: 113 VKDL--LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           +KDL  +G G +G V K         +AVK I++     +Q      +L  L+      D
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK----QLLMDLDVVMRSSD 79
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL---RGLS 227
             +IV+ Y     +    IC EL+ ++  +  K  +     +   ++  K  L   + L+
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 228 LLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRS 281
            LK+   IIH D+KP NILL  S     IK+ DFG      + V S  ++R      Y +
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRS---GNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMA 193
Query: 282 PEVL------LGYQYTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQPP 334
           PE +       GY   +  D+WS G  + EL  G   +P   S FD L ++++     PP
Sbjct: 194 PERIDPSASRQGYDVRS--DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK---GDPP 248
Query: 335 DYVLKEAKNTSKFF 348
                E +  S  F
Sbjct: 249 QLSNSEEREFSPSF 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 63
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 64  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 31/206 (15%)
Query: 117 LGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDK 171
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY----- 89
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGLS 227
             IVR+    +C+        +L   + EL  +N +    R +    +     Q+  G+ 
Sbjct: 90  --IVRMIG--ICEAESW----MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 141
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY---YRS 281
            L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++   + +
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE +  Y++++  D+WSFG ++ E F
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAF 224

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 31/206 (15%)
Query: 117 LGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDK 171
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY----- 89
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGLS 227
             IVR+    +C+        +L   + EL  +N +    R +    +     Q+  G+ 
Sbjct: 90  --IVRMIG--ICEAESW----MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 141
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY---YRS 281
            L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++   + +
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE +  Y++++  D+WSFG ++ E F
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAF 224

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 61
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 62  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP 173
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRM 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CT 265
           R L L  +  FS Q+ +G++ L     IH D+   N+LL         KI DFG A    
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIM 209
Query: 266 EDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
            D        +R    + +PE +    YT   D+WS+G ++ E+F LGL  +PG
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G+FG+V +  D +     AVK ++ +  +  + LV  + L++            IV 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFRVEELVACAGLSS----------PRIVP 128
Query: 177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           +Y        + I  ELL+  +L +LIK      L       +  Q L GL  L    I+
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHTRRIL 186
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSA-CTE-DRTVYSYIQSRY------YRSPEVLLG 287
           H D+K +N+LL  S   +   + DFG A C + D    S +   Y      + +PEV++G
Sbjct: 187 HGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
                 +D+WS  C++  +  G
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CT 265
           R L L  +  FS Q+ +G++ L     IH D+   N+LL         KI DFG A    
Sbjct: 155 RPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIM 211
Query: 266 EDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
            D        +R    + +PE +    YT   D+WS+G ++ E+F LGL  +PG
Sbjct: 212 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 64
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 65  ---KEIKHPNLVQLLG--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 176
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 232

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQPAYYQQALVEVSILTT 161
           ET+ R +   +LG G FG V K  W  E  S    V +K+I+++        V   +L  
Sbjct: 12  ETELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCIC----FELLDSNLYELIKINHFR----GLSLS 213
                   D  HIVR+         L +C     +L+   L     ++H R     L   
Sbjct: 70  -----GSLDHAHIVRL---------LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT----EDRT 269
           ++  +  QI +G+  L++ G++H +L   N+LL +   P+++++ DFG A      + + 
Sbjct: 116 LLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS---PSQVQVADFGVADLLPPDDKQL 172
Query: 270 VYSYIQS--RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
           +YS  ++  ++     +  G +YT   D+WS+G  V EL 
Sbjct: 173 LYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELM 211

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 63
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + +S  ++   + 
Sbjct: 64  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CT 265
           R L L  +  FS Q+ +G++ L     IH D+   N+LL         KI DFG A    
Sbjct: 147 RPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIM 203
Query: 266 EDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
            D        +R    + +PE +    YT   D+WS+G ++ E+F LGL  +PG
Sbjct: 204 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFV--AVKIIK----NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG V +  WDA     V  AVK +K    +QP      + EV+ + +L       
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 78
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    + +  EL  L S L  L K  H     L  +  ++ Q+  G+ 
Sbjct: 79  DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 135
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR------S 281
            L+    IH DL   N+LL T      +KI DFG      +     +   + +      +
Sbjct: 136 YLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D W FG  + E+F
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 27/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKH- 172
           LGHG++G+V K    E     AVK   +    P    + L EV         +++  +H 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG-------SHEKVGQHP 117
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRGLSLLK 230
             VR+ + +     L +  EL   +L +  +     G SL   Q++   +  L  L+ L 
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLH 174
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--YYRSPEVLLGY 288
             G++H D+KP NI L         K+ DFG            +Q     Y +PE+L G 
Sbjct: 175 SQGLVHLDVKPANIFLGPR---GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG- 230
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
            Y TA D++S G  + E+   + L  G   +  LR+     G  PP++ 
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-----GYLPPEFT 274

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G V K         +AVK I+      +Q      +L  L+      D    V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK----RLLMDLDISMRTVDCPFTVT 70
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
            Y     +  + IC EL+D++L +  K  I+  + +   I+   +  I++ L  L     
Sbjct: 71  FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS--RYYRSPEVL---LGY 288
           +IH D+KP N+L+       ++K+ DFG +      V   I +  + Y +PE +   L  
Sbjct: 131 VIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 289 Q-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMIR 327
           + Y+   D+WS G  + EL  L  P     + F  L++++ 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 68
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 69  ---KEIKHPNLVQLLG--VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK----- 171
           +G G FG V K +    N+ VAVK +         A+V+++    L +++D+E K     
Sbjct: 39  MGEGGFGVVYKGYVN--NTTVAVKKLA--------AMVDITT-EELKQQFDQEIKVMAKC 87
Query: 172 --HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG---LSLSIVQLFSKQILRGL 226
              ++V +  +      LC+ +  +  N   L +++   G   LS  +    ++    G+
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYM-PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRS 281
           + L +   IH D+K  NILL  +      KI DFG A   ++   + + SR      Y +
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           PE L G + T   D++SFG ++ E+  GLP      E  LL
Sbjct: 204 PEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMN--SFVAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT- 64
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                       + D  HIV++    + +  + I  EL     L   +++  F  L L+ 
Sbjct: 65  ----------MRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKF-SLDLAS 112
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+  +     +K+ DFG S   ED T Y  
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKA 169
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 68
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 69  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 180
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 68
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 69  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 31/206 (15%)
Query: 117 LGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDK 171
           LG G FG V K +    ++   VAVKI+KN+   PA   + L E +++  L+  Y     
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY----- 79
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGLS 227
             IVR+    +C+        +L   + EL  +N +    R +    +     Q+  G+ 
Sbjct: 80  --IVRMIG--ICEAESW----MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVY-SYIQSRY---YRS 281
            L+++  +H DL   N+LL T       KI DFG   A   D   Y +    ++   + +
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE +  Y++++  D+WSFG ++ E F
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAF 214

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169
           ++ + +G G FG+V        N+ VAVK  +    P    + L E  IL    K+Y   
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL----KQYSHP 172
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           +   IVR+      ++ + I  EL+   +    ++    R    +++Q+       G+  
Sbjct: 173 N---IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA-AGMEY 228
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRSPE 283
           L+    IH DL   N   C   +   +KI DFG +  E   VY+           + +PE
Sbjct: 229 LESKCCIHRDLAARN---CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 284 VLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
            L   +Y++  D+WSFG ++ E F LG   +P  S
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  +  L L+ 
Sbjct: 69  RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLAS 115
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 116 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 172
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 173 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 67
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 68  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  +  L L+ 
Sbjct: 94  RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLAS 140
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 141 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 197
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 198 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 9/104 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH D+   N+LL         KI DFG A     D        
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMNDSNYIVKGN 227
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
           +R    + +PE +    YT   D+WS+G ++ E+F LGL  +PG
Sbjct: 228 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 68
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 69  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEM-NSFVAVKI-IKNQPAYYQQA-----LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M N    +++ +K  P  Y +      L+E  I++  N +    
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQ---- 108
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 109 ---NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYYRKG 217
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 115 SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 170
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   GI+H DLKP N L+   +    +K+IDFG A      T      S + +  Y  PE
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 284 VLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
            +     +              D+WS GCI+  +  G
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G+FG+V +  D +     AVK ++ +  +  + LV  + L++            IV 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFRVEELVACAGLSS----------PRIVP 114
Query: 177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           +Y        + I  ELL+  +L +LIK      L       +  Q L GL  L    I+
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSA-CTE-DRTVYSYIQSRY------YRSPEVLLG 287
           H D+K +N+LL  S   +   + DFG A C + D    S +   Y      + +PEV++G
Sbjct: 173 HGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
                 +D+WS  C++  +  G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 91
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 92  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 150
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 151 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTG 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 68
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 69  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 127
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  +  L L+ 
Sbjct: 71  RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLAS 117
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 174
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 43  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 90
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 91  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 149
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 150 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTG 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 90/219 (41%), Gaps = 44/219 (20%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNKKYDREDKHH 173
           ++LG G FGQ  K    E    + +K +I+      +  L EV ++  L       +  +
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-------EHPN 68
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL--------FSKQILRG 225
           +++        + L        + + E IK    RG+  S+           F+K I  G
Sbjct: 69  VLKFIGVLYKDKRL--------NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRT-------------- 269
           ++ L    IIH DL   N   C   +   + + DFG A    +++T              
Sbjct: 121 MAYLHSMNIIHRDLNSHN---CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 270 -VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
             Y+ + + Y+ +PE++ G  Y   +D++SFG ++ E+ 
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 9/104 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH D+   N+LL         KI DFG A     D        
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
           +R    + +PE +    YT   D+WS+G ++ E+F LGL  +PG
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  +  L L+ 
Sbjct: 68  RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLAS 114
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 115 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 171
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 172 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 91
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 92  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 150
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 151 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTG 233

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 65
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 66  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 177
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 87
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 88  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 191
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 65
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 66  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 177
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 68
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 69  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 127
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 9/104 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH D+   N+LL         KI DFG A     D        
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
           +R    + +PE +    YT   D+WS+G ++ E+F LGL  +PG
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 76
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 77  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 188
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 189 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 244

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMN--SFVAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  +  L L+ 
Sbjct: 66  RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLAS 112
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 169
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYS--- 272
           QI   +  L   G++H DLKP NI          +K+ DFG         E++TV +   
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 273 -------YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
                   + ++ Y SPE + G  Y+  +D++S G I+ EL     L+P +++ + +R +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTL 237
Query: 326 IRILGAQ-PPDYVLK 339
             +   + PP +  K
Sbjct: 238 TDVRNLKFPPLFTQK 252

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           ++ ++G G FG+V         + +  VA+K +K      Q+   L E SI+        
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQF----- 101
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  ++V +       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 102 --DHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKH--DGQFTVIQLVGMLRGIAAG 157
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED--RTVYSYIQSRY---Y 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    VY+    +    +
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLV---CKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW 214
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            +PE +   ++T+A D+WS+G ++ E+ 
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH DL   NILL         KI DFG A     D        
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
           +R    + +PE +    YT   D+WS+G  + ELF LG   +PG        +MI+
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 87
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 88  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 191
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G+FG+V +  D +     AVK ++ +  +  + LV  + L++            IV 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFRVEELVACAGLSS----------PRIVP 130
Query: 177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
           +Y        + I  ELL+  +L +LIK      L       +  Q L GL  L    I+
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHTRRIL 188
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSA-CTE-DRTVYSYIQSRY------YRSPEVLLG 287
           H D+K +N+LL  S   +   + DFG A C + D    S +   Y      + +PEV++G
Sbjct: 189 HGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
                 +D+WS  C++  +  G
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH DL   NILL         KI DFG A     D        
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
           +R    + +PE +    YT   D+WS+G  + ELF LG   +PG        +MI+
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH DL   NILL         KI DFG A     D        
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
           +R    + +PE +    YT   D+WS+G  + ELF LG   +PG        +MI+
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M +      VAVK +    +   +   L+E  I++ LN +    
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ---- 94
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 95  ---NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 152 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYYRKG 203
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 63
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 64  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH DL   NILL         KI DFG A     D        
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
           +R    + +PE +    YT   D+WS+G  + ELF LG   +PG        +MI+
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 18  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 65
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 66  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 124
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 125 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTG 207

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 74
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 75  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 178
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 113 VKDLLGHGTFGQVAKCW---DAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +++++G G FG+V +       +  S VA+K +K      Q+   L E SI+        
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF----- 74
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGL 226
             +  +I+R+         + I  E +++  L   +++N  +   + +V +  + I  G+
Sbjct: 75  --EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML-RGIASGM 131
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---------SACTEDRTVYSYIQSR 277
             L +   +H DL   NIL+ +++     K+ DFG         S  TE  ++   I  R
Sbjct: 132 RYLAEMSYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEENSSDPTETSSLGGKIPIR 188
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
           +  +PE +   ++T+A D WS+G ++ E+ 
Sbjct: 189 WT-APEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 68  SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 123
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   GI+H DLKP N L+   +    +K+IDFG A      T      S + +  Y  PE
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 284 VLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
            +     +              D+WS GCI+  +  G
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 38/184 (20%)
Query: 204 INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
           ++    LS   V+ +   + + L  +   GI+H D+KP N L    +K  +  ++DFG A
Sbjct: 108 LDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK--KYALVDFGLA 165
Query: 264 -CTEDRTV--YSYIQSRY----------------------------YRSPEVLLGY-QYT 291
             T D  +    ++QS                              +R+PEVL      T
Sbjct: 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225
Query: 292 TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKC 350
           TAIDMWS G I   L  G  P +  + +   L +++ I G++     ++ AK   K   C
Sbjct: 226 TAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRE---TIQAAKTFGKSILC 282
Query: 351 IGSV 354
              V
Sbjct: 283 SKEV 286

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 81
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 82  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 185
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 36  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 83
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 84  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 142
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 143 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTG 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  +  L L+ 
Sbjct: 63  RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLAS 109
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 110 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 166
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 63
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 64  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 122
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
           FS Q+ +G++ L     IH DL   NILL         KI DFG A     D        
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
           +R    + +PE +    YT   D+WS+G  + ELF LG   +PG        +MI+
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLGYQY 290
           ++H DLKP N+ L        +K+ DFG A     ++     ++ + YY SPE +    Y
Sbjct: 137 VLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSY 193
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
               D+WS GC++ EL   +P F   S+ +L
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VA+K+IK       + + E  ++  L+ +        +V
Sbjct: 32  LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHE-------KLV 82
Query: 176 RIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y     QR + I  E + +  L   ++    R  +  ++++  K +   +  L+    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQF 141
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           +H DL   N   C       +K+ DFG S    D    S + S++   +  PEVL+  ++
Sbjct: 142 LHRDLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+W+FG ++ E++
Sbjct: 199 SSKSDIWAFGVLMWEIY 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 43/224 (19%)
Query: 108 QRRYI--VKDLLGHGTFGQVAKC-WDAEMNSF---VAVKIIKNQPAYYQQALV--EVSIL 159
           ++R++  ++DL G G FG+V  C +D E ++    VAVK +K +      A +  E+ IL
Sbjct: 19  EKRFLKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLC---------ICFELLDS-NLYELIKINHFRG 209
             L               +E  V  + +C         +  E L S +L E +  N  + 
Sbjct: 78  RNL--------------YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK- 122
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTED 267
           ++L     ++ QI +G+  L     +H DL   N+L+ +     ++KI DFG   A   D
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETD 179
Query: 268 RTVYSYIQSR----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
           +   +    R    ++ +PE L+  ++  A D+WSFG  + EL 
Sbjct: 180 KEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 78
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 79  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 133 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 182
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 183 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 80
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 81  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 184
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M +      VAVK +    +   +   L+E  I++ LN +    
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ---- 108
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 109 ---NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYYRKG 217
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK----- 171
           +G G FG V K +    N+ VAVK +         A+V+++    L +++D+E K     
Sbjct: 39  MGEGGFGVVYKGYVN--NTTVAVKKLA--------AMVDITT-EELKQQFDQEIKVMAKC 87
Query: 172 --HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG---LSLSIVQLFSKQILRGL 226
              ++V +  +      LC+ +  +  N   L +++   G   LS  +    ++    G+
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYM-PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRS 281
           + L +   IH D+K  NILL  +      KI DFG A   ++   + +  R      Y +
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           PE L G + T   D++SFG ++ E+  GLP      E  LL
Sbjct: 204 PEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 192
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 252
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 253 RLLQPEY 259

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 77
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 78  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 132 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 181
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                         D  HIV++    + +  + I  EL     L   +++  +  L L+ 
Sbjct: 66  RQF-----------DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLAS 112
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T Y  
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKA 169
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 63
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +  +  L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 64  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 122
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQY 290
           ++H DLKP N+ L        +K+ DFG A   +       +++ + YY SPE +    Y
Sbjct: 137 VLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
               D+WS GC++ EL   +P F   S+ +L
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 80
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 81  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 184
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 112/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 63
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 64  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++ 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 114 KDLLGHGTFGQVA--KCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           KD+LGHG  G +     +D   N  VAVK I   P  +  A  EV +L        RE  
Sbjct: 29  KDVLGHGAEGTIVYRGMFD---NRDVAVKRI--LPECFSFADREVQLL--------RESD 75
Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
            H  ++R +     ++   I  EL  + L E ++   F  L L  + L  +Q   GL+ L
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLL-QQTTSGLAHL 134
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIK--IIDFGSACTEDRTVYSYIQ------SRYYRS 281
               I+H DLKP NIL+       +IK  I DFG         +S+ +      +  + +
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 282 PEVL---LGYQYTTAIDMWSFGCI 302
           PE+L        T  +D++S GC+
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCV 218

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 250 RLLQPEY 256

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 114 KDLLGHGTFGQV----AKCWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           + ++G G FG+V     K    +    VA+K +K      Q+   L E  I+   +    
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH--- 105
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
               H+I+R+       + + I  E +++    L K    +    S++QL    + I  G
Sbjct: 106 ----HNIIRLEGVISKYKPMMIITEYMENG--ALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L +   +H DL   NIL+ +++     K+ DFG S   ED    +Y  S       +
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            +PE +   ++T+A D+WSFG ++ E+ 
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVM 244

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 74
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 75  --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARN---CXVAEDFTVKIGDFGMT----RDIY---ET 178
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 79
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +     L I  +  + S+LY  +  +  +     ++ + ++Q  RG+  L  
Sbjct: 80  VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDI-ARQTARGMDYLHA 138
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L    +   +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
                 Y+   D+++FG ++ EL  G   +   +  D +  M+   G+  PD
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-RGSLSPD 246

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 193
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 253
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 254 RLLQPEY 260

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 255 RLLQPEY 261

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VA+K+IK       + + E  ++  L+ +        +V
Sbjct: 32  LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHE-------KLV 82
Query: 176 RIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y     QR + I  E + +  L   ++    R  +  ++++  K +   +  L+    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQF 141
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           +H DL   N   C       +K+ DFG S    D    S + S++   +  PEVL+  ++
Sbjct: 142 LHRDLAARN---CLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+W+FG ++ E++
Sbjct: 199 SSKSDIWAFGVLMWEIY 215

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQY 290
           ++H DLKP N+ L        +K+ DFG A   +       +++ + YY SPE +    Y
Sbjct: 137 VLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY 193
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
               D+WS GC++ EL   +P F   S+ +L
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 255 RLLQPEY 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V   +    +  VA+K I+      +  + E  ++  L+          +V+
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHP-------KLVQ 67
Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQL-FSKQILRGLSLLKDAGI 234
           +Y   + Q  +C+  E ++   L + ++    RGL  +   L     +  G++ L++A +
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           IH DL   N   C   +   IK+ DFG +    D    S   +++   + SPEV    +Y
Sbjct: 126 IHRDLAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+WSFG ++ E+F
Sbjct: 183 SSKSDVWSFGVLMWEVF 199

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 212
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 213 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 272
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 273 RLLQPEY 279

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 186
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 187 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 246
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 247 RLLQPEY 253

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 191
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 252 RLLQPEY 258

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A    D+  YS    
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 213
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
              + P      E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 214 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 273
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 274 RLLQPEY 280

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VAVK +    +  ++   L E S++          
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC----- 78
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             +L  + 
Sbjct: 79  --HHVVRLLGVVSKGQPTLVVMELMAHGDLK----SYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C       +KI DFG      R +Y   ++
Sbjct: 133 QMAAEIADGMAYLNAKKFVHRDLAARN---CMVAHDFTVKIGDFGMT----RDIY---ET 182
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            +PE L    +TT+ DMWSFG ++ E+
Sbjct: 183 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VA+K +    +  ++   L E S++   N      
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 109
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             SLS + 
Sbjct: 110 --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C   +   +KI DFG      R +Y   ++
Sbjct: 164 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 213
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            SPE L    +TT  D+WSFG ++ E+
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 43/224 (19%)
Query: 108 QRRYI--VKDLLGHGTFGQVAKC-WDAEMNSF---VAVKIIKNQPAYYQQALV--EVSIL 159
           ++R++  ++DL G G FG+V  C +D E ++    VAVK +K +      A +  E+ IL
Sbjct: 7   EKRFLKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 65
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLC---------ICFELLDS-NLYELIKINHFRG 209
             L               +E  V  + +C         +  E L S +L E +  N  + 
Sbjct: 66  RNL--------------YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK- 110
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTED 267
           ++L     ++ QI +G+  L     +H DL   N+L+ +     ++KI DFG   A   D
Sbjct: 111 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETD 167
Query: 268 RTVYSYIQSR----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
           +   +    R    ++ +PE L+  ++  A D+WSFG  + EL 
Sbjct: 168 KEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG A   ED    +Y          +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLARVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           +IL  LS L   G+++ DLKPENI+L       ++K+ID G+    +   Y Y  +  ++
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLGAVSRINSFGYLY-GTPGFQ 244
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
           +PE++     T A D+++ G  +A L L LP
Sbjct: 245 APEIVR-TGPTVATDIYTVGRTLAALTLDLP 274

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A       +  + ++
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNK 199
Query: 278 Y-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
                   + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 200 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 259
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 260 RLLQPEY 266

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A       +  + ++
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194
Query: 278 Y-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
                   + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 255 RLLQPEY 261

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A       +  + ++
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194
Query: 278 Y-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
                   + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 255 RLLQPEY 261

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 60/237 (25%)
Query: 113 VKDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKK 165
           V+D+ G G FG+V +         E  + VAVK++K + +   QA    E +++      
Sbjct: 52  VRDI-GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF--- 107
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIK---------INH----FRG-- 209
               D  +IV++       + +C+ FE +   +L E ++         ++H     R   
Sbjct: 108 ----DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 210 -------LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262
                  LS +     ++Q+  G++ L +   +H DL   N L+  ++    +KI DFG 
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGL 220
Query: 263 ACTEDRTVYSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
           +    R +YS   + YY++            PE +   +YTT  D+W++G ++ E+F
Sbjct: 221 S----RNIYS---ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 112/250 (44%), Gaps = 25/250 (10%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V      + +  VAVK +K      ++ L E +++     
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 82
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQI 222
              +E KH ++V++      +    I  E +   NL + ++  +   ++  ++   + QI
Sbjct: 83  ---KEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQI 139
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY--- 278
              +  L+    IH DL   N   C   +   +K+ DFG S      T  ++  +++   
Sbjct: 140 SSAMEYLEKKNFIHRDLAARN---CLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLR---RMIRILGA 331
           + +PE L    ++   D+W+FG ++ E+   G+  +PG   +  +DLL    RM +  G 
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGC 256
Query: 332 QPPDYVLKEA 341
            P  Y L  A
Sbjct: 257 PPKVYELMRA 266

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A       +  + ++
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMLDKEFDSVHNK 195
Query: 278 Y-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
                   + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 255
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 256 RLLQPEY 262

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A       +  + ++
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNK 195
Query: 278 Y-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
                   + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 255
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 256 RLLQPEY 262

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 47  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 101
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 102 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 157
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 214
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 215 TSPEAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 87  SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 142
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   GI+H DLKP N L+   +    +K+IDFG A      T      S + +  Y  PE
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 284 VLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
            +     +              D+WS GCI+  +  G
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSY 273
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A      E  +V++ 
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEXXSVHNK 193
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
             ++    + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 253
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 254 RLLQPEY 260

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A       +  + ++
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNK 192
Query: 278 Y-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
                   + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 252
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 253 RLLQPEY 259

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           F  Q+ +G+  L     +H DL   N   C   +   +K+ DFG A       +  + ++
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 278 Y-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329
                   + + E L   ++TT  D+WSFG ++ EL   G P +P  + FD+   +++  
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313
Query: 330 GAQPPDY 336
               P+Y
Sbjct: 314 RLLQPEY 320

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           +G G+FG V K  W  +    VAVK++      P   Q    EV +L        R+ +H
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVL--------RKTRH 63
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
             + ++  +     L I  +  + S+LY  + I   +   + ++ + ++Q  +G+  L  
Sbjct: 64  VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI-ARQTAQGMDYLHA 122
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLL 286
             IIH DLK  NI L   +    +KI DFG A  + R   S+       S  + +PEV+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 287 GYQ---YTTAIDMWSFGCIVAELFLG 309
                 Y+   D+++FG ++ EL  G
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 38/212 (17%)
Query: 113 VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKYDR 168
           +K+ +G G+FG V +  W     S VAVKI+  Q  + ++    L EV+I+  L      
Sbjct: 41  IKEKIGAGSFGTVHRAEWHG---SDVAVKILMEQDFHAERVNEFLREVAIMKRL------ 91
Query: 169 EDKHHIVRIYEYFVCQR-HLCICFELLDS-NLYELI-------KINHFRGLSLSIVQLFS 219
             +H  + ++   V Q  +L I  E L   +LY L+       +++  R LS++      
Sbjct: 92  --RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY----- 144
Query: 220 KQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
             + +G++ L  ++  I+H +LK  N+L+    K   +K+ DFG +  +  T  S   + 
Sbjct: 145 -DVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 278 ---YYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
               + +PEVL         D++SFG I+ EL
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 12  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 70
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 71  SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHT 126
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   GI+H DLKP N L+   +    +K+IDFG A      T      S + +  Y  PE
Sbjct: 127 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 284 VLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
            +     +              D+WS GCI+  +  G
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMN--SFVAVKIIKN------QPAYYQQALVE 155
           E QR  I +   +G G FG V +  + +  N    VA+K  KN      +  + Q+AL  
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT- 64
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSI 214
                       + D  HIV++    + +  + I  EL     L   +++  F  L L+ 
Sbjct: 65  ----------MRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKF-SLDLAS 112
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
           + L++ Q+   L+ L+    +H D+   N+L+ ++     +K+ DFG S   ED T    
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTXXKA 169
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325
            + +    + +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VAVK +    +  ++   L E S++          
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC----- 79
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             +L  + 
Sbjct: 80  --HHVVRLLGVVSKGQPTLVVMELMAHGDLK----SYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C       +KI DFG      R +Y   ++
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARN---CMVAHDFTVKIGDFGMT----RDIY---ET 183
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            +PE L    +TT+ DMWSFG ++ E+
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VAVK +    +  ++   L E S++          
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC----- 79
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             +L  + 
Sbjct: 80  --HHVVRLLGVVSKGQPTLVVMELMAHGDLK----SYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H DL   N   C       +KI DFG      R +Y   ++
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARN---CMVAHDFTVKIGDFGMT----RDIY---ET 183
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            +PE L    +TT+ DMWSFG ++ E+
Sbjct: 184 AYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 41/247 (16%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQPAY--YQQALVEVSILT 160
           R ++   LG G FGQV       ++       + VAVK++K+          + E+ ++ 
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 88
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSI----- 214
            + K        +I+ +         L +  E     NL E ++     GL  S      
Sbjct: 89  MIGKH------KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 215 --VQLFSK-------QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC- 264
              QL SK       Q+ RG+  L     IH DL   N+L+    +   +KI DFG A  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARD 199
Query: 265 -----TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASE 318
                   +T    +  ++  +PE L    YT   D+WSFG ++ E+F LG   +PG   
Sbjct: 200 IHHIDXXKKTTNGRLPVKWM-APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 319 FDLLRRM 325
            +L + +
Sbjct: 259 EELFKLL 265

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK----- 171
           +G G FG V K +    N+ VAVK +         A+V+++    L +++D+E K     
Sbjct: 33  MGEGGFGVVYKGYVN--NTTVAVKKLA--------AMVDITT-EELKQQFDQEIKVMAKC 81
Query: 172 --HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG---LSLSIVQLFSKQILRGL 226
              ++V +  +      LC+ +  +  N   L +++   G   LS  +    ++    G+
Sbjct: 82  QHENLVELLGFSSDGDDLCLVYVYM-PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 140
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRS 281
           + L +   IH D+K  NILL  +      KI DFG A   ++     +  R      Y +
Sbjct: 141 NFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           PE L G + T   D++SFG ++ E+  GLP      E  LL
Sbjct: 198 PEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 37  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 91
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 92  --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 147
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 204
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 205 TSPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 14/127 (11%)
Query: 198 LYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252
           LY   ++ H+       L +  + L+S QI + ++ L+    +H D+   NIL+ +   P
Sbjct: 89  LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS---P 145
Query: 253 AEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAEL-- 306
             +K+ DFG S   ED   Y    +R    + SPE +   ++TTA D+W F   + E+  
Sbjct: 146 ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205
Query: 307 FLGLPLF 313
           F   P F
Sbjct: 206 FGKQPFF 212

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 41/217 (18%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           ++G G F +VA            VK+ +    Y  + + +  +L        RE++  +V
Sbjct: 68  VIGRGAFSEVA-----------VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK------------QIL 223
                ++ Q H    F   D N   L+   +  G  L+++  F +            +I+
Sbjct: 117 NGDRRWITQLH----FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV 172
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSYIQ--SRYY 279
             +  +   G +H D+KP+NILL    +   I++ DFGS      D TV S +   +  Y
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 280 RSPEVLLGYQYTTA-------IDMWSFGCIVAELFLG 309
            SPE+L                D W+ G    E+F G
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 74
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 75  --DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 130
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFV--AVKIIK----NQPAYYQQALVEVSILTTLNKKYDRE 169
           LG G+FG V +  WDA     V  AVK +K    +QP      + EV+ + +L       
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 68
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           D  +++R+Y   V    + +  EL  L S L  L K  H     L  +  ++ Q+  G+ 
Sbjct: 69  DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 125
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR------S 281
            L+    IH DL   N+LL T      +KI DFG      +     +   + +      +
Sbjct: 126 YLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE L    ++ A D W FG  + E+F
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 21/198 (10%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VAVK+IK       +   E   +  L+         H  
Sbjct: 16  LGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKLS---------HPK 64
Query: 176 RIYEYFVCQRH--LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
            +  Y VC +   + I  E + +        +H +GL  S +      +  G++ L+   
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
            IH DL   N   C   +   +K+ DFG +    D    S + +++   + +PEV   ++
Sbjct: 125 FIHRDLAARN---CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 290 YTTAIDMWSFGCIVAELF 307
           Y++  D+W+FG ++ E+F
Sbjct: 182 YSSKSDVWAFGILMWEVF 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VA+K+IK       + + E  ++  L+ +        +V
Sbjct: 23  LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHE-------KLV 73
Query: 176 RIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y     QR + I  E + +  L   ++    R  +  ++++  K +   +  L+    
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQF 132
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           +H DL   N   C       +K+ DFG S    D    S + S++   +  PEVL+  ++
Sbjct: 133 LHRDLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+W+FG ++ E++
Sbjct: 190 SSKSDIWAFGVLMWEIY 206

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M +      VAVK +    +   +   L+E  I++  N +    
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ---- 94
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 95  ---NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 152 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYYRKG 203
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 8   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 66
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 67  SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 122
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
           +   GI+H DLKP N L+   +    +K+IDFG A      T      S + +  Y  PE
Sbjct: 123 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 284 VLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
            +     +              D+WS GCI+  +  G
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 215

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 65
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 66  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  +   +++ 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 177
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 39/246 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQPAY--YQQALVEVSILT 160
           R ++   LG G FGQV       ++       + VAVK++K+          + E+ ++ 
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSI----- 214
            + K        +I+ +         L +  E     NL E ++     GL  S      
Sbjct: 130 MIGKH------KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 215 --VQLFSK-------QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
              QL SK       Q+ RG+  L     IH DL   N+L+    +   +KI DFG A  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARD 240
Query: 266 EDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
                Y    +       + +PE L    YT   D+WSFG ++ E+F LG   +PG    
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 320 DLLRRM 325
           +L + +
Sbjct: 301 ELFKLL 306

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M +      VAVK +    +   +   L+E  I++  N +    
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ---- 108
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 109 ---NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYYRKG 217
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 74
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 75  --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 130
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG S   ED    +Y          +
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I +K  LG G +G+V +    + +  VAVK +K      ++ L E +++     
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM----- 64
Query: 165 KYDREDKH-HIVRIYEYFVCQRH--LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSK 220
              +E KH ++V++    VC R     I  E +   NL + ++  + + ++  ++   + 
Sbjct: 65  ---KEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY- 278
           QI   +  L+    IH DL   N   C   +   +K+ DFG S      T  +   +++ 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 176
Query: 279 --YRSPEVLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLRRMIRI 328
             + +PE L   +++   D+W+FG ++ E+   G+  +PG   +  ++LL +  R+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 232

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNS-----FVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M +      VAVK +    +   +   L+E  I++  N +    
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ---- 120
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 121 ---NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 177
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 178 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYYRKG 229
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 230 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 282

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V    D   N  VAVK IKN  A  Q  L E S++T L          ++V+
Sbjct: 201 IGKGEFGDVM-LGDYRGNK-VAVKCIKND-ATAQAFLAEASVMTQLRHS-------NLVQ 250
Query: 177 IYEYFVCQRH-LCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGLSLLKDA 232
           +    V ++  L I  E +      L+     RG S+     +  FS  +   +  L+  
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
             +H DL   N+L+    +    K+ DFG       T  +      + +PE L   +++T
Sbjct: 309 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 293 AIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPD 335
             D+WSFG ++ E++  G   +P     D++ R+ +      PD
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 409

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
           LGHG FG+V   ++ +++          VAVK +    +   +   L+E  I++  N + 
Sbjct: 56  LGHGAFGEV---YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ- 111
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SK 220
                 +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++
Sbjct: 112 ------NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 165
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYY 279
            I  G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YY
Sbjct: 166 DIACGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RAGYY 217
Query: 280 RS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
           R             PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 218 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 273

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A       Y    +    
Sbjct: 150 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 206
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L + +
Sbjct: 207 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 257

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----Y 279
           G++ L +   IH D+K  NILL  +      KI DFG A   ++       SR      Y
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQXVXXSRIVGTTAY 192
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
            +PE L G + T   D++SFG ++ E+  GLP      E  LL
Sbjct: 193 XAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 18/102 (17%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-----EDRTVYS--- 272
           QI   +  L   G++H DLKP NI          +K+ DFG         E++TV +   
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 273 -------YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
                   + ++ Y SPE + G  Y+  +D++S G I+ EL 
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 19/195 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V    D   N  VAVK IKN  A  Q  L E S++T L          ++V+
Sbjct: 29  IGKGEFGDVM-LGDYRGNK-VAVKCIKND-ATAQAFLAEASVMTQLRHS-------NLVQ 78
Query: 177 IYEYFVCQRH-LCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGLSLLKDA 232
           +    V ++  L I  E +      L+     RG S+     +  FS  +   +  L+  
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
             +H DL   N+L+    +    K+ DFG       T  +      + +PE L   +++T
Sbjct: 137 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 293 AIDMWSFGCIVAELF 307
             D+WSFG ++ E++
Sbjct: 194 KSDVWSFGILLWEIY 208

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 44/215 (20%)
Query: 113 VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKYDR 168
           +K+ +G G+FG V +  W     S VAVKI+  Q  + ++    L EV+I+  L      
Sbjct: 41  IKEKIGAGSFGTVHRAEWHG---SDVAVKILMEQDFHAERVNEFLREVAIMKRL------ 91
Query: 169 EDKHHIVRIYEYFVCQR-HLCICFELLDS-NLYELI-------KINHFRGLSLSIVQLFS 219
             +H  + ++   V Q  +L I  E L   +LY L+       +++  R LS++      
Sbjct: 92  --RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY----- 144
Query: 220 KQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
             + +G++ L  ++  I+H DLK  N+L+    K   +K+ DFG +  +      ++ S+
Sbjct: 145 -DVAKGMNYLHNRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLK---ASXFLXSK 197
Query: 278 Y------YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
                  + +PEVL         D++SFG I+ EL
Sbjct: 198 XAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A       Y    +    
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L + +
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 9/101 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY--SYIQSRY 278
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y  +    R 
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
              + +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L +
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 113 VKDLLGHGTFGQVAKCW---DAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +++++G G FG+V +       +  S VA+K +K      Q+   L E SI+        
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF----- 72
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGL 226
             +  +I+R+         + I  E +++  L   +++N  +   + +V +  + I  G+
Sbjct: 73  --EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML-RGIASGM 129
Query: 227 SLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTEDRTVYSYIQSRY---YRS 281
             L +   +H DL   NIL+ +++  K ++  +  F    + D T  S +  +    + +
Sbjct: 130 RYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA 189
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE +   ++T+A D WS+G ++ E+ 
Sbjct: 190 PEAIAFRKFTSASDAWSYGIVMWEVM 215

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M +      VAVK +    +   +   L+E  I++  N +    
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ---- 100
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 101 ---NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 158 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYYRKG 209
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 262

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQ---ALV--EVSIL 159
           I+K ++G G FG+VA           A+KI+       + + A +++    LV  +   +
Sbjct: 94  IIK-VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWI 152
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
           T L+  Y  +D++H+  + +Y+V    L +  +  D              L   + + + 
Sbjct: 153 TALH--YAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-------------LPEDMARFYI 197
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQ-- 275
            +++  +  +     +H D+KP+N+LL  +     I++ DFGS     +D TV S +   
Sbjct: 198 GEMVLAIDSIHQLHYVHRDIKPDNVLLDVN---GHIRLADFGSCLKMNDDGTVQSSVAVG 254
Query: 276 SRYYRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLG 309
           +  Y SPE+L   +     Y    D WS G  + E+  G
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LGHG FG+V +   + M +      VAVK +    +   +   L+E  I++  N +    
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ---- 134
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SKQIL 223
              +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++ I 
Sbjct: 135 ---NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRS- 281
            G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YYR  
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RAGYYRKG 243
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
                      PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
           LGHG FG+V   ++ +++          VAVK +    +   +   L+E  I++  N + 
Sbjct: 30  LGHGAFGEV---YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ- 85
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SK 220
                 +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++
Sbjct: 86  ------NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 139
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYY 279
            I  G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YY
Sbjct: 140 DIACGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYY 191
Query: 280 RS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
           R             PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 192 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 247

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L +
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
              + +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A       Y    +    
Sbjct: 147 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 203
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L + +
Sbjct: 204 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 254

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
           LGHG FG+V   ++ +++          VAVK +    +   +   L+E  I++  N + 
Sbjct: 55  LGHGAFGEV---YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ- 110
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SK 220
                 +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++
Sbjct: 111 ------NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 164
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYY 279
            I  G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YY
Sbjct: 165 DIACGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYY 216
Query: 280 RS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
           R             PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 217 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 272

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169
           ++ + +G G FG+V        N+ VAVK  +    P    + L E  IL    K+Y   
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL----KQYSHP 172
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           +   IVR+      ++ + I  EL+   +    ++    R    +++Q+       G+  
Sbjct: 173 N---IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA-GMEY 228
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRSPE 283
           L+    IH DL   N   C   +   +KI DFG +  E   V +           + +PE
Sbjct: 229 LESKCCIHRDLAARN---CLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE 285
Query: 284 VLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
            L   +Y++  D+WSFG ++ E F LG   +P  S
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A       Y    +    
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L + +
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
              + +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
              + +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A       Y    +    
Sbjct: 151 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 207
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L + +
Sbjct: 208 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 258

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
           LGHG FG+V   ++ +++          VAVK +    +   +   L+E  I++  N + 
Sbjct: 38  LGHGAFGEV---YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ- 93
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SK 220
                 +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++
Sbjct: 94  ------NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYY 279
            I  G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YY
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYY 199
Query: 280 RS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
           R             PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+        
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF----- 103
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--KQILRG 225
             D  +I+R+       + + I  E +++   +     H      +++QL    + I  G
Sbjct: 104 --DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASG 159
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
           +  L D G +H DL   NIL+ +++     K+ DFG     ED    +Y          +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
            SPE +   ++T+A D+WS+G ++ E+ 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTED 267
           L+   +  F+ Q+ +G+  L+    +H DL   N+L+        +KI DFG A     D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSD 225
Query: 268 RTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
                   +R    + +PE L    YT   D+WS+G ++ E+F LG+  +PG
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
           LGHG FG+V   ++ +++          VAVK +    +   +   L+E  I++  N + 
Sbjct: 38  LGHGAFGEV---YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ- 93
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGL---SLSIVQLF--SK 220
                 +IVR     +      I  EL+   +L   ++    R     SL+++ L   ++
Sbjct: 94  ------NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYY 279
            I  G   L++   IH D+   N LL T   P  + KI DFG A    R +Y   ++ YY
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMA----RDIY---RASYY 199
Query: 280 RS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
           R             PE  +   +T+  D WSFG ++ E+F LG   +P  S  ++L
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTL 162
           R  ++ ++G G  G+V  C+       + +  VA+K +K      Q+   L E SI+   
Sbjct: 50  RIHIEKIIGSGDSGEV--CYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS--K 220
                  D  +I+R+       R   I  E +++   +     H      +I+QL    +
Sbjct: 108 -------DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLR 158
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-- 277
            +  G+  L D G +H DL   N+L+ +++     K+ DFG S   ED    +Y  +   
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLV---CKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 278 ---YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
               + +PE +    +++A D+WSFG ++ E+ 
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VA+K+IK       + + E  ++  L+ +        +V
Sbjct: 16  LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHE-------KLV 66
Query: 176 RIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y     QR + I  E + +  L   ++    R  +  ++++  K +   +  L+    
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQF 125
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           +H DL   N   C       +K+ DFG S    D    S + S++   +  PEVL+  ++
Sbjct: 126 LHRDLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+W+FG ++ E++
Sbjct: 183 SSKSDIWAFGVLMWEIY 199

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A       Y    +    
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L + +
Sbjct: 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 211 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L +
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 154 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L +
Sbjct: 211 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 152 QLARGMEYLASQKCIHRDLTARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L +
Sbjct: 209 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A   +   Y    +    
Sbjct: 157 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
              + +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 214 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 254

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDR 268
           L +  + L+S QI + ++ L+    +H D+   NIL+ +   P  +K+ DFG S   ED 
Sbjct: 122 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS---PECVKLGDFGLSRYIEDE 178
Query: 269 TVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
             Y    +R    + SPE +   ++TTA D+W F   + E+ 
Sbjct: 179 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 220

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VA+K+IK       + + E  ++  L+ +        +V
Sbjct: 17  LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHE-------KLV 67
Query: 176 RIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y     QR + I  E + +  L   ++    R  +  ++++  K +   +  L+    
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQF 126
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           +H DL   N   C       +K+ DFG S    D    S + S++   +  PEVL+  ++
Sbjct: 127 LHRDLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+W+FG ++ E++
Sbjct: 184 SSKSDIWAFGVLMWEIY 200

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQ---ALV--EVSIL 159
           I+K ++G G FG+VA           A+KI+       + + A +++    LV  +   +
Sbjct: 78  IIK-VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWI 136
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
           T L+  Y  +D++H+  + +Y+V    L +  +  D              L   + + + 
Sbjct: 137 TALH--YAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-------------LPEDMARFYI 181
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQ-- 275
            +++  +  +     +H D+KP+N+LL  +     I++ DFGS     +D TV S +   
Sbjct: 182 GEMVLAIDSIHQLHYVHRDIKPDNVLLDVN---GHIRLADFGSCLKMNDDGTVQSSVAVG 238
Query: 276 SRYYRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLG 309
           +  Y SPE+L   +     Y    D WS G  + E+  G
Sbjct: 239 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+    +   +KI DFG A       Y    +    
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
              + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L + +
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDR 268
           L +  + L+S QI + ++ L+    +H D+   NIL+ +   P  +K+ DFG S   ED 
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS---PECVKLGDFGLSRYIEDE 166
Query: 269 TVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
             Y    +R    + SPE +   ++TTA D+W F   + E+ 
Sbjct: 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 19/195 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V    D   N  VAVK IKN  A  Q  L E S++T L          ++V+
Sbjct: 20  IGKGEFGDVM-LGDYRGNK-VAVKCIKND-ATAQAFLAEASVMTQLRHS-------NLVQ 69
Query: 177 IYEYFVCQRH-LCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGLSLLKDA 232
           +    V ++  L I  E +      L+     RG S+     +  FS  +   +  L+  
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 127
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
             +H DL   N+L+    +    K+ DFG       T  +      + +PE L    ++T
Sbjct: 128 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 293 AIDMWSFGCIVAELF 307
             D+WSFG ++ E++
Sbjct: 185 KSDVWSFGILLWEIY 199

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 44/101 (43%), Gaps = 14/101 (13%)
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT------EDRTVYSYIQ 275
           I RGL  +   G  H DLKP NILL    +P  + +     AC       +  T+  +  
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 276 SRY---YRSPEVLLGYQYTTAI----DMWSFGCIVAELFLG 309
            R    YR+PE L   Q    I    D+WS GC++  +  G
Sbjct: 203 QRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ ++       
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------- 76
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D  H+ R+    +      I   +    L + ++  H   +    +  +  QI +G++ L
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSR--YYRSPEV 284
           +D  ++H DL   N+L+ T   P  +KI DFG A     E++  ++        + + E 
Sbjct: 136 EDRRLVHRDLAARNVLVKT---PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 285 LLGYQYTTAIDMWSFGCIVAELF 307
           +L   YT   D+WS+G  V EL 
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 17/221 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           LG G +G V K          AVK I+      +Q      +L  L+      D    V 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQK----RLLXDLDISXRTVDCPFTVT 97
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
            Y     +  + IC EL D++L +  K  I+  + +   I+   +  I++ L  L     
Sbjct: 98  FYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS--RYYRSPEVL---LGY 288
           +IH D+KP N+L+       ++K  DFG +      V   I +  + Y +PE +   L  
Sbjct: 158 VIHRDVKPSNVLINAL---GQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 289 Q-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMIR 327
           + Y+   D+WS G    EL  L  P     + F  L++++ 
Sbjct: 215 KGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE 255

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ ++       
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------- 76
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D  H+ R+    +      I   +    L + ++  H   +    +  +  QI +G++ L
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSR--YYRSPEV 284
           +D  ++H DL   N+L+ T   P  +KI DFG A     E++  ++        + + E 
Sbjct: 136 EDRRLVHRDLAARNVLVKT---PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 285 LLGYQYTTAIDMWSFGCIVAELF 307
           +L   YT   D+WS+G  V EL 
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG V    W  + +  VA+K+IK       + + E  ++  L+ +        +V
Sbjct: 12  LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHE-------KLV 62
Query: 176 RIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
           ++Y     QR + I  E + +  L   ++    R  +  ++++  K +   +  L+    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQF 121
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
           +H DL   N   C       +K+ DFG S    D    S + S++   +  PEVL+  ++
Sbjct: 122 LHRDLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 291 TTAIDMWSFGCIVAELF 307
           ++  D+W+FG ++ E++
Sbjct: 179 SSKSDIWAFGVLMWEIY 195

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 19/195 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
           +G G FG V    D   N  VAVK IKN  A  Q  L E S++T L          ++V+
Sbjct: 14  IGKGEFGDVM-LGDYRGNK-VAVKCIKND-ATAQAFLAEASVMTQLRHS-------NLVQ 63
Query: 177 IYEYFVCQRH-LCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGLSLLKDA 232
           +    V ++  L I  E +      L+     RG S+     +  FS  +   +  L+  
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
             +H DL   N+L+    +    K+ DFG       T  +      + +PE L   +++T
Sbjct: 122 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 293 AIDMWSFGCIVAELF 307
             D+WSFG ++ E++
Sbjct: 179 KSDVWSFGILLWEIY 193

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ ++       
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------- 81
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D  H+ R+    +      I   +    L + ++  H   +    +  +  QI +G++ L
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSR--YYRSPEV 284
           +D  ++H DL   N+L+ T   P  +KI DFG A     E++  ++        + + E 
Sbjct: 141 EDRRLVHRDLAARNVLVKT---PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 285 LLGYQYTTAIDMWSFGCIVAELF 307
           +L   YT   D+WS+G  V EL 
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELM 220

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
           ++ ++G G FG+V         +   FVA+K +K+     Q+   L E SI+        
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF----- 91
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
             D  +++ +         + I  E +++ +L   ++ N  +   + +V +  + I  G+
Sbjct: 92  --DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML-RGIAAGM 148
Query: 227 SLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTEDRTVYSYIQSRY---YRS 281
             L D   +H DL   NIL+ +++  K ++  +  F    T D T  S +  +    + +
Sbjct: 149 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
           PE +   ++T+A D+WS+G ++ E+ 
Sbjct: 209 PEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 38/248 (15%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAK-CWDAEMNSF---VAVKII------KNQPAYYQQALVE 155
           ET+ + +   +LG G FG V K  W  E  +    VA+KI+      K    +  +AL+ 
Sbjct: 37  ETELKRV--KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 94
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
            S+           D  H+VR+    +      +   +    L E +   H   +   ++
Sbjct: 95  ASM-----------DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVH-EHKDNIGSQLL 142
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSY 273
             +  QI +G+  L++  ++H DL   N+L+ +   P  +KI DFG A     D   Y+ 
Sbjct: 143 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS---PNHVKITDFGLARLLEGDEKEYNA 199
Query: 274 IQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAEL--FLGLPL--FPGASEFDLLRRMI 326
              +    + + E +   ++T   D+WS+G  + EL  F G P    P     DLL +  
Sbjct: 200 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 259
Query: 327 RILGAQPP 334
           R+   QPP
Sbjct: 260 RL--PQPP 265

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+ RG+  L     IH DL   N+L+  +     ++I DFG A   +   Y    +    
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
              + +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VAVK +    +  ++   L E S++          
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC----- 80
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             +L  + 
Sbjct: 81  --HHVVRLLGVVSKGQPTLVVMELMAHGDLK----SYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H +L   N   C       +KI DFG      R +Y   ++
Sbjct: 135 QMAAEIADGMAYLNAKKFVHRNLAARN---CMVAHDFTVKIGDFGMT----RDIY---ET 184
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            +PE L    +TT+ DMWSFG ++ E+
Sbjct: 185 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
           LG G+FG V +         E  + VAVK +    +  ++   L E S++          
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC----- 79
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
             HH+VR+       +   +  EL+     +    ++ R L             +L  + 
Sbjct: 80  --HHVVRLLGVVSKGQPTLVVMELMAHGDLK----SYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
             + +I  G++ L     +H +L   N   C       +KI DFG      R +Y   ++
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRNLAARN---CMVAHDFTVKIGDFGMT----RDIY---ET 183
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
            YYR            +PE L    +TT+ DMWSFG ++ E+
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ ++       
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------- 75
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D  H+ R+    +      I   +    L + ++  H   +    +  +  QI +G++ L
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS-----RYYRSPEV 284
           +D  ++H DL   N+L+ T   P  +KI DFG A         Y          + + E 
Sbjct: 135 EDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 285 LLGYQYTTAIDMWSFGCIVAELF 307
           +L   YT   D+WS+G  V EL 
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ ++       
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------- 74
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D  H+ R+    +      I   +    L + ++  H   +    +  +  QI +G++ L
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSR--YYRSPEV 284
           +D  ++H DL   N+L+ T   P  +KI DFG A     E++  ++        + + E 
Sbjct: 134 EDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 285 LLGYQYTTAIDMWSFGCIVAELF 307
           +L   YT   D+WS+G  V EL 
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYI 274
           Q+ RG+  L     IH DL   N+L+  +     +KI DFG A          +T    +
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
             ++  +PE L    YT   D+WSFG ++ E+F LG   +PG
Sbjct: 222 PVKWM-APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
           +LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ ++       
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------- 76
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D  H+ R+    +      I   +    L + ++  H   +    +  +  QI +G++ L
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSR--YYRSPEV 284
           +D  ++H DL   N+L+ T   P  +KI DFG A     E++  ++        + + E 
Sbjct: 136 EDRRLVHRDLAARNVLVKT---PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 285 LLGYQYTTAIDMWSFGCIVAELF 307
           +L   YT   D+WS+G  V EL 
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R Y +   +G G   +V +  + E     A+K +  + A  Q      + +  LNK    
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            DK  I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  +  
Sbjct: 87  SDK--IIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 142
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVYSYIQSRYY 279
           +   GI+H DLKP N L+   +    +K+IDFG A           +D    S + +  Y
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDXXXVVKD----SQVGTVNY 194
Query: 280 RSPEVLLGYQYT-----------TAIDMWSFGCIVAELFLG 309
             PE +     +              D+WS GCI+  +  G
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	837
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-165
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-164
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-150
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-144
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-142
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-129
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-67
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-61
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-59
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-57
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-56
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-56
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-55
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-55
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-55
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-54
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-54
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-54
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-54
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-53
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-53
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-53
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-52
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-52
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-50
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-50
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-49
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-49
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-49
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-49
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-48
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-48
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-48
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-47
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-47
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-44
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-44
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-41
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-41
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-40
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-40
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-40
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-39
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-39
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-39
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-38
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-37
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-37
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-36
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-36
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-36
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-35
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-35
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-35
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-35
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-35
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-34
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-33
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-32
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-32
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-32
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-31
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-30
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-29
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-28
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-28
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-23
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-23
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-20
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-19
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-18
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-18
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-18
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-15
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-15
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-14
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-13
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-08
1twf_A	1733	B220, DNA-directed RNA polymerase II largest subun	4e-07
1twf_A	1733	B220, DNA-directed RNA polymerase II largest subun	6e-04
3h0g_A	1752	DNA-directed RNA polymerase II subunit RPB1; trans	7e-07
3h0g_A	1752	DNA-directed RNA polymerase II subunit RPB1; trans	3e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-05

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  482 bits (1243), Expect = e-165
 Identities = 141/405 (34%), Positives = 207/405 (51%), Gaps = 31/405 (7%)

Query: 55  TYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVK 114
            +                         V NDGYD+ N D I+      ++     RY + 
Sbjct: 5   HHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMD-----RYEID 59

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
            L+G G+FGQV K +D     +VA+KIIKN+ A+  QA +EV +L  +NK  D E K++I
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH-DTEMKYYI 118

Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DA 232
           V +  +F+ + HLC+ FE+L  NLY+L++  +FRG+SL++ + F++Q+   L  L   + 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
            IIHCDLKPENILLC   + A IKI+DFGS+C   + +Y YIQSR+YRSPEVLLG  Y  
Sbjct: 179 SIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDL 237

Query: 293 AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIG 352
           AIDMWS GCI+ E+  G PLF GA+E D + +++ +LG  PP ++L +A    KFF+   
Sbjct: 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG-IPPAHILDQAPKARKFFEK-- 294

Query: 353 SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412
                            +  L + +   RE K P         K    +           
Sbjct: 295 ------------LPDGTWN-LKKTKDGKREYKPP------GTRKLHNILGVETGGPGGRR 335

Query: 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457
             +        L   D +  ++++DP  R  P+ A +H F     
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  483 bits (1246), Expect = e-164
 Identities = 146/417 (35%), Positives = 211/417 (50%), Gaps = 35/417 (8%)

Query: 54  ETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIV 113
           E ++I +    Y   LN K+       G  N GYD+     +   +  +       RY V
Sbjct: 48  EHHEIFSYPEIYFLGLNAKKRQGMTG-GPNNGGYDDDQGSYVQVPHDHVAY-----RYEV 101

Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH 173
             ++G G+FGQV K +D +++  VA+K+++N+  +++QA  E+ IL  L K  D+++  +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK-QDKDNTMN 160

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
           ++ + E F  + H+C+ FELL  NLYELIK N F+G SL +V+ F+  IL+ L  L    
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTA 293
           IIHCDLKPENILL    +   IK+IDFGS+C E + VY+YIQSR+YR+PEV+LG +Y   
Sbjct: 221 IIHCDLKPENILLKQQGRS-GIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMP 279

Query: 294 IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGS 353
           IDMWS GCI+AEL  G PL PG  E D L  MI +LG  P   +L  +K    F      
Sbjct: 280 IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG-MPSQKLLDASKRAKNFVS---- 334

Query: 354 VHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413
                       G   Y  +T +   +  L            +     +   P  +    
Sbjct: 335 ----------SKGYPRYCTVTTLSDGSVVLNGG---------RSRRGKLRGPPESREWGN 375

Query: 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPR 470
                +       +DFLK  +E+DPA R +P QA RHP++       P        R
Sbjct: 376 ALKGCD---DPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  444 bits (1144), Expect = e-150
 Identities = 117/402 (29%), Positives = 178/402 (44%), Gaps = 68/402 (16%)

Query: 88  DNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQP 146
           D+    L+  +   L       RY +   LG GTFG+V +C D A   S VA+KII+N  
Sbjct: 3   DDKEGHLVCRIGDWLQE-----RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG 57

Query: 147 AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINH 206
            Y + A +E+++L  + +  D+E+K   V + ++F    H+CI FELL  N +E +K N+
Sbjct: 58  KYREAARLEINVLKKIKE-KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN 116

Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----------------V 250
           F+   L  V+  + Q+   L  L +  + H DLKPENIL   S                V
Sbjct: 117 FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 251 KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310
           K   I++ DFGSA  +     + + +R+YR PEV+L   +    D+WS GCI+ E + G 
Sbjct: 177 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

Query: 311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAY 370
            LF      + L  M +ILG   P +++   +    F+K                G   +
Sbjct: 237 TLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYK----------------GGLVW 279

Query: 371 QALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFL 430
              +      +E  KPL  K Y     LE                        + L D +
Sbjct: 280 DENSSDGRYVKENCKPL--KSYMLQDSLE-----------------------HVQLFDLM 314

Query: 431 KGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVP 472
           + ++EFDPA+R +  +A  HPF  G     P +    T R P
Sbjct: 315 RRMLEFDPAQRITLAEALLHPFFAGLT---PEERSFHTSRNP 353

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  428 bits (1102), Expect = e-144
 Identities = 106/407 (26%), Positives = 172/407 (42%), Gaps = 70/407 (17%)

Query: 69  LNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKC 128
           ++   +  S     L    D+          ++L N      ++V   +G GTFG+V  C
Sbjct: 1   MHHHHH-HSSGRENLYFQGDDEIVHFSWKKGMLLNN-----AFLVIRKMGDGTFGRVLLC 54

Query: 129 WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188
              +   + AVK+++N   Y + A +E  IL  +    D  + ++IV+ +  F+   H+C
Sbjct: 55  QHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN--DDINNNNIVKYHGKFMYYDHMC 112

Query: 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248
           + FE L  +LYE+I  N++ G  +  ++L+  +IL+ L+ L+   + H DLKPENILL  
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 249 S----------------------VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
                                   K   IK+IDFG A  +     S I +R YR+PEV+L
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL 232

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
              +  + DMWSFGC++AEL+ G  LF      + L  M  I+    P  +L EA  T+ 
Sbjct: 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQ-PIPKNMLYEATKTNG 291

Query: 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP 406
                                          Y  ++  K    +       ++       
Sbjct: 292 SK-----------------------------YVNKDELKLAWPENASSINSIK------H 316

Query: 407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
            +K L +  I K         DFL  +++ DP  R SP +  +H F+
Sbjct: 317 VKKCLPLYKIIK----HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  423 bits (1091), Expect = e-142
 Identities = 113/384 (29%), Positives = 174/384 (45%), Gaps = 65/384 (16%)

Query: 91  NSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS-FVAVKIIKNQPAYY 149
           +  LI     VL       RY + D LG G FG+V +C D +     VAVKI+KN   Y 
Sbjct: 1   SMHLICQSGDVLSA-----RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC 55

Query: 150 QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG 209
           + A  E+ +L  LN   D       V++ E+F    H+CI FELL  + Y+ IK N F  
Sbjct: 56  EAARSEIQVLEHLNTT-DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP 114

Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----------------VKPA 253
             L  ++  + QI + ++ L    + H DLKPENIL   S                +   
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

Query: 254 EIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
           +IK++DFGSA  +D    + + +R+YR+PEV+L   ++   D+WS GCI+ E +LG  +F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

Query: 314 PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQAL 373
           P     + L  M RILG   P +++++ +    F         ++  E S  GR      
Sbjct: 235 PTHDSKEHLAMMERILG-PLPKHMIQKTRKRKYFHH-----DRLDWDEHSSAGRY----- 283

Query: 374 TEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGL 433
                      KPL                    ++ +  +D+  E      L D ++ +
Sbjct: 284 ------VSRACKPL--------------------KEFMLSQDVEHE-----RLFDLIQKM 312

Query: 434 VEFDPAKRWSPFQASRHPFVTGEP 457
           +E+DPAKR +  +A +HPF     
Sbjct: 313 LEYDPAKRITLREALKHPFFDLLK 336

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  390 bits (1003), Expect = e-129
 Identities = 108/377 (28%), Positives = 162/377 (42%), Gaps = 62/377 (16%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK---- 164
            RYI+   LG G F  V    D   N+ VA+KI++    Y + A  E+ +L  +N     
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 165 KYDREDKHHIVRIYEYFV----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
           K D    +HI+++ ++F        H+ + FE+L  NL  LIK    RG+ L  V+  SK
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 221 QILRGLSLL-KDAGIIHCDLKPENILLCTSVKPA---EIKIIDFGSACTEDRTVYSYIQS 276
           Q+L GL  + +  GIIH D+KPEN+L+     P    +IKI D G+AC  D    + IQ+
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILG 330
           R YRSPEVLLG  +    D+WS  C++ EL  G  LF          + D + ++I +LG
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258

Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
            + P Y+L+  K T  FF   G + NI                                 
Sbjct: 259 -ELPSYLLRNGKYTRTFFNSRGLLRNISK------------------------------- 286

Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
                         +   +++  E           + DFL  +++ DP KR        H
Sbjct: 287 ------------LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334

Query: 451 PFVTGEPFTCPYQPPPE 467
           P++         + P  
Sbjct: 335 PWLKDTLGMEEIRVPDR 351

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  229 bits (584), Expect = 1e-67
 Identities = 102/402 (25%), Positives = 162/402 (40%), Gaps = 104/402 (25%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY V   LG G F  V   WD +   FVA+K++K+   Y + AL E+ +L ++    D  
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS-DPN 96

Query: 170 D--KHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
           D  +  +V++ + F        H+C+ FE+L  +L + I  ++++GL L  V+   +Q+L
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 224 RGLSLL-KDAGIIHCDLKPENILLC----------------------------------- 247
           +GL  L     IIH D+KPENILL                                    
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 248 -----------TSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDM 296
                       + +  ++KI D G+AC   +     IQ+R YRS EVL+G  Y T  D+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276

Query: 297 WSFGCIVAELFLGLPLFPG------ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKC 350
           WS  C+  EL  G  LF          + D +  +I +LG + P  ++   K + +FF  
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG-KVPRKLIVAGKYSKEFFT- 334

Query: 351 IGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410
                  + G+                         L          L E++     +  
Sbjct: 335 -------KKGD-------------------------LKHITKLKPWGLFEVLVE---KYE 359

Query: 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
            S E+ +          DFL  ++E  P KR +  +  RHP+
Sbjct: 360 WSQEEAA-------GFTDFLLPMLELIPEKRATAAECLRHPW 394

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  213 bits (543), Expect = 2e-61
 Identities = 96/385 (24%), Positives = 153/385 (39%), Gaps = 84/385 (21%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
             +  Y    ++G+G+FG V +    +    VA+K +     +      E+ I+      
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIM------ 101

Query: 166 YDREDKH-HIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRG--LSLSIVQ 216
             R+  H +IVR+  +F          +L +  + +   +Y + +        L +  V+
Sbjct: 102 --RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYI 274
           L+  Q+ R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 275 QSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
            SRYYR+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG   
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG--T 275

Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
           P         T +  + +                              E K P I    +
Sbjct: 276 P---------TREQIREMNP-------------------------NYTEFKFPQIKAHPW 301

Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
                        +R     E            +     L+E+ P  R +P +A  H F 
Sbjct: 302 TKV----------FRPRTPPE-----------AIALCSRLLEYTPTARLTPLEACAHSFF 340

Query: 454 TGEPFTCPYQPPPETPRVPVAQNFK 478
             +    P    P     P   NF 
Sbjct: 341 --DELRDPNVKLPNGRDTPALFNFT 363

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  204 bits (521), Expect = 4e-59
 Identities = 88/385 (22%), Positives = 152/385 (39%), Gaps = 81/385 (21%)

Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
            + +   R+ V+ + G GTFG V    +      VA+K +   P +      E+ I+  L
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDL 73

Query: 163 NKKYDREDKHH-IVRIYEYFVCQRH-------LCICFELLDSNLYELIKINHFRGLSLSI 214
                    H  IV++  YF            L +  E +   L+   +  + R ++   
Sbjct: 74  -----AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128

Query: 215 --VQLFSKQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR 268
             +++F  Q++R +  L      + H D+KP N+L+  +     +K+ DFGSA   +   
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSPSE 186

Query: 269 TVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +YI SRYYR+PE++ G Q YTTA+D+WS GCI AE+ LG P+F G +    L  ++R
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246

Query: 328 ILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
           +LG   P         + +  + +                          +   +L    
Sbjct: 247 VLG--CP---------SREVLRKLNP-----------------------SHTDVDLYN-- 270

Query: 388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQA 447
                             P+    S   +    +      D L  L+++ P +R  P++A
Sbjct: 271 --------------SKGIPWSNVFSDHSLKDAKE----AYDLLSALLQYLPEERMKPYEA 312

Query: 448 SRHPFVTGEPFTCPYQPPPETPRVP 472
             HP+   +    P    P    +P
Sbjct: 313 LCHPYF--DELHDPATKLPNNKDLP 335

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  201 bits (514), Expect = 1e-57
 Identities = 81/267 (30%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 76  TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
            +P  GV  +  D+ N  + +  +      + +  Y    ++G+G+FG V +    E + 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66

Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQRH------LC 188
            VA+K +     +      E+ I+        R  KH ++V +  +F           L 
Sbjct: 67  -VAIKKVLQDKRF---KNRELQIM--------RIVKHPNVVDLKAFFYSNGDKKDEVFLN 114

Query: 189 ICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246
           +  E +   +Y   +      + + + +++L+  Q+LR L+ +   GI H D+KP+N+LL
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

Query: 247 CTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIV 303
                   +K+IDFGSA          SYI SRYYR+PE++ G   YTT ID+WS GC++
Sbjct: 175 DPPS--GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232

Query: 304 AELFLGLPLFPGASEFDLLRRMIRILG 330
           AEL  G PLFPG S  D L  +I++LG
Sbjct: 233 AELMQGQPLFPGESGIDQLVEIIKVLG 259

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  196 bits (500), Expect = 1e-56
 Identities = 72/229 (31%), Positives = 117/229 (51%), Gaps = 20/229 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKY 166
           +Y     +G G++G V KC + +    VA+K            + AL E+ +L       
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRML------- 56

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            ++ KH ++V + E F  +R L + FE  D  +   +   + RG+   +V+  + Q L+ 
Sbjct: 57  -KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD-RYQRGVPEHLVKSITWQTLQA 114

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSP 282
           ++       IH D+KPENIL+    K + IK+ DFG A             + +R+YRSP
Sbjct: 115 VNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171

Query: 283 EVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           E+L+G  QY   +D+W+ GC+ AEL  G+PL+PG S+ D L  + + LG
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 13/78 (16%), Positives = 25/78 (32%), Gaps = 7/78 (8%)

Query: 400 EIVTNYPYRKNLSMEDISKESQIRLAL-------VDFLKGLVEFDPAKRWSPFQASRHPF 452
           ++ +   Y   + + D      + L         +  LKG +  DP +R +  Q   HP+
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

Query: 453 VTGEPFTCPYQPPPETPR 470
                         + P 
Sbjct: 288 FENIREIEDLAKEHDKPA 305

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  197 bits (502), Expect = 3e-56
 Identities = 90/408 (22%), Positives = 156/408 (38%), Gaps = 116/408 (28%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           ++Y +   LG G+FG V + +D E     A+K +   P Y      E+ I+  L+     
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD----- 58

Query: 169 EDKH-HIVRIYEYFVCQRH--------------------------------------LCI 189
              H +I+++ +YF                                           L +
Sbjct: 59  ---HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 190 CFELLDSNLYELIKINHFRGLSLSI--VQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247
             E +   L++++K     G S+ +  + ++  Q+ R +  +   GI H D+KP+N+L+ 
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 248 TSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVA 304
           +  K   +K+ DFGSA          +YI SR+YR+PE++LG  +YT +ID+WS GC+  
Sbjct: 176 S--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 305 ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSI 364
           EL LG PLF G +  D L R+I+I+G   P         T +    +             
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMG--TP---------TKEQMIRMNP----------- 271

Query: 365 GGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424
                        Y       P +  + +            P                  
Sbjct: 272 ------------HYTEVRF--PTLKAKDWRKI--------LPEGTP-------------S 296

Query: 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTG--EPFTCPYQPPPETPR 470
             +D L+ ++ ++P  R +P++A  HPF       +    +     P 
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPH 344

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  193 bits (493), Expect = 1e-55
 Identities = 69/229 (30%), Positives = 119/229 (51%), Gaps = 20/229 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKY 166
           +Y    L+G G++G V KC + +    VA+K            + A+ E+ +L       
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL------- 78

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            ++ +H ++V + E    ++   + FE +D  + + ++     GL   +VQ +  QI+ G
Sbjct: 79  -KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIING 136

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSP 282
           +       IIH D+KPENIL+    +   +K+ DFG A             + +R+YR+P
Sbjct: 137 IGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 283 EVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           E+L+G  +Y  A+D+W+ GC+V E+F+G PLFPG S+ D L  ++  LG
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG 242

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 44.9 bits (107), Expect = 6e-05
 Identities = 13/82 (15%), Positives = 25/82 (30%), Gaps = 7/82 (8%)

Query: 400 EIVTNYPYRKNLSMEDISKESQIRLAL-------VDFLKGLVEFDPAKRWSPFQASRHPF 452
           E+    P    + + +I +   +           +D  K  +  DP KR    +   H F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

Query: 453 VTGEPFTCPYQPPPETPRVPVA 474
              + F   +    +      A
Sbjct: 310 FQMDGFAERFSQELQLKVQKDA 331

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  194 bits (495), Expect = 3e-55
 Identities = 95/383 (24%), Positives = 155/383 (40%), Gaps = 81/383 (21%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
              +RY     +G G  G V   +DA +   VA+K +        + ++A  E+ ++  +
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81

Query: 163 NKKYDREDKHH--IVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSI 214
           N         H  I+ +   F  Q+ L       I  EL+D+NL ++I+      L    
Sbjct: 82  N---------HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHER 128

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVY 271
           +     Q+L G+  L  AGIIH DLKP NI++   C       +KI+DFG A T   +  
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGLARTAGTSFM 182

Query: 272 S--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
              Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ E+  G  LFPG    D   ++I  L
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242

Query: 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIG 389
           G   P+           F K +                      T +E   +        
Sbjct: 243 GTPCPE-----------FMKKLQP-----------------TVRTYVENRPKYAGYSF-- 272

Query: 390 KEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASR 449
           ++ F          +   + + +               D L  ++  D +KR S  +A +
Sbjct: 273 EKLFPDVLFPADSEHNKLKASQA--------------RDLLSKMLVIDASKRISVDEALQ 318

Query: 450 HPFVTGEPFTCPYQPPPETPRVP 472
           HP++    +  P +     P++P
Sbjct: 319 HPYI--NVWYDPSEAEAPPPKIP 339

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  192 bits (490), Expect = 8e-55
 Identities = 98/392 (25%), Positives = 154/392 (39%), Gaps = 102/392 (26%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLN 163
                + +K LLG G +G V           VA+K I+  ++P +  + L E+ IL    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67

Query: 164 KKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
                   H +I+ I+             + I  EL+ ++L+ +I       LS   +Q 
Sbjct: 68  --------HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQY 116

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS-- 272
           F  Q LR + +L  + +IH DLKP N+L+   C      ++K+ DFG A   D +     
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC------DLKVCDFGLARIIDESAADNS 170

Query: 273 -----------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320
                      ++ +R+YR+PEV+L    Y+ A+D+WS GCI+AELFL  P+FPG     
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230

Query: 321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEA 380
            L  +  I+G    D             +CI S                          A
Sbjct: 231 QLLLIFGIIGTPHSD----------NDLRCIESP------------------------RA 256

Query: 381 RELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAK 440
           R                  E + + P      +E +         + D L+ ++ FDPAK
Sbjct: 257 R------------------EYIKSLPMYPAAPLEKMFPRVN-PKGI-DLLQRMLVFDPAK 296

Query: 441 RWSPFQASRHPFVTG------EPFTCPYQPPP 466
           R +  +A  HP++        EP   P  P  
Sbjct: 297 RITAKEALEHPYLQTYHDPNDEPEGEPIPPSF 328

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  191 bits (488), Expect = 2e-54
 Identities = 83/375 (22%), Positives = 147/375 (39%), Gaps = 89/375 (23%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
           E  + Y+    +G G +G V    D      VA+K +        + ++A  E+ +L  +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSIV 215
                    H +++ + + F     L       +    + ++L +++ +      S   +
Sbjct: 81  Q--------HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKI 128

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS 272
           Q    Q+L+GL  +  AG++H DLKP N+ +   C      E+KI+DFG A   D  +  
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC------ELKILDFGLARHADAEMTG 182

Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           Y+ +R+YR+PEV+L +  Y   +D+WS GCI+AE+  G  LF G    D L +++++ G 
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242

Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
              +           F + +                            A+          
Sbjct: 243 PGTE-----------FVQKLNDKA------------------------AK---------- 257

Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
                     + + P         +   +    A  D L+ ++E D  KR +  QA  HP
Sbjct: 258 --------SYIQSLPQTPRKDFTQLFPRAS-PQAA-DLLEKMLELDVDKRLTAAQALTHP 307

Query: 452 FVTGEPFTCPYQPPP 466
           F   EPF  P +   
Sbjct: 308 FF--EPFRDPEEETE 320

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  192 bits (489), Expect = 2e-54
 Identities = 93/391 (23%), Positives = 154/391 (39%), Gaps = 94/391 (24%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 163 NKKYDREDKHH--IVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSI 214
                     H  ++ + + F   R L       +   L+ ++L  ++K      L+   
Sbjct: 86  K---------HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDH 133

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVY 271
           VQ    QILRGL  +  A IIH DLKP N+ +   C      E+KI+DFG A      + 
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC------ELKILDFGLARHTADEMT 187

Query: 272 SYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            Y+ +R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247

Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
               +             K I S                          AR         
Sbjct: 248 TPGAE-----------LLKKISSES------------------------AR--------- 263

Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
                      + +      ++  ++   +   LA+ D L+ ++  D  KR +  QA  H
Sbjct: 264 ---------NYIQSLTQMPKMNFANVFIGAN-PLAV-DLLEKMLVLDSDKRITAAQALAH 312

Query: 451 PFVTG------EPFTCPYQPPPETPRVPVAQ 475
            +         EP   PY    E+  + + +
Sbjct: 313 AYFAQYHDPDDEPVADPYDQSLESRDLLIDE 343

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  192 bits (490), Expect = 2e-54
 Identities = 100/411 (24%), Positives = 161/411 (39%), Gaps = 93/411 (22%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
              R+Y +   LG G +G V K  D      VAVK I +        Q+   E+ ILT L
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65

Query: 163 NKKYDREDKH-HIVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
           +        H +IV +         R + + F+ ++++L+ +I+ N    L     Q   
Sbjct: 66  SG-------HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI---LEPVHKQYVV 115

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS---- 272
            Q+++ +  L   G++H D+KP NILL   C       +K+ DFG + +           
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAEC------HVKVADFGLSRSFVNIRRVTNNI 169

Query: 273 --------------------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLP 311
                               Y+ +R+YR+PE+LLG   YT  IDMWS GCI+ E+  G P
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

Query: 312 LFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQ 371
           +FPG+S  + L R+I ++     +             + I S                  
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNE-----------DVESIQS------------------ 260

Query: 372 ALTEIEYEARELKK-PLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFL 430
                 +    ++      +    +K            K     D ++E+      +D L
Sbjct: 261 -----PFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA------LDLL 309

Query: 431 KGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDH 481
             L++F+P KR S   A +HPFV    F  P + P     + +  N  V H
Sbjct: 310 DKLLQFNPNKRISANDALKHPFV--SIFHNPNEEPNCDHIITIPINDNVKH 358

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  188 bits (480), Expect = 7e-54
 Identities = 85/384 (22%), Positives = 143/384 (37%), Gaps = 104/384 (27%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNK 164
           +   RY+    LG G  G V    D + +  VA+K I+   P   + AL E+ I+  L+ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD- 66

Query: 165 KYDREDKHH--IVRIYEYFVCQRHLC--------------ICFELLDSNLYELIKINHFR 208
                   H  IV+++E                       I  E ++++L  +++     
Sbjct: 67  --------HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-- 116

Query: 209 GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL----CTSVKPAEIKIIDFGSAC 264
            L     +LF  Q+LRGL  +  A ++H DLKP N+ +            +KI DFG A 
Sbjct: 117 -LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL------VLKIGDFGLAR 169

Query: 265 TEDRTVYS------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGAS 317
             D            + +++YRSP +LL    YT AIDMW+ GCI AE+  G  LF GA 
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229

Query: 318 EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIE 377
           E + ++ ++  +     +             + + S                        
Sbjct: 230 ELEQMQLILESIPVVHEE-----------DRQELLS------------------------ 254

Query: 378 YEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD 437
                                   + N     +  +  +      R A+ DFL+ ++ F 
Sbjct: 255 -VIPVY------------------IRNDMTEPHKPLTQLLPGIS-REAV-DFLEQILTFS 293

Query: 438 PAKRWSPFQASRHPFVTGEPFTCP 461
           P  R +  +A  HP++    ++ P
Sbjct: 294 PMDRLTAEEALSHPYM--SIYSFP 315

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  189 bits (482), Expect = 1e-53
 Identities = 86/390 (22%), Positives = 153/390 (39%), Gaps = 92/390 (23%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
           E +  Y     +G G +G V    D    + VA+K +        + ++A  E+ +L  +
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSIV 215
                    H +++ + + F     L       +    + ++L +L+K      L    +
Sbjct: 82  R--------HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRI 130

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS 272
           Q    Q+L+GL  +  AGIIH DLKP N+ +   C      E+KI+DFG A   D  +  
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC------ELKILDFGLARQADSEMTG 184

Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
           Y+ +R+YR+PEV+L +  YT  +D+WS GCI+AE+  G  LF G+   D L+ ++++ G 
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
            P +           F + + S                          A+          
Sbjct: 245 PPAE-----------FVQRLQSDE------------------------AK---------- 259

Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
                     +   P  +      I   +   LA+ + L+ ++  D  +R +  +A  HP
Sbjct: 260 --------NYMKGLPELEKKDFASILTNAS-PLAV-NLLEKMLVLDAEQRVTAGEALAHP 309

Query: 452 FVTG------EPFTCPYQPPPETPRVPVAQ 475
           +         EP    Y    +     + +
Sbjct: 310 YFESLHDTEDEPQVQKYDDSFDDVDRTLDE 339

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  189 bits (481), Expect = 2e-53
 Identities = 100/378 (26%), Positives = 157/378 (41%), Gaps = 92/378 (24%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN--QPAYYQQALVEVSILTTLN 163
           +   RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL    
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83

Query: 164 KKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
                   H +I+ I +          + + I  +L++++LY+L+K  H   LS   +  
Sbjct: 84  --------HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICY 132

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS-- 272
           F  QILRGL  +  A ++H DLKP N+LL   C      ++KI DFG A   D       
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC------DLKICDFGLARVADPDHDHTG 186

Query: 273 ----YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
               Y+ +R+YR+PE++L  + YT +ID+WS GCI+AE+    P+FPG    D L  ++ 
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

Query: 328 ILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
           ILG+   +              CI ++                         AR      
Sbjct: 247 ILGSPSQE-----------DLNCIINLK------------------------AR------ 265

Query: 388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQA 447
                         + + P++  +    +   +    AL D L  ++ F+P KR    QA
Sbjct: 266 ------------NYLLSLPHKNKVPWNRLFPNAD-SKAL-DLLDKMLTFNPHKRIEVEQA 311

Query: 448 SRHPFVTGEPFTCPYQPP 465
             HP++  E +  P   P
Sbjct: 312 LAHPYL--EQYYDPSDEP 327

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  188 bits (480), Expect = 2e-53
 Identities = 86/387 (22%), Positives = 152/387 (39%), Gaps = 100/387 (25%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY------------QQAL 153
             Q  Y V+  +  G++G V    D+E    VA+K + N  +              ++ L
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 154 VEVSILTTLNKKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHF 207
            E+ +L   +        H +I+ + + FV         L +  EL+ ++L ++I     
Sbjct: 78  REIRLLNHFH--------HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129

Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSA- 263
             +S   +Q F   IL GL +L +AG++H DL P NILL          +I I DF  A 
Sbjct: 130 V-ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN------DITICDFNLAR 182

Query: 264 -CTEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
             T D     Y+  R+YR+PE+++ ++ +T  +DMWS GC++AE+F    LF G++ ++ 
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242

Query: 322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEAR 381
           L +++ ++G    +                 S                          AR
Sbjct: 243 LNKIVEVVGTPKIE-----------DVVMFSSPS------------------------AR 267

Query: 382 ELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKR 441
           +                  +  +       +   +   +   +AL D +  ++EF+P +R
Sbjct: 268 DY-----------------LRNSLSNVPARAWTAVVPTAD-PVAL-DLIAKMLEFNPQRR 308

Query: 442 WSPFQASRHPFVTG------EPFTCPY 462
            S  QA RHP+                
Sbjct: 309 ISTEQALRHPYFESLFDPLDLTEGLSE 335

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  189 bits (482), Expect = 1e-52
 Identities = 93/382 (24%), Positives = 151/382 (39%), Gaps = 81/382 (21%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
              +RY     +G G  G V   +DA ++  VA+K +        + ++A  E+ ++  +
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118

Query: 163 NKKYDREDKHH--IVRIYEYFVCQ------RHLCICFELLDSNLYELIKINHFRGLSLSI 214
           N         H  I+ +   F  Q      + + +  EL+D+NL ++I+      L    
Sbjct: 119 N---------HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHER 165

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVY 271
           +     Q+L G+  L  AGIIH DLKP NI++   C       +KI+DFG A T   +  
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGLARTAGTSFM 219

Query: 272 S--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
              Y+ +RYYR+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  L
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

Query: 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIG 389
           G   P+           F K +                             R   +    
Sbjct: 280 GTPCPE-----------FMKKLQP-------------------------TVRNYVENRPK 303

Query: 390 KEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASR 449
                     ++     +  +L   D            D L  ++  DPAKR S   A +
Sbjct: 304 YA---GLTFPKL-----FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355

Query: 450 HPFVTGEPFTCPYQPPPETPRV 471
           HP++    +  P +     P++
Sbjct: 356 HPYI--NVWYDPAEVEAPPPQI 375

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  179 bits (457), Expect = 1e-50
 Identities = 79/356 (22%), Positives = 144/356 (40%), Gaps = 75/356 (21%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
             Q  Y +   LG G + +V +  +   N  V VKI+K  P   ++   E+ IL  L   
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENL--- 87

Query: 166 YDREDKHH--IVRIYEYF---VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
                +    I+ + +     V +    +   + +++  +L +      L+   ++ +  
Sbjct: 88  -----RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMY 137

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYS-YIQSRY 278
           +IL+ L      GI+H D+KP N+++    +  ++++ID+G A        Y+  + SRY
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 279 YRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           ++ PE+L+ YQ Y  ++DMWS GC++A + F   P F G   +D L R+ ++LG +    
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255

Query: 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK 396
            +                +NIE                            L        K
Sbjct: 256 YID--------------KYNIEL--------------------DPRFNDIL---GRHSRK 278

Query: 397 HLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
             E  V +   +  +S E +           DFL  L+ +D   R +  +A  HP+
Sbjct: 279 RWERFVHSEN-QHLVSPEAL-----------DFLDKLLRYDHQSRLTAREAMEHPY 322

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  176 bits (448), Expect = 8e-50
 Identities = 83/232 (35%), Positives = 125/232 (53%), Gaps = 27/232 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
           +Y   + +G GT+G V K  +       A+K I+ +      P+     + E+SIL    
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPS---TTIREISIL---- 54

Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
               +E KH +IV++Y+    ++ L + FE LD +L +L+      GL     + F  Q+
Sbjct: 55  ----KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQL 109

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
           L G++   D  ++H DLKP+N+L+       E+KI DFG A       R     I + +Y
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTLWY 166

Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           R+P+VL+G  +Y+T ID+WS GCI AE+  G PLFPG SE D L R+ RILG
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  175 bits (447), Expect = 3e-49
 Identities = 75/234 (32%), Positives = 121/234 (51%), Gaps = 26/234 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
           RY     LG GT+G+V K  D   N  VA+K I+ +      P     A+ EVS+L    
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGT---AIREVSLL---- 87

Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
               +E +H +I+ +         L + FE  +++L + +  +    +S+ +++ F  Q+
Sbjct: 88  ----KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM--DKNPDVSMRVIKSFLYQL 141

Query: 223 LRGLSLLKDAGIIHCDLKPENILL--CTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSR 277
           + G++       +H DLKP+N+LL    + +   +KI DFG A       R     I + 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201

Query: 278 YYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           +YR PE+LLG   Y+T++D+WS  CI AE+ +  PLFPG SE D L ++  +LG
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  175 bits (446), Expect = 4e-49
 Identities = 78/231 (33%), Positives = 125/231 (54%), Gaps = 25/231 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNK 164
            YI  D LG GT+  V K      ++ VA+K I+ +     P     A+ EVS+L     
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC---TAIREVSLL----- 54

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
              ++ KH +IV +++    ++ L + FE LD +L + +  +    +++  V+LF  Q+L
Sbjct: 55  ---KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-DCGNIINMHNVKLFLFQLL 110

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYR 280
           RGL+      ++H DLKP+N+L+       E+K+ DFG A       +T  + + + +YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYDNEVVTLWYR 167

Query: 281 SPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            P++LLG   Y+T IDMW  GCI  E+  G PLFPG++  + L  + RILG
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG 218

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  174 bits (444), Expect = 5e-49
 Identities = 74/232 (31%), Positives = 130/232 (56%), Gaps = 27/232 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
           +Y   + +G GT+G V K  D++    VA+K I+        P+    A+ E+S+L    
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPS---TAIREISLL---- 73

Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
               +E  H +IV + +    +R L + FE ++ +L +++   +  GL  S ++++  Q+
Sbjct: 74  ----KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD-ENKTGLQDSQIKIYLYQL 128

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
           LRG++      I+H DLKP+N+L+ +      +K+ DFG A       R+    + + +Y
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVVTLWY 185

Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           R+P+VL+G  +Y+T++D+WS GCI AE+  G PLFPG ++ D L ++  ILG
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  174 bits (443), Expect = 9e-49
 Identities = 79/235 (33%), Positives = 135/235 (57%), Gaps = 28/235 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNK 164
           ++   + LG+GT+  V K  +     +VA+K +K       P+    A+ E+S++     
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS---TAIREISLM----- 57

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIK----INHFRGLSLSIVQLFS 219
              +E KH +IVR+Y+    +  L + FE +D++L + +      N  RGL L++V+ F 
Sbjct: 58  ---KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQS 276
            Q+L+GL+   +  I+H DLKP+N+L+    K  ++K+ DFG A        T  S + +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171

Query: 277 RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            +YR+P+VL+G   Y+T+ID+WS GCI+AE+  G PLFPG ++ + L+ +  I+G
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  173 bits (440), Expect = 1e-48
 Identities = 79/233 (33%), Positives = 123/233 (52%), Gaps = 27/233 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
           +Y   + +G GT+G V K  + E +  VA+K ++        P+    AL E+ +L    
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLL---- 55

Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
               +E KH +IVR+++     + L + FE  D +L +    +    L   IV+ F  Q+
Sbjct: 56  ----KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQL 110

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
           L+GL       ++H DLKP+N+L+    +  E+K+ +FG A       R   + + + +Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167

Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILG 330
           R P+VL G   Y+T+IDMWS GCI AEL   G PLFPG    D L+R+ R+LG
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  173 bits (441), Expect = 2e-48
 Identities = 79/241 (32%), Positives = 112/241 (46%), Gaps = 34/241 (14%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK------NQPAYYQQALVEVSILTTLN 163
           RY     +G G +G V K  D     FVA+K ++               + EV++L  L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 164 KKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSIVQL 217
                  +H ++VR+ +     R      + + FE +D +L   +      GL    ++ 
Sbjct: 70  -----AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
             +Q LRGL  L    I+H DLKPENIL+ +      +K+ DFG A    R  YS  Q  
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLA----RI-YS-YQMA 175

Query: 278 Y--------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
                    YR+PEVLL   Y T +DMWS GCI AE+F   PLF G SE D L ++  ++
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235

Query: 330 G 330
           G
Sbjct: 236 G 236

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  173 bits (442), Expect = 3e-48
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 23/233 (9%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ------ALVEVSILTTL 162
           +RY   D LG G F  V K  D   N  VA+K IK       +      AL E+ +L   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL--- 66

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                +E  H +I+ + + F  + ++ + F+ ++++L  +IK ++   L+ S ++ +   
Sbjct: 67  -----QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLM 120

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRY 278
            L+GL  L    I+H DLKP N+LL    +   +K+ DFG A    + +R     + +R+
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 177

Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           YR+PE+L G   Y   +DMW+ GCI+AEL L +P  PG S+ D L R+   LG
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  169 bits (430), Expect = 6e-47
 Identities = 78/242 (32%), Positives = 121/242 (50%), Gaps = 38/242 (15%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQ------PAYYQQALVEVSILTTL 162
           +Y     +G G +G+V K  D +    FVA+K ++ Q      P      + EV++L  L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL---STIREVAVLRHL 68

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSIVQ 216
                   +H ++VR+++     R      L + FE +D +L   +      G+    ++
Sbjct: 69  E-----TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               Q+LRGL  L    ++H DLKP+NIL+ +S    +IK+ DFG A    R  YS  Q 
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLA----RI-YS-FQM 174

Query: 277 RY--------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
                     YR+PEVLL   Y T +D+WS GCI AE+F   PLF G+S+ D L +++ +
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234

Query: 329 LG 330
           +G
Sbjct: 235 IG 236

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  172 bits (437), Expect = 9e-47
 Identities = 98/404 (24%), Positives = 160/404 (39%), Gaps = 117/404 (28%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
                YI+K L+G G++G V   +D      VA+K +          ++ L E++IL  L
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82

Query: 163 NKKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
                      +I+R+Y+  +         L I  E+ DS+L +L K   F  L+   ++
Sbjct: 83  K--------SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF--LTEEHIK 132

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG---SACTEDRTV 270
                +L G + + ++GIIH DLKP N LL   C       +K+ DFG   +  +E  T 
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDC------SVKVCDFGLARTINSEKDTN 186

Query: 271 YS----------------------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELF 307
                                   ++ +R+YR+PE++L  + YT +ID+WS GCI AEL 
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

Query: 308 LGL-----------PLFPGASEFDLLRRMIRILGAQPPDYV--LKEAKNTSKFFKCIGS- 353
             L           PLFPG+S F L                  L         F  IG+ 
Sbjct: 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSK-KVHEKSNRDQLN------IIFNIIGTP 299

Query: 354 ----VHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409
               + NI   EV                            +Y         +  +P+RK
Sbjct: 300 TEDDLKNINKPEV---------------------------IKY---------IKLFPHRK 323

Query: 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
            ++++           + + L+ +++F+P KR +  QA  HP++
Sbjct: 324 PINLKQKYPSIS-DDGI-NLLESMLKFNPNKRITIDQALDHPYL 365

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  166 bits (423), Expect = 1e-44
 Identities = 91/411 (22%), Positives = 155/411 (37%), Gaps = 109/411 (26%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
           +   RY ++ L+G G++G V + +D      VA+K I          ++ L E++IL  L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109

Query: 163 NKKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
           N        H H+V++ +  + +       L +  E+ DS+  +L +      L+   ++
Sbjct: 110 N--------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP--VYLTELHIK 159

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG------------ 261
                +L G+  +  AGI+H DLKP N L+   C       +K+ DFG            
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC------SVKVCDFGLARTVDYPENGN 213

Query: 262 ------------------SACTEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCI 302
                                   R +  ++ +R+YR+PE++L  + YT AID+WS GCI
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273

Query: 303 VAELFLGL-----------PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCI 351
            AEL   +           PLFPG+S F L     +  G     +        +  F  +
Sbjct: 274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPD--QKAGNDFKFHTRGNRDQLNVIFNIL 331

Query: 352 GSVHNIENGEVSIGGRSAYQALTEIEYE-ARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410
           G+                 + +  +E E A+   +    +E      L E          
Sbjct: 332 GTPSE--------------EDIEALEKEDAKRYIRIFPKRE---GTDLAERFPASS---- 370

Query: 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCP 461
                         A+   LK ++ F+P KR +  +   HPF   +     
Sbjct: 371 ------------ADAI-HLLKRMLVFNPNKRITINECLAHPFF--KEVRIA 406

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  161 bits (409), Expect = 8e-44
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 28/227 (12%)

Query: 109 RRYIVKDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           +   V  LLG G F QV +       DA+      +K+ K           E  I T L 
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK------PANPWEFYIGTQLM 118

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDS----NLYELIKINHFRGLSLSIVQLFS 219
           ++     +H  ++ Y   + Q    +  EL       N   L K    + +   +V  F+
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--------IKIIDFGSACT-----E 266
            ++L  +  + D  IIH D+KP+N +L       +        + +ID G +       +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
                +  ++  ++  E+L    +   ID +     V  +  G  + 
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  153 bits (389), Expect = 1e-41
 Identities = 52/259 (20%), Positives = 103/259 (39%), Gaps = 37/259 (14%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKK 165
           R Y +   +G G   +V +  + E     A+K +   +           E++ L  L + 
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            D      I+R+Y+Y +  +++ +  E  + +L   +K    + +     + + K +L  
Sbjct: 87  SD-----KIIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEA 139

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR----YYR 280
           +  +   GI+H DLKP N L+   +    +K+IDFG +   +  T      S+     Y 
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 281 SPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
            PE +              + +   D+WS GCI+  +  G   F      + + ++  I+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAII 253

Query: 330 GAQP----PDYVLKEAKNT 344
                   PD   K+ ++ 
Sbjct: 254 DPNHEIEFPDIPEKDLQDV 272

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  156 bits (395), Expect = 3e-41
 Identities = 65/255 (25%), Positives = 102/255 (40%), Gaps = 33/255 (12%)

Query: 110 RYIVKDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
            +  KD+LGHG  G +     +D   N  VAVK I   P  +  A  EV +L        
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD---NRDVAVKRI--LPECFSFADREVQLLRES----- 74

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
             D+H +++R +     ++   I  EL  + L E ++   F  L L  + L  +Q   GL
Sbjct: 75  --DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLL-QQTTSGL 131

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQ------SRY 278
           + L    I+H DLKP NIL+       +    I DFG         +S+ +      +  
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 279 YRSPEVLLGYQ---YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPP 334
           + +PE+L        T  +D++S GC+   +   G   F        L+R   IL     
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-----GKSLQRQANILLGACS 246

Query: 335 DYVLKEAKNTSKFFK 349
              L   K+     +
Sbjct: 247 LDCLHPEKHEDVIAR 261

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  151 bits (383), Expect = 2e-40
 Identities = 54/267 (20%), Positives = 104/267 (38%), Gaps = 36/267 (13%)

Query: 99  NLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVE 155
             + V     R Y +   +G G   +V +  + E     A+K +   +           E
Sbjct: 2   ECISVK---GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNE 57

Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
           ++ L  L +  D      I+R+Y+Y +  +++ +  E  + +L   +K    + +     
Sbjct: 58  IAYLNKLQQHSD-----KIIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWER 110

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYI 274
           + + K +L  +  +   GI+H DLKP N L+   +    +K+IDFG +   +  T     
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK 166

Query: 275 QSR----YYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPG-ASE 318
            S+     Y  PE +              + +   D+WS GCI+  +  G   F    ++
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226

Query: 319 FDLLRRMIRILGAQP-PDYVLKEAKNT 344
              L  +I        PD   K+ ++ 
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDV 253

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  154 bits (391), Expect = 4e-40
 Identities = 71/245 (28%), Positives = 120/245 (48%), Gaps = 23/245 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALV--EVSILTTLNKKY 166
            Y     LG G +G+V  C D   +   A+KII K   +    + +  EV++L  L+   
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--- 94

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQIL 223
                H +I+++Y++F  +R+  +  E      L++ I     F   +     +  KQ+L
Sbjct: 95  -----HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF---NEVDAAVIIKQVL 146

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRS 281
            G++ L    I+H DLKPEN+LL +  K A IKI+DFG +      + +   + + YY +
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYVL 338
           PEVL   +Y    D+WS G I+  L  G P F G ++ ++LR++ +      +     V 
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265

Query: 339 KEAKN 343
           + AK+
Sbjct: 266 EGAKD 270

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  153 bits (388), Expect = 8e-40
 Identities = 77/246 (31%), Positives = 121/246 (49%), Gaps = 24/246 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY  + +LG G+FG+V  C D       AVK+I      Q    +  L EV +L  L+  
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-- 84

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQI 222
                 H +I+++YE+F  + +  +  E+     L++ I     F   S        +Q+
Sbjct: 85  ------HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAARIIRQV 135

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYR 280
           L G++ +    I+H DLKPEN+LL +  K A I+IIDFG +      + +   I + YY 
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYV 337
           +PEVL G  Y    D+WS G I+  L  G P F GA+E+D+L+++ +            V
Sbjct: 196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254

Query: 338 LKEAKN 343
            + AK+
Sbjct: 255 SESAKD 260

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  152 bits (387), Expect = 1e-39
 Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 34/256 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--------------NQPAYYQQALVE 155
            Y     LG G +G+V  C +   +S  A+K+IK              N   ++++   E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYE-LIKINHFRGLSL 212
           +S+L +L         H +I+++++ F  +++  +  E  +   L+E +I  + F     
Sbjct: 97  ISLLKSL--------DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF---DE 145

Query: 213 SIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTV 270
                  KQIL G+  L    I+H D+KPENILL        IKI+DFG +   ++D  +
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205

Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--- 327
              + + YY +PEVL   +Y    D+WS G I+  L  G P F G ++ D+++++ +   
Sbjct: 206 RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264

Query: 328 ILGAQPPDYVLKEAKN 343
                    +  EAK 
Sbjct: 265 YFDFNDWKNISDEAKE 280

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  147 bits (374), Expect = 2e-39
 Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 20/243 (8%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLN 163
            Q+ +     LGHG++G+V K    E     AVK        P    + L EV     + 
Sbjct: 55  FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114

Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           +       H   VR+ + +     L +  EL   +L +  +      L  + V  + +  
Sbjct: 115 Q-------HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCE-AWGASLPEAQVWGYLRDT 166

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYR 280
           L  L+ L   G++H D+KP NI L         K+ DFG                   Y 
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPR---GRCKLGDFGLLVELGTAGAGEVQEGDPRYM 223

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
           +PE+L G  Y TA D++S G  + E+   + L  G   +  LR+    L  +    +  E
Sbjct: 224 APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--GYLPPEFTAGLSSE 280

Query: 341 AKN 343
            ++
Sbjct: 281 LRS 283

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  149 bits (378), Expect = 2e-39
 Identities = 59/295 (20%), Positives = 119/295 (40%), Gaps = 41/295 (13%)

Query: 71  PKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWD 130
            ++++ SP +G  +D   + +++  ++V          R Y +   +G G   +V +  +
Sbjct: 26  ERQHMDSPDLGTDDDDKASSSANECISVK--------GRIYSILKQIGSGGSSKVFQVLN 77

Query: 131 AEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187
            E     A+K +   +           E++ L  L +  D      I+R+Y+Y +  +++
Sbjct: 78  -EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-----KIIRLYDYEITDQYI 131

Query: 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247
            +  E  + +L   +K    + +     + + K +L  +  +   GI+H DLKP N L+ 
Sbjct: 132 YMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189

Query: 248 TSVKPAEIKIIDFGSA-----CTEDRTVYSYIQSRYYRSPEVLLG-----------YQYT 291
             +    +K+IDFG A      T      S + +  Y  PE +              + +
Sbjct: 190 DGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245

Query: 292 TAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQP-PDYVLKEAKNT 344
              D+WS GCI+  +  G   F    ++   L  +I        PD   K+ ++ 
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  147 bits (374), Expect = 4e-39
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 38/237 (16%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDRED 170
           +G GTFG+V K    +    VA+K +  +      P     AL E+ IL        +  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIKIL--------QLL 73

Query: 171 KH-HIVRIYEYFVCQRHLCIC--------FELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
           KH ++V + E    +              F+  + +L  L+  N     +LS ++   + 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQM 132

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYIQ-- 275
           +L GL  +    I+H D+K  N+L+    +   +K+ DFG A      ++     Y    
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 276 -SRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
            + +YR PE+LLG   Y   ID+W  GCI+AE++   P+  G +E   L  + ++ G
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  150 bits (380), Expect = 7e-39
 Identities = 78/245 (31%), Positives = 116/245 (47%), Gaps = 23/245 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
           RY +  +LG G+FG+V KC D       AVK+I     +       L EV +L  L+   
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--- 79

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQIL 223
                H +I++++E         I  EL     L++ I K   F   S        KQ+ 
Sbjct: 80  -----HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVF 131

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRS 281
            G++ +    I+H DLKPENILL +  K  +IKIIDFG +    ++  +   I + YY +
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYVL 338
           PEVL G  Y    D+WS G I+  L  G P F G +E+D+L+R+              + 
Sbjct: 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250

Query: 339 KEAKN 343
            +AK+
Sbjct: 251 DDAKD 255

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  146 bits (369), Expect = 9e-39
 Identities = 66/360 (18%), Positives = 119/360 (33%), Gaps = 83/360 (23%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
            +++ D+LG G    V +    +     A+K+  N        +   E  +L  LN    
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN---- 65

Query: 168 REDKH-HIVRIYEYF--VCQRHLCICFELLDS-NLYE-LIKINHFRGLSLSIVQLFSKQI 222
               H +IV+++        RH  +  E     +LY  L + ++  GL  S   +  + +
Sbjct: 66  ----HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
           + G++ L++ GI+H ++KP NI+        +  K+ DFG+A    +D    S   +  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 280 RSPEVLLGY--------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
             P++            +Y   +D+WS G        G   F         + ++     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----- 236

Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
                       T K    I  V   ENG +                             
Sbjct: 237 --------YKIITGKPSGAISGVQKAENGPI----------------------------- 259

Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
                   +   + P   +LS         +++ L   L  ++E D  K W   Q     
Sbjct: 260 --------DWSGDMPVSCSLS-------RGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  148 bits (374), Expect = 1e-38
 Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 38/248 (15%)

Query: 112 IVKDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
                +G GT+G V  AK  D + +   A+K I+        A  E+++L        RE
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALL--------RE 74

Query: 170 DKH-HIVRIYEYFVCQRHLCIC--FELLDSNLYELIK-------INHFRGLSLSIVQLFS 219
            KH +++ + + F+      +   F+  + +L+ +IK             L   +V+   
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSA---CTEDRTVYSYIQ 275
            QIL G+  L    ++H DLKP NIL+         +KI D G A    +  + +     
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 276 S---RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLL 322
                +YR+PE+LLG   YT AID+W+ GCI AEL    P+F    E          D L
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254

Query: 323 RRMIRILG 330
            R+  ++G
Sbjct: 255 DRIFNVMG 262

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  142 bits (360), Expect = 1e-37
 Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 33/249 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDR 168
            +I  ++LG G F +V            A+K IK  PA+   +L  E+++L  +      
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI------ 63

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHF--RGLSLSIVQLFSKQ 221
             KH +IV + + +    H  +  +L+     EL    ++   +  +  SL I     +Q
Sbjct: 64  --KHENIVTLEDIYESTTHYYLVMQLVSGG--ELFDRILERGVYTEKDASLVI-----QQ 114

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYR 280
           +L  +  L + GI+H DLKPEN+L  T  + ++I I DFG S   ++  + +   +  Y 
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYV 174

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ---PPDY- 336
           +PEVL    Y+ A+D WS G I   L  G P F   +E  L     +I          + 
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE---KIKEGYYEFESPFW 231

Query: 337 --VLKEAKN 343
             + + AK+
Sbjct: 232 DDISESAKD 240

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  140 bits (355), Expect = 3e-37
 Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 25/247 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALV-EVSILTTLNKKYD 167
            +I K  LG G FG V    +        +K I K++     + +  E+ +L +L+    
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD---- 78

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLS--IVQLFSKQIL 223
               H +I++I+E F    ++ I  E  +   L E I     RG +LS   V    KQ++
Sbjct: 79  ----HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRS 281
             L+      ++H DLKPENIL   +   + IKIIDFG A     D    +   +  Y +
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PPDY 336
           PEV      T   D+WS G ++  L  G   F G S  ++ +   +    +         
Sbjct: 195 PEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ---KATYKEPNYAVECRP 250

Query: 337 VLKEAKN 343
           +  +A +
Sbjct: 251 LTPQAVD 257

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  144 bits (364), Expect = 3e-37
 Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 59/278 (21%)

Query: 108 QRRYIVKDLLGHGTFGQVAKC--WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           +   + + +LG+G+ G V     +       VAVK +     +   AL+E+ +LT     
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQGSFQGRP---VAVKRM--LIDFCDIALMEIKLLTES--- 65

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS----- 219
               D H +++R Y      R L I  EL + NL +L++  +    +L + + ++     
Sbjct: 66  ----DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTS----------VKPAEIKIIDFGSACTEDRT 269
           +QI  G++ L    IIH DLKP+NIL+ TS           +   I I DFG     D  
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 270 VYSYIQ-------SRYYRSPEVLLGY-------QYTTAIDMWSFGCIVAE-LFLGLPLFP 314
             S+         +  +R+PE+L          + T +ID++S GC+    L  G   F 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF- 240

Query: 315 GASEFDLLRRMIRILGAQ---------PPDYVLKEAKN 343
                D   R   I+                ++ EA +
Sbjct: 241 ----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  140 bits (354), Expect = 4e-37
 Identities = 57/261 (21%), Positives = 92/261 (35%), Gaps = 39/261 (14%)

Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
           V+      +   +L+G G FGQV K           +K +K      ++A  EV  L  L
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKL 61

Query: 163 NKKYDREDKH-HIVRIYEYFV----------------CQRHLCICFELLDS-NLYELIKI 204
           +        H +IV     +                   + L I  E  D   L + I+ 
Sbjct: 62  D--------HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113

Query: 205 NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
                L   +     +QI +G+  +    +I+ DLKP NI L       ++KI DFG   
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVT 170

Query: 265 TEDRTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
           +            +  Y SPE +    Y   +D+++ G I+AEL            F+  
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA-----FETS 225

Query: 323 RRMIRILGAQPPDYVLKEAKN 343
           +    +      D   K+ K 
Sbjct: 226 KFFTDLRDGIISDIFDKKEKT 246

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  140 bits (354), Expect = 6e-37
 Identities = 75/269 (27%), Positives = 114/269 (42%), Gaps = 50/269 (18%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
           +    +LG G FGQV K  +A  + + A+K I++        L EV +L +LN       
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN------- 60

Query: 171 KH-HIVRIYEYFVCQRH-------------LCICFELLDSN-LYELIKINHFRGLSLSIV 215
            H ++VR Y  ++ +R+             L I  E  ++  LY+LI   +         
Sbjct: 61  -HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
           +LF +QIL  LS +   GIIH DLKP NI +    +   +KI DFG A    R++     
Sbjct: 120 RLF-RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 276 SR-----------------YYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
                               Y + EVL G   Y   IDM+S G I  E+    P   G  
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME 233

Query: 318 EFDLLRRMIRILGAQPPDY---VLKEAKN 343
             ++L+++  +    PPD+    +K  K 
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKK 262

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (356), Expect = 1e-36
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 21/233 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY 166
           +Y+    +G G+FG+       E      +K I          +++  EV++L  +    
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--- 81

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
                H +IV+  E F     L I  +  +  +L++ I            +  +  QI  
Sbjct: 82  -----HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRS 281
            L  + D  I+H D+K +NI L    K   +++ DFG A   + TV    + I + YY S
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           PE+     Y    D+W+ GC++ EL      F   S  +L+ ++I   G+ PP
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFPP 244

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  141 bits (357), Expect = 1e-36
 Identities = 67/353 (18%), Positives = 120/353 (33%), Gaps = 85/353 (24%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
            +++ D+LG G    V +    +     A+K+  N        +   E  +L  LN    
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN---- 65

Query: 168 REDKH-HIVRIYEYF--VCQRHLCICFELLDS-NLYE-LIKINHFRGLSLSIVQLFSKQI 222
               H +IV+++        RH  +  E     +LY  L + ++  GL  S   +  + +
Sbjct: 66  ----HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
           + G++ L++ GI+H ++KP NI+        +  K+ DFG+A    +D    S   +  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 280 RSPEVLLGY--------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR-MIRILG 330
             P++            +Y   +D+WS G        G   F         +  M +I+ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII- 240

Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
                        T K    I  V   ENG +                            
Sbjct: 241 -------------TGKPSGAISGVQKAENGPI---------------------------- 259

Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS 443
                    +   + P   +LS         +++ L   L  ++E D  K W 
Sbjct: 260 ---------DWSGDMPVSCSLS-------RGLQVLLTPVLANILEADQEKCWG 296

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  139 bits (352), Expect = 2e-36
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 18/224 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           +Y++ + LG G FG V +C +         K +K +         E+SIL          
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------ 59

Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSKQILRG 225
             H +I+ ++E F     L + FE +   +++E I         L+   +  +  Q+   
Sbjct: 60  --HRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEA 114

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPE 283
           L  L    I H D++PENI +  + + + IKII+FG A              +  Y +PE
Sbjct: 115 LQFLHSHNIGHFDIRPENI-IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           V      +TA DMWS G +V  L  G+  F   +   ++  ++ 
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  136 bits (345), Expect = 6e-36
 Identities = 59/245 (24%), Positives = 103/245 (42%), Gaps = 25/245 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
            Y +++ +G G++G+V            A K I K       +   E+ I+ +L+     
Sbjct: 10  YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD----- 64

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQLFSKQIL 223
              H +I+R+YE F     + +  EL      EL    +    F     S      K +L
Sbjct: 65  ---HPNIIRLYETFEDNTDIYLVMELCTGG--ELFERVVHKRVF---RESDAARIMKDVL 116

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRS 281
             ++      + H DLKPEN L  T    + +K+IDFG A      + + + + + YY S
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYVL 338
           P+VL G  Y    D WS G ++  L  G P F   ++ +++ ++         +    V 
Sbjct: 177 PQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235

Query: 339 KEAKN 343
            +A++
Sbjct: 236 PQAES 240

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  136 bits (344), Expect = 1e-35
 Identities = 70/250 (28%), Positives = 108/250 (43%), Gaps = 32/250 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
            Y VK+ LG G F  V +C         A KII   K     +Q+   E  I   L    
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL---- 62

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQLFSKQ 221
               +H +IVR+++    +    + F+L+     EL    +    +   S +      +Q
Sbjct: 63  ----QHPNIVRLHDSIQEESFHYLVFDLVTGG--ELFEDIVAREFY---SEADASHCIQQ 113

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
           IL  ++     GI+H +LKPEN+LL +  K A +K+ DFG A    +    + +  +  Y
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP 334
            SPEVL    Y+  +D+W+ G I+  L +G P F    +  L     +I         P 
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAYDYPSPE 230

Query: 335 -DYVLKEAKN 343
            D V  EAK+
Sbjct: 231 WDTVTPEAKS 240

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  143 bits (362), Expect = 1e-35
 Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 21/231 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
            + +K+ LG G FG V +    +    VA+K  + + +   +     E+ I+  LN    
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN---- 70

Query: 168 REDKH-HIVRIYEYFVCQRHL------CICFELLDS-NLYELI-KINHFRGLSLSIVQLF 218
               H ++V   E     + L       +  E  +  +L + + +  +  GL    ++  
Sbjct: 71  ----HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
              I   L  L +  IIH DLKPENI+L    +    KIID G A    +      ++ +
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
             Y +PE+L   +YT  +D WSFG +  E   G   F    +       +R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  135 bits (343), Expect = 1e-35
 Identities = 51/251 (20%), Positives = 83/251 (33%), Gaps = 37/251 (14%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNK 164
              +   + +G G FG V KC         A+K  K         Q AL EV     L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSK 220
                  H H+VR +  +    H+ I  E  +  +L + I  N+          ++    
Sbjct: 70  -------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTS----------------VKPAEIKIIDFGSAC 264
           Q+ RGL  +    ++H D+KP NI +  +                      KI D G   
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 265 TEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
                         + + EVL   Y +    D+++    V       PL     ++  +R
Sbjct: 183 RISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241

Query: 324 RMIRILGAQPP 334
           +     G  P 
Sbjct: 242 Q-----GRLPR 247

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  137 bits (348), Expect = 2e-35
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 19/225 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
            Y + + LG G FG V +C +         K I    P        E+SI+  L+     
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH----- 106

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSKQILR 224
              H  ++ +++ F  +  + +  E L    L++ I         +S   V  + +Q   
Sbjct: 107 ---HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACE 160

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
           GL  + +  I+H D+KPENI+ C + K + +KIIDFG A     D  V     +  + +P
Sbjct: 161 GLKHMHEHSIVHLDIKPENIM-CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           E++         DMW+ G +   L  GL  F G  + + L+ + R
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  137 bits (346), Expect = 3e-35
 Identities = 70/250 (28%), Positives = 108/250 (43%), Gaps = 32/250 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
            Y VK+ LG G F  V +C         A KII   K     +Q+   E  I   L    
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL---- 85

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQLFSKQ 221
               +H +IVR+++    +    + F+L+     EL    +    +   S +      +Q
Sbjct: 86  ----QHPNIVRLHDSIQEESFHYLVFDLVTGG--ELFEDIVAREFY---SEADASHCIQQ 136

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
           IL  ++     GI+H +LKPEN+LL +  K A +K+ DFG A    +    + +  +  Y
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP 334
            SPEVL    Y+  +D+W+ G I+  L +G P F    +  L     +I         P 
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAYDYPSPE 253

Query: 335 -DYVLKEAKN 343
            D V  EAK+
Sbjct: 254 WDTVTPEAKS 263

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  136 bits (345), Expect = 3e-35
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 21/222 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALV-EVSILTTLN 163
            Y + +++G G F  V +C + E     AVKI+      + P    + L  E SI   L 
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML- 83

Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELI--KINHFRGLSLSIVQLFS 219
                  KH HIV + E +     L + FE +D ++L   I  + +     S ++   + 
Sbjct: 84  -------KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQS 276
           +QIL  L    D  IIH D+KP  +LL +    A +K+  FG A             + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
            ++ +PEV+    Y   +D+W  G I+  L  G   F G  E
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  133 bits (338), Expect = 4e-35
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 30/237 (12%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKK 165
             Y V   +G G++G+  K         +  K +       A  Q  + EV++L  L   
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-- 63

Query: 166 YDREDKH-HIVRIYEYFVCQR--HLCICFELLDS-NLYELIKINHFRGLSLS---IVQLF 218
                 H +IVR Y+  + +    L I  E  +  +L  +I         L    ++++ 
Sbjct: 64  ------HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117

Query: 219 SKQILRGLSLL-----KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV--- 270
           + Q+   L            ++H DLKP N+ L        +K+ DFG A   +      
Sbjct: 118 T-QLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFA 173

Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
            +++ + YY SPE +    Y    D+WS GC++ EL   +P F   S+ +L  ++  
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  134 bits (339), Expect = 4e-35
 Identities = 79/248 (31%), Positives = 118/248 (47%), Gaps = 29/248 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
           RY +  +LG G+FG+V KC D       AVK+I     +       L EV +L  L+   
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--- 79

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQIL 223
                H +I++++E         I  EL     L++ I K   F   S        KQ+ 
Sbjct: 80  -----HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVF 131

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRS 281
            G++ +    I+H DLKPENILL +  K  +IKIIDFG +    ++  +   I + YY +
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP-D 335
           PEVL G  Y    D+WS G I+  L  G P F G +E+D+L+   R+   +     P   
Sbjct: 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK---RVETGKYAFDLPQWR 247

Query: 336 YVLKEAKN 343
            +  +AK+
Sbjct: 248 TISDDAKD 255

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  140 bits (354), Expect = 6e-35
 Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 15/225 (6%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKY 166
              Y + + LG G FG V +  +    +  A K +     +  +    E+  ++ L    
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--- 212

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILR 224
                H  +V +++ F     + + +E +    L+E +   H + +S      + +Q+ +
Sbjct: 213 -----HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK 266

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
           GL  + +   +H DLKPENI+  T+ +  E+K+IDFG        ++V     +  + +P
Sbjct: 267 GLCHMHENNYVHLDLKPENIM-FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           EV  G       DMWS G +   L  GL  F G ++ + LR +  
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  137 bits (348), Expect = 6e-35
 Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 33/251 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALV--EVSILTTLNKKY 166
            Y + + LG G F  V +C         A  II   + +      +  E  I   L    
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL---- 67

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELI-KINHF--RGLSLSIVQLFSKQ 221
               KH +IVR+++    + H  + F+L+    L+E I    ++     S  I     +Q
Sbjct: 68  ----KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-----QQ 118

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRY 278
           IL  +      G++H +LKPEN+LL + +K A +K+ DFG A     E +  + +  +  
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----P 333
           Y SPEVL    Y   +D+W+ G I+  L +G P F    +  L +   +I         P
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ---QIKAGAYDFPSP 235

Query: 334 P-DYVLKEAKN 343
             D V  EAK+
Sbjct: 236 EWDTVTPEAKD 246

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  135 bits (342), Expect = 8e-35
 Identities = 32/273 (11%), Positives = 74/273 (27%), Gaps = 34/273 (12%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLN 163
           +R+  + + L  G    V    D E     A+K+     +N  +  ++          L 
Sbjct: 61  ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120

Query: 164 KKYDREDKHHIVRIYEYFVCQ-------------------RHLCICFELLDSNLYELIKI 204
            +   E +     +                           +  +       +L  L   
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180

Query: 205 NHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
             F         +  + + + Q++R  + L+  G++H    P+N+ +        + + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD---GRLMLGD 237

Query: 260 FGSACTEDRTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
             +         +      Y   E L      +T A++ W  G  +  ++     F   +
Sbjct: 238 VSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 318 E-FDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
                  +   +                  F K
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK 330

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  133 bits (337), Expect = 9e-35
 Identities = 56/251 (22%), Positives = 92/251 (36%), Gaps = 48/251 (19%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
            +     LG G FG V +  +   +   A+K I+  N+    ++ + EV  L  L     
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 61

Query: 168 REDKH-HIVRIYEYFV------------CQRHLCICFELLDS-NLYELIKINHFRGLS-- 211
               H  IVR +  ++             + +L I  +L    NL + +           
Sbjct: 62  ----HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV- 270
              + +F  QI   +  L   G++H DLKP NI          +K+ DFG     D+   
Sbjct: 118 SVCLHIF-LQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEE 173

Query: 271 --------------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
                            + ++ Y SPE + G  Y+  +D++S G I+ EL   L  F   
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQ 230

Query: 317 SEFDLLRRMIR 327
            E       +R
Sbjct: 231 MERVRTLTDVR 241

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (337), Expect = 1e-34
 Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 25/237 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
            + ++  +G G F +V +         VA+K ++             + E+ +L  LN  
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-- 90

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS---IVQLFSK 220
                 H ++++ Y  F+    L I  EL D+ +L  +IK    +   +    + + F  
Sbjct: 91  ------HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV- 143

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSR 277
           Q+   L  +    ++H D+KP N+ +        +K+ D G            +S + + 
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
           YY SPE +    Y    D+WS GC++ E+      F    + +L     +I     P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDYP 256

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  132 bits (334), Expect = 4e-34
 Identities = 62/233 (26%), Positives = 92/233 (39%), Gaps = 28/233 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
            Y   + LG G F  V KC +       A K IK        +    +    EVSIL  +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQL 217
                   +H +++ ++E +  +  + +  EL+     EL     +       +      
Sbjct: 72  --------QHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESL---TEEEATE 118

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYI 274
           F KQIL G+  L    I H DLKPENI+L     P   IKIIDFG A          +  
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178

Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
            +  + +PE++         DMWS G I   L  G   F G ++ + L  +  
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  132 bits (334), Expect = 5e-34
 Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 16/224 (7%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDR 168
           +    LG G F  V +C         A K +   +       + L E+++L         
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELA------ 85

Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
             K    ++ ++E +     + +  E      ++ L        +S + V    KQIL G
Sbjct: 86  --KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ-SRYYRSPE 283
           +  L    I+H DLKP+NILL +     +IKI+DFG S           I  +  Y +PE
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE 203

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           +L     TTA DMW+ G I   L      F G    +    + +
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (335), Expect = 5e-34
 Identities = 80/349 (22%), Positives = 126/349 (36%), Gaps = 59/349 (16%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
           +     LG G  G V K         +A K+I    +PA   Q + E+ +L   N  Y  
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-- 92

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                IV  Y  F     + IC E +D   L +++K      +   I+   S  +++GL+
Sbjct: 93  -----IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLT 145

Query: 228 LLKDAG-IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVL 285
            L++   I+H D+KP NIL+ +     EIK+ DFG S    D    S++ +R Y SPE L
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 202

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345
            G  Y+   D+WS G  + E+ +G    P     +L       +     +   +      
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405
              K                  + ++ L  I  E      P +    F            
Sbjct: 263 PLNKFGMDSR---------PPMAIFELLDYIVNE----PPPKLPSGVF------------ 297

Query: 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454
                      S E        DF+   +  +PA+R    Q   H F+ 
Sbjct: 298 -----------SLE------FQDFVNKCLIKNPAERADLKQLMVHAFIK 329

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  131 bits (332), Expect = 8e-34
 Identities = 53/254 (20%), Positives = 101/254 (39%), Gaps = 31/254 (12%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           E       +  +G G+FG+V +  D +     AVK ++ +    +    E+     L+  
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE----ELVACAGLS-- 108

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
                    IV +Y        + I  ELL+  +L +LIK      L       +  Q L
Sbjct: 109 ------SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQAL 160

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR----- 277
            GL  L    I+H D+K +N+LL  S   +   + DFG + C +   +   + +      
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
              + +PEV++G      +D+WS  C++  +  G   +   +++      ++I    PP 
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPPP- 274

Query: 336 YVLKEAKNTSKFFK 349
            + +   + +    
Sbjct: 275 -IREIPPSCAPLTA 287

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  131 bits (331), Expect = 9e-34
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 24/231 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
            Y + + LG G F  V KC +       A K IK        +    ++   EVSIL  +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYE-LIKINHFRGLSLSIVQLFS 219
                    H +++ +++ +  +  + +  EL+    L++ L +       S      F 
Sbjct: 73  L--------HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFI 121

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYIQS 276
           KQIL G++ L    I H DLKPENI+L     P   IK+IDFG A    +     +   +
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
             + +PE++         DMWS G I   L  G   F G ++ + L  +  
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  129 bits (327), Expect = 2e-33
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 19/211 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDR 168
               + +LG GT+G V    D      +A+K I  + + Y Q L  E+++   L      
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK----- 77

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRG-LSLSIVQLFSKQILRG 225
              H +IV+    F     + I  E +   +L  L++        +   +  ++KQIL G
Sbjct: 78  ---HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSP 282
           L  L D  I+H D+K +N+L+ T      +KI DFG++      +    ++  +  Y +P
Sbjct: 135 LKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

Query: 283 EVLLGYQ--YTTAIDMWSFGCIVAELFLGLP 311
           E++      Y  A D+WS GC + E+  G P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (328), Expect = 2e-33
 Identities = 54/253 (21%), Positives = 88/253 (34%), Gaps = 37/253 (14%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYD 167
           + Y+    LG G F  V          F A+K I  ++    ++A  E  +    N    
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN---- 84

Query: 168 REDKH-HIVRIYEYFVCQR----HLCICFELLDS-NLYELIKINHFRGLSLS---IVQLF 218
               H +I+R+  Y + +R       +         L+  I+    +G  L+   I+ L 
Sbjct: 85  ----HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR- 277
              I RGL  +   G  H DLKP NILL       +  ++D GS       V    Q+  
Sbjct: 141 L-GICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 278 -----------YYRSPEVLLGYQY---TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
                       YR+PE+     +       D+WS GC++  +  G   +    +     
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

Query: 324 RMIRILGAQPPDY 336
            +        P  
Sbjct: 257 ALAVQNQLSIPQS 269

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (326), Expect = 2e-33
 Identities = 55/247 (22%), Positives = 107/247 (43%), Gaps = 29/247 (11%)

Query: 110 RYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKK 165
           R++     +G G+F  V K  D E    VA   +   K   +  Q+   E  +L  L   
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL--- 82

Query: 166 YDREDKH-HIVRIYEYFVC----QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFS 219
                +H +IVR Y+ +      ++ + +  EL+ S  L   +K   F+ + + +++ + 
Sbjct: 83  -----QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWC 135

Query: 220 KQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQS 276
           +QIL+GL  L  +   IIH DLK +NI +  +     +KI D G +         + I +
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKRASFAKAVIGT 193

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
             + +PE+    +Y  ++D+++FG  + E+      +   SE     ++ R + +     
Sbjct: 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPA 249

Query: 337 VLKEAKN 343
              +   
Sbjct: 250 SFDKVAI 256

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  128 bits (325), Expect = 2e-33
 Identities = 61/233 (26%), Positives = 92/233 (39%), Gaps = 28/233 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
            Y + + LG G F  V KC         A K IK        +    ++   EV+IL  +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQL 217
                    H +I+ +++ F  +  + +  EL+     EL     +       +      
Sbjct: 66  R--------HPNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESL---TEDEATQ 112

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYI 274
           F KQIL G+  L    I H DLKPENI+L     P   IK+IDFG A          +  
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172

Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
            +  + +PE++         DMWS G I   L  G   F G ++ + L  +  
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  130 bits (329), Expect = 5e-33
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 24/231 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
            Y + + LG G F  V KC +       A K IK        +    ++   EVSIL  +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYE-LIKINHFRGLSLSIVQLFS 219
                    H +I+ +++ +  +  + +  EL+    L++ L +       S      F 
Sbjct: 73  --------LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFI 121

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYIQS 276
           KQIL G++ L    I H DLKPENI+L     P   IK+IDFG A    +     +   +
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
             + +PE++         DMWS G I   L  G   F G ++ + L  +  
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  129 bits (326), Expect = 1e-32
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 19/221 (8%)

Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
            ++LG G FGQV KC +      +A KII        ++   E+S++  L+        H
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--------H 145

Query: 173 -HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSKQILRGLSL 228
            +++++Y+ F  +  + +  E +D   L++ I        +L+     LF KQI  G+  
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRH 202

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLL 286
           +    I+H DLKPENI LC +    +IKIIDFG A        +     +  + +PEV+ 
Sbjct: 203 MHQMYILHLDLKPENI-LCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
               +   DMWS G I   L  GL  F G ++ + L  ++ 
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  128 bits (323), Expect = 2e-32
 Identities = 66/297 (22%), Positives = 116/297 (39%), Gaps = 73/297 (24%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK------NQPAYYQQALVEVSILTT 161
           Q++Y +K  +G G++G V    + +  +  A+KI+         P   ++   EV ++  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 162 LNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD------------------------- 195
           L         H +I R+YE +  ++++C+  EL                           
Sbjct: 85  L--------HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 196 ------SNLYELIKINHFRGLSLSIVQLFS--------KQILRGLSLLKDAGIIHCDLKP 241
                     E        G   S+  +          +QI   L  L + GI H D+KP
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196

Query: 242 ENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRSPEVLLG--YQYTT 292
           EN L  T+ K  EIK++DFG +         E   + +   + Y+ +PEVL      Y  
Sbjct: 197 ENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 293 AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP-DYVLKEAKN 343
             D WS G ++  L +G   FPG ++ D +    ++L  +     P  + +   A++
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTIS---QVLNKKLCFENPNYNVLSPLARD 309

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  126 bits (319), Expect = 8e-32
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 35/250 (14%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            + V+  LG G    V +C         A+K++K      +    E+ +L  L       
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRL------- 105

Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHF--RGLSLSIVQLFSKQI 222
             H +I+++ E F     + +  EL+     EL    ++  ++  R  + ++     KQI
Sbjct: 106 -SHPNIIKLKEIFETPTEISLVLELVTGG--ELFDRIVEKGYYSERDAADAV-----KQI 157

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYR 280
           L  ++ L + GI+H DLKPEN+L  T    A +KI DFG +        + +   +  Y 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQ-----PP 334
           +PE+L G  Y   +DMWS G I   L  G   F     +  + R   RIL  +     P 
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR---RILNCEYYFISPW 274

Query: 335 -DYVLKEAKN 343
            D V   AK+
Sbjct: 275 WDEVSLNAKD 284

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  125 bits (315), Expect = 1e-31
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 28/230 (12%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDRE 169
            +    LG G+F    KC   + N   AVKII K   A  Q+   E++ L          
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLC------- 62

Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHF--RGLSLSIVQLFSKQI 222
           + H +IV+++E F  Q H  +  ELL+    EL     K  HF     S  +     +++
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGG--ELFERIKKKKHFSETEASYIM-----RKL 115

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
           +  +S + D G++H DLKPEN+L        EIKIIDFG A     +++ + +   + +Y
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
            +PE+L    Y  + D+WS G I+  +  G   F            + I+
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  123 bits (310), Expect = 7e-31
 Identities = 68/259 (26%), Positives = 101/259 (38%), Gaps = 51/259 (19%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           + K +LG G  G+V +C+        A+K++ + P   Q    EV           +   
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHW-------QASG 80

Query: 172 H-HIVRIYEYFVCQRHLCICF----------ELLDSNLYELIKINHFRGLSLSIVQLFS- 219
             HIV I + +    H   C           EL         +I   RG      Q F+ 
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS-------RIQE-RG-----DQAFTE 127

Query: 220 -------KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVY 271
                  + I   +  L    I H D+KPEN+L  +  K A +K+ DFG +  T    + 
Sbjct: 128 REAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILG 330
           +   + YY +PEVL   +Y  + DMWS G I+  L  G P F   +   +   M  RI  
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247

Query: 331 AQ-----PP-DYVLKEAKN 343
            Q     P    V ++AK 
Sbjct: 248 GQYGFPNPEWSEVSEDAKQ 266

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  121 bits (307), Expect = 9e-31
 Identities = 63/267 (23%), Positives = 93/267 (34%), Gaps = 51/267 (19%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV----------EVS 157
              Y  K++LG G    V +C         AVKII         A            EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHFRGL 210
           IL  +         H +I+++ + +       + F      EL D     L +       
Sbjct: 76  ILRKV-------SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----YLTEKVTL--- 121

Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR 268
           S    +   + +L  +  L    I+H DLKPENILL        IK+ DFG +       
Sbjct: 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGE 178

Query: 269 TVYSYIQSRYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
            +     +  Y +PE++          Y   +DMWS G I+  L  G P F    +  +L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238

Query: 323 RRMIRILGAQ-----PP-DYVLKEAKN 343
           R    I+        P  D      K+
Sbjct: 239 R---MIMSGNYQFGSPEWDDYSDTVKD 262

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  122 bits (308), Expect = 1e-30
 Identities = 67/258 (25%), Positives = 105/258 (40%), Gaps = 39/258 (15%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---------NQPAYYQQALVEVSILT 160
            YI+   LG G  G+V   ++ +    VA+KII           +         E+ IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSI 214
            LN        H  I++I  +F  + +     L    EL D    +++          + 
Sbjct: 71  KLN--------HPCIIKIKNFFDAEDYYIVLELMEGGELFD----KVVGNKRL---KEAT 115

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
            +L+  Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175

Query: 273 YIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-- 327
              +  Y +PEVL+      Y  A+D WS G I+     G P F        L+  I   
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

Query: 328 --ILGAQPPDYVLKEAKN 343
                 +    V ++A +
Sbjct: 236 KYNFIPEVWAEVSEKALD 253

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  124 bits (314), Expect = 1e-30
 Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 35/238 (14%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV---------EVSILT 160
            YI+   LG G  G+V   ++ +    VA++II  +      A           E+ IL 
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSI 214
            LN        H  I++I  +F  + +     L    EL D       K+   + L  + 
Sbjct: 196 KLN--------HPCIIKIKNFFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEAT 240

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
            +L+  Q+L  +  L + GIIH DLKPEN+LL +  +   IKI DFG +    E   + +
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300

Query: 273 YIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
              +  Y +PEVL+      Y  A+D WS G I+     G P F        L+  I 
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  122 bits (307), Expect = 1e-30
 Identities = 51/289 (17%), Positives = 88/289 (30%), Gaps = 75/289 (25%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLN-- 163
              +     +G G FG V +  +   +   A+K I+  N+    ++ + EV  L  L   
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 164 ------------------------------------------------KKYDREDKHHIV 175
                                                           ++ D     + V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
              +    + +L I  +L    NL + +            +      QI   +  L   G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACT---------------EDRTVYSYIQSRY 278
           ++H DLKP NI          +K+ DFG                      T    + ++ 
Sbjct: 185 LMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           Y SPE + G  Y+  +D++S G I+ EL      F    E   +   +R
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR 287

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  123 bits (311), Expect = 2e-30
 Identities = 69/260 (26%), Positives = 106/260 (40%), Gaps = 42/260 (16%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
                +   +LG G  G+V + ++       A+K++++ P   +    EV +    ++  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQ-- 113

Query: 167 DREDKH-HIVRIYEYF----VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFS- 219
                  HIVRI + +      ++ L I  E LD   L+  I     RG      Q F+ 
Sbjct: 114 -----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRG-----DQAFTE 160

Query: 220 -------KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTV 270
                  K I   +  L    I H D+KPEN+L  +    A +K+ DFG A   T   ++
Sbjct: 161 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220

Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RIL 329
            +   + YY +PEVL   +Y  + DMWS G I+  L  G P F       +   M  RI 
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280

Query: 330 GAQ-----PP-DYVLKEAKN 343
             Q     P    V +E K 
Sbjct: 281 MGQYEFPNPEWSEVSEEVKM 300

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (303), Expect = 5e-30
 Identities = 62/252 (24%), Positives = 107/252 (42%), Gaps = 30/252 (11%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
                 +G GT GQV K    +    +AVK ++        ++ L+++ ++   +     
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH----- 81

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            D  +IV+ +  F+    + I  EL+ +   E +K      +   I+   +  I++ L  
Sbjct: 82  -DCPYIVQCFGTFITNTDVFIAMELMGTCA-EKLKKRMQGPIPERILGKMTVAIVKALYY 139

Query: 229 LKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED---RTVYSYIQSRYYRSPE 283
           LK+  G+IH D+KP NILL       +IK+ DFG S    D   +          Y +PE
Sbjct: 140 LKEKHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVDDKAKD--RSAGCAAYMAPE 194

Query: 284 VL-----LGYQYTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMIRILGAQPPDYV 337
            +         Y    D+WS G  + EL  G  P     ++F++L    ++L  +PP  +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT---KVLQEEPP--L 249

Query: 338 LKEAKNTSKFFK 349
           L      S  F+
Sbjct: 250 LPGHMGFSGDFQ 261

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  119 bits (301), Expect = 1e-29
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 44/256 (17%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            Y VK+ +G G++    +C     N   AVKII        +   E+ IL        R 
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILL-------RY 72

Query: 170 DKH-HIVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHF--RGLSLSIVQLFSK 220
            +H +I+ + + +   +++ +        ELLD    ++++   F  R  S  +      
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLD----KILRQKFFSEREASAVL-----F 123

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE-IKIIDFGSAC---TEDRTVYSYIQS 276
            I + +  L   G++H DLKP NIL        E I+I DFG A     E+  + +   +
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT 183

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRMIRILGAQ- 332
             + +PEVL    Y  A D+WS G ++  +  G   F   P  +  ++L    RI   + 
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIGSGKF 240

Query: 333 ----PP-DYVLKEAKN 343
                  + V   AK+
Sbjct: 241 SLSGGYWNSVSDTAKD 256

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  116 bits (293), Expect = 7e-29
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           V++++G G FG V K  W       VA+K I+++    +  +VE+  L+ +N        
Sbjct: 12  VEEVVGRGAFGVVCKAKWR---AKDVAIKQIESES-ERKAFIVELRQLSRVN-------- 59

Query: 172 H-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQILRGLSL 228
           H +IV++Y    C   +C+  E  +  +LY ++         + +    +  Q  +G++ 
Sbjct: 60  HPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 229 L---KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
           L   +   +IH DLKP N+LL         KI DFG+AC     + +   S  + +PEV 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVL--KICDFGTACDIQTHMTNNKGSAAWMAPEVF 175

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
            G  Y+   D++S+G I+ E+      F  
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDE 205

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (293), Expect = 7e-29
 Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 33/257 (12%)

Query: 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEV 156
           VLV+  ++RRY+    LG G F +  +  DA+     A KI+ K+    P   ++  +E+
Sbjct: 7   VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 66

Query: 157 SILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSI 214
           SI  +L         H H+V  + +F     + +  EL     L EL K    + L+   
Sbjct: 67  SIHRSL--------AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPE 116

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
            + + +QI+ G   L    +IH DLK  N+ L       E+KI DFG +   E       
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDG---- 169

Query: 274 IQSRY-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
            + +        Y +PEVL    ++  +D+WS GCI+  L +G P F  +   +   R I
Sbjct: 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-I 227

Query: 327 RILGAQPPDYVLKEAKN 343
           +      P ++   A +
Sbjct: 228 KKNEYSIPKHINPVAAS 244

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  115 bits (291), Expect = 2e-28
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 41/234 (17%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDRED 170
           + +D+LG G   +V  C +   +   AVKII+ QP + +  +  EV +L           
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG------ 69

Query: 171 KH-HIVRIYEYFVCQRHLCICFE------LLDSNLYELIKINHF--RGLSLSIVQLFSKQ 221
            H +++ + E+F  +    + FE      +L      + K  HF     S+ +     + 
Sbjct: 70  -HRNVLELIEFFEEEDRFYLVFEKMRGGSILS----HIHKRRHFNELEASVVV-----QD 119

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR--- 277
           +   L  L + GI H DLKPENIL     + + +KI DF   +  +     S I +    
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 278 ------YYRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320
                  Y +PEV+  +      Y    D+WS G I+  L  G P F G    D
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (288), Expect = 2e-28
 Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 25/243 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYY---QQALVEVSILTTLNKK 165
            + +   LG G FG V    + +    +A+K++ K Q        Q   EV I + L   
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL--- 66

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
                +H +I+R+Y YF     + +  E      +Y  ++              +  ++ 
Sbjct: 67  -----RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELA 119

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSP 282
             LS      +IH D+KPEN+LL ++    E+KI DFG S             +  Y  P
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRTDLCGTLDYLPP 176

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
           E++ G  +   +D+WS G +  E  +G P F   +  +  +   RI   +   PD+V + 
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK---RISRVEFTFPDFVTEG 233

Query: 341 AKN 343
           A++
Sbjct: 234 ARD 236

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (288), Expect = 2e-28
 Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 26/231 (11%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
           LG G +G V K         +AVK I+        ++ L+++ I         R      
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM-------RTVDCPF 67

Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKD 231
            V  Y     +  + IC EL+D++L +  K    +G ++    L   +  I++ L  L  
Sbjct: 68  TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 232 AG-IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV--YSYIQSRYYRSPEVLLGY 288
              +IH D+KP N+L+       ++K+ DFG +      V        + Y +PE +   
Sbjct: 128 KLSVIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE 184

Query: 289 ----QYTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMIRILGAQPP 334
                Y+   D+WS G  + EL +   P     + F  L+   +++    P
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK---QVVEEPSP 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  114 bits (287), Expect = 4e-28
 Identities = 62/253 (24%), Positives = 96/253 (37%), Gaps = 43/253 (16%)

Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           NA      +   +LG G  G+V + ++       A+K++++ P   +    EV +    +
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68

Query: 164 KKYDREDKH-HIVRIYEYF----VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQL 217
           +         HIVRI + +      ++ L I  E LD   L+  I+    +  +      
Sbjct: 69  Q-------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
             K I   +  L    I H D+KPEN+L  +    A +K+ DFG A              
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------- 167

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ---- 332
                E   G +Y  + DMWS G I+  L  G P F       +   M  RI   Q    
Sbjct: 168 ----KET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222

Query: 333 -PP-DYVLKEAKN 343
            P    V +E K 
Sbjct: 223 NPEWSEVSEEVKM 235

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  112 bits (283), Expect = 1e-27
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 27/219 (12%)

Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--------EVSILTTLNK 164
            +  +G G FG V K    +  S VA+K +    +  +  ++        EV I++ LN 
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
                  H +IV++Y   +      +  E +   +LY  +  +    +  S+       I
Sbjct: 82  -------HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDI 131

Query: 223 LRGLSLL--KDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQSRY 278
             G+  +  ++  I+H DL+  NI L +  + A    K+ DFG +     +V   + +  
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQ 191

Query: 279 YRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPG 315
           + +PE +      YT   D +SF  I+  +  G   F  
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (285), Expect = 1e-27
 Identities = 65/254 (25%), Positives = 100/254 (39%), Gaps = 29/254 (11%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
                 +G G +G V K         +AVK I+        +Q L+++ ++   +     
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS----- 78

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLD---SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
            D  +IV+ Y     +    IC EL+       Y+ +       +   I+   +   ++ 
Sbjct: 79  -DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 226 LSLLKDAG-IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED---RTVYSYIQSRYYR 280
           L+ LK+   IIH D+KP NILL  S     IK+ DFG S    D   +T       R Y 
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSIAKT--RDAGCRPYM 192

Query: 281 SPEVLLGYQ----YTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMIRILGAQPPD 335
           +PE +        Y    D+WS G  + EL  G  P     S FD L    +++   PP 
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT---QVVKGDPPQ 249

Query: 336 YVLKEAKNTSKFFK 349
               E +  S  F 
Sbjct: 250 LSNSEEREFSPSFI 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  113 bits (285), Expect = 1e-27
 Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 35/258 (13%)

Query: 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEV 156
           VLV+  ++RRY+    LG G F +  +  DA+     A KI+ K+    P   ++  +E+
Sbjct: 33  VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 92

Query: 157 SILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSI 214
           SI  +L         H H+V  + +F     + +  EL     L EL K    + L+   
Sbjct: 93  SIHRSL--------AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPE 142

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED-----R 268
            + + +QI+ G   L    +IH DLK  N+ L       E+KI DFG +   E      +
Sbjct: 143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDGERKK 199

Query: 269 TV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
            +    +YI      +PEVL    ++  +D+WS GCI+  L +G P F  +   +   R 
Sbjct: 200 VLCGTPNYI------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR- 252

Query: 326 IRILGAQPPDYVLKEAKN 343
           I+      P ++   A +
Sbjct: 253 IKKNEYSIPKHINPVAAS 270

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 4e-27
 Identities = 60/252 (23%), Positives = 93/252 (36%), Gaps = 41/252 (16%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKY 166
           + R  V+ +L  G F  V +  D       A+K +  N+    +  + EV  +  L+   
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS--- 83

Query: 167 DREDKHHIVRIYEYFVCQRH--------LCICFELLDSNLYELIKINHFRG-LSLSIVQL 217
                 +IV+        +           +  EL    L E +K    RG LS   V  
Sbjct: 84  ---GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 218 FSKQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
              Q  R +  +  +   IIH DLK EN+LL        IK+ DFGSA T          
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWS 197

Query: 276 SR---------------YYRSPEVLLGYQ---YTTAIDMWSFGCIVAEL-FLGLPLFPGA 316
           ++                YR+PE++  Y         D+W+ GCI+  L F   P F   
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-FEDG 256

Query: 317 SEFDLLRRMIRI 328
           ++  ++     I
Sbjct: 257 AKLRIVNGKYSI 268

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (283), Expect = 4e-27
 Identities = 62/264 (23%), Positives = 98/264 (37%), Gaps = 50/264 (18%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---------NQPAYYQQALVEVSILT 160
           +Y  KD++G G    V +C         AVKI++               +    E  IL 
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHFRGLSLS 213
            +         H HI+ + + +     + + F      EL D     L +       S  
Sbjct: 155 QVAG-------HPHIITLIDSYESSSFMFLVFDLMRKGELFD----YLTEKVAL---SEK 200

Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVY 271
             +   + +L  +S L    I+H DLKPENILL       +I++ DFG +C       + 
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLR 257

Query: 272 SYIQSRYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
               +  Y +PE+L          Y   +D+W+ G I+  L  G P F    +  +LR  
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR-- 315

Query: 326 IRILGAQ-----PP-DYVLKEAKN 343
             I+  Q     P  D      K+
Sbjct: 316 -MIMEGQYQFSSPEWDDRSSTVKD 338

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (281), Expect = 8e-27
 Identities = 40/262 (15%), Positives = 77/262 (29%), Gaps = 44/262 (16%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTT 161
           E  R  +   +LG        +  D E      V +     +      +Q   EV  L  
Sbjct: 70  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129

Query: 162 LNK------------------KYDREDKHHIVRIYEYF--VCQRHLCICFELLDSNLYEL 201
           L                          K  ++R+      +        +  + SNL   
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189

Query: 202 IKINHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256
            ++          L        + Q++R L+ L   G++H  L+P +I+L        + 
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR---GGVF 246

Query: 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ-----------YTTAIDMWSFGCIVAE 305
           +  F     +   V S + SR +  PE+                 T + D W+ G ++  
Sbjct: 247 LTGFEHLVRDGARVVSSV-SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 306 LFLGLPLFPGASEFDLLRRMIR 327
           ++         +       + R
Sbjct: 306 IWCADLPITKDAALGGSEWIFR 327

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (274), Expect = 1e-26
 Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 32/248 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEVSILTTLNKK 165
            + V +LLG G+F  V +         VA+K+I K         Q+   EV I   L   
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL--- 68

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
                KH  I+ +Y YF    ++ +  E+  +  +   +K N  +  S +  + F  QI+
Sbjct: 69  -----KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQII 122

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---- 278
            G+  L   GI+H DL   N+LL  +     IKI DFG +   +        +  Y    
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRN---MNIKIADFGLATQLKMPH-----EKHYTLCG 174

Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
              Y SPE+     +    D+WS GC+   L +G P F   +  + L + + +   + P 
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-VVLADYEMPS 233

Query: 336 YVLKEAKN 343
           ++  EAK+
Sbjct: 234 FLSIEAKD 241

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  108 bits (273), Expect = 2e-26
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 35/222 (15%)

Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQPAYYQQALV-----EVSILTTLNKKY 166
           +++++G G FG+V +  W       VAVK  ++ P       +     E  +   L    
Sbjct: 11  LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--- 64

Query: 167 DREDKH-HIVRIYEYFVCQR--HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
                H +I+ +    VC +  +LC+  E      L  ++     + +   I+  ++ QI
Sbjct: 65  -----HPNIIALRG--VCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQI 114

Query: 223 LRGLSLL---KDAGIIHCDLKPENILLCTSVKPAE-----IKIIDFGSACTEDRTVYSYI 274
            RG++ L       IIH DLK  NIL+   V+  +     +KI DFG A    RT     
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174

Query: 275 QSRY-YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
              Y + +PEV+    ++   D+WS+G ++ EL  G   F G
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (272), Expect = 5e-26
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 20/204 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
           +Y V  LLG G FG V        N  VA+K ++        +     +  +EV +L  +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSK 220
           +  +       ++R+ ++F       +  E  +    L++ I       L   + + F  
Sbjct: 104 SSGF-----SGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGA-LQEELARSFFW 156

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-SRYY 279
           Q+L  +    + G++H D+K ENIL+   +   E+K+IDFGS      TVY+    +R Y
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 214

Query: 280 RSPEVLLGYQYT-TAIDMWSFGCI 302
             PE +  ++Y   +  +WS G +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGIL 238

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 5e-26
 Identities = 40/267 (14%), Positives = 79/267 (29%), Gaps = 42/267 (15%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
           R  +   +LG        +  D E      V +     +      +Q   EV  L  L  
Sbjct: 78  RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137

Query: 165 ---------------KYDREDKHHIVRIYEYFVCQRHLCIC-----FELLDSNLYELIKI 204
                           +D        ++    + +R + +      +  + SNL    ++
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197

Query: 205 NHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
                     L        + Q++R L+ L   G++H  L+P +I+L        + +  
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR---GGVFLTG 254

Query: 260 FGSACTEDRTVYSYIQSRY----YRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGL 310
           F     +  +  S I   +      +  +L   Q      T A D W+ G  +  ++   
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 311 PLFPGASEFDLLRRMIRILGAQPPDYV 337
                 +       + R      P  V
Sbjct: 315 LPNTDDAALGGSEWIFR-SCKNIPQPV 340

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  108 bits (271), Expect = 8e-26
 Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 20/205 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-----KNQPAYYQQALV--EVSILTTL 162
            Y +  LLG G FG V           VA+K+I                   EV++L  +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFS 219
                    H  ++R+ ++F  Q    +  E       L++ I       L     + F 
Sbjct: 92  G----AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGP-LGEGPSRCFF 145

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-SRY 278
            Q++  +      G++H D+K ENIL+   ++    K+IDFGS        Y+    +R 
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPYTDFDGTRV 203

Query: 279 YRSPEVLLGYQYT-TAIDMWSFGCI 302
           Y  PE +  +QY      +WS G +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGIL 228

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  107 bits (269), Expect = 9e-26
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 35/219 (15%)

Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDRE 169
           V   +G G+FG V   +  + +  VAVK++      P   Q    EV +L          
Sbjct: 28  VGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT------- 77

Query: 170 DKH-HIVRIYEYFVCQR-HLCICFELLD-SNLYELIKINHFRGLSLSIVQL--FSKQILR 224
            +H +I+            L I  +  + S+LY  +   H       + +L   ++Q  R
Sbjct: 78  -RHVNILLFMG--YSTAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTAR 131

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YY 279
           G+  L    IIH DLK  NI L        +KI DFG A  + R   S+   +      +
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLATEKSRWSGSHQFEQLSGSILW 188

Query: 280 RSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPG 315
            +PEV+       Y+   D+++FG ++ EL  G   +  
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (268), Expect = 1e-25
 Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 25/243 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYY---QQALVEVSILTTLNKK 165
            + +   LG G FG V    + +    +A+K++ K+Q        Q   E+ I + L   
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-- 72

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
                 H +I+R+Y YF  ++ + +  E      LY+  ++             F +++ 
Sbjct: 73  ------HPNILRMYNYFHDRKRIYLMLEFAPRGELYK--ELQKHGRFDEQRSATFMEELA 124

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSP 282
             L    +  +IH D+KPEN+L+       E+KI DFG S         +   +  Y  P
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPSLRRRTMCGTLDYLPP 181

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
           E++ G  +   +D+W  G +  E  +G+P F   S  +  R   RI+      P ++   
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR---RIVNVDLKFPPFLSDG 238

Query: 341 AKN 343
           +K+
Sbjct: 239 SKD 241

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (267), Expect = 3e-25
 Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 26/244 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
            Y +   +G G F +V           VA+KII   +  P   Q+   EV I+  LN   
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--- 72

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
                H +IV+++E    ++ L +  E      +++ + + H R +     +   +QI+ 
Sbjct: 73  -----HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGR-MKEKEARSKFRQIVS 125

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
            +       I+H DLK EN+LL   +    IKI DFG +   T    + ++  +  Y +P
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182

Query: 283 EVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA-QPPDYVLK 339
           E+  G +Y    +D+WS G I+  L  G LP F G +  +L  R++R  G  + P Y+  
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR--GKYRIPFYMST 239

Query: 340 EAKN 343
           + +N
Sbjct: 240 DCEN 243

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  104 bits (262), Expect = 1e-24
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDR 168
           +K+ +G G+FG V +  W     S VAVKI+  Q        + L EV+I+  L      
Sbjct: 41  IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRL------ 91

Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG-LSLSIVQLFSKQILRG 225
             +H +IV          +L I  E L   +LY L+  +  R  L        +  + +G
Sbjct: 92  --RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 226 LSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR---YYR 280
           ++ L  ++  I+H +LK  N+L+        +K+ DFG +  +  T  S   +     + 
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWM 206

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
           +PEVL         D++SFG I+ EL      +  
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (260), Expect = 1e-24
 Identities = 56/248 (22%), Positives = 108/248 (43%), Gaps = 25/248 (10%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           +++Y   + +G G  G V    D      VA++ +  Q    ++ ++ E+ ++       
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM------- 71

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
            RE+K+ +IV   + ++    L +  E L   +L +++         ++ V    ++ L+
Sbjct: 72  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQ 127

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS 281
            L  L    +IH D+K +NILL        +K+ DFG             + + + Y+ +
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
           PEV+    Y   +D+WS G +  E+  G P  P  +E + LR +  I     P   L+  
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--PYLNE-NPLRALYLIATNGTP--ELQNP 239

Query: 342 KNTSKFFK 349
           +  S  F+
Sbjct: 240 EKLSAIFR 247

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  104 bits (261), Expect = 1e-24
 Identities = 60/250 (24%), Positives = 111/250 (44%), Gaps = 29/250 (11%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
           +        +G G+ G V    +      VAVK++  +    ++ L  EV I+       
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM------- 96

Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
            R+ +H ++V +Y+ ++    L +  E L    L +++         ++ V    + +L+
Sbjct: 97  -RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV---CEAVLQ 152

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRS 281
            L+ L   G+IH D+K ++ILL        +K+ DFG      + V    S + + Y+ +
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 209

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLK 339
           PEV+    Y T +D+WS G +V E+  G P +     F    ++ M R+  + PP   LK
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPY-----FSDSPVQAMKRLRDSPPP--KLK 262

Query: 340 EAKNTSKFFK 349
            +   S   +
Sbjct: 263 NSHKVSPVLR 272

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  104 bits (262), Expect = 2e-24
 Identities = 75/245 (30%), Positives = 99/245 (40%), Gaps = 23/245 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY     +G G FG      D      VAVK I+   A  +    E+    +L       
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR------ 74

Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
             H +IVR  E  +   HL I  E      LYE I  N  R  S    + F +Q+L G+S
Sbjct: 75  --HPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGR-FSEDEARFFFQQLLSGVS 130

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRSPEVL 285
                 I H DLK EN LL  S  P  +KI DFG S          S + +  Y +PEVL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189

Query: 286 LGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMI-RILGAQ----PPDYVL 338
           L  +Y     D+WS G  +  + +G  P F    E    R+ I RIL  +        + 
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248

Query: 339 KEAKN 343
            E  +
Sbjct: 249 PECCH 253

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (259), Expect = 3e-24
 Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 27/249 (10%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKK 165
           +  + V + LG G++G V K    E    VA+K +   +      +   E+SI+   +  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK---EISIMQQCDSP 84

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
           +       +V+ Y  +     L I  E   + ++ ++I++ + + L+   +    +  L+
Sbjct: 85  H-------VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLK 136

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRS 281
           GL  L     IH D+K  NILL T       K+ DFG A     T+    + I + ++ +
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTE---GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 282 PEVLLGYQYTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
           PEV+    Y    D+WS G I A E+  G P  P  ++   +R +  I    PP    ++
Sbjct: 194 PEVIQEIGYNCVADIWSLG-ITAIEMAEGKP--P-YADIHPMRAIFMIPTNPPP--TFRK 247

Query: 341 AKNTSKFFK 349
            +  S  F 
Sbjct: 248 PELWSDNFT 256

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (257), Expect = 4e-24
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 36/263 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYD 167
            Y +++++G G    V   + A     VA+K I  +       + L E+  ++  +    
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN- 74

Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS------IVQLFSK 220
                 IV  Y  FV +  L +  +LL   ++ ++IK    +G   S       +    +
Sbjct: 75  ------IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-- 277
           ++L GL  L   G IH D+K  NILL        ++I DFG SA        +  + R  
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 278 -----YYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
                 + +PEV+     Y    D+WSFG    EL  G   +    ++  ++ ++  L  
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 242

Query: 332 QPP-----DYVLKEAKNTSKFFK 349
            PP         +  K   K F+
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFR 265

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (257), Expect = 4e-24
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 26/248 (10%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKK 165
           +  +   + +G G+FG+V K  D      VA+KII  + A    +    E+++L+  +  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
           Y       + + Y  ++    L I  E L   +  +L++        ++ +    ++IL+
Sbjct: 81  Y-------VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI---LREILK 130

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS 281
           GL  L     IH D+K  N+LL       E+K+ DFG A     T     +++ + ++ +
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
           PEV+    Y +  D+WS G    EL  G P     SE   ++ +  I    PP   L+  
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKNNPP--TLE-- 240

Query: 342 KNTSKFFK 349
            N SK  K
Sbjct: 241 GNYSKPLK 248

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 4e-24
 Identities = 65/255 (25%), Positives = 112/255 (43%), Gaps = 32/255 (12%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-YQQALVEVSILTTLNKKY 166
              + +   LG G FG+V K  + E  +  A K+I+ +     +  +VE+ IL T +  Y
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQI 222
                  IV++   +     L I  E         +   +     RGL+   +Q+  +Q+
Sbjct: 78  -------IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQM 126

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYY 279
           L  L+ L    IIH DLK  N+L+       +I++ DFG +    +T+    S+I + Y+
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLE---GDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183

Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            +PEV++        Y    D+WS G  + E+    P  P   E + +R +++I  + PP
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKIAKSDPP 240

Query: 335 DYVLKEAKNTSKFFK 349
              L      S  F+
Sbjct: 241 --TLLTPSKWSVEFR 253

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (257), Expect = 6e-24
 Identities = 69/251 (27%), Positives = 106/251 (42%), Gaps = 39/251 (15%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---------NQPAYYQQALVEVSILT 160
           +Y     LG G FG V    D E N  V VK IK          +     +  +E++IL+
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS--NLYELIKINHFRGLSLSIVQL 217
            +         H +I+++ + F  Q    +  E   S  +L+  I   H R L   +   
Sbjct: 85  RVE--------HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPR-LDEPLASY 134

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
             +Q++  +  L+   IIH D+K ENI++        IK+IDFGSA      +  Y++  
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCG 191

Query: 276 SRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA-Q 332
           +  Y +PEVL+G  Y    ++MWS G  +  L     P       F  L   +    A  
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP-------FCELEETVE--AAIH 242

Query: 333 PPDYVLKEAKN 343
           PP  V KE  +
Sbjct: 243 PPYLVSKELMS 253

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (257), Expect = 8e-24
 Identities = 55/386 (14%), Positives = 123/386 (31%), Gaps = 99/386 (25%)

Query: 110 RYIVKDLLGHGTFGQV--AKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLN 163
            Y +   L  G F ++   +    + N F A+K  +     +   + ++  +   + +  
Sbjct: 32  DYRIIRTLNQGKFNKIILCE----KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 164 KKYDRED------KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHF------RG 209
             +  E       K+ + +           + I +E +++ ++ +  +            
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 210 LSLSIVQLFSKQILRGLSLL-KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED 267
           + + +++   K +L   S +  +  I H D+KP NIL+  +     +K+ DFG S    D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN---GRVKLSDFGESEYMVD 204

Query: 268 RTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRR 324
           + +     +  +  PE            +D+WS G  +  +F   +P       F     
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-------FS---- 253

Query: 325 MIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELK 384
                             +  + F       NI    +                      
Sbjct: 254 ---------------LKISLVELFN------NIRTKNIEY-------------------- 272

Query: 385 KPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSP 444
            PL    + +    ++   +  +        +S E        DFLK  +  +PA+R + 
Sbjct: 273 -PLDRNHFLYPLTNKKSTCSNNF--------LSNEDI------DFLKLFLRKNPAERITS 317

Query: 445 FQASRHPFVTGEPFTCPYQPPPETPR 470
             A +H ++         +   E  +
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYK 343

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (258), Expect = 1e-23
 Identities = 52/361 (14%), Positives = 107/361 (29%), Gaps = 68/361 (18%)

Query: 111 YIVKDLLGHG--TFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKK 165
           Y +  ++G G      V          +V V+ I               E+ +    N  
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
                   IV     F+    L +    +   +  +LI  +   G++   +    + +L+
Sbjct: 87  N-------IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED-----RTVYSYIQSR- 277
            L  +   G +H  +K  +IL+       ++ +     +          R V+ + +   
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 278 ---YYRSPEVL--LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
               + SPEVL      Y    D++S G    EL  G   F    +    + ++  L   
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KDMPATQMLLEKLNGT 253

Query: 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY 392
            P   L +          +    ++ N  +S    ++    +  +               
Sbjct: 254 VPC--LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP------------- 298

Query: 393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
                      ++PY +  S                F++  ++ +P  R S      H F
Sbjct: 299 -----------SHPYHRTFSPH-----------FHHFVEQCLQRNPDARPSASTLLNHSF 336

Query: 453 V 453
            
Sbjct: 337 F 337

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  101 bits (254), Expect = 1e-23
 Identities = 45/227 (19%), Positives = 82/227 (36%), Gaps = 42/227 (18%)

Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDR 168
           + +L+G G FGQV    W  E    VA+++I  +       +    EV            
Sbjct: 37  IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT------ 86

Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
               H  +V      +   HL I   L     LY +++      L ++  +  +++I++G
Sbjct: 87  ---RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKG 142

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY------- 278
           +  L   GI+H DLK +N+          + I DFG             + +        
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 279 -YRSPEVL---------LGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
            + +PE++             ++   D+++ G I  EL      F  
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  105 bits (264), Expect = 1e-23
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 28/222 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNS-FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKY 166
           +Y VK  + HG  G +    D  +N   V +K + +         A+ E   L  +    
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--- 137

Query: 167 DREDKH-HIVRIYEYFVCQRHLC-----ICFELLD-SNLYELIKINHFRGLSLSIVQLFS 219
                H  IV+I+ +             I  E +   +L         + L ++    + 
Sbjct: 138 -----HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYL 188

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
            +IL  LS L   G+++ DLKPENI+L       ++K+ID G+    +   Y Y  +  +
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGYLYG-TPGF 243

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
           ++PE++     T A D+++ G  +A L L LP   G     L
Sbjct: 244 QAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (252), Expect = 3e-23
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 36/258 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            + + +L+G+GT+GQV K    +     A+K++       ++   E+++L        ++
Sbjct: 25  IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINML--------KK 76

Query: 170 DKHH--IVRIYEYFV------CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
             HH  I   Y  F+          L +  E   + ++ +LIK      L    +    +
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSR 277
           +ILRGLS L    +IH D+K +N+LL  +   AE+K++DFG +   DRTV    ++I + 
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTP 193

Query: 278 YYRSPEVLLGYQ-----YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILGA 331
           Y+ +PEV+   +     Y    D+WS G I A E+  G P      +   +R +  I   
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPL---CDMHPMRALFLIPRN 249

Query: 332 QPPDYVLKEAKNTSKFFK 349
             P   LK  K  SK F+
Sbjct: 250 PAP--RLKS-KKWSKKFQ 264

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 35/216 (16%), Positives = 73/216 (33%), Gaps = 37/216 (17%)

Query: 117 LGHGTFGQVAK-CWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
           L     G++ K  W     + + VK++K +       +    E   L   +        H
Sbjct: 18  LNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--------H 66

Query: 173 -HIVRIYEYFVCQR----HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
            +++ +     CQ     H  +    +   +LY ++       +  S    F+  + RG+
Sbjct: 67  PNVLPVLG--ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 227 SLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYIQSRYYRSP 282
           + L   +  I    L   ++++   +     +I       +      +Y+      + +P
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGRMYAPA----WVAP 177

Query: 283 EVLLGYQY---TTAIDMWSFGCIVAELFLGLPLFPG 315
           E L          + DMWSF  ++ EL      F  
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (250), Expect = 4e-23
 Identities = 55/253 (21%), Positives = 102/253 (40%), Gaps = 35/253 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNK 164
           +Y++ DLLG G++G+V +  D+E     AVKI+K       P        E+ +L  L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64

Query: 165 KYDREDKH-HIVRIYEYFVCQ--RHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSK 220
                  H +++++ +    +  + + +  E     + E++  +   R   +     +  
Sbjct: 65  -------HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFC 116

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ---- 275
           Q++ GL  L   GI+H D+KP N+LL T      +KI   G +            +    
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAADDTCRTSQG 173

Query: 276 SRYYRSPEVLLGYQ-YT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA- 331
           S  ++ PE+  G   ++   +D+WS G  +  +  G  P F G + + L      I    
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFE---NIGKGS 229

Query: 332 -QPPDYVLKEAKN 343
              P        +
Sbjct: 230 YAIPGDCGPPLSD 242

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 49/224 (21%), Positives = 84/224 (37%), Gaps = 32/224 (14%)

Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA-LVEVSILTTLNKKYDRED 170
           I  ++LG G FGQ  K    E    + +K +       Q+  L EV ++  L        
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-------- 64

Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
           +H ++++        + L    E +    L  +IK +       S    F+K I  G++ 
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAY 123

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-------- 280
           L    IIH DL   N L+  +     + + DFG A             R  +        
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 281 ---------SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
                    +PE++ G  Y   +D++SFG ++ E+   +   P 
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 63/245 (25%), Positives = 113/245 (46%), Gaps = 28/245 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
            YI+++ LG G+FG+V      +    VA+K I      +   + +   E+S L  L   
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-- 67

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
                 H HI+++Y+       + +  E     L++ I +   R ++    + F +QI+ 
Sbjct: 68  ------HPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKR-MTEDEGRRFFQQIIC 119

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRSP 282
            +       I+H DLKPEN+LL  ++    +KI DFG S   T+   + +   S  Y +P
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176

Query: 283 EVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQP--PDYVL 338
           EV+ G  Y    +D+WS G ++  + +G LP F      +L +   ++       PD++ 
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLP-FDDEFIPNLFK---KVNSCVYVMPDFLS 232

Query: 339 KEAKN 343
             A++
Sbjct: 233 PGAQS 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  100 bits (250), Expect = 3e-22
 Identities = 75/357 (21%), Positives = 128/357 (35%), Gaps = 49/357 (13%)

Query: 2   DEGSPSNGGQVFGASWRPKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNP 61
           D   P     +  A   P+   F  +L  +     R      L   L + ++       P
Sbjct: 100 DALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQ-AP 158

Query: 62  LFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGT 121
             ++ + L   R+L    +     G D         V                  LG G 
Sbjct: 159 FQEFLDSLYFLRFLQWKWLEAQPMGEDWFL---DFRV------------------LGRGG 197

Query: 122 FGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRI 177
           FG+V  C         A K +      +   YQ A+VE  IL  ++ ++       IV +
Sbjct: 198 FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF-------IVSL 250

Query: 178 YEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
              F  +  LC+   +     +  ++Y + + N   G        ++ QI+ GL  L   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLHQR 308

Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVLLGYQ 289
            II+ DLKPEN+LL        ++I D G A            Y  +  + +PE+LLG +
Sbjct: 309 NIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365

Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQP--PDYVLKEAKN 343
           Y  ++D ++ G  + E+      F    E    + + + +L      PD     +K+
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.9 bits (249), Expect = 6e-22
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 28/242 (11%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G FG+V  C         A K ++     +      AL E  IL  +N ++     
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF----- 245

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYEL---IKINHFRGLSLSIVQLFSKQILRGLSL 228
             +V +   +  +  LC+   L+  N  +L   I      G   +    ++ +I  GL  
Sbjct: 246 --VVSLAYAYETKDALCLVLTLM--NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSAC--TEDRTVYSYIQSRYYRSPEV 284
           L    I++ DLKPENILL          I+I D G A    E +T+   + +  Y +PEV
Sbjct: 302 LHRERIVYRDLKPENILL-----DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQP--PDYVLKEA 341
           +   +YT + D W+ GC++ E+  G   F    +      + R +        +    +A
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416

Query: 342 KN 343
           ++
Sbjct: 417 RS 418

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.1 bits (242), Expect = 6e-22
 Identities = 57/250 (22%), Positives = 107/250 (42%), Gaps = 27/250 (10%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAY--YQQALVEVSILTTLN 163
           ++ +     +GHG+FG V    D   +  VA+K +    + +   +Q  + EV  L  L 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                      ++    ++ +    +  E    +  +L++++  + L    +   +   L
Sbjct: 113 HPN-------TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGAL 164

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
           +GL+ L    +IH D+K  NILL        +K+ DFGSA        S++ + Y+ +PE
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPA-NSFVGTPYWMAPE 220

Query: 284 VLLGYQ---YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           V+L      Y   +D+WS G I   EL    P  P     + +  +  I   + P   L+
Sbjct: 221 VILAMDEGQYDGKVDVWSLG-ITCIELAERKP--P-LFNMNAMSALYHIAQNESP--ALQ 274

Query: 340 EAKNTSKFFK 349
              + S++F+
Sbjct: 275 S-GHWSEYFR 283

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 41/247 (16%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           +LG G+F  V    +   +   A+KI++       N+  Y      E  +++ L+     
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY---VTRERDVMSRLD----- 88

Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSN---LYELIKINHFRGLSLSIVQLFSKQIL 223
               H   V++Y  F     L         N   L  + KI  F     +  + ++ +I+
Sbjct: 89  ----HPFFVKLYFTFQDDEKLYFGLSYA-KNGELLKYIRKIGSF---DETCTRFYTAEIV 140

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-----CTEDRTVYSYIQSRY 278
             L  L   GIIH DLKPENILL        I+I DFG+A      ++     S++ +  
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDY 336
           Y SPE+L       + D+W+ GCI+ +L  GLP F   +E+ + +   +I+  +   P+ 
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---KIIKLEYDFPEK 254

Query: 337 VLKEAKN 343
              +A++
Sbjct: 255 FFPKARD 261

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.0 bits (244), Expect = 3e-21
 Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 31/258 (12%)

Query: 104 NAETQRRYIVKD-----LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQ 151
           N E      + D     ++G G FG+V  C  A+     A+K +                
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--- 235

Query: 152 ALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGL 210
           AL E  +L+ ++          IV +   F     L    +L+  N  +L   ++     
Sbjct: 236 ALNERIMLSLVSTGDCP----FIVCMSYAFHTPDKLSFILDLM--NGGDLHYHLSQHGVF 289

Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDR 268
           S + ++ ++ +I+ GL  + +  +++ DLKP NILL        ++I D G AC  ++ +
Sbjct: 290 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK 346

Query: 269 TVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
             ++ + +  Y +PEVL  G  Y ++ D +S GC++ +L  G   F      D       
Sbjct: 347 P-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405

Query: 328 ILGAQP--PDYVLKEAKN 343
            L      PD    E ++
Sbjct: 406 TLTMAVELPDSFSPELRS 423

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 29/246 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
            Y++ D LG GTFG+V           VAVKI+            +   E+  L      
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-- 69

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
                 H HI+++Y+         +  E +    L++ I   H R +     +   +QIL
Sbjct: 70  ------HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGR-VEEMEARRLFQQIL 121

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRS 281
             +       ++H DLKPEN+LL   +     KI DFG S   ++   + +   S  Y +
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAA 178

Query: 282 PEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA--QPPDYV 337
           PEV+ G  Y    +D+WS G I+  L  G LP F       L +   +I G     P+Y+
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLP-FDDEHVPTLFK---KIRGGVFYIPEYL 234

Query: 338 LKEAKN 343
            +    
Sbjct: 235 NRSVAT 240

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 54/268 (20%), Positives = 110/268 (41%), Gaps = 57/268 (21%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------------KNQPAYYQQALVEV 156
           +Y +KD +G G++G V   ++   N++ A+K++             +  P   + A    
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 157 SILTTLNKKYDRE-------DKHHIVRIYE--YFVCQRHLCICFELLDSNLYELIKINHF 207
                  ++  +E       D  ++V++ E      + HL + FEL++     ++++   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTL 131

Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-- 265
           + LS    + + + +++G+  L    IIH D+KP N+L+        IKI DFG +    
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED---GHIKIADFGVSNEFK 188

Query: 266 -EDRTVYSYIQSRYYRSPEVLLGYQ--YT-TAIDMWSFGCI---------------VAEL 306
             D  + + + +  + +PE L   +  ++  A+D+W+ G                 +  L
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248

Query: 307 FL----GLPLFPGASEF-----DLLRRM 325
                     FP   +      DL+ RM
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRM 276

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.3 bits (225), Expect = 4e-20
 Identities = 55/247 (22%), Positives = 92/247 (37%), Gaps = 27/247 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYD 167
            + +   LG G +G+V    +      VAVKI+  K      +    E+ I   LN    
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN---- 63

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRG 225
               H ++V+ Y +        +  E       EL  +I    G+     Q F  Q++ G
Sbjct: 64  ----HENVVKFYGHRREGNIQYLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ----SRYYR 280
           +  L   GI H D+KPEN+LL        +KI DFG +           +     +  Y 
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 281 SPEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           +PE+L   ++    +D+WS G ++  +  G LP +   S+        +        +  
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKK 233

Query: 339 --KEAKN 343
                  
Sbjct: 234 IDSAPLA 240

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 33/223 (14%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY + D LG G    V    D  +N  VA+K I   P   ++ L          K+++RE
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL----------KRFERE 61

Query: 170 DKH-------HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQ 221
             +       +IV + +         +  E ++   L E I+ +H   LS+     F+ Q
Sbjct: 62  VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP-LSVDTAINFTNQ 119

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTEDRTVYSYI 274
           IL G+    D  I+H D+KP+NIL+ ++     +KI DFG       ++ T+   V   +
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKALSETSLTQTNHV---L 173

Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
            +  Y SPE   G       D++S G ++ E+ +G P F G +
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.9 bits (231), Expect = 7e-20
 Identities = 66/246 (26%), Positives = 101/246 (41%), Gaps = 29/246 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
            YI+ D LG GTFG+V           VAVKI+            +   E+  L      
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-- 74

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
                 H HI+++Y+       + +  E +    L++ I   + R L     +   +QIL
Sbjct: 75  ------HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGR-LDEKESRRLFQQIL 126

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRS 281
            G+       ++H DLKPEN+LL   +     KI DFG S   ++   + +   S  Y +
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAA 183

Query: 282 PEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA--QPPDYV 337
           PEV+ G  Y    +D+WS G I+  L  G LP F       L +   +I       P Y+
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLP-FDDDHVPTLFK---KICDGIFYTPQYL 239

Query: 338 LKEAKN 343
                +
Sbjct: 240 NPSVIS 245

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 19/213 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY +   +G G+FG +    D      VA+K+   +   + Q  +E  I   +       
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQGG---- 64

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               I  I        +  +  ELL  +L +L      R  SL  V L + Q++  +  +
Sbjct: 65  --VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYI 121

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------CTEDRTVYSYIQSRYY 279
                IH D+KP+N L+    K   + IIDFG A              R   +   +  Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
            S    LG + +   D+ S G ++    LG LP
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 55/247 (22%), Positives = 92/247 (37%), Gaps = 27/247 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYD 167
            + +   LG G +G+V    +      VAVKI+  K      +    E+ I   LN    
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN---- 63

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRG 225
               H ++V+ Y +        +  E       EL  +I    G+     Q F  Q++ G
Sbjct: 64  ----HENVVKFYGHRREGNIQYLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ----SRYYR 280
           +  L   GI H D+KPEN+LL        +KI DFG +           +     +  Y 
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 281 SPEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           +PE+L   ++    +D+WS G ++  +  G LP +   S+        +        +  
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKK 233

Query: 339 --KEAKN 343
                  
Sbjct: 234 IDSAPLA 240

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 47/245 (19%), Positives = 84/245 (34%), Gaps = 50/245 (20%)

Query: 110 RYIVKDL-----LGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           R + +D+     +G G +G+V   W        VAVKI  ++         E+     L 
Sbjct: 4   RTVARDITLLECVGKGRYGEV---WRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML- 59

Query: 164 KKYDREDKH-HIVRIY----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
                  +H +I+               L +     +  +LY+ +++     L       
Sbjct: 60  -------RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLR 109

Query: 218 FSKQILRGLSLL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
               I  GL+ L            I H DLK +NIL+    K  +  I D G A    ++
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQS 166

Query: 270 VYSYIQS-------RYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
                         + Y +PEVL        +     +D+W+FG ++ E+   +      
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

Query: 317 SEFDL 321
            ++  
Sbjct: 227 EDYKP 231

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 48/228 (21%)

Query: 106 ETQRRYIVK-DLLGHGTFGQVAKC-WDAEM---NSFVAVKIIK-NQPAYYQQALVEVSIL 159
           + + R++     LG G FG V  C +D         VAVK ++ +   + +    E+ IL
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 160 TTLNKKYDREDKH-HIVRIYEYFVC----QRHLCICFELLDS-NLYELIKINHFRGLSLS 213
            +L        +H +IV+     VC    +R+L +  E L   +L + ++ +      + 
Sbjct: 66  KSL--------QHDNIVKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERID 112

Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
            ++L  ++ QI +G+  L     IH DL   NIL+        +KI DFG      + + 
Sbjct: 113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT----KVLP 165

Query: 272 SYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
                 +++             PE L   +++ A D+WSFG ++ ELF
Sbjct: 166 Q--DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 46/248 (18%), Positives = 86/248 (34%), Gaps = 50/248 (20%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV-------AKCWDAEMNSFVAVKIIKNQPAYYQQA-LVEV 156
           + +   ++  + LG GTF ++          +     + V +K++      Y ++     
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63

Query: 157 SILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLS 211
           S+++ L          H+V  Y   VC     +  E      LD+ L +           
Sbjct: 64  SMMSKL-------SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-------NKNC 109

Query: 212 LSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE-----IKIIDFGSAC 264
           ++I+     +KQ+   +  L++  +IH ++  +NILL             IK+ D G + 
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS- 168

Query: 265 TEDRTVYSYIQSRYYR------SPEVLL-GYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
               TV         +       PE +        A D WSFG  + E+   G       
Sbjct: 169 ---ITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

Query: 317 SEFDLLRR 324
                L+ 
Sbjct: 223 DSQRKLQF 230

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 48/228 (21%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAE---MNSFVAVKIIKNQPAYYQQALV-EVSIL 159
           + + R++     LG G FG V  C +D         VAVK +++    + +    E+ IL
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96

Query: 160 TTLNKKYDREDKH-HIVRIYEYFVC----QRHLCICFELLDS-NLYELIKINHFRGLSLS 213
            +L        +H +IV+     VC    +R+L +  E L   +L + ++ +      + 
Sbjct: 97  KSL--------QHDNIVKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERID 143

Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
            ++L  ++ QI +G+  L     IH DL   NIL+        +KI DFG      + + 
Sbjct: 144 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT----KVLP 196

Query: 272 SYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
                 YY+             PE L   +++ A D+WSFG ++ ELF
Sbjct: 197 Q--DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 43/238 (18%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           E  R  +   + LG G FG+V    ++      VAVK +K         L E +++  L 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQL- 65

Query: 164 KKYDREDKHHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FS 219
                     +VR+Y   V  Q  + I  E +++ +L + +K     G+ L+I +L   +
Sbjct: 66  ------QHQRLVRLYA--VVTQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMA 115

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILL-CTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
            QI  G++ +++   IH DL+  NIL+  T       KI DFG A    R +     + Y
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLS----CKIADFGLA----RLIED---NEY 164

Query: 279 YRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
                         PE +    +T   D+WSFG ++ E+   G   +PG +  ++++ 
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 21/215 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            Y V   +G G+FG + +  +   N  VA+K    + +   Q   E      L       
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGC---- 65

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               I  +Y +     H  +  +LL  +L +L+ +   R  S+  V + +KQ+L  +  +
Sbjct: 66  --TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 122

Query: 230 KDAGIIHCDLKPENILL--CTSVKPAEIKIIDFGSA------CTED----RTVYSYIQSR 277
            +  +++ D+KP+N L+    S     I ++DFG         T+     R   +   + 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
            Y S    LG + +   D+ + G +      G LP
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 43/238 (18%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           E +R  I     LG G FG V    W  + +  VAVK+IK       +   E   +  L 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKL- 60

Query: 164 KKYDREDKHHIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--F 218
                     +V+ Y   VC  +  + I  E + +  L   ++ +   G  L   QL   
Sbjct: 61  ------SHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEM 109

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
              +  G++ L+    IH DL   N L+    +   +K+ DFG      R V      +Y
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMT----RYVLD---DQY 159

Query: 279 YRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
             S           PEV   ++Y++  D+W+FG ++ E+F LG   +   +  +++ +
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 47/235 (20%), Positives = 76/235 (32%), Gaps = 45/235 (19%)

Query: 115 DLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH- 172
             +G G +G+V   W  +     VAVK+             E+     +        +H 
Sbjct: 43  KQIGKGRYGEV---WMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM--------RHE 91

Query: 173 HIVRIY----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
           +I+       +       L +  +  ++ +LY+ +       L    +   +   + GL 
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLC 148

Query: 228 LL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS--- 276
            L            I H DLK +NIL+    K     I D G A                
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 277 ----RYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
               + Y  PEVL        +Q     DM+SFG I+ E+           E+ L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 49/229 (21%)

Query: 106 ETQRRYIVK-DLLGHGTFGQVAKC-WDAEM---NSFVAVKIIKNQPAYYQQA--LVEVSI 158
             ++R++ +   LG G FG+V  C +D E       VAVK +K +      A    E+ I
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76

Query: 159 LTTLNKKYDREDKH-HIVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSL 212
           L  L         H +IV+     +C       + +  E L S +L E +  N      +
Sbjct: 77  LRNL--------YHENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKI 123

Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           ++ Q   ++ QI +G+  L     +H DL   N+L+       ++KI DFG      + +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLT----KAI 176

Query: 271 YSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
            +     YY              PE L+  ++  A D+WSFG  + EL 
Sbjct: 177 ET--DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 45/244 (18%), Positives = 89/244 (36%), Gaps = 48/244 (19%)

Query: 110 RYIVKDL-----LGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           R I + +     +G G FG+V   W  +     VAVKI  ++    +    E  I  T+ 
Sbjct: 38  RTIARTIVLQESIGKGRFGEV---WRGKWRGEEVAVKIFSSR--EERSWFREAEIYQTVM 92

Query: 164 KKYDREDKHHIVRIY----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
            +++     +I+       +       L +  +  +  +L++ +   +   +++  +   
Sbjct: 93  LRHE-----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKL 144

Query: 219 SKQILRGLSLL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +     GL+ L            I H DLK +NIL+    K     I D G A   D   
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSAT 201

Query: 271 YSYIQSRY-------YRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
            +   +         Y +PEVL        ++     D+++ G +  E+     +     
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 318 EFDL 321
           ++ L
Sbjct: 262 DYQL 265

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 29/221 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKK 165
            Y ++ L+G G  G V +  D      VA+K++       P +  +   E      L   
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-- 92

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQIL 223
                   H+V I+++      L +   L++  +L  +++      L+        +QI 
Sbjct: 93  ------EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIG 144

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTEDRTVYSYIQS 276
             L     AG  H D+KPENIL+          ++DFG          T+       + +
Sbjct: 145 SALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLGNT---VGT 198

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
            YY +PE       T   D+++  C++ E   G P + G  
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 48/228 (21%)

Query: 106 ETQRRYIVK-DLLGHGTFGQVAKC-WDAEMNS---FVAVKIIKNQPAYYQQALV-EVSIL 159
             + R++     LG G FG V  C +D   ++    VAVK +++     Q+    E+ IL
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78

Query: 160 TTLNKKYDREDKH-HIVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSLS 213
             L            IV+     V        L +  E L S  L + ++ +      L 
Sbjct: 79  KAL--------HSDFIVKYRG--VSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLD 125

Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
             +L  +S QI +G+  L     +H DL   NIL+ +    A +KI DFG A    + + 
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES---EAHVKIADFGLA----KLLP 178

Query: 272 SYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
                 YY              PE L    ++   D+WSFG ++ ELF
Sbjct: 179 L--DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 47/240 (19%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTL 162
                 +     +G G FG V         +   VA+K I+      +  + E  ++  L
Sbjct: 4   VIDPSELTFVQEIGSGQFGLV---HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 60

Query: 163 NKKYDREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL- 217
                    H  +V++Y   VC  Q  +C+  E ++   L + ++    RG   +   L 
Sbjct: 61  --------SHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQ--RG-LFAAETLL 107

Query: 218 -FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
                +  G++ L++A +IH DL   N L+    +   IK+ DFG      R V      
Sbjct: 108 GMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMT----RFVLD---D 157

Query: 277 RYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
           +Y  S           PEV    +Y++  D+WSFG ++ E+F  G   +   S  +++  
Sbjct: 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 83.8 bits (208), Expect = 8e-18
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 41/238 (17%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E +R  I  K  LG G +G+V +    + +  VAVK +K      ++ L E +++  +  
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-- 66

Query: 165 KYDREDKHHIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FS 219
                   ++V++    VC  +    I  E +   NL + ++        +S V L   +
Sbjct: 67  -----KHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMA 117

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
            QI   +  L+    IH DL   N L+    +   +K+ DFG +    R     +    Y
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS----R----LMTGDTY 166

Query: 280 RS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
            +            PE L   +++   D+W+FG ++ E+   G+  +PG     +   
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.7 bits (210), Expect = 8e-18
 Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 21/215 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            + V   +G G FG++    +   N +VA+K+   + +   Q  +E      L       
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-SRAPQLHLEYRFYKQLGSG---- 64

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               I ++Y +  C ++  +  ELL  +L +L  +   R  SL  V + + Q++  +  +
Sbjct: 65  --DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYV 121

Query: 230 KDAGIIHCDLKPENILL--CTSVKPAEIKIIDFGSA----CTEDRTVYSYIQSRY----- 278
               +I+ D+KPEN L+    +     I IIDF  A      E +    Y + +      
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
            Y S    LG + +   D+ + G +      G LP
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 85.8 bits (212), Expect = 1e-17
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 19/213 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           ++ +   +G G+FG++    + + N  VA+K+   +   + Q L E  I   L       
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKIYRILQGG---- 62

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               I  +  + V   +  +  +LL  +L +L      R LSL  V + + Q++  +  +
Sbjct: 63  --TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFV 119

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRY------Y 279
                +H D+KP+N L+    +  ++ IIDFG A     T       Y +++       Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
            S    LG + +   D+ S G ++     G LP
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 33/226 (14%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY + ++LG G   +V    D   +  VAVK+++   A                 ++ RE
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFY----------LRFRRE 62

Query: 170 DKH-------HIVRIY---EYFVCQRHLC-ICFELLD-SNLYELIKINHFRGLSLSIVQL 217
            ++        IV +Y   E       L  I  E +D   L +++       ++      
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGP-MTPKRAIE 120

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-- 275
                 + L+     GIIH D+KP NI++  +     +K++DFG A     +  S  Q  
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTA 177

Query: 276 ----SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
               +  Y SPE   G       D++S GC++ E+  G P F G S
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 85.2 bits (211), Expect = 2e-17
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 35/234 (14%)

Query: 106 ETQRRYI-VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           E  R  + ++  LG G FG+V    W+      VA+K +K      +  L E  ++  L 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLR 237

Query: 164 KKYDREDKHHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FS 219
            +        +V++Y   V  +  + I  E +   +L + +K     G  L + QL   +
Sbjct: 238 HE-------KLVQLYA--VVSEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMA 286

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--YIQSR 277
            QI  G++ ++    +H DL+  NIL+  ++     K+ DFG A    R +    Y   +
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLA----RLIEDNEYTARQ 339

Query: 278 YYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
             +      +PE  L  ++T   D+WSFG ++ EL   G   +PG    ++L +
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 49/235 (20%), Positives = 94/235 (40%), Gaps = 44/235 (18%)

Query: 112 IVKDLLGHGTFGQVAK-CWDAEMNSF-VAVKIIKN--QPAYYQQALVEVSILTTLNKKYD 167
           I    LG G FG V +  +        VA+K++K   + A  ++ + E  I+  L+    
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD---- 68

Query: 168 REDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQI 222
               + +IVR+    VCQ   L +  E+     L++ +         + +  +     Q+
Sbjct: 69  ----NPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQV 119

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS- 281
             G+  L++   +H DL   N+LL   V     KI DFG +    + + +     YY + 
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLS----KALGA--DDSYYTAR 170

Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
                      PE +   ++++  D+WS+G  + E    G   +      +++  
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 51/253 (20%), Positives = 99/253 (39%), Gaps = 41/253 (16%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           ++G G F +VA     +     A+KI+         + + +     E  +L   ++++  
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF---REERDVLVNGDRRW-- 122

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                I +++  F  + +L +  E     +L  L+       +   + + +  +I+  + 
Sbjct: 123 -----ITQLHFAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMAID 176

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY------YRS 281
            +   G +H D+KP+NILL        I++ DFGS C + R     ++S        Y S
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC---GHIRLADFGS-CLKLRA-DGTVRSLVAVGTPDYLS 231

Query: 282 PEVLLG-------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL----LRRMIRILG 330
           PE+L           Y    D W+ G    E+F G   F   S  +     +     +  
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291

Query: 331 AQPPDYVLKEAKN 343
               + V +EA++
Sbjct: 292 PLVDEGVPEEARD 304

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 35/243 (14%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           LLG GTFG+V    +     + A+KI++       ++ A+    + E  +L         
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTR----- 63

Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRG 225
               H  +  +   F     LC   E    N  EL   ++  R  +    + +  +I+  
Sbjct: 64  ----HPFLTALKYAFQTHDRLCFVMEYA--NGGELFFHLSRERVFTEERARFYGAEIVSA 117

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSP 282
           L  L    +++ D+K EN++L        IKI DFG      ++  T+ ++  +  Y +P
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
           EVL    Y  A+D W  G ++ E+  G   F       L      IL  +   P  +  E
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPE 231

Query: 341 AKN 343
           AK+
Sbjct: 232 AKS 234

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 64/252 (25%)

Query: 117 LGHGTFGQVAKC-WDAEMNSF---VAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRED 170
           LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ +++       
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------- 75

Query: 171 KH-HIVRIYEYFVCQRH-LCICFEL-----LDSNLYELIKINHFRGLSLSIVQL--FSKQ 221
            + H+ R+    +C    + +  +L     L   + E          ++    L  +  Q
Sbjct: 76  -NPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQ 125

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
           I +G++ L+D  ++H DL   N+L+ T   P  +KI DFG A    + + +  + + Y +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLA----KLLGA--EEKEYHA 176

Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR------ 323
                       E +L   YT   D+WS+G  V EL   G   + G    ++        
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

Query: 324 RMIRILGAQPPD 335
           R+      QPP 
Sbjct: 237 RL-----PQPPI 243

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 84.3 bits (209), Expect = 3e-17
 Identities = 53/237 (22%), Positives = 93/237 (39%), Gaps = 45/237 (18%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQPAYYQQALV-EVSILTTL 162
               + +     +G G FG V      +   + VAVK IK       QA + E S++T L
Sbjct: 189 ALNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQL 243

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRH---LCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
                   +H ++V++    V       L I  E +   +L + ++        L    L
Sbjct: 244 --------RHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCL 291

Query: 218 --FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
             FS  +   +  L+    +H DL   N+L+         K+ DFG      +   S   
Sbjct: 292 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLT----KEASS--- 341

Query: 276 SRYYR-------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
           ++          +PE L   +++T  D+WSFG ++ E++  G   +P     D++ R
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 82.2 bits (204), Expect = 4e-17
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 51/253 (20%)

Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIK--------NQPAYYQQALVEVSILTTLNK 164
           +LG G +G   QV K   A      A+K++K           A+      E +IL  +  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH---TKAERNILEEVK- 79

Query: 165 KYDREDKHH--IVRIYEYFVCQRHLCICFELLDSNLY----EL-IKINHFRGLSLSIVQL 217
                   H  IV +   F     L +  E      Y    EL +++             
Sbjct: 80  --------HPFIVDLIYAFQTGGKLYLILE------YLSGGELFMQLEREGIFMEDTACF 125

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYS 272
           +  +I   L  L   GII+ DLKPENI+L       +  +K+ DFG    +  +    ++
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIML-----NHQGHVKLTDFGLCKESIHDGTVTHT 180

Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
           +  +  Y +PE+L+   +  A+D WS G ++ ++  G P F G +    +    +IL  +
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID---KILKCK 237

Query: 333 P--PDYVLKEAKN 343
              P Y+ +EA++
Sbjct: 238 LNLPPYLTQEARD 250

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 62/243 (25%), Positives = 98/243 (40%), Gaps = 34/243 (13%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           LLG GTFG+V    +     + A+KI+K       ++ A+    L E  +L         
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSR----- 206

Query: 169 EDKHH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGL 226
              H  +  +   F     LC   E    N  EL   ++  R  S    + +  +I+  L
Sbjct: 207 ---HPFLTALKYSFQTHDRLCFVMEYA--NGGELFFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 227 SLL-KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSP 282
             L  +  +++ DLK EN++L        IKI DFG       +  T+ ++  +  Y +P
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
           EVL    Y  A+D W  G ++ E+  G   F       L      IL  +   P  +  E
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLGPE 375

Query: 341 AKN 343
           AK+
Sbjct: 376 AKS 378

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 82.2 bits (204), Expect = 5e-17
 Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 51/252 (20%)

Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKK 165
           +LG G+FG    V K   ++     A+K++K       ++     +  +E  IL  +N  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR----VRTKMERDILVEVN-- 84

Query: 166 YDREDKHH--IVRIYEYFVCQRHLCICFELLDSNLY----EL-IKINHFRGLSLSIVQLF 218
                  H  IV+++  F  +  L +  +      +    +L  +++     +   V+ +
Sbjct: 85  -------HPFIVKLHYAFQTEGKLYLILD------FLRGGDLFTRLSKEVMFTEEDVKFY 131

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSY 273
             ++   L  L   GII+ DLKPENILL       E  IK+ DFG    +   ++  YS+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLD-----EEGHIKLTDFGLSKESIDHEKKAYSF 186

Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
             +  Y +PEV+    +T + D WSFG ++ E+  G   F G    + +     IL A+ 
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT---MILKAKL 243

Query: 334 --PDYVLKEAKN 343
             P ++  EA++
Sbjct: 244 GMPQFLSPEAQS 255

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 66/263 (25%), Positives = 99/263 (37%), Gaps = 60/263 (22%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
           E  R  +     LG G FG+V  A  +    ++    VAVK++K      ++   + E+ 
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD---------SNLY 199
           +L+ L         H +IV +     C       +  E      LL+             
Sbjct: 79  VLSYLGN-------HMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129

Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257
               I     L+L +  L  FS Q+ +G++ L     IH DL   NILL         KI
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKI 186

Query: 258 IDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAE 305
            DFG A    R + +      Y             +PE +    YT   D+WS+G  + E
Sbjct: 187 CDFGLA----RDIKN---DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239

Query: 306 LF-LGLPLFPGASEFDLLRRMIR 327
           LF LG   +PG        +MI+
Sbjct: 240 LFSLGSSPYPGMPVDSKFYKMIK 262

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 82.0 bits (203), Expect = 6e-17
 Identities = 66/251 (26%), Positives = 103/251 (41%), Gaps = 53/251 (21%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LV 154
           E  R+ I     LGHG FG+V   ++ +++          VAVK +    +   +   L+
Sbjct: 26  EVPRKNITLIRGLGHGAFGEV---YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82

Query: 155 EVSILTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNLYELIKINHF 207
           E  I++         +  +IVR     V  +     I  EL     L S L E  +    
Sbjct: 83  EALIISKF-------NHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRET-RPRPS 132

Query: 208 RGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
           +  SL+++ L   ++ I  G   L++   IH D+   N LL         KI DFG A  
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-- 190

Query: 266 EDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPL 312
             R +Y    + YYR             PE  +   +T+  D WSFG ++ E+F LG   
Sbjct: 191 --RDIYR---ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

Query: 313 FPGASEFDLLR 323
           +P  S  ++L 
Sbjct: 246 YPSKSNQEVLE 256

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.1 bits (201), Expect = 6e-17
 Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKNQPAYYQQA--LVEVSIL 159
           E QR  I     +G G FG V +  + +  N    VA+K  KN  +   +   L E   +
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70

Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFEL-----LDSNLYELIKINHFRGLSLS 213
                     D  HIV++    V   + + I  EL     L S L         R  SL 
Sbjct: 71  RQF-------DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQV-------RKYSLD 114

Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
           +  L  ++ Q+   L+ L+    +H D+   N+L+        +K+ DFG +    R + 
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLS----RYME 167

Query: 272 SYIQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
               S YY++           PE +   ++T+A D+W FG  + E+   G+  F G    
Sbjct: 168 D---STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224

Query: 320 DLLRR 324
           D++ R
Sbjct: 225 DVIGR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.0 bits (203), Expect = 7e-17
 Identities = 56/249 (22%), Positives = 101/249 (40%), Gaps = 40/249 (16%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLN 163
           +     LG G+FG+V      E  +  A+KI+         Q  +    L E  IL  +N
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH---TLNEKRILQAVN 99

Query: 164 KKYDREDKHH--IVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLSLSIVQ 216
                       +V++   F    +L +  E      + S+L    +I  F   S    +
Sbjct: 100 ---------FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRF---SEPHAR 144

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
            ++ QI+     L    +I+ DLKPEN+L+    +   I++ DFG A       ++   +
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLCGT 201

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--P 334
               +PE++L   Y  A+D W+ G ++ E+  G P F       +     +I+  +   P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE---KIVSGKVRFP 258

Query: 335 DYVLKEAKN 343
            +   + K+
Sbjct: 259 SHFSSDLKD 267

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 81.2 bits (201), Expect = 9e-17
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 51/229 (22%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WD---AEMNSFVAVKIIKNQPAYYQQA--LVEVSI 158
              +RY+     LG G FG+V+   +D         VAVK +K       ++    E+ I
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86

Query: 159 LTTLNKKYDREDKH-HIVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSL 212
           L TL         H HI++      C+      L +  E +   +L + +  +     S+
Sbjct: 87  LRTL--------YHEHIIKYKG--CCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SI 131

Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
            + QL  F++QI  G++ L     IH DL   N+LL        +KI DFG A    + V
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN---DRLVKIGDFGLA----KAV 184

Query: 271 YSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
                  YYR            +PE L  Y++  A D+WSFG  + EL 
Sbjct: 185 PE--GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.5 bits (206), Expect = 1e-16
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 26/239 (10%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G+FG+V        +   AVKI+K     Q    +  +VE  +L    K       
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------- 400

Query: 172 HH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSLL 229
              + +++  F     L    E +  N  +L   I             ++ +I  GL  L
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYV--NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLL 286
           +  GII+ DLK +N++L +      IKI DFG       +  T  ++  +  Y +PE++ 
Sbjct: 459 QSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKEAKN 343
              Y  ++D W+FG ++ E+  G   F G  E +L +    I+      P  + KEA  
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---SIMEHNVAYPKSMSKEAVA 571

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 52/238 (21%), Positives = 92/238 (38%), Gaps = 43/238 (18%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           E   + +     LG G FG V    W  + +  VA+K+IK       + + E  ++  L 
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNL- 76

Query: 164 KKYDREDKHHIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--F 218
                     +V++Y   VC  QR + I  E + +  L   ++            QL   
Sbjct: 77  ------SHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEM 125

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
            K +   +  L+    +H DL   N L+        +K+ DFG +    R V       Y
Sbjct: 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQG---VVKVSDFGLS----RYVLD---DEY 175

Query: 279 YRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
             S           PEVL+  ++++  D+W+FG ++ E++ LG   +   +  +    
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 64/277 (23%)

Query: 103 VNAETQRRYIVKD-----LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQ 150
           +N     R   +D     ++G G FG+V            A+K++        +  A++ 
Sbjct: 58  INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF- 116

Query: 151 QALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLY----ELIKINH 206
               E  I+   N  +       +V+++  F   R+L +  E      Y    +L+ +  
Sbjct: 117 --WEERDIMAFANSPW-------VVQLFYAFQDDRYLYMVME------YMPGGDLVNLMS 161

Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
              +     + ++ +++  L  +   G IH D+KP+N+LL  S     +K+ DFG+    
Sbjct: 162 NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKM 218

Query: 265 TEDRTVYS--------YIQSRYYRSPEVLLG----YQYTTAIDMWSFGCIVAELFLGLPL 312
            ++  V          YI      SPEVL        Y    D WS G  + E+ +G   
Sbjct: 219 NKEGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

Query: 313 FPGASEFDLLRRMIRILGAQ-----PPD-YVLKEAKN 343
           F   S         +I+  +     P D  + KEAKN
Sbjct: 273 FYADSLVGTYS---KIMNHKNSLTFPDDNDISKEAKN 306

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 47/238 (19%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALV-EVSILTTL 162
               + +     +G G FG V      +   + VAVK IK       QA + E S++T L
Sbjct: 17  ALNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQL 71

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRH---LCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
                   +H ++V++    V       L I  E +   +L + ++        L    L
Sbjct: 72  --------RHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCL 119

Query: 218 --FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYI 274
             FS  +   +  L+    +H DL   N+L    V    + K+ DFG      +   S  
Sbjct: 120 LKFSLDVCEAMEYLEGNNFVHRDLAARNVL----VSEDNVAKVSDFGLT----KEASS-- 169

Query: 275 QSRYYR-------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
            ++          +PE L   +++T  D+WSFG ++ E++  G   +P     D++ R
Sbjct: 170 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 40/225 (17%)

Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
           LG G FG+V    ++      VAVK +K      +  L E +++ TL           +V
Sbjct: 196 LGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-------QHDKLV 246

Query: 176 RIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKD 231
           +++   V  +  + I  E +   +L + +K +   G    + +L  FS QI  G++ ++ 
Sbjct: 247 KLHA--VVTKEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS---------- 281
              IH DL+  NIL+  S+     KI DFG A    R +     + Y             
Sbjct: 303 RNYIHRDLRAANILVSASL---VCKIADFGLA----RVIED---NEYTAREGAKFPIKWT 352

Query: 282 -PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
            PE +    +T   D+WSFG ++ E+   G   +PG S  +++R 
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 49/242 (20%)

Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSF---VAVKIIKNQPAYYQQALVEVSILTT 161
           E +R  I +K  LG G +G+V   ++     +   VAVK +K      ++ L E +++  
Sbjct: 216 EMERTDITMKHKLGGGQYGEV---YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 272

Query: 162 LNKKYDREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
           +         H ++V++    VC  +    I  E +   NL + ++        +S V L
Sbjct: 273 IK--------HPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVL 320

Query: 218 --FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
              + QI   +  L+    IH +L   N L+    +   +K+ DFG +    R     + 
Sbjct: 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS----R----LMT 369

Query: 276 SRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
              Y +            PE L   +++   D+W+FG ++ E+   G+  +PG     + 
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429

Query: 323 RR 324
             
Sbjct: 430 EL 431

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 56/247 (22%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIK-NQPAYYQQALV-EVS 157
           E  R  +     LG G FG+V  A  +     +    VAVK++K    A  ++AL+ E+ 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-----SNLYELIK 203
           I++ L        +H +IV +     C     + +  E      LL+     S + E   
Sbjct: 102 IMSHL-------GQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152

Query: 204 INHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
                  + S   L  FS Q+ +G++ L     IH D+   N+LL         KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFG 209

Query: 262 SACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-L 308
            A    R + +      Y             +PE +    YT   D+WS+G ++ E+F L
Sbjct: 210 LA----RDIMN---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262

Query: 309 GLPLFPG 315
           GL  +PG
Sbjct: 263 GLNPYPG 269

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 67/248 (27%), Positives = 100/248 (40%), Gaps = 47/248 (18%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
           E  R+ I     LGHG FG+V +       +      VAVK +    +   +   L+E  
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNLYELIKINHFRGL 210
           I++  N         +IVR     V  +     I  EL     L S L E  +    +  
Sbjct: 127 IISKFNH-------QNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPS 176

Query: 211 SLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268
           SL+++ L   ++ I  G   L++   IH D+   N LL         KI DFG A    R
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----R 232

Query: 269 TVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
            +Y    + YYR             PE  +   +T+  D WSFG ++ E+F LG   +P 
Sbjct: 233 DIYR---AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

Query: 316 ASEFDLLR 323
            S  ++L 
Sbjct: 290 KSNQEVLE 297

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 59/260 (22%), Positives = 106/260 (40%), Gaps = 57/260 (21%)

Query: 106 ETQRRYIVKD-LLGHGTFGQVAKC-WDAEMNSF---VAVKIIKNQPAYYQQA--LVEVSI 158
             +   + K  +LG G FG V K  W  E  S    V +K+I+++            +  
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68

Query: 159 LTTLNKKYDREDKH-HIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIV 215
           + +L+        H HIVR+    +C    L +  + L   +L + ++ +  RG +L   
Sbjct: 69  IGSLD--------HAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQH--RG-ALGPQ 115

Query: 216 QL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY 273
            L  +  QI +G+  L++ G++H +L   N+LL +   P+++++ DFG A      +   
Sbjct: 116 LLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS---PSQVQVADFGVA----DLLPP- 167

Query: 274 IQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDL 321
              +                E +   +YT   D+WS+G  V EL   G   + G    ++
Sbjct: 168 -DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

Query: 322 LR------RMIRILGAQPPD 335
                   R+     AQP  
Sbjct: 227 PDLLEKGERL-----AQPQI 241

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 83.0 bits (205), Expect = 1e-16
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 34/226 (15%)

Query: 113 VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
           ++  LG G FG+V    W+      VA+K +K      +  L E  ++  L  +      
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHE------ 322

Query: 172 HHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQILRGLS 227
             +V++Y   V  +  + I  E +   +L + +K     G  L + QL   + QI  G++
Sbjct: 323 -KLVQLYA--VVSEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMA 377

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--YIQSRYYR----- 280
            ++    +H DL+  NIL+  ++     K+ DFG A    R +    Y   +  +     
Sbjct: 378 YVERMNYVHRDLRAANILVGENLV---CKVADFGLA----RLIEDNEYTARQGAKFPIKW 430

Query: 281 -SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
            +PE  L  ++T   D+WSFG ++ EL   G   +PG    ++L +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 62/262 (23%), Positives = 95/262 (36%), Gaps = 59/262 (22%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
           E  R  +     LG G FGQV +              VAVK++K    + +    + E+ 
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC---QRHLCICFE------LLD-------SNLYE 200
           IL  +         H ++V +     C      L +  E      L           +  
Sbjct: 83  ILIHI-------GHHLNVVNLLG--ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133

Query: 201 LIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258
            +         L++  L  +S Q+ +G+  L     IH DL   NILL        +KI 
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKIC 190

Query: 259 DFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
           DFG A    R +Y       Y             +PE +    YT   D+WSFG ++ E+
Sbjct: 191 DFGLA----RDIYK---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 307 F-LGLPLFPGASEFDLLRRMIR 327
           F LG   +PG    +   R ++
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLK 265

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 57/253 (22%), Positives = 101/253 (39%), Gaps = 43/253 (16%)

Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYD 167
           +LG G +G    V K    +     A+K++K      +    +    E  +L  +     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR---- 116

Query: 168 REDKHH--IVRIYEYFVCQRHLCICFELLDSN----LYELIKINHFRGLSLSIVQLFSKQ 221
                   +V ++  F  +  L +  + +  N       L +   F   +   VQ++  +
Sbjct: 117 ----QSPFLVTLHYAFQTETKLHLILDYI--NGGELFTHLSQRERF---TEHEVQIYVGE 167

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG----SACTEDRTVYSYIQ 275
           I+  L  L   GII+ D+K ENILL      +   + + DFG        E    Y +  
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLD-----SNGHVVLTDFGLSKEFVADETERAYDFCG 222

Query: 276 SRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQ 332
           +  Y +P+++ G    +  A+D WS G ++ EL  G   F    E +    + R IL ++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282

Query: 333 P--PDYVLKEAKN 343
           P  P  +   AK+
Sbjct: 283 PPYPQEMSALAKD 295

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 55/248 (22%), Positives = 94/248 (37%), Gaps = 40/248 (16%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
            +G G+FG+V      +     A+K +        N+         E+ I+  L      
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN---VFKELQIMQGLE----- 73

Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSN----LYELIKINHFRGLSLSIVQLFSKQI 222
               H  +V ++  F  +  + +  +LL        Y L +  HF       V+LF  ++
Sbjct: 74  ----HPFLVNLWYSFQDEEDMFMVVDLL--LGGDLRYHLQQNVHF---KEETVKLFICEL 124

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYR 280
           +  L  L++  IIH D+KP+NILL        + I DF  A     +  + +   ++ Y 
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEH---GHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 281 SPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PD 335
           +PE+     G  Y+ A+D WS G    EL  G   +   S       +          P 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241

Query: 336 YVLKEAKN 343
              +E  +
Sbjct: 242 AWSQEMVS 249

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 42/234 (17%)

Query: 112 IVKDLLGHGTFGQVAK-CWDAEMNSF-VAVKIIKN---QPAYYQQALVEVSILTTLNKKY 166
           +    LG G FG V K  +  +     VAVKI+KN    PA   + L E +++  L+   
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--- 76

Query: 167 DREDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
                + +IVR+    +C+     +  E+ +   L + ++ N  R +    +     Q+ 
Sbjct: 77  -----NPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVS 127

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS-- 281
            G+  L+++  +H DL   N+LL   V     KI DFG +    + + +     YY++  
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLS----KALRA--DENYYKAQT 178

Query: 282 ----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
                     PE +  Y++++  D+WSFG ++ E F  G   + G    ++   
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 59/333 (17%), Positives = 116/333 (34%), Gaps = 59/333 (17%)

Query: 19  PKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSP 78
           P G     +  ++ + +  ++V +         I    ++   L+K +   N        
Sbjct: 6   PMGHHHHHHGRRRASVAAGILVPRGSPG--LDGICSIEELSTSLYKKAGSENLY----FQ 59

Query: 79  SVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIV-KDLLGHGTFGQVAKC---WDAEMN 134
               ++     +N +L+ AV  V++        +   +++G G FG V       +    
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVI--GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK 117

Query: 135 SFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH---LCI 189
              AVK +       + +  L E  I+             +++ +    +C R      +
Sbjct: 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLG--ICLRSEGSPLV 168

Query: 190 CFEL-----LDSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPE 242
                    L + +            + ++  L  F  Q+ +G+  L     +H DL   
Sbjct: 169 VLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221

Query: 243 NILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-----------SPEVLLGYQYT 291
           N +L        +K+ DFG A    R +Y       +            + E L   ++T
Sbjct: 222 NCMLDEKFT---VKVADFGLA----RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274

Query: 292 TAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
           T  D+WSFG ++ EL   G P +P  + FD+  
Sbjct: 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 69/245 (28%), Positives = 110/245 (44%), Gaps = 38/245 (15%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           +LG G+FG+V      + N F A+K +K       +        +VE  +L+   +    
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---TMVEKRVLSLAWE---- 76

Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRG 225
               H  +  ++  F  + +L    E L  N  +L   I       LS    ++ +I+ G
Sbjct: 77  ----HPFLTHMFCTFQTKENLFFVMEYL--NGGDLMYHIQSCHKFDLSRATFYAAEIILG 130

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSYIQSRYYR 280
           L  L   GI++ DLK +NILL       +  IKI DFG        D    ++  +  Y 
Sbjct: 131 LQFLHSKGIVYRDLKLDNILL-----DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 185

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVL 338
           +PE+LLG +Y  ++D WSFG ++ E+ +G   F G  E +L      I    P  P ++ 
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH---SIRMDNPFYPRWLE 242

Query: 339 KEAKN 343
           KEAK+
Sbjct: 243 KEAKD 247

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 52/259 (20%), Positives = 92/259 (35%), Gaps = 63/259 (24%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
           E     +   + LG   FG+V K         E    VA+K +K++     +     E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNL--------YELI 202
           +   L          ++V +    V  +   L + F       L   L            
Sbjct: 65  LRARL-------QHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115

Query: 203 KINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE---IKI 257
             +     +L          QI  G+  L    ++H DL   N+L+       +   +KI
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV------YDKLNVKI 169

Query: 258 IDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAE 305
            D G      R VY+   + YY+            +PE ++  +++   D+WS+G ++ E
Sbjct: 170 SDLGLF----REVYA---ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222

Query: 306 LF-LGLPLFPGASEFDLLR 323
           +F  GL  + G S  D++ 
Sbjct: 223 VFSYGLQPYCGYSNQDVVE 241

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 55/262 (20%), Positives = 98/262 (37%), Gaps = 51/262 (19%)

Query: 89  NVNSDLILAVNLVLVNAETQRRYIV-KDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKN 144
            +N +L+ AV  V++        +   +++G G FG V       +       AVK +  
Sbjct: 6   ALNPELVQAVQHVVI--GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63

Query: 145 QPAYYQQA--LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH---LCICFELLDS-NL 198
                + +  L E  I+             +++ +    +C R      +    +   +L
Sbjct: 64  ITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDL 114

Query: 199 YELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256
              I+       + ++  L  F  Q+ +G+  L     +H DL   N +L        +K
Sbjct: 115 RNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VK 168

Query: 257 IIDFGSACTEDRTVYSYIQSRYYR--------------SPEVLLGYQYTTAIDMWSFGCI 302
           + DFG A    R +Y      YY               + E L   ++TT  D+WSFG +
Sbjct: 169 VADFGLA----RDMYD---KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221

Query: 303 VAELF-LGLPLFPGASEFDLLR 323
           + EL   G P +P  + FD+  
Sbjct: 222 LWELMTRGAPPYPDVNTFDITV 243

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 55/239 (23%), Positives = 101/239 (42%), Gaps = 37/239 (15%)

Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNS--FVAVKIIKNQPAYYQQA--LVEVSIL 159
           E +   I ++ ++G G  G+V              VA+K +K      Q+   L E SI+
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104

Query: 160 TTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIV 215
              +        H +I+R+    V    R   I  E +++ +L   ++ +       +I+
Sbjct: 105 GQFD--------HPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIM 151

Query: 216 QL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYS 272
           QL    + +  G+  L D G +H DL   N+L+         K+ DFG S   ED    +
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAA 208

Query: 273 YIQS------RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
           Y  +      R+  +PE +    +++A D+WSFG ++ E+   G   +   +  D++  
Sbjct: 209 YTTTGGKIPIRWT-APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 68/255 (26%), Positives = 102/255 (40%), Gaps = 56/255 (21%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALV-EVSI 158
             +RR IV K  LG G FG+V           +    VAVK +K+     ++    E  +
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 159 LTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNL--------YELIK 203
           LT L          HIV+ Y   VC     L + FE      L+  L          +  
Sbjct: 71  LTNL-------QHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121

Query: 204 INHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
                   L + Q+   + QI  G+  L     +H DL   N L+  ++    +KI DFG
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFG 178

Query: 262 SACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-L 308
            +    R VYS   + YYR             PE ++  ++TT  D+WSFG I+ E+F  
Sbjct: 179 MS----RDVYS---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231

Query: 309 GLPLFPGASEFDLLR 323
           G   +   S  +++ 
Sbjct: 232 GKQPWFQLSNTEVIE 246

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 36/244 (14%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           +LG G+FG+V        +   AVKI+K       +        +VE  +L    K    
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC---TMVEKRVLALPGK---- 79

Query: 169 EDKHH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGL 226
                 + +++  F     L    E +  N  +L   I             ++ +I  GL
Sbjct: 80  ---PPFLTQLHSCFQTMDRLYFVMEYV--NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSYIQSRYYRS 281
             L+  GII+ DLK +N++L      +E  IKI DFG       +  T  ++  +  Y +
Sbjct: 135 FFLQSKGIIYRDLKLDNVML-----DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 189

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLK 339
           PE++    Y  ++D W+FG ++ E+  G   F G  E +L +    I+      P  + K
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---SIMEHNVAYPKSMSK 246

Query: 340 EAKN 343
           EA  
Sbjct: 247 EAVA 250

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 66/262 (25%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD-----AEMNSFVAVKIIKNQPAYYQQA--LVE 155
           E  R  +     LG G FGQV  A+         +    VAVK++K+       +  + E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136

Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-------SNLY 199
           + ++  +        KH +I+ +     C     L +  E      L +         + 
Sbjct: 137 MEMMKMI-------GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187

Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--- 254
               IN      ++   L   + Q+ RG+  L     IH DL   N+L+       E   
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------TENNV 241

Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCI 302
           +KI DFG A    R + +     YY+            +PE L    YT   D+WSFG +
Sbjct: 242 MKIADFGLA----RDINN---IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294

Query: 303 VAELF-LGLPLFPGASEFDLLR 323
           + E+F LG   +PG    +L +
Sbjct: 295 MWEIFTLGGSPYPGIPVEELFK 316

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.4 bits (194), Expect = 5e-16
 Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 50/244 (20%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF------VAVKIIKNQPAYYQQA--LVEV 156
              R  +V   +LG G FG+V   ++    +       VAVK  K       +   + E 
Sbjct: 8   GIAREDVVLNRILGEGFFGEV---YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEA 64

Query: 157 SILTTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSI 214
            I+  L       D  HIV++    + +     I  EL     L   ++ N     SL +
Sbjct: 65  VIMKNL-------DHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERN---KNSLKV 112

Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
           + L  +S QI + ++ L+    +H D+   NIL+     P  +K+ DFG +    R +  
Sbjct: 113 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLS----RYIED 165

Query: 273 YIQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFD 320
                YY++           PE +   ++TTA D+W F   + E+   G   F      D
Sbjct: 166 ---EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

Query: 321 LLRR 324
           ++  
Sbjct: 223 VIGV 226

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 66/262 (25%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD-----AEMNSFVAVKIIKNQPAYYQQA--LVE 155
           E  R  +     LG G FGQV  A+         +    VAVK++K+       +  + E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90

Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-------SNLY 199
           + ++  +        KH +I+ +     C     L +  E      L +         + 
Sbjct: 91  MEMMKMI-------GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141

Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--- 254
               IN      ++   L   + Q+ RG+  L     IH DL   N+L+       E   
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------TENNV 195

Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCI 302
           +KI DFG A    R + +     YY+            +PE L    YT   D+WSFG +
Sbjct: 196 MKIADFGLA----RDINN---IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248

Query: 303 VAELF-LGLPLFPGASEFDLLR 323
           + E+F LG   +PG    +L +
Sbjct: 249 MWEIFTLGGSPYPGIPVEELFK 270

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 65/259 (25%), Positives = 100/259 (38%), Gaps = 60/259 (23%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD-----AEMNSFVAVKIIKNQPAYYQQA--LVE 155
           E  R  +V    LG G FGQV  A+            + VAVK++K+       +  + E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124

Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-------SNLY 199
           + ++  + K       H +I+ +     C     L +  E      L +         L 
Sbjct: 125 MEMMKMIGK-------HKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175

Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257
                +H     LS   L   + Q+ RG+  L     IH DL   N+L+        +KI
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKI 232

Query: 258 IDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAE 305
            DFG A    R ++      YY+            +PE L    YT   D+WSFG ++ E
Sbjct: 233 ADFGLA----RDIHH---IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285

Query: 306 LF-LGLPLFPGASEFDLLR 323
           +F LG   +PG    +L +
Sbjct: 286 IFTLGGSPYPGVPVEELFK 304

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 78.9 bits (195), Expect = 7e-16
 Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 50/246 (20%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CW---DAEMNSFVAVKIIKNQPAYYQQA--LVEVSI 158
           E     +  + ++G G FG+V K        +    VA+K +K      Q+   L E  I
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99

Query: 159 LTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL-----LDSNLYELIKINHFRGLS 211
           +            H+I+R+    V    + + I  E      LD  L E       +   
Sbjct: 100 MGQF-------SHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLRE-------KDGE 143

Query: 212 LSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
            S++QL    + I  G+  L +   +H DL   NIL+         K+ DFG +    R 
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS----RV 196

Query: 270 VYSYIQSRYYRS----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASE 318
           +    ++ Y  S          PE +   ++T+A D+WSFG ++ E+   G   +   S 
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256

Query: 319 FDLLRR 324
            ++++ 
Sbjct: 257 HEVMKA 262

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 79.2 bits (196), Expect = 7e-16
 Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 34/243 (13%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           +LG G+FG+V      E     AVK++K       +        + E  IL+        
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC---TMTEKRILSLARN---- 82

Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRG 225
               H  + +++  F     L    E +  N  +L   I   R    +  + ++ +I+  
Sbjct: 83  ----HPFLTQLFCCFQTPDRLFFVMEFV--NGGDLMFHIQKSRRFDEARARFYAAEIISA 136

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSP 282
           L  L D GII+ DLK +N+LL         K+ DFG          T  ++  +  Y +P
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGICNGVTTATFCGTPDYIAP 193

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
           E+L    Y  A+D W+ G ++ E+  G   F   +E DL      IL  +   P ++ ++
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---AILNDEVVYPTWLHED 250

Query: 341 AKN 343
           A  
Sbjct: 251 ATG 253

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.3 bits (194), Expect = 9e-16
 Identities = 62/253 (24%), Positives = 100/253 (39%), Gaps = 58/253 (22%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
            LG G+FG+V          + A+K++K        Q  +      E  +L+ +      
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH---TNDERLMLSIVT----- 64

Query: 169 EDKHH--IVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHFRGLSLSIVQLFSK 220
               H  I+R++  F   + + +        EL       L K   F      + + ++ 
Sbjct: 65  ----HPFIIRMWGTFQDAQQIFMIMDYIEGGELF----SLLRKSQRF---PNPVAKFYAA 113

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYS------ 272
           ++   L  L    II+ DLKPENILL          IKI DFG A       Y+      
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLD-----KNGHIKITDFGFAKYVPDVTYTLCGTPD 168

Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
           YI      +PEV+    Y  +ID WSFG ++ E+  G   F  ++         +IL A+
Sbjct: 169 YI------APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---KILNAE 219

Query: 333 P--PDYVLKEAKN 343
              P +  ++ K+
Sbjct: 220 LRFPPFFNEDVKD 232

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 50/252 (19%), Positives = 81/252 (32%), Gaps = 54/252 (21%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF------VAVKIIKNQPAYYQQA---LVE 155
               +      +LG G FG V    +A++         VAVK++K            L E
Sbjct: 19  LIPEQQFTLGRMLGKGEFGSV---REAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 156 VSILTTLNKKYDREDKHHIVRIY------EYFVCQRHLCICFEL-----LDSNLYELIKI 204
            + +          D  H+ ++                 +         L + L      
Sbjct: 76  AACMKEF-------DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128

Query: 205 NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
            +   L L  +  F   I  G+  L     IH DL   N +L   +    + + DFG + 
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT---VCVADFGLS- 184

Query: 265 TEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLP 311
              R +YS     YYR            + E L    YT   D+W+FG  + E+   G  
Sbjct: 185 ---RKIYS---GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238

Query: 312 LFPGASEFDLLR 323
            + G    ++  
Sbjct: 239 PYAGIENAEIYN 250

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 78.8 bits (195), Expect = 1e-15
 Identities = 56/241 (23%), Positives = 86/241 (35%), Gaps = 45/241 (18%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILT 160
                 +V  + +G G FG+V   +         VAVK  +       +A  L E  IL 
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL--VAVKSCRETLPPDLKAKFLQEARILK 167

Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL- 217
             +        H +IVR+      ++ + I  EL+   +    ++     G  L +  L 
Sbjct: 168 QYS--------HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLL 216

Query: 218 -FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
                   G+  L+    IH DL   N L+        +KI DFG +    R        
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFGMS----REEA---DG 266

Query: 277 RYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
            Y  S            PE L   +Y++  D+WSFG ++ E F LG   +P  S      
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326

Query: 324 R 324
            
Sbjct: 327 F 327

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 49/245 (20%)

Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CW--DAEMNSFVAVKIIKNQPAYYQQA--LVEVSIL 159
           E     I +  ++G G FG+V        ++    VA+K +K      Q+   L E SI+
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 160 TTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL-----LDSNLYELIKINHFRGLSL 212
                     D  +I+R+    V    + + I  E      LDS L +            
Sbjct: 101 GQF-------DHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRK-------HDAQF 144

Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
           +++QL    + I  G+  L D G +H DL   NIL+         K+ DFG      R +
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLG----RVL 197

Query: 271 YSYIQSRYYRS----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
               ++ Y             PE +   ++T+A D+WS+G ++ E+   G   +   S  
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257

Query: 320 DLLRR 324
           D+++ 
Sbjct: 258 DVIKA 262

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 58/255 (22%), Positives = 94/255 (36%), Gaps = 58/255 (22%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILT 160
                 I  +D++G G FGQV  A+     +    A+K +K   +         E+ +L 
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80

Query: 161 TLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFEL-----LDSNL--------YELIKI 204
            L         H +I+ +     C  + +L +  E      L   L             I
Sbjct: 81  KLGH-------HPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131

Query: 205 NHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262
            +    +LS  QL  F+  + RG+  L     IH DL   NIL+  +      KI DFG 
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---VAKIADFGL 188

Query: 263 ACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LG 309
           +  ++           Y             + E L    YTT  D+WS+G ++ E+  LG
Sbjct: 189 SRGQE----------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 238

Query: 310 LPLFPGASEFDLLRR 324
              + G +  +L  +
Sbjct: 239 GTPYCGMTCAELYEK 253

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 61/253 (24%), Positives = 95/253 (37%), Gaps = 57/253 (22%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LV 154
           E  R  I     LG G+FG V   ++              VA+K +    +  ++   L 
Sbjct: 21  EVAREKITMSRELGQGSFGMV---YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 155 EVSILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL---------LDSNLYELIK 203
           E S++          + HH+VR+    V    +   +  EL         L S    +  
Sbjct: 78  EASVMKEF-------NCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128

Query: 204 INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
                  SLS +   + +I  G++ L     +H DL   N ++        +KI DFG  
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMT 185

Query: 264 CTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGL 310
               R +Y    + YYR            SPE L    +TT  D+WSFG ++ E+  L  
Sbjct: 186 ----RDIYE---TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238

Query: 311 PLFPGASEFDLLR 323
             + G S   +LR
Sbjct: 239 QPYQGLSNEQVLR 251

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 50/269 (18%), Positives = 94/269 (34%), Gaps = 64/269 (23%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF------VAVKIIKNQPAYYQQA---LVE 155
              R  ++   +LG G FG V    +  +         VAVK +K   +  ++    L E
Sbjct: 30  VIDRNLLILGKILGEGEFGSV---MEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 156 VSILTTLNKKYDREDKHHIVRIY-----EYFVCQRHLCICFELLDS-NLYELIKIN--HF 207
            + +             +++R+                +    +   +L+  +  +    
Sbjct: 87  AACMKDF-------SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139

Query: 208 RGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
               + +  L  F   I  G+  L +   +H DL   N +L   +    + + DFG +  
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT---VCVADFGLS-- 194

Query: 266 EDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPL 312
             + +YS     YYR            + E L    YT+  D+W+FG  + E+   G+  
Sbjct: 195 --KKIYS---GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

Query: 313 FPGASEFDLLR------RMIRILGAQPPD 335
           +PG    ++        R+      QP D
Sbjct: 250 YPGVQNHEMYDYLLHGHRL-----KQPED 273

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 15/169 (8%)

Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
              ++++   +G G FG +   +        A  ++K +         E+     + KK 
Sbjct: 35  EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKD 94

Query: 167 DREDKHH--------IVRIYEY----FVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
             +            I   Y      F  + +  +  E L  +L ++   N       S 
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN--GTFKKST 152

Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
           V     ++L  L  + +   +H D+K  N+LL     P ++ + D+G +
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLS 200

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 47/227 (20%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIK----NQPAYYQQALVEVS 157
               + +   + LG G+FG V +  WDA       VAVK +K    +QP      + EV+
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSI 214
            + +L+        H +++R+Y   V     + +  EL    +L + ++ +        +
Sbjct: 74  AMHSLD--------HRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLL 120

Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
             L  ++ Q+  G+  L+    IH DL   N+LL        +KI DFG      R +  
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLM----RALPQ 173

Query: 273 YIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
                +Y              PE L    ++ A D W FG  + E+F
Sbjct: 174 --NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 70/257 (27%), Positives = 100/257 (38%), Gaps = 61/257 (23%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALV-EVSI 158
             +RR IV K  LG G FG+V           +    VAVK +K      +Q    E  +
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 159 LTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL-----LDSNL-------YELIKI 204
           LT L          HIVR +   VC   R L + FE      L+  L         L   
Sbjct: 97  LTML-------QHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147

Query: 205 NHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE---IKIID 259
                  L + QL   + Q+  G+  L     +H DL   N L+       +   +KI D
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV------GQGLVVKIGD 201

Query: 260 FGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
           FG +    R +YS   + YYR             PE +L  ++TT  D+WSFG ++ E+F
Sbjct: 202 FGMS----RDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

Query: 308 -LGLPLFPGASEFDLLR 323
             G   +   S  + + 
Sbjct: 255 TYGKQPWYQLSNTEAID 271

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 57/248 (22%), Positives = 104/248 (41%), Gaps = 56/248 (22%)

Query: 117 LGHGTFGQVAKC-WDAEMNSF---VAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRED 170
           LG G FG V K  W  E       VA+K ++    P   ++ L E  ++ +++       
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------- 75

Query: 171 KH-HIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQILRG 225
            + H+ R+    +C    + +  +L+    L + ++ +     ++    L  +  QI +G
Sbjct: 76  -NPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 129

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS---- 281
           ++ L+D  ++H DL   N+L+ T   P  +KI DFG A    + + +  + + Y +    
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLA----KLLGA--EEKEYHAEGGK 180

Query: 282 -------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR------RMIR 327
                   E +L   YT   D+WS+G  V EL   G   + G    ++        R+  
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 238

Query: 328 ILGAQPPD 335
               QPP 
Sbjct: 239 ---PQPPI 243

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.5 bits (191), Expect = 5e-15
 Identities = 58/274 (21%), Positives = 100/274 (36%), Gaps = 52/274 (18%)

Query: 102 LVNAETQRRYIVKD-----LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYY 149
             +   Q R   +D     ++G G FG+VA       +   A+KI+         + A +
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121

Query: 150 QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFR 208
                E  +L   + K+       I  ++  F    +L +  +     +L  L+      
Sbjct: 122 ---REERDVLVNGDSKW-------ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFED 170

Query: 209 GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTE 266
            L   + + +  +++  +  +     +H D+KP+NIL+        I++ DFGS     E
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME 227

Query: 267 DRTVYS--------YIQSRYYRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGLPLF 313
           D TV S        YI      SPE+L   +     Y    D WS G  + E+  G   F
Sbjct: 228 DGTVQSSVAVGTPDYI------SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 314 PGASEFDL----LRRMIRILGAQPPDYVLKEAKN 343
              S  +     +    R         V + AK+
Sbjct: 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 67/269 (24%), Positives = 105/269 (39%), Gaps = 73/269 (27%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
           E  R+ +V    LG G FG+V  A  +        + VAVK++K   +  +    L E +
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD------------- 195
           +L  +N        H H++++Y    C     L +  E      L               
Sbjct: 79  VLKQVN--------HPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128

Query: 196 --SNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251
                     ++H    +L++  L  F+ QI +G+  L +  ++H DL   NIL+     
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV----- 183

Query: 252 PAE---IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDM 296
            AE   +KI DFG +    R VY       Y             + E L  + YTT  D+
Sbjct: 184 -AEGRKMKISDFGLS----RDVYE---EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235

Query: 297 WSFGCIVAELF-LGLPLFPGASEFDLLRR 324
           WSFG ++ E+  LG   +PG     L   
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPERLFNL 264

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.0 bits (192), Expect = 6e-15
 Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 52/245 (21%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKNQPAYYQQA--LVEVSIL 159
           E QR  I     +G G FG V +  + +  N    VA+K  KN  +   +   L E   +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445

Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFEL-----LDSNLYELIKINHFRGLSLS 213
                     D  HIV++    V   + + I  EL     L S L         R  SL 
Sbjct: 446 RQF-------DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQV-------RKFSLD 489

Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
           +  L  ++ Q+   L+ L+    +H D+   N+L+ +      +K+ DFG +    R + 
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLS----RYME 542

Query: 272 SYIQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
               S YY++           PE +   ++T+A D+W FG  + E+   G+  F G    
Sbjct: 543 D---STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

Query: 320 DLLRR 324
           D++ R
Sbjct: 600 DVIGR 604

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.1 bits (188), Expect = 7e-15
 Identities = 55/244 (22%), Positives = 98/244 (40%), Gaps = 36/244 (14%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
           ++G G+FG+V          F AVK+++        +  +    + E ++L        +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH---IMSERNVLL-------K 94

Query: 169 EDKHH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGL 226
             KH  +V ++  F     L    + +  N  EL   +   R       + ++ +I   L
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYI--NGGELFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSYIQSRYYRS 281
             L    I++ DLKPENILL      ++  I + DFG        + T  ++  +  Y +
Sbjct: 153 GYLHSLNIVYRDLKPENILLD-----SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLK 339
           PEVL    Y   +D W  G ++ E+  GLP F   +  ++      IL         +  
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD---NILNKPLQLKPNITN 264

Query: 340 EAKN 343
            A++
Sbjct: 265 SARH 268

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 75.8 bits (187), Expect = 8e-15
 Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 65/268 (24%)

Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIK-NQPAYYQQALV-EVS 157
           E  R  +    +LG G FG+V  A  +      ++  VAVK++K    +  ++AL+ E+ 
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100

Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD------------- 195
           ++T L         H +IV +     C     + + FE      LL+             
Sbjct: 101 MMTQL-------GSHENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151

Query: 196 -SNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252
                +           L+   L  F+ Q+ +G+  L+    +H DL   N+L+      
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--- 208

Query: 253 AEIKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFG 300
             +KI DFG A    R + S      Y             +PE L    YT   D+WS+G
Sbjct: 209 KVVKICDFGLA----RDIMS---DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261

Query: 301 CIVAELF-LGLPLFPGASEFDLLRRMIR 327
            ++ E+F LG+  +PG        ++I+
Sbjct: 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQ 289

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 51/234 (21%), Positives = 84/234 (35%), Gaps = 48/234 (20%)

Query: 114 KDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
            ++   G FG V   W A++   +VAVKI   Q     Q   EV  L  +        KH
Sbjct: 29  LEVKARGRFGCV---WKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM--------KH 77

Query: 173 -HIVRIYEYFVCQR------HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILR 224
            +I++       +R       L +     +  +L + +       +S + +   ++ + R
Sbjct: 78  ENILQFIGA--EKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMAR 132

Query: 225 GLSLL----------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
           GL+ L              I H D+K +N+LL          I DFG A   +    +  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGD 189

Query: 275 QSRY-----YRSPEVL-----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
                    Y +PEVL             IDM++ G ++ EL        G  +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 33/247 (13%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           ++G G++ +V      + +   A+K++K    N          E  +    +        
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN------- 68

Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSL 228
            H  +V ++  F  +  L    E +  N  +L   +   R L     + +S +I   L+ 
Sbjct: 69  -HPFLVGLHSCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEV 284
           L + GII+ DLK +N+LL +      IK+ D+G  C E      T  ++  +  Y +PE+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSTFCGTPNYIAPEI 181

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR-----RMIR-ILGAQP--PDY 336
           L G  Y  ++D W+ G ++ E+  G   F      D         + + IL  Q   P  
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241

Query: 337 VLKEAKN 343
           +  +A +
Sbjct: 242 LSVKAAS 248

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 33/247 (13%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
           ++G G++ +V      + +   A++++K    N          E  +    +        
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN------- 111

Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSL 228
            H  +V ++  F  +  L    E +  N  +L   +   R L     + +S +I   L+ 
Sbjct: 112 -HPFLVGLHSCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEV 284
           L + GII+ DLK +N+LL +      IK+ D+G  C E      T  ++  +  Y +PE+
Sbjct: 169 LHERGIIYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSTFCGTPNYIAPEI 224

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR-----RMIR-ILGAQP--PDY 336
           L G  Y  ++D W+ G ++ E+  G   F      D         + + IL  Q   P  
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284

Query: 337 VLKEAKN 343
           +  +A +
Sbjct: 285 LSVKAAS 291

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 75.4 bits (185), Expect = 3e-14
 Identities = 48/235 (20%), Positives = 94/235 (40%), Gaps = 44/235 (18%)

Query: 112 IVKDLLGHGTFGQVAK-CWDAEMNSF-VAVKIIKN--QPAYYQQALVEVSILTTLNKKYD 167
           I    LG G FG V +  +        VA+K++K   + A  ++ + E  I+  L+    
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD---- 394

Query: 168 REDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQI 222
               + +IVR+    VCQ   L +  E+     L++ +         + +  +     Q+
Sbjct: 395 ----NPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQV 445

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS- 281
             G+  L++   +H +L   N+LL   V     KI DFG +    + + +     YY + 
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLS----KALGA--DDSYYTAR 496

Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
                      PE +   ++++  D+WS+G  + E    G   +      +++  
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 71/267 (26%)

Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
           E  R  I     +G G FG+V +         E  + VAVK++K + +   QA    E +
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL---------------------L 194
           ++          D  +IV++    VC   + +C+ FE                       
Sbjct: 103 LMAEF-------DNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153

Query: 195 DSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252
            S+L    +++      LS  +    ++Q+  G++ L +   +H DL   N L+      
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV------ 207

Query: 253 AE---IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMW 297
            E   +KI DFG +    R +YS   + YY+             PE +   +YTT  D+W
Sbjct: 208 GENMVVKIADFGLS----RNIYS---ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260

Query: 298 SFGCIVAELF-LGLPLFPGASEFDLLR 323
           ++G ++ E+F  GL  + G +  +++ 
Sbjct: 261 AYGVVLWEIFSYGLQPYYGMAHEEVIY 287

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 66/282 (23%)

Query: 89  NVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKC-WDAEMNSF--VAVKIIKNQ 145
           +++S L+  V  VL+  E +       ++G G FG V    +  +  +    A+K +   
Sbjct: 2   DLDSALLAEVKDVLIPHE-RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60

Query: 146 PAYYQQA--LVEVSILTTLNKKYDREDKHHIVRIYEYFVC---QRHLCICFELLDS-NLY 199
               Q    L E  ++  L       +  +++ +    +    +    +    +   +L 
Sbjct: 61  TEMQQVEAFLREGLLMRGL-------NHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLL 111

Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--- 254
           + I+       + ++  L  F  Q+ RG+  L +   +H DL   N +L       E   
Sbjct: 112 QFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML------DESFT 162

Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYR--------------SPEVLLGYQYTTAIDMWSFG 300
           +K+ DFG A    R +       YY               + E L  Y++TT  D+WSFG
Sbjct: 163 VKVADFGLA----RDILD---REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG 215

Query: 301 CIVAELF-LGLPLFPGASEFDLLR------RMIRILGAQPPD 335
            ++ EL   G P +     FDL        R+      QP  
Sbjct: 216 VLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-----PQPEY 252

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 24/170 (14%), Positives = 60/170 (35%), Gaps = 14/170 (8%)

Query: 107 TQRRYIVKDLLGHGTFGQV--------AKCWDAEMNSFVAVKI-IKNQPAYYQQALVEVS 157
           + R++ +K        G +          C         ++K+  K+   + +Q   + +
Sbjct: 40  SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99

Query: 158 ILTTLNKKYDREDKHH---IVRIYEYFV-CQRHLCICFELLDSNLYELIKINHFRGLSLS 213
                  K+ +        I     + V   ++  +    L  +L   + ++    LS  
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSER 159

Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
            V   + ++L  L  L +   +H ++  ENI +      +++ +  +G A
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE-DQSQVTLAGYGFA 208

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 74.1 bits (181), Expect = 1e-13
 Identities = 79/635 (12%), Positives = 169/635 (26%), Gaps = 222/635 (34%)

Query: 50  KDIVETYQ---ICNPLFKYSEELNPKRYLTSPSVG-VLNDGYDNVNSDLILAVNLVLVNA 105
           KDI+  ++   + N   K  +++ PK  L+   +  ++        +  +     +L   
Sbjct: 19  KDILSVFEDAFVDNFDCKDVQDM-PKSILSKEEIDHIIMSKDAVSGTLRLF--WTLLSKQ 75

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
           E   +  V+++L               +N  F+   I   +    Q +++    +   ++
Sbjct: 76  EEMVQKFVEEVL--------------RINYKFLMSPI---KTEQRQPSMMTRMYIEQRDR 118

Query: 165 KY---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
            Y       K+++ R+  Y   ++ L      L       + I+   G          K 
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLE----LRPAKN--VLIDGVLG--------SGKT 164

Query: 222 ILRGLSLLKDAGI-------IH------CDLKPENIL-----LCTSVKPAEIKIIDFGSA 263
            +  L +     +       I       C+  PE +L     L   + P      D  S 
Sbjct: 165 WV-ALDVCLSYKVQCKMDFKIFWLNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSN 222

Query: 264 C------TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGC--IV------------ 303
                   +           Y     VLL  Q   A + ++  C  ++            
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282

Query: 304 ---------------------AELFLGLPLFPGASEFDLLRRM-------IRILGAQPPD 335
                                  L L    +      DL R +       + I+      
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLL---KYLDCRPQDLPREVLTTNPRRLSIIAES--- 336

Query: 336 YVLKEAKNTSKFFKCIG----------SVHNIENGEVSIGGRSAYQALT----------- 374
             +++   T   +K +           S++ +E  E     R  +  L+           
Sbjct: 337 --IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY----RKMFDRLSVFPPSAHIPTI 390

Query: 375 --------EIEYEAREL-----KKPLIGKE------YFHHKHLEE-------------IV 402
                    I+ +   +     K  L+ K+           +LE              IV
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV 450

Query: 403 TNYPYRKNLSMEDISKESQIRLALVD-----FLKG--LVEFDPAKRWSPF---------- 445
            +Y   K    +D+          +D      + G  L   +  +R + F          
Sbjct: 451 DHYNIPKTFDSDDLIPPY------LDQYFYSHI-GHHLKNIEHPERMTLFRMVFLDFRFL 503

Query: 446 -QASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHW------FAAGLSPNIS 498
            Q  RH       +           ++   + +  D+ P           F   +  N+ 
Sbjct: 504 EQKIRH---DSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL- 559

Query: 499 GRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYND 533
                    S +  ++         ++     + +
Sbjct: 560 -------ICSKYTDLLRIALMAEDEAI-----FEE 582

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 43/226 (19%), Positives = 71/226 (31%), Gaps = 50/226 (22%)

Query: 116 LLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
           L+G G +G V   +   ++   VAVK+        Q  + E +I      ++D     +I
Sbjct: 20  LIGRGRYGAV---YKGSLDERPVAVKVFSFA--NRQNFINEKNIYRVPLMEHD-----NI 69

Query: 175 VRIY-----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
            R            +    +  E   + +L + +                +  + RGL+ 
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAY 126

Query: 229 L---------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY- 278
           L             I H DL   N+L+          I DFG +                
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC---VISDFGLSMRLTGNRLVRPGEEDN 183

Query: 279 ----------YRSPEVLLG-------YQYTTAIDMWSFGCIVAELF 307
                     Y +PEVL G             +DM++ G I  E+F
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 29/236 (12%), Positives = 60/236 (25%), Gaps = 53/236 (22%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKK 165
           RY +    G     Q  +  D  ++  VA+  +  Q        Q+ L     L+ ++  
Sbjct: 32  RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-- 89

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLS----LSIVQLFS 219
                    + R+ +    +    +  E +   +L E+         S    +  +Q   
Sbjct: 90  ------KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQ--- 136

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
             +         AG+      P  + +       ++ +                      
Sbjct: 137 -SLAAAADAAHRAGVALSIDHPSRVRVSID---GDVVLAYPA-----------------T 175

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
                          D+   G  +  L +     P A     L    R    QP +
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 41/147 (27%), Positives = 61/147 (41%), Gaps = 25/147 (17%)

Query: 196 SNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253
           S++ E           L++  L  +S Q+ +G+  L     IH DL   NILL       
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-- 231

Query: 254 EIKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGC 301
            +KI DFG A    R +Y       Y             +PE +    YT   D+WSFG 
Sbjct: 232 -VKICDFGLA----RDIYK---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283

Query: 302 IVAELF-LGLPLFPGASEFDLLRRMIR 327
           ++ E+F LG   +PG    +   R ++
Sbjct: 284 LLWEIFSLGASPYPGVKIDEEFCRRLK 310

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 3e-11
 Identities = 36/241 (14%), Positives = 70/241 (29%), Gaps = 59/241 (24%)

Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII---------KNQPAYYQQALVEVSILTTLNKKYD 167
           +G G FG+V +      ++ VA+KII          +    +++ L E+ I   L+    
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 168 REDKHH--IVRIYEYFVCQ------------------------------RHLCICFELLD 195
                    + +      Q                                L I  E   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL-KDAGIIHCDLKPENILLCTSVKPAE 254
                 ++    +  SL+  +    Q+   L++        H DL   N+LL    K + 
Sbjct: 146 GG--IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK---KTSL 200

Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314
            K+    +  +                 +V +   YT +        +  ++ +   LF 
Sbjct: 201 KKLHYTLNGKSSTIPSCGL---------QVSII-DYTLSRLERDGIVVFCDVSMDEDLFT 250

Query: 315 G 315
           G
Sbjct: 251 G 251

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 28/172 (16%), Positives = 60/172 (34%), Gaps = 22/172 (12%)

Query: 109 RRYIVKDLLGHGTFGQV-----AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
             + V   +G G FG +             ++   VK+  +          E+       
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD---NGPLFTELKFYQRAA 91

Query: 164 KKYDREDKHH--------IVRIY----EYFVCQRHLCICFELLDSNLYELIKINHFRGLS 211
           K    +            + + +         + +  +  +   S+L ++ + N  +  S
Sbjct: 92  KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFS 150

Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
              V   S +IL  L  + +   +H D+K  N+LL     P ++ ++D+G A
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLA 201

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 54.1 bits (131), Expect = 7e-08
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 43/217 (19%)

Query: 116 LLGHGTFGQVAKCW-DAEMNSFVAVKIIKNQPAY-----YQQALVEVSILTTLNKKYDRE 169
            +G G FG V K + +   N+ VAVK +            QQ   E+ ++          
Sbjct: 38  KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC------- 87

Query: 170 DKH-HIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLS----LSIVQLFS 219
            +H ++V +  +      LC+ +       L   L  L        LS      I Q   
Sbjct: 88  -QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP---LSWHMRCKIAQ--- 140

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-- 277
                G++ L +   IH D+K  NILL  +      KI DFG A   ++   + + SR  
Sbjct: 141 -GAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQTVMTSRIV 196

Query: 278 --Y-YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
               Y +PE L G + T   D++SFG ++ E+  GLP
Sbjct: 197 GTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232

>1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733

 Score = 52.8 bits (126), Expect = 4e-07
 Identities = 58/250 (23%), Positives = 91/250 (36%), Gaps = 22/250 (8%)

Query: 523  GSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKM 582
            G  G    Y++ +GL ++     D       FSP+  SG N     G +  G   D  + 
Sbjct: 1465 GQDGGVTPYSNESGLVNADLDVKDELM----FSPLVDSGSNDAMAGGFTAYGG-ADYGEA 1519

Query: 583  FIQYSQGNGLGVSPSAGMFVPLPLGTSP--SQFTPP-SSYGQVSSGSPGHYGPTSPARS- 638
               +        SP  G+  P    TSP  S  +P  S      S +   Y PTSP+ S 
Sbjct: 1520 TSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSP 1579

Query: 639  -SCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVL 697
             S   SP     + T         YS    S  SP+S  +        S   +  +P   
Sbjct: 1580 TSPSYSPTSPSYSPTSP------SYSPTSPSY-SPTSPSY-----SPTSPSYSPTSPSYS 1627

Query: 698  GSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVP 757
             ++  + P++PS + +      +  + S ++    P+S +  P     +   P  S + P
Sbjct: 1628 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSP 1687

Query: 758  DPGDWDPNYS 767
                  PNYS
Sbjct: 1688 SYSPTSPNYS 1697

>1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733

 Score = 42.8 bits (100), Expect = 6e-04
 Identities = 53/255 (20%), Positives = 75/255 (29%), Gaps = 32/255 (12%)

Query: 438  PAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNI 497
                +SP   S         FT            P     +    PG G   + G SP  
Sbjct: 1488 DELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVS-SPGFSPTS 1546

Query: 498  SGRSKFSM----------HNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDG 547
               S  S             SP +      Y  +  S          T    S  S    
Sbjct: 1547 PTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1606

Query: 548  GNTFAY------FSPVGPS---GMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSA 598
              + +Y      +SP  PS       ++ +  S   +SP        YS       SP+ 
Sbjct: 1607 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT-----SPAY 1661

Query: 599  GMFVPLPLGTSP--SQFTPPSSYGQV--SSGSPGHYGPTSPARSSCHGSPLGKMTAATHY 654
                P    TSP  S  +P  S      S  SP  Y PTSP+ S    SP     +  + 
Sbjct: 1662 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPN-YSPTSPSYSP--TSPGYSPGSPAYS 1718

Query: 655  NRRKNWGYSGNPQSQ 669
             ++    ++ N  S+
Sbjct: 1719 PKQDEQKHNENENSR 1733

>3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 67/327 (20%), Positives = 107/327 (32%), Gaps = 83/327 (25%)

Query: 442  WSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRS 501
            +SP           E F         +P   V         PG    F++ +SP     S
Sbjct: 1505 FSPLVQG--GSEGREGFGDYGLLGAASPYKGV-------QSPGYTSPFSSAMSPGYGLTS 1555

Query: 502  KFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSG 561
                 +SP       GY  S   + S  SY+       SY        T   +SP  PS 
Sbjct: 1556 PSYSPSSP-------GYSTSPAYMPSSPSYS---PTSPSYSP------TSPSYSPTSPS- 1598

Query: 562  MNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQ 621
               ++ +  S   +SP        YS  +    SP++  + P    TSPS ++P S    
Sbjct: 1599 ---YSPTSPSYSATSPS-------YSPTSP-SYSPTSPSYSP----TSPS-YSPTS---P 1639

Query: 622  VSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQF 681
              S +   Y PTSP+ S                    +  YS       SP+S  +    
Sbjct: 1640 SYSPTSPSYSPTSPSYS------------------PTSPSYSPTS-PSYSPTSPSYSPTS 1680

Query: 682  IDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPA 741
                S     ++P    ++  + P++PS + +      +  + S ++    P+S      
Sbjct: 1681 P-SYSPTSPSYSP----TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS------ 1729

Query: 742  IAEAAHDKPETSLSVPDPGDWDPNYSD 768
                    P  S + P      P+YS 
Sbjct: 1730 --------PSYSPTSPSYSPTSPSYSP 1748

>3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 59/284 (20%), Positives = 92/284 (32%), Gaps = 23/284 (8%)

Query: 504  SMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMN 563
                +    +   G G S    G+   Y     + S +    D       FSP+   G  
Sbjct: 1459 YSLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAA----FSPLVQGGSE 1514

Query: 564  LHAQSGVSVR--GSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQ 621
                 G       +SP        Y+      +SP  G+  P    +SP   T P+    
Sbjct: 1515 GREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAY--- 1571

Query: 622  VSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQF 681
                SP  Y PTSP+ S    SP    T+ ++     ++  +    S  SPS       +
Sbjct: 1572 -MPSSPS-YSPTSPSYSP--TSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSY 1627

Query: 682  IDGASSGQAEWNPQVLGSASLHLPS-NPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGP 740
                S     ++P    S S    S + S TS       +  + S ++    P+S +  P
Sbjct: 1628 ----SPTSPSYSPT---SPSYSPTSPSYSPTSPSYSP--TSPSYSPTSPSYSPTSPSYSP 1678

Query: 741  AIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITT 784
                 +   P  S + P      P+YS         S   S T+
Sbjct: 1679 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1722

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 39/211 (18%)

Query: 116 LLGHGTFGQV--AKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDK 171
           +LG G FG+V   +  D    + VAVK +K         Q   EV +++           
Sbjct: 37  ILGRGGFGKVYKGRLAD---GTLVAVKRLKEERTQGGELQFQTEVEMISMA--------V 85

Query: 172 H-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL---FSKQIL---- 223
           H +++R+  + +      + +  + +        +  R    S   L     ++I     
Sbjct: 86  HRNLLRLRGFCMTPTERLLVYPYMANGSVA----SCLRERPESQPPLDWPKRQRIALGSA 141

Query: 224 RGLSLLKDAG---IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-- 278
           RGL+ L D     IIH D+K  NILL    +     + DFG A   D    +++ +    
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEA---VVGDFGLAKLMDYKD-THVTTAVRG 197

Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
              + +PE L   + +   D++ +G ++ EL
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 44/217 (20%)

Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA----LVEVSILTTLNKKYDREDK 171
           L+GHG FG+V K    +  + VA+K    +     Q       E+  L+           
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKRRTPES---SQGIEEFETEIETLSFC--------- 92

Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL------ 223
            H  +V +  +   +  + + ++ +++   +     H  G  L  + +  +Q L      
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLK----RHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 224 -RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRY- 278
            RGL  L    IIH D+K  NILL  +  P   KI DFG        D+T   ++ +   
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVP---KITDFGISKKGTELDQT---HLSTVVK 202

Query: 279 ----YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
               Y  PE  +  + T   D++SFG ++ E+     
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	837
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.04
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.9
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.4
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.26
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.08
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.04
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.9
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.89
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.39
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.37
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.35
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.05
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.9
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.88
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.73
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.6
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.19
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.84
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.51
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.74
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.89

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-55  Score=485.30  Aligned_cols=255  Identities=23%  Similarity=0.412  Sum_probs=219.8

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ...+|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++|+.|       .|||||+++++|.+++
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-------~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECC
Confidence            3468999999999999999999999999999999997432 3345678999999999       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|||||||. |+|.+++...   .+++.+++.|++||+.||+|||++|||||||||+||||+   .++.+||+|||+|+
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~  218 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCce
Confidence            9999999998 5888887653   599999999999999999999999999999999999995   67899999999997


Q ss_pred             ccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   .....+||+.|||||++.+..|+.++||||||||+|||++|++||.+.+..+.+..|.....   +.      
T Consensus       219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~------  289 (346)
T 4fih_A          219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PR------  289 (346)
T ss_dssp             ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---CC------
T ss_pred             ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CC------
Confidence            6533   34567999999999999999999999999999999999999999999888777766544111   00      


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                +.....
T Consensus       290 --------------------------------------------------------------------------~~~~~~  295 (346)
T 4fih_A          290 --------------------------------------------------------------------------LKNLHK  295 (346)
T ss_dssp             --------------------------------------------------------------------------CSCGGG
T ss_pred             --------------------------------------------------------------------------CCcccc
Confidence                                                                                      000112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +++++.|||.+||+.||++|||++|||+||||++..
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            457899999999999999999999999999999753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.7e-55  Score=483.86  Aligned_cols=253  Identities=24%  Similarity=0.353  Sum_probs=216.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||++++.   ....+.+.+|+++|++|       .|||||+++++|.+++
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIV~~~~~~~~~~   96 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-------KHPNIVQYRESFEENG   96 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-------CCCCCCcEEEEEEECC
Confidence            7999999999999999999999999999999999753   34567789999999999       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|||||||. |+|.+++.......+++.+++.|+.||+.||+|||++|||||||||+||||+   .++.+||+|||+|+
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~  173 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEES
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccce
Confidence            9999999998 5999999876656689999999999999999999999999999999999995   67899999999998


Q ss_pred             ccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .....   ....+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++.+|.+..  .|+       
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~-------  244 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FPP-------  244 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCC-------
T ss_pred             eecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--CCC-------
Confidence            76543   245689999999999999999999999999999999999999999998888777765411  000       


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                       .           ...
T Consensus       245 -----------------------------------------------------------------~-----------~~~  248 (350)
T 4b9d_A          245 -----------------------------------------------------------------V-----------SLH  248 (350)
T ss_dssp             -----------------------------------------------------------------C-----------CTT
T ss_pred             -----------------------------------------------------------------C-----------Ccc
Confidence                                                                             0           001


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      +++++.+||.+||+.||++|||++|||+||||++.
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            34678999999999999999999999999999863

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-55  Score=476.04  Aligned_cols=254  Identities=26%  Similarity=0.457  Sum_probs=221.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||++++.    ....+.+.+|+++|+.|       +|||||+++++|+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~~~  104 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHPFFVKLYFTFQDD  104 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeC
Confidence            6799999999999999999999999999999999753    23456788999999988       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. |+|.+++...  +.++|.+++.+++||+.||+|||++|||||||||+||||+   .++.+||+|||+|
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla  179 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTA  179 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred             CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCc
Confidence            99999999998 5999999765  4699999999999999999999999999999999999995   6789999999999


Q ss_pred             cccC-----CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          264 CTED-----RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       264 ~~~~-----~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +...     ....+.+||+.|||||++.+..|+.++||||||||+|||++|++||.+.+..+++.+|.+.-- .      
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~------  252 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-D------  252 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-C------
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-C------
Confidence            7543     223467999999999999999999999999999999999999999999888877777654100 0      


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                        +|            
T Consensus       253 ------------------------------------------------------------------~p------------  254 (311)
T 4aw0_A          253 ------------------------------------------------------------------FP------------  254 (311)
T ss_dssp             ------------------------------------------------------------------CC------------
T ss_pred             ------------------------------------------------------------------CC------------
Confidence                                                                              00            


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHH------HHcCccCCCCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQ------ASRHPFVTGEPFTC  460 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~E------aL~HPff~~~~~~~  460 (837)
                       ..++++++|||++||+.||++|+|++|      +++||||++..|..
T Consensus       255 -~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          255 -EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             -TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             -cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence             013467899999999999999999988      58999999987754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-54  Score=466.22  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=204.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||+|+||+||+|+++.+++.||||++++.    ....+.+.+|+++|+.+       .|||||+++++|.++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~~   85 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-------RHPHIIKLYDVIKSK   85 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-------CCTTBCCEEEEEECS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-------CCCCCCeEEEEEEEC
Confidence            6899999999999999999999999999999999753    23356788999999999       689999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +.+|||||||+|+|.+++...  +.+++.+++.+++||+.||+|||++|||||||||+|||++   .++.+||+|||+|+
T Consensus        86 ~~~~ivmEy~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~  160 (275)
T 3hyh_A           86 DEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSN  160 (275)
T ss_dssp             SEEEEEEECCCEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC-
T ss_pred             CEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCe
Confidence            999999999999999998765  4699999999999999999999999999999999999995   67899999999997


Q ss_pred             ccCC--cceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....  .....+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+..+.+..+.+..-   +       
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~---~-------  230 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY---T-------  230 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---C-------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---C-------
Confidence            5432  3456799999999999999876 5799999999999999999999998877666655543100   0       


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                     +|             ..
T Consensus       231 ---------------------------------------------------------------~p-------------~~  234 (275)
T 3hyh_A          231 ---------------------------------------------------------------LP-------------KF  234 (275)
T ss_dssp             ---------------------------------------------------------------CC-------------TT
T ss_pred             ---------------------------------------------------------------CC-------------CC
Confidence                                                                           00             01


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      +++++.|||++||+.||++|||++|+|+||||+.
T Consensus       235 ~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          235 LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            3467899999999999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-53  Score=481.03  Aligned_cols=281  Identities=30%  Similarity=0.538  Sum_probs=229.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++.   ....+.+++|+++|+.|       .|||||++++++...
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~l~~~~~~~  125 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-------KHDNIIAIKDILRPT  125 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCCS
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-------CCCCcceEeeeeecc
Confidence            36899999999999999999999999999999999753   34456788999999999       689999999998643


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            +++|||||||+|+|.+++...  +.+++.+++.|++||+.||+|||++|||||||||+|||++   .++.+||+
T Consensus       126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~  200 (398)
T 4b99_A          126 VPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIG  200 (398)
T ss_dssp             SCTTTCCCEEEEEECCSEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEEC
T ss_pred             cccccCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEe
Confidence                  679999999999999988654  4799999999999999999999999999999999999995   67899999


Q ss_pred             ecccccccC-------CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003239          259 DFGSACTED-------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG  330 (837)
Q Consensus       259 DFGlA~~~~-------~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG  330 (837)
                      |||+|+...       ......+||+.|||||++.+. .|+.++||||||||+|||++|++||.+.+..+++..|.+..|
T Consensus       201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g  280 (398)
T 4b99_A          201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG  280 (398)
T ss_dssp             CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence            999997542       223467999999999999886 569999999999999999999999999999999999999999


Q ss_pred             CCCchHHHHhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCC
Q 003239          331 AQPPDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR  408 (837)
Q Consensus       331 ~~Pp~~~l~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~  408 (837)
                       .|+...+......  ..++...                                  +     .+....++.+.+     
T Consensus       281 -~p~~~~~~~~~~~~~~~~~~~~----------------------------------~-----~~~~~~~~~~~~-----  315 (398)
T 4b99_A          281 -TPSPAVIQAVGAERVRAYIQSL----------------------------------P-----PRQPVPWETVYP-----  315 (398)
T ss_dssp             -CCCGGGTC-----CHHHHHHSS----------------------------------C-----CCCCCCHHHHST-----
T ss_pred             -CCChHHhhhhhhhhhhhhhhcC----------------------------------C-----CcCCCCHHHhCC-----
Confidence             4443322211100  0000000                                  0     011122333222     


Q ss_pred             CCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       409 ~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                                  ..+++++|||++||++||++|+||+|||+||||++..
T Consensus       316 ------------~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          316 ------------GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             ------------TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             ------------CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                        2457899999999999999999999999999999854

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.4e-54  Score=486.71  Aligned_cols=255  Identities=23%  Similarity=0.408  Sum_probs=220.0

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|+.|       .|||||+++++|.+++
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-------~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-------CCCCCCceEEEEEECC
Confidence            4478999999999999999999999999999999997532 3345688999999999       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|||||||. |+|.+++...   .+++.+++.|++||+.||+|||++|||||||||+||||+   .++.+||+|||+|+
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~  295 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccce
Confidence            9999999998 5888888653   599999999999999999999999999999999999995   67899999999997


Q ss_pred             ccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   .....+||+.|||||++.+..|+.++||||||||+|||++|++||.+.+..+.+..|.....   +..     
T Consensus       296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~~-----  367 (423)
T 4fie_A          296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PRL-----  367 (423)
T ss_dssp             ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCC-----
T ss_pred             ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCC-----
Confidence            6533   34567999999999999999999999999999999999999999999888777766544111   000     


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                 .....
T Consensus       368 ---------------------------------------------------------------------------~~~~~  372 (423)
T 4fie_A          368 ---------------------------------------------------------------------------KNLHK  372 (423)
T ss_dssp             ---------------------------------------------------------------------------SCTTS
T ss_pred             ---------------------------------------------------------------------------ccccc
Confidence                                                                                       00012


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++++++|||.+||+.||++|+|++|||+||||++..
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            457899999999999999999999999999999743

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5e-54  Score=467.47  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=211.0

Q ss_pred             CceEEEEEeccCCceeEEEeec---cCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~---~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|+++++||+|+||+||+|++   ..+++.||||++++..   .....+.+|+++|++|       +|||||+++++|.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~   96 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-------NHPFIVKLHYAFQ   96 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-------CCTTEECEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-------CCCCCCeEEEEEE
Confidence            6899999999999999999976   3568899999997532   2234567788888777       6999999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +++.+|||||||. |+|.+++...  +.+++.+++.+++||+.||+|||++|||||||||+|||++   .++.+||+|||
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFG  171 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFG  171 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSE
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccc
Confidence            9999999999998 5999998765  3699999999999999999999999999999999999995   67899999999


Q ss_pred             cccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          262 SACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       262 lA~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +|+...   ......+||+.|||||++.+..|+.++||||||||+|||++|++||.+.+..+++..|.+..-   +    
T Consensus       172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~----  244 (304)
T 3ubd_A          172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL---G----  244 (304)
T ss_dssp             EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---C----
T ss_pred             cceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC---C----
Confidence            997532   334567899999999999999999999999999999999999999999888877776654110   0    


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                        +|            
T Consensus       245 ------------------------------------------------------------------~p------------  246 (304)
T 3ubd_A          245 ------------------------------------------------------------------MP------------  246 (304)
T ss_dssp             ------------------------------------------------------------------CC------------
T ss_pred             ------------------------------------------------------------------CC------------
Confidence                                                                              00            


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF  458 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~  458 (837)
                       ..+++++.|||++||+.||++|||     ++|+|+||||++..|
T Consensus       247 -~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          247 -QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence             013467899999999999999998     589999999998665

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-52  Score=452.63  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=208.1

Q ss_pred             Cce-EEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-
Q 003239          109 RRY-IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-  183 (837)
Q Consensus       109 ~~Y-~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-  183 (837)
                      .+| ++.++||+|+||+||+|+++.+++.||||++...   ....+.+.+|+++|++|       .|||||+++++|.. 
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-------QHPNIVRFYDSWEST   97 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEeec
Confidence            444 7888999999999999999999999999999743   34556788999999999       68999999999976 


Q ss_pred             ---cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEE
Q 003239          184 ---QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       184 ---~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                         ++.+|||||||. |+|.+++...  +.+++..++.|++||+.||+|||+++  ||||||||+||||+  ..++.+||
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl  173 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKI  173 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEE
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEE
Confidence               357899999998 5999998765  46999999999999999999999998  99999999999995  34678999


Q ss_pred             EecccccccC-CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          258 IDFGSACTED-RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       258 ~DFGlA~~~~-~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      +|||+|+... ......+||+.|||||++.+ .|+.++||||||||||||+||++||.+.+....+.+.+.. + ..|..
T Consensus       174 ~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~-~~~~~  250 (290)
T 3fpq_A          174 GDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VKPAS  250 (290)
T ss_dssp             CCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CCCGG
T ss_pred             EeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-C-CCCCC
Confidence            9999997544 33456799999999999875 6999999999999999999999999776544433222110 0 00000


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                                                      
T Consensus       251 --------------------------------------------------------------------------------  250 (290)
T 3fpq_A          251 --------------------------------------------------------------------------------  250 (290)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                       .....++++.+||.+||+.||++|||++|+|+||||+++
T Consensus       251 -~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          251 -FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             -GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             -CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence             001134678999999999999999999999999999874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.7e-52  Score=463.17  Aligned_cols=304  Identities=22%  Similarity=0.348  Sum_probs=219.2

Q ss_pred             CCceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|+++   .+++.||||++.+.. ...++.+|+++|+.+.      +|||||+++++|.++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~------~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAG------GQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTC------SBTTBCCCSEEEEET
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhc------CCCCCceEEEEEEEC
Confidence            378999999999999999999764   467899999997653 3456788999999884      589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +++|||||||+ ++|.+++.     .+++.+++.+++||+.||+|||++|||||||||+|||++  .+.+.+||+|||+|
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLA  165 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred             CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCC
Confidence            99999999997 58888773     499999999999999999999999999999999999996  34479999999999


Q ss_pred             cccCC-------------------------------cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCC
Q 003239          264 CTEDR-------------------------------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       264 ~~~~~-------------------------------~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      +....                               .....+||+.|||||++.+. .|+.++||||+|||+|||++|++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            64321                               12345899999999999886 58999999999999999999998


Q ss_pred             CC-CCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCc
Q 003239          312 LF-PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK  390 (837)
Q Consensus       312 PF-~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~  390 (837)
                      || .+.++.+++..|.+.+| .++..........  ......          .........+.  ..........|... 
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G-~~~~~~~~~~~~~--~~~~~~----------~~p~~~~~~~~--~~~~~~~~~~p~~~-  309 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRG-SRETIQAAKTFGK--SILCSK----------EVPAQDLRKLC--ERLRGMDSSTPKLT-  309 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHC-HHHHHHHHHHTTE--EEEESS----------CCCCCCHHHHH--HHHC-----------
T ss_pred             CCCCCCCHHHHHHHHHHhcC-Cccchhhhhhccc--cccccc----------cCcchhhhHHH--Hhhccccccccccc-
Confidence            88 56678899999999999 3322221111000  000000          00000000000  00000000000000 


Q ss_pred             ccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       391 ~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                              ..+...        .........++++++|||++||++||++|+||+|||+||||++.+
T Consensus       310 --------~~~~~~--------~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          310 --------SDIQGH--------ATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             ----------------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             --------cccccc--------cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                    000000        001112234668899999999999999999999999999999854

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.9e-52  Score=455.43  Aligned_cols=202  Identities=24%  Similarity=0.321  Sum_probs=176.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      +.|++.++||+|+||+||+|+++.+++.||||+++.+..    ..+|+.+|+.|       .|||||+++++|.+++.+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-------~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-------SSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-------CCTTBCCEEEEEEETTEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-------CCCCCCcEEEEEEECCEEE
Confidence            679999999999999999999999999999999986532    24689888887       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCC-eEEEEeccccccc
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTE  266 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~-~IKL~DFGlA~~~  266 (837)
                      ||||||. |+|.++++..  +.+++.+++.|+.||+.||+|||+++||||||||+||||+   .++ .+||+|||+|+..
T Consensus       127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEc
Confidence            9999998 5999999765  4699999999999999999999999999999999999996   444 6999999999754


Q ss_pred             CCc--------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          267 DRT--------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       267 ~~~--------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      ...        ....+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++.+|.
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  269 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA  269 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            321        123579999999999999999999999999999999999999998776555544443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.5e-50  Score=436.33  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=196.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-  185 (837)
                      .+|++++.||+|+||+||+|+++.+++.||||+++..  ....+.+.+|+++|++|       .|||||+++++|.+.+ 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-------~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-------EHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEEEC-
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEecCc
Confidence            4699999999999999999999999999999999743  34456788999999988       6899999999998654 


Q ss_pred             -----------eEEEEEeccc-hhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          186 -----------HLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       186 -----------~l~LVmEy~~-gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                                 ++|||||||. |+|.+++.... ....++..++.|+.||++||+|||++|||||||||+||||+   .+
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~  154 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MD  154 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TT
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CC
Confidence                       4799999997 58999887543 22356677999999999999999999999999999999996   67


Q ss_pred             CeEEEEecccccccCCc---------------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          253 AEIKIIDFGSACTEDRT---------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~~---------------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      +.+||+|||+|+.....               ....+||+.|||||++.+..|+.++||||||||+|||++   ||..  
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~--  229 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--  229 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--
Confidence            89999999999754321               234589999999999999999999999999999999996   7743  


Q ss_pred             HHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccc
Q 003239          318 EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKH  397 (837)
Q Consensus       318 ~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~  397 (837)
                      ..+....+........|.                                                              
T Consensus       230 ~~~~~~~~~~~~~~~~p~--------------------------------------------------------------  247 (299)
T 4g31_A          230 QMERVRTLTDVRNLKFPP--------------------------------------------------------------  247 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCH--------------------------------------------------------------
T ss_pred             ccHHHHHHHHHhcCCCCC--------------------------------------------------------------
Confidence            223322222211100000                                                              


Q ss_pred             hHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          398 LEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       398 L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                                          .....++.+.+||++||+.||++|||++|+|+||||++..+
T Consensus       248 --------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          248 --------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             --------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             --------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence                                00113356789999999999999999999999999998654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-49  Score=466.14  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=223.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|+.|       +|||||+++++|.+++.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-------~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-------RHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-------CCTTBCCEEEEEECSSE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-------CCCCCCeEEEEEEECCE
Confidence            37899999999999999999999999999999999864 34566788999999999       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|||||||. |+|.+++.... ..+++.+++.+++||+.||+|||+++||||||||+|||++.+ ..+.+||+|||+|+.
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEE
T ss_pred             EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeE
Confidence            999999998 58998886543 469999999999999999999999999999999999999632 457899999999986


Q ss_pred             cC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          266 ED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       266 ~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ..  ......+||+.|||||++.+..|+.++||||||||||||++|.+||.+.+..+++..|.+.....++.        
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------  378 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--------  378 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG--------
T ss_pred             ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc--------
Confidence            54  33456799999999999999999999999999999999999999999998888777665421100000        


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                                ....++
T Consensus       379 --------------------------------------------------------------------------~~~~~s  384 (573)
T 3uto_A          379 --------------------------------------------------------------------------AFSGIS  384 (573)
T ss_dssp             --------------------------------------------------------------------------GGTTSC
T ss_pred             --------------------------------------------------------------------------cccCCC
Confidence                                                                                      001245


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ++++|||++||++||++|||++|||+||||+....
T Consensus       385 ~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            77899999999999999999999999999997654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2e-48  Score=441.53  Aligned_cols=330  Identities=42%  Similarity=0.746  Sum_probs=260.8

Q ss_pred             CCCccCCCCcceEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhh
Q 003239           84 NDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN  163 (837)
Q Consensus        84 ~~g~d~~~~~~~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~  163 (837)
                      +.++++....+....++.+.     .+|+++++||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.++
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~-----~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~  151 (429)
T 3kvw_A           77 NGGYDDDQGSYVQVPHDHVA-----YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLR  151 (429)
T ss_dssp             HHTTBCTTSCBCCCTTCEET-----TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCccCCCccccCCCccc-----CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHh
Confidence            44555555555444444443     7999999999999999999999999999999999988777788899999999997


Q ss_pred             cccCCCCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       164 ~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                      +. ....|+||+++++++...+++||||||+.++|.+++.......+++..++.++.||+.||+|||+++||||||||+|
T Consensus       152 ~~-~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~N  230 (429)
T 3kvw_A          152 KQ-DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPEN  230 (429)
T ss_dssp             TT-CTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGG
T ss_pred             hc-cccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            64 44578999999999999999999999999999999988776679999999999999999999999999999999999


Q ss_pred             eeeeccCCCCe--EEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 003239          244 ILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL  321 (837)
Q Consensus       244 ILl~~~~~~~~--IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~  321 (837)
                      |||+   .++.  +||+|||+++.........++|+.|+|||++.+..++.++||||||||+|||++|.+||.+.+..+.
T Consensus       231 ILl~---~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  307 (429)
T 3kvw_A          231 ILLK---QQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ  307 (429)
T ss_dssp             EEES---STTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eEEc---cCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9996   3444  9999999998877777778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCchHHHHhhhcchhhhhhcCCccc-----ccCCccccCCccchhhhhHHHHHHHhhcCCcCCcc--ccc
Q 003239          322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHN-----IENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE--YFH  394 (837)
Q Consensus       322 l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~-----~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~--~f~  394 (837)
                      +..+++.++ .|+..++........++...+....     ...+........                 ....+.  ...
T Consensus       308 l~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~  369 (429)
T 3kvw_A          308 LACMIELLG-MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR-----------------SRRGKLRGPPE  369 (429)
T ss_dssp             HHHHHHHHC-CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEE-----------------CTTCCEECSTT
T ss_pred             HHHHHHHcC-CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccc-----------------cchhhccCCcc
Confidence            999999999 7777777776666666554331110     000000000000                 000000  000


Q ss_pred             ccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          395 HKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       395 ~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ...+...+                ....++.++|||++||++||++|||++|||+||||++.
T Consensus       370 ~~~~~~~l----------------~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          370 SREWGNAL----------------KGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             CSCHHHHT----------------TTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             chhhHhhc----------------cccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence            01111111                11235789999999999999999999999999999974

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-49  Score=468.13  Aligned_cols=261  Identities=24%  Similarity=0.382  Sum_probs=213.5

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +.++|+++++||+|+||+||+|+++.+++.||||++++..    .......+|..++..++..    +|||||+++++|+
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~----~HP~IV~l~~~f~  262 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFH  262 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS----CCTTBCCEEEEEE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC----CCCCEeEEEEEEE
Confidence            4589999999999999999999999999999999997532    2234455666666666443    8999999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +.+.+|||||||. |+|.+++...  +.+++..++.+++||+.||+|||++|||||||||+||||+   .++.|||+|||
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld---~~G~vKL~DFG  337 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLG  337 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTSCEEECCCT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe---CCCCEEecccc
Confidence            9999999999998 5999998765  4699999999999999999999999999999999999995   77899999999


Q ss_pred             cccccC-CcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          262 SACTED-RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       262 lA~~~~-~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +|+... ....+.+||+.|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+....+...+. .+      
T Consensus       338 lA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~------  410 (689)
T 3v5w_A          338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MA------  410 (689)
T ss_dssp             TCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CC------
T ss_pred             eeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CC------
Confidence            997654 34456799999999999975 5899999999999999999999999976432211111111000 00      


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                    +                 .+|             
T Consensus       411 ----------------------------------------------~-----------------~~p-------------  414 (689)
T 3v5w_A          411 ----------------------------------------------V-----------------ELP-------------  414 (689)
T ss_dssp             ----------------------------------------------C-----------------CCC-------------
T ss_pred             ----------------------------------------------C-----------------CCC-------------
Confidence                                                          0                 000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT  459 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~  459 (837)
                      ..++++++|||.+||+.||++|++     ++||++||||++..|.
T Consensus       415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            124578899999999999999998     7999999999998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.1e-47  Score=425.11  Aligned_cols=341  Identities=41%  Similarity=0.737  Sum_probs=263.4

Q ss_pred             cCCCccCCCCcceEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHh
Q 003239           83 LNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL  162 (837)
Q Consensus        83 ~~~g~d~~~~~~~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L  162 (837)
                      .++++++.+.++++..++.+.     ++|++.++||+|+||+||+|++..+++.||||+++........+.+|+.+++.+
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~-----~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l  107 (382)
T 2vx3_A           33 YNDGYDDDNYDYIVKNGEKWM-----DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELM  107 (382)
T ss_dssp             BGGGTBCTTSCBCCCTTCEET-----TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH
T ss_pred             CcCCcCCCCCcEEeecCCEee-----eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHH
Confidence            345566666666666666654     899999999999999999999999999999999998777778888999999998


Q ss_pred             hcccCCCCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh--cCCeeeccCC
Q 003239          163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLK  240 (837)
Q Consensus       163 ~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH--s~gIVHrDLK  240 (837)
                      .+. ....|++|+++++++...+.+||||||++++|.+++.......+++..++.++.||+.||.|||  +.||||||||
T Consensus       108 ~~~-~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlk  186 (382)
T 2vx3_A          108 NKH-DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK  186 (382)
T ss_dssp             HHC-SSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCS
T ss_pred             Hhc-ccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCC
Confidence            642 2233457999999999999999999999999999998876667999999999999999999999  5799999999


Q ss_pred             CCCeeeeccCCCCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 003239          241 PENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD  320 (837)
Q Consensus       241 PeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e  320 (837)
                      |+||||+. +..+.+||+|||+++.........++|+.|+|||++.+..++.++||||||||+|||++|++||.+.+..+
T Consensus       187 p~NIll~~-~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~  265 (382)
T 2vx3_A          187 PENILLCN-PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD  265 (382)
T ss_dssp             GGGEEESS-TTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cccEEEec-CCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999953 24678999999999887777777899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccc---cccc
Q 003239          321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF---HHKH  397 (837)
Q Consensus       321 ~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f---~~~~  397 (837)
                      .+..+.+.++ .|+..++........+|.....      +.+.....                   ..+...+   ....
T Consensus       266 ~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------------------~~~~~~~~~~~~~~  319 (382)
T 2vx3_A          266 QMNKIVEVLG-IPPAHILDQAPKARKFFEKLPD------GTWNLKKT-------------------KDGKREYKPPGTRK  319 (382)
T ss_dssp             HHHHHHHHHC-SCCHHHHTTCTTHHHHEEECTT------SCEEECCC-------------------CTTCCCSCCTTCSC
T ss_pred             HHHHHHHHhC-CCCHHHHHhhHHHHHHHHhccc------cccccccc-------------------cccccccCCcchhh
Confidence            9999999998 6777766655555555554321      00000000                   0000000   0112


Q ss_pred             hHHHHhcCCCCC-CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          398 LEEIVTNYPYRK-NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       398 L~~il~~~p~~~-~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      +.+++....... ..............++++|||++||++||++|||++|||+||||++.
T Consensus       320 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          320 LHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             HHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            333322111000 00000111122345689999999999999999999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-48  Score=422.78  Aligned_cols=210  Identities=26%  Similarity=0.371  Sum_probs=180.3

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|.+.++||+|+||+||+|++.     .+++.||||+++.. ....+++.+|+++|++|       .|||||+++++|
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-------~HpnIV~l~g~~   84 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-------QHEHIVKFYGVC   84 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-------CCCCCccEEEEE
Confidence            368999999999999999999754     46889999999864 34567789999999998       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc-----------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH-----------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~-----------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      .+++.+|||||||. |+|.+++....           ...+++.+++.|+.||+.||+|||+++||||||||+||||+  
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~--  162 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG--  162 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC--
Confidence            99999999999998 69999997642           24699999999999999999999999999999999999995  


Q ss_pred             CCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          250 VKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                       .++.+||+|||+|+......     ...+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++.
T Consensus       163 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  241 (299)
T 4asz_A          163 -ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  241 (299)
T ss_dssp             -GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             -CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence             67899999999997543321     23468999999999999999999999999999999998 899999988877766


Q ss_pred             HHHH
Q 003239          324 RMIR  327 (837)
Q Consensus       324 ~I~~  327 (837)
                      .+.+
T Consensus       242 ~i~~  245 (299)
T 4asz_A          242 CITQ  245 (299)
T ss_dssp             HHHH
T ss_pred             HHHc
Confidence            6544

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.8e-48  Score=425.01  Aligned_cols=210  Identities=27%  Similarity=0.370  Sum_probs=176.8

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|.+.++||+|+||+||+|+..     .+++.||||+++.. ....+++.+|+++|++|       .|||||+++++|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-------~HpnIV~l~g~~  112 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-------QHQHIVRFFGVC  112 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEE
Confidence            368999999999999999999753     46889999999854 44567799999999998       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc-------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeee
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH-------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC  247 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~-------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~  247 (837)
                      .+.+.+|||||||. |+|.+++....             ...+++.++..|+.||+.||+|||+++||||||||+||||+
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            99999999999998 69999987542             23599999999999999999999999999999999999996


Q ss_pred             ccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          248 TSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       248 ~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                         +++.+||+|||+|+.....     ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus       193 ---~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~  269 (329)
T 4aoj_A          193 ---QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA  269 (329)
T ss_dssp             ---TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred             ---CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence               6789999999999754322     234578999999999999999999999999999999999 8999998887777


Q ss_pred             HHHHHH
Q 003239          322 LRRMIR  327 (837)
Q Consensus       322 l~~I~~  327 (837)
                      +..+.+
T Consensus       270 ~~~i~~  275 (329)
T 4aoj_A          270 IDCITQ  275 (329)
T ss_dssp             HHHHHH
T ss_pred             HHHHHc
Confidence            666544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.3e-47  Score=418.10  Aligned_cols=302  Identities=32%  Similarity=0.554  Sum_probs=240.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++......+....|+.+++.+.+  ....|+||+++++++...+..|
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~--~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN--DDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCC--CSTTGGGBCCEEEEEEETTEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcc--cCCCCCCeecccceeeECCeeE
Confidence            79999999999999999999999999999999999877777788899999999964  2346999999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc-------------------
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-------------------  249 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-------------------  249 (837)
                      |||||++++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++..                   
T Consensus       113 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence            9999998899999988766679999999999999999999999999999999999999631                   


Q ss_pred             ---CCCCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          250 ---VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       250 ---~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                         ...+.+||+|||++..........++|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+.
T Consensus       193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  272 (360)
T 3llt_A          193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME  272 (360)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence               13678999999999877766677789999999999999999999999999999999999999999999999999999


Q ss_pred             HHhCCCCchHHHHhhhcch--hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhc
Q 003239          327 RILGAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN  404 (837)
Q Consensus       327 ~~lG~~Pp~~~l~~~k~~~--~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~  404 (837)
                      ...+ .+|..++.......  .++......                              ..++.. ......+..+...
T Consensus       273 ~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~p~~-~~~~~~~~~~~~~  320 (360)
T 3llt_A          273 SIIQ-PIPKNMLYEATKTNGSKYVNKDELK------------------------------LAWPEN-ASSINSIKHVKKC  320 (360)
T ss_dssp             HHTC-CCCHHHHHHHTTSGGGGGEETTTTE------------------------------ECTTTT-CSCHHHHHHHHTC
T ss_pred             HhcC-CCCHHHHhhhhhccCccccCcccce------------------------------ecCccc-ccchhhhhhhhhc
Confidence            9888 44444443322111  111100000                              000000 0000000111111


Q ss_pred             CCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCC
Q 003239          405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT  454 (837)
Q Consensus       405 ~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~  454 (837)
                      .|          ......++.+.+||++||++||++|||++|||+||||+
T Consensus       321 ~~----------~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          321 LP----------LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CC----------HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cc----------ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            11          01112347889999999999999999999999999996

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.3e-47  Score=420.90  Aligned_cols=312  Identities=32%  Similarity=0.564  Sum_probs=249.0

Q ss_pred             eEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhccc-CCCCCCc
Q 003239           95 ILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY-DREDKHH  173 (837)
Q Consensus        95 ~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~-~~~~Hpn  173 (837)
                      .+.+++.+.     ++|+++++||+|+||+||+|++..+++.||||+++......+.+.+|+.+|+.+++.. ....|+|
T Consensus        28 ~~~~g~~~~-----~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~  102 (397)
T 1wak_A           28 LVKIGDLFN-----GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM  102 (397)
T ss_dssp             SSCTTCEET-----TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred             EEehhhhcC-----CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence            344455553     7999999999999999999999999999999999987777788999999999997642 2234889


Q ss_pred             eeEEeEEEe----ecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeec
Q 003239          174 IVRIYEYFV----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCT  248 (837)
Q Consensus       174 IVkl~d~f~----~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~  248 (837)
                      |++++++|.    ....+||||||++++|.+.+.......+++..++.++.||+.||+|||++ |||||||||+||||+.
T Consensus       103 iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~  182 (397)
T 1wak_A          103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             BCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred             eeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence            999999998    55689999999999999988877656799999999999999999999998 9999999999999963


Q ss_pred             cC----------------------------------------------CCCeEEEEecccccccCCcceeeccCccccCc
Q 003239          249 SV----------------------------------------------KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSP  282 (837)
Q Consensus       249 ~~----------------------------------------------~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~AP  282 (837)
                      +.                                              ....+||+|||+++.........++|+.|+||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aP  262 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL  262 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCH
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCC
Confidence            21                                              11379999999998777666777899999999


Q ss_pred             hhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCccc
Q 003239          283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHN  356 (837)
Q Consensus       283 Evl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s------~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~  356 (837)
                      |++.+..++.++||||||||+|||++|+.||...+      ..+.+..+.+.+| .+|..++...+....+|.....+..
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG-KVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHC-SCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcC-CCChHHhhcccccccccCCcccccc
Confidence            99999999999999999999999999999998655      6778888999999 5566555555555555554432222


Q ss_pred             ccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhccc
Q 003239          357 IENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEF  436 (837)
Q Consensus       357 ~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~  436 (837)
                      +..       ...+                         ...+.+...+.           .....+..+++||.+||++
T Consensus       342 ~~~-------~~~~-------------------------~~~~~~~~~~~-----------~~~~~~~~~~~li~~~L~~  378 (397)
T 1wak_A          342 ITK-------LKPW-------------------------GLFEVLVEKYE-----------WSQEEAAGFTDFLLPMLEL  378 (397)
T ss_dssp             CCC-------CCCC-------------------------CHHHHHHHTSC-----------CCHHHHHHHHHHHGGGGCS
T ss_pred             ccc-------cCCc-------------------------chhHhhhhhcc-----------cchhhHHHHHHHHHHHhcc
Confidence            111       0000                         00111111111           1234567899999999999


Q ss_pred             CcCCCCCHHHHHcCccCCC
Q 003239          437 DPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       437 DP~kRpTa~EaL~HPff~~  455 (837)
                      ||++|||++|||+||||++
T Consensus       379 dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          379 IPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SGGGSCCHHHHHTSGGGGC
T ss_pred             ChhhcCCHHHHhhCccccC
Confidence            9999999999999999974

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-47  Score=407.67  Aligned_cols=283  Identities=31%  Similarity=0.533  Sum_probs=226.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++..      ........+|+.+++.+...    .||||+++++++.
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~niv~~~~~~~   84 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF----EHPNVVRLMDVCA   84 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH----CCTTBCCEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc----CCCCeEEeeeeee
Confidence            7999999999999999999999999999999999732      12234667889988888654    6999999999998


Q ss_pred             ecc-----eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          183 CQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       183 ~~~-----~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      ...     .+++|||++.++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl  161 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKL  161 (308)
T ss_dssp             ECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTSCEEE
T ss_pred             ccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEE
Confidence            765     68999999999999999877655699999999999999999999999999999999999995   6788999


Q ss_pred             EecccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       258 ~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      +|||++.....  .....++|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++..+..
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99999975432  3345688999999999999999999999999999999999999999999999999999998844433


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      .+..........|                                     +.     .....+..+.             
T Consensus       242 ~~~~~~~~~~~~~-------------------------------------~~-----~~~~~~~~~~-------------  266 (308)
T 3g33_A          242 DWPRDVSLPRGAF-------------------------------------PP-----RGPRPVQSVV-------------  266 (308)
T ss_dssp             TSCSSCSSCGGGS-------------------------------------CC-----CCCCCHHHHS-------------
T ss_pred             hccchhhcccccc-------------------------------------CC-----CCCCcHHHhC-------------
Confidence            2211000000000                                     00     0001112221             


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                          ..+++.+.+||.+||++||++|||++|+|+||||++..
T Consensus       267 ----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          267 ----PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             ----CSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ----ccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                12457899999999999999999999999999999754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.8e-48  Score=419.64  Aligned_cols=208  Identities=22%  Similarity=0.328  Sum_probs=179.0

Q ss_pred             CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .+++++++||+|+||+||+|+.     ..+++.||||+++..  ....+++.+|+.+|++|       .|||||++++++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-------~HpNIV~l~g~~   98 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-------QHPNVVCLLGVV   98 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-------CCCCCCCcceEE
Confidence            6789999999999999999974     346789999999743  34457899999999999       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeee
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL  246 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl  246 (837)
                      ..++.+|||||||. |+|.+++....              ...+++.++..|+.||+.||+|||+++||||||||+||||
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            99999999999998 69999996532              2358999999999999999999999999999999999999


Q ss_pred             eccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          247 CTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       247 ~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      +   +++.+||+|||+|+.....     ....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+
T Consensus       179 ~---~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          179 Y---DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             C---GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             C---CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            6   6789999999999754221     234578999999999999999999999999999999998 899999988777


Q ss_pred             HHHHHH
Q 003239          321 LLRRMI  326 (837)
Q Consensus       321 ~l~~I~  326 (837)
                      ++..+.
T Consensus       256 ~~~~i~  261 (308)
T 4gt4_A          256 VVEMIR  261 (308)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            665543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7e-47  Score=409.32  Aligned_cols=282  Identities=31%  Similarity=0.549  Sum_probs=226.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++. +++.||||+++...   ...+.+.+|+++++.+       .||||+++++++...
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-------HHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-------CCTTBCCEEEEECCS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-------CCCCEeeeeeEEccC
Confidence            389999999999999999999885 58999999997532   2346788999999999       589999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +.+||||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcCce
Confidence            9999999999999999887654 4699999999999999999999999999999999999995   66889999999997


Q ss_pred             ccCC---cceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          265 TEDR---TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       265 ~~~~---~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ....   .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+.+.++..++..+.. 
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-  246 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ-  246 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG-
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh-
Confidence            6542   2344578999999999987 4689999999999999999999999999999999999999998554433221 


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      ......+...                                      ....+....+..+...                
T Consensus       247 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~----------------  272 (311)
T 3niz_A          247 VQELPLWKQR--------------------------------------TFQVFEKKPWSSIIPG----------------  272 (311)
T ss_dssp             GTTSHHHHSC--------------------------------------CCCCCCCCCHHHHSTT----------------
T ss_pred             hhccchhhhc--------------------------------------ccccccCCcHHHhCcc----------------
Confidence            1111110000                                      0011122223333222                


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                       .+++++|||++||++||++|||++|+|+||||++..
T Consensus       273 -~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          273 -FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             -CCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             -cCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence             347889999999999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=415.57  Aligned_cols=203  Identities=27%  Similarity=0.398  Sum_probs=171.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      +++++.++||+|+||+||+|+...   .||||+++.   .....+.+.+|+++|++|       .|||||++++++. ++
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-------~HpNIV~l~g~~~-~~  104 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-------RHVNILLFMGYMT-KD  104 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEC-SS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEE-CC
Confidence            678899999999999999997643   599999974   345567889999999998       6899999999875 46


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|||||||. |+|.+++.... ..+++.++..|+.||+.||+|||+++||||||||+||||+   +++.+||+|||+|+
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~  180 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLAT  180 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCB
T ss_pred             eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCce
Confidence            7899999998 69999887653 4699999999999999999999999999999999999996   67899999999997


Q ss_pred             ccCC-----cceeeccCccccCchhhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          265 TEDR-----TVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       265 ~~~~-----~~~~~~GT~~Y~APEvl~~~---~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      ....     .....+||+.|||||++.+.   .|+.++||||||||||||+||+.||.+.+..+.+..++
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~  250 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV  250 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            5432     23456899999999999743   68999999999999999999999998876655544443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.2e-46  Score=405.35  Aligned_cols=322  Identities=34%  Similarity=0.583  Sum_probs=254.0

Q ss_pred             cCCCCcceEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCC-eEEEEEEEeCChhhHHHHHHHHHHHHHhhccc
Q 003239           88 DNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKY  166 (837)
Q Consensus        88 d~~~~~~~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg-~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~  166 (837)
                      ++..+++.+.+++.+.     ++|++++.||+|+||+||+|++..++ +.||||+++......+.+.+|+.+++.+++. 
T Consensus         3 ~~~~~~~~~~~g~~~~-----~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~-   76 (355)
T 2eu9_A            3 DDKEGHLVCRIGDWLQ-----ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK-   76 (355)
T ss_dssp             BCTTSCBCCCTTCEET-----TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             cccCCCcccccCceec-----ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhc-
Confidence            3445566677777765     89999999999999999999988776 7999999998777778888999999999764 


Q ss_pred             CCCCCCceeEEeEEEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeee
Q 003239          167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL  246 (837)
Q Consensus       167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl  246 (837)
                      ....+.+|+.+++++...+..||||||++++|.+.+.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll  156 (355)
T 2eu9_A           77 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF  156 (355)
T ss_dssp             CTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             CCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            22344569999999999999999999999999998887765679999999999999999999999999999999999999


Q ss_pred             ecc----------------CCCCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCC
Q 003239          247 CTS----------------VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL  310 (837)
Q Consensus       247 ~~~----------------~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~  310 (837)
                      ...                ...+.+||+|||++..........++|+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence            432                2568899999999987766666778999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCc
Q 003239          311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK  390 (837)
Q Consensus       311 ~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~  390 (837)
                      .||...+..+.+..+.+.++ .+|..++...+....++.....                +...............+.   
T Consensus       237 ~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~---  296 (355)
T 2eu9_A          237 TLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLV----------------WDENSSDGRYVKENCKPL---  296 (355)
T ss_dssp             CSCCCSSHHHHHHHHHHHHC-CCCHHHHHHCSCGGGEETTEEC----------------CCTTSHHHHHHHHHCCCG---
T ss_pred             CCCCCCCHHHHHHHHHHHcC-CCcHHHhhhccchhhhcccccc----------------cccccchhccccccCCcc---
Confidence            99999999999999999998 5666665554433322221110                000000000000000000   


Q ss_pred             ccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       391 ~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                                       .     .........+.++.+||++||+.||++|||++|+|+||||++..
T Consensus       297 -----------------~-----~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          297 -----------------K-----SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             -----------------G-----GGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             -----------------c-----ccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence                             0     00011123567899999999999999999999999999999754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-46  Score=428.12  Aligned_cols=285  Identities=30%  Similarity=0.549  Sum_probs=212.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++..+++.||||++.+.   ....+.+.+|+.+|+.+       .|+||+++++++...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-------NHDHVVKVLDIVIPK  124 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCCS
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-------CCCCCCceEEEEecC
Confidence            47999999999999999999999999999999999753   34567788999999999       689999999999543


Q ss_pred             -----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       185 -----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                           ..+||||||++++|.+++...  ..+++..++.+++||+.||+|||++|||||||||+||||+   .++.+||+|
T Consensus       125 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~D  199 (458)
T 3rp9_A          125 DVEKFDELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCD  199 (458)
T ss_dssp             CTTTCCCEEEEECCCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECC
T ss_pred             CcccCceEEEEEeccccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeecc
Confidence                 579999999999999988754  4699999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCC------------------------------cceeeccCccccCchhhc-CCCCCccchHHHHHHHHHHHHh
Q 003239          260 FGSACTEDR------------------------------TVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFL  308 (837)
Q Consensus       260 FGlA~~~~~------------------------------~~~~~~GT~~Y~APEvl~-~~~yt~ksDIWSLG~ILyELlt  308 (837)
                      ||+++....                              .....+||+.|+|||++. ...|+.++||||||||||||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            999975431                              234567899999999875 5579999999999999999998


Q ss_pred             -----------CCCCCCCCC--------------------HHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccc
Q 003239          309 -----------GLPLFPGAS--------------------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNI  357 (837)
Q Consensus       309 -----------G~~PF~g~s--------------------~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~  357 (837)
                                 |+++|++.+                    ..+++..|.+.+| .|+...+........           
T Consensus       280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g-~p~~~~~~~~~~~~~-----------  347 (458)
T 3rp9_A          280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG-TPSEEDIEALEKEDA-----------  347 (458)
T ss_dssp             TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHC-CCCHHHHHTSSCHHH-----------
T ss_pred             hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcC-CCCHHHHhhcCCHHH-----------
Confidence                       888888765                    3678888999999 555554433211000           


Q ss_pred             cCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccC
Q 003239          358 ENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD  437 (837)
Q Consensus       358 ~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~D  437 (837)
                                                               ...+..++........  ......+++++|||++||++|
T Consensus       348 -----------------------------------------~~~~~~~~~~~~~~~~--~~~~~~s~~~~dLl~~mL~~d  384 (458)
T 3rp9_A          348 -----------------------------------------KRYIRIFPKREGTDLA--ERFPASSADAIHLLKRMLVFN  384 (458)
T ss_dssp             -----------------------------------------HHHHTTSCCCCCCCGG--GGSTTSCHHHHHHHHHHSCSS
T ss_pred             -----------------------------------------HHHHHhcCCCCCCCHH--HHCCCCCHHHHHHHHHHhccC
Confidence                                                     0000000100000000  011124578999999999999


Q ss_pred             cCCCCCHHHHHcCccCCCCCCC
Q 003239          438 PAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       438 P~kRpTa~EaL~HPff~~~~~~  459 (837)
                      |++|||++|||+||||++..+.
T Consensus       385 P~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          385 PNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             TTTSCCHHHHHHSGGGTTTCCG
T ss_pred             ccccCCHHHHhcCHhhhhcCCC
Confidence            9999999999999999987654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.6e-46  Score=401.21  Aligned_cols=304  Identities=35%  Similarity=0.599  Sum_probs=242.8

Q ss_pred             CceEEEEEeccCCceeEEEeec-cCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~-~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ++|+++++||+|+||+||+|.+ ..+++.||||+++......+.+.+|+++++.+++. ....|++|+++++++...+.+
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT-DPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHH-CTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhc-CCCCceeeEeeecccccCCcE
Confidence            7999999999999999999988 56889999999998777778899999999999764 234567899999999999999


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC----------------
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK----------------  251 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~----------------  251 (837)
                      ||||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+.                
T Consensus        93 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           93 CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            9999999999999998776567999999999999999999999999999999999999963221                


Q ss_pred             CCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003239          252 PAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA  331 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~  331 (837)
                      .+.+||+|||++..........++|+.|+|||++.+..++.++|||||||++|||++|..||...+..+.+..+.+.++ 
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-  251 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILG-  251 (339)
T ss_dssp             CCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHC-
T ss_pred             CCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-
Confidence            5679999999998777666677899999999999999999999999999999999999999999999999999999988 


Q ss_pred             CCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhh-HHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCC
Q 003239          332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALT-EIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN  410 (837)
Q Consensus       332 ~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s-~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~  410 (837)
                      .+|..++...+....+.....                .|.... ...+.. ....+           +.           
T Consensus       252 ~~p~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~-~~~~~-----------~~-----------  292 (339)
T 1z57_A          252 PLPKHMIQKTRKRKYFHHDRL----------------DWDEHSSAGRYVS-RACKP-----------LK-----------  292 (339)
T ss_dssp             SCCHHHHHHCSCGGGEETTEE----------------CCCTTSHHHHHHH-HHCCC-----------GG-----------
T ss_pred             CCCHHHHhhccchhHHhhccc----------------cccccccccchhh-hcCcc-----------hh-----------
Confidence            555555554433221111100                000000 000000 00000           00           


Q ss_pred             CchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       411 l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                         +........++.+.+||++||+.||++|||++|+|+||||+..
T Consensus       293 ---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          293 ---EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             ---GGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred             ---hhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence               0001112356789999999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-46  Score=431.83  Aligned_cols=290  Identities=29%  Similarity=0.517  Sum_probs=226.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++..+++.||||++.+   .....+.+.+|+.+|+.+       .|+||++++++|...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIISLLNVFTPQ  133 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEccC
Confidence            3899999999999999999999999999999999985   345567788999999998       689999999999765


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            ..+||||||++++|.+.+..    .+++..++.+++||+.||+|||++|||||||||+|||++   .++.+||+
T Consensus       134 ~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~  206 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKIL  206 (464)
T ss_dssp             CSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEEC
T ss_pred             CccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEE
Confidence                  46799999999998887743    499999999999999999999999999999999999995   67899999


Q ss_pred             ecccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          259 DFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       259 DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      |||+++.....  ....+||+.|+|||++.+..|+.++||||||||+|||++|++||.+.+..+++.+|++.+|.++++.
T Consensus       207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             CCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             EEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99999765432  3457899999999999999999999999999999999999999999999999999999999555544


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      +.........++....                                       .+....+..+....-     ...+.
T Consensus       287 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~-----~~~~~  322 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRP---------------------------------------KYAGLTFPKLFPDSL-----FPADS  322 (464)
T ss_dssp             HTTSCHHHHHHHTTSC---------------------------------------CCCCCCHHHHSCGGG-----SCCSS
T ss_pred             HHHcchhhhhHhhccc---------------------------------------ccCCCChHHhCcccc-----ccccc
Confidence            3222111122211110                                       001111112111100     00111


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ......+++++|||++||++||++|||++|||+||||+.
T Consensus       323 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             ccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            223345788999999999999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-46  Score=417.22  Aligned_cols=296  Identities=29%  Similarity=0.550  Sum_probs=220.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++..+++.||||++..   .....+...+|+.+|+.+.      .|+||+++++++...+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~------~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS------GHENIVNLLNVLRADN   82 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT------TCTTBCCEEEEEECTT
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc------CCCCCCeeeeEEecCC
Confidence            799999999999999999999999999999999964   3455677889999999984      4899999999998654


Q ss_pred             --eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          186 --HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       186 --~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                        .+|||||||+++|.+++...   .+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a  156 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLS  156 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTC
T ss_pred             CCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCCccc
Confidence              79999999999999988764   599999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCC------------------------cceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          264 CTEDR------------------------TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       264 ~~~~~------------------------~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      +....                        .....+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            64321                        1234689999999999987 5799999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCchHHHHhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCccccccc
Q 003239          319 FDLLRRMIRILGAQPPDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK  396 (837)
Q Consensus       319 ~e~l~~I~~~lG~~Pp~~~l~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~  396 (837)
                      .+++..|+..++ .|+...+......  ..+++..                           ..............|.  
T Consensus       237 ~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~--  286 (388)
T 3oz6_A          237 MNQLERIIGVID-FPSNEDVESIQSPFAKTMIESL---------------------------KEKVEIRQSNKRDIFT--  286 (388)
T ss_dssp             HHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHH---------------------------HHHCC-----CCCCHH--
T ss_pred             HHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhC---------------------------cccccccCCCHHHhCc--
Confidence            999999999999 5554433321100  0000000                           0000000000000110  


Q ss_pred             chHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          397 HLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       397 ~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+...+....           .....+++++|||++||++||++|||++|||+||||+...
T Consensus       287 ~~~~~~~~~~-----------~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          287 KWKNLLLKIN-----------PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             HHHHHHHHHC-----------TTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred             chhhhccccc-----------ccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence            1111111111           1113467899999999999999999999999999998743

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.7e-46  Score=399.11  Aligned_cols=280  Identities=30%  Similarity=0.505  Sum_probs=224.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++..   ....+.+.+|+.+++.+       .|+||+++++++..++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-------KHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEETT
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-------CCCCEeeEEeEEEeCC
Confidence            6899999999999999999999999999999999743   33456778899999888       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++|||||+++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           75 KLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARA  150 (292)
T ss_dssp             EEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeccccee
Confidence            999999999999888877643 5699999999999999999999999999999999999995   678999999999975


Q ss_pred             cCC---cceeeccCccccCchhhcCCC-CCccchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPL-FPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~~~~-yt~ksDIWSLG~ILyELltG~~P-F~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ...   .....++|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++..+. ..+..
T Consensus       151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~-~~~~~  229 (292)
T 3o0g_A          151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE-EQWPS  229 (292)
T ss_dssp             CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT-TTCTT
T ss_pred             cCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh-hhhhh
Confidence            432   234457899999999998775 89999999999999999986555 7888888999999998884333 22221


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      ......+.                                     +..  .+-....+.                 ....
T Consensus       230 ~~~~~~~~-------------------------------------~~~--~~~~~~~~~-----------------~~~~  253 (292)
T 3o0g_A          230 MTKLPDYK-------------------------------------PYP--MYPATTSLV-----------------NVVP  253 (292)
T ss_dssp             GGGSTTCC-------------------------------------CCC--CCCTTCCCT-----------------TTST
T ss_pred             hccccccc-------------------------------------ccc--cccCCcchh-----------------hccc
Confidence            11100000                                     000  000000000                 0111


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ..++.+.+||++||+.||++|||++|+|+||||++.
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            245788999999999999999999999999999973

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-45  Score=406.54  Aligned_cols=306  Identities=35%  Similarity=0.565  Sum_probs=245.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccC----CCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD----REDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~----~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++.+....+.+.+|+.+++++.+...    ...|+||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            379999999999999999999999999999999999877777888999999999975310    1138899999999987


Q ss_pred             cc----eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeecc---CCCCeE
Q 003239          184 QR----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTS---VKPAEI  255 (837)
Q Consensus       184 ~~----~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~---~~~~~I  255 (837)
                      .+    .+++|||+++++|.+++.......+++..++.++.||+.||+|||++ |||||||||+|||++.+   .....+
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence            65    89999999988999999886666799999999999999999999998 99999999999999633   234589


Q ss_pred             EEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHh
Q 003239          256 KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRIL  329 (837)
Q Consensus       256 KL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s------~~e~l~~I~~~l  329 (837)
                      ||+|||++..........++|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+      ..+.+..+.+.+
T Consensus       178 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (373)
T 1q8y_A          178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL  257 (373)
T ss_dssp             EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred             EEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence            99999999877766667789999999999999999999999999999999999999998654      567788899999


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      | .+|..++...+....+|...+....+..                                 .....+.+++...    
T Consensus       258 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~----  299 (373)
T 1q8y_A          258 G-ELPSYLLRNGKYTRTFFNSRGLLRNISK---------------------------------LKFWPLEDVLTEK----  299 (373)
T ss_dssp             C-SCCHHHHHHCTTHHHHBCC--CBSSCCC---------------------------------CCBCCHHHHHHHT----
T ss_pred             C-CCCHHHHhccchhhhhcCCcchhccccc---------------------------------ccccchhhhhhhc----
Confidence            9 6667777766665555554432211111                                 0001122222110    


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                            .......++++.+||++||+.||++|||++|||+||||++..
T Consensus       300 ------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          300 ------YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             ------TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             ------ccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence                  011234678899999999999999999999999999999854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-46  Score=407.92  Aligned_cols=287  Identities=32%  Similarity=0.540  Sum_probs=224.0

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ..++|+++++||+|+||+||+|++..+++.||||+++...   ...+.+.+|+.+|+.+       .|+||+++++++..
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-------QHRNIIELKSVIHH  104 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-------CCTTBCCEEEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-------CCCCcceEEEEEec
Confidence            3479999999999999999999999999999999997542   2344567899998888       68999999999999


Q ss_pred             cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc--CCCCeEEEEecc
Q 003239          184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFG  261 (837)
Q Consensus       184 ~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~--~~~~~IKL~DFG  261 (837)
                      .+.+||||||++++|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++.+  +....+||+|||
T Consensus       105 ~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          105 NHRLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             CCEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999999999999999987653  59999999999999999999999999999999999999633  245679999999


Q ss_pred             cccccC---CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          262 SACTED---RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       262 lA~~~~---~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ++....   ......++|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+.+.++ .|+...
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~  261 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-LPDDTT  261 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTT
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-CCchhh
Confidence            997543   223445789999999999875 589999999999999999999999999999999999999888 443322


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      +........+...                                       ...+....+...+.              
T Consensus       262 ~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~--------------  288 (329)
T 3gbz_A          262 WPGVTALPDWKQS---------------------------------------FPKFRGKTLKRVLG--------------  288 (329)
T ss_dssp             STTGGGSTTCCTT---------------------------------------CCCCCCCCHHHHHG--------------
T ss_pred             hhhhhhhhhhhhh---------------------------------------hhhhccccHhhhcc--------------
Confidence            2211111100000                                       00011122222221              


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                        ...++++++||++||++||++|||++|+|+||||++..+
T Consensus       289 --~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          289 --ALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             --GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             --cccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence              124578999999999999999999999999999998765

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-45  Score=417.69  Aligned_cols=284  Identities=33%  Similarity=0.563  Sum_probs=226.3

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ..++|+++++||+|+||+||+|++..+++.||||++++.   ....+.+.+|+.+|+.+       .|+||+++++++..
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~nIv~l~~~~~~   96 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-------KSDYIIRLYDLIIP   96 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-------CCCCcceEEEEEec
Confidence            448999999999999999999999999999999999753   34567788999999999       58999999999987


Q ss_pred             c-----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          184 Q-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       184 ~-----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      .     +.+||||||++++|.++++..  ..+++..++.++.||+.||+|||++|||||||||+||||+   .++.+||+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~  171 (432)
T 3n9x_A           97 DDLLKFDELYIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVC  171 (432)
T ss_dssp             SCTTTCCCEEEEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEEC
T ss_pred             CCCCcCCeEEEEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEc
Confidence            6     579999999999999998754  4699999999999999999999999999999999999995   67899999


Q ss_pred             ecccccccCC-------------------------cceeeccCccccCchhhc-CCCCCccchHHHHHHHHHHHHh----
Q 003239          259 DFGSACTEDR-------------------------TVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFL----  308 (837)
Q Consensus       259 DFGlA~~~~~-------------------------~~~~~~GT~~Y~APEvl~-~~~yt~ksDIWSLG~ILyELlt----  308 (837)
                      |||+++....                         .....++|+.|+|||++. ...|+.++||||||||+|||++    
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            9999975432                         135678999999999974 5579999999999999999997    


Q ss_pred             -------CCCCCCCCC-----------------HHHHHHHHHHHhCCCCchHHHHhhhcc--hhhhhhcCCcccccCCcc
Q 003239          309 -------GLPLFPGAS-----------------EFDLLRRMIRILGAQPPDYVLKEAKNT--SKFFKCIGSVHNIENGEV  362 (837)
Q Consensus       309 -------G~~PF~g~s-----------------~~e~l~~I~~~lG~~Pp~~~l~~~k~~--~~~f~~~~~l~~~~~~~~  362 (837)
                             |.++|.+.+                 ..+++..|.+.+| .|+...+......  ..+....           
T Consensus       252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~-----------  319 (432)
T 3n9x_A          252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIG-TPTEDDLKNINKPEVIKYIKLF-----------  319 (432)
T ss_dssp             TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHC-SCCHHHHHTCCCHHHHHHHHTS-----------
T ss_pred             cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhC-----------
Confidence                   677776654                 4788999999999 5555544432110  0000000           


Q ss_pred             ccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCC
Q 003239          363 SIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRW  442 (837)
Q Consensus       363 ~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRp  442 (837)
                                             +     ......+.+..                 ..++++++|||++||++||++||
T Consensus       320 -----------------------~-----~~~~~~~~~~~-----------------~~~s~~~~dLl~~mL~~dP~~R~  354 (432)
T 3n9x_A          320 -----------------------P-----HRKPINLKQKY-----------------PSISDDGINLLESMLKFNPNKRI  354 (432)
T ss_dssp             -----------------------C-----CCCCCCHHHHS-----------------TTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             -----------------------C-----CCCCCCHHHHC-----------------CCCCHHHHHHHHHHhcCCcccCC
Confidence                                   0     00001111111                 12457899999999999999999


Q ss_pred             CHHHHHcCccCCCCCCC
Q 003239          443 SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       443 Ta~EaL~HPff~~~~~~  459 (837)
                      |++|||+||||++....
T Consensus       355 ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          355 TIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             CHHHHHTCGGGTTTCCT
T ss_pred             CHHHHhcChhhhhccCc
Confidence            99999999999987653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-46  Score=416.60  Aligned_cols=204  Identities=27%  Similarity=0.390  Sum_probs=174.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t-----g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||+||+|++..+     ++.||||+++..  ....+.+.+|+++|.++.      +|||||+++++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~------hhpnIV~l~g~  136 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA  136 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC------CCCcEEEEEEE
Confidence            37899999999999999999986543     478999999854  344567899999999995      36899999999


Q ss_pred             Eeec-ceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          181 FVCQ-RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      |... +.+|||||||. |+|.++++...              ...+++.++..|+.||+.||+|||+++||||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            8764 57999999998 69999997643              23489999999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++   +++.+||+|||+|+.....     ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus       217 Ll~---~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          217 LLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             EEC---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             eeC---CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            996   6789999999999754322     224578999999999999999999999999999999998 9999988654


Q ss_pred             HH
Q 003239          319 FD  320 (837)
Q Consensus       319 ~e  320 (837)
                      .+
T Consensus       294 ~~  295 (353)
T 4ase_A          294 DE  295 (353)
T ss_dssp             SH
T ss_pred             HH
Confidence            33

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-46  Score=404.56  Aligned_cols=287  Identities=32%  Similarity=0.586  Sum_probs=217.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++...  ...+.+.+|+.+++.+       .||||+++++++..++.
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-------KHENIVRLYDVIHTENK   77 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-------CBTTBCCEEEEECCTTE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-------CCCCcceEEEEEEECCe
Confidence            78999999999999999999999999999999998532  2346778899999888       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhcc----CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          187 LCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~----~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      +||||||+.++|.+++.....    ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+
T Consensus        78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSS
T ss_pred             EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCcc
Confidence            999999999999998876532    3589999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          263 ACTEDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       263 A~~~~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +.....   .....++|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.+.++ .++...+
T Consensus       155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~  233 (317)
T 2pmi_A          155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG-TPNESLW  233 (317)
T ss_dssp             CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SCCTTTC
T ss_pred             ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCChhHh
Confidence            976432   23445789999999999874 689999999999999999999999999999999999999988 4444333


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                      .......++.....                                       ......+.+.+...            .
T Consensus       234 ~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~------------~  262 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQ---------------------------------------QRPPRDLRQVLQPH------------T  262 (317)
T ss_dssp             GGGGGCTTCCTTCC---------------------------------------CCCCCCSHHHHGGG------------C
T ss_pred             hhhhhhhhcccccc---------------------------------------cccchhHHHhhccc------------c
Confidence            32222111110000                                       00011122222110            0


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ....+.++.+||++||+.||++|||++|+|+||||++..
T Consensus       263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            012457899999999999999999999999999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.4e-46  Score=397.15  Aligned_cols=279  Identities=32%  Similarity=0.555  Sum_probs=220.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++ .+++.||||+++...   ...+.+.+|+++++.+       .||||+++++++...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~   73 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-------KHSNIVKLYDVIHTKK   73 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-------CCTTBCCEEEEEECSS
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-------CCCCEeeeeeEEccCC
Confidence            6899999999999999999988 678999999997542   2235677899998888       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        74 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARA  149 (288)
T ss_dssp             CEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHH
T ss_pred             eEEEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccc
Confidence            999999999999999887643 5699999999999999999999999999999999999995   678999999999975


Q ss_pred             cCC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...   .....++|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.+.++..+...+ ...
T Consensus       150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~  228 (288)
T 1ob3_A          150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW-PNV  228 (288)
T ss_dssp             HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS-TTG
T ss_pred             cCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc-hhh
Confidence            432   23345789999999999765 6899999999999999999999999999999999999998883332221 111


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      ....++-.                                       ....+....++...                 ..
T Consensus       229 ~~~~~~~~---------------------------------------~~~~~~~~~~~~~~-----------------~~  252 (288)
T 1ob3_A          229 TELPKYDP---------------------------------------NFTVYEPLPWESFL-----------------KG  252 (288)
T ss_dssp             GGSTTCCT---------------------------------------TCCCCCCCCGGGTC-----------------CS
T ss_pred             hccccccc---------------------------------------ccccccCccHHHHh-----------------hh
Confidence            10000000                                       00000001111111                 12


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .++++.+||++||+.||++|||++|+|+||||++.
T Consensus       253 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            45788999999999999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=410.58  Aligned_cols=280  Identities=28%  Similarity=0.556  Sum_probs=226.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++++.||+|+||+||+|++..+++.||||++..   .....+.+.+|+++|+.+       .|+||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-------RHENVIGLLDVFTPD   96 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-------CBTTBCCCSEEECSC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-------CCcCCCCceeeEecC
Confidence            4799999999999999999999999999999999964   234456788999999999       589999999999876


Q ss_pred             c------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 R------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ~------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      .      .+|+||||++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~  170 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKIL  170 (367)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEEC
T ss_pred             CccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEE
Confidence            3      46999999988999888763   599999999999999999999999999999999999995   67889999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||+++.........++|+.|+|||++.+ ..++.++||||||||+|||++|++||.+.+..+++..|.+.+| .|+..+
T Consensus       171 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~~~~~~  249 (367)
T 1cm8_A          171 DFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG-TPPAEF  249 (367)
T ss_dssp             CCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred             eeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHH
Confidence            99999887766677789999999999987 6899999999999999999999999999999999999999999 565555


Q ss_pred             HHhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          338 LKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       338 l~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                      +......  ..+.....                                  ...     ...+.++.             
T Consensus       250 ~~~~~~~~~~~~~~~~~----------------------------------~~~-----~~~~~~~~-------------  277 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLP----------------------------------ELE-----KKDFASIL-------------  277 (367)
T ss_dssp             HHTCSCHHHHHHHHHSC----------------------------------CCC-----CCCGGGTC-------------
T ss_pred             HHHhhhHHHHHHHHhCC----------------------------------CCC-----CCCHHHHC-------------
Confidence            4432110  11111110                                  000     01111111             


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                          ...++.++|||++||++||++|||++|||+||||++..
T Consensus       278 ----~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          278 ----TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             ----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             ----CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                12457899999999999999999999999999999754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.3e-45  Score=400.94  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=216.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++++.||+|+||+||+|++..+++.||||++.+.   ....+.+.+|+++|+.+       .||||+++++++...+
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-------NHPNIVKLFEVIETEK   87 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEECSS
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEECC
Confidence            7899999999999999999999999999999999753   34566788999999998       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+. ++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSN  162 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCG
T ss_pred             EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCce
Confidence            9999999997 5899988765  3699999999999999999999999999999999999995   67899999999996


Q ss_pred             ccC--CcceeeccCccccCchhhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TED--RTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~--~~~~~~~GT~~Y~APEvl~~~~yt-~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...  ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+..... .         
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~---------  232 (328)
T 3fe3_A          163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-R---------  232 (328)
T ss_dssp             GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C---------
T ss_pred             ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C---------
Confidence            543  334566899999999999988775 799999999999999999999998877666555443100 0         


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                     .|             ..
T Consensus       233 ---------------------------------------------------------------~p-------------~~  236 (328)
T 3fe3_A          233 ---------------------------------------------------------------IP-------------FY  236 (328)
T ss_dssp             ---------------------------------------------------------------CC-------------TT
T ss_pred             ---------------------------------------------------------------CC-------------CC
Confidence                                                                           00             01


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .++++.+||++||+.||++|||++|+|+||||+...
T Consensus       237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            346788999999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=412.18  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=215.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++.    ....+...+|+.+|+.+.      .||||++++++|..
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~------~hp~Iv~l~~~~~~   95 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR------NHPFLTQLFCCFQT   95 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT------TCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc------CCCceeeEEEEEEe
Confidence            37899999999999999999999999999999999853    234456778999998874      58999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|||||||. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+||||+   .++.+||+|||+
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~  170 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGM  170 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccc
Confidence            999999999998 5888888765  3699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++...   ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..|....- .       
T Consensus       171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~-------  242 (353)
T 3txo_A          171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-V-------  242 (353)
T ss_dssp             CBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C-------
T ss_pred             eeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-C-------
Confidence            97532   334456899999999999998999999999999999999999999999888777766654110 0       


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                       +|             
T Consensus       243 -----------------------------------------------------------------~p-------------  244 (353)
T 3txo_A          243 -----------------------------------------------------------------YP-------------  244 (353)
T ss_dssp             -----------------------------------------------------------------CC-------------
T ss_pred             -----------------------------------------------------------------CC-------------
Confidence                                                                             00             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCH------HHHHcCccCCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSP------FQASRHPFVTGEPFT  459 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa------~EaL~HPff~~~~~~  459 (837)
                      ..+++.+.+||++||+.||++|+++      +|+++||||++..+.
T Consensus       245 ~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          245 TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            0134678999999999999999999      999999999987653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=401.96  Aligned_cols=283  Identities=32%  Similarity=0.507  Sum_probs=221.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh--HHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~--~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++.....  ...+.+|+.+|+.+       .|+||+++++++...+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-------KHANIVTLHDIIHTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-------CCTTBCCEEEEEECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-------CCCCCCeeeeEEeeCCE
Confidence            6899999999999999999999999999999999754321  11345688888877       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      .||||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           75 LTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAK  150 (324)
T ss_dssp             EEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC
T ss_pred             EEEEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCcccccc
Confidence            99999999999999887653 4699999999999999999999999999999999999995   6688999999999754


Q ss_pred             CC---cceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          267 DR---TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       267 ~~---~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..   .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+++.. +....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~  229 (324)
T 3mtl_A          151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET-WPGIL  229 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT-STTGG
T ss_pred             cCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh-chhhh
Confidence            32   2334578999999999987 4789999999999999999999999999999999999999999443332 22111


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                      ....+.. .                                ..+     .+....+.                 .....+
T Consensus       230 ~~~~~~~-~--------------------------------~~~-----~~~~~~~~-----------------~~~~~~  254 (324)
T 3mtl_A          230 SNEEFKT-Y--------------------------------NYP-----KYRAEALL-----------------SHAPRL  254 (324)
T ss_dssp             GCHHHHH-T--------------------------------CCC-----CCCCCCHH-----------------HHCTTS
T ss_pred             cchhhcc-c--------------------------------ccc-----cccchhhh-----------------hhcCCC
Confidence            1100000 0                                000     00000111                 111235


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ++++.+||++||++||++|||++|||+||||.+...
T Consensus       255 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          255 DSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             CHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            578999999999999999999999999999998653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-45  Score=406.38  Aligned_cols=290  Identities=30%  Similarity=0.528  Sum_probs=221.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++++.||+|+||+||+|++..+++.||||+++..   ....+.+.+|+.+++.+       .||||+++++++...+
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEECSCC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-------CCCCccceEEeecccc
Confidence            7999999999999999999999999999999999753   34456788999999998       6899999999998765


Q ss_pred             ------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          186 ------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       186 ------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                            .+||||||++++|.+.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCSEEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECC
T ss_pred             ccccccceEEEEEcCCCCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEE
Confidence                  789999999999988875    2489999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||++......  ....++|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+++.++.++++.+
T Consensus       171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9999765432  34568899999999999999999999999999999999999999999999999999998885444433


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      .........++....                                       .+....+++++.....+     ....
T Consensus       251 ~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~-----~~~~  286 (371)
T 2xrw_A          251 KKLQPTVRTYVENRP---------------------------------------KYAGYSFEKLFPDVLFP-----ADSE  286 (371)
T ss_dssp             TTSCHHHHHHHHSSC---------------------------------------CCCCCCHHHHSCGGGSC-----CSSH
T ss_pred             HHhhhHHHHHHhhCc---------------------------------------cccccchhhhcccccCc-----cccc
Confidence            211111111111100                                       01111222222111110     1111


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .....+.+++|||++||++||++|||++|||+||||+..
T Consensus       287 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          287 HNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            223356789999999999999999999999999999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.8e-45  Score=407.54  Aligned_cols=279  Identities=29%  Similarity=0.551  Sum_probs=212.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-  184 (837)
                      ++|++++.||+|+||.||+|++..+++.||||++...   ....+.+.+|+.+|+.+       .|+||+++++++... 
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-------KHENVIGLLDVFTPAR  101 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSCS
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEecCC
Confidence            8999999999999999999999999999999999753   34566788999999998       689999999999764 


Q ss_pred             -----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       185 -----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                           ..+|+|||+++++|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~D  175 (367)
T 2fst_X          102 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILD  175 (367)
T ss_dssp             SGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECC
T ss_pred             ccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEee
Confidence                 56899999999999888865   3599999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          260 FGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       260 FGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ||+++.........++|+.|+|||++.+ ..++.++||||||||+|||++|++||.+.+..+++..|.+.+| .|+...+
T Consensus       176 FG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~p~~~~~  254 (367)
T 2fst_X          176 FGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-TPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SCCHHHH
T ss_pred             ccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHH
Confidence            9999877666667789999999999987 5899999999999999999999999999999999999999999 5555544


Q ss_pred             Hhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          339 KEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       339 ~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      ......  ..+.....                                  .     .....+..+..             
T Consensus       255 ~~~~~~~~~~~~~~~~----------------------------------~-----~~~~~~~~~~~-------------  282 (367)
T 2fst_X          255 KKISSESARNYIQSLT----------------------------------Q-----MPKMNFANVFI-------------  282 (367)
T ss_dssp             TTCCCHHHHHHHHTSC----------------------------------C-----CCCCCHHHHTT-------------
T ss_pred             HHhhhHHHHHHHhccC----------------------------------C-----CCCCCHHHHCC-------------
Confidence            332110  01111000                                  0     00111222221             


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                          ..++.++|||++||++||++|||++|||+||||++..
T Consensus       283 ----~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          283 ----GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             ----TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ----CCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                2357899999999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3e-45  Score=403.09  Aligned_cols=253  Identities=23%  Similarity=0.400  Sum_probs=216.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++++.||+|+||+||+|+++.+++.||||++++.    ......+.+|+.+|+.+       .||||++++++|..
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-------RHPFLTALKYAFQT   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CCTTBCCEEEEEEC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-------CCCcCcceEEEEEe
Confidence            37899999999999999999999999999999999853    23355678899998877       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+||||||+.+ +|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~  151 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccc
Confidence            9999999999985 888887754  3699999999999999999999999999999999999995   678999999999


Q ss_pred             cccc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +...   .......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+....-         
T Consensus       152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------  222 (337)
T 1o6l_A          152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------  222 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             hhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            9753   2334567899999999999999999999999999999999999999988776665554433000         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .+|             
T Consensus       223 ----------------------------------------------------------------~~p-------------  225 (337)
T 1o6l_A          223 ----------------------------------------------------------------RFP-------------  225 (337)
T ss_dssp             ----------------------------------------------------------------CCC-------------
T ss_pred             ----------------------------------------------------------------CCC-------------
Confidence                                                                            000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      ..+++++.+||++||+.||++|+     +++|+++||||++..+
T Consensus       226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence            01346789999999999999999     9999999999998765

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=401.13  Aligned_cols=253  Identities=24%  Similarity=0.438  Sum_probs=220.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++..    ...+.+.+|+.+++.+       .||||+++++++.+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-------THPFIIRMWGTFQD   77 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CBTTBCCEEEEEEC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-------CCCCCceEeEEEEe
Confidence            378999999999999999999999999999999998532    2345677888888877       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|+||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~  152 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGF  152 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSS
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCc
Confidence            999999999998 5899888764  3699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       263 A~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      +..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+....-            
T Consensus       153 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------  220 (318)
T 1fot_A          153 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------  220 (318)
T ss_dssp             CEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------
T ss_pred             ceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            98777666778999999999999999999999999999999999999999988877666655543100            


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                   .+|             ...
T Consensus       221 -------------------------------------------------------------~~p-------------~~~  226 (318)
T 1fot_A          221 -------------------------------------------------------------RFP-------------PFF  226 (318)
T ss_dssp             -------------------------------------------------------------CCC-------------TTS
T ss_pred             -------------------------------------------------------------CCC-------------CCC
Confidence                                                                         000             013


Q ss_pred             HHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      ++++.+||++||..||++|+     +++|+++||||++..+
T Consensus       227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence            46789999999999999999     9999999999998665

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-45  Score=401.60  Aligned_cols=285  Identities=31%  Similarity=0.546  Sum_probs=224.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh------hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|++++.||+|+||+||+|++..+++.||||+++....      ..+.+.+|+++++.+       .|+||+++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~   81 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-------SHPNIIGLLDAF   81 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-------CCCCCCeEEEEE
Confidence            4799999999999999999999999999999999974321      124577899999998       589999999999


Q ss_pred             eecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          182 VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       182 ~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ...+..++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        82 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg  157 (346)
T 1ua2_A           82 GHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFG  157 (346)
T ss_dssp             CCTTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCG
T ss_pred             eeCCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecc
Confidence            9999999999999999988876543 4689999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          262 SACTEDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       262 lA~~~~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ++.....   .....++|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+.+.++..+++.+
T Consensus       158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            9975432   23445789999999999765 5899999999999999999999999999999999999998884333221


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                       ........+                                        .....+....+..+..              
T Consensus       238 -~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~~--------------  262 (346)
T 1ua2_A          238 -PDMCSLPDY----------------------------------------VTFKSFPGIPLHHIFS--------------  262 (346)
T ss_dssp             -SSTTSSTTC----------------------------------------CCCCCCCCCCHHHHCT--------------
T ss_pred             -hhhccCccc----------------------------------------ccccccCCCChHHhhc--------------
Confidence             111000000                                        0000011112222211              


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCP  461 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~  461 (837)
                         ..++++.+||++||+.||++|||++|+|+||||++.+...+
T Consensus       263 ---~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          263 ---AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             ---TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             ---cCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence               24578999999999999999999999999999998765544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.8e-45  Score=397.44  Aligned_cols=287  Identities=25%  Similarity=0.440  Sum_probs=227.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++..+++.||||++...   ......+.+|+.+++.+       .|+||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTK   88 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-------CCTTBCCEEEEEEEC
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-------cCCCcccHhheeecc
Confidence            37999999999999999999999999999999998643   22345677899999998       589999999999874


Q ss_pred             --------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEE
Q 003239          185 --------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       185 --------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                              +.+||||||+.++|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+|
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~k  164 (351)
T 3mi9_A           89 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLK  164 (351)
T ss_dssp             --------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEE
T ss_pred             ccccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEE
Confidence                    4689999999999998887654 4699999999999999999999999999999999999995   678999


Q ss_pred             EEecccccccC-------CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003239          257 IIDFGSACTED-------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI  328 (837)
Q Consensus       257 L~DFGlA~~~~-------~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~  328 (837)
                      |+|||++....       ......++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.+.
T Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  244 (351)
T 3mi9_A          165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  244 (351)
T ss_dssp             ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            99999996532       222345789999999999874 6899999999999999999999999999999999999999


Q ss_pred             hCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCC
Q 003239          329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR  408 (837)
Q Consensus       329 lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~  408 (837)
                      .+..+++. +....... .+......                                 .    .....+.+.       
T Consensus       245 ~~~~~~~~-~~~~~~~~-~~~~~~~~---------------------------------~----~~~~~~~~~-------  278 (351)
T 3mi9_A          245 CGSITPEV-WPNVDNYE-LYEKLELV---------------------------------K----GQKRKVKDR-------  278 (351)
T ss_dssp             HCCCCTTT-STTGGGCG-GGTSSCCC---------------------------------S----SCCCCHHHH-------
T ss_pred             hCCCChhh-ccccccch-hhcccccc---------------------------------c----ccccCHHHH-------
Confidence            98554433 22211111 00000000                                 0    000001111       


Q ss_pred             CCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       409 ~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                              ......++.+.+||++||++||++|||++|+|+||||+..+.+
T Consensus       279 --------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          279 --------LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             --------HHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             --------hhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence                    1111235779999999999999999999999999999987653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=397.99  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=221.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++........+.+|+.+|+.+       .||||+++++++.+.+.+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-------RHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-------CCTTBCCEEEEEEETTEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-------CCCCCCeEeEEEecCCEE
Confidence            4799999999999999999999999999999999987766677788999999988       689999999999999999


Q ss_pred             EEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++|||||.+ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++...
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeEC
Confidence            999999984 8988886542 469999999999999999999999999999999999999632 3689999999999764


Q ss_pred             C--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          267 D--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       267 ~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      .  .......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..... .++.         
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~---------  224 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-TFDE---------  224 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCH---------
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC-CCCh---------
Confidence            3  334556899999999999998899999999999999999999999998887777666654211 0000         


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                             +                 ....+++
T Consensus       225 -------------------------------------------------------~-----------------~~~~~s~  232 (321)
T 1tki_A          225 -------------------------------------------------------E-----------------AFKEISI  232 (321)
T ss_dssp             -------------------------------------------------------H-----------------HHTTSCH
T ss_pred             -------------------------------------------------------h-----------------hhccCCH
Confidence                                                                   0                 0012346


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ++.+||++||..||++|||++|+|+||||++.
T Consensus       233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            78999999999999999999999999999874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5e-45  Score=392.25  Aligned_cols=255  Identities=22%  Similarity=0.381  Sum_probs=216.1

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..++|++.++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+       .||||++++++|...+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-------CCCCCCeEeEEEEECC
Confidence            447999999999999999999999999999999999743 23356678899999998       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+|||||. ++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~  164 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCA  164 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred             EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCce
Confidence            9999999996 5888888754   499999999999999999999999999999999999995   66889999999987


Q ss_pred             ccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.....  +.       
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~-------  235 (297)
T 3fxz_A          165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--PE-------  235 (297)
T ss_dssp             ECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS--CC-------
T ss_pred             ecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CC-------
Confidence            5432   23456899999999999999999999999999999999999999988776665554433111  00       


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                ......
T Consensus       236 --------------------------------------------------------------------------~~~~~~  241 (297)
T 3fxz_A          236 --------------------------------------------------------------------------LQNPEK  241 (297)
T ss_dssp             --------------------------------------------------------------------------CSCGGG
T ss_pred             --------------------------------------------------------------------------CCCccc
Confidence                                                                                      000012


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            446789999999999999999999999999998643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-44  Score=409.23  Aligned_cols=280  Identities=31%  Similarity=0.562  Sum_probs=222.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec----
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ----  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~----  184 (837)
                      .+|++.++||+|+||+||+|++..+++.||||++..+..   ...+|+++|+.|       .|+|||+++++|...    
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l-------~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-------DHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTC-------CCTTBCCEEEEEEEEETTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHc-------CCCCccceeeEEeccCCCC
Confidence            589999999999999999999999999999999986532   234699999988       689999999998653    


Q ss_pred             --ceEEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 --RHLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 --~~l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                        .++++||||+.++|.+++...  ....+++..++.++.||+.||+|||++|||||||||+||||+  .+.+.+||+||
T Consensus       124 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DF  201 (420)
T 1j1b_A          124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDF  201 (420)
T ss_dssp             TEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCC
T ss_pred             cceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccc
Confidence              357899999999888776642  235699999999999999999999999999999999999996  34567999999


Q ss_pred             ccccccC--CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          261 GSACTED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       261 GlA~~~~--~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |+++...  ......++|+.|+|||++.+. .|+.++||||||||+|||++|++||.+.+..+++.++++.+| .|....
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg-~p~~~~  280 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG-TPTREQ  280 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-SCCHHH
T ss_pred             hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHH
Confidence            9997543  334456889999999999875 799999999999999999999999999999999999999999 454443


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      +......   +....           .                     +     ......+..++   +           
T Consensus       281 ~~~~~~~---~~~~~-----------~---------------------p-----~~~~~~~~~~~---~-----------  306 (420)
T 1j1b_A          281 IREMNPN---YTEFK-----------F---------------------P-----QIKAHPWTKVF---R-----------  306 (420)
T ss_dssp             HHHHCSC---CCCCC-----------C---------------------C-----CCCCCCHHHHS---C-----------
T ss_pred             HHhhChh---hhhhc-----------c---------------------C-----ccCCCCHHHhc---C-----------
Confidence            3321100   00000           0                     0     00011122111   0           


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...+++++|||++||++||++|||++|+|+||||++..
T Consensus       307 --~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          307 --PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             --TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             --CCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence              12457899999999999999999999999999998754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-45  Score=404.63  Aligned_cols=280  Identities=31%  Similarity=0.636  Sum_probs=223.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee----
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC----  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~----  183 (837)
                      .++|+++++||+|+||+||+|++..+++.||||++..+...   ..+|+++|+.+       .|+||++++++|..    
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l-------~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVL-------DHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTC-------CCTTBCCEEEEEEEC---
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHc-------CCCCccchhheeeecCcc
Confidence            47999999999999999999999999999999999865432   23699999888       68999999999954    


Q ss_pred             ----------------------------------cceEEEEEeccchhHHHHHHh--hccCCCCHHHHHHHHHhHHHHHh
Q 003239          184 ----------------------------------QRHLCICFELLDSNLYELIKI--NHFRGLSLSIVQLFSKQILRGLS  227 (837)
Q Consensus       184 ----------------------------------~~~l~LVmEy~~gsL~d~l~~--~~~~~L~e~~i~~I~~QIl~aL~  227 (837)
                                                        ..+++|||||+.++|.+.+..  .....+++..++.++.||+.||+
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              335899999999998887764  23356999999999999999999


Q ss_pred             hhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc--CCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHH
Q 003239          228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--DRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVA  304 (837)
Q Consensus       228 yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~--~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILy  304 (837)
                      |||++||+||||||+|||++  ..++.+||+|||++...  .......++|+.|+|||++.+. .++.++|||||||++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            99999999999999999996  35679999999999754  3334556889999999999875 5999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhc
Q 003239          305 ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELK  384 (837)
Q Consensus       305 ELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~  384 (837)
                      ||++|++||.+.+..+++..+++.+|.++.+.+.......    ....                                
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~----~~~~--------------------------------  277 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY----TEVR--------------------------------  277 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC------CC--------------------------------
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccc----cccc--------------------------------
Confidence            9999999999999999999999999944444433221110    0000                                


Q ss_pred             CCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          385 KPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       385 ~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .+     ......+..++   |             ...++++.+||.+||++||++|||++|+|+||||++.
T Consensus       278 ~~-----~~~~~~~~~~~---~-------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          278 FP-----TLKAKDWRKIL---P-------------EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             CC-----CCCCCCHHHHS---C-------------TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred             CC-----ccCcccHHhhC---C-------------CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence            00     00111122221   1             1245779999999999999999999999999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.6e-45  Score=402.80  Aligned_cols=252  Identities=23%  Similarity=0.404  Sum_probs=220.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||+|+||+||+|++..+++.||||++++..    ...+.+.+|+.+|+.+       .||||+++++++.+.
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~  113 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-------NFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEcC
Confidence            78999999999999999999999999999999997532    2345677888888877       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+||||||+. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||++
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a  188 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFA  188 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccc
Confidence            99999999997 6899888765  3599999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      +.........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..|....-             
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------  255 (350)
T 1rdq_E          189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------------  255 (350)
T ss_dssp             EECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------
T ss_pred             eeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            8777666778999999999999999999999999999999999999999998877666665543100             


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                  .+|             ..++
T Consensus       256 ------------------------------------------------------------~~p-------------~~~~  262 (350)
T 1rdq_E          256 ------------------------------------------------------------RFP-------------SHFS  262 (350)
T ss_dssp             ------------------------------------------------------------CCC-------------TTCC
T ss_pred             ------------------------------------------------------------CCC-------------CCCC
Confidence                                                                        000             0134


Q ss_pred             HHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF  458 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~  458 (837)
                      +.+.+||++||+.||++|++     ++|+++||||++..+
T Consensus       263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            67899999999999999998     999999999998665

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.7e-45  Score=403.68  Aligned_cols=260  Identities=28%  Similarity=0.392  Sum_probs=218.2

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-------hHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++++...       ..+.+.+|+.+|+.+       .||||+++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~   82 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-------LHPNIITLHD   82 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-------CCTTBCCEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-------CCcCCCcEEE
Confidence            34789999999999999999999999999999999985421       346788999999888       6899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC-CCeEEE
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKI  257 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~IKL  257 (837)
                      +|...+.+||||||+. ++|.+++...  ..+++..++.++.||+.||.|||++|||||||||+|||++.+.. ...+||
T Consensus        83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           83 VYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             EEEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            9999999999999996 6899888653  46999999999999999999999999999999999999963211 227999


Q ss_pred             EecccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       258 ~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      +|||++.....  .....+||+.|+|||++.+..++.++||||||||+|+|++|.+||.+.+..+.+..|.......++ 
T Consensus       161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-  239 (361)
T 2yab_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE-  239 (361)
T ss_dssp             CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             EecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-
Confidence            99999976543  334568999999999999999999999999999999999999999998877776665432110000 


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                                                                                      +               
T Consensus       240 ----------------------------------------------------------------~---------------  240 (361)
T 2yab_A          240 ----------------------------------------------------------------E---------------  240 (361)
T ss_dssp             ----------------------------------------------------------------H---------------
T ss_pred             ----------------------------------------------------------------h---------------
Confidence                                                                            0               


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        .....++.+.+||++||..||++|||++|+|+||||+...
T Consensus       241 --~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          241 --FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             --HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             --hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence              0012346789999999999999999999999999998643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.8e-44  Score=402.70  Aligned_cols=281  Identities=30%  Similarity=0.570  Sum_probs=221.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc--
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--  185 (837)
                      ..+|++.++||+|+||+||+|++..+++ ||+|++..+...   ..+|+++|+.+       .|+||++++++|...+  
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l-------~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIV-------KHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTC-------CCTTBCCEEEEEEEESSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhC-------CCCCcceEEEEEEecCCC
Confidence            3689999999999999999999887776 788877654322   23699999988       6899999999996543  


Q ss_pred             ----eEEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          186 ----HLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       186 ----~l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                          .+|+||||+.+++.+.+...  ....+++..++.++.||+.||+|||++||+||||||+|||++  ..++.+||+|
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~D  185 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLID  185 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECC
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEee
Confidence                48999999998877666532  235699999999999999999999999999999999999995  3578999999


Q ss_pred             ccccccc--CCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          260 FGSACTE--DRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       260 FGlA~~~--~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ||+++..  .......++|+.|+|||++.+. .++.++||||||||+|||++|++||.+.+..+.+..+++.+| .|+..
T Consensus       186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~p~~~  264 (394)
T 4e7w_A          186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG-TPSRE  264 (394)
T ss_dssp             CTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCHH
T ss_pred             CCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHH
Confidence            9999754  3334456889999999999875 599999999999999999999999999999999999999999 45444


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      .+.....  .+.. .. .                               +     ......+...+              
T Consensus       265 ~~~~~~~--~~~~-~~-~-------------------------------~-----~~~~~~~~~~~--------------  290 (394)
T 4e7w_A          265 QIKTMNP--NYME-HK-F-------------------------------P-----QIRPHPFSKVF--------------  290 (394)
T ss_dssp             HHHHHCG--GGSS-SC-C-------------------------------C-----CCCCCCHHHHS--------------
T ss_pred             HHHhhCh--hhhh-hc-c-------------------------------c-----cccCCcHHHhc--------------
Confidence            3332110  0000 00 0                               0     00011111111              


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                        ....++++++||.+||++||++|||+.|+|+||||++...
T Consensus       291 --~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          291 --RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             --CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             --cccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence              1124578999999999999999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-44  Score=394.21  Aligned_cols=287  Identities=28%  Similarity=0.490  Sum_probs=218.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---  185 (837)
                      ++|++.++||+|+||+||+|++..+++.||||++..+........+|++.+..+       .|+||++++++|...+   
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-------~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-------HHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-------CCTTBCCEEEEEEEECSSC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-------CCCCcccHHHhhhcccccc
Confidence            789999999999999999999999999999999987655555666677777777       6899999999997643   


Q ss_pred             ----eEEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhh--cCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          186 ----HLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       186 ----~l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLH--s~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                          .+++||||+.++|.+.+...  ....+++..++.++.||+.||.|||  ++|||||||||+|||++  ..++.+||
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl  173 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKL  173 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEE
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEE
Confidence                38999999999887766542  3356899999999999999999999  99999999999999996  23689999


Q ss_pred             EecccccccCC--cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       258 ~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      +|||++.....  .....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~  252 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG-CPS  252 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCC
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC-CCC
Confidence            99999976543  23455789999999999765 489999999999999999999999999999999999999999 555


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                      ..++.........+...                                        ......+..++...+        
T Consensus       253 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~--------  284 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLY----------------------------------------NSKGIPWSNVFSDHS--------  284 (360)
T ss_dssp             HHHHHHHCTTCCCGGGG----------------------------------------CCCCCCHHHHTTTCC--------
T ss_pred             HHHHHhcccchhhcccc----------------------------------------ccccCCcccccchhh--------
Confidence            55544322111000000                                        000111222222111        


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                           ...++++.+||.+||++||++|||+.|||+||||++...
T Consensus       285 -----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          285 -----LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             -----CTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             -----ccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                 124678999999999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=409.87  Aligned_cols=296  Identities=27%  Similarity=0.460  Sum_probs=214.5

Q ss_pred             CceEEE-EEeccCCceeEEEeecc--CCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--
Q 003239          109 RRYIVK-DLLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--  183 (837)
Q Consensus       109 ~~Y~i~-~~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--  183 (837)
                      +.|++. ++||+|+||+||+|+++  .+++.||||+++.... ...+.+|+.+|+.|       .||||++++++|..  
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLREL-------KHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHC-------CCTTBCCCCEEEEETT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhc-------CCCCeeeEeeEEecCC
Confidence            567774 57999999999999854  5789999999986432 34678899999999       58999999999965  


Q ss_pred             cceEEEEEeccchhHHHHHHhhcc-------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc-CCCCeE
Q 003239          184 QRHLCICFELLDSNLYELIKINHF-------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEI  255 (837)
Q Consensus       184 ~~~l~LVmEy~~gsL~d~l~~~~~-------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~I  255 (837)
                      ...+||||||+.++|.+++.....       ..+++..++.|+.||+.||+|||++|||||||||+||||... +..+.+
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            678999999999999988864431       249999999999999999999999999999999999999543 356899


Q ss_pred             EEEecccccccCC------cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCH---------H
Q 003239          256 KIIDFGSACTEDR------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------F  319 (837)
Q Consensus       256 KL~DFGlA~~~~~------~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~---------~  319 (837)
                      ||+|||+++....      .....+||+.|+|||++.+. .++.++||||||||+|||++|++||.+...         .
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            9999999975432      23446889999999999875 599999999999999999999999987654         4


Q ss_pred             HHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchH
Q 003239          320 DLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLE  399 (837)
Q Consensus       320 e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~  399 (837)
                      +++..|++.+| .|+...+........+......                                  .....+....+.
T Consensus       252 ~~l~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~  296 (405)
T 3rgf_A          252 DQLDRIFNVMG-FPADKDWEDIKKMPEHSTLMKD----------------------------------FRRNTYTNCSLI  296 (405)
T ss_dssp             HHHHHHHHHHC-CCCTTTCGGGGGSTTHHHHHHH----------------------------------CCGGGGTTCCHH
T ss_pred             HHHHHHHHhhC-CCChhhcchhhcCcchhhhhhh----------------------------------ccccCCCcchhh
Confidence            78899999999 4444333322221111110000                                  000011111122


Q ss_pred             HHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCC
Q 003239          400 EIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTC  460 (837)
Q Consensus       400 ~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~  460 (837)
                      +.+....             ...++.+++||++||++||++|||++|||+||||++.+.+.
T Consensus       297 ~~~~~~~-------------~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          297 KYMEKHK-------------VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHHTTT-------------CCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             hhHhhcC-------------CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence            2221111             11246789999999999999999999999999999877643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4e-44  Score=395.68  Aligned_cols=280  Identities=33%  Similarity=0.581  Sum_probs=226.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--  184 (837)
                      ++|+++++||+|+||.||+|++..+++.||||+++..  ....+.+.+|+++|+.+       .|+||+++++++...  
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-------CCTTBCCCCEEECCSST
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-------CCCCCccceeEEecCCc
Confidence            6999999999999999999999999999999999743  34457788999999999       589999999999765  


Q ss_pred             ---ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 ---RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ---~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                         ...|+|||+++++|.+++...   .+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCT
T ss_pred             cccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeCc
Confidence               478999999999999988754   499999999999999999999999999999999999995   67889999999


Q ss_pred             cccccCCc------ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          262 SACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       262 lA~~~~~~------~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      ++......      ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...++ .|+
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~  252 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG-SPS  252 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC-SCC
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC-CCC
Confidence            99754432      2345889999999987654 589999999999999999999999999999999999999999 454


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                      ...+....+...                             ..+..   ..+..     ....+..+.            
T Consensus       253 ~~~~~~~~~~~~-----------------------------~~~~~---~~~~~-----~~~~~~~~~------------  283 (364)
T 3qyz_A          253 QEDLNCIINLKA-----------------------------RNYLL---SLPHK-----NKVPWNRLF------------  283 (364)
T ss_dssp             HHHHHTCCCHHH-----------------------------HHHHH---TSCCC-----CCCCHHHHC------------
T ss_pred             HHHHHHhhhhhH-----------------------------HHHHH---hcCCc-----cCCCHHHhC------------
Confidence            443332111000                             00000   00000     001111111            


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                           ...++++.+||++||++||++|||++|||+||||++.
T Consensus       284 -----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          284 -----PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             -----CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                 1245789999999999999999999999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=381.48  Aligned_cols=283  Identities=33%  Similarity=0.542  Sum_probs=220.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++..+++.||||++...   ....+.+.+|+.+++.+       .|+||+++++++...+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-------KHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-------CCCCccchhheeecCC
Confidence            6899999999999999999999999999999998653   23356678899999999       5899999999999999


Q ss_pred             eEEEEEeccchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..++||||+.++ |.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~  150 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFAR  150 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCE
T ss_pred             eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCch
Confidence            999999999965 54444432  4699999999999999999999999999999999999995   67899999999997


Q ss_pred             ccCCc---ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          265 TEDRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       265 ~~~~~---~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      .....   ....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++..++......
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          151 LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence            64422   234578999999999986 57899999999999999999999999999999999999998885544332111


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                       . ...++.... .                               +.+  .  ....+...                 ..
T Consensus       231 -~-~~~~~~~~~-~-------------------------------~~~--~--~~~~~~~~-----------------~~  255 (311)
T 4agu_A          231 -S-TNQYFSGVK-I-------------------------------PDP--E--DMEPLELK-----------------FP  255 (311)
T ss_dssp             -H-TCGGGTTCC-C-------------------------------CCC--S--SCCCHHHH-----------------CT
T ss_pred             -c-cccccccCc-C-------------------------------CCc--c--ccchhhhh-----------------cc
Confidence             1 111111100 0                               000  0  00001111                 11


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                      ..+..+.+||++||+.||++|||++|+|+||||++...
T Consensus       256 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          256 NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             TCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            24577999999999999999999999999999998653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-44  Score=398.23  Aligned_cols=258  Identities=27%  Similarity=0.408  Sum_probs=213.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++...      ...+.+.+|+.+++.+       .||||+++++++.
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~   96 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-------KHPHIVELLETYS   96 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-------CCCCCCcEEEEEE
Confidence            78999999999999999999999999999999997422      1356788999999998       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQRHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..+.+|||||||. ++|.+.+....  ...+++..++.++.||+.||+|||+++||||||||+|||++.+.....+||+|
T Consensus        97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence            9999999999998 58887776543  23489999999999999999999999999999999999997555556799999


Q ss_pred             cccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       260 FGlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ||++......   ....+||+.|+|||++.+..++.++||||||||+|+|++|..||.+.. .+.+..+.......++  
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~--  253 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP--  253 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH--
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc--
Confidence            9999765432   234679999999999999999999999999999999999999997743 3333333221000000  


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                                                      
T Consensus       254 --------------------------------------------------------------------------------  253 (351)
T 3c0i_A          254 --------------------------------------------------------------------------------  253 (351)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .....+++++.+||++||+.||++|||++|+|+||||++.
T Consensus       254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            0011245778999999999999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-44  Score=406.65  Aligned_cols=259  Identities=21%  Similarity=0.372  Sum_probs=218.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++...    ..+.+.+|+.+++.+       .||||++++++|.+
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-------~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-------NSPWVVQLFYAFQD  140 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-------CCTTBCCEEEEEEC
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEE
Confidence            3799999999999999999999999999999999975321    223467899999888       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|||||||. |+|.+++...   .+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC---CCCCEEEeccce
Confidence            999999999996 5898888653   599999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCCc----ceeeccCccccCchhhcCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          263 ACTEDRT----VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       263 A~~~~~~----~~~~~GT~~Y~APEvl~~~~----yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      ++.....    ....+||+.|+|||++.+..    |+.++|||||||++|||++|++||.+.+..+...+|+.....   
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---  291 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---  291 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence            9765432    23568999999999998765    889999999999999999999999998887777766542110   


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                                                                                          ..+|.       
T Consensus       292 --------------------------------------------------------------------~~~p~-------  296 (410)
T 3v8s_A          292 --------------------------------------------------------------------LTFPD-------  296 (410)
T ss_dssp             --------------------------------------------------------------------CCCCT-------
T ss_pred             --------------------------------------------------------------------ccCCC-------
Confidence                                                                                00000       


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCC--CCCHHHHHcCccCCCCCCCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAK--RWSPFQASRHPFVTGEPFTCP  461 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~k--RpTa~EaL~HPff~~~~~~~~  461 (837)
                          ...+++++.+||++||+.+|++  |++++||++||||++..|...
T Consensus       297 ----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~  341 (410)
T 3v8s_A          297 ----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  341 (410)
T ss_dssp             ----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred             ----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence                0113477899999999999998  999999999999999877544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.6e-44  Score=396.24  Aligned_cols=281  Identities=27%  Similarity=0.545  Sum_probs=224.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..   ....+.+.+|+.+++.+       .|+||+++++++...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~  113 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-------QHENVIGLLDVFTPA  113 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-------CCCCchhhhhheecc
Confidence            38999999999999999999999999999999999853   34457788999999998       589999999999987


Q ss_pred             ceE------EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 RHL------CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ~~l------~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      +..      |+||||+.++|.+.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+
T Consensus       114 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~  186 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQTDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKIL  186 (371)
T ss_dssp             SSSTTCCCCEEEEECCCEEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEEC
T ss_pred             CCcccceeEEEEEccccccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEE
Confidence            654      9999999999887763    3499999999999999999999999999999999999995   67889999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||+++.........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+ .++..+
T Consensus       187 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~  265 (371)
T 4exu_A          187 DFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGTEF  265 (371)
T ss_dssp             STTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred             ecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCcHHH
Confidence            99999877776677789999999999987 6899999999999999999999999999999999999999998 554444


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      ........                             ...+....   +.     .....+..+.               
T Consensus       266 ~~~~~~~~-----------------------------~~~~~~~~---~~-----~~~~~~~~~~---------------  293 (371)
T 4exu_A          266 VQKLNDKA-----------------------------AKSYIQSL---PQ-----TPRKDFTQLF---------------  293 (371)
T ss_dssp             HTTCSCHH-----------------------------HHHHHHHS---CC-----CCCCCHHHHS---------------
T ss_pred             HHHhhhhh-----------------------------hhhhhhcc---CC-----CcchhHHHhc---------------
Confidence            33211100                             00000000   00     0001111111               


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...++.+.+||++||++||++|||++|+|+||||+...
T Consensus       294 --~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          294 --PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             --TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             --cccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence              12457899999999999999999999999999999754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.2e-45  Score=408.37  Aligned_cols=198  Identities=22%  Similarity=0.395  Sum_probs=175.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++..    ...+.+.+|..+|+++.      .||||++++++|..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~------~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS------NHPFLVGLHSCFQT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT------TCTTBCCEEEEEEC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC------CCCCcCeeEEEEEE
Confidence            478999999999999999999999999999999998642    22345778999998874      58999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|||||||.+ +|.+++...  +.+++..++.++.||+.||+|||++|||||||||+||||+   .++.+||+|||+
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGl  199 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGM  199 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecce
Confidence            9999999999985 888888765  3699999999999999999999999999999999999995   678999999999


Q ss_pred             cccc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       263 A~~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++..   .......+||+.|+|||++.+..|+.++|||||||++|||++|++||...
T Consensus       200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          200 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             CBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             eeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            9752   33455678999999999999999999999999999999999999999654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.3e-44  Score=408.80  Aligned_cols=262  Identities=19%  Similarity=0.315  Sum_probs=218.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++...    ....+.+|+.++..+       .|+||++++++|.+
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-------~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-------DSKWITTLHYAFQD  145 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-------CTTTBCCEEEEEEC
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEee
Confidence            3789999999999999999999999999999999985321    122377899999887       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|||||||. |+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+||||+   .++.+||+|||+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~---~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGS  221 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---CCCCEEEcchhh
Confidence            999999999996 68999887642 4699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCCc----ceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          263 ACTEDRT----VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       263 A~~~~~~----~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      ++.....    ....+||+.|+|||++.     ...|+.++|||||||++|||++|++||.+.+..+.+.+|+...... 
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-  300 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-  300 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-
Confidence            9654322    22358999999999997     4579999999999999999999999999988877777665421100 


Q ss_pred             chHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       334 p~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                                                                                            .+|  ..   
T Consensus       301 ----------------------------------------------------------------------~~p--~~---  305 (437)
T 4aw2_A          301 ----------------------------------------------------------------------QFP--TQ---  305 (437)
T ss_dssp             ----------------------------------------------------------------------CCC--SS---
T ss_pred             ----------------------------------------------------------------------cCC--cc---
Confidence                                                                                  000  00   


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCC--CCCHHHHHcCccCCCCCCCCC
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAK--RWSPFQASRHPFVTGEPFTCP  461 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~k--RpTa~EaL~HPff~~~~~~~~  461 (837)
                           ...++++++|||++||+.+|++  |++++|+++||||++..|...
T Consensus       306 -----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          306 -----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             -----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             -----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence                 0013477899999999999998  999999999999999877543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-45  Score=403.08  Aligned_cols=254  Identities=28%  Similarity=0.478  Sum_probs=218.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.++||+|+||+||+|+++.+++.||||++++..    ...+....|..+++.+.      .||||++++++|.+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~------~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EHPFLTHMFCTFQT   89 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT------TCTTBCCEEEEEEC
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC------CCCCCCcEEEEEEe
Confidence            379999999999999999999999999999999998542    33456778999988763      58999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|||||||. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~  164 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGM  164 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChh
Confidence            999999999997 5898888764  3699999999999999999999999999999999999995   678999999999


Q ss_pred             cccc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++..   .......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..|....-         
T Consensus       165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------  235 (345)
T 1xjd_A          165 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---------  235 (345)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             hhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            9753   2334567899999999999999999999999999999999999999998887766655533100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .+|             
T Consensus       236 ----------------------------------------------------------------~~p-------------  238 (345)
T 1xjd_A          236 ----------------------------------------------------------------FYP-------------  238 (345)
T ss_dssp             ----------------------------------------------------------------CCC-------------
T ss_pred             ----------------------------------------------------------------CCC-------------
Confidence                                                                            000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHH-HHHcCccCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPF-QASRHPFVTGEPF  458 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~-EaL~HPff~~~~~  458 (837)
                      ..+++++.+||++||+.||++|||+. |+++||||++..+
T Consensus       239 ~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence            01346789999999999999999998 9999999998765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=392.87  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=218.1

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...       ...+.+.+|+.+|+.+       .||||+++++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~   81 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-------QHPNVITLHE   81 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEEE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-------CCCCCCcEEE
Confidence            3478999999999999999999999999999999997532       1356788999999999       5899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC-CCCeEEE
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKI  257 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~IKL  257 (837)
                      ++...+.+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence            9999999999999997 5899888653  4699999999999999999999999999999999999996322 2237999


Q ss_pred             EecccccccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          258 IDFGSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       258 ~DFGlA~~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      +|||++....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..... ..+.
T Consensus       160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~  238 (326)
T 2y0a_A          160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFED  238 (326)
T ss_dssp             CCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-CCCH
T ss_pred             EECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-CcCc
Confidence            9999997653  334456899999999999988999999999999999999999999998877766665543211 0000


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                                                                                      ..              
T Consensus       239 ----------------------------------------------------------------~~--------------  240 (326)
T 2y0a_A          239 ----------------------------------------------------------------EY--------------  240 (326)
T ss_dssp             ----------------------------------------------------------------HH--------------
T ss_pred             ----------------------------------------------------------------cc--------------
Confidence                                                                            00              


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                         ....+..+.+||++||+.||++|||++|+|+||||+...
T Consensus       241 ---~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          241 ---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             ---HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             ---cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence               011346789999999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-44  Score=397.14  Aligned_cols=197  Identities=22%  Similarity=0.400  Sum_probs=176.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++++.||+|+||+||+|+++.+++.||||++++.    ....+.+.+|+.+++++.      .||||++++++|..
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~------~hp~iv~l~~~~~~   81 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS------NHPFLVGLHSCFQT   81 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT------TCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC------CCCccCeEEEEEEe
Confidence            37899999999999999999999999999999999853    344566788999998873      58999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|+||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~  156 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGM  156 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGG
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEeccc
Confidence            999999999997 5888888764  3699999999999999999999999999999999999995   678999999999


Q ss_pred             cccc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       263 A~~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ++..   .......+||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus       157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          157 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            9753   2334567899999999999999999999999999999999999999965

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-44  Score=402.58  Aligned_cols=208  Identities=18%  Similarity=0.252  Sum_probs=181.8

Q ss_pred             CCceEEEEEeccC--CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHG--TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G--~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|+++++||+|  +||+||+|++..+++.||||+++..   ....+.+.+|+.+++.+       .|||||+++++|.
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~   96 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-------NHPNIVPYRATFI   96 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-------CCCCCCcEeEEEE
Confidence            3799999999999  9999999999999999999999854   34456778899999999       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+.+|||||||. ++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg  173 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLR  173 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGG
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccc
Confidence            9999999999998 5899998876556799999999999999999999999999999999999995   67899999999


Q ss_pred             cccccC----------CcceeeccCccccCchhhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          262 SACTED----------RTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       262 lA~~~~----------~~~~~~~GT~~Y~APEvl~~--~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      .+....          ......+||+.|+|||++.+  ..++.++||||||||+|||++|++||.+.+..+.+..+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  249 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK  249 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            885321          11223478999999999988  57999999999999999999999999887665555443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=410.14  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=218.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.++||+|+||+||+|.+..+++.||+|+++...   ...+.+.+|+.+|+.+       .||||+++++++.+.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~~~~~~   82 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-------KHPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-------CBTTBCCEEEEEECS
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCcCCCeEEEEEEEC
Confidence            378999999999999999999999999999999998543   3456688999999998       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..|||||||. ++|.+.+...  ..+++..++.++.||+.||.|||++|||||||||+|||++.+...+.+||+|||++
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            99999999997 5898888765  36999999999999999999999999999999999999976556789999999999


Q ss_pred             cccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ......   ....+||+.|+|||++.+..|+.++||||||||+|+|++|.+||.+.+..+.+..+.......+.      
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------  234 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS------  234 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT------
T ss_pred             EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc------
Confidence            765432   23568999999999999999999999999999999999999999988877776665542110000      


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                             .                     ...
T Consensus       235 -------------------------------------------------------~---------------------~~~  238 (444)
T 3soa_A          235 -------------------------------------------------------P---------------------EWD  238 (444)
T ss_dssp             -------------------------------------------------------T---------------------TTT
T ss_pred             -------------------------------------------------------c---------------------ccc
Confidence                                                                   0                     001


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            234678999999999999999999999999999763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-44  Score=399.77  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=218.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.+.||+|+||.||+|++..+++.||||+++..   ....+.+.+|+.+++.|       .||||+++++++.+.+
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-------QHPNIVRLHDSIQEES  101 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEECSS
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeCC
Confidence            7899999999999999999999999999999999854   34456788999999998       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..|+|||||.+ +|.+.+...  ..+++..++.++.||+.||.|||++|||||||||+|||++.+.....+||+|||++.
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999985 888887654  469999999999999999999999999999999999999755556789999999997


Q ss_pred             ccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      .....  ....+||+.|+|||++.+..++.++||||||||+|+|++|.+||.+.+..+.+..+.......+.        
T Consensus       180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------  251 (362)
T 2bdw_A          180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS--------  251 (362)
T ss_dssp             CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--------
T ss_pred             EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence            65432  33568999999999999989999999999999999999999999988776666555431110000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                                .....+
T Consensus       252 --------------------------------------------------------------------------~~~~~~  257 (362)
T 2bdw_A          252 --------------------------------------------------------------------------PEWDTV  257 (362)
T ss_dssp             --------------------------------------------------------------------------TGGGGS
T ss_pred             --------------------------------------------------------------------------ccccCC
Confidence                                                                                      000123


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            467899999999999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-44  Score=401.06  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=216.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++..    ...+.+..|..+|..+.      .||+|++++++|..
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~------~hp~iv~l~~~~~~   92 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG------KPPFLTQLHSCFQT   92 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT------CCTTBCCEEEEEEC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC------CCCEEeeEEEEEEc
Confidence            379999999999999999999999999999999998532    23456677888876653      68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+||||||+. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~  167 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGM  167 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCc
Confidence            999999999997 5898888765  3599999999999999999999999999999999999995   678999999999


Q ss_pred             cccc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +...   .......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+++..|....-         
T Consensus       168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------  238 (353)
T 2i0e_A          168 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------  238 (353)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            9753   2334567899999999999999999999999999999999999999998887776666544100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .+|             
T Consensus       239 ----------------------------------------------------------------~~p-------------  241 (353)
T 2i0e_A          239 ----------------------------------------------------------------AYP-------------  241 (353)
T ss_dssp             ----------------------------------------------------------------CCC-------------
T ss_pred             ----------------------------------------------------------------CCC-------------
Confidence                                                                            000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      ..+++++.+||++||+.||++|+     +++|+++||||++..+
T Consensus       242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence            01346789999999999999999     4799999999998665

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.8e-45  Score=393.86  Aligned_cols=193  Identities=21%  Similarity=0.250  Sum_probs=158.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---  185 (837)
                      ++|.+.++||+|+||+||+|++  +|+.||||+++...........|+.++..+       .|||||++++++..++   
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-------~HpNIv~l~g~~~~~~~~~   73 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-------RHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-------CCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-------CCCCCCcEEEEEEecCCCc
Confidence            6799999999999999999976  689999999986543222233344443444       7999999999998764   


Q ss_pred             -eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC--------CeeeccCCCCCeeeeccCCCCeE
Q 003239          186 -HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--------GIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       186 -~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~--------gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                       .+|||||||+ |+|.+++...   .++++.+..++.|++.||+|||++        +||||||||+||||+   .++.+
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~---~~~~~  147 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTC  147 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC---TTSCE
T ss_pred             eEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC---CCCCE
Confidence             6899999998 6999998754   499999999999999999999987        999999999999995   67899


Q ss_pred             EEEecccccccCCc-------ceeeccCccccCchhhcCC------CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          256 KIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       256 KL~DFGlA~~~~~~-------~~~~~GT~~Y~APEvl~~~------~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ||+|||+|+.....       ....+||+.|||||++.+.      .|+.++||||||||||||+||.+||...
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~  221 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence            99999999654321       2235899999999999764      4778999999999999999999888543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.6e-44  Score=384.62  Aligned_cols=284  Identities=30%  Similarity=0.514  Sum_probs=227.2

Q ss_pred             CceEEEEEeccCCceeEEEeecc-CCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA-EMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV--  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~-~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~--  182 (837)
                      ++|++++.||+|+||+||+|++. .+++.||||+++...   .....+.+|+.+++.+...    .||||+++++++.  
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~~i~~~~~~~~~~   86 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----EHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT----CCTTBCCEEEEEEEE
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc----CCCCeEeeeeeeeec
Confidence            78999999999999999999985 678999999997422   2223566888888888643    6999999999998  


Q ss_pred             ---ecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 ---CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ---~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                         .....++||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl~D  163 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD  163 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEEec
Confidence               56789999999999999999876656699999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||++.....  ......+|..|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+++.++..+...+
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            999976543  234567899999999999999999999999999999999999999999999999999998883333221


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      ..........+..                                          .....+.++                
T Consensus       244 ~~~~~~~~~~~~~------------------------------------------~~~~~~~~~----------------  265 (326)
T 1blx_A          244 PRDVALPRQAFHS------------------------------------------KSAQPIEKF----------------  265 (326)
T ss_dssp             CTTCSSCGGGSCC------------------------------------------CCCCCGGGT----------------
T ss_pred             ccccccchhhhcc------------------------------------------cCcchhhhc----------------
Confidence            1100000000000                                          000001111                


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                       ...++..+.+||.+||..||++|||++|+|+||||++...
T Consensus       266 -~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          266 -VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             -CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             -cccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence             1124578899999999999999999999999999998653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.5e-43  Score=385.31  Aligned_cols=284  Identities=32%  Similarity=0.553  Sum_probs=224.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-  184 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..  ......+.+|+.+++.+       .|+||+++++++... 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-------KHENIITIFNIQRPDS   82 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCCSC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-------cCCCcCCeeeeecccc
Confidence            47999999999999999999999999999999999743  34456778999999998       689999999988764 


Q ss_pred             ----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 ----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                          ...|+||||+.++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+||
T Consensus        83 ~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Df  156 (353)
T 2b9h_A           83 FENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCDF  156 (353)
T ss_dssp             STTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCC
T ss_pred             cCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEEec
Confidence                679999999999999888763   599999999999999999999999999999999999995   6788999999


Q ss_pred             ccccccCCc-------------ceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          261 GSACTEDRT-------------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       261 GlA~~~~~~-------------~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      |++......             ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            999754321             123478999999999875 679999999999999999999999999999999999988


Q ss_pred             HHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCC
Q 003239          327 RILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP  406 (837)
Q Consensus       327 ~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p  406 (837)
                      ...+.++..........                             ....++...   .+     .+....+..+.    
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~---~~-----~~~~~~~~~~~----  275 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIES-----------------------------PRAREYIKS---LP-----MYPAAPLEKMF----  275 (353)
T ss_dssp             HHHCCCCSTTTTTTCCC-----------------------------HHHHHHHHT---SC-----CCCCCCHHHHS----
T ss_pred             HHhCCCchhcccccccc-----------------------------chhhHHhhc---cc-----CCCCcchhhhc----
Confidence            88883332221110000                             000000000   00     00111122221    


Q ss_pred             CCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       407 ~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                                   ..+++++.+||++||+.||++|||++|+|+||||+....
T Consensus       276 -------------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          276 -------------PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             -------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             -------------ccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence                         124578999999999999999999999999999998654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.9e-44  Score=392.59  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=219.8

Q ss_pred             CceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~-~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|.+. ++||+|+||+||+|++..+++.||||+++..   ......+.+|+.+++.+.      .|+||+++++++...
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK------SCPRVINLHEVYENT  101 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT------TCTTBCCEEEEEECS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc------CCCCEEEEEEEEEeC
Confidence            788888 8999999999999999999999999999853   233567889999999985      579999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+++||||+.+ +|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||++
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            999999999985 8888876554567999999999999999999999999999999999999974434689999999999


Q ss_pred             cccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          264 CTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       264 ~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ......  ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+..      
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  255 (327)
T 3lm5_A          182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE------  255 (327)
T ss_dssp             EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------
T ss_pred             cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch------
Confidence            765432  344679999999999999999999999999999999999999999888777666554422200000      


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                  ....
T Consensus       256 ----------------------------------------------------------------------------~~~~  259 (327)
T 3lm5_A          256 ----------------------------------------------------------------------------TFSS  259 (327)
T ss_dssp             ----------------------------------------------------------------------------TTTT
T ss_pred             ----------------------------------------------------------------------------hhcc
Confidence                                                                                        0011


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY  462 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~  462 (837)
                      .++.+.+||.+||+.||++|||++|+|+||||++..+....
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~  300 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF  300 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence            34678999999999999999999999999999997775443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.6e-44  Score=381.59  Aligned_cols=283  Identities=30%  Similarity=0.498  Sum_probs=218.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe----
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV----  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~----  182 (837)
                      .++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+++++.+       .||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-------DHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEECTTSC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-------CCCCeeEEEEecccccc
Confidence            38999999999999999999999999999999999754 34567788999999988       6899999999874    


Q ss_pred             ----------ecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          183 ----------CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       183 ----------~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                                .....|+||||+.++|.+++..   +.+++..++.++.||+.||+|||++||+||||||+|||++  ..+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~  157 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TED  157 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTT
T ss_pred             ccccccccccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCC
Confidence                      3468999999999999988854   3599999999999999999999999999999999999996  345


Q ss_pred             CeEEEEecccccccCC------cceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          253 AEIKIIDFGSACTEDR------TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~------~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      +.+||+|||++.....      ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7899999999975432      1233467899999999876 57999999999999999999999999999998888888


Q ss_pred             HHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcC
Q 003239          326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY  405 (837)
Q Consensus       326 ~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~  405 (837)
                      .+.......+...+.......+....                               ..        .....+..+.   
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~--------~~~~~~~~~~---  275 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRND-------------------------------MT--------EPHKPLTQLL---  275 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHH-------------------------------TT--------SCCCCHHHHS---
T ss_pred             HHhcCCCchhhhhhhhhcCccccccc-------------------------------cc--------CCCCChhHhc---
Confidence            88766222222111111100000000                               00        0011111211   


Q ss_pred             CCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       406 p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                                    ..++.++.+||++||+.||++|||++|+|+||||+...+
T Consensus       276 --------------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          276 --------------PGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             --------------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             --------------chhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence                          124578999999999999999999999999999998665

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-43  Score=372.61  Aligned_cols=259  Identities=27%  Similarity=0.413  Sum_probs=218.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   ....+.+.+|+.+++.+       .|+||+++++++...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-------QHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-------CCCCcCeEEEEEEcC
Confidence            48999999999999999999999999999999999753   34456788899999998       589999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..++||||+.+ +|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+||+++.+.....+||+|||++
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence            999999999974 888887765  35999999999999999999999999999999999999975555667999999999


Q ss_pred             cccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          264 CTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       264 ~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ......  .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+.       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  228 (284)
T 3kk8_A          156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------  228 (284)
T ss_dssp             EECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------
T ss_pred             EEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-------
Confidence            655433  23457899999999999999999999999999999999999999888776665554432110000       


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                 .....
T Consensus       229 ---------------------------------------------------------------------------~~~~~  233 (284)
T 3kk8_A          229 ---------------------------------------------------------------------------PEWDT  233 (284)
T ss_dssp             ---------------------------------------------------------------------------TTTTT
T ss_pred             ---------------------------------------------------------------------------hhhcc
Confidence                                                                                       00011


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             cCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            346789999999999999999999999999998854

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.1e-44  Score=388.30  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             CCceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      .++|+++++||+|+||+||+|++.   .+++.||||++++..     .....+.+|+.+|+.+       .||||+++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~   88 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-------KHPFIVDLIY   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-------CCTTBCCEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-------CCCCccceeE
Confidence            378999999999999999999875   689999999998542     2345577899999998       6899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      ++...+.+||||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~  163 (327)
T 3a62_A           89 AFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLT  163 (327)
T ss_dssp             EEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEEC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEE
Confidence            9999999999999997 5888888764  3599999999999999999999999999999999999995   67899999


Q ss_pred             ecccccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          259 DFGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       259 DFGlA~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      |||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.+....    
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----  239 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN----  239 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----
Confidence            999986432   2233457899999999999999999999999999999999999999988776666555431100    


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                                                                                           +|         
T Consensus       240 ---------------------------------------------------------------------~p---------  241 (327)
T 3a62_A          240 ---------------------------------------------------------------------LP---------  241 (327)
T ss_dssp             ---------------------------------------------------------------------CC---------
T ss_pred             ---------------------------------------------------------------------CC---------
Confidence                                                                                 00         


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                          ..++..+.+||++||..||++||     |++|+|+||||++..+
T Consensus       242 ----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          242 ----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             ----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             ----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                01346789999999999999999     8999999999998654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.2e-43  Score=380.88  Aligned_cols=286  Identities=23%  Similarity=0.437  Sum_probs=217.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--cc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--QR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~~  185 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++...  .+.+.+|+.+|+.++      .|+||+++++++..  ..
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~------~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR------GGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHT------TSTTBCCEEEEEECTTTC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcC------CCCCEEEeeeeeccCCCC
Confidence            489999999999999999999999999999999998543  467889999999995      48999999999998  67


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..++||||+.+ +|.+++.     .+++..++.++.||+.||+|||++||+||||||+|||++  .+...+||+|||++.
T Consensus       107 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAE  179 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred             ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCce
Confidence            89999999985 6666552     389999999999999999999999999999999999996  233489999999997


Q ss_pred             ccC--CcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          265 TED--RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLF-PGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       265 ~~~--~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF-~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ...  ......+++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+.+.++.......+..
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            543  33345678999999999987 57999999999999999999999888 456777888888877761111111110


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      ...                   ..                              ...+.+++..................
T Consensus       260 ~~~-------------------~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (330)
T 3nsz_A          260 YNI-------------------EL------------------------------DPRFNDILGRHSRKRWERFVHSENQH  290 (330)
T ss_dssp             TTC-------------------CC------------------------------CTHHHHHHCCCCCCCGGGGCCTTTGG
T ss_pred             hcc-------------------cc------------------------------ccchhhhhhhccccchhhhccccccc
Confidence            000                   00                              00000000000000000000001112


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+++++.+||++||++||++|||++|||+||||++..
T Consensus       291 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          291 LVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             GCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            3568899999999999999999999999999999754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-44  Score=396.93  Aligned_cols=259  Identities=28%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|+++++||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.+       .||||+++++++...+.+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-------RHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-------CCTTBCCEEEEEECSSEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-------CCCCCCcEEEEEeeCCEE
Confidence            3799999999999999999999999999999999987665567788999999998       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||. ++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.+ ....+||+|||+++..
T Consensus        92 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC---
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccc
Confidence            99999996 5898888664  369999999999999999999999999999999999999622 2345999999999643


Q ss_pred             --CCcceeeccCccccCchhhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          267 --DRTVYSYIQSRYYRSPEVLLGYQYTTA-IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       267 --~~~~~~~~GT~~Y~APEvl~~~~yt~k-sDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                        .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+++.+....          
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------  238 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK----------  238 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC----------
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC----------
Confidence              233345689999999999998887755 8999999999999999999976543222222211110000          


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                .                 .+|           ....++
T Consensus       239 ------------------------------------------~-----------------~~~-----------~~~~~s  248 (361)
T 3uc3_A          239 ------------------------------------------Y-----------------SIP-----------DDIRIS  248 (361)
T ss_dssp             ------------------------------------------C-----------------CCC-----------TTSCCC
T ss_pred             ------------------------------------------C-----------------CCC-----------CcCCCC
Confidence                                                      0                 000           001134


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      +.+.+||++||+.||++|||++|||+||||.+.
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            678999999999999999999999999999753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.8e-44  Score=407.39  Aligned_cols=254  Identities=25%  Similarity=0.410  Sum_probs=206.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++..    ......+.+|+.+|+.+       .||||++++++|..
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-------RHPFLTALKYSFQT  219 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-------SCTTSCCEEEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-------CCCeEeeEEEEEee
Confidence            47899999999999999999999999999999999853    22334455677666655       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      .+.+|||||||.+ +|.+++...  ..+++..++.++.||+.||+|||+ +|||||||||+||||+   .++.+||+|||
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG  294 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFG  294 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCC
Confidence            9999999999985 888887664  369999999999999999999998 9999999999999995   67899999999


Q ss_pred             cccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          262 SACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       262 lA~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ++....   ......+||+.|+|||++.+..|+.++||||||||+|||++|+.||.+.+..+....+..... .      
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~------  367 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-R------  367 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-C------
Confidence            997532   234456899999999999999999999999999999999999999988877666555433100 0      


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                        +|            
T Consensus       368 ------------------------------------------------------------------~p------------  369 (446)
T 4ejn_A          368 ------------------------------------------------------------------FP------------  369 (446)
T ss_dssp             ------------------------------------------------------------------CC------------
T ss_pred             ------------------------------------------------------------------CC------------
Confidence                                                                              00            


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                       ..+++++.+||.+||+.||++||     |++|+|+||||++..+.
T Consensus       370 -~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          370 -RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence             01346789999999999999999     99999999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=386.44  Aligned_cols=278  Identities=27%  Similarity=0.552  Sum_probs=221.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||++...   ....+.+.+|+.+++.+       .|+||+++++++....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-------QHENVIGLLDVFTPAS   96 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSCS
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-------CCCCcccHhheEeccc
Confidence            7899999999999999999999999999999999753   34456788999999998       6899999999998765


Q ss_pred             e------EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          186 H------LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       186 ~------l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      .      +|+||||+.++|.+++.    ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCSEEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECS
T ss_pred             ccccceeEEEEeccccCCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEee
Confidence            4      59999999998877653    3499999999999999999999999999999999999995   678899999


Q ss_pred             cccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          260 FGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       260 FGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ||++..........++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+..| .|+..+.
T Consensus       170 fg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~  248 (353)
T 3coi_A          170 FGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGTEFV  248 (353)
T ss_dssp             TTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC-BCCHHHH
T ss_pred             cccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHH
Confidence            9999877666666789999999999987 5889999999999999999999999999999999999999998 4544443


Q ss_pred             Hhhhcc--hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          339 KEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       339 ~~~k~~--~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      ......  ..++...                                  +....     ..+..                
T Consensus       249 ~~~~~~~~~~~~~~~----------------------------------~~~~~-----~~~~~----------------  273 (353)
T 3coi_A          249 QKLNDKAAKSYIQSL----------------------------------PQTPR-----KDFTQ----------------  273 (353)
T ss_dssp             TTCSCHHHHHHHHTS----------------------------------CBCSS-----CCTTT----------------
T ss_pred             HHHhhHHHHHHHHhC----------------------------------cCCCC-----ccHHH----------------
Confidence            321110  0000000                                  00000     00000                


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                       .....++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       274 -~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          274 -LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             -TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             -hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence             0112457899999999999999999999999999998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.3e-43  Score=382.71  Aligned_cols=284  Identities=30%  Similarity=0.536  Sum_probs=221.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||.||+|++..+++.||||++...   ....+.+.+|+.+++.+       .|+||+++++++...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-------RHENLVNLLEVCKKK   96 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEET
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-------CCCCEeeEEEEeecC
Confidence            37999999999999999999999999999999998643   33455677899999999       589999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +..|+||||+.+++++.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR  172 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC-
T ss_pred             CEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCce
Confidence            9999999999976555443332 4699999999999999999999999999999999999995   66799999999996


Q ss_pred             ccCC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          265 TEDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       265 ~~~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ....   .....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+..++..... 
T Consensus       173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  251 (331)
T 4aaa_A          173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL-  251 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH-
T ss_pred             eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH-
Confidence            5432   23445789999999999876 789999999999999999999999999999999999999888554433211 


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      ..... .+....                                .+..    -....+..                 ...
T Consensus       252 ~~~~~-~~~~~~--------------------------------~~~~----~~~~~~~~-----------------~~~  277 (331)
T 4aaa_A          252 FNKNP-VFAGVR--------------------------------LPEI----KEREPLER-----------------RYP  277 (331)
T ss_dssp             HHHCG-GGTTCC--------------------------------CCCC----SSCCCHHH-----------------HST
T ss_pred             hhhcc-cccccc--------------------------------Cccc----cccchhhh-----------------ccc
Confidence            11000 000000                                0000    00000111                 111


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       278 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          278 KLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             chhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            2457899999999999999999999999999998743

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=395.47  Aligned_cols=261  Identities=21%  Similarity=0.351  Sum_probs=217.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++..    ...+.+.+|+.++..+       .|+||++++++|.+
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-------~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-------DRRWITQLHFAFQD  132 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-------CTTTBCCEEEEEEC
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEee
Confidence            378999999999999999999999999999999997532    2223467899998887       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|||||||. ++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld---~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGS  208 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---CCCCEEEeechh
Confidence            999999999996 69999887643 4699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCCc----ceeeccCccccCchhhc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003239          263 ACTEDRT----VYSYIQSRYYRSPEVLL-------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA  331 (837)
Q Consensus       263 A~~~~~~----~~~~~GT~~Y~APEvl~-------~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~  331 (837)
                      +......    ....+||+.|+|||++.       ...|+.++|||||||++|||++|++||.+.+..+.+.+|+.... 
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-  287 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-  287 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence            9765332    22458999999999997       35789999999999999999999999999888777666653110 


Q ss_pred             CCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       332 ~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                                        ..                                                    .+|.    
T Consensus       288 ------------------~~----------------------------------------------------~~p~----  293 (412)
T 2vd5_A          288 ------------------HL----------------------------------------------------SLPL----  293 (412)
T ss_dssp             ------------------HC----------------------------------------------------CCC-----
T ss_pred             ------------------Cc----------------------------------------------------CCCc----
Confidence                              00                                                    0000    


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCC---CHHHHHcCccCCCCCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRW---SPFQASRHPFVTGEPFTCP  461 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRp---Ta~EaL~HPff~~~~~~~~  461 (837)
                            ....+++++++||++||+ ||++|+   +++|+++||||++..|...
T Consensus       294 ------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          294 ------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             ---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             ------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                  001245788999999999 999984   9999999999999877654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=395.79  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=217.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++++.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+|+.+       .|+||+++++++...+.
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-------HHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-------CSTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-------CCcCCCeEEEEEEeCCE
Confidence            47899999999999999999999999999999999864 33455788899999888       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|||||||. ++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+ ..+.+||+|||++..
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEeccccee
Confidence            999999997 58888876542 459999999999999999999999999999999999999632 457899999999976


Q ss_pred             cCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          266 EDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       266 ~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...  .....++|+.|+|||++.+..++.++||||||||+|||++|..||.+.+..+.+..+.......+          
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----------  270 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD----------  270 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence            543  23456899999999999999999999999999999999999999998877666655543110000          


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                         ..                     ....++
T Consensus       271 ---------------------------------------------------~~---------------------~~~~~s  278 (387)
T 1kob_A          271 ---------------------------------------------------ED---------------------AFSSVS  278 (387)
T ss_dssp             ---------------------------------------------------SS---------------------TTTTSC
T ss_pred             ---------------------------------------------------cc---------------------ccccCC
Confidence                                                               00                     001134


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +++.+||++||+.||++|||++|+|+||||++..
T Consensus       279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            6789999999999999999999999999999754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.3e-43  Score=385.62  Aligned_cols=283  Identities=28%  Similarity=0.512  Sum_probs=217.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------------hhhHHHHHHHHHHHHHhhcccCCCCCCcee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------------PAYYQQALVEVSILTTLNKKYDREDKHHIV  175 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~------------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIV  175 (837)
                      .++|++.++||+|+||.||+|.+.. ++.||||++...            ....+.+.+|+++++.+       .||||+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv   92 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-------HHPNIL   92 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-------CCTTBC
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-------CCcCcc
Confidence            4899999999999999999998865 899999998632            22347788999999999       589999


Q ss_pred             EEeEEEeec-----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC
Q 003239          176 RIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV  250 (837)
Q Consensus       176 kl~d~f~~~-----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~  250 (837)
                      ++++++...     ..+|+||||+.++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++   
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---
T ss_pred             ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---
Confidence            999999543     4689999999999999887553 4699999999999999999999999999999999999995   


Q ss_pred             CCCeEEEEecccccccC--CcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 003239          251 KPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       251 ~~~~IKL~DFGlA~~~~--~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~  327 (837)
                      .++.+||+|||++....  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  248 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE  248 (362)
T ss_dssp             TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            67889999999997433  23345678999999999987 5799999999999999999999999999999999999999


Q ss_pred             HhCCCCchHHHHhhhc-chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCC
Q 003239          328 ILGAQPPDYVLKEAKN-TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP  406 (837)
Q Consensus       328 ~lG~~Pp~~~l~~~k~-~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p  406 (837)
                      ..+.++.+.+...... ...++...                                      ...+....+..+.    
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~----  286 (362)
T 3pg1_A          249 VVGTPKIEDVVMFSSPSARDYLRNS--------------------------------------LSNVPARAWTAVV----  286 (362)
T ss_dssp             HHCCCCHHHHHHTSCHHHHHHTTTC--------------------------------------CCCCCCCCHHHHS----
T ss_pred             HcCCCChHHhhhccchhhhHHHHhh--------------------------------------cccCChhhHHhhC----
Confidence            9984443332211100 00000000                                      0000111111111    


Q ss_pred             CCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       407 ~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                                   ...++.+.+||.+||+.||++|||++|+|+||||++..
T Consensus       287 -------------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          287 -------------PTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             -------------CCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                         12457899999999999999999999999999999853

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-43  Score=380.20  Aligned_cols=202  Identities=28%  Similarity=0.461  Sum_probs=171.4

Q ss_pred             CCceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~-~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++. ++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|+++.      .||||+++++++...+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~------~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ------GHRNVLELIEFFEEED   84 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC------CCTTBCCEEEEEEETT
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc------CCCCeeeEEEEEeeCC
Confidence            3789986 78999999999999999999999999997643 34567889999998863      6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+||||||+. ++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++.+.....+||+|||++.
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999997 6899988765  369999999999999999999999999999999999999754444569999999986


Q ss_pred             ccCC----------cceeeccCccccCchhhcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          265 TEDR----------TVYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       265 ~~~~----------~~~~~~GT~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ....          .....+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            4321          1224468999999999975     468999999999999999999999997654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-43  Score=386.25  Aligned_cols=255  Identities=22%  Similarity=0.329  Sum_probs=206.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|+++++||+|+||+||+|++..+++.||||++....  ...+.+.+|+.+++.+       .|+||+++++++...+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-------NHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-------CCTTBCCEEEEEECSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-------CCCCCCeEEEEEecCC
Confidence            379999999999999999999999999999999997543  2345678899999998       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..|||||||.+ +|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLAT  153 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred             eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeeccc
Confidence            99999999974 888877543  3599999999999999999999999999999999999995   66889999999996


Q ss_pred             ccC-----CcceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          265 TED-----RTVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       265 ~~~-----~~~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ...     ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.................        
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------  225 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------  225 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC--------
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc--------
Confidence            432     12235688999999999988775 7899999999999999999999976543211111000000        


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                          ..                       ...
T Consensus       226 ----------------------------------------------------~~-----------------------~~~  230 (323)
T 3tki_A          226 ----------------------------------------------------TY-----------------------LNP  230 (323)
T ss_dssp             ----------------------------------------------------TT-----------------------STT
T ss_pred             ----------------------------------------------------cc-----------------------CCc
Confidence                                                                00                       000


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ...+++.+.+||++||+.||++|||++|+|+||||++..
T Consensus       231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            112456789999999999999999999999999998743

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-44  Score=397.23  Aligned_cols=196  Identities=28%  Similarity=0.455  Sum_probs=175.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||++++..    .....+.+|+.+++.+       .||||+++++++...
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-------RHPHIIKLYDVITTP   81 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeC
Confidence            79999999999999999999999999999999997532    2234678899999888       689999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +.+++||||++|+|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTB
T ss_pred             CEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccce
Confidence            9999999999999999887653  699999999999999999999999999999999999995   67889999999997


Q ss_pred             ccCC--cceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ....  .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            5432  3356689999999999998876 68999999999999999999999654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2e-43  Score=376.42  Aligned_cols=258  Identities=28%  Similarity=0.376  Sum_probs=211.0

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ..++|++.++||+|+||+||+|++..+++.||+|++....  ...+.+.+|+++|+.+       .||||+++++++...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-------DHPNIIKIFEVFEDY   92 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-------CCchHHhHHHheecC
Confidence            3479999999999999999999999999999999998543  3457788999999998       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 RHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +..|+||||+. ++|.+.+...  ....+++..++.++.||+.||+|||++||+||||||+|||++.+...+.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            99999999998 4888887654  23569999999999999999999999999999999999999755567889999999


Q ss_pred             cccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          262 SACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       262 lA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++.....  ......+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.....   .     
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~-----  243 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP---N-----  243 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---C-----
T ss_pred             cceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc---c-----
Confidence            9975432  234567899999999986 4789999999999999999999999988776554433322000   0     


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                           +            +.          ..
T Consensus       244 -----------------------------------------------------~------------~~----------~~  248 (285)
T 3is5_A          244 -----------------------------------------------------Y------------AV----------EC  248 (285)
T ss_dssp             -----------------------------------------------------C------------CC------------
T ss_pred             -----------------------------------------------------c------------cc----------cc
Confidence                                                                 0            00          00


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ...++.+.+||++||+.||++|||++|+|+||||++
T Consensus       249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            013467889999999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=379.93  Aligned_cols=249  Identities=25%  Similarity=0.302  Sum_probs=202.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++..+++.||||++...   .........|+..+..+.      .|+||++++++|...+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~------~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG------QHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEEEETT
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc------CCCcEEEEEEEEEeCC
Confidence            7899999999999999999999999999999998753   233444555666665552      6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+||||||++++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||++..
T Consensus       131 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          131 ILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTTCEE
T ss_pred             EEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEccceeeee
Confidence            999999999999999887664 5699999999999999999999999999999999999995   667899999999976


Q ss_pred             cCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          266 EDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       266 ~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ....  .....||+.|+|||++.+ .++.++|||||||++|||++|..+|.+...   ...+.+  + ..+         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~--~-~~~---------  270 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ--G-YLP---------  270 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT--T-CCC---------
T ss_pred             cccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc--c-CCC---------
Confidence            5432  234568999999999886 799999999999999999999776644221   111100  0 000         


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                             .+                 ....++
T Consensus       271 -------------------------------------------------------~~-----------------~~~~~~  278 (311)
T 3p1a_A          271 -------------------------------------------------------PE-----------------FTAGLS  278 (311)
T ss_dssp             -------------------------------------------------------HH-----------------HHTTSC
T ss_pred             -------------------------------------------------------cc-----------------cccCCC
Confidence                                                                   00                 011245


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      +++.+||.+||+.||++|||++|+|+||||++
T Consensus       279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            77899999999999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=382.47  Aligned_cols=250  Identities=25%  Similarity=0.455  Sum_probs=201.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---------------------------hHHHHHHHHHHHHH
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---------------------------YYQQALVEVSILTT  161 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~---------------------------~~~~~~~Ei~iL~~  161 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....                           ..+.+.+|+++|+.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            799999999999999999999999999999999975421                           13457889999998


Q ss_pred             hhcccCCCCCCceeEEeEEEee--cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeecc
Q 003239          162 LNKKYDREDKHHIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCD  238 (837)
Q Consensus       162 L~~~~~~~~HpnIVkl~d~f~~--~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrD  238 (837)
                      +       .||||+++++++..  .+.+|+||||+.+ +|.+++.   ...+++..++.++.||+.||+|||++||+|||
T Consensus        93 l-------~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D  162 (298)
T 2zv2_A           93 L-------DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRD  162 (298)
T ss_dssp             C-------CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             C-------CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence            8       68999999999987  5689999999984 6655432   34699999999999999999999999999999


Q ss_pred             CCCCCeeeeccCCCCeEEEEecccccccCCc---ceeeccCccccCchhhcCCC---CCccchHHHHHHHHHHHHhCCCC
Q 003239          239 LKPENILLCTSVKPAEIKIIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPL  312 (837)
Q Consensus       239 LKPeNILl~~~~~~~~IKL~DFGlA~~~~~~---~~~~~GT~~Y~APEvl~~~~---yt~ksDIWSLG~ILyELltG~~P  312 (837)
                      |||+|||++   .++.+||+|||++......   .....||+.|+|||++.+..   ++.++|||||||++|+|++|+.|
T Consensus       163 lkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          163 IKPSNLLVG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCGGGEEEC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCHHHEEEC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            999999995   6689999999999754332   34457899999999998765   47889999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCccc
Q 003239          313 FPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY  392 (837)
Q Consensus       313 F~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~  392 (837)
                      |...........+.....                                                              
T Consensus       240 f~~~~~~~~~~~~~~~~~--------------------------------------------------------------  257 (298)
T 2zv2_A          240 FMDERIMCLHSKIKSQAL--------------------------------------------------------------  257 (298)
T ss_dssp             SCCSSHHHHHHHHHHCCC--------------------------------------------------------------
T ss_pred             CCCccHHHHHHHHhcccC--------------------------------------------------------------
Confidence            987765444333322000                                                              


Q ss_pred             ccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       393 f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                                 .+|.           ...+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       258 -----------~~~~-----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          258 -----------EFPD-----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             -----------CCCS-----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             -----------CCCC-----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                       0000           0013467899999999999999999999999999963

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=388.80  Aligned_cols=258  Identities=29%  Similarity=0.462  Sum_probs=200.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||+++... ..+.+.+|+.+|+.+       .|+||+++++++...+..
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~  123 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-------SHPNIIKLKEIFETPTEI  123 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-------CCTTBCCEEEEEECSSEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-------CCCCCcceeeeEecCCeE
Confidence            378999999999999999999999999999999998653 345677899999998       589999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++...  +.+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus       124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999997 5898888654  45999999999999999999999999999999999999975455789999999999754


Q ss_pred             CCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCchHHHHhhhc
Q 003239          267 DRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD-LLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       267 ~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e-~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...  ....+||+.|+|||++.+..++.++|||||||++|||++|..||......+ .+..+..... .           
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-~-----------  269 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-Y-----------  269 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-C-----------
T ss_pred             CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-c-----------
Confidence            432  345678999999999999999999999999999999999999997665433 2222221000 0           


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                       +..          +           .....+
T Consensus       270 -------------------------------------------------~~~----------~-----------~~~~~~  279 (349)
T 2w4o_A          270 -------------------------------------------------FIS----------P-----------WWDEVS  279 (349)
T ss_dssp             -------------------------------------------------CCT----------T-----------TTTTSC
T ss_pred             -------------------------------------------------cCC----------c-----------hhhhCC
Confidence                                                             000          0           001134


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..+.+||++||+.||++|||++|+|+||||++..
T Consensus       280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            6789999999999999999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.2e-43  Score=370.65  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=217.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++.++||+|+||+||+|++..+++.||+|++... ....+.+.+|+++++.+       .|+||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-------DHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECSSE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-------CCCCEeeEEEEEecCCe
Confidence            37899999999999999999999999999999999753 23456788999999988       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||+..++..+.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            999999997 4888888765  3599999999999999999999999999999999999996555778999999999975


Q ss_pred             cC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          266 ED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       266 ~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ..  .......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.+... ..+..       
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-------  229 (277)
T 3f3z_A          159 FKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF-TFPEK-------  229 (277)
T ss_dssp             CCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCHH-------
T ss_pred             ccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCch-------
Confidence            43  33345678999999999876 499999999999999999999999998877766665544211 00000       


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                                .....+
T Consensus       230 --------------------------------------------------------------------------~~~~~~  235 (277)
T 3f3z_A          230 --------------------------------------------------------------------------DWLNVS  235 (277)
T ss_dssp             --------------------------------------------------------------------------HHTTSC
T ss_pred             --------------------------------------------------------------------------hhhcCC
Confidence                                                                                      001134


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      +.+.+||++||+.||++|||+.|+|+||||++.
T Consensus       236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            678999999999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-43  Score=394.89  Aligned_cols=255  Identities=22%  Similarity=0.403  Sum_probs=208.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++...    ....+..|..++      .....||||++++++|..
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l------l~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL------LKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC------BCCCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH------HHhCCCCCCCCEEEEEEe
Confidence            3789999999999999999999999999999999986432    122333343332      233489999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+||||||+. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~  185 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGL  185 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCB
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCcc
Confidence            999999999998 4888888764  3699999999999999999999999999999999999995   678999999999


Q ss_pred             cccc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++..   .......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....|....-         
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------  256 (373)
T 2r5t_A          186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------  256 (373)
T ss_dssp             CGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---------
T ss_pred             ccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------
Confidence            9752   2334567899999999999999999999999999999999999999998877766665543100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .+|             
T Consensus       257 ----------------------------------------------------------------~~~-------------  259 (373)
T 2r5t_A          257 ----------------------------------------------------------------QLK-------------  259 (373)
T ss_dssp             ----------------------------------------------------------------CCC-------------
T ss_pred             ----------------------------------------------------------------CCC-------------
Confidence                                                                            000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCH----HHHHcCccCCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSP----FQASRHPFVTGEPFT  459 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa----~EaL~HPff~~~~~~  459 (837)
                      ..++..+.+||++||+.||++|+++    +|+++||||++..|.
T Consensus       260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            0134678999999999999999997    699999999987653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=396.28  Aligned_cols=254  Identities=24%  Similarity=0.415  Sum_probs=211.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++++.||+|+||+||+|++..+++.||||++++..    ...+.+.+|+.+|+.+       .|||||+++++|..
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~Iv~l~~~~~~   86 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-------EHPFLVNLWYSFQD   86 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEEC
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEe
Confidence            379999999999999999999999999999999997532    3346778899999988       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||++|||||||||+||||+   .++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~  161 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNI  161 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEeccce
Confidence            999999999997 5888888754  4699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccC--CcceeeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCc
Q 003239          263 ACTED--RTVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD---LLRRMIRILGAQPP  334 (837)
Q Consensus       263 A~~~~--~~~~~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e---~l~~I~~~lG~~Pp  334 (837)
                      +....  ......+||+.|+|||++..   ..|+.++|||||||++|||++|+.||.......   .+..+.....    
T Consensus       162 a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----  237 (384)
T 4fr4_A          162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV----  237 (384)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC----
T ss_pred             eeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc----
Confidence            97543  33456789999999999974   358999999999999999999999997543211   1111110000    


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                                                                                           .+|        
T Consensus       238 ---------------------------------------------------------------------~~p--------  240 (384)
T 4fr4_A          238 ---------------------------------------------------------------------TYP--------  240 (384)
T ss_dssp             ---------------------------------------------------------------------CCC--------
T ss_pred             ---------------------------------------------------------------------CCC--------
Confidence                                                                                 000        


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCCCCC-HHHHHcCccCCCCCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAKRWS-PFQASRHPFVTGEPFT  459 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~kRpT-a~EaL~HPff~~~~~~  459 (837)
                           ..++..+.+||++||+.||++||+ ++++++||||++..+.
T Consensus       241 -----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          241 -----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             -----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             -----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence                 113467899999999999999998 9999999999987653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.7e-43  Score=394.80  Aligned_cols=201  Identities=29%  Similarity=0.420  Sum_probs=168.0

Q ss_pred             cCCceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--
Q 003239          107 TQRRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--  183 (837)
Q Consensus       107 ~~~~Y~i~-~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--  183 (837)
                      ..++|.+. ++||+|+||+||+|++..+++.||||+++..    ....+|+.++.++.      .|+||++++++|..  
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~------~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS------QCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT------TSTTBCCEEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc------CCCCcceEeEEEeecc
Confidence            34678887 7899999999999999999999999999854    34667888876653      68999999999886  


Q ss_pred             --cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          184 --QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       184 --~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                        ..++|||||||. ++|.+++.......+++..++.|+.||+.||.|||++|||||||||+|||++....++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              678999999997 59999988755456999999999999999999999999999999999999975444789999999


Q ss_pred             ccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          261 GSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       261 GlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      |+++....  .....++|+.|+|||++.+..|+.++||||||||+|||++|..||.+..
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            99975442  2345688999999999999999999999999999999999999997654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=391.67  Aligned_cols=258  Identities=29%  Similarity=0.434  Sum_probs=211.6

Q ss_pred             CceEE--EEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIV--KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i--~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..|++  .++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|+.+       .|+||+++++++...+
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~  159 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-------DHANLIQLYDAFESKN  159 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEECSS
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-------CCCCCCeEEEEEEECC
Confidence            34554  678999999999999999999999999998643 4556788999999888       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++|||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+++|+||||||+|||+.. +..+.+||+|||++.
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLAR  237 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCce
Confidence            9999999997 58888886543 35999999999999999999999999999999999999953 255789999999997


Q ss_pred             ccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ....  .....+||+.|+|||++.+..++.++||||||||+|||++|..||.+.+..+.+..+.......++.       
T Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-------  310 (373)
T 2x4f_A          238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE-------  310 (373)
T ss_dssp             ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-------
T ss_pred             ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-------
Confidence            5432  2344579999999999998899999999999999999999999999988877776665421100000       


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                                 ....+
T Consensus       311 ---------------------------------------------------------------------------~~~~~  315 (373)
T 2x4f_A          311 ---------------------------------------------------------------------------EFQDI  315 (373)
T ss_dssp             ---------------------------------------------------------------------------GGTTS
T ss_pred             ---------------------------------------------------------------------------hhccC
Confidence                                                                                       00113


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++++.+||.+||+.||++|||++|+|+||||++.+
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            46789999999999999999999999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.1e-43  Score=403.22  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=215.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--------------hhHHHHHHHHHHHHHhhcccCCCCCCc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--------------AYYQQALVEVSILTTLNKKYDREDKHH  173 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--------------~~~~~~~~Ei~iL~~L~~~~~~~~Hpn  173 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++..              ...+.+.+|+.+|+.+       .|||
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpn  107 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-------DHPN  107 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-------CCTT
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-------CCCC
Confidence            489999999999999999999999999999999998542              2346788899999998       6899


Q ss_pred             eeEEeEEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          174 IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       174 IVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                      |+++++++...+.+|||||||. ++|.+.+...  ..+++..++.+++||+.||+|||++|||||||||+|||++.+...
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCC
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCC
Confidence            9999999999999999999997 4888888765  369999999999999999999999999999999999999754444


Q ss_pred             CeEEEEecccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003239          253 AEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG  330 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG  330 (837)
                      ..+||+|||++.....  .....+||+.|+|||++.+ .++.++||||||||+|+|++|.+||.+.+..+.+..+.....
T Consensus       186 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  264 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY  264 (504)
T ss_dssp             SSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             ccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            5799999999975443  3445689999999999874 699999999999999999999999999888777766654111


Q ss_pred             CCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCC
Q 003239          331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN  410 (837)
Q Consensus       331 ~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~  410 (837)
                       ..+                                                                            
T Consensus       265 -~~~----------------------------------------------------------------------------  267 (504)
T 3q5i_A          265 -YFD----------------------------------------------------------------------------  267 (504)
T ss_dssp             -CCC----------------------------------------------------------------------------
T ss_pred             -CCC----------------------------------------------------------------------------
Confidence             000                                                                            


Q ss_pred             CchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       411 l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                           ......+++++.+||++||++||++|||++|+|+||||++..
T Consensus       268 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          268 -----FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             -----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             -----ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence                 000112457789999999999999999999999999998743

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-43  Score=422.04  Aligned_cols=256  Identities=25%  Similarity=0.389  Sum_probs=219.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++..    ...+....|..+|..+.      .|++|++++++|..
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~------~~~~i~~l~~~~~~  413 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG------KPPFLTQLHSCFQT  413 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT------CCTTBCCEEEECBC
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc------CCCeEEEEEEEEEe
Confidence            478999999999999999999999999999999998532    23456677888877664      58999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+||||||+. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+||||+   .++.+||+|||+
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGl  488 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGM  488 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecce
Confidence            999999999997 5888888765  3699999999999999999999999999999999999995   678999999999


Q ss_pred             cccc---CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~---~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++..   .......+||+.|+|||++.+..|+.++||||||||||||++|++||.+.+..+++..|.+...         
T Consensus       489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  559 (674)
T 3pfq_A          489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------  559 (674)
T ss_dssp             CEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------
T ss_pred             eeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            9752   2334567899999999999999999999999999999999999999999888777666543100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .+|             
T Consensus       560 ----------------------------------------------------------------~~p-------------  562 (674)
T 3pfq_A          560 ----------------------------------------------------------------AYP-------------  562 (674)
T ss_dssp             ----------------------------------------------------------------CCC-------------
T ss_pred             ----------------------------------------------------------------CCC-------------
Confidence                                                                            000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCH-----HHHHcCccCCCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPFTC  460 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa-----~EaL~HPff~~~~~~~  460 (837)
                      ..+++++.+||++||+.||++|+++     +||++||||++..|..
T Consensus       563 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence            0134678999999999999999997     9999999999877643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-43  Score=385.35  Aligned_cols=199  Identities=31%  Similarity=0.488  Sum_probs=156.1

Q ss_pred             CceEEE---EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVK---DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~---~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.   ++||+|+||+||+|++..+++.||||++.+.  ......+|+.+++.+.      .||||+++++++.+..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~------~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE------GHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT------TCTTBCCEEEEEECSS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc------CCCCeeEEEEEEEcCC
Confidence            567775   7899999999999999999999999999854  3456778999999984      4899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..||||||+.+ +|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++.+.....+||+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999999975 899988764  469999999999999999999999999999999999999754445589999999997


Q ss_pred             ccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       265 ~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ....   .....++|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            5432   2345678999999999999999999999999999999999999997654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-43  Score=389.13  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=208.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||+||+|+++.+++.||||++++...   ...+|++++.++.      .||||+++++++.+.+.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~------~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG------QHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT------TSTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc------CCCCcCeEEEEEEcCCEE
Confidence            3789999999999999999999999999999999986542   2346888888874      589999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC-CCCeEEEEecccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSACT  265 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~IKL~DFGlA~~  265 (837)
                      |||||||. ++|.+.+...  +.+++..++.++.||+.||+|||++|||||||||+|||+.... ....+||+|||++..
T Consensus        92 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999997 5898888754  3699999999999999999999999999999999999985322 234699999999975


Q ss_pred             cC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCchHHHH
Q 003239          266 ED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA---SEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       266 ~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~---s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ..   ......++|+.|+|||++.+..|+.++|||||||++|||++|.+||.+.   ...+.+..+....-         
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~---------  240 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF---------  240 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC---------
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc---------
Confidence            43   2234568899999999999888999999999999999999999999763   23333333222000         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                     .....                          ..
T Consensus       241 -----------------------------------------------~~~~~--------------------------~~  247 (342)
T 2qr7_A          241 -----------------------------------------------SLSGG--------------------------YW  247 (342)
T ss_dssp             -----------------------------------------------CCCST--------------------------TT
T ss_pred             -----------------------------------------------ccCcc--------------------------cc
Confidence                                                           00000                          00


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ..+++++.+||++||..||++|||++|+|+||||.+
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            124577899999999999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8e-43  Score=378.04  Aligned_cols=259  Identities=28%  Similarity=0.412  Sum_probs=216.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...       ...+.+.+|+.+++.+       .||||++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~   83 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-------LHHNVITLHDV   83 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-------CCCCcceEEEE
Confidence            378999999999999999999999999999999997532       1356788999999998       58999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC-CCeEEEE
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKII  258 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~IKL~  258 (837)
                      +...+.+++||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+.. ...+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence            999999999999996 5899988754  46899999999999999999999999999999999999963211 1279999


Q ss_pred             ecccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          259 DFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       259 DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      |||++.....  ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..... ..+. 
T Consensus       162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~-  239 (321)
T 2a2a_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY-DFDE-  239 (321)
T ss_dssp             CCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-CCCH-
T ss_pred             cCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-ccCh-
Confidence            9999975543  23455789999999999999999999999999999999999999988877666655443111 0000 


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                                     ++.              
T Consensus       240 ---------------------------------------------------------------~~~--------------  242 (321)
T 2a2a_A          240 ---------------------------------------------------------------EFF--------------  242 (321)
T ss_dssp             ---------------------------------------------------------------HHH--------------
T ss_pred             ---------------------------------------------------------------hhh--------------
Confidence                                                                           000              


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                         ...++.+.+||++||..||++|||++|+|+||||+...
T Consensus       243 ---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          243 ---SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             ---TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             ---cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence               11346789999999999999999999999999998643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.3e-43  Score=375.90  Aligned_cols=195  Identities=25%  Similarity=0.375  Sum_probs=166.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-  185 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++..  ....+.+.+|+++|+.+       .||||++++++|.+.. 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-------EHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-------CCTTBCCEEEEEEECCS
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEEecc
Confidence            6899999999999999999999999999999999843  34567788999999988       6899999999986543 


Q ss_pred             --------------------------------------------------------eEEEEEeccch-hHHHHHHhhcc-
Q 003239          186 --------------------------------------------------------HLCICFELLDS-NLYELIKINHF-  207 (837)
Q Consensus       186 --------------------------------------------------------~l~LVmEy~~g-sL~d~l~~~~~-  207 (837)
                                                                              .+++|||||.+ +|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    38999999985 88888876432 


Q ss_pred             CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc---------------cee
Q 003239          208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT---------------VYS  272 (837)
Q Consensus       208 ~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~---------------~~~  272 (837)
                      ...++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++......               ...
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhccccccccccccccc
Confidence            2366778999999999999999999999999999999995   6679999999999754432               233


Q ss_pred             eccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       273 ~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      .+||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            47899999999999999999999999999999999987654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.4e-43  Score=402.13  Aligned_cols=258  Identities=32%  Similarity=0.506  Sum_probs=218.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++..+++.||||++++.   ......+.+|+++|+.+       .||||+++++++...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-------DHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECS
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-------CCCCcCeEEEEEEcC
Confidence            37999999999999999999999999999999999742   23456788999999999       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+|||||. ++|.+.+...  ..+++..++.++.||+.||.|||++|||||||||+|||++.....+.+||+|||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            99999999997 5888888665  36999999999999999999999999999999999999976556778999999999


Q ss_pred             cccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          264 CTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       264 ~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .....  .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.......+        
T Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------  242 (486)
T 3mwu_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD--------  242 (486)
T ss_dssp             TTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC--------
T ss_pred             eECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            75432  3345689999999999976 599999999999999999999999999888777666544111000        


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                ......
T Consensus       243 --------------------------------------------------------------------------~~~~~~  248 (486)
T 3mwu_A          243 --------------------------------------------------------------------------LPQWRT  248 (486)
T ss_dssp             --------------------------------------------------------------------------SGGGGG
T ss_pred             --------------------------------------------------------------------------CcccCC
Confidence                                                                                      000112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +++.+.+||++||+.||++|||+.|+|+||||++..
T Consensus       249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            457789999999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.3e-43  Score=404.01  Aligned_cols=255  Identities=30%  Similarity=0.514  Sum_probs=212.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++..+++.||||++++..   .....+.+|+.+|+.+       .||||++++++|...+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~  109 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-------DHPNIMKLYDFFEDKR  109 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-------CCTTBCCEEEEEECSS
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeCC
Confidence            68999999999999999999999999999999998542   2346778899999888       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|||||||. ++|.+.+...  ..+++..++.+++||+.||.|||++|||||||||+|||++.....+.+||+|||++.
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999997 5888887665  369999999999999999999999999999999999999755556789999999996


Q ss_pred             ccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ...  ......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+.        
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--------  258 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS--------  258 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS--------
T ss_pred             ECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence            543  2334568999999999986 47999999999999999999999999998887776666542110000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                           .                     ....+
T Consensus       259 -----------------------------------------------------~---------------------~~~~~  264 (494)
T 3lij_A          259 -----------------------------------------------------P---------------------EWKNV  264 (494)
T ss_dssp             -----------------------------------------------------G---------------------GGTTS
T ss_pred             -----------------------------------------------------h---------------------hcccC
Confidence                                                                 0                     00123


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ++.+.+||++||++||++|||++|||+||||++
T Consensus       265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             CHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            467899999999999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.6e-43  Score=379.23  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=212.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..|+..++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.+       .|+||+++++++...+..
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-------QHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-------CCTTBCCEEEEEEETTEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-------CCCCcceEEEEEEECCEE
Confidence            46888899999999999999999999999999998542 3456788899999888       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...
T Consensus       118 ~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~  191 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQI  191 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeec
Confidence            99999997 478777654   3599999999999999999999999999999999999995   6688999999998754


Q ss_pred             CCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+....   ++.        
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~~~--------  260 (321)
T 2c30_A          192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPK--------  260 (321)
T ss_dssp             CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---CCC--------
T ss_pred             ccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCC--------
Confidence            432   345689999999999999999999999999999999999999998877665554443210   000        


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                              +......+
T Consensus       261 ------------------------------------------------------------------------~~~~~~~~  268 (321)
T 2c30_A          261 ------------------------------------------------------------------------LKNSHKVS  268 (321)
T ss_dssp             ------------------------------------------------------------------------CTTGGGSC
T ss_pred             ------------------------------------------------------------------------cCccccCC
Confidence                                                                                    00001234


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +.+.+||.+||+.||++|||++|+|+||||.+..
T Consensus       269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            6789999999999999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-44  Score=400.48  Aligned_cols=199  Identities=18%  Similarity=0.203  Sum_probs=170.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe-----
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY-----  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~-----  178 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.    .....+.+.+|+.+++.+...    .|||||+++     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l----~hpniv~~~~~~~~  147 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI----KNQKQAKVHLRFIF  147 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTC----CSHHHHHHHHCBCC
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcccc----CCHHHHHHHhhhhh
Confidence            4789999999999999999999999999999999973    334567788999887777543    799999998     


Q ss_pred             --EEEeecc-----------------eEEEEEeccchhHHHHHHhhccCCCC-------HHHHHHHHHhHHHHHhhhhcC
Q 003239          179 --EYFVCQR-----------------HLCICFELLDSNLYELIKINHFRGLS-------LSIVQLFSKQILRGLSLLKDA  232 (837)
Q Consensus       179 --d~f~~~~-----------------~l~LVmEy~~gsL~d~l~~~~~~~L~-------e~~i~~I~~QIl~aL~yLHs~  232 (837)
                        +++...+                 ..||||||++|+|.+++....  .++       +..++.|+.||+.||+|||++
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence              7776653                 389999999999999998653  244       478888999999999999999


Q ss_pred             CeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeeccCccccCchhhcCC-----------CCCccchHHHHHH
Q 003239          233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY-----------QYTTAIDMWSFGC  301 (837)
Q Consensus       233 gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~-----------~yt~ksDIWSLG~  301 (837)
                      |||||||||+||||+   .++.+||+|||+++.........+| +.|+|||++.+.           .++.++|||||||
T Consensus       226 ~ivHrDikp~NIll~---~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          226 GLVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             TEECSCCCGGGEEEC---TTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEc---CCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            999999999999996   6689999999999887776677788 999999999987           8999999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 003239          302 IVAELFLGLPLFPGA  316 (837)
Q Consensus       302 ILyELltG~~PF~g~  316 (837)
                      ++|||++|+.||.+.
T Consensus       302 il~elltg~~Pf~~~  316 (377)
T 3byv_A          302 VIYWIWCADLPITKD  316 (377)
T ss_dssp             HHHHHHHSSCCC---
T ss_pred             HHHHHHHCCCCCccc
Confidence            999999999999554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.5e-43  Score=369.58  Aligned_cols=252  Identities=23%  Similarity=0.413  Sum_probs=211.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||++....    .....+.+|+.+++.+       .||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   80 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-------RHPNILRLYGYFHD   80 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEEC
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-------CCCCCcchhheEec
Confidence            378999999999999999999999999999999997532    2245677888888887       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+..++||||+. ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~  155 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGW  155 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccc
Confidence            999999999998 5888888765  3699999999999999999999999999999999999995   678899999999


Q ss_pred             ccccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          263 ACTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       263 A~~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      +..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... .         
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---------  225 (279)
T 3fdn_A          156 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-T---------  225 (279)
T ss_dssp             ESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-C---------
T ss_pred             cccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-C---------
Confidence            865433 23456789999999999999999999999999999999999999988776665554433111 0         


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                     +|             ..
T Consensus       226 ---------------------------------------------------------------~~-------------~~  229 (279)
T 3fdn_A          226 ---------------------------------------------------------------FP-------------DF  229 (279)
T ss_dssp             ---------------------------------------------------------------CC-------------TT
T ss_pred             ---------------------------------------------------------------CC-------------Cc
Confidence                                                                           00             01


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            336788999999999999999999999999999755

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-43  Score=382.54  Aligned_cols=260  Identities=25%  Similarity=0.462  Sum_probs=210.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++..      ....+.+.+|+.+++.+       .||||+++++++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~   97 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-------HHPNIARLYEVY   97 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-------CCCCcceeehhh
Confidence            37999999999999999999999999999999999743      24456788999999999       589999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc--------------------------------------cCCCCHHHHHHHHHhH
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH--------------------------------------FRGLSLSIVQLFSKQI  222 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------------------------------------~~~L~e~~i~~I~~QI  222 (837)
                      .+.+..|||||||. ++|.+++....                                      ...+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            99999999999996 68888774210                                      0124678899999999


Q ss_pred             HHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC-------cceeeccCccccCchhhcC--CCCCcc
Q 003239          223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-------TVYSYIQSRYYRSPEVLLG--YQYTTA  293 (837)
Q Consensus       223 l~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~-------~~~~~~GT~~Y~APEvl~~--~~yt~k  293 (837)
                      +.||+|||+++|+||||||+|||++.+ ....+||+|||++.....       ......+|+.|+|||++.+  ..++.+
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999999999999999999999622 234899999999964321       2345678999999999975  578999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhh
Q 003239          294 IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQAL  373 (837)
Q Consensus       294 sDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~  373 (837)
                      +|||||||++|||++|+.||.+.+..+.+..+.......+                                        
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------------------  296 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE----------------------------------------  296 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT----------------------------------------
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC----------------------------------------
Confidence            9999999999999999999998887776665544111000                                        


Q ss_pred             hHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          374 TEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       374 s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                                           .                     .....+++.+.+||.+||+.||++|||++|+|+||||
T Consensus       297 ---------------------~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~  334 (345)
T 3hko_A          297 ---------------------N---------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI  334 (345)
T ss_dssp             ---------------------S---------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred             ---------------------C---------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence                                 0                     0001234678999999999999999999999999999


Q ss_pred             CCCC
Q 003239          454 TGEP  457 (837)
Q Consensus       454 ~~~~  457 (837)
                      ++..
T Consensus       335 ~~~~  338 (345)
T 3hko_A          335 SQFS  338 (345)
T ss_dssp             HTTS
T ss_pred             ccCh
Confidence            9854

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-42  Score=383.19  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=215.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++++.||+|+||+||+|++..+++.||||+++..    ....+.+.+|+++|+.+       .||||+++++++..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~  125 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-------RHPNTIQYRGCYLR  125 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEE
Confidence            36799999999999999999999999999999999743    23446788999999998       68999999999999


Q ss_pred             cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       184 ~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .+..+|||||+.|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++
T Consensus       126 ~~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a  201 (348)
T 1u5q_A          126 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA  201 (348)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTC
T ss_pred             CCeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCc
Confidence            99999999999999998886543 5699999999999999999999999999999999999996   6789999999999


Q ss_pred             cccCCcceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ..... ....+||+.|+|||++.   ...++.++||||||||+|||++|++||...+..+.+..+.....  +.      
T Consensus       202 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--~~------  272 (348)
T 1u5q_A          202 SIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA------  272 (348)
T ss_dssp             BSSSS-BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CC------
T ss_pred             eecCC-CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CC------
Confidence            76543 34568999999999995   45789999999999999999999999988776655544433100  00      


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                     .                             ...
T Consensus       273 -----------------------------------------------~-----------------------------~~~  276 (348)
T 1u5q_A          273 -----------------------------------------------L-----------------------------QSG  276 (348)
T ss_dssp             -----------------------------------------------C-----------------------------CCT
T ss_pred             -----------------------------------------------C-----------------------------CCC
Confidence                                                           0                             000


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+++.+.+||.+||+.||++|||++|+|+||||....
T Consensus       277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            1346789999999999999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.7e-43  Score=402.74  Aligned_cols=257  Identities=30%  Similarity=0.512  Sum_probs=219.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||+|++..+++.||||++.+.    ....+.+.+|+.+|+++       .||||+++++++...
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~   98 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-------DHPNIMKLYEFFEDK   98 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEeC
Confidence            7999999999999999999999999999999999743    33467788999999888       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+|||||. ++|.+.+...  ..+++..++.++.||+.||.|||++|||||||||+|||++.....+.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            99999999997 5888888654  46999999999999999999999999999999999999975556789999999999


Q ss_pred             cccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          264 CTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       264 ~~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....  ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.+.....+        
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------  247 (484)
T 3nyv_A          177 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE--------  247 (484)
T ss_dssp             HHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred             EEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence            7543  23345689999999999977 799999999999999999999999999888777766654111000        


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                                ......
T Consensus       248 --------------------------------------------------------------------------~~~~~~  253 (484)
T 3nyv_A          248 --------------------------------------------------------------------------LPQWKK  253 (484)
T ss_dssp             --------------------------------------------------------------------------SGGGGG
T ss_pred             --------------------------------------------------------------------------Cccccc
Confidence                                                                                      000112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +++.+.+||++||++||++|||++|+|+||||+...
T Consensus       254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            457789999999999999999999999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-42  Score=373.36  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=216.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.+       .||||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-------KHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-------CCTTBCCEEEEEECSSE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-------CCCCeeehhhhcccCCE
Confidence            479999999999999999999999999999999998653 2345678899999998       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+. ++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            999999997 5898888765  3699999999999999999999999999999999999996545778999999999975


Q ss_pred             cCCc-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          266 EDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       266 ~~~~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      .... ....++++.|+|||++.+..++.++|||||||++|+|++|..||......+.+..+.+.....+           
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------  227 (304)
T 2jam_A          159 EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE-----------  227 (304)
T ss_dssp             CCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC-----------
T ss_pred             cCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence            4432 3345789999999999999999999999999999999999999988877666555443111000           


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                        .          +           ....+++
T Consensus       228 --------------------------------------------------~----------~-----------~~~~~~~  236 (304)
T 2jam_A          228 --------------------------------------------------S----------P-----------FWDDISE  236 (304)
T ss_dssp             --------------------------------------------------T----------T-----------TTTTSCH
T ss_pred             --------------------------------------------------c----------c-----------ccccCCH
Confidence                                                              0          0           0011346


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+.+||.+||..||++|||++|+|+||||++..
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            789999999999999999999999999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.6e-43  Score=372.88  Aligned_cols=254  Identities=25%  Similarity=0.419  Sum_probs=210.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-  182 (837)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...     ...+.+.+|+++++.+       .|+||+++++++. 
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~   77 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-------RHKNVIQLVDVLYN   77 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEC
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-------CCCCeeEEEEEEEc
Confidence            78999999999999999999999999999999997532     3456788899998888       6899999999984 


Q ss_pred             -ecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 -CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 -~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       .....|+||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg  154 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALG  154 (305)
T ss_dssp             C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCT
T ss_pred             CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeeccc
Confidence             45689999999998888888876666799999999999999999999999999999999999995   66889999999


Q ss_pred             cccccC-----CcceeeccCccccCchhhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003239          262 SACTED-----RTVYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       262 lA~~~~-----~~~~~~~GT~~Y~APEvl~~~~--yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp  334 (837)
                      ++....     .......+|+.|+|||++.+..  ++.++|||||||++|+|++|+.||.+.+..+....+....-    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----  230 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY----  230 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC----
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC----
Confidence            997543     2223456899999999998754  47899999999999999999999988766555444322000    


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                                                                                             +..      
T Consensus       231 -----------------------------------------------------------------------~~~------  233 (305)
T 2wtk_C          231 -----------------------------------------------------------------------AIP------  233 (305)
T ss_dssp             -----------------------------------------------------------------------CCC------
T ss_pred             -----------------------------------------------------------------------CCC------
Confidence                                                                                   000      


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                           ...++.+.+||++||..||++|||++|+|+||||++...
T Consensus       234 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 -----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             -----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             -----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                 013367889999999999999999999999999998653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=381.06  Aligned_cols=197  Identities=24%  Similarity=0.422  Sum_probs=169.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|.+ .+++.||||+++..   ....+.+.+|+.+|+.+.+     .|+||+++++++...
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-----HSDKIIRLYDYEITD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh-----cCCceEEEeeeEeeC
Confidence            37899999999999999999987 46889999999753   3445678899999999964     358999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +.+|||||+.+++|.+++...  +.+++.+++.++.||+.||+|||+++||||||||+|||++    ++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~  155 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN  155 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred             CEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence            999999998888999998764  4699999999999999999999999999999999999995    4679999999997


Q ss_pred             ccCCc-----ceeeccCccccCchhhcC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          265 TEDRT-----VYSYIQSRYYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       265 ~~~~~-----~~~~~GT~~Y~APEvl~~-----------~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      .....     ....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence            54322     234579999999999975           57899999999999999999999999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-42  Score=363.82  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=204.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++..   ......+.+|+.++..+.      .||||+++++++...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~------~h~~iv~~~~~~~~~   83 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG------QHSHVVRYFSAWAED   83 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC------SCTTBCCEEEEEEET
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC------CCCCeeeeeeeeecC
Confidence            37899999999999999999999999999999999853   344567788888888873      589999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhcc--CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC-----------
Q 003239          185 RHLCICFELLDS-NLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-----------  250 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~--~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-----------  250 (837)
                      +..+|||||+.+ +|.+++.....  ..+++..++.++.||+.||+|||++||+||||||+|||++.+.           
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            999999999975 99999876532  5699999999999999999999999999999999999996432           


Q ss_pred             -----CCCeEEEEecccccccCCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003239          251 -----KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR  324 (837)
Q Consensus       251 -----~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~  324 (837)
                           ....+||+|||++...... ....+|+.|+|||++.+. .++.++|||||||++|+|++|.+++.....   ...
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~  239 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE  239 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH
T ss_pred             ccccCCceEEEEcccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH
Confidence                 4557999999999766543 234689999999999876 677899999999999999999987744321   111


Q ss_pred             HHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhc
Q 003239          325 MIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN  404 (837)
Q Consensus       325 I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~  404 (837)
                      +.+  + ..                                                    +                 .
T Consensus       240 ~~~--~-~~----------------------------------------------------~-----------------~  247 (289)
T 1x8b_A          240 IRQ--G-RL----------------------------------------------------P-----------------R  247 (289)
T ss_dssp             HHT--T-CC----------------------------------------------------C-----------------C
T ss_pred             HHc--C-CC----------------------------------------------------C-----------------C
Confidence            111  0 00                                                    0                 0


Q ss_pred             CCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       405 ~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .|             ..+++.+.+||++||+.||++|||++|+|+||||++.
T Consensus       248 ~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          248 IP-------------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             CS-------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             CC-------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            00             0134678999999999999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-42  Score=367.15  Aligned_cols=255  Identities=23%  Similarity=0.337  Sum_probs=192.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHH-HHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSI-LTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~--~~~~~~~Ei~i-L~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++....  .......|..+ ++.       ..||||+++++++...
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~-------~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT-------VDCPFTVTFYGALFRE   78 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTT-------CCCTTBCCEEEEEECS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHh-------CCCCeEEEEeeeeecc
Confidence            3799999999999999999999999999999999985422  22222233322 222       3799999999999999


Q ss_pred             ceEEEEEeccchhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 RHLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +..++||||++++|.+++...  ....+++..++.++.||+.||+|||++ ||+||||||+|||++   ..+.+||+|||
T Consensus        79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg  155 (290)
T 3fme_A           79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFG  155 (290)
T ss_dssp             SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC-
T ss_pred             CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecC
Confidence            999999999999988877652  235699999999999999999999998 999999999999995   66799999999


Q ss_pred             cccccCCc--ceeeccCccccCchhh----cCCCCCccchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCc
Q 003239          262 SACTEDRT--VYSYIQSRYYRSPEVL----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPP  334 (837)
Q Consensus       262 lA~~~~~~--~~~~~GT~~Y~APEvl----~~~~yt~ksDIWSLG~ILyELltG~~PF~g~-s~~e~l~~I~~~lG~~Pp  334 (837)
                      ++......  .....+|+.|+|||++    .+..++.++|||||||++|+|++|+.||... .....+..+.....    
T Consensus       156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  231 (290)
T 3fme_A          156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS----  231 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC----
T ss_pred             CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC----
Confidence            99754332  2334789999999997    4557899999999999999999999999753 33222222221000    


Q ss_pred             hHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchh
Q 003239          335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME  414 (837)
Q Consensus       335 ~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e  414 (837)
                                                                         +.                 .         
T Consensus       232 ---------------------------------------------------~~-----------------~---------  234 (290)
T 3fme_A          232 ---------------------------------------------------PQ-----------------L---------  234 (290)
T ss_dssp             ---------------------------------------------------CC-----------------C---------
T ss_pred             ---------------------------------------------------CC-----------------c---------
Confidence                                                               00                 0         


Q ss_pred             hhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       415 ~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                         .....++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       235 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          235 ---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence               001134678999999999999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-42  Score=368.08  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=217.8

Q ss_pred             eeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeE
Q 003239          101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVR  176 (837)
Q Consensus       101 ~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk  176 (837)
                      .+......++|++.+.||+|+||+||+|++..+++.||+|++...    ....+.+.+|+.+++.+       .|+||++
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~   79 (294)
T 2rku_A            7 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-------AHQHVVG   79 (294)
T ss_dssp             EEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-------CCTTBCC
T ss_pred             eeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-------CCCCEee
Confidence            344455668999999999999999999999999999999999753    34456778899999888       6899999


Q ss_pred             EeEEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeE
Q 003239          177 IYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       177 l~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                      +++++...+..++||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~  154 (294)
T 2rku_A           80 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEV  154 (294)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCE
T ss_pred             eeeeeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCE
Confidence            9999999999999999998 5888877654  3699999999999999999999999999999999999995   67889


Q ss_pred             EEEecccccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          256 KIIDFGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       256 KL~DFGlA~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      ||+|||++....   .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.....  
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--  232 (294)
T 2rku_A          155 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--  232 (294)
T ss_dssp             EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--
T ss_pred             EEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--
Confidence            999999997543   223445789999999999998999999999999999999999999987765544333221000  


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                                                                                             ..|      
T Consensus       233 -----------------------------------------------------------------------~~~------  235 (294)
T 2rku_A          233 -----------------------------------------------------------------------SIP------  235 (294)
T ss_dssp             -----------------------------------------------------------------------CCC------
T ss_pred             -----------------------------------------------------------------------CCc------
Confidence                                                                                   000      


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                             ...++.+.+||++||+.||++|||++|+|+||||++...
T Consensus       236 -------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          236 -------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             -------cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence                   013367889999999999999999999999999998654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-42  Score=387.41  Aligned_cols=197  Identities=23%  Similarity=0.415  Sum_probs=170.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|.+.. ++.||||+++..   ....+.+.+|+.+|+.|.+     .|+||+++++++...+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~-----~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-----HSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc-----CCCeEEEEEEEEecCC
Confidence            679999999999999999998865 889999999753   3455778899999999964     4799999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+|||||+.+++|.+++....  .+++.+++.++.||+.||.|||+++||||||||+|||++    ++.+||+|||++..
T Consensus       130 ~~~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCC
T ss_pred             EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccc
Confidence            999999977789999987653  689999999999999999999999999999999999994    47899999999975


Q ss_pred             cCCc-----ceeeccCccccCchhhcC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          266 EDRT-----VYSYIQSRYYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       266 ~~~~-----~~~~~GT~~Y~APEvl~~-----------~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ....     ....+||+.|+|||++.+           ..++.++||||||||+|||++|++||....
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            4322     234579999999999975           368999999999999999999999997653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-41  Score=362.95  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=215.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----------hhHHHHHHHHHHHHHhhcccCCCCCCceeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----------AYYQQALVEVSILTTLNKKYDREDKHHIVRI  177 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl  177 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...          ...+.+.+|+.+++++.      +||||+++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~   89 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS------GHPNIIQL   89 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT------TCTTBCCE
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc------CCCCEeee
Confidence            489999999999999999999999999999999997532          23456788999999984      48999999


Q ss_pred             eEEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEE
Q 003239          178 YEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       178 ~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                      ++++...+..++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+|
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~k  164 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIK  164 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEE
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEE
Confidence            999999999999999998 5899988764  3699999999999999999999999999999999999995   677899


Q ss_pred             EEecccccccC--CcceeeccCccccCchhhc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003239          257 IIDFGSACTED--RTVYSYIQSRYYRSPEVLL------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI  328 (837)
Q Consensus       257 L~DFGlA~~~~--~~~~~~~GT~~Y~APEvl~------~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~  328 (837)
                      |+|||++....  .......+++.|+|||++.      ...++.++|||||||++|+|++|..||...+..+....+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999997543  2334567899999999986      446889999999999999999999999887766655544331


Q ss_pred             hCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCC
Q 003239          329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR  408 (837)
Q Consensus       329 lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~  408 (837)
                      ....+                                                             .             
T Consensus       245 ~~~~~-------------------------------------------------------------~-------------  250 (298)
T 1phk_A          245 NYQFG-------------------------------------------------------------S-------------  250 (298)
T ss_dssp             CCCCC-------------------------------------------------------------T-------------
T ss_pred             CcccC-------------------------------------------------------------c-------------
Confidence            11000                                                             0             


Q ss_pred             CCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       409 ~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                              ......+..+.+||.+||..||++|||++|+|+||||++..
T Consensus       251 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          251 --------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             --------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             --------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence                    00012346789999999999999999999999999999754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-42  Score=376.76  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=218.3

Q ss_pred             eeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeE
Q 003239          101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVR  176 (837)
Q Consensus       101 ~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk  176 (837)
                      .+......++|++.+.||+|+||.||+|++..+++.||+|++...    ....+.+.+|+.+++.+       .|+||++
T Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~  105 (335)
T 2owb_A           33 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-------AHQHVVG  105 (335)
T ss_dssp             EEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-------CCTTBCC
T ss_pred             eecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-------CCCCCCe
Confidence            334445568999999999999999999999999999999999753    34556788899999888       6899999


Q ss_pred             EeEEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeE
Q 003239          177 IYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       177 l~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                      +++++...+.+|+||||+. ++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~  180 (335)
T 2owb_A          106 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEV  180 (335)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCE
T ss_pred             EEEEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCE
Confidence            9999999999999999998 5888887654  3699999999999999999999999999999999999995   66889


Q ss_pred             EEEecccccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          256 KIIDFGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       256 KL~DFGlA~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      ||+|||++....   .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+....-  
T Consensus       181 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--  258 (335)
T 2owb_A          181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--  258 (335)
T ss_dssp             EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--
T ss_pred             EEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--
Confidence            999999997543   223445789999999999999999999999999999999999999987765554433322000  


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                                                                                             .+|      
T Consensus       259 -----------------------------------------------------------------------~~~------  261 (335)
T 2owb_A          259 -----------------------------------------------------------------------SIP------  261 (335)
T ss_dssp             -----------------------------------------------------------------------CCC------
T ss_pred             -----------------------------------------------------------------------CCC------
Confidence                                                                                   000      


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                             ..+++.+.+||++||+.||++|||++|+|+||||+....
T Consensus       262 -------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          262 -------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             -------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence                   013367889999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=371.72  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=210.2

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      ..++|++++.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++.+.      .|+||+++++++..   
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS------HHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC------CSTTBCCEEEEEEECC-
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc------CCCCeeeeeeEEeeccC
Confidence            348999999999999999999999999999999999876555678889999999984      58999999999987   


Q ss_pred             ---cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          184 ---QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       184 ---~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                         .+.++|||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~kl~D  172 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVD  172 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEEEee
Confidence               4689999999985 999998876556799999999999999999999999999999999999995   678899999


Q ss_pred             cccccccCCc---ceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003239          260 FGSACTEDRT---VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA  331 (837)
Q Consensus       260 FGlA~~~~~~---~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~  331 (837)
                      ||++......   .....+++.|+|||++.     +..++.++|||||||++|+|++|..||...+..+.+..+.+... 
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-  251 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-  251 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-
Confidence            9999754332   23457899999999997     45789999999999999999999999987766554433322000 


Q ss_pred             CCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       332 ~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                        +                                                    ..                       
T Consensus       252 --~----------------------------------------------------~~-----------------------  254 (326)
T 2x7f_A          252 --P----------------------------------------------------RL-----------------------  254 (326)
T ss_dssp             --C----------------------------------------------------CC-----------------------
T ss_pred             --c----------------------------------------------------cC-----------------------
Confidence              0                                                    00                       


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                            ....++..+.+||.+||..||++|||++|+|+||||++.+
T Consensus       255 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          255 ------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             ------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             ------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence                  0001346789999999999999999999999999999755

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-42  Score=365.65  Aligned_cols=252  Identities=23%  Similarity=0.435  Sum_probs=213.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||++....    ...+.+.+|+++++.+       .|+||+++++++..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   85 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-------RHPNILRMYNYFHD   85 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEEC
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-------CCCCEeeEEEEEEc
Confidence            479999999999999999999999999999999997532    2245678899999888       58999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+..++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~  160 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGW  160 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccc
Confidence            999999999997 58998887653  599999999999999999999999999999999999995   667899999999


Q ss_pred             ccccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          263 ACTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       263 A~~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      +..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....           
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------  229 (284)
T 2vgo_A          161 SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-----------  229 (284)
T ss_dssp             CEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------
T ss_pred             cccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-----------
Confidence            865433 23456789999999999999999999999999999999999999988766554443322000           


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                    .+|             ..
T Consensus       230 --------------------------------------------------------------~~~-------------~~  234 (284)
T 2vgo_A          230 --------------------------------------------------------------KFP-------------PF  234 (284)
T ss_dssp             --------------------------------------------------------------CCC-------------TT
T ss_pred             --------------------------------------------------------------CCC-------------Cc
Confidence                                                                          000             01


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+..+.+||.+||..||++|||++|+|+||||+...
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            346789999999999999999999999999998644

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=367.52  Aligned_cols=253  Identities=27%  Similarity=0.456  Sum_probs=186.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||++....    ...+.+.+|+.+++.+       .||||+++++++..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~   82 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-------KHPSILELYNYFED   82 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-------CCTTBCCEEEEEEC
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-------CCCCeEeEEEEEcc
Confidence            378999999999999999999999999999999997532    2236678899988887       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+..++||||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++   .++.+||+|||+
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~  158 (278)
T 3cok_A           83 SNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGL  158 (278)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTT
T ss_pred             CCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecc
Confidence            999999999997 5888887754 35699999999999999999999999999999999999995   678899999999


Q ss_pred             ccccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +.....   ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+..            
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             CEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             eeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            975432   23345789999999999998999999999999999999999999976532211110000            


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                        .             .+..           .
T Consensus       227 --------------------------------------------------~-------------~~~~-----------~  232 (278)
T 3cok_A          227 --------------------------------------------------A-------------DYEM-----------P  232 (278)
T ss_dssp             --------------------------------------------------S-------------CCCC-----------C
T ss_pred             --------------------------------------------------c-------------ccCC-----------c
Confidence                                                              0             0000           0


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ...+.++.+||.+||+.||++|||++|+|+||||.+..
T Consensus       233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             cccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            11346789999999999999999999999999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-42  Score=363.90  Aligned_cols=258  Identities=27%  Similarity=0.406  Sum_probs=212.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...       ...+.+.+|+.+++.+       .||||+++++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~   77 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-------RHPNIITLHDIF   77 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-------CCCCeeehhhee
Confidence            68999999999999999999999999999999997532       1357788999999998       589999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC-CCCeEEEEe
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIID  259 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~IKL~D  259 (837)
                      ...+..++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.+. ....+||+|
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence            99999999999996 6899988764  3699999999999999999999999999999999999996322 233899999


Q ss_pred             cccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||++.....  ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..... ..+   
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---  231 (283)
T 3bhy_A          156 FGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY-DFD---  231 (283)
T ss_dssp             CTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCC---
T ss_pred             cccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-CCc---
Confidence            999975433  23345789999999999998999999999999999999999999988876665554432111 000   


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                   .+..               
T Consensus       232 -------------------------------------------------------------~~~~---------------  235 (283)
T 3bhy_A          232 -------------------------------------------------------------EEYF---------------  235 (283)
T ss_dssp             -------------------------------------------------------------HHHH---------------
T ss_pred             -------------------------------------------------------------chhc---------------
Confidence                                                                         0000               


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...++.+.+||++||..||++|||++|+|+||||+...
T Consensus       236 --~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          236 --SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             --TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             --ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence              11346789999999999999999999999999998743

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-41  Score=362.38  Aligned_cols=254  Identities=23%  Similarity=0.356  Sum_probs=206.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-  183 (837)
                      .+.|++.+.||+|+||+||+|.+..+++.||+|+++..   ....+.+.+|+.+++.+       .|+||+++++++.. 
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-------QHPNIVRFYDSWEST   97 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-------CCCCeeeeeeeeccc
Confidence            46799999999999999999999999999999999753   34556788899999888       68999999999876 


Q ss_pred             ---cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEE
Q 003239          184 ---QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       184 ---~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                         ...+|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++  ...+.+||
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl  173 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKI  173 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEE
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEE
Confidence               467999999997 5999988764  46999999999999999999999999  99999999999995  35678999


Q ss_pred             EecccccccCCc-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          258 IDFGSACTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       258 ~DFGlA~~~~~~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      +|||++...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...... + ..+. 
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~-~~~~-  249 (290)
T 1t4h_A          174 GDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VKPA-  249 (290)
T ss_dssp             CCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CCCG-
T ss_pred             eeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-c-CCcc-
Confidence            999999755433 345678999999998875 6999999999999999999999999775443332221110 0 0000 


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                                                      
T Consensus       250 --------------------------------------------------------------------------------  249 (290)
T 1t4h_A          250 --------------------------------------------------------------------------------  249 (290)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ......++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            0001123678999999999999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.7e-43  Score=386.93  Aligned_cols=199  Identities=15%  Similarity=0.142  Sum_probs=162.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe------
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY------  178 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~------  178 (837)
                      .+|++.++||+|+||+||+|++..+++.||||+++..    ....+.+.+|+.+++.|+.     .||||++++      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-----~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-----ESPEEARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC---------------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-----cChhhhhhceeEEee
Confidence            5699999999999999999999999999999999873    3445667789888888853     589988866      


Q ss_pred             -EEEeec-----------------ceEEEEEeccchhHHHHHHhhccCCCCHHHH------HHHHHhHHHHHhhhhcCCe
Q 003239          179 -EYFVCQ-----------------RHLCICFELLDSNLYELIKINHFRGLSLSIV------QLFSKQILRGLSLLKDAGI  234 (837)
Q Consensus       179 -d~f~~~-----------------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i------~~I~~QIl~aL~yLHs~gI  234 (837)
                       +++...                 ..+|||||||+++|.+++.... ..+.+..+      ..++.||+.||+|||++||
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence             555433                 3489999999999999998753 23455555      6777999999999999999


Q ss_pred             eeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeeccCccccCchhhcC--CCCCccchHHHHHHHHHHHHhCCCC
Q 003239          235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPL  312 (837)
Q Consensus       235 VHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~--~~yt~ksDIWSLG~ILyELltG~~P  312 (837)
                      |||||||+||||+   .++.+||+|||+++..........+|+.|+|||++.+  ..++.++|||||||++|||++|+.|
T Consensus       216 vHrDikp~NIll~---~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          216 VHGHFTPDNLFIM---PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             EETTCSGGGEEEC---TTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCcCCHHHEEEC---CCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999995   6788999999999877766556677899999999987  6899999999999999999999999


Q ss_pred             CCCC
Q 003239          313 FPGA  316 (837)
Q Consensus       313 F~g~  316 (837)
                      |.+.
T Consensus       293 f~~~  296 (371)
T 3q60_A          293 FGLV  296 (371)
T ss_dssp             TTBC
T ss_pred             CCCc
Confidence            9765

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-42  Score=405.12  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=215.7

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..++|++.++||+|+||+||+|++..+++.||||++++..    .....+.+|+++|+.+       .||||++++++|.
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-------~hp~Iv~l~~~~~  254 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-------NSRFVVSLAYAYE  254 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-------CCCCEeeEEEEEe
Confidence            3478999999999999999999999999999999997532    2345678899999998       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +.+.+||||||+. ++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+   .++.+||+|||
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFG  331 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLG  331 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEecc
Confidence            9999999999997 6898888766545699999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          262 SACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       262 lA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ++.....  .....+||+.|+|||++.+..|+.++||||||||+|||++|.+||.+.........+.+.+...+.     
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-----  406 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE-----  406 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-----
T ss_pred             cceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-----
Confidence            9976533  334568999999999999999999999999999999999999999765321111111110000000     


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .+|             
T Consensus       407 ----------------------------------------------------------------~~p-------------  409 (576)
T 2acx_A          407 ----------------------------------------------------------------EYS-------------  409 (576)
T ss_dssp             ----------------------------------------------------------------CCC-------------
T ss_pred             ----------------------------------------------------------------cCC-------------
Confidence                                                                            000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT  459 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~  459 (837)
                      ..+++++.+||++||+.||++|+     |++|+++||||++..+.
T Consensus       410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            11457789999999999999999     89999999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-42  Score=402.76  Aligned_cols=201  Identities=26%  Similarity=0.434  Sum_probs=178.0

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..++|+++++||+|+||+||+|+++.+++.||||++++..    ...+.+.+|+.+|+.+       .||||++++++|.
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-------~hp~Iv~l~~~~~  255 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSRFIVSLAYAFE  255 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-------CCCCEeeEEEEEe
Confidence            3479999999999999999999999999999999997542    2346678899999998       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQRHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..+.+||||||+. ++|.+++....  ...+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~D  332 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISD  332 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEee
Confidence            9999999999998 58888887543  34699999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       260 FGlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ||+++.....   ....+||+.|+|||++.+..|+.++||||||||+|||++|++||.+..
T Consensus       333 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             cceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            9999764332   234589999999999999999999999999999999999999997653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.4e-43  Score=394.00  Aligned_cols=259  Identities=30%  Similarity=0.498  Sum_probs=200.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      .++|++.++||+|+||+||+|++..+++.||||++.+..         .....+.+|+.+|+++       .||||++++
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~l~  206 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-------NHPCIIKIK  206 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-------CCTTBCCCC
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-------CCCCEeeEE
Confidence            478999999999999999999999999999999997532         1122467899999999       689999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      +++.. +..||||||+. ++|.+++...  +.+++..++.++.||+.||+|||+++||||||||+|||++.+.....+||
T Consensus       207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          207 NFFDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             EEEES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             EEEec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence            99864 45899999997 4887776543  46999999999999999999999999999999999999975555667999


Q ss_pred             EecccccccCCc--ceeeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          258 IDFGSACTEDRT--VYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       258 ~DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      +|||+++.....  ....+||+.|+|||++.+   ..++.++|||||||++|+|++|.+||........+...+....  
T Consensus       284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~--  361 (419)
T 3i6u_A          284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--  361 (419)
T ss_dssp             CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC--
T ss_pred             eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC--
Confidence            999999765433  345689999999999864   5788999999999999999999999976432211111111000  


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                                                           +                         ....+.           
T Consensus       362 -------------------------------------~-------------------------~~~~~~-----------  368 (419)
T 3i6u_A          362 -------------------------------------Y-------------------------NFIPEV-----------  368 (419)
T ss_dssp             -------------------------------------C-------------------------CCCHHH-----------
T ss_pred             -------------------------------------C-------------------------CCCchh-----------
Confidence                                                 0                         000000           


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                            ...+++.+.+||++||+.||++|||++|+|+||||++..
T Consensus       369 ------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          369 ------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             ------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             ------hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence                  112457789999999999999999999999999998743

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-42  Score=379.53  Aligned_cols=204  Identities=29%  Similarity=0.450  Sum_probs=178.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+++++||+|+||+||+|++..+++.||+|+++..  ....+.+.+|+.+++.+       .|+||+++++++...+.
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-------CCTTBCCEEEEEEETTE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-------CCCCEEEEeEEEEECCE
Confidence            7899999999999999999999999999999999864  44556788899888887       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +||||||+.+ +|.+++....  .+++..++.++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||++.
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG  180 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCH
T ss_pred             EEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECCCCc
Confidence            9999999975 9999887653  599999999999999999999986 999999999999996   66789999999986


Q ss_pred             ccC-CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003239          265 TED-RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR  324 (837)
Q Consensus       265 ~~~-~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~  324 (837)
                      ... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  241 (360)
T 3eqc_A          181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM  241 (360)
T ss_dssp             HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred             ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            432 223446889999999999999999999999999999999999999988776655433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=372.35  Aligned_cols=202  Identities=22%  Similarity=0.393  Sum_probs=174.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++...  ...+.+.+|+++|+.+       .|+||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~   80 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-------NHKNIVKLFAIEEETT   80 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-------CCCCcceEEEEeecCC
Confidence            479999999999999999999999999999999998532  3356778999999999       5899999999998765


Q ss_pred             --eEEEEEeccc-hhHHHHHHhhcc-CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec-cCCCCeEEEEec
Q 003239          186 --HLCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT-SVKPAEIKIIDF  260 (837)
Q Consensus       186 --~l~LVmEy~~-gsL~d~l~~~~~-~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~-~~~~~~IKL~DF  260 (837)
                        ..||||||+. ++|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||+.. ++..+.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence              8899999997 689998876542 23999999999999999999999999999999999999832 235678999999


Q ss_pred             ccccccCC--cceeeccCccccCchhhc--------CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          261 GSACTEDR--TVYSYIQSRYYRSPEVLL--------GYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       261 GlA~~~~~--~~~~~~GT~~Y~APEvl~--------~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      |+++....  .....++|+.|+|||++.        +..++.++||||||||+|||++|+.||...
T Consensus       161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99976433  334567899999999986        468999999999999999999999999653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-41  Score=376.44  Aligned_cols=254  Identities=26%  Similarity=0.444  Sum_probs=212.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...         ...+.+.+|+.+++++.      .||||+++++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~  167 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA------GHPHIITLID  167 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT------TCTTBCCEEE
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc------CCCCEeEEEE
Confidence            68999999999999999999999999999999997532         22456778999999984      5899999999


Q ss_pred             EEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          180 YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      ++......||||||+.+ +|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~  242 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLS  242 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEEC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEE
Confidence            99999999999999985 898888754  3699999999999999999999999999999999999995   67899999


Q ss_pred             ecccccccC--CcceeeccCccccCchhhcC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003239          259 DFGSACTED--RTVYSYIQSRYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG  330 (837)
Q Consensus       259 DFGlA~~~~--~~~~~~~GT~~Y~APEvl~~------~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG  330 (837)
                      |||++....  ......+||+.|+|||++.+      ..++.++|||||||++|+|++|..||...+..+.+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            999997543  23445689999999999863      3588999999999999999999999988776665555433111


Q ss_pred             CCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCC
Q 003239          331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN  410 (837)
Q Consensus       331 ~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~  410 (837)
                       .++.                                                                           
T Consensus       323 -~~~~---------------------------------------------------------------------------  326 (365)
T 2y7j_A          323 -QFSS---------------------------------------------------------------------------  326 (365)
T ss_dssp             -CCCH---------------------------------------------------------------------------
T ss_pred             -CCCC---------------------------------------------------------------------------
Confidence             0000                                                                           


Q ss_pred             CchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       411 l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                            ......+..+.+||++||+.||++|||++|+|+||||++
T Consensus       327 ------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 ------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                  000113467899999999999999999999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-42  Score=396.42  Aligned_cols=250  Identities=27%  Similarity=0.413  Sum_probs=212.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...    ...+.+.+|+.+|+.+       .||||+++++++...
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-------~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-------RHPHIIKLYQVISTP   88 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEEC
Confidence            78999999999999999999999999999999997542    2345778899999887       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. ++|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||++
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a  163 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLS  163 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccch
Confidence            99999999996 6898888643  4699999999999999999999999999999999999995   6788999999999


Q ss_pred             cccCC--cceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~--~~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      .....  .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+...++..... .        
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~--------  234 (476)
T 2y94_A          164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-Y--------  234 (476)
T ss_dssp             EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-C--------
T ss_pred             hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-C--------
Confidence            76433  3345689999999999998766 6899999999999999999999988766555544432100 0        


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                                      .|             .
T Consensus       235 ----------------------------------------------------------------~p-------------~  237 (476)
T 2y94_A          235 ----------------------------------------------------------------TP-------------Q  237 (476)
T ss_dssp             ----------------------------------------------------------------CC-------------T
T ss_pred             ----------------------------------------------------------------CC-------------c
Confidence                                                                            00             0


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ..++++.+||++||+.||++|||++|+|+||||++.
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            134678999999999999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.1e-42  Score=365.75  Aligned_cols=257  Identities=27%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..++|++++.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.+       .||||+++++++...+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-------DHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECC-
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-------CCCCEeeeeeeeeeCC
Confidence            348999999999999999999999999999999999753 33457788999999988       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      ..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSA  165 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCCc
Confidence            99999999985 7777766543 5699999999999999999999999999999999999995   66789999999875


Q ss_pred             ccC---CcceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          265 TED---RTVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       265 ~~~---~~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ...   .......+++.|+|||++.     +..++.++|||||||++|+|++|..||...+..+.+..+.....   +. 
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-  241 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---PT-  241 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CC-
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC---cc-
Confidence            321   1223457899999999984     56789999999999999999999999988776555444332100   00 


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                                                     .
T Consensus       242 -------------------------------------------------------------------------------~  242 (302)
T 2j7t_A          242 -------------------------------------------------------------------------------L  242 (302)
T ss_dssp             -------------------------------------------------------------------------------C
T ss_pred             -------------------------------------------------------------------------------c
Confidence                                                                                           0


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .....++..+.+||.+||..||++|||++|+|+||||++..
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            00012346789999999999999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.3e-42  Score=371.32  Aligned_cols=259  Identities=30%  Similarity=0.486  Sum_probs=205.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...         .....+.+|+++|+.+       .|+||++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~   81 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-------NHPCIIKIK   81 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-------CCTTBCCEE
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-------CCCCCceEe
Confidence            378999999999999999999999999999999997532         1223477899999998       689999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      +++..+. .|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+.....+||
T Consensus        82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           82 NFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             EEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             eEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEE
Confidence            9987655 899999997 4888887654  46999999999999999999999999999999999999975545567999


Q ss_pred             EecccccccCCc--ceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          258 IDFGSACTEDRT--VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       258 ~DFGlA~~~~~~--~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      +|||++......  .....+|+.|+|||++.   ...++.++|||||||++|+|++|..||........+...+.... .
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~  237 (322)
T 2ycf_A          159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-Y  237 (322)
T ss_dssp             CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC-C
T ss_pred             ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc-c
Confidence            999999765443  23457899999999985   45789999999999999999999999976432211111111000 0


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                                                                                     ..+.+.           
T Consensus       238 ---------------------------------------------------------------~~~~~~-----------  243 (322)
T 2ycf_A          238 ---------------------------------------------------------------NFIPEV-----------  243 (322)
T ss_dssp             ---------------------------------------------------------------CCCHHH-----------
T ss_pred             ---------------------------------------------------------------ccCchh-----------
Confidence                                                                           000000           


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                            ....++.+.+||++||..||++|||++|+|+||||++..
T Consensus       244 ------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          244 ------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             ------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             ------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence                  012347789999999999999999999999999998744

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.9e-42  Score=366.61  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=208.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|+.+++.+       .|+||+++++++...+.+
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-------DSPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-------CCTTBCCEEEEEEETTEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-------CCCCCccEEEEEEeCCEE
Confidence            478999999999999999999999999999999998653 346678899999988       689999999999999999


Q ss_pred             EEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++   .++.+||+|||++...
T Consensus       100 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccchhh
Confidence            999999985 888888644 35699999999999999999999999999999999999995   6678999999999654


Q ss_pred             CCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      ...   .....+++.|+|||++.+..++.++|||||||++|+|++|..||........+..+....   ++.        
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~--------  244 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP---PPT--------  244 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CCC--------
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC---Ccc--------
Confidence            332   334578999999999999999999999999999999999999998766544333221100   000        


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                       +                       .....++
T Consensus       245 -------------------------------------------------~-----------------------~~~~~~~  252 (314)
T 3com_A          245 -------------------------------------------------F-----------------------RKPELWS  252 (314)
T ss_dssp             -------------------------------------------------C-----------------------SSGGGSC
T ss_pred             -------------------------------------------------c-----------------------CCcccCC
Confidence                                                             0                       0001134


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..+.+||.+||..||++|||++|+|+||||++..
T Consensus       253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            6789999999999999999999999999999765

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.5e-42  Score=360.91  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=207.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|++.+.||+|+||.||+|++..+++.||||+++..  ....+.+.+|+.+++.+       .|+||+++++++...+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-------NHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-------CCCCceeeeeEEEcCCE
Confidence            6899999999999999999999999999999999743  23456788899999888       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .|+||||+.+ +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCccc
Confidence            9999999975 888877543  3599999999999999999999999999999999999995   668899999999964


Q ss_pred             cC-----CcceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCchHHH
Q 003239          266 ED-----RTVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDL-LRRMIRILGAQPPDYVL  338 (837)
Q Consensus       266 ~~-----~~~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~-l~~I~~~lG~~Pp~~~l  338 (837)
                      ..     .......+++.|+|||++.+..+ +.++|||||||++|+|++|..||........ +..+... .        
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--------  225 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-K--------  225 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-C--------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-c--------
Confidence            32     12334578999999999988765 7899999999999999999999976543211 1110000 0        


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                          ..                       ...
T Consensus       226 ----------------------------------------------------~~-----------------------~~~  230 (276)
T 2yex_A          226 ----------------------------------------------------TY-----------------------LNP  230 (276)
T ss_dssp             ----------------------------------------------------TT-----------------------STT
T ss_pred             ----------------------------------------------------cc-----------------------cCc
Confidence                                                                00                       000


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ....++.+.+||++||+.||++|||++|+|+||||++..
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            012446789999999999999999999999999998743

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2e-42  Score=373.36  Aligned_cols=256  Identities=24%  Similarity=0.392  Sum_probs=206.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++..    ......+.+|+.+++.+       .||||+++++++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~   83 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-------NHPAIVAVYDTGEA   83 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-------CCTTBCCEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-------CCCCcceEEEeeec
Confidence            38999999999999999999999999999999999853    23345667777777666       68999999999987


Q ss_pred             cce----EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          184 QRH----LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       184 ~~~----l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      ...    .||||||+. ++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~  158 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVM  158 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEEC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEe
Confidence            653    499999997 6899888765  3699999999999999999999999999999999999996   66789999


Q ss_pred             ecccccccCCc------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          259 DFGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       259 DFGlA~~~~~~------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      |||++......      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..... .
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~  237 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-I  237 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-C
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-C
Confidence            99999754322      2235689999999999999999999999999999999999999988877665544433111 0


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                      ++.                                                                             
T Consensus       238 ~~~-----------------------------------------------------------------------------  240 (311)
T 3ork_A          238 PPS-----------------------------------------------------------------------------  240 (311)
T ss_dssp             CHH-----------------------------------------------------------------------------
T ss_pred             Ccc-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                          .....+++++.+||.+||+.||++||++.++|+|+|++...
T Consensus       241 ----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          241 ----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                00012346789999999999999999999999999998644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=381.86  Aligned_cols=197  Identities=23%  Similarity=0.408  Sum_probs=170.1

Q ss_pred             CceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      ++|+++++||+|+||+||+|++.   .+++.||||+++..     ....+.+.+|+++|+.+.      .|+||++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~  127 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR------QSPFLVTLHYA  127 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH------TCTTBCCEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc------CCCceeEEEEE
Confidence            79999999999999999999874   58999999998742     123455677999999995      48999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      +...+.++|||||+. ++|.+++...  ..+++..++.++.||+.||.|||+++||||||||+|||++   .++.+||+|
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~D  202 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTD  202 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESC
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEee
Confidence            999999999999997 5898888765  3699999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCC----cceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          260 FGSACTEDR----TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       260 FGlA~~~~~----~~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ||+++....    .....+||+.|+|||++.+.  .++.++||||||||+|||++|+.||...
T Consensus       203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            999975432    23345799999999999863  5789999999999999999999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-41  Score=359.33  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...    ...+.+.+|+.+++.+       .|+||+++++++...
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-------RHPHIIKLYQVISTP   83 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-------CCCCEeEEEEEEecC
Confidence            79999999999999999999999999999999997532    2345678899999888       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~  158 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLS  158 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGG
T ss_pred             CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeecccc
Confidence            99999999997 59999887653  599999999999999999999999999999999999995   6688999999999


Q ss_pred             cccCCc--ceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDRT--VYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~~--~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ......  .....+++.|+|||++.+..+ +.++|||||||++|+|++|..||......+....+.....          
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (276)
T 2h6d_A          159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF----------  228 (276)
T ss_dssp             GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred             cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------
Confidence            765432  234578999999999988765 6899999999999999999999987765554443322000          


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                                     ..|             .
T Consensus       229 ---------------------------------------------------------------~~~-------------~  232 (276)
T 2h6d_A          229 ---------------------------------------------------------------YIP-------------E  232 (276)
T ss_dssp             ---------------------------------------------------------------CCC-------------T
T ss_pred             ---------------------------------------------------------------cCc-------------h
Confidence                                                                           000             0


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ..+..+.+||.+||+.||++|||++|+|+||||++.
T Consensus       233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            123568899999999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-41  Score=361.85  Aligned_cols=257  Identities=32%  Similarity=0.516  Sum_probs=214.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++..   ....+.+.+|+++++++       .|+||+++++++...
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   93 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-------DHPNIMKLFEILEDS   93 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-------cCCCccEEEEEEeCC
Confidence            37999999999999999999999999999999999753   23456788999999988       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..++|||++. ++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+||+++.+.....+||+|||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             CeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999997 58888876553  6999999999999999999999999999999999999975555668999999998


Q ss_pred             cccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          264 CTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       264 ~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ......  .....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.....  +        
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--------  240 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY--A--------  240 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C--------
T ss_pred             eeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C--------
Confidence            754332  234568999999999876 589999999999999999999999988877665554433100  0        


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                         +.                     ......
T Consensus       241 ---------------------------------------------------~~---------------------~~~~~~  248 (287)
T 2wei_A          241 ---------------------------------------------------FD---------------------LPQWRT  248 (287)
T ss_dssp             ---------------------------------------------------CC---------------------SGGGTT
T ss_pred             ---------------------------------------------------CC---------------------chhhhh
Confidence                                                               00                     000012


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      +++.+.+||++||..||++|||++|+|+||||++.
T Consensus       249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            34678999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=377.16  Aligned_cols=197  Identities=29%  Similarity=0.503  Sum_probs=173.4

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---------hHHHHHHHHHHHHHhhcccCCCCCCceeEE
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---------YYQQALVEVSILTTLNKKYDREDKHHIVRI  177 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~---------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl  177 (837)
                      ..++|+++++||+|+||+||+|++..+++.||||+++....         ..+.+.+|+.+|+.+       .|+||+++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~Iv~~   94 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-------EHANIIKV   94 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-------CCTTBCCE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-------CCCCEeeE
Confidence            34799999999999999999999999999999999986431         233566799999888       68999999


Q ss_pred             eEEEeecceEEEEEeccc-h-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeE
Q 003239          178 YEYFVCQRHLCICFELLD-S-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       178 ~d~f~~~~~l~LVmEy~~-g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                      +++|...+.+++||||+. + +|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+
T Consensus        95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~  169 (335)
T 3dls_A           95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTI  169 (335)
T ss_dssp             EEEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcE
Confidence            999999999999999986 4 888888654  3599999999999999999999999999999999999995   67899


Q ss_pred             EEEecccccccCC--cceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCC
Q 003239          256 KIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       256 KL~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ||+|||++.....  .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus       170 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             EECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             EEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            9999999975543  3345689999999999998876 7899999999999999999999953

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.1e-41  Score=356.19  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=210.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-  183 (837)
                      .++|++++.||+|+||.||+|++..+++.||+|+++..   ....+.+.+|+.+++.+       .|+||+++++++.. 
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~   77 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-------KHPNIVRYYDRIIDR   77 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEEG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-------CCCCCCeEEEEEecC
Confidence            37999999999999999999999999999999999853   34556788999999998       58999999998864 


Q ss_pred             -cceEEEEEeccc-hhHHHHHHhhc--cCCCCHHHHHHHHHhHHHHHhhhhcCC-----eeeccCCCCCeeeeccCCCCe
Q 003239          184 -QRHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAG-----IIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       184 -~~~l~LVmEy~~-gsL~d~l~~~~--~~~L~e~~i~~I~~QIl~aL~yLHs~g-----IVHrDLKPeNILl~~~~~~~~  254 (837)
                       ...+++||||+. ++|.+++....  ...+++..++.++.||+.||+|||+++     |+||||||+|||++   .++.
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~  154 (279)
T 2w5a_A           78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQN  154 (279)
T ss_dssp             GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSC
T ss_pred             CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCC
Confidence             568999999997 49999887643  234999999999999999999999999     99999999999995   6788


Q ss_pred             EEEEecccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003239          255 IKIIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA  331 (837)
Q Consensus       255 IKL~DFGlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~  331 (837)
                      +||+|||++......   .....+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... 
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-  233 (279)
T 2w5a_A          155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-  233 (279)
T ss_dssp             EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred             EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-
Confidence            999999999755432   2345789999999999999999999999999999999999999988776555444432100 


Q ss_pred             CCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCC
Q 003239          332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL  411 (837)
Q Consensus       332 ~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l  411 (837)
                       +                                                                      ..|     
T Consensus       234 -~----------------------------------------------------------------------~~~-----  237 (279)
T 2w5a_A          234 -R----------------------------------------------------------------------RIP-----  237 (279)
T ss_dssp             -C----------------------------------------------------------------------CCC-----
T ss_pred             -c----------------------------------------------------------------------cCC-----
Confidence             0                                                                      000     


Q ss_pred             chhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       412 ~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                              ...++++.+||.+||..||++|||++|+|+|+|+.+..
T Consensus       238 --------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          238 --------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             --------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                    01346789999999999999999999999999999754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.1e-41  Score=360.46  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=212.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++++.||+|+||+||+|++..+++.||||+++..  ....+.+.+|+.+++.+       .|+||+++++++...+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~   93 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYVTKYYGSYLKDT   93 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-------CCCCEeEEEEEEecCC
Confidence            37899999999999999999999999999999999754  34467788999999988       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|+||||+.+ +|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        94 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAG  167 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeecccce
Confidence            99999999985 88887754   3599999999999999999999999999999999999995   66889999999996


Q ss_pred             ccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          265 TEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       265 ~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      .....   .....+++.|+|||++.+..++.++|||||||++|+|++|..||......+....+.+..   ++       
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-------  237 (303)
T 3a7i_A          168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PP-------  237 (303)
T ss_dssp             ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CC-------
T ss_pred             ecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC---CC-------
Confidence            54332   234578999999999999999999999999999999999999998776554443322100   00       


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                   .                 .             ...
T Consensus       238 ---------------------------------------------~-----------------~-------------~~~  242 (303)
T 3a7i_A          238 ---------------------------------------------T-----------------L-------------EGN  242 (303)
T ss_dssp             ---------------------------------------------C-----------------C-------------CSS
T ss_pred             ---------------------------------------------C-----------------C-------------ccc
Confidence                                                         0                 0             001


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++..+.+||.+||..||++|||++|+|+||||....
T Consensus       243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            346789999999999999999999999999997643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.6e-42  Score=373.32  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=184.2

Q ss_pred             CCceEEEE-EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          108 QRRYIVKD-LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       108 ~~~Y~i~~-~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      .++|++++ +||+|+||+||+|++..+++.||||++......    .+|+..+.++.      .|+||+++++++..   
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~------~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQAS------GGPHIVCILDVYENMHH   96 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHT------TSTTBCCEEEEEEEEET
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhc------CCCChHHHHHHHhhccC
Confidence            47899965 699999999999999999999999999875432    23443332321      68999999999987   


Q ss_pred             -cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 -QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 -~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       ...++||||||.+ +|.+++.......+++.+++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             5569999999975 99999987655679999999999999999999999999999999999999765557789999999


Q ss_pred             cccccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          262 SACTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       262 lA~~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ++..... .....++|+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....          
T Consensus       177 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  246 (336)
T 3fhr_A          177 FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR----------  246 (336)
T ss_dssp             TCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred             cceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh----------
Confidence            9975543 23456789999999999888999999999999999999999999976543322111111000          


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                ..                                     ..            .++.         ....
T Consensus       247 ----------~~-------------------------------------~~------------~~~~---------~~~~  258 (336)
T 3fhr_A          247 ----------LG-------------------------------------QY------------GFPN---------PEWS  258 (336)
T ss_dssp             ---------------------------------------------------------------CCCT---------TTST
T ss_pred             ----------cc-------------------------------------cc------------ccCc---------hhhc
Confidence                      00                                     00            0000         0001


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      .+++.+.+||++||+.||++|||++|+|+||||++.
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            245778999999999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3e-41  Score=358.54  Aligned_cols=189  Identities=34%  Similarity=0.501  Sum_probs=162.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-----
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-----  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-----  183 (837)
                      ++|++++.||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.+       .||||+++++++..     
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-------NHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEECCCCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-------CchHHHHHHHHHHhhcchh
Confidence            689999999999999999999999999999999987766678888999999888       68999999998865     


Q ss_pred             --------cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCe
Q 003239          184 --------QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       184 --------~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                              .+..|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~~~  154 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRN  154 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CCCC
Confidence                    467899999997 59999987643 4588999999999999999999999999999999999995   6788


Q ss_pred             EEEEecccccccCC-----------------cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHh
Q 003239          255 IKIIDFGSACTEDR-----------------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFL  308 (837)
Q Consensus       255 IKL~DFGlA~~~~~-----------------~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELlt  308 (837)
                      +||+|||++.....                 ......+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            99999999965432                 22345789999999999865 78999999999999999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=373.36  Aligned_cols=256  Identities=21%  Similarity=0.250  Sum_probs=211.3

Q ss_pred             CCceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~-----~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|+++++||+|+||+||+|+     +..+++.||||+++..  ......+.+|+.+++.+       .|+||++++++
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~  142 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-------NHQNIVRCIGV  142 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-------CCCCCCeEEEE
Confidence            4789999999999999999998     5567889999999753  44556788899999998       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhcc-----CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                      +......+||||||. ++|.+++.....     ..+++.+++.++.||+.||+|||++|||||||||+|||++.+.....
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999996 599999887542     34899999999999999999999999999999999999975545567


Q ss_pred             EEEEeccccccc-----CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 003239          255 IKIIDFGSACTE-----DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRI  328 (837)
Q Consensus       255 IKL~DFGlA~~~-----~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~~  328 (837)
                      +||+|||+++..     ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999999632     122334567899999999999999999999999999999998 99999888776655544331


Q ss_pred             hCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCC
Q 003239          329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR  408 (837)
Q Consensus       329 lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~  408 (837)
                      ....+                                                                           
T Consensus       303 ~~~~~---------------------------------------------------------------------------  307 (367)
T 3l9p_A          303 GRMDP---------------------------------------------------------------------------  307 (367)
T ss_dssp             CCCCC---------------------------------------------------------------------------
T ss_pred             CCCCC---------------------------------------------------------------------------
Confidence            10000                                                                           


Q ss_pred             CCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       409 ~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                                ...++..+.+||.+||+.||++|||++|+|+|.++..
T Consensus       308 ----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          308 ----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                      0013367889999999999999999999999988764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.9e-41  Score=360.30  Aligned_cols=203  Identities=29%  Similarity=0.397  Sum_probs=175.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++++.||+|+||+||+|++..+++.||||++..    .....+.+.+|+.+++.+       .||||+++++++..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~iv~~~~~~~~   82 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-------SHQNIVSMIDVDEE   82 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-------CBTTBCCEEEEEEC
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-------CCCCCceEEEeeee
Confidence            3899999999999999999999999999999999864    234456788899998888       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.+|+||||+.+ +|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~  157 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGI  157 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCCC
Confidence            9999999999975 899888765  3699999999999999999999999999999999999995   668899999999


Q ss_pred             ccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 003239          263 ACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL  322 (837)
Q Consensus       263 A~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l  322 (837)
                      +......    ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA  221 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred             ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            9754332    23457899999999999999999999999999999999999999887765543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-40  Score=361.83  Aligned_cols=201  Identities=23%  Similarity=0.327  Sum_probs=174.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.++||+|+||+||+|++..+++.||||++..... .+.+.+|+.+++.|.      .|+||+++++++...+..+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~------~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLG------SGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHC------SCTTSCCEEEEEEETTEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhh------CCCCCCEEEEEEecCCccE
Confidence            789999999999999999999999999999999985432 345778999999994      5899999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC--CCeEEEEeccccccc
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK--PAEIKIIDFGSACTE  266 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~--~~~IKL~DFGlA~~~  266 (837)
                      |||||++++|.+++.... +.+++..++.++.||+.||+|||++|||||||||+|||++.+..  ...+||+|||++...
T Consensus        82 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999889999988653 56999999999999999999999999999999999999963211  122999999999753


Q ss_pred             CCc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          267 DRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       267 ~~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ...          ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            221          235689999999999999999999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.2e-40  Score=351.29  Aligned_cols=201  Identities=21%  Similarity=0.278  Sum_probs=175.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.+.||+|+||+||+|++..+++.||||+++... ..+.+.+|+.+++.+.      .|+||+++++++......+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~------~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLA------GCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTT------TCTTCCCEEEEEEETTEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHh------cCCCCCeEEeecCCCceeE
Confidence            78999999999999999999999999999999997543 2345778999999985      4789999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc--CCCCeEEEEeccccccc
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTE  266 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~--~~~~~IKL~DFGlA~~~  266 (837)
                      +||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+  .....+||+|||++...
T Consensus        83 lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           83 LVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999999889999987653 459999999999999999999999999999999999999643  12345999999999654


Q ss_pred             CCc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          267 DRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       267 ~~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ...          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            321          234578999999999999999999999999999999999999998743

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-40  Score=359.52  Aligned_cols=197  Identities=23%  Similarity=0.414  Sum_probs=168.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++++.||+|+||.||+|++. +++.||||+++..   ....+.+.+|+.+++.+.+     .|+||+++++++...+
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-----HSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG-----GCTTBCCEEEEEECSS
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc-----cCCceEEEEEEeecCC
Confidence            78999999999999999999885 4889999999743   3456778899999999965     3789999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .+++|||+.+++|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++    ++.+||+|||++..
T Consensus       102 ~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          102 YIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEEECCCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC
T ss_pred             EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccccc
Confidence            99999998888999998764  3699999999999999999999999999999999999995    37899999999975


Q ss_pred             cCCc-----ceeeccCccccCchhhcC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          266 EDRT-----VYSYIQSRYYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       266 ~~~~-----~~~~~GT~~Y~APEvl~~-----------~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ....     .....+++.|+|||++.+           ..++.++|||||||++|+|++|..||....
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            4332     124578999999999976           468889999999999999999999997643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-41  Score=369.55  Aligned_cols=270  Identities=21%  Similarity=0.355  Sum_probs=211.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh------------------HHHHHHHHHHHHHhhcccCCCC
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY------------------YQQALVEVSILTTLNKKYDRED  170 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~------------------~~~~~~Ei~iL~~L~~~~~~~~  170 (837)
                      ++|++.+.||+|+||.||+|++  +++.||||++......                  .+.+.+|+.+++.+       .
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~  101 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-------K  101 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-------C
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-------C
Confidence            7999999999999999999988  8999999999743211                  17788999999888       6


Q ss_pred             CCceeEEeEEEeecceEEEEEeccch-hHHHH------HHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCC
Q 003239          171 KHHIVRIYEYFVCQRHLCICFELLDS-NLYEL------IKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPE  242 (837)
Q Consensus       171 HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~------l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPe  242 (837)
                      |+||+++++++...+..++||||+.+ +|.++      +.......+++..++.++.||+.||.|||+ +||+||||||+
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            89999999999999999999999986 88877      544334679999999999999999999999 99999999999


Q ss_pred             CeeeeccCCCCeEEEEecccccccC-CcceeeccCccccCchhhcCC-CCCc-cchHHHHHHHHHHHHhCCCCCCCCCH-
Q 003239          243 NILLCTSVKPAEIKIIDFGSACTED-RTVYSYIQSRYYRSPEVLLGY-QYTT-AIDMWSFGCIVAELFLGLPLFPGASE-  318 (837)
Q Consensus       243 NILl~~~~~~~~IKL~DFGlA~~~~-~~~~~~~GT~~Y~APEvl~~~-~yt~-ksDIWSLG~ILyELltG~~PF~g~s~-  318 (837)
                      |||++   .++.+||+|||++.... .......++..|+|||++.+. .++. ++|||||||++|||++|..||..... 
T Consensus       182 Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          182 NILMD---KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             GEEEC---TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             hEEEc---CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99995   67899999999997643 334456789999999999887 6776 99999999999999999999987765 


Q ss_pred             HHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccch
Q 003239          319 FDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL  398 (837)
Q Consensus       319 ~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L  398 (837)
                      .+.+..+.......|...        ..+..                                    +      +.....
T Consensus       259 ~~~~~~i~~~~~~~~~~~--------~~~~~------------------------------------~------~~~~~~  288 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDR--------NHFLY------------------------------------P------LTNKKS  288 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSS--------SSSTT------------------------------------T------TCC---
T ss_pred             HHHHHHHhccCcCCccch--------hhhhc------------------------------------c------cccccc
Confidence            444443322100000000        00000                                    0      000000


Q ss_pred             HHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       399 ~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .                 .....++..+.+||++||+.||++|||++|+|+||||++..
T Consensus       289 ~-----------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          289 T-----------------CSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             ----------------------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             c-----------------cchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            0                 00122457899999999999999999999999999999855

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.8e-42  Score=363.35  Aligned_cols=264  Identities=24%  Similarity=0.396  Sum_probs=188.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  ....+.+.+|+.+++.+       .||||+++++++...+
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-------HHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-------CCTTBCCEEEEEESSS
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-------CCCCEeeEEEEEeecC
Confidence            47999999999999999999999999999999998753  23345566777776665       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhh------ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          186 HLCICFELLD-SNLYELIKIN------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~------~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      ..++||||+. ++|.+++...      ....+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEE
Confidence            9999999996 5888888642      224589999999999999999999999999999999999995   66889999


Q ss_pred             ecccccccCC--------cceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          259 DFGSACTEDR--------TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       259 DFGlA~~~~~--------~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      |||++.....        ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.+.....  
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--  241 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--  241 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--
Confidence            9999864322        1234578999999999976 4789999999999999999999999987655443322211  


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      . .++..                     .                               .. ...   .+         
T Consensus       242 ~-~~~~~---------------------~-------------------------------~~-~~~---~~---------  255 (303)
T 2vwi_A          242 N-DPPSL---------------------E-------------------------------TG-VQD---KE---------  255 (303)
T ss_dssp             S-SCCCT---------------------T-------------------------------C---------C---------
T ss_pred             c-CCCcc---------------------c-------------------------------cc-ccc---ch---------
Confidence            0 00000                     0                               00 000   00         


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                              .....+..+.+||.+||..||++|||++|+|+||||++..
T Consensus       256 --------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          256 --------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             --------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             --------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence                    0011346789999999999999999999999999999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.7e-41  Score=365.54  Aligned_cols=249  Identities=24%  Similarity=0.424  Sum_probs=207.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-------hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++....       ..+.+.+|+.+++.+.+     .|+||++++++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~~i~~~~~~  116 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS-----GFSGVIRLLDW  116 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS-----SSCSBCCEEEE
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc-----CCCCceEEEEE
Confidence            3799999999999999999999999999999999975421       22456679999999964     57999999999


Q ss_pred             EeecceEEEEEeccc--hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          181 FVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       181 f~~~~~l~LVmEy~~--gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      +...+..++|||++.  ++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++  ...+.+||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~  192 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLI  192 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEe
Confidence            999999999999997  6899988764  3699999999999999999999999999999999999995  356789999


Q ss_pred             ecccccccCCc-ceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003239          259 DFGSACTEDRT-VYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       259 DFGlA~~~~~~-~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      |||++...... .....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||.....      +..  + ..   
T Consensus       193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~-~~---  260 (320)
T 3a99_A          193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--G-QV---  260 (320)
T ss_dssp             CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--C-CC---
T ss_pred             eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--c-cc---
Confidence            99999765433 344578999999999987765 6889999999999999999999954210      100  0 00   


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                             .+            +          
T Consensus       261 -------------------------------------------------------~~------------~----------  263 (320)
T 3a99_A          261 -------------------------------------------------------FF------------R----------  263 (320)
T ss_dssp             -------------------------------------------------------CC------------S----------
T ss_pred             -------------------------------------------------------cc------------c----------
Confidence                                                                   00            0          


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                         ..+++++.+||++||+.||++|||++|+|+||||++..
T Consensus       264 ---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          264 ---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence               01346789999999999999999999999999999854

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=354.35  Aligned_cols=256  Identities=25%  Similarity=0.351  Sum_probs=201.5

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      +|....+||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.+       .|+||+++++++...+..+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-------KHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-------CCTTBCCEEEEEEETTEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-------CCCCEeeEeeEEEeCCcEE
Confidence            344445899999999999999999999999999864 34456788899999988       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          189 ICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      +||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++  ..++.+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEES
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeeccccccc
Confidence            9999996 68888887653 23467999999999999999999999999999999999996  23678999999999754


Q ss_pred             CCc---ceeeccCccccCchhhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          267 DRT---VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       267 ~~~---~~~~~GT~~Y~APEvl~~~~--yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ...   .....+++.|+|||++.+..  ++.++|||||||++|+|++|+.||.................           
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------  242 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-----------  242 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-----------
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-----------
Confidence            322   33457899999999997653  88999999999999999999999965432221110000000           


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                ..+                 ..             ...
T Consensus       243 ------------------------------------------~~~-----------------~~-------------~~~  250 (295)
T 2clq_A          243 ------------------------------------------VHP-----------------EI-------------PES  250 (295)
T ss_dssp             ------------------------------------------CCC-----------------CC-------------CTT
T ss_pred             ------------------------------------------ccc-----------------cc-------------ccc
Confidence                                                      000                 00             011


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .++.+.+||.+||..||++|||++|+|+||||+...
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            346789999999999999999999999999999754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-40  Score=352.09  Aligned_cols=207  Identities=20%  Similarity=0.301  Sum_probs=177.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|+++++||+|+||+||++.+. +++.||||+++......+.+.+|+++++.+       .|+||+++++++...+..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-------SHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-------CCTTBCCEEEEECSSSSE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-------CCCCEeeEEEEEecCCCe
Confidence            379999999999999999999765 677899999997765667889999999998       589999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGB
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEccccccccc
Confidence            99999996 58988887643 4699999999999999999999999999999999999995   6778999999999755


Q ss_pred             CCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      ....    ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~  235 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA  235 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence            4322    22345678999999998899999999999999999998 999998877666555443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-40  Score=349.73  Aligned_cols=205  Identities=22%  Similarity=0.371  Sum_probs=179.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++++.||+|+||+||+|++. +++.||||+++......+.+.+|+++++++       .||||+++++++.+.+..|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-------SHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-------CCTTBCCEEEEECSSSSEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-------CCCCEeeEEEEEecCCceE
Confidence            78999999999999999999876 477799999997766667889999999998       5899999999999999999


Q ss_pred             EEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred             EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccc
Confidence            99999975 8888886543 4699999999999999999999999999999999999995   56789999999997554


Q ss_pred             Ccc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ...    ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~  220 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI  220 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            322    23355778999999998899999999999999999999 99999887776655544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3e-40  Score=347.14  Aligned_cols=206  Identities=22%  Similarity=0.334  Sum_probs=178.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++++.||+|+||+||+|++. ++..||||+++......+.+.+|+++++.+       .||||+++++++...+..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-------SHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-------CCCCEeeEEEEEccCCce
Confidence            379999999999999999999765 577899999997766667889999999999       589999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEEC
T ss_pred             EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCccceec
Confidence            99999997 57888887653 4599999999999999999999999999999999999995   6789999999999754


Q ss_pred             CCcce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          267 DRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       267 ~~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      .....    ...+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  218 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV  218 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence            43321    2344667999999999899999999999999999999 99999887766554443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=357.07  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=186.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHH-HHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVS-ILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~-iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++++.||+|+||+||+|++..+++.||||+++...  ....+...|+. +++.+       .|+||+++++++...+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-------~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-------DCPYIVQCFGTFITNT   97 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-------TCTTBCCEEEEEECSS
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-------CCCceeeEEEEEecCC
Confidence            79999999999999999999999999999999998643  22233333433 33333       7899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++|||||+++.+..+... ....+++..++.++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||++.
T Consensus        98 ~~~lv~e~~~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC-
T ss_pred             cEEEEEeccCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCch
Confidence            9999999996555555443 345699999999999999999999995 999999999999995   67889999999996


Q ss_pred             ccCC--cceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCchH
Q 003239          265 TEDR--TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDY  336 (837)
Q Consensus       265 ~~~~--~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~-s~~e~l~~I~~~lG~~Pp~~  336 (837)
                      ....  ......+++.|+|||++.     ...++.++|||||||++|+|++|+.||... ...+.+..+....   ++. 
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~-  249 (318)
T 2dyl_A          174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPL-  249 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC---CCC-
T ss_pred             hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC---CCC-
Confidence            5432  233457899999999995     457889999999999999999999999763 3333333332210   000 


Q ss_pred             HHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       337 ~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                                                                                          .|          
T Consensus       250 --------------------------------------------------------------------~~----------  251 (318)
T 2dyl_A          250 --------------------------------------------------------------------LP----------  251 (318)
T ss_dssp             --------------------------------------------------------------------CC----------
T ss_pred             --------------------------------------------------------------------CC----------
Confidence                                                                                00          


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                       ....++..+.+||.+||..||.+|||++|+|+||||++.
T Consensus       252 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          252 -GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             -SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             -ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence             000134678999999999999999999999999999863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-40  Score=352.39  Aligned_cols=204  Identities=21%  Similarity=0.346  Sum_probs=182.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++.+....+.+.+|+++++.+       .|+||+++++++...+..
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEccCCCE
Confidence            3789999999999999999999999999999999998777778899999999999       589999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGGTS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCccceec
Confidence            99999998 6999999876666799999999999999999999999999999999999995   5678999999999765


Q ss_pred             CCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      ....    ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~  221 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV  221 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            4322    22355778999999999999999999999999999999 9999987655443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-40  Score=364.49  Aligned_cols=204  Identities=27%  Similarity=0.393  Sum_probs=174.6

Q ss_pred             CCceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~-----~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||.||+|+     +..+++.||||+++..  ....+.+.+|+++++.+.      .||||++++++
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hpniv~~~~~   94 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA   94 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc------CCcceeeeeee
Confidence            4899999999999999999998     6677899999999864  344567889999999995      58999999999


Q ss_pred             Eeecc-eEEEEEeccc-hhHHHHHHhhcc---------------------------------------------------
Q 003239          181 FVCQR-HLCICFELLD-SNLYELIKINHF---------------------------------------------------  207 (837)
Q Consensus       181 f~~~~-~l~LVmEy~~-gsL~d~l~~~~~---------------------------------------------------  207 (837)
                      +...+ .+++|||||. ++|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            98865 4999999998 599999876532                                                   


Q ss_pred             -------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCc-----
Q 003239          208 -------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-----  269 (837)
Q Consensus       208 -------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~-----  269 (837)
                                   ..+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||++......     
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchh
Confidence                         1289999999999999999999999999999999999995   6678999999999754221     


Q ss_pred             ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       270 ~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      .....+|+.|+|||++.+..++.++||||||||+|||++ |..||.+....+
T Consensus       252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  303 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  303 (359)
T ss_dssp             C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence            233467889999999999999999999999999999998 999998765433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.3e-40  Score=367.91  Aligned_cols=206  Identities=25%  Similarity=0.397  Sum_probs=176.4

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      .++|++.+.||+|+||+||+|++.       .++..||||+++..  ....+.+.+|+.+|+.+.      .||||++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hpnIv~~~  153 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLL  153 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC------CCTTBCCEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc------CCCCEeeEE
Confidence            479999999999999999999754       35678999999864  345567889999999984      489999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhcc--------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                      +++...+.+|+||||+. ++|.+++.....              ..+++.+++.++.||+.||+|||++|||||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            99999999999999997 499999876531              348999999999999999999999999999999999


Q ss_pred             eeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          244 ILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       244 ILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ||++   .++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       234 Ill~---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          234 VLVT---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             EEEC---TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEEC---CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9995   6789999999999754322     223356788999999999999999999999999999999 999998765


Q ss_pred             HHHHH
Q 003239          318 EFDLL  322 (837)
Q Consensus       318 ~~e~l  322 (837)
                      ..+..
T Consensus       311 ~~~~~  315 (370)
T 2psq_A          311 VEELF  315 (370)
T ss_dssp             GGGHH
T ss_pred             HHHHH
Confidence            54443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.7e-40  Score=357.94  Aligned_cols=252  Identities=24%  Similarity=0.272  Sum_probs=201.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ..+|++.++||+|+||+||+|++  +++.||||++...   ....+.+.+|+++|+++       .|+||+++++++...
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-------RHPNIVLFMGAVTQP  106 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEECST
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEEC
Confidence            37999999999999999999965  5889999999754   34456788999999999       589999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 RHLCICFELLDS-NLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      +.+++||||+.+ +|.+++.... ...+++..++.++.||+.||+|||++|  ||||||||+|||++   .++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCC
Confidence            999999999974 8998887543 123899999999999999999999999  99999999999995   6789999999


Q ss_pred             ccccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          261 GSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       261 GlA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |+++.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..... .+    
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~----  258 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-RL----  258 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-CC----
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CC----
Confidence            999754332   3346789999999999999999999999999999999999999988776655444322100 00    


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                          +           
T Consensus       259 --------------------------------------------------------------------~-----------  259 (309)
T 3p86_A          259 --------------------------------------------------------------------E-----------  259 (309)
T ss_dssp             --------------------------------------------------------------------C-----------
T ss_pred             --------------------------------------------------------------------C-----------
Confidence                                                                                0           


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHc--CccCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASR--HPFVTG  455 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~--HPff~~  455 (837)
                      ....+++.+.+||++||..||++|||++|+++  +++++.
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00113467899999999999999999999998  677765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-40  Score=359.45  Aligned_cols=255  Identities=20%  Similarity=0.293  Sum_probs=189.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~---~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|++.+.||+|+||+||+|++..+++   .||||+++..   ....+.+.+|+++++.+       .|+||+++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~   94 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-------DHPHVAKLVGVS   94 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-------CCTTBCCCCEEE
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-------CCCceehhhcee
Confidence            3789999999999999999999887765   8999999753   34567788999999888       689999999999


Q ss_pred             eecceE------EEEEeccch-hHHHHHHhhccC----CCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC
Q 003239          182 VCQRHL------CICFELLDS-NLYELIKINHFR----GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV  250 (837)
Q Consensus       182 ~~~~~l------~LVmEy~~g-sL~d~l~~~~~~----~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~  250 (837)
                      ......      ++||||+.+ +|.+++......    .+++..++.++.||+.||+|||++||+||||||+|||++   
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---
Confidence            887655      999999985 898888765322    489999999999999999999999999999999999995   


Q ss_pred             CCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          251 KPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       251 ~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      .++.+||+|||+++.....     .....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~  251 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY  251 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            6689999999999754322     123355778999999999999999999999999999999 9999987766554443


Q ss_pred             HHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhc
Q 003239          325 MIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN  404 (837)
Q Consensus       325 I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~  404 (837)
                      +.....  +                                                                       
T Consensus       252 ~~~~~~--~-----------------------------------------------------------------------  258 (323)
T 3qup_A          252 LIGGNR--L-----------------------------------------------------------------------  258 (323)
T ss_dssp             HHTTCC--C-----------------------------------------------------------------------
T ss_pred             HhcCCC--C-----------------------------------------------------------------------
Confidence            322000  0                                                                       


Q ss_pred             CCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCC-------HHHHHcCccCCCCC
Q 003239          405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS-------PFQASRHPFVTGEP  457 (837)
Q Consensus       405 ~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpT-------a~EaL~HPff~~~~  457 (837)
                       +           .....++.+.+||.+||+.||++|||       ++++++|||+....
T Consensus       259 -~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          259 -K-----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             -C-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             -C-----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence             0           00113467899999999999999999       78899999999754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=360.38  Aligned_cols=209  Identities=21%  Similarity=0.308  Sum_probs=177.5

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ..++|++.++||+|+||+||+|++..++   ..||||+++..  ....+.+.+|+.+|+.+       .|+||+++++++
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~  119 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-------DHPNIIRLEGVV  119 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEE
Confidence            3489999999999999999999987554   45999999863  44556788999999888       689999999999


Q ss_pred             eecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      ...+..||||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Df  195 (325)
T 3kul_A          120 TRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDF  195 (325)
T ss_dssp             CGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCC
T ss_pred             EeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCC
Confidence            999999999999975 8888886543 4699999999999999999999999999999999999995   6789999999


Q ss_pred             ccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          261 GSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       261 GlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      |+++......      ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  268 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE  268 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            9997553321      12245678999999998899999999999999999999 999998887766655443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=358.27  Aligned_cols=197  Identities=24%  Similarity=0.401  Sum_probs=175.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC-ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~-~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++.++||+|+||+||+|++..+++.||+|++.. .....+.+.+|+++++.+       .||||+++++++...+.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-------EHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEETTE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCcCcccEEEEEecCCe
Confidence            3799999999999999999999999999999999865 445667788999999888       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||++..
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARL  157 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEE
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeeccccee
Confidence            9999999975 8988887643 4699999999999999999999999999999999999995   678899999999965


Q ss_pred             cCCcc-----------------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          266 EDRTV-----------------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       266 ~~~~~-----------------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      .....                 ...+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            43221                 145789999999999999999999999999999999999999854

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-40  Score=361.29  Aligned_cols=195  Identities=27%  Similarity=0.313  Sum_probs=167.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---  185 (837)
                      ++|++.++||+|+||+||+|++.  ++.||||+++..........+|+.+|+.+       .||||+++++++....   
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-------KHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-------CCTTBCCEEEEEEEECSSS
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-------CCCCchhhcceeccCCCCC
Confidence            79999999999999999999764  78999999987665556666788777776       6899999999998854   


Q ss_pred             -eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC----------CeeeccCCCCCeeeeccCCCC
Q 003239          186 -HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA----------GIIHCDLKPENILLCTSVKPA  253 (837)
Q Consensus       186 -~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~----------gIVHrDLKPeNILl~~~~~~~  253 (837)
                       .+|+|||||.+ +|.+++...   .+++..++.++.||+.||+|||+.          +||||||||+|||++   ..+
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~  168 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNL  168 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTC
T ss_pred             ceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCC
Confidence             47999999975 999998764   499999999999999999999999          999999999999995   678


Q ss_pred             eEEEEecccccccCCc-----ceeeccCccccCchhhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          254 EIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      .+||+|||+++.....     ....++|+.|+|||++.+.     .++.++|||||||++|||++|+.||.+...
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            9999999999654322     2235789999999999873     567789999999999999999999976543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.8e-40  Score=348.43  Aligned_cols=201  Identities=25%  Similarity=0.301  Sum_probs=172.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.+|+.+++.+.+      +++|..+..++...+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~------~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG------GVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTT------STTCCCEEEEEEETTEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhc------CCCCCccccccCCCCce
Confidence            3799999999999999999999999999999999975432 3457889999999953      34455555666777889


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ++||||++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++..+.+||+|||++....
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            9999999889999987543 469999999999999999999999999999999999999655567899999999996543


Q ss_pred             Cc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          268 RT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       268 ~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ..          .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            22          23457899999999999999999999999999999999999999764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.1e-40  Score=350.54  Aligned_cols=202  Identities=25%  Similarity=0.299  Sum_probs=169.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.+|+.+++.+.+      +++|..+..++...+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~------~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG------GVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTT------STTCCCEEEEEEETTEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcC------CCCCCeeeeecCCCCce
Confidence            3799999999999999999999999999999999875432 2457789999999953      34566666666778899


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++....
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999889999887543 469999999999999999999999999999999999999544577889999999996543


Q ss_pred             Cc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          268 RT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       268 ~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ..          .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            22          234578999999999999999999999999999999999999997643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=355.86  Aligned_cols=252  Identities=22%  Similarity=0.353  Sum_probs=198.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-------hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.++||+|+||.||+|++..+++.||||+++....       ....+.+|+.+++++...   ..|+||+++++++
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~~h~~i~~~~~~~  107 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG---GGHPGVIRLLDWF  107 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS---CCCSSBCCEEEEC
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc---CCCCCeeeEEEEE
Confidence            789999999999999999999999999999999975432       223455799999998532   2689999999999


Q ss_pred             eecceEEEEEec-cc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          182 VCQRHLCICFEL-LD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       182 ~~~~~l~LVmEy-~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ...+..++|||+ +. ++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++  ..++.+||+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d  183 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID  183 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence            999999999999 54 69999887653  599999999999999999999999999999999999995  3567899999


Q ss_pred             cccccccCC-cceeeccCccccCchhhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTEDR-TVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~~-~~~~~~GT~~Y~APEvl~~~~yt-~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||++..... ......++..|+|||++.+..+. .++|||||||++|+|++|+.||....      .+....-       
T Consensus       184 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~-------  250 (312)
T 2iwi_A          184 FGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL-------  250 (312)
T ss_dssp             CSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC-------
T ss_pred             cchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc-------
Confidence            999975543 33456789999999999877664 59999999999999999999995421      0110000       


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                        .++           
T Consensus       251 ------------------------------------------------------------------~~~-----------  253 (312)
T 2iwi_A          251 ------------------------------------------------------------------HFP-----------  253 (312)
T ss_dssp             ------------------------------------------------------------------CCC-----------
T ss_pred             ------------------------------------------------------------------CCc-----------
Confidence                                                                              000           


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                        ..++..+.+||.+||+.||++|||++|+|+||||+.....
T Consensus       254 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          254 --AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             --ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence              0134678999999999999999999999999999986543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=363.20  Aligned_cols=209  Identities=26%  Similarity=0.394  Sum_probs=179.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC-------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~-------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      .++|++.++||+|+||+||+|++..       .++.||||+++..  ....+.+.+|+++++.+.      .|+||++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hpnIv~~~  141 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG------KHKNIINLL  141 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc------CCchhhhhe
Confidence            4799999999999999999998643       3468999999864  344577889999999994      589999999


Q ss_pred             EEEeecceEEEEEeccch-hHHHHHHhhcc--------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          179 EYFVCQRHLCICFELLDS-NLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~--------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                      +++...+..||||||+.+ +|.+++.....              ..+++..++.++.||+.||+|||+++||||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            999999999999999974 99999887542              359999999999999999999999999999999999


Q ss_pred             eeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          244 ILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       244 ILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      |||+   .++.+||+|||+++.....     .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus       222 Ill~---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          222 VLVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             EEEC---TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEEc---CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9995   6689999999999754322     223456788999999999999999999999999999999 999998877


Q ss_pred             HHHHHHHH
Q 003239          318 EFDLLRRM  325 (837)
Q Consensus       318 ~~e~l~~I  325 (837)
                      ..+....+
T Consensus       299 ~~~~~~~~  306 (382)
T 3tt0_A          299 VEELFKLL  306 (382)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            66554443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-39  Score=369.86  Aligned_cols=257  Identities=27%  Similarity=0.377  Sum_probs=196.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      +.|.+.++||+|+||+||.+ ...+++.||||++..+.  .+.+.+|+.+|+++.      .||||+++++++...+.+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~------~HpnIv~~~~~~~~~~~~~   85 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESD------DHPNVIRYYCSETTDRFLY   85 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHT------TSTTBCCEEEEEECSSEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhcc------CCCCcCeEEEEEecCCeEE
Confidence            67888899999999999875 45679999999997643  456788999998873      5899999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCC-----CCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc----------CCCC
Q 003239          189 ICFELLDSNLYELIKINHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----------VKPA  253 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~-----L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~----------~~~~  253 (837)
                      ||||||+++|.+++.......     .++..++.++.||+.||+|||++|||||||||+|||++.+          ....
T Consensus        86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence            999999999999987653211     1333467899999999999999999999999999999743          2456


Q ss_pred             eEEEEecccccccCCc-------ceeeccCccccCchhhcC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          254 EIKIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~-------~~~~~GT~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      .+||+|||++......       ....+||+.|+|||++.+       ..++.++||||||||+|||++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            8999999999765432       224579999999999976       578999999999999999999 9999966533


Q ss_pred             HHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccch
Q 003239          319 FDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL  398 (837)
Q Consensus       319 ~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L  398 (837)
                      .+  ..+.....  .                    ...                                         +
T Consensus       246 ~~--~~i~~~~~--~--------------------~~~-----------------------------------------~  260 (434)
T 2rio_A          246 RE--SNIIRGIF--S--------------------LDE-----------------------------------------M  260 (434)
T ss_dssp             HH--HHHHHTCC--C--------------------CCC-----------------------------------------C
T ss_pred             hH--HHHhcCCC--C--------------------ccc-----------------------------------------c
Confidence            22  11111000  0                    000                                         0


Q ss_pred             HHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       399 ~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                                .      ......+++++.+||.+||+.||++|||+.|+|+||||..
T Consensus       261 ----------~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          261 ----------K------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             ----------T------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ----------c------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence                      0      0001235678999999999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-40  Score=356.92  Aligned_cols=208  Identities=23%  Similarity=0.390  Sum_probs=178.3

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++++.||+|+||.||+|++.     .+++.||||+++..  ....+.+.+|+.+++.+       .||||++++++
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~  118 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-------DNPNIVKLLGV  118 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEE
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEE
Confidence            479999999999999999999886     45689999999854  34456788999999998       68999999999


Q ss_pred             EeecceEEEEEeccch-hHHHHHHhhc----------------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeec
Q 003239          181 FVCQRHLCICFELLDS-NLYELIKINH----------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHC  237 (837)
Q Consensus       181 f~~~~~l~LVmEy~~g-sL~d~l~~~~----------------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHr  237 (837)
                      +...+..||||||+.+ +|.+++....                      ...+++.+++.++.||+.||.|||++||+||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999999999999985 9999987642                      1469999999999999999999999999999


Q ss_pred             cCCCCCeeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCC
Q 003239          238 DLKPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLP  311 (837)
Q Consensus       238 DLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~  311 (837)
                      ||||+|||++   .++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       199 Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          199 DLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSGGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCcceEEEC---CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999995   6678999999999654322     233467889999999999899999999999999999999 999


Q ss_pred             CCCCCCHHHHHHHH
Q 003239          312 LFPGASEFDLLRRM  325 (837)
Q Consensus       312 PF~g~s~~e~l~~I  325 (837)
                      ||.+.+..+....+
T Consensus       276 p~~~~~~~~~~~~~  289 (343)
T 1luf_A          276 PYYGMAHEEVIYYV  289 (343)
T ss_dssp             TTTTSCHHHHHHHH
T ss_pred             cCCCCChHHHHHHH
Confidence            99887766554443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.9e-40  Score=352.48  Aligned_cols=204  Identities=26%  Similarity=0.424  Sum_probs=175.3

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||.||+|++     ..+++.||||+++..  ....+.+.+|+++++.+       .||||++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~   94 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-------NHPHVIKLYGA   94 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEE
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-------CCCceeeEEEE
Confidence            37999999999999999999986     345689999999853  34556788899999888       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhcc----------------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeec
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHF----------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHC  237 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~----------------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHr  237 (837)
                      +...+..++||||+. ++|.+++.....                      ..+++.+++.++.||+.||+|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999999998 699999876532                      238999999999999999999999999999


Q ss_pred             cCCCCCeeeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCC
Q 003239          238 DLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLP  311 (837)
Q Consensus       238 DLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~  311 (837)
                      ||||+|||++   .++.+||+|||++.......     ....+++.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       175 dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          175 DLAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999996   67889999999997543321     23356788999999999899999999999999999999 999


Q ss_pred             CCCCCCHHHH
Q 003239          312 LFPGASEFDL  321 (837)
Q Consensus       312 PF~g~s~~e~  321 (837)
                      ||.+....+.
T Consensus       252 p~~~~~~~~~  261 (314)
T 2ivs_A          252 PYPGIPPERL  261 (314)
T ss_dssp             SSTTCCGGGH
T ss_pred             CCCCCCHHHH
Confidence            9987655443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=355.13  Aligned_cols=199  Identities=27%  Similarity=0.359  Sum_probs=158.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe-----
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-----  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-----  182 (837)
                      .+|++.++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++++.      +|+||+++++++.     
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS------GHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT------TSTTBCCEEEEEEECTTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc------cCCChhhccccccccccc
Confidence            6899999999999999999999999999999998644 445667889999999994      4899999999994     


Q ss_pred             ---ecceEEEEEeccchhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEE
Q 003239          183 ---CQRHLCICFELLDSNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       183 ---~~~~l~LVmEy~~gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IK  256 (837)
                         ....+++||||+.|+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+|||++   .++.+|
T Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~~k  178 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIK  178 (337)
T ss_dssp             STTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSCEE
T ss_pred             cccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCCEE
Confidence               345689999999999999887632 345999999999999999999999999  99999999999995   667899


Q ss_pred             EEecccccccCCcc---------------eeeccCccccCchhh---cCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          257 IIDFGSACTEDRTV---------------YSYIQSRYYRSPEVL---LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       257 L~DFGlA~~~~~~~---------------~~~~GT~~Y~APEvl---~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      |+|||++.......               ....+|+.|+|||++   .+..++.++|||||||++|+|++|+.||...
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            99999997543321               144689999999999   4667899999999999999999999999653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-39  Score=358.55  Aligned_cols=205  Identities=16%  Similarity=0.187  Sum_probs=171.4

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCChhhHHHHHHHHHHHHHhhc--------ccCCCCCCc
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQPAYYQQALVEVSILTTLNK--------KYDREDKHH  173 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~t-----g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~--------~~~~~~Hpn  173 (837)
                      ..++|++.++||+|+||+||+|++..+     ++.||||++.....   ...+|+++++.+.+        ......|+|
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH---HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch---hHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            347999999999999999999988664     57899999986542   45567777776654        123457999


Q ss_pred             eeEEeEEEeec----ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          174 IVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       174 IVkl~d~f~~~----~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      |+++++++...    .+.|||||||+++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||++.+
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            99999999875    5689999999889999887643 569999999999999999999999999999999999999632


Q ss_pred             CCCCeEEEEecccccccCCc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          250 VKPAEIKIIDFGSACTEDRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~~~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                       ..+.+||+|||+++.....          ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       189 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          189 -NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             -CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             -CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence             5688999999999643321          12345999999999999999999999999999999999999999754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.2e-40  Score=355.88  Aligned_cols=256  Identities=21%  Similarity=0.234  Sum_probs=206.8

Q ss_pred             CCceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~-----~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++++.||+|+||.||+|+     +..+++.||||++...  ......+.+|+.+++.+       .||||++++++
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~  101 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-------NHQNIVRCIGV  101 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-------CCCCCCeEEEE
Confidence            3799999999999999999998     5567889999999743  34556788899999998       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhcc-----CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                      +...+..||||||+. ++|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++.+.....
T Consensus       102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence            999999999999996 699999887542     34899999999999999999999999999999999999975545668


Q ss_pred             EEEEecccccccCC-----cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 003239          255 IKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRI  328 (837)
Q Consensus       255 IKL~DFGlA~~~~~-----~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~~  328 (837)
                      +||+|||++.....     ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+.+..+...
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            99999999864321     1233467889999999999899999999999999999998 99999887765554433221


Q ss_pred             hCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCC
Q 003239          329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR  408 (837)
Q Consensus       329 lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~  408 (837)
                      ..  +                                                                        +  
T Consensus       262 ~~--~------------------------------------------------------------------------~--  265 (327)
T 2yfx_A          262 GR--M------------------------------------------------------------------------D--  265 (327)
T ss_dssp             CC--C------------------------------------------------------------------------C--
T ss_pred             CC--C------------------------------------------------------------------------C--
Confidence            00  0                                                                        0  


Q ss_pred             CCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       409 ~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                               ....++..+.+||.+||..||++|||++|+++|.|+..
T Consensus       266 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          266 ---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                     00013467899999999999999999999999988754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.2e-40  Score=366.18  Aligned_cols=205  Identities=25%  Similarity=0.407  Sum_probs=177.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..  ....+.+.+|+++|+.+       .||||+++++++...+
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-------SHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-------CCTTBCCEEEEECSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEecCC
Confidence            37899999999999999999999999999999999854  23345678899999888       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+||||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||+++
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSR  261 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCE
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCce
Confidence            9999999997 68999887653 4599999999999999999999999999999999999995   67899999999997


Q ss_pred             ccCCccee-----eccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          265 TEDRTVYS-----YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       265 ~~~~~~~~-----~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ........     ..++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~  326 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE  326 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            65433222     134667999999998899999999999999999998 999998877655443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=376.47  Aligned_cols=199  Identities=25%  Similarity=0.259  Sum_probs=163.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      .+|++.++||+|+||+|+. ....+++.||||++.....  ..+.+|+++|+++.      .|||||++++++.+....|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~------~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESD------EHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSC------CCTTBCCEEEEEEETTEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhcc------CCCCcCeEEEEEecCCEEE
Confidence            5799999999999999764 3456789999999975432  23567999999884      5899999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC--CCCeEEEEeccccccc
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTE  266 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~IKL~DFGlA~~~  266 (837)
                      ||||||.++|.+++.... ..+.+..++.++.||+.||+|||++|||||||||+|||++.++  ....+||+|||++...
T Consensus        95 lv~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           95 IAIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999999999999988654 3355666789999999999999999999999999999996432  3346889999999754


Q ss_pred             CC------cceeeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          267 DR------TVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       267 ~~------~~~~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ..      .....+||+.|+|||++.+   ..++.++||||||||+|||++ |.+||....
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~  234 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL  234 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence            32      2334679999999999984   567889999999999999999 999995543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.8e-40  Score=358.25  Aligned_cols=200  Identities=26%  Similarity=0.372  Sum_probs=151.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++++.||+|+||.||+|.+..+++.||||+++..  .........|+..+.+      ...|+||+++++++...+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~------~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR------SSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHS------SCCCTTBCCEEEEEECSS
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHH------cCCCCcEeeeeeEEEeCC
Confidence            48999999999999999999999999999999999864  2333445555553222      227999999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhh---ccCCCCHHHHHHHHHhHHHHHhhhhcC-CeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          186 HLCICFELLDSNLYELIKIN---HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~---~~~~L~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+|||||+.++|.+++...   ....+++..++.++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg  171 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFG  171 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCS
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCC
Confidence            99999999999888877642   235699999999999999999999998 999999999999996   67899999999


Q ss_pred             cccccCCc--ceeeccCccccCchhh----cCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          262 SACTEDRT--VYSYIQSRYYRSPEVL----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       262 lA~~~~~~--~~~~~GT~~Y~APEvl----~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++......  .....+|+.|+|||++    .+..++.++|||||||++|+|++|+.||...
T Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            99765432  2334789999999999    4557899999999999999999999999764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-39  Score=341.06  Aligned_cols=205  Identities=22%  Similarity=0.357  Sum_probs=178.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.+.||+|+||.||+|++. +++.||||+++......+.+.+|+++++.+       .||||+++++++...+..+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-------SHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-------CCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-------CCCCEeeEEEEEccCCCeE
Confidence            78999999999999999999876 577899999997665667889999999988       5899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++....
T Consensus        80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred             EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccc
Confidence            9999997 58988887653 4689999999999999999999999999999999999995   56789999999997554


Q ss_pred             Ccc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ...    ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i  218 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI  218 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence            321    23356778999999998899999999999999999999 89999887766554443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-39  Score=345.49  Aligned_cols=200  Identities=24%  Similarity=0.344  Sum_probs=171.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----h----HHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----Y----YQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~----~----~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....    .    .+.+.+|+.+++.+       .|+||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~   90 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-------NHPNIVKLYG   90 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-------CCTTBCCEEE
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-------CCCCchhhhe
Confidence            3799999999999999999999999999999999864321    1    15678899999888       6899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccC--CCCe
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSV--KPAE  254 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~--~~~~  254 (837)
                      ++....  ++||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+.  ....
T Consensus        91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           91 LMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             EETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             eecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence            987665  79999998 68888886553 56999999999999999999999999  99999999999996321  1224


Q ss_pred             EEEEecccccccCCcceeeccCccccCchhhc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          255 IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       255 IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~--~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      +||+|||++...........+|+.|+|||++.  ...++.++|||||||++|||++|+.||....
T Consensus       168 ~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             EEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             EEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            99999999987777777788999999999994  4468899999999999999999999997654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.6e-39  Score=346.71  Aligned_cols=203  Identities=27%  Similarity=0.378  Sum_probs=176.0

Q ss_pred             CceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~-----~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.+.||+|+||+||+|+     +..+++.||||+++...  ...+.+.+|+.+++++.      .||||+++++++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~i~~~~~~~   96 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG------NHMNIVNLLGAC   96 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc------cCCCeeeEEEEE
Confidence            799999999999999999997     45678899999998542  34577889999999994      589999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhcc----------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHF----------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~----------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      ...+..++||||+. ++|.+++.....                ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999997 499999876542                2489999999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++   .++.+||+|||++.......     ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       177 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          177 LLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEc---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            996   67899999999997554322     23356788999999999999999999999999999998 9999977654


Q ss_pred             HH
Q 003239          319 FD  320 (837)
Q Consensus       319 ~e  320 (837)
                      .+
T Consensus       254 ~~  255 (313)
T 1t46_A          254 DS  255 (313)
T ss_dssp             SH
T ss_pred             hh
Confidence            33

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=368.12  Aligned_cols=201  Identities=22%  Similarity=0.399  Sum_probs=173.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++...  ...+.+.+|+++|+.+       .|+||+++++++...+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-------NHKNIVKLFAIEEETT   80 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-------CCCCCCeEEEeeccCC
Confidence            479999999999999999999999999999999998532  3356778899999999       5899999999998765


Q ss_pred             --eEEEEEeccc-hhHHHHHHhhcc-CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec-cCCCCeEEEEec
Q 003239          186 --HLCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT-SVKPAEIKIIDF  260 (837)
Q Consensus       186 --~l~LVmEy~~-gsL~d~l~~~~~-~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~-~~~~~~IKL~DF  260 (837)
                        ..|||||||. ++|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||+.. ++..+.+||+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence              7899999997 589888876432 23999999999999999999999999999999999999832 235677999999


Q ss_pred             ccccccCCc--ceeeccCccccCchhhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          261 GSACTEDRT--VYSYIQSRYYRSPEVLLG--------YQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       261 GlA~~~~~~--~~~~~GT~~Y~APEvl~~--------~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      |+++.....  ....+||+.|+|||++.+        ..++.++|||||||++|||++|+.||..
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999765432  335678999999999875        5688899999999999999999999964

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-39  Score=342.60  Aligned_cols=203  Identities=27%  Similarity=0.450  Sum_probs=163.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|++.++||+|+||+||+|++.  ++.||||+++...     ...+.+.+|+++++.+       .|+||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~   76 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-------KHPNIIALRGVCL   76 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-------CCTTBCCEEEEEC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-------CCCCEeeEEEEEe
Confidence            379999999999999999999764  8899999987532     2346788899999998       5899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC---eeeccCCCCCeeeeccC-----CCC
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG---IIHCDLKPENILLCTSV-----KPA  253 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g---IVHrDLKPeNILl~~~~-----~~~  253 (837)
                      ..+..++||||+. ++|.+++..   +.+++..++.++.||+.||+|||+++   |+||||||+|||++...     ..+
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             cCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence            9999999999997 577777643   46999999999999999999999999   99999999999996322     267


Q ss_pred             eEEEEecccccccCCc-ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 003239          254 EIKIIDFGSACTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL  322 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~-~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l  322 (837)
                      .+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....
T Consensus       154 ~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  223 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA  223 (271)
T ss_dssp             CEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             ceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            8999999999754332 33457899999999999989999999999999999999999999877655443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-39  Score=346.18  Aligned_cols=202  Identities=23%  Similarity=0.340  Sum_probs=171.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCC-------eEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg-------~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      .++|++.+.||+|+||+||+|++..++       +.||+|+++.. ....+.+.+|+.+++.+       .|+||+++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~   79 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-------SHKHLVLNYG   79 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-------CCTTBCCEEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-------CCCCEeEEEE
Confidence            479999999999999999999988777       57999999754 34567788999999998       5899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC-----CC
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-----PA  253 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-----~~  253 (837)
                      ++...+..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.+..     ..
T Consensus        80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           80 VCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             EECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             EEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence            9999999999999998 59999887654 34999999999999999999999999999999999999973321     12


Q ss_pred             eEEEEecccccccCCcceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhC-CCCCCCCCH
Q 003239          254 EIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLG-LPLFPGASE  318 (837)
Q Consensus       254 ~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG-~~PF~g~s~  318 (837)
                      .+||+|||++...... ....+|..|+|||++.+ ..++.++|||||||++|||++| .+||.....
T Consensus       159 ~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             EEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence            2999999999655433 34567899999999988 6799999999999999999995 555554443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.5e-39  Score=345.03  Aligned_cols=205  Identities=24%  Similarity=0.385  Sum_probs=165.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|++.++||+|+||+||+|++..+   +..||||+++..  ....+.+.+|+.+++.+       .||||+++++++.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~   86 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-------DHPHIVKLIGVIT   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCccceEEEEEc
Confidence            37999999999999999999987653   567999998753  34456788899999888       6899999999984


Q ss_pred             ecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       ++..|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg  161 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFG  161 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC--
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccc
Confidence             5678999999985 8988887553 4699999999999999999999999999999999999996   56899999999


Q ss_pred             cccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          262 SACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       262 lA~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ++......    .....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~  229 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR  229 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH
Confidence            99755332    123356778999999998899999999999999999997 9999987765554443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-39  Score=346.58  Aligned_cols=197  Identities=26%  Similarity=0.402  Sum_probs=169.1

Q ss_pred             CCceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~----~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|+++++||+|+||+||+|+    +..+++.||||+++.. ....+.+.+|+++++.+       .|+||+++++++.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~   81 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-------QHDNIVKYKGVCY   81 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe
Confidence            4899999999999999999998    6778999999999864 34456788999999998       5899999999987


Q ss_pred             ec--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..  ..+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~D  157 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGD  157 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEcc
Confidence            64  46899999996 59999887654 3599999999999999999999999999999999999996   568899999


Q ss_pred             cccccccCCc------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          260 FGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       260 FGlA~~~~~~------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ||++......      .....++..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            9999754322      1223467779999999999999999999999999999999999854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-39  Score=376.64  Aligned_cols=205  Identities=21%  Similarity=0.357  Sum_probs=181.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..+|++.++||+|+||+||+|++..+++.||||+++......+.+.+|+.+|+++       .||||+++++++...+.+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-------CCCCEeeEEEEEecCCcE
Confidence            3689999999999999999999999999999999987766678899999999999       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||. ++|.+++.......+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||+++..
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccceec
Confidence            99999998 6999999876556799999999999999999999999999999999999995   6688999999999765


Q ss_pred             CCcce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          267 DRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       267 ~~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      .....    ...++..|+|||++....++.++|||||||+||||++ |..||.+.+..+..
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~  429 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  429 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            43221    2244678999999999899999999999999999999 99999877654433

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.6e-39  Score=368.72  Aligned_cols=203  Identities=25%  Similarity=0.365  Sum_probs=174.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc-e
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-H  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-~  186 (837)
                      .++|++.++||+|+||+||++.+.  ++.||||+++... ..+.+.+|+.+|+++       .|+||+++++++...+ .
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC-------CCTTBCCEEEEEECTTSC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc-------cCCCEEEEEEEEEcCCCc
Confidence            478999999999999999999764  7899999998654 457788999999998       6899999999987765 7


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|||||||. ++|.+++.......+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||+++.
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCEE
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCccc
Confidence            999999997 5999999876545589999999999999999999999999999999999995   678999999999986


Q ss_pred             cCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          266 EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      .........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+.
T Consensus       339 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~  397 (450)
T 1k9a_A          339 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  397 (450)
T ss_dssp             CC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred             ccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            6554445567889999999999999999999999999999998 999998765544443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-39  Score=351.61  Aligned_cols=207  Identities=25%  Similarity=0.345  Sum_probs=176.4

Q ss_pred             CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.+.||+|+||.||+|++.     .+++.||||+++...  .....+.+|+.+++.+       .|+||+++++++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~   97 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-------NCHHVVRLLGVV   97 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-------CCTTBCCEEEEE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-------CCCCEeeeEEEE
Confidence            78999999999999999999876     467899999997542  3445678899998888       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc--------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH--------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                      ...+..++||||+. ++|.+++....        ...+++..++.++.||+.||.|||++||+||||||+|||++   .+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---ED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CC
Confidence            99999999999997 59999887543        13579999999999999999999999999999999999995   66


Q ss_pred             CeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          253 AEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      +.+||+|||++.......     ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            899999999997543221     23356788999999999899999999999999999999 89999887765554433

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.3e-39  Score=339.76  Aligned_cols=192  Identities=27%  Similarity=0.353  Sum_probs=171.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-----
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-----  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-----  183 (837)
                      .+|++++.||+|+||.||+|++..+++.||||+++...   +.+.+|+++++.+       .|+||+++++++..     
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-------DHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-------CCTTBCCEEEEEEEEEEC-
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-------CCCCEEEEeeeEeccccCc
Confidence            78999999999999999999999999999999998654   3456899999998       68999999999865     


Q ss_pred             -----------cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          184 -----------QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       184 -----------~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                                 ...+++||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~  157 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---D  157 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---E
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---C
Confidence                       4568999999985 999999876656799999999999999999999999999999999999996   6


Q ss_pred             CCeEEEEecccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          252 PAEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      ++.+||+|||++.....  ......+++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            67899999999875433  234457899999999999999999999999999999999998877

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.5e-39  Score=347.12  Aligned_cols=243  Identities=26%  Similarity=0.395  Sum_probs=191.1

Q ss_pred             CCceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          108 QRRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       108 ~~~Y~i~-~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      .++|.++ +.||+|+||.||+|++..+++.||||+++..    ....+|+.++.++.      .|+||+++++++..   
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~------~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS------QCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT------TSTTBCCEEEEEEEEET
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc------cCCCchhHHhhhhhhcC
Confidence            3678887 7899999999999999999999999999864    34567888886553      68999999999987   


Q ss_pred             -cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 -QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 -~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       ...++|||||+.+ +|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             7789999999975 99999987655579999999999999999999999999999999999999754447899999999


Q ss_pred             cccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          262 SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       262 lA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ++....                   +..++.++|||||||++|||++|..||......+....+..              
T Consensus       166 ~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------------  212 (299)
T 3m2w_A          166 FAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------------  212 (299)
T ss_dssp             TCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------------
T ss_pred             cccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------------
Confidence            985432                   24678899999999999999999999976543221000000              


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                              ..      .        ..                     ...+            |         ......
T Consensus       213 --------~~------~--------~~---------------------~~~~------------~---------~~~~~~  228 (299)
T 3m2w_A          213 --------RI------R--------MG---------------------QYEF------------P---------NPEWSE  228 (299)
T ss_dssp             --------SS------C--------TT---------------------CCSS------------C---------HHHHTT
T ss_pred             --------HH------h--------hc---------------------cccC------------C---------chhccc
Confidence                    00      0        00                     0000            0         001122


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            457899999999999999999999999999998754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=353.95  Aligned_cols=198  Identities=16%  Similarity=0.200  Sum_probs=159.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCChhhH------------HHHHHHHHHHHHhhcccCCCCCC
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQPAYY------------QQALVEVSILTTLNKKYDREDKH  172 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~---tg~~VAIKiik~~~~~~------------~~~~~Ei~iL~~L~~~~~~~~Hp  172 (837)
                      .++|++.++||+|+||+||+|++..   +++.||||++.......            ..+.+|+.+++.+       .|+
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-------~h~  108 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-------DYL  108 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-------SCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-------ccc
Confidence            4799999999999999999999887   78899999998653211            1123344444444       799


Q ss_pred             ceeEEeEEEee----cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec
Q 003239          173 HIVRIYEYFVC----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT  248 (837)
Q Consensus       173 nIVkl~d~f~~----~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~  248 (837)
                      ||+++++++..    ....||||||++++|.+++....  .+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus       109 ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          109 GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY  186 (345)
T ss_dssp             CCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES
T ss_pred             CcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc
Confidence            99999999988    78999999999889999887654  6999999999999999999999999999999999999973


Q ss_pred             cCCCCeEEEEecccccccCCc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          249 SVKPAEIKIIDFGSACTEDRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       249 ~~~~~~IKL~DFGlA~~~~~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      + ..+.+||+|||+++.....          .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus       187 ~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          187 K-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             S-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             C-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            2 2238999999999654221          1345789999999999999999999999999999999999999965

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=352.97  Aligned_cols=204  Identities=24%  Similarity=0.383  Sum_probs=172.8

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++..  ....+.+.+|+.+|+.+.      .||||++++++
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~  117 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG------SHENIVNLLGA  117 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc------CCCCeeeEEEE
Confidence            47999999999999999999986     346778999999753  234567889999999994      58999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhcc---------------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeecc
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHF---------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCD  238 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~---------------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrD  238 (837)
                      +...+..+|||||+. ++|.+++.....                     ..+++..++.++.||+.||+|||++||+|||
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            999999999999997 599999876532                     2379999999999999999999999999999


Q ss_pred             CCCCCeeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCC
Q 003239          239 LKPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPL  312 (837)
Q Consensus       239 LKPeNILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~P  312 (837)
                      |||+|||++   .++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       198 ikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          198 LAARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             CSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CChhhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999996   6789999999999654322     123456788999999999999999999999999999998 9999


Q ss_pred             CCCCCHHH
Q 003239          313 FPGASEFD  320 (837)
Q Consensus       313 F~g~s~~e  320 (837)
                      |.+....+
T Consensus       275 ~~~~~~~~  282 (344)
T 1rjb_A          275 YPGIPVDA  282 (344)
T ss_dssp             STTCCCSH
T ss_pred             cccCCcHH
Confidence            98765433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.1e-39  Score=349.50  Aligned_cols=209  Identities=24%  Similarity=0.398  Sum_probs=176.9

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      .++|++.+.||+|+||+||+|++.       .+++.||||+++..  ....+.+.+|+++++.+.      .||||++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~  107 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLL  107 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh------cCCCEeeEE
Confidence            379999999999999999999865       45778999999854  345567889999999994      589999999


Q ss_pred             EEEeecceEEEEEeccch-hHHHHHHhhcc--------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          179 EYFVCQRHLCICFELLDS-NLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~--------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                      +++...+.+++||||+.+ +|.+++.....              ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            999999999999999974 99999876531              248999999999999999999999999999999999


Q ss_pred             eeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          244 ILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       244 ILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ||++   .++.+||+|||++......     .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       188 Ill~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          188 VLVT---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             EEEC---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEEc---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9995   6788999999999755432     123356788999999998899999999999999999999 999998877


Q ss_pred             HHHHHHHH
Q 003239          318 EFDLLRRM  325 (837)
Q Consensus       318 ~~e~l~~I  325 (837)
                      ..+....+
T Consensus       265 ~~~~~~~~  272 (334)
T 2pvf_A          265 VEELFKLL  272 (334)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            65554443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.1e-39  Score=352.87  Aligned_cols=202  Identities=24%  Similarity=0.391  Sum_probs=165.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeE----EEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~----VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|+++++||+|+||+||+|++..+++.    ||+|+++..  ....+.+.+|+.+++.+       .||||+++++++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~   86 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGIC   86 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-------CBTTBCCEEEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-------CCCCEeEEEEEE
Confidence            37899999999999999999998877765    477776532  23456788999999999       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      .... .++|+|++. ++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+||
T Consensus        87 ~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Df  161 (327)
T 3poz_A           87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDF  161 (327)
T ss_dssp             ESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCT
T ss_pred             ecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccC
Confidence            8765 778888887 68998887653 4699999999999999999999999999999999999996   6688999999


Q ss_pred             ccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          261 GSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       261 GlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      |+++.....     .....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  228 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI  228 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH
Confidence            999654322     123355788999999999999999999999999999999 9999987655443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.2e-39  Score=368.22  Aligned_cols=207  Identities=26%  Similarity=0.386  Sum_probs=180.1

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.++||+|+||+||+|++. +++.||||+++......+.+.+|+.+|+.+       .||||+++++++. .+.+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-------QHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-------CCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-------CCCCEeeEEEEEe-CCcc
Confidence            378999999999999999999875 467899999997666678899999999988       6899999999986 6679


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||. ++|.+++.......+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||+++..
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGGGB
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCceEc
Confidence            99999997 5999999866545689999999999999999999999999999999999995   6789999999999765


Q ss_pred             CCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      ....    ....++..|+|||++....++.++|||||||++|||++ |+.||.+.+..+.+..+.
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  399 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE  399 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            4322    22345678999999998899999999999999999999 999999887776665544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-39  Score=346.09  Aligned_cols=187  Identities=24%  Similarity=0.339  Sum_probs=158.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---  184 (837)
                      .++|+++++||+|+||+||+|++  +++.||||+++...  .....+|.+++..+.     ..||||+++++++...   
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~-----l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM-----LRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC-----CCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh-----ccCcCeeeEEEeeccccCC
Confidence            38999999999999999999976  68999999997543  355667888877742     2699999999987653   


Q ss_pred             -ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh--------cCCeeeccCCCCCeeeeccCCCCe
Q 003239          185 -RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--------DAGIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       185 -~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH--------s~gIVHrDLKPeNILl~~~~~~~~  254 (837)
                       ..+|+||||+. ++|.++++.   ..+++..++.++.||+.||+|||        +++|+||||||+|||++   .++.
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---~~~~  151 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---KNGQ  151 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---TTSC
T ss_pred             CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---CCCC
Confidence             56899999998 599998854   35999999999999999999999        99999999999999995   6789


Q ss_pred             EEEEecccccccCCc-------ceeeccCccccCchhhcCC------CCCccchHHHHHHHHHHHHhC
Q 003239          255 IKIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLG  309 (837)
Q Consensus       255 IKL~DFGlA~~~~~~-------~~~~~GT~~Y~APEvl~~~------~yt~ksDIWSLG~ILyELltG  309 (837)
                      +||+|||++......       ....+||+.|+|||++.+.      .++.++|||||||++|||++|
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            999999999643222       1234789999999999876      456799999999999999999

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.6e-39  Score=340.06  Aligned_cols=206  Identities=25%  Similarity=0.423  Sum_probs=176.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++++.||+|+||+||+|++. +++.||||+++......+.+.+|+++++.+       .|+||+++++++. .+..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~-~~~~   82 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-------QHQRLVRLYAVVT-QEPI   82 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEC-SSSC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-------CCcCcceEEEEEc-CCCc
Confidence            379999999999999999999864 567899999987665677889999999999       5899999999986 4568


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCcccccc
Confidence            99999996 6999988765434699999999999999999999999999999999999995   6788999999999765


Q ss_pred             CCcce----eeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          267 DRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       267 ~~~~~----~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      .....    ...++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  223 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL  223 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence            43321    2345778999999998899999999999999999999 99999887766554443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=356.97  Aligned_cols=196  Identities=14%  Similarity=0.166  Sum_probs=168.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCC--------CeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeE---
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEM--------NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR---  176 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~t--------g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk---  176 (837)
                      .++|++.+.||+|+||+||+|++..+        ++.||||+++..    +.+.+|+++++.++       |+||++   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~-------h~niv~~~~  109 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAA-------KPLQVNKWK  109 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHC-------CHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhc-------ccchhhhhh
Confidence            47999999999999999999998874        889999999865    35678999999984       556655   


Q ss_pred             ------------EeEEEee-cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          177 ------------IYEYFVC-QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       177 ------------l~d~f~~-~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                                  +++++.. .+..||||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                        7788876 678999999998899999987644679999999999999999999999999999999999


Q ss_pred             eeeeccCCCC--eEEEEecccccccCCc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCC
Q 003239          244 ILLCTSVKPA--EIKIIDFGSACTEDRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       244 ILl~~~~~~~--~IKL~DFGlA~~~~~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      ||++   .++  .+||+|||+++.....          .....+|+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       190 Il~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          190 IFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             EEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             EEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9996   445  8999999999654322          123478999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 003239          312 LFPGAS  317 (837)
Q Consensus       312 PF~g~s  317 (837)
                      ||....
T Consensus       267 pf~~~~  272 (352)
T 2jii_A          267 PWTNCL  272 (352)
T ss_dssp             TTGGGT
T ss_pred             CcccCC
Confidence            997653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.4e-39  Score=341.87  Aligned_cols=195  Identities=26%  Similarity=0.357  Sum_probs=168.8

Q ss_pred             CceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~----~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|+++++||+|+||.||+|+    +..+++.||||+++...  ...+.+.+|+++++.+       .|+||+++++++.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~   93 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-------YHENIVKYKGICT   93 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-------CCTTBCCEEEEEE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-------CCCCeeeeeeEEe
Confidence            789999999999999999998    67889999999998532  3456788999999998       5899999999998


Q ss_pred             ec--ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQ--RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~--~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..  ..+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~D  169 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGD  169 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECc
Confidence            87  678999999975 9999886553 4699999999999999999999999999999999999996   567999999


Q ss_pred             cccccccCCc------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 003239          260 FGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       260 FGlA~~~~~~------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      ||++......      .....+|..|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            9999755432      123457788999999999999999999999999999999999873

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.5e-39  Score=342.39  Aligned_cols=200  Identities=26%  Similarity=0.357  Sum_probs=165.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec-ce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-RH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-~~  186 (837)
                      .++|++.+.||+|+||+||++++  +++.||||+++... ..+.+.+|+++++.+       .|+||+++++++... +.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTC-------CCTTBCCEEEEECCC--C
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcCCCc
Confidence            37999999999999999999976  48899999998654 456788899999888       689999999997654 57


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      .++||||+.+ +|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE  166 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC---
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeecccccc
Confidence            9999999985 999998876544589999999999999999999999999999999999995   678999999999986


Q ss_pred             cCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          266 EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       266 ~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      .........++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  222 (278)
T 1byg_A          167 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD  222 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred             ccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            6655555677889999999999899999999999999999998 999997665433

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.5e-39  Score=336.76  Aligned_cols=204  Identities=16%  Similarity=0.183  Sum_probs=173.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.+.||+|+||+||+|++.  ++.||||+++..   ....+.+.+|+.+++.+       .||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-------SHPNVLPVLGACQSP   79 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-------SCTTEECEEEEECTT
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-------CCCchhheEEEEccC
Confidence            379999999999999999999874  889999999854   34455677888887776       689999999999987


Q ss_pred             --ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          185 --RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       185 --~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                        +..++||||+. ++|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||++   .++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~  156 (271)
T 3kmu_A           80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISM  156 (271)
T ss_dssp             TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEG
T ss_pred             CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEe
Confidence              78999999998 59999998765446999999999999999999999999  99999999999995   667889998


Q ss_pred             cccccccCCcceeeccCccccCchhhcCCCCCc---cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          260 FGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT---AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       260 FGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~---ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ||++.....  ....+|+.|+|||++.+..++.   ++|||||||++|||++|+.||.+.+..+....+
T Consensus       157 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  223 (271)
T 3kmu_A          157 ADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV  223 (271)
T ss_dssp             GGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred             ccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence            888754322  2357899999999998875554   899999999999999999999887766654443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.5e-39  Score=345.31  Aligned_cols=202  Identities=27%  Similarity=0.398  Sum_probs=172.8

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++..  ....+.+.+|+.+++.+.      .||||++++++
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~   99 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA   99 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc------cCCCeeeEEEE
Confidence            37999999999999999999973     467799999999864  334567889999999995      48999999999


Q ss_pred             Eeecc-eEEEEEeccc-hhHHHHHHhhcc--------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          181 FVCQR-HLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       181 f~~~~-~l~LVmEy~~-gsL~d~l~~~~~--------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      +...+ .+++||||+. ++|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            88765 5999999998 599998876532              1288999999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE  318 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~  318 (837)
                      |++   .++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       180 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          180 LLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             EEC---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             EEC---CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            995   5678999999999754322     123466889999999999999999999999999999998 9999977653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.4e-39  Score=350.02  Aligned_cols=205  Identities=24%  Similarity=0.318  Sum_probs=173.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEE--EEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFV--AVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~V--AIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||+|++..+++.+  |||+++..  ....+.+.+|+++++++.      .||||+++++++...
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHR   98 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC------CCTTBCCEEEEEEET
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc------CCCchhhhceeeeeC
Confidence            79999999999999999999999888865  99999753  334556788999988873      589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          185 RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      +.+||||||+. ++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++  
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~--  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc--
Confidence            99999999997 59999887643              24699999999999999999999999999999999999995  


Q ss_pred             CCCCeEEEEecccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          250 VKPAEIKIIDFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                       .++.+||+|||++......  .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus       177 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~  251 (327)
T 1fvr_A          177 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  251 (327)
T ss_dssp             -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             -CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence             5678999999999744322  223456788999999998899999999999999999998 99999887665543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-38  Score=337.96  Aligned_cols=203  Identities=26%  Similarity=0.349  Sum_probs=170.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|++.+.||+|+||+||+|++..   ++..||||+++..  ....+.+.+|+.+++.+       .||||+++++++.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~   83 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-------DHPHIVKLIGIIE   83 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-------CCTTBCCEEEEEC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-------CCCCcceEEEEEc
Confidence            3799999999999999999998543   4567999999864  34567788999999999       5899999999987


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      . +..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg  158 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFG  158 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccC
Confidence            5 45789999998 58888887653 4699999999999999999999999999999999999996   56799999999


Q ss_pred             cccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          262 SACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       262 lA~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      ++......    .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~  224 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI  224 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH
T ss_pred             CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH
Confidence            99754432    223456788999999998899999999999999999998 99999766554443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-39  Score=354.53  Aligned_cols=203  Identities=24%  Similarity=0.370  Sum_probs=168.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeE----EEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~----VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|+++++||+|+||+||+|++..+++.    ||+|++....  ...+.+.+|+.+++.+       .|+||+++++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~   84 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-------DHAHIVRLLGLC   84 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-------CCTTBCCEEEEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-------CCCCcCeEEEEE
Confidence            47999999999999999999998888765    7777775332  2234566788888887       689999999988


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      . .+..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+||
T Consensus        85 ~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Df  159 (325)
T 3kex_A           85 P-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADF  159 (325)
T ss_dssp             C-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSC
T ss_pred             c-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCC
Confidence            6 567899999998 68998887643 4699999999999999999999999999999999999995   6788999999


Q ss_pred             ccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          261 GSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       261 GlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      |+++.....     .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  227 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP  227 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence            999754322     234467789999999999999999999999999999999 99999876554443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5e-39  Score=370.53  Aligned_cols=203  Identities=23%  Similarity=0.335  Sum_probs=176.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|+++++||+|+||.||+|++..+++.||||+++.... ...+.+|+++++.|.+      +++|+.+..++...+..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~------~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQG------GTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTT------STTCCCEEEEEEETTEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcC------CCCCCeEEEEEeeCCEE
Confidence            3799999999999999999999999999999999875432 2457789999999963      46777777888888999


Q ss_pred             EEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       188 ~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||||||++++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+||||+.++..+.+||+|||+++...
T Consensus        79 ~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999889999987543 469999999999999999999999999999999999999655577899999999996543


Q ss_pred             Cc----------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          268 RT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       268 ~~----------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      ..          ....+||..|+|||++.+..++.++||||||||||||++|+.||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            22          1256789999999999999999999999999999999999999987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-38  Score=344.19  Aligned_cols=199  Identities=24%  Similarity=0.399  Sum_probs=166.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.++||+|+||+||+|++..+++.||||+++..    ....+.+.+|+.+++.+       .||||+++++++..
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~iv~~~~~~~~  105 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-------QEPHVVPIHDFGEI  105 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-------CCCCeeEEEEEEee
Confidence            37999999999999999999999999999999999753    23346778899998887       68999999999999


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++.+|+||||+.+ +|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~  180 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGI  180 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC
T ss_pred             CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCcc
Confidence            9999999999985 899988765  3699999999999999999999999999999999999995   567899999999


Q ss_pred             ccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          263 ACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       263 A~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      +......    .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL  240 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred             CccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence            8654332    2345789999999999999999999999999999999999999987644

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=338.16  Aligned_cols=204  Identities=23%  Similarity=0.314  Sum_probs=172.2

Q ss_pred             CceEEEE-EeccCCceeEEEeec--cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKD-LLGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~-~LG~G~fG~Vyka~~--~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|.+.+ .||+|+||+||+|.+  ..+++.||||+++..  ....+.+.+|+++++.+       .||||+++++++ .
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~-~   80 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-------DNPYIVRLIGVC-Q   80 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEE-E
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-------CCCCEeEEEEEe-c
Confidence            6788887 999999999999975  356889999999863  45567788999999998       589999999999 5


Q ss_pred             cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+..++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~  156 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGL  156 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccc
Confidence            5679999999985 888887643 34699999999999999999999999999999999999996   567999999999


Q ss_pred             ccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          263 ACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       263 A~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      +.......      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  225 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF  225 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence            97553221      12345788999999998899999999999999999998 9999987766554443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.5e-39  Score=346.99  Aligned_cols=205  Identities=24%  Similarity=0.351  Sum_probs=175.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCe-----EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNS-----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~-----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.+.||+|+||+||+|.+..+++     .||||+++..  ....+.+.+|+.+++.+.      .||||++++++
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~  118 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG------QHENIVNLLGA  118 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc------CCCCeeeEEEE
Confidence            4789999999999999999999876654     7999999864  344567889999999994      48999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeee
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC  247 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~  247 (837)
                      +...+.+++||||+. ++|.+++....            ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            999999999999997 49999887643            23589999999999999999999999999999999999996


Q ss_pred             ccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          248 TSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       248 ~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                         .++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus       199 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          199 ---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             ---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             ---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence               5678999999999754221     123356788999999999899999999999999999998 9999987654333

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=353.36  Aligned_cols=191  Identities=23%  Similarity=0.292  Sum_probs=155.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee----
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC----  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~----  183 (837)
                      .++|+++++||+|+||+||+|++  +++.||||+++....  .....|.+++..     ....|+||+++++.+..    
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~-----~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRV-----PLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTS-----TTCCCTTBCCEEEEEEEECTT
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHH-----HhccCcchhhheecccccccC
Confidence            48999999999999999999965  689999999985433  334444444332     12379999999986543    


Q ss_pred             -cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC---------CeeeccCCCCCeeeeccCCC
Q 003239          184 -QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA---------GIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       184 -~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~---------gIVHrDLKPeNILl~~~~~~  252 (837)
                       ...+|||||||. ++|.+++....   +++..++.++.||+.||+|||++         +||||||||+|||++   .+
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~~  156 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---ND  156 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---TT
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---CC
Confidence             246899999996 59999987654   68999999999999999999999         999999999999995   66


Q ss_pred             CeEEEEecccccccCC-----------cceeeccCccccCchhhcC-------CCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          253 AEIKIIDFGSACTEDR-----------TVYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~-----------~~~~~~GT~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      +.+||+|||++.....           .....+||+.|+|||++.+       ..++.++|||||||++|||++|..||
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            8999999999965432           1224478999999999987       45678999999999999999996554

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-38  Score=346.12  Aligned_cols=208  Identities=22%  Similarity=0.314  Sum_probs=171.7

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      ...+|++.++||+|+||+||+|++..++    ..||||+++..  ......+.+|+.+++.+       .|+||++++++
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~  114 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-------SHHNIIRLEGV  114 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEE
Confidence            3489999999999999999999876543    46999999853  34455688899999988       68999999999


Q ss_pred             EeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          181 FVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       181 f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      +...+..+|||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~D  190 (333)
T 1mqb_A          115 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSD  190 (333)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECC
T ss_pred             EecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECC
Confidence            9999999999999985 8888887643 4699999999999999999999999999999999999995   678999999


Q ss_pred             cccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       260 FGlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ||++.......      ....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  263 (333)
T 1mqb_A          191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI  263 (333)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            99997543321      12245778999999999999999999999999999998 99999887765554443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.5e-38  Score=337.36  Aligned_cols=203  Identities=27%  Similarity=0.405  Sum_probs=172.0

Q ss_pred             CceEEEE-EeccCCceeEEEe--eccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKD-LLGHGTFGQVAKC--WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~-~LG~G~fG~Vyka--~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ++|++.+ .||+|+||+||+|  .+..+++.||||+++..   ....+.+.+|+++++.+       .||||+++++++ 
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~-   87 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-------DNPYIVRMIGIC-   87 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-------CCTTBCCEEEEE-
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEE-
Confidence            7899998 9999999999999  45677899999999854   23356788999999988       689999999999 


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+..++||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg  162 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFG  162 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCT
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCC
Confidence            5678899999998 5898888764  3599999999999999999999999999999999999996   56799999999


Q ss_pred             cccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          262 SACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       262 lA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ++.......      ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  232 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM  232 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            997543321      12245688999999998899999999999999999999 9999988776554433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9e-39  Score=346.75  Aligned_cols=198  Identities=28%  Similarity=0.400  Sum_probs=172.3

Q ss_pred             CCceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~----~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|+++++||+|+||.||+|+    +..+++.||||+++.. ....+.+.+|+++++.+       .|+||+++++++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~   94 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-------HSDFIVKYRGVSY   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-------CCCceeEEEEEEe
Confidence            4899999999999999999998    6788999999999865 34456688999999998       6899999999987


Q ss_pred             --ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 --CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 --~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                        ....+||||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~D  170 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIAD  170 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECC
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcc
Confidence              4567999999996 68999887654 3599999999999999999999999999999999999996   678899999


Q ss_pred             cccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       260 FGlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ||++.......      ....+|..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            99997543221      2335778899999999989999999999999999999999999653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.7e-39  Score=364.60  Aligned_cols=206  Identities=24%  Similarity=0.351  Sum_probs=175.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.++||+|+||+||+|.+.. +..||||+++......+.+.+|+++|+++       .||||+++++++.. +.+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECS-SSC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-------CCCCEeeEEEEEcC-Cce
Confidence            3789999999999999999998765 46699999987655567889999999999       68999999999876 779


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ||||||+. ++|.+++.......+++..+..++.||+.||+|||+++||||||||+|||++   .++.+||+|||+++..
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccceec
Confidence            99999997 5999998765545699999999999999999999999999999999999995   5678999999999754


Q ss_pred             CCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ....    ....++..|+|||++....++.++|||||||++|||++ |+.||.+....+.+..+
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i  394 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  394 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            3221    22345778999999998899999999999999999999 99999988776655544

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=344.67  Aligned_cols=197  Identities=23%  Similarity=0.353  Sum_probs=167.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC-ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~-~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      .++|++.+.||+|+||.||+|++..+++.||||++.. .....+.+.+|+.+++.+       .|+||+++++++..   
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-------NHPNILRLVAYCLRERG  100 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEEEEEET
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-------CCCCeeeEEEEEEeccC
Confidence            3799999999999999999999999999999999864 345567788999999988       68999999999973   


Q ss_pred             -cceEEEEEeccch-hHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          184 -QRHLCICFELLDS-NLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       184 -~~~l~LVmEy~~g-sL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                       ....++||||+.+ +|.+++...  ....+++..++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~d  177 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMD  177 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEe
Confidence             4589999999985 998888763  234699999999999999999999999999999999999995   678899999


Q ss_pred             cccccccCCcc------------eeeccCccccCchhhcCCC---CCccchHHHHHHHHHHHHhCCCCCC
Q 003239          260 FGSACTEDRTV------------YSYIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       260 FGlA~~~~~~~------------~~~~GT~~Y~APEvl~~~~---yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      ||++.......            ....+|+.|+|||++.+..   ++.++|||||||++|+|++|+.||.
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            99986543211            1235699999999997653   7899999999999999999999993

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=340.96  Aligned_cols=195  Identities=27%  Similarity=0.437  Sum_probs=161.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.+.||+|+||+||++++.  ++.||||+++... ..+.+.+|+++|+++       .||||+++++++.  +..
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~--~~~   74 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-ERKAFIVELRQLSRV-------NHPNIVKLYGACL--NPV   74 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-HHHHHHHHHHHHHHC-------CCTTBCCEEEBCT--TTT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-HHHHHHHHHHHHhcC-------CCCCcCeEEEEEc--CCc
Confidence            378999999999999999999764  7889999997543 456788999999998       6899999999887  458


Q ss_pred             EEEEeccc-hhHHHHHHhhcc-CCCCHHHHHHHHHhHHHHHhhhhc---CCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          188 CICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKD---AGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~-~~L~e~~i~~I~~QIl~aL~yLHs---~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      |+||||+. ++|.+++..... ..+++..+..++.||++||+|||+   +||+||||||+|||++  .+...+||+|||+
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~  152 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGT  152 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEccccc
Confidence            99999997 599998875432 247899999999999999999999   8999999999999996  2333589999999


Q ss_pred             ccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       263 A~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      +...........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          153 ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             ccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            987665555668999999999999999999999999999999999999999654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.5e-39  Score=348.28  Aligned_cols=202  Identities=24%  Similarity=0.392  Sum_probs=166.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEE----EEEEEeC--ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFV----AVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~V----AIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|+++++||+|+||+||+|++..+++.|    |+|.++.  .....+.+.+|+.+++.+       .||||+++++++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~   86 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGIC   86 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-------CBTTBCCCCEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-------CCCCeeEEEEEE
Confidence            489999999999999999999988887655    6666653  234567788999999888       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      .... .++|||++. ++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+||
T Consensus        87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~Df  161 (327)
T 3lzb_A           87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDF  161 (327)
T ss_dssp             ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCT
T ss_pred             ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccC
Confidence            8765 778888887 68998887654 4699999999999999999999999999999999999996   5678999999


Q ss_pred             ccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003239          261 GSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL  321 (837)
Q Consensus       261 GlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~  321 (837)
                      |+++.....     .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  228 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI  228 (327)
T ss_dssp             TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            999754322     223355778999999999999999999999999999999 9999987665443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.7e-39  Score=357.26  Aligned_cols=207  Identities=23%  Similarity=0.343  Sum_probs=167.6

Q ss_pred             CCceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~---~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..+|++.+.||+|+||+||+|++.   .++..||||+++..  ....+.+.+|+.+|+++       .|+||+++++++.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~  116 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-------DHPNIIRLEGVVT  116 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEe
Confidence            378999999999999999999876   56778999999853  34556788999999888       6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+..+|||||+. ++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++   .++.+||+|||
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg  192 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFG  192 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCc
Confidence            9999999999996 68998887543 4699999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          262 SACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       262 lA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      +++......      ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i  263 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV  263 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            997543321      11234678999999999999999999999999999998 99999887766554443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.7e-38  Score=337.10  Aligned_cols=204  Identities=27%  Similarity=0.395  Sum_probs=162.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|++.++||+|+||+||+|++..   .||||+++..   ....+.+.+|+.+++.+       .|+||++++++. ..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-------RHVNILLFMGYS-TA   91 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEE-CS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-------CCCcEEEEEeec-cC
Confidence            3799999999999999999997653   4999999743   34456788899999888       689999999954 56


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ...++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||++
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~  167 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLA  167 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC--
T ss_pred             CccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceec
Confidence            67899999997 58888775443 5699999999999999999999999999999999999996   6689999999999


Q ss_pred             cccCC-----cceeeccCccccCchhhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          264 CTEDR-----TVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       264 ~~~~~-----~~~~~~GT~~Y~APEvl~---~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      .....     ......+|+.|+|||++.   +..++.++|||||||++|+|++|+.||......+.+..++
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  238 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV  238 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence            64332     223457899999999997   5578899999999999999999999998866655544443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.3e-38  Score=338.93  Aligned_cols=198  Identities=24%  Similarity=0.393  Sum_probs=163.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.+.||+|+||.||+|++..+++.||||+++.    .....+.+.+|+.+++.+       .|+||+++++++...
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-------NHPNVIKYYASFIED  104 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEET
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence            789999999999999999999999999999999974    234566788899999988       689999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          185 RHLCICFELLDS-NLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      +..++||||+.+ +|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg  181 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLG  181 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC-
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEecc
Confidence            999999999985 888888653  234599999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCCc---ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 003239          262 SACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA  316 (837)
Q Consensus       262 lA~~~~~~---~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~  316 (837)
                      ++......   .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             ceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            98654332   23457899999999999999999999999999999999999999654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.9e-39  Score=352.75  Aligned_cols=202  Identities=21%  Similarity=0.311  Sum_probs=172.2

Q ss_pred             CCceEEEEEeccCCceeEEEe-----eccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka-----~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|++.++||+|+||+||+|     .+..+++.||||+++...  ...+.+|+++++.+++.    .|+||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~----~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS----MQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGG----GGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhh----hhhhhhhhheeee
Confidence            378999999999999999999     467789999999998653  45678899999988643    6899999999999


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhc---cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec--------cC
Q 003239          183 CQRHLCICFELLD-SNLYELIKINH---FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT--------SV  250 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~---~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~--------~~  250 (837)
                      ..+..|||||||. ++|.+++....   ...+++..++.|+.||+.||+|||++|||||||||+||||+.        +.
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            9999999999997 69999987532   346999999999999999999999999999999999999963        12


Q ss_pred             CCCeEEEEeccccccc-----CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          251 KPAEIKIIDFGSACTE-----DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       251 ~~~~IKL~DFGlA~~~-----~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ..+.+||+|||+|+..     .......+||+.|+|||++.+..|+.++||||||||+|||++|+.||..
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence            2689999999999643     2233456799999999999999999999999999999999999999943

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.3e-38  Score=340.61  Aligned_cols=206  Identities=20%  Similarity=0.318  Sum_probs=165.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~---tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      .++|++.+.||+|+||.||+|++..   +++.||||+++..   ....+.+.+|+.+++.+       .||||+++++++
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~  105 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-------SHPNVIRLLGVC  105 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEE
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-------CCCCeeeeeEEE
Confidence            3799999999999999999997654   5668999999743   34456788899999988       689999999999


Q ss_pred             eecc-----eEEEEEeccc-hhHHHHHHhh----ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          182 VCQR-----HLCICFELLD-SNLYELIKIN----HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       182 ~~~~-----~l~LVmEy~~-gsL~d~l~~~----~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      ...+     ..++||||+. ++|.+++...    ....+++..++.++.||+.||.|||++||+||||||+|||++   .
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---D  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---T
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---C
Confidence            8765     4599999998 5898888543    234599999999999999999999999999999999999995   6


Q ss_pred             CCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003239          252 PAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR  323 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~  323 (837)
                      ++.+||+|||++......     .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+...
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  260 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD  260 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            678999999999754322     223456788999999999999999999999999999999 899998766544433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-38  Score=338.00  Aligned_cols=203  Identities=22%  Similarity=0.327  Sum_probs=168.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-  182 (837)
                      .+|++.++||+|+||+||+|++..+   ...||+|+++..  ....+.+.+|+.+++++       .|+||+++++++. 
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~   97 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLGICLR   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEECC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-------CCCCEeeeeeEEEc
Confidence            6899999999999999999986543   346999999753  34557788999999988       5899999999854 


Q ss_pred             ecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      .++..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg  173 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFG  173 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCG
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECccc
Confidence            55688999999985 9998887543 5689999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCCc-------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003239          262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL  322 (837)
Q Consensus       262 lA~~~~~~-------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l  322 (837)
                      ++......       .....+|+.|+|||++.+..++.++|||||||++|+|++ +.+||...+..+..
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~  242 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT  242 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            99754322       223456788999999999999999999999999999999 67788766544433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-38  Score=336.27  Aligned_cols=201  Identities=22%  Similarity=0.330  Sum_probs=168.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ..|++.++||+|+||+||+|++..++   ..||+|+++..  ....+.+.+|+.+++.+       .|+||+++++++..
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~   93 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-------NHPNVLALIGIMLP   93 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEECC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEec
Confidence            56888899999999999999865444   48999999753  34557788999999988       68999999999987


Q ss_pred             cceE-EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 QRHL-CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 ~~~l-~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      .+.. ++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        94 ~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg  169 (298)
T 3pls_A           94 PEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFG  169 (298)
T ss_dssp             SSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTT
T ss_pred             CCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCC
Confidence            7655 99999996 68998887643 5689999999999999999999999999999999999995   67799999999


Q ss_pred             cccccCCc-------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       262 lA~~~~~~-------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      ++......       .....++..|+|||++.+..++.++|||||||++|+|++ +.+||...+..+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~  236 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD  236 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence            99644321       223466889999999999999999999999999999999 566665554433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-38  Score=341.99  Aligned_cols=191  Identities=24%  Similarity=0.259  Sum_probs=159.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---  184 (837)
                      .++|+++++||+|+||.||+|++.  ++.||||++.....  ....+|.+++..+.     ..|+||+++++++...   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~-----~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVL-----MRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTT-----CCCTTBCCEEEEEEESCGG
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHh-----hcCCCeeeEEEEEccCCCC
Confidence            379999999999999999999764  89999999975543  34455666655442     2699999999999987   


Q ss_pred             -ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcC--------CeeeccCCCCCeeeeccCCCCe
Q 003239          185 -RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--------GIIHCDLKPENILLCTSVKPAE  254 (837)
Q Consensus       185 -~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~--------gIVHrDLKPeNILl~~~~~~~~  254 (837)
                       ..+|+||||+.+ +|.++++..   .+++..++.++.||+.||+|||++        +||||||||+|||++   .++.
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---~~~~  180 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---KNGT  180 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---TTSC
T ss_pred             CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---CCCC
Confidence             789999999975 999998654   499999999999999999999998        999999999999995   6779


Q ss_pred             EEEEecccccccCCcc-------eeeccCccccCchhhcCCCCCcc------chHHHHHHHHHHHHhCCCCC
Q 003239          255 IKIIDFGSACTEDRTV-------YSYIQSRYYRSPEVLLGYQYTTA------IDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       255 IKL~DFGlA~~~~~~~-------~~~~GT~~Y~APEvl~~~~yt~k------sDIWSLG~ILyELltG~~PF  313 (837)
                      +||+|||++.......       ...+||+.|+|||++.+..++.+      +|||||||++|||++|..|+
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            9999999996543221       24578999999999988766655      99999999999999995444

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-38  Score=369.92  Aligned_cols=206  Identities=24%  Similarity=0.351  Sum_probs=178.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++.++||+|+||+||+|++.. +..||||+++......+.+.+|+++|+.|       .|+||+++++++.. +.+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECS-SSC
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-------CCCCEeeEEEEEee-ccc
Confidence            3789999999999999999998765 46799999987655567899999999999       68999999999876 679


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||. ++|.+++.......+++.+++.|+.||+.||+|||+++||||||||+||||+   .++.+||+|||+++..
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTTC
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEcccccceec
Confidence            99999997 5999999765545699999999999999999999999999999999999995   5678999999999765


Q ss_pred             CCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       267 ~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ....    ....++..|+|||++....++.++|||||||+||||++ |+.||.+....+.+..+
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i  477 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  477 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            4322    22345778999999998899999999999999999999 99999888776665544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.9e-39  Score=347.93  Aligned_cols=199  Identities=23%  Similarity=0.271  Sum_probs=171.9

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+.+++.+       .||||+++++++...+.
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC-------RHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-------CCTTBCCEEEECCCTTC
T ss_pred             HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEcCCCe
Confidence            478999999999999999999864 6889999998754 34456788899988877       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhcc--CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          187 LCICFELLD-SNLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~--~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      .++||||+. ++|.+++.....  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeecccc
Confidence            999999997 588887754432  2489999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCC-----cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          264 CTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       264 ~~~~~-----~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      .....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            65322     1233468999999999999899999999999999999999999997653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-39  Score=366.34  Aligned_cols=204  Identities=18%  Similarity=0.161  Sum_probs=158.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhccc---------CC------C
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKY---------DR------E  169 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~---------~~------~  169 (837)
                      +.|++.++||+|+||+||+|++..+++.||||+++..    ....+.+.+|+.+++.+.+..         ..      .
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            5689999999999999999999999999999999832    223467788998888875410         00      0


Q ss_pred             CCCceeEEeEEEee-----cceEEEEEeccchhHHHHHHhh-----ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          170 DKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKIN-----HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       170 ~HpnIVkl~d~f~~-----~~~l~LVmEy~~gsL~d~l~~~-----~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      ..++...+..++..     ...++++|+++.++|.+++...     ....+++..+..++.||+.||+|||++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence            00111112222222     2357899999999999888522     1234788899999999999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCCcceeeccCccccCchhh----------cCCCCCccchHHHHHHHHHHHHhC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL----------LGYQYTTAIDMWSFGCIVAELFLG  309 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl----------~~~~yt~ksDIWSLG~ILyELltG  309 (837)
                      ||+||||+   .++.+||+|||+++.........+| +.|+|||++          ....++.++|||||||++|||++|
T Consensus       238 Kp~NILl~---~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          238 RPVDIVLD---QRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             CGGGEEEC---TTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             ccceEEEe---cCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            99999996   6678999999999877766667788 999999999          555788999999999999999999


Q ss_pred             CCCCCCC
Q 003239          310 LPLFPGA  316 (837)
Q Consensus       310 ~~PF~g~  316 (837)
                      +.||...
T Consensus       314 ~~Pf~~~  320 (413)
T 3dzo_A          314 DLPNTDD  320 (413)
T ss_dssp             SCCCCTT
T ss_pred             CCCCCCc
Confidence            9999654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.7e-38  Score=334.28  Aligned_cols=206  Identities=24%  Similarity=0.387  Sum_probs=166.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC-CC--eEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE-MN--SFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~-tg--~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||+||+|++.. ++  ..||||+++..    ....+.+.+|+++++.+       .|+||++++++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~   89 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-------DHRNLIRLYGV   89 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-------CCCCcccEEEE
Confidence            3799999999999999999997543 33  36999999743    34567788999999998       58999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      +.... .++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|
T Consensus        90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~D  164 (291)
T 1u46_A           90 VLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGD  164 (291)
T ss_dssp             ECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECC
T ss_pred             EccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcc
Confidence            98765 899999997 68998887653 4599999999999999999999999999999999999996   567899999


Q ss_pred             cccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       260 FGlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ||++.......      ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  237 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  237 (291)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence            99997653321      22356778999999998899999999999999999999 99999887766555443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.1e-38  Score=339.64  Aligned_cols=194  Identities=28%  Similarity=0.377  Sum_probs=166.0

Q ss_pred             CceEEEEEeccCCceeEEEe----eccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKC----WDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka----~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      +.|+++++||+|+||+||++    .+..+++.||||+++..  ....+.+.+|+++|+.+       .|+||+++++++.
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~  103 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-------YHEHIIKYKGCCE  103 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-------CCcchhhEEEEEe
Confidence            34599999999999999665    45668999999999864  34456788999999999       5899999999999


Q ss_pred             ec--ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..  ..+++||||+. ++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~D  177 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGD  177 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred             cCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECC
Confidence            84  68999999997 4898888654   499999999999999999999999999999999999995   668899999


Q ss_pred             cccccccCCc------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          260 FGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       260 FGlA~~~~~~------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ||++......      .....++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            9999765432      2234578889999999998999999999999999999999999954

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.7e-39  Score=348.02  Aligned_cols=196  Identities=24%  Similarity=0.307  Sum_probs=168.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|++.++||+|+||+||+|++ .+++.||||+++....  ....+.+|+++++.+       .|+||+++++++...+
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-------VHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-------CCTTBCCCCEEECCSS
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-------cCCCccceEEEEecCC
Confidence            47899999999999999999975 4688999999975432  223577888888777       6899999999999999


Q ss_pred             eEEEEEeccch-hHHHHHHhhcc--CCCCHHHHHHHHHhHHHHHhhhhcC---CeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          186 HLCICFELLDS-NLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDA---GIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~--~~L~e~~i~~I~~QIl~aL~yLHs~---gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..++||||+.+ +|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||++   .++.+||+|
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~D  177 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGD  177 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEECC
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEecc
Confidence            99999999975 89988876532  3499999999999999999999999   999999999999995   668999999


Q ss_pred             cccccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 003239          260 FGSACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP  314 (837)
Q Consensus       260 FGlA~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~  314 (837)
                      ||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            9999754322    233468999999999998899999999999999999999999995

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.7e-38  Score=334.44  Aligned_cols=196  Identities=26%  Similarity=0.397  Sum_probs=167.7

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .|...++||+|+||+||+|++  +++.||||++...     ....+.+.+|+.+++.+       .||||+++++++...
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~  102 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-------QHENLVELLGFSSDG  102 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-------CCTTBCCEEEEECSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-------CCCCeEEEEEEEecC
Confidence            344558899999999999976  5789999999742     23457788999999998       589999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          185 RHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      +..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~  179 (307)
T 2nru_A          103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGL  179 (307)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTT
T ss_pred             CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeeccc
Confidence            99999999996 68988887543 34599999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          263 ACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       263 A~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      +......     .....+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.....
T Consensus       180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            8754332     223478999999999876 589999999999999999999999976543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-38  Score=350.85  Aligned_cols=201  Identities=22%  Similarity=0.327  Sum_probs=161.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ..|++.++||+|+||+||+|++..+   ...||||+++..  ....+.+.+|+.+++.+       .||||+++++++..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~  161 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLGICLR  161 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-------CCTTBCCCCEEECC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEEc
Confidence            5789999999999999999986543   356899998753  34567788899988887       68999999998654


Q ss_pred             -cceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 -QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 -~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       ++..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||
T Consensus       162 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG  237 (373)
T 3c1x_A          162 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFG  237 (373)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-
T ss_pred             CCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeecc
Confidence             5688999999984 9999887543 4589999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCCc-------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003239          262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD  320 (837)
Q Consensus       262 lA~~~~~~-------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e  320 (837)
                      +++.....       .....+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~  304 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD  304 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence            99754221       123456788999999999999999999999999999999 788887655433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.5e-37  Score=335.82  Aligned_cols=186  Identities=23%  Similarity=0.302  Sum_probs=160.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---  185 (837)
                      ++|++.+.||+|+||+||+|++  +++.||||+++...  ...+.+|+++++.+.     ..|+||+++++++....   
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~-----l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVM-----LRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSC-----CCCTTBCCEEEEEECCCSSC
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhh-----cCCCcEEEEEeeecccCCcc
Confidence            7899999999999999999976  58999999997543  456778999888853     26999999999999876   


Q ss_pred             -eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh--------cCCeeeccCCCCCeeeeccCCCCeE
Q 003239          186 -HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--------DAGIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       186 -~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH--------s~gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                       .+|+||||+.+ +|.+++...   .+++..++.++.||+.||.|||        +++|+||||||+|||++   .++.+
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~---~~~~~  186 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTC  186 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC---TTSCE
T ss_pred             ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC---CCCCE
Confidence             89999999985 999998754   4999999999999999999999        89999999999999995   66789


Q ss_pred             EEEecccccccCCc-------ceeeccCccccCchhhcCC------CCCccchHHHHHHHHHHHHhC
Q 003239          256 KIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLG  309 (837)
Q Consensus       256 KL~DFGlA~~~~~~-------~~~~~GT~~Y~APEvl~~~------~yt~ksDIWSLG~ILyELltG  309 (837)
                      ||+|||++......       .....+|+.|+|||++.+.      .++.++|||||||++|||++|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            99999999654322       2344789999999999876      344789999999999999999

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.1e-39  Score=352.13  Aligned_cols=198  Identities=17%  Similarity=0.180  Sum_probs=160.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHhhcc--cCCCCCCceeEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKK--YDREDKHHIVRI  177 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~--~~~~~HpnIVkl  177 (837)
                      ++|+++++||+|+||+||+|++  +++.||||+++...         ...+.+.+|+.+|++++..  .....|+||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            7899999999999999999987  68999999998542         2347788999999999632  112246677776


Q ss_pred             eEEEe-----------------e-------------cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHH
Q 003239          178 YEYFV-----------------C-------------QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGL  226 (837)
Q Consensus       178 ~d~f~-----------------~-------------~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL  226 (837)
                      ++++.                 .             .+.+|||||||. |++++.+..   +.+++..++.+++||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            66543                 2             678999999997 456665533   4589999999999999999


Q ss_pred             hhhh-cCCeeeccCCCCCeeeeccC-----------------CCCeEEEEecccccccCCcceeeccCccccCchhhcCC
Q 003239          227 SLLK-DAGIIHCDLKPENILLCTSV-----------------KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY  288 (837)
Q Consensus       227 ~yLH-s~gIVHrDLKPeNILl~~~~-----------------~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~  288 (837)
                      +||| ++|||||||||+||||+.+.                 ....+||+|||+|+.....  ..+||+.|+|||++.+.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCCC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcCC
Confidence            9999 99999999999999997432                 1128999999999765443  45899999999999876


Q ss_pred             CCCccchHHHHHHH-HHHHHhCCCCCC
Q 003239          289 QYTTAIDMWSFGCI-VAELFLGLPLFP  314 (837)
Q Consensus       289 ~yt~ksDIWSLG~I-LyELltG~~PF~  314 (837)
                      . +.++|||||+++ .++++.|..||.
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             C-ccceehhhhhCCCCcccccccCCCc
Confidence            6 899999998777 778888999883

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-37  Score=332.91  Aligned_cols=197  Identities=25%  Similarity=0.393  Sum_probs=170.1

Q ss_pred             CCceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~----~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|+++++||+|+||.||+|+    +..+++.||||+++.. ....+.+.+|+++++.+       .|+||+++++++.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~  112 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-------QHDNIVKYKGVCY  112 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEE
Confidence            4789999999999999999998    5678999999999754 34556788999999988       5899999999987


Q ss_pred             ecc--eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          183 CQR--HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       183 ~~~--~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      ..+  .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~D  188 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGD  188 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEec
Confidence            654  7899999997 59999887653 4599999999999999999999999999999999999996   567999999


Q ss_pred             cccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       260 FGlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ||++.......      ....++..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            99997654321      123467789999999998999999999999999999999998853

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.5e-37  Score=364.01  Aligned_cols=205  Identities=26%  Similarity=0.409  Sum_probs=170.2

Q ss_pred             CceEEE-EEeccCCceeEEEee--ccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVK-DLLGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~-~~LG~G~fG~Vyka~--~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..+.+. ++||+|+||+||+|.  ...+++.||||+++..   ....+.+.+|+++|++|       .|+|||++++++.
T Consensus       368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~~~~  440 (635)
T 4fl3_A          368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-------DNPYIVRMIGICE  440 (635)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred             hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe
Confidence            345554 489999999999994  4567789999999853   23467899999999999       6899999999986


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      . +..+||||||. ++|.+++...  ..+++..++.|+.||+.||+|||+++||||||||+||||+   .++.+||+|||
T Consensus       441 ~-~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFG  514 (635)
T 4fl3_A          441 A-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFG  514 (635)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTT
T ss_pred             c-CCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcC
Confidence            4 56899999997 5898888654  4699999999999999999999999999999999999996   56799999999


Q ss_pred             cccccCCc------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          262 SACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       262 lA~~~~~~------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      +++.....      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.
T Consensus       515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~  586 (635)
T 4fl3_A          515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  586 (635)
T ss_dssp             HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99754322      122345788999999999999999999999999999998 999999887766555443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-38  Score=377.32  Aligned_cols=203  Identities=27%  Similarity=0.400  Sum_probs=175.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      ++|++.++||+|+||+||+|.+..+++.||||+++..  ....+.+.+|+++++.+       .||||+++++++..   
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-------~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-------NHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-------CBTTBCCEEECCTTTCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-------CCCCCCceeeeeccccc
Confidence            7899999999999999999999999999999999753  44566788999999999       68999999999766   


Q ss_pred             ---cceEEEEEeccc-hhHHHHHHhhc-cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          184 ---QRHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       184 ---~~~l~LVmEy~~-gsL~d~l~~~~-~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                         .+..|||||||. ++|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|||++.+.....+||+
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence               678899999996 59999887643 2359999999999999999999999999999999999999855555669999


Q ss_pred             ecccccccCCc--ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q 003239          259 DFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE  318 (837)
Q Consensus       259 DFGlA~~~~~~--~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~  318 (837)
                      |||++......  .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~  228 (676)
T 3qa8_A          167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ  228 (676)
T ss_dssp             SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred             ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence            99999765432  3456889999999999999999999999999999999999999976543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.7e-37  Score=361.50  Aligned_cols=205  Identities=22%  Similarity=0.315  Sum_probs=170.5

Q ss_pred             CceEEEE-EeccCCceeEEEeecc--CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKD-LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~-~LG~G~fG~Vyka~~~--~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      +++.+.+ .||+|+||+||+|.+.  .++..||||+++..  ....+.+.+|+++|+.+       .|+|||++++++..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-------~hpniv~l~~~~~~  407 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-------DNPYIVRLIGVCQA  407 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-------CCTTBCCEEEEEES
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEecc
Confidence            5666666 8999999999999765  45678999999853  34567889999999888       68999999999976


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                       +.++||||||. ++|.+++... ...+++..++.++.||+.||+|||+++||||||||+||||+   .++.+||+|||+
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGl  482 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGL  482 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCST
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccC
Confidence             56999999998 5888887644 35699999999999999999999999999999999999996   668999999999


Q ss_pred             ccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          263 ACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       263 A~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      ++......      ....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+.+..+
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i  552 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI  552 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            97643221      12234678999999998999999999999999999998 99999887766655444

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.1e-36  Score=356.34  Aligned_cols=207  Identities=24%  Similarity=0.384  Sum_probs=174.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .++|++.+.||+|+||+||+|++..   .+..||||+++..  ....+.+.+|+.+|+.+       .||||+++++++.
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~~~~~  461 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-------DHPHIVKLIGVIT  461 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEe
Confidence            4789999999999999999998754   3568999998753  34456788999999998       6899999999985


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       ++..|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG  536 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFG  536 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecC
Confidence             567899999998 68998887553 4599999999999999999999999999999999999996   56899999999


Q ss_pred             cccccCCcc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          262 SACTEDRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       262 lA~~~~~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      ++.......    ....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+..+.
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~  606 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  606 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            997654322    22356788999999998899999999999999999997 999999887776655543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.7e-37  Score=331.26  Aligned_cols=202  Identities=21%  Similarity=0.305  Sum_probs=166.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.++||+|+||.||+|++..   .||||+++..   ....+.+.+|+.+++.+       .|+||+++++++...+
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-------RHENVVLFMGACMSPP  102 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-------CCTTBCCCCEEEECSS
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-------CCCCEeEEEEEEecCC
Confidence            789999999999999999998754   3999998743   22234556788888777       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++    ++.+||+|||++.
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFS  177 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC
T ss_pred             ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcc
Confidence            9999999997 58888876542 4699999999999999999999999999999999999994    4689999999975


Q ss_pred             ccC--------CcceeeccCccccCchhhcC---------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003239          265 TED--------RTVYSYIQSRYYRSPEVLLG---------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM  325 (837)
Q Consensus       265 ~~~--------~~~~~~~GT~~Y~APEvl~~---------~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I  325 (837)
                      ...        .......+++.|+|||++.+         ..++.++|||||||++|||++|..||......+....+
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            432        12233468899999999975         35789999999999999999999999887766554443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-35  Score=318.26  Aligned_cols=171  Identities=15%  Similarity=0.128  Sum_probs=149.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||+|++..+++.||||+++..    ....+.+.+|+.++..+       .|+||+++++++...
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~iv~~~~~~~~~  103 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-------DKPGVARVLDVVHTR  103 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEET
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-------CCCCcceeeEEEEEC
Confidence            7899999999999999999999999999999999854    34457788899998877       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..||||||+. ++|.++++.    .....++..++.||+.||+|||++||+||||||+|||++   .++.+||++++  
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~--  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA--  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC--
T ss_pred             CcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc--
Confidence            99999999997 588888743    246667889999999999999999999999999999996   66889998543  


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                                     |++       .++.++|||||||++|||++|+.||.+.+
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                           333       37899999999999999999999997653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-36  Score=359.56  Aligned_cols=190  Identities=26%  Similarity=0.362  Sum_probs=163.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++.. +++.||||++...  ......+.+|+.+|+++       .||||+++++++...+
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-------VHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-------CCTTBCCEEEEEEEEC
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-------CCCCcCeEeeeEeecC
Confidence            799999999999999999999876 7899999998643  34456678899998887       6899999999999876


Q ss_pred             e-----EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          186 H-----LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       186 ~-----l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      .     .||||||+. ++|.+++..    .+++.+++.|+.||+.||.|||++|||||||||+|||++   . +.+||+|
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~D  224 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLID  224 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEe
Confidence            5     799999998 477766543    599999999999999999999999999999999999996   2 4899999


Q ss_pred             cccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          260 FGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       260 FGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ||++...... ...+||+.|+|||++.+. ++.++||||||||+|+|++|.+||.+
T Consensus       225 FG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          225 LGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             CTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             cccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            9999766544 456799999999999764 48899999999999999999988853

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.2e-28  Score=289.61  Aligned_cols=181  Identities=15%  Similarity=0.070  Sum_probs=130.9

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEeCC-----------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-----------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++.|+++.+..++....|+.||||++.++           ....+++.+|+++|+++.      .|+||++++++++++
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~------~~~~i~~~~~~~ed~  314 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP------AGFDAPAVLAHGENA  314 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC------TTCCCCCEEEEEECS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC------CCCCeeEEEEEEEEC
Confidence            467888888888888888999999999753           234567889999999984      589999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||+| +|.+++...  +.+++.   .|+.||+.||+|||++|||||||||+||||+   .++.+||+|||+|
T Consensus       315 ~~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlA  386 (569)
T 4azs_A          315 QSGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSI  386 (569)
T ss_dssp             SEEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTE
T ss_pred             CEEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccC
Confidence            999999999985 899998765  357654   5789999999999999999999999999995   6789999999999


Q ss_pred             cccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCC
Q 003239          264 CTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP  311 (837)
Q Consensus       264 ~~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~  311 (837)
                      +....   .....+||+.|+|||++.+ .+..++|+|++|+++++|.++..
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            76543   2345689999999999976 56778999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=3.6e-24  Score=249.97  Aligned_cols=178  Identities=17%  Similarity=0.175  Sum_probs=139.0

Q ss_pred             EEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       112 ~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ...++||+|+||+||+|  ...++.+|+|+.....         ...+.+.+|+++|+++       .|+||+++..++.
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-------~h~nIv~~~~~~~  409 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-------KDFGIPAPYIFDV  409 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-------GGGTCCCCCEEEE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-------CCCCcCceEEEEE
Confidence            45679999999999999  4457789999875321         1234578999999999       5789995555555


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+..|||||||+ ++|.+++..          ++.++.||++||+|||+++||||||||+|||++   .  .+||+|||
T Consensus       410 ~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFG  474 (540)
T 3en9_A          410 DLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFG  474 (540)
T ss_dssp             ETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCT
T ss_pred             eCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECc
Confidence            7778899999997 688888754          568999999999999999999999999999995   3  89999999


Q ss_pred             cccccCCc----------ceeeccCccccCchhhcC--CCCCccchHHHHHHHHHHHHhCCCCC
Q 003239          262 SACTEDRT----------VYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       262 lA~~~~~~----------~~~~~GT~~Y~APEvl~~--~~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                      +++.....          ....+||+.|+|||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99876543          135689999999999987  57888999999998888887776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=8.8e-22  Score=211.19  Aligned_cols=144  Identities=24%  Similarity=0.300  Sum_probs=115.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------------------hhHHHHHHHHHHHHHhhcccCCC
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------------------AYYQQALVEVSILTTLNKKYDRE  169 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------------------~~~~~~~~Ei~iL~~L~~~~~~~  169 (837)
                      ..|.+.+.||+|+||.||+|++ .+++.||||+++...                   .....+.+|+.+|+.++      
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------  162 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------  162 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc------
Confidence            5677889999999999999999 889999999997432                   13456889999999983      


Q ss_pred             CCCceeEEeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeec
Q 003239          170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT  248 (837)
Q Consensus       170 ~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~  248 (837)
                         | +++.+++. .+..|+||||++| +|.+ +.        ......++.||+.||.|||++|||||||||+|||++ 
T Consensus       163 ---~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 ---G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             ---T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred             ---C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-
Confidence               3 44444443 3567999999975 7776 31        123567999999999999999999999999999995 


Q ss_pred             cCCCCeEEEEecccccccCCcceeeccCccccCchhhcC
Q 003239          249 SVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG  287 (837)
Q Consensus       249 ~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~  287 (837)
                         ++.+||+|||+|+.          +..++|||++..
T Consensus       228 ---~~~vkl~DFG~a~~----------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 ---EEGIWIIDFPQSVE----------VGEEGWREILER  253 (282)
T ss_dssp             ---TTEEEECCCTTCEE----------TTSTTHHHHHHH
T ss_pred             ---CCcEEEEECCCCeE----------CCCCCHHHHHHH
Confidence               67899999999953          345789999854

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=5.8e-19  Score=186.42  Aligned_cols=139  Identities=20%  Similarity=0.209  Sum_probs=107.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeE--EEEEEEeCChhh-------------------------HHHHHHHHHHHHH
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAY-------------------------YQQALVEVSILTT  161 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~--VAIKiik~~~~~-------------------------~~~~~~Ei~iL~~  161 (837)
                      .-|++.+.||+|+||.||+|.+..+|+.  ||||+++.....                         ...+.+|+.+|+.
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3478999999999999999998788999  999998643111                         1357889999999


Q ss_pred             hhcccCCCCCCceeEEeEEEeecceEEEEEeccch------hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh-cCCe
Q 003239          162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS------NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGI  234 (837)
Q Consensus       162 L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g------sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH-s~gI  234 (837)
                      |.+.     ..+++.++++    +..+|||||+++      .|.+....     .++..+..++.||+.+|.||| ++||
T Consensus       127 l~~~-----~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~gi  192 (258)
T 1zth_A          127 AKEA-----GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAEL  192 (258)
T ss_dssp             HHHT-----TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCE
T ss_pred             HHhC-----CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCE
Confidence            9653     1123334432    467999999953      55554321     235568899999999999999 9999


Q ss_pred             eeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       235 VHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||+|||++   .  .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEES---S--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEc---C--cEEEEECcccccC
Confidence            9999999999995   3  8999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=1.1e-15  Score=170.97  Aligned_cols=140  Identities=19%  Similarity=0.199  Sum_probs=98.9

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-----------------------hHHHHHHHHHHHHHhhccc
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-----------------------YYQQALVEVSILTTLNKKY  166 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~-----------------------~~~~~~~Ei~iL~~L~~~~  166 (837)
                      -|+|.++||.|+||.||+|.+. +|+.||||+++....                       ....+.+|...|.+|... 
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~-  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE-  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc-
Confidence            4999999999999999999875 689999999853100                       001234577777777442 


Q ss_pred             CCCCCCceeEEeEEEeecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCee
Q 003239          167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL  245 (837)
Q Consensus       167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL  245 (837)
                          .-.+...+++    ...+|||||++| .|.++        ........++.||+.+|.+||++|||||||||.|||
T Consensus       174 ----gv~vp~p~~~----~~~~LVME~i~G~~L~~l--------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          174 ----GFPVPEPIAQ----SRHTIVMSLVDALPMRQV--------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNIL  237 (397)
T ss_dssp             ----TCSCCCEEEE----ETTEEEEECCSCEEGGGC--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             ----CCCCCeeeec----cCceEEEEecCCccHhhh--------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence                1123333332    234799999986 44322        122345678999999999999999999999999999


Q ss_pred             eeccCCC-------CeEEEEecccccccC
Q 003239          246 LCTSVKP-------AEIKIIDFGSACTED  267 (837)
Q Consensus       246 l~~~~~~-------~~IKL~DFGlA~~~~  267 (837)
                      ++.+.+.       ..+.|+||+.+....
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EeCCCCcccccccccceEEEEeCCcccCC
Confidence            9743211       148999999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.19  E-value=7.7e-11  Score=123.13  Aligned_cols=138  Identities=14%  Similarity=0.055  Sum_probs=106.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..|++...++.|+.+.||++...  ++.+++|+..... .....+.+|+.+|+.|..      +..+.++++++...+..
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~------~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG------KLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT------TSCCCCEEEEEEETTEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc------CCCCCeEEEEEecCCce
Confidence            56889999999999999999643  6789999987421 223457889999999953      45688899998888899


Q ss_pred             EEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-----------------------------------
Q 003239          188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-----------------------------------  231 (837)
Q Consensus       188 ~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-----------------------------------  231 (837)
                      |+|||+++| +|.+.+       .+......++.++.++|..||+                                   
T Consensus        86 ~lv~e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEEEecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999997 554431       1122345778899999999998                                   


Q ss_pred             ------------------------CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          232 ------------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       232 ------------------------~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                                              ..++|+|++|.|||++   +...+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence                                    4589999999999995   33455799998873

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.04  E-value=4.9e-10  Score=115.67  Aligned_cols=136  Identities=12%  Similarity=-0.037  Sum_probs=95.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ..|.+..+.+.|..+.||++.. .+++.+++|+....  ....+.+|+.+++.+.+.     .-.+.+++.+....+..+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~-----~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATT-----GVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTT-----TCCBCCEEEEEECSSCEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhC-----CCCCCeEEEeccCCCCCE
Confidence            3456655545667799999954 45677999998754  234567899999999641     123667888888888899


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC-----------------------------------
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG-----------------------------------  233 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g-----------------------------------  233 (837)
                      +|||+++|.-.+ ..     ...   ...++.+++..|..||+..                                   
T Consensus        92 ~v~e~i~G~~l~-~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           92 LLLGEVPGQDLL-SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEECCSSEETT-TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEecCCcccC-cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            999999873223 11     111   2245666666677776543                                   


Q ss_pred             -----------------------eeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          234 -----------------------IIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       234 -----------------------IVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                                             ++|+|++|.|||++   ....++|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence                                   99999999999995   33456799999974

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.90  E-value=3.3e-09  Score=116.29  Aligned_cols=141  Identities=11%  Similarity=0.220  Sum_probs=102.9

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEe--CCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec---c
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---R  185 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik--~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~  185 (837)
                      .++.|+.|.++.||++...  +..+++|+..  ...  .....+.+|+.+++.|..     .+..+++++.++.+.   +
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~-----~~vpvP~~~~~~~~~~~~g  114 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAG-----TDVPVAKMYALCEDESVIG  114 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTT-----SSSCCCCEEEEECCTTTTS
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhc-----CCCCCCcEEEECCCCCccC
Confidence            3577899999999999654  3568888876  322  223567789999999964     244688888888776   4


Q ss_pred             eEEEEEeccchh-HHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc---------------------------------
Q 003239          186 HLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD---------------------------------  231 (837)
Q Consensus       186 ~l~LVmEy~~gs-L~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs---------------------------------  231 (837)
                      ..++|||+++|. +.+    .....++..+...++.+++..|..||+                                 
T Consensus       115 ~~~~vme~v~G~~l~~----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWD----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             SCEEEEECCCCBCCCC----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             CeEEEEEecCCeecCC----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            589999999974 322    112347788888999999999999996                                 


Q ss_pred             -------------------------CCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          232 -------------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       232 -------------------------~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                                               ..+||+|+++.|||++.+ ....+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECcccccc
Confidence                                     469999999999999632 123469999999854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=3.3e-09  Score=113.76  Aligned_cols=183  Identities=23%  Similarity=0.216  Sum_probs=117.3

Q ss_pred             EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---eEEEEE
Q 003239          115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---HLCICF  191 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---~l~LVm  191 (837)
                      +.|+.|....||++.     ..+++|+.... .....+.+|..+|+.+...    ..-.+.+++......+   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~----~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNK----LPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTS----SSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhc----CCCCCCceEeecCCCCCCCcceEEE
Confidence            358899999999984     34888986543 3456788999999998542    1112445555443333   458999


Q ss_pred             eccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc---------------------------------------
Q 003239          192 ELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD---------------------------------------  231 (837)
Q Consensus       192 Ey~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs---------------------------------------  231 (837)
                      |+++| .+.+...    ..++.++...++.|++..|..||+                                       
T Consensus        96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99997 4433222    136777777777788777777774                                       


Q ss_pred             -------------------CCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeeccCccc---cCchhhcC--
Q 003239          232 -------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY---RSPEVLLG--  287 (837)
Q Consensus       232 -------------------~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~GT~~Y---~APEvl~~--  287 (837)
                                         ..++|+|++|.||+++.+ ....+.|+||+.+...+... .......+   ..|+....  
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHH
Confidence                               247999999999999621 14567899999986433211 00001111   22222211  


Q ss_pred             --C----------CCCccchHHHHHHHHHHHHhCCCCC
Q 003239          288 --Y----------QYTTAIDMWSFGCIVAELFLGLPLF  313 (837)
Q Consensus       288 --~----------~yt~ksDIWSLG~ILyELltG~~PF  313 (837)
                        .          ......+.|+++.++|.+.+|..+|
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              0          1122368999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.40  E-value=2.2e-06  Score=92.24  Aligned_cols=138  Identities=20%  Similarity=0.143  Sum_probs=86.7

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe-ecceEEEEEe
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHLCICFE  192 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-~~~~l~LVmE  192 (837)
                      ++.++.|....||++     ++.+++|+-. .......+.+|..+|+.|.+..    .-.|.+++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~----~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCV----KVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTC----SSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcC----CCCCCCeEeecccCCCceEEEEe
Confidence            345788999999998     3458888854 3344567889999999996421    113556666553 4456789999


Q ss_pred             ccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh-----------------------------------------
Q 003239          193 LLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-----------------------------------------  230 (837)
Q Consensus       193 y~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH-----------------------------------------  230 (837)
                      +++| .+.+...    ..++..+...++.++...|..||                                         
T Consensus        94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            9987 3333110    11233333333333333333333                                         


Q ss_pred             -------------------cCCeeeccCCCCCeeeeccCCCCe-EEEEecccccc
Q 003239          231 -------------------DAGIIHCDLKPENILLCTSVKPAE-IKIIDFGSACT  265 (837)
Q Consensus       231 -------------------s~gIVHrDLKPeNILl~~~~~~~~-IKL~DFGlA~~  265 (837)
                                         ...+||+|+++.|||++.+...+. +.|+||+.+..
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               235799999999999963212344 58999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.26  E-value=1.8e-05  Score=82.43  Aligned_cols=132  Identities=13%  Similarity=0.096  Sum_probs=88.6

Q ss_pred             EeccCCce-eEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEecc
Q 003239          116 LLGHGTFG-QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL  194 (837)
Q Consensus       116 ~LG~G~fG-~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~  194 (837)
                      .+..|..+ .||+......+..+++|+-...  ....+.+|..+|+.|..      +--+.+++.++.+.+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~------~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA------FMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT------TSCCCCEEEEEEETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc------CCCcCeEEEEEEECCeEEEEEEee
Confidence            34445444 6999877777788999987643  34567889999999953      223778888888889999999999


Q ss_pred             ch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc------------------------------------------
Q 003239          195 DS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD------------------------------------------  231 (837)
Q Consensus       195 ~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs------------------------------------------  231 (837)
                      +| .+.+......      .....+..++...|..||.                                          
T Consensus       103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            86 4433322110      1112233333333333332                                          


Q ss_pred             ----------------CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          232 ----------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       232 ----------------~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                                      ..+||+|+++.|||++   ..+.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence                            1379999999999995   44556799999874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.08  E-value=1.4e-05  Score=88.76  Aligned_cols=77  Identities=18%  Similarity=0.193  Sum_probs=50.8

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .+.||.|..+.||++....+++.|+||......        ...+....|.++|+.+...    ....+.+++.+  +.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~----~~~~vP~~~~~--d~~  108 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH----VPHLVPRVFYS--DTE  108 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTT----CGGGSCCEEEE--ETT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhh----CCCCcCeEEEE--cCC
Confidence            567999999999999776667889999865321        1234567899999988642    11234455543  345


Q ss_pred             eEEEEEeccch
Q 003239          186 HLCICFELLDS  196 (837)
Q Consensus       186 ~l~LVmEy~~g  196 (837)
                      ..++|||++.+
T Consensus       109 ~~~lvmE~l~g  119 (397)
T 2olc_A          109 MAVTVMEDLSH  119 (397)
T ss_dssp             TTEEEECCCTT
T ss_pred             ccEEEEEeCCC
Confidence            57899999975

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.90  E-value=5.6e-05  Score=81.00  Aligned_cols=76  Identities=18%  Similarity=0.196  Sum_probs=44.0

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe-E--EEeecceEEEE
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY-E--YFVCQRHLCIC  190 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~-d--~f~~~~~l~LV  190 (837)
                      ++.|+.|..+.||++...  +..+++|+.....   .....|+.+++.|...-  ...|.++... +  +....+..++|
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g--~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKG--MNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHT--CSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcC--CCCCceeecCCCCEEEEECCEEEEE
Confidence            345666778999998642  3458999998643   34456778888876430  1223333210 0  12345678999


Q ss_pred             Eeccch
Q 003239          191 FELLDS  196 (837)
Q Consensus       191 mEy~~g  196 (837)
                      ||+++|
T Consensus       110 ~~~i~G  115 (346)
T 2q83_A          110 YDWIEG  115 (346)
T ss_dssp             EECCCC
T ss_pred             EEeecC
Confidence            999986

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.86  E-value=2.3e-05  Score=85.30  Aligned_cols=81  Identities=4%  Similarity=0.001  Sum_probs=54.9

Q ss_pred             EEEEEe-ccCCceeEEEeecc--C----CCeEEEEEEEeCCh---h-hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          112 IVKDLL-GHGTFGQVAKCWDA--E----MNSFVAVKIIKNQP---A-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       112 ~i~~~L-G~G~fG~Vyka~~~--~----tg~~VAIKiik~~~---~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      ...+.| +.|....+|++...  .    +++.+++|+.....   . ....+.+|+.+|+.|...    ..-.+.+++.+
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~----~~vpvP~v~~~   98 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGEL----TDVPVPRVRWI   98 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHH----CCSCCCCEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhc----CCCCCCcEEEE
Confidence            345678 88999999988543  1    25678889865432   0 124567899999999652    11346777777


Q ss_pred             Eeec---ceEEEEEeccch
Q 003239          181 FVCQ---RHLCICFELLDS  196 (837)
Q Consensus       181 f~~~---~~l~LVmEy~~g  196 (837)
                      ....   +..++|||+++|
T Consensus        99 ~~~~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCC
T ss_pred             ccCCCccCCceEEEEecCC
Confidence            6655   357899999976

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.39  E-value=0.00033  Score=74.61  Aligned_cols=69  Identities=9%  Similarity=-0.057  Sum_probs=43.8

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEec
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL  193 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy  193 (837)
                      ++.|+.|....+|++      +.+++|+............+|+.+++.+...    +-  ..+++.++  .+.-++|+||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~----g~--~P~~~~~~--~~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKA----GV--SPEVLHVD--PATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHT----TS--SCCEEEEC--TTTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHc----CC--CCceEEEE--CCCCEEEEee
Confidence            567888999999998      3488898875322222335689999888653    11  13444433  3345789999


Q ss_pred             c-ch
Q 003239          194 L-DS  196 (837)
Q Consensus       194 ~-~g  196 (837)
                      + +|
T Consensus        89 i~~g   92 (301)
T 3dxq_A           89 IAGA   92 (301)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            9 64

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.37  E-value=0.0006  Score=76.29  Aligned_cols=75  Identities=16%  Similarity=0.210  Sum_probs=45.8

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeC-------C-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-------Q-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~-------~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++.||.|..+.||++..  +++.++||....       . .........|.+++..+...    ....+.+++.+.  .+
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~----~~~~vP~v~~~~--~~  110 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNL----SPDHVPEVYHFD--RT  110 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHH----SGGGSCCEEEEE--TT
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhh----CCCCCCeEEEEC--CC
Confidence            46789999999999954  466799994321       1 10012233455555444321    123566676664  56


Q ss_pred             eEEEEEecc-ch
Q 003239          186 HLCICFELL-DS  196 (837)
Q Consensus       186 ~l~LVmEy~-~g  196 (837)
                      ..++|||++ ++
T Consensus       111 ~~~lv~e~l~~g  122 (420)
T 2pyw_A          111 MALIGMRYLEPP  122 (420)
T ss_dssp             TTEEEECCCCTT
T ss_pred             ccEEEEeecCCc
Confidence            789999999 75

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.35  E-value=0.0013  Score=71.18  Aligned_cols=75  Identities=24%  Similarity=0.216  Sum_probs=59.0

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEec
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL  193 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy  193 (837)
                      .+.|+.|....+|++..  ++..+++|+....  ....+..|...|+.|...    ....+.+++.+....+..++|||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~----~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKT----NSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHT----TSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhh----CCCCcceEEEEeecCCceEEEEEe
Confidence            56789999999999965  4567889987643  356678899999999652    234688888888878889999999


Q ss_pred             cch
Q 003239          194 LDS  196 (837)
Q Consensus       194 ~~g  196 (837)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            975

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.05  E-value=0.0044  Score=66.23  Aligned_cols=74  Identities=16%  Similarity=0.088  Sum_probs=47.8

Q ss_pred             EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE-----EeecceEEEE
Q 003239          116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY-----FVCQRHLCIC  190 (837)
Q Consensus       116 ~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~-----f~~~~~l~LV  190 (837)
                      .|+ |....||++.. .+++.+++|+..........+..|..+++.|...    + -.+++++..     ....+..++|
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~----g-~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVND----E-VPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT----T-CSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHc----C-CeecceeecCCcEEEEECCEEEEE
Confidence            455 77889998854 3456789999874322345677799999998653    1 113333322     2234567899


Q ss_pred             Eeccch
Q 003239          191 FELLDS  196 (837)
Q Consensus       191 mEy~~g  196 (837)
                      ||+++|
T Consensus       106 ~~~i~G  111 (328)
T 1zyl_A          106 FPSVGG  111 (328)
T ss_dssp             EECCCC
T ss_pred             EEecCC
Confidence            999875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.90  E-value=0.0028  Score=70.52  Aligned_cols=140  Identities=16%  Similarity=0.169  Sum_probs=79.0

Q ss_pred             EEeccCCceeEEEeeccC-------CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          115 DLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       115 ~~LG~G~fG~Vyka~~~~-------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      +.|..|-...+|++....       +++.|++|+............+|..+++.|...    +  -..+++.++..    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~----g--v~P~ll~~~~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAER----S--LGPQLYGVFPE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHT----T--SSCCEEEEETT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhc----C--CCCeEEEEcCC----
Confidence            456667777888886532       356789998644322345667899999999753    1  13556666543    


Q ss_pred             EEEEeccch-hH--------------HHHHHhhcc------CCC--CHHHHHHHHHhHHH-------------------H
Q 003239          188 CICFELLDS-NL--------------YELIKINHF------RGL--SLSIVQLFSKQILR-------------------G  225 (837)
Q Consensus       188 ~LVmEy~~g-sL--------------~d~l~~~~~------~~L--~e~~i~~I~~QIl~-------------------a  225 (837)
                      .+||||++| .|              .+.+..-..      +..  -+.++.+++.++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            289999875 11              111111110      111  13556666554422                   1


Q ss_pred             Hhhhh--------cCCeeeccCCCCCeeeecc-CCCCeEEEEeccccc
Q 003239          226 LSLLK--------DAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSAC  264 (837)
Q Consensus       226 L~yLH--------s~gIVHrDLKPeNILl~~~-~~~~~IKL~DFGlA~  264 (837)
                      +..|.        ...++|+|+.+.|||++.+ +..+.+.|+||..+.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            22222        2369999999999999732 123689999999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.88  E-value=0.0047  Score=65.12  Aligned_cols=78  Identities=14%  Similarity=0.055  Sum_probs=53.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .+..-++.+|.|..+.||++.. .+|+.|++|+..... .....+..|...|+.|...    .---+.+++.+    +.-
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~----~~vpvP~v~~~----~~~   85 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRS----FGSPVPQVAGW----DDR   85 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCS----TTCCSCCEEEE----ETT
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhh----CCCCcceEEec----cCc
Confidence            4556678899999999999964 568889999876432 2234567899999999642    11124445543    234


Q ss_pred             EEEEeccc
Q 003239          188 CICFELLD  195 (837)
Q Consensus       188 ~LVmEy~~  195 (837)
                      ++|||++.
T Consensus        86 ~lv~e~l~   93 (288)
T 3f7w_A           86 TLAMEWVD   93 (288)
T ss_dssp             EEEEECCC
T ss_pred             eEEEEeec
Confidence            78999975

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.73  E-value=0.0022  Score=70.18  Aligned_cols=73  Identities=15%  Similarity=0.076  Sum_probs=43.8

Q ss_pred             EEEeccCCceeEEEeeccC--------CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          114 KDLLGHGTFGQVAKCWDAE--------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~--------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++.|+.|....+|++....        .++.+++|+.............|..+++.|...    +  -+.+++..+  . 
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~----g--~~P~~~~~~--~-  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKY----K--IAPQLLNTF--N-  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHT----T--SSCCEEEEE--T-
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhc----C--CCCceEEec--C-
Confidence            4567788888999986543        136788998765432222346799999998653    1  134555544  2 


Q ss_pred             eEEEEEeccch
Q 003239          186 HLCICFELLDS  196 (837)
Q Consensus       186 ~l~LVmEy~~g  196 (837)
                       -++|||+++|
T Consensus       109 -~~~v~e~i~G  118 (369)
T 3c5i_A          109 -GGRIEEWLYG  118 (369)
T ss_dssp             -TEEEEECCCS
T ss_pred             -CcEEEEEecC
Confidence             2689999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.66  E-value=0.0033  Score=67.58  Aligned_cols=35  Identities=29%  Similarity=0.429  Sum_probs=26.9

Q ss_pred             cCCeeeccCCCCCeeeeccCC-CCeEEEEecccccc
Q 003239          231 DAGIIHCDLKPENILLCTSVK-PAEIKIIDFGSACT  265 (837)
Q Consensus       231 s~gIVHrDLKPeNILl~~~~~-~~~IKL~DFGlA~~  265 (837)
                      ...+||+|+.+.|||++.+.. ...+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            457999999999999963111 25789999998853

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.60  E-value=0.01  Score=63.13  Aligned_cols=79  Identities=5%  Similarity=-0.073  Sum_probs=45.3

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEe-E--EEeecceEEE
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY-E--YFVCQRHLCI  189 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~-d--~f~~~~~l~L  189 (837)
                      -++.|+.|....||++... ++ .+++|+.... ...+.+..|+.+++.|...  ....|.++... +  +....+..++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~--g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAK--GLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHT--TCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHC--CCCCCcccCCCCCCEEEEECCEEEE
Confidence            3567888888999998643 33 5789998752 1123456789999988653  01123333211 0  1123466789


Q ss_pred             EEeccch
Q 003239          190 CFELLDS  196 (837)
Q Consensus       190 VmEy~~g  196 (837)
                      ||++++|
T Consensus       101 l~~~l~G  107 (322)
T 2ppq_A          101 LISFLEG  107 (322)
T ss_dssp             EEECCCC
T ss_pred             EEEeCCC
Confidence            9999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.53  E-value=0.014  Score=66.41  Aligned_cols=73  Identities=16%  Similarity=0.168  Sum_probs=46.7

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEec
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL  193 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy  193 (837)
                      ++.|+.|-...+|++.....++.+++|+........-...+|..+++.|...      .-..+++.++.  +  .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~------gl~P~ll~~~~--~--G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNK------NIAKKIYVFFT--N--GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTS------SSBCCEEEEET--T--EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhc------CCCCCEEEEeC--C--eEEEEe
Confidence            5678889999999997654457899998854321111225799999999642      12356777663  2  259999


Q ss_pred             cch
Q 003239          194 LDS  196 (837)
Q Consensus       194 ~~g  196 (837)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.52  E-value=0.013  Score=66.02  Aligned_cols=72  Identities=19%  Similarity=0.176  Sum_probs=48.7

Q ss_pred             EEEeccCCceeEEEeeccC-------CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          114 KDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~-------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++.|+.|-...||++....       .++.|++|+..... ....+.+|..+++.|...      .-..++++.+..   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~------g~~P~l~~~~~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSER------HLGPKLYGIFSG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHT------TSSSCEEEEETT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhC------CCCCcEEEEeCC---
Confidence            4678888889999997542       25789999985421 124556899999999653      113556665542   


Q ss_pred             EEEEEeccch
Q 003239          187 LCICFELLDS  196 (837)
Q Consensus       187 l~LVmEy~~g  196 (837)
                       .+||||++|
T Consensus       148 -g~v~e~l~G  156 (429)
T 1nw1_A          148 -GRLEEYIPS  156 (429)
T ss_dssp             -EEEECCCCE
T ss_pred             -CEEEEEeCC
Confidence             289999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.19  E-value=0.027  Score=61.18  Aligned_cols=68  Identities=12%  Similarity=0.085  Sum_probs=43.5

Q ss_pred             ccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE------EeecceEEEEE
Q 003239          118 GHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY------FVCQRHLCICF  191 (837)
Q Consensus       118 G~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~------f~~~~~l~LVm  191 (837)
                      |.|....||++... ++ .+++|+......     ..|+.+++.|...    +-+.+++++..      ....+..++||
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~----g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDS----GIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHT----TCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhc----CCcccccceecCCCCEEEEECCEEEEEE
Confidence            34446899998643 34 789998875431     4688888888653    22224444322      23357789999


Q ss_pred             eccch
Q 003239          192 ELLDS  196 (837)
Q Consensus       192 Ey~~g  196 (837)
                      ++++|
T Consensus       101 ~~i~G  105 (339)
T 3i1a_A          101 PFIHA  105 (339)
T ss_dssp             ECCCC
T ss_pred             eccCC
Confidence            99875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.84  E-value=0.044  Score=56.36  Aligned_cols=97  Identities=10%  Similarity=0.018  Sum_probs=61.6

Q ss_pred             hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhh-cCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCCcceeecc
Q 003239          197 NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ  275 (837)
Q Consensus       197 sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~~~~~~~G  275 (837)
                      +|.++++... .+++|+++|.++.|.+.+|.-+- .+.-..+=+.|..|+|.   .+|.|.+.+ ..+         ...
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s---------~~~   99 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AAD---------DAG   99 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-ccc---------ccc
Confidence            7888887764 78999999999999999988872 11112333456777775   556666553 111         012


Q ss_pred             CccccCchhhcCCCCCccchHHHHHHHHHHHHh
Q 003239          276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL  308 (837)
Q Consensus       276 T~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt  308 (837)
                      ...+.|||... ...+.+.=|+|||+++|..+-
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence            33467888863 355678899999999999885

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.74  E-value=0.032  Score=62.90  Aligned_cols=73  Identities=14%  Similarity=0.081  Sum_probs=46.8

Q ss_pred             EEEeccCCceeEEEeeccCC-------CeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          114 KDLLGHGTFGQVAKCWDAEM-------NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~t-------g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++.|..|-...+|++.....       ++.|++|+........-...+|..+++.|...      .-..++++.+.    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~------gi~P~l~~~~~----  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNI------NIAPNIIADFP----  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHT------TSSCCEEEEET----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhc------CCCCCEEEEcC----
Confidence            45667788888999865421       57799998754322222345799999998653      12345554332    


Q ss_pred             EEEEEeccch
Q 003239          187 LCICFELLDS  196 (837)
Q Consensus       187 l~LVmEy~~g  196 (837)
                      -++||||++|
T Consensus       145 ~~~I~efI~G  154 (424)
T 3mes_A          145 EGRIEEFIDG  154 (424)
T ss_dssp             TEEEEECCCS
T ss_pred             CCEEEEEeCC
Confidence            2688999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.89  E-value=0.34  Score=53.68  Aligned_cols=32  Identities=28%  Similarity=0.395  Sum_probs=25.9

Q ss_pred             CeeeccCCCCCeeeecc---CCCCeEEEEeccccc
Q 003239          233 GIIHCDLKPENILLCTS---VKPAEIKIIDFGSAC  264 (837)
Q Consensus       233 gIVHrDLKPeNILl~~~---~~~~~IKL~DFGlA~  264 (837)
                      .++|+|+.+.|||+..+   ++...++|+||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36899999999999532   356789999999884

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	837
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-55
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-05
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-04
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-50
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-05
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-05
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-49
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-49
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-04
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-04
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-48
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-04
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	0.001
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-45
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-05
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-04
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	0.003
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-44
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	0.004
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	0.002
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-04
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-41
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-40
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-04
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	0.002
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-34
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-32
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-31
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-31
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-55
 Identities = 75/351 (21%), Positives = 122/351 (34%), Gaps = 59/351 (16%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
            +     LG G  G V K         +A K+I    +PA   Q + E+ +L   N    
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN---- 62

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 +IV  Y  F     + IC E +D    + + +     +   I+   S  +++GL
Sbjct: 63  ----SPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVIKGL 117

Query: 227 SLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEV 284
           + L++   I+H D+KP NIL+ +     EIK+ DFG +    D    S++ +R Y SPE 
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER 174

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
           L G  Y+   D+WS G  + E+ +G    P     +L       +     +   +     
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
                                                              + L+ IV  
Sbjct: 235 RPLSSYGMDSR----------------------------------PPMAIFELLDYIVNE 260

Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455
            P +  L     S E        DF+   +  +PA+R    Q   H F+  
Sbjct: 261 PPPK--LPSGVFSLE------FQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  182 bits (461), Expect = 2e-51
 Identities = 107/376 (28%), Positives = 163/376 (43%), Gaps = 62/376 (16%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK----K 165
           RYI+   LG G F  V    D   N+ VA+KI++    Y + A  E+ +L  +N     K
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 166 YDREDKHHIVRIYEYFVCQR----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
            D    +HI+++ ++F  +     H+ + FE+L  NL  LIK    RG+ L  V+  SKQ
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 222 ILRGLS-LLKDAGIIHCDLKPENILLCTS---VKPAEIKIIDFGSACTEDRTVYSYIQSR 277
           +L GL  + +  GIIH D+KPEN+L+          +IKI D G+AC  D    + IQ+R
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILGA 331
            YRSPEVLLG  +    D+WS  C++ EL  G  LF          + D + ++I +LG 
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG- 252

Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
           + P Y+L+  K T  FF   G + NI   +                              
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLK------------------------------ 282

Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
                        +   +++  E           + DFL  +++ DP KR        HP
Sbjct: 283 -------------FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329

Query: 452 FVTGEPFTCPYQPPPE 467
           ++         + P  
Sbjct: 330 WLKDTLGMEEIRVPDR 345

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-50
 Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 21/245 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
            + +   LG G FG+V K  + E +   A K+I        +  +VE+ IL + +     
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP--- 69

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
               +IV++ + F  + +L I  E       + + +   R L+ S +Q+  KQ L  L+ 
Sbjct: 70  ----NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVL 285
           L D  IIH DLK  NIL        +IK+ DFG +    RT+    S+I + Y+ +PEV+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182

Query: 286 LGYQ-----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDYVL 338
           +        Y    D+WS G  + E+    P     +   +L ++ +        P    
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242

Query: 339 KEAKN 343
              K+
Sbjct: 243 SNFKD 247

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (101), Expect = 8e-05
 Identities = 16/70 (22%), Positives = 29/70 (41%), Gaps = 3/70 (4%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
              +   H  +   ++      +  ++   S+ S       DFLK  +E +   RW+  Q
Sbjct: 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS---NFKDFLKKCLEKNVDARWTTSQ 265

Query: 447 ASRHPFVTGE 456
             +HPFVT +
Sbjct: 266 LLQHPFVTVD 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-50
 Identities = 54/239 (22%), Positives = 98/239 (41%), Gaps = 17/239 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
            + +   LG G FG V    + +    +A+K++      +     Q   EV I + L   
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
                  +I+R+Y YF     + +  E           +             +  ++   
Sbjct: 66  ------PNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANA 118

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEV 284
           LS      +IH D+KPEN+LL ++    E+KI DFG +         +   +  Y  PE+
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 175

Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           + G  +   +D+WS G +  E  +G P F   +  +  +R+ R+     PD+V + A++
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARD 233

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 14/69 (20%), Positives = 29/69 (42%), Gaps = 6/69 (8%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
           L+GK  F     +E        K +S  + +    +     D +  L++ +P++R    +
Sbjct: 198 LVGKPPFEANTYQETY------KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 251

Query: 447 ASRHPFVTG 455
              HP++T 
Sbjct: 252 VLEHPWITA 260

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-50
 Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 19/254 (7%)

Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
           NA      +   +LG G  G+V + ++       A+K++++ P    +A  EV +     
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHW--- 59

Query: 164 KKYDREDKH-HIVRIYEYF----VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
               R  +  HIVRI + +      ++ L I  E LD   L+  I+    +  +      
Sbjct: 60  ----RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115

Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
             K I   +  L    I H D+KPEN+L  +    A +K+ DFG A   T   ++ +   
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175

Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           + YY +PEVL   +Y  + DMWS G I+  L  G P F       +   M   +     +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 336 YVLKEAKNTSKFFK 349
           +   E    S+  K
Sbjct: 236 FPNPEWSEVSEEVK 249

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 16/108 (14%), Positives = 32/108 (29%), Gaps = 14/108 (12%)

Query: 364 IGGRSAYQALTEIEYEARELKKPLIGKEYFH--HKHLEEIVTNYPYRKNLSMEDISKESQ 421
                   +L  I Y       P                I        N    ++S+E  
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE-- 247

Query: 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETP 469
               +   ++ L++ +P +R +  +   HP++            P+TP
Sbjct: 248 ----VKMLIRNLLKTEPTQRMTITEFMNHPWIMQS------TKVPQTP 285

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (448), Expect = 1e-49
 Identities = 53/231 (22%), Positives = 98/231 (42%), Gaps = 13/231 (5%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
            Y + + LG G FG V +  +    +  A K +     +  +    E+  ++ L      
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP--- 83

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                +V +++ F     + + +E +    L+E +   H + +S      + +Q+ +GL 
Sbjct: 84  ----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLC 138

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVL 285
            + +   +H DLKPENI+  T+ +  E+K+IDFG        ++V     +  + +PEV 
Sbjct: 139 HMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
            G       DMWS G +   L  GL  F G ++ + LR +           
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 2/96 (2%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
           L G   F  ++ +E + N   +      D S  S I     DF++ L+  DP  R +  Q
Sbjct: 219 LSGLSPFGGENDDETLRNV--KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276

Query: 447 ASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHH 482
           A  HP++T           P +    +  + K  + 
Sbjct: 277 ALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 312

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-49
 Identities = 92/366 (25%), Positives = 154/366 (42%), Gaps = 82/366 (22%)

Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK------NQPAYYQQALVEVSILTTLNKKYDR 168
           D LG G F  V K  D   N  VA+K IK       +    + AL E+ +L  L+     
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
               +I+ + + F  + ++ + F+ ++++L  +IK N    L+ S ++ +    L+GL  
Sbjct: 60  ---PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEY 115

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVL 285
           L    I+H DLKP N+LL    +   +K+ DFG A    + +R     + +R+YR+PE+L
Sbjct: 116 LHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172

Query: 286 LGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
            G + Y   +DMW+ GCI+AEL L +P  PG S+ D L R+                   
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI------------------- 213

Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
              F+ +G+                    TE ++         +  + F    L  I + 
Sbjct: 214 ---FETLGT-------------------PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251

Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP 464
                         +      L+D ++GL  F+P  R +  QA +  + +  P      P
Sbjct: 252 -----------AGDD------LLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT---P 291

Query: 465 PPETPR 470
             + PR
Sbjct: 292 GCQLPR 297

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-49
 Identities = 91/382 (23%), Positives = 153/382 (40%), Gaps = 82/382 (21%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            Y    ++G+G+FG V +    +    VA+K +     +  +   E+ I+  L+      
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHC---- 73

Query: 170 DKHHIVRIYEYFVC------QRHLCICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQ 221
              +IVR+  +F        + +L +  + +   +Y + +      + L +  V+L+  Q
Sbjct: 74  ---NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
           + R L+ +   GI H D+KP+N+LL      A +K+ DFGSA          SYI SRYY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           R+PE++ G   YT++ID+WS GC++AEL LG P+FPG S  D L  +I++LG    + + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL 398
           +   N ++                                              F    +
Sbjct: 249 EMNPNYTE----------------------------------------------FKFPQI 262

Query: 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458
           +       +R     E            +     L+E+ P  R +P +A  H F   +  
Sbjct: 263 KAHPWTKVFRPRTPPE-----------AIALCSRLLEYTPTARLTPLEACAHSFF--DEL 309

Query: 459 TCPYQPPPETPRVPVAQNFKVD 480
             P    P     P   NF   
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQ 331

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-49
 Identities = 76/371 (20%), Positives = 135/371 (36%), Gaps = 84/371 (22%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
           +Y     +G GTFG+V K    +    VA+K +     +  +   AL E+ IL  L    
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-- 68

Query: 167 DREDKHHIVRIYE--------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLF 218
                 ++V + E        Y  C+  + + F+  + +L  L+  N     +LS ++  
Sbjct: 69  -----ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRV 122

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVY 271
            + +L GL  +    I+H D+K  N+L+    +   +K+ DFG A        ++     
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 272 SYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
           + + + +YR PE+LLG + Y   ID+W  GCI+AE++   P+  G +E   L  + ++ G
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
           +  P+                                                  P +  
Sbjct: 240 SITPEVW------------------------------------------------PNVDN 251

Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
              + K           +  L               +D +  L+  DPA+R     A  H
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPY------ALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 451 PFVTGEPFTCP 461
            F   +P    
Sbjct: 306 DFFWSDPMPSD 316

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 9e-49
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 12/234 (5%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
           E   +Y++ + LG G FG V +C +         K +K +         E+SIL     +
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHR 61

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
                  +I+ ++E F     L + FE +   +++E I  + F  L+   +  +  Q+  
Sbjct: 62  -------NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCE 113

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
            L  L    I H D++PENI+  T  + + IKII+FG A              +  Y +P
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           EV      +TA DMWS G +V  L  G+  F   +   ++  ++        + 
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (93), Expect = 9e-04
 Identities = 16/84 (19%), Positives = 34/84 (40%), Gaps = 2/84 (2%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
           L G   F  +  ++I+ N    +    E+  KE  I +  +DF+  L+  +   R +  +
Sbjct: 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAFKE--ISIEAMDFVDRLLVKERKSRMTASE 254

Query: 447 ASRHPFVTGEPFTCPYQPPPETPR 470
           A +HP++  +      +       
Sbjct: 255 ALQHPWLKQKIERVSTKVIRTLKH 278

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  173 bits (440), Expect = 2e-48
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 13/231 (5%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
            Y + + LG G FG V +C +         K I    P        E+SI+  L+     
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP--- 86

Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                ++ +++ F  +  + +  E L    L++ I    ++ +S + V  + +Q   GL 
Sbjct: 87  ----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLK 141

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVL 285
            + +  I+H D+KPENI+  T  K + +KIIDFG A     D  V     +  + +PE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
                    DMW+ G +   L  GL  F G  + + L+ + R       D 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 8/96 (8%)

Query: 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLK 431
           A+  + Y       P  G++    + L+ +          +   +S E        DF+K
Sbjct: 213 AIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDEDAFSSVSPE------AKDFIK 264

Query: 432 GLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPE 467
            L++ +P KR +   A  HP++ G+      + P  
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 9e-48
 Identities = 82/352 (23%), Positives = 145/352 (41%), Gaps = 73/352 (20%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKK 165
           +Y     +G G +G+V K  D +    FVA+K ++    +       + EV++L  L   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 166 YDREDKHHIVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
               +  ++VR+++     R      L + FE +D +L   +      G+    ++    
Sbjct: 68  ----EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
           Q+LRGL  L    ++H DLKP+NIL+ TS    ++         +    + S + + +YR
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILV-TSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182

Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
           +PEVLL   Y T +D+WS GCI AE+F   PLF G+S+ D L +++ ++G    +   ++
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEE 400
                + F              S   +   + +T+I+   ++L                 
Sbjct: 243 VALPRQAFH-------------SKSAQPIEKFVTDIDELGKDL----------------- 272

Query: 401 IVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
                                        L   + F+PAKR S + A  HP+
Sbjct: 273 -----------------------------LLKCLTFNPAKRISAYSALSHPY 295

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-47
 Identities = 83/370 (22%), Positives = 141/370 (38%), Gaps = 65/370 (17%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKK 165
           +RY     +G G  G V   +DA ++  VA+K +        + ++A  E+ ++  +N  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH- 75

Query: 166 YDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
                  +I+ +   F  Q+       + +  EL+D+NL ++I++          +    
Sbjct: 76  ------KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLL 125

Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
            Q+L G+  L  AGIIH DLKP NI++ +      +              +  Y+ +RYY
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL-DFGLARTAGTSFMMTPYVVTRYY 184

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
           R+PEV+LG  Y   +D+WS GCI+ E+     LFPG    D   ++I  LG   P+++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLE 399
                  + +                                   +P      F      
Sbjct: 245 LQPTVRNYVE----------------------------------NRPKYAGLTFPK---- 266

Query: 400 EIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459
                  +  +L   D            D L  ++  DPAKR S   A +HP++      
Sbjct: 267 ------LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320

Query: 460 CPYQPPPETP 469
              + PP   
Sbjct: 321 AEVEAPPPQI 330

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-47
 Identities = 87/364 (23%), Positives = 147/364 (40%), Gaps = 79/364 (21%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
            +   + +G GT+G V K  +      VA+K I+           A+ E+S+L  LN   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-- 60

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 +IV++ +    +  L + FE L  +L + +  +   G+ L +++ +  Q+L+GL
Sbjct: 61  -----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
           +      ++H DLKP+N+L+ T      IK+ DFG A       RT    + + +YR+PE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
           +LLG +Y +TA+D+WS GCI AE+     LFPG SE D L                    
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF------------------- 213

Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
              + F+ +G+   +                                  +     + +  
Sbjct: 214 ---RIFRTLGTPDEVV---------------------------------WPGVTSMPDYK 237

Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
            ++P         +     +       L  ++ +DP KR S   A  HPF     F    
Sbjct: 238 PSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPF-----FQDVT 290

Query: 463 QPPP 466
           +P P
Sbjct: 291 KPVP 294

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 2e-46
 Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 22/244 (9%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNK 164
           + +     +GHG+FG V    D   +  VA+K +          +Q  + EV  L  L  
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR- 73

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                  H + ++    ++ +    +  E    +  +L++++  + L    +   +   L
Sbjct: 74  -------HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGAL 125

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
           +GL+ L    +IH D+K  NILL    +P  +K+ DFGSA        S++ + Y+ +PE
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-NSFVGTPYWMAPE 181

Query: 284 VLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQPPDYVLK 339
           V+L     QY   +D+WS G    EL    P     +    L  + +    A    +  +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241

Query: 340 EAKN 343
             +N
Sbjct: 242 YFRN 245

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 19/93 (20%), Positives = 28/93 (30%), Gaps = 10/93 (10%)

Query: 365 GGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424
            G+    +L     E  E K PL          L  I  N      L     S+      
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPA--LQSGHWSEY----- 242

Query: 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457
              +F+   ++  P  R +     +H FV  E 
Sbjct: 243 -FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 7e-46
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 25/245 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
            +    +LG G+F  V    +   +   A+KI++     +         E  +++ L+  
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66

Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQIL 223
                 H   V++Y  F     L           L + I          +  + ++ +I+
Sbjct: 67  ------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIV 118

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRY 278
             L  L   GIIH DLKPENILL    +   I+I DFG+A      ++     S++ +  
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
           Y SPE+L       + D+W+ GCI+ +L  GLP F   +E+ + +++I++     P+   
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFF 234

Query: 339 KEAKN 343
            +A++
Sbjct: 235 PKARD 239

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  163 bits (414), Expect = 8e-46
 Identities = 92/350 (26%), Positives = 151/350 (43%), Gaps = 76/350 (21%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
           +Y   + +G GT+G V K  +       A+K I   K         + E+SIL  L    
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-- 59

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 +IV++Y+    ++ L + FE LD +L +L+ +    GL     + F  Q+L G+
Sbjct: 60  -----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGI 113

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
           +   D  ++H DLKP+N+L+    +  E+KI DFG A       R     I + +YR+P+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

Query: 284 VLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
           VL+G + Y+T ID+WS GCI AE+  G PLFPG SE D L                    
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM------------------- 211

Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
              + F+ +G+ ++                                 K + +   L +  
Sbjct: 212 ---RIFRILGTPNS---------------------------------KNWPNVTELPKYD 235

Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
            N+   + L  E   K   +  + +D L  +++ DP +R +  QA  H +
Sbjct: 236 PNFTVYEPLPWESFLK--GLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-45
 Identities = 47/242 (19%), Positives = 93/242 (38%), Gaps = 18/242 (7%)

Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKY 166
           +++Y   + +G G  G V    D      VA++ +   Q    +  + E+ ++       
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP- 77

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 +IV   + ++    L +  E L      L  +     +    +    ++ L+ L
Sbjct: 78  ------NIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQAL 129

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
             L    +IH D+K +NILL        +K+ DFG       E     + + + Y+ +PE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDYVLKEA 341
           V+    Y   +D+WS G +  E+  G P +   +    L  +        Q P+ +    
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 342 KN 343
           ++
Sbjct: 247 RD 248

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 14/98 (14%)

Query: 378 YEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD 437
            E  E + P + +     + L  I TN         E +S          DFL   ++ D
Sbjct: 207 IEMIEGEPPYLNEN--PLRALYLIATNGTPELQNP-EKLSAI------FRDFLNRCLDMD 257

Query: 438 PAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQ 475
             KR S  +  +H F               TP +  A+
Sbjct: 258 VEKRGSAKELLQHQF-----LKIAKPLSSLTPLIAAAK 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-45
 Identities = 90/374 (24%), Positives = 144/374 (38%), Gaps = 83/374 (22%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
           RY     +G G +G V   +D      VA+K I       Y Q+ L E+ IL     +  
Sbjct: 9   RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE-- 66

Query: 168 REDKHHIVRIYEYFV-----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
                +I+ I +          + + +   L+ ++LY+L+K    + LS   +  F  QI
Sbjct: 67  -----NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQI 118

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC------TEDRTVYSYIQS 276
           LRGL  +  A ++H DLKP N+LL       ++KI DFG A            +  Y+ +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 277 RYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L    YT +ID+WS GCI+AE+    P+FPG    D L   I  +   P  
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQ 234

Query: 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHH 395
             L    N       +                                            
Sbjct: 235 EDLNCIINLKARNYLL-------------------------------------------- 250

Query: 396 KHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455
                   + P++  +    +          +D L  ++ F+P KR    QA  HP++  
Sbjct: 251 --------SLPHKNKVPWNRLFPN--ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE- 299

Query: 456 EPFTCPYQPPPETP 469
           + +    +P  E P
Sbjct: 300 QYYDPSDEPIAEAP 313

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-45
 Identities = 84/377 (22%), Positives = 151/377 (40%), Gaps = 84/377 (22%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
           E +  Y     +G G +G V    D    + VA+K +        + ++A  E+ +L  +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 163 NKKYDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
             +       +++ + + F             +    + ++L +L+K      L    +Q
Sbjct: 75  RHE-------NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQ 124

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               Q+L+GL  +  AGIIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVT 181

Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PEV+L +  YT  +D+WS GCI+AE+  G  LF G+   D L+ ++++ G  P +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241

Query: 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHH 395
           +V +   + +K +                                        G      
Sbjct: 242 FVQRLQSDEAKNYMK--------------------------------------GLPELEK 263

Query: 396 KHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455
           K    I+TN            S         V+ L+ ++  D  +R +  +A  HP+   
Sbjct: 264 KDFASILTN-----------ASPL------AVNLLEKMLVLDAEQRVTAGEALAHPYFE- 305

Query: 456 EPFTCPYQPPPETPRVP 472
                      + P+V 
Sbjct: 306 -----SLHDTEDEPQVQ 317

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 6e-45
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 16/233 (6%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
            Y  +D+LG G F +V    D      VA+K I  +    ++  +  E+++L  +     
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK---- 65

Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
               H +IV + + +    HL +  +L+    L++ I        +         Q+L  
Sbjct: 66  ----HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDA 119

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPE 283
           +  L D GI+H DLKPEN+L  +  + ++I I DFG +  ED    + +   +  Y +PE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           VL    Y+ A+D WS G I   L  G P F   ++  L  ++++        Y
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 22/100 (22%), Positives = 41/100 (41%), Gaps = 8/100 (8%)

Query: 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLK 431
           ++  I Y       P   +     K  E+I+       +   +DIS          DF++
Sbjct: 194 SIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEYEFDSPYWDDISDS------AKDFIR 245

Query: 432 GLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRV 471
            L+E DP KR++  QA +HP++ G+           + ++
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  161 bits (409), Expect = 1e-44
 Identities = 72/373 (19%), Positives = 140/373 (37%), Gaps = 68/373 (18%)

Query: 87  YDNVNSDL---ILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK 143
           Y +VN+            +V    Q  Y +   LG G + +V +  +   N  V VKI+K
Sbjct: 10  YTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69

Query: 144 NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIK 203
             P   ++   E+ IL  L          +I+ + +                 N  +  +
Sbjct: 70  --PVKKKKIKREIKILENLR------GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121

Query: 204 INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
              ++ L+   ++ +  +IL+ L      GI+H D+KP N+++    +  ++++ID+G A
Sbjct: 122 --LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLA 177

Query: 264 C--TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLG-LPLFPGASEF 319
                 +     + SRY++ PE+L+ YQ Y  ++DMWS GC++A +     P F G   +
Sbjct: 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237

Query: 320 DLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYE 379
           D L R+ ++LG +     + +                                       
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYN------------------------------------- 260

Query: 380 ARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPA 439
                               +I+  +  ++         +  +    +DFL  L+ +D  
Sbjct: 261 ------------IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 440 KRWSPFQASRHPF 452
            R +  +A  HP+
Sbjct: 309 SRLTAREAMEHPY 321

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 61/259 (23%), Positives = 99/259 (38%), Gaps = 34/259 (13%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----------YYQQALVEVSIL 159
            Y  K++LG G    V +C         AVKII                 +  L EV IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLF 218
             ++         +I+++ + +       + F+L+    L++ +       LS    +  
Sbjct: 64  RKVS------GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKI 115

Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQS 276
            + +L  +  L    I+H DLKPENILL        IK+ DFG +C       +     +
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGT 172

Query: 277 RYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
             Y +PE++          Y   +DMWS G I+  L  G P F    +  +LR ++    
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--- 229

Query: 331 AQPPDYVLKEAKNTSKFFK 349
                +   E  + S   K
Sbjct: 230 -GNYQFGSPEWDDYSDTVK 247

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 40.1 bits (93), Expect = 8e-04
 Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 8/75 (10%)

Query: 378 YEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD 437
           Y       P   ++      L  I++      +   +D S        + D +   +   
Sbjct: 206 YTLLAGSPPFWHRK--QMLMLRMIMSGNYQFGSPEWDDYSDT------VKDLVSRFLVVQ 257

Query: 438 PAKRWSPFQASRHPF 452
           P KR++  +A  HPF
Sbjct: 258 PQKRYTAEEALAHPF 272

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-44
 Identities = 69/242 (28%), Positives = 114/242 (47%), Gaps = 20/242 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKK 165
            +I+  +LG G+FG+V      + N F A+K +K          +  +VE  +L+     
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-- 60

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILR 224
               +   +  ++  F  + +L    E L+  +L   I+        LS    ++ +I+ 
Sbjct: 61  ----EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIIL 114

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRS 281
           GL  L   GI++ DLK +NILL    K   IKI DFG        D    ++  +  Y +
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171

Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
           PE+LLG +Y  ++D WSFG ++ E+ +G   F G  E +L    IR+     P ++ KEA
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HSIRMDNPFYPRWLEKEA 230

Query: 342 KN 343
           K+
Sbjct: 231 KD 232

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (88), Expect = 0.003
 Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 7/91 (7%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS-PF 445
           LIG+  FH +  EE+  +           + KE        D L  L   +P KR     
Sbjct: 197 LIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE------AKDLLVKLFVREPEKRLGVRG 250

Query: 446 QASRHPFVTGEPFTCPYQPPPETPRVPVAQN 476
              +HP      +    +   + P  P  ++
Sbjct: 251 DIRQHPLFREINWEELERKEIDPPFRPKVKS 281

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-44
 Identities = 57/249 (22%), Positives = 95/249 (38%), Gaps = 26/249 (10%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYD 167
           Y V   +G G++G+  K         +  K +       A  Q  + EV++L  L     
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH--- 62

Query: 168 REDKHHIVRIYEYFVCQ--RHLCICFELLD-SNLYELIK--INHFRGLSLSIVQLFSKQI 222
                +IVR Y+  + +    L I  E  +  +L  +I       + L    V     Q+
Sbjct: 63  ----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 223 LRGLSLLKDAG-----IIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYI 274
              L            ++H DLKP N+ L        +K+ DFG A     +     +++
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKAFV 175

Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
            + YY SPE +    Y    D+WS GC++ EL   +P F   S+ +L  ++      + P
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235

Query: 335 DYVLKEAKN 343
                E   
Sbjct: 236 YRYSDELNE 244

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 3e-44
 Identities = 93/364 (25%), Positives = 153/364 (42%), Gaps = 82/364 (22%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
           +Y   + +G GT+G V K  + E +  VA+K ++   +       AL E+ +L  L  K 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK- 61

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                 +IVR+++     + L + FE  D +L +     +   L   IV+ F  Q+L+GL
Sbjct: 62  ------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGL 114

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
                  ++H DLKP+N+L+  +    E+K+ +FG A       R   + + + +YR P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

Query: 284 VLLGYQ-YTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
           VL G + Y+T+IDMWS GCI AEL     PLFPG    D L+R+ R+LG           
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT-------- 223

Query: 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEI 401
                                              E +   + K    K Y  +     +
Sbjct: 224 -----------------------------------EEQWPSMTKLPDYKPYPMYPATTSL 248

Query: 402 VTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCP 461
           V   P         ++          D L+ L++ +P +R S  +A +HP+ +       
Sbjct: 249 VNVVP--------KLNAT------GRDLLQNLLKCNPVQRISAEEALQHPYFS------D 288

Query: 462 YQPP 465
           + PP
Sbjct: 289 FCPP 292

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-44
 Identities = 53/244 (21%), Positives = 91/244 (37%), Gaps = 21/244 (8%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYD 167
            + +   LG G +G+V    +      VAVKI+  K      +    E+ I   LN +  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-- 63

Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
                ++V+ Y +        +  E          +I    G+     Q F  Q++ G+ 
Sbjct: 64  -----NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSP 282
            L   GI H D+KPEN+LL        +KI DFG A        +R +     +  Y +P
Sbjct: 118 YLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 283 EVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA--QPPDYVLK 339
           E+L   ++    +D+WS G ++  +  G   +   S+        +       P   +  
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234

Query: 340 EAKN 343
               
Sbjct: 235 APLA 238

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 6e-44
 Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 16/238 (6%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           +   +   +G G FG V         + VAVK IKN  A  Q  L E S++T L      
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHS--- 60

Query: 169 EDKHHIVRIYEYFVCQR-HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
               ++V++    V ++  L I  E +   +L + ++      L    +  FS  +   +
Sbjct: 61  ----NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
             L+    +H DL   N+L+         K+ DFG       T  +      + +PE L 
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR 173

Query: 287 GYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
             +++T  D+WSFG ++ E++  G   +P     D++ R+ +      PD        
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 5e-43
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 16/227 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
           +Y V  LLG G FG V        N  VA+K ++        +     +  +EV +L  +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
           +  +       ++R+ ++F       +  E  +        I     L   + + F  Q+
Sbjct: 65  SSGF-----SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY-SYIQSRYYRS 281
           L  +    + G++H D+K ENIL+  +    E+K+IDFGS      TVY  +  +R Y  
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKDTVYTDFDGTRVYSP 177

Query: 282 PEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           PE +  ++Y   +  +WS G ++ ++  G   F    E    +   R
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (87), Expect = 0.004
 Identities = 7/67 (10%), Positives = 23/67 (34%), Gaps = 6/67 (8%)

Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP 464
           + + + +    +    ++       ++  +   P+ R +  +   HP++           
Sbjct: 210 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL------ 263

Query: 465 PPETPRV 471
           P ET  +
Sbjct: 264 PQETAEI 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (384), Expect = 8e-42
 Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 19/238 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
           RY + ++LG G   +V    D  ++  VAVK+++      P++Y +   E      LN  
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 166 YDREDKHHIVRIYEYFVCQRH----LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                   IV +Y+    +        I  E +D      I ++    ++          
Sbjct: 68  -------AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMTPKRAIEVIAD 119

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRY 278
             + L+     GIIH D+KP NI++  +     +      +      +V    + I +  
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
           Y SPE   G       D++S GC++ E+  G P F G S   +  + +R     P   
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 8e-42
 Identities = 53/237 (22%), Positives = 101/237 (42%), Gaps = 16/237 (6%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
           + +   LG G+FG+V          + A+K++K     +    +    E  +L+ +    
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP- 64

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                  I+R++  F   + + +  + ++      +     R     + + ++ ++   L
Sbjct: 65  ------FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLAL 117

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
             L    II+ DLKPENILL    K   IKI DFG A       Y+   +  Y +PEV+ 
Sbjct: 118 EYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS 174

Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
              Y  +ID WSFG ++ E+  G   F  ++      +++     + P +  ++ K+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFFNEDVKD 230

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 17/101 (16%), Positives = 31/101 (30%), Gaps = 11/101 (10%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
           L G   F+  +  +        + +   ++         + D L  L+  D ++R    Q
Sbjct: 195 LAGYTPFYDSNTMKTY------EKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248

Query: 447 AS-----RHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHH 482
                   HP+     +        ETP  P  Q  + D  
Sbjct: 249 NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTS 289

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 47/254 (18%), Positives = 92/254 (36%), Gaps = 20/254 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            Y V   +G G+FG + +  +   N  VA+K    + +   Q   E      L       
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGC---- 60

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               I  +Y +     H  +  +LL  +L +L+ +   R  S+  V + +KQ+L  +  +
Sbjct: 61  --TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 117

Query: 230 KDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSA----------CTEDRTVYSYIQSR 277
            +  +++ D+KP+N L+          I ++DFG                R   +   + 
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
            Y S    LG + +   D+ + G +      G   + G       ++  RI   +    +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 338 LKEAKNTSKFFKCI 351
            +      + F   
Sbjct: 238 RELCAGFPEEFYKY 251

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-41
 Identities = 53/247 (21%), Positives = 104/247 (42%), Gaps = 23/247 (9%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKK 165
           R       +G G+F  V K  D E    VA   ++++    +  Q+   E  +L  L   
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH- 67

Query: 166 YDREDKHHIVRIYEYFVC----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
                  +IVR Y+ +      ++ + +  EL+ S   +   +  F+ + + +++ + +Q
Sbjct: 68  ------PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY-LKRFKVMKIKVLRSWCRQ 120

Query: 222 ILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-YSYIQSRY 278
           IL+GL  L      IIH DLK +NI +        +KI D G A  +  +   + I +  
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRASFAKAVIGTPE 178

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDY 336
           + +PE+    +Y  ++D+++FG  + E+      +        + R +   +  A     
Sbjct: 179 FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237

Query: 337 VLKEAKN 343
            + E K 
Sbjct: 238 AIPEVKE 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 18/237 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
            Y   + LG G F  V KC +       A K IK        +    +    EVSIL  +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
                     +++ ++E +  +  + +  EL+               L+      F KQI
Sbjct: 71  QHP-------NVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 122

Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
           L G+  L    I H DLKPENI+L    V    IKIIDFG A          +   +  +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
            +PE++         DMWS G I   L  G   F G ++ + L  +  +      +Y
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 6/84 (7%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
           L G   F     +E + N     N   ED    S       DF++ L+  DP KR +   
Sbjct: 210 LSGASPFLGDTKQETLANV-SAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267

Query: 447 ASRHPFVTG----EPFTCPYQPPP 466
           + +HP++      +  +  +  P 
Sbjct: 268 SLQHPWIKPKDTQQALSSAWSHPQ 291

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 5e-41
 Identities = 55/252 (21%), Positives = 90/252 (35%), Gaps = 18/252 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
           RY +   +G G+FG +    D      VA+K+   +  +  Q  +E  I   +       
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQ------ 60

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               I  I        +  +  ELL  +L +L      R  SL  V L + Q++  +  +
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYI 119

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------CTEDRTVYSYIQSRYY 279
                IH D+KP+N L+    K   + IIDFG A              R   +   +  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
            S    LG + +   D+ S G ++    LG   + G       ++  RI   +    +  
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 340 EAKNTSKFFKCI 351
             K     F   
Sbjct: 240 LCKGYPSEFATY 251

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 72/254 (28%), Positives = 124/254 (48%), Gaps = 23/254 (9%)

Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
           E   RY     +G G +G V   +D +    VAVK +        + ++   E+ +L  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 163 NKKYDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
                     +++ + + F   R       + +   L+ ++L     I   + L+   VQ
Sbjct: 75  KH-------ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN---IVKCQKLTDDHVQ 124

Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
               QILRGL  +  A IIH DLKP N+ +    +  E+KI+DFG A   D  +  Y+ +
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 181

Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
           R+YR+PE++L +  Y   +D+WS GCI+AEL  G  LFPG    D L+ ++R++G    +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241

Query: 336 YVLKEAKNTSKFFK 349
            + K +  +++ + 
Sbjct: 242 LLKKISSESARNYI 255

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 27/230 (11%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
           +  V   +G G+FG V   +  + +  VAVK++      P   Q    EV +L       
Sbjct: 9   QITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV- 64

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
                 +I+    Y      L I  +  + S+LY  + I   +   +  +   ++Q  +G
Sbjct: 65  ------NILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQG 116

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYR 280
           +  L    IIH DLK  NI L    +   +KI DFG A  + R   S+   +      + 
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 281 SPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
           +PEV+       Y+   D+++FG ++ EL  G   +   +  D +  M+ 
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (364), Expect = 5e-39
 Identities = 44/240 (18%), Positives = 98/240 (40%), Gaps = 16/240 (6%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
              +K  LG G +G+V +    + +  VAVK +K      ++ L E +++  +       
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP---- 73

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
              ++V++      +    I  E +   NL + ++  + + +S  ++   + QI   +  
Sbjct: 74  ---NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEV 284
           L+    IH DL   N L+  +     +K+ DFG +                   + +PE 
Sbjct: 131 LEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 285 LLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           L   +++   D+W+FG ++ E+   G+  +PG     +   + +    + P+   ++   
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (365), Expect = 2e-38
 Identities = 52/238 (21%), Positives = 94/238 (39%), Gaps = 16/238 (6%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKK 165
           ++     LG G+FG+V      E  +  A+KI+  Q        +  L E  IL  +N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
                   +V++   F    +L +  E +         +      S    + ++ QI+  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGG-EMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
              L    +I+ DLKPEN+L+        I++ DFG A       ++   +    +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTLCGTPEALAPEII 210

Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           L   Y  A+D W+ G ++ E+  G P F       +    I     + P +   + K+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-EKIVSGKVRFPSHFSSDLKD 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-38
 Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 18/240 (7%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
              + + LG G FG+V   +    ++ VAVK +K         L E +++  L  +    
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ---- 68

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
               +VR+Y     Q  + I  E +++ +L + +K      L+++ +   + QI  G++ 
Sbjct: 69  ---RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEV 284
           +++   IH DL+  NIL+         KI DFG A      E            + +PE 
Sbjct: 125 IEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 285 LLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           +    +T   D+WSFG ++ E+   G   +PG +  ++++ + R      PD   +E   
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  143 bits (362), Expect = 5e-38
 Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 8/238 (3%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
            + V  ++G G FG+V  C  A+     A+K +  +    +Q          +       
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
           D   IV +   F     L    +L++        ++     S + ++ ++ +I+ GL  +
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEVLL-G 287
            +  +++ DLKP NILL    +   ++I D G AC    +  ++ + +  Y +PEVL  G
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLKEAKN 343
             Y ++ D +S GC++ +L  G   F      D   + RM   +  + PD    E ++
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 9e-38
 Identities = 52/240 (21%), Positives = 93/240 (38%), Gaps = 19/240 (7%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKY 166
           +    LLG GTFG+V    +     + A+KI++ +           + E  +L       
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-- 64

Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
                  +  +   F     LC   E  +        ++  R  +    + +  +I+  L
Sbjct: 65  -----PFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSAL 118

Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPE 283
             L    +++ D+K EN++L        IKI DFG      ++  T+ ++  +  Y +PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           VL    Y  A+D W  G ++ E+  G   F       L    I +   + P  +  EAK+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-ILMEEIRFPRTLSPEAKS 234

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 4e-04
 Identities = 19/93 (20%), Positives = 35/93 (37%), Gaps = 14/93 (15%)

Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
           + G+  F+++  E +       + + ME+I     +       L GL++ DP +R     
Sbjct: 199 MCGRLPFYNQDHERLF------ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252

Query: 447 AS-----RHPFVTGEPFTCPYQ---PPPETPRV 471
           +       H F     +    Q    PP  P+V
Sbjct: 253 SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-37
 Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 16/239 (6%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
              ++  LG G FG+V         + VA+K +K      +  L E  ++  L       
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH----- 71

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               +V++Y     +    +   +   +L + +K    + L L  +   + QI  G++ +
Sbjct: 72  --EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYIQSRYYRSPEVL 285
           +    +H DL+  NIL+    +    K+ DFG A      E            + +PE  
Sbjct: 130 ERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186

Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           L  ++T   D+WSFG ++ EL   G   +PG    ++L ++ R      P    +   +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 8e-37
 Identities = 45/239 (18%), Positives = 87/239 (36%), Gaps = 18/239 (7%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
                 LG G FG V           VA+K+IK       + + E  ++  L+       
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------- 57

Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
            H  +V++Y     QR + I  E + +                  +    K +   +  L
Sbjct: 58  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEVL 285
           +    +H DL   N L+        +K+ DFG +      E  +         +  PEVL
Sbjct: 117 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
           +  ++++  D+W+FG ++ E++ LG   +   +  +    + + L    P    ++   
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 46/239 (19%), Positives = 89/239 (37%), Gaps = 16/239 (6%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
                  +G G FG V   +       VA+K I+      +  + E  ++  L+      
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP---- 60

Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
               +V++Y   + Q  +C+ FE ++               +   +      +  G++ L
Sbjct: 61  ---KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEVL 285
           ++A +IH DL   N L+  +     IK+ DFG        +  +         + SPEV 
Sbjct: 118 EEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
              +Y++  D+WSFG ++ E+F  G   +   S  +++  +        P         
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 28/251 (11%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIK----NQPAYYQQALVEVSILTT 161
           +   + + LG G+FG V +      +     VAVK +K    +QP      + EV+ + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 162 LNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
           L+        H +++R+Y   +    + +  EL            H     L  +  ++ 
Sbjct: 68  LD--------HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118

Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
           Q+  G+  L+    IH DL   N+LL T      +KI DFG      +    Y+      
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRK 175

Query: 278 ---YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQP 333
               + +PE L    ++ A D W FG  + E+F  G   + G +   +L ++ +     P
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

Query: 334 -PDYVLKEAKN 343
            P+   ++  N
Sbjct: 236 RPEDCPQDIYN 246

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-34
 Identities = 49/241 (20%), Positives = 97/241 (40%), Gaps = 24/241 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIK-----NQPAYYQQALVEVSILTT 161
            + +  +LG G +G+V         +     A+K++K      +    +    E  +L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
           +           +V ++  F  +  L +  + ++        ++     +   VQ++  +
Sbjct: 85  IR------QSPFLVTLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGE 137

Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSR 277
           I+  L  L   GII+ D+K ENILL ++     + + DFG +      E    Y +  + 
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 278 YYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
            Y +P+++ G    +  A+D WS G ++ EL  G   F    E +    + R +    P 
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254

Query: 336 Y 336
           Y
Sbjct: 255 Y 255

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (89), Expect = 0.002
 Identities = 19/129 (14%), Positives = 35/129 (27%), Gaps = 13/129 (10%)

Query: 353 SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412
           +   +  G+        + +L  + YE      P             EI       +   
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG--EKNSQAEISRRILKSEPPY 255

Query: 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQAS-----RHPFVTGEPFTCPYQPPPE 467
            +++S          D ++ L+  DP KR             H F     +         
Sbjct: 256 PQEMSAL------AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309

Query: 468 TPRVPVAQN 476
            P  PV ++
Sbjct: 310 APFKPVIRD 318

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-34
 Identities = 55/271 (20%), Positives = 102/271 (37%), Gaps = 47/271 (17%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQ--PAYYQQALVEVSILTTL 162
                 +LG G FG+V       ++       VAVK++K +   +  +  + E+ ++T L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG----------- 209
                    H +IV +         + + FE     +L   ++    +            
Sbjct: 98  GS-------HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 210 ----------LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
                     L+   +  F+ Q+ +G+  L+    +H DL   N+L+        +KI D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICD 207

Query: 260 FGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLF 313
           FG A      +      +      + +PE L    YT   D+WS+G ++ E+F LG+  +
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267

Query: 314 PGASEFDLLRRMIR-ILGAQPPDYVLKEAKN 343
           PG        ++I+       P Y  +E   
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYI 298

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 6e-34
 Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 24/239 (10%)

Query: 117 LGHGTFGQVAKCWDA--EMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDK 171
           LG G FG V K +    ++   VAVKI+K   N PA   + L E +++  L+        
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP------ 68

Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
            +IVR+      +    +  E+ +        +   R +    +     Q+  G+  L++
Sbjct: 69  -YIVRMIGICEAE-SWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG------SACTEDRTVYSYIQSRYYRSPEVL 285
           +  +H DL   N+LL T       KI DFG      +     +          + +PE +
Sbjct: 126 SNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
             Y++++  D+WSFG ++ E F  G   + G    ++   + +      P    +E  +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 8e-34
 Identities = 50/245 (20%), Positives = 95/245 (38%), Gaps = 23/245 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNK 164
           R  +   +G G FG V +       +    VA+K  KN    +  ++ L E   +   + 
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66

Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                  H HIV++      +  + I  EL                L L+ + L++ Q+ 
Sbjct: 67  -------HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ----SRYY 279
             L+ L+    +H D+   N+L+        +K+ DFG +   + + Y           +
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            +PE +   ++T+A D+W FG  + E+ + G+  F G    D++ R+        P    
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235

Query: 339 KEAKN 343
               +
Sbjct: 236 PTLYS 240

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 9e-34
 Identities = 43/248 (17%), Positives = 93/248 (37%), Gaps = 24/248 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNK 164
              ++ ++G G FG+V             FVA+K +K+       +  L E SI+   + 
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
                   +++ +         + I  E +++   +     +    ++  +    + I  
Sbjct: 87  P-------NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------CTEDRTVYSYIQS 276
           G+  L D   +H DL   NIL+ ++      K+ DFG +             +       
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPD 335
             + +PE +   ++T+A D+WS+G ++ E+   G   +   +  D++  + +     PP 
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 336 YVLKEAKN 343
                   
Sbjct: 257 DCPSALHQ 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 50/267 (18%), Positives = 99/267 (37%), Gaps = 25/267 (9%)

Query: 91  NSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIK--NQ 145
           N +L+ AV  V++           +++G G FG V      + +      AVK +     
Sbjct: 10  NPELVQAVQHVVIGPS-SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68

Query: 146 PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHLCICFELLDSNLYELIKI 204
                Q L E  I+   +         +++ +    +  +    +    +          
Sbjct: 69  IGEVSQFLTEGIIMKDFSH-------PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121

Query: 205 NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
           N     ++  +  F  Q+ +G+  L     +H DL   N +L    +   +K+ DFG A 
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLAR 178

Query: 265 TEDRTVYSYIQSR-------YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
                 +  + ++        + + E L   ++TT  D+WSFG ++ EL   G P +P  
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

Query: 317 SEFDLLRRMIRILGAQPPDYVLKEAKN 343
           + FD+   +++      P+Y       
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPDPLYE 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-33
 Identities = 55/261 (21%), Positives = 95/261 (36%), Gaps = 33/261 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQ--PAYYQQALVEVSILT 160
           R ++   LG G FGQV       ++       + VAVK++K+          + E+ ++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG---------- 209
            + K        +I+ +         L +  E     NL E ++     G          
Sbjct: 74  MIGKH------KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 210 ----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSA 263
               LS   +   + Q+ RG+  L     IH DL   N+L+     +K A+  +      
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
               +   +      + +PE L    YT   D+WSFG ++ E+F LG   +PG    +L 
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 323 RRMIRILGAQPPDYVLKEAKN 343
           + +        P     E   
Sbjct: 248 KLLKEGHRMDKPSNCTNELYM 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-33
 Identities = 51/256 (19%), Positives = 93/256 (36%), Gaps = 31/256 (12%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
               +D++G G FGQV K    +    +   I +         ++    E+ +L  L   
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-- 68

Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF--------------RGL 210
                  +I+ +      + +L +  E     NL + ++ +                  L
Sbjct: 69  ----HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR 268
           S   +  F+  + RG+  L     IH DL   NIL+    +    KI DFG +       
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV 181

Query: 269 TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
                     + + E L    YTT  D+WS+G ++ E+  LG   + G +  +L  ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241

Query: 328 ILGAQPPDYVLKEAKN 343
               + P     E  +
Sbjct: 242 GYRLEKPLNCDDEVYD 257

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 1e-32
 Identities = 47/246 (19%), Positives = 92/246 (37%), Gaps = 23/246 (9%)

Query: 110 RYIVKDL-LGHGTFGQVAKCWDAEMNS--FVAVKIIK--NQPAYYQQALVEVSILTTLNK 164
             ++ D+ LG G FG V +           VA+K++K   + A  ++ + E  I+  L+ 
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
                   +IVR+      +  L +  E+          +     + +S V     Q+  
Sbjct: 69  P-------YIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR------Y 278
           G+  L++   +H DL   N+LL         KI DFG +         Y           
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
           + +PE +   ++++  D+WS+G  + E    G   +      +++  + +    + P   
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237

Query: 338 LKEAKN 343
             E   
Sbjct: 238 PPELYA 243

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (316), Expect = 1e-32
 Identities = 50/270 (18%), Positives = 101/270 (37%), Gaps = 46/270 (17%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTL 162
                  +G G FG+V +     +      + VAVK++K +           E +++   
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIK------------------ 203
           +         +IV++       + +C+ FE +   +L E ++                  
Sbjct: 74  DN-------PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 204 ----INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
                     LS +     ++Q+  G++ L +   +H DL   N L+  ++    +KI D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VVKIAD 183

Query: 260 FGSACTEDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLF 313
           FG +       Y            +  PE +   +YTT  D+W++G ++ E+F  GL  +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 314 PGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
            G +  +++  +        P+    E  N
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYN 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-32
 Identities = 50/245 (20%), Positives = 90/245 (36%), Gaps = 23/245 (9%)

Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIK--NQPAYYQQALVEVSILTTLNK 164
           +    +LG G FG V K             VA+K ++    P   ++ L E  ++ +++ 
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
                   H+ R+    +      I   +    L +     H   +    +  +  QI +
Sbjct: 71  -------PHVCRLLGICLTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 122

Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YY 279
           G++ L+D  ++H DL   N+L+ T      +KI DFG A         Y          +
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
            + E +L   YT   D+WS+G  V EL   G   + G    ++   + +      P    
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239

Query: 339 KEAKN 343
            +   
Sbjct: 240 IDVYM 244

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 5e-31
 Identities = 53/253 (20%), Positives = 92/253 (36%), Gaps = 26/253 (10%)

Query: 110 RYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTL 162
           +  +   LG G+FG V +         E  + VA+K +          + L E S++   
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINH--------FRGLSLS 213
           N        HH+VR+       +   +  EL+   +L   ++               SLS
Sbjct: 81  NC-------HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVY 271
            +   + +I  G++ L     +H DL   N ++     VK  +  +          R   
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILG 330
             +    + SPE L    +TT  D+WSFG ++ E+  L    + G S   +LR ++    
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 331 AQPPDYVLKEAKN 343
              PD        
Sbjct: 254 LDKPDNCPDMLFE 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 6e-31
 Identities = 46/247 (18%), Positives = 89/247 (36%), Gaps = 23/247 (9%)

Query: 110 RYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLN 163
               + ++G G FG+V K        +    VA+K +K           L E  I+   +
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
                   H+I+R+       + + I  E +++   +          S+  +    + I 
Sbjct: 68  H-------HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC------TEDRTVYSYIQSR 277
            G+  L +   +H DL   NIL+         K+ DFG +           T        
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDY 336
            + +PE +   ++T+A D+WSFG ++ E+   G   +   S  ++++ +        P  
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 337 VLKEAKN 343
                  
Sbjct: 238 CPSAIYQ 244

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 7e-31
 Identities = 40/237 (16%), Positives = 85/237 (35%), Gaps = 41/237 (17%)

Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
           R  ++++ +G G FG+V +         VAVKI  ++         E+     L  +   
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHE--- 57

Query: 169 EDKHHIVRIYEYFV----CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
               +I+               L +  +  +  +L++ +   +   +++  +   +    
Sbjct: 58  ----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTA 110

Query: 224 RGLSLL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTEDR 268
            GL+ L            I H DLK +NIL+  +       I D G       +  T D 
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDTIDI 167

Query: 269 TVYSYIQSRYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319
                + ++ Y +PEVL        ++     D+++ G +  E+     +     ++
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-29
 Identities = 59/265 (22%), Positives = 96/265 (36%), Gaps = 40/265 (15%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIK--NQPAYYQQALVEVSILTTL 162
           R      LG G FG+V +     +        VAVK++K        +  + E+ +L+ L
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIK----------------IN 205
                  +  +IV +           +  E     +L   ++                 +
Sbjct: 84  G------NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 206 HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
               L L  +  FS Q+ +G++ L     IH DL   NILL         KI DFG A  
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARD 194

Query: 266 EDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
                   ++        + +PE +    YT   D+WS+G  + ELF LG   +PG    
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 320 DLLRRMIR-ILGAQPPDYVLKEAKN 343
               +MI+       P++   E  +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYD 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-25
 Identities = 60/265 (22%), Positives = 98/265 (36%), Gaps = 41/265 (15%)

Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNS-----FVAVKIIKNQ--PAYYQQALVEVSILTTL 162
           R  +   LG G FGQV +     ++       VAVK++K     + ++  + E+ IL   
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI-- 71

Query: 163 NKKYDREDKHHIVRIYEYFVCQ--RHLCICFELLD-SNLYELIK--------------IN 205
                    H  V        +    L +  E     NL   ++                
Sbjct: 72  -----HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 206 HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
           +   L+L  +  +S Q+ +G+  L     IH DL   NILL    +   +KI DFG A  
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARD 183

Query: 266 EDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL-PLFPGASEF 319
             +      +        + +PE +    YT   D+WSFG ++ E+F      +PG    
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 320 DLLRRMIR-ILGAQPPDYVLKEAKN 343
           +   R ++     + PDY   E   
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQ 268

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 1e-19
 Identities = 34/201 (16%), Positives = 58/201 (28%), Gaps = 21/201 (10%)

Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
           +  L+G G    V  C+  +      VK  K     +++           +  +      
Sbjct: 4   IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKV---KEKRDYGDLHFSVLAIR 59

Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLY---ELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
                +      + L +             ELI       + +         IL  ++  
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY--RSPEVLLG 287
              GI+H DL   N+L    V    I IIDF  +             R    R    ++ 
Sbjct: 120 YHRGIVHGDLSQYNVL----VSEEGIWIIDFPQSVEVGEE-----GWREILERDVRNIIT 170

Query: 288 Y---QYTTAIDMWSFGCIVAE 305
           Y    Y T  D+ S    + +
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	837
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.73
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.48
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.87
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.07

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=458.18  Aligned_cols=284  Identities=31%  Similarity=0.522  Sum_probs=225.0

Q ss_pred             EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh------hHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       113 i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .+++||+|+||+||+|+++.+++.||||+++....      ..+.+.+|+++|+++       .|||||+++++|..+++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-------~hpnIv~~~~~~~~~~~   74 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-------SHPNIIGLLDAFGHKSN   74 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-------CCTTBCCEEEEECCTTC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-------CCCCEeEEEeeeccCCc
Confidence            46899999999999999999999999999974321      234678999999999       68999999999999999


Q ss_pred             EEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       187 l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      +|||||||.+++...+... ...+++.+++.+++||+.||+|||++|||||||||+|||++   ..+.+||+|||+|+..
T Consensus        75 ~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          75 ISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSF  150 (299)
T ss_dssp             CEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTT
T ss_pred             eeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCcccccc
Confidence            9999999998766655443 35699999999999999999999999999999999999995   6789999999999765


Q ss_pred             CC---cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          267 DR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       267 ~~---~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..   .....+||+.|+|||++... .|+.++||||||||+|||++|.+||.+.++.+++.+|.+.+| .|+...+....
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~-~~~~~~~~~~~  229 (299)
T d1ua2a_         151 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG-TPTEEQWPDMC  229 (299)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTSSSTT
T ss_pred             CCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC-CCChhhccchh
Confidence            43   23456899999999999755 689999999999999999999999999999999999999998 44332211110


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                      ....                                        ......+....+.++..                 ..
T Consensus       230 ~~~~----------------------------------------~~~~~~~~~~~~~~~~~-----------------~~  252 (299)
T d1ua2a_         230 SLPD----------------------------------------YVTFKSFPGIPLHHIFS-----------------AA  252 (299)
T ss_dssp             SSTT----------------------------------------CCCCCCCCCCCHHHHCT-----------------TC
T ss_pred             ccch----------------------------------------hhhhccCCCCChHHhcc-----------------cC
Confidence            0000                                        00000111222222221                 24


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCCCCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP  465 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~  465 (837)
                      +++++|||++||++||++||||+|||+||||++.+.+.|....
T Consensus       253 s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~  295 (299)
T d1ua2a_         253 GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL  295 (299)
T ss_dssp             CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCC
Confidence            5789999999999999999999999999999998876554433

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=453.44  Aligned_cols=252  Identities=21%  Similarity=0.385  Sum_probs=216.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++|+++       .|||||+++++|.+++.
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~   91 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDSYLVGDE   91 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETTE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-------CCCCEeeEeEEEEECCE
Confidence            478999999999999999999999999999999997532 3456789999999998       68999999999999999


Q ss_pred             EEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|||||||.+ +|.+++...   .+++.+++.+++||+.||+|||++|||||||||+|||++   .++.+||+|||+|+.
T Consensus        92 ~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~  165 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQ  165 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhhee
Confidence            9999999984 787776543   599999999999999999999999999999999999995   568999999999976


Q ss_pred             cC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          266 ED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       266 ~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..   ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.....  ++        
T Consensus       166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~--------  235 (293)
T d1yhwa1         166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--PE--------  235 (293)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS--CC--------
T ss_pred             eccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CC--------
Confidence            43   234456899999999999999999999999999999999999999998887776655544211  00        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                               +.....+
T Consensus       236 -------------------------------------------------------------------------~~~~~~~  242 (293)
T d1yhwa1         236 -------------------------------------------------------------------------LQNPEKL  242 (293)
T ss_dssp             -------------------------------------------------------------------------CSSGGGS
T ss_pred             -------------------------------------------------------------------------CCCcccC
Confidence                                                                                     0000124


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ++++++||++||+.||++|||++|+|+||||+.
T Consensus       243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            577899999999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=448.69  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=216.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+.    ....+.+.+|+++|+.+       .|||||++++++.++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~   78 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-------RHPNILRLYGYFHDA   78 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-------CCCCCCeEEEEEEEC
Confidence            6899999999999999999999999999999999743    23356788899999998       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. |+|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+|
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a  153 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS  153 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSC
T ss_pred             CEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeeccccee
Confidence            99999999998 58988887653  699999999999999999999999999999999999995   6688999999999


Q ss_pred             cccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          264 CTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       264 ~~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.+.-.   +        
T Consensus       154 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---~--------  222 (263)
T d2j4za1         154 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---T--------  222 (263)
T ss_dssp             SCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---C--------
T ss_pred             eecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---C--------
Confidence            76543 34566899999999999999999999999999999999999999998877766655433100   0        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                    +|             ..+
T Consensus       223 --------------------------------------------------------------~p-------------~~~  227 (263)
T d2j4za1         223 --------------------------------------------------------------FP-------------DFV  227 (263)
T ss_dssp             --------------------------------------------------------------CC-------------TTS
T ss_pred             --------------------------------------------------------------CC-------------ccC
Confidence                                                                          00             013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ++++.+||.+||+.||++|||++|+|+||||++
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            467899999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-53  Score=448.75  Aligned_cols=252  Identities=22%  Similarity=0.335  Sum_probs=207.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||+++...  ...+.+.+|+++|+++       .|||||++++++.+++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-------~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-------NHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-------CCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-------CCCCEeeEeeeeccCce
Confidence            68999999999999999999999999999999997542  3345688999999998       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|||||||. |+|.+++...  ..+++.+++.+++||+.||+|||++|||||||||+|||++   +++.+||+|||+|+.
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~  152 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV  152 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhhee
Confidence            999999998 5898887543  4699999999999999999999999999999999999995   667899999999975


Q ss_pred             cC-----CcceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          266 ED-----RTVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       266 ~~-----~~~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      ..     ......+||+.|+|||++.+..+ +.++||||||||+|||++|++||...+.............  .      
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--~------  224 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--T------  224 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--T------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--C------
Confidence            42     12345689999999999998876 5789999999999999999999976543322221111000  0      


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                           +                      ....
T Consensus       225 -----------------------------------------------------~----------------------~~~~  229 (271)
T d1nvra_         225 -----------------------------------------------------Y----------------------LNPW  229 (271)
T ss_dssp             -----------------------------------------------------T----------------------STTG
T ss_pred             -----------------------------------------------------C----------------------CCcc
Confidence                                                                 0                      0001


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ..+++++.|||++||+.||++|||++|+|+||||++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            124577899999999999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.3e-52  Score=455.52  Aligned_cols=260  Identities=26%  Similarity=0.402  Sum_probs=223.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ++|++++.||+|+||+||+|+++.+++.||||++... ....+.+.+|+++|++|       .|||||+++++|.+++.+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-------RHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-------CCTTBCCEEEEEEETTEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECCEE
Confidence            6899999999999999999999999999999999764 34456788999999999       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||. |+|.+++.... ..+++..++.|++||+.||+|||++|||||||||+|||++.+ .++.+||+|||+|+..
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheec
Confidence            99999998 58988885443 469999999999999999999999999999999999999632 4578999999999765


Q ss_pred             CC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          267 DR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       267 ~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      ..  .....+||+.|+|||++.+..|+.++||||||||+|||++|+.||.+.+..+.+..|.......++          
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------  246 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------  246 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC----------
T ss_pred             ccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence            43  344578999999999999999999999999999999999999999998888877776552220000          


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                                              .....+++
T Consensus       247 ------------------------------------------------------------------------~~~~~~s~  254 (350)
T d1koaa2         247 ------------------------------------------------------------------------SAFSGISE  254 (350)
T ss_dssp             ------------------------------------------------------------------------GGGGGCCH
T ss_pred             ------------------------------------------------------------------------ccccCCCH
Confidence                                                                                    00012456


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT  459 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~~  459 (837)
                      +++|||++||++||++|||++|||+||||++....
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            78999999999999999999999999999986543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-52  Score=444.45  Aligned_cols=282  Identities=31%  Similarity=0.571  Sum_probs=228.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||+++...   ...+.+.+|+++|+++       +|||||+++++|.+.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-------~Hp~Iv~~~~~~~~~~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-------NHPNIVKLLDVIHTEN   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-------CCTTBCCEEEEEEETT
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-------CCCcEEEecccccccc
Confidence            68999999999999999999999999999999997532   2346788999999988       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ++|||||||.+++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+.
T Consensus        75 ~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          75 KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARA  151 (298)
T ss_dssp             EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHH
T ss_pred             ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCccee
Confidence            99999999999888888777667899999999999999999999999999999999999995   677899999999965


Q ss_pred             cC---CcceeeccCccccCchhhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 ED---RTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~---~~~~~~~GT~~Y~APEvl~~~~-yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ..   ......+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+ .+.+..+...
T Consensus       152 ~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~  230 (298)
T d1gz8a_         152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVWPGV  230 (298)
T ss_dssp             HCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTTSTTG
T ss_pred             ccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC-CCchhhcccc
Confidence            43   2334558999999999988775 57899999999999999999999999999999999999888 4443332221


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      .....+....                                  +     ......+....                 ..
T Consensus       231 ~~~~~~~~~~----------------------------------~-----~~~~~~~~~~~-----------------~~  254 (298)
T d1gz8a_         231 TSMPDYKPSF----------------------------------P-----KWARQDFSKVV-----------------PP  254 (298)
T ss_dssp             GGSTTCCTTS----------------------------------C-----CCCCCCHHHHS-----------------TT
T ss_pred             cccccccccc----------------------------------c-----cccccchhhhc-----------------cC
Confidence            1111000000                                  0     00001111111                 12


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+++++|||++||++||++|||++|||+||||++.+
T Consensus       255 ~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         255 LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            457899999999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-52  Score=452.20  Aligned_cols=259  Identities=29%  Similarity=0.451  Sum_probs=206.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++.+..  ...+.+.+|+.+|+.+       .|||||+++++|.+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-------KHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-------CCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECC
Confidence            478999999999999999999999999999999998543  2345677899999988       6899999999999999


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+|||||||. ++|.+++...  +.+++.+++.++.||+.||+|||++|||||||||+|||+...++++.+||+|||+|+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            9999999998 6999998764  469999999999999999999999999999999999999765677899999999997


Q ss_pred             ccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          265 TED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       265 ~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ...  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+.+... .++        
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~~--------  229 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-EFD--------  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC-CCC--------
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCC--------
Confidence            553  334556899999999999999999999999999999999999999998887776665543111 000        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                          .          +           ....+
T Consensus       230 ----------------------------------------------------~----------~-----------~~~~~  236 (307)
T d1a06a_         230 ----------------------------------------------------S----------P-----------YWDDI  236 (307)
T ss_dssp             ----------------------------------------------------T----------T-----------TTTTS
T ss_pred             ----------------------------------------------------C----------c-----------cccCC
Confidence                                                                0          0           00124


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            57889999999999999999999999999998743

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=447.07  Aligned_cols=255  Identities=30%  Similarity=0.492  Sum_probs=215.5

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      .+.|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|+++       .|||||++++++.+++.
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~~~~~   83 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIVKLLDAFYYENN   83 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-------CCTTBCCEEEEEEETTE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEeeCCe
Confidence            36899999999999999999999999999999999753 34557788999999998       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      +|||||||. |+|.+++.... +.+++.+++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAK  159 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhc
Confidence            999999998 47777766543 5699999999999999999999999999999999999996   678899999999965


Q ss_pred             cCC---cceeeccCccccCchhhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          266 EDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       266 ~~~---~~~~~~GT~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ...   .....+||+.|+|||++.     +..|+.++|||||||++|||++|++||.+.+..+.+.++.+.   .++.  
T Consensus       160 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~--  234 (288)
T d2jfla1         160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPT--  234 (288)
T ss_dssp             CHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCC--
T ss_pred             cCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCC--
Confidence            432   234568999999999984     446899999999999999999999999888776666555431   0000  


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                                                    +.
T Consensus       235 ------------------------------------------------------------------------------~~  236 (288)
T d2jfla1         235 ------------------------------------------------------------------------------LA  236 (288)
T ss_dssp             ------------------------------------------------------------------------------CS
T ss_pred             ------------------------------------------------------------------------------CC
Confidence                                                                                          00


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ....+++++.|||++||+.||++|||++|+|+||||+..
T Consensus       237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            011245789999999999999999999999999999853

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=454.47  Aligned_cols=199  Identities=30%  Similarity=0.461  Sum_probs=177.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||+++..  ....+.+.+|+.+|+++       +|||||+++++|.++++
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~l~~~~~~~~~   78 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE   78 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-------CCTTBCCEEEEEECSSE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECCE
Confidence            7899999999999999999999999999999999853  34457788999999888       68999999999999999


Q ss_pred             EEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       187 l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      +|||||||. |+|.+++...  +.+++..++.++.||+.||.|||+ +|||||||||+||||+   .++.+||+|||+|+
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~  153 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCH
T ss_pred             EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCcc
Confidence            999999998 5888888765  369999999999999999999997 5999999999999995   67899999999997


Q ss_pred             ccC-CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q 003239          265 TED-RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF  319 (837)
Q Consensus       265 ~~~-~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~  319 (837)
                      ... ......+||+.|+|||++.+..|+.++||||||||+|||++|+.||.+.+..
T Consensus       154 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~  209 (322)
T d1s9ja_         154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  209 (322)
T ss_dssp             HHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred             ccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            543 2334679999999999999999999999999999999999999999876543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=441.03  Aligned_cols=261  Identities=28%  Similarity=0.400  Sum_probs=219.6

Q ss_pred             cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeE
Q 003239          107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE  179 (837)
Q Consensus       107 ~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~-------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d  179 (837)
                      ..++|++++.||+|+||+||+|+++.+++.||||++++.       ....+.+.+|+++|++|       .|||||++++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~   80 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-------QHPNVITLHE   80 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-------CCCCCCcEEE
Confidence            347899999999999999999999999999999999743       12357789999999999       6899999999


Q ss_pred             EEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC-CCCeEEE
Q 003239          180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKI  257 (837)
Q Consensus       180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~IKL  257 (837)
                      +|.+.+.+|||||||. |+|.+++...  +.+++..++.+++||+.||+|||+++||||||||+|||++.+. ....+||
T Consensus        81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          81 VYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEe
Confidence            9999999999999998 5899988765  3699999999999999999999999999999999999996432 2346999


Q ss_pred             EecccccccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003239          258 IDFGSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD  335 (837)
Q Consensus       258 ~DFGlA~~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~  335 (837)
                      +|||+|....  .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.+... .++.
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~  237 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFED  237 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCc
Confidence            9999997653  334456899999999999999999999999999999999999999999888777666544211 0000


Q ss_pred             HHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhh
Q 003239          336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED  415 (837)
Q Consensus       336 ~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~  415 (837)
                                                                                      .               
T Consensus       238 ----------------------------------------------------------------~---------------  238 (293)
T d1jksa_         238 ----------------------------------------------------------------E---------------  238 (293)
T ss_dssp             ----------------------------------------------------------------H---------------
T ss_pred             ----------------------------------------------------------------h---------------
Confidence                                                                            0               


Q ss_pred             hhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       416 l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                        .....++.+.|||++||+.||++|||++|+|+||||++...
T Consensus       239 --~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         239 --YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             --hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence              01124577899999999999999999999999999987543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=442.72  Aligned_cols=282  Identities=30%  Similarity=0.527  Sum_probs=226.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC-CeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t-g~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-  183 (837)
                      ++|+++++||+|+||+||+|++..+ ++.||||+++..   ......+.+|+.+|+.|...    .||||++++++|.. 
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~----~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----EHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT----CCTTBCCEEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc----CCCCcceeeeeeccc
Confidence            7999999999999999999998765 678999999742   22234567899999988654    79999999999864 


Q ss_pred             ----cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          184 ----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       184 ----~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                          ..++++|||+|.+++..+........+++..++.+++||+.||+|||+++||||||||+|||++   ..+.+||+|
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~d  159 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD  159 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecc
Confidence                3579999999998777777666667799999999999999999999999999999999999995   678999999


Q ss_pred             cccccccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||++....  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|++.++ .|+...
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~  238 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEED  238 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCGGG
T ss_pred             hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC-CCchhc
Confidence            99987543  334567899999999999999999999999999999999999999999999999999999998 343322


Q ss_pred             HHhhhcch-hhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhh
Q 003239          338 LKEAKNTS-KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI  416 (837)
Q Consensus       338 l~~~k~~~-~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l  416 (837)
                      +....... ..+..                                          .....+..                
T Consensus       239 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~----------------  260 (305)
T d1blxa_         239 WPRDVALPRQAFHS------------------------------------------KSAQPIEK----------------  260 (305)
T ss_dssp             SCTTCSSCGGGSCC------------------------------------------CCCCCGGG----------------
T ss_pred             ccccccchhhhhcc------------------------------------------ccccchhh----------------
Confidence            21110000 00000                                          00000000                


Q ss_pred             hhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       417 ~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                       .....++.++|||++||++||++||||+|||+||||++..
T Consensus       261 -~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         261 -FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             -TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             -ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence             0112457889999999999999999999999999999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=445.23  Aligned_cols=253  Identities=26%  Similarity=0.479  Sum_probs=216.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||++++.    ....+.+.+|+++|+++       +|||||+++++|.++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHPFFVKLYFTFQDD   80 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-------CSTTBCCEEEEEECS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-------CCCCeeEEEEEEEEC
Confidence            6799999999999999999999999999999999743    23446788999999998       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. |+|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++   +++.+||+|||+|
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a  155 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTA  155 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred             CEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccc
Confidence            99999999998 5898887765  3699999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCC-----cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          264 CTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       264 ~~~~~-----~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      +....     .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.+.--        
T Consensus       156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--------  227 (288)
T d1uu3a_         156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--------  227 (288)
T ss_dssp             EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--------
T ss_pred             eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--------
Confidence            75432     23346899999999999999999999999999999999999999998887776665543100        


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                       .+|            
T Consensus       228 -----------------------------------------------------------------~~p------------  230 (288)
T d1uu3a_         228 -----------------------------------------------------------------DFP------------  230 (288)
T ss_dssp             -----------------------------------------------------------------CCC------------
T ss_pred             -----------------------------------------------------------------CCC------------
Confidence                                                                             000            


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHH------HHcCccCCCCCCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQ------ASRHPFVTGEPFT  459 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~E------aL~HPff~~~~~~  459 (837)
                       ..+++++.|||++||+.||++|||++|      +++||||++..+.
T Consensus       231 -~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         231 -EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             -TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             -ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence             013467899999999999999999987      5889999987664

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-51  Score=447.97  Aligned_cols=252  Identities=24%  Similarity=0.441  Sum_probs=220.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||++++.    ....+.+.+|+.+|+.+       .|||||++++++.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~   76 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-------THPFIIRMWGTFQDA   76 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CBTTBCCEEEEEECS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-------cCcChhheeeeEeeC
Confidence            6899999999999999999999999999999999753    23356788999999988       689999999999999


Q ss_pred             ceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|+|||||.| +|..++...  ..+++..++.++.||+.||+|||++|||||||||+||||+   .++.+||+|||+|
T Consensus        77 ~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a  151 (316)
T d1fota_          77 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFA  151 (316)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSC
T ss_pred             CeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccc
Confidence            999999999985 666666544  4689999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      +.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++.+.-..            
T Consensus       152 ~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------------  219 (316)
T d1fota_         152 KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------  219 (316)
T ss_dssp             EECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC------------
T ss_pred             eEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence            98877777889999999999999999999999999999999999999999998887776665541100            


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                   +|             ..++
T Consensus       220 -------------------------------------------------------------~p-------------~~~s  225 (316)
T d1fota_         220 -------------------------------------------------------------FP-------------PFFN  225 (316)
T ss_dssp             -------------------------------------------------------------CC-------------TTSC
T ss_pred             -------------------------------------------------------------CC-------------CCCC
Confidence                                                                         00             0134


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      +++.+||++||+.||.+|+     |++|+|+||||++..+
T Consensus       226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence            6789999999999999997     9999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=449.94  Aligned_cols=253  Identities=23%  Similarity=0.390  Sum_probs=219.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++.    ....+.+.+|+.+|+.+       .||||++++++|.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-------~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-------RHPFLTALKYAFQT   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CCTTBCCEEEEEEC
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-------CCCCEEEEEeeecc
Confidence            37899999999999999999999999999999999853    23456788999999988       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++.+|+|||||. |+|.+++....  .+++..++.+++||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~---~~g~vkl~DFG~  151 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred             ccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---CCCCEEEeeccc
Confidence            999999999998 58888877653  699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          263 ACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       263 A~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      |+...   ......+||+.|+|||++.+..|+.++||||||||+|||++|++||.+.+..+++..+....-         
T Consensus       152 a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---------  222 (337)
T d1o6la_         152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------  222 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC---------
Confidence            97543   334567899999999999999999999999999999999999999999887766655443100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                                                                      .+|             
T Consensus       223 ----------------------------------------------------------------~~p-------------  225 (337)
T d1o6la_         223 ----------------------------------------------------------------RFP-------------  225 (337)
T ss_dssp             ----------------------------------------------------------------CCC-------------
T ss_pred             ----------------------------------------------------------------CCC-------------
Confidence                                                                            000             


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      ..++++++|||++||++||++|+     |++|+|+||||++..+
T Consensus       226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            01346789999999999999999     4999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=432.54  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=206.0

Q ss_pred             ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       110 ~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      .|++.++||+|+||+||+|++..+++.||||+++..   ....+.+.+|+++|+++       .|||||+++++|..   
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-------QHPNIVRFYDSWESTVK   82 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEEESS
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEeeccc
Confidence            347888999999999999999999999999999753   34456788999999988       68999999999876   


Q ss_pred             -cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCC--eeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          184 -QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       184 -~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                       +..+|||||||. |+|.+++...  ..+++..++.++.||+.||+|||+++  ||||||||+|||++  ++++.+||+|
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~D  158 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGD  158 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEee
Confidence             357899999998 5888888765  36999999999999999999999998  99999999999995  3467899999


Q ss_pred             cccccccCC-cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003239          260 FGSACTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL  338 (837)
Q Consensus       260 FGlA~~~~~-~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l  338 (837)
                      ||+|+.... .....+||+.|+|||++.+ .|+.++||||||||+|||++|+.||.+....+.+.+.+.. + ..+..  
T Consensus       159 FGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~-~~~~~--  233 (270)
T d1t4ha_         159 LGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VKPAS--  233 (270)
T ss_dssp             TTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CCCGG--
T ss_pred             cCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-C-CCCcc--
Confidence            999976443 3456789999999999876 6999999999999999999999999766544333221110 0 00000  


Q ss_pred             HhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhh
Q 003239          339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK  418 (837)
Q Consensus       339 ~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~  418 (837)
                                                                                                     .
T Consensus       234 -------------------------------------------------------------------------------~  234 (270)
T d1t4ha_         234 -------------------------------------------------------------------------------F  234 (270)
T ss_dssp             -------------------------------------------------------------------------------G
T ss_pred             -------------------------------------------------------------------------------c
Confidence                                                                                           0


Q ss_pred             hHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCC
Q 003239          419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT  454 (837)
Q Consensus       419 ~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~  454 (837)
                      ....++++.+||.+||+.||++|||++|+|+||||+
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            011346789999999999999999999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-51  Score=451.40  Aligned_cols=258  Identities=26%  Similarity=0.423  Sum_probs=220.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ++|++++.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|++|       .|||||+++++|.+++.+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-------HHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-------CSTTBCCEEEEEECSSEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECCEE
Confidence            68999999999999999999999999999999998653 4456678899999888       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||. |+|.+.+.... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.. ..+.+||+|||+|...
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~  179 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceec
Confidence            99999998 58888765443 469999999999999999999999999999999999999632 4678999999999765


Q ss_pred             CC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          267 DR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       267 ~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      ..  .....++|+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.+.....+.          
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~----------  249 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------  249 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS----------
T ss_pred             CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence            43  345678999999999999999999999999999999999999999999888877776552210000          


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                    .                          ....+++
T Consensus       250 ----------------------------------------------~--------------------------~~~~~s~  257 (352)
T d1koba_         250 ----------------------------------------------D--------------------------AFSSVSP  257 (352)
T ss_dssp             ----------------------------------------------S--------------------------TTTTSCH
T ss_pred             ----------------------------------------------c--------------------------cccCCCH
Confidence                                                          0                          0012457


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ++.|||++||++||++|||++|||+||||++..
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            789999999999999999999999999998753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-51  Score=443.43  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=214.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++++.||+|+||+||+|++..+++.||||+++..    ....+.+.+|+++|++|       .|||||+++++|.+
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-------RHPNTIQYRGCYLR   86 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-------CCCCEeeEEEEEEE
Confidence            36799999999999999999999999999999999753    23446788999999988       68999999999999


Q ss_pred             cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       184 ~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      ++.+|||||||.+++++.+.... +.+++.+++.+++||+.||.|||++|||||||||+||||+   .++.+||+|||+|
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a  162 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA  162 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTC
T ss_pred             CCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccc
Confidence            99999999999875555444332 5699999999999999999999999999999999999996   6789999999999


Q ss_pred             cccCCcceeeccCccccCchhhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~---~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ...... ...+||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+.+..+.+..+....-  ++      
T Consensus       163 ~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~--~~------  233 (309)
T d1u5ra_         163 SIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA------  233 (309)
T ss_dssp             BSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CC------
T ss_pred             cccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--CC------
Confidence            765443 45689999999999974   3689999999999999999999999988877766655543100  00      


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                     +                             ...
T Consensus       234 -----------------------------------------------~-----------------------------~~~  237 (309)
T d1u5ra_         234 -----------------------------------------------L-----------------------------QSG  237 (309)
T ss_dssp             -----------------------------------------------C-----------------------------SCT
T ss_pred             -----------------------------------------------C-----------------------------CCC
Confidence                                                           0                             001


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            1346789999999999999999999999999998643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-51  Score=451.78  Aligned_cols=252  Identities=23%  Similarity=0.403  Sum_probs=221.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||++++.    ....+.+.+|+++|+.+       .|||||+++++|...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~  113 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-------NFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-------CCCcEeecccccccc
Confidence            6899999999999999999999999999999999743    23356788999999888       689999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+++||||+. |+|.+.+...  +.+++..++.++.||+.||.|||+++||||||||+||||+   .++.+||+|||+|
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a  188 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFA  188 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred             cccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceee
Confidence            99999999998 5787877655  3699999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003239          264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN  343 (837)
Q Consensus       264 ~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~  343 (837)
                      +.........+||+.|+|||++.+..|+.++||||||||+|||++|++||.+.+....+.+|..... .           
T Consensus       189 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~-----------  256 (350)
T d1rdqe_         189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-R-----------  256 (350)
T ss_dssp             EECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C-----------
T ss_pred             eecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-C-----------
Confidence            9887777788999999999999999999999999999999999999999998887776666544110 0           


Q ss_pred             chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhH
Q 003239          344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR  423 (837)
Q Consensus       344 ~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s  423 (837)
                                                                                   +|             ..++
T Consensus       257 -------------------------------------------------------------~p-------------~~~s  262 (350)
T d1rdqe_         257 -------------------------------------------------------------FP-------------SHFS  262 (350)
T ss_dssp             -------------------------------------------------------------CC-------------TTCC
T ss_pred             -------------------------------------------------------------CC-------------ccCC
Confidence                                                                         00             0134


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCC
Q 003239          424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF  458 (837)
Q Consensus       424 ~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~  458 (837)
                      +++.+||++||+.||++|+     |++|||+||||++..+
T Consensus       263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence            6789999999999999995     9999999999998765

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=435.26  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee--
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--  183 (837)
                      ++|++++.||+|+||+||+|+++.+++.||||+++..   ....+.+.+|+++|+++       .|||||++++++.+  
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~   76 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-------KHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-------CCTTBCCEEEEEEC--
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-------CCCCEeeEEEEEEeCC
Confidence            6899999999999999999999999999999999753   34456688899998888       68999999999975  


Q ss_pred             cceEEEEEeccc-hhHHHHHHhh--ccCCCCHHHHHHHHHhHHHHHhhhhcCC-----eeeccCCCCCeeeeccCCCCeE
Q 003239          184 QRHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAG-----IIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~--~~~~L~e~~i~~I~~QIl~aL~yLHs~g-----IVHrDLKPeNILl~~~~~~~~I  255 (837)
                      .+.+|||||||. |+|.+++...  ....+++..++.++.||+.||+|||+++     ||||||||+||||+   .++.+
T Consensus        77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~v  153 (269)
T d2java1          77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNV  153 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcE
Confidence            457899999998 5899988653  2356999999999999999999999876     99999999999995   67899


Q ss_pred             EEEecccccccCC---cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003239          256 KIIDFGSACTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ  332 (837)
Q Consensus       256 KL~DFGlA~~~~~---~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~  332 (837)
                      ||+|||+|+....   .....+||+.|+|||++.+..|+.++||||||||+|||++|++||.+.+..++...+.+..-  
T Consensus       154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~--  231 (269)
T d2java1         154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--  231 (269)
T ss_dssp             EECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--
T ss_pred             EEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--
Confidence            9999999976433   23456899999999999999999999999999999999999999998887776665543100  


Q ss_pred             CchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCc
Q 003239          333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS  412 (837)
Q Consensus       333 Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~  412 (837)
                      +                                                                      ..|      
T Consensus       232 ~----------------------------------------------------------------------~~~------  235 (269)
T d2java1         232 R----------------------------------------------------------------------RIP------  235 (269)
T ss_dssp             C----------------------------------------------------------------------CCC------
T ss_pred             C----------------------------------------------------------------------CCC------
Confidence            0                                                                      000      


Q ss_pred             hhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccC
Q 003239          413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV  453 (837)
Q Consensus       413 ~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff  453 (837)
                             ..+++++.+||++||+.||++|||++|+|+|||+
T Consensus       236 -------~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 -------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                   0134678999999999999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=443.07  Aligned_cols=258  Identities=25%  Similarity=0.407  Sum_probs=223.6

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      .++|++++.||+|+||+||+|+++.+++.||||+++........+.+|+++|+.+       .|||||+++++|.+++.+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-------RHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-------CCTTBCCEEEEEEETTEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-------CCCCCCeEEEEEEECCEE
Confidence            4799999999999999999999999999999999998776667788999999998       689999999999999999


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      |||||||. ++|.+++.... ..+++.+++.|+.||+.||+|||++|||||||||+|||++.+ ....+||+|||+++..
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhcc
Confidence            99999998 58998886543 359999999999999999999999999999999999999632 4568999999999765


Q ss_pred             C--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003239          267 D--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT  344 (837)
Q Consensus       267 ~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k~~  344 (837)
                      .  ......++|+.|+|||++.+..|+.++||||||||+|+|++|.+||.+.+..+.+..|.+... .++..        
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~--------  225 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-TFDEE--------  225 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCHH--------
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCChh--------
Confidence            4  334566889999999999999999999999999999999999999999988888777765211 00000        


Q ss_pred             hhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHhHH
Q 003239          345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL  424 (837)
Q Consensus       345 ~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~s~  424 (837)
                                                                                               ....+++
T Consensus       226 -------------------------------------------------------------------------~~~~~s~  232 (321)
T d1tkia_         226 -------------------------------------------------------------------------AFKEISI  232 (321)
T ss_dssp             -------------------------------------------------------------------------HHTTSCH
T ss_pred             -------------------------------------------------------------------------hccCCCH
Confidence                                                                                     0012457


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       425 ~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      +++|||++||+.||++|||++|+|+||||++.
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            78999999999999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=440.73  Aligned_cols=282  Identities=28%  Similarity=0.555  Sum_probs=226.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++.   ....+.+.+|+++|+.+       .|||||+++++|...
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-------~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-------RHENVIGLLDVFTPD   89 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-------CBTTBCCCSEEECSC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-------CCCCeeEEEEEeccC
Confidence            48999999999999999999999999999999999753   34567788999999998       689999999999876


Q ss_pred             c------eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 R------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ~------~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      +      ++|||||||+.+|..+++..   .+++..++.+++||+.||+|||++|||||||||+|||++   .++.+||+
T Consensus        90 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~  163 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKIL  163 (346)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEEC
T ss_pred             ccccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---cccccccc
Confidence            5      57999999987887776543   599999999999999999999999999999999999995   77899999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||+|+.........++|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+....+ .++..+
T Consensus       164 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~  242 (346)
T d1cm8a_         164 DFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG-TPPAEF  242 (346)
T ss_dssp             CCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred             cccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC-CCcHHH
Confidence            999999888888888999999999999875 578999999999999999999999999999999999999998 555554


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      +.........                             .+..   ..+..     ....+..++               
T Consensus       243 ~~~~~~~~~~-----------------------------~~~~---~~~~~-----~~~~~~~~~---------------  270 (346)
T d1cm8a_         243 VQRLQSDEAK-----------------------------NYMK---GLPEL-----EKKDFASIL---------------  270 (346)
T ss_dssp             HHTCSCHHHH-----------------------------HHHH---HSCCC-----CCCCGGGTC---------------
T ss_pred             Hhhhcchhhh-----------------------------hhhc---cCCcc-----cccchHHhc---------------
Confidence            4432111000                             0000   00000     001111111               


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...++.++|||++||++||++||||+|||+||||++..
T Consensus       271 --~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         271 --TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             --TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             --cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence              12457889999999999999999999999999999754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.4e-50  Score=428.78  Aligned_cols=278  Identities=32%  Similarity=0.549  Sum_probs=220.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|+++ +++.||||+++...   ...+.+.+|+.+|+++       .|||||+++++|..++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~~   73 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-------KHSNIVKLYDVIHTKK   73 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-------CCTTBCCEEEEEECSS
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-------CCCcEEeeeeecccCC
Confidence            68999999999999999999885 78999999997542   2356788999999988       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..++|||++.+.+...+.... +.+++..++.+++||+.||+|||+++||||||||+|||++   .++.+||+|||.+..
T Consensus        74 ~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARA  149 (286)
T ss_dssp             CEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHH
T ss_pred             ceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---CCCCEEeccccccee
Confidence            999999999987777776544 5799999999999999999999999999999999999995   678999999999975


Q ss_pred             cCCc---ceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      ....   .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+++.++.+.++..+. ..+...
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  228 (286)
T d1ob3a_         150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS-KNWPNV  228 (286)
T ss_dssp             HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT-TTSTTG
T ss_pred             cccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCCh-hhccch
Confidence            4432   3445789999999999865 5789999999999999999999999999999999999999884332 222211


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                      ....++-....                                       ..........                 ...
T Consensus       229 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~-----------------~~~  252 (286)
T d1ob3a_         229 TELPKYDPNFT---------------------------------------VYEPLPWESF-----------------LKG  252 (286)
T ss_dssp             GGSTTCCTTCC---------------------------------------CCCCCCGGGT-----------------CCS
T ss_pred             hhhhhcccccc---------------------------------------cccCcchhhh-----------------ccc
Confidence            11110000000                                       0000000000                 112


Q ss_pred             hHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      .++.++|||++||++||++||||+|||+||||++
T Consensus       253 ~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            4578899999999999999999999999999985

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-49  Score=424.28  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=216.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      ++|++++.||+|+||+||+|+++.+++.||||++++..          ...+.+.+|+.+|++|.      .|||||+++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~hpnIv~~~   76 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS------GHPNIIQLK   76 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT------TCTTBCCEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc------CCCCeEEEE
Confidence            78999999999999999999999999999999997531          22346788999999994      489999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEE
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI  257 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL  257 (837)
                      ++|.+++++|||||||. ++|.++++..  ..+++.+++.++.||++||+|||++|||||||||+|||++   .++.+||
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl  151 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKL  151 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEE
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEE
Confidence            99999999999999997 5999999765  3699999999999999999999999999999999999995   6789999


Q ss_pred             EecccccccCC--cceeeccCccccCchhhcC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003239          258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL  329 (837)
Q Consensus       258 ~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~------~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~l  329 (837)
                      +|||+++....  .....+||+.|+|||++.+      ..++.++||||+|||+|||++|+.||.+.+..+.+..+.+.-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999976543  3455689999999999963      357889999999999999999999999988877766665411


Q ss_pred             CCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCC
Q 003239          330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK  409 (837)
Q Consensus       330 G~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~  409 (837)
                      - .++                                                            .              
T Consensus       232 ~-~~~------------------------------------------------------------~--------------  236 (277)
T d1phka_         232 Y-QFG------------------------------------------------------------S--------------  236 (277)
T ss_dssp             C-CCC------------------------------------------------------------T--------------
T ss_pred             C-CCC------------------------------------------------------------C--------------
Confidence            1 000                                                            0              


Q ss_pred             CCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       410 ~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                             .....++++++|||.+||+.||++|||++|||+||||++
T Consensus       237 -------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         237 -------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             -------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             -------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                   001124578999999999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=440.43  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=211.6

Q ss_pred             CCceEEEE-EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee---
Q 003239          108 QRRYIVKD-LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---  183 (837)
Q Consensus       108 ~~~Y~i~~-~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---  183 (837)
                      .++|++++ +||+|+||+||+|++..+++.||||++++.    ....+|+.++.++.      +|||||+++++|.+   
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~------~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS------QCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT------TSTTBCCEEEEEEEEET
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc------CCCCCCeEEEEEeeccc
Confidence            37899875 599999999999999999999999999864    34667998876663      69999999999976   


Q ss_pred             -cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          184 -QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       184 -~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                       +.++|||||||. |+|.+++.......+++.+++.|++||+.||+|||++|||||||||+|||++.....+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             467999999997 699999987555579999999999999999999999999999999999999866567889999999


Q ss_pred             cccccC--CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003239          262 SACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK  339 (837)
Q Consensus       262 lA~~~~--~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~  339 (837)
                      +|+...  ......+||+.|+|||++.+..|+.++||||||||+|+|+||++||.+.+..+....+.....         
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~---------  230 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---------  230 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC---------
T ss_pred             eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh---------
Confidence            997543  334567899999999999999999999999999999999999999987654333322221100         


Q ss_pred             hhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       340 ~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                                         .+                             ...|+.                     ...
T Consensus       231 -------------------~~-----------------------------~~~~~~---------------------~~~  241 (335)
T d2ozaa1         231 -------------------MG-----------------------------QYEFPN---------------------PEW  241 (335)
T ss_dssp             -------------------SC-----------------------------SSSCCT---------------------THH
T ss_pred             -------------------cC-----------------------------CCCCCC---------------------ccc
Confidence                               00                             000000                     011


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ..+++++.|||++||+.||++|||++|||+||||.+.
T Consensus       242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            2356789999999999999999999999999999764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=428.58  Aligned_cols=286  Identities=26%  Similarity=0.437  Sum_probs=223.0

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-  183 (837)
                      .++|+++++||+|+||+||+|++..+++.||||+++..   ....+.+.+|+++|+++       .|+||+++++++.. 
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~h~nii~~~~~~~~~   81 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTK   81 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-------CCTTBCCEEEEEEC-
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-------cCCCccceEeeeecc
Confidence            48999999999999999999999999999999998643   23456788999999999       68999999999865 


Q ss_pred             -------cceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEE
Q 003239          184 -------QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK  256 (837)
Q Consensus       184 -------~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IK  256 (837)
                             ++++|+|||+|.+++...+... ...+++..++.+++||+.||.|||++|||||||||+|||++   .++.+|
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~k  157 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLK  157 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEE
T ss_pred             cccccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEE
Confidence                   3568999999998777665443 35799999999999999999999999999999999999996   678999


Q ss_pred             EEecccccccCC-------cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003239          257 IIDFGSACTEDR-------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI  328 (837)
Q Consensus       257 L~DFGlA~~~~~-------~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~  328 (837)
                      |+|||++.....       .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++.+.+..+.+.
T Consensus       158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~  237 (318)
T d3blha1         158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  237 (318)
T ss_dssp             ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence            999999964332       22345799999999999876 7899999999999999999999999999999999999999


Q ss_pred             hCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCC
Q 003239          329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR  408 (837)
Q Consensus       329 lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~  408 (837)
                      ++..+++. .........+.. ..                                .     ..-....+.+.+      
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~-~~--------------------------------~-----~~~~~~~~~~~~------  272 (318)
T d3blha1         238 CGSITPEV-WPNVDNYELYEK-LE--------------------------------L-----VKGQKRKVKDRL------  272 (318)
T ss_dssp             HCCCCTTT-STTCCCC----------------------------------------C-----CSSCCBCHHHHH------
T ss_pred             cCCCChhh-ccccchhhhhhh-hc--------------------------------c-----cccccccchhhh------
Confidence            98444332 211111000000 00                                0     000001111111      


Q ss_pred             CCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCCC
Q 003239          409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF  458 (837)
Q Consensus       409 ~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~~  458 (837)
                               .....++.++|||.+||++||++|+||+|||+||||+..+.
T Consensus       273 ---------~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         273 ---------KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             ---------HHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             ---------ccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence                     12234578899999999999999999999999999997654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.7e-50  Score=444.04  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=211.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||++.+..    .....+.+|..+++.+++.    +|||||+++++|.+.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~----~hpnIv~l~~~~~~~   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTP   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS----CCTTBCCEEEEEECS
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC----CCCcEEEEEEEEEEC
Confidence            78999999999999999999999999999999997432    2234456676667666543    799999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. |+|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++   ..+.+||+|||+|
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla  154 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLA  154 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTC
T ss_pred             CEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeecee
Confidence            99999999998 6899888765  3689999999999999999999999999999999999995   6789999999999


Q ss_pred             cccCC-cceeeccCccccCchhhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003239          264 CTEDR-TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA  341 (837)
Q Consensus       264 ~~~~~-~~~~~~GT~~Y~APEvl~~-~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~  341 (837)
                      +.... .....+||+.|+|||++.. ..|+.++||||||||+|||++|+.||.+.+..+... +.+.....+        
T Consensus       155 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~--------  225 (364)
T d1omwa3         155 CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA--------  225 (364)
T ss_dssp             EECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC--------
T ss_pred             eecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC--------
Confidence            86543 3455689999999999975 479999999999999999999999997754322221 111100000        


Q ss_pred             hcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHH
Q 003239          342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ  421 (837)
Q Consensus       342 k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~  421 (837)
                                                                                     .+.           ...
T Consensus       226 ---------------------------------------------------------------~~~-----------~~~  231 (364)
T d1omwa3         226 ---------------------------------------------------------------VEL-----------PDS  231 (364)
T ss_dssp             ---------------------------------------------------------------CCC-----------CSS
T ss_pred             ---------------------------------------------------------------CCC-----------CCC
Confidence                                                                           000           011


Q ss_pred             hHHHHHHHHHHhcccCcCCCCC-----HHHHHcCccCCCCCC
Q 003239          422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF  458 (837)
Q Consensus       422 ~s~~l~DLL~kmL~~DP~kRpT-----a~EaL~HPff~~~~~  458 (837)
                      +++++.|||.+||+.||++|||     |+|||+||||++..+
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            4577899999999999999999     899999999998764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=436.01  Aligned_cols=280  Identities=31%  Similarity=0.572  Sum_probs=221.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec----
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ----  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~----  184 (837)
                      .+|+.+++||+|+||+||+|+++.+++.||||+++++...   ..+|+++|++|       +|+||++++++|...    
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l-------~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKL-------DHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHC-------CCTTBCCEEEEEEEC--CC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhc-------CCCCCCcEEEEEEecCccC
Confidence            4799999999999999999999999999999999875432   34799999998       689999999999653    


Q ss_pred             --ceEEEEEeccchhHHHHHHh--hccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          185 --RHLCICFELLDSNLYELIKI--NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       185 --~~l~LVmEy~~gsL~d~l~~--~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                        .++|||||||++++.+.+..  .....+++.+++.+++||+.||+|||++|||||||||+|||++  .+...+||+||
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DF  167 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDF  167 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCC
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecc
Confidence              36899999999877666543  2334699999999999999999999999999999999999996  23358999999


Q ss_pred             ccccccC--CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          261 GSACTED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       261 GlA~~~~--~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |++....  ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||...+..+++..|.+.+| .++...
T Consensus       168 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g-~~~~~~  246 (350)
T d1q5ka_         168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG-TPTREQ  246 (350)
T ss_dssp             TTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred             cchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC-CChHHh
Confidence            9997543  344567899999999998764 789999999999999999999999999999999999999999 455444


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      +......   +....           .                     +....     ..+.++                
T Consensus       247 ~~~~~~~---~~~~~-----------~---------------------~~~~~-----~~~~~~----------------  270 (350)
T d1q5ka_         247 IREMNPN---YTEFK-----------F---------------------PQIKA-----HPWTKV----------------  270 (350)
T ss_dssp             HHHHCC------CCC-----------C---------------------CCCCC-----CCGGGT----------------
T ss_pred             hhhhccc---hhhcc-----------c---------------------ccccc-----Cchhhh----------------
Confidence            4322110   00000           0                     00000     000000                


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      .....+++++|||++||++||++||||+|||+||||++..
T Consensus       271 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            0112457899999999999999999999999999998753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=432.39  Aligned_cols=303  Identities=28%  Similarity=0.482  Sum_probs=228.0

Q ss_pred             ceEEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCC
Q 003239           94 LILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDRED  170 (837)
Q Consensus        94 ~~~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~  170 (837)
                      +.+.+++..-  ...++|+++++||+|+||+||+|+++.+++.||||++++.   .....++.+|+.+|+++       .
T Consensus         4 ~~~~~~~~~f--~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-------~   74 (355)
T d2b1pa1           4 YSVEVGDSTF--TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------N   74 (355)
T ss_dssp             EEEEETTEEE--EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-------C
T ss_pred             EEEEeCCcce--eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-------C
Confidence            4555555211  1227899999999999999999999999999999999854   34456788999999998       6


Q ss_pred             CCceeEEeEEEeec------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCe
Q 003239          171 KHHIVRIYEYFVCQ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI  244 (837)
Q Consensus       171 HpnIVkl~d~f~~~------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI  244 (837)
                      |||||+++++|...      .++|+|||||.+++++.+.    ..+++..++.+++||+.||+|||++||+||||||+||
T Consensus        75 hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Ni  150 (355)
T d2b1pa1          75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  150 (355)
T ss_dssp             CTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccc
Confidence            89999999999743      6899999999998877663    3599999999999999999999999999999999999


Q ss_pred             eeeccCCCCeEEEEecccccccCC--cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 003239          245 LLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL  322 (837)
Q Consensus       245 Ll~~~~~~~~IKL~DFGlA~~~~~--~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l  322 (837)
                      |++   .++.+||+|||+++....  .....++|+.|+|||++.+..++.++||||+||++|||++|++||.+.+....+
T Consensus       151 l~~---~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~  227 (355)
T d2b1pa1         151 VVK---SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW  227 (355)
T ss_dssp             EEC---TTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ccc---cccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH
Confidence            995   678899999999865433  344568999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHH
Q 003239          323 RRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV  402 (837)
Q Consensus       323 ~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il  402 (837)
                      .++++.++..+++.+.........++.....                                       +.......+.
T Consensus       228 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~  268 (355)
T d2b1pa1         228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPK---------------------------------------YAGLTFPKLF  268 (355)
T ss_dssp             HHHHHHHCCCCHHHHTTSCHHHHHHHHTSCC---------------------------------------CCCCCHHHHS
T ss_pred             HHHHHhccCCCHHHHHHhhhhHHHHhhcCcc---------------------------------------cccccccccc
Confidence            9999999855555443322222222221110                                       0001111111


Q ss_pred             hcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       403 ~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                      ....     ...+.......+++++|||++||++||++||||+|||+||||++.
T Consensus       269 ~~~~-----~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         269 PDSL-----FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CGGG-----SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cccc-----ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            1100     001112334467889999999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=435.48  Aligned_cols=253  Identities=28%  Similarity=0.495  Sum_probs=215.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|+++++||+|+||+||+|+++.+++.||||+++++    ....+.+..|+.++....      +|||||++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~------~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT------TCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC------CCCcEEEEEEEEccC
Confidence            6799999999999999999999999999999999753    233456677777765431      699999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+|||||||. |+|.+++...  ..+++.+++.++.||+.||+|||+++||||||||+|||++   ..+.+||+|||++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a  150 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMC  150 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred             CceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchh
Confidence            99999999998 5898888765  3699999999999999999999999999999999999995   6789999999999


Q ss_pred             cccC---CcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          264 CTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       264 ~~~~---~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      +...   ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++..+..  + .++      
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~-~~~------  221 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--D-NPF------  221 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C-CCC------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--C-CCC------
Confidence            7543   233456899999999999999999999999999999999999999999888776666543  1 000      


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                                                                                      +|             .
T Consensus       222 ----------------------------------------------------------------~p-------------~  224 (320)
T d1xjda_         222 ----------------------------------------------------------------YP-------------R  224 (320)
T ss_dssp             ----------------------------------------------------------------CC-------------T
T ss_pred             ----------------------------------------------------------------CC-------------c
Confidence                                                                            00             0


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHH-HHHcCccCCCCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPF-QASRHPFVTGEPF  458 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~-EaL~HPff~~~~~  458 (837)
                      .+++++.|||++||+.||++|||++ |+++||||++..+
T Consensus       225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence            1346789999999999999999995 8999999998654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=422.38  Aligned_cols=247  Identities=25%  Similarity=0.433  Sum_probs=205.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.++||+|+||+||+|++..+++.||||++++..       ....++.+|+.+|+++++     .|||||+++++|
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~-----~h~nIv~~~~~~   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS-----GFSGVIRLLDWF   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS-----SSCSBCCEEEEE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc-----CCCCccEEEEEE
Confidence            78999999999999999999999999999999997532       112345689999999964     589999999999


Q ss_pred             eecceEEEEEeccch--hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          182 VCQRHLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       182 ~~~~~l~LVmEy~~g--sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      .+.+..|+||||+.+  ++.+++...  ..+++.+++.++.||+.||+|||++|||||||||+|||++  .+.+.+||+|
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~D  154 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLID  154 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECC
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECc
Confidence            999999999999963  677777654  3699999999999999999999999999999999999996  3457899999


Q ss_pred             cccccccCCc-ceeeccCccccCchhhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          260 FGSACTEDRT-VYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       260 FGlA~~~~~~-~~~~~GT~~Y~APEvl~~~~y-t~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      ||+|+..... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+      .+.+  + .     
T Consensus       155 FG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--~-~-----  220 (273)
T d1xwsa_         155 FGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--G-Q-----  220 (273)
T ss_dssp             CTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--C-C-----
T ss_pred             cccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--c-c-----
Confidence            9999765433 355789999999999987765 578999999999999999999996531      1111  0 0     


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                                                                           ..+              +         
T Consensus       221 -----------------------------------------------------~~~--------------~---------  224 (273)
T d1xwsa_         221 -----------------------------------------------------VFF--------------R---------  224 (273)
T ss_dssp             -----------------------------------------------------CCC--------------S---------
T ss_pred             -----------------------------------------------------cCC--------------C---------
Confidence                                                                 000              0         


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE  456 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~  456 (837)
                        ..+++++.|||++||++||++|||++|||+||||++.
T Consensus       225 --~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         225 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             --SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             --CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence              0134678999999999999999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-48  Score=424.43  Aligned_cols=285  Identities=25%  Similarity=0.451  Sum_probs=217.3

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec--c
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--R  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--~  185 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||+++...  .+++.+|+++|+.+.      +||||++++++|...  .
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~------~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR------GGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT------TSTTBCCEEEEEECTTTC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc------CCCCCcEEEEEEEecCCC
Confidence            378999999999999999999999999999999998643  467889999999995      589999999999854  5


Q ss_pred             eEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .+++|||||.+ +|..+     .+.+++..++.+++||+.||+|||++|||||||||+||||+  .+...+||+|||+|.
T Consensus       106 ~~~~v~e~~~~~~L~~~-----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGT-----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHH-----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccce
Confidence            79999999985 55433     24699999999999999999999999999999999999996  345579999999997


Q ss_pred             ccC--CcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          265 TED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       265 ~~~--~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g-~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ...  ......++|+.|+|||++.+. .++.++|||||||++|||++|+.||.. .+..++...+.+.+|.+.+..+...
T Consensus       179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            543  344566889999999999876 589999999999999999999999865 4566777778887772222111111


Q ss_pred             hhc-chhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhh
Q 003239          341 AKN-TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE  419 (837)
Q Consensus       341 ~k~-~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~  419 (837)
                      ... ....+....             .                   ..      ....+....            .....
T Consensus       259 ~~~~~~~~~~~~~-------------~-------------------~~------~~~~~~~~~------------~~~~~  288 (328)
T d3bqca1         259 YNIELDPRFNDIL-------------G-------------------RH------SRKRWERFV------------HSENQ  288 (328)
T ss_dssp             TTCCCCGGGGGTC-------------C-------------------CC------CCCCGGGGC------------CTTTG
T ss_pred             cccccCcccchhc-------------c-------------------cc------cccchhhcc------------ccccc
Confidence            000 000000000             0                   00      000000000            00011


Q ss_pred             HHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       420 ~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      ..++++++|||++||++||++||||+|||+||||+...
T Consensus       289 ~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         289 HLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             GGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            23567899999999999999999999999999999754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=425.36  Aligned_cols=282  Identities=29%  Similarity=0.544  Sum_probs=223.2

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      .++|+++++||+|+||+||+|+++.+++.||||++++.   ....+.+.+|+++|+.|       .|+|||+++++|...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-------~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-------KHENVIGLLDVFTPA   89 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEeec
Confidence            37899999999999999999999999999999999753   34556788999999999       689999999999643


Q ss_pred             ------ceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       185 ------~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                            ...++++++++++|.+++..   +++++.+++.+++||+.||+|||++|||||||||+|||++   .++.+||+
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---~~~~~kl~  163 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKIL  163 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEEC
T ss_pred             cccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---cccccccc
Confidence                  34666666666899988754   3599999999999999999999999999999999999995   67899999


Q ss_pred             ecccccccCCcceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003239          259 DFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV  337 (837)
Q Consensus       259 DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~Pp~~~  337 (837)
                      |||++...........|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......|.+..+ .++..+
T Consensus       164 dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~-~~~~~~  242 (348)
T d2gfsa1         164 DFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-TPGAEL  242 (348)
T ss_dssp             CC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred             ccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCChHH
Confidence            999998888877888999999999998776 468899999999999999999999999999999999999888 444433


Q ss_pred             HHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhh
Q 003239          338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS  417 (837)
Q Consensus       338 l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~  417 (837)
                      ..........                             ...   ...+     ......+..+.               
T Consensus       243 ~~~~~~~~~~-----------------------------~~~---~~~~-----~~~~~~~~~~~---------------  270 (348)
T d2gfsa1         243 LKKISSESAR-----------------------------NYI---QSLT-----QMPKMNFANVF---------------  270 (348)
T ss_dssp             HTTCCCHHHH-----------------------------HHH---TTSC-----CCCCCCHHHHS---------------
T ss_pred             hhhccchhhh-----------------------------hhh---hhcc-----cCCCcchhhhc---------------
Confidence            3221100000                             000   0000     00111122211               


Q ss_pred             hhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       418 ~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                        ...+++++|||++||++||++||||+|||+||||++..
T Consensus       271 --~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         271 --IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             --TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             --CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence              12457899999999999999999999999999999754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-48  Score=421.98  Aligned_cols=282  Identities=33%  Similarity=0.569  Sum_probs=220.7

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ..+|+++++||+|+||+||+|+++.+++.||||++++.  ....+.+++|+++|++|       .||||+++++++....
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-------~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHENIIGINDIIRAPT   79 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-------CCTTBCCCCEEECCSS
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-------CCCCCCcEEEEEeecc
Confidence            36899999999999999999999999999999999753  44567788999999999       6899999999997653


Q ss_pred             -----eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          186 -----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       186 -----~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                           .+||||++++++|.+++...   .+++..++.+++||+.||+|||++|||||||||+||||+   ..+.+||+||
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~Df  153 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDF  153 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEccc
Confidence                 57888888888999998754   599999999999999999999999999999999999995   6789999999


Q ss_pred             ccccccCC------cceeeccCccccCchhhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          261 GSACTEDR------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       261 GlA~~~~~------~~~~~~GT~~Y~APEvl~~~-~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      |+|.....      .....+||+.|+|||++... .++.++||||+||++|||++|++||.+.+..+....+...++ .+
T Consensus       154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~-~~  232 (345)
T d1pmea_         154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG-SP  232 (345)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SC
T ss_pred             CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc-CC
Confidence            99964332      23456789999999998554 678999999999999999999999999999999998888887 44


Q ss_pred             chHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       334 p~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                      ...........    ..                         ....   ...+.     .....+..+.           
T Consensus       233 ~~~~~~~~~~~----~~-------------------------~~~~---~~~~~-----~~~~~~~~~~-----------  264 (345)
T d1pmea_         233 SQEDLNCIINL----KA-------------------------RNYL---LSLPH-----KNKVPWNRLF-----------  264 (345)
T ss_dssp             CHHHHHTCCCH----HH-------------------------HHHH---HTSCC-----CCCCCHHHHC-----------
T ss_pred             Chhhhhhhhhh----hh-------------------------hccc---ccCCc-----cCCCCHHHhC-----------
Confidence            33322111000    00                         0000   00000     0011112221           


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                            ...+.+++|||.+||++||++||||+|||+||||++..
T Consensus       265 ------~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         265 ------PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             ------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             ------CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence                  12457899999999999999999999999999999754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=411.47  Aligned_cols=279  Identities=30%  Similarity=0.514  Sum_probs=219.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++..   ....+++.+|+.+|+.+       .|+||++++++|....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~h~niv~~~~~~~~~~   74 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-------KHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEECSS
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-------CcCCEEeecccccccc
Confidence            6899999999999999999999999999999999753   34567888999999888       6899999999999999


Q ss_pred             eEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccc
Q 003239          186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT  265 (837)
Q Consensus       186 ~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~  265 (837)
                      ..++|||++.+.++..+... .+.+++..++.+++|++.||+|||++|||||||||+|||++   ..+.+||+|||.++.
T Consensus        75 ~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~  150 (292)
T d1unla_          75 KLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARA  150 (292)
T ss_dssp             EEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             ceeEEeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhc
Confidence            99999999987554444433 35799999999999999999999999999999999999995   567899999999976


Q ss_pred             cCCc---ceeeccCccccCchhhcCCC-CCccchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003239          266 EDRT---VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPL-FPGASEFDLLRRMIRILGAQPPDYVLKE  340 (837)
Q Consensus       266 ~~~~---~~~~~GT~~Y~APEvl~~~~-yt~ksDIWSLG~ILyELltG~~P-F~g~s~~e~l~~I~~~lG~~Pp~~~l~~  340 (837)
                      ....   .....+++.|+|||++.... ++.++|||||||++|||++|+.| |.+.+..+.+.++....+ .++...+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  229 (292)
T d1unla_         151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEEQWPS  229 (292)
T ss_dssp             CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC-CCCTTTCTT
T ss_pred             ccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC-CCChhhhhh
Confidence            5432   23446788899999998765 68999999999999999998776 677778888888888887 333322211


Q ss_pred             hhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhH
Q 003239          341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES  420 (837)
Q Consensus       341 ~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~  420 (837)
                      ......+..                                   .+....    ..                 .......
T Consensus       230 ~~~~~~~~~-----------------------------------~~~~~~----~~-----------------~~~~~~~  253 (292)
T d1unla_         230 MTKLPDYKP-----------------------------------YPMYPA----TT-----------------SLVNVVP  253 (292)
T ss_dssp             GGGSTTCCC-----------------------------------CCCCCT----TC-----------------CCTTTST
T ss_pred             hhhcccccc-----------------------------------cccccc----cc-----------------hhhhccc
Confidence            111000000                                   000000    00                 0000111


Q ss_pred             HhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCC
Q 003239          421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG  455 (837)
Q Consensus       421 ~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~  455 (837)
                      ..++.++|||++||++||++||||+|||+||||++
T Consensus       254 ~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            24578999999999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-47  Score=411.48  Aligned_cols=202  Identities=21%  Similarity=0.311  Sum_probs=179.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.++||+|+||+||+|+++.+++.||||+++.+....+++.+|+++|+++       .|||||+++++|.+.+.++
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-------CCCCEecCCccEeeCCeeE
Confidence            689999999999999999999999999999999987776778899999999999       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||||||. |+|.+++.......+++..++.++.||+.||+|||+++||||||||+||||+   .++.+||+|||+|+...
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTTTCC
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEccccceeecC
Confidence            9999998 6899988876666799999999999999999999999999999999999996   66899999999997654


Q ss_pred             Ccc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCC-CCCCCHHH
Q 003239          268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL-FPGASEFD  320 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~P-F~g~s~~e  320 (837)
                      ...    ....+++.|+|||++.+..|+.++|||||||++|||++|..| |.+.+..+
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~  224 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  224 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH
Confidence            332    223578899999999999999999999999999999996555 54444433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-46  Score=410.81  Aligned_cols=314  Identities=32%  Similarity=0.510  Sum_probs=239.3

Q ss_pred             EEeeeeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCC----CCC
Q 003239           96 LAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR----EDK  171 (837)
Q Consensus        96 ~~l~~~l~~~~~~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~----~~H  171 (837)
                      +.+++.+.+    +||+++++||+|+||+||+|+++.+++.||||+++++....+...+|+++|+.+.+....    ..|
T Consensus         4 ~~~g~~~~~----~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~   79 (362)
T d1q8ya_           4 AFKGEPYKD----ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA   79 (362)
T ss_dssp             CCTTCEETT----TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             CCCCCCccC----CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence            344555532    679999999999999999999999999999999998877778889999999999764211    257


Q ss_pred             CceeEEeEEEeec--ceEEEEEeccc--hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc-CCeeeccCCCCCeee
Q 003239          172 HHIVRIYEYFVCQ--RHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILL  246 (837)
Q Consensus       172 pnIVkl~d~f~~~--~~l~LVmEy~~--gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl  246 (837)
                      +||+++++++...  ...++||+++.  +.............+++..++.++.||+.||+|||+ .|||||||||+||||
T Consensus        80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll  159 (362)
T d1q8ya_          80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM  159 (362)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred             CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence            8999999998765  35556666553  455555555556679999999999999999999997 899999999999999


Q ss_pred             eccCC---CCeEEEEecccccccCCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------
Q 003239          247 CTSVK---PAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------  317 (837)
Q Consensus       247 ~~~~~---~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s------  317 (837)
                      +.+..   ...+||+|||.+..........++|+.|+|||++....|+.++|||||||++++|++|+.||...+      
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             eccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence            64322   135899999999877777777899999999999999999999999999999999999999997543      


Q ss_pred             HHHHHHHHHHHhCCCCchHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccc
Q 003239          318 EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKH  397 (837)
Q Consensus       318 ~~e~l~~I~~~lG~~Pp~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~  397 (837)
                      ..+.+..++..+| .++.+++........++........+..                                 .....
T Consensus       240 ~~~~~~~~~~~lg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~  285 (362)
T d1q8ya_         240 DDDHIAQIIELLG-ELPSYLLRNGKYTRTFFNSRGLLRNISK---------------------------------LKFWP  285 (362)
T ss_dssp             HHHHHHHHHHHHC-SCCHHHHHHCTTHHHHBCC--CBSSCCC---------------------------------CCBCC
T ss_pred             hhHHHHHHHHHhC-CCCHHHhhcccccccccccchhhhcccc---------------------------------ccCCc
Confidence            4567788888999 6667776665555555543331111110                                 00111


Q ss_pred             hHHHHhcCCCCCCCchhhhhhhHHhHHHHHHHHHHhcccCcCCCCCHHHHHcCccCCCCC
Q 003239          398 LEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP  457 (837)
Q Consensus       398 L~~il~~~p~~~~l~~e~l~~~~~~s~~l~DLL~kmL~~DP~kRpTa~EaL~HPff~~~~  457 (837)
                      +...+...          .......+++++|||.+||++||++||||+|||+||||++..
T Consensus       286 ~~~~~~~~----------~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         286 LEDVLTEK----------YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHHHT----------TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             hhhhcccc----------cccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence            22222110          112234678899999999999999999999999999999654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=406.95  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=208.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.++||+|+||+||+|+++ +++.||||+++......+.+.+|+++|+++       .|||||++++++. ++.++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~-~~~~~   83 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-------QHQRLVRLYAVVT-QEPIY   83 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEC-SSSCE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-------CCCCEeEEEeeec-cCCeE
Confidence            78999999999999999999865 678899999987766678899999999999       6899999999875 45689


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||||||. |+|.+++.......+++..++.|+.||++||.|||+++||||||||+||||+   +++.+||+|||+|+...
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE  160 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---cccceeeccccceEEcc
Confidence            9999998 5888877665555699999999999999999999999999999999999995   67899999999997654


Q ss_pred             Ccc----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       268 ~~~----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ...    ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.+..+.....  ++        
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~--~~--------  230 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--MV--------  230 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CC--------
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CC--------
Confidence            322    23467889999999999899999999999999999999 5667776666655544432100  00        


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                                 ....+
T Consensus       231 ---------------------------------------------------------------------------~p~~~  235 (272)
T d1qpca_         231 ---------------------------------------------------------------------------RPDNC  235 (272)
T ss_dssp             ---------------------------------------------------------------------------CCTTC
T ss_pred             ---------------------------------------------------------------------------CcccC
Confidence                                                                                       00013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHc--CccCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASR--HPFVTG  455 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~--HPff~~  455 (837)
                      ++++.+||.+||+.||++|||++|+++  |+||+.
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            467899999999999999999999998  888863

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-47  Score=401.46  Aligned_cols=207  Identities=22%  Similarity=0.366  Sum_probs=173.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|+++++||+|+||+||+|++. +++.||||+++.+....+++.+|+++++++       .|||||++++++..++.++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-------SHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-------CCCCcccccceeccCCceE
Confidence            68999999999999999999875 567899999987766678899999999999       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      ||||||. |+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++   .++.+||+|||+++...
T Consensus        77 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC------
T ss_pred             EEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheecc
Confidence            9999998 68888876543 5689999999999999999999999999999999999996   67899999999997543


Q ss_pred             Cc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003239          268 RT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       268 ~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~  327 (837)
                      ..    .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+..
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~  217 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST  217 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH
T ss_pred             CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh
Confidence            22    223578999999999999999999999999999999999 6788877776666655443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.1e-47  Score=403.65  Aligned_cols=208  Identities=26%  Similarity=0.444  Sum_probs=175.4

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..    ....+.+.+|+++|+.+       +|||||++++++..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-------~hpniv~~~~~~~~   78 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-------NHPAIVAVYDTGEA   78 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-------CCCCCCcccceeee
Confidence            37899999999999999999999999999999999753    34456788999999888       68999999999987


Q ss_pred             cc----eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEE
Q 003239          184 QR----HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII  258 (837)
Q Consensus       184 ~~----~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~  258 (837)
                      .+    .+|||||||. ++|.+++...  +.+++.+++.+++||+.||+|||++|||||||||+|||++   ..+.++|+
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~  153 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVM  153 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEEC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceee
Confidence            64    4899999998 4788777655  3699999999999999999999999999999999999996   67889999


Q ss_pred             ecccccccCC------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 003239          259 DFGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       259 DFGlA~~~~~------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~  327 (837)
                      |||.+.....      .....+||+.|+|||++.+..|+.++||||||||+|||+||++||.+.+..+.+.++++
T Consensus       154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~  228 (277)
T d1o6ya_         154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR  228 (277)
T ss_dssp             CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence            9998854322      23456899999999999999999999999999999999999999998887776665544

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-47  Score=398.53  Aligned_cols=207  Identities=20%  Similarity=0.307  Sum_probs=182.2

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|+++++||+|+||+||+|+. .+++.||||++++.....+++++|+++++++       .|||||++++++.+++.++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-------~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-------SHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-------CCTTBCCEEEEECCSSSEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-------CCCceeeEEEEEeeCCceE
Confidence            6888999999999999999997 4788999999998776678899999999998       6899999999999999999


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +||||+. |+|.+++.... ..+++..+++++.||++||+|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        76 iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCS
T ss_pred             EEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheecc
Confidence            9999997 57777766554 5699999999999999999999999999999999999995   67899999999997543


Q ss_pred             Cc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003239          268 RT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       268 ~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~  327 (837)
                      ..    .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+.+
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~  216 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ  216 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred             CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence            22    223568899999999999999999999999999999998 8999999888776665543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-46  Score=402.64  Aligned_cols=207  Identities=21%  Similarity=0.335  Sum_probs=169.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~---~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|++.++||+|+||+||+|+++.+++   .||||++...  ....+.+.+|+++|++|       .|||||++++++..
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-------DHPNVIHLEGVVTK   98 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEECS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-------CCCCCccEEEEEee
Confidence            789999999999999999999876654   6899988753  44556789999999988       68999999999999


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      .+.++||||||. |+|.+++.... ..+++.+++.++.||+.||+|||+++||||||||+||||+   .++.+||+|||+
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGl  174 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGL  174 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC--
T ss_pred             CCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---CCCcEEECCccc
Confidence            999999999998 47777776543 4699999999999999999999999999999999999995   678999999999


Q ss_pred             ccccCCcc--------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          263 ACTEDRTV--------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       263 A~~~~~~~--------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      |+......        ....+|+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..+.+..+.
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~  247 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE  247 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            97543221        12356889999999999999999999999999999998 899999888776665543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=408.68  Aligned_cols=209  Identities=24%  Similarity=0.379  Sum_probs=175.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCC-----eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMN-----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg-----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.++||+|+||+||+|++..++     ..||||++...  ......+.+|+.+|.++.      .|||||++++++
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~HpnIv~l~~~~  110 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG------SHENIVNLLGAC  110 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc------CCCcEeEEEEEE
Confidence            78999999999999999999876554     37999998643  334457889999999984      589999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhcc---------------------CCCCHHHHHHHHHhHHHHHhhhhcCCeeeccC
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHF---------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL  239 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~---------------------~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDL  239 (837)
                      .+.+.+|||||||+ |+|.++++....                     ..+++..++.++.||+.||+|||+++||||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            99999999999998 699999876431                     34899999999999999999999999999999


Q ss_pred             CCCCeeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 003239          240 KPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLF  313 (837)
Q Consensus       240 KPeNILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF  313 (837)
                      ||+|||++   .++.+||+|||+|+.....     .....+|+.|+|||++.+..|+.++|||||||++|||++ |++||
T Consensus       191 Kp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         191 AARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             SGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             chhccccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999996   6789999999999654322     124567999999999999999999999999999999997 89999


Q ss_pred             CCCCHHHHHHHHH
Q 003239          314 PGASEFDLLRRMI  326 (837)
Q Consensus       314 ~g~s~~e~l~~I~  326 (837)
                      .+.+..+.+.+++
T Consensus       268 ~~~~~~~~~~~~~  280 (325)
T d1rjba_         268 PGIPVDANFYKLI  280 (325)
T ss_dssp             TTCCCSHHHHHHH
T ss_pred             CCCCHHHHHHHHH
Confidence            8876555544443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=410.06  Aligned_cols=272  Identities=22%  Similarity=0.373  Sum_probs=215.6

Q ss_pred             CceEEEEEeccCCceeEEEeec---cCCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~---~~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      ++|+++++||+|+||+||+|++   ..+++.||||++++.     ....+.+.+|+++|++++|      ||||++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h------~pnIv~~~~~   97 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ------SPFLVTLHYA   97 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT------CTTBCCEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC------CCeEEEeeee
Confidence            7899999999999999999976   457899999998642     2334667889999999963      5899999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEe
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID  259 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~D  259 (837)
                      +.+...+++||||+. ++|.+++....  .+++..++.+++||+.||+|||+++||||||||+|||++   .++.+||+|
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~D  172 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTD  172 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESC
T ss_pred             eccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEee
Confidence            999999999999998 58888887654  588999999999999999999999999999999999996   668999999


Q ss_pred             cccccccCC----cceeeccCccccCchhhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003239          260 FGSACTEDR----TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP  333 (837)
Q Consensus       260 FGlA~~~~~----~~~~~~GT~~Y~APEvl~~~--~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~~~lG~~P  333 (837)
                      ||++.....    ......+++.|+|||++.+.  .++.++|||||||+||||++|+.||.+.+..+....+.+..... 
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-  251 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-  251 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-
Confidence            999965432    23456789999999999865  47789999999999999999999998775544433333211000 


Q ss_pred             chHHHHhhhcchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCch
Q 003239          334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM  413 (837)
Q Consensus       334 p~~~l~~~k~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~  413 (837)
                                                                         .+                   +.      
T Consensus       252 ---------------------------------------------------~~-------------------~~------  255 (322)
T d1vzoa_         252 ---------------------------------------------------EP-------------------PY------  255 (322)
T ss_dssp             ---------------------------------------------------CC-------------------CC------
T ss_pred             ---------------------------------------------------CC-------------------CC------
Confidence                                                               00                   00      


Q ss_pred             hhhhhhHHhHHHHHHHHHHhcccCcCCCC-----CHHHHHcCccCCCCCCCCCCCCCCCCCCCCc
Q 003239          414 EDISKESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCPYQPPPETPRVPV  473 (837)
Q Consensus       414 e~l~~~~~~s~~l~DLL~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~~  473 (837)
                           ....++++++||++||++||++|+     |++|+|+||||++..+..........|..|.
T Consensus       256 -----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~  315 (322)
T d1vzoa_         256 -----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV  315 (322)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             -----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence                 012457899999999999999999     5999999999998665433333333444443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=398.05  Aligned_cols=203  Identities=28%  Similarity=0.378  Sum_probs=170.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      ++|++.++||+|+||+||+|+..   ..||||+++.   +....+.+.+|+++|+++       .|||||++++++. ++
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~~~~~-~~   76 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-------RHVNILLFMGYST-AP   76 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEC-SS
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCEeeeeEEEe-cc
Confidence            78999999999999999999754   3599999974   344567888999999988       6899999999865 45


Q ss_pred             eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccc
Q 003239          186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC  264 (837)
Q Consensus       186 ~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~  264 (837)
                      .++||||||+ |+|.+++.... ..+++..+..|+.||++||+|||+++||||||||+||||+   .++.+||+|||+|+
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~  152 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLAT  152 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSC
T ss_pred             EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEcccccee
Confidence            7899999998 69999887553 4699999999999999999999999999999999999996   67899999999996


Q ss_pred             ccCC-----cceeeccCccccCchhhcCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003239          265 TEDR-----TVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       265 ~~~~-----~~~~~~GT~~Y~APEvl~~~---~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~~I~  326 (837)
                      ....     ......||+.|+|||++.+.   .|+.++|||||||+||||+||+.||.+.+..+.+..++
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~  222 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV  222 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            5432     22345789999999999753   58999999999999999999999998876655554443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=394.31  Aligned_cols=202  Identities=26%  Similarity=0.419  Sum_probs=168.5

Q ss_pred             eEEE-EEeccCCceeEEEeec--cCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          111 YIVK-DLLGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       111 Y~i~-~~LG~G~fG~Vyka~~--~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      +.+. ++||+|+||+||+|..  ..+++.||||+++..   ....+.+.+|+++|+++       .|||||++++++.. 
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~g~~~~-   79 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-------DNPYIVRMIGICEA-   79 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEES-
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-------CCCCCceEEEEecc-
Confidence            3443 4799999999999974  455688999999743   33456789999999998       68999999999865 


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +..+||||||+ |+|.+++...  ..+++..+..++.||+.||+|||+++||||||||+|||++   .++.+||+|||++
T Consensus        80 ~~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla  154 (277)
T d1xbba_          80 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLS  154 (277)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTC
T ss_pred             CCEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhh
Confidence            46789999998 5888888754  4699999999999999999999999999999999999996   6789999999999


Q ss_pred             cccCCc------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          264 CTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       264 ~~~~~~------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      +.....      .....||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+
T Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i  223 (277)
T d1xbba_         155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML  223 (277)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence            754322      123468899999999999999999999999999999998 89999988776655444

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-46  Score=396.13  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=204.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|++.+.||+|+||+||+|++..+ +.||||+++......+.+.+|+.+|+++       +|+|||++++++.+ +.++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-------~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECS-SSCE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-------ccCCEeEEEEEEec-CCeE
Confidence            6899999999999999999988655 5699999987766678899999999999       68999999999854 5689


Q ss_pred             EEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccC
Q 003239          189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED  267 (837)
Q Consensus       189 LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~  267 (837)
                      +|||||. |+|..++.......+++.+++.++.||+.||+|||+++||||||||+||||+   .++.+||+|||+|+...
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE  164 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC---
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhcc
Confidence            9999998 5777777666556799999999999999999999999999999999999995   56889999999997543


Q ss_pred             Cc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003239          268 RT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK  342 (837)
Q Consensus       268 ~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~PF~g~s~~e~l~~I~~~lG~~Pp~~~l~~~k  342 (837)
                      ..    .....+|+.|+|||++....++.++||||||||+|||++| .++|......+.+..+.+...  +         
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--~---------  233 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--M---------  233 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--C---------
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--C---------
Confidence            22    2335789999999999999999999999999999999995 666666666665555432110  0         


Q ss_pred             cchhhhhhcCCcccccCCccccCCccchhhhhHHHHHHHhhcCCcCCcccccccchHHHHhcCCCCCCCchhhhhhhHHh
Q 003239          343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI  422 (837)
Q Consensus       343 ~~~~~f~~~~~l~~~~~~~~~i~~~~~y~~~s~~~~~~~~~~~p~~~~~~f~~~~L~~il~~~p~~~~l~~e~l~~~~~~  422 (837)
                                                                                     +..           ..+
T Consensus       234 ---------------------------------------------------------------~~~-----------~~~  239 (285)
T d1fmka3         234 ---------------------------------------------------------------PCP-----------PEC  239 (285)
T ss_dssp             ---------------------------------------------------------------CCC-----------TTS
T ss_pred             ---------------------------------------------------------------CCC-----------ccc
Confidence                                                                           000           013


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHc--CccCCCC
Q 003239          423 RLALVDFLKGLVEFDPAKRWSPFQASR--HPFVTGE  456 (837)
Q Consensus       423 s~~l~DLL~kmL~~DP~kRpTa~EaL~--HPff~~~  456 (837)
                      ++++.+||.+||+.||++|||++|+++  |+||+..
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            467899999999999999999999988  8999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=395.48  Aligned_cols=205  Identities=22%  Similarity=0.334  Sum_probs=174.1

Q ss_pred             CceEEEEE-eccCCceeEEEeecc--CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDL-LGHGTFGQVAKCWDA--EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~-LG~G~fG~Vyka~~~--~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|.+.+. ||+|+||+||+|.++  .++..||||+++..  ....+.+.+|+++|+++       .|||||++++++..
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~g~~~~   80 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-------DNPYIVRLIGVCQA   80 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEES
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-------CCCCEeeEeeeecc
Confidence            67888885 999999999999765  34568999999753  45567899999999999       68999999999865


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                       +.+|||||||+ |+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||++   .++.+||+|||+
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGl  155 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGL  155 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTT
T ss_pred             -CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchh
Confidence             56899999998 58888765433 4699999999999999999999999999999999999996   678999999999


Q ss_pred             ccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003239          263 ACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM  325 (837)
Q Consensus       263 A~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I  325 (837)
                      |+......      ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i  225 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI  225 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            97543321      23467899999999999999999999999999999998 99999887776655544

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=387.51  Aligned_cols=206  Identities=24%  Similarity=0.385  Sum_probs=166.7

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC  183 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~  183 (837)
                      ++|++.++||+|+||+||+|++..+   +..||||+++..  ....+.+.+|+++|+++       .|||||++++++. 
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-------DHPHIVKLIGVIT-   78 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC-
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe-
Confidence            7899999999999999999987654   457899998743  44456788999999998       6899999999986 


Q ss_pred             cceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccc
Q 003239          184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS  262 (837)
Q Consensus       184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGl  262 (837)
                      ++.+|||||||. |+|.+++.... ..+++..++.++.||+.||.|||+++||||||||+||+++   ..+.+||+|||+
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~  154 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL  154 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred             cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchh
Confidence            568999999998 57777665543 5699999999999999999999999999999999999996   668999999999


Q ss_pred             ccccCCc----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003239          263 ACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI  326 (837)
Q Consensus       263 A~~~~~~----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~  326 (837)
                      |+.....    .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~  223 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  223 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9754322    234567899999999999999999999999999999998 899998877766655543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=384.96  Aligned_cols=205  Identities=21%  Similarity=0.294  Sum_probs=166.4

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      ..|++.++||+|+||+||+|+.+.++    ..||||+++..  ......+++|+++|+++       .|||||++++++.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-------~H~nIv~~~g~~~   79 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-------SHHNIIRLEGVIS   79 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-------CCCCEeeeeEEEe
Confidence            67999999999999999999876554    47999999753  34455788999999998       6899999999999


Q ss_pred             ecceEEEEEeccch-hHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ..+.+++|||||.+ .+.+++... ...+++.++..++.||+.||+|||+++||||||||+||||+   .++.+||+|||
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG  155 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFG  155 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCC
T ss_pred             cCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---CCCeEEEcccc
Confidence            99999999999985 565555544 35699999999999999999999999999999999999995   67899999999


Q ss_pred             cccccCCc------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 003239          262 SACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRR  324 (837)
Q Consensus       262 lA~~~~~~------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~PF~g~s~~e~l~~  324 (837)
                      +++.....      .....||+.|+|||++.+..++.++|||||||++|||+++ .+||...+..+.+..
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~  225 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA  225 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH
Confidence            99754322      1234678999999999999999999999999999999995 555655555544433

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=391.82  Aligned_cols=204  Identities=24%  Similarity=0.376  Sum_probs=167.6

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEe
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV  182 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~  182 (837)
                      .+|+++++||+|+||+||+|++..+++    .||||+++..  ....+.+.+|+.+|+++       .|||||++++++.
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~g~~~   81 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGICL   81 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe
Confidence            579999999999999999999887776    5888888643  34467889999999999       6899999999998


Q ss_pred             ecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecc
Q 003239          183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG  261 (837)
Q Consensus       183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFG  261 (837)
                      ++. .++|||++. ++|.+.+.... ..+++..++.++.||+.||+|||+++||||||||+||||+   .++.+||+|||
T Consensus        82 ~~~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFG  156 (317)
T d1xkka_          82 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFG  156 (317)
T ss_dssp             SSS-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCS
T ss_pred             cCC-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccc
Confidence            765 556666665 78888777653 5699999999999999999999999999999999999996   67899999999


Q ss_pred             cccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          262 SACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       262 lA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      +|+.....     .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~  225 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI  225 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH
T ss_pred             cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence            99754322     223467999999999999999999999999999999998 8999987765554433

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-45  Score=386.11  Aligned_cols=203  Identities=26%  Similarity=0.366  Sum_probs=167.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-cceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-QRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-~~~l  187 (837)
                      ++|+++++||+|+||.||+|+.  +++.||||+++++. ..+.+.+|+++|+++       .|||||++++++.+ ++.+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTC-------CCTTBCCEEEEECCC--CC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-HHHHHHHHHHHHHhC-------CCCCEeeEEEEEEecCCcE
Confidence            6899999999999999999976  47889999998654 457788999999888       68999999999865 4678


Q ss_pred             EEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEeccccccc
Q 003239          188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE  266 (837)
Q Consensus       188 ~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~  266 (837)
                      ||||||+. |+|.+++.......+++..++.++.||+.||.|||+++||||||||+|||++   .++.+||+|||+++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC----
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeecccccceec
Confidence            99999997 6899998766545699999999999999999999999999999999999995   6789999999999887


Q ss_pred             CCcceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003239          267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR  324 (837)
Q Consensus       267 ~~~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~  324 (837)
                      ........++..|+|||++.+..++.++|||||||++|||+| |++||...+..+....
T Consensus       154 ~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~  212 (262)
T d1byga_         154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  212 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH
T ss_pred             CCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence            766667788999999999999999999999999999999998 7999877665554443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-44  Score=385.28  Aligned_cols=207  Identities=24%  Similarity=0.286  Sum_probs=176.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++.... .+++.+|+++++.+.      +|++|+.+..++...+..+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~------~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQ------GGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHST------TSTTCCCEEEEEEETTEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHcc------CCCcccEEEEEEecCCEEE
Confidence            689999999999999999999999999999999886432 345778999999985      3566778888888889999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccccccCC
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR  268 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA~~~~~  268 (837)
                      +||||++++|.+.+.... +.+++..++.++.||+.||+|||++|||||||||+|||++..+....+||+|||+|+....
T Consensus        80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999999998888776543 5699999999999999999999999999999999999997666677899999999975322


Q ss_pred             ----------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 003239          269 ----------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR  323 (837)
Q Consensus       269 ----------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s~~e~l~  323 (837)
                                .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~  223 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  223 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence                      1234579999999999999999999999999999999999999998766544433

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=386.22  Aligned_cols=205  Identities=26%  Similarity=0.362  Sum_probs=164.5

Q ss_pred             CceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.++||+|+||+||+|++..     +++.||||+++..  ....+.+.+|+.++.++.      +|+||+++++++
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~------~h~~iv~~~~~~   86 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGAC   86 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc------CCCeEEEeeeee
Confidence            789999999999999999998543     4578999999753  344567788888888885      588999999988


Q ss_pred             eec-ceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCee
Q 003239          182 VCQ-RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL  245 (837)
Q Consensus       182 ~~~-~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL  245 (837)
                      ... ..+++|||||+ |+|.+++....              ...+++.+++.++.||+.||+|||+++||||||||+|||
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence            765 47899999998 68999987543              134899999999999999999999999999999999999


Q ss_pred             eeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCHH
Q 003239          246 LCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEF  319 (837)
Q Consensus       246 l~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~PF~g~s~~  319 (837)
                      |+   .++.+||+|||+|+.....     .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..
T Consensus       167 l~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         167 LS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             EC---GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EC---CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            95   6689999999999653322     2345789999999999999999999999999999999986 6788776544


Q ss_pred             HHH
Q 003239          320 DLL  322 (837)
Q Consensus       320 e~l  322 (837)
                      +.+
T Consensus       244 ~~~  246 (299)
T d1ywna1         244 EEF  246 (299)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            433

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-43  Score=380.82  Aligned_cols=209  Identities=22%  Similarity=0.371  Sum_probs=177.5

Q ss_pred             CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++++.||+|+||+||+|+.+     .+++.||||+++..  ....+++.+|+++|+++       .|+||++++++
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-------~h~niv~~~~~   84 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-------DNPNIVKLLGV   84 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEE
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-------CCCCcccceee
Confidence            478999999999999999999854     45689999999753  34456789999999998       68999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc----------------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeec
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH----------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHC  237 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~----------------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHr  237 (837)
                      +...+..++||||+. |+|.+++....                      ...+++..+..|+.||+.||+|||+++||||
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr  164 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  164 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence            999999999999997 68998886432                      1248899999999999999999999999999


Q ss_pred             cCCCCCeeeeccCCCCeEEEEecccccccCC-----cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CC
Q 003239          238 DLKPENILLCTSVKPAEIKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP  311 (837)
Q Consensus       238 DLKPeNILl~~~~~~~~IKL~DFGlA~~~~~-----~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~  311 (837)
                      ||||+||||+   .++.+||+|||+|+....     ......+++.|+|||++.+..|+.++||||||||+|||++| .+
T Consensus       165 DlKp~NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         165 DLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSGGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEcccceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999996   668899999999964322     12345788999999999999999999999999999999998 57


Q ss_pred             CCCCCCHHHHHHHHH
Q 003239          312 LFPGASEFDLLRRMI  326 (837)
Q Consensus       312 PF~g~s~~e~l~~I~  326 (837)
                      ||.+.+..+.+..+.
T Consensus       242 p~~~~~~~e~~~~v~  256 (301)
T d1lufa_         242 PYYGMAHEEVIYYVR  256 (301)
T ss_dssp             TTTTSCHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHH
Confidence            898888777665543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=379.72  Aligned_cols=208  Identities=26%  Similarity=0.407  Sum_probs=172.8

Q ss_pred             CCceEEEEEeccCCceeEEEeeccCCC-------eEEEEEEEeCCh--hhHHHHHHHHHHHHHhhcccCCCCCCceeEEe
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIY  178 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~~~tg-------~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~  178 (837)
                      .++|++.+.||+|+||.||+|++..++       ..||||+++.+.  ....++.+|+.++.++.      .|||||+++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~------~HpnIv~~~   85 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG------KHKNIINLL   85 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc------CCCeEEecc
Confidence            379999999999999999999865543       479999997643  44577888999988884      589999999


Q ss_pred             EEEeecceEEEEEeccc-hhHHHHHHhhc--------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          179 EYFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                      ++|.+++.+++|||||. |+|.+++....              ...+++.+++.++.||+.||+|||+++||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            99999999999999998 68999887553              2358999999999999999999999999999999999


Q ss_pred             eeeeccCCCCeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          244 ILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       244 ILl~~~~~~~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ||++   .++.+||+|||+++.....     .....+++.|+|||++.+..|+.++||||||||+|||++ |.+||.+.+
T Consensus       166 iLl~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         166 VLVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             EEEC---TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eeec---CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            9995   6789999999999754322     233578899999999999999999999999999999998 799998877


Q ss_pred             HHHHHHH
Q 003239          318 EFDLLRR  324 (837)
Q Consensus       318 ~~e~l~~  324 (837)
                      ..+....
T Consensus       243 ~~~~~~~  249 (299)
T d1fgka_         243 VEELFKL  249 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            6655443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=383.80  Aligned_cols=208  Identities=24%  Similarity=0.309  Sum_probs=174.1

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeE--EEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeec
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSF--VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ  184 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~--VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~  184 (837)
                      ++|++.++||+|+||+||+|+++.++..  ||||+++..  ....+.+.+|+++|+++.      +|||||++++++..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------~HpnIv~~~~~~~~~   83 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHR   83 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC------CCTTBCCEEEEEEET
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc------CCCCEeeEEEEEecC
Confidence            6899999999999999999999888864  777887643  334567889999999873      489999999999999


Q ss_pred             ceEEEEEeccc-hhHHHHHHhh--------------ccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeecc
Q 003239          185 RHLCICFELLD-SNLYELIKIN--------------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS  249 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~--------------~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~  249 (837)
                      +.++||||||. |+|.+++...              ....+++..+..++.||+.||.|||+++||||||||+|||++  
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~--  161 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--  161 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc--
Confidence            99999999998 6999988653              235699999999999999999999999999999999999995  


Q ss_pred             CCCCeEEEEecccccccCCcc--eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 003239          250 VKPAEIKIIDFGSACTEDRTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRM  325 (837)
Q Consensus       250 ~~~~~IKL~DFGlA~~~~~~~--~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~PF~g~s~~e~l~~I  325 (837)
                       ..+.+||+|||+++......  ....+|..|+|||.+.+..|+.++||||||||+|||++| .+||.+.+..+.+..+
T Consensus       162 -~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         162 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             -CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence             66889999999997544332  344689999999999999999999999999999999996 5678877766654443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=376.76  Aligned_cols=207  Identities=24%  Similarity=0.378  Sum_probs=168.0

Q ss_pred             CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC----hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~t---g~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++++.||+|+||+||+|+...+   ...||||++++.    ....+.+.+|+.+|+++       +|||||++++++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-------~H~nIv~~~g~~   80 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-------DHRNLIRLYGVV   80 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEE
Confidence            7899999999999999999975432   347899998743    34557789999999999       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEec
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF  260 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DF  260 (837)
                      .+ ..+++|||||. +++.+.+.... ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+||
T Consensus        81 ~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~Df  155 (273)
T d1u46a_          81 LT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDF  155 (273)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCC
T ss_pred             ee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccc
Confidence            75 57899999998 57777766554 4699999999999999999999999999999999999996   5679999999


Q ss_pred             ccccccCCcc------eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003239          261 GSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR  327 (837)
Q Consensus       261 GlA~~~~~~~------~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s~~e~l~~I~~  327 (837)
                      |+++......      ....++..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.+..+.+
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~  229 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK  229 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh
Confidence            9997654332      22356788999999999999999999999999999998 8999999888877666543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=376.04  Aligned_cols=210  Identities=27%  Similarity=0.378  Sum_probs=178.5

Q ss_pred             CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEE
Q 003239          108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY  180 (837)
Q Consensus       108 ~~~Y~i~~~LG~G~fG~Vyka~~-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~  180 (837)
                      .++|++.++||+|+||.||+|+.     ..+++.||||+++..  ......+.+|+.+++++.      +|||||+++++
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~------~HpnIv~~~g~   95 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG------NHMNIVNLLGA   95 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc------CCCCEEEEEEE
Confidence            37999999999999999999964     356789999999854  345567889999999984      59999999999


Q ss_pred             EeecceEEEEEeccc-hhHHHHHHhhc----------------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCC
Q 003239          181 FVCQRHLCICFELLD-SNLYELIKINH----------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN  243 (837)
Q Consensus       181 f~~~~~l~LVmEy~~-gsL~d~l~~~~----------------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN  243 (837)
                      +...+.++||||||. |+|.+++....                ...+++..++.++.||+.||+|||+++||||||||+|
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            999999999999998 58888886542                2258999999999999999999999999999999999


Q ss_pred             eeeeccCCCCeEEEEecccccccCCcc-----eeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 003239          244 ILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS  317 (837)
Q Consensus       244 ILl~~~~~~~~IKL~DFGlA~~~~~~~-----~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELlt-G~~PF~g~s  317 (837)
                      ||++   ..+.+||+|||.++......     ...++|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+
T Consensus       176 Il~~---~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         176 ILLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             EEEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccc---ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            9996   67899999999997544321     23577999999999999999999999999999999998 777787766


Q ss_pred             HHHHHHHHH
Q 003239          318 EFDLLRRMI  326 (837)
Q Consensus       318 ~~e~l~~I~  326 (837)
                      ..+.+.+++
T Consensus       253 ~~~~~~~~i  261 (311)
T d1t46a_         253 VDSKFYKMI  261 (311)
T ss_dssp             SSHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            555555444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.1e-42  Score=370.79  Aligned_cols=201  Identities=21%  Similarity=0.281  Sum_probs=175.9

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC  188 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~  188 (837)
                      ++|+++++||+|+||+||+|++..+++.||||+++.... ...+.+|+++++.|.      +|+||+.+++++......+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~------~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLA------GCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTT------TCTTCCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhc------CCCCCCEEEEEeecCCccE
Confidence            799999999999999999999999999999999875432 345678999999985      3689999999999999999


Q ss_pred             EEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccC--CCCeEEEEeccccccc
Q 003239          189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTE  266 (837)
Q Consensus       189 LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~IKL~DFGlA~~~  266 (837)
                      +|||||+++|.+++.... ..+++.++..++.|++.||+|||++|||||||||+|||++...  ..+.+||+|||+|+..
T Consensus        78 ~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999999998886543 5699999999999999999999999999999999999996432  3578999999999643


Q ss_pred             CC----------cceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 003239          267 DR----------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS  317 (837)
Q Consensus       267 ~~----------~~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g~s  317 (837)
                      ..          .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence            21          1234579999999999999999999999999999999999999997654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-43  Score=377.49  Aligned_cols=208  Identities=25%  Similarity=0.335  Sum_probs=177.2

Q ss_pred             CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF  181 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f  181 (837)
                      ++|++.++||+|+||+||+|.+.     .+++.||||+++..  ......+.+|+++++++       +|||||++++++
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-------~h~nIv~~~~~~   92 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-------NCHHVVRLLGVV   92 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-------CCTTBCCEEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-------CCCCEeeeeeEE
Confidence            79999999999999999999864     34678999999853  33445678999999888       689999999999


Q ss_pred             eecceEEEEEeccc-hhHHHHHHhhc--------cCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCC
Q 003239          182 VCQRHLCICFELLD-SNLYELIKINH--------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP  252 (837)
Q Consensus       182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~  252 (837)
                      ..++..++|||||. |+|.+++....        ...+++..+..++.||+.||.|||+++||||||||+||||+   .+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld---~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---ED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec---CC
Confidence            99999999999997 68888776432        13478999999999999999999999999999999999995   77


Q ss_pred             CeEEEEecccccccCCc-----ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q 003239          253 AEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMI  326 (837)
Q Consensus       253 ~~IKL~DFGlA~~~~~~-----~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG-~~PF~g~s~~e~l~~I~  326 (837)
                      +.+||+|||+|+.....     .....+|+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+.
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            89999999999754332     2233678999999999999999999999999999999998 68898887777666554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=365.78  Aligned_cols=192  Identities=22%  Similarity=0.276  Sum_probs=157.8

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc---
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---  185 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---  185 (837)
                      ++|.+.++||+|+||+||+|+.  +++.||||+++.+..  +...+|.+++...     ...|||||++++++..++   
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~-----~~~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTV-----MLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTST-----TCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHh-----hCCCCcCcceEEEEEeCCCcc
Confidence            6899999999999999999974  689999999976543  3444555444322     126999999999998764   


Q ss_pred             -eEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhc--------CCeeeccCCCCCeeeeccCCCCeE
Q 003239          186 -HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD--------AGIIHCDLKPENILLCTSVKPAEI  255 (837)
Q Consensus       186 -~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs--------~gIVHrDLKPeNILl~~~~~~~~I  255 (837)
                       .+|||||||. |+|.++++..   .+++..+..++.|++.||+|||+        ++||||||||+||||+   .++.+
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---~~~~~  147 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTC  147 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---TTSCE
T ss_pred             eEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---CCCCe
Confidence             6899999997 5999998764   49999999999999999999996        5999999999999995   67899


Q ss_pred             EEEecccccccCC-------cceeeccCccccCchhhcCC------CCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          256 KIIDFGSACTEDR-------TVYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       256 KL~DFGlA~~~~~-------~~~~~~GT~~Y~APEvl~~~------~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      ||+|||++.....       .....+||+.|+|||++.+.      .++.++|||||||+||||+||.+||..
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            9999999964322       12346789999999998764      367899999999999999999988854

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-41  Score=366.55  Aligned_cols=194  Identities=20%  Similarity=0.262  Sum_probs=162.7

Q ss_pred             eEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeC--ChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEee-c
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-Q  184 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg---~~VAIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-~  184 (837)
                      +.+.++||+|+||+||+|++..++   ..||||++++  .....+++.+|+++|+++       .|||||++++++.. +
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~~~~  101 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLGICLRSE  101 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEEEETT
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-------CCCCEeEEeEEEEecC
Confidence            344688999999999999876543   4699999974  445567899999999998       68999999999775 4


Q ss_pred             ceEEEEEeccc-hhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCCCCeEEEEecccc
Q 003239          185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA  263 (837)
Q Consensus       185 ~~l~LVmEy~~-gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~IKL~DFGlA  263 (837)
                      +.+++|||||. ++|.+++... ...+++..+..++.||+.||.|||+.+|+||||||+||||+   +++.+||+|||++
T Consensus       102 ~~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~---~~~~~kL~DFG~~  177 (311)
T d1r0pa_         102 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA  177 (311)
T ss_dssp             TEEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSSGGG
T ss_pred             CceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC---CCCCEEEecccch
Confidence            68999999998 4777776544 35688899999999999999999999999999999999995   6789999999999


Q ss_pred             cccCCc-------ceeeccCccccCchhhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 003239          264 CTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG  315 (837)
Q Consensus       264 ~~~~~~-------~~~~~GT~~Y~APEvl~~~~yt~ksDIWSLG~ILyELltG~~PF~g  315 (837)
                      +.....       .....+|..|+|||++....++.++|||||||++|||++|..||..
T Consensus       178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence            754322       1234678999999999999999999999999999999997776654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=8.2e-23  Score=203.76  Aligned_cols=164  Identities=21%  Similarity=0.236  Sum_probs=117.6

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------------------hhHHHHHHHHHHHHHhhcccCCCCC
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------------------AYYQQALVEVSILTTLNKKYDREDK  171 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-------------------~~~~~~~~Ei~iL~~L~~~~~~~~H  171 (837)
                      +.+.++||+|+||+||+|++. +++.||||+++...                   .......+|...+.++       .|
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~   73 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-------QG   73 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-------TT
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-------cC
Confidence            457899999999999999874 68999999975311                   1122344577777777       46


Q ss_pred             CceeEEeEEEeecceEEEEEeccchhHHHHHHhhccCCCCHHHHHHHHHhHHHHHhhhhcCCeeeccCCCCCeeeeccCC
Q 003239          172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK  251 (837)
Q Consensus       172 pnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~L~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~  251 (837)
                      .+++..+++.    ..++||||+++...        ..+++..+..++.||+.+|+|||++||+||||||+|||++    
T Consensus        74 ~~v~~~~~~~----~~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----  137 (191)
T d1zara2          74 LAVPKVYAWE----GNAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----  137 (191)
T ss_dssp             SSSCCEEEEE----TTEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----
T ss_pred             CCcceEEEec----CCEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----
Confidence            7888877653    23799999986422        1255666788999999999999999999999999999996    


Q ss_pred             CCeEEEEecccccccCCcceeeccCccccCc--h---hhcCCCCCccchHHHHHHHH
Q 003239          252 PAEIKIIDFGSACTEDRTVYSYIQSRYYRSP--E---VLLGYQYTTAIDMWSFGCIV  303 (837)
Q Consensus       252 ~~~IKL~DFGlA~~~~~~~~~~~GT~~Y~AP--E---vl~~~~yt~ksDIWSLG~IL  303 (837)
                      +..++|+|||+|.........     .|...  +   ......|..++|+||+.--+
T Consensus       138 ~~~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         138 EEGIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTEEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            345999999999765432211     11110  0   01235788999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.10  E-value=6.7e-06  Score=82.81  Aligned_cols=80  Identities=11%  Similarity=0.018  Sum_probs=57.3

Q ss_pred             CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceE
Q 003239          109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL  187 (837)
Q Consensus       109 ~~Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l  187 (837)
                      ..|++++..+-++.+.||++.  .+++.++||+..... .....+.+|..+++.|..      +--+.+++.+...++..
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~------~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG------KLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT------TSCCCCEEEEEEETTEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc------cCCCCcEEEEEecCCce
Confidence            567777766656668999884  345567788876432 223456789999998853      23367778888888899


Q ss_pred             EEEEeccch
Q 003239          188 CICFELLDS  196 (837)
Q Consensus       188 ~LVmEy~~g  196 (837)
                      ++||++++|
T Consensus        86 ~lv~~~l~G   94 (263)
T d1j7la_          86 NLLMSEADG   94 (263)
T ss_dssp             EEEEECCSS
T ss_pred             EEEEEeccc
Confidence            999999986

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.73  E-value=6.5e-05  Score=81.16  Aligned_cols=77  Identities=19%  Similarity=0.225  Sum_probs=50.3

Q ss_pred             EEEeccCCceeEEEeeccCCCeEEEEEEEeCC--------hhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecc
Q 003239          114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR  185 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~--------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~  185 (837)
                      .+.||.|....||++.+..+++.|+||.-...        .....+...|.++|+.+...    ....+.+++.+  +.+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~----~p~~vP~v~~~--d~~  104 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH----VPHLVPRVFYS--DTE  104 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTT----CGGGSCCEEEE--ETT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhh----CCCCcceEEEE--cCC
Confidence            45689999999999988888888999975321        11234566799999888542    11245666654  445


Q ss_pred             eEEEEEeccch
Q 003239          186 HLCICFELLDS  196 (837)
Q Consensus       186 ~l~LVmEy~~g  196 (837)
                      ..++|||++.+
T Consensus       105 ~~~lvmE~L~~  115 (392)
T d2pula1         105 MAVTVMEDLSH  115 (392)
T ss_dssp             TTEEEECCCTT
T ss_pred             CCEEEEeccCC
Confidence            66899999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.48  E-value=0.00013  Score=72.52  Aligned_cols=73  Identities=10%  Similarity=-0.045  Sum_probs=51.9

Q ss_pred             EeccCC-ceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecceEEEEEecc
Q 003239          116 LLGHGT-FGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL  194 (837)
Q Consensus       116 ~LG~G~-fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~  194 (837)
                      .+..|. -+.||++.. ..+..+++|+.....  ...+..|..+|+.|...     .-.+.+++.+..+.+..++|||++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~-----gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATT-----GVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTT-----TCCBCCEEEEEECSSCEEEEEECC
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhc-----CCCCCceeeecccccceEEEEEee
Confidence            344454 468999864 446668889876543  23467799999988653     223777888888888999999999


Q ss_pred             ch
Q 003239          195 DS  196 (837)
Q Consensus       195 ~g  196 (837)
                      +|
T Consensus        89 ~G   90 (255)
T d1nd4a_          89 PG   90 (255)
T ss_dssp             SS
T ss_pred             ec
Confidence            75

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.87  E-value=0.0013  Score=68.59  Aligned_cols=72  Identities=17%  Similarity=0.023  Sum_probs=46.3

Q ss_pred             ceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEE--eEEEeecceEEEEEeccch
Q 003239          122 FGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRI--YEYFVCQRHLCICFELLDS  196 (837)
Q Consensus       122 fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl--~d~f~~~~~l~LVmEy~~g  196 (837)
                      -..||++.. ++|+.|++|+.+......+++..|+..+..|...-..  .+..+..  -..+...+..+.|++++.|
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gip--v~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVP--VAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCS--BCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCC--CCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            358999965 5678899999986554567788899999999754111  1111111  0123345678888998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.70  E-value=0.0017  Score=69.46  Aligned_cols=72  Identities=19%  Similarity=0.187  Sum_probs=49.3

Q ss_pred             EEEeccCCceeEEEeeccC-------CCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcccCCCCCCceeEEeEEEeecce
Q 003239          114 KDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH  186 (837)
Q Consensus       114 ~~~LG~G~fG~Vyka~~~~-------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~  186 (837)
                      ++.|+.|-.-.+|++....       ..+.|.+++.-.... .....+|..+++.+...      .-..+++.++..   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~idr~~E~~i~~~ls~~------gl~Pkll~~~~~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSER------HLGPKLYGIFSG---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHT------TSSSCEEEEETT---
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hhHHHHHHHHHHHHHhC------CCCCeEEEEcCC---
Confidence            3568888889999986542       346788888764333 34566899999998642      224577777653   


Q ss_pred             EEEEEeccch
Q 003239          187 LCICFELLDS  196 (837)
Q Consensus       187 l~LVmEy~~g  196 (837)
                       .+||||+.|
T Consensus       117 -g~I~efi~g  125 (395)
T d1nw1a_         117 -GRLEEYIPS  125 (395)
T ss_dssp             -EEEECCCCE
T ss_pred             -ceEEEEecc
Confidence             578899875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.07  E-value=0.019  Score=58.54  Aligned_cols=52  Identities=6%  Similarity=-0.008  Sum_probs=31.8

Q ss_pred             eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHhhcc
Q 003239          111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK  165 (837)
Q Consensus       111 Y~i~~~LG~G~fG~Vyka~~~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~  165 (837)
                      ..-.+.|..|---+.|+++.. .+ .+++|++.... ..+.+..|++++..|...
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~   71 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAK   71 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHT
T ss_pred             ceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhc
Confidence            344566778888889998643 34 48899986432 234556688888888764